data_1q56_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q56 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.571 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.6 pt-20 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.243 0.544 . . . . 1.0 110.531 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -95.35 136.95 35.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.662 -1.274 . . . . 1.0 110.766 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.468 HG21 ' O ' ' A' ' 190' ' ' LEU . 8.9 mm -127.43 118.16 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.278 -0.888 . . . . 1.0 109.702 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -80.76 142.46 33.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 1.0 111.216 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.597 ' CD1' HD13 ' A' ' 167' ' ' ILE . 9.1 m-85 -106.6 172.07 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 1.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.467 ' C ' HG12 ' A' ' 164' ' ' ILE . 3.8 p30 -127.32 -3.62 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 1.0 110.637 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.482 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 110.17 -9.8 31.34 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.85 -1.7 . . . . 1.0 108.85 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -127.72 -24.95 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -1.186 . . . . 1.0 110.773 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 133.76 37.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 1.0 110.369 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.618 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -128.17 114.55 17.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 1.0 110.365 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.527 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 6.0 mmt -83.23 99.07 9.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.85 -1.156 . . . . 1.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.59 ' HG3' ' CH2' ' A' ' 142' ' ' TRP . 46.8 tt0 -87.77 87.98 7.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 1.0 109.456 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.559 ' CD1' ' HB3' ' A' ' 182' ' ' ASP . 8.0 m-30 -92.18 97.03 10.65 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 1.0 110.236 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.15 104.39 16.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 1.0 110.007 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 138' ' ' ASP . 1.4 t-20 -147.36 162.97 37.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 1.0 110.338 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.69 50.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 1.0 110.376 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.457 HG13 ' HG3' ' A' ' 175' ' ' GLN . 4.6 m . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.271 -0.893 . . . . 1.0 110.907 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' A' ' 40' ' ' SER . 2.5 tm0? . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.667 0.746 . . . . 1.0 109.809 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.41 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -160.72 146.22 14.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.732 -0.605 . . . . 1.0 109.467 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.609 ' ND2' ' N ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -133.23 155.28 49.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.049 -1.032 . . . . 1.0 111.597 -178.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 8.8 m-70 -114.67 143.97 44.18 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 58.4 m-85 -129.02 121.76 28.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.097 -1.002 . . . . 1.0 110.644 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 2.8 mt-10 -127.92 147.24 50.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.014 -1.054 . . . . 1.0 109.928 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.573 ' HB2' ' CG1' ' A' ' 170' ' ' VAL . 1.3 pt? 179.89 150.22 0.36 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.759 . . . . 1.0 110.548 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.479 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 1.9 m -120.17 154.07 35.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.497 HG23 HD13 ' A' ' 47' ' ' ILE . 1.5 pt -147.49 155.09 10.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.824 -1.55 . . . . 1.0 112.86 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.645 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -112.61 82.68 1.69 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 176.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.2 OUTLIER -70.19 163.63 25.98 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.867 -1.146 . . . . 1.0 111.289 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 0.8 OUTLIER -145.39 29.84 1.14 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.299 -0.96 . . . . 1.0 110.845 -178.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.616 ' O ' ' CG2' ' A' ' 52' ' ' THR . . . -162.24 -96.68 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.943 -1.103 . . . . 1.0 110.324 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.616 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 176.07 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.431 0.634 . . . . 1.0 109.824 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.498 ' HG3' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -119.23 138.77 52.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.43 -0.794 . . . . 1.0 110.61 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.81 135.77 1.89 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.255 -1.938 . . . . 1.0 108.255 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -84.87 131.68 34.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.743 -1.445 . . . . 1.0 109.552 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.592 HD11 ' HA ' ' A' ' 72' ' ' ALA . 4.6 mp -95.75 -40.28 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 1.0 112.714 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 7.1 tt -141.13 148.36 39.95 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.254 -1.529 . . . . 1.0 113.652 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.633 ' CH2' ' CG2' ' A' ' 151' ' ' VAL . 7.3 t-105 -152.02 129.06 11.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.73 163.28 32.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.654 -1.279 . . . . 1.0 110.307 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 110.119 -1.192 . . . . 1.0 110.119 179.834 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 8.5 m-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mt -112.54 130.76 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.54 -1.35 . . . . 1.0 109.916 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.587 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -153.74 174.57 14.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 1.0 110.717 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 79.0 mt -146.22 110.4 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -129.98 164.38 24.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 1.0 112.466 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.577 HG13 ' CD1' ' A' ' 56' ' ' ILE . 9.3 mt -102.59 136.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.639 -0.663 . . . . 1.0 110.678 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.514 HG11 ' CZ ' ' A' ' 92' ' ' ARG . 4.0 p -140.63 131.44 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.157 -0.965 . . . . 1.0 110.806 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 7.4 m-20 63.8 8.79 4.0 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.352 -0.842 . . . . 1.0 111.032 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 104.56 13.73 25.4 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 35.8 m-85 -135.53 152.73 51.6 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.29 -1.124 . . . . 1.0 109.976 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.541 ' CG1' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -92.44 166.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 1.0 109.46 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 8.5 pt20 -164.12 126.39 2.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.094 -1.003 . . . . 1.0 110.936 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.576 ' CE ' ' O ' ' A' ' 115' ' ' SER . 1.0 OUTLIER -86.53 103.24 14.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.587 ' HE3' ' CB ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -104.78 119.39 38.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -0.751 . . . . 1.0 110.433 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.655 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 3.7 p90 -141.24 143.65 34.26 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.008 -1.477 . . . . 1.0 111.455 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 16.9 t0 -136.27 108.51 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.698 0.761 . . . . 1.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -110.39 30.4 6.81 Favored 'General case' 0 C--N 1.287 -2.122 0 O-C-N 121.723 -0.61 . . . . 1.0 109.852 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 86' ' ' SER . . . -164.21 -50.86 0.02 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 1.4 t 178.18 -18.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -1.11 . . . . 1.0 111.471 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 17.5 mmtt -119.51 117.86 32.63 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.724 -1.235 . . . . 1.0 110.662 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.07 143.92 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.877 1.462 . . . . 1.0 109.236 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.626 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.77 104.47 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 1.0 109.075 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.581 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 8.7 p -91.1 82.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.483 -1.385 . . . . 1.0 111.261 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.579 ' CA ' HG23 ' A' ' 124' ' ' ILE . 5.6 mt -75.02 74.51 2.21 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 14.3 mtp180 -59.16 178.88 0.11 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.929 0.871 . . . . 1.0 111.213 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.475 ' OG ' HG22 ' A' ' 118' ' ' VAL . 2.0 t -109.97 143.12 40.38 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.4 m -99.82 31.16 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.124 -0.985 . . . . 1.0 109.93 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.55 HG13 ' CG1' ' A' ' 118' ' ' VAL . 3.0 t -136.27 145.89 53.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 1.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.533 ' HD2' HG11 ' A' ' 95' ' ' VAL . 40.1 Cg_endo -65.2 134.48 39.44 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.612 1.322 . . . . 1.0 110.751 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 98' ' ' ASN . 2.6 tp -117.6 -24.5 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 1.0 110.581 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 97' ' ' ILE . 8.4 p-10 -76.37 55.95 1.03 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.889 . . . . 1.0 109.177 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.451 ' O ' ' CG2' ' A' ' 99' ' ' THR . 24.2 m -110.89 14.62 22.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.485 -0.76 . . . . 1.0 110.588 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.67 18.76 0.77 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.08 -1.013 . . . . 1.0 110.624 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.439 ' HB2' HG22 ' A' ' 99' ' ' THR . 1.9 m-70 -117.32 162.95 17.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.129 -0.982 . . . . 1.0 110.378 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.645 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 16.5 m95 -76.74 101.64 5.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.149 -0.969 . . . . 1.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.519 HG21 ' N ' ' A' ' 104' ' ' HIS . 49.4 m -94.99 165.33 12.49 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.576 -0.85 . . . . 1.0 109.498 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.519 ' N ' HG21 ' A' ' 103' ' ' THR . 1.0 OUTLIER -118.06 136.82 53.32 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.485 HD12 HD12 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -135.31 155.83 37.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.052 -1.03 . . . . 1.0 108.953 -178.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -152.53 174.5 13.84 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.12 -1.432 . . . . 1.0 110.498 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -161.23 123.97 3.15 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.328 -0.949 . . . . 1.0 111.214 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.495 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 24.6 m-85 -105.24 106.68 17.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.52 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -105.98 117.7 34.7 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.319 -0.952 . . . . 1.0 111.67 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.518 ' CG1' ' OE1' ' A' ' 111' ' ' GLN . 1.8 t -118.6 134.52 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.536 ' N ' ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 29.74 -90.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.675 -0.641 . . . . 1.0 112.047 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.508 ' HD3' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -115.14 -14.78 11.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 1.0 112.138 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.59 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.7 tt0 -98.97 118.38 35.61 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.83 -1.169 . . . . 1.0 110.914 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.01 171.53 18.99 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.32 -0.943 . . . . 1.0 111.034 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.576 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -147.45 160.89 42.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.586 -0.95 . . . . 1.0 110.206 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.537 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -148.87 141.99 24.94 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.268 -0.895 . . . . 1.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.537 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -143.78 130.51 20.27 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.076 -1.05 . . . . 1.0 111.233 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.55 ' CG1' HG13 ' A' ' 95' ' ' VAL . 2.2 t -89.65 97.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.627 -1.62 . . . . 1.0 106.627 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 71.48 40.51 59.69 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.94 31.99 17.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.059 . . . . 1.0 110.497 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.529 ' N ' ' HG2' ' A' ' 117' ' ' GLN . 2.9 mt-10 -105.08 -158.18 0.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 1.0 110.619 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.34 99.9 0.19 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.664 -0.648 . . . . 1.0 110.013 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 48.5 Cg_endo -75.73 135.47 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.154 1.607 . . . . 1.0 111.363 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 124' ' ' ILE . 1.5 mp -103.49 119.52 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -118.35 172.21 7.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.822 -1.174 . . . . 1.0 112.658 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.437 ' HA3' HD23 ' A' ' 91' ' ' LEU . . . -179.68 153.98 12.99 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.694 -2.163 . . . . 1.0 107.694 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.59 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -138.26 161.93 35.62 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.006 -1.291 . . . . 1.0 110.986 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 m -89.94 163.58 31.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.764 . . . . 1.0 109.684 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -68.83 62.36 1.28 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.006 1.53 . . . . 1.0 109.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.518 ' HG ' ' C ' ' A' ' 129' ' ' PRO . 1.2 pp 16.55 50.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.376 0.608 . . . . 1.0 112.366 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -99.95 2.66 56.9 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.668 -1.373 . . . . 1.0 109.668 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 84' ' ' LEU . . . -161.85 84.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -1.109 . . . . 1.0 109.651 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 133' ' ' THR . 91.2 m -87.92 11.5 15.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 1.0 110.624 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.424 ' HG3' ' C ' ' A' ' 133' ' ' THR . 86.3 mt-30 -144.23 92.08 2.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 1.0 110.632 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.71 160.21 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 1.0 109.598 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -130.65 111.53 12.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.928 -1.107 . . . . 1.0 110.774 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 t -136.18 149.25 48.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -0.885 . . . . 1.0 109.847 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.545 ' OD1' ' CB ' ' A' ' 140' ' ' ALA . 5.5 p-10 -87.68 29.17 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 1.0 110.671 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 58.69 13.61 18.62 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.545 ' CB ' ' OD1' ' A' ' 138' ' ' ASP . . . -57.77 170.22 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 1.0 108.516 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 142' ' ' TRP . 0.2 OUTLIER -160.88 145.94 14.2 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.276 -1.37 . . . . 1.0 112.026 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.59 ' CH2' ' HG3' ' A' ' 26' ' ' GLU . 49.6 m95 -135.08 119.13 17.5 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.268 -1.752 . . . . 1.0 106.268 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 1.7 tt -130.93 123.46 28.94 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.334 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.87 2.17 10.42 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.503 ' HA2' HD22 ' A' ' 55' ' ' LEU . . . 141.58 -139.28 9.3 Favored Glycine 0 C--N 1.293 -1.828 0 C-N-CA 118.991 -1.576 . . . . 1.0 109.726 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.692 ' CB ' HD12 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -170.74 130.86 0.84 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.948 -1.101 . . . . 1.0 112.178 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -64.99 -42.65 94.34 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -113.14 67.95 0.67 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.975 -1.491 . . . . 1.0 106.975 177.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.692 HD12 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -66.32 37.78 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.194 -0.941 . . . . 1.0 113.403 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 148' ' ' ARG . 53.4 p -83.8 3.39 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 175.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.633 ' CG2' ' CH2' ' A' ' 58' ' ' TRP . 14.9 p -86.59 -23.87 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.308 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 153' ' ' HIS . . . -41.82 -26.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 1.0 109.508 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.56 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER 83.38 -85.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.965 -0.459 . . . . 1.0 111.245 179.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -143.91 -7.17 0.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 1.0 111.776 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.615 HD12 ' CD1' ' A' ' 159' ' ' TYR . 4.2 pp -53.65 167.07 0.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.108 -0.995 . . . . 1.0 110.377 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.543 ' O ' ' CD1' ' A' ' 155' ' ' LEU . 42.7 Cg_endo -68.96 -165.67 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.734 1.386 . . . . 1.0 112.278 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.5 ' O ' ' C ' ' A' ' 158' ' ' ALA . 1.5 mttp -56.25 -9.97 0.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.189 -0.944 . . . . 1.0 112.171 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -38.2 -44.36 0.85 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 1.0 109.784 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.642 ' CE1' ' CB ' ' A' ' 72' ' ' ALA . 6.0 m-85 -87.87 -27.07 22.44 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.989 -1.084 . . . . 1.0 108.748 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -73.17 -6.59 46.78 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.435 -1.306 . . . . 1.0 107.981 177.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 162' ' ' GLY . 4.4 m -122.2 83.91 2.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.67 171.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.645 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 6.2 t80 -89.55 144.23 26.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -1.218 . . . . 1.0 111.391 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.567 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 5.9 mt -123.2 91.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.645 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -169.63 -154.07 8.97 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.48 -1.848 . . . . 1.0 108.48 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.546 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 2.9 m -124.09 144.56 49.8 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.204 -1.174 . . . . 1.0 110.516 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.597 HD13 ' CD1' ' A' ' 19' ' ' PHE 0.251 3.4 mt -134.1 145.59 32.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.534 -0.729 . . . . 1.0 109.425 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 6.5 ttp180 -162.0 157.25 23.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.69 -1.256 . . . . 1.0 111.023 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 4.2 m-20 57.37 63.49 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 27.1 m -119.58 117.82 55.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.937 0.875 . . . . 1.0 109.653 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.5 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.5 OUTLIER -135.6 155.9 37.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.09 -1.044 . . . . 1.0 110.915 -178.072 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 3.6 p -134.74 112.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 94.6 m-20 59.04 37.49 24.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.24 32.59 14.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.764 -0.585 . . . . 1.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 176' ' ' GLU . 19.4 mm100 -118.45 176.16 5.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.186 -0.946 . . . . 1.0 110.44 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.571 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 59.5 mm-40 65.18 -121.35 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 1.0 110.756 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 178' ' ' HIS . 0.1 OUTLIER 57.62 7.31 0.52 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.866 . . . . 1.0 112.205 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 176' ' ' GLU . 15.3 m-70 -110.14 56.53 0.62 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.545 -1.347 . . . . 1.0 108.538 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.553 ' O ' ' CB ' ' A' ' 183' ' ' ALA 0.261 12.3 mt -28.24 -61.45 0.11 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.966 0.889 . . . . 1.0 112.839 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.526 HG13 HD12 ' A' ' 184' ' ' LEU . 2.2 t -77.29 -20.28 14.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 113.367 0.877 . . . . 1.0 113.367 -176.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.565 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.1 mm-40 -63.46 -48.6 77.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.228 -1.545 . . . . 1.0 110.803 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.559 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.43 -12.12 20.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.155 -0.966 . . . . 1.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -70.09 -33.71 72.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.018 -1.052 . . . . 1.0 108.738 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 180' ' ' VAL . 1.2 mp -48.63 -23.66 1.09 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.795 . . . . 1.0 109.075 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -59.43 -16.52 24.02 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.875 0.845 . . . . 1.0 109.02 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.497 ' CG ' ' CD ' ' A' ' 187' ' ' PRO . 20.1 t30 -89.1 172.31 7.63 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.497 ' CD ' ' CG ' ' A' ' 186' ' ' ASN . 44.8 Cg_endo -87.73 -48.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.187 1.098 . . . . 1.0 111.357 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -118.31 145.87 44.76 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.427 -0.796 . . . . 1.0 111.115 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.34 130.29 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 1.0 110.208 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.468 ' O ' HG21 ' A' ' 17' ' ' ILE . 4.4 mt -115.62 169.13 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -110.6 -82.23 0.58 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.094 -1.004 . . . . 1.0 111.23 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 O-C-N 121.033 -1.042 . . . . 1.0 111.044 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.591 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.4 pt-20 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.409 0.623 . . . . 1.0 110.948 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.589 ' O ' ' CD2' ' A' ' 191' ' ' HIS . . . -85.17 140.98 30.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.402 -1.436 . . . . 1.0 109.302 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.571 HD11 ' CE1' ' A' ' 191' ' ' HIS . 21.9 mm -111.52 122.71 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.694 -1.203 . . . . 1.0 110.788 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.32 122.05 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.369 -0.832 . . . . 1.0 110.093 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.623 ' CZ ' HD12 ' A' ' 167' ' ' ILE . 4.6 m-85 -94.27 140.23 30.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 1.0 110.023 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -107.95 -7.66 16.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 1.0 110.214 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 162' ' ' GLY . . . 114.64 -11.83 21.06 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -124.06 -1.74 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.861 -1.376 . . . . 1.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.27 110.03 22.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.985 -1.072 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 5.4 p90 -100.17 156.09 17.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.177 -0.952 . . . . 1.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.586 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 3.4 mmt -122.16 100.32 6.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.154 -1.018 . . . . 1.0 110.341 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.596 ' HB3' ' CZ3' ' A' ' 142' ' ' TRP . 1.3 pp20? -78.36 106.08 10.04 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 44.2 m-85 -101.11 98.51 8.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.912 -1.118 . . . . 1.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -93.03 102.15 14.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 1.0 109.692 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -121.61 138.64 54.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 1.0 110.184 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -86.11 95.56 9.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 1.0 109.842 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' A' ' 138' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 1.0 110.534 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.802 0.334 . . . . 1.0 110.311 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -143.0 178.42 7.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.149 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.407 ' N ' ' OG ' ' A' ' 40' ' ' SER . 30.2 m120 -119.69 156.05 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 1.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 7.7 m80 -119.24 117.34 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 1.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.517 ' C ' ' HG3' ' A' ' 44' ' ' GLU . 21.2 m-85 -112.28 120.25 41.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.694 . . . . 1.0 110.234 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.587 ' HA ' ' HG2' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -130.19 139.98 50.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.858 -1.151 . . . . 1.0 111.322 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 1.2 pt? -176.59 150.76 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 1.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.424 ' C ' HG21 ' A' ' 47' ' ' ILE . 5.2 m -120.34 146.47 46.11 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 166' ' ' CYS . 0.9 OUTLIER -127.69 -170.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.126 -1.43 . . . . 1.0 111.261 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.626 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.7 OUTLIER -153.16 136.77 15.99 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.014 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.601 ' O ' ' O ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER 52.68 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.51 -1.369 . . . . 1.0 109.238 -177.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.533 ' OE2' ' CG2' ' A' ' 73' ' ' ILE . 15.1 tt0 -173.87 22.63 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.305 -1.497 . . . . 1.0 110.283 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.575 ' HB1' ' CG2' ' A' ' 164' ' ' ILE . . . 45.93 -114.68 0.49 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.681 -1.208 . . . . 1.0 109.201 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.54 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 18.3 p -155.17 -40.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.002 -1.061 . . . . 1.0 109.583 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -122.66 131.33 53.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.415 -0.803 . . . . 1.0 109.647 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 168.07 138.3 2.43 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.439 -1.362 . . . . 1.0 109.885 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.773 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -88.97 124.41 34.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.971 -1.311 . . . . 1.0 109.005 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 143' ' ' LEU . 0.5 OUTLIER -91.3 -27.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.423 0.897 . . . . 1.0 113.423 -176.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.667 ' CB ' ' HB2' ' A' ' 71' ' ' LEU . 1.7 tt -143.32 151.69 40.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 119.85 -1.781 . . . . 1.0 113.089 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' A' ' 58' ' ' TRP . 5.3 t-105 -160.22 106.93 1.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.403 0.621 . . . . 1.0 109.604 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.491 ' HB2' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -121.43 155.61 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 1.0 109.08 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.62 ' HA2' ' CG ' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.333 0 C-N-CA 118.725 -1.702 . . . . 1.0 111.749 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.663 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 110.776 -0.083 . . . . 1.0 110.776 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.546 ' HA ' ' CB ' ' A' ' 82' ' ' TYR . 8.9 pt -158.46 153.43 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.42 -0.8 . . . . 1.0 111.171 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.599 ' CB ' ' CE ' ' A' ' 81' ' ' MET . . . -166.14 174.55 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.494 -0.754 . . . . 1.0 109.079 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.667 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 95.9 mt -150.91 134.28 16.22 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.925 -1.109 . . . . 1.0 108.165 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.773 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -146.87 179.55 7.51 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.032 -1.042 . . . . 1.0 112.652 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.557 ' CA ' ' OE1' ' A' ' 79' ' ' GLN . 2.5 mt -133.27 139.37 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.717 -0.614 . . . . 1.0 111.623 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.58 HG22 ' NE2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -140.42 131.54 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.274 -0.891 . . . . 1.0 109.224 178.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 1.5 m-20 69.29 9.73 7.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.138 -0.976 . . . . 1.0 111.036 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 96.75 16.38 36.57 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.098 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.527 ' O ' ' CG2' ' A' ' 73' ' ' ILE . 90.6 m-85 -130.05 159.65 36.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -1.097 . . . . 1.0 109.32 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.533 HG12 ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -102.57 164.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.185 -0.947 . . . . 1.0 111.824 -178.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.58 ' NE2' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -160.52 130.88 5.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.383 0.611 . . . . 1.0 110.413 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.553 ' CE ' ' O ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -92.69 115.95 28.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.049 . . . . 1.0 109.571 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.599 ' CE ' ' CB ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.61 122.05 43.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.284 -0.885 . . . . 1.0 109.805 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.674 ' CE2' ' CG1' ' A' ' 89' ' ' VAL . 15.9 p90 -140.73 144.98 35.85 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.561 -1.256 . . . . 1.0 111.351 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 86' ' ' SER . 0.1 OUTLIER -141.19 108.3 5.47 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.35 1.072 . . . . 1.0 109.652 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.54 34.49 3.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.436 -0.802 . . . . 1.0 109.897 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -168.34 -41.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.6 OUTLIER 165.63 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.291 -1.123 . . . . 1.0 111.146 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.432 ' HD3' ' HG3' ' A' ' 129' ' ' PRO . 13.1 mtpt -121.18 116.98 30.83 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.831 -1.168 . . . . 1.0 110.572 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.5 ' N ' ' HB2' ' A' ' 83' ' ' ASP . 45.3 Cg_endo -75.62 160.63 37.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.928 1.488 . . . . 1.0 110.676 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.674 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -133.05 107.01 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 108.749 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 1.8 p -95.89 123.94 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.455 -1.403 . . . . 1.0 111.242 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.548 ' CB ' HG22 ' A' ' 124' ' ' ILE . 0.7 OUTLIER -113.58 84.58 2.04 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.513 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 30.9 mtp180 -59.65 178.01 0.18 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.239 -0.984 . . . . 1.0 111.266 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.497 ' OG ' HG21 ' A' ' 118' ' ' VAL . 2.9 t -101.78 159.03 15.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.512 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.18 24.61 12.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 1.0 109.522 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG11 ' N ' ' A' ' 96' ' ' PRO . 1.3 t -147.22 154.67 46.25 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 1.0 109.429 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.539 ' N ' HG11 ' A' ' 95' ' ' VAL . 38.3 Cg_endo -64.25 134.5 42.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.77 1.405 . . . . 1.0 109.715 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -114.15 -31.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 1.0 111.048 -178.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.461 ' CA ' ' HB3' ' A' ' 50' ' ' GLU . 12.6 p30 -82.16 47.88 1.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.968 -1.082 . . . . 1.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.505 ' O ' ' CG2' ' A' ' 99' ' ' THR . 2.0 m -87.59 6.55 33.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 110.906 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 99' ' ' THR . 0.6 OUTLIER 66.7 7.43 5.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 111.538 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.483 ' HB2' HG22 ' A' ' 99' ' ' THR . 4.2 m80 -112.53 173.63 6.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.896 -1.128 . . . . 1.0 110.366 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.626 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 2.6 m95 -75.98 88.37 2.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 1.0 109.967 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 104' ' ' HIS . 7.7 m -79.75 172.25 14.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.047 -1.033 . . . . 1.0 109.579 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.535 ' N ' ' CG2' ' A' ' 103' ' ' THR . 0.7 OUTLIER -123.19 119.84 31.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.519 HD13 ' CG2' ' A' ' 47' ' ' ILE . 1.6 mp -118.28 142.71 31.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.73 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 mttp -153.7 178.99 9.26 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.305 -1.358 . . . . 1.0 109.391 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 43' ' ' PHE . . . -164.9 158.37 17.14 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.625 -1.23 . . . . 1.0 111.629 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.36 103.93 5.44 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -91.24 117.88 30.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 1.0 109.785 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 111' ' ' GLN . 20.6 t -114.88 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.078 -1.014 . . . . 1.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.504 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 9.9 tt0 60.1 -92.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 1.0 110.236 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.566 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -111.4 -21.23 11.92 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 1.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.621 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 6.2 tt0 -92.22 108.27 19.83 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.966 0.889 . . . . 1.0 111.11 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -94.75 165.7 25.92 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 120.34 -0.933 . . . . 1.0 110.854 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.553 ' O ' ' CE ' ' A' ' 80' ' ' MET . 16.2 t -146.48 156.88 43.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.259 -1.142 . . . . 1.0 110.73 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 2.7 tm? -123.1 146.9 47.32 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.095 -1.003 . . . . 1.0 108.859 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.73 ' HB3' ' CB ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -126.52 92.97 3.67 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.347 -0.845 . . . . 1.0 111.844 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.51 ' CG2' HD13 ' A' ' 116' ' ' LEU . 52.9 t -86.78 85.43 2.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.33 53.72 16.35 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.488 ' OD1' ' OE1' ' A' ' 117' ' ' GLN . 1.7 m-20 44.68 21.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.157 -1.202 . . . . 1.0 111.178 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.466 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -91.49 -176.37 4.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 1.0 109.813 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -41.12 100.46 0.22 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 1.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 121' ' ' GLU . 41.1 Cg_endo -67.91 134.8 33.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.228 1.646 . . . . 1.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.548 HG22 ' CB ' ' A' ' 91' ' ' LEU . 1.5 mp -97.95 115.18 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 12.2 p -120.25 174.48 6.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.072 -1.017 . . . . 1.0 112.181 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 114' ' ' GLY . . . -178.72 163.36 31.11 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.253 -2.339 . . . . 1.0 107.253 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -140.82 169.84 16.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.581 -1.54 . . . . 1.0 111.153 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.68 166.65 12.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.243 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.549 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.4 Cg_endo -66.94 89.92 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.779 1.41 . . . . 1.0 108.51 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -14.5 131.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.214 0.53 . . . . 1.0 112.111 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 130.43 55.92 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -103.84 -122.31 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -1.125 . . . . 1.0 109.926 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 135' ' ' LEU . 13.1 t -167.79 59.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.71 -1.244 . . . . 1.0 110.279 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 135' ' ' LEU . 11.3 mm-40 54.96 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 133' ' ' THR . 0.2 OUTLIER 66.46 97.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 1.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.3 m-20 -69.28 178.96 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 1.0 109.723 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -153.08 105.77 2.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 1.0 109.805 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.552 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 1.9 p30 164.04 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.646 -0.659 . . . . 1.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -38.54 -44.31 1.73 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -164.87 162.75 21.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 1.0 110.257 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.533 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 14.7 tp -145.41 146.03 31.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 1.0 109.976 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.604 ' CG ' ' HE1' ' A' ' 146' ' ' MET . 37.1 m95 -135.81 131.36 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.575 ' CD1' ' O ' ' A' ' 56' ' ' ILE . 5.4 tp -133.21 122.22 23.65 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.177 -1.409 . . . . 1.0 112.698 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 119.51 16.27 5.16 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.862 -1.295 . . . . 1.0 109.862 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.547 ' HA2' HD22 ' A' ' 55' ' ' LEU . . . 130.05 -137.54 9.6 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 119.099 -1.524 . . . . 1.0 109.919 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.745 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -168.05 134.38 2.01 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.846 -0.741 . . . . 1.0 110.388 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -47.45 -20.58 0.24 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.448 -0.782 . . . . 1.0 110.856 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.595 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -157.51 85.94 0.93 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.745 ' CD1' ' HB2' ' A' ' 146' ' ' MET . 0.2 OUTLIER -78.8 38.17 0.32 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.555 -1.341 . . . . 1.0 112.772 -177.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 151' ' ' VAL . 1.9 p -54.26 -26.37 28.59 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 104.55 -2.389 . . . . 1.0 104.55 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 152' ' ' ALA 0.282 7.7 p -59.28 -132.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.297 -1.32 . . . . 1.0 108.807 177.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 159' ' ' TYR . . . 65.21 -67.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.136 -0.978 . . . . 1.0 109.544 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 151' ' ' VAL . 18.9 m170 38.16 -74.84 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.427 1.269 . . . . 1.0 114.427 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -52.6 -3.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.576 1.324 . . . . 1.0 114.576 -176.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.595 HD12 ' CD1' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -146.51 175.54 2.67 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 119.79 -1.819 . . . . 1.0 111.833 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 50.3 Cg_endo -77.51 -161.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.868 1.712 . . . . 1.0 113.809 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.1 OUTLIER -43.77 -20.7 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.365 -0.834 . . . . 1.0 113.071 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.549 ' CB ' HD12 ' A' ' 155' ' ' LEU . . . -36.77 -43.33 0.42 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.093 -1.004 . . . . 1.0 109.357 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.598 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 5.5 m-85 -89.27 -27.52 20.51 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.124 -0.985 . . . . 1.0 109.543 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -72.26 -7.87 51.76 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.225 -1.39 . . . . 1.0 107.407 177.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.511 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -130.84 98.51 4.64 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 21' ' ' GLY . . . -49.81 -175.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.597 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 44.6 t80 -67.58 152.77 45.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -1.135 . . . . 1.0 112.056 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.575 ' CG2' ' HB1' ' A' ' 51' ' ' ALA . 1.3 mp -131.57 80.38 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.846 0.831 . . . . 1.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.597 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.67 -161.23 20.92 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 106.778 -2.529 . . . . 1.0 106.778 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 48' ' ' LYS . 3.4 m -125.19 143.81 50.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.84 -1.388 . . . . 1.0 109.597 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.623 HD12 ' CZ ' ' A' ' 19' ' ' PHE . 3.3 mt -124.0 156.77 31.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.749 -1.219 . . . . 1.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.567 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -167.47 152.56 7.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.883 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.524 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 17.4 m-20 56.11 64.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.115 -0.991 . . . . 1.0 110.426 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 24.3 m -116.64 133.1 64.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.528 ' HA ' ' HG3' ' A' ' 176' ' ' GLU . 1.0 OUTLIER -148.64 155.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.425 -1.31 . . . . 1.0 110.969 -176.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 13.4 t -132.82 91.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 8.0 m-20 57.05 46.26 19.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.862 -1.149 . . . . 1.0 108.023 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 72.26 31.79 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.257 0.551 . . . . 1.0 110.375 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 34.2 mt-30 -108.42 176.06 5.25 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.3 -0.875 . . . . 1.0 110.076 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 177' ' ' LEU . 6.9 pt-20 44.09 -114.66 0.38 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.365 -0.209 . . . . 1.0 110.912 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.58 ' CB ' ' O ' ' A' ' 176' ' ' GLU . 8.6 tp 78.77 -59.24 0.41 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.35 -0.844 . . . . 1.0 110.375 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 4.8 m-70 -68.98 70.63 0.21 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.085 . . . . 1.0 109.288 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 183' ' ' ALA 0.255 3.7 mp -44.1 -61.53 1.44 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.689 0.756 . . . . 1.0 112.087 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 15' ' ' GLU . 94.5 t -68.29 -9.7 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.233 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 11.0 mt-10 -74.61 -62.09 1.65 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.699 -1.251 . . . . 1.0 110.012 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.599 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 8.2 m-20 -83.03 -12.62 57.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.99 . . . . 1.0 109.183 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -72.74 -31.31 64.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 1.0 109.038 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER -59.94 -14.14 14.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 1.0 109.188 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -46.27 -25.79 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.311 -0.868 . . . . 1.0 109.462 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.519 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 1.5 t-20 -93.26 175.12 3.32 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 43.7 Cg_endo -84.44 -90.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 122.889 0.942 . . . . 1.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.403 ' C ' HG13 ' A' ' 189' ' ' ILE . 2.8 t -66.78 144.49 56.28 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.334 -0.854 . . . . 1.0 110.727 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.474 HD12 ' CD2' ' A' ' 184' ' ' LEU . 3.2 mt -126.89 117.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 1.0 109.689 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.655 ' CD1' ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -94.39 136.06 35.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 1.0 109.055 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 16' ' ' ALA . 9.7 m80 -114.72 149.16 37.26 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.089 -1.007 . . . . 1.0 110.126 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 166' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 1.0 110.051 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.756 0.788 . . . . 1.0 109.507 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -113.13 153.94 27.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 1.0 111.085 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 191' ' ' HIS . 0.8 OUTLIER -114.84 144.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 177.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -104.2 136.07 44.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.756 -1.215 . . . . 1.0 111.443 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 167' ' ' ILE . 6.6 m-85 -100.72 148.16 25.21 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -113.88 1.18 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 1.0 111.102 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.467 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 108.11 -18.13 34.03 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.396 -1.882 . . . . 1.0 108.396 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 42.02 3.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.932 . . . . 1.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -112.89 127.16 56.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.0 110.943 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.542 ' CG ' ' HG3' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -118.76 87.56 2.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.323 -0.86 . . . . 1.0 109.684 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.459 ' SD ' ' OH ' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -76.0 100.7 4.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.15 -0.969 . . . . 1.0 110.475 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 6.2 tt0 -79.43 90.32 5.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 4.2 m-30 -95.24 111.8 23.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.487 -0.885 . . . . 1.0 111.319 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -133.44 153.7 51.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 1.0 109.71 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.49 167.44 27.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.001 -1.062 . . . . 1.0 110.398 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.28 97.16 9.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 1.0 110.443 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 1.0 110.034 179.817 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.505 ' NE2' HG11 ' A' ' 110' ' ' VAL . 3.0 tm0? . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.641 0.734 . . . . 1.0 110.101 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.575 -0.703 . . . . 1.0 110.187 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.532 ' ND2' ' HG2' ' A' ' 109' ' ' ARG . 52.6 p-10 -108.52 149.41 28.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.175 -0.953 . . . . 1.0 110.666 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -123.41 125.65 45.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 1.0 109.42 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 m-85 -133.21 131.6 40.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.129 -0.982 . . . . 1.0 111.05 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 106' ' ' LYS . 6.7 mt-10 -137.9 140.61 40.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 1.0 110.404 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.9 OUTLIER 179.92 154.28 0.54 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.289 -0.882 . . . . 1.0 110.798 179.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.502 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -117.49 155.7 29.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.566 ' CD1' HD13 ' A' ' 105' ' ' ILE . 6.5 pt -149.16 176.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 1.0 112.802 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.615 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -130.92 83.22 2.1 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.483 ' OG1' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -67.04 152.14 46.34 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.127 0.965 . . . . 1.0 112.603 -176.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.645 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 11.0 mm-40 -141.92 1.03 1.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.396 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.24 124.86 11.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.973 -1.08 . . . . 1.0 110.187 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.526 ' CG2' ' HA2' ' A' ' 76' ' ' GLY . 17.8 p -59.96 -10.9 4.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.798 . . . . 1.0 110.796 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -128.35 130.11 47.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.063 . . . . 1.0 111.211 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 160.03 137.63 2.27 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -90.44 127.75 36.31 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.549 -1.559 . . . . 1.0 108.884 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.583 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.07 -40.04 12.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.449 -0.782 . . . . 1.0 112.2 -176.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.653 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 5.7 tt -142.79 139.11 30.86 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.092 -1.63 . . . . 1.0 113.693 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.564 ' O ' ' CD1' ' A' ' 58' ' ' TRP . 1.1 t-105 -145.32 106.35 4.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.281 -0.887 . . . . 1.0 108.661 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -121.65 -166.58 1.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.782 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.08 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.793 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' A' ' 83' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 122.051 0.929 . . . . 1.0 111.236 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -146.39 155.63 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.597 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HB2' ' CE ' ' A' ' 81' ' ' MET . . . -149.1 -175.79 5.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.946 -1.096 . . . . 1.0 111.033 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 61.1 mt -151.31 116.54 5.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -136.38 171.47 14.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.749 -1.219 . . . . 1.0 111.764 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 45.7 mt -114.87 130.53 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.528 -0.732 . . . . 1.0 110.586 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -140.48 143.7 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 1.0 110.131 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.497 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 50.7 m-20 60.25 13.52 3.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 1.0 111.695 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.526 ' HA2' ' CG2' ' A' ' 52' ' ' THR . . . 93.09 10.04 60.11 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.587 -1.292 . . . . 1.0 109.997 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.28 141.7 48.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -1.141 . . . . 1.0 109.551 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.583 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -77.14 178.62 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.859 -1.151 . . . . 1.0 108.655 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.573 ' CB ' ' HA ' ' A' ' 92' ' ' ARG . 1.4 pp0? -173.98 125.67 0.36 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.61 -1.307 . . . . 1.0 111.694 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.566 ' CE ' ' O ' ' A' ' 115' ' ' SER . 2.8 ttm -69.41 129.04 38.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.596 ' HE3' ' CD2' ' A' ' 153' ' ' HIS . 13.2 tmm? -132.11 109.12 9.75 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.419 -0.801 . . . . 1.0 110.466 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.661 ' CE2' ' CG1' ' A' ' 89' ' ' VAL . 11.5 p90 -133.95 133.1 40.98 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.914 -1.514 . . . . 1.0 112.107 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -118.47 88.14 2.86 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.567 0.699 . . . . 1.0 109.728 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -73.14 -76.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.441 -0.787 . . . . 1.0 109.111 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -71.08 -42.56 58.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.004 -2.039 . . . . 1.0 108.004 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.606 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 1.3 t 160.79 147.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.606 ' CB ' ' O ' ' A' ' 86' ' ' SER . 0.2 OUTLIER 83.92 93.76 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.534 ' HB2' ' HG2' ' A' ' 81' ' ' MET . 41.4 Cg_endo -67.53 146.44 74.05 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.492 1.785 . . . . 1.0 111.763 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.661 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.69 117.44 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.568 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -99.47 98.14 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.96 -1.088 . . . . 1.0 110.573 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 126' ' ' GLY . 6.0 mt -93.94 75.45 4.17 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.573 ' HA ' ' CB ' ' A' ' 79' ' ' GLN . 6.4 mtt180 -56.77 174.95 0.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.397 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.53 ' OG ' ' CG2' ' A' ' 118' ' ' VAL . 14.5 t -92.9 160.45 14.9 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.335 0.588 . . . . 1.0 110.564 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 122' ' ' ALA . 14.9 t -102.64 8.04 39.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 1.0 109.642 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.541 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 51.2 t -129.87 150.9 77.19 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.541 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 45.3 Cg_endo -69.59 135.58 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.482 1.254 . . . . 1.0 110.2 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.49 HG22 HG23 ' A' ' 78' ' ' VAL . 1.1 tp -115.77 -31.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 1.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.458 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 17.2 p-10 -69.57 60.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.034 . . . . 1.0 109.909 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 99' ' ' THR . 18.0 m -124.06 16.63 9.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.46 -0.775 . . . . 1.0 110.392 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 48.0 t-20 50.65 39.13 20.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.69 135.74 48.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 1.0 110.111 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 44.9 m95 -57.29 110.29 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -0.97 . . . . 1.0 110.291 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 104' ' ' HIS . 35.9 m -110.62 171.94 7.16 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.478 ' N ' HG22 ' A' ' 103' ' ' THR . 31.8 t60 -117.39 129.64 55.98 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.987 -1.071 . . . . 1.0 108.412 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.566 HD13 ' CD1' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -122.01 147.89 25.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.318 -0.864 . . . . 1.0 108.823 -179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.777 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.0 OUTLIER -152.5 173.16 15.49 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.404 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -165.37 116.9 1.12 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.69 -1.256 . . . . 1.0 111.323 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 25.9 p90 -119.41 109.82 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.532 ' HG2' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -106.55 164.4 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 1.0 111.309 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.505 HG11 ' NE2' ' A' ' 39' ' ' GLN . 12.8 t -145.15 113.96 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 19.8 mt-30 58.46 -129.95 1.33 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.246 -0.909 . . . . 1.0 110.462 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -85.19 -1.22 56.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.96 -1.088 . . . . 1.0 110.22 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.608 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 7.6 tt0 -107.26 120.77 43.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.436 -0.79 . . . . 1.0 110.226 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -119.66 157.43 15.51 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 119.971 -1.109 . . . . 1.0 111.465 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.566 ' O ' ' CE ' ' A' ' 80' ' ' MET . 2.8 t -133.26 150.93 51.91 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.192 -1.181 . . . . 1.0 110.836 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 3.3 tm? -113.83 154.11 28.01 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.123 -0.986 . . . . 1.0 109.434 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.777 ' HB3' ' CB ' ' A' ' 106' ' ' LYS 0.26 0.1 OUTLIER -130.03 87.21 2.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.543 -0.723 . . . . 1.0 112.725 -178.495 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.53 ' CG2' ' OG ' ' A' ' 93' ' ' SER . 24.6 t -80.56 82.71 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.729 -1.212 . . . . 1.0 107.729 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 66.52 60.87 5.81 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 120' ' ' ASN . 12.8 p30 38.8 25.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.569 -0.96 . . . . 1.0 111.694 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 121' ' ' GLU . 1.3 pm0 -86.01 -174.77 5.26 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.355 -0.84 . . . . 1.0 109.236 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.511 ' N ' ' HG2' ' A' ' 121' ' ' GLU . . . -46.62 104.66 0.42 Allowed Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.336 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 121' ' ' GLU . 40.5 Cg_endo -65.13 130.24 25.12 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.971 1.511 . . . . 1.0 110.559 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.538 ' N ' HD11 ' A' ' 124' ' ' ILE . 3.8 mp -91.03 109.32 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.557 -0.857 . . . . 1.0 108.984 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.538 ' CG2' ' OG ' ' A' ' 115' ' ' SER . 15.8 p -107.52 169.35 8.63 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.246 1.022 . . . . 1.0 111.291 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.534 ' N ' HD21 ' A' ' 91' ' ' LEU . . . 169.33 161.25 19.33 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 106.723 -2.551 . . . . 1.0 106.723 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.608 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -133.18 168.99 17.53 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.65 -1.5 . . . . 1.0 110.379 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.535 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -113.3 177.45 1.18 Allowed Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.742 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.2 Cg_endo -66.77 91.84 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.944 1.497 . . . . 1.0 108.851 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 129' ' ' PRO . 1.1 pp -47.64 -178.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.511 -0.743 . . . . 1.0 110.531 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 161.08 -56.18 0.31 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.034 -1.626 . . . . 1.0 109.034 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -107.99 102.91 12.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 1.0 109.663 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 t -86.1 37.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 1.0 110.413 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -136.87 63.79 1.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 1.0 109.929 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.24 131.08 44.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 1.0 110.412 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -124.42 175.4 7.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 1.0 110.127 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 140.7 44.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 1.0 110.21 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 140' ' ' ALA . 24.0 p-10 -88.53 35.66 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 1.0 110.519 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 42.63 25.44 0.31 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -116.35 166.5 11.99 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.075 -1.25 . . . . 1.0 109.301 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.543 ' CD1' HD23 ' A' ' 57' ' ' LEU . 10.6 tp -160.63 152.79 20.26 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.972 -1.091 . . . . 1.0 111.409 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.599 ' CZ3' ' HB2' ' A' ' 26' ' ' GLU . 25.2 m95 -133.96 126.05 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.621 -1.622 . . . . 1.0 106.621 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -143.05 135.81 27.74 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 117.899 -1.52 . . . . 1.0 113.725 -176.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 104.38 24.99 7.21 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.212 -1.955 . . . . 1.0 108.212 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.702 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 109.48 -153.35 16.93 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 106.663 -2.575 . . . . 1.0 106.663 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.702 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.6 OUTLIER -170.75 174.0 5.1 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.159 -1.416 . . . . 1.0 111.958 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.542 ' HG3' ' CG ' ' A' ' 24' ' ' TYR . 37.6 mt-10 -96.05 -9.1 31.73 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -152.48 27.0 0.58 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.535 -0.728 . . . . 1.0 110.596 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.671 ' CD1' ' HB2' ' A' ' 146' ' ' MET . 3.2 mt -70.54 61.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.597 -1.241 . . . . 1.0 109.293 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 148' ' ' ARG . 2.3 p -79.0 65.98 4.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.309 -2.108 . . . . 1.0 105.309 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.636 ' CG1' ' CD2' ' A' ' 149' ' ' LEU . 1.2 p -149.58 -77.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.13 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.72 ' CB ' ' CG ' ' A' ' 159' ' ' TYR . . . 45.54 30.95 0.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.046 -1.033 . . . . 1.0 108.962 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.619 ' CE1' ' HB3' ' A' ' 155' ' ' LEU . 1.0 OUTLIER 34.34 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.249 0.547 . . . . 1.0 110.781 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -148.51 10.75 0.86 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 1.0 111.198 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.619 ' HB3' ' CE1' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -76.42 179.33 1.55 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 1.0 110.727 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 155' ' ' LEU . 48.2 Cg_endo -73.13 -161.39 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.301 1.685 . . . . 1.0 112.974 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -51.44 -9.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.654 -0.653 . . . . 1.0 112.417 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.592 ' CB ' ' CD1' ' A' ' 155' ' ' LEU . . . -34.75 -42.96 0.16 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.035 -1.041 . . . . 1.0 110.028 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.72 ' CG ' ' CB ' ' A' ' 152' ' ' ALA . 6.6 m-85 -82.56 -33.39 28.11 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.317 -1.353 . . . . 1.0 109.916 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.6 OUTLIER -67.09 -11.51 57.36 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.876 -1.13 . . . . 1.0 108.406 178.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 162' ' ' GLY . 1.8 m -129.27 96.48 4.32 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -48.29 178.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.632 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 23.0 t80 -68.64 145.24 54.08 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.342 . . . . 1.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.645 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 2.6 mt -123.1 86.43 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.31 -1.367 . . . . 1.0 107.31 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.632 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.97 -157.5 14.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 48' ' ' LYS . 80.0 m -130.72 143.82 51.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -1.125 . . . . 1.0 109.748 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 3.2 mt -128.82 157.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.299 -0.876 . . . . 1.0 110.644 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 2.8 ttt85 -164.24 144.71 8.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.202 -0.937 . . . . 1.0 109.894 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 68.8 m-20 58.44 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.479 -0.763 . . . . 1.0 110.066 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.461 HG12 ' CB ' ' A' ' 45' ' ' LEU 0.251 26.8 m -132.92 135.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 119.989 -0.685 . . . . 1.0 109.257 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 175' ' ' GLN . 0.1 OUTLIER -141.63 152.18 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.741 -1.184 . . . . 1.0 111.679 -177.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 92.0 t -134.11 113.8 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 0.9 OUTLIER 56.49 38.01 29.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 1.0 108.104 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.495 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 73.28 30.06 1.6 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.276 0.56 . . . . 1.0 110.835 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.506 ' N ' HG22 ' A' ' 171' ' ' ILE . 4.1 mm-40 -98.01 110.91 23.4 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.249 -0.907 . . . . 1.0 109.967 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.7 102.17 10.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 1.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.568 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 4.1 mm? -86.26 92.76 8.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.817 -1.177 . . . . 1.0 110.987 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.545 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 0.4 OUTLIER -40.64 113.37 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.045 0.926 . . . . 1.0 110.166 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.534 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 10.9 mt -40.49 -56.53 2.03 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.847 0.832 . . . . 1.0 112.655 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.526 ' HA ' ' HB1' ' A' ' 183' ' ' ALA . 51.3 t -84.82 -22.25 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 2.3 mt-10 -62.07 -55.99 23.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.137 -1.602 . . . . 1.0 110.315 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.583 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -84.63 -19.47 32.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.356 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -64.28 -36.7 84.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.926 -1.109 . . . . 1.0 109.629 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 5.2 mt -50.05 -21.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.177 -0.952 . . . . 1.0 109.345 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 2.7 t-20 -54.99 -20.77 9.91 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.882 0.849 . . . . 1.0 108.876 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.467 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 4.3 t30 -95.83 152.36 39.0 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 40.6 Cg_endo -66.3 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.371 1.195 . . . . 1.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 12.4 m -68.74 135.97 52.1 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.234 -0.916 . . . . 1.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 186' ' ' ASN . 25.3 mm -122.92 127.46 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 1.0 109.805 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 17' ' ' ILE . 7.7 mt -121.34 173.18 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 1.0 110.394 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.543 ' O ' ' N ' ' A' ' 18' ' ' ALA . 2.5 m-70 -107.54 -84.3 0.53 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.144 -0.973 . . . . 1.0 111.185 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.293 -1.854 0 O-C-N 121.157 -0.964 . . . . 1.0 110.671 179.861 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 1.1 tt0 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.48 0.657 . . . . 1.0 109.685 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.433 ' C ' HG12 ' A' ' 17' ' ' ILE . . . -95.62 155.16 16.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.347 -0.941 . . . . 1.0 110.289 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.6 ' CD1' ' CE1' ' A' ' 191' ' ' HIS . 13.4 mm -135.66 122.82 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 1.0 110.576 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.442 ' O ' HD22 ' A' ' 190' ' ' LEU . . . -89.25 132.49 34.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.875 . . . . 1.0 109.896 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.622 ' CE1' ' CD1' ' A' ' 167' ' ' ILE . 9.6 m-85 -102.47 172.67 6.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.216 . . . . 1.0 110.25 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 164' ' ' ILE . 0.5 OUTLIER -134.38 1.9 3.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 1.0 110.802 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.508 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.18 -26.22 25.03 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 8.1 ttt180 -104.45 10.8 35.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.912 -1.346 . . . . 1.0 109.364 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 144' ' ' GLY . 6.3 t -55.22 175.53 0.07 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.676 0.75 . . . . 1.0 110.741 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.633 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -171.57 73.42 0.05 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.415 ' HE2' HG21 ' A' ' 17' ' ' ILE . 2.3 mmt -85.79 99.72 11.55 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.861 -1.149 . . . . 1.0 109.539 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.55 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -91.39 134.81 34.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.596 ' CD2' ' HB2' ' A' ' 182' ' ' ASP . 48.9 m-85 -121.25 149.03 43.48 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.982 -1.074 . . . . 1.0 110.72 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -149.8 97.93 2.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.811 . . . . 1.0 110.186 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -139.31 174.99 9.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 1.0 110.084 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.06 148.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 1.0 110.033 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 1.0 110.323 -179.677 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.244 0.545 . . . . 1.0 110.074 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.44 122.53 13.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 1.0 110.209 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.556 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.3 OUTLIER -124.58 117.08 23.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.475 -0.766 . . . . 1.0 110.279 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 0.6 OUTLIER -84.67 142.22 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 1.0 109.463 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.644 ' CE1' ' CG2' ' A' ' 172' ' ' VAL . 41.8 m-85 -130.81 120.98 24.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.133 -0.98 . . . . 1.0 111.151 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.569 ' CG ' ' HE2' ' A' ' 106' ' ' LYS . 39.7 mt-10 -128.6 142.8 50.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 1.0 110.521 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 1.1 pt? -179.69 149.72 0.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.38 -0.825 . . . . 1.0 110.397 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.7 m -121.24 149.36 42.98 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.598 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 1.7 pt -126.49 179.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.379 -0.928 . . . . 1.0 109.168 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.634 ' O ' ' OG1' ' A' ' 49' ' ' THR . 5.9 tttt -167.74 82.6 0.2 Allowed 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.674 -1.21 . . . . 1.0 110.641 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.634 ' OG1' ' O ' ' A' ' 48' ' ' LYS . 90.2 m -171.97 -108.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.81 -0.556 . . . . 1.0 111.313 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 0.5 OUTLIER -122.18 -46.09 2.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.594 1.188 . . . . 1.0 109.626 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.568 ' O ' ' CG2' ' A' ' 73' ' ' ILE . . . 39.44 22.75 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.841 -1.072 . . . . 1.0 111.656 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.605 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 60.4 p -70.79 -18.22 62.76 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.409 -1.432 . . . . 1.0 108.796 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -159.6 118.68 2.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.093 -0.643 . . . . 1.0 109.727 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 155.21 136.74 2.25 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.194 -1.479 . . . . 1.0 109.541 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.729 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -85.61 128.17 34.69 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.628 -1.229 . . . . 1.0 109.246 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.588 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 1.0 OUTLIER -90.49 -34.09 6.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.502 -0.749 . . . . 1.0 111.602 -177.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.59 ' CB ' ' HB2' ' A' ' 71' ' ' LEU . 5.7 tt -146.18 143.4 29.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.536 -1.353 . . . . 1.0 113.079 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.652 ' CH2' ' CG2' ' A' ' 151' ' ' VAL . 31.0 t-105 -152.09 105.69 3.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 p -110.29 123.17 49.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 1.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 138' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 137' ' ' THR . 1.8 t80 . . . . . 0 N--CA 1.511 2.577 0 N-CA-C 111.857 0.317 . . . . 1.0 111.857 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 70' ' ' ALA . 5.6 mt -151.13 171.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.648 -1.282 . . . . 1.0 112.838 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.56 ' N ' ' CG2' ' A' ' 69' ' ' ILE . . . -177.18 167.12 2.4 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 90.4 mt -145.95 103.37 3.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.721 -1.237 . . . . 1.0 108.439 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -123.46 167.76 13.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 1.0 112.058 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.5 132.53 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.739 0.78 . . . . 1.0 111.131 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.487 HG22 ' OD2' ' A' ' 75' ' ' ASP . 2.0 p -141.17 140.65 31.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.6 -0.687 . . . . 1.0 110.968 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.487 ' OD2' HG22 ' A' ' 74' ' ' VAL . 5.7 m-20 67.96 22.49 8.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.481 -0.762 . . . . 1.0 111.47 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 86.84 4.74 82.06 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.06 -1.543 . . . . 1.0 109.76 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 75' ' ' ASP . 87.2 m-85 -130.94 150.24 52.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.95 -1.324 . . . . 1.0 110.569 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.01 177.6 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.148 -0.97 . . . . 1.0 110.535 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 7.8 pt20 -167.49 123.81 1.12 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.254 -0.904 . . . . 1.0 110.89 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.607 ' CE ' ' O ' ' A' ' 115' ' ' SER . 6.0 tmm? -83.69 115.95 22.42 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 10.1 ptt? -119.79 149.15 42.51 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.905 -1.122 . . . . 1.0 111.143 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.624 ' CE2' ' CG1' ' A' ' 89' ' ' VAL . 24.7 p90 -158.03 132.81 8.45 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.194 -1.002 . . . . 1.0 110.951 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.667 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -121.02 75.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 1.0 110.329 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.448 ' HB2' ' HG ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER -79.11 -5.86 55.11 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.68 -0.637 . . . . 1.0 110.379 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -121.5 -65.83 0.24 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.057 -1.217 . . . . 1.0 110.057 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.33 -33.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.053 -1.263 . . . . 1.0 111.243 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.504 ' HD3' ' HD3' ' A' ' 129' ' ' PRO . 9.0 ptmt -124.58 138.06 30.48 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.944 -1.097 . . . . 1.0 110.959 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.516 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 49.8 Cg_endo -76.23 121.82 6.31 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 124.15 1.605 . . . . 1.0 111.414 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.624 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -77.4 168.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 178.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.563 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 10.6 p -147.69 85.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.751 -1.218 . . . . 1.0 111.667 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 126' ' ' GLY . 0.7 OUTLIER -77.34 75.31 3.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.881 -1.137 . . . . 1.0 108.398 178.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 34.8 mtp180 -58.47 178.82 0.09 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.955 0.884 . . . . 1.0 110.837 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.51 ' OG ' ' CG2' ' A' ' 118' ' ' VAL . 11.5 t -109.64 149.31 29.89 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.916 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.75 29.91 6.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -0.999 . . . . 1.0 109.908 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.559 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 74.2 t -133.74 150.27 74.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.514 -0.741 . . . . 1.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 42.1 Cg_endo -66.93 120.35 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.569 1.299 . . . . 1.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.531 ' CD1' HG22 ' A' ' 103' ' ' THR . 4.1 tp -104.89 -11.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 1.0 110.344 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.481 ' HB3' HG22 ' A' ' 52' ' ' THR . 8.5 p-10 -87.96 55.69 3.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 1.0 109.679 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.468 HG23 ' HB2' ' A' ' 101' ' ' HIS . 68.8 m -112.38 8.29 19.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.311 -0.868 . . . . 1.0 110.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.53 ' HA ' ' N ' ' A' ' 49' ' ' THR . 79.2 m-20 54.62 16.86 1.48 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 1.0 110.436 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.468 ' HB2' HG23 ' A' ' 99' ' ' THR . 3.6 m-70 -113.41 150.13 33.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.881 . . . . 1.0 109.984 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.619 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 4.3 m95 -60.75 89.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.013 -1.054 . . . . 1.0 110.687 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.531 HG22 ' CD1' ' A' ' 97' ' ' ILE . 23.3 m -87.56 150.57 23.62 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.498 ' N ' HG21 ' A' ' 103' ' ' THR . 78.8 t60 -108.71 135.34 50.1 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.989 -1.085 . . . . 1.0 108.73 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.429 HD12 ' CD1' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -132.51 156.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.174 -0.954 . . . . 1.0 109.457 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.569 ' HE2' ' CG ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -152.23 167.41 28.68 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.731 -1.188 . . . . 1.0 110.125 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -152.16 109.7 3.61 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.255 -0.978 . . . . 1.0 111.251 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.536 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 18.4 m-30 -83.58 102.28 12.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 1.0 108.802 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -92.99 127.37 38.48 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.96 -1.087 . . . . 1.0 109.728 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 111' ' ' GLN . 3.3 t -132.62 157.57 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 1.0 110.269 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -40.14 111.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.0 110.497 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.626 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 51.98 65.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 1.0 110.377 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.626 ' CB ' ' O ' ' A' ' 112' ' ' ARG . 2.2 tt0 156.85 113.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.632 0.73 . . . . 1.0 109.986 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 82' ' ' TYR . . . -120.86 166.15 13.96 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.199 -1.0 . . . . 1.0 110.618 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.607 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -144.51 166.7 24.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.491 -1.006 . . . . 1.0 110.315 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 117' ' ' GLN 0.252 1.1 tm? -145.47 151.92 38.96 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.151 -0.968 . . . . 1.0 109.312 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.55 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.6 OUTLIER -153.89 107.95 3.02 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.813 -1.155 . . . . 1.0 111.788 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.522 ' N ' ' OE1' ' A' ' 121' ' ' GLU . 2.0 t -72.41 104.92 2.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.73 35.58 91.17 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.207 . . . . 1.0 110.084 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER 60.95 39.47 16.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.093 -1.239 . . . . 1.0 110.97 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.577 ' HG2' ' N ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -102.4 -167.84 1.45 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.522 -0.736 . . . . 1.0 110.733 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.577 ' N ' ' HG2' ' A' ' 121' ' ' GLU . . . -35.0 112.23 0.44 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 1.0 109.579 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.526 ' HB3' ' OE1' ' A' ' 117' ' ' GLN . 45.8 Cg_endo -72.95 118.14 5.43 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.133 1.596 . . . . 1.0 112.834 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' A' ' 91' ' ' LEU . 5.4 mp -85.8 110.85 20.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 106.313 -1.736 . . . . 1.0 106.313 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 30.9 p -119.65 174.38 6.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.507 1.146 . . . . 1.0 112.756 -176.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.559 ' N ' HD12 ' A' ' 91' ' ' LEU . . . 169.69 169.47 32.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 106.622 -2.591 . . . . 1.0 106.622 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -146.53 163.95 34.12 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.511 -1.582 . . . . 1.0 111.11 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.421 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -83.98 173.54 7.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.663 -0.648 . . . . 1.0 110.494 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -69.7 57.55 1.46 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 1.0 110.113 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.554 ' CA ' ' HG3' ' A' ' 112' ' ' ARG . 1.2 pp 10.22 57.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -132.68 73.35 0.46 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 133' ' ' THR . . . -159.94 -71.41 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -1.136 . . . . 1.0 110.493 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.8 OUTLIER 62.85 129.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -0.99 . . . . 1.0 109.887 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.17 75.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 1.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 84' ' ' LEU . 1.3 tm? -88.86 108.42 19.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 1.0 109.719 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -67.74 148.79 50.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 1.0 110.724 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -138.4 141.45 39.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 1.0 109.787 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 140' ' ' ALA . 40.4 p-10 -84.16 22.1 1.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.194 -0.941 . . . . 1.0 111.075 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 45.51 22.41 0.65 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.405 -1.478 . . . . 1.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -104.92 162.57 13.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.109 -1.23 . . . . 1.0 109.252 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 27' ' ' TYR . 6.7 tp -159.53 144.78 15.63 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.99 -1.069 . . . . 1.0 110.821 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.627 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 13.1 m95 -125.99 141.88 51.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.577 ' CD2' ' O ' ' A' ' 56' ' ' ILE . 1.5 tt -148.0 128.47 14.02 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 116.908 -1.917 . . . . 1.0 113.375 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 23' ' ' THR . . . 113.54 -5.32 24.66 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 146.69 -140.87 9.0 Favored Glycine 0 C--N 1.289 -2.039 0 C-N-CA 118.945 -1.598 . . . . 1.0 109.755 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.611 ' HE1' ' CE3' ' A' ' 142' ' ' TRP . 0.4 OUTLIER -171.43 141.18 1.5 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.091 -1.043 . . . . 1.0 111.939 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.01 -16.08 55.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.783 0.801 . . . . 1.0 109.079 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -137.0 45.84 2.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.497 -1.298 . . . . 1.0 107.497 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 55' ' ' LEU . 11.5 tp -65.32 56.83 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.753 0.787 . . . . 1.0 112.146 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 148' ' ' ARG . 56.9 p -84.88 1.7 45.9 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.509 -1.663 . . . . 1.0 106.509 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.652 ' CG2' ' CH2' ' A' ' 58' ' ' TRP . 3.3 p -85.47 -104.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.614 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.661 ' CB ' ' CD2' ' A' ' 159' ' ' TYR . . . 52.64 45.52 28.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.476 -1.39 . . . . 1.0 108.936 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.525 ' C ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -18.03 -77.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.516 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 9.5 ptmt -97.95 -43.65 7.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.985 . . . . 1.0 111.874 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.648 ' CD2' ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -81.07 113.41 40.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 O-C-N 121.324 -0.86 . . . . 1.0 110.231 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 154' ' ' LYS . 51.1 Cg_endo -88.39 -68.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.58 1.305 . . . . 1.0 111.594 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 1.8 tttm -54.86 -50.67 68.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 1.0 111.944 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.507 ' HB1' ' CD1' ' A' ' 155' ' ' LEU . . . -43.72 -42.76 5.59 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.729 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 3.2 m-85 -78.42 -32.2 48.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.554 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -68.93 -12.35 61.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.753 -0.779 . . . . 1.0 109.926 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 161' ' ' THR . 1.2 m -128.65 81.9 2.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -41.31 158.35 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.607 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 62.9 t80 -71.57 137.08 47.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.959 -1.318 . . . . 1.0 110.5 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.513 ' O ' HG21 ' A' ' 49' ' ' THR . 4.4 mt -118.72 75.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.627 ' CA ' ' OG1' ' A' ' 49' ' ' THR . . . -159.11 -160.21 10.23 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.515 ' N ' ' OG1' ' A' ' 49' ' ' THR . 20.0 m -118.61 147.48 43.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -1.175 . . . . 1.0 111.445 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.622 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -134.95 157.22 40.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.694 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.524 ' NH2' ' OD1' ' A' ' 169' ' ' ASP . 22.1 ttt-85 -165.52 157.85 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.818 -1.176 . . . . 1.0 111.262 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 20.0 m-20 51.25 78.61 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.9 . . . . 1.0 110.451 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.469 HG13 ' HB2' ' A' ' 45' ' ' LEU . 16.8 m -124.81 129.55 73.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.363 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.407 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -148.13 148.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.269 -0.972 . . . . 1.0 110.947 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 43' ' ' PHE . 14.9 p -135.7 123.56 36.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 23.2 m-20 49.95 30.92 4.3 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.409 -1.432 . . . . 1.0 107.86 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 68.09 28.76 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.186 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' ' 176' ' ' GLU . 0.8 OUTLIER -109.66 -170.06 1.59 Allowed 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.262 -0.899 . . . . 1.0 109.34 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.572 ' HB3' ' O ' ' A' ' 175' ' ' GLN . 36.6 tp10 76.59 -106.22 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.601 -0.687 . . . . 1.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 3.6 mp 63.37 -94.91 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.185 -0.947 . . . . 1.0 112.515 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 7.3 m-70 -56.64 90.02 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.937 -1.102 . . . . 1.0 111.438 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' A' ' 183' ' ' ALA 0.272 3.5 mp -63.57 -58.78 5.87 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.214 1.006 . . . . 1.0 110.868 178.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.531 HG13 ' CD1' ' A' ' 184' ' ' LEU . 2.1 t -61.44 -16.45 14.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.933 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 3.4 mt-10 -72.3 -45.27 60.76 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.386 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.596 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 1.6 m-20 -101.8 -15.52 16.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.257 -0.902 . . . . 1.0 109.277 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -78.2 -37.51 45.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.326 -0.859 . . . . 1.0 109.299 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.531 ' CD1' HG13 ' A' ' 180' ' ' VAL . 11.4 mt -55.74 -16.29 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 1.0 109.877 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 184' ' ' LEU . 9.8 t-20 -42.98 -27.01 0.16 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.824 0.821 . . . . 1.0 109.271 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.443 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 2.3 t30 -134.74 143.17 45.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.459 ' O ' HG22 ' A' ' 188' ' ' THR . 46.1 Cg_endo -71.0 -158.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.632 1.333 . . . . 1.0 110.98 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' A' ' 188' ' ' THR . 0.4 OUTLIER 64.09 22.91 13.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.603 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.484 HD11 ' O ' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -92.78 112.6 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.272 -0.893 . . . . 1.0 110.781 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.642 ' CD1' ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -109.48 149.56 29.41 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.13 -0.981 . . . . 1.0 109.201 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.6 ' CE1' ' CD1' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -99.63 101.63 12.89 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.97 -1.081 . . . . 1.0 109.835 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' HIS . 9.0 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 1.0 110.476 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.457 0.646 . . . . 1.0 110.047 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' ' CG ' ' A' ' 191' ' ' HIS . . . -110.47 160.93 16.17 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.291 -0.88 . . . . 1.0 110.453 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.525 HG21 ' CE ' ' A' ' 25' ' ' MET . 6.4 mm -127.27 125.71 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 1.0 109.222 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.55 138.57 31.39 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.415 -0.803 . . . . 1.0 110.964 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CE1' ' CD1' ' A' ' 167' ' ' ILE . 12.2 m-85 -101.27 169.05 9.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.568 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -128.82 -7.56 5.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.967 . . . . 1.0 110.634 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.35 37.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -129.24 -13.15 4.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.05 -1.265 . . . . 1.0 110.737 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.465 ' OG1' ' OD2' ' A' ' 20' ' ' ASP . 2.3 m -69.53 130.47 42.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.211 -0.931 . . . . 1.0 110.507 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.591 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -116.09 118.02 31.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.358 -0.838 . . . . 1.0 109.487 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -91.55 101.3 13.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.641 -1.287 . . . . 1.0 110.096 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.602 ' OE1' ' CZ2' ' A' ' 142' ' ' TRP . 5.4 tp10 -79.99 97.03 6.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.852 -0.795 . . . . 1.0 108.852 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.593 ' CD1' ' HB3' ' A' ' 182' ' ' ASP . 19.0 m-85 -95.37 97.57 9.93 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.103 -1.039 . . . . 1.0 111.362 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.82 123.72 41.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 1.0 108.849 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -133.3 157.33 45.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.852 -1.155 . . . . 1.0 111.225 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' VAL . . . -105.94 101.8 11.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.662 -0.649 . . . . 1.0 109.553 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.494 ' CG2' ' OD2' ' A' ' 138' ' ' ASP . 2.8 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 1.0 109.988 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 35.7 tt0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.3 0.571 . . . . 1.0 110.658 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 109' ' ' ARG . 1.2 p -167.29 155.13 9.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.049 -1.032 . . . . 1.0 110.635 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.578 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -128.17 148.68 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 1.0 110.077 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.5 ' CD2' ' OD1' ' A' ' 173' ' ' ASP . 13.8 m-70 -114.47 126.59 55.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 1.0 109.641 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.649 ' CZ ' ' CD1' ' A' ' 69' ' ' ILE . 73.9 m-85 -120.21 122.47 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -0.987 . . . . 1.0 111.137 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.625 ' HA ' ' HG2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -128.3 134.96 49.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.032 . . . . 1.0 110.576 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 1.1 pt? -175.18 156.59 2.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.956 -1.09 . . . . 1.0 111.293 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.446 ' C ' HG22 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -119.68 155.18 32.88 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.559 HG22 ' CD1' ' A' ' 105' ' ' ILE . 6.9 pt -146.35 169.6 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 118.665 -1.214 . . . . 1.0 112.286 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.599 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -129.01 92.57 3.42 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 178.322 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.627 ' CG2' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -73.21 157.6 36.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 1.0 112.286 -177.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.611 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 6.8 mm-40 -148.9 12.65 0.87 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.043 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -151.07 8.32 0.54 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.454 -1.404 . . . . 1.0 112.223 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.571 HG23 ' HB3' ' A' ' 98' ' ' ASN . 0.7 OUTLIER 50.98 11.03 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.969 -1.082 . . . . 1.0 111.823 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.8 tt0 -158.76 137.92 11.43 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.902 -1.124 . . . . 1.0 110.163 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 148.35 139.35 3.16 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -87.07 126.21 34.62 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.021 -1.282 . . . . 1.0 108.693 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.638 HD13 ' HA ' ' A' ' 72' ' ' ALA . 3.4 mp -92.49 -32.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 1.0 111.708 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.644 ' CB ' ' HB2' ' A' ' 71' ' ' LEU . 1.3 tt -144.15 148.17 34.68 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.802 -1.186 . . . . 1.0 113.017 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.677 ' CH2' ' CG2' ' A' ' 151' ' ' VAL . 21.3 t-105 -156.23 111.82 2.97 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.77 128.5 56.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.829 -1.17 . . . . 1.0 111.511 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 108.286 -1.926 . . . . 1.0 108.286 178.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 2.7 m-85 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.868 0.366 . . . . 1.0 110.603 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.649 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 2.5 tt -110.67 110.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.006 -1.059 . . . . 1.0 110.19 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.543 ' C ' ' HG ' ' A' ' 71' ' ' LEU . . . -133.67 176.52 8.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.132 -0.98 . . . . 1.0 110.476 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.644 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 42.4 mt -147.88 113.09 5.54 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -131.8 164.25 26.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.95 -1.094 . . . . 1.0 111.855 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.627 ' CD1' ' CG2' ' A' ' 49' ' ' THR . 7.0 mt -108.64 136.46 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.849 . . . . 1.0 110.669 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' A' ' 92' ' ' ARG . 4.2 p -141.67 120.6 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.81 . . . . 1.0 111.28 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER 70.57 14.08 7.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 1.0 110.938 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 99.05 7.68 54.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.789 -1.324 . . . . 1.0 109.789 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.22 146.44 49.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -1.225 . . . . 1.0 109.385 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.585 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -93.38 162.58 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 1.0 109.589 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.536 ' CB ' ' HA ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -159.17 139.41 12.13 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.212 -0.93 . . . . 1.0 110.152 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.589 ' O ' ' HG3' ' A' ' 80' ' ' MET . 0.1 OUTLIER -107.61 115.86 30.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.349 -0.941 . . . . 1.0 110.253 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.53 ' CE ' ' OH ' ' A' ' 159' ' ' TYR . 3.0 ptp -89.39 133.79 34.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.582 -1.323 . . . . 1.0 110.128 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -126.92 128.93 47.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 1.0 110.688 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.547 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.5 t0 -146.53 66.21 1.18 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.287 1.041 . . . . 1.0 109.466 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.531 ' CB ' HD13 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -66.87 -3.68 7.51 Favored 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.563 -0.71 . . . . 1.0 111.074 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -137.98 -55.43 0.05 OUTLIER Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.554 -1.308 . . . . 1.0 110.62 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.49 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -176.01 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.213 -1.169 . . . . 1.0 110.678 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 15.8 mmtp -98.48 110.87 58.44 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.009 -1.057 . . . . 1.0 109.795 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 82' ' ' TYR . 43.1 Cg_endo -71.93 159.9 49.13 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.86 1.453 . . . . 1.0 110.712 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -137.02 116.98 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.587 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 1.8 p -95.99 112.44 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.404 -1.435 . . . . 1.0 110.974 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.582 ' HB3' ' CG2' ' A' ' 124' ' ' ILE . 4.6 mt -105.69 71.56 0.92 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.536 ' HA ' ' CB ' ' A' ' 79' ' ' GLN . 3.4 mtp180 -60.07 178.14 0.2 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.99 0.9 . . . . 1.0 110.909 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.468 ' OG ' HG22 ' A' ' 118' ' ' VAL . 7.9 t -100.11 161.35 13.66 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.648 -0.658 . . . . 1.0 110.656 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.71 25.75 10.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 1.0 109.485 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.54 ' HB ' ' CG1' ' A' ' 118' ' ' VAL . 2.2 t -137.53 147.34 57.19 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.708 -0.62 . . . . 1.0 109.617 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.2 Cg_endo -65.91 137.12 47.77 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.806 1.424 . . . . 1.0 110.783 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -128.94 -22.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 1.0 111.197 -179.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.571 ' HB3' HG23 ' A' ' 52' ' ' THR . 6.7 p30 -74.2 54.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.982 . . . . 1.0 111.317 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 14.2 t -128.87 30.77 5.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.263 -0.898 . . . . 1.0 108.906 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.461 ' CG ' ' O ' ' A' ' 99' ' ' THR . 5.9 p-10 40.49 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.948 -0.47 . . . . 1.0 111.578 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 0.3 OUTLIER -102.02 160.03 14.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.0 -1.062 . . . . 1.0 109.049 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.599 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 20.0 m95 -81.11 102.34 10.19 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.037 -1.039 . . . . 1.0 109.838 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.524 ' CG2' ' N ' ' A' ' 104' ' ' HIS . 18.2 m -93.8 173.79 7.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 1.0 109.246 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.524 ' N ' ' CG2' ' A' ' 103' ' ' THR . 3.2 t60 -121.81 125.57 46.8 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.316 -1.364 . . . . 1.0 107.316 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.559 ' CD1' HG22 ' A' ' 47' ' ' ILE . 1.5 mp -124.25 147.67 28.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.722 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -152.94 179.42 8.7 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.27 -1.372 . . . . 1.0 109.38 -178.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.564 ' O ' ' CD1' ' A' ' 108' ' ' TYR . . . -164.4 145.98 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.834 -1.166 . . . . 1.0 111.811 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 4.7 m-85 -136.54 104.8 5.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.448 -0.782 . . . . 1.0 109.576 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -95.63 131.28 42.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.978 . . . . 1.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.554 ' N ' ' HD3' ' A' ' 109' ' ' ARG . 85.8 t -137.53 104.22 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.365 -0.835 . . . . 1.0 110.687 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.475 ' O ' ' CB ' ' A' ' 112' ' ' ARG . 16.4 mt-30 40.83 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.591 -0.693 . . . . 1.0 112.206 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.1 OUTLIER 71.59 -50.61 0.69 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 1.0 112.734 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.597 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 6.3 tt0 -85.04 122.03 28.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.691 -1.256 . . . . 1.0 111.511 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.35 166.7 12.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.546 ' O ' ' CE ' ' A' ' 80' ' ' MET . 42.1 t -145.0 151.83 39.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.288 -1.125 . . . . 1.0 111.075 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.556 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -111.77 147.25 36.07 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.722 ' HB3' ' CB ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -127.45 91.65 3.35 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.778 -1.169 . . . . 1.0 112.591 -177.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.54 ' CG1' ' HB ' ' A' ' 95' ' ' VAL . 70.4 t -78.93 87.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.748 -1.204 . . . . 1.0 107.748 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 56.88 58.28 15.33 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.802 -1.19 . . . . 1.0 110.348 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 41.4 24.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.433 -1.039 . . . . 1.0 112.237 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 1.1 mt-10 -97.83 -166.7 1.41 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.748 -1.22 . . . . 1.0 109.304 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.7 96.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.87 0 C-N-CA 120.0 -0.68 . . . . 1.0 109.587 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.529 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.8 Cg_endo -74.93 130.43 13.34 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.091 1.574 . . . . 1.0 110.871 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.582 ' CG2' ' HB3' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.05 144.5 9.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 O-C-N 121.153 -0.967 . . . . 1.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.539 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 4.6 p -138.83 158.13 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.524 -1.36 . . . . 1.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.52 ' N ' HD23 ' A' ' 91' ' ' LEU . . . -166.21 165.47 38.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.209 -2.356 . . . . 1.0 107.209 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.597 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -152.91 151.2 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.594 -1.533 . . . . 1.0 111.79 -179.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.1 p -106.02 173.96 2.89 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.746 -0.596 . . . . 1.0 109.911 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 131' ' ' GLY . 45.2 Cg_endo -70.65 67.77 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.915 1.482 . . . . 1.0 110.18 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.544 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.0 OUTLIER -4.04 70.28 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 121.581 0.705 . . . . 1.0 112.798 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -84.68 -71.17 1.32 Allowed Glycine 0 C--N 1.288 -2.093 0 N-CA-C 109.196 -1.562 . . . . 1.0 109.196 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.543 ' O ' ' C ' ' A' ' 133' ' ' THR . . . -67.7 86.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -1.186 . . . . 1.0 109.369 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.543 ' C ' ' O ' ' A' ' 132' ' ' ALA . 16.7 m -19.0 -69.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.036 0.446 . . . . 1.0 111.986 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.65 -45.87 3.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 1.0 110.023 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.531 HD13 ' CB ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER 62.2 113.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.899 . . . . 1.0 110.346 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.504 ' C ' ' CG2' ' A' ' 137' ' ' THR . 15.2 m-20 -73.19 138.97 45.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 1.0 109.534 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.531 ' O ' ' HB3' ' A' ' 138' ' ' ASP . 7.2 p -153.53 105.0 2.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 1.0 109.792 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 137' ' ' THR . 7.9 p-10 170.61 -39.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -24.91 -43.91 0.01 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -146.99 173.81 12.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.903 -1.351 . . . . 1.0 110.445 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.549 ' C ' ' CD1' ' A' ' 142' ' ' TRP . 10.3 tp -160.86 148.79 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.344 -0.848 . . . . 1.0 110.248 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.602 ' CZ2' ' OE1' ' A' ' 26' ' ' GLU . 20.7 m95 -133.23 143.49 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.303 -0.999 . . . . 1.0 108.303 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.565 HD11 ' CB ' ' A' ' 57' ' ' LEU . 6.6 tp -145.68 118.89 8.89 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.945 -1.502 . . . . 1.0 112.974 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 122.67 1.86 9.75 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.367 -1.093 . . . . 1.0 110.367 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.479 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 144.32 -135.24 6.09 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 118.936 -1.602 . . . . 1.0 109.727 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.615 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -170.79 176.48 4.17 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.816 -0.814 . . . . 1.0 111.714 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -96.37 -25.35 15.76 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.919 0.866 . . . . 1.0 108.918 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.562 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.91 74.59 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.822 -1.548 . . . . 1.0 106.822 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.615 ' CD1' ' HB2' ' A' ' 146' ' ' MET . 3.8 tp -71.39 24.69 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 113.926 1.084 . . . . 1.0 113.926 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.6 p -62.16 -21.01 64.72 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 104.68 -2.341 . . . . 1.0 104.68 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.677 ' CG2' ' CH2' ' A' ' 58' ' ' TRP 0.284 13.5 p -58.32 -118.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.348 -1.297 . . . . 1.0 110.154 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.629 ' O ' ' CB ' ' A' ' 153' ' ' HIS . . . 70.24 -71.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.809 -1.182 . . . . 1.0 109.927 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.629 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 18.3 m170 132.16 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.438 ' HD3' ' HB3' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -137.14 12.11 3.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.005 . . . . 1.0 109.706 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -70.36 165.61 42.86 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.421 -0.799 . . . . 1.0 111.126 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.575 ' CD ' HD21 ' A' ' 155' ' ' LEU . 40.9 Cg_endo -64.97 -168.68 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.967 1.509 . . . . 1.0 112.448 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 160' ' ' SER . 2.2 mttp -53.28 -10.77 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.578 ' CB ' ' CD2' ' A' ' 155' ' ' LEU . . . -38.25 -44.82 0.91 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.044 -1.035 . . . . 1.0 109.983 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.62 ' CG ' ' HB3' ' A' ' 152' ' ' ALA . 15.4 m-85 -84.37 -28.45 26.99 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.945 -1.097 . . . . 1.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -71.64 -7.08 45.67 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.57 -1.252 . . . . 1.0 108.544 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 161' ' ' THR . 1.3 m -131.72 98.27 4.44 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -47.38 175.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.641 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 54.5 t80 -79.07 149.24 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -1.157 . . . . 1.0 112.061 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.611 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 1.1 mt -130.8 88.17 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.641 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.2 -153.69 9.48 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.061 -1.616 . . . . 1.0 109.061 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.525 ' C ' HG13 ' A' ' 167' ' ' ILE . 15.0 m -137.32 148.03 46.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.465 -1.021 . . . . 1.0 110.06 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.617 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -133.84 153.64 36.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.526 -0.734 . . . . 1.0 109.717 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.49 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 18.7 ttt180 -163.02 162.37 25.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.657 -1.277 . . . . 1.0 110.963 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.49 ' N ' ' HG2' ' A' ' 168' ' ' ARG . 0.7 OUTLIER 48.71 78.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.394 -0.816 . . . . 1.0 110.464 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 16.2 m -121.77 135.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 119.362 -0.935 . . . . 1.0 108.937 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.456 HG12 ' C ' ' A' ' 170' ' ' VAL . 0.0 OUTLIER -146.22 148.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.319 -0.953 . . . . 1.0 111.176 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 175' ' ' GLN . 1.7 t -130.32 102.43 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 10.9 m-20 51.96 42.55 30.35 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 1.0 108.143 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 75.51 26.38 1.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.254 0.549 . . . . 1.0 110.421 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.567 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . 63.9 mt-30 -102.15 -174.67 2.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.358 -0.838 . . . . 1.0 109.726 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 1.9 mm-40 62.64 -92.99 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.685 -0.634 . . . . 1.0 110.656 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER 65.88 -87.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 1.0 111.21 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 59.7 m-70 -74.72 102.39 4.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.998 -1.063 . . . . 1.0 111.509 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.471 ' O ' ' HB1' ' A' ' 183' ' ' ALA 0.253 0.4 OUTLIER -57.22 -58.4 8.38 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 122.419 1.104 . . . . 1.0 109.709 177.881 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.493 HG12 HD11 ' A' ' 184' ' ' LEU . 95.0 t -50.54 -31.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.99 -1.005 . . . . 1.0 111.262 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 19.7 mt-10 -61.69 -53.81 51.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.121 -0.987 . . . . 1.0 109.929 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.593 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 2.7 t0 -89.79 -15.46 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 1.0 109.665 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 179' ' ' LEU . . . -72.82 -25.08 61.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.326 -0.859 . . . . 1.0 109.032 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.493 HD11 HG12 ' A' ' 180' ' ' VAL . 0.1 OUTLIER -62.61 -15.49 51.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 1.0 109.438 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -24.15 63.93 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.938 0.875 . . . . 1.0 108.777 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 187' ' ' PRO . 3.6 t-20 -96.46 151.06 37.8 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.487 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 38.8 Cg_endo -64.87 143.61 80.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.538 1.283 . . . . 1.0 111.212 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.473 ' CG2' ' N ' ' A' ' 189' ' ' ILE . 0.8 OUTLIER 49.9 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.585 -0.697 . . . . 1.0 110.648 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.473 ' N ' ' CG2' ' A' ' 188' ' ' THR . 14.2 mm -141.03 121.99 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 1.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 mt -111.25 159.23 18.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.148 -0.97 . . . . 1.0 110.641 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -127.57 153.33 46.52 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 1.0 109.409 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.021 -1.05 . . . . 1.0 110.47 -179.712 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.54 0.686 . . . . 1.0 110.367 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.51 134.21 34.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.157 -1.589 . . . . 1.0 110.925 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 190' ' ' LEU . 6.8 mm -125.94 142.14 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -0.975 . . . . 1.0 109.29 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -98.58 133.58 42.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.425 -0.797 . . . . 1.0 111.043 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 167' ' ' ILE . 7.5 m-85 -95.84 175.74 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 1.0 109.192 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 45.6 p-10 -139.5 4.63 2.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.956 . . . . 1.0 110.655 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.488 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.74 -30.58 10.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.577 -1.809 . . . . 1.0 108.577 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.457 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 3.4 ttp-105 -100.92 -12.78 18.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.455 -1.027 . . . . 1.0 109.628 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.581 HG23 ' CD2' ' A' ' 19' ' ' PHE . 11.8 m -42.82 135.52 2.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 1.0 110.379 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.669 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -133.75 99.14 4.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 4.1 mtt -93.98 100.63 12.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.39 -1.444 . . . . 1.0 109.407 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.633 ' CG ' ' CZ3' ' A' ' 142' ' ' TRP . 2.7 tm-20 -103.72 101.8 11.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 1.0 110.325 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.583 ' CE1' ' HB3' ' A' ' 182' ' ' ASP . 19.7 m-30 -108.81 116.41 31.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.258 -0.902 . . . . 1.0 109.346 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -115.67 122.39 45.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 1.0 110.59 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -156.35 163.4 39.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.0 110.242 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.27 167.28 19.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.46 HG11 ' NE2' ' A' ' 175' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.089 -1.007 . . . . 1.0 110.83 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.657 0.742 . . . . 1.0 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.6 p -118.38 149.9 40.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.551 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 23.8 m-80 -133.59 117.31 16.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.032 -1.043 . . . . 1.0 111.158 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 6.5 m-70 -94.87 108.74 20.77 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 41' ' ' ASN . 8.4 m-85 -113.83 118.04 33.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 1.0 111.333 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.492 ' HG2' ' HD3' ' A' ' 106' ' ' LYS . 2.1 mt-10 -127.99 150.62 49.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.183 -0.948 . . . . 1.0 110.577 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER 179.9 153.55 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.266 -0.896 . . . . 1.0 110.552 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 167' ' ' ILE . 0.7 OUTLIER -130.12 149.42 51.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 1.0 109.787 179.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 9.4 pt -131.22 177.28 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.186 -1.006 . . . . 1.0 110.067 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.642 ' O ' ' OG1' ' A' ' 49' ' ' THR . 12.4 tttt -167.0 82.31 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.204 -0.935 . . . . 1.0 111.018 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.642 ' OG1' ' O ' ' A' ' 48' ' ' LYS . 29.5 m -172.03 -114.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.238 0.542 . . . . 1.0 111.095 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.556 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 0.9 OUTLIER -115.04 -47.45 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.683 1.23 . . . . 1.0 109.586 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.593 ' O ' ' CG2' ' A' ' 73' ' ' ILE . . . 34.98 41.99 0.07 Allowed 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.413 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.615 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 64.9 p -85.51 -17.25 36.97 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.87 -1.144 . . . . 1.0 108.537 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.483 ' HG3' ' HA ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -159.95 119.82 2.92 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 154.73 129.05 1.22 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.15 -1.58 . . . . 1.0 109.15 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -81.3 131.12 35.27 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.652 -1.499 . . . . 1.0 109.334 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.602 ' O ' ' CD1' ' A' ' 143' ' ' LEU . 1.3 mp -97.21 -25.75 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.492 -0.755 . . . . 1.0 112.217 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.599 ' CG ' HD13 ' A' ' 143' ' ' LEU . 6.1 tt -148.7 133.74 18.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.723 -1.86 . . . . 1.0 113.211 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.593 ' CG ' HD22 ' A' ' 149' ' ' LEU . 20.4 t-105 -145.73 117.59 8.2 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -137.6 153.03 49.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.841 -1.162 . . . . 1.0 111.024 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' C ' ' OG1' ' A' ' 137' ' ' THR . . . . . . . . 0 N--CA 1.494 2.514 0 N-CA-C 108.579 -1.809 . . . . 1.0 108.579 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.617 ' CD1' ' CG2' ' A' ' 137' ' ' THR . 6.6 t80 . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 120.487 0.184 . . . . 1.0 111.029 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.575 HG21 ' CZ ' ' A' ' 68' ' ' TYR . 1.8 tt -153.79 162.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.523 -1.361 . . . . 1.0 111.843 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.563 ' CB ' ' HE2' ' A' ' 81' ' ' MET . . . -157.71 170.15 23.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 1.0 110.032 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 77.6 mt -145.17 125.79 14.17 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.576 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -152.71 172.36 16.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.94 -1.1 . . . . 1.0 111.325 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.593 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 5.5 mt -127.49 146.01 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 1.0 111.452 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.62 ' CG1' ' CG ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -141.46 122.69 13.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.306 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.1 m-20 73.76 -3.98 2.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.335 -0.853 . . . . 1.0 112.169 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 127.4 -0.65 6.97 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 118.866 -1.635 . . . . 1.0 111.045 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.562 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 25.7 m-85 -133.93 134.13 42.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.93 -1.335 . . . . 1.0 110.545 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -59.97 -167.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 1.0 109.946 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 1.3 pt20 -174.75 97.37 0.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.441 -0.787 . . . . 1.0 109.819 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.566 ' CE ' ' O ' ' A' ' 115' ' ' SER . 3.2 ttp -62.21 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.614 -0.834 . . . . 1.0 109.233 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 12.2 ttp -95.02 108.77 20.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.651 -0.656 . . . . 1.0 110.21 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.62 ' CE2' HG11 ' A' ' 89' ' ' VAL . 1.4 p90 -125.74 138.57 53.87 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.015 -1.474 . . . . 1.0 111.013 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.53 ' OD2' ' CD ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -136.6 94.93 3.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.75 -0.594 . . . . 1.0 110.444 -179.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.531 HD21 ' CD1' ' A' ' 82' ' ' TYR . 0.5 OUTLIER -102.52 3.27 37.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.835 -0.541 . . . . 1.0 110.654 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -136.44 -43.03 0.1 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.302 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 167.72 -20.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.193 -1.181 . . . . 1.0 110.983 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 7.8 mttt -118.8 120.35 31.6 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.097 . . . . 1.0 110.081 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.6 ' HG3' ' CE1' ' A' ' 153' ' ' HIS . 52.6 Cg_endo -78.31 146.62 22.36 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.946 1.498 . . . . 1.0 110.151 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.62 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -112.97 121.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.323 -0.861 . . . . 1.0 108.729 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -102.5 111.29 31.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.09 -1.444 . . . . 1.0 110.427 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.544 ' CD1' ' HE1' ' A' ' 80' ' ' MET . 11.7 mt -105.61 70.05 0.86 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.9 -1.519 . . . . 1.0 106.9 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 20.0 mtp180 -60.5 148.97 35.89 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 122.121 0.963 . . . . 1.0 111.22 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 118' ' ' VAL 0.253 48.2 t -67.57 150.67 48.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.824 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.51 ' N ' HD11 ' A' ' 124' ' ' ILE . 12.1 t -107.57 26.73 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.789 . . . . 1.0 109.023 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 118' ' ' VAL . 2.1 t -139.88 153.3 69.6 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.517 ' HD2' HG12 ' A' ' 95' ' ' VAL . 40.9 Cg_endo -65.84 124.69 13.07 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.661 1.348 . . . . 1.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.435 ' CG1' ' CD1' ' A' ' 47' ' ' ILE . 3.3 tp -109.55 -8.42 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.805 . . . . 1.0 110.03 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 5.4 p-10 -93.77 56.89 2.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.758 . . . . 1.0 109.896 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 99' ' ' THR . 98.1 m -114.61 7.04 15.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.227 -0.921 . . . . 1.0 110.739 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.472 ' HA ' ' CA ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 60.54 10.94 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.331 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -104.47 163.11 12.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 1.0 109.742 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.614 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 15.6 m95 -78.08 91.87 4.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.003 -1.061 . . . . 1.0 110.864 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.449 ' O ' ' HB3' ' A' ' 46' ' ' SER . 22.9 m -86.63 167.5 14.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.76 -0.829 . . . . 1.0 108.76 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.476 ' O ' ' N ' ' A' ' 119' ' ' GLY . 23.1 t60 -123.98 132.45 53.71 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.208 -0.997 . . . . 1.0 109.782 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.78 142.94 41.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.318 -0.864 . . . . 1.0 108.979 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.68 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -148.34 179.65 7.62 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.018 -1.073 . . . . 1.0 109.309 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 108' ' ' TYR . . . -165.11 157.63 15.9 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.808 -1.182 . . . . 1.0 111.824 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 6.0 m-85 -136.21 104.39 5.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 1.0 109.299 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.487 ' NH2' HD13 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -103.02 134.75 45.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.911 -1.118 . . . . 1.0 109.945 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.527 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 3.0 t -130.56 84.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.161 -1.016 . . . . 1.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 32.4 mt-30 53.85 -2.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -179.37 -27.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.042 -1.661 . . . . 1.0 111.066 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.569 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -110.35 115.9 30.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 1.0 110.718 -178.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -103.54 149.89 17.46 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.566 ' O ' ' CE ' ' A' ' 80' ' ' MET . 12.5 t -132.36 155.59 48.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.274 -1.133 . . . . 1.0 110.266 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 1.6 tm? -123.65 144.89 49.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.802 -1.186 . . . . 1.0 108.679 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.68 ' HB3' ' CB ' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -121.04 81.35 1.76 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.411 -0.806 . . . . 1.0 112.3 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.546 ' CG2' ' OG ' ' A' ' 93' ' ' SER . 91.4 t -70.29 80.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.772 -1.171 . . . . 1.0 107.933 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 67.12 59.77 6.61 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.072 -1.211 . . . . 1.0 110.072 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 119' ' ' GLY . 7.8 m120 36.68 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.898 . . . . 1.0 111.25 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -103.18 -161.4 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 1.0 109.919 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -39.82 99.38 0.2 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.555 -0.716 . . . . 1.0 109.375 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.1 Cg_endo -71.17 129.88 16.78 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.211 1.638 . . . . 1.0 110.892 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.51 HD11 ' N ' ' A' ' 94' ' ' THR . 3.0 mt -101.45 102.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 30.2 p -114.06 173.42 6.45 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.261 1.029 . . . . 1.0 112.299 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.498 ' N ' HD22 ' A' ' 91' ' ' LEU . . . -178.09 -171.35 41.37 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.532 -2.227 . . . . 1.0 107.532 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.569 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -159.5 171.01 20.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.597 -1.531 . . . . 1.0 110.892 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.552 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.6 OUTLIER -107.97 -177.89 0.52 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 1.0 110.193 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.8 Cg_endo -69.39 94.88 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 1.0 108.946 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 129' ' ' PRO . 3.4 mp -34.32 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.228 0.537 . . . . 1.0 111.098 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.03 -29.04 1.25 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.614 -1.394 . . . . 1.0 109.614 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.66 135.33 33.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -1.16 . . . . 1.0 110.333 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.422 ' C ' ' HG2' ' A' ' 134' ' ' GLN . 9.7 m -138.38 23.47 2.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 1.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.506 ' O ' ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -158.52 -49.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 1.0 110.398 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER 28.14 64.01 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.232 0.539 . . . . 1.0 111.523 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -52.55 96.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.122 -0.986 . . . . 1.0 110.199 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 68' ' ' TYR . 10.5 t -159.72 -172.88 3.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 1.0 109.759 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 91.59 -19.87 0.12 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 121.298 0.571 . . . . 1.0 110.544 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -47.99 -17.0 0.51 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 120.198 -1.001 . . . . 1.0 110.743 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -128.79 168.36 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.631 -1.511 . . . . 1.0 109.748 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.533 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 0.5 OUTLIER -154.88 145.96 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 1.0 110.861 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.633 ' CZ3' ' CG ' ' A' ' 26' ' ' GLU . 30.2 m95 -136.6 96.47 3.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.131 -1.803 . . . . 1.0 106.131 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.602 ' CD1' ' O ' ' A' ' 56' ' ' ILE . 1.7 tp -112.34 130.05 56.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.97 1.47 . . . . 1.0 114.97 -175.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 106.99 10.05 28.88 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.694 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 124.93 -160.82 19.56 Favored Glycine 0 C--N 1.278 -2.648 0 N-CA-C 107.762 -2.135 . . . . 1.0 107.762 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.713 ' HG3' ' HG ' ' A' ' 149' ' ' LEU . 1.9 mmt -168.78 169.5 9.91 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.282 -1.367 . . . . 1.0 111.059 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.9 11.32 38.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -165.43 16.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.667 -0.646 . . . . 1.0 111.525 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.713 ' HG ' ' HG3' ' A' ' 146' ' ' MET . 9.2 mt -68.42 53.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.402 -1.436 . . . . 1.0 109.865 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 148' ' ' ARG . 10.5 p -55.19 -24.31 26.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.413 -1.699 . . . . 1.0 106.413 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.632 ' CG1' ' CD2' ' A' ' 149' ' ' LEU 0.311 12.7 p -48.21 -118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.051 -1.431 . . . . 1.0 111.86 178.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 159' ' ' TYR . . . 79.81 -23.25 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.11 -0.993 . . . . 1.0 109.993 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.6 ' CE1' ' HG3' ' A' ' 88' ' ' PRO . 0.2 OUTLIER 75.68 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 1.0 111.163 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.577 ' CG ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -150.04 74.92 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.823 -1.173 . . . . 1.0 111.137 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.623 HD13 ' CD1' ' A' ' 159' ' ' TYR . 0.4 OUTLIER -142.47 178.41 1.51 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 120.696 -1.252 . . . . 1.0 110.029 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.62 ' CG ' ' CG1' ' A' ' 74' ' ' VAL . 52.6 Cg_endo -76.76 -164.2 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.707 1.372 . . . . 1.0 111.948 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 161' ' ' THR . 2.8 mttm -51.21 -10.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.609 -0.682 . . . . 1.0 112.131 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.538 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -32.75 -46.52 0.14 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.121 -0.987 . . . . 1.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.661 ' HA ' HD22 ' A' ' 55' ' ' LEU . 3.6 m-85 -83.97 -33.98 24.49 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.558 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -76.06 -1.7 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.977 -1.089 . . . . 1.0 108.813 178.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 157' ' ' LYS . 2.6 m -140.74 83.24 1.88 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.547 -0.72 . . . . 1.0 109.29 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -43.54 165.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.154 -1.578 . . . . 1.0 109.154 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.626 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 32.6 t80 -70.63 142.67 51.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.286 . . . . 1.0 110.485 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.606 ' O ' HG23 ' A' ' 49' ' ' THR . 19.3 mt -119.79 79.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.626 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -165.48 -163.19 18.33 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.521 ' N ' ' OG1' ' A' ' 49' ' ' THR . 1.8 m -114.41 146.92 40.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -1.183 . . . . 1.0 111.585 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.645 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -136.45 152.62 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.166 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.457 ' HG2' ' OD1' ' A' ' 169' ' ' ASP . 13.5 ttp180 -158.6 159.1 35.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 1.0 110.769 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.7 m-20 53.13 79.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 1.0 110.509 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.495 ' C ' ' CG1' ' A' ' 171' ' ' ILE . 28.5 m -128.72 131.71 68.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.495 ' CG1' ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -150.88 149.24 14.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.03 -1.068 . . . . 1.0 110.899 -176.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.535 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 8.9 t -135.25 108.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 1.5 m-20 50.53 42.96 27.33 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.391 -1.443 . . . . 1.0 107.469 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.31 28.7 2.93 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.906 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.546 ' O ' ' HB2' ' A' ' 176' ' ' GLU . 22.3 mt-30 -100.98 -178.13 3.66 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.102 -0.999 . . . . 1.0 109.217 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 4.5 mm-40 69.62 -98.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.634 -0.666 . . . . 1.0 110.44 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER 69.27 -88.02 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.256 -0.903 . . . . 1.0 111.05 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 17.4 m-70 -97.44 103.17 15.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.739 -1.225 . . . . 1.0 111.097 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.5 OUTLIER -67.4 -53.56 28.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 22.1 t -51.47 -23.05 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.699 . . . . 1.0 110.381 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 35.5 mt-10 -71.69 -58.43 3.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 1.0 110.01 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.583 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 12.3 t0 -87.49 -14.63 39.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 1.0 109.619 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -69.65 -34.16 73.62 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.254 -0.904 . . . . 1.0 108.873 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.433 ' HA ' ' CD1' ' A' ' 189' ' ' ILE . 11.3 mt -48.68 -24.23 1.3 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 1.0 108.975 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 1.2 t-20 -57.22 -20.11 25.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.101 0.953 . . . . 1.0 109.009 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.525 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 1.8 t30 -89.61 151.95 46.5 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.525 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 37.5 Cg_endo -61.82 -149.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.3 1.158 . . . . 1.0 109.309 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.504 ' C ' ' O ' ' A' ' 187' ' ' PRO . 20.5 m -33.06 136.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.355 -0.84 . . . . 1.0 111.197 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.471 HG21 HD13 ' A' ' 189' ' ' ILE . 13.4 mt -127.78 153.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.505 -0.747 . . . . 1.0 109.795 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 17' ' ' ILE . 23.1 mt -131.2 155.27 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 1.0 110.648 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 18' ' ' ALA . 1.9 m-70 -92.29 -87.96 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.818 . . . . 1.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 191' ' ' HIS . 5.3 t . . . . . 0 C--N 1.296 -1.759 0 C-N-CA 119.373 -0.931 . . . . 1.0 111.498 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.579 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.1 pt-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 121.459 0.647 . . . . 1.0 110.785 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -112.3 119.41 38.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.533 -1.354 . . . . 1.0 109.79 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.567 ' CG1' ' HB3' ' A' ' 179' ' ' LEU . 10.1 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.533 -1.267 . . . . 1.0 110.421 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -91.15 115.59 28.14 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.731 -0.606 . . . . 1.0 110.532 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.624 ' CZ ' ' CD1' ' A' ' 167' ' ' ILE . 5.0 m-30 -74.52 167.6 21.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 1.0 109.114 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 23' ' ' THR . 1.4 p-10 -117.57 -10.13 10.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.057 -1.027 . . . . 1.0 110.18 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 105.45 -9.28 45.07 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.54 ' CD ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -147.04 21.16 1.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.167 -1.196 . . . . 1.0 110.055 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m -115.62 102.81 10.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.0 109.867 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.632 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -67.12 117.46 9.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 1.0 111.015 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.509 ' HE3' HG23 ' A' ' 17' ' ' ILE . 3.4 mmm -106.8 98.56 8.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.689 -1.257 . . . . 1.0 108.27 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.606 ' OE1' ' CZ3' ' A' ' 142' ' ' TRP . 4.6 pt-20 -107.84 152.3 24.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.311 -0.868 . . . . 1.0 110.261 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 3.3 m-85 -130.48 124.66 32.49 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.243 -0.983 . . . . 1.0 110.001 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.502 ' CE1' ' HB3' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -97.55 89.64 4.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.567 -0.708 . . . . 1.0 110.287 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -88.67 151.72 22.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 1.0 109.781 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.32 108.4 19.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.172 -0.955 . . . . 1.0 110.666 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.496 ' CG1' ' NE2' ' A' ' 175' ' ' GLN . 19.1 m . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 1.0 110.003 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.515 ' HG2' ' N ' ' A' ' 40' ' ' SER . 31.8 tt0 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.949 0.88 . . . . 1.0 109.18 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.515 ' N ' ' HG2' ' A' ' 39' ' ' GLN . 5.7 m -157.03 119.15 3.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.19 0.519 . . . . 1.0 110.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -103.67 163.3 12.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 1.0 110.439 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.507 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 59.1 m-70 -139.07 132.84 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 1.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.509 ' HB2' ' CB ' ' A' ' 107' ' ' ALA . 93.5 m-85 -135.24 115.44 13.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.57 -0.706 . . . . 1.0 109.625 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 mp0 -123.72 144.19 49.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.823 -1.173 . . . . 1.0 109.756 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.569 ' HB2' ' CG1' ' A' ' 170' ' ' VAL . 0.8 OUTLIER -178.38 159.39 1.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.393 -0.923 . . . . 1.0 110.882 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.481 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 1.0 OUTLIER -123.49 154.38 39.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 166' ' ' CYS . 1.9 pt -148.14 156.01 9.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 117.907 -1.517 . . . . 1.0 112.045 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.621 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -105.94 86.45 2.38 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 176.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.568 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -75.27 153.36 38.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.125 -1.03 . . . . 1.0 112.841 -175.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 3.2 mm-40 -143.48 1.97 1.23 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.434 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.39 128.78 24.18 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.047 -1.033 . . . . 1.0 110.285 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.511 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 58.3 p -62.88 -15.4 54.72 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.379 -0.826 . . . . 1.0 110.844 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.513 ' HG2' ' N ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -129.82 135.65 48.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.846 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 159.33 137.14 2.17 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -90.84 126.24 35.97 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.051 -1.264 . . . . 1.0 108.797 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.582 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.25 -34.32 6.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.067 0.766 . . . . 1.0 113.067 -176.298 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.618 ' CB ' ' HB2' ' A' ' 71' ' ' LEU . 3.1 tt -142.76 151.91 41.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.018 -1.676 . . . . 1.0 113.338 -175.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.488 ' O ' ' HB2' ' A' ' 142' ' ' TRP . 9.6 t-105 -162.88 107.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -114.35 137.27 52.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.661 -1.274 . . . . 1.0 111.023 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 108.37 -1.892 . . . . 1.0 108.37 179.307 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 1.1 t80 . . . . . 0 N--CA 1.504 2.267 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.629 ' CG1' ' CE1' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -130.06 172.88 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.734 -1.229 . . . . 1.0 111.001 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' C ' ' HG ' ' A' ' 71' ' ' LEU . . . -174.95 174.67 2.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.692 -0.63 . . . . 1.0 109.636 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.618 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 70.8 mt -152.43 117.59 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.92 -1.113 . . . . 1.0 109.146 -178.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -132.79 171.07 14.37 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 1.0 112.011 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.56 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 30.7 mt -121.86 139.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.476 -0.765 . . . . 1.0 111.559 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.548 ' CG1' ' CZ ' ' A' ' 92' ' ' ARG . 11.7 p -141.43 144.66 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.675 -0.64 . . . . 1.0 110.112 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 52.94 27.07 5.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.142 -0.974 . . . . 1.0 110.614 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 80.42 14.32 80.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 7.5 m-85 -126.64 148.52 49.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 1.0 110.071 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.582 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -99.15 168.05 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.06 -1.025 . . . . 1.0 109.757 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 22.9 pt20 -160.17 123.23 3.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.098 -1.001 . . . . 1.0 110.944 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.564 ' CE ' HD22 ' A' ' 91' ' ' LEU . 5.4 tmm? -86.83 113.61 22.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.38 -0.825 . . . . 1.0 109.119 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.585 ' SD ' ' CE1' ' A' ' 153' ' ' HIS . 2.2 ptt? -100.94 141.12 34.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 1.0 110.765 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.629 ' CE1' ' CG1' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -120.19 105.43 10.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 1.0 110.583 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 85' ' ' GLY . 6.4 t0 -120.86 40.38 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 1.0 109.901 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -39.17 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.569 -0.707 . . . . 1.0 112.132 -178.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -142.8 -50.34 0.04 OUTLIER Glycine 0 N--CA 1.494 2.527 0 C-N-CA 118.862 -1.637 . . . . 1.0 110.83 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.41 ' C ' ' HG3' ' A' ' 87' ' ' LYS . 1.1 m -173.7 22.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -1.2 . . . . 1.0 110.717 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.562 ' CB ' ' HB3' ' A' ' 128' ' ' SER . 0.0 OUTLIER -129.99 80.91 70.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 1.0 109.292 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 42.5 Cg_endo -68.92 89.66 0.44 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.025 1.54 . . . . 1.0 111.192 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -75.18 155.23 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -127.99 119.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.321 -1.487 . . . . 1.0 110.801 178.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' A' ' 125' ' ' THR . 10.6 mp -112.73 69.25 0.69 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.548 ' CZ ' ' CG1' ' A' ' 74' ' ' VAL . 4.6 mtt180 -56.78 178.01 0.07 Allowed 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.668 -1.213 . . . . 1.0 109.822 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.483 ' HA ' ' CD1' ' A' ' 124' ' ' ILE . 3.0 t -95.68 169.57 9.93 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.693 -0.629 . . . . 1.0 110.16 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.503 HG22 ' HB1' ' A' ' 122' ' ' ALA . 14.0 t -121.22 16.46 11.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 1.0 109.062 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.515 ' CG2' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.84 160.56 60.32 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.661 -0.649 . . . . 1.0 109.331 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.515 ' HD2' ' CG2' ' A' ' 95' ' ' VAL . 44.3 Cg_endo -70.06 138.48 36.95 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.859 1.452 . . . . 1.0 110.358 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.482 ' CG2' ' O ' ' A' ' 76' ' ' GLY . 2.7 tp -121.53 -30.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.096 -1.002 . . . . 1.0 110.706 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 11.2 p30 -73.7 57.45 0.58 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 1.0 109.544 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 99' ' ' THR . 16.8 m -114.12 19.77 16.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.563 -0.711 . . . . 1.0 110.282 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 46.7 22.28 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 1.0 110.921 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.475 ' HB2' HG23 ' A' ' 99' ' ' THR . 0.1 OUTLIER -115.32 144.94 43.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.056 -1.028 . . . . 1.0 110.1 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.621 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 7.5 m95 -59.46 95.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 1.0 109.881 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 104' ' ' HIS . 26.5 m -94.09 164.7 12.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.156 -0.965 . . . . 1.0 109.485 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.507 ' N ' HG22 ' A' ' 103' ' ' THR . 40.6 t-80 -116.34 147.64 41.39 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.258 -0.901 . . . . 1.0 108.614 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.468 HD12 HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -134.97 152.74 33.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.126 -0.984 . . . . 1.0 109.365 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.534 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -138.57 146.23 41.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.8 -1.188 . . . . 1.0 110.329 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 43' ' ' PHE . . . -143.93 92.35 2.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 1.0 110.675 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.598 ' CZ ' ' OG ' ' A' ' 115' ' ' SER . 47.9 p90 -112.18 107.53 16.45 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.056 -1.058 . . . . 1.0 109.014 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.575 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -109.67 130.66 55.49 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.969 -178.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' A' ' 111' ' ' GLN . 4.2 t -104.5 102.15 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.415 -0.803 . . . . 1.0 109.506 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.534 ' HA ' ' NH2' ' A' ' 109' ' ' ARG . 10.0 pt20 38.65 100.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.581 0.705 . . . . 1.0 112.469 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.538 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 1.1 ptt85 70.18 -50.0 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 1.0 111.644 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.6 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -81.49 112.09 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.785 -1.197 . . . . 1.0 110.019 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.575 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -103.39 159.65 16.9 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.144 -1.027 . . . . 1.0 111.732 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.598 ' OG ' ' CZ ' ' A' ' 108' ' ' TYR . 1.0 OUTLIER -137.35 151.93 49.14 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.835 -0.803 . . . . 1.0 109.656 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -138.33 153.6 48.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.083 -1.011 . . . . 1.0 109.406 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.596 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 1.1 mt-30 -158.28 111.32 2.38 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.768 -1.173 . . . . 1.0 111.644 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 90.7 t -71.29 97.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 64.54 43.12 97.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 1.0 109.509 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.9 OUTLIER 61.84 36.53 15.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -1.136 . . . . 1.0 110.713 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -96.29 -162.93 1.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.123 -0.985 . . . . 1.0 110.791 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.503 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -43.2 118.17 2.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 1.0 109.246 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 47.7 Cg_endo -73.27 115.22 4.26 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.068 1.562 . . . . 1.0 112.436 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.54 ' CB ' ' O ' ' A' ' 92' ' ' ARG . 4.1 mp -91.23 102.08 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.597 ' HA ' HD21 ' A' ' 91' ' ' LEU . 15.9 p -116.96 179.93 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.502 1.144 . . . . 1.0 112.874 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.432 ' C ' ' OG ' ' A' ' 127' ' ' SER . . . 169.42 -173.2 43.74 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 106.667 -2.573 . . . . 1.0 106.667 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.6 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -160.46 162.03 33.04 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.471 -1.605 . . . . 1.0 110.686 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.562 ' HB3' ' CB ' ' A' ' 87' ' ' LYS . 19.8 m -111.21 161.31 25.69 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.148 -0.97 . . . . 1.0 110.222 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.547 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.7 Cg_endo -68.16 78.32 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.972 1.511 . . . . 1.0 108.811 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.547 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.4 mt -12.99 131.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.596 0.712 . . . . 1.0 112.815 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.45 ' O ' ' HB1' ' A' ' 132' ' ' ALA . . . 161.85 99.62 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.537 ' O ' ' CG2' ' A' ' 133' ' ' THR . . . 173.68 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.459 -1.024 . . . . 1.0 109.716 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 132' ' ' ALA . 5.7 t 42.69 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.465 0.65 . . . . 1.0 110.779 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 133' ' ' THR . 0.0 OUTLIER 40.0 26.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 1.0 110.704 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.545 ' O ' ' CG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -89.87 36.62 0.86 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.118 -0.989 . . . . 1.0 109.5 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.7 OUTLIER -51.37 171.03 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.053 -1.029 . . . . 1.0 109.076 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 137' ' ' THR . 3.0 t -113.16 133.41 55.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.037 -1.039 . . . . 1.0 109.748 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 140' ' ' ALA . 28.9 p-10 -84.67 30.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 1.0 110.32 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 44.84 24.1 0.68 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.502 ' HB3' ' CE1' ' A' ' 28' ' ' HIS . . . -116.75 151.67 35.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.146 . . . . 1.0 109.839 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.597 ' CD1' ' CD2' ' A' ' 57' ' ' LEU . 11.9 tp -154.22 150.05 27.65 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.482 -0.887 . . . . 1.0 110.639 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.624 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 8.0 m95 -126.48 118.19 24.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.074 -1.454 . . . . 1.0 107.074 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 1.1 tt -125.59 120.01 29.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 117.812 -1.555 . . . . 1.0 112.651 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 124.76 8.21 5.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.515 ' HA2' HD22 ' A' ' 55' ' ' LEU . . . 136.66 -134.34 7.06 Favored Glycine 0 C--N 1.291 -1.923 0 C-N-CA 119.007 -1.568 . . . . 1.0 109.848 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.582 ' HE2' ' CD2' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -170.74 158.94 6.27 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.424 -0.911 . . . . 1.0 111.712 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -92.23 -14.88 28.29 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -143.5 51.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.576 HD13 ' CB ' ' A' ' 146' ' ' MET . 10.0 tp -65.5 49.3 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.878 0.696 . . . . 1.0 112.878 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.5 p -73.83 -19.67 60.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 105.167 -2.16 . . . . 1.0 105.167 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.535 ' CG1' HD11 ' A' ' 149' ' ' LEU 0.267 3.9 p -61.55 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.588 -1.187 . . . . 1.0 109.909 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.642 ' CB ' ' CD2' ' A' ' 159' ' ' TYR . . . 53.77 20.15 2.16 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.408 -1.432 . . . . 1.0 110.195 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.585 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 48.1 m80 32.98 -85.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.83 -0.544 . . . . 1.0 112.323 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ALA . 2.9 ptpp? -134.67 -29.83 1.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 1.0 113.082 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.684 ' HG ' ' CD2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -60.34 138.44 91.99 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.684 -1.26 . . . . 1.0 109.078 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.553 ' N ' HD12 ' A' ' 155' ' ' LEU . 56.4 Cg_endo -81.54 -92.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.902 1.475 . . . . 1.0 114.642 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -55.03 -47.56 74.6 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.045 1.869 . . . . 1.0 116.045 -174.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.591 ' CB ' ' CD1' ' A' ' 155' ' ' LEU . . . -41.57 -44.19 2.94 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 120.731 1.605 . . . . 1.0 108.987 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.684 ' CD2' ' HG ' ' A' ' 155' ' ' LEU . 30.6 m-85 -84.39 -25.67 28.92 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.632 -1.227 . . . . 1.0 108.572 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.545 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -78.19 -3.28 41.85 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.336 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.526 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.2 m -135.02 82.81 1.98 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.19 166.46 0.01 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.653 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 12.9 t80 -65.79 143.56 57.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.394 . . . . 1.0 112.046 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.612 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 4.6 mt -122.02 85.14 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.653 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.33 -156.41 11.75 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 48' ' ' LYS . 1.7 m -127.73 142.34 51.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.529 -0.983 . . . . 1.0 110.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.624 ' CD1' ' CZ ' ' A' ' 19' ' ' PHE . 3.3 mt -126.78 147.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.755 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.478 ' CG ' ' N ' ' A' ' 169' ' ' ASP . 0.2 OUTLIER -160.28 170.79 20.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 1.0 110.231 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.478 ' N ' ' CG ' ' A' ' 168' ' ' ARG . 1.3 m-20 41.71 67.83 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 1.0 109.852 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.569 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 33.1 m -124.38 126.47 72.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 O-C-N 121.063 -1.023 . . . . 1.0 109.895 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 175' ' ' GLN . 0.3 OUTLIER -134.67 151.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.889 -1.125 . . . . 1.0 111.666 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.566 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 2.4 p -134.32 108.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.553 ' C ' ' HG3' ' A' ' 174' ' ' ARG . 68.6 m-20 59.98 67.92 0.82 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.492 -1.67 . . . . 1.0 106.492 -176.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.553 ' HG3' ' C ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 35.34 28.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.473 -0.785 . . . . 1.0 111.633 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 8.6 mt-30 -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.294 -0.879 . . . . 1.0 109.644 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' CD2' ' A' ' 178' ' ' HIS . 18.3 tt0 -78.1 107.76 10.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 1.0 110.619 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.3 mt -90.0 85.24 6.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 1.0 110.53 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.577 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 1.8 m170 -56.96 114.42 2.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 1.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.596 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 3.6 mm? -59.3 -38.28 79.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.355 -0.841 . . . . 1.0 111.767 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.402 HG22 HD13 ' A' ' 17' ' ' ILE . 56.1 t -85.21 -39.62 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.196 0.813 . . . . 1.0 113.196 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 14.2 mt-10 -57.78 -49.51 76.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.463 -1.398 . . . . 1.0 110.913 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 31.9 m-20 -87.54 -19.01 28.49 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.461 -0.774 . . . . 1.0 110.928 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.596 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -60.57 -34.95 74.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.52 -1.272 . . . . 1.0 108.452 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.2 mt -50.83 -22.76 2.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.715 -0.615 . . . . 1.0 109.805 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -51.2 -22.47 2.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.172 -0.955 . . . . 1.0 108.894 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.502 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 2.0 t-20 -99.52 156.13 35.74 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.502 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 39.0 Cg_endo -65.17 -56.49 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.238 1.125 . . . . 1.0 110.948 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 189' ' ' ILE . 5.8 t -103.11 146.49 28.3 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.594 -0.691 . . . . 1.0 110.375 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 188' ' ' THR . 2.9 mp -139.99 124.29 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 1.0 110.349 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 20.8 mt -109.56 159.36 17.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 1.0 109.559 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -101.61 -81.68 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.832 -1.168 . . . . 1.0 111.075 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.29 -2.011 0 O-C-N 121.052 -1.03 . . . . 1.0 110.098 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.595 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.0 pt-20 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.514 0.674 . . . . 1.0 110.661 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -81.21 158.85 24.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.22 -1.55 . . . . 1.0 110.481 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.503 ' CG2' ' HE2' ' A' ' 25' ' ' MET . 12.3 mm -119.78 116.45 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 1.0 110.224 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 191' ' ' HIS . . . -81.12 122.73 27.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.418 -0.801 . . . . 1.0 110.537 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.599 ' CZ ' HD12 ' A' ' 167' ' ' ILE . 3.0 m-85 -86.15 166.97 15.34 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.598 -0.89 . . . . 1.0 108.598 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -127.37 3.07 6.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.84 -1.162 . . . . 1.0 111.083 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 99.88 -18.87 55.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.326 -1.51 . . . . 1.0 109.326 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 14.3 ttt180 -118.79 22.39 12.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.293 -1.122 . . . . 1.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 172.96 12.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 1.0 110.873 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.656 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -166.04 87.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.579 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 26.8 mtt -90.34 101.39 14.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.658 -1.276 . . . . 1.0 110.517 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 8.8 pt-20 -83.08 110.57 18.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.243 -0.91 . . . . 1.0 108.657 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 47.8 m-85 -100.95 99.24 9.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.975 -1.078 . . . . 1.0 110.387 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.461 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -93.14 103.35 15.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 1.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -94.96 164.58 12.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 1.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.3 94.36 9.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.283 -0.885 . . . . 1.0 110.405 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.488 HG21 ' CA ' ' A' ' 139' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.317 -0.864 . . . . 1.0 109.779 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.506 ' CG ' ' N ' ' A' ' 40' ' ' SER . 1.3 tt0 . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 108.935 -0.765 . . . . 1.0 108.935 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -169.92 157.91 6.96 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.154 -1.018 . . . . 1.0 112.302 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -130.12 139.22 50.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 1.0 109.886 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.517 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 71.1 m-70 -110.45 125.71 53.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.319 -0.863 . . . . 1.0 109.95 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.552 ' CE2' HG21 ' A' ' 172' ' ' VAL . 26.9 m-85 -140.16 119.34 12.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.921 . . . . 1.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -127.48 151.54 48.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.749 -1.22 . . . . 1.0 110.817 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.522 ' HB2' ' CG1' ' A' ' 170' ' ' VAL . 0.9 OUTLIER 178.86 150.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 1.0 110.991 179.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.5 m -114.06 150.25 34.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.521 ' CD1' HD13 ' A' ' 97' ' ' ILE . 1.4 pt -144.38 153.3 15.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 117.821 -1.552 . . . . 1.0 112.583 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.604 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.5 OUTLIER -109.82 83.07 1.69 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.491 ' OG1' HG12 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -73.65 148.06 43.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.266 1.031 . . . . 1.0 112.808 -175.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 5.3 mm-40 -124.62 -18.49 5.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.711 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.85 130.3 46.71 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.729 -0.607 . . . . 1.0 109.677 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.515 HG21 ' CA ' ' A' ' 76' ' ' GLY . 1.9 p -60.92 -8.08 2.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 1.0 111.073 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.437 ' CG ' ' HA ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -130.66 134.19 46.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.71 -1.244 . . . . 1.0 110.673 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.86 135.8 1.89 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.203 -1.559 . . . . 1.0 109.203 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.703 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -92.99 127.33 38.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.632 -1.511 . . . . 1.0 109.291 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.583 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -96.67 -27.05 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.715 . . . . 1.0 112.408 -176.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.596 ' CD2' ' CD1' ' A' ' 141' ' ' LEU . 6.0 tt -144.28 146.18 32.46 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.246 -1.534 . . . . 1.0 112.58 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.556 ' CH2' HG22 ' A' ' 151' ' ' VAL . 5.4 t-105 -159.6 116.33 2.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.782 -0.574 . . . . 1.0 109.538 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.47 120.47 38.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.085 -1.01 . . . . 1.0 110.316 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.867 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.567 ' CE1' ' CB ' ' A' ' 83' ' ' ASP . 2.4 p90 . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 122.052 0.93 . . . . 1.0 110.461 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 82' ' ' TYR . 1.5 mt -132.32 167.47 26.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.151 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.545 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -171.02 178.12 3.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.216 -0.927 . . . . 1.0 110.874 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 83.2 mt -146.66 129.88 16.58 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.604 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -150.77 165.11 34.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.833 -1.167 . . . . 1.0 112.559 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.9 mt -104.54 137.94 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.706 0.765 . . . . 1.0 110.654 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.516 ' CG1' ' OE1' ' A' ' 79' ' ' GLN . 2.3 p -139.87 118.63 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.738 -0.601 . . . . 1.0 110.097 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 2.2 m-20 67.26 3.65 3.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 1.0 111.235 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.515 ' CA ' HG21 ' A' ' 52' ' ' THR . . . 113.97 4.17 22.78 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.343 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.7 m-85 -131.41 126.67 35.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.053 -1.263 . . . . 1.0 109.701 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -59.43 -173.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.929 -1.107 . . . . 1.0 110.461 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 9.0 pt20 -176.33 101.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.019 0.914 . . . . 1.0 110.133 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.62 ' CE ' ' O ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -78.47 126.01 30.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 5.0 ptt? -122.8 146.48 47.5 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.106 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.701 ' CZ ' ' CG1' ' A' ' 89' ' ' VAL . 4.3 p90 -129.77 120.56 25.25 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.888 -1.525 . . . . 1.0 110.519 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.567 ' CB ' ' CE1' ' A' ' 68' ' ' TYR . 12.7 t70 -94.05 47.4 1.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.313 0.578 . . . . 1.0 110.568 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.61 HD23 ' CD1' ' A' ' 82' ' ' TYR . 0.5 OUTLIER -62.83 -10.8 14.46 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -144.44 41.55 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.959 -1.257 . . . . 1.0 109.959 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 77.49 -35.28 0.21 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.5 -1.0 . . . . 1.0 111.516 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 87' ' ' LYS . 5.8 mmmm -102.51 103.84 34.32 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.767 -1.208 . . . . 1.0 110.362 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 51.6 Cg_endo -74.46 116.78 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.191 1.627 . . . . 1.0 111.234 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.701 ' CG1' ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -71.91 172.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 178.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.567 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 1.2 t -144.27 107.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.635 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.549 ' CD1' ' HA ' ' A' ' 125' ' ' THR . 3.0 mm? -95.23 90.11 5.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.293 -1.743 . . . . 1.0 106.293 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 30.7 mtp180 -73.22 154.09 40.38 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.988 -1.085 . . . . 1.0 110.271 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.3 t -68.62 143.6 54.77 Favored 'General case' 0 C--N 1.288 -2.075 0 O-C-N 120.986 -1.071 . . . . 1.0 109.925 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.54 ' HB ' ' CD1' ' A' ' 124' ' ' ILE . 4.7 t -94.25 21.09 7.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.756 -1.215 . . . . 1.0 110.035 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.582 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 19.6 t -135.16 149.08 69.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 1.0 109.956 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.582 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 40.6 Cg_endo -66.53 134.39 35.43 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.681 1.358 . . . . 1.0 110.123 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.521 HD13 ' CD1' ' A' ' 47' ' ' ILE . 1.8 tt -125.15 -26.36 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 1.0 110.627 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.476 ' N ' HG22 ' A' ' 97' ' ' ILE . 8.7 p30 -70.73 58.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.212 -0.93 . . . . 1.0 110.475 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 7.8 t -130.91 22.31 4.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.339 -0.851 . . . . 1.0 109.956 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 m120 56.84 24.79 9.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.107 -0.996 . . . . 1.0 110.733 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.528 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 15.2 m80 -113.23 152.97 29.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.03 . . . . 1.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.604 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 15.6 m95 -74.54 97.21 3.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.095 -1.003 . . . . 1.0 109.93 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 46' ' ' SER . 24.7 m -93.1 141.41 28.44 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.203 -0.999 . . . . 1.0 108.713 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 119' ' ' GLY . 25.5 t60 -98.49 142.49 30.04 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.425 -0.91 . . . . 1.0 108.566 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 105' ' ' ILE . 0.4 OUTLIER -140.78 156.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.964 -1.085 . . . . 1.0 110.218 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.467 ' O ' HD21 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -149.21 128.62 13.0 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.426 -0.796 . . . . 1.0 110.016 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 116' ' ' LEU . . . -115.25 102.57 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.208 -0.933 . . . . 1.0 110.979 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 108' ' ' TYR . 2.9 p90 -117.38 109.4 16.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 1.0 109.381 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.4 OUTLIER -103.49 142.86 33.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.35 -0.844 . . . . 1.0 110.848 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 109' ' ' ARG . 1.5 t -127.91 122.46 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.466 -0.771 . . . . 1.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 113' ' ' GLU . 23.1 mt-30 37.83 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 1.0 111.037 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.53 ' O ' ' OH ' ' A' ' 82' ' ' TYR . 11.4 mmt85 65.34 -56.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.356 -0.84 . . . . 1.0 111.738 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.592 ' N ' ' HB3' ' A' ' 127' ' ' SER . 0.0 OUTLIER -67.1 114.72 6.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.945 0.878 . . . . 1.0 111.794 -176.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -100.25 159.19 19.39 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.62 ' O ' ' CE ' ' A' ' 80' ' ' MET . 12.5 t -141.04 148.84 40.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.527 -0.984 . . . . 1.0 109.925 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.539 ' C ' ' HG3' ' A' ' 117' ' ' GLN . 1.0 OUTLIER -145.81 131.15 18.58 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.036 -1.04 . . . . 1.0 110.042 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.539 ' HG3' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -135.37 145.3 47.21 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.937 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.554 HG13 ' CG2' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -89.81 113.68 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 52.14 46.09 56.73 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER 65.43 43.44 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -1.085 . . . . 1.0 111.38 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 2.2 mt-10 -105.5 -162.14 0.85 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.251 -0.905 . . . . 1.0 110.643 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.415 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -49.92 115.87 5.68 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.237 -0.915 . . . . 1.0 109.558 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.53 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 46.2 Cg_endo -73.57 119.08 5.75 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.879 1.462 . . . . 1.0 111.672 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -86.32 118.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.549 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 12.3 p -126.73 171.65 11.01 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.606 -1.237 . . . . 1.0 113.628 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.534 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 169.51 153.62 8.62 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.513 -2.635 . . . . 1.0 106.513 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.592 ' HB3' ' N ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -119.71 163.48 17.36 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.607 -1.525 . . . . 1.0 111.028 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -67.64 -176.85 0.28 Allowed Pre-proline 0 C--N 1.3 -1.579 0 C-N-CA 119.906 -0.717 . . . . 1.0 109.207 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 131' ' ' GLY . 48.1 Cg_endo -74.59 42.44 0.8 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.548 1.288 . . . . 1.0 110.24 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.479 ' HG ' ' C ' ' A' ' 129' ' ' PRO . 0.1 OUTLIER 34.63 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.841 0.829 . . . . 1.0 109.991 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -131.9 106.75 0.68 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.958 -1.257 . . . . 1.0 109.958 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.518 ' O ' ' CG2' ' A' ' 133' ' ' THR . . . 178.17 -54.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.5 -1.0 . . . . 1.0 109.88 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 132' ' ' ALA . 7.4 t 39.73 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.462 -0.773 . . . . 1.0 111.027 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -161.58 111.97 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.056 -1.028 . . . . 1.0 110.714 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -166.73 135.32 2.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 1.0 109.369 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 135' ' ' LEU . 14.2 m-20 -140.47 179.58 6.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.331 -0.856 . . . . 1.0 109.415 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 137' ' ' THR . 4.8 t -115.41 132.62 56.56 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.052 -1.03 . . . . 1.0 109.883 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.512 ' OD2' ' CB ' ' A' ' 140' ' ' ALA . 7.9 p-10 -78.77 13.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 1.0 110.44 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.488 ' CA ' HG21 ' A' ' 31' ' ' VAL . . . 54.69 18.38 10.83 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.283 -1.927 . . . . 1.0 108.283 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.512 ' CB ' ' OD2' ' A' ' 138' ' ' ASP . . . -136.47 170.34 16.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.443 -1.034 . . . . 1.0 109.937 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.596 ' CD1' ' CD2' ' A' ' 57' ' ' LEU . 12.3 tp -160.83 155.51 23.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.284 -0.885 . . . . 1.0 110.702 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.649 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 9.9 m95 -131.32 136.76 48.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.58 ' CD1' ' O ' ' A' ' 56' ' ' ILE . 5.1 tp -140.97 123.74 16.15 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.593 -1.643 . . . . 1.0 113.321 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.32 1.05 12.63 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 110.098 -1.201 . . . . 1.0 110.098 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.471 ' HA2' HD23 ' A' ' 55' ' ' LEU . . . 144.05 -129.02 3.48 Favored Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.902 -1.679 . . . . 1.0 108.902 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.601 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -171.2 126.63 0.67 Allowed 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.358 -0.937 . . . . 1.0 111.747 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -12.69 27.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 1.0 108.872 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.578 ' N ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -152.73 61.59 0.8 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 146' ' ' MET . 10.0 tp -64.39 44.33 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.386 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 148' ' ' ARG . 83.7 p -55.0 -28.83 55.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.587 ' CG1' HD11 ' A' ' 149' ' ' LEU 0.29 6.2 p -62.76 -135.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 114.414 -1.267 . . . . 1.0 108.137 177.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.593 ' HA ' HD22 ' A' ' 155' ' ' LEU . . . 54.56 18.06 1.87 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.936 -1.102 . . . . 1.0 110.861 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -79.58 0.18 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.942 -1.099 . . . . 1.0 112.928 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.491 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -52.03 -14.04 0.37 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.0 112.234 -177.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.643 HD22 ' CD2' ' A' ' 159' ' ' TYR . 1.6 pp -99.61 168.75 9.06 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.842 -1.162 . . . . 1.0 110.337 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 43.6 Cg_endo -68.33 -176.73 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.55 1.29 . . . . 1.0 113.228 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -62.05 -13.95 31.29 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.977 -0.556 . . . . 1.0 112.27 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.475 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -41.13 -35.12 0.53 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 1.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.703 ' CE2' ' CD1' ' A' ' 55' ' ' LEU . 5.4 m-85 -83.94 -30.12 26.54 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.32 -0.952 . . . . 1.0 109.766 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -68.67 -8.9 46.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.796 -1.162 . . . . 1.0 108.895 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.504 ' O ' ' O ' ' A' ' 162' ' ' GLY . 1.2 m -128.8 86.43 2.44 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -39.63 164.31 0.01 OUTLIER Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.212 -1.155 . . . . 1.0 110.212 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.656 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 35.9 t80 -79.14 144.03 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.027 -1.278 . . . . 1.0 111.396 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.536 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 2.9 mt -128.98 68.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.656 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -148.83 -162.62 10.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.913 -2.075 . . . . 1.0 107.913 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.51 ' C ' HG13 ' A' ' 167' ' ' ILE . 13.4 m -118.97 148.05 43.4 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.405 -1.644 . . . . 1.0 111.138 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.599 HD12 ' CZ ' ' A' ' 19' ' ' PHE . 3.5 mt -131.95 151.14 34.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.651 -0.656 . . . . 1.0 109.504 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.544 ' HD3' ' N ' ' A' ' 169' ' ' ASP . 0.0 OUTLIER -161.6 151.75 17.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 1.0 110.178 -178.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.544 ' N ' ' HD3' ' A' ' 168' ' ' ARG . 36.1 m-20 56.44 75.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.455 -0.778 . . . . 1.0 109.972 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.522 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 26.9 m -128.32 122.45 57.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.699 -0.801 . . . . 1.0 109.559 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.47 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -132.73 156.59 42.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.459 -0.896 . . . . 1.0 111.124 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.552 HG21 ' CE2' ' A' ' 43' ' ' PHE . 6.6 t -134.35 104.65 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.7 OUTLIER 50.31 40.66 23.05 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.455 -1.403 . . . . 1.0 107.477 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER 72.7 27.68 2.23 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.054 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 29.0 mt-30 -103.08 177.66 4.78 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.039 -1.038 . . . . 1.0 110.703 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 6.0 tt0 66.12 -105.36 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.826 -0.547 . . . . 1.0 110.923 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 67.01 -58.11 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.301 -0.874 . . . . 1.0 111.232 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.563 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.3 m-70 -80.34 73.73 7.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.763 -1.21 . . . . 1.0 110.135 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 3.6 mt -49.8 -58.85 4.55 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.152 0.977 . . . . 1.0 112.217 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 30.1 t -74.39 -19.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.5 mt-10 -67.55 -62.26 1.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.351 -1.468 . . . . 1.0 110.002 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -71.84 -19.61 61.95 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 1.0 109.2 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 180' ' ' VAL . . . -68.44 -27.42 66.16 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.508 -0.877 . . . . 1.0 108.81 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 10.5 mt -57.66 -16.46 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 1.0 109.178 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -57.97 -14.61 6.71 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.496 -0.752 . . . . 1.0 109.699 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.434 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 13.0 t30 -127.42 148.88 68.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.52 -0.737 . . . . 1.0 109.1 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.441 ' O ' HG13 ' A' ' 189' ' ' ILE . 46.9 Cg_endo -73.63 -44.81 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.701 1.369 . . . . 1.0 110.81 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.07 103.1 0.7 Allowed 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.637 0.732 . . . . 1.0 110.639 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.452 HG21 HD12 ' A' ' 189' ' ' ILE . 6.5 mt -144.46 98.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.465 ' O ' HG21 ' A' ' 17' ' ' ILE . 33.9 mt -111.92 152.6 27.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 1.0 110.81 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.53 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 8.1 m-70 -95.84 -174.61 3.18 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.469 -0.769 . . . . 1.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 1.0 110.476 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.5 pt-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.297 0.57 . . . . 1.0 110.858 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -68.35 158.22 33.98 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.136 -1.603 . . . . 1.0 109.487 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.508 HG23 ' CE ' ' A' ' 25' ' ' MET . 17.3 mm -136.92 108.96 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.027 -1.046 . . . . 1.0 110.579 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 190' ' ' LEU . . . -78.82 138.4 38.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.741 . . . . 1.0 110.234 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.592 ' CZ ' HD12 ' A' ' 167' ' ' ILE . 3.7 m-85 -104.16 175.36 5.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 1.0 109.633 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 1.9 p30 -128.37 -14.43 4.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 1.0 111.084 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 115.51 -13.84 18.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.909 -1.677 . . . . 1.0 108.909 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.91 15.11 4.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.44 -1.035 . . . . 1.0 109.109 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.418 ' OG1' ' OD2' ' A' ' 20' ' ' ASP . 3.1 m -75.63 174.65 9.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.596 -0.69 . . . . 1.0 110.185 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.552 ' OH ' ' N ' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -147.62 103.67 3.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.526 -0.734 . . . . 1.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.586 ' HG3' ' CE2' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -99.35 101.53 12.85 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.774 -1.204 . . . . 1.0 109.186 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.521 ' HG2' ' CE3' ' A' ' 142' ' ' TRP . 14.9 mt-10 -95.88 136.72 35.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 1.0 109.485 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.586 ' CE2' ' HG3' ' A' ' 25' ' ' MET . 69.8 m-85 -131.29 99.05 4.72 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.216 -0.994 . . . . 1.0 110.475 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.45 118.69 37.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 1.0 110.215 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.467 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 12.1 t-20 -140.44 156.73 46.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 1.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.67 149.14 23.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.961 . . . . 1.0 110.142 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 1.0 109.907 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.025 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -171.07 167.87 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.252 -1.53 . . . . 1.0 111.38 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -138.79 116.04 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.513 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 0.3 OUTLIER -89.96 143.67 26.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.118 -0.989 . . . . 1.0 110.956 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.587 ' CE1' ' CG2' ' A' ' 172' ' ' VAL . 51.2 m-85 -138.17 106.85 5.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.637 -0.664 . . . . 1.0 110.074 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 3.5 mt-10 -114.78 145.82 41.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.98 -1.075 . . . . 1.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -179.45 152.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.529 -0.868 . . . . 1.0 111.244 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' A' ' 103' ' ' THR . 1.5 m -118.52 152.71 35.46 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 105' ' ' ILE . 2.2 pt -148.34 157.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 117.897 -1.521 . . . . 1.0 112.152 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.609 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 2.5 tttt -113.15 84.3 1.98 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.504 ' OG1' ' CG1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -67.31 147.25 53.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 1.0 111.193 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.659 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 2.3 mm-40 -129.34 6.79 5.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.808 -0.757 . . . . 1.0 111.0 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.629 ' O ' ' CG2' ' A' ' 52' ' ' THR . . . -134.77 -85.97 0.4 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.91 -1.119 . . . . 1.0 110.624 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.629 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.98 -25.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.88 139.03 54.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.716 -0.615 . . . . 1.0 109.419 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 158.67 135.88 1.96 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.436 -1.364 . . . . 1.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.584 ' HA ' ' CB ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -85.33 121.53 28.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 1.0 108.963 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.596 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -96.66 -29.25 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.782 -0.574 . . . . 1.0 112.482 -176.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 6.4 tt -147.73 152.9 38.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.39 -1.444 . . . . 1.0 113.145 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.575 ' CB ' ' SD ' ' A' ' 146' ' ' MET . 4.2 t-105 -162.61 107.26 1.14 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.589 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.51 149.6 42.16 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.13 -0.981 . . . . 1.0 108.784 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.577 0 C-N-CA 119.313 -1.422 . . . . 1.0 110.846 -179.283 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.591 ' CZ ' ' O ' ' A' ' 84' ' ' LEU . 10.1 m-85 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 113.159 0.8 . . . . 1.0 113.159 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 68' ' ' TYR . 5.5 mm -148.01 153.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.839 -1.788 . . . . 1.0 113.566 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 57' ' ' LEU . . . -177.69 166.58 2.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 93.4 mt -150.72 99.83 2.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.445 -1.41 . . . . 1.0 109.945 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -114.06 175.09 5.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.306 -0.871 . . . . 1.0 111.837 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 20.4 mt -115.34 138.3 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.827 -0.546 . . . . 1.0 110.056 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.475 HG11 ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -141.23 125.3 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 110.516 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 5.9 m-20 62.77 33.98 14.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.335 -0.853 . . . . 1.0 111.739 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.532 ' HA2' ' CG2' ' A' ' 52' ' ' THR . . . 81.43 8.08 87.52 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.741 -1.219 . . . . 1.0 110.41 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -129.36 165.89 20.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.272 . . . . 1.0 109.382 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.596 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -116.05 164.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 1.0 110.679 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.546 ' OE1' ' CG2' ' A' ' 90' ' ' VAL . 6.9 pt20 -149.66 133.3 16.77 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.565 -0.854 . . . . 1.0 111.432 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.547 ' CE ' ' O ' ' A' ' 115' ' ' SER . 6.7 tmm? -99.24 120.12 39.02 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 7.3 ptt? -120.24 143.54 48.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.87 -1.144 . . . . 1.0 111.569 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.635 ' CE2' ' CG1' ' A' ' 89' ' ' VAL . 19.6 p90 -139.85 129.03 23.81 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.531 -1.268 . . . . 1.0 110.905 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 86' ' ' SER . 66.7 t0 -120.45 60.82 0.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.232 1.015 . . . . 1.0 109.378 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.591 ' O ' ' CZ ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -38.35 -35.65 0.19 Allowed 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.705 -179.062 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.28 -54.77 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.527 -1.32 . . . . 1.0 110.887 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 3.4 t -163.28 -22.84 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.393 . . . . 1.0 112.269 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HD2' ' HG3' ' A' ' 129' ' ' PRO . 4.7 mmtp -98.86 100.58 10.02 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.66 -1.275 . . . . 1.0 110.21 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 86' ' ' SER . 47.0 Cg_endo -72.5 141.96 35.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.926 1.487 . . . . 1.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.635 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.97 126.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.546 ' CG2' ' OE1' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -103.93 120.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 117.802 -1.559 . . . . 1.0 110.328 178.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.535 ' CA ' HG22 ' A' ' 124' ' ' ILE . 33.3 mt -113.09 71.94 0.76 Allowed 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 2.9 mtt180 -58.7 179.16 0.09 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.138 0.971 . . . . 1.0 110.822 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.412 ' OG ' HG21 ' A' ' 118' ' ' VAL . 1.6 t -105.82 155.77 18.98 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.721 -0.612 . . . . 1.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.45 ' HB ' HD13 ' A' ' 124' ' ' ILE . 15.2 t -111.19 26.87 10.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 1.0 109.912 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.542 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 8.3 t -133.77 147.38 64.11 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.445 -0.785 . . . . 1.0 109.62 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.7 Cg_endo -67.47 138.32 45.69 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.629 1.331 . . . . 1.0 110.554 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.504 ' CG1' ' OG1' ' A' ' 49' ' ' THR . 0.6 OUTLIER -126.91 -30.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 1.0 110.686 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.488 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 31.2 p-10 -72.54 62.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 1.0 110.52 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.507 HG21 ' CG ' ' A' ' 101' ' ' HIS . 15.2 t -124.86 13.18 8.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 1.0 109.868 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.471 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 0.7 OUTLIER 62.95 10.6 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.239 -0.913 . . . . 1.0 111.236 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.507 ' CG ' HG21 ' A' ' 99' ' ' THR . 2.6 m-70 -102.51 175.15 5.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.87 -1.143 . . . . 1.0 110.288 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.609 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 27.0 m95 -92.95 105.84 17.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.9 . . . . 1.0 110.074 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 46' ' ' SER . 47.4 m -99.31 171.06 8.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.274 -0.891 . . . . 1.0 109.597 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 119' ' ' GLY . 12.0 t-80 -125.02 130.18 51.81 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.085 -1.009 . . . . 1.0 108.423 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 47' ' ' ILE . 1.9 mt -123.46 159.6 27.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.128 -0.982 . . . . 1.0 110.123 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.513 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.8 tppt? -149.84 147.99 28.63 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.184 -1.006 . . . . 1.0 110.039 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.485 ' HB3' ' HE3' ' A' ' 80' ' ' MET . . . -151.52 108.3 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.604 -0.685 . . . . 1.0 109.954 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 20.0 p90 -120.88 105.39 10.65 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.05 -1.06 . . . . 1.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.558 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 3.8 ttp180 -72.17 123.84 23.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.575 -0.703 . . . . 1.0 110.006 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' GLN . 3.6 t -110.08 88.51 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.076 -1.015 . . . . 1.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.573 ' O ' ' O ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER 35.4 103.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.144 0.497 . . . . 1.0 110.934 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.567 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 66.1 -53.71 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.286 -0.884 . . . . 1.0 110.235 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.635 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.6 tt0 -87.08 120.88 28.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.756 -1.215 . . . . 1.0 110.811 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.28 161.83 12.56 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.929 -1.129 . . . . 1.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 15.5 t -136.43 162.11 33.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.307 -1.114 . . . . 1.0 111.174 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 117' ' ' GLN . 1.4 tm? -147.4 139.15 24.11 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.584 ' CG ' ' HB3' ' A' ' 123' ' ' PRO . 3.6 mt-30 -142.83 146.26 33.99 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.686 -1.205 . . . . 1.0 111.67 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 1.8 t -104.19 101.69 12.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.498 -1.667 . . . . 1.0 106.498 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 70.65 33.5 67.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.717 -1.753 . . . . 1.0 108.717 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.27 38.07 26.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.518 -0.99 . . . . 1.0 110.312 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -108.77 -156.97 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.66 -0.65 . . . . 1.0 110.826 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.91 99.66 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.709 -0.62 . . . . 1.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.584 ' HB3' ' CG ' ' A' ' 117' ' ' GLN . 48.5 Cg_endo -73.23 131.36 16.42 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 O-C-N 124.314 1.691 . . . . 1.0 112.009 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.535 HG22 ' CA ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -97.19 101.96 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 176.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 61.4 p -107.07 170.6 7.85 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.154 0.978 . . . . 1.0 112.023 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.66 157.6 18.89 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 107.644 -2.183 . . . . 1.0 107.644 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.635 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -133.63 162.66 31.32 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.866 -1.373 . . . . 1.0 110.275 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 5.0 p -90.08 172.18 7.46 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 1.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.486 ' HG3' ' HD2' ' A' ' 87' ' ' LYS . 51.6 Cg_endo -80.82 36.58 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.728 1.383 . . . . 1.0 109.133 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.503 HD11 ' NH1' ' A' ' 112' ' ' ARG . 1.5 mt 43.8 -162.91 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.5 -0.75 . . . . 1.0 110.307 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.02 -29.69 11.95 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.54 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.438 -1.036 . . . . 1.0 109.747 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -154.4 97.61 2.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 1.0 110.281 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 133' ' ' THR . 1.3 tt0 43.76 -158.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 1.0 110.131 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -160.31 104.08 1.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 1.0 110.348 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -92.55 176.5 6.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 1.0 109.514 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 137' ' ' THR . 3.2 t -138.15 136.58 36.82 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.891 -1.131 . . . . 1.0 110.055 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 140' ' ' ALA . 44.9 p-10 -89.06 22.78 2.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 1.0 109.457 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 52.52 18.15 5.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.943 -1.663 . . . . 1.0 108.943 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.461 ' HB2' ' OD2' ' A' ' 138' ' ' ASP . . . -109.63 150.18 28.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 1.0 109.273 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.594 ' CD1' ' CD2' ' A' ' 57' ' ' LEU . 7.4 tp -160.66 156.35 25.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 1.0 111.122 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.522 ' N ' ' HG ' ' A' ' 141' ' ' LEU . 76.5 m95 -131.7 105.43 7.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.919 -1.512 . . . . 1.0 106.919 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 3.6 tp -116.95 116.42 27.37 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.24 -1.384 . . . . 1.0 113.602 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 132.29 -1.04 4.86 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 119.668 -1.253 . . . . 1.0 110.638 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.536 ' O ' ' SD ' ' A' ' 146' ' ' MET . . . 154.37 -154.95 25.87 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 117.956 -2.069 . . . . 1.0 109.731 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.593 ' CB ' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -154.05 139.38 17.61 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.254 -0.978 . . . . 1.0 112.941 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.552 ' N ' ' OH ' ' A' ' 24' ' ' TYR . 40.9 tt0 -68.43 -50.91 49.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.582 0.706 . . . . 1.0 109.665 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -116.15 69.8 0.75 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.541 -1.281 . . . . 1.0 107.541 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.593 HD21 ' CB ' ' A' ' 146' ' ' MET . 0.1 OUTLIER -65.33 49.52 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.439 -0.788 . . . . 1.0 112.976 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 148' ' ' ARG . 88.0 p -83.34 -10.08 58.69 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.975 -1.861 . . . . 1.0 105.975 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.535 HG21 ' CZ3' ' A' ' 58' ' ' TRP . 4.9 p -79.86 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 115.227 -0.897 . . . . 1.0 110.336 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.593 ' HB2' ' CG ' ' A' ' 159' ' ' TYR . . . 53.18 38.17 26.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.326 -1.484 . . . . 1.0 108.546 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.477 ' C ' ' O ' ' A' ' 152' ' ' ALA . 59.8 m170 3.92 -95.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.771 1.397 . . . . 1.0 114.771 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.478 ' CE ' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -98.31 26.59 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 1.0 112.739 -176.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.634 ' CD2' ' HB1' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -156.55 131.81 5.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 120.649 -1.282 . . . . 1.0 110.031 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 160' ' ' SER . 55.1 Cg_endo -92.14 -66.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.793 1.418 . . . . 1.0 113.747 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.586 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.49 -56.9 15.43 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 114.403 1.26 . . . . 1.0 114.403 -176.062 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.634 ' HB1' ' CD2' ' A' ' 155' ' ' LEU . . . -41.38 -41.23 1.93 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.44 -1.413 . . . . 1.0 108.103 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.606 ' CE1' HD21 ' A' ' 155' ' ' LEU . 21.8 m-85 -83.27 -32.13 26.57 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.957 -1.097 . . . . 1.0 108.141 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -67.71 -10.51 53.15 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.107 -1.037 . . . . 1.0 109.079 178.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 162' ' ' GLY . 1.4 m -129.56 99.33 5.13 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -49.76 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.658 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 19.3 t80 -79.76 148.19 31.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -1.175 . . . . 1.0 112.49 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.659 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 3.8 mt -124.94 82.32 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.658 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.48 -163.49 26.4 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.533 -1.827 . . . . 1.0 108.533 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.457 ' C ' HG13 ' A' ' 167' ' ' ILE . 24.1 m -122.88 151.02 42.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.012 -1.287 . . . . 1.0 110.431 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.592 HD12 ' CZ ' ' A' ' 19' ' ' PHE . 3.5 mt -127.35 152.37 35.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.46 ' NH1' ' OD2' ' A' ' 169' ' ' ASP . 13.9 ttt-85 -159.09 148.37 18.64 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.049 -1.06 . . . . 1.0 110.721 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.46 ' OD2' ' NH1' ' A' ' 168' ' ' ARG . 93.6 m-20 52.5 84.52 0.05 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.877 -0.729 . . . . 1.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.459 HG11 ' HB2' ' A' ' 45' ' ' LEU . 20.7 m -127.78 131.2 70.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 C-N-CA 119.586 -0.845 . . . . 1.0 108.889 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.531 ' CG2' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -145.91 144.43 20.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 118.964 -1.094 . . . . 1.0 111.237 -177.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.587 ' CG2' ' CE1' ' A' ' 43' ' ' PHE . 3.0 p -132.14 121.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 28.8 m-20 47.59 31.68 2.16 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.721 -1.237 . . . . 1.0 108.634 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 76.04 10.37 3.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.794 -0.566 . . . . 1.0 111.413 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.543 ' O ' ' HB3' ' A' ' 176' ' ' GLU . 1.6 mp0 -91.84 -171.89 3.01 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.944 -1.098 . . . . 1.0 109.851 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.543 ' HB3' ' O ' ' A' ' 175' ' ' GLN . 1.2 tt0 72.52 -107.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.614 -0.679 . . . . 1.0 110.084 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.531 HD13 ' CG2' ' A' ' 171' ' ' ILE . 0.1 OUTLIER 67.18 -83.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.038 -1.039 . . . . 1.0 112.227 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.0 m-70 -60.75 84.75 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.947 -1.096 . . . . 1.0 111.079 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -55.74 -58.15 9.05 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.216 1.007 . . . . 1.0 111.354 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.554 ' O ' ' CD1' ' A' ' 184' ' ' LEU . 85.9 t -65.29 -23.56 33.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.898 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.525 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.2 mt-10 -63.6 -52.32 61.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.283 -1.511 . . . . 1.0 110.327 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.56 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 3.6 m-20 -94.98 -3.12 49.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.234 -0.916 . . . . 1.0 110.216 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 180' ' ' VAL . . . -78.24 -28.91 47.92 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.263 -0.975 . . . . 1.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 184' ' ' LEU . 8.1 mp -59.27 -15.3 14.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 1.0 109.173 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 4.2 t-20 -51.23 -24.09 4.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.472 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 3.6 t30 -97.3 148.79 34.92 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.472 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 41.3 Cg_endo -67.48 -55.38 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.658 1.346 . . . . 1.0 111.588 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.441 ' C ' HG13 ' A' ' 189' ' ' ILE . 5.1 m -101.46 132.4 47.08 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.371 -0.831 . . . . 1.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.441 HG13 ' C ' ' A' ' 188' ' ' THR . 3.8 mt -130.46 111.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.73 . . . . 1.0 109.494 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.74 175.92 8.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.267 -0.896 . . . . 1.0 109.338 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.529 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.59 18.85 4.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.581 -1.247 . . . . 1.0 111.109 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . 0.448 ' CA ' ' HB2' ' A' ' 18' ' ' ALA . 1.5 t . . . . . 0 C--N 1.299 -1.609 0 O-C-N 121.308 -0.87 . . . . 1.0 109.71 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.0 tt0 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.383 0.611 . . . . 1.0 109.457 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -116.49 138.26 51.52 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.471 -0.768 . . . . 1.0 111.356 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 0.8 OUTLIER -123.22 146.53 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 192' ' ' CYS . . . -113.53 122.79 48.31 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.21 -0.931 . . . . 1.0 111.153 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.64 ' CE2' ' CD1' ' A' ' 167' ' ' ILE . 8.5 m-30 -87.88 148.03 24.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.457 -0.777 . . . . 1.0 109.3 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' HB ' ' A' ' 23' ' ' THR . 7.0 p-10 -103.4 2.47 33.92 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.181 -0.949 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.86 65.21 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.303 -1.519 . . . . 1.0 109.303 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.48 23.35 4.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -1.207 . . . . 1.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.464 ' HB ' ' OD1' ' A' ' 20' ' ' ASP . 5.2 t -109.55 163.26 13.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.898 . . . . 1.0 110.066 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.58 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 14.7 p90 -147.04 123.22 10.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 1.0 110.301 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.467 ' HG2' ' OH ' ' A' ' 27' ' ' TYR . 4.6 mtt -98.48 99.95 11.16 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.778 -1.201 . . . . 1.0 109.364 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 14.1 tt0 -88.87 98.51 11.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.509 -0.744 . . . . 1.0 109.989 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 13.1 m-30 -96.58 111.69 23.73 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.989 -1.07 . . . . 1.0 110.589 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -104.24 118.03 35.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.449 -0.782 . . . . 1.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 139' ' ' GLY . 9.4 m-20 -140.41 128.45 22.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 1.0 110.391 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.2 141.54 38.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 1.0 109.499 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.094 . . . . 1.0 111.027 -179.518 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.383 0.611 . . . . 1.0 109.889 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.1 p -157.85 155.36 29.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 1.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 1.7 m-20 -131.66 160.15 36.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 1.0 110.486 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 20.8 m-70 -130.43 115.99 17.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 1.0 109.952 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 23.1 m-30 -119.5 114.81 22.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.179 -0.951 . . . . 1.0 109.816 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.5 ' C ' ' CD2' ' A' ' 45' ' ' LEU . 1.4 mp0 -125.21 140.65 52.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 1.0 110.794 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.6 OUTLIER 179.84 159.26 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.098 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.507 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.64 161.19 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.507 ' CG2' ' C ' ' A' ' 46' ' ' SER . 7.4 pt -150.29 170.87 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 117.995 -1.482 . . . . 1.0 112.615 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.555 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 4.1 tttm -131.82 85.35 2.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.542 HG22 ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -72.01 156.42 39.24 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.045 -1.034 . . . . 1.0 111.609 -177.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.1 mm-40 -136.9 -4.84 1.94 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.222 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.633 ' O ' ' CG2' ' A' ' 52' ' ' THR . . . -125.79 -82.54 0.63 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.144 -0.972 . . . . 1.0 110.429 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.633 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 158.57 -20.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.255 0.55 . . . . 1.0 109.641 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -130.2 146.46 51.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 1.0 110.353 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 149.2 135.11 2.45 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.685 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -82.31 132.42 35.22 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.943 -1.327 . . . . 1.0 110.008 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.57 HD12 ' CG1' ' A' ' 78' ' ' VAL . 3.9 mp -97.84 -8.8 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 1.0 111.391 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.615 ' HB3' HD12 ' A' ' 71' ' ' LEU 0.292 6.5 tt -168.96 146.08 3.66 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 117.643 -1.623 . . . . 1.0 113.012 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.653 ' CE2' ' CG2' ' A' ' 151' ' ' VAL . 12.5 t-105 -150.89 118.2 6.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.661 . . . . 1.0 109.318 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.431 ' HB3' HD11 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -130.01 122.98 29.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.075 -1.016 . . . . 1.0 109.874 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.158 -1.577 . . . . 1.0 109.158 -179.908 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.63 ' CZ ' ' CB ' ' A' ' 83' ' ' ASP . 7.8 p90 . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 122.024 0.916 . . . . 1.0 109.953 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 82' ' ' TYR . 5.2 mt -146.14 119.27 2.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.646 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.584 ' CB ' ' CE ' ' A' ' 81' ' ' MET . . . -140.95 -178.05 5.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.753 -1.217 . . . . 1.0 110.68 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.615 HD12 ' HB3' ' A' ' 57' ' ' LEU . 3.6 mp -149.24 116.06 5.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.684 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -129.19 178.87 6.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.173 -0.955 . . . . 1.0 111.842 -178.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.542 HG13 ' CD1' ' A' ' 56' ' ' ILE . 4.0 mt -120.43 134.43 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.431 -0.793 . . . . 1.0 109.745 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.519 HG23 ' NE2' ' A' ' 79' ' ' GLN . 1.3 t -141.09 134.03 30.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.203 -0.935 . . . . 1.0 110.367 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 59.66 22.04 10.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.325 -0.859 . . . . 1.0 110.682 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 84.72 31.61 23.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -146.9 130.3 16.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -1.086 . . . . 1.0 110.079 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.57 ' CG1' HD12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -78.16 -177.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 92' ' ' ARG . 2.6 pt20 176.5 133.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.664 -1.273 . . . . 1.0 111.491 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.548 ' CG ' ' O ' ' A' ' 80' ' ' MET . 0.0 OUTLIER -91.14 109.43 20.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 1.0 109.219 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.584 ' CE ' ' CB ' ' A' ' 70' ' ' ALA . 8.3 ptt? -94.01 106.35 18.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.917 -1.114 . . . . 1.0 109.779 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.579 ' CE1' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -93.47 127.73 39.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.226 -0.921 . . . . 1.0 109.965 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.63 ' CB ' ' CZ ' ' A' ' 68' ' ' TYR . 5.7 t0 -131.88 43.2 3.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.054 -1.059 . . . . 1.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.513 HD13 ' CB ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -64.37 -10.62 25.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.45 -0.9 . . . . 1.0 110.155 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -139.78 39.23 1.54 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.696 -1.24 . . . . 1.0 110.707 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.27 -8.22 1.37 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -1.201 . . . . 1.0 111.773 179.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 9.4 mmtt -109.12 102.96 50.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 120.783 -1.198 . . . . 1.0 109.76 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.487 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 45.9 Cg_endo -73.63 105.4 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.219 1.641 . . . . 1.0 110.836 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.597 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -85.21 106.58 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.196 -0.94 . . . . 1.0 109.135 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.553 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 7.9 p -86.38 81.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.138 -1.602 . . . . 1.0 111.269 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.54 ' CA ' HG22 ' A' ' 124' ' ' ILE . 29.1 mt -71.97 70.12 0.75 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.539 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 11.5 mtp180 -64.35 171.53 3.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.547 -0.861 . . . . 1.0 110.347 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.2 t -96.96 152.19 18.96 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.788 -0.57 . . . . 1.0 109.761 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.3 t -102.25 26.85 7.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.924 -1.11 . . . . 1.0 109.407 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.557 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 9.0 t -128.31 147.69 64.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 1.0 109.177 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 43.3 Cg_endo -68.03 132.31 25.97 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.533 1.281 . . . . 1.0 110.228 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.469 ' O ' ' OG1' ' A' ' 49' ' ' THR . 0.7 OUTLIER -110.94 -30.8 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.867 . . . . 1.0 110.701 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.43 ' HB3' HG21 ' A' ' 52' ' ' THR . 14.9 p-10 -69.09 61.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.032 -1.042 . . . . 1.0 109.415 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.517 HG21 ' HB2' ' A' ' 101' ' ' HIS . 19.0 m -122.43 10.34 9.82 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.498 -0.751 . . . . 1.0 109.999 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 99' ' ' THR . 6.8 m120 55.25 15.64 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 1.0 110.515 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.517 ' HB2' HG21 ' A' ' 99' ' ' THR . 0.1 OUTLIER -109.03 172.68 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 1.0 109.435 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.555 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 45.3 m95 -94.7 118.12 31.21 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.075 -1.016 . . . . 1.0 111.004 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 104' ' ' HIS . 54.3 m -116.5 152.36 34.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.518 ' N ' HG22 ' A' ' 103' ' ' THR . 65.0 t-80 -101.77 156.73 17.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.882 -1.136 . . . . 1.0 108.987 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -145.84 154.65 13.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.132 -0.98 . . . . 1.0 109.614 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -148.21 147.62 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 1.0 109.905 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.457 ' HA ' HD23 ' A' ' 116' ' ' LEU . . . -139.72 99.19 3.64 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.651 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.637 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 52.6 p90 -110.0 106.83 16.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.958 -1.089 . . . . 1.0 109.136 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.548 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 4.5 tmm_? -94.11 144.7 25.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.543 -0.723 . . . . 1.0 111.28 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 15.4 t -128.56 116.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.8 mm-40 59.19 -89.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 1.0 109.954 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 127' ' ' SER . 2.6 ptt180 -128.08 -28.01 2.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.546 -0.721 . . . . 1.0 110.521 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.619 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 10.6 tt0 -82.47 114.9 21.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 1.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -102.17 156.76 18.54 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.637 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 40.6 t -129.81 151.16 50.69 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.481 -1.011 . . . . 1.0 109.896 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.515 ' C ' ' HG3' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -148.9 126.32 11.58 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.127 -0.983 . . . . 1.0 110.812 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.543 ' CG ' ' HA ' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -134.66 135.53 42.14 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.849 -1.157 . . . . 1.0 110.254 178.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 118' ' ' VAL . 1.2 t -81.67 101.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . 71.29 40.81 60.38 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.011 -1.636 . . . . 1.0 109.011 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 36.0 m-80 61.64 27.68 17.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.467 -1.019 . . . . 1.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 2.4 mt-10 -93.0 -158.12 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.2 -0.937 . . . . 1.0 110.866 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 124' ' ' ILE . . . -41.15 109.92 0.68 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.443 -0.785 . . . . 1.0 109.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 117' ' ' GLN . 44.5 Cg_endo -73.28 119.15 5.84 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.977 1.514 . . . . 1.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.54 HG22 ' CA ' ' A' ' 91' ' ' LEU . 1.8 mp -95.19 100.07 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.704 -1.591 . . . . 1.0 106.704 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 114' ' ' GLY . 12.3 p -109.03 148.99 29.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.177 0.989 . . . . 1.0 112.161 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.502 ' N ' HD22 ' A' ' 91' ' ' LEU . . . -152.2 161.31 29.33 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 106.786 -2.526 . . . . 1.0 106.786 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.619 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -135.52 159.01 42.94 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.68 -1.483 . . . . 1.0 111.029 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.579 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -94.61 -177.61 0.69 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.669 -0.645 . . . . 1.0 109.634 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 38.1 Cg_endo -64.14 102.25 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.376 -1.432 . . . . 1.0 108.376 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.486 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.3 pp -33.46 153.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.399 0.618 . . . . 1.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 132' ' ' ALA . . . 99.77 -64.92 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.311 -1.516 . . . . 1.0 109.311 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.513 ' CB ' HD13 ' A' ' 84' ' ' LEU . . . 39.18 -145.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.477 -1.014 . . . . 1.0 109.842 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 134' ' ' GLN . 2.4 p -154.84 59.59 0.67 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.019 -1.051 . . . . 1.0 110.57 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 133' ' ' THR . 5.2 mt-30 56.94 153.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 1.0 110.078 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 69' ' ' ILE . 13.6 tp -135.82 109.61 8.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.978 -1.076 . . . . 1.0 110.654 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.5 m-20 -106.92 158.75 16.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 1.0 109.557 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -113.65 153.28 29.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.075 -1.016 . . . . 1.0 110.281 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 140' ' ' ALA . 28.0 p-10 -90.91 27.13 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.268 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 44.75 23.77 0.61 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.712 -1.755 . . . . 1.0 108.712 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -133.51 152.39 51.9 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.388 -1.066 . . . . 1.0 109.158 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.495 ' CD1' HD21 ' A' ' 57' ' ' LEU . 8.0 tp -158.61 161.36 37.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.105 -0.997 . . . . 1.0 110.703 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.601 ' CG ' ' HE1' ' A' ' 146' ' ' MET . 45.0 m95 -127.59 159.67 33.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.551 ' CD2' ' O ' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -153.91 118.84 5.02 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 116.873 -1.931 . . . . 1.0 113.801 -177.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . 111.26 5.66 26.37 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.477 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 134.27 -136.22 8.47 Favored Glycine 0 C--N 1.283 -2.366 0 C-N-CA 118.542 -1.789 . . . . 1.0 109.917 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.666 ' CB ' HD12 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -167.3 126.1 1.34 Allowed 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.892 -1.123 . . . . 1.0 112.037 -178.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.553 ' HB2' ' CG ' ' A' ' 24' ' ' TYR . 6.5 tp10 -58.74 -19.27 38.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.535 ' N ' ' HD3' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -146.03 69.69 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.468 -1.679 . . . . 1.0 106.468 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.666 HD12 ' CB ' ' A' ' 146' ' ' MET . 3.5 tp -71.81 41.09 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.55 0.945 . . . . 1.0 113.55 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 p -76.79 -9.56 58.77 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.477 -1.675 . . . . 1.0 106.477 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.653 ' CG2' ' CE2' ' A' ' 58' ' ' TRP 0.269 8.2 p -72.66 -26.37 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.044 -0.98 . . . . 1.0 111.238 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.636 ' CB ' ' CD2' ' A' ' 159' ' ' TYR . . . -40.23 -27.52 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.286 -0.884 . . . . 1.0 110.197 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 151' ' ' VAL . 28.7 m170 70.8 -92.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.324 0.583 . . . . 1.0 110.496 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -139.6 -4.11 1.45 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 111.217 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.592 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 3.7 pp -47.16 170.01 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 1.0 108.608 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 37.6 Cg_endo -61.12 178.4 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.331 1.174 . . . . 1.0 112.173 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -60.42 -6.7 1.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -0.865 . . . . 1.0 111.738 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -42.02 -38.98 1.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.91 -1.119 . . . . 1.0 108.934 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.685 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 3.8 m-85 -79.3 -34.0 42.79 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.323 -0.951 . . . . 1.0 109.113 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -65.64 -11.77 47.58 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.337 -0.945 . . . . 1.0 109.597 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 161' ' ' THR . 1.2 m -123.89 82.66 2.05 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.581 -0.699 . . . . 1.0 109.302 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 161' ' ' THR . . . -41.04 159.21 0.03 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.647 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 8.4 t80 -76.93 141.64 40.4 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.909 -1.348 . . . . 1.0 112.183 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.621 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 6.0 mt -121.36 84.69 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.647 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.46 -154.38 9.45 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.427 -1.869 . . . . 1.0 108.427 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.501 ' C ' HG13 ' A' ' 167' ' ' ILE . 3.6 m -130.19 153.7 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.128 -1.219 . . . . 1.0 111.232 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.64 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.5 mt -134.76 153.19 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 3.6 ttt-85 -158.79 153.98 25.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.624 -1.298 . . . . 1.0 111.538 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 59.8 m-20 50.29 81.64 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.622 -0.674 . . . . 1.0 110.992 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 19.4 m -123.3 130.6 74.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.145 -1.022 . . . . 1.0 110.174 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.527 HD12 HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -138.51 144.36 30.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.246 -0.982 . . . . 1.0 110.948 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.549 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 70.1 t -127.89 91.22 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 12.3 m-20 57.96 50.87 9.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.574 -1.329 . . . . 1.0 107.855 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 37.6 mmm-85 61.56 34.74 17.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.708 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 3.1 mm100 -112.46 164.51 13.19 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.088 -1.007 . . . . 1.0 109.596 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.55 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 0.0 OUTLIER 71.5 -109.94 0.05 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.0 110.563 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.658 ' CD1' ' CE1' ' A' ' 178' ' ' HIS . 0.2 OUTLIER 55.24 11.97 0.62 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 1.0 112.088 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.658 ' CE1' ' CD1' ' A' ' 177' ' ' LEU . 58.7 m-70 -144.45 75.5 1.46 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.996 -1.065 . . . . 1.0 108.776 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 183' ' ' ALA 0.25 7.9 mp -54.64 -55.04 33.76 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.199 1.0 . . . . 1.0 111.17 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.452 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 4.9 t -63.2 -16.48 17.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.884 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.544 ' CG ' ' HB3' ' A' ' 178' ' ' HIS . 16.1 mt-10 -71.55 -51.54 22.96 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.882 -1.127 . . . . 1.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.519 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 82.1 m-20 -96.49 -14.96 21.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.559 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -65.78 -38.12 88.15 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.28 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.0 mt -45.6 -25.75 0.51 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 1.0 109.336 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -53.04 -23.14 6.89 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.155 0.979 . . . . 1.0 108.466 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.521 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 1.7 t-20 -98.72 160.78 27.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.694 -1.224 . . . . 1.0 107.694 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 37.6 Cg_endo -62.94 -157.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.87 0.932 . . . . 1.0 111.119 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 187' ' ' PRO . 7.3 m -36.14 137.43 0.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 1.0 111.228 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.9 mm -86.5 156.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.502 -0.749 . . . . 1.0 109.985 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 17' ' ' ILE . 18.6 mt -127.51 152.88 47.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 1.0 110.885 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.489 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -107.36 157.5 17.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.305 -0.872 . . . . 1.0 109.618 179.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . 0.508 ' HA ' ' CB ' ' A' ' 18' ' ' ALA . 38.9 t . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.0 111.704 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.49 ' OE1' ' NE2' ' A' ' 191' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--O 1.214 -0.767 0 CA-C-O 121.886 0.851 . . . . 1.0 109.821 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -108.46 148.83 29.62 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.906 -0.496 . . . . 1.0 109.91 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.526 ' CG2' ' HE2' ' A' ' 25' ' ' MET . 13.3 mm -121.56 131.69 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 1.0 109.251 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 192' ' ' CYS . . . -96.18 130.1 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 1.0 110.998 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CZ ' ' SD ' ' A' ' 25' ' ' MET . 5.8 m-30 -94.89 174.71 6.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.389 -0.819 . . . . 1.0 109.473 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 10.0 p-10 -127.58 -6.82 5.73 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.235 -0.916 . . . . 1.0 110.546 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.468 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 98.38 -1.66 58.88 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 52.0 ttp85 -134.92 -5.71 2.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.947 -1.326 . . . . 1.0 110.947 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -87.42 140.27 29.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.774 -1.204 . . . . 1.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CD2' ' HA ' ' A' ' 147' ' ' GLU . 3.0 p90 -112.26 95.21 5.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.298 -0.876 . . . . 1.0 110.188 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.56 ' SD ' ' CZ ' ' A' ' 19' ' ' PHE . 8.7 mtt -77.06 100.76 5.79 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.465 -0.894 . . . . 1.0 109.902 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 3.4 pm0 -107.29 121.91 45.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 1.0 110.606 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.542 ' HA ' ' CB ' ' A' ' 182' ' ' ASP . 17.4 m-85 -111.03 107.96 17.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.414 -0.804 . . . . 1.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.95 112.84 24.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 1.0 110.152 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.479 ' OD1' ' OE1' ' A' ' 175' ' ' GLN . 1.7 t-20 -127.77 137.44 52.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 1.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.44 27.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 1.0 110.0 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.004 -1.06 . . . . 1.0 110.412 179.831 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.455 ' O ' HG12 ' A' ' 110' ' ' VAL . 3.2 pt20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.686 0.755 . . . . 1.0 110.688 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 47.8 m -149.25 148.72 29.91 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.376 -0.828 . . . . 1.0 110.454 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.02 147.18 36.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 1.0 110.158 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 30.7 m80 -123.01 123.36 40.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 1.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 26.5 m-85 -122.18 117.83 27.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 1.0 109.535 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.479 ' C ' ' CD2' ' A' ' 45' ' ' LEU . 1.4 mt-10 -126.74 139.87 52.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 1.0 110.882 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.4 OUTLIER 179.1 164.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.489 -0.884 . . . . 1.0 111.003 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 103' ' ' THR . 50.0 m -124.7 149.71 46.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.352 -1.351 . . . . 1.0 107.352 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.514 HD12 HD12 ' A' ' 105' ' ' ILE . 3.7 pt -139.36 164.41 24.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.163 -1.415 . . . . 1.0 112.312 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.57 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.2 OUTLIER -116.45 86.9 2.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 177.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -72.31 155.67 39.92 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.977 -1.077 . . . . 1.0 111.063 -177.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.4 mm-40 -138.21 10.19 2.77 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.755 -0.778 . . . . 1.0 110.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.623 ' O ' ' CG2' ' A' ' 52' ' ' THR . . . -140.43 -85.51 0.21 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.117 -0.989 . . . . 1.0 110.61 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.623 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.64 -24.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.5 tt0 -125.03 138.19 54.21 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 156.73 138.81 2.6 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.042 -1.623 . . . . 1.0 109.042 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.695 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -88.72 128.32 35.61 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.83 -1.394 . . . . 1.0 109.602 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -90.83 -35.93 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.788 -0.57 . . . . 1.0 112.508 -176.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.647 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.3 tt -149.05 146.02 27.55 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.859 -1.151 . . . . 1.0 111.981 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.582 ' CD1' ' SD ' ' A' ' 146' ' ' MET . 3.5 t-105 -149.09 111.76 4.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.583 -1.266 . . . . 1.0 107.583 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.79 161.4 20.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.873 -1.142 . . . . 1.0 111.394 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 108.504 -1.838 . . . . 1.0 108.504 179.597 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 122.159 0.98 . . . . 1.0 111.983 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -148.26 146.0 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.425 -178.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.555 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -146.63 -175.11 4.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 1.0 110.39 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 66.3 mt -149.56 126.2 11.0 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.009 -1.108 . . . . 1.0 108.009 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.556 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -145.22 173.33 12.04 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.824 -1.172 . . . . 1.0 111.964 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.9 mt -117.56 141.81 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.593 0.711 . . . . 1.0 111.086 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -139.28 130.17 33.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.743 -0.598 . . . . 1.0 110.164 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 1.2 m-20 58.36 21.31 8.19 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.224 -0.922 . . . . 1.0 111.602 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' A' ' 77' ' ' PHE . . . 92.39 20.05 36.47 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.628 -1.272 . . . . 1.0 110.252 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 76' ' ' GLY . 16.9 m-85 -138.19 144.29 40.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -1.126 . . . . 1.0 109.411 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -79.59 -167.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 1.0 109.103 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER 175.75 102.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 1.0 110.534 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.554 ' HA ' ' CD2' ' A' ' 71' ' ' LEU . 2.3 ttm -61.68 93.08 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.914 -0.714 . . . . 1.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.67 ' CE ' ' OH ' ' A' ' 159' ' ' TYR . 11.3 tmm? -89.94 111.29 22.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.804 -0.56 . . . . 1.0 110.005 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.66 ' CE2' ' CG1' ' A' ' 89' ' ' VAL . 2.8 p90 -143.1 141.29 31.2 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.346 -1.341 . . . . 1.0 110.986 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.522 ' HB3' ' CA ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -138.52 71.44 1.39 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.668 -0.645 . . . . 1.0 110.132 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.544 HD22 ' CE1' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -67.89 -7.37 27.67 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 120.069 -0.652 . . . . 1.0 110.006 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.62 -57.57 0.37 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.01 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -1.113 . . . . 1.0 110.55 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -110.37 124.48 33.17 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.95 . . . . 1.0 109.739 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.522 ' CA ' ' HB3' ' A' ' 83' ' ' ASP . 48.6 Cg_endo -73.7 139.12 27.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.784 1.413 . . . . 1.0 110.371 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.66 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.52 121.06 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.58 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 7.2 p -99.06 81.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 118.346 -1.341 . . . . 1.0 111.09 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.562 ' CA ' HG21 ' A' ' 124' ' ' ILE . 8.5 mt -76.63 71.33 3.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.622 -1.251 . . . . 1.0 107.622 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 38.6 mtp180 -59.1 179.04 0.1 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.192 0.996 . . . . 1.0 111.347 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.472 ' HA ' HD12 ' A' ' 124' ' ' ILE . 3.1 t -114.84 149.1 37.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.45 -0.795 . . . . 1.0 109.904 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 94' ' ' THR . 54.5 m -106.85 34.37 3.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 1.0 109.423 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.563 HG13 ' CB ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -128.43 151.87 77.31 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.559 -0.713 . . . . 1.0 109.955 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.562 ' HD2' ' CG2' ' A' ' 95' ' ' VAL . 43.5 Cg_endo -69.53 121.41 8.15 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.399 1.21 . . . . 1.0 109.892 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.472 ' CG2' ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -109.58 -27.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 1.0 110.683 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.535 ' HB3' HG22 ' A' ' 52' ' ' THR . 6.3 p-10 -82.06 61.11 5.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 1.0 109.847 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.503 ' O ' ' CG2' ' A' ' 99' ' ' THR . 27.0 m -123.1 14.86 9.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.823 . . . . 1.0 110.195 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.496 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 12.3 t-20 53.54 18.05 1.32 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.937 -1.102 . . . . 1.0 110.108 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.493 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 5.5 m80 -116.14 144.59 43.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 1.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.57 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 21.1 m95 -59.44 109.52 0.91 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.437 -0.789 . . . . 1.0 111.138 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 104' ' ' HIS . 2.7 m -98.03 170.52 8.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.589 ' HB3' ' CA ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER -123.08 138.64 54.62 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.042 -1.037 . . . . 1.0 108.244 178.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.514 HD12 HD12 ' A' ' 47' ' ' ILE . 1.2 mt -134.91 149.16 29.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.103 -0.998 . . . . 1.0 109.608 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -148.34 130.19 15.2 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 1.0 109.709 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.419 ' HB3' ' HE1' ' A' ' 80' ' ' MET . . . -122.46 109.39 14.31 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.263 -0.975 . . . . 1.0 111.295 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.662 ' CE2' ' CB ' ' A' ' 115' ' ' SER . 3.8 p90 -116.48 110.27 18.38 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.236 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.537 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 3.6 ttp180 -125.1 133.92 52.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.381 0.61 . . . . 1.0 110.44 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.505 ' O ' ' C ' ' A' ' 111' ' ' GLN . 3.1 t -97.38 89.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 1.0 109.7 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.539 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 0.3 OUTLIER 21.24 48.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 4.3 tmm_? 167.96 -55.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.221 -0.924 . . . . 1.0 109.857 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.589 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -111.46 120.06 40.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 1.0 109.785 -179.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.537 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.06 162.57 15.29 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.946 -1.121 . . . . 1.0 111.618 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.662 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 13.5 t -141.61 155.6 45.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.737 -0.861 . . . . 1.0 109.829 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.528 ' C ' ' HG3' ' A' ' 117' ' ' GLN . 0.3 OUTLIER -149.65 125.98 10.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 120.956 -1.09 . . . . 1.0 110.908 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.545 ' HG2' ' HB3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -135.1 134.99 40.85 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 118' ' ' VAL . 9.9 p -76.2 102.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.589 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . 68.96 30.83 72.21 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 108.819 -1.712 . . . . 1.0 108.819 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 1.0 OUTLIER 72.93 29.99 1.75 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 1.0 110.688 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -97.3 -153.57 0.42 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 110.491 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -36.81 101.92 0.23 Allowed Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.407 -0.808 . . . . 1.0 110.3 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.545 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 44.9 Cg_endo -71.02 116.65 4.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.57 . . . . 1.0 111.794 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.562 HG21 ' CA ' ' A' ' 91' ' ' LEU . 1.2 mp -94.67 99.46 9.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 37.2 p -99.95 174.14 6.33 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.342 1.068 . . . . 1.0 112.39 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' A' ' 91' ' ' LEU . . . 173.12 154.1 10.15 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.486 -2.246 . . . . 1.0 107.486 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.589 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -137.14 167.18 22.04 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.26 -1.141 . . . . 1.0 109.927 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.0 174.75 5.68 Favored Pre-proline 0 C--N 1.3 -1.557 0 C-N-CA 119.089 -1.044 . . . . 1.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 130' ' ' LEU . 49.1 Cg_endo -78.71 43.68 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.735 1.387 . . . . 1.0 109.435 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.2 OUTLIER 42.47 105.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.724 0.773 . . . . 1.0 111.478 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.81 87.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.972 -1.251 . . . . 1.0 109.972 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.457 ' O ' ' HB ' ' A' ' 133' ' ' THR . . . -170.95 174.78 4.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -1.101 . . . . 1.0 109.788 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.8 t -179.22 156.98 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 1.0 110.427 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER 69.97 -60.44 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 1.0 111.131 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.597 ' C ' ' O ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -1.18 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.797 0.808 . . . . 1.0 112.064 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.49 ' C ' ' CG2' ' A' ' 137' ' ' THR . 37.5 m-20 -116.66 149.01 40.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.11 . . . . 1.0 110.038 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.49 ' CG2' ' C ' ' A' ' 136' ' ' ASP . 33.3 p -154.15 105.91 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 1.0 110.115 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 137' ' ' THR . 0.6 OUTLIER 167.11 -43.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.69 0.757 . . . . 1.0 109.206 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.4 -24.85 7.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.783 -1.327 . . . . 1.0 109.783 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -163.97 135.03 4.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.995 -1.297 . . . . 1.0 110.598 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 6.2 tp -135.8 142.72 44.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 1.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.577 ' CG ' ' HE3' ' A' ' 146' ' ' MET . 44.2 m95 -117.73 148.09 42.35 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.561 ' HG ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 tt -148.59 119.55 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 117.644 -1.623 . . . . 1.0 112.995 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.59 9.3 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.77 -1.332 . . . . 1.0 109.77 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.601 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 129.94 -148.52 18.5 Favored Glycine 0 C--N 1.287 -2.158 0 N-CA-C 108.024 -2.031 . . . . 1.0 108.024 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.619 ' HB2' ' CD1' ' A' ' 149' ' ' LEU 0.266 5.6 mmt -152.53 128.78 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.655 -0.818 . . . . 1.0 110.95 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.462 ' HA ' ' CD2' ' A' ' 24' ' ' TYR . 5.3 tm-20 -43.53 -50.23 7.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.023 -1.048 . . . . 1.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -127.88 79.24 1.88 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 123.022 1.392 . . . . 1.0 107.73 177.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.667 HD13 ' CG1' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -62.1 42.79 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.177 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 148' ' ' ARG . 92.9 p -50.81 -32.75 21.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 177.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.667 ' CG1' HD13 ' A' ' 149' ' ' LEU 0.313 7.1 p -65.9 -141.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 113.542 -1.663 . . . . 1.0 106.557 176.022 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.666 ' CB ' ' HB3' ' A' ' 159' ' ' TYR 0.278 . . 50.63 14.21 0.16 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.597 -1.314 . . . . 1.0 111.508 177.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.79 -45.23 6.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.688 -1.257 . . . . 1.0 111.402 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.491 ' NZ ' ' OD2' ' A' ' 83' ' ' ASP . 2.6 pttt -61.13 -6.69 2.13 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.279 -0.888 . . . . 1.0 111.15 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.686 ' CD1' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -121.96 -174.82 0.32 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.904 -1.123 . . . . 1.0 110.781 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.577 ' N ' ' HG ' ' A' ' 155' ' ' LEU . 44.1 Cg_endo -70.19 174.98 9.09 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.626 1.329 . . . . 1.0 112.536 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.9 -11.43 1.45 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.682 -0.636 . . . . 1.0 111.948 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -37.29 -41.03 0.38 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.194 -0.941 . . . . 1.0 109.961 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.695 ' CE2' ' CD1' ' A' ' 55' ' ' LEU . 4.0 m-85 -83.0 -32.97 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.093 -1.043 . . . . 1.0 109.522 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -60.53 -15.47 27.69 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.88 -1.128 . . . . 1.0 108.227 178.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 161' ' ' THR . 1.2 m -115.9 83.5 1.95 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.03 163.94 0.01 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.808 -1.317 . . . . 1.0 109.808 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.593 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 20.0 t80 -77.01 142.32 39.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.763 -1.434 . . . . 1.0 111.647 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.621 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 3.6 mt -123.93 87.15 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.593 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.25 -153.19 9.07 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 108.184 -1.966 . . . . 1.0 108.184 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 9.6 m -135.73 155.14 50.86 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.893 -1.123 . . . . 1.0 110.758 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.552 HD11 ' CZ ' ' A' ' 19' ' ' PHE . 3.6 mt -133.68 153.34 36.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 121.385 -0.822 . . . . 1.0 109.412 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 15' ' ' GLU . 11.2 ttp85 -159.09 158.55 33.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.932 -1.105 . . . . 1.0 110.857 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 22.6 m-20 48.92 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.303 -0.873 . . . . 1.0 110.043 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 18.5 m -126.77 131.71 70.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 C-N-CA 119.179 -1.008 . . . . 1.0 110.004 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -136.92 149.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.579 -0.849 . . . . 1.0 110.511 -177.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 173' ' ' ASP . 54.4 t -131.46 94.19 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 1.3 m-20 71.44 38.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 74.51 18.1 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.248 0.547 . . . . 1.0 110.127 -179.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.479 ' OE1' ' OD1' ' A' ' 29' ' ' ASN . 7.0 mm-40 -89.09 111.02 21.67 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.344 -0.847 . . . . 1.0 109.732 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.44 106.4 6.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.887 -1.133 . . . . 1.0 109.274 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.32 86.96 6.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 1.0 111.077 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.574 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 80.2 m-70 -53.37 104.47 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.174 0.988 . . . . 1.0 109.39 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -46.84 -61.94 1.63 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.166 0.984 . . . . 1.0 109.777 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.502 ' CG1' HD22 ' A' ' 184' ' ' LEU . 36.2 t -54.04 -21.86 6.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.41 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 13.4 mt-10 -64.95 -53.06 52.32 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.265 -1.374 . . . . 1.0 109.914 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.542 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -105.59 -22.48 12.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.009 -1.057 . . . . 1.0 109.731 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -59.39 -35.8 74.61 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.785 -1.197 . . . . 1.0 108.153 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.514 ' HA ' HD13 ' A' ' 189' ' ' ILE . 1.3 mm? -50.25 -20.73 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.718 . . . . 1.0 109.748 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.3 OUTLIER -52.22 -22.53 4.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 1.0 108.956 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.451 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 8.4 t30 -86.18 149.05 49.02 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 45.2 Cg_endo -72.35 -47.54 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.742 1.391 . . . . 1.0 110.599 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.91 118.99 37.6 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.746 -0.596 . . . . 1.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 184' ' ' LEU . 0.7 OUTLIER -117.9 128.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.308 -0.87 . . . . 1.0 109.515 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 19.9 mt -103.23 171.97 7.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.861 . . . . 1.0 110.088 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.527 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -121.72 1.78 10.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.056 -1.027 . . . . 1.0 110.911 -179.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 191' ' ' HIS . 6.3 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 1.0 110.623 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--O 1.215 -0.741 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.09 131.79 35.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.304 -0.873 . . . . 1.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.546 HG21 ' CE ' ' A' ' 25' ' ' MET . 26.4 mm -127.07 117.95 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 1.0 109.437 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 192' ' ' CYS . . . -85.37 139.94 31.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 1.0 111.318 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CZ ' HD13 ' A' ' 167' ' ' ILE . 8.3 m-85 -108.09 159.92 16.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.407 ' C ' HG12 ' A' ' 164' ' ' ILE . 4.1 p-10 -115.8 -3.31 12.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.952 -1.092 . . . . 1.0 110.779 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.485 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 109.49 -18.29 30.15 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 30.39 7.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.585 -0.95 . . . . 1.0 109.182 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.551 HG23 ' CE2' ' A' ' 19' ' ' PHE . 1.9 m -69.87 172.69 7.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 1.0 110.894 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.585 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 10.8 t80 -167.72 74.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.572 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 3.8 mmt -86.95 99.43 11.86 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.845 -1.142 . . . . 1.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.77 136.4 34.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 1.0 108.63 179.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.572 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 96.0 m-85 -130.92 104.5 7.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.017 -1.052 . . . . 1.0 110.903 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.507 ' NE2' ' CZ2' ' A' ' 142' ' ' TRP . 22.7 m-70 -108.13 120.21 41.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 1.0 109.576 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -155.31 170.69 21.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 1.0 110.524 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.15 153.88 17.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.412 -0.805 . . . . 1.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG21 ' NE2' ' A' ' 175' ' ' GLN . 9.8 p . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 1.0 110.735 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.885 0.85 . . . . 1.0 109.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.7 p -163.6 133.55 4.23 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.704 -0.622 . . . . 1.0 110.342 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.4 OUTLIER -100.93 152.39 20.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 1.0 109.943 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.552 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 11.5 m80 -123.88 138.16 54.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -0.951 . . . . 1.0 110.03 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 42' ' ' HIS . 21.2 m-85 -134.73 128.03 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 1.0 110.204 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 8.2 mt-10 -133.8 148.9 51.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 1.0 110.114 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.548 ' HB2' ' CG1' ' A' ' 170' ' ' VAL . 0.8 OUTLIER 179.26 151.55 0.35 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.395 -0.922 . . . . 1.0 111.158 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.504 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.09 154.11 35.16 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.547 HD11 HD12 ' A' ' 105' ' ' ILE . 5.5 pt -150.81 173.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 C-N-CA 117.96 -1.496 . . . . 1.0 112.312 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.62 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -127.33 82.92 2.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 178.284 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.546 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -66.86 161.21 24.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.119 -0.988 . . . . 1.0 111.256 -177.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.622 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 8.0 mm-40 -140.81 7.96 2.1 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.531 -0.867 . . . . 1.0 110.939 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.612 ' O ' ' CG2' ' A' ' 52' ' ' THR . . . -137.04 -86.66 0.31 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.142 -1.023 . . . . 1.0 111.063 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.612 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.93 -24.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.302 -0.999 . . . . 1.0 108.302 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -125.01 132.43 53.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.67 -0.644 . . . . 1.0 109.831 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 162.98 137.81 2.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.266 -1.534 . . . . 1.0 109.266 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.587 ' HA ' ' CB ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -86.07 130.09 34.64 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.903 -1.351 . . . . 1.0 108.305 179.151 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.664 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -98.31 -26.27 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.553 -0.717 . . . . 1.0 112.178 -176.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 71' ' ' LEU 0.264 7.9 tt -156.88 155.41 31.4 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 117.736 -1.586 . . . . 1.0 113.09 -175.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.628 ' CH2' ' CG2' ' A' ' 151' ' ' VAL . 2.7 t-105 -156.23 114.35 3.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.481 ' OG ' HD23 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -133.89 179.92 5.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.89 -1.132 . . . . 1.0 111.063 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.301 -1.519 . . . . 1.0 109.301 179.896 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.578 ' CG ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 m-30 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.066 0.46 . . . . 1.0 112.211 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 59' ' ' SER . 21.0 mm -98.34 77.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.0 109.24 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 57' ' ' LEU . . . -120.88 179.29 4.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 1.0 111.192 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 81.8 mt -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.252 -0.905 . . . . 1.0 108.723 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -112.18 178.39 4.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.079 . . . . 1.0 111.671 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 60.1 mt -129.6 139.58 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.456 -0.778 . . . . 1.0 110.971 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.9 p -140.41 139.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.759 -0.588 . . . . 1.0 109.945 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 69.3 m-20 59.13 20.49 8.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 1.0 110.944 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.511 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 88.14 16.54 59.11 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.845 -1.302 . . . . 1.0 109.845 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.409 ' O ' HG21 ' A' ' 73' ' ' ILE . 52.5 m-85 -133.97 135.76 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 1.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.664 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 1.6 t -76.24 177.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 1.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.548 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -163.46 127.66 2.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.2 -0.937 . . . . 1.0 110.891 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.544 ' HB2' ' CD2' ' A' ' 116' ' ' LEU . 8.4 tmm? -82.39 94.52 7.41 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.443 0.64 . . . . 1.0 110.606 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.594 ' CE ' ' OH ' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -73.81 120.56 19.57 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 178.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.531 ' CZ ' ' HG3' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -143.35 91.73 2.3 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.426 -1.71 . . . . 1.0 111.691 -178.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.578 ' OD1' ' CG ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -112.57 152.07 29.31 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.28 -35.56 1.34 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -103.41 -33.12 4.31 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.666 -1.773 . . . . 1.0 108.666 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 162.02 -12.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.445 -1.032 . . . . 1.0 111.523 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.455 ' C ' ' HB2' ' A' ' 83' ' ' ASP . 3.7 mttt -102.64 96.16 7.16 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.751 -1.218 . . . . 1.0 110.043 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' HA ' ' CB ' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -70.42 123.99 10.39 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.065 1.561 . . . . 1.0 110.464 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -88.89 119.73 36.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 1.0 109.06 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.598 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 8.7 p -99.29 81.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.667 -1.271 . . . . 1.0 110.529 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.547 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 10.4 mt -78.15 82.08 4.49 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.533 ' O ' HG22 ' A' ' 124' ' ' ILE . 1.2 mtt180 -57.9 176.58 0.15 Allowed 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 118.599 -1.24 . . . . 1.0 109.725 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.586 ' HA ' ' CD1' ' A' ' 124' ' ' ILE . 1.8 t -95.26 159.03 15.2 Favored 'General case' 0 C--N 1.286 -2.164 0 O-C-N 121.691 -0.63 . . . . 1.0 110.341 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 8.57 40.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 1.0 109.834 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' A' ' 118' ' ' VAL . 21.8 t -130.15 146.78 62.96 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 1.0 109.316 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.2 Cg_endo -69.76 153.04 69.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.588 1.31 . . . . 1.0 111.101 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.53 ' CG1' ' OG1' ' A' ' 49' ' ' THR . 0.7 OUTLIER -133.14 -27.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.862 . . . . 1.0 111.032 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.512 ' CB ' HG21 ' A' ' 52' ' ' THR . 9.1 p30 -72.16 65.0 0.57 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.994 -1.066 . . . . 1.0 111.061 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 14.7 t -135.82 18.3 3.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 1.0 109.522 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 50' ' ' GLU . 1.0 OUTLIER 57.31 23.64 9.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.82 . . . . 1.0 111.189 179.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.532 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 2.8 m80 -112.0 147.71 35.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 1.0 110.007 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.62 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 23.4 m95 -68.21 104.7 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 1.0 110.057 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.565 ' CG2' ' N ' ' A' ' 104' ' ' HIS . 2.4 m -98.73 172.41 7.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 1.0 109.003 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.598 ' CD2' ' HA2' ' A' ' 119' ' ' GLY . 1.7 t60 -124.62 139.66 53.66 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 47' ' ' ILE . 1.2 mt -129.28 157.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 119.193 -1.003 . . . . 1.0 109.19 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.551 ' O ' HD21 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -146.46 156.5 43.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.105 -0.997 . . . . 1.0 109.539 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.508 ' N ' ' HG3' ' A' ' 106' ' ' LYS . . . -158.22 119.46 3.49 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.526 -0.87 . . . . 1.0 110.516 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 2.3 p90 -129.27 107.3 9.43 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.203 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.568 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.4 OUTLIER -83.71 139.97 32.42 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.987 -0.685 . . . . 1.0 109.839 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.3 t -132.59 88.98 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 1.0 110.041 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 38.8 mt-30 44.58 102.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 1.0 111.121 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.551 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 5.3 ttt180 64.24 -52.34 0.27 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 1.0 111.423 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.65 ' CB ' ' OG ' ' A' ' 127' ' ' SER . 4.3 pt-20 -82.09 117.97 22.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.596 -1.315 . . . . 1.0 111.386 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.98 152.56 17.11 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.164 -1.174 . . . . 1.0 110.164 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.609 ' OG ' ' CZ ' ' A' ' 108' ' ' TYR . 32.8 t -133.84 161.88 33.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.13 -1.218 . . . . 1.0 111.538 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.556 ' CD1' ' N ' ' A' ' 117' ' ' GLN 0.252 1.7 tm? -144.24 155.42 43.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.556 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -163.02 123.13 2.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.334 -1.346 . . . . 1.0 112.742 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.538 HG22 ' CG2' ' A' ' 95' ' ' VAL . 3.0 m -71.4 106.53 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.639 -1.615 . . . . 1.0 106.639 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.598 ' HA2' ' CD2' ' A' ' 104' ' ' HIS . . . 75.54 -73.75 1.59 Allowed Glycine 0 C--N 1.287 -2.184 0 N-CA-C 108.817 -1.713 . . . . 1.0 108.817 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 3.5 t-20 178.22 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.404 -1.056 . . . . 1.0 109.602 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -96.99 -158.74 0.69 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.584 -0.698 . . . . 1.0 111.064 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -40.2 103.61 0.3 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 1.0 109.653 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.517 ' CB ' ' OH ' ' A' ' 108' ' ' TYR . 42.2 Cg_endo -71.33 126.45 12.29 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.02 1.537 . . . . 1.0 111.012 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 1.7 mp -82.46 99.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.824 -1.172 . . . . 1.0 107.901 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 16.4 p -98.18 177.08 5.51 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.057 -1.027 . . . . 1.0 110.838 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 113' ' ' GLU . . . -179.75 -161.86 27.75 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 107.122 -2.391 . . . . 1.0 107.122 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.65 ' OG ' ' CB ' ' A' ' 113' ' ' GLU . 3.5 m -174.71 154.01 1.89 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.099 -1.236 . . . . 1.0 110.721 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.566 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -80.32 -176.87 0.81 Allowed Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 36.0 Cg_endo -63.23 -60.02 0.19 Allowed 'Trans proline' 0 C--N 1.301 -1.96 0 N-CA-C 108.086 -1.544 . . . . 1.0 108.086 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 129' ' ' PRO . 3.4 pp 152.56 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.631 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 133' ' ' THR . . . 77.45 -73.16 2.07 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.486 ' HB2' HD12 ' A' ' 84' ' ' LEU . . . -64.43 75.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 1.0 110.199 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 131' ' ' GLY . 7.0 m -86.97 -23.82 24.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 1.0 110.133 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -100.43 121.49 41.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 1.0 110.124 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.486 ' O ' HD13 ' A' ' 135' ' ' LEU . 3.1 tm? -155.81 106.68 2.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 1.0 109.808 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.63 136.73 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 1.0 110.429 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -157.4 106.21 2.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 1.0 110.255 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 137' ' ' THR . 2.6 p30 161.28 -32.53 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.589 -0.695 . . . . 1.0 109.785 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -53.22 -21.38 11.62 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -143.64 164.89 29.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.346 . . . . 1.0 110.637 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.456 ' C ' ' CD1' ' A' ' 142' ' ' TRP . 9.1 tp -160.13 142.49 13.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 1.0 110.754 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 25.5 m95 -132.23 147.27 52.4 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.172 -1.418 . . . . 1.0 107.172 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.541 ' C ' ' CD1' ' A' ' 143' ' ' LEU . 1.4 tm? -153.1 117.72 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.705 -1.598 . . . . 1.0 113.305 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 119.38 5.12 11.59 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.323 -1.111 . . . . 1.0 110.323 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.456 ' HA2' HD22 ' A' ' 55' ' ' LEU . . . 139.89 -133.31 5.98 Favored Glycine 0 C--N 1.289 -2.075 0 C-N-CA 118.624 -1.751 . . . . 1.0 109.668 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.62 ' CB ' HD11 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -168.99 142.18 2.81 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.515 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.537 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 4.6 tm-20 -71.72 -26.98 62.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.51 -1.293 . . . . 1.0 107.51 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.501 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.82 80.36 1.69 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.62 HD11 ' CB ' ' A' ' 146' ' ' MET . 0.3 OUTLIER -69.83 36.44 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.406 -0.809 . . . . 1.0 113.178 -176.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -71.27 -11.13 60.75 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.628 ' CG2' ' CH2' ' A' ' 58' ' ' TRP 0.26 10.5 p -79.74 -9.64 12.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.212 -0.903 . . . . 1.0 110.676 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 153' ' ' HIS . . . -70.11 51.99 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 1.0 109.867 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.665 ' CD2' ' N ' ' A' ' 153' ' ' HIS . 1.8 p80 4.26 -86.29 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -160.77 100.2 1.27 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 123.299 1.523 . . . . 1.0 109.19 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.607 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -154.0 175.54 2.99 Favored Pre-proline 0 C--N 1.283 -2.314 0 O-C-N 120.843 -1.16 . . . . 1.0 109.756 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 37.0 Cg_endo -61.29 -178.14 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 122.851 0.921 . . . . 1.0 111.572 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -55.61 -11.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.383 -0.823 . . . . 1.0 112.064 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.491 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -36.23 -43.77 0.37 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.915 . . . . 1.0 109.859 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.594 ' OH ' ' CE ' ' A' ' 81' ' ' MET . 8.9 m-85 -86.4 -27.7 24.03 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 1.0 109.384 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -75.8 -3.49 35.28 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.657 -1.217 . . . . 1.0 108.243 177.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 162' ' ' GLY . 1.8 m -135.35 91.53 2.74 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.26 170.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 1.0 110.069 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.657 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 13.3 t80 -74.18 147.15 42.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.146 -1.208 . . . . 1.0 112.295 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.622 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 3.6 mt -124.28 87.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.657 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.64 -153.9 9.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.147 -1.581 . . . . 1.0 109.147 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 48' ' ' LYS . 39.4 m -130.5 146.29 52.01 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.387 -1.066 . . . . 1.0 110.457 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.602 HD13 ' CZ ' ' A' ' 19' ' ' PHE . 3.5 mt -129.62 150.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.348 -0.845 . . . . 1.0 110.655 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.482 ' CG ' ' N ' ' A' ' 169' ' ' ASP . 9.4 ttt180 -159.49 168.47 26.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.012 -1.055 . . . . 1.0 110.452 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 14.2 m-20 44.63 58.87 3.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.895 . . . . 1.0 110.38 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.548 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 24.2 m -114.19 121.73 66.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.66 -0.816 . . . . 1.0 109.677 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.496 HG13 ' C ' ' A' ' 170' ' ' VAL . 1.0 OUTLIER -134.49 155.74 39.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.352 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 3.2 t -134.72 106.48 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 53.8 m-20 49.91 36.57 11.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.334 -1.479 . . . . 1.0 107.302 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 76.33 22.33 1.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.841 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 21.6 mt-30 -99.34 -171.94 2.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.941 -1.1 . . . . 1.0 110.408 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 10.5 tt0 72.49 -102.77 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.675 -0.641 . . . . 1.0 110.801 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.1 mt 68.6 -92.98 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.43 -0.794 . . . . 1.0 112.479 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 88.3 m-70 -89.51 103.86 16.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.667 -1.271 . . . . 1.0 112.486 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.1 OUTLIER -68.67 -48.71 63.26 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 177.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 10.3 t -47.5 -26.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 1.0 110.004 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 0.6 OUTLIER -72.11 -60.64 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 1.0 110.898 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.555 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -92.93 -15.81 25.88 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.007 -1.058 . . . . 1.0 110.397 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -71.69 -34.92 70.05 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 186' ' ' ASN . 12.7 mt -51.06 -21.15 1.7 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.533 -0.729 . . . . 1.0 109.207 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 16.9 t-20 -42.71 -27.8 0.2 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.006 0.907 . . . . 1.0 108.701 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 187' ' ' PRO . 2.4 t30 -131.2 146.32 61.57 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.491 ' O ' ' ND2' ' A' ' 186' ' ' ASN . 42.7 Cg_endo -68.06 -157.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.765 1.402 . . . . 1.0 110.853 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 187' ' ' PRO . 0.4 OUTLIER 63.54 9.98 4.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 1.0 110.514 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 30.7 mm -68.53 94.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 1.0 109.951 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.98 164.14 12.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 1.0 110.597 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.15 154.25 22.0 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.214 -0.929 . . . . 1.0 110.092 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . 6.5 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.965 . . . . 1.0 110.563 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.529 ' O ' ' CD ' ' A' ' 168' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.214 -0.792 0 CA-C-O 121.841 0.829 . . . . 1.0 109.967 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -138.44 168.3 20.05 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.741 -0.599 . . . . 1.0 109.839 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 191' ' ' HIS . 13.3 mm -134.11 109.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 1.0 110.137 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -73.25 129.83 38.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.539 -0.726 . . . . 1.0 109.934 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' A' ' 167' ' ' ILE . 3.0 m-30 -95.68 133.49 39.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.404 -0.81 . . . . 1.0 109.326 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 -1.09 54.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 1.0 110.673 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.08 -7.39 62.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -122.02 7.13 9.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.206 -1.173 . . . . 1.0 109.904 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.575 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 8.9 t -81.63 164.45 21.84 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.995 0.902 . . . . 1.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' A' ' 23' ' ' THR . 6.0 m-30 -142.8 94.18 2.61 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.803 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 19' ' ' PHE . 2.4 mmt -94.21 101.63 13.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.841 -1.162 . . . . 1.0 109.795 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -117.65 120.54 38.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 1.0 110.361 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 2.9 m-85 -115.03 110.89 20.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.836 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -101.57 85.18 2.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.08 -1.013 . . . . 1.0 110.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -112.8 163.17 14.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 1.0 109.982 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.27 94.5 4.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 1.0 110.24 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' A' ' 175' ' ' GLN . 17.3 m . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.902 . . . . 1.0 110.335 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.404 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 7.0 tt0 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.656 0.741 . . . . 1.0 111.33 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -127.89 163.75 23.76 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.369 -0.832 . . . . 1.0 110.982 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.97 155.67 20.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.45 -0.781 . . . . 1.0 109.748 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.473 ' O ' HG22 ' A' ' 172' ' ' VAL . 14.8 m-70 -123.48 133.39 54.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.071 . . . . 1.0 110.486 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.483 ' CE1' HG22 ' A' ' 172' ' ' VAL . 28.9 m-85 -136.76 117.09 13.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 1.0 109.926 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 9.6 mt-10 -125.62 145.59 50.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.901 -1.124 . . . . 1.0 110.443 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.9 OUTLIER 179.79 154.2 0.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.718 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.497 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -118.65 152.7 35.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.534 ' CD1' HD12 ' A' ' 105' ' ' ILE . 4.0 pt -148.67 160.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 117.81 -1.556 . . . . 1.0 112.697 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.618 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -114.63 83.79 1.95 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.332 -1.729 . . . . 1.0 106.332 177.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -66.97 150.87 48.64 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.042 0.925 . . . . 1.0 112.594 -176.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.65 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.5 mm-40 -140.85 2.99 1.81 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.863 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.25 125.64 12.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 1.0 110.12 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.441 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 74.1 p -57.07 -14.95 4.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.473 -0.767 . . . . 1.0 111.408 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -128.76 132.01 47.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.936 -1.103 . . . . 1.0 111.452 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 166.66 136.28 2.0 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.397 -1.382 . . . . 1.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.698 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -89.64 118.86 29.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -1.213 . . . . 1.0 108.326 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.587 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -92.86 -31.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.756 -176.325 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.596 ' CD2' ' CD1' ' A' ' 141' ' ' LEU . 4.9 tt -147.3 151.47 36.66 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.664 -1.272 . . . . 1.0 112.605 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.666 ' CD1' ' CE ' ' A' ' 146' ' ' MET . 0.6 OUTLIER -161.24 124.28 3.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.686 178.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.585 ' CB ' ' CD1' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -121.89 156.57 33.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.951 -1.093 . . . . 1.0 109.719 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 109.148 -1.581 . . . . 1.0 109.148 179.706 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.588 ' CE2' HD11 ' A' ' 135' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 110.53 -0.174 . . . . 1.0 110.53 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.585 ' CD1' ' CB ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -159.19 176.82 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.315 -1.491 . . . . 1.0 111.315 -179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.569 ' HB1' ' CE ' ' A' ' 81' ' ' MET . . . -172.37 174.36 3.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.723 -0.611 . . . . 1.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.587 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 78.4 mt -146.16 95.57 2.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 1.0 109.139 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.607 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -115.53 177.13 4.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.505 -0.747 . . . . 1.0 112.112 -178.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 2.5 mt -117.81 138.2 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.767 -0.583 . . . . 1.0 110.025 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -142.39 133.25 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.42 -0.8 . . . . 1.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 3.3 m-20 61.62 23.86 14.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.068 -1.02 . . . . 1.0 111.432 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 84.39 18.66 61.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.974 -1.25 . . . . 1.0 109.974 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.29 150.27 45.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -1.091 . . . . 1.0 108.901 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.587 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -91.45 -176.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.734 -1.228 . . . . 1.0 109.878 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.597 ' NE2' ' CG2' ' A' ' 90' ' ' VAL . 1.5 pt20 -174.11 136.37 0.5 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.357 -0.839 . . . . 1.0 110.836 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.573 ' CE ' ' O ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -93.07 132.58 37.06 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.824 -0.75 . . . . 1.0 110.227 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.569 ' CE ' ' HB1' ' A' ' 70' ' ' ALA . 3.6 ttm -107.74 137.64 45.39 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.637 -0.664 . . . . 1.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.582 ' CE2' ' HD2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -134.71 102.03 5.14 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.127 -0.983 . . . . 1.0 109.758 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' TYR . 2.1 m-20 -110.79 34.35 4.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.652 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.511 HD22 ' NH1' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -34.03 -29.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.731 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -118.4 -41.31 0.63 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.756 -1.337 . . . . 1.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 168.7 -28.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 1.0 109.743 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HG3' ' CG ' ' A' ' 129' ' ' PRO . 12.4 mmmt -89.58 117.93 68.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.493 -0.754 . . . . 1.0 109.772 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 51.1 Cg_endo -78.06 130.38 10.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.922 1.485 . . . . 1.0 111.927 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.4 OUTLIER -109.27 126.63 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 178.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.597 ' CG2' ' NE2' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -109.04 123.27 64.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.447 -1.408 . . . . 1.0 111.865 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.553 ' CA ' HG23 ' A' ' 124' ' ' ILE . 0.3 OUTLIER -111.99 74.69 0.88 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.176 -1.416 . . . . 1.0 107.176 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -57.9 178.65 0.08 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.311 -0.956 . . . . 1.0 110.492 -178.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . 0.251 2.4 t -108.23 151.19 26.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.549 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.475 HG23 HD13 ' A' ' 124' ' ' ILE . 0.7 OUTLIER -103.63 26.18 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 1.0 109.73 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.526 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 2.4 t -128.57 146.98 62.2 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.508 -0.745 . . . . 1.0 109.146 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.526 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 40.8 Cg_endo -65.64 124.52 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.538 1.283 . . . . 1.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 98' ' ' ASN . 6.6 tp -109.95 -39.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 1.0 110.655 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.499 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 6.3 p-10 -67.56 63.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 1.0 110.635 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.578 ' O ' ' CE1' ' A' ' 101' ' ' HIS . 15.0 t -124.09 11.19 8.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -0.999 . . . . 1.0 110.345 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 57.45 33.08 22.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.948 -1.095 . . . . 1.0 110.447 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 99' ' ' THR . 5.7 m-70 -121.65 179.36 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 1.0 109.8 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.618 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 17.0 m95 -98.18 100.96 12.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.029 -1.044 . . . . 1.0 110.175 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.515 ' CG2' ' N ' ' A' ' 104' ' ' HIS . 9.7 m -96.43 170.7 9.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.362 -0.836 . . . . 1.0 109.429 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.524 ' O ' ' N ' ' A' ' 119' ' ' GLY . 6.9 t60 -122.15 120.83 35.37 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.682 -1.229 . . . . 1.0 107.682 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.534 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -107.92 146.65 13.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 120.937 -1.102 . . . . 1.0 109.456 -178.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.507 ' O ' HD23 ' A' ' 116' ' ' LEU . 6.9 tptm -142.38 142.09 32.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.318 -0.953 . . . . 1.0 109.527 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -137.03 110.09 7.73 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.966 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 108' ' ' TYR . 4.5 p90 -111.14 110.36 20.85 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.582 ' HD2' ' CE2' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -99.62 141.05 32.93 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.031 -0.668 . . . . 1.0 111.194 -178.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 5.9 t -127.55 97.61 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.628 -0.67 . . . . 1.0 109.199 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.453 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 2.0 mt-30 58.26 -134.54 1.04 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 1.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.505 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -70.81 -11.41 60.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.984 -1.072 . . . . 1.0 110.863 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.623 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -104.4 123.24 47.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 1.0 110.505 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.526 ' CA ' ' HG2' ' A' ' 109' ' ' ARG . . . -114.41 163.66 12.15 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.296 -0.954 . . . . 1.0 110.961 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.573 ' O ' ' CE ' ' A' ' 80' ' ' MET . 47.5 t -147.64 162.89 38.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.522 -0.987 . . . . 1.0 110.722 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 117' ' ' GLN 0.254 1.0 OUTLIER -139.5 157.08 46.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.177 -0.952 . . . . 1.0 108.892 -178.816 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.545 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.39 113.92 4.02 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.684 -1.26 . . . . 1.0 111.97 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 16.8 t -70.22 100.35 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.86 37.08 92.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.423 ' C ' ' HG2' ' A' ' 117' ' ' GLN . 0.3 OUTLIER 61.38 38.58 16.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -1.146 . . . . 1.0 110.704 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 9.6 mt-10 -108.47 -161.18 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.325 -0.859 . . . . 1.0 110.944 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -39.22 98.32 0.16 Allowed Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 45.8 Cg_endo -77.43 142.96 21.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 124.068 1.562 . . . . 1.0 112.394 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.553 HG23 ' CA ' ' A' ' 91' ' ' LEU . 1.1 mp -106.05 110.43 31.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.877 -1.527 . . . . 1.0 106.877 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.512 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 7.2 p -105.81 177.52 4.83 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.375 1.083 . . . . 1.0 112.146 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.495 ' N ' HD12 ' A' ' 91' ' ' LEU . . . 170.78 160.98 20.62 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.834 -2.507 . . . . 1.0 106.834 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -139.28 168.52 19.63 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.735 -1.45 . . . . 1.0 110.892 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.2 p -87.2 -179.73 1.47 Allowed Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.515 -0.874 . . . . 1.0 110.037 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.483 ' CG ' ' HG3' ' A' ' 87' ' ' LYS . 46.2 Cg_endo -77.49 48.25 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.837 1.441 . . . . 1.0 109.675 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.9 OUTLIER 46.46 -176.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.614 -0.679 . . . . 1.0 110.5 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 132' ' ' ALA . . . 79.05 88.63 0.46 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.487 ' CB ' HD13 ' A' ' 84' ' ' LEU . . . 170.02 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -1.132 . . . . 1.0 110.166 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 59.11 90.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 1.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.0 OUTLIER 44.94 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 1.0 110.309 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.588 HD11 ' CE2' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -175.72 97.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 1.0 110.309 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.503 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 3.1 m-20 -52.17 -179.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 1.0 109.213 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 137' ' ' THR . 8.1 t -129.1 121.06 27.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.085 -1.01 . . . . 1.0 109.695 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 138' ' ' ASP . 4.4 p-10 -60.93 -3.56 0.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 1.0 111.05 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 65.9 9.12 45.19 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.841 -1.704 . . . . 1.0 108.841 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.479 ' HB2' ' OD2' ' A' ' 138' ' ' ASP . . . -102.31 132.2 48.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -1.127 . . . . 1.0 108.394 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.596 ' CD1' ' CD2' ' A' ' 57' ' ' LEU . 9.5 tp -141.14 148.79 40.6 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.764 -1.174 . . . . 1.0 111.651 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 24.2 m95 -130.88 119.46 22.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.59 HD11 ' CB ' ' A' ' 57' ' ' LEU . 8.3 tp -125.13 118.83 26.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.934 -1.506 . . . . 1.0 113.539 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.81 8.8 7.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 119.99 -1.1 . . . . 1.0 110.672 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.57 ' O ' ' HE3' ' A' ' 146' ' ' MET . . . 148.33 -148.44 19.92 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.373 -1.87 . . . . 1.0 109.08 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.666 ' CE ' ' CD1' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -152.82 148.06 26.76 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.37 -0.932 . . . . 1.0 112.881 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.423 ' C ' ' HG2' ' A' ' 148' ' ' ARG . 12.1 tt0 -93.9 19.92 8.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.423 ' HG2' ' C ' ' A' ' 147' ' ' GLU . 2.0 ptm180 173.16 68.65 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.555 -1.646 . . . . 1.0 106.555 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.625 HD11 ' CB ' ' A' ' 146' ' ' MET . 1.4 tp -73.46 36.03 0.08 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 1.0 112.706 -177.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.1 p -71.69 -13.67 61.8 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.795 -1.928 . . . . 1.0 105.795 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.649 ' CG2' ' CZ3' ' A' ' 58' ' ' TRP 0.257 7.1 p -76.28 -110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 114.889 -1.051 . . . . 1.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.638 ' CB ' ' CD2' ' A' ' 159' ' ' TYR . . . 50.0 39.1 18.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.308 -1.495 . . . . 1.0 108.946 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.628 ' CE1' HD23 ' A' ' 155' ' ' LEU . 1.5 p80 13.39 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.786 0.661 . . . . 1.0 112.786 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 5.74 2.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.032 -1.042 . . . . 1.0 111.821 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.703 ' CD2' ' CE1' ' A' ' 159' ' ' TYR . 2.7 pp -60.63 178.81 0.24 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.197 -0.939 . . . . 1.0 110.979 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 46.4 Cg_endo -83.01 -159.49 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.461 1.243 . . . . 1.0 112.681 -178.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.505 ' O ' ' C ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -51.01 -13.08 0.13 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 113.042 0.756 . . . . 1.0 113.042 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.57 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . -37.69 -45.64 0.81 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.013 -1.055 . . . . 1.0 109.707 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.703 ' CE1' ' CD2' ' A' ' 155' ' ' LEU . 4.3 m-85 -84.57 -28.98 26.23 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.204 -0.935 . . . . 1.0 109.111 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -70.38 -8.53 51.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.246 -1.382 . . . . 1.0 108.402 178.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.52 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.3 m -128.47 98.47 5.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -50.1 -178.19 0.02 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.62 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 71.0 t80 -83.01 144.72 29.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.909 -1.347 . . . . 1.0 112.262 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.65 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 1.6 mt -127.57 88.67 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.62 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.94 -157.39 13.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.743 -1.743 . . . . 1.0 108.743 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.537 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 1.7 m -128.59 145.45 51.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.128 -1.219 . . . . 1.0 109.802 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.573 HD12 ' CE2' ' A' ' 163' ' ' PHE . 3.4 mt -130.28 147.4 33.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.437 -0.789 . . . . 1.0 110.423 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -159.48 156.12 27.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 1.0 110.351 -179.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 17.8 m-20 51.38 81.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 1.0 110.411 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.494 HG12 ' CB ' ' A' ' 45' ' ' LEU 0.251 25.7 m -122.43 130.62 74.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.017 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -145.04 141.4 22.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.102 -1.039 . . . . 1.0 111.649 -176.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 1.3 p -127.0 119.34 52.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 1.5 m-20 62.14 30.53 17.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.23 32.09 2.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.756 -0.59 . . . . 1.0 110.451 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 71.9 mm-40 -104.73 120.13 40.63 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.354 -0.841 . . . . 1.0 110.064 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -78.55 110.97 14.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 1.0 109.556 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 179' ' ' LEU . 83.8 mt -78.81 96.21 5.57 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 1.0 111.31 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.567 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 46.8 m-70 -39.21 98.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.045 0.926 . . . . 1.0 110.247 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.609 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 8.9 mt -49.09 -59.57 3.53 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.924 0.869 . . . . 1.0 112.963 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.557 ' HA ' ' CD2' ' A' ' 184' ' ' LEU . 86.7 t -75.52 -28.52 19.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 113.541 0.941 . . . . 1.0 113.541 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.567 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -58.64 -50.51 73.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 112.284 -178.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.3 OUTLIER -108.19 -28.51 9.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.946 -1.096 . . . . 1.0 111.535 -178.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.609 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -63.05 -25.08 68.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.853 -1.539 . . . . 1.0 108.601 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.557 ' CD2' ' HA ' ' A' ' 180' ' ' VAL . 1.4 mm? -70.43 -2.19 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 1.0 110.303 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -55.65 -29.62 59.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 1.0 109.469 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.47 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 2.7 t-20 -88.09 151.32 49.07 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.586 ' O ' ' CG2' ' A' ' 188' ' ' THR . 38.3 Cg_endo -64.77 149.47 89.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.45 1.237 . . . . 1.0 109.684 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.586 ' CG2' ' O ' ' A' ' 187' ' ' PRO . 5.2 t 49.34 148.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 122.272 1.034 . . . . 1.0 112.116 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.537 HG13 ' CD1' ' A' ' 184' ' ' LEU . 33.6 mm -144.71 113.06 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 1.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.25 176.48 6.3 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.053 -1.03 . . . . 1.0 109.349 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -115.96 -60.99 1.8 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.7 -1.2 . . . . 1.0 111.264 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 191' ' ' HIS . 0.9 OUTLIER . . . . . 0 C--N 1.29 -2.005 0 O-C-N 121.422 -0.799 . . . . 1.0 110.195 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.646 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.3 pt-20 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 122.196 0.998 . . . . 1.0 110.157 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.02 137.15 33.75 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 120.333 -1.479 . . . . 1.0 111.231 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.528 HD13 ' CE1' ' A' ' 191' ' ' HIS . 12.2 mm -117.43 131.25 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.184 -0.948 . . . . 1.0 109.273 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.517 ' CB ' ' SG ' ' A' ' 192' ' ' CYS . . . -90.09 131.85 35.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.46 -0.775 . . . . 1.0 110.792 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CE1' ' CD1' ' A' ' 167' ' ' ILE . 62.3 m-85 -101.51 177.02 5.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.712 -1.243 . . . . 1.0 109.29 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.433 ' C ' HG13 ' A' ' 164' ' ' ILE . 11.1 p-10 -141.92 -11.6 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.678 -1.264 . . . . 1.0 112.842 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 162' ' ' GLY . . . 111.64 -11.69 27.84 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.95 -1.595 . . . . 1.0 109.144 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 3.6 ttp-105 -135.15 10.8 3.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -1.165 . . . . 1.0 111.504 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -112.81 121.17 43.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 1.0 110.627 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 1.9 p90 -104.02 122.25 44.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 1.0 110.256 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.56 ' HE2' ' CZ ' ' A' ' 19' ' ' PHE . 3.2 mtp -119.45 98.41 6.12 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.937 -1.105 . . . . 1.0 108.307 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.585 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 0.8 OUTLIER -103.08 145.12 30.38 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.707 -0.797 . . . . 1.0 110.027 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.639 ' HA ' ' CB ' ' A' ' 182' ' ' ASP . 4.6 m-85 -126.1 116.52 21.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.011 -1.076 . . . . 1.0 110.477 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 139' ' ' GLY . 19.8 t60 -96.99 99.98 11.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.735 . . . . 1.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.6 131.32 34.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 1.0 110.03 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.16 95.37 8.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 1.0 110.194 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 1.0 110.406 -179.848 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 120.943 0.401 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.521 ' OG ' ' NE2' ' A' ' 42' ' ' HIS . 1.2 p -126.82 104.87 8.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.247 -0.908 . . . . 1.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 109' ' ' ARG . 19.5 p-10 -85.65 142.75 28.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.529 -0.732 . . . . 1.0 110.222 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.639 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 49.7 m-70 -131.15 111.59 12.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.579 ' CE1' HG11 ' A' ' 172' ' ' VAL . 9.2 m-85 -116.81 115.55 25.77 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.525 -0.734 . . . . 1.0 110.902 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 0.5 OUTLIER -124.97 144.42 50.38 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.037 -1.039 . . . . 1.0 109.174 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.4 OUTLIER -179.56 159.18 0.87 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.154 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 103' ' ' THR . 74.8 m -128.75 145.72 51.1 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.563 HD12 ' CG1' ' A' ' 97' ' ' ILE . 1.4 pt -124.72 -170.46 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 118.449 -1.3 . . . . 1.0 111.532 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.591 ' HD2' ' CD2' ' A' ' 102' ' ' TRP . 0.4 OUTLIER -148.11 146.13 28.67 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.343 -1.355 . . . . 1.0 107.343 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 46.1 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.042 -1.063 . . . . 1.0 110.014 -178.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.612 ' O ' ' CB ' ' A' ' 51' ' ' ALA . 8.3 tt0 -176.95 -22.75 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.376 -0.827 . . . . 1.0 110.55 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.649 ' HB3' ' HB ' ' A' ' 164' ' ' ILE . . . 78.64 -3.62 2.23 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.931 -0.481 . . . . 1.0 110.088 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 51' ' ' ALA . 1.7 p 78.82 -19.97 0.41 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.312 0.577 . . . . 1.0 111.387 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.537 ' HG3' ' CB ' ' A' ' 158' ' ' ALA . 0.3 OUTLIER -143.91 124.26 13.86 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.324 -0.86 . . . . 1.0 109.881 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 164.86 139.92 2.75 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.622 ' HB2' ' CD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -89.45 145.62 25.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.754 -1.439 . . . . 1.0 109.365 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.586 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -116.3 -4.61 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -174.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.562 ' CD1' ' CD2' ' A' ' 143' ' ' LEU . 2.8 tt -168.56 152.12 5.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 119.206 -2.184 . . . . 1.0 113.105 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.58 ' CD1' ' SD ' ' A' ' 146' ' ' MET . 1.5 t-105 -164.64 113.72 1.12 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.8 -0.562 . . . . 1.0 110.157 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.473 ' HB3' HD12 ' A' ' 141' ' ' LEU . 1.4 p -120.99 141.69 50.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.934 -1.104 . . . . 1.0 109.647 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 -179.683 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.701 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.218 0 CA-C-O 121.304 0.573 . . . . 1.0 110.242 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.542 ' O ' HG13 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -108.66 111.05 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 178.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.556 ' CB ' ' HE1' ' A' ' 81' ' ' MET . . . -138.44 -173.92 3.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 1.0 111.185 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 56' ' ' ILE . 82.5 mt -153.31 110.83 3.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -126.95 176.19 7.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.75 -1.219 . . . . 1.0 111.321 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -124.46 140.22 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -0.834 . . . . 1.0 111.621 -178.135 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.479 HG21 ' OD2' ' A' ' 75' ' ' ASP . 2.4 p -142.58 132.85 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.82 -0.55 . . . . 1.0 110.324 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.479 ' OD2' HG21 ' A' ' 74' ' ' VAL . 2.9 m-20 66.45 27.02 9.95 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.949 -1.094 . . . . 1.0 110.826 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.51 ' O ' ' CG2' ' A' ' 97' ' ' ILE . . . 81.41 -5.36 68.49 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -109.18 149.47 29.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.305 -1.114 . . . . 1.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -98.22 -169.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 1.0 109.647 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER 178.12 126.47 0.05 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.101 -1.0 . . . . 1.0 111.31 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.564 ' CE ' ' O ' ' A' ' 115' ' ' SER . 22.8 ttp -91.54 125.7 36.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 1.0 109.59 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.556 ' HE1' ' CB ' ' A' ' 70' ' ' ALA . 4.0 ptt? -112.56 128.87 56.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.947 -1.095 . . . . 1.0 110.491 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.489 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -118.58 121.21 39.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 1.0 110.211 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.701 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.2 t70 -126.99 46.54 2.49 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.607 0.718 . . . . 1.0 109.965 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.556 HD21 ' CZ ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -70.34 53.8 0.14 Allowed 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.005 179.631 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.417 ' C ' ' OG ' ' A' ' 86' ' ' SER . . . 161.77 -66.4 0.25 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.417 ' OG ' ' C ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -169.03 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.001 -1.294 . . . . 1.0 111.53 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -99.48 112.65 63.87 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.809 -1.182 . . . . 1.0 111.222 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -76.11 114.98 4.02 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.939 1.494 . . . . 1.0 109.708 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.632 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -93.1 105.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.248 -0.907 . . . . 1.0 110.458 -179.229 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -90.26 120.79 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 119.972 -1.705 . . . . 1.0 110.445 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.558 ' HB3' ' O ' ' A' ' 124' ' ' ILE . 33.6 mt -113.35 76.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 21.6 mtp180 -57.87 179.15 0.07 Allowed 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.213 -0.995 . . . . 1.0 110.651 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.484 ' HA ' ' CD1' ' A' ' 124' ' ' ILE . 1.4 t -104.77 167.02 9.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.005 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.27 17.42 15.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.332 -0.855 . . . . 1.0 109.771 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.581 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 68.0 t -135.45 150.46 72.41 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.534 -0.729 . . . . 1.0 110.171 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 42.8 Cg_endo -68.85 139.08 42.51 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.796 1.419 . . . . 1.0 110.39 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.563 ' CG1' HD12 ' A' ' 47' ' ' ILE . 2.7 tt -129.17 -27.21 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 1.0 111.034 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.597 ' CB ' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p30 -80.93 44.6 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.125 -0.984 . . . . 1.0 110.288 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 100' ' ' ASN . 94.3 m -117.64 24.67 10.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 1.0 110.359 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 99' ' ' THR . 62.1 t30 59.77 41.16 18.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 1.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -130.02 137.69 50.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.832 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.591 ' CD2' ' HD2' ' A' ' 48' ' ' LYS . 3.9 m95 -61.93 91.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 1.0 110.315 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.54 ' O ' ' CB ' ' A' ' 46' ' ' SER . 54.5 m -80.56 172.5 13.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.061 -1.024 . . . . 1.0 108.927 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -129.99 106.59 8.75 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.111 -0.993 . . . . 1.0 108.672 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.542 ' CD1' HG23 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -97.64 136.57 28.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 O-C-N 121.094 -1.004 . . . . 1.0 109.2 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' A' ' 107' ' ' ALA . 1.3 tppt? -137.22 155.87 48.99 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.98 -1.088 . . . . 1.0 110.169 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -153.59 123.24 6.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.096 -1.002 . . . . 1.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.624 ' O ' ' CD1' ' A' ' 108' ' ' TYR . 41.6 p90 -126.24 112.16 15.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.556 ' CZ ' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -120.53 154.8 34.83 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.369 -0.832 . . . . 1.0 110.432 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.518 ' N ' ' HG2' ' A' ' 109' ' ' ARG . 2.4 t -128.65 95.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 1.0 110.721 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 22.8 mt-30 34.71 24.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 0.2 OUTLIER 173.2 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.486 -1.384 . . . . 1.0 110.437 179.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.586 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -97.72 117.91 33.07 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.566 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.501 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.84 157.36 16.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.608 ' OG ' ' CE2' ' A' ' 108' ' ' TYR . 38.7 t -135.69 157.59 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.452 -1.028 . . . . 1.0 109.949 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 2.3 tm? -137.19 153.1 50.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.577 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -158.59 128.12 5.72 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.538 -1.265 . . . . 1.0 111.617 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.535 HG22 ' CG2' ' A' ' 95' ' ' VAL . 20.4 m -92.05 100.2 10.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . 68.62 42.49 80.28 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.366 -1.093 . . . . 1.0 110.366 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 10.6 m-80 58.06 31.69 21.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.244 -1.151 . . . . 1.0 111.073 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 122' ' ' ALA . 1.3 tt0 -100.09 167.01 10.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 1.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.598 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -19.73 102.96 0.06 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 CA-C-O 120.989 0.423 . . . . 1.0 110.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 40.0 Cg_endo -69.24 131.38 21.85 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.258 1.662 . . . . 1.0 112.478 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.558 ' O ' ' HB3' ' A' ' 91' ' ' LEU . 4.5 mp -92.42 104.89 16.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 105.84 -1.911 . . . . 1.0 105.84 177.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.544 ' CG2' ' OG ' ' A' ' 115' ' ' SER . 32.7 p -118.55 160.98 20.8 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.902 -1.119 . . . . 1.0 112.401 -176.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.63 173.16 38.84 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 107.108 -2.397 . . . . 1.0 107.108 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -154.7 160.62 41.49 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.645 -1.503 . . . . 1.0 110.396 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.45 ' O ' ' CG ' ' A' ' 112' ' ' ARG . 50.1 m -105.71 160.86 24.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 118.955 -1.098 . . . . 1.0 109.248 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 130' ' ' LEU . 38.1 Cg_endo -64.51 -21.34 66.05 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 N-CA-C 108.196 -1.501 . . . . 1.0 108.196 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.564 ' CB ' ' O ' ' A' ' 129' ' ' PRO . 1.0 OUTLIER 155.92 -161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.36 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 148.09 -44.77 0.76 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -155.66 114.24 3.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -1.124 . . . . 1.0 110.381 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -63.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 1.0 110.222 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -100.55 76.76 1.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.0 110.508 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 84' ' ' LEU . 1.1 tp -71.46 112.28 7.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.862 . . . . 1.0 109.789 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.22 127.13 31.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.895 . . . . 1.0 109.937 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -148.94 105.66 3.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 1.0 110.12 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.6 OUTLIER 163.3 -38.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.65 0.738 . . . . 1.0 109.07 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.506 ' O ' ' ND1' ' A' ' 28' ' ' HIS . . . -44.57 -32.88 3.03 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.175 -1.17 . . . . 1.0 110.175 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . . . -161.02 153.33 20.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.769 -1.43 . . . . 1.0 109.897 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.524 HD13 ' CD2' ' A' ' 57' ' ' LEU . 30.0 tp -155.73 152.8 28.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 110.519 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.667 ' CG ' ' HE2' ' A' ' 146' ' ' MET . 31.4 m95 -118.31 161.87 19.22 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.562 ' CD2' ' CD1' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -152.83 111.29 3.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.2 -1.8 . . . . 1.0 113.42 -177.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.555 ' O ' ' CA ' ' A' ' 162' ' ' GLY . . . 125.96 -11.18 7.38 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.529 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 158.2 -140.43 6.98 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 119.005 -1.569 . . . . 1.0 109.707 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.714 ' CE ' ' HA ' ' A' ' 146' ' ' MET . 0.1 OUTLIER -168.11 152.35 6.24 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.183 -1.007 . . . . 1.0 111.098 -179.362 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -96.58 -8.96 30.47 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.877 0.846 . . . . 1.0 109.513 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -141.64 53.03 1.51 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.689 ' CD1' ' CB ' ' A' ' 146' ' ' MET . 0.2 OUTLIER -62.82 57.17 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 1.0 111.854 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 148' ' ' ARG . 29.6 p -59.49 -22.53 61.72 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.79 -1.93 . . . . 1.0 105.79 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 152' ' ' ALA 0.289 9.8 p -76.92 -130.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.49 -1.232 . . . . 1.0 108.831 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.634 ' HA ' ' CE2' ' A' ' 159' ' ' TYR . . . 55.86 50.72 13.47 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.804 -1.185 . . . . 1.0 108.578 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -52.58 -111.81 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.293 1.961 . . . . 1.0 116.293 -175.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 18.25 0.24 Allowed 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 113.944 1.09 . . . . 1.0 113.944 -175.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.637 ' CD2' ' CD2' ' A' ' 159' ' ' TYR . 5.1 tt -95.71 141.08 22.68 Favored Pre-proline 0 C--N 1.288 -2.089 0 O-C-N 120.858 -1.152 . . . . 1.0 110.499 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.56 ' O ' ' CD2' ' A' ' 155' ' ' LEU . 37.6 Cg_endo -62.05 -149.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.045 1.55 . . . . 1.0 111.327 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -60.41 -10.42 4.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.837 -1.165 . . . . 1.0 112.869 -177.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.606 ' CB ' ' CD2' ' A' ' 155' ' ' LEU . . . -41.71 -35.35 0.76 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.814 -1.179 . . . . 1.0 109.428 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.637 ' CD2' ' CD2' ' A' ' 155' ' ' LEU . 32.4 m-85 -86.79 -31.99 20.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.744 -1.223 . . . . 1.0 108.928 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -72.68 -5.88 40.62 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.436 -1.305 . . . . 1.0 108.0 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.635 ' CG2' ' CD1' ' A' ' 164' ' ' ILE . 33.4 m -122.23 90.26 3.27 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 163' ' ' PHE . . . -57.06 106.87 0.8 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.057 -1.068 . . . . 1.0 110.562 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.666 ' O ' ' O ' ' A' ' 162' ' ' GLY . 89.5 t80 12.95 137.8 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 115.761 1.763 . . . . 1.0 115.761 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.649 ' HB ' ' HB3' ' A' ' 51' ' ' ALA . 2.2 mt -131.08 86.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.084 -0.962 . . . . 1.0 108.827 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.18 -161.17 21.38 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 107.2 -2.36 . . . . 1.0 107.2 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.571 ' O ' ' N ' ' A' ' 48' ' ' LYS . 3.3 m -129.27 142.57 50.8 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.87 -1.371 . . . . 1.0 110.023 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -128.24 157.89 40.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.402 -1.436 . . . . 1.0 112.285 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.572 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -165.36 168.31 16.92 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.061 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.4 m-20 43.78 72.89 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.214 -0.929 . . . . 1.0 110.658 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 26.8 m -127.67 123.25 60.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.89 -1.124 . . . . 1.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.499 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -136.0 152.17 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.53 -177.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -133.8 103.35 5.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 6.7 m-20 57.55 35.46 25.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.975 -1.121 . . . . 1.0 107.975 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 75.0 6.34 4.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.828 -0.545 . . . . 1.0 111.088 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.563 ' O ' ' CB ' ' A' ' 176' ' ' GLU . 77.8 mm-40 -91.18 176.39 6.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.143 -0.973 . . . . 1.0 110.105 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.563 ' CB ' ' O ' ' A' ' 175' ' ' GLN . 30.0 tt0 83.68 -109.66 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 176' ' ' GLU . 0.4 OUTLIER 29.97 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.304 -0.873 . . . . 1.0 112.499 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 181' ' ' GLU . 2.3 m80 -160.89 44.5 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.994 -1.066 . . . . 1.0 110.597 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.64 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 0.0 OUTLIER -52.17 -27.89 16.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.553 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 9.2 t -71.3 -35.23 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.12 0.486 . . . . 1.0 111.198 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 51.0 mt-10 -62.16 -56.07 22.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.049 -1.032 . . . . 1.0 109.54 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.639 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -81.89 -19.7 40.36 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.086 179.008 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.64 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -48.14 -41.76 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.818 -1.153 . . . . 1.0 107.94 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ALA . 3.4 mt -41.78 -26.3 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.369 0.604 . . . . 1.0 109.598 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 6.3 t-20 -62.8 -11.61 19.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.353 -0.842 . . . . 1.0 109.808 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 187' ' ' PRO . 0.5 OUTLIER -123.85 154.21 67.35 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.539 -0.725 . . . . 1.0 109.182 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.518 ' O ' ' ND2' ' A' ' 186' ' ' ASN . 37.3 Cg_endo -61.27 -162.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.671 1.353 . . . . 1.0 111.215 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 187' ' ' PRO . 4.8 m -40.74 134.56 1.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.21 -0.931 . . . . 1.0 111.263 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.55 ' CD1' ' CB ' ' A' ' 183' ' ' ALA . 3.1 mt -102.91 144.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.443 -0.785 . . . . 1.0 109.452 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.492 ' O ' HG21 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -100.37 153.41 19.35 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.098 -1.001 . . . . 1.0 109.889 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.528 ' CE1' HD13 ' A' ' 17' ' ' ILE . 1.6 m-70 -112.68 152.25 29.23 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.289 -0.882 . . . . 1.0 109.618 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.674 0 C-N-CA 119.424 -0.91 . . . . 1.0 109.974 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.9 pt-20 . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 121.937 0.875 . . . . 1.0 110.154 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.22 151.28 37.23 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.063 -1.023 . . . . 1.0 109.712 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 7.0 mm -119.52 133.27 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.037 . . . . 1.0 110.328 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -91.49 124.15 35.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.651 . . . . 1.0 110.431 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 167' ' ' ILE . 4.0 m-30 -91.1 132.69 35.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.0 109.209 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 2.3 p30 -97.74 2.16 49.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 1.0 110.545 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 103.51 -22.8 34.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.506 -1.838 . . . . 1.0 108.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 5.3 ttt-85 -107.25 -8.1 16.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.634 -0.921 . . . . 1.0 109.672 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.495 HG22 ' CD2' ' A' ' 19' ' ' PHE . 14.9 t -48.08 174.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 1.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.619 ' CE1' ' HB2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER 179.86 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 1.0 109.104 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.468 ' O ' ' HA ' ' A' ' 142' ' ' TRP . 25.0 mtt -96.26 101.33 12.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.943 -1.098 . . . . 1.0 111.007 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.619 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 18.7 tt0 -93.39 121.97 35.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.347 -0.846 . . . . 1.0 109.481 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CE2' ' CB ' ' A' ' 182' ' ' ASP . 6.2 m-85 -113.62 105.63 13.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.184 -0.947 . . . . 1.0 109.993 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.16 86.63 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 1.0 110.449 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -121.88 176.82 5.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.227 -0.92 . . . . 1.0 110.132 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.02 99.94 12.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.196 -0.94 . . . . 1.0 110.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.9 t . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.235 -0.915 . . . . 1.0 109.977 179.787 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.639 0.733 . . . . 1.0 109.345 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -161.61 131.26 4.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.529 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 5.0 m-80 -98.64 163.05 12.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.966 -1.084 . . . . 1.0 110.472 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -134.99 137.48 43.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 1.0 110.112 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 41' ' ' ASN . 91.0 m-85 -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 1.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 3.0 mt-10 -126.75 145.24 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.981 -1.074 . . . . 1.0 109.867 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.5 OUTLIER 179.08 156.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.401 -0.92 . . . . 1.0 111.412 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 103' ' ' THR . 4.8 m -122.13 154.99 36.66 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.612 -1.255 . . . . 1.0 107.612 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 166' ' ' CYS . 3.3 pt -148.82 163.46 4.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 117.829 -1.548 . . . . 1.0 112.652 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.8 OUTLIER -114.3 83.31 1.86 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 177.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.488 ' OG1' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -70.67 150.7 45.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.084 -1.01 . . . . 1.0 112.434 -176.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.651 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 6.7 mm-40 -135.68 -3.12 2.35 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.35 0.595 . . . . 1.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.51 125.96 11.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.257 -0.902 . . . . 1.0 109.84 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.469 ' HB ' ' N ' ' A' ' 76' ' ' GLY . 47.5 p -55.51 -15.02 2.35 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.553 -0.717 . . . . 1.0 111.327 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -123.4 133.63 54.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.902 -1.124 . . . . 1.0 111.655 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 157.9 134.74 1.78 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.159 -1.177 . . . . 1.0 110.159 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.595 ' HA ' ' CB ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -83.08 143.35 30.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.769 -1.43 . . . . 1.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.8 OUTLIER -111.81 -47.03 5.94 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 C-N-CA 119.741 -0.784 . . . . 1.0 111.762 -177.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 5.7 tt -134.58 145.14 48.4 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.278 -1.514 . . . . 1.0 113.031 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.671 ' CZ3' ' CD1' ' A' ' 68' ' ' TYR . 2.3 t-105 -149.68 117.12 6.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.804 . . . . 1.0 109.041 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -127.22 -176.08 3.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 1.0 110.694 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.732 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.671 ' CD1' ' CZ3' ' A' ' 58' ' ' TRP . 2.5 p90 . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.559 0.695 . . . . 1.0 109.572 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.561 HD13 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -147.56 136.16 15.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 121.68 -0.637 . . . . 1.0 110.059 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.572 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -132.87 -174.33 3.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 1.0 110.455 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 70' ' ' ALA . 66.0 mt -149.0 101.14 3.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.849 . . . . 1.0 108.722 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.648 ' CB ' ' CE1' ' A' ' 159' ' ' TYR . . . -119.38 174.41 6.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.957 -1.089 . . . . 1.0 112.211 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 56.3 mt -113.86 131.17 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.668 -0.645 . . . . 1.0 110.597 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.495 HG12 ' NH2' ' A' ' 92' ' ' ARG . 2.5 p -139.96 131.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.415 -0.803 . . . . 1.0 110.077 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 28.0 m-20 61.24 10.12 2.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 1.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.469 ' N ' ' HB ' ' A' ' 52' ' ' THR . . . 95.19 9.36 58.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 78' ' ' VAL . 61.5 m-85 -133.32 108.46 8.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -1.095 . . . . 1.0 110.048 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.596 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -48.6 -175.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.77 0.795 . . . . 1.0 111.412 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 0.8 OUTLIER -172.9 124.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.672 0.749 . . . . 1.0 110.893 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.56 ' CE ' ' O ' ' A' ' 115' ' ' SER . 2.2 ttm -85.03 110.54 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.791 -0.568 . . . . 1.0 110.481 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.599 ' CE ' ' OH ' ' A' ' 159' ' ' TYR . 37.1 mtm -89.45 116.71 27.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.906 -1.121 . . . . 1.0 109.885 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.561 ' CZ ' HD13 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -111.92 116.38 30.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.693 -1.255 . . . . 1.0 109.163 178.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -124.98 48.09 2.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 1.0 110.469 -179.156 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.552 ' HB3' ' CD1' ' A' ' 135' ' ' LEU . 0.4 OUTLIER -65.06 61.66 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.975 -0.69 . . . . 1.0 110.138 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 132.4 33.09 0.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.956 -1.258 . . . . 1.0 109.956 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.01 9.69 5.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.237 -1.155 . . . . 1.0 110.107 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.49 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -108.0 89.32 5.4 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 1.0 109.333 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.533 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -72.11 140.81 35.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.157 1.609 . . . . 1.0 111.599 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -137.12 119.14 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.569 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 1.0 OUTLIER -97.46 114.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.354 -1.466 . . . . 1.0 111.403 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.496 HD13 ' CE ' ' A' ' 80' ' ' MET . 38.3 mt -104.38 71.97 1.03 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.137 -1.431 . . . . 1.0 107.137 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 51.1 mtp180 -57.33 178.58 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.052 0.93 . . . . 1.0 111.046 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.53 ' OG ' ' CG2' ' A' ' 118' ' ' VAL . 3.3 t -108.35 155.21 20.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.175 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.474 ' OG1' HD13 ' A' ' 124' ' ' ILE . 1.4 p -112.11 26.38 10.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 1.0 109.673 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 96' ' ' PRO . 8.0 t -129.07 146.62 61.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.519 -0.738 . . . . 1.0 109.454 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.488 ' N ' HG13 ' A' ' 95' ' ' VAL . 43.6 Cg_endo -67.85 116.17 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.754 1.397 . . . . 1.0 109.767 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.488 HG13 ' OG1' ' A' ' 49' ' ' THR . 1.8 tp -106.78 -33.36 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.14 -0.975 . . . . 1.0 111.055 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -71.64 61.22 0.36 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 1.0 110.738 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -127.21 14.28 7.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 1.0 110.167 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.481 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 1.9 m120 58.63 40.88 23.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.995 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . 0.549 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 1.1 m-70 -132.11 159.14 39.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 1.0 110.172 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.602 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 22.2 m95 -78.87 101.37 7.65 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.292 -0.963 . . . . 1.0 109.729 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' SER . 5.9 m -101.93 171.66 7.39 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.441 -0.904 . . . . 1.0 109.009 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.525 ' N ' ' CG2' ' A' ' 103' ' ' THR . 8.4 t60 -119.97 143.9 47.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.07 -1.019 . . . . 1.0 108.791 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.463 HD11 HD11 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -133.67 159.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.22 -0.925 . . . . 1.0 109.172 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.522 ' O ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -152.45 148.47 27.47 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.659 -1.217 . . . . 1.0 110.307 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.485 ' HB3' HD23 ' A' ' 116' ' ' LEU . . . -144.23 102.21 3.82 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.526 -0.733 . . . . 1.0 110.374 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.58 ' CE1' ' OG ' ' A' ' 115' ' ' SER . 37.1 p90 -117.07 105.48 12.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 108.689 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.638 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -91.44 150.87 21.05 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.655 -0.818 . . . . 1.0 111.225 -178.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.7 t -136.93 96.51 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.679 -0.638 . . . . 1.0 110.799 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.582 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 17.4 mt-30 43.74 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.662 -0.649 . . . . 1.0 111.779 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.582 ' CD ' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 54.2 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.651 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.8 tm-20 -95.97 109.75 22.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.108 -1.62 . . . . 1.0 109.919 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -99.05 161.43 20.07 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.067 -1.063 . . . . 1.0 110.892 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 108' ' ' TYR . 33.7 t -132.7 156.67 46.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -1.17 . . . . 1.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 2.1 tm? -140.09 151.51 45.41 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.574 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.52 144.59 25.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.888 -1.133 . . . . 1.0 111.514 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.53 ' CG2' ' OG ' ' A' ' 93' ' ' SER . 41.1 t -102.86 98.92 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 177.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.21 39.52 82.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.715 -1.354 . . . . 1.0 109.715 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 119' ' ' GLY . 21.8 t-20 57.36 32.13 21.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -1.104 . . . . 1.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 123' ' ' PRO . 5.3 mt-10 -114.8 -158.11 0.66 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.569 -0.707 . . . . 1.0 110.593 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -30.43 93.77 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.936 -0.477 . . . . 1.0 110.576 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.9 Cg_endo -77.12 142.65 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.039 1.547 . . . . 1.0 112.012 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.543 ' CB ' ' O ' ' A' ' 92' ' ' ARG . 3.3 mp -108.53 100.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.9 p -108.19 166.96 10.35 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.192 0.996 . . . . 1.0 111.962 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.7 167.76 38.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.222 -2.351 . . . . 1.0 107.222 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.651 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -136.88 170.0 16.82 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.555 -1.556 . . . . 1.0 110.929 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 31.7 p -96.92 163.57 19.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.921 -1.112 . . . . 1.0 110.431 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 130' ' ' LEU . 45.6 Cg_endo -71.65 55.62 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.954 1.502 . . . . 1.0 108.735 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 129' ' ' PRO . 4.7 mp 41.05 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.637 -0.665 . . . . 1.0 110.056 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.29 10.57 47.87 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.499 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -133.58 145.54 50.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.113 -1.228 . . . . 1.0 109.867 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 134' ' ' GLN . 34.5 m -137.52 13.94 2.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.089 -1.007 . . . . 1.0 110.676 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 133' ' ' THR . 1.7 mt-30 179.94 160.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 1.0 110.54 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.552 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -166.08 61.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.485 -0.759 . . . . 1.0 109.893 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 4.2 m-20 -77.4 122.19 24.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.056 . . . . 1.0 109.439 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.77 164.23 18.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.08 . . . . 1.0 110.877 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 138' ' ' ASP . 20.4 p-10 -89.82 29.35 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 1.0 110.204 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 52.29 18.09 4.64 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 1.0 109.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 27' ' ' TYR . . . -64.34 158.76 22.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -1.21 . . . . 1.0 109.072 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.535 ' C ' ' CD1' ' A' ' 142' ' ' TRP . 6.8 tp -158.47 144.06 16.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.446 -1.302 . . . . 1.0 112.481 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.581 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 19.2 m95 -131.88 97.27 4.13 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 2.8 tt -112.82 119.73 39.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.627 -1.295 . . . . 1.0 113.544 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 128.67 3.74 5.45 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.538 ' O ' ' HE3' ' A' ' 146' ' ' MET . . . 145.91 -147.72 18.93 Favored Glycine 0 C--N 1.283 -2.378 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' MET . . . . . 0.682 ' CB ' HD12 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -151.64 113.13 4.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.082 -1.047 . . . . 1.0 111.772 -178.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.64 -24.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.997 0.903 . . . . 1.0 109.025 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.548 ' N ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -145.68 83.47 1.65 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 178.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.682 HD12 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -71.58 22.84 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.275 -0.891 . . . . 1.0 112.757 -176.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.3 p -61.67 -19.68 62.6 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.619 HG23 ' CZ3' ' A' ' 58' ' ' TRP 0.288 10.5 p -71.51 -123.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.67 -1.15 . . . . 1.0 110.301 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.583 ' HB2' ' CB ' ' A' ' 159' ' ' TYR . . . 72.1 -71.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.702 -1.249 . . . . 1.0 108.796 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.531 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 52.94 155.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.919 1.342 . . . . 1.0 112.545 178.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER 44.16 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.006 1.484 . . . . 1.0 115.006 178.11 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -135.86 154.0 77.52 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.057 -1.652 . . . . 1.0 111.054 -179.387 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.568 ' N ' HD21 ' A' ' 155' ' ' LEU . 41.0 Cg_endo -65.62 -161.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.594 1.529 . . . . 1.0 113.629 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.517 ' HG3' ' CB ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -55.93 -8.88 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.561 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.554 ' CB ' HD23 ' A' ' 155' ' ' LEU . . . -39.85 -38.35 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.915 -1.116 . . . . 1.0 109.44 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.648 ' CE1' ' CB ' ' A' ' 72' ' ' ALA . 10.2 m-85 -85.85 -31.6 22.16 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.855 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.517 ' CB ' ' HG3' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -65.04 -11.04 34.82 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.952 -1.499 . . . . 1.0 108.243 177.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.522 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.2 m -122.27 98.94 6.16 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -49.82 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.637 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 32.8 t80 -88.79 145.5 25.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.119 -1.224 . . . . 1.0 111.575 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.651 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 2.5 mt -123.42 85.39 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.139 -1.43 . . . . 1.0 107.139 177.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.637 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.67 -156.13 11.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.316 -1.914 . . . . 1.0 108.316 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.0 m -133.41 154.06 51.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.112 -1.228 . . . . 1.0 110.311 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.9 mt -134.76 144.96 33.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.774 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.503 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 26.9 ttt180 -150.72 164.6 35.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.892 -1.13 . . . . 1.0 110.659 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.6 m-20 43.57 74.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.202 -0.936 . . . . 1.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 45' ' ' LEU . 22.7 m -126.74 124.17 64.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 119.311 -0.955 . . . . 1.0 109.891 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.515 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -131.95 158.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.929 -1.108 . . . . 1.0 111.331 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 76.5 t -134.15 114.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 63.3 m-20 50.01 36.58 12.14 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.878 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.7 OUTLIER 67.61 34.25 4.64 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.377 0.608 . . . . 1.0 110.411 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 19.2 mm100 -114.45 -176.53 2.92 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 121.323 -0.861 . . . . 1.0 110.616 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 0.3 OUTLIER 67.91 -98.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 1.0 110.66 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 12.1 mt 60.37 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.894 -1.128 . . . . 1.0 111.477 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 2.6 m-70 -70.09 79.74 0.5 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.716 -1.24 . . . . 1.0 110.546 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.546 ' O ' ' CB ' ' A' ' 183' ' ' ALA 0.263 0.5 OUTLIER -52.7 -61.23 2.42 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.201 1.001 . . . . 1.0 110.752 178.931 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.518 ' HA ' ' CD2' ' A' ' 184' ' ' LEU . 12.9 t -52.91 -18.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.632 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 0.7 OUTLIER -73.63 -56.51 4.91 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.732 -1.187 . . . . 1.0 109.901 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.612 ' CB ' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -95.81 -18.38 20.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.099 -1.0 . . . . 1.0 109.8 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -73.74 -29.92 62.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.144 -0.972 . . . . 1.0 108.703 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.555 ' N ' HD23 ' A' ' 184' ' ' LEU . 1.5 mm? -65.06 -8.8 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.424 -0.798 . . . . 1.0 109.987 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 184' ' ' LEU . 8.5 t-20 -43.85 -26.43 0.26 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.391 -0.818 . . . . 1.0 109.095 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.476 ' O ' HG12 ' A' ' 189' ' ' ILE . 2.2 t-20 -113.9 148.89 40.89 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 47.8 Cg_endo -76.97 -34.74 2.11 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.824 1.434 . . . . 1.0 110.68 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 4.51 0.42 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.697 -0.683 . . . . 1.0 112.76 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 186' ' ' ASN . 23.4 mm -61.95 117.35 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.323 -1.485 . . . . 1.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -120.59 159.64 24.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 110.829 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . 0.458 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 18.9 m-70 -93.54 151.55 19.62 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.344 -0.847 . . . . 1.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' CYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 9.2 t . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 1.0 111.913 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.501 -1.439 . . . . 1.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 t -125.97 127.9 46.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 1.0 110.004 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -98.29 21.48 10.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 1.0 110.295 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 3' ' ' GLU . 1.1 mttt 66.91 -172.85 0.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 1.0 110.309 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 5' ' ' VAL . 8.5 p -132.6 102.88 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 1.0 110.101 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -87.03 155.26 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 1.0 110.474 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mt -125.92 82.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 1.0 110.17 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.77 87.74 2.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.082 -1.011 . . . . 1.0 110.229 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.48 109.58 10.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 1.0 110.403 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.62 86.84 2.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.055 -1.028 . . . . 1.0 109.842 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.09 26.32 2.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.88 . . . . 1.0 109.391 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.74 165.45 22.15 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -143.79 68.58 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -1.186 . . . . 1.0 110.382 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -128.54 63.38 1.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 1.0 110.049 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.571 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.6 pt-20 -60.6 71.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.481 -0.762 . . . . 1.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -95.35 136.95 35.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.662 -1.274 . . . . 1.0 110.766 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.468 HG21 ' O ' ' A' ' 190' ' ' LEU . 8.9 mm -127.43 118.16 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.278 -0.888 . . . . 1.0 109.702 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -80.76 142.46 33.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 1.0 111.216 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.597 ' CD1' HD13 ' A' ' 167' ' ' ILE . 9.1 m-85 -106.6 172.07 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 1.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.467 ' C ' HG12 ' A' ' 164' ' ' ILE . 3.8 p30 -127.32 -3.62 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 1.0 110.637 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.482 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 110.17 -9.8 31.34 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.85 -1.7 . . . . 1.0 108.85 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -127.72 -24.95 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -1.186 . . . . 1.0 110.773 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 133.76 37.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 1.0 110.369 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.618 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -128.17 114.55 17.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 1.0 110.365 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.527 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 6.0 mmt -83.23 99.07 9.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.85 -1.156 . . . . 1.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.59 ' HG3' ' CH2' ' A' ' 142' ' ' TRP . 46.8 tt0 -87.77 87.98 7.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 1.0 109.456 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.559 ' CD1' ' HB3' ' A' ' 182' ' ' ASP . 8.0 m-30 -92.18 97.03 10.65 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 1.0 110.236 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.15 104.39 16.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 1.0 110.007 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 138' ' ' ASP . 1.4 t-20 -147.36 162.97 37.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 1.0 110.338 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.69 50.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 1.0 110.376 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.457 HG13 ' HG3' ' A' ' 175' ' ' GLN . 4.6 m -58.84 -47.93 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.271 -0.893 . . . . 1.0 110.907 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.455 HG21 ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -163.21 110.54 1.2 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.936 -1.102 . . . . 1.0 110.463 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 34' ' ' SER . 47.2 mttp -62.91 97.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.273 -0.892 . . . . 1.0 110.004 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER 175.25 -51.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.153 -0.967 . . . . 1.0 110.765 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 28.9 mt-10 -101.7 -67.3 0.87 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 1.0 110.533 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 1.0 OUTLIER 63.01 77.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 1.0 110.01 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 36' ' ' LYS . . . 172.58 44.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 1.0 109.377 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.637 ' N ' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -47.75 173.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.775 0.798 . . . . 1.0 111.694 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.41 ' NE2' ' HB2' ' A' ' 40' ' ' SER . 2.5 tm0? -119.91 -20.61 7.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 1.0 109.809 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.506 ' N ' HD21 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -160.72 146.22 14.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.732 -0.605 . . . . 1.0 109.467 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.609 ' ND2' ' N ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -133.23 155.28 49.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.049 -1.032 . . . . 1.0 111.597 -178.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 8.8 m-70 -114.67 143.97 44.18 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 58.4 m-85 -129.02 121.76 28.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.097 -1.002 . . . . 1.0 110.644 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 2.8 mt-10 -127.92 147.24 50.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.014 -1.054 . . . . 1.0 109.928 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.573 ' HB2' ' CG1' ' A' ' 170' ' ' VAL . 1.3 pt? 179.89 150.22 0.36 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.759 . . . . 1.0 110.548 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.479 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 1.9 m -120.17 154.07 35.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.497 HG23 HD13 ' A' ' 47' ' ' ILE . 1.5 pt -147.49 155.09 10.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.824 -1.55 . . . . 1.0 112.86 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.645 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -112.61 82.68 1.69 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 176.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.582 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.2 OUTLIER -70.19 163.63 25.98 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.867 -1.146 . . . . 1.0 111.289 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 0.8 OUTLIER -145.39 29.84 1.14 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.299 -0.96 . . . . 1.0 110.845 -178.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.616 ' O ' ' CG2' ' A' ' 52' ' ' THR . . . -162.24 -96.68 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.943 -1.103 . . . . 1.0 110.324 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.616 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 176.07 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.431 0.634 . . . . 1.0 109.824 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.498 ' HG3' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -119.23 138.77 52.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.43 -0.794 . . . . 1.0 110.61 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.81 135.77 1.89 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.255 -1.938 . . . . 1.0 108.255 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -84.87 131.68 34.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.743 -1.445 . . . . 1.0 109.552 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.592 HD11 ' HA ' ' A' ' 72' ' ' ALA . 4.6 mp -95.75 -40.28 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 1.0 112.714 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 7.1 tt -141.13 148.36 39.95 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.254 -1.529 . . . . 1.0 113.652 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.633 ' CH2' ' CG2' ' A' ' 151' ' ' VAL . 7.3 t-105 -152.02 129.06 11.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.73 163.28 32.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.654 -1.279 . . . . 1.0 110.307 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -178.37 -112.94 0.35 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.119 -1.192 . . . . 1.0 110.119 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 61.05 90.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.425 -1.044 . . . . 1.0 110.525 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 136' ' ' ASP . . . 168.25 -24.8 0.12 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.667 ' CD1' ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -143.39 -168.11 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -1.144 . . . . 1.0 110.372 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.24 -2.69 10.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 1.0 110.122 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.481 ' HA ' ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -168.66 27.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 1.0 109.626 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -133.56 -174.02 3.39 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.662 -0.815 . . . . 1.0 111.147 -178.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.487 ' HB3' HD13 ' A' ' 63' ' ' LEU . 5.8 t0 33.53 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.089 0.471 . . . . 1.0 111.416 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.655 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 8.5 m-30 -116.49 102.15 9.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.582 -0.699 . . . . 1.0 109.482 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.0 mt -112.54 130.76 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.54 -1.35 . . . . 1.0 109.916 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -153.74 174.57 14.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 1.0 110.717 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 79.0 mt -146.22 110.4 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -129.98 164.38 24.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 1.0 112.466 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.577 HG13 ' CD1' ' A' ' 56' ' ' ILE . 9.3 mt -102.59 136.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.639 -0.663 . . . . 1.0 110.678 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.514 HG11 ' CZ ' ' A' ' 92' ' ' ARG . 4.0 p -140.63 131.44 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.157 -0.965 . . . . 1.0 110.806 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 7.4 m-20 63.8 8.79 4.0 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.352 -0.842 . . . . 1.0 111.032 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 104.56 13.73 25.4 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 35.8 m-85 -135.53 152.73 51.6 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.29 -1.124 . . . . 1.0 109.976 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.541 ' CG1' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -92.44 166.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 1.0 109.46 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 8.5 pt20 -164.12 126.39 2.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.094 -1.003 . . . . 1.0 110.936 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.576 ' CE ' ' O ' ' A' ' 115' ' ' SER . 1.0 OUTLIER -86.53 103.24 14.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.587 ' HE3' ' CB ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -104.78 119.39 38.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -0.751 . . . . 1.0 110.433 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.655 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 3.7 p90 -141.24 143.65 34.26 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.008 -1.477 . . . . 1.0 111.455 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 16.9 t0 -136.27 108.51 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.698 0.761 . . . . 1.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -110.39 30.4 6.81 Favored 'General case' 0 C--N 1.287 -2.122 0 O-C-N 121.723 -0.61 . . . . 1.0 109.852 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 86' ' ' SER . . . -164.21 -50.86 0.02 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 1.4 t 178.18 -18.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -1.11 . . . . 1.0 111.471 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 17.5 mmtt -119.51 117.86 32.63 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.724 -1.235 . . . . 1.0 110.662 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.07 143.92 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.877 1.462 . . . . 1.0 109.236 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.626 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.77 104.47 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 1.0 109.075 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.581 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 8.7 p -91.1 82.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.483 -1.385 . . . . 1.0 111.261 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.579 ' CA ' HG23 ' A' ' 124' ' ' ILE . 5.6 mt -75.02 74.51 2.21 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 14.3 mtp180 -59.16 178.88 0.11 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.929 0.871 . . . . 1.0 111.213 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.475 ' OG ' HG22 ' A' ' 118' ' ' VAL . 2.0 t -109.97 143.12 40.38 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.4 m -99.82 31.16 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.124 -0.985 . . . . 1.0 109.93 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.55 HG13 ' CG1' ' A' ' 118' ' ' VAL . 3.0 t -136.27 145.89 53.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 1.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.533 ' HD2' HG11 ' A' ' 95' ' ' VAL . 40.1 Cg_endo -65.2 134.48 39.44 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.612 1.322 . . . . 1.0 110.751 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 98' ' ' ASN . 2.6 tp -117.6 -24.5 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 1.0 110.581 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 97' ' ' ILE . 8.4 p-10 -76.37 55.95 1.03 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.889 . . . . 1.0 109.177 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.451 ' O ' ' CG2' ' A' ' 99' ' ' THR . 24.2 m -110.89 14.62 22.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.485 -0.76 . . . . 1.0 110.588 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.67 18.76 0.77 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.08 -1.013 . . . . 1.0 110.624 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.439 ' HB2' HG22 ' A' ' 99' ' ' THR . 1.9 m-70 -117.32 162.95 17.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.129 -0.982 . . . . 1.0 110.378 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.645 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 16.5 m95 -76.74 101.64 5.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.149 -0.969 . . . . 1.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.519 HG21 ' N ' ' A' ' 104' ' ' HIS . 49.4 m -94.99 165.33 12.49 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.576 -0.85 . . . . 1.0 109.498 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.519 ' N ' HG21 ' A' ' 103' ' ' THR . 1.0 OUTLIER -118.06 136.82 53.32 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.485 HD12 HD12 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -135.31 155.83 37.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.052 -1.03 . . . . 1.0 108.953 -178.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -152.53 174.5 13.84 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.12 -1.432 . . . . 1.0 110.498 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -161.23 123.97 3.15 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.328 -0.949 . . . . 1.0 111.214 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.495 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 24.6 m-85 -105.24 106.68 17.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.52 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.2 OUTLIER -105.98 117.7 34.7 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.319 -0.952 . . . . 1.0 111.67 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.518 ' CG1' ' OE1' ' A' ' 111' ' ' GLN . 1.8 t -118.6 134.52 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.536 ' N ' ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 29.74 -90.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.675 -0.641 . . . . 1.0 112.047 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.508 ' HD3' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -115.14 -14.78 11.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 1.0 112.138 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.59 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.7 tt0 -98.97 118.38 35.61 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.83 -1.169 . . . . 1.0 110.914 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.01 171.53 18.99 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.32 -0.943 . . . . 1.0 111.034 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.576 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -147.45 160.89 42.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.586 -0.95 . . . . 1.0 110.206 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.537 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -148.87 141.99 24.94 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.268 -0.895 . . . . 1.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.537 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -143.78 130.51 20.27 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.076 -1.05 . . . . 1.0 111.233 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.55 ' CG1' HG13 ' A' ' 95' ' ' VAL . 2.2 t -89.65 97.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.627 -1.62 . . . . 1.0 106.627 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 71.48 40.51 59.69 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.94 31.99 17.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.059 . . . . 1.0 110.497 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.529 ' N ' ' HG2' ' A' ' 117' ' ' GLN . 2.9 mt-10 -105.08 -158.18 0.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 1.0 110.619 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.34 99.9 0.19 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.664 -0.648 . . . . 1.0 110.013 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 48.5 Cg_endo -75.73 135.47 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.154 1.607 . . . . 1.0 111.363 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 124' ' ' ILE . 1.5 mp -103.49 119.52 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.5 p -118.35 172.21 7.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.822 -1.174 . . . . 1.0 112.658 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.437 ' HA3' HD23 ' A' ' 91' ' ' LEU . . . -179.68 153.98 12.99 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.694 -2.163 . . . . 1.0 107.694 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.59 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -138.26 161.93 35.62 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.006 -1.291 . . . . 1.0 110.986 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 3.2 m -89.94 163.58 31.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.764 . . . . 1.0 109.684 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -68.83 62.36 1.28 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.006 1.53 . . . . 1.0 109.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.518 ' HG ' ' C ' ' A' ' 129' ' ' PRO . 1.2 pp 16.55 50.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.376 0.608 . . . . 1.0 112.366 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -99.95 2.66 56.9 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.668 -1.373 . . . . 1.0 109.668 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 84' ' ' LEU . . . -161.85 84.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -1.109 . . . . 1.0 109.651 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 133' ' ' THR . 91.2 m -87.92 11.5 15.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 1.0 110.624 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.424 ' HG3' ' C ' ' A' ' 133' ' ' THR . 86.3 mt-30 -144.23 92.08 2.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 1.0 110.632 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.416 HD12 ' CG ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -100.71 160.21 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 1.0 109.598 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.47 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 29.1 m-20 -130.65 111.53 12.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.928 -1.107 . . . . 1.0 110.774 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 t -136.18 149.25 48.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -0.885 . . . . 1.0 109.847 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.545 ' OD1' ' CB ' ' A' ' 140' ' ' ALA . 5.5 p-10 -87.68 29.17 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 1.0 110.671 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 58.69 13.61 18.62 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.545 ' CB ' ' OD1' ' A' ' 138' ' ' ASP . . . -57.77 170.22 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 1.0 108.516 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 142' ' ' TRP . 0.2 OUTLIER -160.88 145.94 14.2 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.276 -1.37 . . . . 1.0 112.026 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.59 ' CH2' ' HG3' ' A' ' 26' ' ' GLU . 49.6 m95 -135.08 119.13 17.5 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.268 -1.752 . . . . 1.0 106.268 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 1.7 tt -130.93 123.46 28.94 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.334 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.87 2.17 10.42 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.503 ' HA2' HD22 ' A' ' 55' ' ' LEU . . . 141.58 -139.28 9.3 Favored Glycine 0 C--N 1.293 -1.828 0 C-N-CA 118.991 -1.576 . . . . 1.0 109.726 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.692 ' CB ' HD12 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -170.74 130.86 0.84 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.948 -1.101 . . . . 1.0 112.178 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -64.99 -42.65 94.34 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -113.14 67.95 0.67 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.975 -1.491 . . . . 1.0 106.975 177.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.692 HD12 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -66.32 37.78 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.194 -0.941 . . . . 1.0 113.403 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 148' ' ' ARG . 53.4 p -83.8 3.39 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 175.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.633 ' CG2' ' CH2' ' A' ' 58' ' ' TRP . 14.9 p -86.59 -23.87 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.308 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 153' ' ' HIS . . . -41.82 -26.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 1.0 109.508 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.56 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER 83.38 -85.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.965 -0.459 . . . . 1.0 111.245 179.218 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -143.91 -7.17 0.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 1.0 111.776 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.615 HD12 ' CD1' ' A' ' 159' ' ' TYR . 4.2 pp -53.65 167.07 0.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.108 -0.995 . . . . 1.0 110.377 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.543 ' O ' ' CD1' ' A' ' 155' ' ' LEU . 42.7 Cg_endo -68.96 -165.67 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.734 1.386 . . . . 1.0 112.278 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.5 ' O ' ' C ' ' A' ' 158' ' ' ALA . 1.5 mttp -56.25 -9.97 0.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.189 -0.944 . . . . 1.0 112.171 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -38.2 -44.36 0.85 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 1.0 109.784 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.642 ' CE1' ' CB ' ' A' ' 72' ' ' ALA . 6.0 m-85 -87.87 -27.07 22.44 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.989 -1.084 . . . . 1.0 108.748 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -73.17 -6.59 46.78 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.435 -1.306 . . . . 1.0 107.981 177.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 162' ' ' GLY . 4.4 m -122.2 83.91 2.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.67 171.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.645 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 6.2 t80 -89.55 144.23 26.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -1.218 . . . . 1.0 111.391 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.567 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 5.9 mt -123.2 91.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.645 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -169.63 -154.07 8.97 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.48 -1.848 . . . . 1.0 108.48 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.546 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 2.9 m -124.09 144.56 49.8 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.204 -1.174 . . . . 1.0 110.516 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.597 HD13 ' CD1' ' A' ' 19' ' ' PHE 0.251 3.4 mt -134.1 145.59 32.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.534 -0.729 . . . . 1.0 109.425 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 6.5 ttp180 -162.0 157.25 23.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.69 -1.256 . . . . 1.0 111.023 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 4.2 m-20 57.37 63.49 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 27.1 m -119.58 117.82 55.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.937 0.875 . . . . 1.0 109.653 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.5 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.5 OUTLIER -135.6 155.9 37.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.09 -1.044 . . . . 1.0 110.915 -178.072 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 3.6 p -134.74 112.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.515 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 94.6 m-20 59.04 37.49 24.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.24 32.59 14.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.764 -0.585 . . . . 1.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 176' ' ' GLU . 19.4 mm100 -118.45 176.16 5.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.186 -0.946 . . . . 1.0 110.44 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.571 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 59.5 mm-40 65.18 -121.35 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 1.0 110.756 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.571 HD22 ' CE1' ' A' ' 178' ' ' HIS . 0.1 OUTLIER 57.62 7.31 0.52 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.866 . . . . 1.0 112.205 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.571 ' CD2' ' O ' ' A' ' 176' ' ' GLU . 15.3 m-70 -110.14 56.53 0.62 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.545 -1.347 . . . . 1.0 108.538 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.553 ' O ' ' CB ' ' A' ' 183' ' ' ALA 0.261 12.3 mt -28.24 -61.45 0.11 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.966 0.889 . . . . 1.0 112.839 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.526 HG13 HD12 ' A' ' 184' ' ' LEU . 2.2 t -77.29 -20.28 14.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 113.367 0.877 . . . . 1.0 113.367 -176.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.565 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.1 mm-40 -63.46 -48.6 77.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.228 -1.545 . . . . 1.0 110.803 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.559 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.43 -12.12 20.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.155 -0.966 . . . . 1.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -70.09 -33.71 72.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.018 -1.052 . . . . 1.0 108.738 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 180' ' ' VAL . 1.2 mp -48.63 -23.66 1.09 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.795 . . . . 1.0 109.075 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -59.43 -16.52 24.02 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.875 0.845 . . . . 1.0 109.02 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.497 ' CG ' ' CD ' ' A' ' 187' ' ' PRO . 20.1 t30 -89.1 172.31 7.63 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.497 ' CD ' ' CG ' ' A' ' 186' ' ' ASN . 44.8 Cg_endo -87.73 -48.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.187 1.098 . . . . 1.0 111.357 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -118.31 145.87 44.76 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.427 -0.796 . . . . 1.0 111.115 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.34 130.29 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 1.0 110.208 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.468 ' O ' HG21 ' A' ' 17' ' ' ILE . 4.4 mt -115.62 169.13 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -110.6 -82.23 0.58 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.094 -1.004 . . . . 1.0 111.23 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -177.28 178.93 1.03 Allowed 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.033 -1.042 . . . . 1.0 111.044 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 194' ' ' ALA . 0.0 OUTLIER -128.81 170.35 13.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.503 -0.748 . . . . 1.0 110.455 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 193' ' ' SER . . . 75.23 37.46 0.46 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.418 0.628 . . . . 1.0 110.087 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.047 0 C-N-CA 118.84 -1.144 . . . . 1.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.609 -1.396 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 3' ' ' GLU . 22.9 t 50.79 79.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -1.189 . . . . 1.0 110.157 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 4' ' ' LYS . 0.4 OUTLIER 58.75 47.88 12.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.343 -0.848 . . . . 1.0 110.508 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 3' ' ' GLU . 3.5 mmmm 55.33 108.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.296 -0.877 . . . . 1.0 110.63 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 5' ' ' VAL . 28.2 m -68.54 122.76 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.98 . . . . 1.0 110.121 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.36 155.51 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 1.0 110.539 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 mt -102.81 81.87 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 1.0 109.939 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.32 129.29 40.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.988 . . . . 1.0 110.389 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.84 101.4 3.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 1.0 110.352 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.97 118.41 19.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 1.0 110.102 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.3 50.56 1.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 1.0 110.168 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.18 60.87 0.31 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.598 -1.401 . . . . 1.0 109.598 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' NH2' ' A' ' 168' ' ' ARG . 10.4 p-10 -116.0 8.04 14.49 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.739 -0.86 . . . . 1.0 109.961 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -118.36 59.07 0.81 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 1.0 109.805 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.591 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.4 pt-20 -66.31 70.54 0.07 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.267 -0.896 . . . . 1.0 110.948 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.589 ' O ' ' CD2' ' A' ' 191' ' ' HIS . . . -85.17 140.98 30.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.402 -1.436 . . . . 1.0 109.302 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.571 HD11 ' CE1' ' A' ' 191' ' ' HIS . 21.9 mm -111.52 122.71 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.694 -1.203 . . . . 1.0 110.788 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.32 122.05 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.369 -0.832 . . . . 1.0 110.093 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.623 ' CZ ' HD12 ' A' ' 167' ' ' ILE . 4.6 m-85 -94.27 140.23 30.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 1.0 110.023 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -107.95 -7.66 16.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 1.0 110.214 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 162' ' ' GLY . . . 114.64 -11.83 21.06 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -124.06 -1.74 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.861 -1.376 . . . . 1.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.27 110.03 22.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.985 -1.072 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 5.4 p90 -100.17 156.09 17.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.177 -0.952 . . . . 1.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.586 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 3.4 mmt -122.16 100.32 6.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.154 -1.018 . . . . 1.0 110.341 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.596 ' HB3' ' CZ3' ' A' ' 142' ' ' TRP . 1.3 pp20? -78.36 106.08 10.04 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.599 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 44.2 m-85 -101.11 98.51 8.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.912 -1.118 . . . . 1.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -93.03 102.15 14.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 1.0 109.692 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -121.61 138.64 54.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 1.0 110.184 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -86.11 95.56 9.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 1.0 109.842 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.552 ' CG1' ' HB2' ' A' ' 138' ' ' ASP . 1.0 OUTLIER -40.03 -79.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 1.0 110.534 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.434 ' HB ' ' O ' ' A' ' 31' ' ' VAL . 8.2 t -177.14 165.27 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.819 -1.175 . . . . 1.0 110.487 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 34' ' ' SER . 7.5 mmtm -73.56 96.57 2.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 1.0 110.078 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.479 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 9.9 t 174.97 -26.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.207 -0.933 . . . . 1.0 110.676 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 34' ' ' SER . 2.3 tt0 65.83 120.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.355 -0.841 . . . . 1.0 110.711 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -119.5 145.73 46.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.888 . . . . 1.0 110.261 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.424 ' HB1' ' HA ' ' A' ' 136' ' ' ASP . . . -179.16 49.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.904 . . . . 1.0 110.219 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 39' ' ' GLN . 2.2 pt? -151.32 -165.08 2.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 1.0 110.271 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' LEU . 31.8 tt0 39.77 -113.75 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.47 -0.769 . . . . 1.0 110.311 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -143.0 178.42 7.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.149 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.407 ' N ' ' OG ' ' A' ' 40' ' ' SER . 30.2 m120 -119.69 156.05 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 1.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.403 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 7.7 m80 -119.24 117.34 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 1.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.517 ' C ' ' HG3' ' A' ' 44' ' ' GLU . 21.2 m-85 -112.28 120.25 41.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.694 . . . . 1.0 110.234 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.587 ' HA ' ' HG2' ' A' ' 106' ' ' LYS . 0.9 OUTLIER -130.19 139.98 50.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.858 -1.151 . . . . 1.0 111.322 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.567 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 1.2 pt? -176.59 150.76 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 1.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.424 ' C ' HG21 ' A' ' 47' ' ' ILE . 5.2 m -120.34 146.47 46.11 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 166' ' ' CYS . 0.9 OUTLIER -127.69 -170.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.126 -1.43 . . . . 1.0 111.261 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.626 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.7 OUTLIER -153.16 136.77 15.99 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.014 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.601 ' O ' ' O ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER 52.68 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.51 -1.369 . . . . 1.0 109.238 -177.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.533 ' OE2' ' CG2' ' A' ' 73' ' ' ILE . 15.1 tt0 -173.87 22.63 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.305 -1.497 . . . . 1.0 110.283 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.575 ' HB1' ' CG2' ' A' ' 164' ' ' ILE . . . 45.93 -114.68 0.49 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.681 -1.208 . . . . 1.0 109.201 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.54 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 18.3 p -155.17 -40.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.002 -1.061 . . . . 1.0 109.583 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -122.66 131.33 53.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.415 -0.803 . . . . 1.0 109.647 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 168.07 138.3 2.43 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.439 -1.362 . . . . 1.0 109.885 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.773 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -88.97 124.41 34.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.971 -1.311 . . . . 1.0 109.005 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 143' ' ' LEU . 0.5 OUTLIER -91.3 -27.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.423 0.897 . . . . 1.0 113.423 -176.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.667 ' CB ' ' HB2' ' A' ' 71' ' ' LEU . 1.7 tt -143.32 151.69 40.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 119.85 -1.781 . . . . 1.0 113.089 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' A' ' 58' ' ' TRP . 5.3 t-105 -160.22 106.93 1.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.403 0.621 . . . . 1.0 109.604 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.491 ' HB2' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -121.43 155.61 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 1.0 109.08 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -148.59 -29.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.333 0 C-N-CA 118.725 -1.702 . . . . 1.0 111.749 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 73.2 -45.39 0.62 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.346 1.073 . . . . 1.0 110.615 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . -175.32 -136.11 2.23 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.496 HD21 ' CD2' ' A' ' 135' ' ' LEU . 1.5 mp 43.03 95.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.244 -1.15 . . . . 1.0 110.409 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.05 47.29 1.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 1.0 111.079 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.24 37.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.962 -1.086 . . . . 1.0 109.634 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.6 ' OG ' ' CD1' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -147.02 -179.14 6.6 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.141 -1.024 . . . . 1.0 110.675 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.628 ' O ' ' CD2' ' A' ' 68' ' ' TYR . 2.5 m-20 -108.78 -27.82 9.55 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.833 -1.167 . . . . 1.0 110.723 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.663 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 0.0 OUTLIER 53.35 -82.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.149 -0.969 . . . . 1.0 110.776 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.546 ' HA ' ' CB ' ' A' ' 82' ' ' TYR . 8.9 pt -158.46 153.43 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.42 -0.8 . . . . 1.0 111.171 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.599 ' CB ' ' CE ' ' A' ' 81' ' ' MET . . . -166.14 174.55 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.494 -0.754 . . . . 1.0 109.079 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.667 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 95.9 mt -150.91 134.28 16.22 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.925 -1.109 . . . . 1.0 108.165 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.773 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -146.87 179.55 7.51 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.032 -1.042 . . . . 1.0 112.652 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.557 ' CA ' ' OE1' ' A' ' 79' ' ' GLN . 2.5 mt -133.27 139.37 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.717 -0.614 . . . . 1.0 111.623 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.58 HG22 ' NE2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -140.42 131.54 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.274 -0.891 . . . . 1.0 109.224 178.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 1.5 m-20 69.29 9.73 7.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.138 -0.976 . . . . 1.0 111.036 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 96.75 16.38 36.57 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.098 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.527 ' O ' ' CG2' ' A' ' 73' ' ' ILE . 90.6 m-85 -130.05 159.65 36.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -1.097 . . . . 1.0 109.32 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.533 HG12 ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -102.57 164.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.185 -0.947 . . . . 1.0 111.824 -178.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.58 ' NE2' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -160.52 130.88 5.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.383 0.611 . . . . 1.0 110.413 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.553 ' CE ' ' O ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -92.69 115.95 28.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.049 . . . . 1.0 109.571 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.599 ' CE ' ' CB ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.61 122.05 43.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.284 -0.885 . . . . 1.0 109.805 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.674 ' CE2' ' CG1' ' A' ' 89' ' ' VAL . 15.9 p90 -140.73 144.98 35.85 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.561 -1.256 . . . . 1.0 111.351 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.54 ' CB ' ' HB2' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -141.19 108.3 5.47 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.35 1.072 . . . . 1.0 109.652 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.54 34.49 3.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.436 -0.802 . . . . 1.0 109.897 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -168.34 -41.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.6 OUTLIER 165.63 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.291 -1.123 . . . . 1.0 111.146 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.432 ' HD3' ' HG3' ' A' ' 129' ' ' PRO . 13.1 mtpt -121.18 116.98 30.83 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.831 -1.168 . . . . 1.0 110.572 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.5 ' N ' ' HB2' ' A' ' 83' ' ' ASP . 45.3 Cg_endo -75.62 160.63 37.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.928 1.488 . . . . 1.0 110.676 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.674 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -133.05 107.01 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 108.749 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 1.8 p -95.89 123.94 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.455 -1.403 . . . . 1.0 111.242 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.548 ' CB ' HG22 ' A' ' 124' ' ' ILE . 0.7 OUTLIER -113.58 84.58 2.04 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.513 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 30.9 mtp180 -59.65 178.01 0.18 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.239 -0.984 . . . . 1.0 111.266 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.497 ' OG ' HG21 ' A' ' 118' ' ' VAL . 2.9 t -101.78 159.03 15.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.512 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.18 24.61 12.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 1.0 109.522 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.539 HG11 ' N ' ' A' ' 96' ' ' PRO . 1.3 t -147.22 154.67 46.25 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 1.0 109.429 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.539 ' N ' HG11 ' A' ' 95' ' ' VAL . 38.3 Cg_endo -64.25 134.5 42.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.77 1.405 . . . . 1.0 109.715 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -114.15 -31.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 1.0 111.048 -178.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.461 ' CA ' ' HB3' ' A' ' 50' ' ' GLU . 12.6 p30 -82.16 47.88 1.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.968 -1.082 . . . . 1.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.505 ' O ' ' CG2' ' A' ' 99' ' ' THR . 2.0 m -87.59 6.55 33.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 110.906 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 99' ' ' THR . 0.6 OUTLIER 66.7 7.43 5.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 111.538 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.483 ' HB2' HG22 ' A' ' 99' ' ' THR . 4.2 m80 -112.53 173.63 6.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.896 -1.128 . . . . 1.0 110.366 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.626 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 2.6 m95 -75.98 88.37 2.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 1.0 109.967 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 104' ' ' HIS . 7.7 m -79.75 172.25 14.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.047 -1.033 . . . . 1.0 109.579 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.535 ' N ' ' CG2' ' A' ' 103' ' ' THR . 0.7 OUTLIER -123.19 119.84 31.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.519 HD13 ' CG2' ' A' ' 47' ' ' ILE . 1.6 mp -118.28 142.71 31.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.73 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 mttp -153.7 178.99 9.26 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.305 -1.358 . . . . 1.0 109.391 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 43' ' ' PHE . . . -164.9 158.37 17.14 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.625 -1.23 . . . . 1.0 111.629 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.36 103.93 5.44 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -91.24 117.88 30.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 1.0 109.785 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 111' ' ' GLN . 20.6 t -114.88 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.078 -1.014 . . . . 1.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.504 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 9.9 tt0 60.1 -92.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 1.0 110.236 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.566 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -111.4 -21.23 11.92 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 1.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.621 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 6.2 tt0 -92.22 108.27 19.83 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.966 0.889 . . . . 1.0 111.11 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -94.75 165.7 25.92 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 120.34 -0.933 . . . . 1.0 110.854 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.553 ' O ' ' CE ' ' A' ' 80' ' ' MET . 16.2 t -146.48 156.88 43.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.259 -1.142 . . . . 1.0 110.73 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.576 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 2.7 tm? -123.1 146.9 47.32 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.095 -1.003 . . . . 1.0 108.859 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.73 ' HB3' ' CB ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -126.52 92.97 3.67 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.347 -0.845 . . . . 1.0 111.844 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.51 ' CG2' HD13 ' A' ' 116' ' ' LEU . 52.9 t -86.78 85.43 2.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.33 53.72 16.35 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.488 ' OD1' ' OE1' ' A' ' 117' ' ' GLN . 1.7 m-20 44.68 21.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.157 -1.202 . . . . 1.0 111.178 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.466 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -91.49 -176.37 4.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 1.0 109.813 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -41.12 100.46 0.22 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 1.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 121' ' ' GLU . 41.1 Cg_endo -67.91 134.8 33.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.228 1.646 . . . . 1.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.548 HG22 ' CB ' ' A' ' 91' ' ' LEU . 1.5 mp -97.95 115.18 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 12.2 p -120.25 174.48 6.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.072 -1.017 . . . . 1.0 112.181 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 114' ' ' GLY . . . -178.72 163.36 31.11 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.253 -2.339 . . . . 1.0 107.253 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -140.82 169.84 16.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.581 -1.54 . . . . 1.0 111.153 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.68 166.65 12.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.243 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.549 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.4 Cg_endo -66.94 89.92 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.779 1.41 . . . . 1.0 108.51 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -14.5 131.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.214 0.53 . . . . 1.0 112.111 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 130.43 55.92 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -103.84 -122.31 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -1.125 . . . . 1.0 109.926 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 135' ' ' LEU . 13.1 t -167.79 59.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.71 -1.244 . . . . 1.0 110.279 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 135' ' ' LEU . 11.3 mm-40 54.96 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 133' ' ' THR . 0.2 OUTLIER 66.46 97.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 1.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.3 m-20 -69.28 178.96 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 1.0 109.723 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -153.08 105.77 2.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 1.0 109.805 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.552 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 1.9 p30 164.04 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.646 -0.659 . . . . 1.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -38.54 -44.31 1.73 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -164.87 162.75 21.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 1.0 110.257 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.533 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 14.7 tp -145.41 146.03 31.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 1.0 109.976 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.604 ' CG ' ' HE1' ' A' ' 146' ' ' MET . 37.1 m95 -135.81 131.36 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.575 ' CD1' ' O ' ' A' ' 56' ' ' ILE . 5.4 tp -133.21 122.22 23.65 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.177 -1.409 . . . . 1.0 112.698 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 119.51 16.27 5.16 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.862 -1.295 . . . . 1.0 109.862 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.547 ' HA2' HD22 ' A' ' 55' ' ' LEU . . . 130.05 -137.54 9.6 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 119.099 -1.524 . . . . 1.0 109.919 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.745 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -168.05 134.38 2.01 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.846 -0.741 . . . . 1.0 110.388 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -47.45 -20.58 0.24 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.448 -0.782 . . . . 1.0 110.856 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.595 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -157.51 85.94 0.93 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.745 ' CD1' ' HB2' ' A' ' 146' ' ' MET . 0.2 OUTLIER -78.8 38.17 0.32 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.555 -1.341 . . . . 1.0 112.772 -177.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 151' ' ' VAL . 1.9 p -54.26 -26.37 28.59 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 104.55 -2.389 . . . . 1.0 104.55 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.573 ' CG1' ' N ' ' A' ' 152' ' ' ALA 0.282 7.7 p -59.28 -132.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.297 -1.32 . . . . 1.0 108.807 177.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' A' ' 159' ' ' TYR . . . 65.21 -67.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.136 -0.978 . . . . 1.0 109.544 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 151' ' ' VAL . 18.9 m170 38.16 -74.84 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.427 1.269 . . . . 1.0 114.427 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -52.6 -3.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.576 1.324 . . . . 1.0 114.576 -176.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.595 HD12 ' CD1' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -146.51 175.54 2.67 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 119.79 -1.819 . . . . 1.0 111.833 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 50.3 Cg_endo -77.51 -161.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.868 1.712 . . . . 1.0 113.809 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.1 OUTLIER -43.77 -20.7 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.365 -0.834 . . . . 1.0 113.071 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.549 ' CB ' HD12 ' A' ' 155' ' ' LEU . . . -36.77 -43.33 0.42 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.093 -1.004 . . . . 1.0 109.357 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.598 ' HB2' ' HB1' ' A' ' 152' ' ' ALA . 5.5 m-85 -89.27 -27.52 20.51 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.124 -0.985 . . . . 1.0 109.543 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -72.26 -7.87 51.76 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.225 -1.39 . . . . 1.0 107.407 177.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.511 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -130.84 98.51 4.64 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.549 ' N ' ' O ' ' A' ' 21' ' ' GLY . . . -49.81 -175.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.597 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 44.6 t80 -67.58 152.77 45.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -1.135 . . . . 1.0 112.056 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.575 ' CG2' ' HB1' ' A' ' 51' ' ' ALA . 1.3 mp -131.57 80.38 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.846 0.831 . . . . 1.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.597 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.67 -161.23 20.92 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 106.778 -2.529 . . . . 1.0 106.778 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.556 ' O ' ' N ' ' A' ' 48' ' ' LYS . 3.4 m -125.19 143.81 50.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.84 -1.388 . . . . 1.0 109.597 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.623 HD12 ' CZ ' ' A' ' 19' ' ' PHE . 3.3 mt -124.0 156.77 31.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.749 -1.219 . . . . 1.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.567 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -167.47 152.56 7.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.883 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.524 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 17.4 m-20 56.11 64.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.115 -0.991 . . . . 1.0 110.426 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.561 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 24.3 m -116.64 133.1 64.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.528 ' HA ' ' HG3' ' A' ' 176' ' ' GLU . 1.0 OUTLIER -148.64 155.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.425 -1.31 . . . . 1.0 110.969 -176.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 13.4 t -132.82 91.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 8.0 m-20 57.05 46.26 19.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.862 -1.149 . . . . 1.0 108.023 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 72.26 31.79 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.257 0.551 . . . . 1.0 110.375 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.554 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 34.2 mt-30 -108.42 176.06 5.25 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.3 -0.875 . . . . 1.0 110.076 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 177' ' ' LEU . 6.9 pt-20 44.09 -114.66 0.38 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.365 -0.209 . . . . 1.0 110.912 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.58 ' CB ' ' O ' ' A' ' 176' ' ' GLU . 8.6 tp 78.77 -59.24 0.41 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.35 -0.844 . . . . 1.0 110.375 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 4.8 m-70 -68.98 70.63 0.21 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.085 . . . . 1.0 109.288 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.57 ' O ' ' CB ' ' A' ' 183' ' ' ALA 0.255 3.7 mp -44.1 -61.53 1.44 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.689 0.756 . . . . 1.0 112.087 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 15' ' ' GLU . 94.5 t -68.29 -9.7 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.233 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 11.0 mt-10 -74.61 -62.09 1.65 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.699 -1.251 . . . . 1.0 110.012 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.599 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 8.2 m-20 -83.03 -12.62 57.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.99 . . . . 1.0 109.183 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -72.74 -31.31 64.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 1.0 109.038 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER -59.94 -14.14 14.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 1.0 109.188 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -46.27 -25.79 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.311 -0.868 . . . . 1.0 109.462 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.519 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 1.5 t-20 -93.26 175.12 3.32 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 43.7 Cg_endo -84.44 -90.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 122.889 0.942 . . . . 1.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.403 ' C ' HG13 ' A' ' 189' ' ' ILE . 2.8 t -66.78 144.49 56.28 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.334 -0.854 . . . . 1.0 110.727 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.474 HD12 ' CD2' ' A' ' 184' ' ' LEU . 3.2 mt -126.89 117.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 1.0 109.689 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.655 ' CD1' ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -94.39 136.06 35.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 1.0 109.055 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 16' ' ' ALA . 9.7 m80 -114.72 149.16 37.26 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.089 -1.007 . . . . 1.0 110.126 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 166' ' ' CYS . 0.9 OUTLIER -70.68 -162.28 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 1.0 110.051 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 194' ' ' ALA . 0.0 OUTLIER -125.6 138.39 53.93 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.267 -0.896 . . . . 1.0 109.988 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 193' ' ' SER . . . 161.4 37.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.772 -0.58 . . . . 1.0 110.114 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.291 -1.954 0 C-N-CA 118.616 -1.234 . . . . 1.0 110.546 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.444 -1.463 . . . . 1.0 109.444 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 92.4 p 43.72 -92.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -1.125 . . . . 1.0 110.307 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER -45.67 -50.09 13.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.985 . . . . 1.0 110.052 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 3' ' ' GLU . 4.1 ttmm 55.88 164.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -0.835 . . . . 1.0 110.146 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 6' ' ' ILE . 60.7 t -61.81 156.2 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 1.0 110.362 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.453 ' N ' HG12 ' A' ' 5' ' ' VAL . 3.7 mt -120.94 115.19 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 1.0 110.368 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.481 ' N ' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -67.44 148.92 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.775 . . . . 1.0 110.596 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -91.83 157.74 16.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 1.0 109.974 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -124.72 138.16 54.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.947 . . . . 1.0 110.416 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -104.38 87.68 2.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.279 -0.888 . . . . 1.0 109.486 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 13' ' ' ASP . . . -74.05 2.26 9.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 1.0 110.364 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' ASP . . . 58.91 -83.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.118 -1.593 . . . . 1.0 109.118 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.4 OUTLIER 70.64 9.79 6.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -1.046 . . . . 1.0 110.632 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -176.56 37.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 1.0 110.421 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -64.94 89.28 0.07 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.294 -0.879 . . . . 1.0 109.507 179.654 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -113.13 153.94 27.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 1.0 111.085 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 191' ' ' HIS . 0.8 OUTLIER -114.84 144.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 177.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -104.2 136.07 44.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.756 -1.215 . . . . 1.0 111.443 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.637 ' CE1' ' CD1' ' A' ' 167' ' ' ILE . 6.6 m-85 -100.72 148.16 25.21 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -113.88 1.18 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 1.0 111.102 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.467 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 108.11 -18.13 34.03 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.396 -1.882 . . . . 1.0 108.396 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 42.02 3.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.932 . . . . 1.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -112.89 127.16 56.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.0 110.943 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.542 ' CG ' ' HG3' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -118.76 87.56 2.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.323 -0.86 . . . . 1.0 109.684 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.459 ' SD ' ' OH ' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -76.0 100.7 4.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.15 -0.969 . . . . 1.0 110.475 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 6.2 tt0 -79.43 90.32 5.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 4.2 m-30 -95.24 111.8 23.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.487 -0.885 . . . . 1.0 111.319 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -133.44 153.7 51.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 1.0 109.71 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.49 167.44 27.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.001 -1.062 . . . . 1.0 110.398 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.28 97.16 9.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 1.0 110.443 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 t -73.12 -115.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 1.0 110.034 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.29 171.91 13.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.833 -1.167 . . . . 1.0 110.128 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -116.1 78.67 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -0.966 . . . . 1.0 110.122 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 2.0 p 164.85 -71.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.474 -0.766 . . . . 1.0 109.927 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 83.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 1.0 110.411 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 167.88 10.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 1.0 110.142 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 48.64 71.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 1.0 110.132 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -166.9 0.37 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.29 -0.881 . . . . 1.0 110.138 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.505 ' NE2' HG11 ' A' ' 110' ' ' VAL . 3.0 tm0? -106.5 -14.45 15.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 1.0 110.101 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.575 -0.703 . . . . 1.0 110.187 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.532 ' ND2' ' HG2' ' A' ' 109' ' ' ARG . 52.6 p-10 -108.52 149.41 28.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.175 -0.953 . . . . 1.0 110.666 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -123.41 125.65 45.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 1.0 109.42 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 m-85 -133.21 131.6 40.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.129 -0.982 . . . . 1.0 111.05 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 106' ' ' LYS . 6.7 mt-10 -137.9 140.61 40.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 1.0 110.404 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.9 OUTLIER 179.92 154.28 0.54 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.289 -0.882 . . . . 1.0 110.798 179.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.502 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -117.49 155.7 29.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.566 ' CD1' HD13 ' A' ' 105' ' ' ILE . 6.5 pt -149.16 176.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 1.0 112.802 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.615 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -130.92 83.22 2.1 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.483 ' OG1' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -67.04 152.14 46.34 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.127 0.965 . . . . 1.0 112.603 -176.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.645 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 11.0 mm-40 -141.92 1.03 1.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.396 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.24 124.86 11.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.973 -1.08 . . . . 1.0 110.187 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.526 ' CG2' ' HA2' ' A' ' 76' ' ' GLY . 17.8 p -59.96 -10.9 4.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.798 . . . . 1.0 110.796 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -128.35 130.11 47.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.063 . . . . 1.0 111.211 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 160.03 137.63 2.27 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -90.44 127.75 36.31 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.549 -1.559 . . . . 1.0 108.884 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.583 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.07 -40.04 12.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.449 -0.782 . . . . 1.0 112.2 -176.181 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.653 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 5.7 tt -142.79 139.11 30.86 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.092 -1.63 . . . . 1.0 113.693 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.564 ' O ' ' CD1' ' A' ' 58' ' ' TRP . 1.1 t-105 -145.32 106.35 4.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.281 -0.887 . . . . 1.0 108.661 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -121.65 -166.58 1.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.782 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' LYS . . . 97.15 48.33 2.07 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER 45.0 70.3 0.36 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.32 -1.106 . . . . 1.0 109.877 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 61' ' ' LYS . . . -41.38 132.34 3.54 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.805 -1.318 . . . . 1.0 109.805 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.502 HD23 ' NH2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -149.2 -166.69 2.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -1.121 . . . . 1.0 110.13 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 4.1 mt-10 -109.89 14.09 23.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.145 -0.972 . . . . 1.0 110.297 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.502 ' NH2' HD23 ' A' ' 63' ' ' LEU . 23.7 ptt-85 173.8 63.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 1.0 109.435 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.582 ' O ' ' CE2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -144.92 -177.31 5.46 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.807 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.539 ' HB3' ' HA ' ' A' ' 84' ' ' LEU . 44.5 m-20 -94.58 162.29 13.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.431 -0.793 . . . . 1.0 109.768 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.582 ' CE2' ' O ' ' A' ' 66' ' ' SER . 0.3 OUTLIER 177.01 -167.0 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.467 -1.396 . . . . 1.0 111.236 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.547 ' CD1' ' HB3' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -146.39 155.63 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.597 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HB2' ' CE ' ' A' ' 81' ' ' MET . . . -149.1 -175.79 5.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.946 -1.096 . . . . 1.0 111.033 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 61.1 mt -151.31 116.54 5.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -136.38 171.47 14.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.749 -1.219 . . . . 1.0 111.764 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 45.7 mt -114.87 130.53 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.528 -0.732 . . . . 1.0 110.586 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -140.48 143.7 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 1.0 110.131 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.497 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 50.7 m-20 60.25 13.52 3.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 1.0 111.695 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.526 ' HA2' ' CG2' ' A' ' 52' ' ' THR . . . 93.09 10.04 60.11 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.587 -1.292 . . . . 1.0 109.997 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.28 141.7 48.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -1.141 . . . . 1.0 109.551 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.583 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 0.2 OUTLIER -77.14 178.62 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.859 -1.151 . . . . 1.0 108.655 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.573 ' CB ' ' HA ' ' A' ' 92' ' ' ARG . 1.4 pp0? -173.98 125.67 0.36 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.61 -1.307 . . . . 1.0 111.694 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.566 ' CE ' ' O ' ' A' ' 115' ' ' SER . 2.8 ttm -69.41 129.04 38.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.596 ' HE3' ' CD2' ' A' ' 153' ' ' HIS . 13.2 tmm? -132.11 109.12 9.75 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.419 -0.801 . . . . 1.0 110.466 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.661 ' CE2' ' CG1' ' A' ' 89' ' ' VAL . 11.5 p90 -133.95 133.1 40.98 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.914 -1.514 . . . . 1.0 112.107 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -118.47 88.14 2.86 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.567 0.699 . . . . 1.0 109.728 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.539 ' HA ' ' HB3' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -73.14 -76.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.441 -0.787 . . . . 1.0 109.111 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -71.08 -42.56 58.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.004 -2.039 . . . . 1.0 108.004 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.606 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 1.3 t 160.79 147.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.606 ' CB ' ' O ' ' A' ' 86' ' ' SER . 0.2 OUTLIER 83.92 93.76 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.534 ' HB2' ' HG2' ' A' ' 81' ' ' MET . 41.4 Cg_endo -67.53 146.44 74.05 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.492 1.785 . . . . 1.0 111.763 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.661 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.69 117.44 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.568 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -99.47 98.14 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.96 -1.088 . . . . 1.0 110.573 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.534 HD21 ' N ' ' A' ' 126' ' ' GLY . 6.0 mt -93.94 75.45 4.17 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.573 ' HA ' ' CB ' ' A' ' 79' ' ' GLN . 6.4 mtt180 -56.77 174.95 0.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.397 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.53 ' OG ' ' CG2' ' A' ' 118' ' ' VAL . 14.5 t -92.9 160.45 14.9 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.335 0.588 . . . . 1.0 110.564 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.46 HG22 ' HB2' ' A' ' 122' ' ' ALA . 14.9 t -102.64 8.04 39.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 1.0 109.642 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.541 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 51.2 t -129.87 150.9 77.19 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.541 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 45.3 Cg_endo -69.59 135.58 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.482 1.254 . . . . 1.0 110.2 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.49 HG22 HG23 ' A' ' 78' ' ' VAL . 1.1 tp -115.77 -31.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 1.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.458 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 17.2 p-10 -69.57 60.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.034 . . . . 1.0 109.909 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 99' ' ' THR . 18.0 m -124.06 16.63 9.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.46 -0.775 . . . . 1.0 110.392 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 48.0 t-20 50.65 39.13 20.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.69 135.74 48.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 1.0 110.111 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 44.9 m95 -57.29 110.29 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -0.97 . . . . 1.0 110.291 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 104' ' ' HIS . 35.9 m -110.62 171.94 7.16 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.478 ' N ' HG22 ' A' ' 103' ' ' THR . 31.8 t60 -117.39 129.64 55.98 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.987 -1.071 . . . . 1.0 108.412 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.566 HD13 ' CD1' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -122.01 147.89 25.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.318 -0.864 . . . . 1.0 108.823 -179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.777 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.0 OUTLIER -152.5 173.16 15.49 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.404 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -165.37 116.9 1.12 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.69 -1.256 . . . . 1.0 111.323 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 25.9 p90 -119.41 109.82 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.532 ' HG2' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -106.55 164.4 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 1.0 111.309 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.505 HG11 ' NE2' ' A' ' 39' ' ' GLN . 12.8 t -145.15 113.96 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 19.8 mt-30 58.46 -129.95 1.33 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.246 -0.909 . . . . 1.0 110.462 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -85.19 -1.22 56.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.96 -1.088 . . . . 1.0 110.22 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.608 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 7.6 tt0 -107.26 120.77 43.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.436 -0.79 . . . . 1.0 110.226 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -119.66 157.43 15.51 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 119.971 -1.109 . . . . 1.0 111.465 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.566 ' O ' ' CE ' ' A' ' 80' ' ' MET . 2.8 t -133.26 150.93 51.91 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.192 -1.181 . . . . 1.0 110.836 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 3.3 tm? -113.83 154.11 28.01 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.123 -0.986 . . . . 1.0 109.434 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.777 ' HB3' ' CB ' ' A' ' 106' ' ' LYS 0.26 0.1 OUTLIER -130.03 87.21 2.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.543 -0.723 . . . . 1.0 112.725 -178.495 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.53 ' CG2' ' OG ' ' A' ' 93' ' ' SER . 24.6 t -80.56 82.71 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.729 -1.212 . . . . 1.0 107.729 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 66.52 60.87 5.81 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 120' ' ' ASN . 12.8 p30 38.8 25.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.569 -0.96 . . . . 1.0 111.694 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 121' ' ' GLU . 1.3 pm0 -86.01 -174.77 5.26 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.355 -0.84 . . . . 1.0 109.236 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.511 ' N ' ' HG2' ' A' ' 121' ' ' GLU . . . -46.62 104.66 0.42 Allowed Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.336 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 121' ' ' GLU . 40.5 Cg_endo -65.13 130.24 25.12 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.971 1.511 . . . . 1.0 110.559 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.538 ' N ' HD11 ' A' ' 124' ' ' ILE . 3.8 mp -91.03 109.32 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.557 -0.857 . . . . 1.0 108.984 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.538 ' CG2' ' OG ' ' A' ' 115' ' ' SER . 15.8 p -107.52 169.35 8.63 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.246 1.022 . . . . 1.0 111.291 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.534 ' N ' HD21 ' A' ' 91' ' ' LEU . . . 169.33 161.25 19.33 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 106.723 -2.551 . . . . 1.0 106.723 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.608 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -133.18 168.99 17.53 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.65 -1.5 . . . . 1.0 110.379 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.535 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -113.3 177.45 1.18 Allowed Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.742 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.2 Cg_endo -66.77 91.84 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.944 1.497 . . . . 1.0 108.851 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' A' ' 129' ' ' PRO . 1.1 pp -47.64 -178.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.511 -0.743 . . . . 1.0 110.531 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 161.08 -56.18 0.31 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.034 -1.626 . . . . 1.0 109.034 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -107.99 102.91 12.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 1.0 109.663 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 t -86.1 37.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 1.0 110.413 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -136.87 63.79 1.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 1.0 109.929 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -98.24 131.08 44.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 1.0 110.412 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.0 OUTLIER -124.42 175.4 7.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 1.0 110.127 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 140.7 44.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 1.0 110.21 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 140' ' ' ALA . 24.0 p-10 -88.53 35.66 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 1.0 110.519 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 42.63 25.44 0.31 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -116.35 166.5 11.99 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.075 -1.25 . . . . 1.0 109.301 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.543 ' CD1' HD23 ' A' ' 57' ' ' LEU . 10.6 tp -160.63 152.79 20.26 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.972 -1.091 . . . . 1.0 111.409 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.599 ' CZ3' ' HB2' ' A' ' 26' ' ' GLU . 25.2 m95 -133.96 126.05 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.621 -1.622 . . . . 1.0 106.621 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -143.05 135.81 27.74 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 117.899 -1.52 . . . . 1.0 113.725 -176.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 104.38 24.99 7.21 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.212 -1.955 . . . . 1.0 108.212 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.702 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 109.48 -153.35 16.93 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 106.663 -2.575 . . . . 1.0 106.663 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.702 ' HG2' ' O ' ' A' ' 145' ' ' GLY . 0.6 OUTLIER -170.75 174.0 5.1 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.159 -1.416 . . . . 1.0 111.958 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.542 ' HG3' ' CG ' ' A' ' 24' ' ' TYR . 37.6 mt-10 -96.05 -9.1 31.73 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -152.48 27.0 0.58 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.535 -0.728 . . . . 1.0 110.596 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.671 ' CD1' ' HB2' ' A' ' 146' ' ' MET . 3.2 mt -70.54 61.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.597 -1.241 . . . . 1.0 109.293 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 148' ' ' ARG . 2.3 p -79.0 65.98 4.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.309 -2.108 . . . . 1.0 105.309 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.636 ' CG1' ' CD2' ' A' ' 149' ' ' LEU . 1.2 p -149.58 -77.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.13 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.72 ' CB ' ' CG ' ' A' ' 159' ' ' TYR . . . 45.54 30.95 0.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.046 -1.033 . . . . 1.0 108.962 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.619 ' CE1' ' HB3' ' A' ' 155' ' ' LEU . 1.0 OUTLIER 34.34 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.249 0.547 . . . . 1.0 110.781 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -148.51 10.75 0.86 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 1.0 111.198 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.619 ' HB3' ' CE1' ' A' ' 153' ' ' HIS . 0.3 OUTLIER -76.42 179.33 1.55 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 1.0 110.727 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 155' ' ' LEU . 48.2 Cg_endo -73.13 -161.39 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.301 1.685 . . . . 1.0 112.974 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -51.44 -9.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.654 -0.653 . . . . 1.0 112.417 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.592 ' CB ' ' CD1' ' A' ' 155' ' ' LEU . . . -34.75 -42.96 0.16 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.035 -1.041 . . . . 1.0 110.028 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.72 ' CG ' ' CB ' ' A' ' 152' ' ' ALA . 6.6 m-85 -82.56 -33.39 28.11 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.317 -1.353 . . . . 1.0 109.916 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.6 OUTLIER -67.09 -11.51 57.36 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.876 -1.13 . . . . 1.0 108.406 178.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.495 ' O ' ' O ' ' A' ' 162' ' ' GLY . 1.8 m -129.27 96.48 4.32 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -48.29 178.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.632 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 23.0 t80 -68.64 145.24 54.08 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.342 . . . . 1.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.645 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 2.6 mt -123.1 86.43 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.31 -1.367 . . . . 1.0 107.31 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.632 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.97 -157.5 14.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 48' ' ' LYS . 80.0 m -130.72 143.82 51.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -1.125 . . . . 1.0 109.748 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.637 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 3.2 mt -128.82 157.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.299 -0.876 . . . . 1.0 110.644 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 2.8 ttt85 -164.24 144.71 8.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.202 -0.937 . . . . 1.0 109.894 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 68.8 m-20 58.44 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.479 -0.763 . . . . 1.0 110.066 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.461 HG12 ' CB ' ' A' ' 45' ' ' LEU 0.251 26.8 m -132.92 135.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 119.989 -0.685 . . . . 1.0 109.257 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 175' ' ' GLN . 0.1 OUTLIER -141.63 152.18 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.741 -1.184 . . . . 1.0 111.679 -177.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 92.0 t -134.11 113.8 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.495 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 0.9 OUTLIER 56.49 38.01 29.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 1.0 108.104 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.495 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 73.28 30.06 1.6 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.276 0.56 . . . . 1.0 110.835 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.506 ' N ' HG22 ' A' ' 171' ' ' ILE . 4.1 mm-40 -98.01 110.91 23.4 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.249 -0.907 . . . . 1.0 109.967 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.7 102.17 10.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 1.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.568 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 4.1 mm? -86.26 92.76 8.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.817 -1.177 . . . . 1.0 110.987 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.545 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 0.4 OUTLIER -40.64 113.37 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.045 0.926 . . . . 1.0 110.166 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.534 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 10.9 mt -40.49 -56.53 2.03 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.847 0.832 . . . . 1.0 112.655 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.526 ' HA ' ' HB1' ' A' ' 183' ' ' ALA . 51.3 t -84.82 -22.25 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 2.3 mt-10 -62.07 -55.99 23.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.137 -1.602 . . . . 1.0 110.315 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.583 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -84.63 -19.47 32.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.356 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -64.28 -36.7 84.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.926 -1.109 . . . . 1.0 109.629 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 5.2 mt -50.05 -21.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.177 -0.952 . . . . 1.0 109.345 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 2.7 t-20 -54.99 -20.77 9.91 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.882 0.849 . . . . 1.0 108.876 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.467 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 4.3 t30 -95.83 152.36 39.0 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 40.6 Cg_endo -66.3 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.371 1.195 . . . . 1.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 12.4 m -68.74 135.97 52.1 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.234 -0.916 . . . . 1.0 110.452 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 186' ' ' ASN . 25.3 mm -122.92 127.46 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 1.0 109.805 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 17' ' ' ILE . 7.7 mt -121.34 173.18 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 1.0 110.394 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.543 ' O ' ' N ' ' A' ' 18' ' ' ALA . 2.5 m-70 -107.54 -84.3 0.53 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.144 -0.973 . . . . 1.0 111.185 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.1 t -170.02 134.19 1.25 Allowed 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.157 -0.964 . . . . 1.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 194' ' ' ALA . 1.4 m -112.29 144.75 41.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 1.0 110.276 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 193' ' ' SER . . . 160.08 40.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.65 -0.656 . . . . 1.0 109.745 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.86 0 C-N-CA 118.902 -1.119 . . . . 1.0 110.513 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m -106.68 -60.81 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -1.154 . . . . 1.0 110.205 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.0 -68.95 0.25 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 1.0 110.512 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -164.75 28.4 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.15 -0.969 . . . . 1.0 110.457 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.77 88.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 1.0 110.415 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.519 ' N ' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -124.39 82.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 1.0 109.682 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.03 92.49 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.221 -0.924 . . . . 1.0 110.057 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.52 114.21 26.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 1.0 110.234 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -127.37 147.02 50.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.381 -0.824 . . . . 1.0 109.766 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.02 164.27 12.1 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.332 -0.855 . . . . 1.0 110.383 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.88 -4.81 30.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.499 -0.75 . . . . 1.0 110.219 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.53 -174.37 15.2 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.215 -1.554 . . . . 1.0 109.215 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -121.02 63.56 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -1.205 . . . . 1.0 110.476 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -114.56 58.95 0.69 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.105 -0.997 . . . . 1.0 110.629 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 1.1 tt0 -55.94 90.58 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.237 -0.914 . . . . 1.0 109.685 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -95.62 155.16 16.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.347 -0.941 . . . . 1.0 110.289 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.6 ' CD1' ' CE1' ' A' ' 191' ' ' HIS . 13.4 mm -135.66 122.82 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 1.0 110.576 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.442 ' O ' HD22 ' A' ' 190' ' ' LEU . . . -89.25 132.49 34.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.875 . . . . 1.0 109.896 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.622 ' CE1' ' CD1' ' A' ' 167' ' ' ILE . 9.6 m-85 -102.47 172.67 6.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.216 . . . . 1.0 110.25 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 164' ' ' ILE . 0.5 OUTLIER -134.38 1.9 3.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 1.0 110.802 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.508 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.18 -26.22 25.03 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 8.1 ttt180 -104.45 10.8 35.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.912 -1.346 . . . . 1.0 109.364 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 144' ' ' GLY . 6.3 t -55.22 175.53 0.07 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.676 0.75 . . . . 1.0 110.741 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.633 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -171.57 73.42 0.05 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.415 ' HE2' HG21 ' A' ' 17' ' ' ILE . 2.3 mmt -85.79 99.72 11.55 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.861 -1.149 . . . . 1.0 109.539 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.55 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -91.39 134.81 34.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.596 ' CD2' ' HB2' ' A' ' 182' ' ' ASP . 48.9 m-85 -121.25 149.03 43.48 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.982 -1.074 . . . . 1.0 110.72 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -149.8 97.93 2.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.811 . . . . 1.0 110.186 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -139.31 174.99 9.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 1.0 110.084 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.06 148.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 1.0 110.033 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG11 ' OG1' ' A' ' 32' ' ' THR . 7.4 p -129.56 7.28 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 1.0 110.323 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -154.31 -178.29 7.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.16 -0.962 . . . . 1.0 110.168 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.93 87.51 7.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 1.0 110.419 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.57 18.79 6.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -0.909 . . . . 1.0 110.472 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' O ' ' HB ' ' A' ' 32' ' ' THR . 2.6 mm-40 -143.72 -171.43 3.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.866 . . . . 1.0 109.811 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -179.35 109.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.081 -1.012 . . . . 1.0 110.162 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 36' ' ' LYS . . . -177.62 73.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 1.0 110.2 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' A' ' 38' ' ' LEU . 4.1 mm? -104.44 168.43 9.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.347 -0.846 . . . . 1.0 110.155 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -114.42 4.16 15.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.244 -0.91 . . . . 1.0 110.074 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.44 122.53 13.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 1.0 110.209 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.556 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.3 OUTLIER -124.58 117.08 23.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.475 -0.766 . . . . 1.0 110.279 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 0.6 OUTLIER -84.67 142.22 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 1.0 109.463 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.644 ' CE1' ' CG2' ' A' ' 172' ' ' VAL . 41.8 m-85 -130.81 120.98 24.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.133 -0.98 . . . . 1.0 111.151 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.569 ' CG ' ' HE2' ' A' ' 106' ' ' LYS . 39.7 mt-10 -128.6 142.8 50.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 1.0 110.521 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 1.1 pt? -179.69 149.72 0.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.38 -0.825 . . . . 1.0 110.397 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.7 m -121.24 149.36 42.98 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.598 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 1.7 pt -126.49 179.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.379 -0.928 . . . . 1.0 109.168 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.634 ' O ' ' OG1' ' A' ' 49' ' ' THR . 5.9 tttt -167.74 82.6 0.2 Allowed 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.674 -1.21 . . . . 1.0 110.641 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.634 ' OG1' ' O ' ' A' ' 48' ' ' LYS . 90.2 m -171.97 -108.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.81 -0.556 . . . . 1.0 111.313 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.558 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 0.5 OUTLIER -122.18 -46.09 2.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.594 1.188 . . . . 1.0 109.626 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.568 ' O ' ' CG2' ' A' ' 73' ' ' ILE . . . 39.44 22.75 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.841 -1.072 . . . . 1.0 111.656 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.605 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 60.4 p -70.79 -18.22 62.76 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.409 -1.432 . . . . 1.0 108.796 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -159.6 118.68 2.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.093 -0.643 . . . . 1.0 109.727 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 155.21 136.74 2.25 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.194 -1.479 . . . . 1.0 109.541 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.729 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -85.61 128.17 34.69 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.628 -1.229 . . . . 1.0 109.246 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.588 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 1.0 OUTLIER -90.49 -34.09 6.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.502 -0.749 . . . . 1.0 111.602 -177.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.59 ' CB ' ' HB2' ' A' ' 71' ' ' LEU . 5.7 tt -146.18 143.4 29.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.536 -1.353 . . . . 1.0 113.079 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.652 ' CH2' ' CG2' ' A' ' 151' ' ' VAL . 31.0 t-105 -152.09 105.69 3.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 p -110.29 123.17 49.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 1.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 138' ' ' ASP . . . -125.05 141.26 12.95 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 138' ' ' ASP . 0.8 OUTLIER -61.86 -43.25 99.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.321 -1.105 . . . . 1.0 110.487 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.63 -127.12 2.36 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.616 -1.394 . . . . 1.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.6 mt 47.71 -162.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -1.129 . . . . 1.0 110.237 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.11 37.25 4.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 1.0 110.399 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 177.19 46.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.343 -0.848 . . . . 1.0 109.358 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.91 142.78 48.39 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.626 -0.829 . . . . 1.0 110.942 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.671 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 25.1 m-20 -98.53 -103.64 0.21 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.748 . . . . 1.0 110.035 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.671 ' CB ' ' O ' ' A' ' 67' ' ' ASP . 1.8 t80 102.6 -91.75 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 123.037 0.535 . . . . 1.0 111.857 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 70' ' ' ALA . 5.6 mt -151.13 171.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.648 -1.282 . . . . 1.0 112.838 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.56 ' N ' ' CG2' ' A' ' 69' ' ' ILE . . . -177.18 167.12 2.4 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 90.4 mt -145.95 103.37 3.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.721 -1.237 . . . . 1.0 108.439 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -123.46 167.76 13.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 1.0 112.058 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.5 132.53 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.739 0.78 . . . . 1.0 111.131 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.487 HG22 ' OD2' ' A' ' 75' ' ' ASP . 2.0 p -141.17 140.65 31.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.6 -0.687 . . . . 1.0 110.968 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.487 ' OD2' HG22 ' A' ' 74' ' ' VAL . 5.7 m-20 67.96 22.49 8.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.481 -0.762 . . . . 1.0 111.47 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 86.84 4.74 82.06 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.06 -1.543 . . . . 1.0 109.76 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 75' ' ' ASP . 87.2 m-85 -130.94 150.24 52.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.95 -1.324 . . . . 1.0 110.569 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.01 177.6 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.148 -0.97 . . . . 1.0 110.535 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 7.8 pt20 -167.49 123.81 1.12 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.254 -0.904 . . . . 1.0 110.89 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.607 ' CE ' ' O ' ' A' ' 115' ' ' SER . 6.0 tmm? -83.69 115.95 22.42 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 10.1 ptt? -119.79 149.15 42.51 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.905 -1.122 . . . . 1.0 111.143 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.624 ' CE2' ' CG1' ' A' ' 89' ' ' VAL . 24.7 p90 -158.03 132.81 8.45 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.194 -1.002 . . . . 1.0 110.951 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.667 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -121.02 75.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 1.0 110.329 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.448 ' HB2' ' HG ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER -79.11 -5.86 55.11 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.68 -0.637 . . . . 1.0 110.379 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -121.5 -65.83 0.24 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.057 -1.217 . . . . 1.0 110.057 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.33 -33.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.053 -1.263 . . . . 1.0 111.243 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.504 ' HD3' ' HD3' ' A' ' 129' ' ' PRO . 9.0 ptmt -124.58 138.06 30.48 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.944 -1.097 . . . . 1.0 110.959 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.516 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 49.8 Cg_endo -76.23 121.82 6.31 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 124.15 1.605 . . . . 1.0 111.414 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.624 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -77.4 168.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 178.14 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.563 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 10.6 p -147.69 85.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.751 -1.218 . . . . 1.0 111.667 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 126' ' ' GLY . 0.7 OUTLIER -77.34 75.31 3.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.881 -1.137 . . . . 1.0 108.398 178.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 34.8 mtp180 -58.47 178.82 0.09 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.955 0.884 . . . . 1.0 110.837 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.51 ' OG ' ' CG2' ' A' ' 118' ' ' VAL . 11.5 t -109.64 149.31 29.89 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.916 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.75 29.91 6.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -0.999 . . . . 1.0 109.908 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.559 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 74.2 t -133.74 150.27 74.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.514 -0.741 . . . . 1.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.559 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 42.1 Cg_endo -66.93 120.35 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.569 1.299 . . . . 1.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.531 ' CD1' HG22 ' A' ' 103' ' ' THR . 4.1 tp -104.89 -11.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 1.0 110.344 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.481 ' HB3' HG22 ' A' ' 52' ' ' THR . 8.5 p-10 -87.96 55.69 3.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 1.0 109.679 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.468 HG23 ' HB2' ' A' ' 101' ' ' HIS . 68.8 m -112.38 8.29 19.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.311 -0.868 . . . . 1.0 110.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.53 ' HA ' ' N ' ' A' ' 49' ' ' THR . 79.2 m-20 54.62 16.86 1.48 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 1.0 110.436 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.468 ' HB2' HG23 ' A' ' 99' ' ' THR . 3.6 m-70 -113.41 150.13 33.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.881 . . . . 1.0 109.984 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.619 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 4.3 m95 -60.75 89.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.013 -1.054 . . . . 1.0 110.687 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.531 HG22 ' CD1' ' A' ' 97' ' ' ILE . 23.3 m -87.56 150.57 23.62 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.498 ' N ' HG21 ' A' ' 103' ' ' THR . 78.8 t60 -108.71 135.34 50.1 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.989 -1.085 . . . . 1.0 108.73 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.429 HD12 ' CD1' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -132.51 156.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.174 -0.954 . . . . 1.0 109.457 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.569 ' HE2' ' CG ' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -152.23 167.41 28.68 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.731 -1.188 . . . . 1.0 110.125 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -152.16 109.7 3.61 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.255 -0.978 . . . . 1.0 111.251 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.536 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 18.4 m-30 -83.58 102.28 12.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 1.0 108.802 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -92.99 127.37 38.48 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.96 -1.087 . . . . 1.0 109.728 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 111' ' ' GLN . 3.3 t -132.62 157.57 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 1.0 110.269 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -40.14 111.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.0 110.497 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.626 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 51.98 65.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 1.0 110.377 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.626 ' CB ' ' O ' ' A' ' 112' ' ' ARG . 2.2 tt0 156.85 113.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.632 0.73 . . . . 1.0 109.986 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 82' ' ' TYR . . . -120.86 166.15 13.96 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.199 -1.0 . . . . 1.0 110.618 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.607 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -144.51 166.7 24.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.491 -1.006 . . . . 1.0 110.315 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.55 ' CD1' ' N ' ' A' ' 117' ' ' GLN 0.252 1.1 tm? -145.47 151.92 38.96 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.151 -0.968 . . . . 1.0 109.312 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.55 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.6 OUTLIER -153.89 107.95 3.02 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.813 -1.155 . . . . 1.0 111.788 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.522 ' N ' ' OE1' ' A' ' 121' ' ' GLU . 2.0 t -72.41 104.92 2.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.73 35.58 91.17 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.207 . . . . 1.0 110.084 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER 60.95 39.47 16.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.093 -1.239 . . . . 1.0 110.97 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.577 ' HG2' ' N ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -102.4 -167.84 1.45 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.522 -0.736 . . . . 1.0 110.733 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.577 ' N ' ' HG2' ' A' ' 121' ' ' GLU . . . -35.0 112.23 0.44 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 1.0 109.579 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.526 ' HB3' ' OE1' ' A' ' 117' ' ' GLN . 45.8 Cg_endo -72.95 118.14 5.43 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.133 1.596 . . . . 1.0 112.834 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' A' ' 91' ' ' LEU . 5.4 mp -85.8 110.85 20.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 106.313 -1.736 . . . . 1.0 106.313 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 30.9 p -119.65 174.38 6.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.507 1.146 . . . . 1.0 112.756 -176.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.559 ' N ' HD12 ' A' ' 91' ' ' LEU . . . 169.69 169.47 32.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 106.622 -2.591 . . . . 1.0 106.622 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -146.53 163.95 34.12 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.511 -1.582 . . . . 1.0 111.11 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.421 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -83.98 173.54 7.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.663 -0.648 . . . . 1.0 110.494 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -69.7 57.55 1.46 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 1.0 110.113 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.554 ' CA ' ' HG3' ' A' ' 112' ' ' ARG . 1.2 pp 10.22 57.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -132.68 73.35 0.46 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 133' ' ' THR . . . -159.94 -71.41 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -1.136 . . . . 1.0 110.493 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.8 OUTLIER 62.85 129.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -0.99 . . . . 1.0 109.887 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.17 75.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 1.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.448 ' HG ' ' HB2' ' A' ' 84' ' ' LEU . 1.3 tm? -88.86 108.42 19.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 1.0 109.719 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -67.74 148.79 50.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 1.0 110.724 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -138.4 141.45 39.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 1.0 109.787 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.469 ' N ' ' HD3' ' A' ' 61' ' ' LYS . 40.4 p-10 -84.16 22.1 1.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.194 -0.941 . . . . 1.0 111.075 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 45.51 22.41 0.65 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.405 -1.478 . . . . 1.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -104.92 162.57 13.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.109 -1.23 . . . . 1.0 109.252 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.453 ' O ' ' N ' ' A' ' 27' ' ' TYR . 6.7 tp -159.53 144.78 15.63 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.99 -1.069 . . . . 1.0 110.821 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.627 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 13.1 m95 -125.99 141.88 51.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.577 ' CD2' ' O ' ' A' ' 56' ' ' ILE . 1.5 tt -148.0 128.47 14.02 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 116.908 -1.917 . . . . 1.0 113.375 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 23' ' ' THR . . . 113.54 -5.32 24.66 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 146.69 -140.87 9.0 Favored Glycine 0 C--N 1.289 -2.039 0 C-N-CA 118.945 -1.598 . . . . 1.0 109.755 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.611 ' HE1' ' CE3' ' A' ' 142' ' ' TRP . 0.4 OUTLIER -171.43 141.18 1.5 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.091 -1.043 . . . . 1.0 111.939 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.01 -16.08 55.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.783 0.801 . . . . 1.0 109.079 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.475 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -137.0 45.84 2.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.497 -1.298 . . . . 1.0 107.497 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 55' ' ' LEU . 11.5 tp -65.32 56.83 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.753 0.787 . . . . 1.0 112.146 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 148' ' ' ARG . 56.9 p -84.88 1.7 45.9 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.509 -1.663 . . . . 1.0 106.509 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.652 ' CG2' ' CH2' ' A' ' 58' ' ' TRP . 3.3 p -85.47 -104.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.614 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.661 ' CB ' ' CD2' ' A' ' 159' ' ' TYR . . . 52.64 45.52 28.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.476 -1.39 . . . . 1.0 108.936 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.525 ' C ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -18.03 -77.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.516 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 9.5 ptmt -97.95 -43.65 7.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.985 . . . . 1.0 111.874 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.648 ' CD2' ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -81.07 113.41 40.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 O-C-N 121.324 -0.86 . . . . 1.0 110.231 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 154' ' ' LYS . 51.1 Cg_endo -88.39 -68.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.58 1.305 . . . . 1.0 111.594 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 1.8 tttm -54.86 -50.67 68.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 1.0 111.944 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.507 ' HB1' ' CD1' ' A' ' 155' ' ' LEU . . . -43.72 -42.76 5.59 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.729 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 3.2 m-85 -78.42 -32.2 48.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.554 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -68.93 -12.35 61.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.753 -0.779 . . . . 1.0 109.926 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 161' ' ' THR . 1.2 m -128.65 81.9 2.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -41.31 158.35 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.607 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 62.9 t80 -71.57 137.08 47.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.959 -1.318 . . . . 1.0 110.5 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.513 ' O ' HG21 ' A' ' 49' ' ' THR . 4.4 mt -118.72 75.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.627 ' CA ' ' OG1' ' A' ' 49' ' ' THR . . . -159.11 -160.21 10.23 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.515 ' N ' ' OG1' ' A' ' 49' ' ' THR . 20.0 m -118.61 147.48 43.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -1.175 . . . . 1.0 111.445 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.622 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -134.95 157.22 40.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.694 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.524 ' NH2' ' OD1' ' A' ' 169' ' ' ASP . 22.1 ttt-85 -165.52 157.85 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.818 -1.176 . . . . 1.0 111.262 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 20.0 m-20 51.25 78.61 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.9 . . . . 1.0 110.451 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.469 HG13 ' HB2' ' A' ' 45' ' ' LEU . 16.8 m -124.81 129.55 73.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.363 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.407 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -148.13 148.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.269 -0.972 . . . . 1.0 110.947 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.644 ' CG2' ' CE1' ' A' ' 43' ' ' PHE . 14.9 p -135.7 123.56 36.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 23.2 m-20 49.95 30.92 4.3 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.409 -1.432 . . . . 1.0 107.86 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 68.09 28.76 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.186 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.572 ' O ' ' HB3' ' A' ' 176' ' ' GLU . 0.8 OUTLIER -109.66 -170.06 1.59 Allowed 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.262 -0.899 . . . . 1.0 109.34 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.572 ' HB3' ' O ' ' A' ' 175' ' ' GLN . 36.6 tp10 76.59 -106.22 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.601 -0.687 . . . . 1.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 3.6 mp 63.37 -94.91 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.185 -0.947 . . . . 1.0 112.515 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 7.3 m-70 -56.64 90.02 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.937 -1.102 . . . . 1.0 111.438 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' A' ' 183' ' ' ALA 0.272 3.5 mp -63.57 -58.78 5.87 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.214 1.006 . . . . 1.0 110.868 178.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.531 HG13 ' CD1' ' A' ' 184' ' ' LEU . 2.1 t -61.44 -16.45 14.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.933 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 3.4 mt-10 -72.3 -45.27 60.76 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.386 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.596 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 1.6 m-20 -101.8 -15.52 16.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.257 -0.902 . . . . 1.0 109.277 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -78.2 -37.51 45.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.326 -0.859 . . . . 1.0 109.299 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.531 ' CD1' HG13 ' A' ' 180' ' ' VAL . 11.4 mt -55.74 -16.29 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 1.0 109.877 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 184' ' ' LEU . 9.8 t-20 -42.98 -27.01 0.16 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.824 0.821 . . . . 1.0 109.271 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.443 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 2.3 t30 -134.74 143.17 45.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.459 ' O ' HG22 ' A' ' 188' ' ' THR . 46.1 Cg_endo -71.0 -158.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.632 1.333 . . . . 1.0 110.98 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' A' ' 188' ' ' THR . 0.4 OUTLIER 64.09 22.91 13.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.603 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.484 HD11 ' O ' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -92.78 112.6 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.272 -0.893 . . . . 1.0 110.781 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.642 ' CD1' ' N ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -109.48 149.56 29.41 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.13 -0.981 . . . . 1.0 109.201 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.6 ' CE1' ' CD1' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -99.63 101.63 12.89 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.97 -1.081 . . . . 1.0 109.835 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' HIS . 9.0 t -41.74 112.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 1.0 110.476 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 1.7 m -63.82 149.65 46.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.116 -0.99 . . . . 1.0 110.154 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.458 ' HB2' ' NZ ' ' A' ' 48' ' ' LYS . . . 173.91 46.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 1.0 110.578 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.873 0 C-N-CA 118.433 -1.307 . . . . 1.0 110.55 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.9 p -128.14 99.7 5.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -1.137 . . . . 1.0 110.259 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -44.9 135.52 5.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 1.0 110.148 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -139.21 126.62 21.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 1.0 110.076 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.9 t -105.17 140.82 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 1.0 110.315 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.427 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.8 mp -70.13 143.05 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 1.0 109.973 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mt -111.04 83.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 1.0 110.153 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.72 109.36 21.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 1.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -66.19 129.1 38.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 1.0 110.359 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.84 126.43 37.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.344 -0.847 . . . . 1.0 110.257 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.21 69.1 1.52 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 1.0 110.486 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.1 111.47 3.4 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.23 -1.548 . . . . 1.0 109.23 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -138.01 68.38 1.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -1.172 . . . . 1.0 110.515 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -103.12 17.36 24.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 1.0 110.284 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -46.08 90.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.815 . . . . 1.0 110.047 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -110.47 160.93 16.17 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.291 -0.88 . . . . 1.0 110.453 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.525 HG21 ' CE ' ' A' ' 25' ' ' MET . 6.4 mm -127.27 125.71 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 1.0 109.222 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.55 138.57 31.39 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.415 -0.803 . . . . 1.0 110.964 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.617 ' CE1' ' CD1' ' A' ' 167' ' ' ILE . 12.2 m-85 -101.27 169.05 9.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.568 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 0.6 OUTLIER -128.82 -7.56 5.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.967 . . . . 1.0 110.634 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.35 37.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -129.24 -13.15 4.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.05 -1.265 . . . . 1.0 110.737 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.465 ' OG1' ' OD2' ' A' ' 20' ' ' ASP . 2.3 m -69.53 130.47 42.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.211 -0.931 . . . . 1.0 110.507 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.591 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 0.4 OUTLIER -116.09 118.02 31.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.358 -0.838 . . . . 1.0 109.487 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -91.55 101.3 13.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.641 -1.287 . . . . 1.0 110.096 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.602 ' OE1' ' CZ2' ' A' ' 142' ' ' TRP . 5.4 tp10 -79.99 97.03 6.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.852 -0.795 . . . . 1.0 108.852 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.593 ' CD1' ' HB3' ' A' ' 182' ' ' ASP . 19.0 m-85 -95.37 97.57 9.93 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.103 -1.039 . . . . 1.0 111.362 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.82 123.72 41.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 1.0 108.849 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -133.3 157.33 45.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.852 -1.155 . . . . 1.0 111.225 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' VAL . . . -105.94 101.8 11.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.662 -0.649 . . . . 1.0 109.553 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.494 ' CG2' ' OD2' ' A' ' 138' ' ' ASP . 2.8 t -62.12 -132.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 1.0 109.988 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.2 t -124.87 158.65 32.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.756 -1.215 . . . . 1.0 110.836 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 34' ' ' SER . 1.3 pttp -96.52 82.39 3.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.817 . . . . 1.0 109.773 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER 170.93 -32.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 1.0 109.813 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -94.64 13.27 24.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.505 -0.747 . . . . 1.0 109.908 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 36' ' ' LYS . 4.9 pttt -41.63 140.97 0.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.442 -0.786 . . . . 1.0 110.133 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.4 ' HA ' ' OD1' ' A' ' 136' ' ' ASP . . . 61.48 52.62 3.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 1.0 110.13 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.523 ' CD1' ' OD1' ' A' ' 41' ' ' ASN . 0.4 OUTLIER -61.85 162.5 8.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 110.163 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 35.7 tt0 -94.69 -3.79 48.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 1.0 110.658 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.468 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.2 p -167.29 155.13 9.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.049 -1.032 . . . . 1.0 110.635 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.578 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -128.17 148.68 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 1.0 110.077 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.5 ' CD2' ' OD1' ' A' ' 173' ' ' ASP . 13.8 m-70 -114.47 126.59 55.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 1.0 109.641 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.649 ' CZ ' ' CD1' ' A' ' 69' ' ' ILE . 73.9 m-85 -120.21 122.47 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -0.987 . . . . 1.0 111.137 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.625 ' HA ' ' HG2' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -128.3 134.96 49.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.032 . . . . 1.0 110.576 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 45' ' ' LEU . 1.1 pt? -175.18 156.59 2.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.956 -1.09 . . . . 1.0 111.293 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.446 ' C ' HG22 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -119.68 155.18 32.88 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.559 HG22 ' CD1' ' A' ' 105' ' ' ILE . 6.9 pt -146.35 169.6 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 118.665 -1.214 . . . . 1.0 112.286 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.599 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -129.01 92.57 3.42 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 178.322 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.627 ' CG2' ' CD1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -73.21 157.6 36.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 1.0 112.286 -177.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.611 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 6.8 mm-40 -148.9 12.65 0.87 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.043 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -151.07 8.32 0.54 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.454 -1.404 . . . . 1.0 112.223 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.571 HG23 ' HB3' ' A' ' 98' ' ' ASN . 0.7 OUTLIER 50.98 11.03 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.969 -1.082 . . . . 1.0 111.823 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.8 tt0 -158.76 137.92 11.43 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.902 -1.124 . . . . 1.0 110.163 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 148.35 139.35 3.16 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -87.07 126.21 34.62 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.021 -1.282 . . . . 1.0 108.693 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.638 HD13 ' HA ' ' A' ' 72' ' ' ALA . 3.4 mp -92.49 -32.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 1.0 111.708 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.644 ' CB ' ' HB2' ' A' ' 71' ' ' LEU . 1.3 tt -144.15 148.17 34.68 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.802 -1.186 . . . . 1.0 113.017 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.677 ' CH2' ' CG2' ' A' ' 151' ' ' VAL . 21.3 t-105 -156.23 111.82 2.97 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.77 128.5 56.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.829 -1.17 . . . . 1.0 111.511 -178.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.97 98.7 0.62 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.286 -1.926 . . . . 1.0 108.286 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HD2' ' O ' ' A' ' 61' ' ' LYS . 29.4 tptt -43.17 -57.3 3.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -1.103 . . . . 1.0 111.788 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . -161.29 -92.16 0.09 OUTLIER Glycine 0 N--CA 1.493 2.436 0 C-N-CA 118.494 -1.812 . . . . 1.0 111.544 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -31.66 152.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.955 -0.732 . . . . 1.0 111.62 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -81.67 43.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 1.0 110.227 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.51 31.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 1.0 109.404 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -131.37 171.05 13.82 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.325 -0.95 . . . . 1.0 111.648 -177.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.452 ' C ' ' O ' ' A' ' 66' ' ' SER . 34.7 t0 31.01 78.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.13 0.49 . . . . 1.0 112.091 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.547 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 2.7 m-85 -92.47 77.55 5.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 1.0 110.603 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.649 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 2.5 tt -110.67 110.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.006 -1.059 . . . . 1.0 110.19 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.543 ' C ' ' HG ' ' A' ' 71' ' ' LEU . . . -133.67 176.52 8.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.132 -0.98 . . . . 1.0 110.476 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.644 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 42.4 mt -147.88 113.09 5.54 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -131.8 164.25 26.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.95 -1.094 . . . . 1.0 111.855 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.627 ' CD1' ' CG2' ' A' ' 49' ' ' THR . 7.0 mt -108.64 136.46 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.849 . . . . 1.0 110.669 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.526 HG11 ' CZ ' ' A' ' 92' ' ' ARG . 4.2 p -141.67 120.6 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.81 . . . . 1.0 111.28 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 0.9 OUTLIER 70.57 14.08 7.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 1.0 110.938 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 99.05 7.68 54.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.789 -1.324 . . . . 1.0 109.789 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.22 146.44 49.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -1.225 . . . . 1.0 109.385 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.585 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -93.38 162.58 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 1.0 109.589 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.536 ' CB ' ' HA ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -159.17 139.41 12.13 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.212 -0.93 . . . . 1.0 110.152 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.589 ' O ' ' HG3' ' A' ' 80' ' ' MET . 0.1 OUTLIER -107.61 115.86 30.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.349 -0.941 . . . . 1.0 110.253 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.53 ' CE ' ' OH ' ' A' ' 159' ' ' TYR . 3.0 ptp -89.39 133.79 34.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.582 -1.323 . . . . 1.0 110.128 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -126.92 128.93 47.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 1.0 110.688 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.547 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.5 t0 -146.53 66.21 1.18 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.287 1.041 . . . . 1.0 109.466 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.531 ' CB ' HD13 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -66.87 -3.68 7.51 Favored 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.563 -0.71 . . . . 1.0 111.074 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -137.98 -55.43 0.05 OUTLIER Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.554 -1.308 . . . . 1.0 110.62 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.49 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -176.01 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.213 -1.169 . . . . 1.0 110.678 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 15.8 mmtp -98.48 110.87 58.44 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.009 -1.057 . . . . 1.0 109.795 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 82' ' ' TYR . 43.1 Cg_endo -71.93 159.9 49.13 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.86 1.453 . . . . 1.0 110.712 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -137.02 116.98 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.587 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 1.8 p -95.99 112.44 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.404 -1.435 . . . . 1.0 110.974 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.582 ' HB3' ' CG2' ' A' ' 124' ' ' ILE . 4.6 mt -105.69 71.56 0.92 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.536 ' HA ' ' CB ' ' A' ' 79' ' ' GLN . 3.4 mtp180 -60.07 178.14 0.2 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.99 0.9 . . . . 1.0 110.909 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.468 ' OG ' HG22 ' A' ' 118' ' ' VAL . 7.9 t -100.11 161.35 13.66 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.648 -0.658 . . . . 1.0 110.656 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.71 25.75 10.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 1.0 109.485 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.54 ' HB ' ' CG1' ' A' ' 118' ' ' VAL . 2.2 t -137.53 147.34 57.19 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.708 -0.62 . . . . 1.0 109.617 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.508 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.2 Cg_endo -65.91 137.12 47.77 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.806 1.424 . . . . 1.0 110.783 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 98' ' ' ASN . 1.0 OUTLIER -128.94 -22.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 1.0 111.197 -179.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.571 ' HB3' HG23 ' A' ' 52' ' ' THR . 6.7 p30 -74.2 54.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.982 . . . . 1.0 111.317 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 14.2 t -128.87 30.77 5.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.263 -0.898 . . . . 1.0 108.906 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.461 ' CG ' ' O ' ' A' ' 99' ' ' THR . 5.9 p-10 40.49 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.948 -0.47 . . . . 1.0 111.578 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.567 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 0.3 OUTLIER -102.02 160.03 14.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.0 -1.062 . . . . 1.0 109.049 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.599 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 20.0 m95 -81.11 102.34 10.19 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.037 -1.039 . . . . 1.0 109.838 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.524 ' CG2' ' N ' ' A' ' 104' ' ' HIS . 18.2 m -93.8 173.79 7.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 1.0 109.246 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.524 ' N ' ' CG2' ' A' ' 103' ' ' THR . 3.2 t60 -121.81 125.57 46.8 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.316 -1.364 . . . . 1.0 107.316 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.559 ' CD1' HG22 ' A' ' 47' ' ' ILE . 1.5 mp -124.25 147.67 28.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.722 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -152.94 179.42 8.7 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.27 -1.372 . . . . 1.0 109.38 -178.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.564 ' O ' ' CD1' ' A' ' 108' ' ' TYR . . . -164.4 145.98 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.834 -1.166 . . . . 1.0 111.811 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 4.7 m-85 -136.54 104.8 5.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.448 -0.782 . . . . 1.0 109.576 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.556 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -95.63 131.28 42.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.978 . . . . 1.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.554 ' N ' ' HD3' ' A' ' 109' ' ' ARG . 85.8 t -137.53 104.22 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.365 -0.835 . . . . 1.0 110.687 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.475 ' O ' ' CB ' ' A' ' 112' ' ' ARG . 16.4 mt-30 40.83 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.591 -0.693 . . . . 1.0 112.206 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.1 OUTLIER 71.59 -50.61 0.69 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 1.0 112.734 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.597 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 6.3 tt0 -85.04 122.03 28.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.691 -1.256 . . . . 1.0 111.511 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.35 166.7 12.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.546 ' O ' ' CE ' ' A' ' 80' ' ' MET . 42.1 t -145.0 151.83 39.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.288 -1.125 . . . . 1.0 111.075 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.556 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -111.77 147.25 36.07 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.722 ' HB3' ' CB ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -127.45 91.65 3.35 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.778 -1.169 . . . . 1.0 112.591 -177.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.54 ' CG1' ' HB ' ' A' ' 95' ' ' VAL . 70.4 t -78.93 87.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.748 -1.204 . . . . 1.0 107.748 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 56.88 58.28 15.33 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.802 -1.19 . . . . 1.0 110.348 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 41.4 24.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.433 -1.039 . . . . 1.0 112.237 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 1.1 mt-10 -97.83 -166.7 1.41 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.748 -1.22 . . . . 1.0 109.304 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.7 96.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.87 0 C-N-CA 120.0 -0.68 . . . . 1.0 109.587 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.529 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.8 Cg_endo -74.93 130.43 13.34 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.091 1.574 . . . . 1.0 110.871 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.582 ' CG2' ' HB3' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -86.05 144.5 9.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 O-C-N 121.153 -0.967 . . . . 1.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.539 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 4.6 p -138.83 158.13 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.524 -1.36 . . . . 1.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.52 ' N ' HD23 ' A' ' 91' ' ' LEU . . . -166.21 165.47 38.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.209 -2.356 . . . . 1.0 107.209 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.597 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -152.91 151.2 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.594 -1.533 . . . . 1.0 111.79 -179.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.448 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.1 p -106.02 173.96 2.89 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.746 -0.596 . . . . 1.0 109.911 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 131' ' ' GLY . 45.2 Cg_endo -70.65 67.77 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.915 1.482 . . . . 1.0 110.18 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.544 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.0 OUTLIER -4.04 70.28 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 121.581 0.705 . . . . 1.0 112.798 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -84.68 -71.17 1.32 Allowed Glycine 0 C--N 1.288 -2.093 0 N-CA-C 109.196 -1.562 . . . . 1.0 109.196 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.543 ' O ' ' C ' ' A' ' 133' ' ' THR . . . -67.7 86.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -1.186 . . . . 1.0 109.369 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.543 ' C ' ' O ' ' A' ' 132' ' ' ALA . 16.7 m -19.0 -69.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.036 0.446 . . . . 1.0 111.986 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -113.65 -45.87 3.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 1.0 110.023 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.531 HD13 ' CB ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER 62.2 113.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.899 . . . . 1.0 110.346 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.504 ' C ' ' CG2' ' A' ' 137' ' ' THR . 15.2 m-20 -73.19 138.97 45.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 1.0 109.534 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.531 ' O ' ' HB3' ' A' ' 138' ' ' ASP . 7.2 p -153.53 105.0 2.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 1.0 109.792 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.531 ' HB3' ' O ' ' A' ' 137' ' ' THR . 7.9 p-10 170.61 -39.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -24.91 -43.91 0.01 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -146.99 173.81 12.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.903 -1.351 . . . . 1.0 110.445 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.549 ' C ' ' CD1' ' A' ' 142' ' ' TRP . 10.3 tp -160.86 148.79 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.344 -0.848 . . . . 1.0 110.248 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.602 ' CZ2' ' OE1' ' A' ' 26' ' ' GLU . 20.7 m95 -133.23 143.49 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.303 -0.999 . . . . 1.0 108.303 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.565 HD11 ' CB ' ' A' ' 57' ' ' LEU . 6.6 tp -145.68 118.89 8.89 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.945 -1.502 . . . . 1.0 112.974 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 122.67 1.86 9.75 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.367 -1.093 . . . . 1.0 110.367 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.479 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 144.32 -135.24 6.09 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 118.936 -1.602 . . . . 1.0 109.727 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.615 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -170.79 176.48 4.17 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.816 -0.814 . . . . 1.0 111.714 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -96.37 -25.35 15.76 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.919 0.866 . . . . 1.0 108.918 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.562 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.91 74.59 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.822 -1.548 . . . . 1.0 106.822 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.615 ' CD1' ' HB2' ' A' ' 146' ' ' MET . 3.8 tp -71.39 24.69 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 113.926 1.084 . . . . 1.0 113.926 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.6 p -62.16 -21.01 64.72 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 104.68 -2.341 . . . . 1.0 104.68 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.677 ' CG2' ' CH2' ' A' ' 58' ' ' TRP 0.284 13.5 p -58.32 -118.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.348 -1.297 . . . . 1.0 110.154 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.629 ' O ' ' CB ' ' A' ' 153' ' ' HIS . . . 70.24 -71.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.809 -1.182 . . . . 1.0 109.927 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.629 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 18.3 m170 132.16 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.438 ' HD3' ' HB3' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -137.14 12.11 3.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.005 . . . . 1.0 109.706 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -70.36 165.61 42.86 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.421 -0.799 . . . . 1.0 111.126 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.575 ' CD ' HD21 ' A' ' 155' ' ' LEU . 40.9 Cg_endo -64.97 -168.68 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.967 1.509 . . . . 1.0 112.448 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 160' ' ' SER . 2.2 mttp -53.28 -10.77 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.578 ' CB ' ' CD2' ' A' ' 155' ' ' LEU . . . -38.25 -44.82 0.91 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.044 -1.035 . . . . 1.0 109.983 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.62 ' CG ' ' HB3' ' A' ' 152' ' ' ALA . 15.4 m-85 -84.37 -28.45 26.99 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.945 -1.097 . . . . 1.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -71.64 -7.08 45.67 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.57 -1.252 . . . . 1.0 108.544 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.515 HG22 ' O ' ' A' ' 161' ' ' THR . 1.3 m -131.72 98.27 4.44 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -47.38 175.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.641 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 54.5 t80 -79.07 149.24 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -1.157 . . . . 1.0 112.061 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.611 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 1.1 mt -130.8 88.17 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.641 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.2 -153.69 9.48 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.061 -1.616 . . . . 1.0 109.061 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.525 ' C ' HG13 ' A' ' 167' ' ' ILE . 15.0 m -137.32 148.03 46.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.465 -1.021 . . . . 1.0 110.06 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.617 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -133.84 153.64 36.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.526 -0.734 . . . . 1.0 109.717 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.49 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 18.7 ttt180 -163.02 162.37 25.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.657 -1.277 . . . . 1.0 110.963 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.49 ' N ' ' HG2' ' A' ' 168' ' ' ARG . 0.7 OUTLIER 48.71 78.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.394 -0.816 . . . . 1.0 110.464 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 16.2 m -121.77 135.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 119.362 -0.935 . . . . 1.0 108.937 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.456 HG12 ' C ' ' A' ' 170' ' ' VAL . 0.0 OUTLIER -146.22 148.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.319 -0.953 . . . . 1.0 111.176 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 175' ' ' GLN . 1.7 t -130.32 102.43 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 10.9 m-20 51.96 42.55 30.35 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 1.0 108.143 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 75.51 26.38 1.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.254 0.549 . . . . 1.0 110.421 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.567 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . 63.9 mt-30 -102.15 -174.67 2.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.358 -0.838 . . . . 1.0 109.726 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.526 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 1.9 mm-40 62.64 -92.99 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.685 -0.634 . . . . 1.0 110.656 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER 65.88 -87.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 1.0 111.21 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 59.7 m-70 -74.72 102.39 4.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.998 -1.063 . . . . 1.0 111.509 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.471 ' O ' ' HB1' ' A' ' 183' ' ' ALA 0.253 0.4 OUTLIER -57.22 -58.4 8.38 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 122.419 1.104 . . . . 1.0 109.709 177.881 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.493 HG12 HD11 ' A' ' 184' ' ' LEU . 95.0 t -50.54 -31.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.99 -1.005 . . . . 1.0 111.262 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 19.7 mt-10 -61.69 -53.81 51.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.121 -0.987 . . . . 1.0 109.929 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.593 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 2.7 t0 -89.79 -15.46 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 1.0 109.665 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 179' ' ' LEU . . . -72.82 -25.08 61.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.326 -0.859 . . . . 1.0 109.032 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.493 HD11 HG12 ' A' ' 180' ' ' VAL . 0.1 OUTLIER -62.61 -15.49 51.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 1.0 109.438 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -24.15 63.93 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.938 0.875 . . . . 1.0 108.777 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 187' ' ' PRO . 3.6 t-20 -96.46 151.06 37.8 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.487 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 38.8 Cg_endo -64.87 143.61 80.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.538 1.283 . . . . 1.0 111.212 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.473 ' CG2' ' N ' ' A' ' 189' ' ' ILE . 0.8 OUTLIER 49.9 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.585 -0.697 . . . . 1.0 110.648 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.473 ' N ' ' CG2' ' A' ' 188' ' ' THR . 14.2 mm -141.03 121.99 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 1.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 mt -111.25 159.23 18.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.148 -0.97 . . . . 1.0 110.641 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -127.57 153.33 46.52 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 1.0 109.409 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 4.1 t -70.36 165.95 21.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.021 -1.05 . . . . 1.0 110.47 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.69 166.98 19.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 1.0 110.045 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -169.52 46.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 1.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.834 0 C-N-CA 118.717 -1.193 . . . . 1.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.7 OUTLIER 66.69 -161.6 0.24 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -1.186 . . . . 1.0 109.999 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 2' ' ' SER . 3.0 mt-10 56.46 167.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 1.0 110.302 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -173.28 88.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 1.0 109.897 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 5' ' ' VAL . 10.4 p -70.17 113.09 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 1.0 110.394 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.456 HG21 ' O ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -127.65 128.82 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 1.0 109.784 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.419 ' O ' HD13 ' A' ' 6' ' ' ILE . 35.4 pt -91.19 146.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.111 -0.993 . . . . 1.0 110.37 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.53 138.33 36.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 1.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -127.77 90.52 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.85 . . . . 1.0 110.364 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.96 132.33 55.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.491 -0.756 . . . . 1.0 109.652 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.47 60.22 6.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 1.0 110.384 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.43 108.17 2.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.629 -1.388 . . . . 1.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -164.49 46.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -1.234 . . . . 1.0 110.185 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.93 53.77 1.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 1.0 110.408 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 2.4 pt-20 -77.85 79.96 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.845 . . . . 1.0 110.367 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.51 134.21 34.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.157 -1.589 . . . . 1.0 110.925 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 190' ' ' LEU . 6.8 mm -125.94 142.14 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -0.975 . . . . 1.0 109.29 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -98.58 133.58 42.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.425 -0.797 . . . . 1.0 111.043 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.645 ' CE1' ' CD1' ' A' ' 167' ' ' ILE . 7.5 m-85 -95.84 175.74 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 1.0 109.192 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 45.6 p-10 -139.5 4.63 2.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.956 . . . . 1.0 110.655 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.488 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.74 -30.58 10.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.577 -1.809 . . . . 1.0 108.577 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.457 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 3.4 ttp-105 -100.92 -12.78 18.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.455 -1.027 . . . . 1.0 109.628 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.581 HG23 ' CD2' ' A' ' 19' ' ' PHE . 11.8 m -42.82 135.52 2.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 1.0 110.379 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.669 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -133.75 99.14 4.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 4.1 mtt -93.98 100.63 12.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.39 -1.444 . . . . 1.0 109.407 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.633 ' CG ' ' CZ3' ' A' ' 142' ' ' TRP . 2.7 tm-20 -103.72 101.8 11.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 1.0 110.325 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.583 ' CE1' ' HB3' ' A' ' 182' ' ' ASP . 19.7 m-30 -108.81 116.41 31.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.258 -0.902 . . . . 1.0 109.346 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -115.67 122.39 45.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 1.0 110.59 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -156.35 163.4 39.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.0 110.242 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.27 167.28 19.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.49 ' O ' ' HB ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -148.04 24.45 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.089 -1.007 . . . . 1.0 110.83 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 31' ' ' VAL . 5.8 t -178.53 -177.61 0.55 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.002 -1.061 . . . . 1.0 110.386 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -83.43 94.42 7.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.218 -0.926 . . . . 1.0 110.557 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 33' ' ' LYS . 2.0 t 35.88 39.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.618 -0.676 . . . . 1.0 110.802 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.77 74.9 0.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.215 -0.928 . . . . 1.0 110.336 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.466 ' HA ' HG21 ' A' ' 32' ' ' THR . 1.9 mptp? -61.07 116.69 4.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 1.0 110.127 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.33 117.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.383 -0.823 . . . . 1.0 109.715 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tp -127.5 -170.63 2.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 1.0 110.754 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.2 -34.64 0.64 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.657 0.742 . . . . 1.0 109.764 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.6 p -118.38 149.9 40.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.551 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 23.8 m-80 -133.59 117.31 16.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.032 -1.043 . . . . 1.0 111.158 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 6.5 m-70 -94.87 108.74 20.77 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 41' ' ' ASN . 8.4 m-85 -113.83 118.04 33.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 1.0 111.333 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.492 ' HG2' ' HD3' ' A' ' 106' ' ' LYS . 2.1 mt-10 -127.99 150.62 49.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.183 -0.948 . . . . 1.0 110.577 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.48 ' HB3' ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER 179.9 153.55 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.266 -0.896 . . . . 1.0 110.552 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 167' ' ' ILE . 0.7 OUTLIER -130.12 149.42 51.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 1.0 109.787 179.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 167' ' ' ILE . 9.4 pt -131.22 177.28 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.186 -1.006 . . . . 1.0 110.067 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.642 ' O ' ' OG1' ' A' ' 49' ' ' THR . 12.4 tttt -167.0 82.31 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.204 -0.935 . . . . 1.0 111.018 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.642 ' OG1' ' O ' ' A' ' 48' ' ' LYS . 29.5 m -172.03 -114.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.238 0.542 . . . . 1.0 111.095 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.556 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 0.9 OUTLIER -115.04 -47.45 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.683 1.23 . . . . 1.0 109.586 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.593 ' O ' ' CG2' ' A' ' 73' ' ' ILE . . . 34.98 41.99 0.07 Allowed 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.413 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.615 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 64.9 p -85.51 -17.25 36.97 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.87 -1.144 . . . . 1.0 108.537 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.483 ' HG3' ' HA ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -159.95 119.82 2.92 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 154.73 129.05 1.22 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.15 -1.58 . . . . 1.0 109.15 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.661 HD22 ' HA ' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -81.3 131.12 35.27 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.652 -1.499 . . . . 1.0 109.334 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.602 ' O ' ' CD1' ' A' ' 143' ' ' LEU . 1.3 mp -97.21 -25.75 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.492 -0.755 . . . . 1.0 112.217 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.599 ' CG ' HD13 ' A' ' 143' ' ' LEU . 6.1 tt -148.7 133.74 18.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.723 -1.86 . . . . 1.0 113.211 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.593 ' CG ' HD22 ' A' ' 149' ' ' LEU . 20.4 t-105 -145.73 117.59 8.2 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -137.6 153.03 49.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.841 -1.162 . . . . 1.0 111.024 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 61' ' ' LYS . . . -158.37 -121.09 0.62 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.579 -1.809 . . . . 1.0 108.579 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.552 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER 172.33 -84.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.224 -1.162 . . . . 1.0 110.09 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.552 ' N ' ' HG3' ' A' ' 61' ' ' LYS . . . -61.31 132.0 47.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.81 -1.716 . . . . 1.0 108.81 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.5 ' O ' ' O ' ' A' ' 62' ' ' GLY . 18.6 mt 58.61 137.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.449 -1.03 . . . . 1.0 109.965 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 4.2 pt-20 -71.33 56.11 0.23 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.813 -1.179 . . . . 1.0 109.997 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.47 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 8.4 ptp180 167.98 45.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -92.52 -176.67 4.36 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-O 121.868 0.842 . . . . 1.0 112.441 -177.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 9.8 p-10 -87.59 141.7 28.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.777 -0.577 . . . . 1.0 111.548 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.617 ' CD1' ' CG2' ' A' ' 137' ' ' THR . 6.6 t80 174.19 -100.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.561 -0.712 . . . . 1.0 111.029 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.575 HG21 ' CZ ' ' A' ' 68' ' ' TYR . 1.8 tt -153.79 162.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.523 -1.361 . . . . 1.0 111.843 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.563 ' CB ' ' HE2' ' A' ' 81' ' ' MET . . . -157.71 170.15 23.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 1.0 110.032 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 77.6 mt -145.17 125.79 14.17 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.576 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -152.71 172.36 16.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.94 -1.1 . . . . 1.0 111.325 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.593 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 5.5 mt -127.49 146.01 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 1.0 111.452 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.62 ' CG1' ' CG ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -141.46 122.69 13.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.306 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.1 m-20 73.76 -3.98 2.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.335 -0.853 . . . . 1.0 112.169 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 127.4 -0.65 6.97 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 118.866 -1.635 . . . . 1.0 111.045 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.562 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 25.7 m-85 -133.93 134.13 42.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.93 -1.335 . . . . 1.0 110.545 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -59.97 -167.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 1.0 109.946 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 1.3 pt20 -174.75 97.37 0.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.441 -0.787 . . . . 1.0 109.819 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.566 ' CE ' ' O ' ' A' ' 115' ' ' SER . 3.2 ttp -62.21 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.614 -0.834 . . . . 1.0 109.233 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 12.2 ttp -95.02 108.77 20.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.651 -0.656 . . . . 1.0 110.21 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.62 ' CE2' HG11 ' A' ' 89' ' ' VAL . 1.4 p90 -125.74 138.57 53.87 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.015 -1.474 . . . . 1.0 111.013 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 0.6 OUTLIER -136.6 94.93 3.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.75 -0.594 . . . . 1.0 110.444 -179.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.531 HD21 ' CD1' ' A' ' 82' ' ' TYR . 0.5 OUTLIER -102.52 3.27 37.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.835 -0.541 . . . . 1.0 110.654 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -136.44 -43.03 0.1 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.302 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 167.72 -20.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.193 -1.181 . . . . 1.0 110.983 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 7.8 mttt -118.8 120.35 31.6 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.097 . . . . 1.0 110.081 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.6 ' HG3' ' CE1' ' A' ' 153' ' ' HIS . 52.6 Cg_endo -78.31 146.62 22.36 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.946 1.498 . . . . 1.0 110.151 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.62 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -112.97 121.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.323 -0.861 . . . . 1.0 108.729 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 0.5 OUTLIER -102.5 111.29 31.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.09 -1.444 . . . . 1.0 110.427 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.544 ' CD1' ' HE1' ' A' ' 80' ' ' MET . 11.7 mt -105.61 70.05 0.86 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.9 -1.519 . . . . 1.0 106.9 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 20.0 mtp180 -60.5 148.97 35.89 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 122.121 0.963 . . . . 1.0 111.22 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.546 ' OG ' ' CG2' ' A' ' 118' ' ' VAL 0.253 48.2 t -67.57 150.67 48.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.824 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.51 ' N ' HD11 ' A' ' 124' ' ' ILE . 12.1 t -107.57 26.73 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.789 . . . . 1.0 109.023 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 118' ' ' VAL . 2.1 t -139.88 153.3 69.6 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.517 ' HD2' HG12 ' A' ' 95' ' ' VAL . 40.9 Cg_endo -65.84 124.69 13.07 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.661 1.348 . . . . 1.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.435 ' CG1' ' CD1' ' A' ' 47' ' ' ILE . 3.3 tp -109.55 -8.42 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.805 . . . . 1.0 110.03 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 5.4 p-10 -93.77 56.89 2.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.758 . . . . 1.0 109.896 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 99' ' ' THR . 98.1 m -114.61 7.04 15.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.227 -0.921 . . . . 1.0 110.739 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.472 ' HA ' ' CA ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 60.54 10.94 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.331 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -104.47 163.11 12.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 1.0 109.742 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.614 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 15.6 m95 -78.08 91.87 4.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.003 -1.061 . . . . 1.0 110.864 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.449 ' O ' ' HB3' ' A' ' 46' ' ' SER . 22.9 m -86.63 167.5 14.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.76 -0.829 . . . . 1.0 108.76 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.476 ' O ' ' N ' ' A' ' 119' ' ' GLY . 23.1 t60 -123.98 132.45 53.71 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.208 -0.997 . . . . 1.0 109.782 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -126.78 142.94 41.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.318 -0.864 . . . . 1.0 108.979 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.68 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -148.34 179.65 7.62 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.018 -1.073 . . . . 1.0 109.309 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 108' ' ' TYR . . . -165.11 157.63 15.9 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.808 -1.182 . . . . 1.0 111.824 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 6.0 m-85 -136.21 104.39 5.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 1.0 109.299 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.487 ' NH2' HD13 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -103.02 134.75 45.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.911 -1.118 . . . . 1.0 109.945 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.527 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 3.0 t -130.56 84.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.161 -1.016 . . . . 1.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 32.4 mt-30 53.85 -2.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -179.37 -27.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.042 -1.661 . . . . 1.0 111.066 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.569 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -110.35 115.9 30.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 1.0 110.718 -178.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -103.54 149.89 17.46 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.566 ' O ' ' CE ' ' A' ' 80' ' ' MET . 12.5 t -132.36 155.59 48.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.274 -1.133 . . . . 1.0 110.266 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 1.6 tm? -123.65 144.89 49.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.802 -1.186 . . . . 1.0 108.679 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.68 ' HB3' ' CB ' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -121.04 81.35 1.76 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.411 -0.806 . . . . 1.0 112.3 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.546 ' CG2' ' OG ' ' A' ' 93' ' ' SER . 91.4 t -70.29 80.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.772 -1.171 . . . . 1.0 107.933 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 67.12 59.77 6.61 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.072 -1.211 . . . . 1.0 110.072 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 119' ' ' GLY . 7.8 m120 36.68 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.898 . . . . 1.0 111.25 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -103.18 -161.4 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 1.0 109.919 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.472 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -39.82 99.38 0.2 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.555 -0.716 . . . . 1.0 109.375 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.1 Cg_endo -71.17 129.88 16.78 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.211 1.638 . . . . 1.0 110.892 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.51 HD11 ' N ' ' A' ' 94' ' ' THR . 3.0 mt -101.45 102.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 30.2 p -114.06 173.42 6.45 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.261 1.029 . . . . 1.0 112.299 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.498 ' N ' HD22 ' A' ' 91' ' ' LEU . . . -178.09 -171.35 41.37 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.532 -2.227 . . . . 1.0 107.532 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.569 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -159.5 171.01 20.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.597 -1.531 . . . . 1.0 110.892 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.552 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.6 OUTLIER -107.97 -177.89 0.52 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 1.0 110.193 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.8 Cg_endo -69.39 94.88 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 1.0 108.946 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 129' ' ' PRO . 3.4 mp -34.32 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.228 0.537 . . . . 1.0 111.098 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.03 -29.04 1.25 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.614 -1.394 . . . . 1.0 109.614 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -90.66 135.33 33.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -1.16 . . . . 1.0 110.333 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.422 ' C ' ' HG2' ' A' ' 134' ' ' GLN . 9.7 m -138.38 23.47 2.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 1.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.506 ' O ' ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -158.52 -49.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 1.0 110.398 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER 28.14 64.01 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.232 0.539 . . . . 1.0 111.523 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -52.55 96.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.122 -0.986 . . . . 1.0 110.199 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 68' ' ' TYR . 10.5 t -159.72 -172.88 3.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 1.0 109.759 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 91.59 -19.87 0.12 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 121.298 0.571 . . . . 1.0 110.544 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -47.99 -17.0 0.51 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 120.198 -1.001 . . . . 1.0 110.743 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -128.79 168.36 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.631 -1.511 . . . . 1.0 109.748 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.533 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 0.5 OUTLIER -154.88 145.96 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 1.0 110.861 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.633 ' CZ3' ' CG ' ' A' ' 26' ' ' GLU . 30.2 m95 -136.6 96.47 3.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.131 -1.803 . . . . 1.0 106.131 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.602 ' CD1' ' O ' ' A' ' 56' ' ' ILE . 1.7 tp -112.34 130.05 56.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.97 1.47 . . . . 1.0 114.97 -175.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 106.99 10.05 28.88 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.694 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 124.93 -160.82 19.56 Favored Glycine 0 C--N 1.278 -2.648 0 N-CA-C 107.762 -2.135 . . . . 1.0 107.762 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.713 ' HG3' ' HG ' ' A' ' 149' ' ' LEU . 1.9 mmt -168.78 169.5 9.91 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.282 -1.367 . . . . 1.0 111.059 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.9 11.32 38.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -165.43 16.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.667 -0.646 . . . . 1.0 111.525 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.713 ' HG ' ' HG3' ' A' ' 146' ' ' MET . 9.2 mt -68.42 53.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.402 -1.436 . . . . 1.0 109.865 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 148' ' ' ARG . 10.5 p -55.19 -24.31 26.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.413 -1.699 . . . . 1.0 106.413 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.632 ' CG1' ' CD2' ' A' ' 149' ' ' LEU 0.311 12.7 p -48.21 -118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.051 -1.431 . . . . 1.0 111.86 178.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' A' ' 159' ' ' TYR . . . 79.81 -23.25 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.11 -0.993 . . . . 1.0 109.993 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.6 ' CE1' ' HG3' ' A' ' 88' ' ' PRO . 0.2 OUTLIER 75.68 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 1.0 111.163 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.577 ' CG ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -150.04 74.92 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.823 -1.173 . . . . 1.0 111.137 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.623 HD13 ' CD1' ' A' ' 159' ' ' TYR . 0.4 OUTLIER -142.47 178.41 1.51 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 120.696 -1.252 . . . . 1.0 110.029 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.62 ' CG ' ' CG1' ' A' ' 74' ' ' VAL . 52.6 Cg_endo -76.76 -164.2 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.707 1.372 . . . . 1.0 111.948 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 161' ' ' THR . 2.8 mttm -51.21 -10.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.609 -0.682 . . . . 1.0 112.131 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.538 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -32.75 -46.52 0.14 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.121 -0.987 . . . . 1.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.661 ' HA ' HD22 ' A' ' 55' ' ' LEU . 3.6 m-85 -83.97 -33.98 24.49 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.558 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -76.06 -1.7 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.977 -1.089 . . . . 1.0 108.813 178.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.555 ' N ' ' O ' ' A' ' 157' ' ' LYS . 2.6 m -140.74 83.24 1.88 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.547 -0.72 . . . . 1.0 109.29 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -43.54 165.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.154 -1.578 . . . . 1.0 109.154 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.626 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 32.6 t80 -70.63 142.67 51.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.286 . . . . 1.0 110.485 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.606 ' O ' HG23 ' A' ' 49' ' ' THR . 19.3 mt -119.79 79.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.626 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -165.48 -163.19 18.33 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.521 ' N ' ' OG1' ' A' ' 49' ' ' THR . 1.8 m -114.41 146.92 40.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -1.183 . . . . 1.0 111.585 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.645 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -136.45 152.62 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.166 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.457 ' HG2' ' OD1' ' A' ' 169' ' ' ASP . 13.5 ttp180 -158.6 159.1 35.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 1.0 110.769 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.7 m-20 53.13 79.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 1.0 110.509 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.495 ' C ' ' CG1' ' A' ' 171' ' ' ILE . 28.5 m -128.72 131.71 68.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.495 ' CG1' ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -150.88 149.24 14.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.03 -1.068 . . . . 1.0 110.899 -176.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.535 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 8.9 t -135.25 108.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 1.5 m-20 50.53 42.96 27.33 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.391 -1.443 . . . . 1.0 107.469 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.31 28.7 2.93 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.906 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.546 ' O ' ' HB2' ' A' ' 176' ' ' GLU . 22.3 mt-30 -100.98 -178.13 3.66 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.102 -0.999 . . . . 1.0 109.217 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 4.5 mm-40 69.62 -98.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.634 -0.666 . . . . 1.0 110.44 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER 69.27 -88.02 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.256 -0.903 . . . . 1.0 111.05 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 17.4 m-70 -97.44 103.17 15.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.739 -1.225 . . . . 1.0 111.097 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.5 OUTLIER -67.4 -53.56 28.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 22.1 t -51.47 -23.05 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.699 . . . . 1.0 110.381 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 35.5 mt-10 -71.69 -58.43 3.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 1.0 110.01 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.583 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 12.3 t0 -87.49 -14.63 39.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 1.0 109.619 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -69.65 -34.16 73.62 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.254 -0.904 . . . . 1.0 108.873 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.433 ' HA ' ' CD1' ' A' ' 189' ' ' ILE . 11.3 mt -48.68 -24.23 1.3 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 1.0 108.975 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 1.2 t-20 -57.22 -20.11 25.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.101 0.953 . . . . 1.0 109.009 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.525 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 1.8 t30 -89.61 151.95 46.5 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.525 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 37.5 Cg_endo -61.82 -149.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.3 1.158 . . . . 1.0 109.309 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.504 ' C ' ' O ' ' A' ' 187' ' ' PRO . 20.5 m -33.06 136.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.355 -0.84 . . . . 1.0 111.197 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.471 HG21 HD13 ' A' ' 189' ' ' ILE . 13.4 mt -127.78 153.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.505 -0.747 . . . . 1.0 109.795 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 17' ' ' ILE . 23.1 mt -131.2 155.27 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 1.0 110.648 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 18' ' ' ALA . 1.9 m-70 -92.29 -87.96 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.818 . . . . 1.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 191' ' ' HIS . 5.3 t -178.31 167.54 1.9 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.373 -0.931 . . . . 1.0 111.498 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 74.5 m -128.24 163.78 23.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.583 -0.698 . . . . 1.0 109.545 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -131.53 111.02 11.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 1.0 110.215 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.763 0 C-N-CA 118.904 -1.118 . . . . 1.0 110.497 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.584 -1.406 . . . . 1.0 109.584 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 p -128.1 48.08 2.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 1.0 110.059 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.29 41.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.372 -0.83 . . . . 1.0 110.319 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -117.58 -162.9 0.9 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 1.0 110.205 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.9 m -53.11 119.56 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.24 -0.913 . . . . 1.0 110.308 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.405 HG21 ' N ' ' A' ' 7' ' ' ILE . 23.0 mm -79.56 148.92 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.83 . . . . 1.0 110.39 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.2 pp -119.72 120.47 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 1.0 110.06 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -121.4 115.62 23.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.104 -0.997 . . . . 1.0 110.098 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 10' ' ' ALA . 22.3 ttpt -64.73 166.54 8.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.394 -0.816 . . . . 1.0 110.403 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' N ' ' HG2' ' A' ' 9' ' ' LYS . . . -82.64 147.57 28.47 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.219 -0.926 . . . . 1.0 109.894 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.58 66.43 6.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.45 -0.781 . . . . 1.0 110.519 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.57 130.42 9.74 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -158.63 21.79 0.22 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.189 -1.183 . . . . 1.0 110.483 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.52 49.99 1.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.93 . . . . 1.0 110.133 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.1 pt-20 -72.4 70.62 0.88 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.267 -0.896 . . . . 1.0 110.785 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -112.3 119.41 38.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.533 -1.354 . . . . 1.0 109.79 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.567 ' CG1' ' HB3' ' A' ' 179' ' ' LEU . 10.1 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.533 -1.267 . . . . 1.0 110.421 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -91.15 115.59 28.14 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.731 -0.606 . . . . 1.0 110.532 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.624 ' CZ ' ' CD1' ' A' ' 167' ' ' ILE . 5.0 m-30 -74.52 167.6 21.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 1.0 109.114 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 23' ' ' THR . 1.4 p-10 -117.57 -10.13 10.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.057 -1.027 . . . . 1.0 110.18 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 105.45 -9.28 45.07 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' CD ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -147.04 21.16 1.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.167 -1.196 . . . . 1.0 110.055 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m -115.62 102.81 10.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.0 109.867 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.632 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -67.12 117.46 9.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 1.0 111.015 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.509 ' HE3' HG23 ' A' ' 17' ' ' ILE . 3.4 mmm -106.8 98.56 8.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.689 -1.257 . . . . 1.0 108.27 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' OE1' ' CZ3' ' A' ' 142' ' ' TRP . 4.6 pt-20 -107.84 152.3 24.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.311 -0.868 . . . . 1.0 110.261 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 3.3 m-85 -130.48 124.66 32.49 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.243 -0.983 . . . . 1.0 110.001 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.502 ' CE1' ' HB3' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -97.55 89.64 4.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.567 -0.708 . . . . 1.0 110.287 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -88.67 151.72 22.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 1.0 109.781 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.32 108.4 19.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.172 -0.955 . . . . 1.0 110.666 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.496 ' CG1' ' NE2' ' A' ' 175' ' ' GLN . 19.1 m -135.3 169.35 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 1.0 110.003 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.24 126.06 18.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 1.0 110.314 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 103.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 1.0 110.002 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -58.57 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 1.0 110.489 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 36' ' ' LYS . 3.7 mt-10 -147.67 119.73 8.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.004 . . . . 1.0 110.789 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER 69.68 145.03 0.05 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.314 -0.867 . . . . 1.0 111.177 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.5 ' CB ' ' OD1' ' A' ' 136' ' ' ASP . . . -88.92 -37.58 15.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.764 . . . . 1.0 108.97 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.565 ' O ' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -106.94 155.42 19.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 1.0 110.091 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.55 ' CB ' ' O ' ' A' ' 38' ' ' LEU . 31.8 tt0 160.71 -75.63 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.949 0.88 . . . . 1.0 109.18 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.515 ' N ' ' HG2' ' A' ' 39' ' ' GLN . 5.7 m -157.03 119.15 3.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.19 0.519 . . . . 1.0 110.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -103.67 163.3 12.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 1.0 110.439 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.507 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 59.1 m-70 -139.07 132.84 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 1.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.509 ' HB2' ' CB ' ' A' ' 107' ' ' ALA . 93.5 m-85 -135.24 115.44 13.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.57 -0.706 . . . . 1.0 109.625 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 mp0 -123.72 144.19 49.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.823 -1.173 . . . . 1.0 109.756 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.569 ' HB2' ' CG1' ' A' ' 170' ' ' VAL . 0.8 OUTLIER -178.38 159.39 1.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.393 -0.923 . . . . 1.0 110.882 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.481 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 1.0 OUTLIER -123.49 154.38 39.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.509 ' HA ' ' O ' ' A' ' 166' ' ' CYS . 1.9 pt -148.14 156.01 9.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 117.907 -1.517 . . . . 1.0 112.045 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.621 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -105.94 86.45 2.38 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 176.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.568 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -75.27 153.36 38.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.125 -1.03 . . . . 1.0 112.841 -175.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 3.2 mm-40 -143.48 1.97 1.23 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.434 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.39 128.78 24.18 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.047 -1.033 . . . . 1.0 110.285 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.511 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 58.3 p -62.88 -15.4 54.72 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.379 -0.826 . . . . 1.0 110.844 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.513 ' HG2' ' N ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -129.82 135.65 48.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.846 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 159.33 137.14 2.17 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -90.84 126.24 35.97 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.051 -1.264 . . . . 1.0 108.797 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.582 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.25 -34.32 6.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.067 0.766 . . . . 1.0 113.067 -176.298 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.618 ' CB ' ' HB2' ' A' ' 71' ' ' LEU . 3.1 tt -142.76 151.91 41.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.018 -1.676 . . . . 1.0 113.338 -175.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.488 ' O ' ' HB2' ' A' ' 142' ' ' TRP . 9.6 t-105 -162.88 107.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 141' ' ' LEU . 0.2 OUTLIER -114.35 137.27 52.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.661 -1.274 . . . . 1.0 111.023 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.89 -179.64 16.2 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.37 -1.892 . . . . 1.0 108.37 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 13.6 tttp -118.54 54.08 0.96 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.885 -1.362 . . . . 1.0 110.299 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.47 -142.99 16.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mp 48.23 -152.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -1.102 . . . . 1.0 110.321 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 43.1 mt-10 -139.68 13.21 2.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 1.0 110.345 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER 171.0 64.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 1.0 108.949 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.57 140.17 49.0 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.182 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.62 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -56.49 164.89 1.25 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.634 -0.666 . . . . 1.0 110.796 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 1.1 t80 169.62 -118.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.829 -0.544 . . . . 1.0 109.798 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.629 ' CG1' ' CE1' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -130.06 172.88 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.734 -1.229 . . . . 1.0 111.001 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' C ' ' HG ' ' A' ' 71' ' ' LEU . . . -174.95 174.67 2.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.692 -0.63 . . . . 1.0 109.636 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.618 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 70.8 mt -152.43 117.59 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.92 -1.113 . . . . 1.0 109.146 -178.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -132.79 171.07 14.37 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 1.0 112.011 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.56 ' CG1' ' CG1' ' A' ' 78' ' ' VAL . 30.7 mt -121.86 139.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.476 -0.765 . . . . 1.0 111.559 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.548 ' CG1' ' CZ ' ' A' ' 92' ' ' ARG . 11.7 p -141.43 144.66 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.675 -0.64 . . . . 1.0 110.112 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 52.94 27.07 5.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.142 -0.974 . . . . 1.0 110.614 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 80.42 14.32 80.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 7.5 m-85 -126.64 148.52 49.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 1.0 110.071 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.582 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -99.15 168.05 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.06 -1.025 . . . . 1.0 109.757 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 22.9 pt20 -160.17 123.23 3.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.098 -1.001 . . . . 1.0 110.944 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.564 ' CE ' HD22 ' A' ' 91' ' ' LEU . 5.4 tmm? -86.83 113.61 22.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.38 -0.825 . . . . 1.0 109.119 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.585 ' SD ' ' CE1' ' A' ' 153' ' ' HIS . 2.2 ptt? -100.94 141.12 34.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 1.0 110.765 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.629 ' CE1' ' CG1' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -120.19 105.43 10.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 1.0 110.583 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 6.4 t0 -120.86 40.38 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 1.0 109.901 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -39.17 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.569 -0.707 . . . . 1.0 112.132 -178.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -142.8 -50.34 0.04 OUTLIER Glycine 0 N--CA 1.494 2.527 0 C-N-CA 118.862 -1.637 . . . . 1.0 110.83 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.41 ' C ' ' HG3' ' A' ' 87' ' ' LYS . 1.1 m -173.7 22.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -1.2 . . . . 1.0 110.717 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.562 ' CB ' ' HB3' ' A' ' 128' ' ' SER . 0.0 OUTLIER -129.99 80.91 70.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 1.0 109.292 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 42.5 Cg_endo -68.92 89.66 0.44 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.025 1.54 . . . . 1.0 111.192 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -75.18 155.23 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -127.99 119.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.321 -1.487 . . . . 1.0 110.801 178.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.597 HD21 ' HA ' ' A' ' 125' ' ' THR . 10.6 mp -112.73 69.25 0.69 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.548 ' CZ ' ' CG1' ' A' ' 74' ' ' VAL . 4.6 mtt180 -56.78 178.01 0.07 Allowed 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.668 -1.213 . . . . 1.0 109.822 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.483 ' HA ' ' CD1' ' A' ' 124' ' ' ILE . 3.0 t -95.68 169.57 9.93 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.693 -0.629 . . . . 1.0 110.16 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.503 HG22 ' HB1' ' A' ' 122' ' ' ALA . 14.0 t -121.22 16.46 11.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 1.0 109.062 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.515 ' CG2' ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.84 160.56 60.32 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.661 -0.649 . . . . 1.0 109.331 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.515 ' HD2' ' CG2' ' A' ' 95' ' ' VAL . 44.3 Cg_endo -70.06 138.48 36.95 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.859 1.452 . . . . 1.0 110.358 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.482 ' CG2' ' O ' ' A' ' 76' ' ' GLY . 2.7 tp -121.53 -30.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.096 -1.002 . . . . 1.0 110.706 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 11.2 p30 -73.7 57.45 0.58 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 1.0 109.544 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 99' ' ' THR . 16.8 m -114.12 19.77 16.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.563 -0.711 . . . . 1.0 110.282 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 46.7 22.28 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 1.0 110.921 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.475 ' HB2' HG23 ' A' ' 99' ' ' THR . 0.1 OUTLIER -115.32 144.94 43.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.056 -1.028 . . . . 1.0 110.1 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.621 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 7.5 m95 -59.46 95.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 1.0 109.881 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 104' ' ' HIS . 26.5 m -94.09 164.7 12.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.156 -0.965 . . . . 1.0 109.485 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.507 ' N ' HG22 ' A' ' 103' ' ' THR . 40.6 t-80 -116.34 147.64 41.39 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.258 -0.901 . . . . 1.0 108.614 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.468 HD12 HD11 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -134.97 152.74 33.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.126 -0.984 . . . . 1.0 109.365 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.534 ' O ' HD23 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -138.57 146.23 41.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.8 -1.188 . . . . 1.0 110.329 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 43' ' ' PHE . . . -143.93 92.35 2.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 1.0 110.675 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.598 ' CZ ' ' OG ' ' A' ' 115' ' ' SER . 47.9 p90 -112.18 107.53 16.45 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.056 -1.058 . . . . 1.0 109.014 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.575 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -109.67 130.66 55.49 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.969 -178.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.52 ' O ' ' CG ' ' A' ' 111' ' ' GLN . 4.2 t -104.5 102.15 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.415 -0.803 . . . . 1.0 109.506 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.534 ' HA ' ' NH2' ' A' ' 109' ' ' ARG . 10.0 pt20 38.65 100.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.581 0.705 . . . . 1.0 112.469 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.538 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 1.1 ptt85 70.18 -50.0 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 1.0 111.644 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.6 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -81.49 112.09 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.785 -1.197 . . . . 1.0 110.019 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.575 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -103.39 159.65 16.9 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.144 -1.027 . . . . 1.0 111.732 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.598 ' OG ' ' CZ ' ' A' ' 108' ' ' TYR . 1.0 OUTLIER -137.35 151.93 49.14 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.835 -0.803 . . . . 1.0 109.656 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -138.33 153.6 48.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.083 -1.011 . . . . 1.0 109.406 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.596 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 1.1 mt-30 -158.28 111.32 2.38 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.768 -1.173 . . . . 1.0 111.644 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 90.7 t -71.29 97.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 64.54 43.12 97.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 1.0 109.509 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.9 OUTLIER 61.84 36.53 15.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -1.136 . . . . 1.0 110.713 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -96.29 -162.93 1.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.123 -0.985 . . . . 1.0 110.791 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.503 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -43.2 118.17 2.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 1.0 109.246 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 47.7 Cg_endo -73.27 115.22 4.26 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.068 1.562 . . . . 1.0 112.436 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.54 ' CB ' ' O ' ' A' ' 92' ' ' ARG . 4.1 mp -91.23 102.08 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.597 ' HA ' HD21 ' A' ' 91' ' ' LEU . 15.9 p -116.96 179.93 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.502 1.144 . . . . 1.0 112.874 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.432 ' C ' ' OG ' ' A' ' 127' ' ' SER . . . 169.42 -173.2 43.74 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 106.667 -2.573 . . . . 1.0 106.667 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.6 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -160.46 162.03 33.04 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.471 -1.605 . . . . 1.0 110.686 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.562 ' HB3' ' CB ' ' A' ' 87' ' ' LYS . 19.8 m -111.21 161.31 25.69 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.148 -0.97 . . . . 1.0 110.222 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.547 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.7 Cg_endo -68.16 78.32 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.972 1.511 . . . . 1.0 108.811 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.547 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.4 mt -12.99 131.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.596 0.712 . . . . 1.0 112.815 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.45 ' O ' ' HB1' ' A' ' 132' ' ' ALA . . . 161.85 99.62 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' O ' ' CG2' ' A' ' 133' ' ' THR . . . 173.68 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.459 -1.024 . . . . 1.0 109.716 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 132' ' ' ALA . 5.7 t 42.69 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.465 0.65 . . . . 1.0 110.779 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 133' ' ' THR . 0.0 OUTLIER 40.0 26.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 1.0 110.704 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.545 ' O ' ' CG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -89.87 36.62 0.86 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.118 -0.989 . . . . 1.0 109.5 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.5 ' OD1' ' CB ' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -51.37 171.03 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.053 -1.029 . . . . 1.0 109.076 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 137' ' ' THR . 3.0 t -113.16 133.41 55.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.037 -1.039 . . . . 1.0 109.748 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 140' ' ' ALA . 28.9 p-10 -84.67 30.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 1.0 110.32 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 44.84 24.1 0.68 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.502 ' HB3' ' CE1' ' A' ' 28' ' ' HIS . . . -116.75 151.67 35.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.146 . . . . 1.0 109.839 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.597 ' CD1' ' CD2' ' A' ' 57' ' ' LEU . 11.9 tp -154.22 150.05 27.65 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.482 -0.887 . . . . 1.0 110.639 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.624 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 8.0 m95 -126.48 118.19 24.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.074 -1.454 . . . . 1.0 107.074 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 1.1 tt -125.59 120.01 29.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 117.812 -1.555 . . . . 1.0 112.651 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 124.76 8.21 5.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.515 ' HA2' HD22 ' A' ' 55' ' ' LEU . . . 136.66 -134.34 7.06 Favored Glycine 0 C--N 1.291 -1.923 0 C-N-CA 119.007 -1.568 . . . . 1.0 109.848 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.582 ' HE2' ' CD2' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -170.74 158.94 6.27 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.424 -0.911 . . . . 1.0 111.712 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -92.23 -14.88 28.29 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -143.5 51.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.576 HD13 ' CB ' ' A' ' 146' ' ' MET . 10.0 tp -65.5 49.3 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.878 0.696 . . . . 1.0 112.878 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.5 p -73.83 -19.67 60.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 105.167 -2.16 . . . . 1.0 105.167 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.535 ' CG1' HD11 ' A' ' 149' ' ' LEU 0.267 3.9 p -61.55 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.588 -1.187 . . . . 1.0 109.909 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.642 ' CB ' ' CD2' ' A' ' 159' ' ' TYR . . . 53.77 20.15 2.16 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.408 -1.432 . . . . 1.0 110.195 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.585 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 48.1 m80 32.98 -85.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.83 -0.544 . . . . 1.0 112.323 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ALA . 2.9 ptpp? -134.67 -29.83 1.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 1.0 113.082 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.684 ' HG ' ' CD2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -60.34 138.44 91.99 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.684 -1.26 . . . . 1.0 109.078 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.553 ' N ' HD12 ' A' ' 155' ' ' LEU . 56.4 Cg_endo -81.54 -92.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.902 1.475 . . . . 1.0 114.642 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -55.03 -47.56 74.6 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.045 1.869 . . . . 1.0 116.045 -174.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.591 ' CB ' ' CD1' ' A' ' 155' ' ' LEU . . . -41.57 -44.19 2.94 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 120.731 1.605 . . . . 1.0 108.987 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.684 ' CD2' ' HG ' ' A' ' 155' ' ' LEU . 30.6 m-85 -84.39 -25.67 28.92 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.632 -1.227 . . . . 1.0 108.572 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.545 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -78.19 -3.28 41.85 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.336 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.526 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.2 m -135.02 82.81 1.98 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.19 166.46 0.01 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.653 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 12.9 t80 -65.79 143.56 57.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.394 . . . . 1.0 112.046 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.612 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 4.6 mt -122.02 85.14 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.653 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.33 -156.41 11.75 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 48' ' ' LYS . 1.7 m -127.73 142.34 51.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.529 -0.983 . . . . 1.0 110.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.624 ' CD1' ' CZ ' ' A' ' 19' ' ' PHE . 3.3 mt -126.78 147.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.755 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.478 ' CG ' ' N ' ' A' ' 169' ' ' ASP . 0.2 OUTLIER -160.28 170.79 20.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 1.0 110.231 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.478 ' N ' ' CG ' ' A' ' 168' ' ' ARG . 1.3 m-20 41.71 67.83 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 1.0 109.852 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.569 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 33.1 m -124.38 126.47 72.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 O-C-N 121.063 -1.023 . . . . 1.0 109.895 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.532 ' CG2' ' O ' ' A' ' 175' ' ' GLN . 0.3 OUTLIER -134.67 151.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.889 -1.125 . . . . 1.0 111.666 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.566 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 2.4 p -134.32 108.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.553 ' C ' ' HG3' ' A' ' 174' ' ' ARG . 68.6 m-20 59.98 67.92 0.82 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.492 -1.67 . . . . 1.0 106.492 -176.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.553 ' HG3' ' C ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 35.34 28.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.473 -0.785 . . . . 1.0 111.633 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 8.6 mt-30 -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.294 -0.879 . . . . 1.0 109.644 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' CD2' ' A' ' 178' ' ' HIS . 18.3 tt0 -78.1 107.76 10.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 1.0 110.619 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 15.3 mt -90.0 85.24 6.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 1.0 110.53 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.577 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 1.8 m170 -56.96 114.42 2.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 1.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.596 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 3.6 mm? -59.3 -38.28 79.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.355 -0.841 . . . . 1.0 111.767 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.402 HG22 HD13 ' A' ' 17' ' ' ILE . 56.1 t -85.21 -39.62 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.196 0.813 . . . . 1.0 113.196 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 14.2 mt-10 -57.78 -49.51 76.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.463 -1.398 . . . . 1.0 110.913 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 31.9 m-20 -87.54 -19.01 28.49 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.461 -0.774 . . . . 1.0 110.928 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.596 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -60.57 -34.95 74.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.52 -1.272 . . . . 1.0 108.452 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.2 mt -50.83 -22.76 2.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.715 -0.615 . . . . 1.0 109.805 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -51.2 -22.47 2.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.172 -0.955 . . . . 1.0 108.894 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.502 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 2.0 t-20 -99.52 156.13 35.74 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.502 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 39.0 Cg_endo -65.17 -56.49 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.238 1.125 . . . . 1.0 110.948 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 189' ' ' ILE . 5.8 t -103.11 146.49 28.3 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.594 -0.691 . . . . 1.0 110.375 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 188' ' ' THR . 2.9 mp -139.99 124.29 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 1.0 110.349 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 20.8 mt -109.56 159.36 17.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 1.0 109.559 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -101.61 -81.68 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.832 -1.168 . . . . 1.0 111.075 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -169.66 158.51 7.67 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.052 -1.03 . . . . 1.0 110.098 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.8 m -127.09 156.04 42.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 1.0 110.431 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -168.15 98.07 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.275 -0.891 . . . . 1.0 110.052 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.59 0 C-N-CA 118.701 -1.199 . . . . 1.0 110.537 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.306 -1.518 . . . . 1.0 109.306 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER -55.06 -165.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -1.174 . . . . 1.0 110.162 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 4' ' ' LYS . 2.9 tt0 -162.78 -63.12 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 1.0 110.311 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 3' ' ' GLU . 7.0 tttt 66.75 139.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 1.0 110.241 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 5' ' ' VAL . 35.2 m -89.05 141.14 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 1.0 110.15 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -139.17 92.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.922 . . . . 1.0 110.35 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 mp -51.18 91.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 1.0 110.2 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 6' ' ' ILE . 13.1 tt0 -49.92 130.31 21.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.887 . . . . 1.0 110.173 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -112.02 144.02 42.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 1.0 110.11 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.5 132.5 52.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 1.0 110.291 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.28 47.61 1.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.735 . . . . 1.0 110.378 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.08 100.41 0.9 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.894 -1.282 . . . . 1.0 109.894 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -114.96 -30.88 6.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -1.145 . . . . 1.0 109.67 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -140.0 60.34 1.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.403 -0.81 . . . . 1.0 109.614 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.595 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.0 pt-20 -60.3 71.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.574 -0.704 . . . . 1.0 110.661 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -81.21 158.85 24.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.22 -1.55 . . . . 1.0 110.481 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.503 ' CG2' ' HE2' ' A' ' 25' ' ' MET . 12.3 mm -119.78 116.45 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 1.0 110.224 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 191' ' ' HIS . . . -81.12 122.73 27.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.418 -0.801 . . . . 1.0 110.537 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.599 ' CZ ' HD12 ' A' ' 167' ' ' ILE . 3.0 m-85 -86.15 166.97 15.34 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.598 -0.89 . . . . 1.0 108.598 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -127.37 3.07 6.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.84 -1.162 . . . . 1.0 111.083 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 99.88 -18.87 55.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.326 -1.51 . . . . 1.0 109.326 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 14.3 ttt180 -118.79 22.39 12.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.293 -1.122 . . . . 1.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 172.96 12.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 1.0 110.873 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.656 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -166.04 87.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.579 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 26.8 mtt -90.34 101.39 14.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.658 -1.276 . . . . 1.0 110.517 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.605 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 8.8 pt-20 -83.08 110.57 18.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.243 -0.91 . . . . 1.0 108.657 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.579 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 47.8 m-85 -100.95 99.24 9.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.975 -1.078 . . . . 1.0 110.387 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.461 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -93.14 103.35 15.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 1.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -94.96 164.58 12.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 1.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.3 94.36 9.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.283 -0.885 . . . . 1.0 110.405 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.488 HG21 ' CA ' ' A' ' 139' ' ' GLY . 0.0 OUTLIER -137.75 165.91 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.317 -0.864 . . . . 1.0 109.779 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.01 135.98 46.93 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.37 -0.831 . . . . 1.0 110.192 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -46.44 104.66 0.05 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.321 -0.862 . . . . 1.0 109.751 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 35' ' ' GLU . 6.8 p -77.73 6.68 6.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.298 -0.876 . . . . 1.0 110.545 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 34' ' ' SER . 1.3 tp10 71.13 1.69 3.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 1.0 110.165 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 18.7 pttt -83.73 152.41 24.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.126 -0.984 . . . . 1.0 109.62 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 135' ' ' LEU . . . -146.59 -78.35 0.17 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.022 -1.049 . . . . 1.0 109.887 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.625 ' O ' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.5 144.76 43.99 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.384 -0.926 . . . . 1.0 109.406 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.621 ' CB ' ' O ' ' A' ' 38' ' ' LEU . 1.3 tt0 151.98 -90.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.935 -0.765 . . . . 1.0 108.935 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -169.92 157.91 6.96 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.154 -1.018 . . . . 1.0 112.302 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -130.12 139.22 50.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 1.0 109.886 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.517 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 71.1 m-70 -110.45 125.71 53.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.319 -0.863 . . . . 1.0 109.95 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.552 ' CE2' HG21 ' A' ' 172' ' ' VAL . 26.9 m-85 -140.16 119.34 12.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.921 . . . . 1.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -127.48 151.54 48.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.749 -1.22 . . . . 1.0 110.817 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.522 ' HB2' ' CG1' ' A' ' 170' ' ' VAL . 0.9 OUTLIER 178.86 150.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 1.0 110.991 179.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.5 m -114.06 150.25 34.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.521 ' CD1' HD13 ' A' ' 97' ' ' ILE . 1.4 pt -144.38 153.3 15.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 117.821 -1.552 . . . . 1.0 112.583 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.604 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.5 OUTLIER -109.82 83.07 1.69 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.43 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.491 ' OG1' HG12 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -73.65 148.06 43.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.266 1.031 . . . . 1.0 112.808 -175.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 5.3 mm-40 -124.62 -18.49 5.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.711 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.85 130.3 46.71 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.729 -0.607 . . . . 1.0 109.677 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.515 HG21 ' CA ' ' A' ' 76' ' ' GLY . 1.9 p -60.92 -8.08 2.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 1.0 111.073 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.437 ' CG ' ' HA ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -130.66 134.19 46.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.71 -1.244 . . . . 1.0 110.673 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.86 135.8 1.89 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.203 -1.559 . . . . 1.0 109.203 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.703 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -92.99 127.33 38.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.632 -1.511 . . . . 1.0 109.291 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.583 HD11 ' CG2' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -96.67 -27.05 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.715 . . . . 1.0 112.408 -176.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.596 ' CD2' ' CD1' ' A' ' 141' ' ' LEU . 6.0 tt -144.28 146.18 32.46 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.246 -1.534 . . . . 1.0 112.58 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.556 ' CH2' HG22 ' A' ' 151' ' ' VAL . 5.4 t-105 -159.6 116.33 2.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.782 -0.574 . . . . 1.0 109.538 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.45 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 0.9 OUTLIER -116.47 120.47 38.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.085 -1.01 . . . . 1.0 110.316 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.09 164.47 27.34 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HA ' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -119.07 -89.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -1.23 . . . . 1.0 110.899 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.38 145.01 17.64 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.828 -1.309 . . . . 1.0 109.828 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tp 48.22 -165.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -1.135 . . . . 1.0 110.277 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -109.69 27.36 9.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 1.0 109.933 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -169.25 58.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 1.0 109.842 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -148.83 93.46 2.12 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.252 -0.979 . . . . 1.0 110.457 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 66' ' ' SER . 1.6 t0 55.13 150.49 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.568 -0.707 . . . . 1.0 110.645 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.567 ' CE1' ' CB ' ' A' ' 83' ' ' ASP . 2.4 p90 175.24 173.84 0.25 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 120.692 -1.255 . . . . 1.0 110.461 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 82' ' ' TYR . 1.5 mt -132.32 167.47 26.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.151 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.545 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -171.02 178.12 3.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.216 -0.927 . . . . 1.0 110.874 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 83.2 mt -146.66 129.88 16.58 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.604 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -150.77 165.11 34.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.833 -1.167 . . . . 1.0 112.559 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 5.9 mt -104.54 137.94 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.706 0.765 . . . . 1.0 110.654 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.516 ' CG1' ' OE1' ' A' ' 79' ' ' GLN . 2.3 p -139.87 118.63 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.738 -0.601 . . . . 1.0 110.097 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 2.2 m-20 67.26 3.65 3.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 1.0 111.235 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.515 ' CA ' HG21 ' A' ' 52' ' ' THR . . . 113.97 4.17 22.78 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.343 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.7 m-85 -131.41 126.67 35.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.053 -1.263 . . . . 1.0 109.701 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -59.43 -173.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.929 -1.107 . . . . 1.0 110.461 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 9.0 pt20 -176.33 101.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.019 0.914 . . . . 1.0 110.133 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.62 ' CE ' ' O ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -78.47 126.01 30.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 5.0 ptt? -122.8 146.48 47.5 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.106 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.701 ' CZ ' ' CG1' ' A' ' 89' ' ' VAL . 4.3 p90 -129.77 120.56 25.25 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.888 -1.525 . . . . 1.0 110.519 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.567 ' CB ' ' CE1' ' A' ' 68' ' ' TYR . 12.7 t70 -94.05 47.4 1.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.313 0.578 . . . . 1.0 110.568 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.61 HD23 ' CD1' ' A' ' 82' ' ' TYR . 0.5 OUTLIER -62.83 -10.8 14.46 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -144.44 41.55 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.959 -1.257 . . . . 1.0 109.959 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 77.49 -35.28 0.21 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.5 -1.0 . . . . 1.0 111.516 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 87' ' ' LYS . 5.8 mmmm -102.51 103.84 34.32 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.767 -1.208 . . . . 1.0 110.362 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.491 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 51.6 Cg_endo -74.46 116.78 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.191 1.627 . . . . 1.0 111.234 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.701 ' CG1' ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -71.91 172.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 178.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.567 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 1.2 t -144.27 107.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.635 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.549 ' CD1' ' HA ' ' A' ' 125' ' ' THR . 3.0 mm? -95.23 90.11 5.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.293 -1.743 . . . . 1.0 106.293 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 30.7 mtp180 -73.22 154.09 40.38 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.988 -1.085 . . . . 1.0 110.271 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.3 t -68.62 143.6 54.77 Favored 'General case' 0 C--N 1.288 -2.075 0 O-C-N 120.986 -1.071 . . . . 1.0 109.925 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.54 ' HB ' ' CD1' ' A' ' 124' ' ' ILE . 4.7 t -94.25 21.09 7.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.756 -1.215 . . . . 1.0 110.035 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.582 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 19.6 t -135.16 149.08 69.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 1.0 109.956 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.582 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 40.6 Cg_endo -66.53 134.39 35.43 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.681 1.358 . . . . 1.0 110.123 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.521 HD13 ' CD1' ' A' ' 47' ' ' ILE . 1.8 tt -125.15 -26.36 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 1.0 110.627 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.476 ' N ' HG22 ' A' ' 97' ' ' ILE . 8.7 p30 -70.73 58.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.212 -0.93 . . . . 1.0 110.475 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 7.8 t -130.91 22.31 4.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.339 -0.851 . . . . 1.0 109.956 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 m120 56.84 24.79 9.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.107 -0.996 . . . . 1.0 110.733 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.528 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 15.2 m80 -113.23 152.97 29.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.03 . . . . 1.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.604 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 15.6 m95 -74.54 97.21 3.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.095 -1.003 . . . . 1.0 109.93 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 46' ' ' SER . 24.7 m -93.1 141.41 28.44 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.203 -0.999 . . . . 1.0 108.713 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 119' ' ' GLY . 25.5 t60 -98.49 142.49 30.04 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.425 -0.91 . . . . 1.0 108.566 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.484 HG23 HD11 ' A' ' 105' ' ' ILE . 0.4 OUTLIER -140.78 156.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.964 -1.085 . . . . 1.0 110.218 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.467 ' O ' HD21 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -149.21 128.62 13.0 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.426 -0.796 . . . . 1.0 110.016 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 116' ' ' LEU . . . -115.25 102.57 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.208 -0.933 . . . . 1.0 110.979 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 108' ' ' TYR . 2.9 p90 -117.38 109.4 16.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 1.0 109.381 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.625 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.4 OUTLIER -103.49 142.86 33.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.35 -0.844 . . . . 1.0 110.848 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.593 ' N ' ' HD2' ' A' ' 109' ' ' ARG . 1.5 t -127.91 122.46 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.466 -0.771 . . . . 1.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 113' ' ' GLU . 23.1 mt-30 37.83 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 1.0 111.037 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.53 ' O ' ' OH ' ' A' ' 82' ' ' TYR . 11.4 mmt85 65.34 -56.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.356 -0.84 . . . . 1.0 111.738 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.592 ' N ' ' HB3' ' A' ' 127' ' ' SER . 0.0 OUTLIER -67.1 114.72 6.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.945 0.878 . . . . 1.0 111.794 -176.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -100.25 159.19 19.39 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.62 ' O ' ' CE ' ' A' ' 80' ' ' MET . 12.5 t -141.04 148.84 40.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.527 -0.984 . . . . 1.0 109.925 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.539 ' C ' ' HG3' ' A' ' 117' ' ' GLN . 1.0 OUTLIER -145.81 131.15 18.58 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.036 -1.04 . . . . 1.0 110.042 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.539 ' HG3' ' C ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -135.37 145.3 47.21 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.937 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.554 HG13 ' CG2' ' A' ' 95' ' ' VAL . 0.3 OUTLIER -89.81 113.68 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 52.14 46.09 56.73 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER 65.43 43.44 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -1.085 . . . . 1.0 111.38 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 2.2 mt-10 -105.5 -162.14 0.85 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.251 -0.905 . . . . 1.0 110.643 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.415 ' HB1' HG22 ' A' ' 94' ' ' THR . . . -49.92 115.87 5.68 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.237 -0.915 . . . . 1.0 109.558 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.53 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 46.2 Cg_endo -73.57 119.08 5.75 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.879 1.462 . . . . 1.0 111.672 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -86.32 118.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.549 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 12.3 p -126.73 171.65 11.01 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.606 -1.237 . . . . 1.0 113.628 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.534 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 169.51 153.62 8.62 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.513 -2.635 . . . . 1.0 106.513 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.592 ' HB3' ' N ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -119.71 163.48 17.36 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.607 -1.525 . . . . 1.0 111.028 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -67.64 -176.85 0.28 Allowed Pre-proline 0 C--N 1.3 -1.579 0 C-N-CA 119.906 -0.717 . . . . 1.0 109.207 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 131' ' ' GLY . 48.1 Cg_endo -74.59 42.44 0.8 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.548 1.288 . . . . 1.0 110.24 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.479 ' HG ' ' C ' ' A' ' 129' ' ' PRO . 0.1 OUTLIER 34.63 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.841 0.829 . . . . 1.0 109.991 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -131.9 106.75 0.68 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.958 -1.257 . . . . 1.0 109.958 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.518 ' O ' ' CG2' ' A' ' 133' ' ' THR . . . 178.17 -54.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.5 -1.0 . . . . 1.0 109.88 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' A' ' 132' ' ' ALA . 7.4 t 39.73 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.462 -0.773 . . . . 1.0 111.027 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -161.58 111.97 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.056 -1.028 . . . . 1.0 110.714 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -166.73 135.32 2.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 1.0 109.369 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 135' ' ' LEU . 14.2 m-20 -140.47 179.58 6.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.331 -0.856 . . . . 1.0 109.415 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 137' ' ' THR . 4.8 t -115.41 132.62 56.56 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.052 -1.03 . . . . 1.0 109.883 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.568 ' HB3' ' HA ' ' A' ' 61' ' ' LYS . 7.9 p-10 -78.77 13.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 1.0 110.44 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.488 ' CA ' HG21 ' A' ' 31' ' ' VAL . . . 54.69 18.38 10.83 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.283 -1.927 . . . . 1.0 108.283 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.512 ' CB ' ' OD2' ' A' ' 138' ' ' ASP . . . -136.47 170.34 16.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.443 -1.034 . . . . 1.0 109.937 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.596 ' CD1' ' CD2' ' A' ' 57' ' ' LEU . 12.3 tp -160.83 155.51 23.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.284 -0.885 . . . . 1.0 110.702 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.649 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 9.9 m95 -131.32 136.76 48.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.58 ' CD1' ' O ' ' A' ' 56' ' ' ILE . 5.1 tp -140.97 123.74 16.15 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.593 -1.643 . . . . 1.0 113.321 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.32 1.05 12.63 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 110.098 -1.201 . . . . 1.0 110.098 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.471 ' HA2' HD23 ' A' ' 55' ' ' LEU . . . 144.05 -129.02 3.48 Favored Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.902 -1.679 . . . . 1.0 108.902 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.601 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -171.2 126.63 0.67 Allowed 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.358 -0.937 . . . . 1.0 111.747 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -12.69 27.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 1.0 108.872 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.578 ' N ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -152.73 61.59 0.8 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 146' ' ' MET . 10.0 tp -64.39 44.33 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.386 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 148' ' ' ARG . 83.7 p -55.0 -28.83 55.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.587 ' CG1' HD11 ' A' ' 149' ' ' LEU 0.29 6.2 p -62.76 -135.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 114.414 -1.267 . . . . 1.0 108.137 177.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.593 ' HA ' HD22 ' A' ' 155' ' ' LEU . . . 54.56 18.06 1.87 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.936 -1.102 . . . . 1.0 110.861 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -79.58 0.18 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.942 -1.099 . . . . 1.0 112.928 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.491 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -52.03 -14.04 0.37 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.0 112.234 -177.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.643 HD22 ' CD2' ' A' ' 159' ' ' TYR . 1.6 pp -99.61 168.75 9.06 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.842 -1.162 . . . . 1.0 110.337 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 43.6 Cg_endo -68.33 -176.73 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.55 1.29 . . . . 1.0 113.228 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -62.05 -13.95 31.29 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.977 -0.556 . . . . 1.0 112.27 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.475 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -41.13 -35.12 0.53 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 1.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.703 ' CE2' ' CD1' ' A' ' 55' ' ' LEU . 5.4 m-85 -83.94 -30.12 26.54 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.32 -0.952 . . . . 1.0 109.766 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -68.67 -8.9 46.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.796 -1.162 . . . . 1.0 108.895 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.504 ' O ' ' O ' ' A' ' 162' ' ' GLY . 1.2 m -128.8 86.43 2.44 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -39.63 164.31 0.01 OUTLIER Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.212 -1.155 . . . . 1.0 110.212 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.656 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 35.9 t80 -79.14 144.03 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.027 -1.278 . . . . 1.0 111.396 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.536 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 2.9 mt -128.98 68.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.656 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -148.83 -162.62 10.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.913 -2.075 . . . . 1.0 107.913 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.51 ' C ' HG13 ' A' ' 167' ' ' ILE . 13.4 m -118.97 148.05 43.4 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.405 -1.644 . . . . 1.0 111.138 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.599 HD12 ' CZ ' ' A' ' 19' ' ' PHE . 3.5 mt -131.95 151.14 34.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.651 -0.656 . . . . 1.0 109.504 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.544 ' HD3' ' N ' ' A' ' 169' ' ' ASP . 0.0 OUTLIER -161.6 151.75 17.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 1.0 110.178 -178.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.544 ' N ' ' HD3' ' A' ' 168' ' ' ARG . 36.1 m-20 56.44 75.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.455 -0.778 . . . . 1.0 109.972 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.522 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 26.9 m -128.32 122.45 57.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.699 -0.801 . . . . 1.0 109.559 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.47 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -132.73 156.59 42.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.459 -0.896 . . . . 1.0 111.124 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.552 HG21 ' CE2' ' A' ' 43' ' ' PHE . 6.6 t -134.35 104.65 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.7 OUTLIER 50.31 40.66 23.05 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.455 -1.403 . . . . 1.0 107.477 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER 72.7 27.68 2.23 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.054 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.529 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 29.0 mt-30 -103.08 177.66 4.78 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.039 -1.038 . . . . 1.0 110.703 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 6.0 tt0 66.12 -105.36 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.826 -0.547 . . . . 1.0 110.923 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 67.01 -58.11 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.301 -0.874 . . . . 1.0 111.232 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.563 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.3 m-70 -80.34 73.73 7.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.763 -1.21 . . . . 1.0 110.135 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 3.6 mt -49.8 -58.85 4.55 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.152 0.977 . . . . 1.0 112.217 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 30.1 t -74.39 -19.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.563 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.5 mt-10 -67.55 -62.26 1.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.351 -1.468 . . . . 1.0 110.002 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -71.84 -19.61 61.95 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 1.0 109.2 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 180' ' ' VAL . . . -68.44 -27.42 66.16 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.508 -0.877 . . . . 1.0 108.81 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 10.5 mt -57.66 -16.46 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 1.0 109.178 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -57.97 -14.61 6.71 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.496 -0.752 . . . . 1.0 109.699 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.434 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 13.0 t30 -127.42 148.88 68.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.52 -0.737 . . . . 1.0 109.1 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.441 ' O ' HG13 ' A' ' 189' ' ' ILE . 46.9 Cg_endo -73.63 -44.81 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.701 1.369 . . . . 1.0 110.81 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.07 103.1 0.7 Allowed 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.637 0.732 . . . . 1.0 110.639 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.452 HG21 HD12 ' A' ' 189' ' ' ILE . 6.5 mt -144.46 98.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.465 ' O ' HG21 ' A' ' 17' ' ' ILE . 33.9 mt -111.92 152.6 27.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 1.0 110.81 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.53 ' O ' ' CB ' ' A' ' 18' ' ' ALA . 8.1 m-70 -95.84 -174.61 3.18 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.469 -0.769 . . . . 1.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.0 t -102.16 153.53 19.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 1.0 110.476 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.4 m -128.97 166.7 18.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.332 -0.855 . . . . 1.0 109.808 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -170.71 98.41 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.968 . . . . 1.0 110.482 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.297 -1.699 0 C-N-CA 118.82 -1.152 . . . . 1.0 110.464 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.9 92.01 2.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -1.133 . . . . 1.0 110.071 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -73.72 66.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 1.0 110.183 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -145.73 36.1 1.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 1.0 110.059 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 5' ' ' VAL . 12.0 p -129.08 112.05 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 1.0 110.332 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 tt -135.44 137.57 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.85 . . . . 1.0 110.0 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 8' ' ' GLU . 5.4 tp -128.98 154.8 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -0.948 . . . . 1.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.443 ' N ' HG13 ' A' ' 7' ' ' ILE . 5.5 tt0 -92.96 121.29 34.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.917 . . . . 1.0 110.074 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 9' ' ' LYS . 9.6 mmtm -49.57 97.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.841 . . . . 1.0 110.247 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.25 139.91 58.11 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.198 -0.939 . . . . 1.0 109.971 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.57 55.23 2.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.478 -0.764 . . . . 1.0 110.47 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.37 100.41 2.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.479 -1.448 . . . . 1.0 109.479 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -137.42 -77.96 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 1.0 110.315 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . 52.34 50.55 18.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 1.0 109.929 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.5 pt-20 -59.81 72.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.749 . . . . 1.0 110.858 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -68.35 158.22 33.98 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.136 -1.603 . . . . 1.0 109.487 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.508 HG23 ' CE ' ' A' ' 25' ' ' MET . 17.3 mm -136.92 108.96 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.027 -1.046 . . . . 1.0 110.579 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 190' ' ' LEU . . . -78.82 138.4 38.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.741 . . . . 1.0 110.234 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.592 ' CZ ' HD12 ' A' ' 167' ' ' ILE . 3.7 m-85 -104.16 175.36 5.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 1.0 109.633 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 1.9 p30 -128.37 -14.43 4.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 1.0 111.084 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 115.51 -13.84 18.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.909 -1.677 . . . . 1.0 108.909 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.91 15.11 4.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.44 -1.035 . . . . 1.0 109.109 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.418 ' OG1' ' OD2' ' A' ' 20' ' ' ASP . 3.1 m -75.63 174.65 9.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.596 -0.69 . . . . 1.0 110.185 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.552 ' OH ' ' N ' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -147.62 103.67 3.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.526 -0.734 . . . . 1.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.586 ' HG3' ' CE2' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -99.35 101.53 12.85 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.774 -1.204 . . . . 1.0 109.186 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.521 ' HG2' ' CE3' ' A' ' 142' ' ' TRP . 14.9 mt-10 -95.88 136.72 35.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 1.0 109.485 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.586 ' CE2' ' HG3' ' A' ' 25' ' ' MET . 69.8 m-85 -131.29 99.05 4.72 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.216 -0.994 . . . . 1.0 110.475 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.45 118.69 37.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 1.0 110.215 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.467 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 12.1 t-20 -140.44 156.73 46.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 1.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.67 149.14 23.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.961 . . . . 1.0 110.142 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.95 -95.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 1.0 109.907 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.86 107.19 4.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.064 . . . . 1.0 110.553 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -65.9 89.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 1.0 110.083 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.16 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -0.832 . . . . 1.0 109.329 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -148.47 -36.14 0.19 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.533 -0.729 . . . . 1.0 109.965 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 136' ' ' ASP . 18.8 mtmt 43.42 54.24 5.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 1.0 110.036 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . 175.43 134.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 1.0 109.986 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.558 ' O ' ' CG ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -138.51 53.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.015 -1.053 . . . . 1.0 110.048 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER 54.68 3.82 0.06 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 179.699 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -171.07 167.87 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.252 -1.53 . . . . 1.0 111.38 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -138.79 116.04 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.513 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 0.3 OUTLIER -89.96 143.67 26.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.118 -0.989 . . . . 1.0 110.956 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.587 ' CE1' ' CG2' ' A' ' 172' ' ' VAL . 51.2 m-85 -138.17 106.85 5.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.637 -0.664 . . . . 1.0 110.074 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 3.5 mt-10 -114.78 145.82 41.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.98 -1.075 . . . . 1.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 0.6 OUTLIER -179.45 152.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.529 -0.868 . . . . 1.0 111.244 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' A' ' 103' ' ' THR . 1.5 m -118.52 152.71 35.46 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 105' ' ' ILE . 2.2 pt -148.34 157.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 117.897 -1.521 . . . . 1.0 112.152 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.609 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 2.5 tttt -113.15 84.3 1.98 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.504 ' OG1' ' CG1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -67.31 147.25 53.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 1.0 111.193 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.659 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 2.3 mm-40 -129.34 6.79 5.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.808 -0.757 . . . . 1.0 111.0 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.629 ' O ' ' CG2' ' A' ' 52' ' ' THR . . . -134.77 -85.97 0.4 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.91 -1.119 . . . . 1.0 110.624 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.629 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.98 -25.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.88 139.03 54.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.716 -0.615 . . . . 1.0 109.419 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 158.67 135.88 1.96 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.436 -1.364 . . . . 1.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.584 ' HA ' ' CB ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -85.33 121.53 28.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 1.0 108.963 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.596 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -96.66 -29.25 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.782 -0.574 . . . . 1.0 112.482 -176.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 6.4 tt -147.73 152.9 38.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.39 -1.444 . . . . 1.0 113.145 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.575 ' CB ' ' SD ' ' A' ' 146' ' ' MET . 4.2 t-105 -162.61 107.26 1.14 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.589 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.51 149.6 42.16 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.13 -0.981 . . . . 1.0 108.784 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 62' ' ' GLY . . . -138.01 39.05 1.64 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.313 -1.422 . . . . 1.0 110.846 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 60' ' ' GLY . 6.7 ttpp 44.38 24.7 0.1 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.907 -1.349 . . . . 1.0 110.293 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.491 ' N ' ' OD2' ' A' ' 138' ' ' ASP . . . 99.4 -139.03 14.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.256 -1.538 . . . . 1.0 109.256 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 57.14 -179.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -1.194 . . . . 1.0 110.67 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 12.0 pt-20 -133.95 35.8 3.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 1.0 110.573 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -179.89 32.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.147 -0.971 . . . . 1.0 109.625 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.43 152.36 30.17 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.401 -0.919 . . . . 1.0 111.492 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.522 ' HA ' ' CH2' ' A' ' 58' ' ' TRP . 70.9 m-20 -96.56 -80.71 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.402 -0.811 . . . . 1.0 109.364 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.591 ' CZ ' ' O ' ' A' ' 84' ' ' LEU . 10.1 m-85 60.17 -59.34 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.259 -0.9 . . . . 1.0 113.159 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' ASP . 5.5 mm -148.01 153.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.839 -1.788 . . . . 1.0 113.566 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 57' ' ' LEU . . . -177.69 166.58 2.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 93.4 mt -150.72 99.83 2.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.445 -1.41 . . . . 1.0 109.945 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -114.06 175.09 5.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.306 -0.871 . . . . 1.0 111.837 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.535 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 20.4 mt -115.34 138.3 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.827 -0.546 . . . . 1.0 110.056 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.475 HG11 ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -141.23 125.3 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 110.516 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 5.9 m-20 62.77 33.98 14.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.335 -0.853 . . . . 1.0 111.739 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.532 ' HA2' ' CG2' ' A' ' 52' ' ' THR . . . 81.43 8.08 87.52 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.741 -1.219 . . . . 1.0 110.41 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -129.36 165.89 20.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.272 . . . . 1.0 109.382 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.596 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -116.05 164.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 1.0 110.679 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.546 ' OE1' ' CG2' ' A' ' 90' ' ' VAL . 6.9 pt20 -149.66 133.3 16.77 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.565 -0.854 . . . . 1.0 111.432 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.547 ' CE ' ' O ' ' A' ' 115' ' ' SER . 6.7 tmm? -99.24 120.12 39.02 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 7.3 ptt? -120.24 143.54 48.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.87 -1.144 . . . . 1.0 111.569 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.635 ' CE2' ' CG1' ' A' ' 89' ' ' VAL . 19.6 p90 -139.85 129.03 23.81 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.531 -1.268 . . . . 1.0 110.905 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 86' ' ' SER . 66.7 t0 -120.45 60.82 0.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.232 1.015 . . . . 1.0 109.378 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.591 ' O ' ' CZ ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -38.35 -35.65 0.19 Allowed 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.705 -179.062 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.28 -54.77 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.527 -1.32 . . . . 1.0 110.887 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 3.4 t -163.28 -22.84 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.393 . . . . 1.0 112.269 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HD2' ' HG3' ' A' ' 129' ' ' PRO . 4.7 mmtp -98.86 100.58 10.02 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.66 -1.275 . . . . 1.0 110.21 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 86' ' ' SER . 47.0 Cg_endo -72.5 141.96 35.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.926 1.487 . . . . 1.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.635 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.97 126.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.546 ' CG2' ' OE1' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -103.93 120.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 117.802 -1.559 . . . . 1.0 110.328 178.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.535 ' CA ' HG22 ' A' ' 124' ' ' ILE . 33.3 mt -113.09 71.94 0.76 Allowed 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 2.9 mtt180 -58.7 179.16 0.09 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.138 0.971 . . . . 1.0 110.822 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.412 ' OG ' HG21 ' A' ' 118' ' ' VAL . 1.6 t -105.82 155.77 18.98 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.721 -0.612 . . . . 1.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.45 ' HB ' HD13 ' A' ' 124' ' ' ILE . 15.2 t -111.19 26.87 10.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 1.0 109.912 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.542 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 8.3 t -133.77 147.38 64.11 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.445 -0.785 . . . . 1.0 109.62 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.542 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.7 Cg_endo -67.47 138.32 45.69 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.629 1.331 . . . . 1.0 110.554 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.504 ' CG1' ' OG1' ' A' ' 49' ' ' THR . 0.6 OUTLIER -126.91 -30.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 1.0 110.686 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.488 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 31.2 p-10 -72.54 62.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 1.0 110.52 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.507 HG21 ' CG ' ' A' ' 101' ' ' HIS . 15.2 t -124.86 13.18 8.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 1.0 109.868 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.471 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 0.7 OUTLIER 62.95 10.6 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.239 -0.913 . . . . 1.0 111.236 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.507 ' CG ' HG21 ' A' ' 99' ' ' THR . 2.6 m-70 -102.51 175.15 5.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.87 -1.143 . . . . 1.0 110.288 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.609 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 27.0 m95 -92.95 105.84 17.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.9 . . . . 1.0 110.074 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 46' ' ' SER . 47.4 m -99.31 171.06 8.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.274 -0.891 . . . . 1.0 109.597 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 119' ' ' GLY . 12.0 t-80 -125.02 130.18 51.81 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.085 -1.009 . . . . 1.0 108.423 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.502 HD11 HD11 ' A' ' 47' ' ' ILE . 1.9 mt -123.46 159.6 27.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.128 -0.982 . . . . 1.0 110.123 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.513 ' O ' HD23 ' A' ' 116' ' ' LEU . 1.8 tppt? -149.84 147.99 28.63 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.184 -1.006 . . . . 1.0 110.039 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.485 ' HB3' ' HE3' ' A' ' 80' ' ' MET . . . -151.52 108.3 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.604 -0.685 . . . . 1.0 109.954 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 20.0 p90 -120.88 105.39 10.65 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.05 -1.06 . . . . 1.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.558 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 3.8 ttp180 -72.17 123.84 23.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.575 -0.703 . . . . 1.0 110.006 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' GLN . 3.6 t -110.08 88.51 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.076 -1.015 . . . . 1.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.573 ' O ' ' O ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER 35.4 103.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.144 0.497 . . . . 1.0 110.934 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.567 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 66.1 -53.71 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.286 -0.884 . . . . 1.0 110.235 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.635 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.6 tt0 -87.08 120.88 28.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.756 -1.215 . . . . 1.0 110.811 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.28 161.83 12.56 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.929 -1.129 . . . . 1.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 15.5 t -136.43 162.11 33.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.307 -1.114 . . . . 1.0 111.174 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 117' ' ' GLN . 1.4 tm? -147.4 139.15 24.11 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.584 ' CG ' ' HB3' ' A' ' 123' ' ' PRO . 3.6 mt-30 -142.83 146.26 33.99 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.686 -1.205 . . . . 1.0 111.67 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 1.8 t -104.19 101.69 12.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.498 -1.667 . . . . 1.0 106.498 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 70.65 33.5 67.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.717 -1.753 . . . . 1.0 108.717 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.27 38.07 26.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.518 -0.99 . . . . 1.0 110.312 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -108.77 -156.97 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.66 -0.65 . . . . 1.0 110.826 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.91 99.66 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.709 -0.62 . . . . 1.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.584 ' HB3' ' CG ' ' A' ' 117' ' ' GLN . 48.5 Cg_endo -73.23 131.36 16.42 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 O-C-N 124.314 1.691 . . . . 1.0 112.009 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.535 HG22 ' CA ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -97.19 101.96 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 176.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 61.4 p -107.07 170.6 7.85 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.154 0.978 . . . . 1.0 112.023 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.66 157.6 18.89 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 107.644 -2.183 . . . . 1.0 107.644 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.635 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -133.63 162.66 31.32 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.866 -1.373 . . . . 1.0 110.275 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 5.0 p -90.08 172.18 7.46 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 1.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.486 ' HG3' ' HD2' ' A' ' 87' ' ' LYS . 51.6 Cg_endo -80.82 36.58 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.728 1.383 . . . . 1.0 109.133 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.503 HD11 ' NH1' ' A' ' 112' ' ' ARG . 1.5 mt 43.8 -162.91 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.5 -0.75 . . . . 1.0 110.307 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.02 -29.69 11.95 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.54 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.438 -1.036 . . . . 1.0 109.747 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -154.4 97.61 2.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 1.0 110.281 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 133' ' ' THR . 1.3 tt0 43.76 -158.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 1.0 110.131 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -160.31 104.08 1.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 1.0 110.348 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -92.55 176.5 6.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 1.0 109.514 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 137' ' ' THR . 3.2 t -138.15 136.58 36.82 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.891 -1.131 . . . . 1.0 110.055 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.491 ' OD2' ' N ' ' A' ' 62' ' ' GLY . 44.9 p-10 -89.06 22.78 2.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 1.0 109.457 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 52.52 18.15 5.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.943 -1.663 . . . . 1.0 108.943 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.461 ' HB2' ' OD2' ' A' ' 138' ' ' ASP . . . -109.63 150.18 28.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 1.0 109.273 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.594 ' CD1' ' CD2' ' A' ' 57' ' ' LEU . 7.4 tp -160.66 156.35 25.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 1.0 111.122 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.522 ' N ' ' HG ' ' A' ' 141' ' ' LEU . 76.5 m95 -131.7 105.43 7.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.919 -1.512 . . . . 1.0 106.919 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 57' ' ' LEU . 3.6 tp -116.95 116.42 27.37 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.24 -1.384 . . . . 1.0 113.602 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 132.29 -1.04 4.86 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 119.668 -1.253 . . . . 1.0 110.638 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.536 ' O ' ' SD ' ' A' ' 146' ' ' MET . . . 154.37 -154.95 25.87 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 117.956 -2.069 . . . . 1.0 109.731 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.593 ' CB ' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -154.05 139.38 17.61 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.254 -0.978 . . . . 1.0 112.941 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.552 ' N ' ' OH ' ' A' ' 24' ' ' TYR . 40.9 tt0 -68.43 -50.91 49.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.582 0.706 . . . . 1.0 109.665 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -116.15 69.8 0.75 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.541 -1.281 . . . . 1.0 107.541 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.593 HD21 ' CB ' ' A' ' 146' ' ' MET . 0.1 OUTLIER -65.33 49.52 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.439 -0.788 . . . . 1.0 112.976 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 148' ' ' ARG . 88.0 p -83.34 -10.08 58.69 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.975 -1.861 . . . . 1.0 105.975 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.535 HG21 ' CZ3' ' A' ' 58' ' ' TRP . 4.9 p -79.86 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 115.227 -0.897 . . . . 1.0 110.336 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.593 ' HB2' ' CG ' ' A' ' 159' ' ' TYR . . . 53.18 38.17 26.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.326 -1.484 . . . . 1.0 108.546 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.488 ' NE2' ' CG ' ' A' ' 67' ' ' ASP . 59.8 m170 3.92 -95.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.771 1.397 . . . . 1.0 114.771 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.478 ' CE ' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -98.31 26.59 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 1.0 112.739 -176.535 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.634 ' CD2' ' HB1' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -156.55 131.81 5.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 120.649 -1.282 . . . . 1.0 110.031 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 160' ' ' SER . 55.1 Cg_endo -92.14 -66.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.793 1.418 . . . . 1.0 113.747 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.586 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.49 -56.9 15.43 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 114.403 1.26 . . . . 1.0 114.403 -176.062 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.634 ' HB1' ' CD2' ' A' ' 155' ' ' LEU . . . -41.38 -41.23 1.93 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.44 -1.413 . . . . 1.0 108.103 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.606 ' CE1' HD21 ' A' ' 155' ' ' LEU . 21.8 m-85 -83.27 -32.13 26.57 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.957 -1.097 . . . . 1.0 108.141 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -67.71 -10.51 53.15 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.107 -1.037 . . . . 1.0 109.079 178.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 162' ' ' GLY . 1.4 m -129.56 99.33 5.13 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -49.76 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.658 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 19.3 t80 -79.76 148.19 31.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -1.175 . . . . 1.0 112.49 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.659 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 3.8 mt -124.94 82.32 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.658 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.48 -163.49 26.4 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.533 -1.827 . . . . 1.0 108.533 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.457 ' C ' HG13 ' A' ' 167' ' ' ILE . 24.1 m -122.88 151.02 42.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.012 -1.287 . . . . 1.0 110.431 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.592 HD12 ' CZ ' ' A' ' 19' ' ' PHE . 3.5 mt -127.35 152.37 35.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.46 ' NH1' ' OD2' ' A' ' 169' ' ' ASP . 13.9 ttt-85 -159.09 148.37 18.64 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.049 -1.06 . . . . 1.0 110.721 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.46 ' OD2' ' NH1' ' A' ' 168' ' ' ARG . 93.6 m-20 52.5 84.52 0.05 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.877 -0.729 . . . . 1.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.459 HG11 ' HB2' ' A' ' 45' ' ' LEU . 20.7 m -127.78 131.2 70.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 C-N-CA 119.586 -0.845 . . . . 1.0 108.889 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.531 ' CG2' HD13 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -145.91 144.43 20.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 118.964 -1.094 . . . . 1.0 111.237 -177.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.587 ' CG2' ' CE1' ' A' ' 43' ' ' PHE . 3.0 p -132.14 121.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 28.8 m-20 47.59 31.68 2.16 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.721 -1.237 . . . . 1.0 108.634 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 76.04 10.37 3.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.794 -0.566 . . . . 1.0 111.413 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.543 ' O ' ' HB3' ' A' ' 176' ' ' GLU . 1.6 mp0 -91.84 -171.89 3.01 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.944 -1.098 . . . . 1.0 109.851 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.543 ' HB3' ' O ' ' A' ' 175' ' ' GLN . 1.2 tt0 72.52 -107.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.614 -0.679 . . . . 1.0 110.084 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.531 HD13 ' CG2' ' A' ' 171' ' ' ILE . 0.1 OUTLIER 67.18 -83.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.038 -1.039 . . . . 1.0 112.227 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.525 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.0 m-70 -60.75 84.75 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.947 -1.096 . . . . 1.0 111.079 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -55.74 -58.15 9.05 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.216 1.007 . . . . 1.0 111.354 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.554 ' O ' ' CD1' ' A' ' 184' ' ' LEU . 85.9 t -65.29 -23.56 33.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.898 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.525 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.2 mt-10 -63.6 -52.32 61.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.283 -1.511 . . . . 1.0 110.327 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.56 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 3.6 m-20 -94.98 -3.12 49.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.234 -0.916 . . . . 1.0 110.216 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 180' ' ' VAL . . . -78.24 -28.91 47.92 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.263 -0.975 . . . . 1.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 184' ' ' LEU . 8.1 mp -59.27 -15.3 14.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 1.0 109.173 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 4.2 t-20 -51.23 -24.09 4.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.472 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 3.6 t30 -97.3 148.79 34.92 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.472 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 41.3 Cg_endo -67.48 -55.38 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.658 1.346 . . . . 1.0 111.588 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.441 ' C ' HG13 ' A' ' 189' ' ' ILE . 5.1 m -101.46 132.4 47.08 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.371 -0.831 . . . . 1.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.441 HG13 ' C ' ' A' ' 188' ' ' THR . 3.8 mt -130.46 111.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.73 . . . . 1.0 109.494 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.74 175.92 8.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.267 -0.896 . . . . 1.0 109.338 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.529 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.59 18.85 4.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.581 -1.247 . . . . 1.0 111.109 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . 0.448 ' CA ' ' HB2' ' A' ' 18' ' ' ALA . 1.5 t 57.18 165.38 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.308 -0.87 . . . . 1.0 109.71 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.04 146.34 50.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.063 -1.023 . . . . 1.0 110.455 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 176.55 40.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.327 -0.858 . . . . 1.0 110.659 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? . . . . . 0 C--N 1.291 -1.959 0 C-N-CA 118.427 -1.309 . . . . 1.0 110.647 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.595 -1.402 . . . . 1.0 109.595 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 m -102.93 -170.53 1.81 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -1.178 . . . . 1.0 110.41 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -130.38 8.62 5.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 1.0 109.857 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 124.5 27.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 1.0 109.922 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 t -105.2 114.88 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 1.0 110.122 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.466 ' O ' HG13 ' A' ' 6' ' ' ILE . 10.3 pt -121.21 83.87 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 1.0 110.554 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.75 133.6 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.003 -1.06 . . . . 1.0 110.295 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.93 91.16 3.51 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.249 -0.907 . . . . 1.0 110.073 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.84 96.9 4.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.082 -1.011 . . . . 1.0 110.543 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.62 121.61 45.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 1.0 109.928 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.91 -18.64 5.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 1.0 110.186 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' C ' ' OD1' ' A' ' 13' ' ' ASP . . . 68.79 -158.95 52.72 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.63 -1.388 . . . . 1.0 109.63 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' GLU . 1.5 m-20 -135.24 -101.36 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 1.0 110.128 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 41.99 24.42 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.008 -1.058 . . . . 1.0 111.029 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.0 tt0 -64.5 87.78 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.1 -1.0 . . . . 1.0 109.457 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -116.49 138.26 51.52 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.471 -0.768 . . . . 1.0 111.356 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 0.8 OUTLIER -123.22 146.53 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.508 ' CB ' ' HA ' ' A' ' 192' ' ' CYS . . . -113.53 122.79 48.31 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.21 -0.931 . . . . 1.0 111.153 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.64 ' CE2' ' CD1' ' A' ' 167' ' ' ILE . 8.5 m-30 -87.88 148.03 24.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.457 -0.777 . . . . 1.0 109.3 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.464 ' OD1' ' HB ' ' A' ' 23' ' ' THR . 7.0 p-10 -103.4 2.47 33.92 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.181 -0.949 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.86 65.21 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.303 -1.519 . . . . 1.0 109.303 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.48 23.35 4.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -1.207 . . . . 1.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.464 ' HB ' ' OD1' ' A' ' 20' ' ' ASP . 5.2 t -109.55 163.26 13.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.898 . . . . 1.0 110.066 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.58 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 14.7 p90 -147.04 123.22 10.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 1.0 110.301 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.467 ' HG2' ' OH ' ' A' ' 27' ' ' TYR . 4.6 mtt -98.48 99.95 11.16 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.778 -1.201 . . . . 1.0 109.364 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 14.1 tt0 -88.87 98.51 11.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.509 -0.744 . . . . 1.0 109.989 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.519 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 13.1 m-30 -96.58 111.69 23.73 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.989 -1.07 . . . . 1.0 110.589 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -104.24 118.03 35.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.449 -0.782 . . . . 1.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 139' ' ' GLY . 9.4 m-20 -140.41 128.45 22.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 1.0 110.391 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.2 141.54 38.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 1.0 109.499 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -166.32 133.82 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.094 . . . . 1.0 111.027 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -165.1 100.52 0.75 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 34' ' ' SER . 11.8 mtmm -91.43 77.59 5.77 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.402 -0.919 . . . . 1.0 109.525 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 35.4 m 57.03 94.25 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER 66.91 116.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.038 -0.726 . . . . 1.0 109.038 -178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 51.61 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.461 -0.774 . . . . 1.0 110.519 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 38' ' ' LEU . . . -131.53 44.63 2.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.273 -0.892 . . . . 1.0 109.248 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 37' ' ' ALA . 1.7 mp -51.97 -170.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.59 -0.693 . . . . 1.0 110.779 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -124.74 16.36 8.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.595 -0.691 . . . . 1.0 109.889 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.1 p -157.85 155.36 29.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 1.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 1.7 m-20 -131.66 160.15 36.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 1.0 110.486 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 20.8 m-70 -130.43 115.99 17.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 1.0 109.952 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 23.1 m-30 -119.5 114.81 22.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.179 -0.951 . . . . 1.0 109.816 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.5 ' C ' ' CD2' ' A' ' 45' ' ' LEU . 1.4 mp0 -125.21 140.65 52.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 1.0 110.794 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.6 OUTLIER 179.84 159.26 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.098 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.507 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.64 161.19 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.507 ' CG2' ' C ' ' A' ' 46' ' ' SER . 7.4 pt -150.29 170.87 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 117.995 -1.482 . . . . 1.0 112.615 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.555 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 4.1 tttm -131.82 85.35 2.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.542 HG22 ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -72.01 156.42 39.24 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.045 -1.034 . . . . 1.0 111.609 -177.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.1 mm-40 -136.9 -4.84 1.94 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.222 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.633 ' O ' ' CG2' ' A' ' 52' ' ' THR . . . -125.79 -82.54 0.63 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.144 -0.972 . . . . 1.0 110.429 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.633 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 158.57 -20.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.255 0.55 . . . . 1.0 109.641 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -130.2 146.46 51.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 1.0 110.353 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 149.2 135.11 2.45 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.685 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -82.31 132.42 35.22 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.943 -1.327 . . . . 1.0 110.008 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.57 HD12 ' CG1' ' A' ' 78' ' ' VAL . 3.9 mp -97.84 -8.8 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 1.0 111.391 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.615 ' HB3' HD12 ' A' ' 71' ' ' LEU 0.292 6.5 tt -168.96 146.08 3.66 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 117.643 -1.623 . . . . 1.0 113.012 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.653 ' CE2' ' CG2' ' A' ' 151' ' ' VAL . 12.5 t-105 -150.89 118.2 6.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.661 . . . . 1.0 109.318 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.431 ' HB3' HD11 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -130.01 122.98 29.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.075 -1.016 . . . . 1.0 109.874 179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.02 167.81 23.2 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.158 -1.577 . . . . 1.0 109.158 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -140.63 -23.15 0.8 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.285 . . . . 1.0 111.548 -179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . -134.07 132.68 6.5 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.531 -1.319 . . . . 1.0 110.563 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 62' ' ' GLY . 1.8 mt 46.9 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.974 . . . . 1.0 111.196 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -119.0 31.87 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 1.0 110.188 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -158.81 24.89 0.22 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.867 . . . . 1.0 108.923 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -116.65 -165.27 1.04 Allowed 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.828 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 1.3 t0 -43.94 135.72 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 1.0 109.985 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.63 ' CZ ' ' CB ' ' A' ' 83' ' ' ASP . 7.8 p90 -154.84 171.88 18.91 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.101 -1.0 . . . . 1.0 109.953 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.579 HD11 ' CE1' ' A' ' 82' ' ' TYR . 5.2 mt -146.14 119.27 2.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.646 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.584 ' CB ' ' CE ' ' A' ' 81' ' ' MET . . . -140.95 -178.05 5.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.753 -1.217 . . . . 1.0 110.68 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.615 HD12 ' HB3' ' A' ' 57' ' ' LEU . 3.6 mp -149.24 116.06 5.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.684 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -129.19 178.87 6.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.173 -0.955 . . . . 1.0 111.842 -178.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.542 HG13 ' CD1' ' A' ' 56' ' ' ILE . 4.0 mt -120.43 134.43 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.431 -0.793 . . . . 1.0 109.745 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.519 HG23 ' NE2' ' A' ' 79' ' ' GLN . 1.3 t -141.09 134.03 30.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.203 -0.935 . . . . 1.0 110.367 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 59.66 22.04 10.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.325 -0.859 . . . . 1.0 110.682 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 84.72 31.61 23.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -146.9 130.3 16.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -1.086 . . . . 1.0 110.079 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.57 ' CG1' HD12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -78.16 -177.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.539 ' HB3' ' HA ' ' A' ' 92' ' ' ARG . 2.6 pt20 176.5 133.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.664 -1.273 . . . . 1.0 111.491 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.548 ' CG ' ' O ' ' A' ' 80' ' ' MET . 0.0 OUTLIER -91.14 109.43 20.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 1.0 109.219 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.584 ' CE ' ' CB ' ' A' ' 70' ' ' ALA . 8.3 ptt? -94.01 106.35 18.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.917 -1.114 . . . . 1.0 109.779 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.579 ' CE1' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -93.47 127.73 39.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.226 -0.921 . . . . 1.0 109.965 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.63 ' CB ' ' CZ ' ' A' ' 68' ' ' TYR . 5.7 t0 -131.88 43.2 3.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.054 -1.059 . . . . 1.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.513 HD13 ' CB ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -64.37 -10.62 25.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.45 -0.9 . . . . 1.0 110.155 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -139.78 39.23 1.54 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.696 -1.24 . . . . 1.0 110.707 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.27 -8.22 1.37 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -1.201 . . . . 1.0 111.773 179.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 9.4 mmtt -109.12 102.96 50.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 120.783 -1.198 . . . . 1.0 109.76 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.487 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 45.9 Cg_endo -73.63 105.4 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.219 1.641 . . . . 1.0 110.836 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.597 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -85.21 106.58 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.196 -0.94 . . . . 1.0 109.135 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.553 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 7.9 p -86.38 81.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.138 -1.602 . . . . 1.0 111.269 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.54 ' CA ' HG22 ' A' ' 124' ' ' ILE . 29.1 mt -71.97 70.12 0.75 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.539 ' HA ' ' HB3' ' A' ' 79' ' ' GLN . 11.5 mtp180 -64.35 171.53 3.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.547 -0.861 . . . . 1.0 110.347 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.2 t -96.96 152.19 18.96 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.788 -0.57 . . . . 1.0 109.761 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.3 t -102.25 26.85 7.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.924 -1.11 . . . . 1.0 109.407 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.557 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 9.0 t -128.31 147.69 64.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 1.0 109.177 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.557 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 43.3 Cg_endo -68.03 132.31 25.97 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.533 1.281 . . . . 1.0 110.228 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.469 ' O ' ' OG1' ' A' ' 49' ' ' THR . 0.7 OUTLIER -110.94 -30.8 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.867 . . . . 1.0 110.701 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.43 ' HB3' HG21 ' A' ' 52' ' ' THR . 14.9 p-10 -69.09 61.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.032 -1.042 . . . . 1.0 109.415 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.517 HG21 ' HB2' ' A' ' 101' ' ' HIS . 19.0 m -122.43 10.34 9.82 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.498 -0.751 . . . . 1.0 109.999 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 99' ' ' THR . 6.8 m120 55.25 15.64 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 1.0 110.515 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.517 ' HB2' HG21 ' A' ' 99' ' ' THR . 0.1 OUTLIER -109.03 172.68 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 1.0 109.435 179.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.555 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 45.3 m95 -94.7 118.12 31.21 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.075 -1.016 . . . . 1.0 111.004 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.518 HG22 ' N ' ' A' ' 104' ' ' HIS . 54.3 m -116.5 152.36 34.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.518 ' N ' HG22 ' A' ' 103' ' ' THR . 65.0 t-80 -101.77 156.73 17.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.882 -1.136 . . . . 1.0 108.987 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -145.84 154.65 13.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.132 -0.98 . . . . 1.0 109.614 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -148.21 147.62 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 1.0 109.905 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.457 ' HA ' HD23 ' A' ' 116' ' ' LEU . . . -139.72 99.19 3.64 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.651 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.637 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 52.6 p90 -110.0 106.83 16.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.958 -1.089 . . . . 1.0 109.136 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.548 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 4.5 tmm_? -94.11 144.7 25.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.543 -0.723 . . . . 1.0 111.28 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 15.4 t -128.56 116.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.8 mm-40 59.19 -89.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 1.0 109.954 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 127' ' ' SER . 2.6 ptt180 -128.08 -28.01 2.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.546 -0.721 . . . . 1.0 110.521 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.619 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 10.6 tt0 -82.47 114.9 21.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 1.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -102.17 156.76 18.54 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.637 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 40.6 t -129.81 151.16 50.69 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.481 -1.011 . . . . 1.0 109.896 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.515 ' C ' ' HG3' ' A' ' 117' ' ' GLN . 0.2 OUTLIER -148.9 126.32 11.58 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.127 -0.983 . . . . 1.0 110.812 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.543 ' CG ' ' HA ' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -134.66 135.53 42.14 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.849 -1.157 . . . . 1.0 110.254 178.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 118' ' ' VAL . 1.2 t -81.67 101.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . 71.29 40.81 60.38 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.011 -1.636 . . . . 1.0 109.011 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 36.0 m-80 61.64 27.68 17.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.467 -1.019 . . . . 1.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 2.4 mt-10 -93.0 -158.12 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.2 -0.937 . . . . 1.0 110.866 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 124' ' ' ILE . . . -41.15 109.92 0.68 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.443 -0.785 . . . . 1.0 109.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 117' ' ' GLN . 44.5 Cg_endo -73.28 119.15 5.84 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.977 1.514 . . . . 1.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.54 HG22 ' CA ' ' A' ' 91' ' ' LEU . 1.8 mp -95.19 100.07 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.704 -1.591 . . . . 1.0 106.704 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 114' ' ' GLY . 12.3 p -109.03 148.99 29.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.177 0.989 . . . . 1.0 112.161 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.502 ' N ' HD22 ' A' ' 91' ' ' LEU . . . -152.2 161.31 29.33 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 106.786 -2.526 . . . . 1.0 106.786 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.619 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -135.52 159.01 42.94 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.68 -1.483 . . . . 1.0 111.029 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.579 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -94.61 -177.61 0.69 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.669 -0.645 . . . . 1.0 109.634 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 38.1 Cg_endo -64.14 102.25 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.376 -1.432 . . . . 1.0 108.376 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.486 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.3 pp -33.46 153.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.399 0.618 . . . . 1.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 132' ' ' ALA . . . 99.77 -64.92 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.311 -1.516 . . . . 1.0 109.311 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.513 ' CB ' HD13 ' A' ' 84' ' ' LEU . . . 39.18 -145.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.477 -1.014 . . . . 1.0 109.842 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 134' ' ' GLN . 2.4 p -154.84 59.59 0.67 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.019 -1.051 . . . . 1.0 110.57 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 133' ' ' THR . 5.2 mt-30 56.94 153.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 1.0 110.078 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 69' ' ' ILE . 13.6 tp -135.82 109.61 8.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.978 -1.076 . . . . 1.0 110.654 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.5 m-20 -106.92 158.75 16.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 1.0 109.557 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -113.65 153.28 29.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.075 -1.016 . . . . 1.0 110.281 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 61' ' ' LYS . 28.0 p-10 -90.91 27.13 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.268 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 44.75 23.77 0.61 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.712 -1.755 . . . . 1.0 108.712 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -133.51 152.39 51.9 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.388 -1.066 . . . . 1.0 109.158 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.495 ' CD1' HD21 ' A' ' 57' ' ' LEU . 8.0 tp -158.61 161.36 37.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.105 -0.997 . . . . 1.0 110.703 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.601 ' CG ' ' HE1' ' A' ' 146' ' ' MET . 45.0 m95 -127.59 159.67 33.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.551 ' CD2' ' O ' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -153.91 118.84 5.02 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 116.873 -1.931 . . . . 1.0 113.801 -177.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 19' ' ' PHE . . . 111.26 5.66 26.37 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.477 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 134.27 -136.22 8.47 Favored Glycine 0 C--N 1.283 -2.366 0 C-N-CA 118.542 -1.789 . . . . 1.0 109.917 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.666 ' CB ' HD12 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -167.3 126.1 1.34 Allowed 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.892 -1.123 . . . . 1.0 112.037 -178.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.553 ' HB2' ' CG ' ' A' ' 24' ' ' TYR . 6.5 tp10 -58.74 -19.27 38.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.535 ' N ' ' HD3' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -146.03 69.69 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.468 -1.679 . . . . 1.0 106.468 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.666 HD12 ' CB ' ' A' ' 146' ' ' MET . 3.5 tp -71.81 41.09 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.55 0.945 . . . . 1.0 113.55 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 p -76.79 -9.56 58.77 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.477 -1.675 . . . . 1.0 106.477 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.653 ' CG2' ' CE2' ' A' ' 58' ' ' TRP 0.269 8.2 p -72.66 -26.37 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.044 -0.98 . . . . 1.0 111.238 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.636 ' CB ' ' CD2' ' A' ' 159' ' ' TYR . . . -40.23 -27.52 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.286 -0.884 . . . . 1.0 110.197 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 151' ' ' VAL . 28.7 m170 70.8 -92.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.324 0.583 . . . . 1.0 110.496 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -139.6 -4.11 1.45 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 111.217 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.592 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 3.7 pp -47.16 170.01 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 1.0 108.608 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 37.6 Cg_endo -61.12 178.4 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.331 1.174 . . . . 1.0 112.173 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -60.42 -6.7 1.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -0.865 . . . . 1.0 111.738 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -42.02 -38.98 1.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.91 -1.119 . . . . 1.0 108.934 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.685 ' CE1' ' HB2' ' A' ' 55' ' ' LEU . 3.8 m-85 -79.3 -34.0 42.79 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.323 -0.951 . . . . 1.0 109.113 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -65.64 -11.77 47.58 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.337 -0.945 . . . . 1.0 109.597 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 161' ' ' THR . 1.2 m -123.89 82.66 2.05 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.581 -0.699 . . . . 1.0 109.302 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 161' ' ' THR . . . -41.04 159.21 0.03 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.647 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 8.4 t80 -76.93 141.64 40.4 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.909 -1.348 . . . . 1.0 112.183 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.621 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 6.0 mt -121.36 84.69 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.647 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.46 -154.38 9.45 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.427 -1.869 . . . . 1.0 108.427 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.501 ' C ' HG13 ' A' ' 167' ' ' ILE . 3.6 m -130.19 153.7 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.128 -1.219 . . . . 1.0 111.232 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.64 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.5 mt -134.76 153.19 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.508 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 3.6 ttt-85 -158.79 153.98 25.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.624 -1.298 . . . . 1.0 111.538 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 59.8 m-20 50.29 81.64 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.622 -0.674 . . . . 1.0 110.992 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 19.4 m -123.3 130.6 74.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.145 -1.022 . . . . 1.0 110.174 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.527 HD12 HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -138.51 144.36 30.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.246 -0.982 . . . . 1.0 110.948 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.549 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 70.1 t -127.89 91.22 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 12.3 m-20 57.96 50.87 9.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.574 -1.329 . . . . 1.0 107.855 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 37.6 mmm-85 61.56 34.74 17.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.708 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 3.1 mm100 -112.46 164.51 13.19 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.088 -1.007 . . . . 1.0 109.596 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.55 ' O ' ' CD2' ' A' ' 177' ' ' LEU . 0.0 OUTLIER 71.5 -109.94 0.05 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.0 110.563 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.658 ' CD1' ' CE1' ' A' ' 178' ' ' HIS . 0.2 OUTLIER 55.24 11.97 0.62 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 1.0 112.088 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.658 ' CE1' ' CD1' ' A' ' 177' ' ' LEU . 58.7 m-70 -144.45 75.5 1.46 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.996 -1.065 . . . . 1.0 108.776 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.536 ' O ' ' CB ' ' A' ' 183' ' ' ALA 0.25 7.9 mp -54.64 -55.04 33.76 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.199 1.0 . . . . 1.0 111.17 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.452 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 4.9 t -63.2 -16.48 17.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.884 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.544 ' CG ' ' HB3' ' A' ' 178' ' ' HIS . 16.1 mt-10 -71.55 -51.54 22.96 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.882 -1.127 . . . . 1.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.519 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 82.1 m-20 -96.49 -14.96 21.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.559 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -65.78 -38.12 88.15 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.28 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.0 mt -45.6 -25.75 0.51 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 1.0 109.336 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -53.04 -23.14 6.89 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.155 0.979 . . . . 1.0 108.466 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.521 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 1.7 t-20 -98.72 160.78 27.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.694 -1.224 . . . . 1.0 107.694 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 37.6 Cg_endo -62.94 -157.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.87 0.932 . . . . 1.0 111.119 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 187' ' ' PRO . 7.3 m -36.14 137.43 0.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 1.0 111.228 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.9 mm -86.5 156.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.502 -0.749 . . . . 1.0 109.985 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 17' ' ' ILE . 18.6 mt -127.51 152.88 47.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 1.0 110.885 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.489 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 0.4 OUTLIER -107.36 157.5 17.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.305 -0.872 . . . . 1.0 109.618 179.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . 0.508 ' HA ' ' CB ' ' A' ' 18' ' ' ALA . 38.9 t -48.74 141.78 6.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.0 111.704 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.89 144.93 47.79 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 195' ' ' LYS . . . -130.07 103.51 6.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.956 -1.09 . . . . 1.0 111.019 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 194' ' ' ALA . 40.5 pttt . . . . . 0 C--N 1.297 -1.69 0 C-N-CA 118.987 -1.085 . . . . 1.0 110.604 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.594 -1.403 . . . . 1.0 109.594 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -68.88 -50.44 49.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -1.169 . . . . 1.0 110.082 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.46 173.17 4.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.828 . . . . 1.0 110.148 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -115.06 97.25 6.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 1.0 110.142 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.466 ' O ' HG11 ' A' ' 5' ' ' VAL . 7.6 p -133.43 133.56 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 1.0 110.034 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mt -117.93 112.1 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 1.0 110.338 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 7' ' ' ILE . 11.2 pt -100.15 81.91 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 1.0 109.897 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -132.07 123.94 28.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.913 . . . . 1.0 110.291 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -51.84 125.04 14.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.248 -0.908 . . . . 1.0 109.899 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.69 153.93 5.46 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.094 -1.004 . . . . 1.0 110.002 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.39 39.1 0.99 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.53 -0.731 . . . . 1.0 110.318 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.96 163.97 12.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 14' ' ' ALA . 3.0 m-20 -158.66 -57.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -1.128 . . . . 1.0 110.044 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 41.89 48.03 3.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 1.0 109.942 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.49 ' OE1' ' NE2' ' A' ' 191' ' ' HIS . 0.7 OUTLIER -120.36 -164.81 1.12 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.886 0.851 . . . . 1.0 109.821 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -108.46 148.83 29.62 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.906 -0.496 . . . . 1.0 109.91 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.526 ' CG2' ' HE2' ' A' ' 25' ' ' MET . 13.3 mm -121.56 131.69 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 1.0 109.251 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 192' ' ' CYS . . . -96.18 130.1 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 1.0 110.998 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CZ ' ' SD ' ' A' ' 25' ' ' MET . 5.8 m-30 -94.89 174.71 6.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.389 -0.819 . . . . 1.0 109.473 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.426 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 10.0 p-10 -127.58 -6.82 5.73 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.235 -0.916 . . . . 1.0 110.546 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.468 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 98.38 -1.66 58.88 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 52.0 ttp85 -134.92 -5.71 2.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.947 -1.326 . . . . 1.0 110.947 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -87.42 140.27 29.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.774 -1.204 . . . . 1.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.462 ' CD2' ' HA ' ' A' ' 147' ' ' GLU . 3.0 p90 -112.26 95.21 5.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.298 -0.876 . . . . 1.0 110.188 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.56 ' SD ' ' CZ ' ' A' ' 19' ' ' PHE . 8.7 mtt -77.06 100.76 5.79 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.465 -0.894 . . . . 1.0 109.902 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 3.4 pm0 -107.29 121.91 45.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 1.0 110.606 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.542 ' HA ' ' CB ' ' A' ' 182' ' ' ASP . 17.4 m-85 -111.03 107.96 17.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.414 -0.804 . . . . 1.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.95 112.84 24.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 1.0 110.152 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.479 ' OD1' ' OE1' ' A' ' 175' ' ' GLN . 1.7 t-20 -127.77 137.44 52.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 1.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.44 27.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 1.0 110.0 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.429 ' O ' ' HB ' ' A' ' 32' ' ' THR . 34.1 m -122.72 -43.38 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.004 -1.06 . . . . 1.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 32' ' ' THR . 1.9 t -179.77 110.58 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.011 -1.056 . . . . 1.0 110.416 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 79.34 6.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 1.0 109.998 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -174.08 -67.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.365 -0.834 . . . . 1.0 110.014 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 36' ' ' LYS . 1.8 tt0 -67.7 62.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 1.0 109.425 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -39.23 118.84 0.84 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.751 . . . . 1.0 110.984 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 36' ' ' LYS . . . 67.15 152.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.4 -0.813 . . . . 1.0 110.873 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 39' ' ' GLN . 5.4 mp -119.26 138.92 52.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.381 -0.825 . . . . 1.0 109.818 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.455 ' O ' HG12 ' A' ' 110' ' ' VAL . 3.2 pt20 -41.57 -32.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 1.0 110.688 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 47.8 m -149.25 148.72 29.91 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.376 -0.828 . . . . 1.0 110.454 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.02 147.18 36.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 1.0 110.158 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.488 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 30.7 m80 -123.01 123.36 40.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 1.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 26.5 m-85 -122.18 117.83 27.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 1.0 109.535 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.479 ' C ' ' CD2' ' A' ' 45' ' ' LEU . 1.4 mt-10 -126.74 139.87 52.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 1.0 110.882 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.4 OUTLIER 179.1 164.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.489 -0.884 . . . . 1.0 111.003 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 103' ' ' THR . 50.0 m -124.7 149.71 46.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.352 -1.351 . . . . 1.0 107.352 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.514 HD12 HD12 ' A' ' 105' ' ' ILE . 3.7 pt -139.36 164.41 24.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.163 -1.415 . . . . 1.0 112.312 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.57 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.2 OUTLIER -116.45 86.9 2.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 177.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.481 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -72.31 155.67 39.92 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.977 -1.077 . . . . 1.0 111.063 -177.516 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.4 mm-40 -138.21 10.19 2.77 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.755 -0.778 . . . . 1.0 110.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.623 ' O ' ' CG2' ' A' ' 52' ' ' THR . . . -140.43 -85.51 0.21 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.117 -0.989 . . . . 1.0 110.61 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.623 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.64 -24.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.5 tt0 -125.03 138.19 54.21 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 156.73 138.81 2.6 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.042 -1.623 . . . . 1.0 109.042 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.695 ' CD1' ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -88.72 128.32 35.61 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.83 -1.394 . . . . 1.0 109.602 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.536 ' O ' ' HG ' ' A' ' 143' ' ' LEU . 0.9 OUTLIER -90.83 -35.93 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.788 -0.57 . . . . 1.0 112.508 -176.143 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.647 ' HB3' ' HB2' ' A' ' 71' ' ' LEU . 2.3 tt -149.05 146.02 27.55 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.859 -1.151 . . . . 1.0 111.981 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.582 ' CD1' ' SD ' ' A' ' 146' ' ' MET . 3.5 t-105 -149.09 111.76 4.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.583 -1.266 . . . . 1.0 107.583 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.79 161.4 20.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.873 -1.142 . . . . 1.0 111.394 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.5 127.04 1.29 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.504 -1.838 . . . . 1.0 108.504 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' CB ' ' HB2' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -76.59 11.7 1.55 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.054 -1.262 . . . . 1.0 110.829 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.54 51.8 53.51 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.101 -1.2 . . . . 1.0 110.101 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 66' ' ' SER . 0.7 OUTLIER -59.55 -165.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.202 -1.176 . . . . 1.0 109.589 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -108.02 -14.82 14.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.061 -1.024 . . . . 1.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -168.27 27.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.413 -0.804 . . . . 1.0 109.456 179.431 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -103.31 -177.91 3.51 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.627 -0.829 . . . . 1.0 110.196 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.644 ' CB ' ' O ' ' A' ' 83' ' ' ASP . 9.3 m-20 -103.89 -122.42 0.2 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.06 -1.025 . . . . 1.0 110.901 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.611 ' CG ' ' C ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER 179.12 -162.66 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.197 -1.564 . . . . 1.0 111.983 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -148.26 146.0 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.425 -178.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.555 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -146.63 -175.11 4.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 1.0 110.39 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 66.3 mt -149.56 126.2 11.0 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.009 -1.108 . . . . 1.0 108.009 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.556 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -145.22 173.33 12.04 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.824 -1.172 . . . . 1.0 111.964 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 16.9 mt -117.56 141.81 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.593 0.711 . . . . 1.0 111.086 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.426 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -139.28 130.17 33.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.743 -0.598 . . . . 1.0 110.164 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 1.2 m-20 58.36 21.31 8.19 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.224 -0.922 . . . . 1.0 111.602 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.557 ' O ' ' CD1' ' A' ' 77' ' ' PHE . . . 92.39 20.05 36.47 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.628 -1.272 . . . . 1.0 110.252 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 76' ' ' GLY . 16.9 m-85 -138.19 144.29 40.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -1.126 . . . . 1.0 109.411 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -79.59 -167.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 1.0 109.103 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER 175.75 102.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 1.0 110.534 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.554 ' HA ' ' CD2' ' A' ' 71' ' ' LEU . 2.3 ttm -61.68 93.08 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.914 -0.714 . . . . 1.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.67 ' CE ' ' OH ' ' A' ' 159' ' ' TYR . 11.3 tmm? -89.94 111.29 22.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.804 -0.56 . . . . 1.0 110.005 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.66 ' CE2' ' CG1' ' A' ' 89' ' ' VAL . 2.8 p90 -143.1 141.29 31.2 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.346 -1.341 . . . . 1.0 110.986 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.644 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 0.6 OUTLIER -138.52 71.44 1.39 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.668 -0.645 . . . . 1.0 110.132 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.544 HD22 ' CE1' ' A' ' 82' ' ' TYR . 0.2 OUTLIER -67.89 -7.37 27.67 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 120.069 -0.652 . . . . 1.0 110.006 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.62 -57.57 0.37 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.01 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -1.113 . . . . 1.0 110.55 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -110.37 124.48 33.17 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.95 . . . . 1.0 109.739 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.522 ' CA ' ' HB3' ' A' ' 83' ' ' ASP . 48.6 Cg_endo -73.7 139.12 27.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.784 1.413 . . . . 1.0 110.371 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.66 ' CG1' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.52 121.06 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.58 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 7.2 p -99.06 81.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 118.346 -1.341 . . . . 1.0 111.09 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.562 ' CA ' HG21 ' A' ' 124' ' ' ILE . 8.5 mt -76.63 71.33 3.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.622 -1.251 . . . . 1.0 107.622 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 38.6 mtp180 -59.1 179.04 0.1 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.192 0.996 . . . . 1.0 111.347 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.472 ' HA ' HD12 ' A' ' 124' ' ' ILE . 3.1 t -114.84 149.1 37.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.45 -0.795 . . . . 1.0 109.904 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 94' ' ' THR . 54.5 m -106.85 34.37 3.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 1.0 109.423 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.563 HG13 ' CB ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -128.43 151.87 77.31 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.559 -0.713 . . . . 1.0 109.955 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.562 ' HD2' ' CG2' ' A' ' 95' ' ' VAL . 43.5 Cg_endo -69.53 121.41 8.15 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.399 1.21 . . . . 1.0 109.892 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.472 ' CG2' ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -109.58 -27.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 1.0 110.683 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.535 ' HB3' HG22 ' A' ' 52' ' ' THR . 6.3 p-10 -82.06 61.11 5.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 1.0 109.847 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.503 ' O ' ' CG2' ' A' ' 99' ' ' THR . 27.0 m -123.1 14.86 9.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.823 . . . . 1.0 110.195 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.496 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 12.3 t-20 53.54 18.05 1.32 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.937 -1.102 . . . . 1.0 110.108 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.493 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 5.5 m80 -116.14 144.59 43.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 1.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.57 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 21.1 m95 -59.44 109.52 0.91 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.437 -0.789 . . . . 1.0 111.138 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 104' ' ' HIS . 2.7 m -98.03 170.52 8.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.589 ' HB3' ' CA ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER -123.08 138.64 54.62 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.042 -1.037 . . . . 1.0 108.244 178.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.514 HD12 HD12 ' A' ' 47' ' ' ILE . 1.2 mt -134.91 149.16 29.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.103 -0.998 . . . . 1.0 109.608 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -148.34 130.19 15.2 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 1.0 109.709 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.419 ' HB3' ' HE1' ' A' ' 80' ' ' MET . . . -122.46 109.39 14.31 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.263 -0.975 . . . . 1.0 111.295 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.662 ' CE2' ' CB ' ' A' ' 115' ' ' SER . 3.8 p90 -116.48 110.27 18.38 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.236 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.537 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 3.6 ttp180 -125.1 133.92 52.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.381 0.61 . . . . 1.0 110.44 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.505 ' O ' ' C ' ' A' ' 111' ' ' GLN . 3.1 t -97.38 89.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 1.0 109.7 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.539 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 0.3 OUTLIER 21.24 48.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 4.3 tmm_? 167.96 -55.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.221 -0.924 . . . . 1.0 109.857 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.589 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -111.46 120.06 40.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 1.0 109.785 -179.725 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.537 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.06 162.57 15.29 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.946 -1.121 . . . . 1.0 111.618 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.662 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 13.5 t -141.61 155.6 45.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.737 -0.861 . . . . 1.0 109.829 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.528 ' C ' ' HG3' ' A' ' 117' ' ' GLN . 0.3 OUTLIER -149.65 125.98 10.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 120.956 -1.09 . . . . 1.0 110.908 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.545 ' HG2' ' HB3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -135.1 134.99 40.85 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 118' ' ' VAL . 9.9 p -76.2 102.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.589 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . 68.96 30.83 72.21 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 108.819 -1.712 . . . . 1.0 108.819 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 1.0 OUTLIER 72.93 29.99 1.75 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 1.0 110.688 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -97.3 -153.57 0.42 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 110.491 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.47 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -36.81 101.92 0.23 Allowed Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.407 -0.808 . . . . 1.0 110.3 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.545 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 44.9 Cg_endo -71.02 116.65 4.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.57 . . . . 1.0 111.794 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.562 HG21 ' CA ' ' A' ' 91' ' ' LEU . 1.2 mp -94.67 99.46 9.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 37.2 p -99.95 174.14 6.33 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.342 1.068 . . . . 1.0 112.39 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.403 ' HA3' HD21 ' A' ' 91' ' ' LEU . . . 173.12 154.1 10.15 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.486 -2.246 . . . . 1.0 107.486 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.589 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -137.14 167.18 22.04 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.26 -1.141 . . . . 1.0 109.927 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.0 174.75 5.68 Favored Pre-proline 0 C--N 1.3 -1.557 0 C-N-CA 119.089 -1.044 . . . . 1.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 130' ' ' LEU . 49.1 Cg_endo -78.71 43.68 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.735 1.387 . . . . 1.0 109.435 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.2 OUTLIER 42.47 105.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.724 0.773 . . . . 1.0 111.478 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.81 87.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.972 -1.251 . . . . 1.0 109.972 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.457 ' O ' ' HB ' ' A' ' 133' ' ' THR . . . -170.95 174.78 4.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -1.101 . . . . 1.0 109.788 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.8 t -179.22 156.98 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 1.0 110.427 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER 69.97 -60.44 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 1.0 111.131 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.597 ' C ' ' O ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -1.18 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.797 0.808 . . . . 1.0 112.064 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.491 ' HB2' ' CB ' ' A' ' 61' ' ' LYS . 37.5 m-20 -116.66 149.01 40.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.11 . . . . 1.0 110.038 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.49 ' CG2' ' C ' ' A' ' 136' ' ' ASP . 33.3 p -154.15 105.91 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 1.0 110.115 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.49 ' HB3' ' O ' ' A' ' 137' ' ' THR . 0.6 OUTLIER 167.11 -43.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.69 0.757 . . . . 1.0 109.206 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.4 -24.85 7.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.783 -1.327 . . . . 1.0 109.783 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -163.97 135.03 4.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.995 -1.297 . . . . 1.0 110.598 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 6.2 tp -135.8 142.72 44.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 1.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.577 ' CG ' ' HE3' ' A' ' 146' ' ' MET . 44.2 m95 -117.73 148.09 42.35 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.561 ' HG ' ' HB2' ' A' ' 57' ' ' LEU . 1.6 tt -148.59 119.55 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 117.644 -1.623 . . . . 1.0 112.995 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.59 9.3 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.77 -1.332 . . . . 1.0 109.77 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.601 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 129.94 -148.52 18.5 Favored Glycine 0 C--N 1.287 -2.158 0 N-CA-C 108.024 -2.031 . . . . 1.0 108.024 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.619 ' HB2' ' CD1' ' A' ' 149' ' ' LEU 0.266 5.6 mmt -152.53 128.78 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.655 -0.818 . . . . 1.0 110.95 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.462 ' HA ' ' CD2' ' A' ' 24' ' ' TYR . 5.3 tm-20 -43.53 -50.23 7.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.023 -1.048 . . . . 1.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.697 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -127.88 79.24 1.88 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 123.022 1.392 . . . . 1.0 107.73 177.68 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.667 HD13 ' CG1' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -62.1 42.79 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.177 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 148' ' ' ARG . 92.9 p -50.81 -32.75 21.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 177.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.667 ' CG1' HD13 ' A' ' 149' ' ' LEU 0.313 7.1 p -65.9 -141.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 113.542 -1.663 . . . . 1.0 106.557 176.022 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.666 ' CB ' ' HB3' ' A' ' 159' ' ' TYR 0.278 . . 50.63 14.21 0.16 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.597 -1.314 . . . . 1.0 111.508 177.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.79 -45.23 6.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.688 -1.257 . . . . 1.0 111.402 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.491 ' NZ ' ' OD2' ' A' ' 83' ' ' ASP . 2.6 pttt -61.13 -6.69 2.13 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.279 -0.888 . . . . 1.0 111.15 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.686 ' CD1' ' CE1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -121.96 -174.82 0.32 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.904 -1.123 . . . . 1.0 110.781 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.577 ' N ' ' HG ' ' A' ' 155' ' ' LEU . 44.1 Cg_endo -70.19 174.98 9.09 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.626 1.329 . . . . 1.0 112.536 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.9 -11.43 1.45 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.682 -0.636 . . . . 1.0 111.948 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -37.29 -41.03 0.38 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.194 -0.941 . . . . 1.0 109.961 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.695 ' CE2' ' CD1' ' A' ' 55' ' ' LEU . 4.0 m-85 -83.0 -32.97 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.093 -1.043 . . . . 1.0 109.522 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -60.53 -15.47 27.69 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.88 -1.128 . . . . 1.0 108.227 178.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.516 ' CG2' ' O ' ' A' ' 161' ' ' THR . 1.2 m -115.9 83.5 1.95 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.03 163.94 0.01 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.808 -1.317 . . . . 1.0 109.808 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.593 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 20.0 t80 -77.01 142.32 39.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.763 -1.434 . . . . 1.0 111.647 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.621 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 3.6 mt -123.93 87.15 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.593 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.25 -153.19 9.07 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 108.184 -1.966 . . . . 1.0 108.184 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 9.6 m -135.73 155.14 50.86 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.893 -1.123 . . . . 1.0 110.758 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.552 HD11 ' CZ ' ' A' ' 19' ' ' PHE . 3.6 mt -133.68 153.34 36.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 121.385 -0.822 . . . . 1.0 109.412 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 15' ' ' GLU . 11.2 ttp85 -159.09 158.55 33.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.932 -1.105 . . . . 1.0 110.857 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 22.6 m-20 48.92 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.303 -0.873 . . . . 1.0 110.043 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 44' ' ' GLU . 18.5 m -126.77 131.71 70.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 C-N-CA 119.179 -1.008 . . . . 1.0 110.004 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -136.92 149.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.579 -0.849 . . . . 1.0 110.511 -177.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 173' ' ' ASP . 54.4 t -131.46 94.19 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 1.3 m-20 71.44 38.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 74.51 18.1 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.248 0.547 . . . . 1.0 110.127 -179.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.479 ' OE1' ' OD1' ' A' ' 29' ' ' ASN . 7.0 mm-40 -89.09 111.02 21.67 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.344 -0.847 . . . . 1.0 109.732 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.44 106.4 6.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.887 -1.133 . . . . 1.0 109.274 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.32 86.96 6.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 1.0 111.077 -178.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.574 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 80.2 m-70 -53.37 104.47 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.174 0.988 . . . . 1.0 109.39 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -46.84 -61.94 1.63 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.166 0.984 . . . . 1.0 109.777 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.502 ' CG1' HD22 ' A' ' 184' ' ' LEU . 36.2 t -54.04 -21.86 6.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.41 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 13.4 mt-10 -64.95 -53.06 52.32 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.265 -1.374 . . . . 1.0 109.914 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.542 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -105.59 -22.48 12.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.009 -1.057 . . . . 1.0 109.731 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -59.39 -35.8 74.61 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.785 -1.197 . . . . 1.0 108.153 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.514 ' HA ' HD13 ' A' ' 189' ' ' ILE . 1.3 mm? -50.25 -20.73 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.718 . . . . 1.0 109.748 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.3 OUTLIER -52.22 -22.53 4.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 1.0 108.956 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.451 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 8.4 t30 -86.18 149.05 49.02 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 45.2 Cg_endo -72.35 -47.54 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.742 1.391 . . . . 1.0 110.599 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.91 118.99 37.6 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.746 -0.596 . . . . 1.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 184' ' ' LEU . 0.7 OUTLIER -117.9 128.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.308 -0.87 . . . . 1.0 109.515 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 18' ' ' ALA . 19.9 mt -103.23 171.97 7.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.861 . . . . 1.0 110.088 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.527 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -121.72 1.78 10.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.056 -1.027 . . . . 1.0 110.911 -179.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . 0.475 ' CB ' ' O ' ' A' ' 191' ' ' HIS . 6.3 t 66.44 154.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 1.0 110.623 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.25 157.37 26.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 1.0 110.04 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -139.94 105.13 5.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.972 . . . . 1.0 110.581 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.7 0 C-N-CA 119.012 -1.075 . . . . 1.0 110.557 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 27.3 t 56.38 -83.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -1.103 . . . . 1.0 110.178 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.5 OUTLIER -44.73 144.32 1.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 1.0 110.132 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.11 159.14 1.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 1.0 109.84 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 m -109.44 149.7 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 1.0 110.122 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.44 ' O ' HG13 ' A' ' 6' ' ' ILE . 27.6 pt -80.33 144.98 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.086 -1.009 . . . . 1.0 110.228 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 7' ' ' ILE . 7.4 tt -122.51 103.3 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 1.0 110.18 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.48 120.18 35.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 1.0 110.07 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -74.04 156.55 37.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 1.0 110.182 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 12' ' ' GLY . . . -87.03 112.95 22.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.252 -0.905 . . . . 1.0 110.401 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.6 76.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.164 -0.96 . . . . 1.0 110.154 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 10' ' ' ALA . . . 153.99 158.28 8.55 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.514 -1.434 . . . . 1.0 109.514 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 7.9 t0 -166.15 -38.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.192 -1.181 . . . . 1.0 110.458 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 13' ' ' ASP . . . 71.32 88.97 0.1 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.247 -0.908 . . . . 1.0 110.156 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -112.57 -165.2 0.97 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.343 -0.848 . . . . 1.0 108.893 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.09 131.79 35.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.304 -0.873 . . . . 1.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.546 HG21 ' CE ' ' A' ' 25' ' ' MET . 26.4 mm -127.07 117.95 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 1.0 109.437 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 192' ' ' CYS . . . -85.37 139.94 31.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 1.0 111.318 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CZ ' HD13 ' A' ' 167' ' ' ILE . 8.3 m-85 -108.09 159.92 16.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.407 ' C ' HG12 ' A' ' 164' ' ' ILE . 4.1 p-10 -115.8 -3.31 12.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.952 -1.092 . . . . 1.0 110.779 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.485 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 109.49 -18.29 30.15 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 30.39 7.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.585 -0.95 . . . . 1.0 109.182 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.551 HG23 ' CE2' ' A' ' 19' ' ' PHE . 1.9 m -69.87 172.69 7.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 1.0 110.894 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.585 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 10.8 t80 -167.72 74.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.572 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 3.8 mmt -86.95 99.43 11.86 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.845 -1.142 . . . . 1.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.77 136.4 34.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 1.0 108.63 179.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.572 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 96.0 m-85 -130.92 104.5 7.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.017 -1.052 . . . . 1.0 110.903 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.507 ' NE2' ' CZ2' ' A' ' 142' ' ' TRP . 22.7 m-70 -108.13 120.21 41.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 1.0 109.576 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -155.31 170.69 21.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 1.0 110.524 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.15 153.88 17.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.412 -0.805 . . . . 1.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG21 ' NE2' ' A' ' 175' ' ' GLN . 9.8 p -162.48 26.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 1.0 110.735 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 35' ' ' GLU . 15.3 t -163.12 155.41 18.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 1.0 110.161 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 34' ' ' SER . 3.4 tttt -104.57 78.72 1.48 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 1.0 110.233 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER 73.9 -48.49 0.67 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -0.775 . . . . 1.0 110.624 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.471 ' O ' ' OG1' ' A' ' 32' ' ' THR . 5.8 tt0 -66.1 158.22 29.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 1.0 110.123 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -153.31 -168.38 2.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -0.873 . . . . 1.0 110.086 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 36' ' ' LYS . . . 65.77 98.18 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 1.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD21 ' N ' ' A' ' 38' ' ' LEU . 3.5 mm? -94.38 177.38 5.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 1.0 109.941 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -93.6 -26.36 17.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 1.0 109.986 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.7 p -163.6 133.55 4.23 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.704 -0.622 . . . . 1.0 110.342 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.4 OUTLIER -100.93 152.39 20.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 1.0 109.943 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.552 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 11.5 m80 -123.88 138.16 54.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -0.951 . . . . 1.0 110.03 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.552 ' CD1' ' O ' ' A' ' 42' ' ' HIS . 21.2 m-85 -134.73 128.03 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 1.0 110.204 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 8.2 mt-10 -133.8 148.9 51.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 1.0 110.114 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.548 ' HB2' ' CG1' ' A' ' 170' ' ' VAL . 0.8 OUTLIER 179.26 151.55 0.35 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.395 -0.922 . . . . 1.0 111.158 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.504 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.09 154.11 35.16 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.547 HD11 HD12 ' A' ' 105' ' ' ILE . 5.5 pt -150.81 173.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 C-N-CA 117.96 -1.496 . . . . 1.0 112.312 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.62 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -127.33 82.92 2.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 178.284 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.546 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -66.86 161.21 24.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.119 -0.988 . . . . 1.0 111.256 -177.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.622 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 8.0 mm-40 -140.81 7.96 2.1 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.531 -0.867 . . . . 1.0 110.939 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.612 ' O ' ' CG2' ' A' ' 52' ' ' THR . . . -137.04 -86.66 0.31 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.142 -1.023 . . . . 1.0 111.063 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.612 ' CG2' ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.93 -24.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.302 -0.999 . . . . 1.0 108.302 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -125.01 132.43 53.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.67 -0.644 . . . . 1.0 109.831 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.491 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 162.98 137.81 2.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.266 -1.534 . . . . 1.0 109.266 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.587 ' HA ' ' CB ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -86.07 130.09 34.64 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.903 -1.351 . . . . 1.0 108.305 179.151 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.664 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -98.31 -26.27 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.553 -0.717 . . . . 1.0 112.178 -176.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 71' ' ' LEU 0.264 7.9 tt -156.88 155.41 31.4 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 117.736 -1.586 . . . . 1.0 113.09 -175.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.628 ' CH2' ' CG2' ' A' ' 151' ' ' VAL . 2.7 t-105 -156.23 114.35 3.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.481 ' OG ' HD23 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -133.89 179.92 5.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.89 -1.132 . . . . 1.0 111.063 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 61' ' ' LYS . . . 175.2 -131.55 1.97 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.301 -1.519 . . . . 1.0 109.301 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.1 OUTLIER 170.64 93.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.256 . . . . 1.0 110.073 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.32 -88.39 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tp -119.94 -173.06 2.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 1.0 110.718 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -93.23 44.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 1.0 110.051 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -177.54 35.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 1.0 109.371 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -128.09 140.05 52.17 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 119.739 -0.785 . . . . 1.0 110.718 -178.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.532 ' O ' ' O ' ' A' ' 66' ' ' SER . 11.3 t0 55.39 130.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.613 -0.68 . . . . 1.0 111.01 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.578 ' CG ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 m-30 -105.32 77.93 1.34 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.608 -1.307 . . . . 1.0 112.211 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.427 ' CG1' ' OD2' ' A' ' 67' ' ' ASP . 21.0 mm -98.34 77.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.0 109.24 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 57' ' ' LEU . . . -120.88 179.29 4.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 1.0 111.192 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . 81.8 mt -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.252 -0.905 . . . . 1.0 108.723 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -112.18 178.39 4.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.079 . . . . 1.0 111.671 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 60.1 mt -129.6 139.58 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.456 -0.778 . . . . 1.0 110.971 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 1.9 p -140.41 139.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.759 -0.588 . . . . 1.0 109.945 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 69.3 m-20 59.13 20.49 8.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 1.0 110.944 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.511 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 88.14 16.54 59.11 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.845 -1.302 . . . . 1.0 109.845 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.409 ' O ' HG21 ' A' ' 73' ' ' ILE . 52.5 m-85 -133.97 135.76 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 1.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.664 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 1.6 t -76.24 177.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 1.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.548 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -163.46 127.66 2.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.2 -0.937 . . . . 1.0 110.891 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.544 ' HB2' ' CD2' ' A' ' 116' ' ' LEU . 8.4 tmm? -82.39 94.52 7.41 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.443 0.64 . . . . 1.0 110.606 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.594 ' CE ' ' OH ' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -73.81 120.56 19.57 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 178.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.531 ' CZ ' ' HG3' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -143.35 91.73 2.3 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.426 -1.71 . . . . 1.0 111.691 -178.25 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.578 ' OD1' ' CG ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -112.57 152.07 29.31 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.28 -35.56 1.34 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -103.41 -33.12 4.31 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.666 -1.773 . . . . 1.0 108.666 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 162.02 -12.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.445 -1.032 . . . . 1.0 111.523 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.455 ' C ' ' HB2' ' A' ' 83' ' ' ASP . 3.7 mttt -102.64 96.16 7.16 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.751 -1.218 . . . . 1.0 110.043 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' HA ' ' CB ' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -70.42 123.99 10.39 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.065 1.561 . . . . 1.0 110.464 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -88.89 119.73 36.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 1.0 109.06 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.598 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 8.7 p -99.29 81.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.667 -1.271 . . . . 1.0 110.529 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.547 ' CD1' ' O ' ' A' ' 114' ' ' GLY . 10.4 mt -78.15 82.08 4.49 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' O ' HG22 ' A' ' 124' ' ' ILE . 1.2 mtt180 -57.9 176.58 0.15 Allowed 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 118.599 -1.24 . . . . 1.0 109.725 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.586 ' HA ' ' CD1' ' A' ' 124' ' ' ILE . 1.8 t -95.26 159.03 15.2 Favored 'General case' 0 C--N 1.286 -2.164 0 O-C-N 121.691 -0.63 . . . . 1.0 110.341 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 8.57 40.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 1.0 109.834 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' A' ' 118' ' ' VAL . 21.8 t -130.15 146.78 62.96 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 1.0 109.316 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.536 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.2 Cg_endo -69.76 153.04 69.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.588 1.31 . . . . 1.0 111.101 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.53 ' CG1' ' OG1' ' A' ' 49' ' ' THR . 0.7 OUTLIER -133.14 -27.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.862 . . . . 1.0 111.032 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.512 ' CB ' HG21 ' A' ' 52' ' ' THR . 9.1 p30 -72.16 65.0 0.57 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.994 -1.066 . . . . 1.0 111.061 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 14.7 t -135.82 18.3 3.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 1.0 109.522 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 50' ' ' GLU . 1.0 OUTLIER 57.31 23.64 9.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.82 . . . . 1.0 111.189 179.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.532 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 2.8 m80 -112.0 147.71 35.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 1.0 110.007 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.62 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 23.4 m95 -68.21 104.7 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 1.0 110.057 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.565 ' CG2' ' N ' ' A' ' 104' ' ' HIS . 2.4 m -98.73 172.41 7.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 1.0 109.003 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.598 ' CD2' ' HA2' ' A' ' 119' ' ' GLY . 1.7 t60 -124.62 139.66 53.66 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 47' ' ' ILE . 1.2 mt -129.28 157.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 119.193 -1.003 . . . . 1.0 109.19 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.551 ' O ' HD21 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -146.46 156.5 43.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.105 -0.997 . . . . 1.0 109.539 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.508 ' N ' ' HG3' ' A' ' 106' ' ' LYS . . . -158.22 119.46 3.49 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.526 -0.87 . . . . 1.0 110.516 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 2.3 p90 -129.27 107.3 9.43 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.203 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.568 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.4 OUTLIER -83.71 139.97 32.42 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.987 -0.685 . . . . 1.0 109.839 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.3 t -132.59 88.98 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 1.0 110.041 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.551 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 38.8 mt-30 44.58 102.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 1.0 111.121 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.551 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 5.3 ttt180 64.24 -52.34 0.27 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 1.0 111.423 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.65 ' CB ' ' OG ' ' A' ' 127' ' ' SER . 4.3 pt-20 -82.09 117.97 22.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.596 -1.315 . . . . 1.0 111.386 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.98 152.56 17.11 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.164 -1.174 . . . . 1.0 110.164 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.609 ' OG ' ' CZ ' ' A' ' 108' ' ' TYR . 32.8 t -133.84 161.88 33.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.13 -1.218 . . . . 1.0 111.538 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.556 ' CD1' ' N ' ' A' ' 117' ' ' GLN 0.252 1.7 tm? -144.24 155.42 43.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.556 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.8 OUTLIER -163.02 123.13 2.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.334 -1.346 . . . . 1.0 112.742 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.538 HG22 ' CG2' ' A' ' 95' ' ' VAL . 3.0 m -71.4 106.53 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.639 -1.615 . . . . 1.0 106.639 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.598 ' HA2' ' CD2' ' A' ' 104' ' ' HIS . . . 75.54 -73.75 1.59 Allowed Glycine 0 C--N 1.287 -2.184 0 N-CA-C 108.817 -1.713 . . . . 1.0 108.817 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 3.5 t-20 178.22 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.404 -1.056 . . . . 1.0 109.602 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -96.99 -158.74 0.69 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.584 -0.698 . . . . 1.0 111.064 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -40.2 103.61 0.3 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 1.0 109.653 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.517 ' CB ' ' OH ' ' A' ' 108' ' ' TYR . 42.2 Cg_endo -71.33 126.45 12.29 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.02 1.537 . . . . 1.0 111.012 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.586 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 1.7 mp -82.46 99.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.824 -1.172 . . . . 1.0 107.901 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 16.4 p -98.18 177.08 5.51 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.057 -1.027 . . . . 1.0 110.838 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 113' ' ' GLU . . . -179.75 -161.86 27.75 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 107.122 -2.391 . . . . 1.0 107.122 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.65 ' OG ' ' CB ' ' A' ' 113' ' ' GLU . 3.5 m -174.71 154.01 1.89 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.099 -1.236 . . . . 1.0 110.721 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.566 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -80.32 -176.87 0.81 Allowed Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 36.0 Cg_endo -63.23 -60.02 0.19 Allowed 'Trans proline' 0 C--N 1.301 -1.96 0 N-CA-C 108.086 -1.544 . . . . 1.0 108.086 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 129' ' ' PRO . 3.4 pp 152.56 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.631 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 133' ' ' THR . . . 77.45 -73.16 2.07 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.486 ' HB2' HD12 ' A' ' 84' ' ' LEU . . . -64.43 75.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 1.0 110.199 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 131' ' ' GLY . 7.0 m -86.97 -23.82 24.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 1.0 110.133 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.447 ' O ' ' HG3' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -100.43 121.49 41.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 1.0 110.124 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.486 ' O ' HD13 ' A' ' 135' ' ' LEU . 3.1 tm? -155.81 106.68 2.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 1.0 109.808 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 36' ' ' LYS . 11.0 m-20 -67.63 136.73 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 1.0 110.429 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -157.4 106.21 2.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 1.0 110.255 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 137' ' ' THR . 2.6 p30 161.28 -32.53 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.589 -0.695 . . . . 1.0 109.785 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.484 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -53.22 -21.38 11.62 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -143.64 164.89 29.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.346 . . . . 1.0 110.637 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.456 ' C ' ' CD1' ' A' ' 142' ' ' TRP . 9.1 tp -160.13 142.49 13.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 1.0 110.754 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 25.5 m95 -132.23 147.27 52.4 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.172 -1.418 . . . . 1.0 107.172 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.541 ' C ' ' CD1' ' A' ' 143' ' ' LEU . 1.4 tm? -153.1 117.72 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.705 -1.598 . . . . 1.0 113.305 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 119.38 5.12 11.59 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.323 -1.111 . . . . 1.0 110.323 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.456 ' HA2' HD22 ' A' ' 55' ' ' LEU . . . 139.89 -133.31 5.98 Favored Glycine 0 C--N 1.289 -2.075 0 C-N-CA 118.624 -1.751 . . . . 1.0 109.668 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.62 ' CB ' HD11 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -168.99 142.18 2.81 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.515 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.537 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 4.6 tm-20 -71.72 -26.98 62.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.51 -1.293 . . . . 1.0 107.51 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.501 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.82 80.36 1.69 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.62 HD11 ' CB ' ' A' ' 146' ' ' MET . 0.3 OUTLIER -69.83 36.44 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.406 -0.809 . . . . 1.0 113.178 -176.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -71.27 -11.13 60.75 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.628 ' CG2' ' CH2' ' A' ' 58' ' ' TRP 0.26 10.5 p -79.74 -9.64 12.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.212 -0.903 . . . . 1.0 110.676 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 153' ' ' HIS . . . -70.11 51.99 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 1.0 109.867 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.665 ' CD2' ' N ' ' A' ' 153' ' ' HIS . 1.8 p80 4.26 -86.29 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -160.77 100.2 1.27 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 123.299 1.523 . . . . 1.0 109.19 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.607 ' HB2' ' HD2' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -154.0 175.54 2.99 Favored Pre-proline 0 C--N 1.283 -2.314 0 O-C-N 120.843 -1.16 . . . . 1.0 109.756 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 37.0 Cg_endo -61.29 -178.14 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 122.851 0.921 . . . . 1.0 111.572 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -55.61 -11.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.383 -0.823 . . . . 1.0 112.064 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.491 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -36.23 -43.77 0.37 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.915 . . . . 1.0 109.859 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.594 ' OH ' ' CE ' ' A' ' 81' ' ' MET . 8.9 m-85 -86.4 -27.7 24.03 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 1.0 109.384 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -75.8 -3.49 35.28 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.657 -1.217 . . . . 1.0 108.243 177.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.49 ' O ' ' O ' ' A' ' 162' ' ' GLY . 1.8 m -135.35 91.53 2.74 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.26 170.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 1.0 110.069 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.657 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 13.3 t80 -74.18 147.15 42.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.146 -1.208 . . . . 1.0 112.295 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.622 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 3.6 mt -124.28 87.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.657 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.64 -153.9 9.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.147 -1.581 . . . . 1.0 109.147 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 48' ' ' LYS . 39.4 m -130.5 146.29 52.01 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.387 -1.066 . . . . 1.0 110.457 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.602 HD13 ' CZ ' ' A' ' 19' ' ' PHE . 3.5 mt -129.62 150.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.348 -0.845 . . . . 1.0 110.655 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.482 ' CG ' ' N ' ' A' ' 169' ' ' ASP . 9.4 ttt180 -159.49 168.47 26.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.012 -1.055 . . . . 1.0 110.452 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 14.2 m-20 44.63 58.87 3.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.895 . . . . 1.0 110.38 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.548 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 24.2 m -114.19 121.73 66.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.66 -0.816 . . . . 1.0 109.677 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.496 HG13 ' C ' ' A' ' 170' ' ' VAL . 1.0 OUTLIER -134.49 155.74 39.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.352 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 3.2 t -134.72 106.48 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 53.8 m-20 49.91 36.57 11.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.334 -1.479 . . . . 1.0 107.302 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 76.33 22.33 1.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.841 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 21.6 mt-30 -99.34 -171.94 2.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.941 -1.1 . . . . 1.0 110.408 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 10.5 tt0 72.49 -102.77 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.675 -0.641 . . . . 1.0 110.801 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.1 mt 68.6 -92.98 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.43 -0.794 . . . . 1.0 112.479 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 88.3 m-70 -89.51 103.86 16.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.667 -1.271 . . . . 1.0 112.486 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.1 OUTLIER -68.67 -48.71 63.26 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 177.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 184' ' ' LEU . 10.3 t -47.5 -26.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 1.0 110.004 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 0.6 OUTLIER -72.11 -60.64 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 1.0 110.898 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.555 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -92.93 -15.81 25.88 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.007 -1.058 . . . . 1.0 110.397 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -71.69 -34.92 70.05 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 186' ' ' ASN . 12.7 mt -51.06 -21.15 1.7 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.533 -0.729 . . . . 1.0 109.207 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 16.9 t-20 -42.71 -27.8 0.2 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.006 0.907 . . . . 1.0 108.701 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 187' ' ' PRO . 2.4 t30 -131.2 146.32 61.57 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.491 ' O ' ' ND2' ' A' ' 186' ' ' ASN . 42.7 Cg_endo -68.06 -157.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.765 1.402 . . . . 1.0 110.853 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 187' ' ' PRO . 0.4 OUTLIER 63.54 9.98 4.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 1.0 110.514 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 30.7 mm -68.53 94.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 1.0 109.951 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.98 164.14 12.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 1.0 110.597 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.15 154.25 22.0 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.214 -0.929 . . . . 1.0 110.092 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . 6.5 t -80.19 140.91 36.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.965 . . . . 1.0 110.563 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 58.7 m -102.29 160.5 14.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.343 -0.848 . . . . 1.0 110.298 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 179.62 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 1.0 110.361 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 118.714 -1.195 . . . . 1.0 110.519 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.7 p -137.66 -67.84 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -1.121 . . . . 1.0 110.194 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.83 179.19 7.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 1.0 110.268 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -105.41 -160.4 0.75 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 1.0 109.934 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 5' ' ' VAL . 8.4 p -61.89 116.42 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 1.0 109.607 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 tp -141.47 104.62 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 1.0 110.466 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 7' ' ' ILE . 4.5 mp -114.08 156.05 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 1.0 109.614 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -134.73 110.72 9.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 1.0 110.857 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 16.4 ptpt -125.44 137.67 53.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.044 -1.035 . . . . 1.0 109.603 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.7 127.28 50.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 1.0 110.274 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.46 48.22 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 1.0 110.119 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASP . . . 137.64 -112.69 0.93 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.549 ' CB ' ' O ' ' A' ' 12' ' ' GLY . 2.0 t70 75.21 -6.3 1.99 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.49 -1.006 . . . . 1.0 110.849 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 13' ' ' ASP . . . 164.54 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 1.0 109.657 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.529 ' O ' ' CD ' ' A' ' 168' ' ' ARG . 0.4 OUTLIER -133.11 -166.33 1.75 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.141 -0.975 . . . . 1.0 109.967 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -138.44 168.3 20.05 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.741 -0.599 . . . . 1.0 109.839 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 191' ' ' HIS . 13.3 mm -134.11 109.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 1.0 110.137 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -73.25 129.83 38.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.539 -0.726 . . . . 1.0 109.934 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.532 ' CE2' HD13 ' A' ' 167' ' ' ILE . 3.0 m-30 -95.68 133.49 39.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.404 -0.81 . . . . 1.0 109.326 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 -1.09 54.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 1.0 110.673 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.08 -7.39 62.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -122.02 7.13 9.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.206 -1.173 . . . . 1.0 109.904 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.575 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 8.9 t -81.63 164.45 21.84 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.995 0.902 . . . . 1.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' A' ' 23' ' ' THR . 6.0 m-30 -142.8 94.18 2.61 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.803 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 19' ' ' PHE . 2.4 mmt -94.21 101.63 13.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.841 -1.162 . . . . 1.0 109.795 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -117.65 120.54 38.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 1.0 110.361 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 2.9 m-85 -115.03 110.89 20.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.836 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -101.57 85.18 2.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.08 -1.013 . . . . 1.0 110.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -112.8 163.17 14.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 1.0 109.982 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.27 94.5 4.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 1.0 110.24 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' A' ' 175' ' ' GLN . 17.3 m -45.41 -41.78 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.902 . . . . 1.0 110.335 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -178.4 107.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.28 -0.887 . . . . 1.0 110.004 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.76 86.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 1.0 110.394 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.75 -77.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 1.0 110.123 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -125.63 -41.95 1.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 1.0 110.231 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER 47.08 43.55 14.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 1.0 110.63 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.421 ' HB2' ' OE1' ' A' ' 134' ' ' GLN . . . -141.91 87.6 2.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.471 -0.768 . . . . 1.0 109.592 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 40' ' ' SER . 2.8 mp -100.67 54.48 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 1.0 111.07 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.502 ' HB3' ' O ' ' A' ' 38' ' ' LEU . 7.0 tt0 64.12 -58.03 0.22 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.656 0.741 . . . . 1.0 111.33 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -127.89 163.75 23.76 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.369 -0.832 . . . . 1.0 110.982 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.97 155.67 20.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.45 -0.781 . . . . 1.0 109.748 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.473 ' O ' HG22 ' A' ' 172' ' ' VAL . 14.8 m-70 -123.48 133.39 54.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.071 . . . . 1.0 110.486 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.483 ' CE1' HG22 ' A' ' 172' ' ' VAL . 28.9 m-85 -136.76 117.09 13.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 1.0 109.926 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 9.6 mt-10 -125.62 145.59 50.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.901 -1.124 . . . . 1.0 110.443 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.9 OUTLIER 179.79 154.2 0.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.718 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.497 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -118.65 152.7 35.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.534 ' CD1' HD12 ' A' ' 105' ' ' ILE . 4.0 pt -148.67 160.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 117.81 -1.556 . . . . 1.0 112.697 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.618 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -114.63 83.79 1.95 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.332 -1.729 . . . . 1.0 106.332 177.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.465 ' OG1' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -66.97 150.87 48.64 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.042 0.925 . . . . 1.0 112.594 -176.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.65 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.5 mm-40 -140.85 2.99 1.81 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.863 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.25 125.64 12.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 1.0 110.12 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.441 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 74.1 p -57.07 -14.95 4.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.473 -0.767 . . . . 1.0 111.408 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG2' ' N ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -128.76 132.01 47.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.936 -1.103 . . . . 1.0 111.452 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 166.66 136.28 2.0 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.397 -1.382 . . . . 1.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.698 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -89.64 118.86 29.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -1.213 . . . . 1.0 108.326 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.587 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -92.86 -31.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.756 -176.325 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.596 ' CD2' ' CD1' ' A' ' 141' ' ' LEU . 4.9 tt -147.3 151.47 36.66 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.664 -1.272 . . . . 1.0 112.605 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.666 ' CD1' ' CE ' ' A' ' 146' ' ' MET . 0.6 OUTLIER -161.24 124.28 3.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.686 178.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.585 ' CB ' ' CD1' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -121.89 156.57 33.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.951 -1.093 . . . . 1.0 109.719 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.1 133.45 3.2 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.148 -1.581 . . . . 1.0 109.148 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.539 ' CB ' ' HB3' ' A' ' 138' ' ' ASP . 18.2 tttt -85.02 40.19 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -1.218 . . . . 1.0 110.446 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 61.14 131.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.23 -1.148 . . . . 1.0 110.23 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.517 HD13 ' CB ' ' A' ' 66' ' ' SER . 1.1 mt 176.25 174.87 0.32 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -1.071 . . . . 1.0 109.963 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.62 11.11 32.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 1.0 110.538 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 ptt-85 179.33 59.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.044 . . . . 1.0 109.71 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.517 ' CB ' HD13 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -140.79 152.43 45.2 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.55 -0.86 . . . . 1.0 110.514 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 2.9 m-20 -113.89 -48.97 2.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.008 . . . . 1.0 110.382 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.588 ' CE2' HD11 ' A' ' 135' ' ' LEU . 0.3 OUTLIER 79.37 -89.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 1.0 110.53 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.585 ' CD1' ' CB ' ' A' ' 59' ' ' SER . 0.0 OUTLIER -159.19 176.82 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.315 -1.491 . . . . 1.0 111.315 -179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.569 ' HB1' ' CE ' ' A' ' 81' ' ' MET . . . -172.37 174.36 3.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.723 -0.611 . . . . 1.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.587 ' HB2' ' CB ' ' A' ' 57' ' ' LEU . 78.4 mt -146.16 95.57 2.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 1.0 109.139 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.607 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -115.53 177.13 4.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.505 -0.747 . . . . 1.0 112.112 -178.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.586 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 2.5 mt -117.81 138.2 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.767 -0.583 . . . . 1.0 110.025 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -142.39 133.25 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.42 -0.8 . . . . 1.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 3.3 m-20 61.62 23.86 14.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.068 -1.02 . . . . 1.0 111.432 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.478 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 84.39 18.66 61.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.974 -1.25 . . . . 1.0 109.974 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.29 150.27 45.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -1.091 . . . . 1.0 108.901 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.587 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -91.45 -176.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.734 -1.228 . . . . 1.0 109.878 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.597 ' NE2' ' CG2' ' A' ' 90' ' ' VAL . 1.5 pt20 -174.11 136.37 0.5 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.357 -0.839 . . . . 1.0 110.836 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.573 ' CE ' ' O ' ' A' ' 115' ' ' SER . 0.7 OUTLIER -93.07 132.58 37.06 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.824 -0.75 . . . . 1.0 110.227 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.569 ' CE ' ' HB1' ' A' ' 70' ' ' ALA . 3.6 ttm -107.74 137.64 45.39 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.637 -0.664 . . . . 1.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.582 ' CE2' ' HD2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -134.71 102.03 5.14 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.127 -0.983 . . . . 1.0 109.758 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' TYR . 2.1 m-20 -110.79 34.35 4.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.652 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.511 HD22 ' NH1' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -34.03 -29.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.731 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -118.4 -41.31 0.63 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.756 -1.337 . . . . 1.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 168.7 -28.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 1.0 109.743 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.483 ' HG3' ' CG ' ' A' ' 129' ' ' PRO . 12.4 mmmt -89.58 117.93 68.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.493 -0.754 . . . . 1.0 109.772 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.485 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 51.1 Cg_endo -78.06 130.38 10.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.922 1.485 . . . . 1.0 111.927 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.4 OUTLIER -109.27 126.63 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 178.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.597 ' CG2' ' NE2' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -109.04 123.27 64.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.447 -1.408 . . . . 1.0 111.865 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.553 ' CA ' HG23 ' A' ' 124' ' ' ILE . 0.3 OUTLIER -111.99 74.69 0.88 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.176 -1.416 . . . . 1.0 107.176 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 0.8 OUTLIER -57.9 178.65 0.08 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.311 -0.956 . . . . 1.0 110.492 -178.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . 0.251 2.4 t -108.23 151.19 26.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.549 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.475 HG23 HD13 ' A' ' 124' ' ' ILE . 0.7 OUTLIER -103.63 26.18 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 1.0 109.73 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.526 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 2.4 t -128.57 146.98 62.2 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.508 -0.745 . . . . 1.0 109.146 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.526 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 40.8 Cg_endo -65.64 124.52 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.538 1.283 . . . . 1.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 98' ' ' ASN . 6.6 tp -109.95 -39.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 1.0 110.655 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.499 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 6.3 p-10 -67.56 63.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 1.0 110.635 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.578 ' O ' ' CE1' ' A' ' 101' ' ' HIS . 15.0 t -124.09 11.19 8.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -0.999 . . . . 1.0 110.345 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 57.45 33.08 22.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.948 -1.095 . . . . 1.0 110.447 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.578 ' CE1' ' O ' ' A' ' 99' ' ' THR . 5.7 m-70 -121.65 179.36 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 1.0 109.8 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.618 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 17.0 m95 -98.18 100.96 12.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.029 -1.044 . . . . 1.0 110.175 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.515 ' CG2' ' N ' ' A' ' 104' ' ' HIS . 9.7 m -96.43 170.7 9.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.362 -0.836 . . . . 1.0 109.429 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.524 ' O ' ' N ' ' A' ' 119' ' ' GLY . 6.9 t60 -122.15 120.83 35.37 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.682 -1.229 . . . . 1.0 107.682 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.534 HD12 ' CD1' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -107.92 146.65 13.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 120.937 -1.102 . . . . 1.0 109.456 -178.598 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.507 ' O ' HD23 ' A' ' 116' ' ' LEU . 6.9 tptm -142.38 142.09 32.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.318 -0.953 . . . . 1.0 109.527 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -137.03 110.09 7.73 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.966 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 108' ' ' TYR . 4.5 p90 -111.14 110.36 20.85 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.582 ' HD2' ' CE2' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -99.62 141.05 32.93 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.031 -0.668 . . . . 1.0 111.194 -178.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 5.9 t -127.55 97.61 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.628 -0.67 . . . . 1.0 109.199 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.453 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 2.0 mt-30 58.26 -134.54 1.04 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 1.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.505 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -70.81 -11.41 60.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.984 -1.072 . . . . 1.0 110.863 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.623 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -104.4 123.24 47.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 1.0 110.505 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.526 ' CA ' ' HG2' ' A' ' 109' ' ' ARG . . . -114.41 163.66 12.15 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.296 -0.954 . . . . 1.0 110.961 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.573 ' O ' ' CE ' ' A' ' 80' ' ' MET . 47.5 t -147.64 162.89 38.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.522 -0.987 . . . . 1.0 110.722 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 117' ' ' GLN 0.254 1.0 OUTLIER -139.5 157.08 46.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.177 -0.952 . . . . 1.0 108.892 -178.816 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.545 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.39 113.92 4.02 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.684 -1.26 . . . . 1.0 111.97 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 16.8 t -70.22 100.35 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.86 37.08 92.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.423 ' C ' ' HG2' ' A' ' 117' ' ' GLN . 0.3 OUTLIER 61.38 38.58 16.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -1.146 . . . . 1.0 110.704 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 9.6 mt-10 -108.47 -161.18 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.325 -0.859 . . . . 1.0 110.944 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -39.22 98.32 0.16 Allowed Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 45.8 Cg_endo -77.43 142.96 21.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 124.068 1.562 . . . . 1.0 112.394 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.553 HG23 ' CA ' ' A' ' 91' ' ' LEU . 1.1 mp -106.05 110.43 31.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.877 -1.527 . . . . 1.0 106.877 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.512 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 7.2 p -105.81 177.52 4.83 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.375 1.083 . . . . 1.0 112.146 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.495 ' N ' HD12 ' A' ' 91' ' ' LEU . . . 170.78 160.98 20.62 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.834 -2.507 . . . . 1.0 106.834 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -139.28 168.52 19.63 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.735 -1.45 . . . . 1.0 110.892 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.465 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.2 p -87.2 -179.73 1.47 Allowed Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.515 -0.874 . . . . 1.0 110.037 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.483 ' CG ' ' HG3' ' A' ' 87' ' ' LYS . 46.2 Cg_endo -77.49 48.25 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.837 1.441 . . . . 1.0 109.675 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.9 OUTLIER 46.46 -176.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.614 -0.679 . . . . 1.0 110.5 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.481 ' O ' ' CB ' ' A' ' 132' ' ' ALA . . . 79.05 88.63 0.46 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.487 ' CB ' HD13 ' A' ' 84' ' ' LEU . . . 170.02 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -1.132 . . . . 1.0 110.166 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 59.11 90.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 1.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.421 ' OE1' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 44.94 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 1.0 110.309 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.588 HD11 ' CE2' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -175.72 97.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 1.0 110.309 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.503 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 3.1 m-20 -52.17 -179.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 1.0 109.213 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.45 ' O ' HG23 ' A' ' 137' ' ' THR . 8.1 t -129.1 121.06 27.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.085 -1.01 . . . . 1.0 109.695 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.539 ' HB3' ' CB ' ' A' ' 61' ' ' LYS . 4.4 p-10 -60.93 -3.56 0.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 1.0 111.05 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 65.9 9.12 45.19 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.841 -1.704 . . . . 1.0 108.841 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.479 ' HB2' ' OD2' ' A' ' 138' ' ' ASP . . . -102.31 132.2 48.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -1.127 . . . . 1.0 108.394 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.596 ' CD1' ' CD2' ' A' ' 57' ' ' LEU . 9.5 tp -141.14 148.79 40.6 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.764 -1.174 . . . . 1.0 111.651 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 24.2 m95 -130.88 119.46 22.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.59 HD11 ' CB ' ' A' ' 57' ' ' LEU . 8.3 tp -125.13 118.83 26.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.934 -1.506 . . . . 1.0 113.539 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.81 8.8 7.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 119.99 -1.1 . . . . 1.0 110.672 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.57 ' O ' ' HE3' ' A' ' 146' ' ' MET . . . 148.33 -148.44 19.92 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.373 -1.87 . . . . 1.0 109.08 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.666 ' CE ' ' CD1' ' A' ' 58' ' ' TRP . 0.1 OUTLIER -152.82 148.06 26.76 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.37 -0.932 . . . . 1.0 112.881 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.423 ' C ' ' HG2' ' A' ' 148' ' ' ARG . 12.1 tt0 -93.9 19.92 8.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.423 ' HG2' ' C ' ' A' ' 147' ' ' GLU . 2.0 ptm180 173.16 68.65 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.555 -1.646 . . . . 1.0 106.555 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.625 HD11 ' CB ' ' A' ' 146' ' ' MET . 1.4 tp -73.46 36.03 0.08 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 1.0 112.706 -177.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.1 p -71.69 -13.67 61.8 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.795 -1.928 . . . . 1.0 105.795 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.649 ' CG2' ' CZ3' ' A' ' 58' ' ' TRP 0.257 7.1 p -76.28 -110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 114.889 -1.051 . . . . 1.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.638 ' CB ' ' CD2' ' A' ' 159' ' ' TYR . . . 50.0 39.1 18.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.308 -1.495 . . . . 1.0 108.946 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.628 ' CE1' HD23 ' A' ' 155' ' ' LEU . 1.5 p80 13.39 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.786 0.661 . . . . 1.0 112.786 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 5.74 2.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.032 -1.042 . . . . 1.0 111.821 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.703 ' CD2' ' CE1' ' A' ' 159' ' ' TYR . 2.7 pp -60.63 178.81 0.24 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.197 -0.939 . . . . 1.0 110.979 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 46.4 Cg_endo -83.01 -159.49 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.461 1.243 . . . . 1.0 112.681 -178.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.505 ' O ' ' C ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -51.01 -13.08 0.13 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 113.042 0.756 . . . . 1.0 113.042 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.57 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . -37.69 -45.64 0.81 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.013 -1.055 . . . . 1.0 109.707 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.703 ' CE1' ' CD2' ' A' ' 155' ' ' LEU . 4.3 m-85 -84.57 -28.98 26.23 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.204 -0.935 . . . . 1.0 109.111 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -70.38 -8.53 51.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.246 -1.382 . . . . 1.0 108.402 178.261 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.52 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.3 m -128.47 98.47 5.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -50.1 -178.19 0.02 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.62 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 71.0 t80 -83.01 144.72 29.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.909 -1.347 . . . . 1.0 112.262 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.65 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 1.6 mt -127.57 88.67 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.62 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.94 -157.39 13.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.743 -1.743 . . . . 1.0 108.743 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.537 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 1.7 m -128.59 145.45 51.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.128 -1.219 . . . . 1.0 109.802 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.573 HD12 ' CE2' ' A' ' 163' ' ' PHE . 3.4 mt -130.28 147.4 33.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.437 -0.789 . . . . 1.0 110.423 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -159.48 156.12 27.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 1.0 110.351 -179.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 17.8 m-20 51.38 81.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 1.0 110.411 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.494 HG12 ' CB ' ' A' ' 45' ' ' LEU 0.251 25.7 m -122.43 130.62 74.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.017 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -145.04 141.4 22.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.102 -1.039 . . . . 1.0 111.649 -176.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 173' ' ' ASP . 1.3 p -127.0 119.34 52.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 1.5 m-20 62.14 30.53 17.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.23 32.09 2.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.756 -0.59 . . . . 1.0 110.451 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 71.9 mm-40 -104.73 120.13 40.63 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.354 -0.841 . . . . 1.0 110.064 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -78.55 110.97 14.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 1.0 109.556 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 179' ' ' LEU . 83.8 mt -78.81 96.21 5.57 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 1.0 111.31 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.567 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 46.8 m-70 -39.21 98.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.045 0.926 . . . . 1.0 110.247 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.609 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 8.9 mt -49.09 -59.57 3.53 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.924 0.869 . . . . 1.0 112.963 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.557 ' HA ' ' CD2' ' A' ' 184' ' ' LEU . 86.7 t -75.52 -28.52 19.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 113.541 0.941 . . . . 1.0 113.541 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.567 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -58.64 -50.51 73.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 112.284 -178.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.3 OUTLIER -108.19 -28.51 9.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.946 -1.096 . . . . 1.0 111.535 -178.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.609 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -63.05 -25.08 68.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.853 -1.539 . . . . 1.0 108.601 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.557 ' CD2' ' HA ' ' A' ' 180' ' ' VAL . 1.4 mm? -70.43 -2.19 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 1.0 110.303 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -55.65 -29.62 59.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 1.0 109.469 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.47 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 2.7 t-20 -88.09 151.32 49.07 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.586 ' O ' ' CG2' ' A' ' 188' ' ' THR . 38.3 Cg_endo -64.77 149.47 89.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.45 1.237 . . . . 1.0 109.684 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.586 ' CG2' ' O ' ' A' ' 187' ' ' PRO . 5.2 t 49.34 148.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 122.272 1.034 . . . . 1.0 112.116 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.537 HG13 ' CD1' ' A' ' 184' ' ' LEU . 33.6 mm -144.71 113.06 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 1.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.25 176.48 6.3 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.053 -1.03 . . . . 1.0 109.349 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -115.96 -60.99 1.8 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.7 -1.2 . . . . 1.0 111.264 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 191' ' ' HIS . 0.9 OUTLIER 178.25 162.4 0.65 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.422 -0.799 . . . . 1.0 110.195 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.508 ' O ' ' CB ' ' A' ' 194' ' ' ALA . 1.4 m -131.0 148.37 52.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.146 -0.971 . . . . 1.0 109.886 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.508 ' CB ' ' O ' ' A' ' 193' ' ' SER . . . 167.17 41.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.18 -0.95 . . . . 1.0 110.395 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.291 -1.978 0 C-N-CA 118.701 -1.199 . . . . 1.0 110.528 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -117.57 89.04 3.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -1.133 . . . . 1.0 110.349 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 4' ' ' LYS . 2.2 tt0 -91.75 -67.14 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 1.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 3' ' ' GLU . 19.6 mtpp 48.87 -178.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.846 . . . . 1.0 110.372 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -83.5 102.04 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 1.0 110.321 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 tt -97.86 142.93 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 1.0 110.057 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 pt -94.53 146.88 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.923 . . . . 1.0 110.406 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -109.96 108.84 19.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.22 -0.925 . . . . 1.0 110.274 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -49.72 133.0 21.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.875 . . . . 1.0 110.363 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.37 117.34 34.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 1.0 110.222 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.72 78.55 0.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 1.0 110.584 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.12 131.61 10.64 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.15 -62.15 0.85 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.261 . . . . 1.0 110.839 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . 177.77 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.948 -1.095 . . . . 1.0 110.817 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.646 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.3 pt-20 -35.35 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.196 0.998 . . . . 1.0 110.157 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -84.02 137.15 33.75 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 120.333 -1.479 . . . . 1.0 111.231 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.528 HD13 ' CE1' ' A' ' 191' ' ' HIS . 12.2 mm -117.43 131.25 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.184 -0.948 . . . . 1.0 109.273 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.517 ' CB ' ' SG ' ' A' ' 192' ' ' CYS . . . -90.09 131.85 35.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.46 -0.775 . . . . 1.0 110.792 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.639 ' CE1' ' CD1' ' A' ' 167' ' ' ILE . 62.3 m-85 -101.51 177.02 5.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.712 -1.243 . . . . 1.0 109.29 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.433 ' C ' HG13 ' A' ' 164' ' ' ILE . 11.1 p-10 -141.92 -11.6 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.678 -1.264 . . . . 1.0 112.842 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.648 ' HA2' ' O ' ' A' ' 162' ' ' GLY . . . 111.64 -11.69 27.84 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.95 -1.595 . . . . 1.0 109.144 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 3.6 ttp-105 -135.15 10.8 3.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -1.165 . . . . 1.0 111.504 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -112.81 121.17 43.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 1.0 110.627 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 1.9 p90 -104.02 122.25 44.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 1.0 110.256 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.56 ' HE2' ' CZ ' ' A' ' 19' ' ' PHE . 3.2 mtp -119.45 98.41 6.12 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.937 -1.105 . . . . 1.0 108.307 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.585 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 0.8 OUTLIER -103.08 145.12 30.38 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.707 -0.797 . . . . 1.0 110.027 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.639 ' HA ' ' CB ' ' A' ' 182' ' ' ASP . 4.6 m-85 -126.1 116.52 21.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.011 -1.076 . . . . 1.0 110.477 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 139' ' ' GLY . 19.8 t60 -96.99 99.98 11.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.735 . . . . 1.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.6 131.32 34.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 1.0 110.03 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.16 95.37 8.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 1.0 110.194 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.77 -29.66 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 1.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.462 ' CG2' ' O ' ' A' ' 35' ' ' GLU . 1.8 t -178.36 177.44 0.96 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.093 -1.005 . . . . 1.0 110.719 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 34' ' ' SER . 3.5 pttp -63.77 94.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.428 -0.795 . . . . 1.0 110.818 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER 37.35 56.29 1.37 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.706 -0.622 . . . . 1.0 110.965 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' O ' ' CG2' ' A' ' 32' ' ' THR . 0.0 OUTLIER -145.38 84.88 1.7 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.937 . . . . 1.0 110.107 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -122.28 132.01 54.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 1.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . 178.67 111.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 1.0 110.692 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.488 ' CD2' ' OD2' ' A' ' 138' ' ' ASP . 0.4 OUTLIER -137.42 -164.83 1.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 1.0 109.954 179.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -139.89 -15.41 1.02 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.123 -0.985 . . . . 1.0 111.475 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.521 ' OG ' ' NE2' ' A' ' 42' ' ' HIS . 1.2 p -126.82 104.87 8.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.247 -0.908 . . . . 1.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 109' ' ' ARG . 19.5 p-10 -85.65 142.75 28.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.529 -0.732 . . . . 1.0 110.222 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.639 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 49.7 m-70 -131.15 111.59 12.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.579 ' CE1' HG11 ' A' ' 172' ' ' VAL . 9.2 m-85 -116.81 115.55 25.77 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.525 -0.734 . . . . 1.0 110.902 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 0.5 OUTLIER -124.97 144.42 50.38 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.037 -1.039 . . . . 1.0 109.174 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.4 OUTLIER -179.56 159.18 0.87 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.154 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 103' ' ' THR . 74.8 m -128.75 145.72 51.1 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.563 HD12 ' CG1' ' A' ' 97' ' ' ILE . 1.4 pt -124.72 -170.46 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 118.449 -1.3 . . . . 1.0 111.532 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.591 ' HD2' ' CD2' ' A' ' 102' ' ' TRP . 0.4 OUTLIER -148.11 146.13 28.67 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.343 -1.355 . . . . 1.0 107.343 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 46.1 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.042 -1.063 . . . . 1.0 110.014 -178.459 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.612 ' O ' ' CB ' ' A' ' 51' ' ' ALA . 8.3 tt0 -176.95 -22.75 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.376 -0.827 . . . . 1.0 110.55 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.649 ' HB3' ' HB ' ' A' ' 164' ' ' ILE . . . 78.64 -3.62 2.23 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.931 -0.481 . . . . 1.0 110.088 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 51' ' ' ALA . 1.7 p 78.82 -19.97 0.41 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.312 0.577 . . . . 1.0 111.387 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.537 ' HG3' ' CB ' ' A' ' 158' ' ' ALA . 0.3 OUTLIER -143.91 124.26 13.86 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.324 -0.86 . . . . 1.0 109.881 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 164.86 139.92 2.75 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.622 ' HB2' ' CD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -89.45 145.62 25.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.754 -1.439 . . . . 1.0 109.365 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.586 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -116.3 -4.61 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -174.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.562 ' CD1' ' CD2' ' A' ' 143' ' ' LEU . 2.8 tt -168.56 152.12 5.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 119.206 -2.184 . . . . 1.0 113.105 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.58 ' CD1' ' SD ' ' A' ' 146' ' ' MET . 1.5 t-105 -164.64 113.72 1.12 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.8 -0.562 . . . . 1.0 110.157 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.473 ' HB3' HD12 ' A' ' 141' ' ' LEU . 1.4 p -120.99 141.69 50.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.934 -1.104 . . . . 1.0 109.647 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 61' ' ' LYS . . . -99.12 -81.61 1.61 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.585 ' CA ' ' HE2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER 73.8 91.15 0.09 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.444 -1.033 . . . . 1.0 110.711 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.92 -103.8 0.46 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.04 -175.33 2.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.214 -1.168 . . . . 1.0 109.842 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -87.78 23.71 1.93 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.949 . . . . 1.0 110.073 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.612 ' CG ' ' O ' ' A' ' 65' ' ' ARG 0.253 0.0 OUTLIER -159.13 24.26 0.2 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 123.002 1.382 . . . . 1.0 107.699 -179.269 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -87.92 -158.44 0.46 Allowed 'General case' 0 C--N 1.284 -2.254 0 O-C-N 120.829 -1.17 . . . . 1.0 111.948 -177.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.538 ' CB ' ' HA ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -47.26 155.61 0.3 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.879 -0.513 . . . . 1.0 112.009 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.701 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -124.03 102.5 7.78 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.874 -1.13 . . . . 1.0 110.242 178.184 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.542 ' O ' HG13 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -108.66 111.05 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 178.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.556 ' CB ' ' HE1' ' A' ' 81' ' ' MET . . . -138.44 -173.92 3.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 1.0 111.185 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.561 ' O ' ' N ' ' A' ' 56' ' ' ILE . 82.5 mt -153.31 110.83 3.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -126.95 176.19 7.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.75 -1.219 . . . . 1.0 111.321 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -124.46 140.22 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -0.834 . . . . 1.0 111.621 -178.135 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.479 HG21 ' OD2' ' A' ' 75' ' ' ASP . 2.4 p -142.58 132.85 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.82 -0.55 . . . . 1.0 110.324 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.479 ' OD2' HG21 ' A' ' 74' ' ' VAL . 2.9 m-20 66.45 27.02 9.95 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.949 -1.094 . . . . 1.0 110.826 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.51 ' O ' ' CG2' ' A' ' 97' ' ' ILE . . . 81.41 -5.36 68.49 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -109.18 149.47 29.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.305 -1.114 . . . . 1.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -98.22 -169.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 1.0 109.647 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER 178.12 126.47 0.05 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.101 -1.0 . . . . 1.0 111.31 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.564 ' CE ' ' O ' ' A' ' 115' ' ' SER . 22.8 ttp -91.54 125.7 36.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 1.0 109.59 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.556 ' HE1' ' CB ' ' A' ' 70' ' ' ALA . 4.0 ptt? -112.56 128.87 56.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.947 -1.095 . . . . 1.0 110.491 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.489 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -118.58 121.21 39.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 1.0 110.211 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.701 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.2 t70 -126.99 46.54 2.49 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.607 0.718 . . . . 1.0 109.965 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.556 HD21 ' CZ ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -70.34 53.8 0.14 Allowed 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.005 179.631 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' C ' ' OG ' ' A' ' 86' ' ' SER . . . 161.77 -66.4 0.25 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.417 ' OG ' ' C ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -169.03 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.001 -1.294 . . . . 1.0 111.53 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -99.48 112.65 63.87 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.809 -1.182 . . . . 1.0 111.222 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -76.11 114.98 4.02 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.939 1.494 . . . . 1.0 109.708 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.632 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -93.1 105.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.248 -0.907 . . . . 1.0 110.458 -179.229 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -90.26 120.79 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 119.972 -1.705 . . . . 1.0 110.445 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.558 ' HB3' ' O ' ' A' ' 124' ' ' ILE . 33.6 mt -113.35 76.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.521 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 21.6 mtp180 -57.87 179.15 0.07 Allowed 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.213 -0.995 . . . . 1.0 110.651 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.484 ' HA ' ' CD1' ' A' ' 124' ' ' ILE . 1.4 t -104.77 167.02 9.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.005 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.27 17.42 15.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.332 -0.855 . . . . 1.0 109.771 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.581 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 68.0 t -135.45 150.46 72.41 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.534 -0.729 . . . . 1.0 110.171 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.581 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 42.8 Cg_endo -68.85 139.08 42.51 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.796 1.419 . . . . 1.0 110.39 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.563 ' CG1' HD12 ' A' ' 47' ' ' ILE . 2.7 tt -129.17 -27.21 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 1.0 111.034 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.597 ' CB ' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p30 -80.93 44.6 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.125 -0.984 . . . . 1.0 110.288 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 100' ' ' ASN . 94.3 m -117.64 24.67 10.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 1.0 110.359 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 99' ' ' THR . 62.1 t30 59.77 41.16 18.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 1.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -130.02 137.69 50.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.832 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.591 ' CD2' ' HD2' ' A' ' 48' ' ' LYS . 3.9 m95 -61.93 91.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 1.0 110.315 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.54 ' O ' ' CB ' ' A' ' 46' ' ' SER . 54.5 m -80.56 172.5 13.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.061 -1.024 . . . . 1.0 108.927 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -129.99 106.59 8.75 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.111 -0.993 . . . . 1.0 108.672 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.542 ' CD1' HG23 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -97.64 136.57 28.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 O-C-N 121.094 -1.004 . . . . 1.0 109.2 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HG3' ' N ' ' A' ' 107' ' ' ALA . 1.3 tppt? -137.22 155.87 48.99 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.98 -1.088 . . . . 1.0 110.169 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -153.59 123.24 6.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.096 -1.002 . . . . 1.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.624 ' O ' ' CD1' ' A' ' 108' ' ' TYR . 41.6 p90 -126.24 112.16 15.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.556 ' CZ ' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -120.53 154.8 34.83 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.369 -0.832 . . . . 1.0 110.432 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.518 ' N ' ' HG2' ' A' ' 109' ' ' ARG . 2.4 t -128.65 95.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 1.0 110.721 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 22.8 mt-30 34.71 24.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 0.2 OUTLIER 173.2 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.486 -1.384 . . . . 1.0 110.437 179.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.586 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -97.72 117.91 33.07 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.566 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.501 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.84 157.36 16.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.608 ' OG ' ' CE2' ' A' ' 108' ' ' TYR . 38.7 t -135.69 157.59 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.452 -1.028 . . . . 1.0 109.949 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 2.3 tm? -137.19 153.1 50.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.577 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.1 OUTLIER -158.59 128.12 5.72 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.538 -1.265 . . . . 1.0 111.617 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.535 HG22 ' CG2' ' A' ' 95' ' ' VAL . 20.4 m -92.05 100.2 10.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' ASN . . . 68.62 42.49 80.28 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.366 -1.093 . . . . 1.0 110.366 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 10.6 m-80 58.06 31.69 21.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.244 -1.151 . . . . 1.0 111.073 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 122' ' ' ALA . 1.3 tt0 -100.09 167.01 10.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 1.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.598 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -19.73 102.96 0.06 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 CA-C-O 120.989 0.423 . . . . 1.0 110.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 40.0 Cg_endo -69.24 131.38 21.85 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.258 1.662 . . . . 1.0 112.478 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.558 ' O ' ' HB3' ' A' ' 91' ' ' LEU . 4.5 mp -92.42 104.89 16.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 105.84 -1.911 . . . . 1.0 105.84 177.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.544 ' CG2' ' OG ' ' A' ' 115' ' ' SER . 32.7 p -118.55 160.98 20.8 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.902 -1.119 . . . . 1.0 112.401 -176.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.63 173.16 38.84 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 107.108 -2.397 . . . . 1.0 107.108 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -154.7 160.62 41.49 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.645 -1.503 . . . . 1.0 110.396 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.45 ' O ' ' CG ' ' A' ' 112' ' ' ARG . 50.1 m -105.71 160.86 24.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 118.955 -1.098 . . . . 1.0 109.248 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 130' ' ' LEU . 38.1 Cg_endo -64.51 -21.34 66.05 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 N-CA-C 108.196 -1.501 . . . . 1.0 108.196 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.564 ' CB ' ' O ' ' A' ' 129' ' ' PRO . 1.0 OUTLIER 155.92 -161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.36 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 148.09 -44.77 0.76 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -155.66 114.24 3.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -1.124 . . . . 1.0 110.381 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -63.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 1.0 110.222 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -100.55 76.76 1.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.0 110.508 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.468 HD13 ' HB3' ' A' ' 84' ' ' LEU . 1.1 tp -71.46 112.28 7.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.862 . . . . 1.0 109.789 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 5.3 m-20 -79.22 127.13 31.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.895 . . . . 1.0 109.937 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -148.94 105.66 3.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 1.0 110.12 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.6 OUTLIER 163.3 -38.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.65 0.738 . . . . 1.0 109.07 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.552 ' N ' ' HD3' ' A' ' 61' ' ' LYS . . . -44.57 -32.88 3.03 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.175 -1.17 . . . . 1.0 110.175 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.536 ' N ' ' HE3' ' A' ' 61' ' ' LYS . . . -161.02 153.33 20.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.769 -1.43 . . . . 1.0 109.897 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.524 HD13 ' CD2' ' A' ' 57' ' ' LEU . 30.0 tp -155.73 152.8 28.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 110.519 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.667 ' CG ' ' HE2' ' A' ' 146' ' ' MET . 31.4 m95 -118.31 161.87 19.22 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.562 ' CD2' ' CD1' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -152.83 111.29 3.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.2 -1.8 . . . . 1.0 113.42 -177.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.555 ' O ' ' CA ' ' A' ' 162' ' ' GLY . . . 125.96 -11.18 7.38 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.529 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 158.2 -140.43 6.98 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 119.005 -1.569 . . . . 1.0 109.707 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.714 ' CE ' ' HA ' ' A' ' 146' ' ' MET . 0.1 OUTLIER -168.11 152.35 6.24 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.183 -1.007 . . . . 1.0 111.098 -179.362 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -96.58 -8.96 30.47 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.877 0.846 . . . . 1.0 109.513 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -141.64 53.03 1.51 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.689 ' CD1' ' CB ' ' A' ' 146' ' ' MET . 0.2 OUTLIER -62.82 57.17 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 1.0 111.854 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 148' ' ' ARG . 29.6 p -59.49 -22.53 61.72 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.79 -1.93 . . . . 1.0 105.79 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 152' ' ' ALA 0.289 9.8 p -76.92 -130.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.49 -1.232 . . . . 1.0 108.831 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.634 ' HA ' ' CE2' ' A' ' 159' ' ' TYR . . . 55.86 50.72 13.47 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.804 -1.185 . . . . 1.0 108.578 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -52.58 -111.81 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.293 1.961 . . . . 1.0 116.293 -175.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 18.25 0.24 Allowed 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 113.944 1.09 . . . . 1.0 113.944 -175.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.637 ' CD2' ' CD2' ' A' ' 159' ' ' TYR . 5.1 tt -95.71 141.08 22.68 Favored Pre-proline 0 C--N 1.288 -2.089 0 O-C-N 120.858 -1.152 . . . . 1.0 110.499 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.56 ' O ' ' CD2' ' A' ' 155' ' ' LEU . 37.6 Cg_endo -62.05 -149.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.045 1.55 . . . . 1.0 111.327 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -60.41 -10.42 4.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.837 -1.165 . . . . 1.0 112.869 -177.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.606 ' CB ' ' CD2' ' A' ' 155' ' ' LEU . . . -41.71 -35.35 0.76 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.814 -1.179 . . . . 1.0 109.428 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.637 ' CD2' ' CD2' ' A' ' 155' ' ' LEU . 32.4 m-85 -86.79 -31.99 20.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.744 -1.223 . . . . 1.0 108.928 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -72.68 -5.88 40.62 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.436 -1.305 . . . . 1.0 108.0 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.635 ' CG2' ' CD1' ' A' ' 164' ' ' ILE . 33.4 m -122.23 90.26 3.27 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 163' ' ' PHE . . . -57.06 106.87 0.8 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.057 -1.068 . . . . 1.0 110.562 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.666 ' O ' ' O ' ' A' ' 162' ' ' GLY . 89.5 t80 12.95 137.8 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 115.761 1.763 . . . . 1.0 115.761 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.649 ' HB ' ' HB3' ' A' ' 51' ' ' ALA . 2.2 mt -131.08 86.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.084 -0.962 . . . . 1.0 108.827 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.18 -161.17 21.38 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 107.2 -2.36 . . . . 1.0 107.2 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.571 ' O ' ' N ' ' A' ' 48' ' ' LYS . 3.3 m -129.27 142.57 50.8 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.87 -1.371 . . . . 1.0 110.023 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -128.24 157.89 40.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.402 -1.436 . . . . 1.0 112.285 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.572 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -165.36 168.31 16.92 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.061 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.4 m-20 43.78 72.89 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.214 -0.929 . . . . 1.0 110.658 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 45' ' ' LEU . 26.8 m -127.67 123.25 60.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.89 -1.124 . . . . 1.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.499 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -136.0 152.17 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.53 -177.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -133.8 103.35 5.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 6.7 m-20 57.55 35.46 25.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.975 -1.121 . . . . 1.0 107.975 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 75.0 6.34 4.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.828 -0.545 . . . . 1.0 111.088 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.563 ' O ' ' CB ' ' A' ' 176' ' ' GLU . 77.8 mm-40 -91.18 176.39 6.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.143 -0.973 . . . . 1.0 110.105 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.563 ' CB ' ' O ' ' A' ' 175' ' ' GLN . 30.0 tt0 83.68 -109.66 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 176' ' ' GLU . 0.4 OUTLIER 29.97 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.304 -0.873 . . . . 1.0 112.499 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 181' ' ' GLU . 2.3 m80 -160.89 44.5 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.994 -1.066 . . . . 1.0 110.597 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.64 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 0.0 OUTLIER -52.17 -27.89 16.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.553 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 9.2 t -71.3 -35.23 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.12 0.486 . . . . 1.0 111.198 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 51.0 mt-10 -62.16 -56.07 22.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.049 -1.032 . . . . 1.0 109.54 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.639 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -81.89 -19.7 40.36 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.086 179.008 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.64 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -48.14 -41.76 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.818 -1.153 . . . . 1.0 107.94 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ALA . 3.4 mt -41.78 -26.3 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.369 0.604 . . . . 1.0 109.598 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 6.3 t-20 -62.8 -11.61 19.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.353 -0.842 . . . . 1.0 109.808 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 187' ' ' PRO . 0.5 OUTLIER -123.85 154.21 67.35 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.539 -0.725 . . . . 1.0 109.182 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.518 ' O ' ' ND2' ' A' ' 186' ' ' ASN . 37.3 Cg_endo -61.27 -162.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.671 1.353 . . . . 1.0 111.215 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 187' ' ' PRO . 4.8 m -40.74 134.56 1.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.21 -0.931 . . . . 1.0 111.263 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.55 ' CD1' ' CB ' ' A' ' 183' ' ' ALA . 3.1 mt -102.91 144.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.443 -0.785 . . . . 1.0 109.452 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.492 ' O ' HG21 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -100.37 153.41 19.35 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.098 -1.001 . . . . 1.0 109.889 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.528 ' CE1' HD13 ' A' ' 17' ' ' ILE . 1.6 m-70 -112.68 152.25 29.23 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.289 -0.882 . . . . 1.0 109.618 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -105.77 119.98 40.53 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.424 -0.91 . . . . 1.0 109.974 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 20.5 m -121.73 165.36 15.92 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.984 -1.073 . . . . 1.0 110.909 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . 173.15 91.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.477 -0.764 . . . . 1.0 110.048 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.297 -1.694 0 C-N-CA 118.743 -1.183 . . . . 1.0 110.47 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -162.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.363 -1.081 . . . . 1.0 110.36 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.94 85.73 3.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 110.396 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -148.19 140.16 24.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.13 -0.982 . . . . 1.0 110.136 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.1 m -108.24 94.9 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 1.0 110.192 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 pt -70.59 143.94 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 1.0 110.334 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 7' ' ' ILE . 18.3 tt -125.62 87.93 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 1.0 110.201 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -43.63 130.15 5.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 1.0 110.184 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -126.34 152.96 45.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -0.979 . . . . 1.0 110.061 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.22 143.26 48.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.895 . . . . 1.0 110.362 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.98 81.71 7.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 1.0 110.146 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.81 115.87 1.85 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.533 -1.427 . . . . 1.0 109.533 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -137.89 70.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.152 -1.205 . . . . 1.0 110.268 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.12 72.53 1.41 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 1.0 109.964 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.9 pt-20 -130.58 109.95 11.05 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.245 -0.909 . . . . 1.0 110.154 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -117.22 151.28 37.23 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.063 -1.023 . . . . 1.0 109.712 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 7.0 mm -119.52 133.27 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.037 . . . . 1.0 110.328 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -91.49 124.15 35.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.651 . . . . 1.0 110.431 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 167' ' ' ILE . 4.0 m-30 -91.1 132.69 35.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.0 109.209 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 2.3 p30 -97.74 2.16 49.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 1.0 110.545 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 103.51 -22.8 34.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.506 -1.838 . . . . 1.0 108.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.481 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 5.3 ttt-85 -107.25 -8.1 16.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.634 -0.921 . . . . 1.0 109.672 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.495 HG22 ' CD2' ' A' ' 19' ' ' PHE . 14.9 t -48.08 174.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 1.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.619 ' CE1' ' HB2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER 179.86 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 1.0 109.104 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.468 ' O ' ' HA ' ' A' ' 142' ' ' TRP . 25.0 mtt -96.26 101.33 12.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.943 -1.098 . . . . 1.0 111.007 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.619 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 18.7 tt0 -93.39 121.97 35.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.347 -0.846 . . . . 1.0 109.481 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CE2' ' CB ' ' A' ' 182' ' ' ASP . 6.2 m-85 -113.62 105.63 13.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.184 -0.947 . . . . 1.0 109.993 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.16 86.63 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 1.0 110.449 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -121.88 176.82 5.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.227 -0.92 . . . . 1.0 110.132 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.02 99.94 12.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.196 -0.94 . . . . 1.0 110.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 32' ' ' THR . 76.9 t -60.03 168.99 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.235 -0.915 . . . . 1.0 109.977 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.477 ' N ' HG12 ' A' ' 31' ' ' VAL . 6.0 p -126.94 -178.36 4.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.056 -1.028 . . . . 1.0 110.369 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -51.76 91.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 1.0 110.566 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' THR . 4.5 t -123.47 -19.22 5.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 1.0 110.311 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 1.5 mt-10 -177.25 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 1.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 23.5 ttpt 55.57 97.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.08 -1.013 . . . . 1.0 109.877 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 36' ' ' LYS . . . 43.28 70.59 0.29 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.253 -0.904 . . . . 1.0 109.311 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.575 HD21 ' N ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.38 -172.95 1.01 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.376 -0.827 . . . . 1.0 111.664 -178.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -119.25 9.26 11.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.517 -0.74 . . . . 1.0 109.345 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -161.61 131.26 4.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.529 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 5.0 m-80 -98.64 163.05 12.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.966 -1.084 . . . . 1.0 110.472 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -134.99 137.48 43.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 1.0 110.112 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 41' ' ' ASN . 91.0 m-85 -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 1.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.51 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 3.0 mt-10 -126.75 145.24 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.981 -1.074 . . . . 1.0 109.867 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.543 ' HA ' ' O ' ' A' ' 169' ' ' ASP . 0.5 OUTLIER 179.08 156.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.401 -0.92 . . . . 1.0 111.412 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 103' ' ' THR . 4.8 m -122.13 154.99 36.66 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.612 -1.255 . . . . 1.0 107.612 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 166' ' ' CYS . 3.3 pt -148.82 163.46 4.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 117.829 -1.548 . . . . 1.0 112.652 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.602 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.8 OUTLIER -114.3 83.31 1.86 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 177.241 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.488 ' OG1' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -70.67 150.7 45.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.084 -1.01 . . . . 1.0 112.434 -176.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.651 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 6.7 mm-40 -135.68 -3.12 2.35 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.35 0.595 . . . . 1.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.51 125.96 11.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.257 -0.902 . . . . 1.0 109.84 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.469 ' HB ' ' N ' ' A' ' 76' ' ' GLY . 47.5 p -55.51 -15.02 2.35 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.553 -0.717 . . . . 1.0 111.327 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -123.4 133.63 54.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.902 -1.124 . . . . 1.0 111.655 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 157.9 134.74 1.78 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.159 -1.177 . . . . 1.0 110.159 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.595 ' HA ' ' CB ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -83.08 143.35 30.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.769 -1.43 . . . . 1.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.622 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.8 OUTLIER -111.81 -47.03 5.94 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 C-N-CA 119.741 -0.784 . . . . 1.0 111.762 -177.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 5.7 tt -134.58 145.14 48.4 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.278 -1.514 . . . . 1.0 113.031 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.671 ' CZ3' ' CD1' ' A' ' 68' ' ' TYR . 2.3 t-105 -149.68 117.12 6.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.804 . . . . 1.0 109.041 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -127.22 -176.08 3.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 1.0 110.694 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 61' ' ' LYS . . . 125.05 10.44 4.71 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER 78.33 -37.18 0.21 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.497 -1.002 . . . . 1.0 110.817 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 118.51 85.91 1.05 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.486 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 3.4 mm? -114.51 156.56 24.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -1.164 . . . . 1.0 109.72 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.429 ' C ' ' HG2' ' A' ' 65' ' ' ARG . 7.5 mm-40 -62.48 -30.7 71.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 1.0 110.339 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' HG2' ' C ' ' A' ' 64' ' ' GLU . 2.1 ptm180 178.13 43.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.678 0.752 . . . . 1.0 109.187 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.451 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -110.63 -167.72 1.22 Allowed 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.725 -0.79 . . . . 1.0 110.628 -178.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 5.5 p-10 -40.31 133.21 1.87 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 1.0 110.829 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.671 ' CD1' ' CZ3' ' A' ' 58' ' ' TRP . 2.5 p90 -171.14 159.15 5.81 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.242 -0.911 . . . . 1.0 109.572 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.561 HD13 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -147.56 136.16 15.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 121.68 -0.637 . . . . 1.0 110.059 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.572 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -132.87 -174.33 3.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 1.0 110.455 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' A' ' 70' ' ' ALA . 66.0 mt -149.0 101.14 3.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.849 . . . . 1.0 108.722 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.648 ' CB ' ' CE1' ' A' ' 159' ' ' TYR . . . -119.38 174.41 6.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.957 -1.089 . . . . 1.0 112.211 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 78' ' ' VAL . 56.3 mt -113.86 131.17 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.668 -0.645 . . . . 1.0 110.597 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.495 HG12 ' NH2' ' A' ' 92' ' ' ARG . 2.5 p -139.96 131.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.415 -0.803 . . . . 1.0 110.077 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 28.0 m-20 61.24 10.12 2.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 1.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.469 ' N ' ' HB ' ' A' ' 52' ' ' THR . . . 95.19 9.36 58.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 78' ' ' VAL . 61.5 m-85 -133.32 108.46 8.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -1.095 . . . . 1.0 110.048 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.596 ' CG1' ' CD1' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -48.6 -175.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.77 0.795 . . . . 1.0 111.412 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 0.8 OUTLIER -172.9 124.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.672 0.749 . . . . 1.0 110.893 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.56 ' CE ' ' O ' ' A' ' 115' ' ' SER . 2.2 ttm -85.03 110.54 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.791 -0.568 . . . . 1.0 110.481 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.599 ' CE ' ' OH ' ' A' ' 159' ' ' TYR . 37.1 mtm -89.45 116.71 27.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.906 -1.121 . . . . 1.0 109.885 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.561 ' CZ ' HD13 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -111.92 116.38 30.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.693 -1.255 . . . . 1.0 109.163 178.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -124.98 48.09 2.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 1.0 110.469 -179.156 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.552 ' HB3' ' CD1' ' A' ' 135' ' ' LEU . 0.4 OUTLIER -65.06 61.66 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.975 -0.69 . . . . 1.0 110.138 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 132.4 33.09 0.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.956 -1.258 . . . . 1.0 109.956 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.01 9.69 5.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.237 -1.155 . . . . 1.0 110.107 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.49 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -108.0 89.32 5.4 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 1.0 109.333 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.533 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -72.11 140.81 35.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.157 1.609 . . . . 1.0 111.599 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -137.12 119.14 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.569 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 1.0 OUTLIER -97.46 114.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.354 -1.466 . . . . 1.0 111.403 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.496 HD13 ' CE ' ' A' ' 80' ' ' MET . 38.3 mt -104.38 71.97 1.03 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.137 -1.431 . . . . 1.0 107.137 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 51.1 mtp180 -57.33 178.58 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.052 0.93 . . . . 1.0 111.046 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.53 ' OG ' ' CG2' ' A' ' 118' ' ' VAL . 3.3 t -108.35 155.21 20.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.175 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.474 ' OG1' HD13 ' A' ' 124' ' ' ILE . 1.4 p -112.11 26.38 10.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 1.0 109.673 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 96' ' ' PRO . 8.0 t -129.07 146.62 61.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.519 -0.738 . . . . 1.0 109.454 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.488 ' N ' HG13 ' A' ' 95' ' ' VAL . 43.6 Cg_endo -67.85 116.17 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.754 1.397 . . . . 1.0 109.767 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.488 HG13 ' OG1' ' A' ' 49' ' ' THR . 1.8 tp -106.78 -33.36 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.14 -0.975 . . . . 1.0 111.055 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -71.64 61.22 0.36 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 1.0 110.738 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -127.21 14.28 7.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 1.0 110.167 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.481 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 1.9 m120 58.63 40.88 23.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.995 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.549 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 1.1 m-70 -132.11 159.14 39.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 1.0 110.172 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.602 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 22.2 m95 -78.87 101.37 7.65 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.292 -0.963 . . . . 1.0 109.729 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 46' ' ' SER . 5.9 m -101.93 171.66 7.39 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.441 -0.904 . . . . 1.0 109.009 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.525 ' N ' ' CG2' ' A' ' 103' ' ' THR . 8.4 t60 -119.97 143.9 47.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.07 -1.019 . . . . 1.0 108.791 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.463 HD11 HD11 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -133.67 159.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.22 -0.925 . . . . 1.0 109.172 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.522 ' O ' HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -152.45 148.47 27.47 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.659 -1.217 . . . . 1.0 110.307 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.485 ' HB3' HD23 ' A' ' 116' ' ' LEU . . . -144.23 102.21 3.82 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.526 -0.733 . . . . 1.0 110.374 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.58 ' CE1' ' OG ' ' A' ' 115' ' ' SER . 37.1 p90 -117.07 105.48 12.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 108.689 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.638 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -91.44 150.87 21.05 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.655 -0.818 . . . . 1.0 111.225 -178.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.7 t -136.93 96.51 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.679 -0.638 . . . . 1.0 110.799 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.582 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 17.4 mt-30 43.74 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.662 -0.649 . . . . 1.0 111.779 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.582 ' CD ' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 54.2 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.651 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.8 tm-20 -95.97 109.75 22.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.108 -1.62 . . . . 1.0 109.919 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -99.05 161.43 20.07 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.067 -1.063 . . . . 1.0 110.892 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 108' ' ' TYR . 33.7 t -132.7 156.67 46.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -1.17 . . . . 1.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 117' ' ' GLN . 2.1 tm? -140.09 151.51 45.41 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.574 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.52 144.59 25.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.888 -1.133 . . . . 1.0 111.514 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.53 ' CG2' ' OG ' ' A' ' 93' ' ' SER . 41.1 t -102.86 98.92 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 177.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.522 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.21 39.52 82.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.715 -1.354 . . . . 1.0 109.715 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 119' ' ' GLY . 21.8 t-20 57.36 32.13 21.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -1.104 . . . . 1.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 123' ' ' PRO . 5.3 mt-10 -114.8 -158.11 0.66 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.569 -0.707 . . . . 1.0 110.593 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -30.43 93.77 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.936 -0.477 . . . . 1.0 110.576 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.9 Cg_endo -77.12 142.65 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.039 1.547 . . . . 1.0 112.012 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.543 ' CB ' ' O ' ' A' ' 92' ' ' ARG . 3.3 mp -108.53 100.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.9 p -108.19 166.96 10.35 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.192 0.996 . . . . 1.0 111.962 -177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.7 167.76 38.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.222 -2.351 . . . . 1.0 107.222 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.651 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -136.88 170.0 16.82 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.555 -1.556 . . . . 1.0 110.929 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 31.7 p -96.92 163.57 19.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.921 -1.112 . . . . 1.0 110.431 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 130' ' ' LEU . 45.6 Cg_endo -71.65 55.62 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.954 1.502 . . . . 1.0 108.735 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 129' ' ' PRO . 4.7 mp 41.05 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.637 -0.665 . . . . 1.0 110.056 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.29 10.57 47.87 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.499 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -133.58 145.54 50.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.113 -1.228 . . . . 1.0 109.867 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 134' ' ' GLN . 34.5 m -137.52 13.94 2.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.089 -1.007 . . . . 1.0 110.676 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 133' ' ' THR . 1.7 mt-30 179.94 160.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 1.0 110.54 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.552 ' CD1' ' HB3' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -166.08 61.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.485 -0.759 . . . . 1.0 109.893 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 4.2 m-20 -77.4 122.19 24.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.056 . . . . 1.0 109.439 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.77 164.23 18.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.08 . . . . 1.0 110.877 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 138' ' ' ASP . 20.4 p-10 -89.82 29.35 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 1.0 110.204 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 52.29 18.09 4.64 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 1.0 109.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 27' ' ' TYR . . . -64.34 158.76 22.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -1.21 . . . . 1.0 109.072 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.535 ' C ' ' CD1' ' A' ' 142' ' ' TRP . 6.8 tp -158.47 144.06 16.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.446 -1.302 . . . . 1.0 112.481 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.581 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 19.2 m95 -131.88 97.27 4.13 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 2.8 tt -112.82 119.73 39.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.627 -1.295 . . . . 1.0 113.544 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 128.67 3.74 5.45 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.538 ' O ' ' HE3' ' A' ' 146' ' ' MET . . . 145.91 -147.72 18.93 Favored Glycine 0 C--N 1.283 -2.378 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' MET . . . . . 0.682 ' CB ' HD12 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -151.64 113.13 4.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.082 -1.047 . . . . 1.0 111.772 -178.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.64 -24.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.997 0.903 . . . . 1.0 109.025 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.548 ' N ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -145.68 83.47 1.65 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 178.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.682 HD12 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -71.58 22.84 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.275 -0.891 . . . . 1.0 112.757 -176.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.3 p -61.67 -19.68 62.6 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.619 HG23 ' CZ3' ' A' ' 58' ' ' TRP 0.288 10.5 p -71.51 -123.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.67 -1.15 . . . . 1.0 110.301 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.583 ' HB2' ' CB ' ' A' ' 159' ' ' TYR . . . 72.1 -71.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.702 -1.249 . . . . 1.0 108.796 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.531 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 52.94 155.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.919 1.342 . . . . 1.0 112.545 178.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER 44.16 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.006 1.484 . . . . 1.0 115.006 178.11 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.587 ' HG ' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -135.86 154.0 77.52 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.057 -1.652 . . . . 1.0 111.054 -179.387 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.568 ' N ' HD21 ' A' ' 155' ' ' LEU . 41.0 Cg_endo -65.62 -161.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.594 1.529 . . . . 1.0 113.629 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.517 ' HG3' ' CB ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -55.93 -8.88 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.561 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.554 ' CB ' HD23 ' A' ' 155' ' ' LEU . . . -39.85 -38.35 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.915 -1.116 . . . . 1.0 109.44 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.648 ' CE1' ' CB ' ' A' ' 72' ' ' ALA . 10.2 m-85 -85.85 -31.6 22.16 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.855 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.517 ' CB ' ' HG3' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -65.04 -11.04 34.82 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.952 -1.499 . . . . 1.0 108.243 177.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.522 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.2 m -122.27 98.94 6.16 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -49.82 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.637 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 32.8 t80 -88.79 145.5 25.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.119 -1.224 . . . . 1.0 111.575 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.651 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 2.5 mt -123.42 85.39 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.139 -1.43 . . . . 1.0 107.139 177.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.637 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.67 -156.13 11.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.316 -1.914 . . . . 1.0 108.316 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.0 m -133.41 154.06 51.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.112 -1.228 . . . . 1.0 110.311 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.9 mt -134.76 144.96 33.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.774 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.503 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 26.9 ttt180 -150.72 164.6 35.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.892 -1.13 . . . . 1.0 110.659 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.6 m-20 43.57 74.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.202 -0.936 . . . . 1.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 45' ' ' LEU . 22.7 m -126.74 124.17 64.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 119.311 -0.955 . . . . 1.0 109.891 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.515 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -131.95 158.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.929 -1.108 . . . . 1.0 111.331 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 76.5 t -134.15 114.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 63.3 m-20 50.01 36.58 12.14 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.878 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.7 OUTLIER 67.61 34.25 4.64 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.377 0.608 . . . . 1.0 110.411 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 19.2 mm100 -114.45 -176.53 2.92 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 121.323 -0.861 . . . . 1.0 110.616 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 0.3 OUTLIER 67.91 -98.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 1.0 110.66 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.518 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 12.1 mt 60.37 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.894 -1.128 . . . . 1.0 111.477 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 2.6 m-70 -70.09 79.74 0.5 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.716 -1.24 . . . . 1.0 110.546 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.546 ' O ' ' CB ' ' A' ' 183' ' ' ALA 0.263 0.5 OUTLIER -52.7 -61.23 2.42 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.201 1.001 . . . . 1.0 110.752 178.931 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.518 ' HA ' ' CD2' ' A' ' 184' ' ' LEU . 12.9 t -52.91 -18.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.632 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 0.7 OUTLIER -73.63 -56.51 4.91 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.732 -1.187 . . . . 1.0 109.901 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.612 ' CB ' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -95.81 -18.38 20.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.099 -1.0 . . . . 1.0 109.8 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -73.74 -29.92 62.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.144 -0.972 . . . . 1.0 108.703 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.555 ' N ' HD23 ' A' ' 184' ' ' LEU . 1.5 mm? -65.06 -8.8 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.424 -0.798 . . . . 1.0 109.987 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 184' ' ' LEU . 8.5 t-20 -43.85 -26.43 0.26 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.391 -0.818 . . . . 1.0 109.095 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.476 ' O ' HG12 ' A' ' 189' ' ' ILE . 2.2 t-20 -113.9 148.89 40.89 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 47.8 Cg_endo -76.97 -34.74 2.11 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.824 1.434 . . . . 1.0 110.68 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 4.51 0.42 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.697 -0.683 . . . . 1.0 112.76 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 186' ' ' ASN . 23.4 mm -61.95 117.35 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.323 -1.485 . . . . 1.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -120.59 159.64 24.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 110.829 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . 0.458 ' O ' ' HB1' ' A' ' 18' ' ' ALA . 18.9 m-70 -93.54 151.55 19.62 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.344 -0.847 . . . . 1.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' CYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 9.2 t -52.65 139.79 25.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 1.0 111.913 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.67 145.88 48.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.479 -0.763 . . . . 1.0 109.763 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.37 96.99 1.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 1.0 110.566 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 118.952 -1.099 . . . . 1.0 110.466 179.086 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.571 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.6 pt-20 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.243 0.544 . . . . 1.0 110.531 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -95.35 136.95 35.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.662 -1.274 . . . . 1.0 110.766 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 190' ' ' LEU . 8.9 mm -127.43 118.16 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.278 -0.888 . . . . 1.0 109.702 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -80.76 142.46 33.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 1.0 111.216 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.718 ' CE1' HD12 ' A' ' 167' ' ' ILE . 9.1 m-85 -106.6 172.07 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 1.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.491 ' C ' HG12 ' A' ' 164' ' ' ILE . 3.8 p30 -127.32 -3.62 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 1.0 110.637 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.482 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 110.17 -9.8 31.34 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.85 -1.7 . . . . 1.0 108.85 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -127.72 -24.95 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -1.186 . . . . 1.0 110.773 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 133.76 37.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 1.0 110.369 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.618 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -128.17 114.55 17.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 1.0 110.365 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.527 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 6.0 mmt -83.23 99.07 9.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.85 -1.156 . . . . 1.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HG3' ' CH2' ' A' ' 142' ' ' TRP . 46.8 tt0 -87.77 87.98 7.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 1.0 109.456 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 182' ' ' ASP . 8.0 m-30 -92.18 97.03 10.65 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 1.0 110.236 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.15 104.39 16.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 1.0 110.007 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 138' ' ' ASP . 1.4 t-20 -147.36 162.97 37.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 1.0 110.338 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.69 50.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 1.0 110.376 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.472 ' H ' HG22 ' A' ' 31' ' ' VAL . 4.6 m . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.271 -0.893 . . . . 1.0 110.907 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.403 ' NE2' ' HB2' ' A' ' 40' ' ' SER . 2.5 tm0? . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.667 0.746 . . . . 1.0 109.809 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.455 ' OG ' HG13 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -160.72 146.22 14.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.732 -0.605 . . . . 1.0 109.467 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.609 ' ND2' ' N ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -133.23 155.28 49.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.049 -1.032 . . . . 1.0 111.597 -178.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 8.8 m-70 -114.67 143.97 44.18 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 58.4 m-85 -129.02 121.76 28.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.097 -1.002 . . . . 1.0 110.644 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.746 ' C ' HD23 ' A' ' 45' ' ' LEU . 2.8 mt-10 -127.92 147.24 50.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.014 -1.054 . . . . 1.0 109.928 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.001 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.3 pt? 179.89 150.22 0.36 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.759 . . . . 1.0 110.548 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.479 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 1.9 m -120.17 154.07 35.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.479 ' CG2' ' C ' ' A' ' 46' ' ' SER . 1.5 pt -147.49 155.09 10.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.824 -1.55 . . . . 1.0 112.86 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -112.61 82.68 1.69 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 176.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.644 HG21 HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -70.19 163.63 25.98 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.867 -1.146 . . . . 1.0 111.289 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 0.8 OUTLIER -145.39 29.84 1.14 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.299 -0.96 . . . . 1.0 110.845 -178.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.984 ' O ' HG23 ' A' ' 52' ' ' THR . . . -162.24 -96.68 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.943 -1.103 . . . . 1.0 110.324 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.984 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 176.07 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.431 0.634 . . . . 1.0 109.824 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.519 ' HG3' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -119.23 138.77 52.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.43 -0.794 . . . . 1.0 110.61 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.81 135.77 1.89 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.255 -1.938 . . . . 1.0 108.255 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.937 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -84.87 131.68 34.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.743 -1.445 . . . . 1.0 109.552 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.977 HD12 ' HA ' ' A' ' 72' ' ' ALA . 4.6 mp -95.75 -40.28 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 1.0 112.714 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.984 HD13 HD12 ' A' ' 71' ' ' LEU . 7.1 tt -141.13 148.36 39.95 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.254 -1.529 . . . . 1.0 113.652 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.824 ' N ' HD23 ' A' ' 57' ' ' LEU . 7.3 t-105 -152.02 129.06 11.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.73 163.28 32.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.654 -1.279 . . . . 1.0 110.307 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 110.119 -1.192 . . . . 1.0 110.119 179.834 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.683 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 8.5 m-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 109' ' ' ARG . 19.0 mt -112.54 130.76 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.54 -1.35 . . . . 1.0 109.916 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.735 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -153.74 174.57 14.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 1.0 110.717 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.984 HD12 HD13 ' A' ' 57' ' ' LEU . 79.0 mt -146.22 110.4 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.977 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -129.98 164.38 24.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 1.0 112.466 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.942 ' CG1' HD11 ' A' ' 56' ' ' ILE . 9.3 mt -102.59 136.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.639 -0.663 . . . . 1.0 110.678 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 75' ' ' ASP . 4.0 p -140.63 131.44 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.157 -0.965 . . . . 1.0 110.806 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.567 ' CG ' HG22 ' A' ' 74' ' ' VAL . 7.4 m-20 63.8 8.79 4.0 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.352 -0.842 . . . . 1.0 111.032 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 104.56 13.73 25.4 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 35.8 m-85 -135.53 152.73 51.6 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.29 -1.124 . . . . 1.0 109.976 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.773 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.44 166.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 1.0 109.46 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 8.5 pt20 -164.12 126.39 2.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.094 -1.003 . . . . 1.0 110.936 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.813 ' CE ' HD12 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -86.53 103.24 14.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.735 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -104.78 119.39 38.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -0.751 . . . . 1.0 110.433 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.714 ' CE2' HG11 ' A' ' 89' ' ' VAL . 3.7 p90 -141.24 143.65 34.26 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.008 -1.477 . . . . 1.0 111.455 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 16.9 t0 -136.27 108.51 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.698 0.761 . . . . 1.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -110.39 30.4 6.81 Favored 'General case' 0 C--N 1.287 -2.122 0 O-C-N 121.723 -0.61 . . . . 1.0 109.852 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 86' ' ' SER . . . -164.21 -50.86 0.02 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 1.4 t 178.18 -18.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -1.11 . . . . 1.0 111.471 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 17.5 mmtt -119.51 117.86 32.63 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.724 -1.235 . . . . 1.0 110.662 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.07 143.92 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.877 1.462 . . . . 1.0 109.236 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.77 104.47 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 1.0 109.075 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 90' ' ' VAL . 8.7 p -91.1 82.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.483 -1.385 . . . . 1.0 111.261 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.813 HD12 ' CE ' ' A' ' 80' ' ' MET . 5.6 mt -75.02 74.51 2.21 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.572 ' O ' HG21 ' A' ' 124' ' ' ILE . 14.3 mtp180 -59.16 178.88 0.11 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.929 0.871 . . . . 1.0 111.213 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 118' ' ' VAL . 2.0 t -109.97 143.12 40.38 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.49 ' O ' HG22 ' A' ' 94' ' ' THR . 24.4 m -99.82 31.16 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.124 -0.985 . . . . 1.0 109.93 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.936 HG11 HG11 ' A' ' 118' ' ' VAL . 3.0 t -136.27 145.89 53.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 1.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.484 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.1 Cg_endo -65.2 134.48 39.44 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.612 1.322 . . . . 1.0 110.751 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 76' ' ' GLY . 2.6 tp -117.6 -24.5 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 1.0 110.581 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 8.4 p-10 -76.37 55.95 1.03 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.889 . . . . 1.0 109.177 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.618 ' O ' HG22 ' A' ' 99' ' ' THR . 24.2 m -110.89 14.62 22.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.485 -0.76 . . . . 1.0 110.588 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.1 t30 51.67 18.76 0.77 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.08 -1.013 . . . . 1.0 110.624 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -117.32 162.95 17.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.129 -0.982 . . . . 1.0 110.378 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.677 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 16.5 m95 -76.74 101.64 5.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.149 -0.969 . . . . 1.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 104' ' ' HIS . 49.4 m -94.99 165.33 12.49 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.576 -0.85 . . . . 1.0 109.498 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.49 ' N ' HG22 ' A' ' 103' ' ' THR . 1.0 OUTLIER -118.06 136.82 53.32 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -135.31 155.83 37.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.052 -1.03 . . . . 1.0 108.953 -178.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.811 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -152.53 174.5 13.84 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.12 -1.432 . . . . 1.0 110.498 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.672 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -161.23 123.97 3.15 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.328 -0.949 . . . . 1.0 111.214 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 24.6 m-85 -105.24 106.68 17.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.8 ' CZ ' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -105.98 117.7 34.7 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.319 -0.952 . . . . 1.0 111.67 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.917 HG12 ' OE1' ' A' ' 111' ' ' GLN . 1.8 t -118.6 134.52 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.917 ' OE1' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER 29.74 -90.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.675 -0.641 . . . . 1.0 112.047 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -115.14 -14.78 11.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 1.0 112.138 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.7 tt0 -98.97 118.38 35.61 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.83 -1.169 . . . . 1.0 110.914 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.01 171.53 18.99 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.32 -0.943 . . . . 1.0 111.034 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.576 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -147.45 160.89 42.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.586 -0.95 . . . . 1.0 110.206 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.933 HD13 ' N ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -148.87 141.99 24.94 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.268 -0.895 . . . . 1.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.933 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -143.78 130.51 20.27 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.076 -1.05 . . . . 1.0 111.233 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.936 HG11 HG11 ' A' ' 95' ' ' VAL . 2.2 t -89.65 97.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.627 -1.62 . . . . 1.0 106.627 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 71.48 40.51 59.69 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.94 31.99 17.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.059 . . . . 1.0 110.497 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.541 ' N ' ' HG2' ' A' ' 117' ' ' GLN . 2.9 mt-10 -105.08 -158.18 0.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 1.0 110.619 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.34 99.9 0.19 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.664 -0.648 . . . . 1.0 110.013 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.639 ' C ' HD12 ' A' ' 124' ' ' ILE . 48.5 Cg_endo -75.73 135.47 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.154 1.607 . . . . 1.0 111.363 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.639 HD12 ' C ' ' A' ' 123' ' ' PRO . 1.5 mp -103.49 119.52 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.697 ' HA ' HD13 ' A' ' 91' ' ' LEU . 28.5 p -118.35 172.21 7.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.822 -1.174 . . . . 1.0 112.658 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -179.68 153.98 12.99 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.694 -2.163 . . . . 1.0 107.694 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -138.26 161.93 35.62 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.006 -1.291 . . . . 1.0 110.986 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 130' ' ' LEU . 3.2 m -89.94 163.58 31.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.764 . . . . 1.0 109.684 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -68.83 62.36 1.28 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.006 1.53 . . . . 1.0 109.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.2 pp 16.55 50.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.376 0.608 . . . . 1.0 112.366 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -99.95 2.66 56.9 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.668 -1.373 . . . . 1.0 109.668 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 84' ' ' LEU . . . -161.85 84.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -1.109 . . . . 1.0 109.651 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 133' ' ' THR . 91.2 m -87.92 11.5 15.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 1.0 110.624 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.431 ' HG3' ' C ' ' A' ' 133' ' ' THR . 86.3 mt-30 -144.23 92.08 2.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 1.0 110.632 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.475 HD22 HH21 ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.71 160.21 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 1.0 109.598 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -130.65 111.53 12.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.928 -1.107 . . . . 1.0 110.774 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 t -136.18 149.25 48.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -0.885 . . . . 1.0 109.847 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.713 ' OD1' ' HB2' ' A' ' 140' ' ' ALA . 5.5 p-10 -87.68 29.17 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 1.0 110.671 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 58.69 13.61 18.62 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.713 ' HB2' ' OD1' ' A' ' 138' ' ' ASP . . . -57.77 170.22 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 1.0 108.516 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -160.88 145.94 14.2 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.276 -1.37 . . . . 1.0 112.026 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.577 ' CH2' ' HG3' ' A' ' 26' ' ' GLU . 49.6 m95 -135.08 119.13 17.5 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.268 -1.752 . . . . 1.0 106.268 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.613 HD21 HG22 ' A' ' 56' ' ' ILE . 1.7 tt -130.93 123.46 28.94 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.334 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.87 2.17 10.42 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.454 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 141.58 -139.28 9.3 Favored Glycine 0 C--N 1.293 -1.828 0 C-N-CA 118.991 -1.576 . . . . 1.0 109.726 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.904 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -170.74 130.86 0.84 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.948 -1.101 . . . . 1.0 112.178 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -64.99 -42.65 94.34 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -113.14 67.95 0.67 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.975 -1.491 . . . . 1.0 106.975 177.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.904 HD13 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -66.32 37.78 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.194 -0.941 . . . . 1.0 113.403 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 148' ' ' ARG . 53.4 p -83.8 3.39 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 175.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.812 HG21 ' CZ2' ' A' ' 58' ' ' TRP . 14.9 p -86.59 -23.87 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.308 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 153' ' ' HIS . . . -41.82 -26.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 1.0 109.508 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.56 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER 83.38 -85.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.965 -0.459 . . . . 1.0 111.245 179.218 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -143.91 -7.17 0.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 1.0 111.776 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.746 HD22 ' CE1' ' A' ' 159' ' ' TYR . 4.2 pp -53.65 167.07 0.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.108 -0.995 . . . . 1.0 110.377 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.702 ' O ' HD12 ' A' ' 155' ' ' LEU . 42.7 Cg_endo -68.96 -165.67 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.734 1.386 . . . . 1.0 112.278 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 1.5 mttp -56.25 -9.97 0.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.189 -0.944 . . . . 1.0 112.171 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.519 ' HA ' ' HG3' ' A' ' 53' ' ' GLN . . . -38.2 -44.36 0.85 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 1.0 109.784 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.937 ' CE2' HD13 ' A' ' 55' ' ' LEU . 6.0 m-85 -87.87 -27.07 22.44 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.989 -1.084 . . . . 1.0 108.748 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.567 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -73.17 -6.59 46.78 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.435 -1.306 . . . . 1.0 107.981 177.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 161' ' ' THR . 4.4 m -122.2 83.91 2.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.67 171.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 167' ' ' ILE . 6.2 t80 -89.55 144.23 26.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -1.218 . . . . 1.0 111.391 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.567 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 5.9 mt -123.2 91.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.636 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -169.63 -154.07 8.97 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.48 -1.848 . . . . 1.0 108.48 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.562 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 2.9 m -124.09 144.56 49.8 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.204 -1.174 . . . . 1.0 110.516 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.718 HD12 ' CE1' ' A' ' 19' ' ' PHE 0.251 3.4 mt -134.1 145.59 32.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.534 -0.729 . . . . 1.0 109.425 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 6.5 ttp180 -162.0 157.25 23.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.69 -1.256 . . . . 1.0 111.023 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 4.2 m-20 57.37 63.49 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 1.001 HG12 ' CB ' ' A' ' 45' ' ' LEU . 27.1 m -119.58 117.82 55.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.937 0.875 . . . . 1.0 109.653 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 175' ' ' GLN . 0.5 OUTLIER -135.6 155.9 37.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.09 -1.044 . . . . 1.0 110.915 -178.072 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 3.6 p -134.74 112.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 94.6 m-20 59.04 37.49 24.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.24 32.59 14.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.764 -0.585 . . . . 1.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.603 ' O ' HG23 ' A' ' 171' ' ' ILE . 76.5 mm-40 -118.45 176.16 5.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.186 -0.946 . . . . 1.0 110.44 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.606 ' O ' HD23 ' A' ' 177' ' ' LEU . 59.5 mm-40 65.18 -121.35 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 1.0 110.756 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.622 ' HG ' ' CD2' ' A' ' 178' ' ' HIS . 0.1 OUTLIER 57.62 7.31 0.52 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.866 . . . . 1.0 112.205 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.622 ' CD2' ' HG ' ' A' ' 177' ' ' LEU . 8.3 m80 -110.14 56.53 0.62 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.545 -1.347 . . . . 1.0 108.538 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.72 ' O ' ' HB2' ' A' ' 183' ' ' ALA 0.261 12.3 mt -28.24 -61.45 0.11 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.966 0.889 . . . . 1.0 112.839 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.726 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.2 t -77.29 -20.28 14.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 113.367 0.877 . . . . 1.0 113.367 -176.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.581 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.1 mm-40 -63.46 -48.6 77.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.228 -1.545 . . . . 1.0 110.803 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.43 -12.12 20.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.155 -0.966 . . . . 1.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -70.09 -33.71 72.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.018 -1.052 . . . . 1.0 108.738 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.726 HD13 ' O ' ' A' ' 180' ' ' VAL . 1.2 mp -48.63 -23.66 1.09 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.795 . . . . 1.0 109.075 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -59.43 -16.52 24.02 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.875 0.845 . . . . 1.0 109.02 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.534 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 20.1 t30 -89.1 172.31 7.63 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 44.8 Cg_endo -87.73 -48.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.187 1.098 . . . . 1.0 111.357 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -118.31 145.87 44.76 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.427 -0.796 . . . . 1.0 111.115 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.34 130.29 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 1.0 110.208 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 17' ' ' ILE . 4.4 mt -115.62 169.13 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -110.6 -82.23 0.58 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.094 -1.004 . . . . 1.0 111.23 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 O-C-N 121.033 -1.042 . . . . 1.0 111.044 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.591 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.4 pt-20 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.409 0.623 . . . . 1.0 110.948 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' O ' ' CG ' ' A' ' 191' ' ' HIS . . . -85.17 140.98 30.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.402 -1.436 . . . . 1.0 109.302 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.868 HG21 ' CE ' ' A' ' 25' ' ' MET . 21.9 mm -111.52 122.71 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.694 -1.203 . . . . 1.0 110.788 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.32 122.05 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.369 -0.832 . . . . 1.0 110.093 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.812 ' CE1' HD12 ' A' ' 167' ' ' ILE . 4.6 m-85 -94.27 140.23 30.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 1.0 110.023 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -107.95 -7.66 16.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 1.0 110.214 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' GLY . . . 114.64 -11.83 21.06 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -124.06 -1.74 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.861 -1.376 . . . . 1.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.27 110.03 22.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.985 -1.072 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 5.4 p90 -100.17 156.09 17.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.177 -0.952 . . . . 1.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.868 ' CE ' HG21 ' A' ' 17' ' ' ILE . 3.4 mmt -122.16 100.32 6.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.154 -1.018 . . . . 1.0 110.341 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.618 ' HB3' ' CZ3' ' A' ' 142' ' ' TRP . 1.3 pp20? -78.36 106.08 10.04 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.618 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 44.2 m-85 -101.11 98.51 8.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.912 -1.118 . . . . 1.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -93.03 102.15 14.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 1.0 109.692 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -121.61 138.64 54.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 1.0 110.184 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -86.11 95.56 9.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 1.0 109.842 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.604 HG11 ' CB ' ' A' ' 138' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 1.0 110.534 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.802 0.334 . . . . 1.0 110.311 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -143.0 178.42 7.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.149 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.407 ' N ' ' OG ' ' A' ' 40' ' ' SER . 30.2 m120 -119.69 156.05 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 1.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 7.7 m80 -119.24 117.34 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 1.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.759 ' HD1' HG22 ' A' ' 172' ' ' VAL . 21.2 m-85 -112.28 120.25 41.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.694 . . . . 1.0 110.234 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.742 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -130.19 139.98 50.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.858 -1.151 . . . . 1.0 111.322 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.945 ' HB2' HG12 ' A' ' 170' ' ' VAL . 1.2 pt? -176.59 150.76 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 1.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -120.34 146.47 46.11 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.95 HG23 ' CD1' ' A' ' 105' ' ' ILE . 0.9 OUTLIER -127.69 -170.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.126 -1.43 . . . . 1.0 111.261 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.658 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.7 OUTLIER -153.16 136.77 15.99 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.014 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.622 HG23 ' HA ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER 52.68 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.51 -1.369 . . . . 1.0 109.238 -177.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.795 ' CG ' HD13 ' A' ' 73' ' ' ILE . 15.1 tt0 -173.87 22.63 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.305 -1.497 . . . . 1.0 110.283 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.703 ' HB2' ' CG2' ' A' ' 164' ' ' ILE . . . 45.93 -114.68 0.49 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.681 -1.208 . . . . 1.0 109.201 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.583 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 18.3 p -155.17 -40.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.002 -1.061 . . . . 1.0 109.583 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.66 131.33 53.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.415 -0.803 . . . . 1.0 109.647 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 168.07 138.3 2.43 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.439 -1.362 . . . . 1.0 109.885 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.947 HD22 HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -88.97 124.41 34.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.971 -1.311 . . . . 1.0 109.005 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.692 HD11 HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.3 -27.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.423 0.897 . . . . 1.0 113.423 -176.01 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.031 HD12 HD13 ' A' ' 143' ' ' LEU . 1.7 tt -143.32 151.69 40.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 119.85 -1.781 . . . . 1.0 113.089 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' A' ' 58' ' ' TRP . 5.3 t-105 -160.22 106.93 1.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.403 0.621 . . . . 1.0 109.604 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.535 ' HG ' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -121.43 155.61 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 1.0 109.08 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.649 ' HA2' ' CG ' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.333 0 C-N-CA 118.725 -1.702 . . . . 1.0 111.749 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.681 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 110.776 -0.083 . . . . 1.0 110.776 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.547 ' HA ' ' CB ' ' A' ' 82' ' ' TYR . 8.9 pt -158.46 153.43 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.42 -0.8 . . . . 1.0 111.171 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.729 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -166.14 174.55 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.494 -0.754 . . . . 1.0 109.079 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.958 HD12 HD13 ' A' ' 57' ' ' LEU . 95.9 mt -150.91 134.28 16.22 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.925 -1.109 . . . . 1.0 108.165 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -146.87 179.55 7.51 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.032 -1.042 . . . . 1.0 112.652 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.795 HD13 ' CG ' ' A' ' 50' ' ' GLU . 2.5 mt -133.27 139.37 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.717 -0.614 . . . . 1.0 111.623 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.696 HG22 ' OE1' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -140.42 131.54 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.274 -0.891 . . . . 1.0 109.224 178.372 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 1.5 m-20 69.29 9.73 7.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.138 -0.976 . . . . 1.0 111.036 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 96.75 16.38 36.57 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.098 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.594 ' O ' HG23 ' A' ' 73' ' ' ILE . 90.6 m-85 -130.05 159.65 36.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -1.097 . . . . 1.0 109.32 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.692 HG12 HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -102.57 164.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.185 -0.947 . . . . 1.0 111.824 -178.264 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.837 ' HB2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -160.52 130.88 5.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.383 0.611 . . . . 1.0 110.413 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.806 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -92.69 115.95 28.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.049 . . . . 1.0 109.571 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.729 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.61 122.05 43.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.284 -0.885 . . . . 1.0 109.805 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.681 ' HB2' ' O ' ' A' ' 68' ' ' TYR . 15.9 p90 -140.73 144.98 35.85 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.561 -1.256 . . . . 1.0 111.351 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 86' ' ' SER . 0.1 OUTLIER -141.19 108.3 5.47 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.35 1.072 . . . . 1.0 109.652 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.564 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -104.54 34.49 3.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.436 -0.802 . . . . 1.0 109.897 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -168.34 -41.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.6 OUTLIER 165.63 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.291 -1.123 . . . . 1.0 111.146 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HD3' ' HG3' ' A' ' 129' ' ' PRO . 13.1 mtpt -121.18 116.98 30.83 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.831 -1.168 . . . . 1.0 110.572 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.516 ' N ' ' HB2' ' A' ' 83' ' ' ASP . 45.3 Cg_endo -75.62 160.63 37.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.928 1.488 . . . . 1.0 110.676 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.786 HG13 HD21 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -133.05 107.01 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 108.749 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.837 HG22 ' HB2' ' A' ' 79' ' ' GLN . 1.8 p -95.89 123.94 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.455 -1.403 . . . . 1.0 111.242 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.794 HD12 ' HE3' ' A' ' 80' ' ' MET . 0.7 OUTLIER -113.58 84.58 2.04 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.666 ' O ' HG21 ' A' ' 124' ' ' ILE . 30.9 mtp180 -59.65 178.01 0.18 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.239 -0.984 . . . . 1.0 111.266 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.727 ' OG ' HG21 ' A' ' 118' ' ' VAL . 2.9 t -101.78 159.03 15.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.512 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.18 24.61 12.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 1.0 109.522 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 96' ' ' PRO . 1.3 t -147.22 154.67 46.25 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 1.0 109.429 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 95' ' ' VAL . 38.3 Cg_endo -64.25 134.5 42.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.77 1.405 . . . . 1.0 109.715 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -114.15 -31.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 1.0 111.048 -178.312 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.601 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 1.9 p-10 -82.16 47.88 1.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.968 -1.082 . . . . 1.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.553 ' O ' HG22 ' A' ' 99' ' ' THR . 2.0 m -87.59 6.55 33.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 110.906 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.622 ' HA ' HG23 ' A' ' 49' ' ' THR . 0.6 OUTLIER 66.7 7.43 5.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 111.538 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 4.2 m80 -112.53 173.63 6.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.896 -1.128 . . . . 1.0 110.366 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.658 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 2.6 m95 -75.98 88.37 2.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 1.0 109.967 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 104' ' ' HIS . 7.7 m -79.75 172.25 14.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.047 -1.033 . . . . 1.0 109.579 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.597 ' N ' HG22 ' A' ' 103' ' ' THR . 0.7 OUTLIER -123.19 119.84 31.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.95 ' CD1' HG23 ' A' ' 47' ' ' ILE . 1.6 mp -118.28 142.71 31.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.768 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 mttp -153.7 178.99 9.26 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.305 -1.358 . . . . 1.0 109.391 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -164.9 158.37 17.14 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.625 -1.23 . . . . 1.0 111.629 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.36 103.93 5.44 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -91.24 117.88 30.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 1.0 109.785 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 111' ' ' GLN . 20.6 t -114.88 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.078 -1.014 . . . . 1.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.504 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 46.4 tt0 60.1 -92.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 1.0 110.236 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.582 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -111.4 -21.23 11.92 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 1.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.582 ' N ' ' HG2' ' A' ' 112' ' ' ARG . 6.2 tt0 -92.22 108.27 19.83 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.966 0.889 . . . . 1.0 111.11 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -94.75 165.7 25.92 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 120.34 -0.933 . . . . 1.0 110.854 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.66 ' CB ' HG22 ' A' ' 125' ' ' THR . 16.2 t -146.48 156.88 43.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.259 -1.142 . . . . 1.0 110.73 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.072 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.7 tm? -123.1 146.9 47.32 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.095 -1.003 . . . . 1.0 108.859 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 1.072 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -126.52 92.97 3.67 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.347 -0.845 . . . . 1.0 111.844 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 116' ' ' LEU . 52.9 t -86.78 85.43 2.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.33 53.72 16.35 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.488 ' OD1' ' OE1' ' A' ' 117' ' ' GLN . 1.7 m-20 44.68 21.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.157 -1.202 . . . . 1.0 111.178 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -91.49 -176.37 4.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 1.0 109.813 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -41.12 100.46 0.22 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 1.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.464 ' N ' ' O ' ' A' ' 121' ' ' GLU . 41.1 Cg_endo -67.91 134.8 33.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.228 1.646 . . . . 1.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.747 HG22 ' HB3' ' A' ' 91' ' ' LEU . 1.5 mp -97.95 115.18 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.66 HG22 ' CB ' ' A' ' 115' ' ' SER . 12.2 p -120.25 174.48 6.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.072 -1.017 . . . . 1.0 112.181 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 114' ' ' GLY . . . -178.72 163.36 31.11 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.253 -2.339 . . . . 1.0 107.253 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.577 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -140.82 169.84 16.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.581 -1.54 . . . . 1.0 111.153 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.68 166.65 12.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.243 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.549 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.4 Cg_endo -66.94 89.92 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.779 1.41 . . . . 1.0 108.51 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -14.5 131.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.214 0.53 . . . . 1.0 112.111 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 130.43 55.92 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.564 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . -103.84 -122.31 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -1.125 . . . . 1.0 109.926 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 133' ' ' THR . 13.1 t -167.79 59.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.71 -1.244 . . . . 1.0 110.279 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 135' ' ' LEU . 11.3 mm-40 54.96 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.562 HD23 HG23 ' A' ' 133' ' ' THR . 0.2 OUTLIER 66.46 97.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 1.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.3 m-20 -69.28 178.96 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 1.0 109.723 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -153.08 105.77 2.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 1.0 109.805 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.604 ' CB ' HG11 ' A' ' 31' ' ' VAL . 1.9 p30 164.04 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.646 -0.659 . . . . 1.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -38.54 -44.31 1.73 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -164.87 162.75 21.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 1.0 110.257 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.533 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 14.7 tp -145.41 146.03 31.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 1.0 109.976 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.656 ' CG ' ' HE1' ' A' ' 146' ' ' MET . 37.1 m95 -135.81 131.36 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 1.031 HD13 HD12 ' A' ' 57' ' ' LEU . 5.4 tp -133.21 122.22 23.65 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.177 -1.409 . . . . 1.0 112.698 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 119.51 16.27 5.16 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.862 -1.295 . . . . 1.0 109.862 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 130.05 -137.54 9.6 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 119.099 -1.524 . . . . 1.0 109.919 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.791 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -168.05 134.38 2.01 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.846 -0.741 . . . . 1.0 110.388 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -47.45 -20.58 0.24 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.448 -0.782 . . . . 1.0 110.856 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.595 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -157.51 85.94 0.93 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.947 HD21 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -78.8 38.17 0.32 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.555 -1.341 . . . . 1.0 112.772 -177.259 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 151' ' ' VAL . 1.9 p -54.26 -26.37 28.59 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 104.55 -2.389 . . . . 1.0 104.55 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.833 HG13 ' N ' ' A' ' 152' ' ' ALA 0.282 7.7 p -59.28 -132.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.297 -1.32 . . . . 1.0 108.807 177.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.833 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 65.21 -67.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.136 -0.978 . . . . 1.0 109.544 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 151' ' ' VAL . 18.9 m170 38.16 -74.84 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.427 1.269 . . . . 1.0 114.427 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -52.6 -3.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.576 1.324 . . . . 1.0 114.576 -176.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.928 HD11 ' CD1' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -146.51 175.54 2.67 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 119.79 -1.819 . . . . 1.0 111.833 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 50.3 Cg_endo -77.51 -161.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.868 1.712 . . . . 1.0 113.809 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.635 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.1 OUTLIER -43.77 -20.7 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.365 -0.834 . . . . 1.0 113.071 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.542 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -36.77 -43.33 0.42 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.093 -1.004 . . . . 1.0 109.357 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.928 ' CD1' HD11 ' A' ' 155' ' ' LEU . 5.5 m-85 -89.27 -27.52 20.51 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.124 -0.985 . . . . 1.0 109.543 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -72.26 -7.87 51.76 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.225 -1.39 . . . . 1.0 107.407 177.197 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.537 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -130.84 98.51 4.64 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 21' ' ' GLY . . . -49.81 -175.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.618 ' CD2' HD11 ' A' ' 167' ' ' ILE . 44.6 t80 -67.58 152.77 45.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -1.135 . . . . 1.0 112.056 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 164' ' ' ILE . 1.3 mp -131.57 80.38 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.846 0.831 . . . . 1.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.57 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.67 -161.23 20.92 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 106.778 -2.529 . . . . 1.0 106.778 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.4 m -125.19 143.81 50.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.84 -1.388 . . . . 1.0 109.597 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.812 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.3 mt -124.0 156.77 31.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.749 -1.219 . . . . 1.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.591 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -167.47 152.56 7.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.883 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.538 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 17.4 m-20 56.11 64.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.115 -0.991 . . . . 1.0 110.426 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.945 HG12 ' HB2' ' A' ' 45' ' ' LEU . 24.3 m -116.64 133.1 64.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.566 ' HA ' ' HG3' ' A' ' 176' ' ' GLU . 1.0 OUTLIER -148.64 155.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.425 -1.31 . . . . 1.0 110.969 -176.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.759 HG22 ' HD1' ' A' ' 43' ' ' PHE . 13.4 t -132.82 91.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 8.0 m-20 57.05 46.26 19.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.862 -1.149 . . . . 1.0 108.023 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 72.26 31.79 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.257 0.551 . . . . 1.0 110.375 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.557 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . 34.2 mt-30 -108.42 176.06 5.25 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.3 -0.875 . . . . 1.0 110.076 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 177' ' ' LEU . 6.9 pt-20 44.09 -114.66 0.38 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.365 -0.209 . . . . 1.0 110.912 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 179' ' ' LEU . 8.6 tp 78.77 -59.24 0.41 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.35 -0.844 . . . . 1.0 110.375 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 4.8 m-70 -68.98 70.63 0.21 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.085 . . . . 1.0 109.288 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.866 HD11 HG22 ' A' ' 170' ' ' VAL 0.255 3.7 mp -44.1 -61.53 1.44 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.689 0.756 . . . . 1.0 112.087 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.565 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 94.5 t -68.29 -9.7 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.233 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 11.0 mt-10 -74.61 -62.09 1.65 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.699 -1.251 . . . . 1.0 110.012 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.618 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 8.2 m-20 -83.03 -12.62 57.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.99 . . . . 1.0 109.183 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -72.74 -31.31 64.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 1.0 109.038 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER -59.94 -14.14 14.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 1.0 109.188 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -46.27 -25.79 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.311 -0.868 . . . . 1.0 109.462 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.582 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 14.2 t30 -93.26 175.12 3.32 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.582 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 43.7 Cg_endo -84.44 -90.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 122.889 0.942 . . . . 1.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 188' ' ' THR . 2.8 t -66.78 144.49 56.28 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.334 -0.854 . . . . 1.0 110.727 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.747 ' C ' HD13 ' A' ' 190' ' ' LEU . 3.2 mt -126.89 117.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 1.0 109.689 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.922 ' H ' HD22 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -94.39 136.06 35.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 1.0 109.055 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 16' ' ' ALA . 3.2 m-70 -114.72 149.16 37.26 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.089 -1.007 . . . . 1.0 110.126 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 166' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 1.0 110.051 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.551 ' HG2' ' CD1' ' A' ' 179' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.756 0.788 . . . . 1.0 109.507 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -113.13 153.94 27.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 1.0 111.085 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.608 HG13 HD22 ' A' ' 179' ' ' LEU . 0.8 OUTLIER -114.84 144.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 177.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -104.2 136.07 44.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.756 -1.215 . . . . 1.0 111.443 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.841 ' CE1' HD12 ' A' ' 167' ' ' ILE . 6.6 m-85 -100.72 148.16 25.21 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -113.88 1.18 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 1.0 111.102 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 108.11 -18.13 34.03 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.396 -1.882 . . . . 1.0 108.396 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 42.02 3.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.932 . . . . 1.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -112.89 127.16 56.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.0 110.943 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CG ' ' HG3' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -118.76 87.56 2.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.323 -0.86 . . . . 1.0 109.684 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.458 ' SD ' ' CE1' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -76.0 100.7 4.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.15 -0.969 . . . . 1.0 110.475 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 6.2 tt0 -79.43 90.32 5.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 4.2 m-30 -95.24 111.8 23.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.487 -0.885 . . . . 1.0 111.319 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -133.44 153.7 51.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 1.0 109.71 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.49 167.44 27.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.001 -1.062 . . . . 1.0 110.398 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.28 97.16 9.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 1.0 110.443 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 1.0 110.034 179.817 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.706 ' NE2' HG13 ' A' ' 110' ' ' VAL . 3.0 tm0? . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.641 0.734 . . . . 1.0 110.101 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.575 -0.703 . . . . 1.0 110.187 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 109' ' ' ARG . 52.6 p-10 -108.52 149.41 28.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.175 -0.953 . . . . 1.0 110.666 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -123.41 125.65 45.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 1.0 109.42 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 m-85 -133.21 131.6 40.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.129 -0.982 . . . . 1.0 111.05 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.751 ' C ' HD23 ' A' ' 45' ' ' LEU . 6.7 mt-10 -137.9 140.61 40.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 1.0 110.404 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.816 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 179.92 154.28 0.54 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.289 -0.882 . . . . 1.0 110.798 179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.502 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -117.49 155.7 29.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.84 HD13 HD11 ' A' ' 105' ' ' ILE . 6.5 pt -149.16 176.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 1.0 112.802 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.604 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -130.92 83.22 2.1 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.2 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.509 ' OG1' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -67.04 152.14 46.34 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.127 0.965 . . . . 1.0 112.603 -176.306 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.928 ' HB2' HG22 ' A' ' 164' ' ' ILE . 11.0 mm-40 -141.92 1.03 1.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.396 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.24 124.86 11.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.973 -1.08 . . . . 1.0 110.187 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.879 HG22 ' HA2' ' A' ' 76' ' ' GLY . 17.8 p -59.96 -10.9 4.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.798 . . . . 1.0 110.796 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -128.35 130.11 47.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.063 . . . . 1.0 111.211 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 160.03 137.63 2.27 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.022 HD21 HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -90.44 127.75 36.31 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.549 -1.559 . . . . 1.0 108.884 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.728 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.07 -40.04 12.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.449 -0.782 . . . . 1.0 112.2 -176.181 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 141' ' ' LEU . 5.7 tt -142.79 139.11 30.86 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.092 -1.63 . . . . 1.0 113.693 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.73 ' N ' HD23 ' A' ' 57' ' ' LEU . 1.1 t-105 -145.32 106.35 4.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.281 -0.887 . . . . 1.0 108.661 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.578 ' CB ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -121.65 -166.58 1.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.782 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.08 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.793 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' A' ' 83' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 122.051 0.929 . . . . 1.0 111.236 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.562 ' CD1' ' HB3' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -146.39 155.63 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.597 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.984 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -149.1 -175.79 5.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.946 -1.096 . . . . 1.0 111.033 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.994 HD12 HD13 ' A' ' 57' ' ' LEU . 61.1 mt -151.31 116.54 5.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -136.38 171.47 14.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.749 -1.219 . . . . 1.0 111.764 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.593 HG13 HD11 ' A' ' 56' ' ' ILE . 45.7 mt -114.87 130.53 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.528 -0.732 . . . . 1.0 110.586 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -140.48 143.7 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 1.0 110.131 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.497 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 50.7 m-20 60.25 13.52 3.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 1.0 111.695 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.879 ' HA2' HG22 ' A' ' 52' ' ' THR . . . 93.09 10.04 60.11 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.587 -1.292 . . . . 1.0 109.997 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.28 141.7 48.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -1.141 . . . . 1.0 109.551 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.728 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -77.14 178.62 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.859 -1.151 . . . . 1.0 108.655 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.923 ' CD ' HG22 ' A' ' 90' ' ' VAL . 1.4 pp0? -173.98 125.67 0.36 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.61 -1.307 . . . . 1.0 111.694 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.641 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.8 ttm -69.41 129.04 38.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.984 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 13.2 tmm? -132.11 109.12 9.75 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.419 -0.801 . . . . 1.0 110.466 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.765 ' CE2' HG11 ' A' ' 89' ' ' VAL . 11.5 p90 -133.95 133.1 40.98 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.914 -1.514 . . . . 1.0 112.107 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -118.47 88.14 2.86 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.567 0.699 . . . . 1.0 109.728 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -73.14 -76.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.441 -0.787 . . . . 1.0 109.111 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -71.08 -42.56 58.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.004 -2.039 . . . . 1.0 108.004 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.606 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 1.3 t 160.79 147.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.606 ' CB ' ' O ' ' A' ' 86' ' ' SER . 0.2 OUTLIER 83.92 93.76 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.58 ' HB2' ' HG2' ' A' ' 81' ' ' MET . 41.4 Cg_endo -67.53 146.44 74.05 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.492 1.785 . . . . 1.0 111.763 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.69 117.44 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -99.47 98.14 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.96 -1.088 . . . . 1.0 110.573 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.623 HD12 ' HB3' ' A' ' 80' ' ' MET . 6.0 mt -93.94 75.45 4.17 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.696 ' O ' HG21 ' A' ' 124' ' ' ILE . 6.4 mtt180 -56.77 174.95 0.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.397 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 1.065 ' OG ' HG21 ' A' ' 118' ' ' VAL . 14.5 t -92.9 160.45 14.9 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.335 0.588 . . . . 1.0 110.564 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.694 HG21 ' HB3' ' A' ' 122' ' ' ALA . 14.9 t -102.64 8.04 39.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 1.0 109.642 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.751 HG13 ' HD2' ' A' ' 96' ' ' PRO . 51.2 t -129.87 150.9 77.19 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.751 ' HD2' HG13 ' A' ' 95' ' ' VAL . 45.3 Cg_endo -69.59 135.58 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.482 1.254 . . . . 1.0 110.2 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.613 HG21 HG22 ' A' ' 78' ' ' VAL . 1.1 tp -115.77 -31.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 1.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.45 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 17.2 p-10 -69.57 60.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.034 . . . . 1.0 109.909 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.696 ' O ' HG22 ' A' ' 99' ' ' THR . 18.0 m -124.06 16.63 9.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.46 -0.775 . . . . 1.0 110.392 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.487 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 48.0 t-20 50.65 39.13 20.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -129.69 135.74 48.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 1.0 110.111 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.604 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 44.9 m95 -57.29 110.29 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -0.97 . . . . 1.0 110.291 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 104' ' ' HIS . 35.9 m -110.62 171.94 7.16 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.59 ' N ' HG22 ' A' ' 103' ' ' THR . 31.8 t60 -117.39 129.64 55.98 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.987 -1.071 . . . . 1.0 108.412 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.84 HD11 HD13 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -122.01 147.89 25.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.318 -0.864 . . . . 1.0 108.823 -179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.819 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.0 OUTLIER -152.5 173.16 15.49 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.404 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -165.37 116.9 1.12 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.69 -1.256 . . . . 1.0 111.323 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 25.9 p90 -119.41 109.82 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.548 ' HG2' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -106.55 164.4 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 1.0 111.309 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.706 HG13 ' NE2' ' A' ' 39' ' ' GLN . 12.8 t -145.15 113.96 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 19.8 mt-30 58.46 -129.95 1.33 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.246 -0.909 . . . . 1.0 110.462 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -85.19 -1.22 56.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.96 -1.088 . . . . 1.0 110.22 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 7.6 tt0 -107.26 120.77 43.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.436 -0.79 . . . . 1.0 110.226 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -119.66 157.43 15.51 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 119.971 -1.109 . . . . 1.0 111.465 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 1.058 ' OG ' HG22 ' A' ' 125' ' ' THR . 2.8 t -133.26 150.93 51.91 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.192 -1.181 . . . . 1.0 110.836 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.125 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.3 tm? -113.83 154.11 28.01 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.123 -0.986 . . . . 1.0 109.434 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 1.125 ' N ' HD13 ' A' ' 116' ' ' LEU 0.26 4.1 tp60 -130.03 87.21 2.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.543 -0.723 . . . . 1.0 112.725 -178.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 1.065 HG21 ' OG ' ' A' ' 93' ' ' SER . 24.6 t -80.56 82.71 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.729 -1.212 . . . . 1.0 107.729 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 66.52 60.87 5.81 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 120' ' ' ASN . 12.8 p30 38.8 25.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.569 -0.96 . . . . 1.0 111.694 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 121' ' ' GLU . 1.3 pm0 -86.01 -174.77 5.26 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.355 -0.84 . . . . 1.0 109.236 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.694 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -46.62 104.66 0.42 Allowed Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.336 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.422 ' N ' ' O ' ' A' ' 121' ' ' GLU . 40.5 Cg_endo -65.13 130.24 25.12 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.971 1.511 . . . . 1.0 110.559 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.696 HG21 ' O ' ' A' ' 92' ' ' ARG . 3.8 mp -91.03 109.32 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.557 -0.857 . . . . 1.0 108.984 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 1.058 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.8 p -107.52 169.35 8.63 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.246 1.022 . . . . 1.0 111.291 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.444 ' N ' ' CD2' ' A' ' 91' ' ' LEU . . . 169.33 161.25 19.33 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 106.723 -2.551 . . . . 1.0 106.723 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 112' ' ' ARG . 0.7 OUTLIER -133.18 168.99 17.53 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.65 -1.5 . . . . 1.0 110.379 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -113.3 177.45 1.18 Allowed Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.742 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.2 Cg_endo -66.77 91.84 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.944 1.497 . . . . 1.0 108.851 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 131' ' ' GLY . 1.1 pp -47.64 -178.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.511 -0.743 . . . . 1.0 110.531 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.517 ' N ' HD12 ' A' ' 130' ' ' LEU . . . 161.08 -56.18 0.31 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.034 -1.626 . . . . 1.0 109.034 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -107.99 102.91 12.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 1.0 109.663 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 t -86.1 37.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 1.0 110.413 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -136.87 63.79 1.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 1.0 109.929 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -98.24 131.08 44.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 1.0 110.412 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.634 ' N ' HD13 ' A' ' 135' ' ' LEU . 1.0 OUTLIER -124.42 175.4 7.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 1.0 110.127 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 140.7 44.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 1.0 110.21 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.683 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 24.0 p-10 -88.53 35.66 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 1.0 110.519 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 42.63 25.44 0.31 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.683 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -116.35 166.5 11.99 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.075 -1.25 . . . . 1.0 109.301 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 1.001 HD11 HD21 ' A' ' 57' ' ' LEU . 10.6 tp -160.63 152.79 20.26 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.972 -1.091 . . . . 1.0 111.409 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.649 ' HB3' ' HE3' ' A' ' 146' ' ' MET . 25.2 m95 -133.96 126.05 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.621 -1.622 . . . . 1.0 106.621 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -143.05 135.81 27.74 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 117.899 -1.52 . . . . 1.0 113.725 -176.539 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 104.38 24.99 7.21 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.212 -1.955 . . . . 1.0 108.212 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.714 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 109.48 -153.35 16.93 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 106.663 -2.575 . . . . 1.0 106.663 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.936 ' HB2' HD12 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -170.75 174.0 5.1 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.159 -1.416 . . . . 1.0 111.958 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.56 ' HG3' ' CG ' ' A' ' 24' ' ' TYR . 37.6 mt-10 -96.05 -9.1 31.73 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -152.48 27.0 0.58 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.535 -0.728 . . . . 1.0 110.596 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.022 HD13 HD21 ' A' ' 55' ' ' LEU . 3.2 mt -70.54 61.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.597 -1.241 . . . . 1.0 109.293 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 148' ' ' ARG . 2.3 p -79.0 65.98 4.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.309 -2.108 . . . . 1.0 105.309 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.781 HG13 ' H ' ' A' ' 152' ' ' ALA . 1.2 p -149.58 -77.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.13 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.909 ' HB2' ' CB ' ' A' ' 159' ' ' TYR . . . 45.54 30.95 0.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.046 -1.033 . . . . 1.0 108.962 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 155' ' ' LEU . 1.0 OUTLIER 34.34 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.249 0.547 . . . . 1.0 110.781 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -148.51 10.75 0.86 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 1.0 111.198 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.3 OUTLIER -76.42 179.33 1.55 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 1.0 110.727 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 155' ' ' LEU . 48.2 Cg_endo -73.13 -161.39 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.301 1.685 . . . . 1.0 112.974 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -51.44 -9.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.654 -0.653 . . . . 1.0 112.417 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.951 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -34.75 -42.96 0.16 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.035 -1.041 . . . . 1.0 110.028 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.909 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . 6.6 m-85 -82.56 -33.39 28.11 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.317 -1.353 . . . . 1.0 109.916 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.6 OUTLIER -67.09 -11.51 57.36 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.876 -1.13 . . . . 1.0 108.406 178.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 161' ' ' THR . 1.8 m -129.27 96.48 4.32 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -48.29 178.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.696 ' CD2' HD11 ' A' ' 167' ' ' ILE . 23.0 t80 -68.64 145.24 54.08 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.342 . . . . 1.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.928 HG22 ' HB2' ' A' ' 50' ' ' GLU . 2.6 mt -123.1 86.43 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.31 -1.367 . . . . 1.0 107.31 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.621 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.97 -157.5 14.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 80.0 m -130.72 143.82 51.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -1.125 . . . . 1.0 109.748 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.841 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.2 mt -128.82 157.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.299 -0.876 . . . . 1.0 110.644 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 2.8 ttt85 -164.24 144.71 8.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.202 -0.937 . . . . 1.0 109.894 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 68.8 m-20 58.44 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.479 -0.763 . . . . 1.0 110.066 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.816 HG12 ' HB2' ' A' ' 45' ' ' LEU 0.251 26.8 m -132.92 135.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 119.989 -0.685 . . . . 1.0 109.257 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.515 HG22 ' N ' ' A' ' 175' ' ' GLN . 0.1 OUTLIER -141.63 152.18 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.741 -1.184 . . . . 1.0 111.679 -177.382 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.496 HG22 ' HD1' ' A' ' 43' ' ' PHE . 92.0 t -134.11 113.8 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.9 OUTLIER 56.49 38.01 29.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 1.0 108.104 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 73.28 30.06 1.6 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.276 0.56 . . . . 1.0 110.835 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.515 ' N ' HG22 ' A' ' 171' ' ' ILE . 4.1 mm-40 -98.01 110.91 23.4 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.249 -0.907 . . . . 1.0 109.967 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.7 102.17 10.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 1.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.587 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 4.1 mm? -86.26 92.76 8.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.817 -1.177 . . . . 1.0 110.987 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 5.8 m170 -40.64 113.37 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.045 0.926 . . . . 1.0 110.166 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.813 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 10.9 mt -40.49 -56.53 2.03 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.847 0.832 . . . . 1.0 112.655 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 51.3 t -84.82 -22.25 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 2.3 mt-10 -62.07 -55.99 23.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.137 -1.602 . . . . 1.0 110.315 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.612 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -84.63 -19.47 32.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.356 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.813 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -64.28 -36.7 84.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.926 -1.109 . . . . 1.0 109.629 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 5.2 mt -50.05 -21.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.177 -0.952 . . . . 1.0 109.345 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 2.7 t-20 -54.99 -20.77 9.91 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.882 0.849 . . . . 1.0 108.876 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.476 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 4.3 t30 -95.83 152.36 39.0 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 40.6 Cg_endo -66.3 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.371 1.195 . . . . 1.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.716 ' O ' HD13 ' A' ' 189' ' ' ILE . 12.4 m -68.74 135.97 52.1 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.234 -0.916 . . . . 1.0 110.452 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 188' ' ' THR . 25.3 mm -122.92 127.46 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 1.0 109.805 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.462 ' O ' HG23 ' A' ' 17' ' ' ILE . 7.7 mt -121.34 173.18 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 1.0 110.394 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 2.5 m-70 -107.54 -84.3 0.53 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.144 -0.973 . . . . 1.0 111.185 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.293 -1.854 0 O-C-N 121.157 -0.964 . . . . 1.0 110.671 179.861 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 1.1 tt0 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.48 0.657 . . . . 1.0 109.685 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -95.62 155.16 16.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.347 -0.941 . . . . 1.0 110.289 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.906 HG21 ' HE1' ' A' ' 25' ' ' MET . 13.4 mm -135.66 122.82 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 1.0 110.576 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.25 132.49 34.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.875 . . . . 1.0 109.896 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.9 ' CE1' HD12 ' A' ' 167' ' ' ILE . 9.6 m-85 -102.47 172.67 6.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.216 . . . . 1.0 110.25 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.512 ' O ' HG12 ' A' ' 164' ' ' ILE . 0.5 OUTLIER -134.38 1.9 3.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 1.0 110.802 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.18 -26.22 25.03 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 8.1 ttt180 -104.45 10.8 35.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.912 -1.346 . . . . 1.0 109.364 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.691 HG21 ' HD2' ' A' ' 19' ' ' PHE . 6.3 t -55.22 175.53 0.07 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.676 0.75 . . . . 1.0 110.741 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.633 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -171.57 73.42 0.05 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.906 ' HE1' HG21 ' A' ' 17' ' ' ILE . 2.3 mmt -85.79 99.72 11.55 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.861 -1.149 . . . . 1.0 109.539 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -91.39 134.81 34.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 182' ' ' ASP . 48.9 m-85 -121.25 149.03 43.48 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.982 -1.074 . . . . 1.0 110.72 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -149.8 97.93 2.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.811 . . . . 1.0 110.186 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -139.31 174.99 9.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 1.0 110.084 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.06 148.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 1.0 110.033 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 31' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 1.0 110.323 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 111' ' ' GLN . 3.9 pt20 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.244 0.545 . . . . 1.0 110.074 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.44 122.53 13.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 1.0 110.209 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.564 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -124.58 117.08 23.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.475 -0.766 . . . . 1.0 110.279 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.515 ' O ' HG23 ' A' ' 172' ' ' VAL . 0.6 OUTLIER -84.67 142.22 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 1.0 109.463 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CE1' HG21 ' A' ' 172' ' ' VAL . 41.8 m-85 -130.81 120.98 24.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.133 -0.98 . . . . 1.0 111.151 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.729 ' C ' HD23 ' A' ' 45' ' ' LEU . 39.7 mt-10 -128.6 142.8 50.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 1.0 110.521 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.932 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.1 pt? -179.69 149.72 0.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.38 -0.825 . . . . 1.0 110.397 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 167' ' ' ILE . 49.7 m -121.24 149.36 42.98 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.598 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.551 HD11 HG13 ' A' ' 97' ' ' ILE . 1.7 pt -126.49 179.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.379 -0.928 . . . . 1.0 109.168 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.632 ' O ' ' OG1' ' A' ' 49' ' ' THR . 5.9 tttt -167.74 82.6 0.2 Allowed 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.674 -1.21 . . . . 1.0 110.641 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 1.069 HG22 ' HG2' ' A' ' 50' ' ' GLU . 90.2 m -171.97 -108.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.81 -0.556 . . . . 1.0 111.313 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.069 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.5 OUTLIER -122.18 -46.09 2.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.594 1.188 . . . . 1.0 109.626 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.883 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . 39.44 22.75 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.841 -1.072 . . . . 1.0 111.656 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.611 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 60.4 p -70.79 -18.22 62.76 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.409 -1.432 . . . . 1.0 108.796 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -159.6 118.68 2.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.093 -0.643 . . . . 1.0 109.727 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 155.21 136.74 2.25 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.194 -1.479 . . . . 1.0 109.541 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.92 HD13 ' CZ ' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -85.61 128.17 34.69 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.628 -1.229 . . . . 1.0 109.246 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.87 HD11 ' CG1' ' A' ' 78' ' ' VAL . 1.0 OUTLIER -90.49 -34.09 6.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.502 -0.749 . . . . 1.0 111.602 -177.081 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.094 HD13 HD12 ' A' ' 71' ' ' LEU . 5.7 tt -146.18 143.4 29.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.536 -1.353 . . . . 1.0 113.079 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.997 ' CZ2' HG21 ' A' ' 151' ' ' VAL . 31.0 t-105 -152.09 105.69 3.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 p -110.29 123.17 49.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 1.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 138' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 137' ' ' THR . 1.8 t80 . . . . . 0 N--CA 1.511 2.577 0 N-CA-C 111.857 0.317 . . . . 1.0 111.857 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 70' ' ' ALA . 5.6 mt -151.13 171.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.648 -1.282 . . . . 1.0 112.838 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.56 ' N ' ' CG2' ' A' ' 69' ' ' ILE . . . -177.18 167.12 2.4 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.094 HD12 HD13 ' A' ' 57' ' ' LEU . 90.4 mt -145.95 103.37 3.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.721 -1.237 . . . . 1.0 108.439 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -123.46 167.76 13.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 1.0 112.058 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.977 HG12 HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.5 132.53 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.739 0.78 . . . . 1.0 111.131 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.87 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.0 p -141.17 140.65 31.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.6 -0.687 . . . . 1.0 110.968 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.87 ' CG ' HG22 ' A' ' 74' ' ' VAL . 5.7 m-20 67.96 22.49 8.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.481 -0.762 . . . . 1.0 111.47 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.845 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 86.84 4.74 82.06 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.06 -1.543 . . . . 1.0 109.76 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 75' ' ' ASP . 87.2 m-85 -130.94 150.24 52.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.95 -1.324 . . . . 1.0 110.569 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.977 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.01 177.6 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.148 -0.97 . . . . 1.0 110.535 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 7.8 pt20 -167.49 123.81 1.12 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.254 -0.904 . . . . 1.0 110.89 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.87 ' HE1' HD23 ' A' ' 91' ' ' LEU . 6.0 tmm? -83.69 115.95 22.42 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 10.1 ptt? -119.79 149.15 42.51 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.905 -1.122 . . . . 1.0 111.143 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.777 ' CE2' HG11 ' A' ' 89' ' ' VAL . 24.7 p90 -158.03 132.81 8.45 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.194 -1.002 . . . . 1.0 110.951 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.667 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -121.02 75.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 1.0 110.329 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.676 HD12 ' CB ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -79.11 -5.86 55.11 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.68 -0.637 . . . . 1.0 110.379 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -121.5 -65.83 0.24 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.057 -1.217 . . . . 1.0 110.057 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.33 -33.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.053 -1.263 . . . . 1.0 111.243 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HD3' ' HD3' ' A' ' 129' ' ' PRO . 9.0 ptmt -124.58 138.06 30.48 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.944 -1.097 . . . . 1.0 110.959 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.536 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 49.8 Cg_endo -76.23 121.82 6.31 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 124.15 1.605 . . . . 1.0 111.414 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.777 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -77.4 168.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 178.14 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 90' ' ' VAL . 10.6 p -147.69 85.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.751 -1.218 . . . . 1.0 111.667 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.87 HD23 ' HE1' ' A' ' 80' ' ' MET . 0.7 OUTLIER -77.34 75.31 3.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.881 -1.137 . . . . 1.0 108.398 178.055 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 90' ' ' VAL . 34.8 mtp180 -58.47 178.82 0.09 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.955 0.884 . . . . 1.0 110.837 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.612 ' OG ' HG21 ' A' ' 118' ' ' VAL . 11.5 t -109.64 149.31 29.89 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.916 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.75 29.91 6.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -0.999 . . . . 1.0 109.908 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.726 HG13 ' HD2' ' A' ' 96' ' ' PRO . 74.2 t -133.74 150.27 74.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.514 -0.741 . . . . 1.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.726 ' HD2' HG13 ' A' ' 95' ' ' VAL . 42.1 Cg_endo -66.93 120.35 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.569 1.299 . . . . 1.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.845 HG22 ' O ' ' A' ' 76' ' ' GLY . 4.1 tp -104.89 -11.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 1.0 110.344 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.602 ' HB3' HG22 ' A' ' 52' ' ' THR . 8.5 p-10 -87.96 55.69 3.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 1.0 109.679 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 99' ' ' THR . 68.8 m -112.38 8.29 19.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.311 -0.868 . . . . 1.0 110.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.559 ' HA ' ' N ' ' A' ' 49' ' ' THR . 79.2 m-20 54.62 16.86 1.48 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 1.0 110.436 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -113.41 150.13 33.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.881 . . . . 1.0 109.984 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.62 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 4.3 m95 -60.75 89.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.013 -1.054 . . . . 1.0 110.687 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.676 HG21 HD12 ' A' ' 97' ' ' ILE . 23.3 m -87.56 150.57 23.62 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 119' ' ' GLY . 78.8 t60 -108.71 135.34 50.1 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.989 -1.085 . . . . 1.0 108.73 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 105' ' ' ILE . 0.5 OUTLIER -132.51 156.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.174 -0.954 . . . . 1.0 109.457 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.922 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -152.23 167.41 28.68 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.731 -1.188 . . . . 1.0 110.125 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -152.16 109.7 3.61 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.255 -0.978 . . . . 1.0 111.251 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 18.4 m-30 -83.58 102.28 12.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 1.0 108.802 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -92.99 127.37 38.48 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.96 -1.087 . . . . 1.0 109.728 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 111' ' ' GLN . 3.3 t -132.62 157.57 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 1.0 110.269 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -40.14 111.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.0 110.497 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.626 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 51.98 65.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 1.0 110.377 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.626 ' CB ' ' O ' ' A' ' 112' ' ' ARG . 2.2 tt0 156.85 113.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.632 0.73 . . . . 1.0 109.986 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 82' ' ' TYR . . . -120.86 166.15 13.96 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.199 -1.0 . . . . 1.0 110.618 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.607 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -144.51 166.7 24.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.491 -1.006 . . . . 1.0 110.315 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 117' ' ' GLN 0.252 1.1 tm? -145.47 151.92 38.96 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.151 -0.968 . . . . 1.0 109.312 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.992 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -153.89 107.95 3.02 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.813 -1.155 . . . . 1.0 111.788 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.612 HG21 ' OG ' ' A' ' 93' ' ' SER . 2.0 t -72.41 104.92 2.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.73 35.58 91.17 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.207 . . . . 1.0 110.084 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER 60.95 39.47 16.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.093 -1.239 . . . . 1.0 110.97 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -102.4 -167.84 1.45 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.522 -0.736 . . . . 1.0 110.733 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.572 ' N ' ' HG2' ' A' ' 121' ' ' GLU . . . -35.0 112.23 0.44 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 1.0 109.579 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.533 ' HB3' ' OE1' ' A' ' 117' ' ' GLN . 45.8 Cg_endo -72.95 118.14 5.43 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.133 1.596 . . . . 1.0 112.834 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.733 ' H ' HD12 ' A' ' 124' ' ' ILE . 5.4 mp -85.8 110.85 20.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 106.313 -1.736 . . . . 1.0 106.313 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 30.9 p -119.65 174.38 6.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.507 1.146 . . . . 1.0 112.756 -176.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.584 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 169.69 169.47 32.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 106.622 -2.591 . . . . 1.0 106.622 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -146.53 163.95 34.12 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.511 -1.582 . . . . 1.0 111.11 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.429 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -83.98 173.54 7.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.663 -0.648 . . . . 1.0 110.494 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -69.7 57.55 1.46 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 1.0 110.113 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.2 pp 10.22 57.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -132.68 73.35 0.46 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.676 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -159.94 -71.41 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -1.136 . . . . 1.0 110.493 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.8 OUTLIER 62.85 129.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -0.99 . . . . 1.0 109.887 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.17 75.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 1.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 68' ' ' TYR . 1.3 tm? -88.86 108.42 19.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 1.0 109.719 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.408 ' N ' HD22 ' A' ' 135' ' ' LEU . 60.9 m-20 -67.74 148.79 50.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 1.0 110.724 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -138.4 141.45 39.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 1.0 109.787 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.674 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 40.4 p-10 -84.16 22.1 1.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.194 -0.941 . . . . 1.0 111.075 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 45.51 22.41 0.65 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.405 -1.478 . . . . 1.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.674 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -104.92 162.57 13.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.109 -1.23 . . . . 1.0 109.252 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.723 HD11 ' HG ' ' A' ' 57' ' ' LEU . 6.7 tp -159.53 144.78 15.63 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.99 -1.069 . . . . 1.0 110.821 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.671 ' HB3' ' HE3' ' A' ' 146' ' ' MET . 13.1 m95 -125.99 141.88 51.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.768 HD21 HG22 ' A' ' 56' ' ' ILE . 1.5 tt -148.0 128.47 14.02 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 116.908 -1.917 . . . . 1.0 113.375 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 23' ' ' THR . . . 113.54 -5.32 24.66 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 146.69 -140.87 9.0 Favored Glycine 0 C--N 1.289 -2.039 0 C-N-CA 118.945 -1.598 . . . . 1.0 109.755 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' MET . . . . . 1.003 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -171.43 141.18 1.5 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.091 -1.043 . . . . 1.0 111.939 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.01 -16.08 55.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.783 0.801 . . . . 1.0 109.079 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HD2' ' SD ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -137.0 45.84 2.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.497 -1.298 . . . . 1.0 107.497 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' A' ' 146' ' ' MET . 11.5 tp -65.32 56.83 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.753 0.787 . . . . 1.0 112.146 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 148' ' ' ARG . 56.9 p -84.88 1.7 45.9 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.509 -1.663 . . . . 1.0 106.509 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.997 HG21 ' CZ2' ' A' ' 58' ' ' TRP . 3.3 p -85.47 -104.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.614 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.886 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . 52.64 45.52 28.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.476 -1.39 . . . . 1.0 108.936 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.525 ' C ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -18.03 -77.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.536 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 9.5 ptmt -97.95 -43.65 7.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.985 . . . . 1.0 111.874 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 1.118 HD21 ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -81.07 113.41 40.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 O-C-N 121.324 -0.86 . . . . 1.0 110.231 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -88.39 -68.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.58 1.305 . . . . 1.0 111.594 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.61 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 1.8 tttm -54.86 -50.67 68.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 1.0 111.944 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.671 ' CB ' HD12 ' A' ' 155' ' ' LEU . . . -43.72 -42.76 5.59 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 1.118 ' CE1' HD21 ' A' ' 155' ' ' LEU . 3.2 m-85 -78.42 -32.2 48.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -68.93 -12.35 61.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.753 -0.779 . . . . 1.0 109.926 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -128.65 81.9 2.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -41.31 158.35 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' A' ' 167' ' ' ILE . 62.9 t80 -71.57 137.08 47.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.959 -1.318 . . . . 1.0 110.5 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.756 ' O ' HG21 ' A' ' 49' ' ' THR . 4.4 mt -118.72 75.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.733 ' HA2' HG21 ' A' ' 49' ' ' THR . . . -159.11 -160.21 10.23 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.515 ' N ' ' OG1' ' A' ' 49' ' ' THR . 20.0 m -118.61 147.48 43.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -1.175 . . . . 1.0 111.445 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.9 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -134.95 157.22 40.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.694 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.524 ' NH2' ' OD1' ' A' ' 169' ' ' ASP . 22.1 ttt-85 -165.52 157.85 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.818 -1.176 . . . . 1.0 111.262 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.551 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 20.0 m-20 51.25 78.61 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.9 . . . . 1.0 110.451 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.932 HG12 ' CB ' ' A' ' 45' ' ' LEU . 16.8 m -124.81 129.55 73.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.363 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.436 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -148.13 148.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.269 -0.972 . . . . 1.0 110.947 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.692 HG21 ' CE1' ' A' ' 43' ' ' PHE . 14.9 p -135.7 123.56 36.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 23.2 m-20 49.95 30.92 4.3 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.409 -1.432 . . . . 1.0 107.86 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 68.09 28.76 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.186 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.678 ' O ' HD12 ' A' ' 177' ' ' LEU . 2.2 mm-40 -109.66 -170.06 1.59 Allowed 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.262 -0.899 . . . . 1.0 109.34 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.593 ' HB3' ' O ' ' A' ' 175' ' ' GLN . 36.6 tp10 76.59 -106.22 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.601 -0.687 . . . . 1.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.927 ' O ' HD12 ' A' ' 179' ' ' LEU . 3.6 mp 63.37 -94.91 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.185 -0.947 . . . . 1.0 112.515 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 7.3 m-70 -56.64 90.02 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.937 -1.102 . . . . 1.0 111.438 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.927 HD12 ' O ' ' A' ' 177' ' ' LEU 0.272 3.5 mp -63.57 -58.78 5.87 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.214 1.006 . . . . 1.0 110.868 178.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 184' ' ' LEU . 2.1 t -61.44 -16.45 14.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.933 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 3.4 mt-10 -72.3 -45.27 60.76 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.386 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.616 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 1.6 m-20 -101.8 -15.52 16.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.257 -0.902 . . . . 1.0 109.277 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -78.2 -37.51 45.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.326 -0.859 . . . . 1.0 109.299 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 180' ' ' VAL . 11.4 mt -55.74 -16.29 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 1.0 109.877 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 184' ' ' LEU . 9.8 t-20 -42.98 -27.01 0.16 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.824 0.821 . . . . 1.0 109.271 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 184' ' ' LEU . 2.3 t30 -134.74 143.17 45.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 188' ' ' THR . 46.1 Cg_endo -71.0 -158.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.632 1.333 . . . . 1.0 110.98 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 188' ' ' THR . 0.4 OUTLIER 64.09 22.91 13.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.603 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 1.001 ' C ' HD13 ' A' ' 190' ' ' LEU . 0.9 OUTLIER -92.78 112.6 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.272 -0.893 . . . . 1.0 110.781 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 1.001 HD13 ' C ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -109.48 149.56 29.41 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.13 -0.981 . . . . 1.0 109.201 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.6 ' CE1' ' CD1' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -99.63 101.63 12.89 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.97 -1.081 . . . . 1.0 109.835 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' HIS . 9.0 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 1.0 110.476 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.457 0.646 . . . . 1.0 110.047 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' ' CG ' ' A' ' 191' ' ' HIS . . . -110.47 160.93 16.17 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.291 -0.88 . . . . 1.0 110.453 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.69 HG21 ' CE ' ' A' ' 25' ' ' MET . 6.4 mm -127.27 125.71 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 1.0 109.222 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -92.55 138.57 31.39 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.415 -0.803 . . . . 1.0 110.964 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.903 ' CE1' HD12 ' A' ' 167' ' ' ILE . 12.2 m-85 -101.27 169.05 9.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.568 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.82 -7.56 5.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.967 . . . . 1.0 110.634 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.35 37.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -129.24 -13.15 4.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.05 -1.265 . . . . 1.0 110.737 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.861 HG23 ' ND2' ' A' ' 186' ' ' ASN . 2.3 m -69.53 130.47 42.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.211 -0.931 . . . . 1.0 110.507 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -116.09 118.02 31.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.358 -0.838 . . . . 1.0 109.487 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.69 ' CE ' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -91.55 101.3 13.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.641 -1.287 . . . . 1.0 110.096 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.602 ' OE1' ' CZ2' ' A' ' 142' ' ' TRP . 5.4 tp10 -79.99 97.03 6.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.852 -0.795 . . . . 1.0 108.852 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 25' ' ' MET . 19.0 m-85 -95.37 97.57 9.93 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.103 -1.039 . . . . 1.0 111.362 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.82 123.72 41.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 1.0 108.849 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -133.3 157.33 45.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.852 -1.155 . . . . 1.0 111.225 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' VAL . . . -105.94 101.8 11.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.662 -0.649 . . . . 1.0 109.553 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.942 HG21 ' OD2' ' A' ' 138' ' ' ASP . 2.8 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 1.0 109.988 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 35.7 tt0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.3 0.571 . . . . 1.0 110.658 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB2' HG22 ' A' ' 110' ' ' VAL . 1.2 p -167.29 155.13 9.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.049 -1.032 . . . . 1.0 110.635 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.595 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -128.17 148.68 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 1.0 110.077 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 13.8 m-70 -114.47 126.59 55.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 1.0 109.641 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.695 ' CZ ' HD11 ' A' ' 69' ' ' ILE . 73.9 m-85 -120.21 122.47 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -0.987 . . . . 1.0 111.137 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.766 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -128.3 134.96 49.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.032 . . . . 1.0 110.576 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.894 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.1 pt? -175.18 156.59 2.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.956 -1.09 . . . . 1.0 111.293 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.406 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -119.68 155.18 32.88 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.608 HG23 ' CD1' ' A' ' 105' ' ' ILE . 6.9 pt -146.35 169.6 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 118.665 -1.214 . . . . 1.0 112.286 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.626 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -129.01 92.57 3.42 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 178.322 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.932 ' CG2' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -73.21 157.6 36.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 1.0 112.286 -177.012 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.885 ' HB2' HG22 ' A' ' 164' ' ' ILE . 6.8 mm-40 -148.9 12.65 0.87 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.043 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -151.07 8.32 0.54 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.454 -1.404 . . . . 1.0 112.223 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.876 HG22 ' CA ' ' A' ' 76' ' ' GLY . 0.7 OUTLIER 50.98 11.03 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.969 -1.082 . . . . 1.0 111.823 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.8 tt0 -158.76 137.92 11.43 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.902 -1.124 . . . . 1.0 110.163 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 148.35 139.35 3.16 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.982 ' CD2' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -87.07 126.21 34.62 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.021 -1.282 . . . . 1.0 108.693 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.968 HD11 ' CG1' ' A' ' 73' ' ' ILE . 3.4 mp -92.49 -32.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 1.0 111.708 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.021 HD13 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -144.15 148.17 34.68 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.802 -1.186 . . . . 1.0 113.017 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.816 ' CZ2' HG21 ' A' ' 151' ' ' VAL . 21.3 t-105 -156.23 111.82 2.97 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.576 ' CB ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -114.77 128.5 56.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.829 -1.17 . . . . 1.0 111.511 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 108.286 -1.926 . . . . 1.0 108.286 178.877 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.567 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 2.7 m-85 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.868 0.366 . . . . 1.0 110.603 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.695 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 2.5 tt -110.67 110.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.006 -1.059 . . . . 1.0 110.19 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.598 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -133.67 176.52 8.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.132 -0.98 . . . . 1.0 110.476 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.021 HD12 HD13 ' A' ' 57' ' ' LEU . 42.4 mt -147.88 113.09 5.54 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.966 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -131.8 164.25 26.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.95 -1.094 . . . . 1.0 111.855 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.968 ' CG1' HD11 ' A' ' 56' ' ' ILE . 7.0 mt -108.64 136.46 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.849 . . . . 1.0 110.669 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.74 HG22 ' CG ' ' A' ' 75' ' ' ASP . 4.2 p -141.67 120.6 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.81 . . . . 1.0 111.28 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.74 ' CG ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER 70.57 14.08 7.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 1.0 110.938 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.95 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 99.05 7.68 54.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.789 -1.324 . . . . 1.0 109.789 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.22 146.44 49.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -1.225 . . . . 1.0 109.385 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.821 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -93.38 162.58 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 1.0 109.589 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.522 ' CB ' ' HA ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -159.17 139.41 12.13 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.212 -0.93 . . . . 1.0 110.152 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.719 ' CB ' HD23 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -107.61 115.86 30.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.349 -0.941 . . . . 1.0 110.253 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.598 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 3.0 ptp -89.39 133.79 34.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.582 -1.323 . . . . 1.0 110.128 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.616 ' OH ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -126.92 128.93 47.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 1.0 110.688 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.567 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.5 t0 -146.53 66.21 1.18 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.287 1.041 . . . . 1.0 109.466 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.766 ' HB3' HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -66.87 -3.68 7.51 Favored 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.563 -0.71 . . . . 1.0 111.074 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -137.98 -55.43 0.05 OUTLIER Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.554 -1.308 . . . . 1.0 110.62 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.49 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -176.01 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.213 -1.169 . . . . 1.0 110.678 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 15.8 mmtp -98.48 110.87 58.44 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.009 -1.057 . . . . 1.0 109.795 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 82' ' ' TYR . 43.1 Cg_endo -71.93 159.9 49.13 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.86 1.453 . . . . 1.0 110.712 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -137.02 116.98 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 90' ' ' VAL . 1.8 p -95.99 112.44 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.404 -1.435 . . . . 1.0 110.974 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.738 ' C ' HG21 ' A' ' 124' ' ' ILE . 4.6 mt -105.69 71.56 0.92 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.536 ' O ' HG21 ' A' ' 124' ' ' ILE . 3.4 mtp180 -60.07 178.14 0.2 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.99 0.9 . . . . 1.0 110.909 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.524 ' OG ' HG21 ' A' ' 118' ' ' VAL . 7.9 t -100.11 161.35 13.66 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.648 -0.658 . . . . 1.0 110.656 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.581 HG23 ' CD1' ' A' ' 124' ' ' ILE . 0.8 OUTLIER -118.71 25.75 10.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 1.0 109.485 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.004 ' HB ' HG11 ' A' ' 118' ' ' VAL . 2.2 t -137.53 147.34 57.19 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.708 -0.62 . . . . 1.0 109.617 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.449 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.2 Cg_endo -65.91 137.12 47.77 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.806 1.424 . . . . 1.0 110.783 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.95 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -128.94 -22.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 1.0 111.197 -179.113 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.48 ' CB ' HG23 ' A' ' 52' ' ' THR . 6.7 p30 -74.2 54.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.982 . . . . 1.0 111.317 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.783 HG23 ' HB2' ' A' ' 101' ' ' HIS . 14.2 t -128.87 30.77 5.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.263 -0.898 . . . . 1.0 108.906 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.461 ' CG ' ' O ' ' A' ' 99' ' ' THR . 5.9 p-10 40.49 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.948 -0.47 . . . . 1.0 111.578 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.783 ' HB2' HG23 ' A' ' 99' ' ' THR . 0.3 OUTLIER -102.02 160.03 14.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.0 -1.062 . . . . 1.0 109.049 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.626 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 20.0 m95 -81.11 102.34 10.19 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.037 -1.039 . . . . 1.0 109.838 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 104' ' ' HIS . 18.2 m -93.8 173.79 7.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 1.0 109.246 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.611 ' N ' HG22 ' A' ' 103' ' ' THR . 3.2 t60 -121.81 125.57 46.8 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.316 -1.364 . . . . 1.0 107.316 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.608 ' CD1' HG23 ' A' ' 47' ' ' ILE . 1.5 mp -124.25 147.67 28.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.759 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -152.94 179.42 8.7 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.27 -1.372 . . . . 1.0 109.38 -178.15 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -164.4 145.98 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.834 -1.166 . . . . 1.0 111.811 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 4.7 m-85 -136.54 104.8 5.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.448 -0.782 . . . . 1.0 109.576 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.593 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -95.63 131.28 42.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.978 . . . . 1.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.551 ' N ' ' HD3' ' A' ' 109' ' ' ARG . 85.8 t -137.53 104.22 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.365 -0.835 . . . . 1.0 110.687 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.475 ' O ' ' CB ' ' A' ' 112' ' ' ARG . 16.4 mt-30 40.83 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.591 -0.693 . . . . 1.0 112.206 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.1 OUTLIER 71.59 -50.61 0.69 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 1.0 112.734 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 6.3 tt0 -85.04 122.03 28.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.691 -1.256 . . . . 1.0 111.511 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.35 166.7 12.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.546 ' O ' ' CE ' ' A' ' 80' ' ' MET . 42.1 t -145.0 151.83 39.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.288 -1.125 . . . . 1.0 111.075 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.078 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -111.77 147.25 36.07 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 1.078 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -127.45 91.65 3.35 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.778 -1.169 . . . . 1.0 112.591 -177.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 1.004 HG11 ' HB ' ' A' ' 95' ' ' VAL . 70.4 t -78.93 87.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.748 -1.204 . . . . 1.0 107.748 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 56.88 58.28 15.33 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.802 -1.19 . . . . 1.0 110.348 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' A' ' 117' ' ' GLN . 3.6 t-20 41.4 24.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.433 -1.039 . . . . 1.0 112.237 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 1.1 mt-10 -97.83 -166.7 1.41 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.748 -1.22 . . . . 1.0 109.304 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.7 96.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.87 0 C-N-CA 120.0 -0.68 . . . . 1.0 109.587 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.529 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.8 Cg_endo -74.93 130.43 13.34 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.091 1.574 . . . . 1.0 110.871 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.746 HG22 ' HB3' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -86.05 144.5 9.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 O-C-N 121.153 -0.967 . . . . 1.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.61 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 4.6 p -138.83 158.13 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.524 -1.36 . . . . 1.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.734 ' N ' HD21 ' A' ' 91' ' ' LEU . . . -166.21 165.47 38.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.209 -2.356 . . . . 1.0 107.209 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -152.91 151.2 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.594 -1.533 . . . . 1.0 111.79 -179.342 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.1 p -106.02 173.96 2.89 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.746 -0.596 . . . . 1.0 109.911 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 131' ' ' GLY . 45.2 Cg_endo -70.65 67.77 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.915 1.482 . . . . 1.0 110.18 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.0 OUTLIER -4.04 70.28 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 121.581 0.705 . . . . 1.0 112.798 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -84.68 -71.17 1.32 Allowed Glycine 0 C--N 1.288 -2.093 0 N-CA-C 109.196 -1.562 . . . . 1.0 109.196 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.765 ' HB3' HD12 ' A' ' 84' ' ' LEU . . . -67.7 86.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -1.186 . . . . 1.0 109.369 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.877 HG22 ' NE2' ' A' ' 134' ' ' GLN . 16.7 m -19.0 -69.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.036 0.446 . . . . 1.0 111.986 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.877 ' NE2' HG22 ' A' ' 133' ' ' THR . 0.0 OUTLIER -113.65 -45.87 3.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 1.0 110.023 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 84' ' ' LEU . 0.2 OUTLIER 62.2 113.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.899 . . . . 1.0 110.346 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.504 ' C ' ' CG2' ' A' ' 137' ' ' THR . 15.2 m-20 -73.19 138.97 45.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 1.0 109.534 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.673 ' CG2' HD13 ' A' ' 135' ' ' LEU . 7.2 p -153.53 105.0 2.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 1.0 109.792 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.942 ' OD2' HG21 ' A' ' 31' ' ' VAL . 7.9 p-10 170.61 -39.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -24.91 -43.91 0.01 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -146.99 173.81 12.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.903 -1.351 . . . . 1.0 110.445 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.635 ' CD1' HD21 ' A' ' 57' ' ' LEU . 10.3 tp -160.86 148.79 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.344 -0.848 . . . . 1.0 110.248 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.607 ' CG ' ' HE3' ' A' ' 146' ' ' MET . 20.7 m95 -133.23 143.49 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.303 -0.999 . . . . 1.0 108.303 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.991 HD13 HD12 ' A' ' 57' ' ' LEU . 6.6 tp -145.68 118.89 8.89 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.945 -1.502 . . . . 1.0 112.974 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 122.67 1.86 9.75 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.367 -1.093 . . . . 1.0 110.367 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.493 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 144.32 -135.24 6.09 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 118.936 -1.602 . . . . 1.0 109.727 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' MET . . . . . 1.065 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -170.79 176.48 4.17 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.816 -0.814 . . . . 1.0 111.714 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -96.37 -25.35 15.76 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.919 0.866 . . . . 1.0 108.918 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.562 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.91 74.59 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.822 -1.548 . . . . 1.0 106.822 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.065 HD13 ' HB2' ' A' ' 146' ' ' MET . 3.8 tp -71.39 24.69 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 113.926 1.084 . . . . 1.0 113.926 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.6 p -62.16 -21.01 64.72 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 104.68 -2.341 . . . . 1.0 104.68 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.861 HG12 ' HA ' ' A' ' 149' ' ' LEU 0.284 13.5 p -58.32 -118.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.348 -1.297 . . . . 1.0 110.154 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 151' ' ' VAL . . . 70.24 -71.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.809 -1.182 . . . . 1.0 109.927 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.629 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 18.3 m170 132.16 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.477 ' HD3' ' HB3' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -137.14 12.11 3.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.005 . . . . 1.0 109.706 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 1.084 ' CD2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -70.36 165.61 42.86 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.421 -0.799 . . . . 1.0 111.126 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.611 ' N ' HD22 ' A' ' 155' ' ' LEU . 40.9 Cg_endo -64.97 -168.68 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.967 1.509 . . . . 1.0 112.448 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.565 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 2.2 mttp -53.28 -10.77 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 1.084 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -38.25 -44.82 0.91 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.044 -1.035 . . . . 1.0 109.983 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.981 ' O ' HD23 ' A' ' 149' ' ' LEU . 15.4 m-85 -84.37 -28.45 26.99 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.945 -1.097 . . . . 1.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -71.64 -7.08 45.67 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.57 -1.252 . . . . 1.0 108.544 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 161' ' ' THR . 1.3 m -131.72 98.27 4.44 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -47.38 175.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.628 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 54.5 t80 -79.07 149.24 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -1.157 . . . . 1.0 112.061 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.885 HG22 ' HB2' ' A' ' 50' ' ' GLU . 1.1 mt -130.8 88.17 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.628 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.2 -153.69 9.48 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.061 -1.616 . . . . 1.0 109.061 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.523 ' C ' HG13 ' A' ' 167' ' ' ILE . 15.0 m -137.32 148.03 46.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.465 -1.021 . . . . 1.0 110.06 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.903 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -133.84 153.64 36.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.526 -0.734 . . . . 1.0 109.717 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.503 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 18.7 ttt180 -163.02 162.37 25.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.657 -1.277 . . . . 1.0 110.963 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER 48.71 78.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.394 -0.816 . . . . 1.0 110.464 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.894 HG12 ' CB ' ' A' ' 45' ' ' LEU . 16.2 m -121.77 135.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 119.362 -0.935 . . . . 1.0 108.937 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.474 HG12 ' C ' ' A' ' 170' ' ' VAL . 0.0 OUTLIER -146.22 148.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.319 -0.953 . . . . 1.0 111.176 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.625 HG13 ' CD1' ' A' ' 43' ' ' PHE . 1.7 t -130.32 102.43 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 10.9 m-20 51.96 42.55 30.35 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 1.0 108.143 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 75.51 26.38 1.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.254 0.549 . . . . 1.0 110.421 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.614 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . 63.9 mt-30 -102.15 -174.67 2.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.358 -0.838 . . . . 1.0 109.726 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 1.9 mm-40 62.64 -92.99 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.685 -0.634 . . . . 1.0 110.656 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER 65.88 -87.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 1.0 111.21 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 47.8 m80 -74.72 102.39 4.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.998 -1.063 . . . . 1.0 111.509 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 183' ' ' ALA 0.253 0.4 OUTLIER -57.22 -58.4 8.38 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 122.419 1.104 . . . . 1.0 109.709 177.881 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.694 ' O ' HD22 ' A' ' 184' ' ' LEU . 95.0 t -50.54 -31.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.99 -1.005 . . . . 1.0 111.262 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 19.7 mt-10 -61.69 -53.81 51.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.121 -0.987 . . . . 1.0 109.929 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.588 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 2.7 t0 -89.79 -15.46 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 1.0 109.665 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 180' ' ' VAL . . . -72.82 -25.08 61.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.326 -0.859 . . . . 1.0 109.032 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.694 HD22 ' O ' ' A' ' 180' ' ' VAL . 0.1 OUTLIER -62.61 -15.49 51.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 1.0 109.438 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -24.15 63.93 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.938 0.875 . . . . 1.0 108.777 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.861 ' ND2' HG23 ' A' ' 23' ' ' THR . 3.6 t-20 -96.46 151.06 37.8 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.487 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 38.8 Cg_endo -64.87 143.61 80.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.538 1.283 . . . . 1.0 111.212 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.473 ' CG2' ' N ' ' A' ' 189' ' ' ILE . 0.8 OUTLIER 49.9 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.585 -0.697 . . . . 1.0 110.648 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.473 ' N ' ' CG2' ' A' ' 188' ' ' THR . 14.2 mm -141.03 121.99 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 1.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 mt -111.25 159.23 18.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.148 -0.97 . . . . 1.0 110.641 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -127.57 153.33 46.52 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 1.0 109.409 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 4.1 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.021 -1.05 . . . . 1.0 110.47 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.54 0.686 . . . . 1.0 110.367 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.51 134.21 34.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.157 -1.589 . . . . 1.0 110.925 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 190' ' ' LEU . 6.8 mm -125.94 142.14 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -0.975 . . . . 1.0 109.29 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -98.58 133.58 42.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.425 -0.797 . . . . 1.0 111.043 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.815 ' CE1' HD12 ' A' ' 167' ' ' ILE . 7.5 m-85 -95.84 175.74 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 1.0 109.192 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 45.6 p-10 -139.5 4.63 2.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.956 . . . . 1.0 110.655 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.483 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.74 -30.58 10.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.577 -1.809 . . . . 1.0 108.577 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 23' ' ' THR . 3.4 ttp-105 -100.92 -12.78 18.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.455 -1.027 . . . . 1.0 109.628 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.809 HG21 ' CD2' ' A' ' 19' ' ' PHE . 11.8 m -42.82 135.52 2.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 1.0 110.379 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.669 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -133.75 99.14 4.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 4.1 mtt -93.98 100.63 12.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.39 -1.444 . . . . 1.0 109.407 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.633 ' CG ' ' CZ3' ' A' ' 142' ' ' TRP . 2.7 tm-20 -103.72 101.8 11.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 1.0 110.325 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 182' ' ' ASP . 19.7 m-30 -108.81 116.41 31.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.258 -0.902 . . . . 1.0 109.346 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -115.67 122.39 45.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 1.0 110.59 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -156.35 163.4 39.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.0 110.242 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.27 167.28 19.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.089 -1.007 . . . . 1.0 110.83 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.657 0.742 . . . . 1.0 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.6 p -118.38 149.9 40.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 7.4 m120 -133.59 117.31 16.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.032 -1.043 . . . . 1.0 111.158 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 6.5 m-70 -94.87 108.74 20.77 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 8.4 m-85 -113.83 118.04 33.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 1.0 111.333 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.644 ' C ' HD23 ' A' ' 45' ' ' LEU . 2.1 mt-10 -127.99 150.62 49.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.183 -0.948 . . . . 1.0 110.577 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER 179.9 153.55 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.266 -0.896 . . . . 1.0 110.552 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 167' ' ' ILE . 0.7 OUTLIER -130.12 149.42 51.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 1.0 109.787 179.029 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.994 HD11 ' CG1' ' A' ' 97' ' ' ILE . 9.4 pt -131.22 177.28 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.186 -1.006 . . . . 1.0 110.067 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.641 ' O ' ' OG1' ' A' ' 49' ' ' THR . 12.4 tttt -167.0 82.31 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.204 -0.935 . . . . 1.0 111.018 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.998 HG22 ' HG2' ' A' ' 50' ' ' GLU . 29.5 m -172.03 -114.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.238 0.542 . . . . 1.0 111.095 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.998 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -115.04 -47.45 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.683 1.23 . . . . 1.0 109.586 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 1.042 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . 34.98 41.99 0.07 Allowed 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.413 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.626 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 64.9 p -85.51 -17.25 36.97 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.87 -1.144 . . . . 1.0 108.537 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.478 ' OE1' ' HB2' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -159.95 119.82 2.92 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 154.73 129.05 1.22 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.15 -1.58 . . . . 1.0 109.15 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.863 HD21 ' CD1' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -81.3 131.12 35.27 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.652 -1.499 . . . . 1.0 109.334 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.833 HD12 ' HA ' ' A' ' 72' ' ' ALA . 1.3 mp -97.21 -25.75 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.492 -0.755 . . . . 1.0 112.217 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.923 HD13 HD12 ' A' ' 71' ' ' LEU . 6.1 tt -148.7 133.74 18.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.723 -1.86 . . . . 1.0 113.211 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.977 ' CH2' HG21 ' A' ' 151' ' ' VAL . 20.4 t-105 -145.73 117.59 8.2 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB2' ' HA ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -137.6 153.03 49.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.841 -1.162 . . . . 1.0 111.024 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' C ' ' OG1' ' A' ' 137' ' ' THR . . . . . . . . 0 N--CA 1.494 2.514 0 N-CA-C 108.579 -1.809 . . . . 1.0 108.579 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.794 ' CG ' HG22 ' A' ' 69' ' ' ILE . 6.6 t80 . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 120.487 0.184 . . . . 1.0 111.029 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.794 HG22 ' CG ' ' A' ' 68' ' ' TYR . 1.8 tt -153.79 162.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.523 -1.361 . . . . 1.0 111.843 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.904 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -157.71 170.15 23.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 1.0 110.032 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.923 HD12 HD13 ' A' ' 57' ' ' LEU . 77.6 mt -145.17 125.79 14.17 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.833 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -152.71 172.36 16.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.94 -1.1 . . . . 1.0 111.325 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.042 HD13 ' HB1' ' A' ' 51' ' ' ALA . 5.5 mt -127.49 146.01 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 1.0 111.452 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.62 ' CG1' ' CG ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -141.46 122.69 13.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.306 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.1 m-20 73.76 -3.98 2.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.335 -0.853 . . . . 1.0 112.169 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.68 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 127.4 -0.65 6.97 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 118.866 -1.635 . . . . 1.0 111.045 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.723 ' C ' HG23 ' A' ' 73' ' ' ILE . 25.7 m-85 -133.93 134.13 42.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.93 -1.335 . . . . 1.0 110.545 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.79 HG23 HG13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -59.97 -167.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 1.0 109.946 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.947 ' HB2' HG22 ' A' ' 90' ' ' VAL . 1.3 pt20 -174.75 97.37 0.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.441 -0.787 . . . . 1.0 109.819 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.607 ' HE3' ' CD1' ' A' ' 91' ' ' LEU . 3.2 ttp -62.21 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.614 -0.834 . . . . 1.0 109.233 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.904 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 12.2 ttp -95.02 108.77 20.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.651 -0.656 . . . . 1.0 110.21 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.884 ' CE2' HG11 ' A' ' 89' ' ' VAL . 1.4 p90 -125.74 138.57 53.87 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.015 -1.474 . . . . 1.0 111.013 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.53 ' OD2' ' CD ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -136.6 94.93 3.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.75 -0.594 . . . . 1.0 110.444 -179.288 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.493 HD12 ' CB ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -102.52 3.27 37.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.835 -0.541 . . . . 1.0 110.654 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -136.44 -43.03 0.1 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.302 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 167.72 -20.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.193 -1.181 . . . . 1.0 110.983 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 7.8 mttt -118.8 120.35 31.6 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.097 . . . . 1.0 110.081 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.602 ' HG3' ' CE1' ' A' ' 153' ' ' HIS . 52.6 Cg_endo -78.31 146.62 22.36 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.946 1.498 . . . . 1.0 110.151 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.884 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -112.97 121.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.323 -0.861 . . . . 1.0 108.729 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.947 HG22 ' HB2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -102.5 111.29 31.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.09 -1.444 . . . . 1.0 110.427 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.607 ' CD1' ' HE3' ' A' ' 80' ' ' MET . 11.7 mt -105.61 70.05 0.86 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.9 -1.519 . . . . 1.0 106.9 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.618 ' O ' HD13 ' A' ' 124' ' ' ILE . 20.0 mtp180 -60.5 148.97 35.89 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 122.121 0.963 . . . . 1.0 111.22 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.738 ' OG ' HG21 ' A' ' 118' ' ' VAL 0.253 48.2 t -67.57 150.67 48.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.824 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.588 ' N ' HD11 ' A' ' 124' ' ' ILE . 12.1 t -107.57 26.73 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.789 . . . . 1.0 109.023 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.975 ' HB ' HG11 ' A' ' 118' ' ' VAL . 2.1 t -139.88 153.3 69.6 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.663 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.9 Cg_endo -65.84 124.69 13.07 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.661 1.348 . . . . 1.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.994 ' CG1' HD11 ' A' ' 47' ' ' ILE . 3.3 tp -109.55 -8.42 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.805 . . . . 1.0 110.03 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 5.4 p-10 -93.77 56.89 2.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.758 . . . . 1.0 109.896 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 99' ' ' THR . 98.1 m -114.61 7.04 15.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.227 -0.921 . . . . 1.0 110.739 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.458 ' HA ' ' CA ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 60.54 10.94 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.331 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -104.47 163.11 12.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 1.0 109.742 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 15.6 m95 -78.08 91.87 4.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.003 -1.061 . . . . 1.0 110.864 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.552 HG21 HD12 ' A' ' 97' ' ' ILE . 22.9 m -86.63 167.5 14.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.76 -0.829 . . . . 1.0 108.76 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.523 ' N ' HG22 ' A' ' 103' ' ' THR . 23.1 t60 -123.98 132.45 53.71 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.208 -0.997 . . . . 1.0 109.782 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.488 HG22 HD11 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -126.78 142.94 41.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.318 -0.864 . . . . 1.0 108.979 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.724 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -148.34 179.65 7.62 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.018 -1.073 . . . . 1.0 109.309 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 108' ' ' TYR . . . -165.11 157.63 15.9 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.808 -1.182 . . . . 1.0 111.824 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 6.0 m-85 -136.21 104.39 5.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 1.0 109.299 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -103.02 134.75 45.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.911 -1.118 . . . . 1.0 109.945 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.527 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 3.0 t -130.56 84.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.161 -1.016 . . . . 1.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 32.4 mt-30 53.85 -2.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -179.37 -27.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.042 -1.661 . . . . 1.0 111.066 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.526 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -110.35 115.9 30.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 1.0 110.718 -178.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -103.54 149.89 17.46 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.72 ' CB ' HG22 ' A' ' 125' ' ' THR . 12.5 t -132.36 155.59 48.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.274 -1.133 . . . . 1.0 110.266 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 117' ' ' GLN . 1.6 tm? -123.65 144.89 49.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.802 -1.186 . . . . 1.0 108.679 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 1.033 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -121.04 81.35 1.76 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.411 -0.806 . . . . 1.0 112.3 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.975 HG11 ' HB ' ' A' ' 95' ' ' VAL . 91.4 t -70.29 80.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.772 -1.171 . . . . 1.0 107.933 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 67.12 59.77 6.61 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.072 -1.211 . . . . 1.0 110.072 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.456 ' H ' ' HG3' ' A' ' 117' ' ' GLN . 7.8 m120 36.68 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.898 . . . . 1.0 111.25 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -103.18 -161.4 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 1.0 109.919 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.577 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -39.82 99.38 0.2 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.555 -0.716 . . . . 1.0 109.375 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.1 Cg_endo -71.17 129.88 16.78 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.211 1.638 . . . . 1.0 110.892 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 93' ' ' SER . 3.0 mt -101.45 102.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.72 HG22 ' CB ' ' A' ' 115' ' ' SER . 30.2 p -114.06 173.42 6.45 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.261 1.029 . . . . 1.0 112.299 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.405 ' C ' ' OG ' ' A' ' 127' ' ' SER . . . -178.09 -171.35 41.37 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.532 -2.227 . . . . 1.0 107.532 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -159.5 171.01 20.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.597 -1.531 . . . . 1.0 110.892 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.564 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.6 OUTLIER -107.97 -177.89 0.52 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 1.0 110.193 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.8 Cg_endo -69.39 94.88 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 1.0 108.946 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.666 ' H ' HD12 ' A' ' 130' ' ' LEU . 3.4 mp -34.32 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.228 0.537 . . . . 1.0 111.098 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.03 -29.04 1.25 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.614 -1.394 . . . . 1.0 109.614 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.493 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -90.66 135.33 33.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -1.16 . . . . 1.0 110.333 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.435 ' C ' ' HG2' ' A' ' 134' ' ' GLN . 9.7 m -138.38 23.47 2.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 1.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.51 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -158.52 -49.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 1.0 110.398 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER 28.14 64.01 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.232 0.539 . . . . 1.0 111.523 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -52.55 96.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.122 -0.986 . . . . 1.0 110.199 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 68' ' ' TYR . 10.5 t -159.72 -172.88 3.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 1.0 109.759 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 91.59 -19.87 0.12 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 121.298 0.571 . . . . 1.0 110.544 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -47.99 -17.0 0.51 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 120.198 -1.001 . . . . 1.0 110.743 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -128.79 168.36 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.631 -1.511 . . . . 1.0 109.748 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 0.5 OUTLIER -154.88 145.96 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 1.0 110.861 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.633 ' CZ3' ' CG ' ' A' ' 26' ' ' GLU . 30.2 m95 -136.6 96.47 3.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.131 -1.803 . . . . 1.0 106.131 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.688 HD12 ' CB ' ' A' ' 57' ' ' LEU . 1.7 tp -112.34 130.05 56.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.97 1.47 . . . . 1.0 114.97 -175.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 106.99 10.05 28.88 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.701 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 124.93 -160.82 19.56 Favored Glycine 0 C--N 1.278 -2.648 0 N-CA-C 107.762 -2.135 . . . . 1.0 107.762 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.931 ' HB2' HD12 ' A' ' 149' ' ' LEU . 1.9 mmt -168.78 169.5 9.91 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.282 -1.367 . . . . 1.0 111.059 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.9 11.32 38.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -165.43 16.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.667 -0.646 . . . . 1.0 111.525 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.931 HD12 ' HB2' ' A' ' 146' ' ' MET . 9.2 mt -68.42 53.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.402 -1.436 . . . . 1.0 109.865 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 148' ' ' ARG . 10.5 p -55.19 -24.31 26.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.413 -1.699 . . . . 1.0 106.413 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.977 HG21 ' CH2' ' A' ' 58' ' ' TRP 0.311 12.7 p -48.21 -118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.051 -1.431 . . . . 1.0 111.86 178.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' A' ' 155' ' ' LEU . . . 79.81 -23.25 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.11 -0.993 . . . . 1.0 109.993 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.602 ' CE1' ' HG3' ' A' ' 88' ' ' PRO . 0.2 OUTLIER 75.68 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 1.0 111.163 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.577 ' CG ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -150.04 74.92 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.823 -1.173 . . . . 1.0 111.137 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -142.47 178.41 1.51 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 120.696 -1.252 . . . . 1.0 110.029 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.62 ' CG ' ' CG1' ' A' ' 74' ' ' VAL . 52.6 Cg_endo -76.76 -164.2 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.707 1.372 . . . . 1.0 111.948 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 161' ' ' THR . 2.8 mttm -51.21 -10.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.609 -0.682 . . . . 1.0 112.131 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.609 ' HB3' ' CD1' ' A' ' 155' ' ' LEU . . . -32.75 -46.52 0.14 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.121 -0.987 . . . . 1.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.964 ' CD2' ' HB2' ' A' ' 152' ' ' ALA . 3.6 m-85 -83.97 -33.98 24.49 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.558 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -76.06 -1.7 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.977 -1.089 . . . . 1.0 108.813 178.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 161' ' ' THR . 2.6 m -140.74 83.24 1.88 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.547 -0.72 . . . . 1.0 109.29 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -43.54 165.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.154 -1.578 . . . . 1.0 109.154 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.802 ' CE1' ' HB2' ' A' ' 51' ' ' ALA . 32.6 t80 -70.63 142.67 51.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.286 . . . . 1.0 110.485 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.672 ' O ' HG21 ' A' ' 49' ' ' THR . 19.3 mt -119.79 79.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.761 ' HA2' HG21 ' A' ' 49' ' ' THR . . . -165.48 -163.19 18.33 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 1.8 m -114.41 146.92 40.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -1.183 . . . . 1.0 111.585 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.815 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -136.45 152.62 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.166 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.468 ' HG2' ' OD1' ' A' ' 169' ' ' ASP . 13.5 ttp180 -158.6 159.1 35.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 1.0 110.769 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.7 m-20 53.13 79.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 1.0 110.509 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.589 HG12 ' CB ' ' A' ' 45' ' ' LEU . 28.5 m -128.72 131.71 68.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.495 ' CG1' ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -150.88 149.24 14.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.03 -1.068 . . . . 1.0 110.899 -176.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.531 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 8.9 t -135.25 108.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 1.5 m-20 50.53 42.96 27.33 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.391 -1.443 . . . . 1.0 107.469 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.31 28.7 2.93 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.906 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 176' ' ' GLU . 4.7 mt-30 -100.98 -178.13 3.66 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.102 -0.999 . . . . 1.0 109.217 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 4.5 mm-40 69.62 -98.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.634 -0.666 . . . . 1.0 110.44 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER 69.27 -88.02 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.256 -0.903 . . . . 1.0 111.05 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 9.3 m80 -97.44 103.17 15.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.739 -1.225 . . . . 1.0 111.097 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.5 OUTLIER -67.4 -53.56 28.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 22.1 t -51.47 -23.05 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.699 . . . . 1.0 110.381 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 35.5 mt-10 -71.69 -58.43 3.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 1.0 110.01 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.575 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 12.3 t0 -87.49 -14.63 39.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 1.0 109.619 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -69.65 -34.16 73.62 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.254 -0.904 . . . . 1.0 108.873 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.655 ' HA ' HD11 ' A' ' 189' ' ' ILE . 11.3 mt -48.68 -24.23 1.3 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 1.0 108.975 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 1.2 t-20 -57.22 -20.11 25.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.101 0.953 . . . . 1.0 109.009 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.512 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 1.8 t30 -89.61 151.95 46.5 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.512 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 37.5 Cg_endo -61.82 -149.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.3 1.158 . . . . 1.0 109.309 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.504 ' C ' ' O ' ' A' ' 187' ' ' PRO . 20.5 m -33.06 136.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.355 -0.84 . . . . 1.0 111.197 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 184' ' ' LEU . 13.4 mt -127.78 153.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.505 -0.747 . . . . 1.0 109.795 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 17' ' ' ILE . 23.1 mt -131.2 155.27 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 1.0 110.648 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 18' ' ' ALA . 1.9 m-70 -92.29 -87.96 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.818 . . . . 1.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 191' ' ' HIS . 5.3 t . . . . . 0 C--N 1.296 -1.759 0 C-N-CA 119.373 -0.931 . . . . 1.0 111.498 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.579 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.1 pt-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 121.459 0.647 . . . . 1.0 110.785 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -112.3 119.41 38.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.533 -1.354 . . . . 1.0 109.79 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.628 ' CG1' HD12 ' A' ' 179' ' ' LEU . 10.1 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.533 -1.267 . . . . 1.0 110.421 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -91.15 115.59 28.14 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.731 -0.606 . . . . 1.0 110.532 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.783 ' CZ ' HD13 ' A' ' 167' ' ' ILE . 5.0 m-30 -74.52 167.6 21.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 1.0 109.114 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 23' ' ' THR . 1.4 p-10 -117.57 -10.13 10.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.057 -1.027 . . . . 1.0 110.18 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.497 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 105.45 -9.28 45.07 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.54 ' CD ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -147.04 21.16 1.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.167 -1.196 . . . . 1.0 110.055 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m -115.62 102.81 10.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.0 109.867 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.632 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -67.12 117.46 9.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 1.0 111.015 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.614 ' HE1' HG21 ' A' ' 17' ' ' ILE . 3.4 mmm -106.8 98.56 8.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.689 -1.257 . . . . 1.0 108.27 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.606 ' OE1' ' CZ3' ' A' ' 142' ' ' TRP . 4.6 pt-20 -107.84 152.3 24.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.311 -0.868 . . . . 1.0 110.261 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.562 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 3.3 m-85 -130.48 124.66 32.49 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.243 -0.983 . . . . 1.0 110.001 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.441 ' CD2' ' HB2' ' A' ' 140' ' ' ALA . 0.0 OUTLIER -97.55 89.64 4.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.567 -0.708 . . . . 1.0 110.287 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -88.67 151.72 22.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 1.0 109.781 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.32 108.4 19.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.172 -0.955 . . . . 1.0 110.666 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.787 HG11 ' OE1' ' A' ' 175' ' ' GLN . 19.1 m . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 1.0 110.003 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 40' ' ' SER . 31.8 tt0 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.949 0.88 . . . . 1.0 109.18 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.74 ' OG ' HG13 ' A' ' 110' ' ' VAL . 5.7 m -157.03 119.15 3.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.19 0.519 . . . . 1.0 110.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -103.67 163.3 12.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 1.0 110.439 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.556 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 59.1 m-70 -139.07 132.84 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 1.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.074 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 93.5 m-85 -135.24 115.44 13.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.57 -0.706 . . . . 1.0 109.625 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.825 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.1 mp0 -123.72 144.19 49.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.823 -1.173 . . . . 1.0 109.756 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.871 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -178.38 159.39 1.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.393 -0.923 . . . . 1.0 110.882 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 103' ' ' THR . 1.0 OUTLIER -123.49 154.38 39.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.156 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 166' ' ' CYS . 1.9 pt -148.14 156.01 9.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 117.907 -1.517 . . . . 1.0 112.045 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.615 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -105.94 86.45 2.38 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 176.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.566 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -75.27 153.36 38.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.125 -1.03 . . . . 1.0 112.841 -175.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 3.2 mm-40 -143.48 1.97 1.23 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.434 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.39 128.78 24.18 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.047 -1.033 . . . . 1.0 110.285 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.547 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 58.3 p -62.88 -15.4 54.72 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.379 -0.826 . . . . 1.0 110.844 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HG2' ' N ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -129.82 135.65 48.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.846 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 159.33 137.14 2.17 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -90.84 126.24 35.97 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.051 -1.264 . . . . 1.0 108.797 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.913 HG22 HD21 ' A' ' 143' ' ' LEU . 0.5 OUTLIER -91.25 -34.32 6.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.067 0.766 . . . . 1.0 113.067 -176.298 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 71' ' ' LEU . 3.1 tt -142.76 151.91 41.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.018 -1.676 . . . . 1.0 113.338 -175.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.686 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 9.6 t-105 -162.88 107.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -114.35 137.27 52.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.661 -1.274 . . . . 1.0 111.023 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 108.37 -1.892 . . . . 1.0 108.37 179.307 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 1.1 t80 . . . . . 0 N--CA 1.504 2.267 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.946 HD11 ' CD2' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -130.06 172.88 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.734 -1.229 . . . . 1.0 111.001 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.801 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -174.95 174.67 2.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.692 -0.63 . . . . 1.0 109.636 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 57' ' ' LEU . 70.8 mt -152.43 117.59 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.92 -1.113 . . . . 1.0 109.146 -178.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -132.79 171.07 14.37 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 1.0 112.011 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.112 ' CG1' HG13 ' A' ' 78' ' ' VAL . 30.7 mt -121.86 139.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.476 -0.765 . . . . 1.0 111.559 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.922 HG11 ' NH2' ' A' ' 92' ' ' ARG . 11.7 p -141.43 144.66 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.675 -0.64 . . . . 1.0 110.112 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.779 ' OD1' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER 52.94 27.07 5.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.142 -0.974 . . . . 1.0 110.614 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.744 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 80.42 14.32 80.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 7.5 m-85 -126.64 148.52 49.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 1.0 110.071 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.112 HG13 ' CG1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.15 168.05 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.06 -1.025 . . . . 1.0 109.757 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 22.9 pt20 -160.17 123.23 3.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.098 -1.001 . . . . 1.0 110.944 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.802 ' HA ' HD23 ' A' ' 71' ' ' LEU . 5.4 tmm? -86.83 113.61 22.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.38 -0.825 . . . . 1.0 109.119 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.801 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 2.2 ptt? -100.94 141.12 34.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 1.0 110.765 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.946 ' CD2' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -120.19 105.43 10.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 1.0 110.583 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 85' ' ' GLY . 6.4 t0 -120.86 40.38 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 1.0 109.901 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.812 HD23 ' HD1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -39.17 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.569 -0.707 . . . . 1.0 112.132 -178.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -142.8 -50.34 0.04 OUTLIER Glycine 0 N--CA 1.494 2.527 0 C-N-CA 118.862 -1.637 . . . . 1.0 110.83 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.46 ' H ' ' HD3' ' A' ' 87' ' ' LYS . 1.1 m -173.7 22.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -1.2 . . . . 1.0 110.717 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.574 ' CB ' ' HB3' ' A' ' 128' ' ' SER . 0.0 OUTLIER -129.99 80.91 70.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 1.0 109.292 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 42.5 Cg_endo -68.92 89.66 0.44 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.025 1.54 . . . . 1.0 111.192 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -75.18 155.23 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -127.99 119.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.321 -1.487 . . . . 1.0 110.801 178.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.822 HD21 ' C ' ' A' ' 114' ' ' GLY . 10.6 mp -112.73 69.25 0.69 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.922 ' NH2' HG11 ' A' ' 74' ' ' VAL . 4.6 mtt180 -56.78 178.01 0.07 Allowed 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.668 -1.213 . . . . 1.0 109.822 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.758 ' OG ' HG21 ' A' ' 118' ' ' VAL . 3.0 t -95.68 169.57 9.93 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.693 -0.629 . . . . 1.0 110.16 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 1.011 ' CG2' ' HB3' ' A' ' 122' ' ' ALA . 14.0 t -121.22 16.46 11.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 1.0 109.062 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.951 HG22 ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.84 160.56 60.32 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.661 -0.649 . . . . 1.0 109.331 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.951 ' HD2' HG22 ' A' ' 95' ' ' VAL . 44.3 Cg_endo -70.06 138.48 36.95 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.859 1.452 . . . . 1.0 110.358 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 76' ' ' GLY . 2.7 tp -121.53 -30.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.096 -1.002 . . . . 1.0 110.706 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 2.3 p-10 -73.7 57.45 0.58 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 1.0 109.544 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.724 ' O ' HG22 ' A' ' 99' ' ' THR . 16.8 m -114.12 19.77 16.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.563 -0.711 . . . . 1.0 110.282 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 46.7 22.28 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 1.0 110.921 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.32 144.94 43.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.056 -1.028 . . . . 1.0 110.1 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 7.5 m95 -59.46 95.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 1.0 109.881 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' SER . 26.5 m -94.09 164.7 12.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.156 -0.965 . . . . 1.0 109.485 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 40.6 t-80 -116.34 147.64 41.39 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.258 -0.901 . . . . 1.0 108.614 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.516 HD11 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -134.97 152.74 33.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.126 -0.984 . . . . 1.0 109.365 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.995 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -138.57 146.23 41.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.8 -1.188 . . . . 1.0 110.329 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 1.074 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -143.93 92.35 2.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 1.0 110.675 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.598 ' CZ ' ' OG ' ' A' ' 115' ' ' SER . 47.9 p90 -112.18 107.53 16.45 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.056 -1.058 . . . . 1.0 109.014 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.606 ' HD3' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -109.67 130.66 55.49 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.969 -178.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.74 HG13 ' OG ' ' A' ' 40' ' ' SER . 4.2 t -104.5 102.15 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.415 -0.803 . . . . 1.0 109.506 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.56 ' HA ' ' NH2' ' A' ' 109' ' ' ARG . 10.0 pt20 38.65 100.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.581 0.705 . . . . 1.0 112.469 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.56 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 1.1 ptt85 70.18 -50.0 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 1.0 111.644 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.56 ' N ' ' HG2' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -81.49 112.09 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.785 -1.197 . . . . 1.0 110.019 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.822 ' C ' HD21 ' A' ' 91' ' ' LEU . . . -103.39 159.65 16.9 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.144 -1.027 . . . . 1.0 111.732 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 125' ' ' THR . 1.0 OUTLIER -137.35 151.93 49.14 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.835 -0.803 . . . . 1.0 109.656 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -138.33 153.6 48.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.083 -1.011 . . . . 1.0 109.406 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 1.115 ' N ' HD13 ' A' ' 116' ' ' LEU . 1.1 mt-30 -158.28 111.32 2.38 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.768 -1.173 . . . . 1.0 111.644 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.828 HG11 ' CG1' ' A' ' 95' ' ' VAL . 90.7 t -71.29 97.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 64.54 43.12 97.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 1.0 109.509 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.9 OUTLIER 61.84 36.53 15.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -1.136 . . . . 1.0 110.713 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -96.29 -162.93 1.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.123 -0.985 . . . . 1.0 110.791 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 1.011 ' HB3' ' CG2' ' A' ' 94' ' ' THR . . . -43.2 118.17 2.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 1.0 109.246 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 47.7 Cg_endo -73.27 115.22 4.26 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.068 1.562 . . . . 1.0 112.436 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.703 HG21 ' O ' ' A' ' 92' ' ' ARG . 4.1 mp -91.23 102.08 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.619 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.9 p -116.96 179.93 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.502 1.144 . . . . 1.0 112.874 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 113' ' ' GLU . . . 169.42 -173.2 43.74 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 106.667 -2.573 . . . . 1.0 106.667 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -160.46 162.03 33.04 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.471 -1.605 . . . . 1.0 110.686 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.574 ' HB3' ' CB ' ' A' ' 87' ' ' LYS . 19.8 m -111.21 161.31 25.69 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.148 -0.97 . . . . 1.0 110.222 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.547 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.7 Cg_endo -68.16 78.32 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.972 1.511 . . . . 1.0 108.811 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.547 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.4 mt -12.99 131.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.596 0.712 . . . . 1.0 112.815 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 132' ' ' ALA . . . 161.85 99.62 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.756 ' O ' HG22 ' A' ' 133' ' ' THR . . . 173.68 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.459 -1.024 . . . . 1.0 109.716 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 132' ' ' ALA . 5.7 t 42.69 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.465 0.65 . . . . 1.0 110.779 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 133' ' ' THR . 0.5 OUTLIER 40.0 26.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 1.0 110.704 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -89.87 36.62 0.86 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.118 -0.989 . . . . 1.0 109.5 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.7 OUTLIER -51.37 171.03 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.053 -1.029 . . . . 1.0 109.076 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.0 t -113.16 133.41 55.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.037 -1.039 . . . . 1.0 109.748 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.739 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 28.9 p-10 -84.67 30.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 1.0 110.32 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 31' ' ' VAL . . . 44.84 24.1 0.68 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.739 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -116.75 151.67 35.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.146 . . . . 1.0 109.839 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.876 ' CD1' HD21 ' A' ' 57' ' ' LEU . 11.9 tp -154.22 150.05 27.65 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.482 -0.887 . . . . 1.0 110.639 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.624 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 8.0 m95 -126.48 118.19 24.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.074 -1.454 . . . . 1.0 107.074 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.913 HD21 HG22 ' A' ' 56' ' ' ILE . 1.1 tt -125.59 120.01 29.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 117.812 -1.555 . . . . 1.0 112.651 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 124.76 8.21 5.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 136.66 -134.34 7.06 Favored Glycine 0 C--N 1.291 -1.923 0 C-N-CA 119.007 -1.568 . . . . 1.0 109.848 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' MET . . . . . 1.055 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -170.74 158.94 6.27 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.424 -0.911 . . . . 1.0 111.712 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -92.23 -14.88 28.29 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -143.5 51.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.055 HD13 ' HB2' ' A' ' 146' ' ' MET . 10.0 tp -65.5 49.3 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.878 0.696 . . . . 1.0 112.878 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 148' ' ' ARG . 20.5 p -73.83 -19.67 60.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 105.167 -2.16 . . . . 1.0 105.167 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.749 ' CG1' HD12 ' A' ' 149' ' ' LEU 0.267 3.9 p -61.55 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.588 -1.187 . . . . 1.0 109.909 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.765 ' HB1' ' CD2' ' A' ' 159' ' ' TYR . . . 53.77 20.15 2.16 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.408 -1.432 . . . . 1.0 110.195 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.585 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 48.1 m80 32.98 -85.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.83 -0.544 . . . . 1.0 112.323 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ALA . 2.9 ptpp? -134.67 -29.83 1.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 1.0 113.082 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.996 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -60.34 138.44 91.99 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.684 -1.26 . . . . 1.0 109.078 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.594 ' N ' HD12 ' A' ' 155' ' ' LEU . 56.4 Cg_endo -81.54 -92.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.902 1.475 . . . . 1.0 114.642 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.612 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -55.03 -47.56 74.6 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.045 1.869 . . . . 1.0 116.045 -174.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.996 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -41.57 -44.19 2.94 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 120.731 1.605 . . . . 1.0 108.987 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.791 ' CE2' HD23 ' A' ' 155' ' ' LEU . 30.6 m-85 -84.39 -25.67 28.92 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.632 -1.227 . . . . 1.0 108.572 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.612 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -78.19 -3.28 41.85 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.336 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -135.02 82.81 1.98 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.19 166.46 0.01 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CD2' HD11 ' A' ' 167' ' ' ILE . 12.9 t80 -65.79 143.56 57.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.394 . . . . 1.0 112.046 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 164' ' ' ILE . 4.6 mt -122.02 85.14 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.648 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.33 -156.41 11.75 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.565 ' HB2' ' HB2' ' A' ' 48' ' ' LYS . 1.7 m -127.73 142.34 51.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.529 -0.983 . . . . 1.0 110.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.783 HD13 ' CZ ' ' A' ' 19' ' ' PHE . 3.3 mt -126.78 147.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.755 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.637 ' O ' HG13 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -160.28 170.79 20.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 1.0 110.231 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.3 m-20 41.71 67.83 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 1.0 109.852 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.871 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.1 m -124.38 126.47 72.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 O-C-N 121.063 -1.023 . . . . 1.0 109.895 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 175' ' ' GLN . 0.3 OUTLIER -134.67 151.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.889 -1.125 . . . . 1.0 111.666 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 2.4 p -134.32 108.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.568 ' O ' ' HD3' ' A' ' 174' ' ' ARG . 68.6 m-20 59.98 67.92 0.82 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.492 -1.67 . . . . 1.0 106.492 -176.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 35.34 28.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.473 -0.785 . . . . 1.0 111.633 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.787 ' OE1' HG11 ' A' ' 31' ' ' VAL . 32.2 mt-30 -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.294 -0.879 . . . . 1.0 109.644 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' CD2' ' A' ' 178' ' ' HIS . 18.3 tt0 -78.1 107.76 10.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 1.0 110.619 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.644 ' HB2' HG23 ' A' ' 170' ' ' VAL . 15.3 mt -90.0 85.24 6.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 1.0 110.53 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.577 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 1.8 m170 -56.96 114.42 2.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 1.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.975 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 3.6 mm? -59.3 -38.28 79.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.355 -0.841 . . . . 1.0 111.767 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 56.1 t -85.21 -39.62 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.196 0.813 . . . . 1.0 113.196 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 14.2 mt-10 -57.78 -49.51 76.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.463 -1.398 . . . . 1.0 110.913 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.562 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 31.9 m-20 -87.54 -19.01 28.49 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.461 -0.774 . . . . 1.0 110.928 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.975 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -60.57 -34.95 74.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.52 -1.272 . . . . 1.0 108.452 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.2 mt -50.83 -22.76 2.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.715 -0.615 . . . . 1.0 109.805 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -51.2 -22.47 2.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.172 -0.955 . . . . 1.0 108.894 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.517 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 5.1 t30 -99.52 156.13 35.74 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 39.0 Cg_endo -65.17 -56.49 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.238 1.125 . . . . 1.0 110.948 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.473 ' O ' HG13 ' A' ' 189' ' ' ILE . 5.8 t -103.11 146.49 28.3 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.594 -0.691 . . . . 1.0 110.375 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 188' ' ' THR . 2.9 mp -139.99 124.29 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 1.0 110.349 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.536 ' O ' HG23 ' A' ' 17' ' ' ILE . 20.8 mt -109.56 159.36 17.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 1.0 109.559 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -101.61 -81.68 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.832 -1.168 . . . . 1.0 111.075 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.29 -2.011 0 O-C-N 121.052 -1.03 . . . . 1.0 110.098 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.595 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.0 pt-20 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.514 0.674 . . . . 1.0 110.661 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -81.21 158.85 24.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.22 -1.55 . . . . 1.0 110.481 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.82 HG21 ' CE ' ' A' ' 25' ' ' MET . 12.3 mm -119.78 116.45 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 1.0 110.224 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 191' ' ' HIS . . . -81.12 122.73 27.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.418 -0.801 . . . . 1.0 110.537 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.74 ' CE1' HD12 ' A' ' 167' ' ' ILE . 3.0 m-85 -86.15 166.97 15.34 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.598 -0.89 . . . . 1.0 108.598 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 1.0 ' HA ' HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -127.37 3.07 6.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.84 -1.162 . . . . 1.0 111.083 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 99.88 -18.87 55.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.326 -1.51 . . . . 1.0 109.326 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 14.3 ttt180 -118.79 22.39 12.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.293 -1.122 . . . . 1.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 172.96 12.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 1.0 110.873 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.656 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -166.04 87.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.82 ' CE ' HG21 ' A' ' 17' ' ' ILE . 26.8 mtt -90.34 101.39 14.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.658 -1.276 . . . . 1.0 110.517 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.622 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 8.8 pt-20 -83.08 110.57 18.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.243 -0.91 . . . . 1.0 108.657 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.606 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 47.8 m-85 -100.95 99.24 9.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.975 -1.078 . . . . 1.0 110.387 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.461 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -93.14 103.35 15.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 1.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -94.96 164.58 12.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 1.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.3 94.36 9.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.283 -0.885 . . . . 1.0 110.405 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG21 HE22 ' A' ' 175' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.317 -0.864 . . . . 1.0 109.779 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.506 ' CG ' ' N ' ' A' ' 40' ' ' SER . 1.3 tt0 . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 108.935 -0.765 . . . . 1.0 108.935 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -169.92 157.91 6.96 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.154 -1.018 . . . . 1.0 112.302 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -130.12 139.22 50.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 1.0 109.886 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.517 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 24.7 m80 -110.45 125.71 53.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.319 -0.863 . . . . 1.0 109.95 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.717 ' CD2' HG22 ' A' ' 172' ' ' VAL . 26.9 m-85 -140.16 119.34 12.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.921 . . . . 1.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.747 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -127.48 151.54 48.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.749 -1.22 . . . . 1.0 110.817 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.977 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 178.86 150.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 1.0 110.991 179.251 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.5 m -114.06 150.25 34.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.722 HG12 HD11 ' A' ' 97' ' ' ILE . 1.4 pt -144.38 153.3 15.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 117.821 -1.552 . . . . 1.0 112.583 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.632 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.5 OUTLIER -109.82 83.07 1.69 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.43 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.693 HG22 ' CE1' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -73.65 148.06 43.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.266 1.031 . . . . 1.0 112.808 -175.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 5.3 mm-40 -124.62 -18.49 5.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.711 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.85 130.3 46.71 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.729 -0.607 . . . . 1.0 109.677 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.727 HG22 ' CA ' ' A' ' 76' ' ' GLY . 1.9 p -60.92 -8.08 2.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 1.0 111.073 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -130.66 134.19 46.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.71 -1.244 . . . . 1.0 110.673 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.86 135.8 1.89 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.203 -1.559 . . . . 1.0 109.203 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.208 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -92.99 127.33 38.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.632 -1.511 . . . . 1.0 109.291 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -96.67 -27.05 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.715 . . . . 1.0 112.408 -176.657 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.003 HD13 HD12 ' A' ' 71' ' ' LEU . 6.0 tt -144.28 146.18 32.46 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.246 -1.534 . . . . 1.0 112.58 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.871 ' CH2' HG21 ' A' ' 151' ' ' VAL . 5.4 t-105 -159.6 116.33 2.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.782 -0.574 . . . . 1.0 109.538 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.47 120.47 38.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.085 -1.01 . . . . 1.0 110.316 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.867 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 83' ' ' ASP . 2.4 p90 . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 122.052 0.93 . . . . 1.0 110.461 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.539 HG12 ' HB3' ' A' ' 82' ' ' TYR . 1.5 mt -132.32 167.47 26.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.151 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.805 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -171.02 178.12 3.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.216 -0.927 . . . . 1.0 110.874 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.003 HD12 HD13 ' A' ' 57' ' ' LEU . 83.2 mt -146.66 129.88 16.58 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.591 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -150.77 165.11 34.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.833 -1.167 . . . . 1.0 112.559 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 56' ' ' ILE . 5.9 mt -104.54 137.94 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.706 0.765 . . . . 1.0 110.654 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.847 HG11 ' OE1' ' A' ' 79' ' ' GLN . 2.3 p -139.87 118.63 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.738 -0.601 . . . . 1.0 110.097 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 2.2 m-20 67.26 3.65 3.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 1.0 111.235 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 113.97 4.17 22.78 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.343 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.7 m-85 -131.41 126.67 35.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.053 -1.263 . . . . 1.0 109.701 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.722 HG13 ' N ' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -59.43 -173.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.929 -1.107 . . . . 1.0 110.461 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.847 ' OE1' HG11 ' A' ' 74' ' ' VAL . 9.0 pt20 -176.33 101.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.019 0.914 . . . . 1.0 110.133 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.918 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -78.47 126.01 30.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.805 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 5.0 ptt? -122.8 146.48 47.5 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.106 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.939 ' CZ ' HG11 ' A' ' 89' ' ' VAL . 4.3 p90 -129.77 120.56 25.25 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.888 -1.525 . . . . 1.0 110.519 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.572 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . 12.7 t70 -94.05 47.4 1.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.313 0.578 . . . . 1.0 110.568 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.046 ' HB3' HD13 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -62.83 -10.8 14.46 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -144.44 41.55 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.959 -1.257 . . . . 1.0 109.959 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 77.49 -35.28 0.21 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.5 -1.0 . . . . 1.0 111.516 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -102.51 103.84 34.32 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.767 -1.208 . . . . 1.0 110.362 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.522 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 51.6 Cg_endo -74.46 116.78 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.191 1.627 . . . . 1.0 111.234 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.939 HG11 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -71.91 172.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 178.472 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 90' ' ' VAL . 1.2 t -144.27 107.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.635 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.721 ' N ' HD22 ' A' ' 91' ' ' LEU . 3.0 mm? -95.23 90.11 5.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.293 -1.743 . . . . 1.0 106.293 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.904 ' O ' HD13 ' A' ' 124' ' ' ILE . 30.7 mtp180 -73.22 154.09 40.38 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.988 -1.085 . . . . 1.0 110.271 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.3 t -68.62 143.6 54.77 Favored 'General case' 0 C--N 1.288 -2.075 0 O-C-N 120.986 -1.071 . . . . 1.0 109.925 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.848 ' HB ' HD12 ' A' ' 124' ' ' ILE . 4.7 t -94.25 21.09 7.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.756 -1.215 . . . . 1.0 110.035 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.964 HG21 HG11 ' A' ' 118' ' ' VAL . 19.6 t -135.16 149.08 69.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 1.0 109.956 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.586 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 40.6 Cg_endo -66.53 134.39 35.43 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.681 1.358 . . . . 1.0 110.123 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.915 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.8 tt -125.15 -26.36 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 1.0 110.627 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 8.7 p30 -70.73 58.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.212 -0.93 . . . . 1.0 110.475 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.846 HG23 ' HB2' ' A' ' 101' ' ' HIS . 7.8 t -130.91 22.31 4.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.339 -0.851 . . . . 1.0 109.956 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 m120 56.84 24.79 9.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.107 -0.996 . . . . 1.0 110.733 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.846 ' HB2' HG23 ' A' ' 99' ' ' THR . 15.2 m80 -113.23 152.97 29.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.03 . . . . 1.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.632 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 15.6 m95 -74.54 97.21 3.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.095 -1.003 . . . . 1.0 109.93 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.564 HG21 HD12 ' A' ' 97' ' ' ILE . 24.7 m -93.1 141.41 28.44 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.203 -0.999 . . . . 1.0 108.713 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 119' ' ' GLY . 25.5 t60 -98.49 142.49 30.04 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.425 -0.91 . . . . 1.0 108.566 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.656 HG22 HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -140.78 156.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.964 -1.085 . . . . 1.0 110.218 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.707 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -149.21 128.62 13.0 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.426 -0.796 . . . . 1.0 110.016 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -115.25 102.57 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.208 -0.933 . . . . 1.0 110.979 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 108' ' ' TYR . 2.9 p90 -117.38 109.4 16.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 1.0 109.381 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.638 ' HG3' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -103.49 142.86 33.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.35 -0.844 . . . . 1.0 110.848 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 109' ' ' ARG . 1.5 t -127.91 122.46 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.466 -0.771 . . . . 1.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 113' ' ' GLU . 23.1 mt-30 37.83 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 1.0 111.037 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 127' ' ' SER . 11.4 mmt85 65.34 -56.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.356 -0.84 . . . . 1.0 111.738 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.594 ' N ' ' HB3' ' A' ' 127' ' ' SER . 0.0 OUTLIER -67.1 114.72 6.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.945 0.878 . . . . 1.0 111.794 -176.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -100.25 159.19 19.39 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.62 ' O ' ' CE ' ' A' ' 80' ' ' MET . 12.5 t -141.04 148.84 40.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.527 -0.984 . . . . 1.0 109.925 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.918 HD23 ' HG2' ' A' ' 80' ' ' MET . 1.0 OUTLIER -145.81 131.15 18.58 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.036 -1.04 . . . . 1.0 110.042 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.853 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -135.37 145.3 47.21 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.937 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.964 HG11 HG21 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -89.81 113.68 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 52.14 46.09 56.73 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER 65.43 43.44 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -1.085 . . . . 1.0 111.38 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.534 ' HB2' HG12 ' A' ' 118' ' ' VAL . 2.2 mt-10 -105.5 -162.14 0.85 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.251 -0.905 . . . . 1.0 110.643 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.782 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -49.92 115.87 5.68 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.237 -0.915 . . . . 1.0 109.558 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.545 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 46.2 Cg_endo -73.57 119.08 5.75 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.879 1.462 . . . . 1.0 111.672 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.904 HD13 ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -86.32 118.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.686 ' HA ' HD12 ' A' ' 91' ' ' LEU . 12.3 p -126.73 171.65 11.01 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.606 -1.237 . . . . 1.0 113.628 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.512 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 169.51 153.62 8.62 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.513 -2.635 . . . . 1.0 106.513 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.594 ' HB3' ' N ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -119.71 163.48 17.36 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.607 -1.525 . . . . 1.0 111.028 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -67.64 -176.85 0.28 Allowed Pre-proline 0 C--N 1.3 -1.579 0 C-N-CA 119.906 -0.717 . . . . 1.0 109.207 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 131' ' ' GLY . 48.1 Cg_endo -74.59 42.44 0.8 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.548 1.288 . . . . 1.0 110.24 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER 34.63 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.841 0.829 . . . . 1.0 109.991 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -131.9 106.75 0.68 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.958 -1.257 . . . . 1.0 109.958 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 133' ' ' THR . . . 178.17 -54.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.5 -1.0 . . . . 1.0 109.88 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 132' ' ' ALA . 7.4 t 39.73 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.462 -0.773 . . . . 1.0 111.027 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -161.58 111.97 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.056 -1.028 . . . . 1.0 110.714 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.046 HD13 ' HB3' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -166.73 135.32 2.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 1.0 109.369 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 135' ' ' LEU . 14.2 m-20 -140.47 179.58 6.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.331 -0.856 . . . . 1.0 109.415 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.8 t -115.41 132.62 56.56 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.052 -1.03 . . . . 1.0 109.883 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 1.057 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 7.9 p-10 -78.77 13.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 1.0 110.44 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.69 18.38 10.83 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.283 -1.927 . . . . 1.0 108.283 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 1.057 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -136.47 170.34 16.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.443 -1.034 . . . . 1.0 109.937 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.903 ' CD1' HD21 ' A' ' 57' ' ' LEU . 12.3 tp -160.83 155.51 23.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.284 -0.885 . . . . 1.0 110.702 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.649 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 9.9 m95 -131.32 136.76 48.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.662 HD12 ' CB ' ' A' ' 57' ' ' LEU . 5.1 tp -140.97 123.74 16.15 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.593 -1.643 . . . . 1.0 113.321 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.32 1.05 12.63 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 110.098 -1.201 . . . . 1.0 110.098 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 144.05 -129.02 3.48 Favored Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.902 -1.679 . . . . 1.0 108.902 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' MET . . . . . 1.097 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -171.2 126.63 0.67 Allowed 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.358 -0.937 . . . . 1.0 111.747 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -12.69 27.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 1.0 108.872 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.578 ' N ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -152.73 61.59 0.8 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.097 HD13 ' HB2' ' A' ' 146' ' ' MET . 10.0 tp -64.39 44.33 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.386 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 148' ' ' ARG . 83.7 p -55.0 -28.83 55.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.871 HG21 ' CH2' ' A' ' 58' ' ' TRP 0.29 6.2 p -62.76 -135.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 114.414 -1.267 . . . . 1.0 108.137 177.514 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.808 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 54.56 18.06 1.87 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.936 -1.102 . . . . 1.0 110.861 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -79.58 0.18 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.942 -1.099 . . . . 1.0 112.928 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.522 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -52.03 -14.04 0.37 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.0 112.234 -177.858 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.73 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.6 pp -99.61 168.75 9.06 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.842 -1.162 . . . . 1.0 110.337 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 43.6 Cg_endo -68.33 -176.73 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.55 1.29 . . . . 1.0 113.228 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -62.05 -13.95 31.29 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.977 -0.556 . . . . 1.0 112.27 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -41.13 -35.12 0.53 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 1.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 1.208 ' CE2' HD13 ' A' ' 55' ' ' LEU . 5.4 m-85 -83.94 -30.12 26.54 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.32 -0.952 . . . . 1.0 109.766 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -68.67 -8.9 46.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.796 -1.162 . . . . 1.0 108.895 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -128.8 86.43 2.44 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -39.63 164.31 0.01 OUTLIER Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.212 -1.155 . . . . 1.0 110.212 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.693 ' CE1' HG22 ' A' ' 49' ' ' THR . 35.9 t80 -79.14 144.03 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.027 -1.278 . . . . 1.0 111.396 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 1.0 HG23 ' HA ' ' A' ' 20' ' ' ASP . 2.9 mt -128.98 68.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.644 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -148.83 -162.62 10.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.913 -2.075 . . . . 1.0 107.913 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.504 ' C ' HG13 ' A' ' 167' ' ' ILE . 13.4 m -118.97 148.05 43.4 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.405 -1.644 . . . . 1.0 111.138 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.74 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -131.95 151.14 34.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.651 -0.656 . . . . 1.0 109.504 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.55 ' NH2' HD13 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -161.6 151.75 17.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 1.0 110.178 -178.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.538 ' N ' ' HD3' ' A' ' 168' ' ' ARG . 36.1 m-20 56.44 75.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.455 -0.778 . . . . 1.0 109.972 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.977 HG12 ' CB ' ' A' ' 45' ' ' LEU . 26.9 m -128.32 122.45 57.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.699 -0.801 . . . . 1.0 109.559 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.493 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -132.73 156.59 42.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.459 -0.896 . . . . 1.0 111.124 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.717 HG22 ' CD2' ' A' ' 43' ' ' PHE . 6.6 t -134.35 104.65 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.7 OUTLIER 50.31 40.66 23.05 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.455 -1.403 . . . . 1.0 107.477 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER 72.7 27.68 2.23 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.054 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 29.0 mt-30 -103.08 177.66 4.78 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.039 -1.038 . . . . 1.0 110.703 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 6.0 tt0 66.12 -105.36 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.826 -0.547 . . . . 1.0 110.923 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 67.01 -58.11 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.301 -0.874 . . . . 1.0 111.232 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.576 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.3 m-70 -80.34 73.73 7.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.763 -1.21 . . . . 1.0 110.135 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 3.6 mt -49.8 -58.85 4.55 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.152 0.977 . . . . 1.0 112.217 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.587 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 30.1 t -74.39 -19.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.576 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.5 mt-10 -67.55 -62.26 1.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.351 -1.468 . . . . 1.0 110.002 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -71.84 -19.61 61.95 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 1.0 109.2 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -68.44 -27.42 66.16 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.508 -0.877 . . . . 1.0 108.81 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 184' ' ' LEU . 10.5 mt -57.66 -16.46 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 1.0 109.178 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -57.97 -14.61 6.71 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.496 -0.752 . . . . 1.0 109.699 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.54 ' O ' HD11 ' A' ' 189' ' ' ILE . 13.0 t30 -127.42 148.88 68.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.52 -0.737 . . . . 1.0 109.1 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' HG13 ' A' ' 189' ' ' ILE . 46.9 Cg_endo -73.63 -44.81 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.701 1.369 . . . . 1.0 110.81 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.07 103.1 0.7 Allowed 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.637 0.732 . . . . 1.0 110.639 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.54 HD11 ' O ' ' A' ' 186' ' ' ASN . 6.5 mt -144.46 98.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 18' ' ' ALA . 33.9 mt -111.92 152.6 27.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 1.0 110.81 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 8.1 m-70 -95.84 -174.61 3.18 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.469 -0.769 . . . . 1.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 1.0 110.476 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.5 pt-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.297 0.57 . . . . 1.0 110.858 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -68.35 158.22 33.98 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.136 -1.603 . . . . 1.0 109.487 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.012 HG21 ' CE ' ' A' ' 25' ' ' MET . 17.3 mm -136.92 108.96 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.027 -1.046 . . . . 1.0 110.579 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 190' ' ' LEU . . . -78.82 138.4 38.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.741 . . . . 1.0 110.234 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.781 ' CE1' HD12 ' A' ' 167' ' ' ILE . 3.7 m-85 -104.16 175.36 5.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 1.0 109.633 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 1.9 p30 -128.37 -14.43 4.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 1.0 111.084 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 115.51 -13.84 18.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.909 -1.677 . . . . 1.0 108.909 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.91 15.11 4.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.44 -1.035 . . . . 1.0 109.109 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 24' ' ' TYR . 3.1 m -75.63 174.65 9.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.596 -0.69 . . . . 1.0 110.185 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.548 ' OH ' ' N ' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -147.62 103.67 3.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.526 -0.734 . . . . 1.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . 1.012 ' CE ' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -99.35 101.53 12.85 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.774 -1.204 . . . . 1.0 109.186 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.513 ' HG2' ' CE3' ' A' ' 142' ' ' TRP . 14.9 mt-10 -95.88 136.72 35.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 1.0 109.485 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.599 ' CE2' ' HG3' ' A' ' 25' ' ' MET . 69.8 m-85 -131.29 99.05 4.72 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.216 -0.994 . . . . 1.0 110.475 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.45 118.69 37.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 1.0 110.215 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.464 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 12.1 t-20 -140.44 156.73 46.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 1.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.67 149.14 23.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.961 . . . . 1.0 110.142 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 1.0 109.907 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.025 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -171.07 167.87 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.252 -1.53 . . . . 1.0 111.38 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -138.79 116.04 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.689 ' O ' HG23 ' A' ' 172' ' ' VAL . 0.3 OUTLIER -89.96 143.67 26.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.118 -0.989 . . . . 1.0 110.956 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.657 ' CE1' HG21 ' A' ' 172' ' ' VAL . 51.2 m-85 -138.17 106.85 5.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.637 -0.664 . . . . 1.0 110.074 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.57 ' C ' HD23 ' A' ' 45' ' ' LEU . 3.5 mt-10 -114.78 145.82 41.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.98 -1.075 . . . . 1.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.81 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -179.45 152.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.529 -0.868 . . . . 1.0 111.244 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 103' ' ' THR . 1.5 m -118.52 152.71 35.46 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.48 HD13 HD11 ' A' ' 105' ' ' ILE . 2.2 pt -148.34 157.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 117.897 -1.521 . . . . 1.0 112.152 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.616 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 2.5 tttt -113.15 84.3 1.98 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.58 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -67.31 147.25 53.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 1.0 111.193 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.753 ' HB2' HG22 ' A' ' 164' ' ' ILE . 2.3 mm-40 -129.34 6.79 5.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.808 -0.757 . . . . 1.0 111.0 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.862 ' O ' HG23 ' A' ' 52' ' ' THR . . . -134.77 -85.97 0.4 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.91 -1.119 . . . . 1.0 110.624 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.001 HG22 ' CA ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER 155.98 -25.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.88 139.03 54.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.716 -0.615 . . . . 1.0 109.419 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 158.67 135.88 1.96 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.436 -1.364 . . . . 1.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.76 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -85.33 121.53 28.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 1.0 108.963 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.827 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -96.66 -29.25 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.782 -0.574 . . . . 1.0 112.482 -176.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.086 HD13 HD12 ' A' ' 71' ' ' LEU . 6.4 tt -147.73 152.9 38.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.39 -1.444 . . . . 1.0 113.145 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.958 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 4.2 t-105 -162.61 107.26 1.14 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.589 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.51 149.6 42.16 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.13 -0.981 . . . . 1.0 108.784 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.577 0 C-N-CA 119.313 -1.422 . . . . 1.0 110.846 -179.283 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.591 ' CZ ' ' O ' ' A' ' 84' ' ' LEU . 10.1 m-85 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 113.159 0.8 . . . . 1.0 113.159 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 68' ' ' TYR . 5.5 mm -148.01 153.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.839 -1.788 . . . . 1.0 113.566 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.737 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -177.69 166.58 2.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.086 HD12 HD13 ' A' ' 57' ' ' LEU . 93.4 mt -150.72 99.83 2.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.445 -1.41 . . . . 1.0 109.945 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.581 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -114.06 175.09 5.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.306 -0.871 . . . . 1.0 111.837 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.949 HG12 HG13 ' A' ' 78' ' ' VAL . 20.4 mt -115.34 138.3 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.827 -0.546 . . . . 1.0 110.056 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.509 HG11 ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -141.23 125.3 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 110.516 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 5.9 m-20 62.77 33.98 14.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.335 -0.853 . . . . 1.0 111.739 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 1.001 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 81.43 8.08 87.52 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.741 -1.219 . . . . 1.0 110.41 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 74' ' ' VAL . 46.3 m-85 -129.36 165.89 20.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.272 . . . . 1.0 109.382 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.949 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -116.05 164.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 1.0 110.679 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.552 ' OE1' HG21 ' A' ' 90' ' ' VAL . 6.9 pt20 -149.66 133.3 16.77 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.565 -0.854 . . . . 1.0 111.432 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.971 ' CE ' HD12 ' A' ' 91' ' ' LEU . 6.7 tmm? -99.24 120.12 39.02 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.737 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 7.3 ptt? -120.24 143.54 48.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.87 -1.144 . . . . 1.0 111.569 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.887 ' CZ ' HG11 ' A' ' 89' ' ' VAL . 19.6 p90 -139.85 129.03 23.81 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.531 -1.268 . . . . 1.0 110.905 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 86' ' ' SER . 66.7 t0 -120.45 60.82 0.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.232 1.015 . . . . 1.0 109.378 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.642 HD21 ' CD1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -38.35 -35.65 0.19 Allowed 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.705 -179.062 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.28 -54.77 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.527 -1.32 . . . . 1.0 110.887 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 3.4 t -163.28 -22.84 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.393 . . . . 1.0 112.269 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.522 ' HD2' ' HG3' ' A' ' 129' ' ' PRO . 4.7 mmtp -98.86 100.58 10.02 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.66 -1.275 . . . . 1.0 110.21 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 86' ' ' SER . 47.0 Cg_endo -72.5 141.96 35.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.926 1.487 . . . . 1.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.887 HG11 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.97 126.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.552 HG21 ' OE1' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -103.93 120.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 117.802 -1.559 . . . . 1.0 110.328 178.652 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.971 HD12 ' CE ' ' A' ' 80' ' ' MET . 33.3 mt -113.09 71.94 0.76 Allowed 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.687 ' O ' HG21 ' A' ' 124' ' ' ILE . 2.9 mtt180 -58.7 179.16 0.09 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.138 0.971 . . . . 1.0 110.822 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.558 ' HA ' HD13 ' A' ' 124' ' ' ILE . 1.6 t -105.82 155.77 18.98 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.721 -0.612 . . . . 1.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.804 ' HB ' HD11 ' A' ' 124' ' ' ILE . 15.2 t -111.19 26.87 10.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 1.0 109.912 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.802 ' CB ' HG11 ' A' ' 118' ' ' VAL . 8.3 t -133.77 147.38 64.11 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.445 -0.785 . . . . 1.0 109.62 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.7 Cg_endo -67.47 138.32 45.69 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.629 1.331 . . . . 1.0 110.554 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.79 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -126.91 -30.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 1.0 110.686 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.462 HD22 HG23 ' A' ' 52' ' ' THR . 31.2 p-10 -72.54 62.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 1.0 110.52 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 101' ' ' HIS . 15.2 t -124.86 13.18 8.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 1.0 109.868 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.474 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 2.2 m-80 62.95 10.6 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.239 -0.913 . . . . 1.0 111.236 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.47 ' H ' HG23 ' A' ' 99' ' ' THR . 2.6 m-70 -102.51 175.15 5.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.87 -1.143 . . . . 1.0 110.288 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.616 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 27.0 m95 -92.95 105.84 17.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.9 . . . . 1.0 110.074 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 104' ' ' HIS . 47.4 m -99.31 171.06 8.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.274 -0.891 . . . . 1.0 109.597 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.593 ' N ' HG22 ' A' ' 103' ' ' THR . 12.0 t-80 -125.02 130.18 51.81 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.085 -1.009 . . . . 1.0 108.423 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 47' ' ' ILE . 1.9 mt -123.46 159.6 27.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.128 -0.982 . . . . 1.0 110.123 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.882 ' O ' HD22 ' A' ' 116' ' ' LEU . 1.8 tppt? -149.84 147.99 28.63 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.184 -1.006 . . . . 1.0 110.039 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -151.52 108.3 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.604 -0.685 . . . . 1.0 109.954 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 20.0 p90 -120.88 105.39 10.65 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.05 -1.06 . . . . 1.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.622 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 3.8 ttp180 -72.17 123.84 23.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.575 -0.703 . . . . 1.0 110.006 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' GLN . 3.6 t -110.08 88.51 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.076 -1.015 . . . . 1.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 0.0 OUTLIER 35.4 103.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.144 0.497 . . . . 1.0 110.934 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.574 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 66.1 -53.71 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.286 -0.884 . . . . 1.0 110.235 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.591 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.6 tt0 -87.08 120.88 28.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.756 -1.215 . . . . 1.0 110.811 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.28 161.83 12.56 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.929 -1.129 . . . . 1.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 15.5 t -136.43 162.11 33.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.307 -1.114 . . . . 1.0 111.174 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.008 HD13 ' N ' ' A' ' 117' ' ' GLN . 1.4 tm? -147.4 139.15 24.11 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 1.008 ' N ' HD13 ' A' ' 116' ' ' LEU . 3.6 mt-30 -142.83 146.26 33.99 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.686 -1.205 . . . . 1.0 111.67 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.802 HG11 ' CB ' ' A' ' 95' ' ' VAL . 1.8 t -104.19 101.69 12.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.498 -1.667 . . . . 1.0 106.498 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 70.65 33.5 67.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.717 -1.753 . . . . 1.0 108.717 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.27 38.07 26.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.518 -0.99 . . . . 1.0 110.312 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -108.77 -156.97 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.66 -0.65 . . . . 1.0 110.826 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.91 99.66 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.709 -0.62 . . . . 1.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.59 ' HB3' ' CG ' ' A' ' 117' ' ' GLN . 48.5 Cg_endo -73.23 131.36 16.42 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 O-C-N 124.314 1.691 . . . . 1.0 112.009 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.804 HD11 ' HB ' ' A' ' 94' ' ' THR . 0.4 OUTLIER -97.19 101.96 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 176.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.43 HG22 ' CB ' ' A' ' 115' ' ' SER . 61.4 p -107.07 170.6 7.85 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.154 0.978 . . . . 1.0 112.023 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.66 157.6 18.89 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 107.644 -2.183 . . . . 1.0 107.644 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.591 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -133.63 162.66 31.32 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.866 -1.373 . . . . 1.0 110.275 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 5.0 p -90.08 172.18 7.46 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 1.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.522 ' HG3' ' HD2' ' A' ' 87' ' ' LYS . 51.6 Cg_endo -80.82 36.58 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.728 1.383 . . . . 1.0 109.133 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.422 HD12 ' NH1' ' A' ' 112' ' ' ARG . 1.5 mt 43.8 -162.91 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.5 -0.75 . . . . 1.0 110.307 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.02 -29.69 11.95 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.54 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.438 -1.036 . . . . 1.0 109.747 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -154.4 97.61 2.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 1.0 110.281 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 133' ' ' THR . 1.3 tt0 43.76 -158.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 1.0 110.131 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.607 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -160.31 104.08 1.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 1.0 110.348 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -92.55 176.5 6.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 1.0 109.514 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 t -138.15 136.58 36.82 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.891 -1.131 . . . . 1.0 110.055 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.75 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 44.9 p-10 -89.06 22.78 2.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 1.0 109.457 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 52.52 18.15 5.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.943 -1.663 . . . . 1.0 108.943 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -109.63 150.18 28.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 1.0 109.273 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.925 HD11 ' CG ' ' A' ' 57' ' ' LEU . 7.4 tp -160.66 156.35 25.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 1.0 111.122 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.536 ' N ' ' HG ' ' A' ' 141' ' ' LEU . 76.5 m95 -131.7 105.43 7.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.919 -1.512 . . . . 1.0 106.919 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.838 HD13 HD12 ' A' ' 57' ' ' LEU . 3.6 tp -116.95 116.42 27.37 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.24 -1.384 . . . . 1.0 113.602 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 132.29 -1.04 4.86 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 119.668 -1.253 . . . . 1.0 110.638 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.536 ' O ' ' SD ' ' A' ' 146' ' ' MET . . . 154.37 -154.95 25.87 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 117.956 -2.069 . . . . 1.0 109.731 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.955 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -154.05 139.38 17.61 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.254 -0.978 . . . . 1.0 112.941 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.548 ' N ' ' OH ' ' A' ' 24' ' ' TYR . 40.9 tt0 -68.43 -50.91 49.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.582 0.706 . . . . 1.0 109.665 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -116.15 69.8 0.75 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.541 -1.281 . . . . 1.0 107.541 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.955 HD13 ' CB ' ' A' ' 146' ' ' MET . 0.1 OUTLIER -65.33 49.52 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.439 -0.788 . . . . 1.0 112.976 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 148' ' ' ARG . 88.0 p -83.34 -10.08 58.69 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.975 -1.861 . . . . 1.0 105.975 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.958 HG21 ' CZ3' ' A' ' 58' ' ' TRP . 4.9 p -79.86 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 115.227 -0.897 . . . . 1.0 110.336 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.797 ' HB1' ' O ' ' A' ' 155' ' ' LEU . . . 53.18 38.17 26.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.326 -1.484 . . . . 1.0 108.546 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.477 ' C ' ' O ' ' A' ' 152' ' ' ALA . 59.8 m170 3.92 -95.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.771 1.397 . . . . 1.0 114.771 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.463 ' CE ' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -98.31 26.59 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 1.0 112.739 -176.535 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 1.007 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -156.55 131.81 5.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 120.649 -1.282 . . . . 1.0 110.031 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.59 ' N ' HD12 ' A' ' 155' ' ' LEU . 55.1 Cg_endo -92.14 -66.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.793 1.418 . . . . 1.0 113.747 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.49 -56.9 15.43 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 114.403 1.26 . . . . 1.0 114.403 -176.062 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 1.007 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -41.38 -41.23 1.93 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.44 -1.413 . . . . 1.0 108.103 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.799 ' HD2' HD11 ' A' ' 149' ' ' LEU . 21.8 m-85 -83.27 -32.13 26.57 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.957 -1.097 . . . . 1.0 108.141 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.657 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -67.71 -10.51 53.15 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.107 -1.037 . . . . 1.0 109.079 178.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.499 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.4 m -129.56 99.33 5.13 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -49.76 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.655 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 19.3 t80 -79.76 148.19 31.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -1.175 . . . . 1.0 112.49 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.753 HG22 ' HB2' ' A' ' 50' ' ' GLU . 3.8 mt -124.94 82.32 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.655 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.48 -163.49 26.4 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.533 -1.827 . . . . 1.0 108.533 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 24.1 m -122.88 151.02 42.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.012 -1.287 . . . . 1.0 110.431 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -127.35 152.37 35.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.46 ' NH1' ' OD2' ' A' ' 169' ' ' ASP . 13.9 ttt-85 -159.09 148.37 18.64 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.049 -1.06 . . . . 1.0 110.721 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 93.6 m-20 52.5 84.52 0.05 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.877 -0.729 . . . . 1.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.81 HG12 ' CB ' ' A' ' 45' ' ' LEU . 20.7 m -127.78 131.2 70.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 C-N-CA 119.586 -0.845 . . . . 1.0 108.889 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.447 HG12 ' C ' ' A' ' 170' ' ' VAL . 0.0 OUTLIER -145.91 144.43 20.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 118.964 -1.094 . . . . 1.0 111.237 -177.092 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 175' ' ' GLN . 3.0 p -132.14 121.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 28.8 m-20 47.59 31.68 2.16 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.721 -1.237 . . . . 1.0 108.634 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 76.04 10.37 3.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.794 -0.566 . . . . 1.0 111.413 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.767 ' HB2' HG13 ' A' ' 172' ' ' VAL . 1.6 mp0 -91.84 -171.89 3.01 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.944 -1.098 . . . . 1.0 109.851 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.668 ' HG2' HG23 ' A' ' 170' ' ' VAL . 1.2 tt0 72.52 -107.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.614 -0.679 . . . . 1.0 110.084 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 67.18 -83.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.038 -1.039 . . . . 1.0 112.227 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.0 m-70 -60.75 84.75 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.947 -1.096 . . . . 1.0 111.079 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -55.74 -58.15 9.05 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.216 1.007 . . . . 1.0 111.354 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.969 ' O ' HD13 ' A' ' 184' ' ' LEU . 85.9 t -65.29 -23.56 33.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.898 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.2 mt-10 -63.6 -52.32 61.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.283 -1.511 . . . . 1.0 110.327 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.573 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 3.6 m-20 -94.98 -3.12 49.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.234 -0.916 . . . . 1.0 110.216 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -78.24 -28.91 47.92 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.263 -0.975 . . . . 1.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.969 HD13 ' O ' ' A' ' 180' ' ' VAL . 8.1 mp -59.27 -15.3 14.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 1.0 109.173 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 4.2 t-20 -51.23 -24.09 4.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.465 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 3.6 t30 -97.3 148.79 34.92 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.465 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 41.3 Cg_endo -67.48 -55.38 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.658 1.346 . . . . 1.0 111.588 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.437 ' C ' HG13 ' A' ' 189' ' ' ILE . 5.1 m -101.46 132.4 47.08 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.371 -0.831 . . . . 1.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.437 HG13 ' C ' ' A' ' 188' ' ' THR . 3.8 mt -130.46 111.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.73 . . . . 1.0 109.494 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.74 175.92 8.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.267 -0.896 . . . . 1.0 109.338 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.59 18.85 4.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.581 -1.247 . . . . 1.0 111.109 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.44 ' CA ' ' HB2' ' A' ' 18' ' ' ALA . 1.5 t . . . . . 0 C--N 1.299 -1.609 0 O-C-N 121.308 -0.87 . . . . 1.0 109.71 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.0 tt0 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.383 0.611 . . . . 1.0 109.457 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.464 ' C ' HD13 ' A' ' 17' ' ' ILE . . . -116.49 138.26 51.52 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.471 -0.768 . . . . 1.0 111.356 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.638 HG13 HD23 ' A' ' 179' ' ' LEU . 0.8 OUTLIER -123.22 146.53 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.998 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -113.53 122.79 48.31 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.21 -0.931 . . . . 1.0 111.153 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.743 ' CE2' HD13 ' A' ' 167' ' ' ILE . 8.5 m-30 -87.88 148.03 24.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.457 -0.777 . . . . 1.0 109.3 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.475 ' OD1' ' HB ' ' A' ' 23' ' ' THR . 7.0 p-10 -103.4 2.47 33.92 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.181 -0.949 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.86 65.21 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.303 -1.519 . . . . 1.0 109.303 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.48 23.35 4.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -1.207 . . . . 1.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.475 ' HB ' ' OD1' ' A' ' 20' ' ' ASP . 5.2 t -109.55 163.26 13.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.898 . . . . 1.0 110.066 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.58 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 14.7 p90 -147.04 123.22 10.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 1.0 110.301 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.545 ' HE1' HG21 ' A' ' 17' ' ' ILE . 4.6 mtt -98.48 99.95 11.16 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.778 -1.201 . . . . 1.0 109.364 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 14.1 tt0 -88.87 98.51 11.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.509 -0.744 . . . . 1.0 109.989 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 13.1 m-30 -96.58 111.69 23.73 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.989 -1.07 . . . . 1.0 110.589 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -104.24 118.03 35.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.449 -0.782 . . . . 1.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 139' ' ' GLY . 9.4 m-20 -140.41 128.45 22.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 1.0 110.391 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.2 141.54 38.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 1.0 109.499 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 31' ' ' VAL . 8.7 p . . . . . 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.094 . . . . 1.0 111.027 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.383 0.611 . . . . 1.0 109.889 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.1 p -157.85 155.36 29.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 1.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 1.7 m-20 -131.66 160.15 36.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 1.0 110.486 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 20.8 m-70 -130.43 115.99 17.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 1.0 109.952 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.893 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 23.1 m-30 -119.5 114.81 22.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.179 -0.951 . . . . 1.0 109.816 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.856 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.4 mp0 -125.21 140.65 52.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 1.0 110.794 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.917 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.6 OUTLIER 179.84 159.26 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.098 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.507 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.64 161.19 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.507 ' CG2' ' C ' ' A' ' 46' ' ' SER . 7.4 pt -150.29 170.87 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 117.995 -1.482 . . . . 1.0 112.615 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 4.1 tttm -131.82 85.35 2.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.5 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -72.01 156.42 39.24 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.045 -1.034 . . . . 1.0 111.609 -177.521 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.1 mm-40 -136.9 -4.84 1.94 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.222 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.875 ' O ' HG23 ' A' ' 52' ' ' THR . . . -125.79 -82.54 0.63 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.144 -0.972 . . . . 1.0 110.429 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 158.57 -20.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.255 0.55 . . . . 1.0 109.641 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -130.2 146.46 51.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 1.0 110.353 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 149.2 135.11 2.45 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.047 HD13 ' CZ ' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -82.31 132.42 35.22 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.943 -1.327 . . . . 1.0 110.008 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.031 HD12 ' HA ' ' A' ' 72' ' ' ALA . 3.9 mp -97.84 -8.8 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 1.0 111.391 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.893 HD13 HD13 ' A' ' 71' ' ' LEU 0.292 6.5 tt -168.96 146.08 3.66 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 117.643 -1.623 . . . . 1.0 113.012 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 1.004 ' CE2' HG21 ' A' ' 151' ' ' VAL . 12.5 t-105 -150.89 118.2 6.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.661 . . . . 1.0 109.318 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.01 122.98 29.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.075 -1.016 . . . . 1.0 109.874 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.158 -1.577 . . . . 1.0 109.158 -179.908 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.63 ' CZ ' ' CB ' ' A' ' 83' ' ' ASP . 7.8 p90 . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 122.024 0.916 . . . . 1.0 109.953 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.905 HD11 HD21 ' A' ' 135' ' ' LEU . 5.2 mt -146.14 119.27 2.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.646 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.943 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -140.95 -178.05 5.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.753 -1.217 . . . . 1.0 110.68 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.893 HD13 HD13 ' A' ' 57' ' ' LEU . 3.6 mp -149.24 116.06 5.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 1.031 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -129.19 178.87 6.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.173 -0.955 . . . . 1.0 111.842 -178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.992 ' CG1' HD11 ' A' ' 56' ' ' ILE . 4.0 mt -120.43 134.43 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.431 -0.793 . . . . 1.0 109.745 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.601 HG23 ' NE2' ' A' ' 79' ' ' GLN . 1.3 t -141.09 134.03 30.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.203 -0.935 . . . . 1.0 110.367 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 59.66 22.04 10.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.325 -0.859 . . . . 1.0 110.682 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.616 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 84.72 31.61 23.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -146.9 130.3 16.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -1.086 . . . . 1.0 110.079 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.631 ' CG2' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -78.16 -177.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.601 ' NE2' HG23 ' A' ' 74' ' ' VAL . 2.6 pt20 176.5 133.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.664 -1.273 . . . . 1.0 111.491 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.998 ' CE ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -91.14 109.43 20.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 1.0 109.219 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.943 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 8.3 ptt? -94.01 106.35 18.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.917 -1.114 . . . . 1.0 109.779 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.73 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -93.47 127.73 39.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.226 -0.921 . . . . 1.0 109.965 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.63 ' CB ' ' CZ ' ' A' ' 68' ' ' TYR . 5.7 t0 -131.88 43.2 3.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.054 -1.059 . . . . 1.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.867 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -64.37 -10.62 25.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.45 -0.9 . . . . 1.0 110.155 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -139.78 39.23 1.54 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.696 -1.24 . . . . 1.0 110.707 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.27 -8.22 1.37 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -1.201 . . . . 1.0 111.773 179.092 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 9.4 mmtt -109.12 102.96 50.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 120.783 -1.198 . . . . 1.0 109.76 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 82' ' ' TYR . 45.9 Cg_endo -73.63 105.4 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.219 1.641 . . . . 1.0 110.836 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.73 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -85.21 106.58 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.196 -0.94 . . . . 1.0 109.135 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 90' ' ' VAL . 7.9 p -86.38 81.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.138 -1.602 . . . . 1.0 111.269 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.998 HD12 ' CE ' ' A' ' 80' ' ' MET . 29.1 mt -71.97 70.12 0.75 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.76 ' CG ' HG22 ' A' ' 90' ' ' VAL . 11.5 mtp180 -64.35 171.53 3.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.547 -0.861 . . . . 1.0 110.347 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.2 t -96.96 152.19 18.96 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.788 -0.57 . . . . 1.0 109.761 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 94' ' ' THR . 2.3 t -102.25 26.85 7.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.924 -1.11 . . . . 1.0 109.407 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.562 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 9.0 t -128.31 147.69 64.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 1.0 109.177 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 43.3 Cg_endo -68.03 132.31 25.97 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.533 1.281 . . . . 1.0 110.228 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.631 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -110.94 -30.8 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.867 . . . . 1.0 110.701 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -69.09 61.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.032 -1.042 . . . . 1.0 109.415 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.602 ' O ' HG22 ' A' ' 99' ' ' THR . 19.0 m -122.43 10.34 9.82 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.498 -0.751 . . . . 1.0 109.999 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 99' ' ' THR . 7.0 m-80 55.25 15.64 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 1.0 110.515 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.03 172.68 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 1.0 109.435 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.572 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 45.3 m95 -94.7 118.12 31.21 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.075 -1.016 . . . . 1.0 111.004 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 46' ' ' SER . 54.3 m -116.5 152.36 34.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.487 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 65.0 t-80 -101.77 156.73 17.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.882 -1.136 . . . . 1.0 108.987 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.557 HG22 HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -145.84 154.65 13.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.132 -0.98 . . . . 1.0 109.614 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.755 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -148.21 147.62 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 1.0 109.905 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.893 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -139.72 99.19 3.64 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.651 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.637 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 52.6 p90 -110.0 106.83 16.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.958 -1.089 . . . . 1.0 109.136 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.559 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 4.5 tmm_? -94.11 144.7 25.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.543 -0.723 . . . . 1.0 111.28 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 15.4 t -128.56 116.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.8 mm-40 59.19 -89.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 1.0 109.954 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 127' ' ' SER . 2.6 ptt180 -128.08 -28.01 2.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.546 -0.721 . . . . 1.0 110.521 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.576 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 10.6 tt0 -82.47 114.9 21.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 1.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -102.17 156.76 18.54 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.637 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 40.6 t -129.81 151.16 50.69 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.481 -1.011 . . . . 1.0 109.896 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.755 HD22 ' O ' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -148.9 126.32 11.58 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.127 -0.983 . . . . 1.0 110.812 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.673 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -134.66 135.53 42.14 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.849 -1.157 . . . . 1.0 110.254 178.407 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 118' ' ' VAL . 1.2 t -81.67 101.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 71.29 40.81 60.38 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.011 -1.636 . . . . 1.0 109.011 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 36.0 m-80 61.64 27.68 17.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.467 -1.019 . . . . 1.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 2.4 mt-10 -93.0 -158.12 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.2 -0.937 . . . . 1.0 110.866 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 124' ' ' ILE . . . -41.15 109.92 0.68 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.443 -0.785 . . . . 1.0 109.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.557 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 44.5 Cg_endo -73.28 119.15 5.84 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.977 1.514 . . . . 1.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.726 HG21 ' O ' ' A' ' 92' ' ' ARG . 1.8 mp -95.19 100.07 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.704 -1.591 . . . . 1.0 106.704 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 115' ' ' SER . 12.3 p -109.03 148.99 29.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.177 0.989 . . . . 1.0 112.161 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.488 ' N ' ' CD2' ' A' ' 91' ' ' LEU . . . -152.2 161.31 29.33 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 106.786 -2.526 . . . . 1.0 106.786 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -135.52 159.01 42.94 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.68 -1.483 . . . . 1.0 111.029 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.59 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -94.61 -177.61 0.69 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.669 -0.645 . . . . 1.0 109.634 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 38.1 Cg_endo -64.14 102.25 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.376 -1.432 . . . . 1.0 108.376 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.486 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.3 pp -33.46 153.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.399 0.618 . . . . 1.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 132' ' ' ALA . . . 99.77 -64.92 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.311 -1.516 . . . . 1.0 109.311 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . 39.18 -145.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.477 -1.014 . . . . 1.0 109.842 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 132' ' ' ALA . 2.4 p -154.84 59.59 0.67 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.019 -1.051 . . . . 1.0 110.57 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 133' ' ' THR . 5.2 mt-30 56.94 153.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 1.0 110.078 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.905 HD21 HD11 ' A' ' 69' ' ' ILE . 13.6 tp -135.82 109.61 8.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.978 -1.076 . . . . 1.0 110.654 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.5 m-20 -106.92 158.75 16.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 1.0 109.557 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -113.65 153.28 29.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.075 -1.016 . . . . 1.0 110.281 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.721 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 28.0 p-10 -90.91 27.13 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.268 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 44.75 23.77 0.61 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.712 -1.755 . . . . 1.0 108.712 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.721 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -133.51 152.39 51.9 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.388 -1.066 . . . . 1.0 109.158 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.719 HD11 ' HG ' ' A' ' 57' ' ' LEU . 8.0 tp -158.61 161.36 37.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.105 -0.997 . . . . 1.0 110.703 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.744 ' CE3' ' HE3' ' A' ' 146' ' ' MET . 45.0 m95 -127.59 159.67 33.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.881 HD22 ' O ' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -153.91 118.84 5.02 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 116.873 -1.931 . . . . 1.0 113.801 -177.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.664 ' N ' HD13 ' A' ' 143' ' ' LEU . . . 111.26 5.66 26.37 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.497 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 134.27 -136.22 8.47 Favored Glycine 0 C--N 1.283 -2.366 0 C-N-CA 118.542 -1.789 . . . . 1.0 109.917 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.874 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -167.3 126.1 1.34 Allowed 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.892 -1.123 . . . . 1.0 112.037 -178.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.565 ' HB2' ' CG ' ' A' ' 24' ' ' TYR . 6.5 tp10 -58.74 -19.27 38.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.533 ' N ' ' HD3' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -146.03 69.69 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.468 -1.679 . . . . 1.0 106.468 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.922 HD11 ' CD2' ' A' ' 159' ' ' TYR . 3.5 tp -71.81 41.09 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.55 0.945 . . . . 1.0 113.55 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 p -76.79 -9.56 58.77 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.477 -1.675 . . . . 1.0 106.477 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' CE2' ' A' ' 58' ' ' TRP 0.269 8.2 p -72.66 -26.37 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.044 -0.98 . . . . 1.0 111.238 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.718 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . -40.23 -27.52 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.286 -0.884 . . . . 1.0 110.197 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 151' ' ' VAL . 28.7 m170 70.8 -92.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.324 0.583 . . . . 1.0 110.496 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -139.6 -4.11 1.45 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 111.217 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 155' ' ' LEU . 3.7 pp -47.16 170.01 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 1.0 108.608 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.679 ' O ' HD12 ' A' ' 155' ' ' LEU . 37.6 Cg_endo -61.12 178.4 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.331 1.174 . . . . 1.0 112.173 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -60.42 -6.7 1.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -0.865 . . . . 1.0 111.738 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -42.02 -38.98 1.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.91 -1.119 . . . . 1.0 108.934 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 1.047 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 3.8 m-85 -79.3 -34.0 42.79 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.323 -0.951 . . . . 1.0 109.113 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -65.64 -11.77 47.58 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.337 -0.945 . . . . 1.0 109.597 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -123.89 82.66 2.05 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.581 -0.699 . . . . 1.0 109.302 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 161' ' ' THR . . . -41.04 159.21 0.03 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.64 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 8.4 t80 -76.93 141.64 40.4 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.909 -1.348 . . . . 1.0 112.183 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 164' ' ' ILE . 6.0 mt -121.36 84.69 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.64 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.46 -154.38 9.45 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.427 -1.869 . . . . 1.0 108.427 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.49 ' C ' HG13 ' A' ' 167' ' ' ILE . 3.6 m -130.19 153.7 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.128 -1.219 . . . . 1.0 111.232 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.743 HD13 ' CE2' ' A' ' 19' ' ' PHE . 3.5 mt -134.76 153.19 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 3.6 ttt-85 -158.79 153.98 25.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.624 -1.298 . . . . 1.0 111.538 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 59.8 m-20 50.29 81.64 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.622 -0.674 . . . . 1.0 110.992 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.917 HG12 ' CB ' ' A' ' 45' ' ' LEU . 19.4 m -123.3 130.6 74.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.145 -1.022 . . . . 1.0 110.174 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.509 ' HB ' ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -138.51 144.36 30.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.246 -0.982 . . . . 1.0 110.948 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.557 HG13 ' HE1' ' A' ' 43' ' ' PHE . 70.1 t -127.89 91.22 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 12.3 m-20 57.96 50.87 9.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.574 -1.329 . . . . 1.0 107.855 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 37.6 mmm-85 61.56 34.74 17.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.708 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 3.1 mm100 -112.46 164.51 13.19 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.088 -1.007 . . . . 1.0 109.596 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.696 ' OE2' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER 71.5 -109.94 0.05 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.0 110.563 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 178' ' ' HIS . 0.2 OUTLIER 55.24 11.97 0.62 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 1.0 112.088 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.702 ' CE1' HD11 ' A' ' 177' ' ' LEU . 58.7 m-70 -144.45 75.5 1.46 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.996 -1.065 . . . . 1.0 108.776 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.696 HD12 ' OE2' ' A' ' 176' ' ' GLU 0.25 7.9 mp -54.64 -55.04 33.76 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.199 1.0 . . . . 1.0 111.17 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 4.9 t -63.2 -16.48 17.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.884 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.572 ' CG ' ' HB3' ' A' ' 178' ' ' HIS . 16.1 mt-10 -71.55 -51.54 22.96 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.882 -1.127 . . . . 1.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 82.1 m-20 -96.49 -14.96 21.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.559 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -65.78 -38.12 88.15 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.28 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.0 mt -45.6 -25.75 0.51 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 1.0 109.336 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -53.04 -23.14 6.89 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.155 0.979 . . . . 1.0 108.466 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.545 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 14.4 t30 -98.72 160.78 27.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.694 -1.224 . . . . 1.0 107.694 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 37.6 Cg_endo -62.94 -157.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.87 0.932 . . . . 1.0 111.119 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 187' ' ' PRO . 7.3 m -36.14 137.43 0.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 1.0 111.228 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.9 mm -86.5 156.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.502 -0.749 . . . . 1.0 109.985 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.6 mt -127.51 152.88 47.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 1.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -107.36 157.5 17.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.305 -0.872 . . . . 1.0 109.618 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.998 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 38.9 t . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.0 111.704 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.49 ' OE1' ' NE2' ' A' ' 191' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--O 1.214 -0.767 0 CA-C-O 121.886 0.851 . . . . 1.0 109.821 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -108.46 148.83 29.62 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.906 -0.496 . . . . 1.0 109.91 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 13.3 mm -121.56 131.69 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 1.0 109.251 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.49 ' HB2' ' CA ' ' A' ' 192' ' ' CYS . . . -96.18 130.1 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 1.0 110.998 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CZ ' ' SD ' ' A' ' 25' ' ' MET . 5.8 m-30 -94.89 174.71 6.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.389 -0.819 . . . . 1.0 109.473 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 10.0 p-10 -127.58 -6.82 5.73 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.235 -0.916 . . . . 1.0 110.546 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.47 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 98.38 -1.66 58.88 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 52.0 ttp85 -134.92 -5.71 2.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.947 -1.326 . . . . 1.0 110.947 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -87.42 140.27 29.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.774 -1.204 . . . . 1.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.423 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 3.0 p90 -112.26 95.21 5.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.298 -0.876 . . . . 1.0 110.188 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.56 ' SD ' ' CZ ' ' A' ' 19' ' ' PHE . 8.7 mtt -77.06 100.76 5.79 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.465 -0.894 . . . . 1.0 109.902 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 3.4 pm0 -107.29 121.91 45.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 1.0 110.606 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 25' ' ' MET . 17.4 m-85 -111.03 107.96 17.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.414 -0.804 . . . . 1.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.95 112.84 24.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 1.0 110.152 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.6 ' ND2' ' OE1' ' A' ' 175' ' ' GLN . 5.1 t30 -127.77 137.44 52.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 1.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.44 27.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 1.0 110.0 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.004 -1.06 . . . . 1.0 110.412 179.831 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 3.2 pt20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.686 0.755 . . . . 1.0 110.688 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.777 ' OG ' HG13 ' A' ' 110' ' ' VAL . 47.8 m -149.25 148.72 29.91 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.376 -0.828 . . . . 1.0 110.454 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.437 HD21 ' HZ ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -112.02 147.18 36.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 1.0 110.158 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 30.7 m80 -123.01 123.36 40.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 1.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.731 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 26.5 m-85 -122.18 117.83 27.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 1.0 109.535 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.869 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.4 mt-10 -126.74 139.87 52.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 1.0 110.882 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.897 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.4 OUTLIER 179.1 164.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.489 -0.884 . . . . 1.0 111.003 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 103' ' ' THR . 50.0 m -124.7 149.71 46.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.352 -1.351 . . . . 1.0 107.352 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.621 HD13 HD11 ' A' ' 105' ' ' ILE . 3.7 pt -139.36 164.41 24.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.163 -1.415 . . . . 1.0 112.312 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.2 OUTLIER -116.45 86.9 2.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 177.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -72.31 155.67 39.92 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.977 -1.077 . . . . 1.0 111.063 -177.516 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.4 mm-40 -138.21 10.19 2.77 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.755 -0.778 . . . . 1.0 110.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 52' ' ' THR . . . -140.43 -85.51 0.21 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.117 -0.989 . . . . 1.0 110.61 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.64 -24.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.9 tt0 -125.03 138.19 54.21 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 156.73 138.81 2.6 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.042 -1.623 . . . . 1.0 109.042 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.244 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -88.72 128.32 35.61 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.83 -1.394 . . . . 1.0 109.602 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.796 HG22 HD21 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -90.83 -35.93 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.788 -0.57 . . . . 1.0 112.508 -176.143 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.084 HD13 HD12 ' A' ' 71' ' ' LEU . 2.3 tt -149.05 146.02 27.55 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.859 -1.151 . . . . 1.0 111.981 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.949 ' N ' HD23 ' A' ' 57' ' ' LEU . 3.5 t-105 -149.09 111.76 4.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.583 -1.266 . . . . 1.0 107.583 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.578 ' OG ' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -118.79 161.4 20.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.873 -1.142 . . . . 1.0 111.394 -178.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 108.504 -1.838 . . . . 1.0 108.504 179.597 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 122.159 0.98 . . . . 1.0 111.983 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.989 HD12 ' N ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -148.26 146.0 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.425 -178.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.113 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -146.63 -175.11 4.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 1.0 110.39 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.084 HD12 HD13 ' A' ' 57' ' ' LEU . 66.3 mt -149.56 126.2 11.0 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.009 -1.108 . . . . 1.0 108.009 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -145.22 173.33 12.04 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.824 -1.172 . . . . 1.0 111.964 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.67 HG12 HG13 ' A' ' 78' ' ' VAL . 16.9 mt -117.56 141.81 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.593 0.711 . . . . 1.0 111.086 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -139.28 130.17 33.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.743 -0.598 . . . . 1.0 110.164 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 1.2 m-20 58.36 21.31 8.19 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.224 -0.922 . . . . 1.0 111.602 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.823 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 92.39 20.05 36.47 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.628 -1.272 . . . . 1.0 110.252 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 76' ' ' GLY . 16.9 m-85 -138.19 144.29 40.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -1.126 . . . . 1.0 109.411 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.755 HG22 HD13 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -79.59 -167.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 1.0 109.103 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER 175.75 102.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 1.0 110.534 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.946 ' CE ' HD12 ' A' ' 91' ' ' LEU . 2.3 ttm -61.68 93.08 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.914 -0.714 . . . . 1.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 1.113 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 11.3 tmm? -89.94 111.29 22.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.804 -0.56 . . . . 1.0 110.005 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.871 ' CE2' HG11 ' A' ' 89' ' ' VAL . 2.8 p90 -143.1 141.29 31.2 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.346 -1.341 . . . . 1.0 110.986 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.53 ' HB3' ' CA ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -138.52 71.44 1.39 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.668 -0.645 . . . . 1.0 110.132 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.824 HD13 ' CD2' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -67.89 -7.37 27.67 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 120.069 -0.652 . . . . 1.0 110.006 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.62 -57.57 0.37 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.01 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -1.113 . . . . 1.0 110.55 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -110.37 124.48 33.17 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.95 . . . . 1.0 109.739 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.53 ' CA ' ' HB3' ' A' ' 83' ' ' ASP . 48.6 Cg_endo -73.7 139.12 27.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.784 1.413 . . . . 1.0 110.371 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.871 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.52 121.06 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 90' ' ' VAL . 7.2 p -99.06 81.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 118.346 -1.341 . . . . 1.0 111.09 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.946 HD12 ' CE ' ' A' ' 80' ' ' MET . 8.5 mt -76.63 71.33 3.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.622 -1.251 . . . . 1.0 107.622 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.641 ' O ' HG21 ' A' ' 124' ' ' ILE . 38.6 mtp180 -59.1 179.04 0.1 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.192 0.996 . . . . 1.0 111.347 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.864 ' HA ' HD13 ' A' ' 124' ' ' ILE . 3.1 t -114.84 149.1 37.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.45 -0.795 . . . . 1.0 109.904 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.756 ' O ' HG22 ' A' ' 94' ' ' THR . 54.5 m -106.85 34.37 3.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 1.0 109.423 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 1.014 HG11 HG21 ' A' ' 118' ' ' VAL . 0.8 OUTLIER -128.43 151.87 77.31 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.559 -0.713 . . . . 1.0 109.955 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 95' ' ' VAL . 43.5 Cg_endo -69.53 121.41 8.15 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.399 1.21 . . . . 1.0 109.892 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -109.58 -27.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 1.0 110.683 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 6.3 p-10 -82.06 61.11 5.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 1.0 109.847 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.708 ' O ' HG22 ' A' ' 99' ' ' THR . 27.0 m -123.1 14.86 9.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.823 . . . . 1.0 110.195 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.496 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER 53.54 18.05 1.32 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.937 -1.102 . . . . 1.0 110.108 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 5.5 m80 -116.14 144.59 43.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 1.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.56 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 21.1 m95 -59.44 109.52 0.91 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.437 -0.789 . . . . 1.0 111.138 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 104' ' ' HIS . 2.7 m -98.03 170.52 8.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.597 ' HB3' ' CA ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER -123.08 138.64 54.62 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.042 -1.037 . . . . 1.0 108.244 178.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.621 HD11 HD13 ' A' ' 47' ' ' ILE . 1.2 mt -134.91 149.16 29.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.103 -0.998 . . . . 1.0 109.608 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -148.34 130.19 15.2 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 1.0 109.709 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.731 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -122.46 109.39 14.31 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.263 -0.975 . . . . 1.0 111.295 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.662 ' CE2' ' CB ' ' A' ' 115' ' ' SER . 3.8 p90 -116.48 110.27 18.38 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.236 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.563 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 3.6 ttp180 -125.1 133.92 52.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.381 0.61 . . . . 1.0 110.44 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.777 HG13 ' OG ' ' A' ' 40' ' ' SER . 3.1 t -97.38 89.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 1.0 109.7 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 0.3 OUTLIER 21.24 48.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 4.3 tmm_? 167.96 -55.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.221 -0.924 . . . . 1.0 109.857 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -111.46 120.06 40.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 1.0 109.785 -179.725 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.06 162.57 15.29 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.946 -1.121 . . . . 1.0 111.618 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.662 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 13.5 t -141.61 155.6 45.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.737 -0.861 . . . . 1.0 109.829 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 117' ' ' GLN . 0.3 OUTLIER -149.65 125.98 10.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 120.956 -1.09 . . . . 1.0 110.908 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.745 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -135.1 134.99 40.85 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 1.014 HG21 HG11 ' A' ' 95' ' ' VAL . 9.9 p -76.2 102.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.597 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . 68.96 30.83 72.21 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 108.819 -1.712 . . . . 1.0 108.819 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 1.0 OUTLIER 72.93 29.99 1.75 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 1.0 110.688 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -97.3 -153.57 0.42 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 110.491 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 124' ' ' ILE . . . -36.81 101.92 0.23 Allowed Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.407 -0.808 . . . . 1.0 110.3 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.57 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 44.9 Cg_endo -71.02 116.65 4.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.57 . . . . 1.0 111.794 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.864 HD13 ' HA ' ' A' ' 93' ' ' SER . 1.2 mp -94.67 99.46 9.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 37.2 p -99.95 174.14 6.33 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.342 1.068 . . . . 1.0 112.39 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.12 154.1 10.15 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.486 -2.246 . . . . 1.0 107.486 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -137.14 167.18 22.04 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.26 -1.141 . . . . 1.0 109.927 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.0 174.75 5.68 Favored Pre-proline 0 C--N 1.3 -1.557 0 C-N-CA 119.089 -1.044 . . . . 1.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 130' ' ' LEU . 49.1 Cg_endo -78.71 43.68 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.735 1.387 . . . . 1.0 109.435 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.2 OUTLIER 42.47 105.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.724 0.773 . . . . 1.0 111.478 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.81 87.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.972 -1.251 . . . . 1.0 109.972 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.716 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -170.95 174.78 4.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -1.101 . . . . 1.0 109.788 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.8 t -179.22 156.98 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 1.0 110.427 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 135' ' ' LEU . 2.2 tt0 69.97 -60.44 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 1.0 111.131 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.824 ' CD2' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -1.18 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.797 0.808 . . . . 1.0 112.064 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.573 ' C ' HG23 ' A' ' 137' ' ' THR . 37.5 m-20 -116.66 149.01 40.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.11 . . . . 1.0 110.038 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.573 HG23 ' C ' ' A' ' 136' ' ' ASP . 33.3 p -154.15 105.91 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 1.0 110.115 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.6 OUTLIER 167.11 -43.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.69 0.757 . . . . 1.0 109.206 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.4 -24.85 7.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.783 -1.327 . . . . 1.0 109.783 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -163.97 135.03 4.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.995 -1.297 . . . . 1.0 110.598 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 57' ' ' LEU . 6.2 tp -135.8 142.72 44.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 1.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 26' ' ' GLU . 44.2 m95 -117.73 148.09 42.35 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.796 HD21 HG22 ' A' ' 56' ' ' ILE . 1.6 tt -148.59 119.55 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 117.644 -1.623 . . . . 1.0 112.995 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.59 9.3 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.77 -1.332 . . . . 1.0 109.77 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 129.94 -148.52 18.5 Favored Glycine 0 C--N 1.287 -2.158 0 N-CA-C 108.024 -2.031 . . . . 1.0 108.024 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.964 ' CB ' HD13 ' A' ' 149' ' ' LEU 0.266 5.6 mmt -152.53 128.78 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.655 -0.818 . . . . 1.0 110.95 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 146' ' ' MET . 5.3 tm-20 -43.53 -50.23 7.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.023 -1.048 . . . . 1.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.723 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -127.88 79.24 1.88 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 123.022 1.392 . . . . 1.0 107.73 177.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.965 HD12 ' CG1' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -62.1 42.79 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.177 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 148' ' ' ARG . 92.9 p -50.81 -32.75 21.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 177.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.965 ' CG1' HD12 ' A' ' 149' ' ' LEU 0.313 7.1 p -65.9 -141.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 113.542 -1.663 . . . . 1.0 106.557 176.022 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.829 ' HB1' ' CB ' ' A' ' 159' ' ' TYR 0.278 . . 50.63 14.21 0.16 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.597 -1.314 . . . . 1.0 111.508 177.324 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.79 -45.23 6.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.688 -1.257 . . . . 1.0 111.402 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.491 ' NZ ' ' OD2' ' A' ' 83' ' ' ASP . 2.6 pttt -61.13 -6.69 2.13 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.279 -0.888 . . . . 1.0 111.15 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 1.063 HD11 ' CD1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -121.96 -174.82 0.32 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.904 -1.123 . . . . 1.0 110.781 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.591 ' N ' ' HG ' ' A' ' 155' ' ' LEU . 44.1 Cg_endo -70.19 174.98 9.09 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.626 1.329 . . . . 1.0 112.536 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.9 -11.43 1.45 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.682 -0.636 . . . . 1.0 111.948 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -37.29 -41.03 0.38 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.194 -0.941 . . . . 1.0 109.961 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 1.244 ' CE2' HD13 ' A' ' 55' ' ' LEU . 4.0 m-85 -83.0 -32.97 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.093 -1.043 . . . . 1.0 109.522 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -60.53 -15.47 27.69 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.88 -1.128 . . . . 1.0 108.227 178.652 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -115.9 83.5 1.95 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.03 163.94 0.01 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.808 -1.317 . . . . 1.0 109.808 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.586 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 20.0 t80 -77.01 142.32 39.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.763 -1.434 . . . . 1.0 111.647 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 164' ' ' ILE . 3.6 mt -123.93 87.15 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.586 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.25 -153.19 9.07 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 108.184 -1.966 . . . . 1.0 108.184 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 9.6 m -135.73 155.14 50.86 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.893 -1.123 . . . . 1.0 110.758 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.6 mt -133.68 153.34 36.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 121.385 -0.822 . . . . 1.0 109.412 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.415 ' HD3' ' O ' ' A' ' 15' ' ' GLU . 11.2 ttp85 -159.09 158.55 33.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.932 -1.105 . . . . 1.0 110.857 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 22.6 m-20 48.92 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.303 -0.873 . . . . 1.0 110.043 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.897 HG12 ' CB ' ' A' ' 45' ' ' LEU . 18.5 m -126.77 131.71 70.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 C-N-CA 119.179 -1.008 . . . . 1.0 110.004 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.92 149.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.579 -0.849 . . . . 1.0 110.511 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 54.4 t -131.46 94.19 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 1.3 m-20 71.44 38.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 74.51 18.1 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.248 0.547 . . . . 1.0 110.127 -179.342 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.6 ' OE1' ' ND2' ' A' ' 29' ' ' ASN . 7.0 mm-40 -89.09 111.02 21.67 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.344 -0.847 . . . . 1.0 109.732 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.44 106.4 6.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.887 -1.133 . . . . 1.0 109.274 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -89.32 86.96 6.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 1.0 111.077 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.583 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 80.2 m-70 -53.37 104.47 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.174 0.988 . . . . 1.0 109.39 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -46.84 -61.94 1.63 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.166 0.984 . . . . 1.0 109.777 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.752 HG13 HD21 ' A' ' 184' ' ' LEU . 36.2 t -54.04 -21.86 6.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.41 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 13.4 mt-10 -64.95 -53.06 52.32 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.265 -1.374 . . . . 1.0 109.914 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.9 OUTLIER -105.59 -22.48 12.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.009 -1.057 . . . . 1.0 109.731 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -59.39 -35.8 74.61 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.785 -1.197 . . . . 1.0 108.153 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.752 HD21 HG13 ' A' ' 180' ' ' VAL . 1.3 mm? -50.25 -20.73 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.718 . . . . 1.0 109.748 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 15.3 t-20 -52.22 -22.53 4.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 1.0 108.956 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.461 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 8.4 t30 -86.18 149.05 49.02 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 45.2 Cg_endo -72.35 -47.54 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.742 1.391 . . . . 1.0 110.599 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.91 118.99 37.6 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.746 -0.596 . . . . 1.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.571 HD12 HD22 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -117.9 128.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.308 -0.87 . . . . 1.0 109.515 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 19.9 mt -103.23 171.97 7.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.861 . . . . 1.0 110.088 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.599 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -121.72 1.78 10.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.056 -1.027 . . . . 1.0 110.911 -179.499 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.49 ' CA ' ' HB2' ' A' ' 18' ' ' ALA . 6.3 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 1.0 110.623 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--O 1.215 -0.741 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.09 131.79 35.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.304 -0.873 . . . . 1.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.514 HG21 ' CE ' ' A' ' 25' ' ' MET . 26.4 mm -127.07 117.95 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 1.0 109.437 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.37 139.94 31.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 1.0 111.318 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.889 ' CD2' HG21 ' A' ' 23' ' ' THR . 8.3 m-85 -108.09 159.92 16.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' C ' HG12 ' A' ' 164' ' ' ILE . 4.1 p-10 -115.8 -3.31 12.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.952 -1.092 . . . . 1.0 110.779 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.478 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 109.49 -18.29 30.15 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 30.39 7.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.585 -0.95 . . . . 1.0 109.182 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.889 HG21 ' CD2' ' A' ' 19' ' ' PHE . 1.9 m -69.87 172.69 7.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 1.0 110.894 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.585 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 10.8 t80 -167.72 74.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.597 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 3.8 mmt -86.95 99.43 11.86 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.845 -1.142 . . . . 1.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.77 136.4 34.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 1.0 108.63 179.056 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 96.0 m-85 -130.92 104.5 7.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.017 -1.052 . . . . 1.0 110.903 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.536 ' HE2' ' HZ2' ' A' ' 142' ' ' TRP . 22.7 m-70 -108.13 120.21 41.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 1.0 109.576 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -155.31 170.69 21.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 1.0 110.524 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.15 153.88 17.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.412 -0.805 . . . . 1.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 1.0 110.735 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.885 0.85 . . . . 1.0 109.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.7 p -163.6 133.55 4.23 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.704 -0.622 . . . . 1.0 110.342 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.6 HD21 ' HZ ' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -100.93 152.39 20.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 1.0 109.943 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.552 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 11.5 m80 -123.88 138.16 54.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -0.951 . . . . 1.0 110.03 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 1.016 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 21.2 m-85 -134.73 128.03 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 1.0 110.204 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.793 ' C ' HD23 ' A' ' 45' ' ' LEU . 8.2 mt-10 -133.8 148.9 51.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 1.0 110.114 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.994 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.8 OUTLIER 179.26 151.55 0.35 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.395 -0.922 . . . . 1.0 111.158 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.504 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.09 154.11 35.16 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 97' ' ' ILE . 5.5 pt -150.81 173.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 C-N-CA 117.96 -1.496 . . . . 1.0 112.312 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.652 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -127.33 82.92 2.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 178.284 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -66.86 161.21 24.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.119 -0.988 . . . . 1.0 111.256 -177.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.622 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 8.0 mm-40 -140.81 7.96 2.1 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.531 -0.867 . . . . 1.0 110.939 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 52' ' ' THR . . . -137.04 -86.66 0.31 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.142 -1.023 . . . . 1.0 111.063 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.93 -24.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.302 -0.999 . . . . 1.0 108.302 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -125.01 132.43 53.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.67 -0.644 . . . . 1.0 109.831 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 162.98 137.81 2.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.266 -1.534 . . . . 1.0 109.266 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.755 ' CD2' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -86.07 130.09 34.64 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.903 -1.351 . . . . 1.0 108.305 179.151 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.122 HD11 HG13 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -98.31 -26.27 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.553 -0.717 . . . . 1.0 112.178 -176.713 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.061 HD13 HD12 ' A' ' 71' ' ' LEU 0.264 7.9 tt -156.88 155.41 31.4 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 117.736 -1.586 . . . . 1.0 113.09 -175.432 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.811 ' N ' HD23 ' A' ' 57' ' ' LEU . 2.7 t-105 -156.23 114.35 3.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.683 ' OG ' HD21 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -133.89 179.92 5.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.89 -1.132 . . . . 1.0 111.063 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.301 -1.519 . . . . 1.0 109.301 179.896 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.578 ' CG ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 m-30 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.066 0.46 . . . . 1.0 112.211 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 59' ' ' SER . 21.0 mm -98.34 77.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.0 109.24 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.845 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -120.88 179.29 4.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 1.0 111.192 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.061 HD12 HD13 ' A' ' 57' ' ' LEU . 81.8 mt -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.252 -0.905 . . . . 1.0 108.723 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -112.18 178.39 4.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.079 . . . . 1.0 111.671 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.671 HG12 HG13 ' A' ' 78' ' ' VAL . 60.1 mt -129.6 139.58 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.456 -0.778 . . . . 1.0 110.971 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.613 HG13 ' NH1' ' A' ' 92' ' ' ARG . 1.9 p -140.41 139.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.759 -0.588 . . . . 1.0 109.945 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.515 ' OD2' HG22 ' A' ' 74' ' ' VAL . 69.3 m-20 59.13 20.49 8.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 1.0 110.944 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.828 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 88.14 16.54 59.11 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.845 -1.302 . . . . 1.0 109.845 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.421 ' C ' HG23 ' A' ' 73' ' ' ILE . 52.5 m-85 -133.97 135.76 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 1.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.122 HG13 HD11 ' A' ' 56' ' ' ILE . 1.6 t -76.24 177.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 1.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -163.46 127.66 2.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.2 -0.937 . . . . 1.0 110.891 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.803 ' HB2' HD23 ' A' ' 116' ' ' LEU . 8.4 tmm? -82.39 94.52 7.41 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.443 0.64 . . . . 1.0 110.606 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.845 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -73.81 120.56 19.57 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 178.089 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.667 ' CE1' HD22 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -143.35 91.73 2.3 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.426 -1.71 . . . . 1.0 111.691 -178.25 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.674 ' C ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.57 152.07 29.31 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.432 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.769 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.28 -35.56 1.34 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -103.41 -33.12 4.31 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.666 -1.773 . . . . 1.0 108.666 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 162.02 -12.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.445 -1.032 . . . . 1.0 111.523 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' C ' ' HB2' ' A' ' 83' ' ' ASP . 3.7 mttt -102.64 96.16 7.16 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.751 -1.218 . . . . 1.0 110.043 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HA ' ' CB ' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -70.42 123.99 10.39 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.065 1.561 . . . . 1.0 110.464 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -88.89 119.73 36.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 1.0 109.06 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 90' ' ' VAL . 8.7 p -99.29 81.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.667 -1.271 . . . . 1.0 110.529 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.649 HD12 ' CE ' ' A' ' 80' ' ' MET . 10.4 mt -78.15 82.08 4.49 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.613 ' NH1' HG13 ' A' ' 74' ' ' VAL . 1.2 mtt180 -57.9 176.58 0.15 Allowed 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 118.599 -1.24 . . . . 1.0 109.725 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.595 ' HA ' ' CD1' ' A' ' 124' ' ' ILE . 1.8 t -95.26 159.03 15.2 Favored 'General case' 0 C--N 1.286 -2.164 0 O-C-N 121.691 -0.63 . . . . 1.0 110.341 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 8.57 40.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 1.0 109.834 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.893 ' CG2' HG21 ' A' ' 118' ' ' VAL . 21.8 t -130.15 146.78 62.96 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 1.0 109.316 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.538 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.2 Cg_endo -69.76 153.04 69.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.588 1.31 . . . . 1.0 111.101 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -133.14 -27.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.862 . . . . 1.0 111.032 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 3.4 p-10 -72.16 65.0 0.57 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.994 -1.066 . . . . 1.0 111.061 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 101' ' ' HIS . 14.7 t -135.82 18.3 3.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 1.0 109.522 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.0 m120 57.31 23.64 9.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.82 . . . . 1.0 111.189 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.73 ' HB2' HG23 ' A' ' 99' ' ' THR . 2.8 m80 -112.0 147.71 35.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 1.0 110.007 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.652 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 23.4 m95 -68.21 104.7 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 1.0 110.057 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 104' ' ' HIS . 2.4 m -98.73 172.41 7.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 1.0 109.003 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.609 ' CD2' ' HA2' ' A' ' 119' ' ' GLY . 1.7 t60 -124.62 139.66 53.66 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.477 HD11 HD13 ' A' ' 47' ' ' ILE . 1.2 mt -129.28 157.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 119.193 -1.003 . . . . 1.0 109.19 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.842 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -146.46 156.5 43.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.105 -0.997 . . . . 1.0 109.539 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -158.22 119.46 3.49 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.526 -0.87 . . . . 1.0 110.516 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 2.3 p90 -129.27 107.3 9.43 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.203 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.605 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.4 OUTLIER -83.71 139.97 32.42 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.987 -0.685 . . . . 1.0 109.839 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.3 t -132.59 88.98 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 1.0 110.041 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 38.8 mt-30 44.58 102.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 1.0 111.121 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 5.3 ttt180 64.24 -52.34 0.27 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 1.0 111.423 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.65 ' CB ' ' OG ' ' A' ' 127' ' ' SER . 4.3 pt-20 -82.09 117.97 22.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.596 -1.315 . . . . 1.0 111.386 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.98 152.56 17.11 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.164 -1.174 . . . . 1.0 110.164 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.603 ' OG ' ' CZ ' ' A' ' 108' ' ' TYR . 32.8 t -133.84 161.88 33.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.13 -1.218 . . . . 1.0 111.538 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.051 HD13 ' N ' ' A' ' 117' ' ' GLN 0.252 1.7 tm? -144.24 155.42 43.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 1.051 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -163.02 123.13 2.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.334 -1.346 . . . . 1.0 112.742 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.893 HG21 ' CG2' ' A' ' 95' ' ' VAL . 3.0 m -71.4 106.53 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.639 -1.615 . . . . 1.0 106.639 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.609 ' HA2' ' CD2' ' A' ' 104' ' ' HIS . . . 75.54 -73.75 1.59 Allowed Glycine 0 C--N 1.287 -2.184 0 N-CA-C 108.817 -1.713 . . . . 1.0 108.817 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 3.5 t-20 178.22 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.404 -1.056 . . . . 1.0 109.602 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -96.99 -158.74 0.69 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.584 -0.698 . . . . 1.0 111.064 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -40.2 103.61 0.3 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 1.0 109.653 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 42.2 Cg_endo -71.33 126.45 12.29 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.02 1.537 . . . . 1.0 111.012 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.595 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 1.7 mp -82.46 99.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.824 -1.172 . . . . 1.0 107.901 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 16.4 p -98.18 177.08 5.51 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.057 -1.027 . . . . 1.0 110.838 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 113' ' ' GLU . . . -179.75 -161.86 27.75 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 107.122 -2.391 . . . . 1.0 107.122 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.65 ' OG ' ' CB ' ' A' ' 113' ' ' GLU . 3.5 m -174.71 154.01 1.89 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.099 -1.236 . . . . 1.0 110.721 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.576 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -80.32 -176.87 0.81 Allowed Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 36.0 Cg_endo -63.23 -60.02 0.19 Allowed 'Trans proline' 0 C--N 1.301 -1.96 0 N-CA-C 108.086 -1.544 . . . . 1.0 108.086 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 129' ' ' PRO . 3.4 pp 152.56 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.631 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.479 ' N ' HD12 ' A' ' 130' ' ' LEU . . . 77.45 -73.16 2.07 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 84' ' ' LEU . . . -64.43 75.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 1.0 110.199 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 131' ' ' GLY . 7.0 m -86.97 -23.82 24.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 1.0 110.133 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -100.43 121.49 41.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 1.0 110.124 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.547 HD13 ' C ' ' A' ' 135' ' ' LEU . 3.1 tm? -155.81 106.68 2.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 1.0 109.808 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.63 136.73 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 1.0 110.429 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -157.4 106.21 2.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 1.0 110.255 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 137' ' ' THR . 2.6 p30 161.28 -32.53 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.589 -0.695 . . . . 1.0 109.785 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -53.22 -21.38 11.62 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -143.64 164.89 29.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.346 . . . . 1.0 110.637 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 142' ' ' TRP . 9.1 tp -160.13 142.49 13.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 1.0 110.754 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 25.5 m95 -132.23 147.27 52.4 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.172 -1.418 . . . . 1.0 107.172 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.94 HD23 HD12 ' A' ' 57' ' ' LEU . 1.4 tm? -153.1 117.72 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.705 -1.598 . . . . 1.0 113.305 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.622 ' N ' HD13 ' A' ' 143' ' ' LEU . . . 119.38 5.12 11.59 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.323 -1.111 . . . . 1.0 110.323 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 139.89 -133.31 5.98 Favored Glycine 0 C--N 1.289 -2.075 0 C-N-CA 118.624 -1.751 . . . . 1.0 109.668 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.64 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -168.99 142.18 2.81 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.515 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.545 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 4.6 tm-20 -71.72 -26.98 62.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.51 -1.293 . . . . 1.0 107.51 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.501 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.82 80.36 1.69 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.845 HD23 ' O ' ' A' ' 159' ' ' TYR . 0.3 OUTLIER -69.83 36.44 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.406 -0.809 . . . . 1.0 113.178 -176.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -71.27 -11.13 60.75 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.669 HG21 ' CZ2' ' A' ' 58' ' ' TRP 0.26 10.5 p -79.74 -9.64 12.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.212 -0.903 . . . . 1.0 110.676 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 153' ' ' HIS . . . -70.11 51.99 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 1.0 109.867 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.665 ' CD2' ' N ' ' A' ' 153' ' ' HIS . 1.8 p80 4.26 -86.29 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.688 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -160.77 100.2 1.27 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 123.299 1.523 . . . . 1.0 109.19 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.783 HD21 ' HD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -154.0 175.54 2.99 Favored Pre-proline 0 C--N 1.283 -2.314 0 O-C-N 120.843 -1.16 . . . . 1.0 109.756 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.732 ' O ' HD22 ' A' ' 155' ' ' LEU . 37.0 Cg_endo -61.29 -178.14 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 122.851 0.921 . . . . 1.0 111.572 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -55.61 -11.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.383 -0.823 . . . . 1.0 112.064 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.699 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -36.23 -43.77 0.37 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.915 . . . . 1.0 109.859 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.845 ' O ' HD23 ' A' ' 149' ' ' LEU . 8.9 m-85 -86.4 -27.7 24.03 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 1.0 109.384 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -75.8 -3.49 35.28 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.657 -1.217 . . . . 1.0 108.243 177.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 161' ' ' THR . 1.8 m -135.35 91.53 2.74 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.26 170.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 1.0 110.069 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.657 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 13.3 t80 -74.18 147.15 42.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.146 -1.208 . . . . 1.0 112.295 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.772 HG22 ' O ' ' A' ' 164' ' ' ILE . 3.6 mt -124.28 87.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.657 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.64 -153.9 9.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.147 -1.581 . . . . 1.0 109.147 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 48' ' ' LYS . 39.4 m -130.5 146.29 52.01 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.387 -1.066 . . . . 1.0 110.457 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.854 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -129.62 150.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.348 -0.845 . . . . 1.0 110.655 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 170' ' ' VAL . 9.4 ttt180 -159.49 168.47 26.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.012 -1.055 . . . . 1.0 110.452 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 14.2 m-20 44.63 58.87 3.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.895 . . . . 1.0 110.38 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.994 HG12 ' CB ' ' A' ' 45' ' ' LEU . 24.2 m -114.19 121.73 66.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.66 -0.816 . . . . 1.0 109.677 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.52 HG13 ' C ' ' A' ' 170' ' ' VAL . 1.0 OUTLIER -134.49 155.74 39.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.352 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.887 HG22 ' CD1' ' A' ' 43' ' ' PHE . 3.2 t -134.72 106.48 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 53.8 m-20 49.91 36.57 11.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.334 -1.479 . . . . 1.0 107.302 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 76.33 22.33 1.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.841 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 176' ' ' GLU . 21.6 mt-30 -99.34 -171.94 2.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.941 -1.1 . . . . 1.0 110.408 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.616 ' HG2' HG23 ' A' ' 170' ' ' VAL . 10.5 tt0 72.49 -102.77 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.675 -0.641 . . . . 1.0 110.801 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.1 mt 68.6 -92.98 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.43 -0.794 . . . . 1.0 112.479 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 88.3 m-70 -89.51 103.86 16.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.667 -1.271 . . . . 1.0 112.486 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.1 OUTLIER -68.67 -48.71 63.26 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 177.482 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.449 ' O ' HD12 ' A' ' 184' ' ' LEU . 10.3 t -47.5 -26.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 1.0 110.004 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 0.6 OUTLIER -72.11 -60.64 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 1.0 110.898 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.581 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -92.93 -15.81 25.88 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.007 -1.058 . . . . 1.0 110.397 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -71.69 -34.92 70.05 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 184' ' ' LEU . 12.7 mt -51.06 -21.15 1.7 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.533 -0.729 . . . . 1.0 109.207 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -42.71 -27.8 0.2 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.006 0.907 . . . . 1.0 108.701 179.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 187' ' ' PRO . 2.4 t30 -131.2 146.32 61.57 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.541 ' O ' HG22 ' A' ' 188' ' ' THR . 42.7 Cg_endo -68.06 -157.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.765 1.402 . . . . 1.0 110.853 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 187' ' ' PRO . 0.4 OUTLIER 63.54 9.98 4.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 1.0 110.514 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 189' ' ' ILE . 30.7 mm -68.53 94.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 1.0 109.951 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.98 164.14 12.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 1.0 110.597 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.15 154.25 22.0 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.214 -0.929 . . . . 1.0 110.092 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.965 . . . . 1.0 110.563 -179.8 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.529 ' O ' ' CD ' ' A' ' 168' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.214 -0.792 0 CA-C-O 121.841 0.829 . . . . 1.0 109.967 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -138.44 168.3 20.05 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.741 -0.599 . . . . 1.0 109.839 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 191' ' ' HIS . 13.3 mm -134.11 109.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 1.0 110.137 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.787 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -73.25 129.83 38.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.539 -0.726 . . . . 1.0 109.934 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.586 ' CZ ' HD13 ' A' ' 167' ' ' ILE . 3.0 m-30 -95.68 133.49 39.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.404 -0.81 . . . . 1.0 109.326 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 -1.09 54.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 1.0 110.673 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.08 -7.39 62.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -122.02 7.13 9.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.206 -1.173 . . . . 1.0 109.904 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.575 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 8.9 t -81.63 164.45 21.84 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.995 0.902 . . . . 1.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' A' ' 23' ' ' THR . 6.0 m-30 -142.8 94.18 2.61 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.803 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 19' ' ' PHE . 2.4 mmt -94.21 101.63 13.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.841 -1.162 . . . . 1.0 109.795 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -117.65 120.54 38.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 1.0 110.361 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 2.9 m-85 -115.03 110.89 20.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.836 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -101.57 85.18 2.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.08 -1.013 . . . . 1.0 110.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -112.8 163.17 14.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 1.0 109.982 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.27 94.5 4.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 1.0 110.24 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.902 . . . . 1.0 110.335 179.86 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.656 0.741 . . . . 1.0 111.33 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -127.89 163.75 23.76 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.369 -0.832 . . . . 1.0 110.982 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -108.97 155.67 20.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.45 -0.781 . . . . 1.0 109.748 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.533 ' O ' HG23 ' A' ' 172' ' ' VAL . 14.8 m-70 -123.48 133.39 54.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.071 . . . . 1.0 110.486 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.814 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 28.9 m-85 -136.76 117.09 13.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 1.0 109.926 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.715 ' C ' HD23 ' A' ' 45' ' ' LEU . 9.6 mt-10 -125.62 145.59 50.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.901 -1.124 . . . . 1.0 110.443 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.749 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 179.79 154.2 0.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.718 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.497 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -118.65 152.7 35.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.977 HD13 HD11 ' A' ' 105' ' ' ILE . 4.0 pt -148.67 160.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 117.81 -1.556 . . . . 1.0 112.697 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.644 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -114.63 83.79 1.95 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.332 -1.729 . . . . 1.0 106.332 177.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.495 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -66.97 150.87 48.64 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.042 0.925 . . . . 1.0 112.594 -176.416 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.853 ' HB2' HG22 ' A' ' 164' ' ' ILE . 4.5 mm-40 -140.85 2.99 1.81 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.863 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.25 125.64 12.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 1.0 110.12 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.452 ' HB ' ' N ' ' A' ' 76' ' ' GLY . 74.1 p -57.07 -14.95 4.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.473 -0.767 . . . . 1.0 111.408 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.615 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -128.76 132.01 47.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.936 -1.103 . . . . 1.0 111.452 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 166.66 136.28 2.0 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.397 -1.382 . . . . 1.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.732 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -89.64 118.86 29.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -1.213 . . . . 1.0 108.326 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.812 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -92.86 -31.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.756 -176.325 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.085 HD13 HD12 ' A' ' 71' ' ' LEU . 4.9 tt -147.3 151.47 36.66 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.664 -1.272 . . . . 1.0 112.605 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 1.154 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 0.6 OUTLIER -161.24 124.28 3.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.686 178.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.73 ' HB3' HD11 ' A' ' 69' ' ' ILE . 1.0 OUTLIER -121.89 156.57 33.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.951 -1.093 . . . . 1.0 109.719 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 109.148 -1.581 . . . . 1.0 109.148 179.706 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.741 ' CE2' HD11 ' A' ' 135' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 110.53 -0.174 . . . . 1.0 110.53 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -159.19 176.82 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.315 -1.491 . . . . 1.0 111.315 -179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.03 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -172.37 174.36 3.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.723 -0.611 . . . . 1.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.085 HD12 HD13 ' A' ' 57' ' ' LEU . 78.4 mt -146.16 95.57 2.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 1.0 109.139 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.586 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -115.53 177.13 4.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.505 -0.747 . . . . 1.0 112.112 -178.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 2.5 mt -117.81 138.2 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.767 -0.583 . . . . 1.0 110.025 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -142.39 133.25 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.42 -0.8 . . . . 1.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 3.3 m-20 61.62 23.86 14.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.068 -1.02 . . . . 1.0 111.432 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 84.39 18.66 61.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.974 -1.25 . . . . 1.0 109.974 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.29 150.27 45.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -1.091 . . . . 1.0 108.901 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.812 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -91.45 -176.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.734 -1.228 . . . . 1.0 109.878 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.738 ' HB2' HG22 ' A' ' 90' ' ' VAL . 3.4 pt20 -174.11 136.37 0.5 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.357 -0.839 . . . . 1.0 110.836 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.756 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -93.07 132.58 37.06 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.824 -0.75 . . . . 1.0 110.227 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . 1.03 ' HE3' ' CB ' ' A' ' 70' ' ' ALA . 3.6 ttm -107.74 137.64 45.39 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.637 -0.664 . . . . 1.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.594 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -134.71 102.03 5.14 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.127 -0.983 . . . . 1.0 109.758 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' TYR . 2.1 m-20 -110.79 34.35 4.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.652 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.804 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.4 OUTLIER -34.03 -29.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.731 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -118.4 -41.31 0.63 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.756 -1.337 . . . . 1.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 168.7 -28.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 1.0 109.743 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.497 ' HG3' ' CG ' ' A' ' 129' ' ' PRO . 12.4 mmmt -89.58 117.93 68.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.493 -0.754 . . . . 1.0 109.772 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 51.1 Cg_endo -78.06 130.38 10.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.922 1.485 . . . . 1.0 111.927 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -109.27 126.63 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 178.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -109.04 123.27 64.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.447 -1.408 . . . . 1.0 111.865 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.6 HD23 ' CE ' ' A' ' 80' ' ' MET . 0.3 OUTLIER -111.99 74.69 0.88 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.176 -1.416 . . . . 1.0 107.176 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.557 ' O ' HG21 ' A' ' 124' ' ' ILE . 0.8 OUTLIER -57.9 178.65 0.08 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.311 -0.956 . . . . 1.0 110.492 -178.165 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.488 ' OG ' HG21 ' A' ' 118' ' ' VAL 0.251 2.4 t -108.23 151.19 26.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.549 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.47 ' CG2' HD11 ' A' ' 124' ' ' ILE . 0.7 OUTLIER -103.63 26.18 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 1.0 109.73 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.554 HG12 ' HD2' ' A' ' 96' ' ' PRO . 2.4 t -128.57 146.98 62.2 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.508 -0.745 . . . . 1.0 109.146 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.554 ' HD2' HG12 ' A' ' 95' ' ' VAL . 40.8 Cg_endo -65.64 124.52 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.538 1.283 . . . . 1.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 98' ' ' ASN . 6.6 tp -109.95 -39.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 1.0 110.655 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.499 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 6.3 p-10 -67.56 63.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 1.0 110.635 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.685 HG23 ' CG ' ' A' ' 101' ' ' HIS . 15.0 t -124.09 11.19 8.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -0.999 . . . . 1.0 110.345 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 57.45 33.08 22.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.948 -1.095 . . . . 1.0 110.447 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.685 ' CG ' HG23 ' A' ' 99' ' ' THR . 5.7 m-70 -121.65 179.36 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 1.0 109.8 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.644 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 17.0 m95 -98.18 100.96 12.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.029 -1.044 . . . . 1.0 110.175 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 104' ' ' HIS . 9.7 m -96.43 170.7 9.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.362 -0.836 . . . . 1.0 109.429 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.564 ' N ' HG22 ' A' ' 103' ' ' THR . 6.9 t60 -122.15 120.83 35.37 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.682 -1.229 . . . . 1.0 107.682 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.977 HD11 HD13 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -107.92 146.65 13.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 120.937 -1.102 . . . . 1.0 109.456 -178.598 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.658 ' O ' HD22 ' A' ' 116' ' ' LEU . 6.9 tptm -142.38 142.09 32.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.318 -0.953 . . . . 1.0 109.527 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -137.03 110.09 7.73 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 108' ' ' TYR . 4.5 p90 -111.14 110.36 20.85 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.567 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -99.62 141.05 32.93 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.031 -0.668 . . . . 1.0 111.194 -178.036 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 5.9 t -127.55 97.61 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.628 -0.67 . . . . 1.0 109.199 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.453 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 2.0 mt-30 58.26 -134.54 1.04 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 1.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -70.81 -11.41 60.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.984 -1.072 . . . . 1.0 110.863 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.586 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -104.4 123.24 47.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 1.0 110.505 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.526 ' CA ' ' HG2' ' A' ' 109' ' ' ARG . . . -114.41 163.66 12.15 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.296 -0.954 . . . . 1.0 110.961 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.573 ' O ' ' CE ' ' A' ' 80' ' ' MET . 47.5 t -147.64 162.89 38.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.522 -0.987 . . . . 1.0 110.722 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.949 HD13 ' N ' ' A' ' 117' ' ' GLN 0.254 1.0 OUTLIER -139.5 157.08 46.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.177 -0.952 . . . . 1.0 108.892 -178.816 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.949 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.39 113.92 4.02 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.684 -1.26 . . . . 1.0 111.97 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 16.8 t -70.22 100.35 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.86 37.08 92.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 117' ' ' GLN . 0.3 OUTLIER 61.38 38.58 16.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -1.146 . . . . 1.0 110.704 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 9.6 mt-10 -108.47 -161.18 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.325 -0.859 . . . . 1.0 110.944 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -39.22 98.32 0.16 Allowed Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 45.8 Cg_endo -77.43 142.96 21.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 124.068 1.562 . . . . 1.0 112.394 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.557 HG21 ' O ' ' A' ' 92' ' ' ARG . 1.1 mp -106.05 110.43 31.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.877 -1.527 . . . . 1.0 106.877 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.561 ' C ' HD11 ' A' ' 91' ' ' LEU . 7.2 p -105.81 177.52 4.83 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.375 1.083 . . . . 1.0 112.146 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.597 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 170.78 160.98 20.62 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.834 -2.507 . . . . 1.0 106.834 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -139.28 168.52 19.63 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.735 -1.45 . . . . 1.0 110.892 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.2 p -87.2 -179.73 1.47 Allowed Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.515 -0.874 . . . . 1.0 110.037 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.497 ' CG ' ' HG3' ' A' ' 87' ' ' LYS . 46.2 Cg_endo -77.49 48.25 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.837 1.441 . . . . 1.0 109.675 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.9 OUTLIER 46.46 -176.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.614 -0.679 . . . . 1.0 110.5 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.689 ' O ' ' HB2' ' A' ' 132' ' ' ALA . . . 79.05 88.63 0.46 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.804 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . 170.02 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -1.132 . . . . 1.0 110.166 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 59.11 90.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 1.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.0 OUTLIER 44.94 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 1.0 110.309 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.741 HD11 ' CE2' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -175.72 97.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 1.0 110.309 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 3.1 m-20 -52.17 -179.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 1.0 109.213 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 137' ' ' THR . 8.1 t -129.1 121.06 27.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.085 -1.01 . . . . 1.0 109.695 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.901 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 4.4 p-10 -60.93 -3.56 0.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 1.0 111.05 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 65.9 9.12 45.19 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.841 -1.704 . . . . 1.0 108.841 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.901 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -102.31 132.2 48.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -1.127 . . . . 1.0 108.394 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.989 ' CD1' HD21 ' A' ' 57' ' ' LEU . 9.5 tp -141.14 148.79 40.6 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.764 -1.174 . . . . 1.0 111.651 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 24.2 m95 -130.88 119.46 22.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 1.0 HD13 HD12 ' A' ' 57' ' ' LEU . 8.3 tp -125.13 118.83 26.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.934 -1.506 . . . . 1.0 113.539 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.81 8.8 7.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 119.99 -1.1 . . . . 1.0 110.672 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.582 ' O ' ' HE3' ' A' ' 146' ' ' MET . . . 148.33 -148.44 19.92 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.373 -1.87 . . . . 1.0 109.08 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.714 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -152.82 148.06 26.76 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.37 -0.932 . . . . 1.0 112.881 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.42 ' C ' ' HG2' ' A' ' 148' ' ' ARG . 12.1 tt0 -93.9 19.92 8.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.42 ' HG2' ' C ' ' A' ' 147' ' ' GLU . 2.0 ptm180 173.16 68.65 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.555 -1.646 . . . . 1.0 106.555 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.791 HD11 ' CD2' ' A' ' 159' ' ' TYR . 1.4 tp -73.46 36.03 0.08 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 1.0 112.706 -177.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.1 p -71.69 -13.67 61.8 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.795 -1.928 . . . . 1.0 105.795 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 1.154 HG21 ' CZ3' ' A' ' 58' ' ' TRP 0.257 7.1 p -76.28 -110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 114.889 -1.051 . . . . 1.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.693 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . 50.0 39.1 18.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.308 -1.495 . . . . 1.0 108.946 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.917 ' CE1' HD23 ' A' ' 155' ' ' LEU . 1.5 p80 13.39 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.786 0.661 . . . . 1.0 112.786 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 5.74 2.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.032 -1.042 . . . . 1.0 111.821 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.917 HD23 ' CE1' ' A' ' 153' ' ' HIS . 2.7 pp -60.63 178.81 0.24 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.197 -0.939 . . . . 1.0 110.979 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 46.4 Cg_endo -83.01 -159.49 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.461 1.243 . . . . 1.0 112.681 -178.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.0 OUTLIER -51.01 -13.08 0.13 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 113.042 0.756 . . . . 1.0 113.042 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.601 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . -37.69 -45.64 0.81 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.013 -1.055 . . . . 1.0 109.707 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.86 ' CE1' HD21 ' A' ' 155' ' ' LEU . 4.3 m-85 -84.57 -28.98 26.23 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.204 -0.935 . . . . 1.0 109.111 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.541 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -70.38 -8.53 51.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.246 -1.382 . . . . 1.0 108.402 178.261 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 161' ' ' THR . 1.3 m -128.47 98.47 5.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -50.1 -178.19 0.02 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.609 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 71.0 t80 -83.01 144.72 29.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.909 -1.347 . . . . 1.0 112.262 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.853 HG22 ' HB2' ' A' ' 50' ' ' GLU . 1.6 mt -127.57 88.67 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.609 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.94 -157.39 13.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.743 -1.743 . . . . 1.0 108.743 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 1.7 m -128.59 145.45 51.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.128 -1.219 . . . . 1.0 109.802 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.586 HD13 ' CZ ' ' A' ' 19' ' ' PHE . 3.4 mt -130.28 147.4 33.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.437 -0.789 . . . . 1.0 110.423 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -159.48 156.12 27.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 1.0 110.351 -179.249 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 17.8 m-20 51.38 81.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 1.0 110.411 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.749 HG12 ' HB2' ' A' ' 45' ' ' LEU 0.251 25.7 m -122.43 130.62 74.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.017 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.44 HG22 ' C ' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -145.04 141.4 22.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.102 -1.039 . . . . 1.0 111.649 -176.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 42' ' ' HIS . 1.3 p -127.0 119.34 52.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 1.5 m-20 62.14 30.53 17.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.23 32.09 2.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.756 -0.59 . . . . 1.0 110.451 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 71.9 mm-40 -104.73 120.13 40.63 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.354 -0.841 . . . . 1.0 110.064 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -78.55 110.97 14.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 1.0 109.556 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 179' ' ' LEU . 83.8 mt -78.81 96.21 5.57 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 1.0 111.31 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.586 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 46.8 m-70 -39.21 98.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.045 0.926 . . . . 1.0 110.247 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.777 ' O ' ' HB3' ' A' ' 183' ' ' ALA . 8.9 mt -49.09 -59.57 3.53 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.924 0.869 . . . . 1.0 112.963 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.781 ' HA ' HD23 ' A' ' 184' ' ' LEU . 86.7 t -75.52 -28.52 19.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 113.541 0.941 . . . . 1.0 113.541 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.586 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -58.64 -50.51 73.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 112.284 -178.365 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.3 OUTLIER -108.19 -28.51 9.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.946 -1.096 . . . . 1.0 111.535 -178.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 179' ' ' LEU . . . -63.05 -25.08 68.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.853 -1.539 . . . . 1.0 108.601 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.804 HD13 HG13 ' A' ' 189' ' ' ILE . 1.4 mm? -70.43 -2.19 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 1.0 110.303 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 11.3 t-20 -55.65 -29.62 59.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 1.0 109.469 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.48 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 2.7 t-20 -88.09 151.32 49.07 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.866 ' O ' HG22 ' A' ' 188' ' ' THR . 38.3 Cg_endo -64.77 149.47 89.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.45 1.237 . . . . 1.0 109.684 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 187' ' ' PRO . 5.2 t 49.34 148.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 122.272 1.034 . . . . 1.0 112.116 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.804 HG13 HD13 ' A' ' 184' ' ' LEU . 33.6 mm -144.71 113.06 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 1.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.25 176.48 6.3 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.053 -1.03 . . . . 1.0 109.349 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -115.96 -60.99 1.8 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.7 -1.2 . . . . 1.0 111.264 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.787 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.29 -2.005 0 O-C-N 121.422 -0.799 . . . . 1.0 110.195 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.646 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.3 pt-20 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 122.196 0.998 . . . . 1.0 110.157 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.02 137.15 33.75 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 120.333 -1.479 . . . . 1.0 111.231 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.617 HG21 ' HE1' ' A' ' 25' ' ' MET . 12.2 mm -117.43 131.25 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.184 -0.948 . . . . 1.0 109.273 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.57 ' HB2' ' SG ' ' A' ' 192' ' ' CYS . . . -90.09 131.85 35.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.46 -0.775 . . . . 1.0 110.792 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.962 ' CE1' HD12 ' A' ' 167' ' ' ILE . 62.3 m-85 -101.51 177.02 5.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.712 -1.243 . . . . 1.0 109.29 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' C ' HG13 ' A' ' 164' ' ' ILE . 11.1 p-10 -141.92 -11.6 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.678 -1.264 . . . . 1.0 112.842 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 162' ' ' GLY . . . 111.64 -11.69 27.84 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.95 -1.595 . . . . 1.0 109.144 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 3.6 ttp-105 -135.15 10.8 3.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -1.165 . . . . 1.0 111.504 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -112.81 121.17 43.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 1.0 110.627 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 1.9 p90 -104.02 122.25 44.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 1.0 110.256 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.617 ' HE1' HG21 ' A' ' 17' ' ' ILE . 3.2 mtp -119.45 98.41 6.12 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.937 -1.105 . . . . 1.0 108.307 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.6 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 0.8 OUTLIER -103.08 145.12 30.38 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.707 -0.797 . . . . 1.0 110.027 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.65 ' HA ' ' CB ' ' A' ' 182' ' ' ASP . 4.6 m-85 -126.1 116.52 21.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.011 -1.076 . . . . 1.0 110.477 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 139' ' ' GLY . 19.8 t60 -96.99 99.98 11.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.735 . . . . 1.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.6 131.32 34.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 1.0 110.03 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.16 95.37 8.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 1.0 110.194 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 1.0 110.406 -179.848 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 120.943 0.401 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.521 ' OG ' ' NE2' ' A' ' 42' ' ' HIS . 1.2 p -126.82 104.87 8.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.247 -0.908 . . . . 1.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 109' ' ' ARG . 19.5 p-10 -85.65 142.75 28.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.529 -0.732 . . . . 1.0 110.222 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.673 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 49.7 m-70 -131.15 111.59 12.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 9.2 m-85 -116.81 115.55 25.77 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.525 -0.734 . . . . 1.0 110.902 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.833 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -124.97 144.42 50.38 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.037 -1.039 . . . . 1.0 109.174 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.013 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.4 OUTLIER -179.56 159.18 0.87 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.154 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 103' ' ' THR . 74.8 m -128.75 145.72 51.1 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.063 HG23 HD11 ' A' ' 105' ' ' ILE . 1.4 pt -124.72 -170.46 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 118.449 -1.3 . . . . 1.0 111.532 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.615 ' HD2' ' CD2' ' A' ' 102' ' ' TRP . 0.4 OUTLIER -148.11 146.13 28.67 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.343 -1.355 . . . . 1.0 107.343 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 46.1 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.042 -1.063 . . . . 1.0 110.014 -178.459 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.101 ' HG3' HD13 ' A' ' 73' ' ' ILE . 8.3 tt0 -176.95 -22.75 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.376 -0.827 . . . . 1.0 110.55 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 50' ' ' GLU . . . 78.64 -3.62 2.23 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.931 -0.481 . . . . 1.0 110.088 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.767 HG23 ' C ' ' A' ' 51' ' ' ALA . 1.7 p 78.82 -19.97 0.41 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.312 0.577 . . . . 1.0 111.387 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.734 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.3 OUTLIER -143.91 124.26 13.86 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.324 -0.86 . . . . 1.0 109.881 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.618 ' O ' HD12 ' A' ' 73' ' ' ILE . . . 164.86 139.92 2.75 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.043 HD22 HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -89.45 145.62 25.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.754 -1.439 . . . . 1.0 109.365 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.734 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -116.3 -4.61 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -174.727 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.995 HD13 HD12 ' A' ' 71' ' ' LEU . 2.8 tt -168.56 152.12 5.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 119.206 -2.184 . . . . 1.0 113.105 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.58 ' CD1' ' SD ' ' A' ' 146' ' ' MET . 1.5 t-105 -164.64 113.72 1.12 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.8 -0.562 . . . . 1.0 110.157 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 p -120.99 141.69 50.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.934 -1.104 . . . . 1.0 109.647 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 -179.683 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.739 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.218 0 CA-C-O 121.304 0.573 . . . . 1.0 110.242 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.74 ' C ' HD12 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -108.66 111.05 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 178.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.897 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -138.44 -173.92 3.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 1.0 111.185 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 57' ' ' LEU . 82.5 mt -153.31 110.83 3.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.666 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -126.95 176.19 7.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.75 -1.219 . . . . 1.0 111.321 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.101 HD13 ' HG3' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -124.46 140.22 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -0.834 . . . . 1.0 111.621 -178.135 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.792 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.4 p -142.58 132.85 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.82 -0.55 . . . . 1.0 110.324 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.792 ' CG ' HG22 ' A' ' 74' ' ' VAL . 2.9 m-20 66.45 27.02 9.95 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.949 -1.094 . . . . 1.0 110.826 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 81.41 -5.36 68.49 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -109.18 149.47 29.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.305 -1.114 . . . . 1.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.734 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -98.22 -169.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 1.0 109.647 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.513 ' HB2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER 178.12 126.47 0.05 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.101 -1.0 . . . . 1.0 111.31 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.982 ' HE3' HD12 ' A' ' 91' ' ' LEU . 22.8 ttp -91.54 125.7 36.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 1.0 109.59 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.897 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 4.0 ptt? -112.56 128.87 56.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.947 -1.095 . . . . 1.0 110.491 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.616 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -118.58 121.21 39.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 1.0 110.211 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.739 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.2 t70 -126.99 46.54 2.49 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.607 0.718 . . . . 1.0 109.965 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.709 ' CB ' HD13 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -70.34 53.8 0.14 Allowed 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.005 179.631 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.417 ' C ' ' OG ' ' A' ' 86' ' ' SER . . . 161.77 -66.4 0.25 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.417 ' OG ' ' C ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -169.03 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.001 -1.294 . . . . 1.0 111.53 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -99.48 112.65 63.87 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.809 -1.182 . . . . 1.0 111.222 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -76.11 114.98 4.02 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.939 1.494 . . . . 1.0 109.708 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.632 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -93.1 105.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.248 -0.907 . . . . 1.0 110.458 -179.229 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -90.26 120.79 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 119.972 -1.705 . . . . 1.0 110.445 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.982 HD12 ' HE3' ' A' ' 80' ' ' MET . 33.6 mt -113.35 76.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.506 ' O ' HG21 ' A' ' 124' ' ' ILE . 21.6 mtp180 -57.87 179.15 0.07 Allowed 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.213 -0.995 . . . . 1.0 110.651 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.692 ' OG ' HG11 ' A' ' 118' ' ' VAL . 1.4 t -104.77 167.02 9.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.005 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.27 17.42 15.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.332 -0.855 . . . . 1.0 109.771 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.756 HG13 ' HD2' ' A' ' 96' ' ' PRO . 68.0 t -135.45 150.46 72.41 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.534 -0.729 . . . . 1.0 110.171 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.756 ' HD2' HG13 ' A' ' 95' ' ' VAL . 42.8 Cg_endo -68.85 139.08 42.51 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.796 1.419 . . . . 1.0 110.39 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.93 HG23 ' OE1' ' A' ' 50' ' ' GLU . 2.7 tt -129.17 -27.21 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 1.0 111.034 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.607 ' CB ' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p30 -80.93 44.6 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.125 -0.984 . . . . 1.0 110.288 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.723 ' O ' HG22 ' A' ' 99' ' ' THR . 94.3 m -117.64 24.67 10.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 1.0 110.359 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 99' ' ' THR . 62.1 t30 59.77 41.16 18.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 1.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -130.02 137.69 50.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.832 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CD2' ' HD2' ' A' ' 48' ' ' LYS . 3.9 m95 -61.93 91.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 1.0 110.315 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.61 HG22 ' N ' ' A' ' 104' ' ' HIS . 54.5 m -80.56 172.5 13.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.061 -1.024 . . . . 1.0 108.927 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.61 ' N ' HG22 ' A' ' 103' ' ' THR . 0.9 OUTLIER -129.99 106.59 8.75 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.111 -0.993 . . . . 1.0 108.672 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.063 HD11 HG23 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -97.64 136.57 28.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 O-C-N 121.094 -1.004 . . . . 1.0 109.2 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.805 ' O ' HD22 ' A' ' 116' ' ' LEU . 1.3 tppt? -137.22 155.87 48.99 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.98 -1.088 . . . . 1.0 110.169 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -153.59 123.24 6.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.096 -1.002 . . . . 1.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.624 ' O ' ' CD1' ' A' ' 108' ' ' TYR . 41.6 p90 -126.24 112.16 15.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.538 ' NH1' ' N ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -120.53 154.8 34.83 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.369 -0.832 . . . . 1.0 110.432 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 112' ' ' ARG . 2.4 t -128.65 95.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 1.0 110.721 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 22.8 mt-30 34.71 24.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 0.2 OUTLIER 173.2 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.486 -1.384 . . . . 1.0 110.437 179.084 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -97.72 117.91 33.07 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.566 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.84 157.36 16.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.819 ' OG ' HG22 ' A' ' 125' ' ' THR . 38.7 t -135.69 157.59 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.452 -1.028 . . . . 1.0 109.949 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.068 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.3 tm? -137.19 153.1 50.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 1.068 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -158.59 128.12 5.72 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.538 -1.265 . . . . 1.0 111.617 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.692 HG11 ' OG ' ' A' ' 93' ' ' SER . 20.4 m -92.05 100.2 10.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 68.62 42.49 80.28 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.366 -1.093 . . . . 1.0 110.366 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 10.6 m-80 58.06 31.69 21.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.244 -1.151 . . . . 1.0 111.073 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 122' ' ' ALA . 1.3 tt0 -100.09 167.01 10.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 1.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.598 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -19.73 102.96 0.06 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 CA-C-O 120.989 0.423 . . . . 1.0 110.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 40.0 Cg_endo -69.24 131.38 21.85 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.258 1.662 . . . . 1.0 112.478 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 124' ' ' ILE . 4.5 mp -92.42 104.89 16.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 105.84 -1.911 . . . . 1.0 105.84 177.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.819 HG22 ' OG ' ' A' ' 115' ' ' SER . 32.7 p -118.55 160.98 20.8 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.902 -1.119 . . . . 1.0 112.401 -176.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.63 173.16 38.84 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 107.108 -2.397 . . . . 1.0 107.108 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -154.7 160.62 41.49 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.645 -1.503 . . . . 1.0 110.396 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.45 ' O ' ' CG ' ' A' ' 112' ' ' ARG . 50.1 m -105.71 160.86 24.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 118.955 -1.098 . . . . 1.0 109.248 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 130' ' ' LEU . 38.1 Cg_endo -64.51 -21.34 66.05 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 N-CA-C 108.196 -1.501 . . . . 1.0 108.196 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.564 ' CB ' ' O ' ' A' ' 129' ' ' PRO . 1.0 OUTLIER 155.92 -161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.36 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 148.09 -44.77 0.76 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -155.66 114.24 3.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -1.124 . . . . 1.0 110.381 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -63.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 1.0 110.222 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -100.55 76.76 1.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.0 110.508 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.709 HD13 ' CB ' ' A' ' 84' ' ' LEU . 1.1 tp -71.46 112.28 7.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.862 . . . . 1.0 109.789 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.22 127.13 31.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.895 . . . . 1.0 109.937 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -148.94 105.66 3.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 1.0 110.12 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.6 OUTLIER 163.3 -38.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.65 0.738 . . . . 1.0 109.07 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.506 ' O ' ' ND1' ' A' ' 28' ' ' HIS . . . -44.57 -32.88 3.03 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.175 -1.17 . . . . 1.0 110.175 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . . . -161.02 153.33 20.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.769 -1.43 . . . . 1.0 109.897 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.922 HD11 HD21 ' A' ' 57' ' ' LEU . 30.0 tp -155.73 152.8 28.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 110.519 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.753 ' CD2' ' HE1' ' A' ' 146' ' ' MET . 31.4 m95 -118.31 161.87 19.22 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.881 ' CD2' HD12 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -152.83 111.29 3.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.2 -1.8 . . . . 1.0 113.42 -177.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.555 ' O ' ' CA ' ' A' ' 162' ' ' GLY . . . 125.96 -11.18 7.38 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.553 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 158.2 -140.43 6.98 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 119.005 -1.569 . . . . 1.0 109.707 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.753 ' HE1' ' CD2' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -168.11 152.35 6.24 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.183 -1.007 . . . . 1.0 111.098 -179.362 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -96.58 -8.96 30.47 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.877 0.846 . . . . 1.0 109.513 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -141.64 53.03 1.51 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.043 HD21 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.82 57.17 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 1.0 111.854 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 148' ' ' ARG . 29.6 p -59.49 -22.53 61.72 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.79 -1.93 . . . . 1.0 105.79 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.811 HG13 ' N ' ' A' ' 152' ' ' ALA 0.289 9.8 p -76.92 -130.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.49 -1.232 . . . . 1.0 108.831 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.811 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 55.86 50.72 13.47 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.804 -1.185 . . . . 1.0 108.578 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -52.58 -111.81 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.293 1.961 . . . . 1.0 116.293 -175.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 18.25 0.24 Allowed 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 113.944 1.09 . . . . 1.0 113.944 -175.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 1.102 HD22 ' CD2' ' A' ' 159' ' ' TYR . 5.1 tt -95.71 141.08 22.68 Favored Pre-proline 0 C--N 1.288 -2.089 0 O-C-N 120.858 -1.152 . . . . 1.0 110.499 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.895 ' O ' HD23 ' A' ' 155' ' ' LEU . 37.6 Cg_endo -62.05 -149.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.045 1.55 . . . . 1.0 111.327 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.1 OUTLIER -60.41 -10.42 4.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.837 -1.165 . . . . 1.0 112.869 -177.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 1.098 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -41.71 -35.35 0.76 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.814 -1.179 . . . . 1.0 109.428 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 1.102 ' CD2' HD22 ' A' ' 155' ' ' LEU . 32.4 m-85 -86.79 -31.99 20.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.744 -1.223 . . . . 1.0 108.928 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.531 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -72.68 -5.88 40.62 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.436 -1.305 . . . . 1.0 108.0 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.705 HG22 ' CD1' ' A' ' 164' ' ' ILE . 33.4 m -122.23 90.26 3.27 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 163' ' ' PHE . . . -57.06 106.87 0.8 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.057 -1.068 . . . . 1.0 110.562 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.929 ' HD1' HD11 ' A' ' 73' ' ' ILE . 89.5 t80 12.95 137.8 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 115.761 1.763 . . . . 1.0 115.761 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.705 ' CD1' HG22 ' A' ' 161' ' ' THR . 2.2 mt -131.08 86.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.084 -0.962 . . . . 1.0 108.827 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 48' ' ' LYS . . . -171.18 -161.17 21.38 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 107.2 -2.36 . . . . 1.0 107.2 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.3 m -129.27 142.57 50.8 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.87 -1.371 . . . . 1.0 110.023 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.962 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -128.24 157.89 40.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.402 -1.436 . . . . 1.0 112.285 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.576 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -165.36 168.31 16.92 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.061 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.4 m-20 43.78 72.89 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.214 -0.929 . . . . 1.0 110.658 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 1.013 HG12 ' CB ' ' A' ' 45' ' ' LEU . 26.8 m -127.67 123.25 60.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.89 -1.124 . . . . 1.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.521 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -136.0 152.17 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.53 -177.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -133.8 103.35 5.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.7 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 6.7 m-20 57.55 35.46 25.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.975 -1.121 . . . . 1.0 107.975 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 75.0 6.34 4.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.828 -0.545 . . . . 1.0 111.088 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.847 ' HB2' HG23 ' A' ' 172' ' ' VAL . 77.8 mm-40 -91.18 176.39 6.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.143 -0.973 . . . . 1.0 110.105 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.563 ' CB ' ' O ' ' A' ' 175' ' ' GLN . 30.0 tt0 83.68 -109.66 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 175' ' ' GLN . 0.4 OUTLIER 29.97 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.304 -0.873 . . . . 1.0 112.499 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 181' ' ' GLU . 9.5 m-70 -160.89 44.5 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.994 -1.066 . . . . 1.0 110.597 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.985 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 0.0 OUTLIER -52.17 -27.89 16.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 9.2 t -71.3 -35.23 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.12 0.486 . . . . 1.0 111.198 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 51.0 mt-10 -62.16 -56.07 22.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.049 -1.032 . . . . 1.0 109.54 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.65 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -81.89 -19.7 40.36 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.086 179.008 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 1.023 ' HB1' HD11 ' A' ' 189' ' ' ILE . . . -48.14 -41.76 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.818 -1.153 . . . . 1.0 107.94 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ALA . 3.4 mt -41.78 -26.3 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.369 0.604 . . . . 1.0 109.598 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 6.3 t-20 -62.8 -11.61 19.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.353 -0.842 . . . . 1.0 109.808 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.478 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 2.8 t-20 -123.85 154.21 67.35 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.539 -0.725 . . . . 1.0 109.182 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.478 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 37.3 Cg_endo -61.27 -162.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.671 1.353 . . . . 1.0 111.215 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 187' ' ' PRO . 4.8 m -40.74 134.56 1.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.21 -0.931 . . . . 1.0 111.263 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 1.023 HD11 ' HB1' ' A' ' 183' ' ' ALA . 3.1 mt -102.91 144.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.443 -0.785 . . . . 1.0 109.452 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.37 153.41 19.35 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.098 -1.001 . . . . 1.0 109.889 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.606 ' ND1' HD13 ' A' ' 17' ' ' ILE . 1.6 m-70 -112.68 152.25 29.23 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.289 -0.882 . . . . 1.0 109.618 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.674 0 C-N-CA 119.424 -0.91 . . . . 1.0 109.974 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.9 pt-20 . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 121.937 0.875 . . . . 1.0 110.154 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -117.22 151.28 37.23 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.063 -1.023 . . . . 1.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 7.0 mm -119.52 133.27 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.037 . . . . 1.0 110.328 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -91.49 124.15 35.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.651 . . . . 1.0 110.431 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.751 ' CD2' HG21 ' A' ' 23' ' ' THR . 4.0 m-30 -91.1 132.69 35.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.0 109.209 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 2.3 p30 -97.74 2.16 49.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 1.0 110.545 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 103.51 -22.8 34.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.506 -1.838 . . . . 1.0 108.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.449 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 5.3 ttt-85 -107.25 -8.1 16.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.634 -0.921 . . . . 1.0 109.672 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.751 HG21 ' CD2' ' A' ' 19' ' ' PHE . 14.9 t -48.08 174.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 1.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.64 ' CE1' ' HB2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER 179.86 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 1.0 109.104 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 142' ' ' TRP . 25.0 mtt -96.26 101.33 12.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.943 -1.098 . . . . 1.0 111.007 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.64 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 18.7 tt0 -93.39 121.97 35.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.347 -0.846 . . . . 1.0 109.481 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CE2' ' CB ' ' A' ' 182' ' ' ASP . 6.2 m-85 -113.62 105.63 13.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.184 -0.947 . . . . 1.0 109.993 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.16 86.63 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 1.0 110.449 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -121.88 176.82 5.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.227 -0.92 . . . . 1.0 110.132 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.02 99.94 12.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.196 -0.94 . . . . 1.0 110.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.9 t . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.235 -0.915 . . . . 1.0 109.977 179.787 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.639 0.733 . . . . 1.0 109.345 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -161.61 131.26 4.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 5.0 m-80 -98.64 163.05 12.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.966 -1.084 . . . . 1.0 110.472 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -134.99 137.48 43.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 1.0 110.112 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.801 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 91.0 m-85 -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 1.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.81 ' C ' HD23 ' A' ' 45' ' ' LEU . 3.0 mt-10 -126.75 145.24 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.981 -1.074 . . . . 1.0 109.867 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.005 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.5 OUTLIER 179.08 156.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.401 -0.92 . . . . 1.0 111.412 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 103' ' ' THR . 4.8 m -122.13 154.99 36.66 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.612 -1.255 . . . . 1.0 107.612 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.571 HD13 HD11 ' A' ' 105' ' ' ILE . 3.3 pt -148.82 163.46 4.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 117.829 -1.548 . . . . 1.0 112.652 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.636 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.8 OUTLIER -114.3 83.31 1.86 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 177.241 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.569 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -70.67 150.7 45.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.084 -1.01 . . . . 1.0 112.434 -176.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.651 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 6.7 mm-40 -135.68 -3.12 2.35 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.35 0.595 . . . . 1.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.51 125.96 11.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.257 -0.902 . . . . 1.0 109.84 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.797 ' O ' HG22 ' A' ' 73' ' ' ILE . 47.5 p -55.51 -15.02 2.35 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.553 -0.717 . . . . 1.0 111.327 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -123.4 133.63 54.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.902 -1.124 . . . . 1.0 111.655 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 157.9 134.74 1.78 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.159 -1.177 . . . . 1.0 110.159 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.74 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -83.08 143.35 30.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.769 -1.43 . . . . 1.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.781 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -111.81 -47.03 5.94 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 C-N-CA 119.741 -0.784 . . . . 1.0 111.762 -177.19 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.98 HD13 HD12 ' A' ' 71' ' ' LEU . 5.7 tt -134.58 145.14 48.4 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.278 -1.514 . . . . 1.0 113.031 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.681 ' CH2' HG21 ' A' ' 151' ' ' VAL . 2.3 t-105 -149.68 117.12 6.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.804 . . . . 1.0 109.041 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -127.22 -176.08 3.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 1.0 110.694 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.732 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.671 ' CD1' ' CZ3' ' A' ' 58' ' ' TRP . 2.5 p90 . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.559 0.695 . . . . 1.0 109.572 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.704 HD12 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -147.56 136.16 15.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 121.68 -0.637 . . . . 1.0 110.059 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.034 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -132.87 -174.33 3.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 1.0 110.455 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.98 HD12 HD13 ' A' ' 57' ' ' LEU . 66.0 mt -149.0 101.14 3.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.849 . . . . 1.0 108.722 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.785 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . . . -119.38 174.41 6.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.957 -1.089 . . . . 1.0 112.211 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 52' ' ' THR . 56.3 mt -113.86 131.17 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.668 -0.645 . . . . 1.0 110.597 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.568 HG22 ' OD2' ' A' ' 75' ' ' ASP . 2.5 p -139.96 131.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.415 -0.803 . . . . 1.0 110.077 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.568 ' OD2' HG22 ' A' ' 74' ' ' VAL . 28.0 m-20 61.24 10.12 2.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 1.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.658 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 95.19 9.36 58.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 78' ' ' VAL . 61.5 m-85 -133.32 108.46 8.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -1.095 . . . . 1.0 110.048 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.781 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -48.6 -175.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.77 0.795 . . . . 1.0 111.412 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.675 ' HB2' HG22 ' A' ' 90' ' ' VAL . 2.7 pt20 -172.9 124.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.672 0.749 . . . . 1.0 110.893 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.983 ' CE ' HD12 ' A' ' 91' ' ' LEU . 2.2 ttm -85.03 110.54 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.791 -0.568 . . . . 1.0 110.481 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . 1.034 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 37.1 mtm -89.45 116.71 27.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.906 -1.121 . . . . 1.0 109.885 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.704 ' CZ ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -111.92 116.38 30.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.693 -1.255 . . . . 1.0 109.163 178.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -124.98 48.09 2.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 1.0 110.469 -179.156 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -65.06 61.66 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.975 -0.69 . . . . 1.0 110.138 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 132.4 33.09 0.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.956 -1.258 . . . . 1.0 109.956 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.01 9.69 5.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.237 -1.155 . . . . 1.0 110.107 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -108.0 89.32 5.4 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 1.0 109.333 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.533 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -72.11 140.81 35.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.157 1.609 . . . . 1.0 111.599 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.625 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -137.12 119.14 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -97.46 114.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.354 -1.466 . . . . 1.0 111.403 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.983 HD12 ' CE ' ' A' ' 80' ' ' MET . 38.3 mt -104.38 71.97 1.03 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.137 -1.431 . . . . 1.0 107.137 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 51.1 mtp180 -57.33 178.58 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.052 0.93 . . . . 1.0 111.046 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.758 ' OG ' HG21 ' A' ' 118' ' ' VAL . 3.3 t -108.35 155.21 20.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.175 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.626 ' OG1' HD11 ' A' ' 124' ' ' ILE . 1.4 p -112.11 26.38 10.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 1.0 109.673 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.752 ' CG1' HG11 ' A' ' 118' ' ' VAL . 8.0 t -129.07 146.62 61.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.519 -0.738 . . . . 1.0 109.454 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.575 ' HD2' HG13 ' A' ' 95' ' ' VAL . 43.6 Cg_endo -67.85 116.17 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.754 1.397 . . . . 1.0 109.767 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.8 tp -106.78 -33.36 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.14 -0.975 . . . . 1.0 111.055 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -71.64 61.22 0.36 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 1.0 110.738 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -127.21 14.28 7.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 1.0 110.167 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.481 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 1.9 m120 58.63 40.88 23.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.995 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . 0.554 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 1.1 m-70 -132.11 159.14 39.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 1.0 110.172 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.636 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 22.2 m95 -78.87 101.37 7.65 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.292 -0.963 . . . . 1.0 109.729 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.588 HG22 ' N ' ' A' ' 104' ' ' HIS . 5.9 m -101.93 171.66 7.39 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.441 -0.904 . . . . 1.0 109.009 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.588 ' N ' HG22 ' A' ' 103' ' ' THR . 8.4 t60 -119.97 143.9 47.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.07 -1.019 . . . . 1.0 108.791 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.571 HD11 HD13 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -133.67 159.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.22 -0.925 . . . . 1.0 109.172 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.808 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -152.45 148.47 27.47 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.659 -1.217 . . . . 1.0 110.307 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.801 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -144.23 102.21 3.82 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.526 -0.733 . . . . 1.0 110.374 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 108' ' ' TYR . 37.1 p90 -117.07 105.48 12.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 108.689 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.668 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -91.44 150.87 21.05 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.655 -0.818 . . . . 1.0 111.225 -178.486 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.7 t -136.93 96.51 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.679 -0.638 . . . . 1.0 110.799 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.582 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 61.0 mt-30 43.74 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.662 -0.649 . . . . 1.0 111.779 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER 54.2 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.616 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.8 tm-20 -95.97 109.75 22.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.108 -1.62 . . . . 1.0 109.919 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -99.05 161.43 20.07 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.067 -1.063 . . . . 1.0 110.892 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 125' ' ' THR . 33.7 t -132.7 156.67 46.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -1.17 . . . . 1.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.068 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.1 tm? -140.09 151.51 45.41 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 1.068 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.52 144.59 25.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.888 -1.133 . . . . 1.0 111.514 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.758 HG21 ' OG ' ' A' ' 93' ' ' SER . 41.1 t -102.86 98.92 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 177.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.21 39.52 82.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.715 -1.354 . . . . 1.0 109.715 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 119' ' ' GLY . 21.8 t-20 57.36 32.13 21.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -1.104 . . . . 1.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 5.3 mt-10 -114.8 -158.11 0.66 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.569 -0.707 . . . . 1.0 110.593 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -30.43 93.77 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.936 -0.477 . . . . 1.0 110.576 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.9 Cg_endo -77.12 142.65 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.039 1.547 . . . . 1.0 112.012 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 124' ' ' ILE . 3.3 mp -108.53 100.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.613 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.9 p -108.19 166.96 10.35 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.192 0.996 . . . . 1.0 111.962 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.7 167.76 38.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.222 -2.351 . . . . 1.0 107.222 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -136.88 170.0 16.82 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.555 -1.556 . . . . 1.0 110.929 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 31.7 p -96.92 163.57 19.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.921 -1.112 . . . . 1.0 110.431 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 130' ' ' LEU . 45.6 Cg_endo -71.65 55.62 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.954 1.502 . . . . 1.0 108.735 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.492 ' O ' ' HD2' ' A' ' 87' ' ' LYS . 4.7 mp 41.05 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.637 -0.665 . . . . 1.0 110.056 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.29 10.57 47.87 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.523 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -133.58 145.54 50.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.113 -1.228 . . . . 1.0 109.867 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 133' ' ' THR . 34.5 m -137.52 13.94 2.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.089 -1.007 . . . . 1.0 110.676 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' THR . 1.7 mt-30 179.94 160.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 1.0 110.54 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.745 HD13 ' HB3' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -166.08 61.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.485 -0.759 . . . . 1.0 109.893 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 4.2 m-20 -77.4 122.19 24.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.056 . . . . 1.0 109.439 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.77 164.23 18.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.08 . . . . 1.0 110.877 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.819 ' OD2' ' HB2' ' A' ' 140' ' ' ALA . 20.4 p-10 -89.82 29.35 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 1.0 110.204 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 52.29 18.09 4.64 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 1.0 109.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.819 ' HB2' ' OD2' ' A' ' 138' ' ' ASP . . . -64.34 158.76 22.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -1.21 . . . . 1.0 109.072 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.745 HD12 ' N ' ' A' ' 142' ' ' TRP . 6.8 tp -158.47 144.06 16.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.446 -1.302 . . . . 1.0 112.481 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.745 ' N ' HD12 ' A' ' 141' ' ' LEU . 19.2 m95 -131.88 97.27 4.13 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.952 HD12 HD12 ' A' ' 57' ' ' LEU . 2.8 tt -112.82 119.73 39.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.627 -1.295 . . . . 1.0 113.544 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 128.67 3.74 5.45 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.517 ' O ' ' SD ' ' A' ' 146' ' ' MET . . . 145.91 -147.72 18.93 Favored Glycine 0 C--N 1.283 -2.378 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' MET . . . . . 0.732 ' CB ' HD22 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -151.64 113.13 4.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.082 -1.047 . . . . 1.0 111.772 -178.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.64 -24.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.997 0.903 . . . . 1.0 109.025 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.555 ' HD2' ' N ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -145.68 83.47 1.65 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 178.316 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.732 HD22 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -71.58 22.84 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.275 -0.891 . . . . 1.0 112.757 -176.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.3 p -61.67 -19.68 62.6 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.768 HG13 ' N ' ' A' ' 152' ' ' ALA 0.288 10.5 p -71.51 -123.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.67 -1.15 . . . . 1.0 110.301 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.768 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 72.1 -71.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.702 -1.249 . . . . 1.0 108.796 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.559 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 52.94 155.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.919 1.342 . . . . 1.0 112.545 178.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER 44.16 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.006 1.484 . . . . 1.0 115.006 178.11 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 1.087 HD13 ' O ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -135.86 154.0 77.52 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.057 -1.652 . . . . 1.0 111.054 -179.387 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.654 ' N ' HD22 ' A' ' 155' ' ' LEU . 41.0 Cg_endo -65.62 -161.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.594 1.529 . . . . 1.0 113.629 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.0 OUTLIER -55.93 -8.88 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.561 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.988 ' HB3' HD21 ' A' ' 155' ' ' LEU . . . -39.85 -38.35 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.915 -1.116 . . . . 1.0 109.44 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.785 ' CZ ' ' HB2' ' A' ' 72' ' ' ALA . 10.2 m-85 -85.85 -31.6 22.16 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.855 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -65.04 -11.04 34.82 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.952 -1.499 . . . . 1.0 108.243 177.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -122.27 98.94 6.16 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -49.82 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.63 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 32.8 t80 -88.79 145.5 25.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.119 -1.224 . . . . 1.0 111.575 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 164' ' ' ILE . 2.5 mt -123.42 85.39 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.139 -1.43 . . . . 1.0 107.139 177.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.63 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.67 -156.13 11.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.316 -1.914 . . . . 1.0 108.316 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.0 m -133.41 154.06 51.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.112 -1.228 . . . . 1.0 110.311 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.9 mt -134.76 144.96 33.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.774 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.519 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 26.9 ttt180 -150.72 164.6 35.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.892 -1.13 . . . . 1.0 110.659 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.6 m-20 43.57 74.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.202 -0.936 . . . . 1.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 1.005 HG12 ' CB ' ' A' ' 45' ' ' LEU . 22.7 m -126.74 124.17 64.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 119.311 -0.955 . . . . 1.0 109.891 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.527 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -131.95 158.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.929 -1.108 . . . . 1.0 111.331 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 76.5 t -134.15 114.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 63.3 m-20 50.01 36.58 12.14 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.878 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.7 OUTLIER 67.61 34.25 4.64 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.377 0.608 . . . . 1.0 110.411 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 19.2 mm100 -114.45 -176.53 2.92 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 121.323 -0.861 . . . . 1.0 110.616 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 0.3 OUTLIER 67.91 -98.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 1.0 110.66 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 12.1 mt 60.37 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.894 -1.128 . . . . 1.0 111.477 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.536 ' HB3' ' HG3' ' A' ' 181' ' ' GLU . 2.6 m-70 -70.09 79.74 0.5 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.716 -1.24 . . . . 1.0 110.546 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.627 HD11 HG22 ' A' ' 170' ' ' VAL 0.263 0.5 OUTLIER -52.7 -61.23 2.42 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.201 1.001 . . . . 1.0 110.752 178.931 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.882 ' HA ' HD23 ' A' ' 184' ' ' LEU . 12.9 t -52.91 -18.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.632 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 178' ' ' HIS . 0.7 OUTLIER -73.63 -56.51 4.91 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.732 -1.187 . . . . 1.0 109.901 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.612 ' CB ' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -95.81 -18.38 20.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.099 -1.0 . . . . 1.0 109.8 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -73.74 -29.92 62.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.144 -0.972 . . . . 1.0 108.703 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.882 HD23 ' HA ' ' A' ' 180' ' ' VAL . 1.5 mm? -65.06 -8.8 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.424 -0.798 . . . . 1.0 109.987 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 184' ' ' LEU . 8.5 t-20 -43.85 -26.43 0.26 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.391 -0.818 . . . . 1.0 109.095 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 189' ' ' ILE . 2.2 t-20 -113.9 148.89 40.89 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 47.8 Cg_endo -76.97 -34.74 2.11 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.824 1.434 . . . . 1.0 110.68 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 4.51 0.42 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.697 -0.683 . . . . 1.0 112.76 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 186' ' ' ASN . 23.4 mm -61.95 117.35 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.323 -1.485 . . . . 1.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -120.59 159.64 24.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 110.829 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 18.9 m-70 -93.54 151.55 19.62 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.344 -0.847 . . . . 1.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' CYS . . . . . 0.741 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 9.2 t . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 1.0 111.913 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.501 -1.439 . . . . 1.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 t -125.97 127.9 46.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 1.0 110.004 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -98.29 21.48 10.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 1.0 110.295 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 3' ' ' GLU . 1.1 mttt 66.91 -172.85 0.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 1.0 110.309 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 5' ' ' VAL . 8.5 p -132.6 102.88 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 1.0 110.101 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -87.03 155.26 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 1.0 110.474 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mt -125.92 82.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 1.0 110.17 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.77 87.74 2.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.082 -1.011 . . . . 1.0 110.229 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.48 109.58 10.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 1.0 110.403 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.62 86.84 2.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.055 -1.028 . . . . 1.0 109.842 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.09 26.32 2.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.88 . . . . 1.0 109.391 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.74 165.45 22.15 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -143.79 68.58 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -1.186 . . . . 1.0 110.382 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -128.54 63.38 1.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 1.0 110.049 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.571 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.6 pt-20 -60.6 71.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.481 -0.762 . . . . 1.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -95.35 136.95 35.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.662 -1.274 . . . . 1.0 110.766 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 190' ' ' LEU . 8.9 mm -127.43 118.16 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.278 -0.888 . . . . 1.0 109.702 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -80.76 142.46 33.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 1.0 111.216 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.718 ' CE1' HD12 ' A' ' 167' ' ' ILE . 9.1 m-85 -106.6 172.07 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 1.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.491 ' C ' HG12 ' A' ' 164' ' ' ILE . 3.8 p30 -127.32 -3.62 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 1.0 110.637 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.482 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 110.17 -9.8 31.34 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.85 -1.7 . . . . 1.0 108.85 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -127.72 -24.95 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -1.186 . . . . 1.0 110.773 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 133.76 37.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 1.0 110.369 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.618 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -128.17 114.55 17.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 1.0 110.365 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.527 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 6.0 mmt -83.23 99.07 9.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.85 -1.156 . . . . 1.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HG3' ' CH2' ' A' ' 142' ' ' TRP . 46.8 tt0 -87.77 87.98 7.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 1.0 109.456 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 182' ' ' ASP . 8.0 m-30 -92.18 97.03 10.65 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 1.0 110.236 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.15 104.39 16.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 1.0 110.007 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 138' ' ' ASP . 1.4 t-20 -147.36 162.97 37.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 1.0 110.338 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.69 50.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 1.0 110.376 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 32' ' ' THR . 4.6 m -58.84 -47.93 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.271 -0.893 . . . . 1.0 110.907 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -163.21 110.54 1.2 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.936 -1.102 . . . . 1.0 110.463 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 34' ' ' SER . 47.2 mttp -62.91 97.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.273 -0.892 . . . . 1.0 110.004 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER 175.25 -51.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.153 -0.967 . . . . 1.0 110.765 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 28.9 mt-10 -101.7 -67.3 0.87 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 1.0 110.533 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.633 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 1.0 OUTLIER 63.01 77.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 1.0 110.01 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . 172.58 44.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 1.0 109.377 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.793 ' C ' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -47.75 173.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.775 0.798 . . . . 1.0 111.694 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.647 ' N ' HD22 ' A' ' 38' ' ' LEU . 2.5 tm0? -119.91 -20.61 7.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 1.0 109.809 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.455 ' OG ' HG13 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -160.72 146.22 14.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.732 -0.605 . . . . 1.0 109.467 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.678 HD22 ' HE ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -133.23 155.28 49.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.049 -1.032 . . . . 1.0 111.597 -178.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 8.8 m-70 -114.67 143.97 44.18 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 58.4 m-85 -129.02 121.76 28.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.097 -1.002 . . . . 1.0 110.644 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.746 ' C ' HD23 ' A' ' 45' ' ' LEU . 2.8 mt-10 -127.92 147.24 50.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.014 -1.054 . . . . 1.0 109.928 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.001 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.3 pt? 179.89 150.22 0.36 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.759 . . . . 1.0 110.548 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.479 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 1.9 m -120.17 154.07 35.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.479 ' CG2' ' C ' ' A' ' 46' ' ' SER . 1.5 pt -147.49 155.09 10.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.824 -1.55 . . . . 1.0 112.86 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -112.61 82.68 1.69 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 176.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.644 HG21 HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -70.19 163.63 25.98 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.867 -1.146 . . . . 1.0 111.289 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 0.8 OUTLIER -145.39 29.84 1.14 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.299 -0.96 . . . . 1.0 110.845 -178.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.984 ' O ' HG23 ' A' ' 52' ' ' THR . . . -162.24 -96.68 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.943 -1.103 . . . . 1.0 110.324 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.984 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 176.07 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.431 0.634 . . . . 1.0 109.824 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.519 ' HG3' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -119.23 138.77 52.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.43 -0.794 . . . . 1.0 110.61 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.81 135.77 1.89 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.255 -1.938 . . . . 1.0 108.255 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.937 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -84.87 131.68 34.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.743 -1.445 . . . . 1.0 109.552 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.977 HD12 ' HA ' ' A' ' 72' ' ' ALA . 4.6 mp -95.75 -40.28 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 1.0 112.714 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.984 HD13 HD12 ' A' ' 71' ' ' LEU . 7.1 tt -141.13 148.36 39.95 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.254 -1.529 . . . . 1.0 113.652 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.824 ' N ' HD23 ' A' ' 57' ' ' LEU . 7.3 t-105 -152.02 129.06 11.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.73 163.28 32.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.654 -1.279 . . . . 1.0 110.307 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -178.37 -112.94 0.35 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.119 -1.192 . . . . 1.0 110.119 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 61.05 90.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.425 -1.044 . . . . 1.0 110.525 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.911 ' C ' HD13 ' A' ' 63' ' ' LEU . . . 168.25 -24.8 0.12 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.917 ' N ' HD13 ' A' ' 63' ' ' LEU . 0.0 OUTLIER -143.39 -168.11 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -1.144 . . . . 1.0 110.372 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.24 -2.69 10.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 1.0 110.122 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.513 ' HA ' ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -168.66 27.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 1.0 109.626 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -133.56 -174.02 3.39 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.662 -0.815 . . . . 1.0 111.147 -178.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.51 ' HB3' HD11 ' A' ' 63' ' ' LEU . 5.8 t0 33.53 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.089 0.471 . . . . 1.0 111.416 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.683 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 8.5 m-30 -116.49 102.15 9.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.582 -0.699 . . . . 1.0 109.482 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 109' ' ' ARG . 19.0 mt -112.54 130.76 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.54 -1.35 . . . . 1.0 109.916 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.735 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -153.74 174.57 14.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 1.0 110.717 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.984 HD12 HD13 ' A' ' 57' ' ' LEU . 79.0 mt -146.22 110.4 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.977 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -129.98 164.38 24.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 1.0 112.466 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.942 ' CG1' HD11 ' A' ' 56' ' ' ILE . 9.3 mt -102.59 136.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.639 -0.663 . . . . 1.0 110.678 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 75' ' ' ASP . 4.0 p -140.63 131.44 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.157 -0.965 . . . . 1.0 110.806 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.567 ' CG ' HG22 ' A' ' 74' ' ' VAL . 7.4 m-20 63.8 8.79 4.0 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.352 -0.842 . . . . 1.0 111.032 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 104.56 13.73 25.4 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 35.8 m-85 -135.53 152.73 51.6 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.29 -1.124 . . . . 1.0 109.976 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.773 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.44 166.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 1.0 109.46 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 8.5 pt20 -164.12 126.39 2.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.094 -1.003 . . . . 1.0 110.936 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.813 ' CE ' HD12 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -86.53 103.24 14.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.735 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -104.78 119.39 38.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -0.751 . . . . 1.0 110.433 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.714 ' CE2' HG11 ' A' ' 89' ' ' VAL . 3.7 p90 -141.24 143.65 34.26 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.008 -1.477 . . . . 1.0 111.455 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 16.9 t0 -136.27 108.51 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.698 0.761 . . . . 1.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -110.39 30.4 6.81 Favored 'General case' 0 C--N 1.287 -2.122 0 O-C-N 121.723 -0.61 . . . . 1.0 109.852 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 86' ' ' SER . . . -164.21 -50.86 0.02 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 1.4 t 178.18 -18.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -1.11 . . . . 1.0 111.471 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 17.5 mmtt -119.51 117.86 32.63 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.724 -1.235 . . . . 1.0 110.662 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.07 143.92 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.877 1.462 . . . . 1.0 109.236 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.77 104.47 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 1.0 109.075 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 90' ' ' VAL . 8.7 p -91.1 82.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.483 -1.385 . . . . 1.0 111.261 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.813 HD12 ' CE ' ' A' ' 80' ' ' MET . 5.6 mt -75.02 74.51 2.21 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.572 ' O ' HG21 ' A' ' 124' ' ' ILE . 14.3 mtp180 -59.16 178.88 0.11 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.929 0.871 . . . . 1.0 111.213 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 118' ' ' VAL . 2.0 t -109.97 143.12 40.38 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.49 ' O ' HG22 ' A' ' 94' ' ' THR . 24.4 m -99.82 31.16 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.124 -0.985 . . . . 1.0 109.93 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.936 HG11 HG11 ' A' ' 118' ' ' VAL . 3.0 t -136.27 145.89 53.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 1.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.484 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.1 Cg_endo -65.2 134.48 39.44 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.612 1.322 . . . . 1.0 110.751 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 76' ' ' GLY . 2.6 tp -117.6 -24.5 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 1.0 110.581 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 8.4 p-10 -76.37 55.95 1.03 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.889 . . . . 1.0 109.177 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.618 ' O ' HG22 ' A' ' 99' ' ' THR . 24.2 m -110.89 14.62 22.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.485 -0.76 . . . . 1.0 110.588 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.1 t30 51.67 18.76 0.77 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.08 -1.013 . . . . 1.0 110.624 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -117.32 162.95 17.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.129 -0.982 . . . . 1.0 110.378 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.677 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 16.5 m95 -76.74 101.64 5.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.149 -0.969 . . . . 1.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 104' ' ' HIS . 49.4 m -94.99 165.33 12.49 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.576 -0.85 . . . . 1.0 109.498 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.49 ' N ' HG22 ' A' ' 103' ' ' THR . 1.0 OUTLIER -118.06 136.82 53.32 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -135.31 155.83 37.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.052 -1.03 . . . . 1.0 108.953 -178.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.811 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -152.53 174.5 13.84 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.12 -1.432 . . . . 1.0 110.498 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.672 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -161.23 123.97 3.15 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.328 -0.949 . . . . 1.0 111.214 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 24.6 m-85 -105.24 106.68 17.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.8 ' CZ ' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -105.98 117.7 34.7 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.319 -0.952 . . . . 1.0 111.67 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.917 HG12 ' OE1' ' A' ' 111' ' ' GLN . 1.8 t -118.6 134.52 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.917 ' OE1' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER 29.74 -90.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.675 -0.641 . . . . 1.0 112.047 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -115.14 -14.78 11.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 1.0 112.138 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.7 tt0 -98.97 118.38 35.61 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.83 -1.169 . . . . 1.0 110.914 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.01 171.53 18.99 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.32 -0.943 . . . . 1.0 111.034 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.576 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -147.45 160.89 42.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.586 -0.95 . . . . 1.0 110.206 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.933 HD13 ' N ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -148.87 141.99 24.94 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.268 -0.895 . . . . 1.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.933 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -143.78 130.51 20.27 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.076 -1.05 . . . . 1.0 111.233 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.936 HG11 HG11 ' A' ' 95' ' ' VAL . 2.2 t -89.65 97.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.627 -1.62 . . . . 1.0 106.627 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 71.48 40.51 59.69 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.94 31.99 17.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.059 . . . . 1.0 110.497 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.541 ' N ' ' HG2' ' A' ' 117' ' ' GLN . 2.9 mt-10 -105.08 -158.18 0.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 1.0 110.619 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.34 99.9 0.19 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.664 -0.648 . . . . 1.0 110.013 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.639 ' C ' HD12 ' A' ' 124' ' ' ILE . 48.5 Cg_endo -75.73 135.47 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.154 1.607 . . . . 1.0 111.363 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.639 HD12 ' C ' ' A' ' 123' ' ' PRO . 1.5 mp -103.49 119.52 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.697 ' HA ' HD13 ' A' ' 91' ' ' LEU . 28.5 p -118.35 172.21 7.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.822 -1.174 . . . . 1.0 112.658 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -179.68 153.98 12.99 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.694 -2.163 . . . . 1.0 107.694 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -138.26 161.93 35.62 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.006 -1.291 . . . . 1.0 110.986 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 130' ' ' LEU . 3.2 m -89.94 163.58 31.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.764 . . . . 1.0 109.684 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -68.83 62.36 1.28 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.006 1.53 . . . . 1.0 109.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.2 pp 16.55 50.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.376 0.608 . . . . 1.0 112.366 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -99.95 2.66 56.9 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.668 -1.373 . . . . 1.0 109.668 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 84' ' ' LEU . . . -161.85 84.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -1.109 . . . . 1.0 109.651 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 133' ' ' THR . 91.2 m -87.92 11.5 15.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 1.0 110.624 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.431 ' HG3' ' C ' ' A' ' 133' ' ' THR . 86.3 mt-30 -144.23 92.08 2.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 1.0 110.632 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.475 HD22 HH21 ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.71 160.21 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 1.0 109.598 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.488 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 29.1 m-20 -130.65 111.53 12.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.928 -1.107 . . . . 1.0 110.774 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 t -136.18 149.25 48.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -0.885 . . . . 1.0 109.847 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.713 ' OD1' ' HB2' ' A' ' 140' ' ' ALA . 5.5 p-10 -87.68 29.17 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 1.0 110.671 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 58.69 13.61 18.62 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.713 ' HB2' ' OD1' ' A' ' 138' ' ' ASP . . . -57.77 170.22 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 1.0 108.516 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -160.88 145.94 14.2 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.276 -1.37 . . . . 1.0 112.026 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.577 ' CH2' ' HG3' ' A' ' 26' ' ' GLU . 49.6 m95 -135.08 119.13 17.5 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.268 -1.752 . . . . 1.0 106.268 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.613 HD21 HG22 ' A' ' 56' ' ' ILE . 1.7 tt -130.93 123.46 28.94 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.334 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.87 2.17 10.42 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.454 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 141.58 -139.28 9.3 Favored Glycine 0 C--N 1.293 -1.828 0 C-N-CA 118.991 -1.576 . . . . 1.0 109.726 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.904 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -170.74 130.86 0.84 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.948 -1.101 . . . . 1.0 112.178 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -64.99 -42.65 94.34 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -113.14 67.95 0.67 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.975 -1.491 . . . . 1.0 106.975 177.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.904 HD13 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -66.32 37.78 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.194 -0.941 . . . . 1.0 113.403 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 148' ' ' ARG . 53.4 p -83.8 3.39 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 175.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.812 HG21 ' CZ2' ' A' ' 58' ' ' TRP . 14.9 p -86.59 -23.87 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.308 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 153' ' ' HIS . . . -41.82 -26.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 1.0 109.508 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.56 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER 83.38 -85.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.965 -0.459 . . . . 1.0 111.245 179.218 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -143.91 -7.17 0.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 1.0 111.776 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.746 HD22 ' CE1' ' A' ' 159' ' ' TYR . 4.2 pp -53.65 167.07 0.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.108 -0.995 . . . . 1.0 110.377 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.702 ' O ' HD12 ' A' ' 155' ' ' LEU . 42.7 Cg_endo -68.96 -165.67 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.734 1.386 . . . . 1.0 112.278 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 1.5 mttp -56.25 -9.97 0.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.189 -0.944 . . . . 1.0 112.171 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.519 ' HA ' ' HG3' ' A' ' 53' ' ' GLN . . . -38.2 -44.36 0.85 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 1.0 109.784 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.937 ' CE2' HD13 ' A' ' 55' ' ' LEU . 6.0 m-85 -87.87 -27.07 22.44 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.989 -1.084 . . . . 1.0 108.748 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.567 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -73.17 -6.59 46.78 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.435 -1.306 . . . . 1.0 107.981 177.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 161' ' ' THR . 4.4 m -122.2 83.91 2.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.67 171.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 167' ' ' ILE . 6.2 t80 -89.55 144.23 26.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -1.218 . . . . 1.0 111.391 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.567 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 5.9 mt -123.2 91.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.636 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -169.63 -154.07 8.97 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.48 -1.848 . . . . 1.0 108.48 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.562 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 2.9 m -124.09 144.56 49.8 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.204 -1.174 . . . . 1.0 110.516 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.718 HD12 ' CE1' ' A' ' 19' ' ' PHE 0.251 3.4 mt -134.1 145.59 32.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.534 -0.729 . . . . 1.0 109.425 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 6.5 ttp180 -162.0 157.25 23.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.69 -1.256 . . . . 1.0 111.023 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 4.2 m-20 57.37 63.49 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 1.001 HG12 ' CB ' ' A' ' 45' ' ' LEU . 27.1 m -119.58 117.82 55.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.937 0.875 . . . . 1.0 109.653 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 175' ' ' GLN . 0.5 OUTLIER -135.6 155.9 37.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.09 -1.044 . . . . 1.0 110.915 -178.072 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 3.6 p -134.74 112.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 94.6 m-20 59.04 37.49 24.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.24 32.59 14.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.764 -0.585 . . . . 1.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.603 ' O ' HG23 ' A' ' 171' ' ' ILE . 76.5 mm-40 -118.45 176.16 5.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.186 -0.946 . . . . 1.0 110.44 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.606 ' O ' HD23 ' A' ' 177' ' ' LEU . 59.5 mm-40 65.18 -121.35 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 1.0 110.756 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.622 ' HG ' ' CD2' ' A' ' 178' ' ' HIS . 0.1 OUTLIER 57.62 7.31 0.52 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.866 . . . . 1.0 112.205 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.622 ' CD2' ' HG ' ' A' ' 177' ' ' LEU . 8.3 m80 -110.14 56.53 0.62 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.545 -1.347 . . . . 1.0 108.538 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.72 ' O ' ' HB2' ' A' ' 183' ' ' ALA 0.261 12.3 mt -28.24 -61.45 0.11 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.966 0.889 . . . . 1.0 112.839 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.726 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.2 t -77.29 -20.28 14.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 113.367 0.877 . . . . 1.0 113.367 -176.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.581 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.1 mm-40 -63.46 -48.6 77.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.228 -1.545 . . . . 1.0 110.803 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.43 -12.12 20.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.155 -0.966 . . . . 1.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -70.09 -33.71 72.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.018 -1.052 . . . . 1.0 108.738 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.726 HD13 ' O ' ' A' ' 180' ' ' VAL . 1.2 mp -48.63 -23.66 1.09 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.795 . . . . 1.0 109.075 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -59.43 -16.52 24.02 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.875 0.845 . . . . 1.0 109.02 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.534 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 20.1 t30 -89.1 172.31 7.63 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 44.8 Cg_endo -87.73 -48.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.187 1.098 . . . . 1.0 111.357 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -118.31 145.87 44.76 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.427 -0.796 . . . . 1.0 111.115 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.34 130.29 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 1.0 110.208 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 17' ' ' ILE . 4.4 mt -115.62 169.13 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -110.6 -82.23 0.58 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.094 -1.004 . . . . 1.0 111.23 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -177.28 178.93 1.03 Allowed 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.033 -1.042 . . . . 1.0 111.044 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.773 ' O ' ' HB3' ' A' ' 194' ' ' ALA . 0.0 OUTLIER -128.81 170.35 13.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.503 -0.748 . . . . 1.0 110.455 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 193' ' ' SER . . . 75.23 37.46 0.46 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.418 0.628 . . . . 1.0 110.087 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.047 0 C-N-CA 118.84 -1.144 . . . . 1.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.609 -1.396 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 3' ' ' GLU . 22.9 t 50.79 79.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -1.189 . . . . 1.0 110.157 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 4' ' ' LYS . 0.4 OUTLIER 58.75 47.88 12.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.343 -0.848 . . . . 1.0 110.508 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 3' ' ' GLU . 3.5 mmmm 55.33 108.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.296 -0.877 . . . . 1.0 110.63 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 5' ' ' VAL . 28.2 m -68.54 122.76 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.98 . . . . 1.0 110.121 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 6' ' ' ILE . 2.6 pp -70.36 155.51 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 1.0 110.539 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.533 HG22 ' O ' ' A' ' 7' ' ' ILE . 5.6 mt -102.81 81.87 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 1.0 109.939 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.32 129.29 40.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.988 . . . . 1.0 110.389 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.84 101.4 3.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 1.0 110.352 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.97 118.41 19.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 1.0 110.102 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.3 50.56 1.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 1.0 110.168 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.18 60.87 0.31 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.598 -1.401 . . . . 1.0 109.598 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' NH2' ' A' ' 168' ' ' ARG . 10.4 p-10 -116.0 8.04 14.49 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.739 -0.86 . . . . 1.0 109.961 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -118.36 59.07 0.81 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 1.0 109.805 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.591 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.4 pt-20 -66.31 70.54 0.07 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.267 -0.896 . . . . 1.0 110.948 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' O ' ' CG ' ' A' ' 191' ' ' HIS . . . -85.17 140.98 30.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.402 -1.436 . . . . 1.0 109.302 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.868 HG21 ' CE ' ' A' ' 25' ' ' MET . 21.9 mm -111.52 122.71 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.694 -1.203 . . . . 1.0 110.788 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.32 122.05 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.369 -0.832 . . . . 1.0 110.093 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.812 ' CE1' HD12 ' A' ' 167' ' ' ILE . 4.6 m-85 -94.27 140.23 30.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 1.0 110.023 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -107.95 -7.66 16.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 1.0 110.214 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' GLY . . . 114.64 -11.83 21.06 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -124.06 -1.74 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.861 -1.376 . . . . 1.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.27 110.03 22.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.985 -1.072 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.511 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 5.4 p90 -100.17 156.09 17.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.177 -0.952 . . . . 1.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.868 ' CE ' HG21 ' A' ' 17' ' ' ILE . 3.4 mmt -122.16 100.32 6.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.154 -1.018 . . . . 1.0 110.341 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.618 ' HB3' ' CZ3' ' A' ' 142' ' ' TRP . 1.3 pp20? -78.36 106.08 10.04 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.618 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 44.2 m-85 -101.11 98.51 8.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.912 -1.118 . . . . 1.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -93.03 102.15 14.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 1.0 109.692 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -121.61 138.64 54.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 1.0 110.184 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -86.11 95.56 9.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 1.0 109.842 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.686 HG23 ' H ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -40.03 -79.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 1.0 110.534 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.686 ' H ' HG23 ' A' ' 31' ' ' VAL . 8.2 t -177.14 165.27 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.819 -1.175 . . . . 1.0 110.487 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' SER . 7.5 mmtm -73.56 96.57 2.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 1.0 110.078 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 9.9 t 174.97 -26.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.207 -0.933 . . . . 1.0 110.676 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 34' ' ' SER . 2.3 tt0 65.83 120.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.355 -0.841 . . . . 1.0 110.711 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 1.5 mtpt -119.5 145.73 46.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.888 . . . . 1.0 110.261 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . -179.16 49.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.904 . . . . 1.0 110.219 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.55 ' N ' HD23 ' A' ' 38' ' ' LEU . 2.2 pt? -151.32 -165.08 2.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 1.0 110.271 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' LEU . 31.8 tt0 39.77 -113.75 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.47 -0.769 . . . . 1.0 110.311 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -143.0 178.42 7.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.149 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.407 ' N ' ' OG ' ' A' ' 40' ' ' SER . 30.2 m120 -119.69 156.05 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 1.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 7.7 m80 -119.24 117.34 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 1.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.759 ' HD1' HG22 ' A' ' 172' ' ' VAL . 21.2 m-85 -112.28 120.25 41.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.694 . . . . 1.0 110.234 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.742 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -130.19 139.98 50.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.858 -1.151 . . . . 1.0 111.322 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.945 ' HB2' HG12 ' A' ' 170' ' ' VAL . 1.2 pt? -176.59 150.76 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 1.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -120.34 146.47 46.11 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.95 HG23 ' CD1' ' A' ' 105' ' ' ILE . 0.9 OUTLIER -127.69 -170.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.126 -1.43 . . . . 1.0 111.261 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.658 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.7 OUTLIER -153.16 136.77 15.99 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.014 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.622 HG23 ' HA ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER 52.68 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.51 -1.369 . . . . 1.0 109.238 -177.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.795 ' CG ' HD13 ' A' ' 73' ' ' ILE . 15.1 tt0 -173.87 22.63 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.305 -1.497 . . . . 1.0 110.283 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.703 ' HB2' ' CG2' ' A' ' 164' ' ' ILE . . . 45.93 -114.68 0.49 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.681 -1.208 . . . . 1.0 109.201 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.583 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 18.3 p -155.17 -40.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.002 -1.061 . . . . 1.0 109.583 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.66 131.33 53.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.415 -0.803 . . . . 1.0 109.647 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 168.07 138.3 2.43 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.439 -1.362 . . . . 1.0 109.885 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.947 HD22 HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -88.97 124.41 34.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.971 -1.311 . . . . 1.0 109.005 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.692 HD11 HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.3 -27.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.423 0.897 . . . . 1.0 113.423 -176.01 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.031 HD12 HD13 ' A' ' 143' ' ' LEU . 1.7 tt -143.32 151.69 40.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 119.85 -1.781 . . . . 1.0 113.089 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.458 ' O ' ' CD1' ' A' ' 58' ' ' TRP . 5.3 t-105 -160.22 106.93 1.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.403 0.621 . . . . 1.0 109.604 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.535 ' HG ' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -121.43 155.61 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 1.0 109.08 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.661 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -148.59 -29.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.333 0 C-N-CA 118.725 -1.702 . . . . 1.0 111.749 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.661 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 73.2 -45.39 0.62 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.346 1.073 . . . . 1.0 110.615 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . -175.32 -136.11 2.23 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.646 HD22 HD21 ' A' ' 135' ' ' LEU . 1.5 mp 43.03 95.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.244 -1.15 . . . . 1.0 110.409 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.05 47.29 1.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 1.0 111.079 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.24 37.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.962 -1.086 . . . . 1.0 109.634 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.533 ' O ' ' CZ ' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -147.02 -179.14 6.6 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.141 -1.024 . . . . 1.0 110.675 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.628 ' O ' ' CD2' ' A' ' 68' ' ' TYR . 2.5 m-20 -108.78 -27.82 9.55 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.833 -1.167 . . . . 1.0 110.723 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.681 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 0.0 OUTLIER 53.35 -82.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.149 -0.969 . . . . 1.0 110.776 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.547 ' HA ' ' CB ' ' A' ' 82' ' ' TYR . 8.9 pt -158.46 153.43 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.42 -0.8 . . . . 1.0 111.171 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.729 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -166.14 174.55 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.494 -0.754 . . . . 1.0 109.079 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.958 HD12 HD13 ' A' ' 57' ' ' LEU . 95.9 mt -150.91 134.28 16.22 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.925 -1.109 . . . . 1.0 108.165 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -146.87 179.55 7.51 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.032 -1.042 . . . . 1.0 112.652 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.795 HD13 ' CG ' ' A' ' 50' ' ' GLU . 2.5 mt -133.27 139.37 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.717 -0.614 . . . . 1.0 111.623 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.696 HG22 ' OE1' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -140.42 131.54 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.274 -0.891 . . . . 1.0 109.224 178.372 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 1.5 m-20 69.29 9.73 7.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.138 -0.976 . . . . 1.0 111.036 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 96.75 16.38 36.57 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.098 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.594 ' O ' HG23 ' A' ' 73' ' ' ILE . 90.6 m-85 -130.05 159.65 36.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -1.097 . . . . 1.0 109.32 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.692 HG12 HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -102.57 164.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.185 -0.947 . . . . 1.0 111.824 -178.264 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.837 ' HB2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -160.52 130.88 5.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.383 0.611 . . . . 1.0 110.413 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.806 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -92.69 115.95 28.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.049 . . . . 1.0 109.571 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.729 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.61 122.05 43.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.284 -0.885 . . . . 1.0 109.805 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.681 ' HB2' ' O ' ' A' ' 68' ' ' TYR . 15.9 p90 -140.73 144.98 35.85 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.561 -1.256 . . . . 1.0 111.351 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.566 ' CB ' ' HB2' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -141.19 108.3 5.47 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.35 1.072 . . . . 1.0 109.652 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.564 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -104.54 34.49 3.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.436 -0.802 . . . . 1.0 109.897 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -168.34 -41.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.6 OUTLIER 165.63 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.291 -1.123 . . . . 1.0 111.146 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HD3' ' HG3' ' A' ' 129' ' ' PRO . 13.1 mtpt -121.18 116.98 30.83 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.831 -1.168 . . . . 1.0 110.572 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.516 ' N ' ' HB2' ' A' ' 83' ' ' ASP . 45.3 Cg_endo -75.62 160.63 37.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.928 1.488 . . . . 1.0 110.676 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.786 HG13 HD21 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -133.05 107.01 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 108.749 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.837 HG22 ' HB2' ' A' ' 79' ' ' GLN . 1.8 p -95.89 123.94 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.455 -1.403 . . . . 1.0 111.242 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.794 HD12 ' HE3' ' A' ' 80' ' ' MET . 0.7 OUTLIER -113.58 84.58 2.04 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.666 ' O ' HG21 ' A' ' 124' ' ' ILE . 30.9 mtp180 -59.65 178.01 0.18 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.239 -0.984 . . . . 1.0 111.266 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.727 ' OG ' HG21 ' A' ' 118' ' ' VAL . 2.9 t -101.78 159.03 15.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.512 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.18 24.61 12.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 1.0 109.522 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 96' ' ' PRO . 1.3 t -147.22 154.67 46.25 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 1.0 109.429 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 95' ' ' VAL . 38.3 Cg_endo -64.25 134.5 42.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.77 1.405 . . . . 1.0 109.715 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -114.15 -31.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 1.0 111.048 -178.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.601 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 1.9 p-10 -82.16 47.88 1.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.968 -1.082 . . . . 1.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.553 ' O ' HG22 ' A' ' 99' ' ' THR . 2.0 m -87.59 6.55 33.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 110.906 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.622 ' HA ' HG23 ' A' ' 49' ' ' THR . 0.6 OUTLIER 66.7 7.43 5.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 111.538 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 4.2 m80 -112.53 173.63 6.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.896 -1.128 . . . . 1.0 110.366 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.658 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 2.6 m95 -75.98 88.37 2.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 1.0 109.967 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 104' ' ' HIS . 7.7 m -79.75 172.25 14.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.047 -1.033 . . . . 1.0 109.579 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.597 ' N ' HG22 ' A' ' 103' ' ' THR . 0.7 OUTLIER -123.19 119.84 31.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.95 ' CD1' HG23 ' A' ' 47' ' ' ILE . 1.6 mp -118.28 142.71 31.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.768 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 mttp -153.7 178.99 9.26 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.305 -1.358 . . . . 1.0 109.391 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -164.9 158.37 17.14 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.625 -1.23 . . . . 1.0 111.629 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.36 103.93 5.44 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -91.24 117.88 30.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 1.0 109.785 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 111' ' ' GLN . 20.6 t -114.88 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.078 -1.014 . . . . 1.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.504 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 46.4 tt0 60.1 -92.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 1.0 110.236 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.582 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -111.4 -21.23 11.92 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 1.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.582 ' N ' ' HG2' ' A' ' 112' ' ' ARG . 6.2 tt0 -92.22 108.27 19.83 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.966 0.889 . . . . 1.0 111.11 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -94.75 165.7 25.92 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 120.34 -0.933 . . . . 1.0 110.854 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.66 ' CB ' HG22 ' A' ' 125' ' ' THR . 16.2 t -146.48 156.88 43.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.259 -1.142 . . . . 1.0 110.73 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.072 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.7 tm? -123.1 146.9 47.32 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.095 -1.003 . . . . 1.0 108.859 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 1.072 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -126.52 92.97 3.67 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.347 -0.845 . . . . 1.0 111.844 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 116' ' ' LEU . 52.9 t -86.78 85.43 2.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.33 53.72 16.35 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.488 ' OD1' ' OE1' ' A' ' 117' ' ' GLN . 1.7 m-20 44.68 21.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.157 -1.202 . . . . 1.0 111.178 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -91.49 -176.37 4.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 1.0 109.813 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -41.12 100.46 0.22 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 1.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.464 ' N ' ' O ' ' A' ' 121' ' ' GLU . 41.1 Cg_endo -67.91 134.8 33.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.228 1.646 . . . . 1.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.747 HG22 ' HB3' ' A' ' 91' ' ' LEU . 1.5 mp -97.95 115.18 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.66 HG22 ' CB ' ' A' ' 115' ' ' SER . 12.2 p -120.25 174.48 6.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.072 -1.017 . . . . 1.0 112.181 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 114' ' ' GLY . . . -178.72 163.36 31.11 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.253 -2.339 . . . . 1.0 107.253 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.577 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -140.82 169.84 16.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.581 -1.54 . . . . 1.0 111.153 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.68 166.65 12.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.243 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.549 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.4 Cg_endo -66.94 89.92 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.779 1.41 . . . . 1.0 108.51 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -14.5 131.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.214 0.53 . . . . 1.0 112.111 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 130.43 55.92 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.564 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . -103.84 -122.31 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -1.125 . . . . 1.0 109.926 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 133' ' ' THR . 13.1 t -167.79 59.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.71 -1.244 . . . . 1.0 110.279 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 135' ' ' LEU . 11.3 mm-40 54.96 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.646 HD21 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 66.46 97.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 1.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.3 m-20 -69.28 178.96 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 1.0 109.723 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -153.08 105.77 2.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 1.0 109.805 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.604 ' CB ' HG11 ' A' ' 31' ' ' VAL . 1.9 p30 164.04 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.646 -0.659 . . . . 1.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -38.54 -44.31 1.73 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -164.87 162.75 21.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 1.0 110.257 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.533 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 14.7 tp -145.41 146.03 31.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 1.0 109.976 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.656 ' CG ' ' HE1' ' A' ' 146' ' ' MET . 37.1 m95 -135.81 131.36 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 1.031 HD13 HD12 ' A' ' 57' ' ' LEU . 5.4 tp -133.21 122.22 23.65 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.177 -1.409 . . . . 1.0 112.698 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 119.51 16.27 5.16 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.862 -1.295 . . . . 1.0 109.862 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 130.05 -137.54 9.6 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 119.099 -1.524 . . . . 1.0 109.919 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.791 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -168.05 134.38 2.01 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.846 -0.741 . . . . 1.0 110.388 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -47.45 -20.58 0.24 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.448 -0.782 . . . . 1.0 110.856 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.595 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -157.51 85.94 0.93 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.947 HD21 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -78.8 38.17 0.32 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.555 -1.341 . . . . 1.0 112.772 -177.259 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 151' ' ' VAL . 1.9 p -54.26 -26.37 28.59 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 104.55 -2.389 . . . . 1.0 104.55 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.833 HG13 ' N ' ' A' ' 152' ' ' ALA 0.282 7.7 p -59.28 -132.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.297 -1.32 . . . . 1.0 108.807 177.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.833 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 65.21 -67.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.136 -0.978 . . . . 1.0 109.544 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 151' ' ' VAL . 18.9 m170 38.16 -74.84 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.427 1.269 . . . . 1.0 114.427 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -52.6 -3.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.576 1.324 . . . . 1.0 114.576 -176.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.928 HD11 ' CD1' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -146.51 175.54 2.67 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 119.79 -1.819 . . . . 1.0 111.833 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 50.3 Cg_endo -77.51 -161.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.868 1.712 . . . . 1.0 113.809 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.635 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.1 OUTLIER -43.77 -20.7 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.365 -0.834 . . . . 1.0 113.071 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.542 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -36.77 -43.33 0.42 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.093 -1.004 . . . . 1.0 109.357 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.928 ' CD1' HD11 ' A' ' 155' ' ' LEU . 5.5 m-85 -89.27 -27.52 20.51 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.124 -0.985 . . . . 1.0 109.543 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -72.26 -7.87 51.76 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.225 -1.39 . . . . 1.0 107.407 177.197 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.537 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -130.84 98.51 4.64 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 21' ' ' GLY . . . -49.81 -175.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.618 ' CD2' HD11 ' A' ' 167' ' ' ILE . 44.6 t80 -67.58 152.77 45.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -1.135 . . . . 1.0 112.056 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 164' ' ' ILE . 1.3 mp -131.57 80.38 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.846 0.831 . . . . 1.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.57 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.67 -161.23 20.92 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 106.778 -2.529 . . . . 1.0 106.778 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.4 m -125.19 143.81 50.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.84 -1.388 . . . . 1.0 109.597 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.812 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.3 mt -124.0 156.77 31.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.749 -1.219 . . . . 1.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.591 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -167.47 152.56 7.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.883 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.538 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 17.4 m-20 56.11 64.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.115 -0.991 . . . . 1.0 110.426 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.945 HG12 ' HB2' ' A' ' 45' ' ' LEU . 24.3 m -116.64 133.1 64.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.566 ' HA ' ' HG3' ' A' ' 176' ' ' GLU . 1.0 OUTLIER -148.64 155.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.425 -1.31 . . . . 1.0 110.969 -176.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.759 HG22 ' HD1' ' A' ' 43' ' ' PHE . 13.4 t -132.82 91.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 8.0 m-20 57.05 46.26 19.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.862 -1.149 . . . . 1.0 108.023 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 72.26 31.79 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.257 0.551 . . . . 1.0 110.375 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.557 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . 34.2 mt-30 -108.42 176.06 5.25 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.3 -0.875 . . . . 1.0 110.076 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 177' ' ' LEU . 6.9 pt-20 44.09 -114.66 0.38 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.365 -0.209 . . . . 1.0 110.912 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 179' ' ' LEU . 8.6 tp 78.77 -59.24 0.41 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.35 -0.844 . . . . 1.0 110.375 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 4.8 m-70 -68.98 70.63 0.21 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.085 . . . . 1.0 109.288 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.866 HD11 HG22 ' A' ' 170' ' ' VAL 0.255 3.7 mp -44.1 -61.53 1.44 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.689 0.756 . . . . 1.0 112.087 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.565 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 94.5 t -68.29 -9.7 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.233 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 11.0 mt-10 -74.61 -62.09 1.65 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.699 -1.251 . . . . 1.0 110.012 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.618 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 8.2 m-20 -83.03 -12.62 57.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.99 . . . . 1.0 109.183 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -72.74 -31.31 64.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 1.0 109.038 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER -59.94 -14.14 14.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 1.0 109.188 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -46.27 -25.79 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.311 -0.868 . . . . 1.0 109.462 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.582 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 14.2 t30 -93.26 175.12 3.32 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.582 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 43.7 Cg_endo -84.44 -90.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 122.889 0.942 . . . . 1.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 188' ' ' THR . 2.8 t -66.78 144.49 56.28 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.334 -0.854 . . . . 1.0 110.727 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.747 ' C ' HD13 ' A' ' 190' ' ' LEU . 3.2 mt -126.89 117.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 1.0 109.689 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.922 ' H ' HD22 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -94.39 136.06 35.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 1.0 109.055 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 16' ' ' ALA . 3.2 m-70 -114.72 149.16 37.26 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.089 -1.007 . . . . 1.0 110.126 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 166' ' ' CYS . 0.9 OUTLIER -70.68 -162.28 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 1.0 110.051 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.76 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 0.0 OUTLIER -125.6 138.39 53.93 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.267 -0.896 . . . . 1.0 109.988 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 161.4 37.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.772 -0.58 . . . . 1.0 110.114 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.291 -1.954 0 C-N-CA 118.616 -1.234 . . . . 1.0 110.546 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.444 -1.463 . . . . 1.0 109.444 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 92.4 p 43.72 -92.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -1.125 . . . . 1.0 110.307 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER -45.67 -50.09 13.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.985 . . . . 1.0 110.052 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 3' ' ' GLU . 4.1 ttmm 55.88 164.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -0.835 . . . . 1.0 110.146 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.81 156.2 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 1.0 110.362 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mt -120.94 115.19 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 1.0 110.368 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.568 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -67.44 148.92 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.775 . . . . 1.0 110.596 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -91.83 157.74 16.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 1.0 109.974 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -124.72 138.16 54.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.947 . . . . 1.0 110.416 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -104.38 87.68 2.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.279 -0.888 . . . . 1.0 109.486 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 13' ' ' ASP . . . -74.05 2.26 9.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 1.0 110.364 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' ASP . . . 58.91 -83.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.118 -1.593 . . . . 1.0 109.118 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.4 OUTLIER 70.64 9.79 6.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -1.046 . . . . 1.0 110.632 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 13' ' ' ASP . . . -176.56 37.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 1.0 110.421 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.551 ' HG2' ' CD1' ' A' ' 179' ' ' LEU . 0.5 OUTLIER -64.94 89.28 0.07 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.294 -0.879 . . . . 1.0 109.507 179.654 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -113.13 153.94 27.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 1.0 111.085 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.608 HG13 HD22 ' A' ' 179' ' ' LEU . 0.8 OUTLIER -114.84 144.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 177.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -104.2 136.07 44.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.756 -1.215 . . . . 1.0 111.443 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.841 ' CE1' HD12 ' A' ' 167' ' ' ILE . 6.6 m-85 -100.72 148.16 25.21 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -113.88 1.18 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 1.0 111.102 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 108.11 -18.13 34.03 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.396 -1.882 . . . . 1.0 108.396 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 42.02 3.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.932 . . . . 1.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -112.89 127.16 56.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.0 110.943 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CG ' ' HG3' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -118.76 87.56 2.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.323 -0.86 . . . . 1.0 109.684 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.458 ' SD ' ' CE1' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -76.0 100.7 4.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.15 -0.969 . . . . 1.0 110.475 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 6.2 tt0 -79.43 90.32 5.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 4.2 m-30 -95.24 111.8 23.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.487 -0.885 . . . . 1.0 111.319 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -133.44 153.7 51.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 1.0 109.71 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.49 167.44 27.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.001 -1.062 . . . . 1.0 110.398 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.28 97.16 9.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 1.0 110.443 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 32' ' ' THR . 16.6 t -73.12 -115.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 1.0 110.034 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.429 ' N ' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -132.29 171.91 13.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.833 -1.167 . . . . 1.0 110.128 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -116.1 78.67 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -0.966 . . . . 1.0 110.122 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 2.0 p 164.85 -71.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.474 -0.766 . . . . 1.0 109.927 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 83.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 1.0 110.411 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 167.88 10.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 1.0 110.142 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.69 ' HB2' ' OD2' ' A' ' 136' ' ' ASP . . . 48.64 71.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 1.0 110.132 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -166.9 0.37 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.29 -0.881 . . . . 1.0 110.138 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.706 ' NE2' HG13 ' A' ' 110' ' ' VAL . 3.0 tm0? -106.5 -14.45 15.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 1.0 110.101 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.575 -0.703 . . . . 1.0 110.187 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 109' ' ' ARG . 52.6 p-10 -108.52 149.41 28.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.175 -0.953 . . . . 1.0 110.666 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -123.41 125.65 45.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 1.0 109.42 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 m-85 -133.21 131.6 40.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.129 -0.982 . . . . 1.0 111.05 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.751 ' C ' HD23 ' A' ' 45' ' ' LEU . 6.7 mt-10 -137.9 140.61 40.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 1.0 110.404 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.816 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 179.92 154.28 0.54 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.289 -0.882 . . . . 1.0 110.798 179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.502 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -117.49 155.7 29.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.84 HD13 HD11 ' A' ' 105' ' ' ILE . 6.5 pt -149.16 176.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 1.0 112.802 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.604 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -130.92 83.22 2.1 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.2 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.509 ' OG1' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -67.04 152.14 46.34 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.127 0.965 . . . . 1.0 112.603 -176.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.928 ' HB2' HG22 ' A' ' 164' ' ' ILE . 11.0 mm-40 -141.92 1.03 1.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.396 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.24 124.86 11.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.973 -1.08 . . . . 1.0 110.187 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.879 HG22 ' HA2' ' A' ' 76' ' ' GLY . 17.8 p -59.96 -10.9 4.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.798 . . . . 1.0 110.796 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -128.35 130.11 47.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.063 . . . . 1.0 111.211 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 160.03 137.63 2.27 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.022 HD21 HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -90.44 127.75 36.31 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.549 -1.559 . . . . 1.0 108.884 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.728 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.07 -40.04 12.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.449 -0.782 . . . . 1.0 112.2 -176.181 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 141' ' ' LEU . 5.7 tt -142.79 139.11 30.86 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.092 -1.63 . . . . 1.0 113.693 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.73 ' N ' HD23 ' A' ' 57' ' ' LEU . 1.1 t-105 -145.32 106.35 4.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.281 -0.887 . . . . 1.0 108.661 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.578 ' CB ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -121.65 -166.58 1.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.782 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' LYS . . . 97.15 48.33 2.07 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER 45.0 70.3 0.36 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.32 -1.106 . . . . 1.0 109.877 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 61' ' ' LYS . . . -41.38 132.34 3.54 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.805 -1.318 . . . . 1.0 109.805 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -149.2 -166.69 2.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -1.121 . . . . 1.0 110.13 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' H ' HD23 ' A' ' 63' ' ' LEU . 4.1 mt-10 -109.89 14.09 23.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.145 -0.972 . . . . 1.0 110.297 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 23.7 ptt-85 173.8 63.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 1.0 109.435 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.582 ' O ' ' CE2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -144.92 -177.31 5.46 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.807 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 84' ' ' LEU . 44.5 m-20 -94.58 162.29 13.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.431 -0.793 . . . . 1.0 109.768 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.582 ' CE2' ' O ' ' A' ' 66' ' ' SER . 0.3 OUTLIER 177.01 -167.0 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.467 -1.396 . . . . 1.0 111.236 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.562 ' CD1' ' HB3' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -146.39 155.63 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.597 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.984 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -149.1 -175.79 5.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.946 -1.096 . . . . 1.0 111.033 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.994 HD12 HD13 ' A' ' 57' ' ' LEU . 61.1 mt -151.31 116.54 5.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -136.38 171.47 14.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.749 -1.219 . . . . 1.0 111.764 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.593 HG13 HD11 ' A' ' 56' ' ' ILE . 45.7 mt -114.87 130.53 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.528 -0.732 . . . . 1.0 110.586 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -140.48 143.7 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 1.0 110.131 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.497 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 50.7 m-20 60.25 13.52 3.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 1.0 111.695 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.879 ' HA2' HG22 ' A' ' 52' ' ' THR . . . 93.09 10.04 60.11 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.587 -1.292 . . . . 1.0 109.997 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.28 141.7 48.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -1.141 . . . . 1.0 109.551 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.728 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -77.14 178.62 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.859 -1.151 . . . . 1.0 108.655 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.923 ' CD ' HG22 ' A' ' 90' ' ' VAL . 1.4 pp0? -173.98 125.67 0.36 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.61 -1.307 . . . . 1.0 111.694 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.641 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.8 ttm -69.41 129.04 38.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.984 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 13.2 tmm? -132.11 109.12 9.75 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.419 -0.801 . . . . 1.0 110.466 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.765 ' CE2' HG11 ' A' ' 89' ' ' VAL . 11.5 p90 -133.95 133.1 40.98 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.914 -1.514 . . . . 1.0 112.107 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -118.47 88.14 2.86 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.567 0.699 . . . . 1.0 109.728 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -73.14 -76.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.441 -0.787 . . . . 1.0 109.111 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -71.08 -42.56 58.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.004 -2.039 . . . . 1.0 108.004 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.606 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 1.3 t 160.79 147.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.606 ' CB ' ' O ' ' A' ' 86' ' ' SER . 0.2 OUTLIER 83.92 93.76 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.58 ' HB2' ' HG2' ' A' ' 81' ' ' MET . 41.4 Cg_endo -67.53 146.44 74.05 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.492 1.785 . . . . 1.0 111.763 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.69 117.44 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -99.47 98.14 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.96 -1.088 . . . . 1.0 110.573 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.623 HD12 ' HB3' ' A' ' 80' ' ' MET . 6.0 mt -93.94 75.45 4.17 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.696 ' O ' HG21 ' A' ' 124' ' ' ILE . 6.4 mtt180 -56.77 174.95 0.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.397 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 1.065 ' OG ' HG21 ' A' ' 118' ' ' VAL . 14.5 t -92.9 160.45 14.9 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.335 0.588 . . . . 1.0 110.564 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.694 HG21 ' HB3' ' A' ' 122' ' ' ALA . 14.9 t -102.64 8.04 39.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 1.0 109.642 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.751 HG13 ' HD2' ' A' ' 96' ' ' PRO . 51.2 t -129.87 150.9 77.19 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.751 ' HD2' HG13 ' A' ' 95' ' ' VAL . 45.3 Cg_endo -69.59 135.58 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.482 1.254 . . . . 1.0 110.2 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.613 HG21 HG22 ' A' ' 78' ' ' VAL . 1.1 tp -115.77 -31.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 1.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.45 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 17.2 p-10 -69.57 60.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.034 . . . . 1.0 109.909 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.696 ' O ' HG22 ' A' ' 99' ' ' THR . 18.0 m -124.06 16.63 9.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.46 -0.775 . . . . 1.0 110.392 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.487 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 48.0 t-20 50.65 39.13 20.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -129.69 135.74 48.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 1.0 110.111 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.604 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 44.9 m95 -57.29 110.29 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -0.97 . . . . 1.0 110.291 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 104' ' ' HIS . 35.9 m -110.62 171.94 7.16 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.59 ' N ' HG22 ' A' ' 103' ' ' THR . 31.8 t60 -117.39 129.64 55.98 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.987 -1.071 . . . . 1.0 108.412 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.84 HD11 HD13 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -122.01 147.89 25.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.318 -0.864 . . . . 1.0 108.823 -179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.819 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.0 OUTLIER -152.5 173.16 15.49 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.404 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -165.37 116.9 1.12 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.69 -1.256 . . . . 1.0 111.323 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 25.9 p90 -119.41 109.82 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.548 ' HG2' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -106.55 164.4 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 1.0 111.309 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.706 HG13 ' NE2' ' A' ' 39' ' ' GLN . 12.8 t -145.15 113.96 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 19.8 mt-30 58.46 -129.95 1.33 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.246 -0.909 . . . . 1.0 110.462 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -85.19 -1.22 56.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.96 -1.088 . . . . 1.0 110.22 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 7.6 tt0 -107.26 120.77 43.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.436 -0.79 . . . . 1.0 110.226 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -119.66 157.43 15.51 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 119.971 -1.109 . . . . 1.0 111.465 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 1.058 ' OG ' HG22 ' A' ' 125' ' ' THR . 2.8 t -133.26 150.93 51.91 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.192 -1.181 . . . . 1.0 110.836 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.125 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.3 tm? -113.83 154.11 28.01 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.123 -0.986 . . . . 1.0 109.434 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 1.125 ' N ' HD13 ' A' ' 116' ' ' LEU 0.26 4.1 tp60 -130.03 87.21 2.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.543 -0.723 . . . . 1.0 112.725 -178.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 1.065 HG21 ' OG ' ' A' ' 93' ' ' SER . 24.6 t -80.56 82.71 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.729 -1.212 . . . . 1.0 107.729 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 66.52 60.87 5.81 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 120' ' ' ASN . 12.8 p30 38.8 25.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.569 -0.96 . . . . 1.0 111.694 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 121' ' ' GLU . 1.3 pm0 -86.01 -174.77 5.26 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.355 -0.84 . . . . 1.0 109.236 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.694 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -46.62 104.66 0.42 Allowed Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.336 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.422 ' N ' ' O ' ' A' ' 121' ' ' GLU . 40.5 Cg_endo -65.13 130.24 25.12 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.971 1.511 . . . . 1.0 110.559 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.696 HG21 ' O ' ' A' ' 92' ' ' ARG . 3.8 mp -91.03 109.32 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.557 -0.857 . . . . 1.0 108.984 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 1.058 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.8 p -107.52 169.35 8.63 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.246 1.022 . . . . 1.0 111.291 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.444 ' N ' ' CD2' ' A' ' 91' ' ' LEU . . . 169.33 161.25 19.33 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 106.723 -2.551 . . . . 1.0 106.723 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 112' ' ' ARG . 0.7 OUTLIER -133.18 168.99 17.53 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.65 -1.5 . . . . 1.0 110.379 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -113.3 177.45 1.18 Allowed Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.742 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.2 Cg_endo -66.77 91.84 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.944 1.497 . . . . 1.0 108.851 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 131' ' ' GLY . 1.1 pp -47.64 -178.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.511 -0.743 . . . . 1.0 110.531 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.517 ' N ' HD12 ' A' ' 130' ' ' LEU . . . 161.08 -56.18 0.31 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.034 -1.626 . . . . 1.0 109.034 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -107.99 102.91 12.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 1.0 109.663 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 t -86.1 37.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 1.0 110.413 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -136.87 63.79 1.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 1.0 109.929 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -98.24 131.08 44.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 1.0 110.412 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.69 ' OD2' ' HB2' ' A' ' 37' ' ' ALA . 1.0 OUTLIER -124.42 175.4 7.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 1.0 110.127 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 140.7 44.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 1.0 110.21 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.683 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 24.0 p-10 -88.53 35.66 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 1.0 110.519 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 42.63 25.44 0.31 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.683 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -116.35 166.5 11.99 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.075 -1.25 . . . . 1.0 109.301 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 1.001 HD11 HD21 ' A' ' 57' ' ' LEU . 10.6 tp -160.63 152.79 20.26 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.972 -1.091 . . . . 1.0 111.409 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.649 ' HB3' ' HE3' ' A' ' 146' ' ' MET . 25.2 m95 -133.96 126.05 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.621 -1.622 . . . . 1.0 106.621 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -143.05 135.81 27.74 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 117.899 -1.52 . . . . 1.0 113.725 -176.539 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 104.38 24.99 7.21 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.212 -1.955 . . . . 1.0 108.212 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.714 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 109.48 -153.35 16.93 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 106.663 -2.575 . . . . 1.0 106.663 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.936 ' HB2' HD12 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -170.75 174.0 5.1 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.159 -1.416 . . . . 1.0 111.958 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.56 ' HG3' ' CG ' ' A' ' 24' ' ' TYR . 37.6 mt-10 -96.05 -9.1 31.73 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -152.48 27.0 0.58 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.535 -0.728 . . . . 1.0 110.596 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.022 HD13 HD21 ' A' ' 55' ' ' LEU . 3.2 mt -70.54 61.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.597 -1.241 . . . . 1.0 109.293 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 148' ' ' ARG . 2.3 p -79.0 65.98 4.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.309 -2.108 . . . . 1.0 105.309 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.781 HG13 ' H ' ' A' ' 152' ' ' ALA . 1.2 p -149.58 -77.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.13 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.909 ' HB2' ' CB ' ' A' ' 159' ' ' TYR . . . 45.54 30.95 0.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.046 -1.033 . . . . 1.0 108.962 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 155' ' ' LEU . 1.0 OUTLIER 34.34 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.249 0.547 . . . . 1.0 110.781 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -148.51 10.75 0.86 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 1.0 111.198 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.3 OUTLIER -76.42 179.33 1.55 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 1.0 110.727 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 155' ' ' LEU . 48.2 Cg_endo -73.13 -161.39 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.301 1.685 . . . . 1.0 112.974 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -51.44 -9.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.654 -0.653 . . . . 1.0 112.417 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.951 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -34.75 -42.96 0.16 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.035 -1.041 . . . . 1.0 110.028 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.909 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . 6.6 m-85 -82.56 -33.39 28.11 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.317 -1.353 . . . . 1.0 109.916 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.6 OUTLIER -67.09 -11.51 57.36 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.876 -1.13 . . . . 1.0 108.406 178.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 161' ' ' THR . 1.8 m -129.27 96.48 4.32 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -48.29 178.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.696 ' CD2' HD11 ' A' ' 167' ' ' ILE . 23.0 t80 -68.64 145.24 54.08 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.342 . . . . 1.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.928 HG22 ' HB2' ' A' ' 50' ' ' GLU . 2.6 mt -123.1 86.43 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.31 -1.367 . . . . 1.0 107.31 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.621 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.97 -157.5 14.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 80.0 m -130.72 143.82 51.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -1.125 . . . . 1.0 109.748 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.841 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.2 mt -128.82 157.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.299 -0.876 . . . . 1.0 110.644 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 2.8 ttt85 -164.24 144.71 8.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.202 -0.937 . . . . 1.0 109.894 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 68.8 m-20 58.44 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.479 -0.763 . . . . 1.0 110.066 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.816 HG12 ' HB2' ' A' ' 45' ' ' LEU 0.251 26.8 m -132.92 135.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 119.989 -0.685 . . . . 1.0 109.257 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.515 HG22 ' N ' ' A' ' 175' ' ' GLN . 0.1 OUTLIER -141.63 152.18 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.741 -1.184 . . . . 1.0 111.679 -177.382 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.496 HG22 ' HD1' ' A' ' 43' ' ' PHE . 92.0 t -134.11 113.8 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.9 OUTLIER 56.49 38.01 29.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 1.0 108.104 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 73.28 30.06 1.6 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.276 0.56 . . . . 1.0 110.835 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.515 ' N ' HG22 ' A' ' 171' ' ' ILE . 4.1 mm-40 -98.01 110.91 23.4 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.249 -0.907 . . . . 1.0 109.967 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.7 102.17 10.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 1.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.587 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 4.1 mm? -86.26 92.76 8.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.817 -1.177 . . . . 1.0 110.987 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 5.8 m170 -40.64 113.37 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.045 0.926 . . . . 1.0 110.166 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.813 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 10.9 mt -40.49 -56.53 2.03 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.847 0.832 . . . . 1.0 112.655 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 51.3 t -84.82 -22.25 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 2.3 mt-10 -62.07 -55.99 23.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.137 -1.602 . . . . 1.0 110.315 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.612 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -84.63 -19.47 32.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.356 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.813 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -64.28 -36.7 84.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.926 -1.109 . . . . 1.0 109.629 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 5.2 mt -50.05 -21.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.177 -0.952 . . . . 1.0 109.345 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 2.7 t-20 -54.99 -20.77 9.91 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.882 0.849 . . . . 1.0 108.876 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.476 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 4.3 t30 -95.83 152.36 39.0 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 40.6 Cg_endo -66.3 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.371 1.195 . . . . 1.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.716 ' O ' HD13 ' A' ' 189' ' ' ILE . 12.4 m -68.74 135.97 52.1 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.234 -0.916 . . . . 1.0 110.452 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 188' ' ' THR . 25.3 mm -122.92 127.46 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 1.0 109.805 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.462 ' O ' HG23 ' A' ' 17' ' ' ILE . 7.7 mt -121.34 173.18 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 1.0 110.394 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 2.5 m-70 -107.54 -84.3 0.53 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.144 -0.973 . . . . 1.0 111.185 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.1 t -170.02 134.19 1.25 Allowed 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.157 -0.964 . . . . 1.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.752 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 1.4 m -112.29 144.75 41.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 1.0 110.276 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 160.08 40.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.65 -0.656 . . . . 1.0 109.745 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.86 0 C-N-CA 118.902 -1.119 . . . . 1.0 110.513 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m -106.68 -60.81 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -1.154 . . . . 1.0 110.205 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.0 -68.95 0.25 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 1.0 110.512 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -164.75 28.4 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.15 -0.969 . . . . 1.0 110.457 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.77 88.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 1.0 110.415 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.705 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -124.39 82.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 1.0 109.682 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -115.03 92.49 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.221 -0.924 . . . . 1.0 110.057 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.52 114.21 26.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 1.0 110.234 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -127.37 147.02 50.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.381 -0.824 . . . . 1.0 109.766 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.02 164.27 12.1 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.332 -0.855 . . . . 1.0 110.383 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.88 -4.81 30.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.499 -0.75 . . . . 1.0 110.219 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.53 -174.37 15.2 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.215 -1.554 . . . . 1.0 109.215 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -121.02 63.56 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -1.205 . . . . 1.0 110.476 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -114.56 58.95 0.69 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.105 -0.997 . . . . 1.0 110.629 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 1.1 tt0 -55.94 90.58 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.237 -0.914 . . . . 1.0 109.685 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -95.62 155.16 16.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.347 -0.941 . . . . 1.0 110.289 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.906 HG21 ' HE1' ' A' ' 25' ' ' MET . 13.4 mm -135.66 122.82 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 1.0 110.576 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.25 132.49 34.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.875 . . . . 1.0 109.896 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.9 ' CE1' HD12 ' A' ' 167' ' ' ILE . 9.6 m-85 -102.47 172.67 6.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.216 . . . . 1.0 110.25 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.512 ' O ' HG12 ' A' ' 164' ' ' ILE . 0.5 OUTLIER -134.38 1.9 3.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 1.0 110.802 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.18 -26.22 25.03 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 8.1 ttt180 -104.45 10.8 35.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.912 -1.346 . . . . 1.0 109.364 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.691 HG21 ' HD2' ' A' ' 19' ' ' PHE . 6.3 t -55.22 175.53 0.07 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.676 0.75 . . . . 1.0 110.741 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.633 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -171.57 73.42 0.05 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.906 ' HE1' HG21 ' A' ' 17' ' ' ILE . 2.3 mmt -85.79 99.72 11.55 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.861 -1.149 . . . . 1.0 109.539 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -91.39 134.81 34.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 182' ' ' ASP . 48.9 m-85 -121.25 149.03 43.48 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.982 -1.074 . . . . 1.0 110.72 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -149.8 97.93 2.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.811 . . . . 1.0 110.186 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -139.31 174.99 9.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 1.0 110.084 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.06 148.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 1.0 110.033 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 31' ' ' VAL . 7.4 p -129.56 7.28 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 1.0 110.323 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.47 ' OG1' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -154.31 -178.29 7.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.16 -0.962 . . . . 1.0 110.168 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.93 87.51 7.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 1.0 110.419 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.57 18.79 6.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -0.909 . . . . 1.0 110.472 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 32' ' ' THR . 2.6 mm-40 -143.72 -171.43 3.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.866 . . . . 1.0 109.811 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -179.35 109.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.081 -1.012 . . . . 1.0 110.162 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' C ' HD22 ' A' ' 38' ' ' LEU . . . -177.62 73.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 1.0 110.2 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.501 HD22 ' C ' ' A' ' 37' ' ' ALA . 4.1 mm? -104.44 168.43 9.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.347 -0.846 . . . . 1.0 110.155 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 111' ' ' GLN . 3.9 pt20 -114.42 4.16 15.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.244 -0.91 . . . . 1.0 110.074 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.44 122.53 13.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 1.0 110.209 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.564 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -124.58 117.08 23.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.475 -0.766 . . . . 1.0 110.279 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.515 ' O ' HG23 ' A' ' 172' ' ' VAL . 0.6 OUTLIER -84.67 142.22 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 1.0 109.463 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CE1' HG21 ' A' ' 172' ' ' VAL . 41.8 m-85 -130.81 120.98 24.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.133 -0.98 . . . . 1.0 111.151 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.729 ' C ' HD23 ' A' ' 45' ' ' LEU . 39.7 mt-10 -128.6 142.8 50.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 1.0 110.521 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.932 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.1 pt? -179.69 149.72 0.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.38 -0.825 . . . . 1.0 110.397 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 167' ' ' ILE . 49.7 m -121.24 149.36 42.98 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.598 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.551 HD11 HG13 ' A' ' 97' ' ' ILE . 1.7 pt -126.49 179.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.379 -0.928 . . . . 1.0 109.168 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.632 ' O ' ' OG1' ' A' ' 49' ' ' THR . 5.9 tttt -167.74 82.6 0.2 Allowed 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.674 -1.21 . . . . 1.0 110.641 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 1.069 HG22 ' HG2' ' A' ' 50' ' ' GLU . 90.2 m -171.97 -108.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.81 -0.556 . . . . 1.0 111.313 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.069 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.5 OUTLIER -122.18 -46.09 2.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.594 1.188 . . . . 1.0 109.626 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.883 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . 39.44 22.75 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.841 -1.072 . . . . 1.0 111.656 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.611 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 60.4 p -70.79 -18.22 62.76 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.409 -1.432 . . . . 1.0 108.796 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -159.6 118.68 2.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.093 -0.643 . . . . 1.0 109.727 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 155.21 136.74 2.25 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.194 -1.479 . . . . 1.0 109.541 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.92 HD13 ' CZ ' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -85.61 128.17 34.69 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.628 -1.229 . . . . 1.0 109.246 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.87 HD11 ' CG1' ' A' ' 78' ' ' VAL . 1.0 OUTLIER -90.49 -34.09 6.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.502 -0.749 . . . . 1.0 111.602 -177.081 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.094 HD13 HD12 ' A' ' 71' ' ' LEU . 5.7 tt -146.18 143.4 29.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.536 -1.353 . . . . 1.0 113.079 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.997 ' CZ2' HG21 ' A' ' 151' ' ' VAL . 31.0 t-105 -152.09 105.69 3.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 p -110.29 123.17 49.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 1.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 138' ' ' ASP . . . -125.05 141.26 12.95 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 138' ' ' ASP . 0.8 OUTLIER -61.86 -43.25 99.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.321 -1.105 . . . . 1.0 110.487 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.63 -127.12 2.36 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.616 -1.394 . . . . 1.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.6 mt 47.71 -162.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -1.129 . . . . 1.0 110.237 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.11 37.25 4.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 1.0 110.399 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 177.19 46.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.343 -0.848 . . . . 1.0 109.358 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.91 142.78 48.39 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.626 -0.829 . . . . 1.0 110.942 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.671 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 25.1 m-20 -98.53 -103.64 0.21 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.748 . . . . 1.0 110.035 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.671 ' CB ' ' O ' ' A' ' 67' ' ' ASP . 1.8 t80 102.6 -91.75 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 123.037 0.535 . . . . 1.0 111.857 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 70' ' ' ALA . 5.6 mt -151.13 171.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.648 -1.282 . . . . 1.0 112.838 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.56 ' N ' ' CG2' ' A' ' 69' ' ' ILE . . . -177.18 167.12 2.4 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.094 HD12 HD13 ' A' ' 57' ' ' LEU . 90.4 mt -145.95 103.37 3.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.721 -1.237 . . . . 1.0 108.439 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -123.46 167.76 13.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 1.0 112.058 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.977 HG12 HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.5 132.53 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.739 0.78 . . . . 1.0 111.131 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.87 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.0 p -141.17 140.65 31.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.6 -0.687 . . . . 1.0 110.968 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.87 ' CG ' HG22 ' A' ' 74' ' ' VAL . 5.7 m-20 67.96 22.49 8.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.481 -0.762 . . . . 1.0 111.47 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.845 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 86.84 4.74 82.06 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.06 -1.543 . . . . 1.0 109.76 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 75' ' ' ASP . 87.2 m-85 -130.94 150.24 52.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.95 -1.324 . . . . 1.0 110.569 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.977 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.01 177.6 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.148 -0.97 . . . . 1.0 110.535 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 7.8 pt20 -167.49 123.81 1.12 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.254 -0.904 . . . . 1.0 110.89 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.87 ' HE1' HD23 ' A' ' 91' ' ' LEU . 6.0 tmm? -83.69 115.95 22.42 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 10.1 ptt? -119.79 149.15 42.51 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.905 -1.122 . . . . 1.0 111.143 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.777 ' CE2' HG11 ' A' ' 89' ' ' VAL . 24.7 p90 -158.03 132.81 8.45 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.194 -1.002 . . . . 1.0 110.951 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.667 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -121.02 75.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 1.0 110.329 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.676 HD12 ' CB ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -79.11 -5.86 55.11 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.68 -0.637 . . . . 1.0 110.379 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -121.5 -65.83 0.24 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.057 -1.217 . . . . 1.0 110.057 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.33 -33.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.053 -1.263 . . . . 1.0 111.243 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HD3' ' HD3' ' A' ' 129' ' ' PRO . 9.0 ptmt -124.58 138.06 30.48 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.944 -1.097 . . . . 1.0 110.959 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.536 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 49.8 Cg_endo -76.23 121.82 6.31 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 124.15 1.605 . . . . 1.0 111.414 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.777 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -77.4 168.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 178.14 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 90' ' ' VAL . 10.6 p -147.69 85.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.751 -1.218 . . . . 1.0 111.667 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.87 HD23 ' HE1' ' A' ' 80' ' ' MET . 0.7 OUTLIER -77.34 75.31 3.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.881 -1.137 . . . . 1.0 108.398 178.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 90' ' ' VAL . 34.8 mtp180 -58.47 178.82 0.09 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.955 0.884 . . . . 1.0 110.837 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.612 ' OG ' HG21 ' A' ' 118' ' ' VAL . 11.5 t -109.64 149.31 29.89 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.916 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.75 29.91 6.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -0.999 . . . . 1.0 109.908 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.726 HG13 ' HD2' ' A' ' 96' ' ' PRO . 74.2 t -133.74 150.27 74.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.514 -0.741 . . . . 1.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.726 ' HD2' HG13 ' A' ' 95' ' ' VAL . 42.1 Cg_endo -66.93 120.35 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.569 1.299 . . . . 1.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.845 HG22 ' O ' ' A' ' 76' ' ' GLY . 4.1 tp -104.89 -11.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 1.0 110.344 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.602 ' HB3' HG22 ' A' ' 52' ' ' THR . 8.5 p-10 -87.96 55.69 3.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 1.0 109.679 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 99' ' ' THR . 68.8 m -112.38 8.29 19.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.311 -0.868 . . . . 1.0 110.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.559 ' HA ' ' N ' ' A' ' 49' ' ' THR . 79.2 m-20 54.62 16.86 1.48 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 1.0 110.436 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -113.41 150.13 33.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.881 . . . . 1.0 109.984 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.62 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 4.3 m95 -60.75 89.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.013 -1.054 . . . . 1.0 110.687 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.676 HG21 HD12 ' A' ' 97' ' ' ILE . 23.3 m -87.56 150.57 23.62 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 119' ' ' GLY . 78.8 t60 -108.71 135.34 50.1 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.989 -1.085 . . . . 1.0 108.73 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 105' ' ' ILE . 0.5 OUTLIER -132.51 156.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.174 -0.954 . . . . 1.0 109.457 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.922 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -152.23 167.41 28.68 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.731 -1.188 . . . . 1.0 110.125 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -152.16 109.7 3.61 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.255 -0.978 . . . . 1.0 111.251 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 18.4 m-30 -83.58 102.28 12.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 1.0 108.802 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -92.99 127.37 38.48 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.96 -1.087 . . . . 1.0 109.728 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 111' ' ' GLN . 3.3 t -132.62 157.57 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 1.0 110.269 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -40.14 111.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.0 110.497 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.626 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 51.98 65.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 1.0 110.377 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.626 ' CB ' ' O ' ' A' ' 112' ' ' ARG . 2.2 tt0 156.85 113.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.632 0.73 . . . . 1.0 109.986 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 82' ' ' TYR . . . -120.86 166.15 13.96 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.199 -1.0 . . . . 1.0 110.618 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.607 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -144.51 166.7 24.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.491 -1.006 . . . . 1.0 110.315 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 117' ' ' GLN 0.252 1.1 tm? -145.47 151.92 38.96 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.151 -0.968 . . . . 1.0 109.312 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.992 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -153.89 107.95 3.02 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.813 -1.155 . . . . 1.0 111.788 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.612 HG21 ' OG ' ' A' ' 93' ' ' SER . 2.0 t -72.41 104.92 2.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.73 35.58 91.17 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.207 . . . . 1.0 110.084 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER 60.95 39.47 16.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.093 -1.239 . . . . 1.0 110.97 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -102.4 -167.84 1.45 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.522 -0.736 . . . . 1.0 110.733 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.572 ' N ' ' HG2' ' A' ' 121' ' ' GLU . . . -35.0 112.23 0.44 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 1.0 109.579 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.533 ' HB3' ' OE1' ' A' ' 117' ' ' GLN . 45.8 Cg_endo -72.95 118.14 5.43 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.133 1.596 . . . . 1.0 112.834 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.733 ' H ' HD12 ' A' ' 124' ' ' ILE . 5.4 mp -85.8 110.85 20.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 106.313 -1.736 . . . . 1.0 106.313 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 30.9 p -119.65 174.38 6.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.507 1.146 . . . . 1.0 112.756 -176.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.584 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 169.69 169.47 32.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 106.622 -2.591 . . . . 1.0 106.622 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -146.53 163.95 34.12 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.511 -1.582 . . . . 1.0 111.11 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.429 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -83.98 173.54 7.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.663 -0.648 . . . . 1.0 110.494 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -69.7 57.55 1.46 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 1.0 110.113 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.2 pp 10.22 57.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -132.68 73.35 0.46 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.676 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -159.94 -71.41 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -1.136 . . . . 1.0 110.493 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.8 OUTLIER 62.85 129.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -0.99 . . . . 1.0 109.887 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.17 75.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 1.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 68' ' ' TYR . 1.3 tm? -88.86 108.42 19.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 1.0 109.719 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.408 ' N ' HD22 ' A' ' 135' ' ' LEU . 60.9 m-20 -67.74 148.79 50.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 1.0 110.724 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -138.4 141.45 39.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 1.0 109.787 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.674 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 40.4 p-10 -84.16 22.1 1.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.194 -0.941 . . . . 1.0 111.075 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 45.51 22.41 0.65 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.405 -1.478 . . . . 1.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.674 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -104.92 162.57 13.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.109 -1.23 . . . . 1.0 109.252 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.723 HD11 ' HG ' ' A' ' 57' ' ' LEU . 6.7 tp -159.53 144.78 15.63 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.99 -1.069 . . . . 1.0 110.821 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.671 ' HB3' ' HE3' ' A' ' 146' ' ' MET . 13.1 m95 -125.99 141.88 51.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.768 HD21 HG22 ' A' ' 56' ' ' ILE . 1.5 tt -148.0 128.47 14.02 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 116.908 -1.917 . . . . 1.0 113.375 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 23' ' ' THR . . . 113.54 -5.32 24.66 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 146.69 -140.87 9.0 Favored Glycine 0 C--N 1.289 -2.039 0 C-N-CA 118.945 -1.598 . . . . 1.0 109.755 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' MET . . . . . 1.003 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -171.43 141.18 1.5 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.091 -1.043 . . . . 1.0 111.939 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.01 -16.08 55.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.783 0.801 . . . . 1.0 109.079 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HD2' ' SD ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -137.0 45.84 2.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.497 -1.298 . . . . 1.0 107.497 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' A' ' 146' ' ' MET . 11.5 tp -65.32 56.83 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.753 0.787 . . . . 1.0 112.146 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 148' ' ' ARG . 56.9 p -84.88 1.7 45.9 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.509 -1.663 . . . . 1.0 106.509 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.997 HG21 ' CZ2' ' A' ' 58' ' ' TRP . 3.3 p -85.47 -104.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.614 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.886 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . 52.64 45.52 28.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.476 -1.39 . . . . 1.0 108.936 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.525 ' C ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -18.03 -77.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.536 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 9.5 ptmt -97.95 -43.65 7.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.985 . . . . 1.0 111.874 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 1.118 HD21 ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -81.07 113.41 40.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 O-C-N 121.324 -0.86 . . . . 1.0 110.231 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -88.39 -68.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.58 1.305 . . . . 1.0 111.594 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.61 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 1.8 tttm -54.86 -50.67 68.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 1.0 111.944 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.671 ' CB ' HD12 ' A' ' 155' ' ' LEU . . . -43.72 -42.76 5.59 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 1.118 ' CE1' HD21 ' A' ' 155' ' ' LEU . 3.2 m-85 -78.42 -32.2 48.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -68.93 -12.35 61.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.753 -0.779 . . . . 1.0 109.926 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -128.65 81.9 2.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -41.31 158.35 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' A' ' 167' ' ' ILE . 62.9 t80 -71.57 137.08 47.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.959 -1.318 . . . . 1.0 110.5 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.756 ' O ' HG21 ' A' ' 49' ' ' THR . 4.4 mt -118.72 75.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.733 ' HA2' HG21 ' A' ' 49' ' ' THR . . . -159.11 -160.21 10.23 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.515 ' N ' ' OG1' ' A' ' 49' ' ' THR . 20.0 m -118.61 147.48 43.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -1.175 . . . . 1.0 111.445 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.9 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -134.95 157.22 40.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.694 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.524 ' NH2' ' OD1' ' A' ' 169' ' ' ASP . 22.1 ttt-85 -165.52 157.85 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.818 -1.176 . . . . 1.0 111.262 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.551 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 20.0 m-20 51.25 78.61 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.9 . . . . 1.0 110.451 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.932 HG12 ' CB ' ' A' ' 45' ' ' LEU . 16.8 m -124.81 129.55 73.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.363 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.436 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -148.13 148.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.269 -0.972 . . . . 1.0 110.947 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.692 HG21 ' CE1' ' A' ' 43' ' ' PHE . 14.9 p -135.7 123.56 36.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 23.2 m-20 49.95 30.92 4.3 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.409 -1.432 . . . . 1.0 107.86 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 68.09 28.76 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.186 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.678 ' O ' HD12 ' A' ' 177' ' ' LEU . 2.2 mm-40 -109.66 -170.06 1.59 Allowed 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.262 -0.899 . . . . 1.0 109.34 178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.593 ' HB3' ' O ' ' A' ' 175' ' ' GLN . 36.6 tp10 76.59 -106.22 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.601 -0.687 . . . . 1.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.927 ' O ' HD12 ' A' ' 179' ' ' LEU . 3.6 mp 63.37 -94.91 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.185 -0.947 . . . . 1.0 112.515 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 7.3 m-70 -56.64 90.02 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.937 -1.102 . . . . 1.0 111.438 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.927 HD12 ' O ' ' A' ' 177' ' ' LEU 0.272 3.5 mp -63.57 -58.78 5.87 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.214 1.006 . . . . 1.0 110.868 178.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 184' ' ' LEU . 2.1 t -61.44 -16.45 14.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.933 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 3.4 mt-10 -72.3 -45.27 60.76 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.386 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.616 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 1.6 m-20 -101.8 -15.52 16.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.257 -0.902 . . . . 1.0 109.277 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -78.2 -37.51 45.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.326 -0.859 . . . . 1.0 109.299 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 180' ' ' VAL . 11.4 mt -55.74 -16.29 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 1.0 109.877 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 184' ' ' LEU . 9.8 t-20 -42.98 -27.01 0.16 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.824 0.821 . . . . 1.0 109.271 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 184' ' ' LEU . 2.3 t30 -134.74 143.17 45.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 188' ' ' THR . 46.1 Cg_endo -71.0 -158.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.632 1.333 . . . . 1.0 110.98 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.648 HG23 ' O ' ' A' ' 188' ' ' THR . 0.4 OUTLIER 64.09 22.91 13.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.603 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 1.001 ' C ' HD13 ' A' ' 190' ' ' LEU . 0.9 OUTLIER -92.78 112.6 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.272 -0.893 . . . . 1.0 110.781 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 1.001 HD13 ' C ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -109.48 149.56 29.41 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.13 -0.981 . . . . 1.0 109.201 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.6 ' CE1' ' CD1' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -99.63 101.63 12.89 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.97 -1.081 . . . . 1.0 109.835 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' HIS . 9.0 t -41.74 112.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 1.0 110.476 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 1.7 m -63.82 149.65 46.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.116 -0.99 . . . . 1.0 110.154 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 173.91 46.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 1.0 110.578 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.873 0 C-N-CA 118.433 -1.307 . . . . 1.0 110.55 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.9 p -128.14 99.7 5.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -1.137 . . . . 1.0 110.259 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -44.9 135.52 5.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 1.0 110.148 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -139.21 126.62 21.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 1.0 110.076 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.9 t -105.17 140.82 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 1.0 110.315 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.565 HD12 ' N ' ' A' ' 6' ' ' ILE . 1.8 mp -70.13 143.05 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 1.0 109.973 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mt -111.04 83.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 1.0 110.153 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.72 109.36 21.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 1.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -66.19 129.1 38.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 1.0 110.359 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.84 126.43 37.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.344 -0.847 . . . . 1.0 110.257 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.21 69.1 1.52 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 1.0 110.486 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.1 111.47 3.4 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.23 -1.548 . . . . 1.0 109.23 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -138.01 68.38 1.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -1.172 . . . . 1.0 110.515 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -103.12 17.36 24.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 1.0 110.284 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -46.08 90.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.815 . . . . 1.0 110.047 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -110.47 160.93 16.17 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.291 -0.88 . . . . 1.0 110.453 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.69 HG21 ' CE ' ' A' ' 25' ' ' MET . 6.4 mm -127.27 125.71 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 1.0 109.222 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -92.55 138.57 31.39 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.415 -0.803 . . . . 1.0 110.964 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.903 ' CE1' HD12 ' A' ' 167' ' ' ILE . 12.2 m-85 -101.27 169.05 9.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.568 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.82 -7.56 5.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.967 . . . . 1.0 110.634 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.35 37.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -129.24 -13.15 4.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.05 -1.265 . . . . 1.0 110.737 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.861 HG23 ' ND2' ' A' ' 186' ' ' ASN . 2.3 m -69.53 130.47 42.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.211 -0.931 . . . . 1.0 110.507 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -116.09 118.02 31.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.358 -0.838 . . . . 1.0 109.487 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.69 ' CE ' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -91.55 101.3 13.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.641 -1.287 . . . . 1.0 110.096 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.602 ' OE1' ' CZ2' ' A' ' 142' ' ' TRP . 5.4 tp10 -79.99 97.03 6.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.852 -0.795 . . . . 1.0 108.852 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 25' ' ' MET . 19.0 m-85 -95.37 97.57 9.93 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.103 -1.039 . . . . 1.0 111.362 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.82 123.72 41.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 1.0 108.849 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -133.3 157.33 45.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.852 -1.155 . . . . 1.0 111.225 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' VAL . . . -105.94 101.8 11.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.662 -0.649 . . . . 1.0 109.553 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.942 HG21 ' OD2' ' A' ' 138' ' ' ASP . 2.8 t -62.12 -132.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 1.0 109.988 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.476 ' H ' HG12 ' A' ' 31' ' ' VAL . 9.2 t -124.87 158.65 32.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.756 -1.215 . . . . 1.0 110.836 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 34' ' ' SER . 1.3 pttp -96.52 82.39 3.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.817 . . . . 1.0 109.773 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER 170.93 -32.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 1.0 109.813 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -94.64 13.27 24.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.505 -0.747 . . . . 1.0 109.908 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 4.9 pttt -41.63 140.97 0.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.442 -0.786 . . . . 1.0 110.133 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 36' ' ' LYS . . . 61.48 52.62 3.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 1.0 110.13 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.685 HD11 ' OD1' ' A' ' 41' ' ' ASN . 0.4 OUTLIER -61.85 162.5 8.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 110.163 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 35.7 tt0 -94.69 -3.79 48.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 1.0 110.658 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.499 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.2 p -167.29 155.13 9.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.049 -1.032 . . . . 1.0 110.635 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.685 ' OD1' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -128.17 148.68 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 1.0 110.077 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 13.8 m-70 -114.47 126.59 55.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 1.0 109.641 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.695 ' CZ ' HD11 ' A' ' 69' ' ' ILE . 73.9 m-85 -120.21 122.47 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -0.987 . . . . 1.0 111.137 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.766 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -128.3 134.96 49.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.032 . . . . 1.0 110.576 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.894 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.1 pt? -175.18 156.59 2.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.956 -1.09 . . . . 1.0 111.293 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.406 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -119.68 155.18 32.88 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.608 HG23 ' CD1' ' A' ' 105' ' ' ILE . 6.9 pt -146.35 169.6 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 118.665 -1.214 . . . . 1.0 112.286 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.626 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -129.01 92.57 3.42 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 178.322 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.932 ' CG2' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -73.21 157.6 36.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 1.0 112.286 -177.012 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.885 ' HB2' HG22 ' A' ' 164' ' ' ILE . 6.8 mm-40 -148.9 12.65 0.87 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.043 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -151.07 8.32 0.54 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.454 -1.404 . . . . 1.0 112.223 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.876 HG22 ' CA ' ' A' ' 76' ' ' GLY . 0.7 OUTLIER 50.98 11.03 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.969 -1.082 . . . . 1.0 111.823 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.8 tt0 -158.76 137.92 11.43 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.902 -1.124 . . . . 1.0 110.163 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 148.35 139.35 3.16 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.982 ' CD2' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -87.07 126.21 34.62 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.021 -1.282 . . . . 1.0 108.693 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.968 HD11 ' CG1' ' A' ' 73' ' ' ILE . 3.4 mp -92.49 -32.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 1.0 111.708 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.021 HD13 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -144.15 148.17 34.68 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.802 -1.186 . . . . 1.0 113.017 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.816 ' CZ2' HG21 ' A' ' 151' ' ' VAL . 21.3 t-105 -156.23 111.82 2.97 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.576 ' CB ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -114.77 128.5 56.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.829 -1.17 . . . . 1.0 111.511 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.97 98.7 0.62 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.286 -1.926 . . . . 1.0 108.286 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 61' ' ' LYS . 29.4 tptt -43.17 -57.3 3.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -1.103 . . . . 1.0 111.788 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . -161.29 -92.16 0.09 OUTLIER Glycine 0 N--CA 1.493 2.436 0 C-N-CA 118.494 -1.812 . . . . 1.0 111.544 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -31.66 152.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.955 -0.732 . . . . 1.0 111.62 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -81.67 43.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 1.0 110.227 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.51 31.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 1.0 109.404 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -131.37 171.05 13.82 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.325 -0.95 . . . . 1.0 111.648 -177.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.603 ' HA ' HD11 ' A' ' 135' ' ' LEU . 34.7 t0 31.01 78.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.13 0.49 . . . . 1.0 112.091 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.567 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 2.7 m-85 -92.47 77.55 5.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 1.0 110.603 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.695 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 2.5 tt -110.67 110.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.006 -1.059 . . . . 1.0 110.19 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.598 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -133.67 176.52 8.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.132 -0.98 . . . . 1.0 110.476 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.021 HD12 HD13 ' A' ' 57' ' ' LEU . 42.4 mt -147.88 113.09 5.54 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.966 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -131.8 164.25 26.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.95 -1.094 . . . . 1.0 111.855 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.968 ' CG1' HD11 ' A' ' 56' ' ' ILE . 7.0 mt -108.64 136.46 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.849 . . . . 1.0 110.669 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.74 HG22 ' CG ' ' A' ' 75' ' ' ASP . 4.2 p -141.67 120.6 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.81 . . . . 1.0 111.28 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.74 ' CG ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER 70.57 14.08 7.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 1.0 110.938 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.95 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 99.05 7.68 54.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.789 -1.324 . . . . 1.0 109.789 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.22 146.44 49.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -1.225 . . . . 1.0 109.385 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.821 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -93.38 162.58 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 1.0 109.589 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.522 ' CB ' ' HA ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -159.17 139.41 12.13 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.212 -0.93 . . . . 1.0 110.152 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.719 ' CB ' HD23 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -107.61 115.86 30.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.349 -0.941 . . . . 1.0 110.253 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.598 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 3.0 ptp -89.39 133.79 34.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.582 -1.323 . . . . 1.0 110.128 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.616 ' OH ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -126.92 128.93 47.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 1.0 110.688 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.567 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.5 t0 -146.53 66.21 1.18 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.287 1.041 . . . . 1.0 109.466 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.766 ' HB3' HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -66.87 -3.68 7.51 Favored 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.563 -0.71 . . . . 1.0 111.074 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -137.98 -55.43 0.05 OUTLIER Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.554 -1.308 . . . . 1.0 110.62 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.49 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -176.01 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.213 -1.169 . . . . 1.0 110.678 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 15.8 mmtp -98.48 110.87 58.44 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.009 -1.057 . . . . 1.0 109.795 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 82' ' ' TYR . 43.1 Cg_endo -71.93 159.9 49.13 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.86 1.453 . . . . 1.0 110.712 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -137.02 116.98 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 90' ' ' VAL . 1.8 p -95.99 112.44 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.404 -1.435 . . . . 1.0 110.974 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.738 ' C ' HG21 ' A' ' 124' ' ' ILE . 4.6 mt -105.69 71.56 0.92 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.536 ' O ' HG21 ' A' ' 124' ' ' ILE . 3.4 mtp180 -60.07 178.14 0.2 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.99 0.9 . . . . 1.0 110.909 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.524 ' OG ' HG21 ' A' ' 118' ' ' VAL . 7.9 t -100.11 161.35 13.66 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.648 -0.658 . . . . 1.0 110.656 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.581 HG23 ' CD1' ' A' ' 124' ' ' ILE . 0.8 OUTLIER -118.71 25.75 10.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 1.0 109.485 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.004 ' HB ' HG11 ' A' ' 118' ' ' VAL . 2.2 t -137.53 147.34 57.19 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.708 -0.62 . . . . 1.0 109.617 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.449 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.2 Cg_endo -65.91 137.12 47.77 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.806 1.424 . . . . 1.0 110.783 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.95 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -128.94 -22.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 1.0 111.197 -179.113 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.48 ' CB ' HG23 ' A' ' 52' ' ' THR . 6.7 p30 -74.2 54.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.982 . . . . 1.0 111.317 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.783 HG23 ' HB2' ' A' ' 101' ' ' HIS . 14.2 t -128.87 30.77 5.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.263 -0.898 . . . . 1.0 108.906 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.461 ' CG ' ' O ' ' A' ' 99' ' ' THR . 5.9 p-10 40.49 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.948 -0.47 . . . . 1.0 111.578 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.783 ' HB2' HG23 ' A' ' 99' ' ' THR . 0.3 OUTLIER -102.02 160.03 14.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.0 -1.062 . . . . 1.0 109.049 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.626 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 20.0 m95 -81.11 102.34 10.19 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.037 -1.039 . . . . 1.0 109.838 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 104' ' ' HIS . 18.2 m -93.8 173.79 7.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 1.0 109.246 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.611 ' N ' HG22 ' A' ' 103' ' ' THR . 3.2 t60 -121.81 125.57 46.8 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.316 -1.364 . . . . 1.0 107.316 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.608 ' CD1' HG23 ' A' ' 47' ' ' ILE . 1.5 mp -124.25 147.67 28.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.759 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -152.94 179.42 8.7 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.27 -1.372 . . . . 1.0 109.38 -178.15 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -164.4 145.98 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.834 -1.166 . . . . 1.0 111.811 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 4.7 m-85 -136.54 104.8 5.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.448 -0.782 . . . . 1.0 109.576 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.593 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -95.63 131.28 42.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.978 . . . . 1.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.551 ' N ' ' HD3' ' A' ' 109' ' ' ARG . 85.8 t -137.53 104.22 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.365 -0.835 . . . . 1.0 110.687 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.475 ' O ' ' CB ' ' A' ' 112' ' ' ARG . 16.4 mt-30 40.83 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.591 -0.693 . . . . 1.0 112.206 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.1 OUTLIER 71.59 -50.61 0.69 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 1.0 112.734 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 6.3 tt0 -85.04 122.03 28.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.691 -1.256 . . . . 1.0 111.511 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.35 166.7 12.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.546 ' O ' ' CE ' ' A' ' 80' ' ' MET . 42.1 t -145.0 151.83 39.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.288 -1.125 . . . . 1.0 111.075 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.078 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -111.77 147.25 36.07 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 1.078 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -127.45 91.65 3.35 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.778 -1.169 . . . . 1.0 112.591 -177.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 1.004 HG11 ' HB ' ' A' ' 95' ' ' VAL . 70.4 t -78.93 87.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.748 -1.204 . . . . 1.0 107.748 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 56.88 58.28 15.33 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.802 -1.19 . . . . 1.0 110.348 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' A' ' 117' ' ' GLN . 3.6 t-20 41.4 24.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.433 -1.039 . . . . 1.0 112.237 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 1.1 mt-10 -97.83 -166.7 1.41 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.748 -1.22 . . . . 1.0 109.304 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.7 96.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.87 0 C-N-CA 120.0 -0.68 . . . . 1.0 109.587 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.529 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.8 Cg_endo -74.93 130.43 13.34 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.091 1.574 . . . . 1.0 110.871 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.746 HG22 ' HB3' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -86.05 144.5 9.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 O-C-N 121.153 -0.967 . . . . 1.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.61 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 4.6 p -138.83 158.13 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.524 -1.36 . . . . 1.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.734 ' N ' HD21 ' A' ' 91' ' ' LEU . . . -166.21 165.47 38.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.209 -2.356 . . . . 1.0 107.209 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -152.91 151.2 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.594 -1.533 . . . . 1.0 111.79 -179.342 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.1 p -106.02 173.96 2.89 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.746 -0.596 . . . . 1.0 109.911 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 131' ' ' GLY . 45.2 Cg_endo -70.65 67.77 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.915 1.482 . . . . 1.0 110.18 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.0 OUTLIER -4.04 70.28 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 121.581 0.705 . . . . 1.0 112.798 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -84.68 -71.17 1.32 Allowed Glycine 0 C--N 1.288 -2.093 0 N-CA-C 109.196 -1.562 . . . . 1.0 109.196 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.765 ' HB3' HD12 ' A' ' 84' ' ' LEU . . . -67.7 86.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -1.186 . . . . 1.0 109.369 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.877 HG22 ' NE2' ' A' ' 134' ' ' GLN . 16.7 m -19.0 -69.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.036 0.446 . . . . 1.0 111.986 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.877 ' NE2' HG22 ' A' ' 133' ' ' THR . 0.0 OUTLIER -113.65 -45.87 3.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 1.0 110.023 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 84' ' ' LEU . 0.2 OUTLIER 62.2 113.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.899 . . . . 1.0 110.346 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.504 ' C ' ' CG2' ' A' ' 137' ' ' THR . 15.2 m-20 -73.19 138.97 45.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 1.0 109.534 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.673 ' CG2' HD13 ' A' ' 135' ' ' LEU . 7.2 p -153.53 105.0 2.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 1.0 109.792 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.942 ' OD2' HG21 ' A' ' 31' ' ' VAL . 7.9 p-10 170.61 -39.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -24.91 -43.91 0.01 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -146.99 173.81 12.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.903 -1.351 . . . . 1.0 110.445 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.635 ' CD1' HD21 ' A' ' 57' ' ' LEU . 10.3 tp -160.86 148.79 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.344 -0.848 . . . . 1.0 110.248 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.607 ' CG ' ' HE3' ' A' ' 146' ' ' MET . 20.7 m95 -133.23 143.49 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.303 -0.999 . . . . 1.0 108.303 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.991 HD13 HD12 ' A' ' 57' ' ' LEU . 6.6 tp -145.68 118.89 8.89 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.945 -1.502 . . . . 1.0 112.974 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 122.67 1.86 9.75 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.367 -1.093 . . . . 1.0 110.367 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.493 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 144.32 -135.24 6.09 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 118.936 -1.602 . . . . 1.0 109.727 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' MET . . . . . 1.065 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -170.79 176.48 4.17 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.816 -0.814 . . . . 1.0 111.714 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -96.37 -25.35 15.76 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.919 0.866 . . . . 1.0 108.918 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.562 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.91 74.59 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.822 -1.548 . . . . 1.0 106.822 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.065 HD13 ' HB2' ' A' ' 146' ' ' MET . 3.8 tp -71.39 24.69 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 113.926 1.084 . . . . 1.0 113.926 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.6 p -62.16 -21.01 64.72 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 104.68 -2.341 . . . . 1.0 104.68 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.861 HG12 ' HA ' ' A' ' 149' ' ' LEU 0.284 13.5 p -58.32 -118.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.348 -1.297 . . . . 1.0 110.154 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 151' ' ' VAL . . . 70.24 -71.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.809 -1.182 . . . . 1.0 109.927 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.629 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 18.3 m170 132.16 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.477 ' HD3' ' HB3' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -137.14 12.11 3.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.005 . . . . 1.0 109.706 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 1.084 ' CD2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -70.36 165.61 42.86 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.421 -0.799 . . . . 1.0 111.126 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.611 ' N ' HD22 ' A' ' 155' ' ' LEU . 40.9 Cg_endo -64.97 -168.68 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.967 1.509 . . . . 1.0 112.448 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.565 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 2.2 mttp -53.28 -10.77 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 1.084 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -38.25 -44.82 0.91 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.044 -1.035 . . . . 1.0 109.983 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.981 ' O ' HD23 ' A' ' 149' ' ' LEU . 15.4 m-85 -84.37 -28.45 26.99 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.945 -1.097 . . . . 1.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -71.64 -7.08 45.67 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.57 -1.252 . . . . 1.0 108.544 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 161' ' ' THR . 1.3 m -131.72 98.27 4.44 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -47.38 175.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.628 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 54.5 t80 -79.07 149.24 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -1.157 . . . . 1.0 112.061 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.885 HG22 ' HB2' ' A' ' 50' ' ' GLU . 1.1 mt -130.8 88.17 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.628 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.2 -153.69 9.48 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.061 -1.616 . . . . 1.0 109.061 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.523 ' C ' HG13 ' A' ' 167' ' ' ILE . 15.0 m -137.32 148.03 46.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.465 -1.021 . . . . 1.0 110.06 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.903 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -133.84 153.64 36.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.526 -0.734 . . . . 1.0 109.717 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.503 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 18.7 ttt180 -163.02 162.37 25.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.657 -1.277 . . . . 1.0 110.963 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER 48.71 78.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.394 -0.816 . . . . 1.0 110.464 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.894 HG12 ' CB ' ' A' ' 45' ' ' LEU . 16.2 m -121.77 135.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 119.362 -0.935 . . . . 1.0 108.937 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.474 HG12 ' C ' ' A' ' 170' ' ' VAL . 0.0 OUTLIER -146.22 148.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.319 -0.953 . . . . 1.0 111.176 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.625 HG13 ' CD1' ' A' ' 43' ' ' PHE . 1.7 t -130.32 102.43 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 10.9 m-20 51.96 42.55 30.35 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 1.0 108.143 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 75.51 26.38 1.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.254 0.549 . . . . 1.0 110.421 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.614 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . 63.9 mt-30 -102.15 -174.67 2.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.358 -0.838 . . . . 1.0 109.726 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 1.9 mm-40 62.64 -92.99 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.685 -0.634 . . . . 1.0 110.656 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER 65.88 -87.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 1.0 111.21 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 47.8 m80 -74.72 102.39 4.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.998 -1.063 . . . . 1.0 111.509 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 183' ' ' ALA 0.253 0.4 OUTLIER -57.22 -58.4 8.38 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 122.419 1.104 . . . . 1.0 109.709 177.881 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.694 ' O ' HD22 ' A' ' 184' ' ' LEU . 95.0 t -50.54 -31.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.99 -1.005 . . . . 1.0 111.262 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 19.7 mt-10 -61.69 -53.81 51.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.121 -0.987 . . . . 1.0 109.929 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.588 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 2.7 t0 -89.79 -15.46 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 1.0 109.665 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 180' ' ' VAL . . . -72.82 -25.08 61.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.326 -0.859 . . . . 1.0 109.032 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.694 HD22 ' O ' ' A' ' 180' ' ' VAL . 0.1 OUTLIER -62.61 -15.49 51.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 1.0 109.438 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -24.15 63.93 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.938 0.875 . . . . 1.0 108.777 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.861 ' ND2' HG23 ' A' ' 23' ' ' THR . 3.6 t-20 -96.46 151.06 37.8 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.487 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 38.8 Cg_endo -64.87 143.61 80.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.538 1.283 . . . . 1.0 111.212 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.473 ' CG2' ' N ' ' A' ' 189' ' ' ILE . 0.8 OUTLIER 49.9 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.585 -0.697 . . . . 1.0 110.648 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.473 ' N ' ' CG2' ' A' ' 188' ' ' THR . 14.2 mm -141.03 121.99 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 1.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 mt -111.25 159.23 18.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.148 -0.97 . . . . 1.0 110.641 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -127.57 153.33 46.52 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 1.0 109.409 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 4.1 t -70.36 165.95 21.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.021 -1.05 . . . . 1.0 110.47 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.69 166.98 19.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 1.0 110.045 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -169.52 46.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 1.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.834 0 C-N-CA 118.717 -1.193 . . . . 1.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.7 OUTLIER 66.69 -161.6 0.24 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -1.186 . . . . 1.0 109.999 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 2' ' ' SER . 3.0 mt-10 56.46 167.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 1.0 110.302 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -173.28 88.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 1.0 109.897 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 5' ' ' VAL . 10.4 p -70.17 113.09 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 1.0 110.394 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.528 HD13 ' C ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -127.65 128.82 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 1.0 109.784 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.4 pt -91.19 146.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.111 -0.993 . . . . 1.0 110.37 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.53 138.33 36.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 1.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -127.77 90.52 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.85 . . . . 1.0 110.364 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.96 132.33 55.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.491 -0.756 . . . . 1.0 109.652 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.47 60.22 6.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 1.0 110.384 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.43 108.17 2.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.629 -1.388 . . . . 1.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -164.49 46.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -1.234 . . . . 1.0 110.185 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 168' ' ' ARG . . . -122.93 53.77 1.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 1.0 110.408 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 2.4 pt-20 -77.85 79.96 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.845 . . . . 1.0 110.367 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.51 134.21 34.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.157 -1.589 . . . . 1.0 110.925 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 190' ' ' LEU . 6.8 mm -125.94 142.14 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -0.975 . . . . 1.0 109.29 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -98.58 133.58 42.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.425 -0.797 . . . . 1.0 111.043 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.815 ' CE1' HD12 ' A' ' 167' ' ' ILE . 7.5 m-85 -95.84 175.74 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 1.0 109.192 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 45.6 p-10 -139.5 4.63 2.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.956 . . . . 1.0 110.655 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.483 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.74 -30.58 10.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.577 -1.809 . . . . 1.0 108.577 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 23' ' ' THR . 3.4 ttp-105 -100.92 -12.78 18.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.455 -1.027 . . . . 1.0 109.628 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.809 HG21 ' CD2' ' A' ' 19' ' ' PHE . 11.8 m -42.82 135.52 2.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 1.0 110.379 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.669 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -133.75 99.14 4.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 4.1 mtt -93.98 100.63 12.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.39 -1.444 . . . . 1.0 109.407 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.633 ' CG ' ' CZ3' ' A' ' 142' ' ' TRP . 2.7 tm-20 -103.72 101.8 11.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 1.0 110.325 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 182' ' ' ASP . 19.7 m-30 -108.81 116.41 31.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.258 -0.902 . . . . 1.0 109.346 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -115.67 122.39 45.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 1.0 110.59 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -156.35 163.4 39.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.0 110.242 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.27 167.28 19.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.503 ' O ' ' HB ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -148.04 24.45 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.089 -1.007 . . . . 1.0 110.83 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.832 HG21 ' O ' ' A' ' 35' ' ' GLU . 5.8 t -178.53 -177.61 0.55 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.002 -1.061 . . . . 1.0 110.386 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -83.43 94.42 7.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.218 -0.926 . . . . 1.0 110.557 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 33' ' ' LYS . 2.0 t 35.88 39.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.618 -0.676 . . . . 1.0 110.802 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.832 ' O ' HG21 ' A' ' 32' ' ' THR . 0.3 OUTLIER -154.77 74.9 0.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.215 -0.928 . . . . 1.0 110.336 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 1.9 mptp? -61.07 116.69 4.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 1.0 110.127 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . 175.33 117.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.383 -0.823 . . . . 1.0 109.715 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tp -127.5 -170.63 2.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 1.0 110.754 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.2 -34.64 0.64 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.657 0.742 . . . . 1.0 109.764 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.6 p -118.38 149.9 40.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 7.4 m120 -133.59 117.31 16.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.032 -1.043 . . . . 1.0 111.158 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 6.5 m-70 -94.87 108.74 20.77 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 8.4 m-85 -113.83 118.04 33.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 1.0 111.333 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.644 ' C ' HD23 ' A' ' 45' ' ' LEU . 2.1 mt-10 -127.99 150.62 49.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.183 -0.948 . . . . 1.0 110.577 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER 179.9 153.55 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.266 -0.896 . . . . 1.0 110.552 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 167' ' ' ILE . 0.7 OUTLIER -130.12 149.42 51.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 1.0 109.787 179.029 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.994 HD11 ' CG1' ' A' ' 97' ' ' ILE . 9.4 pt -131.22 177.28 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.186 -1.006 . . . . 1.0 110.067 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.641 ' O ' ' OG1' ' A' ' 49' ' ' THR . 12.4 tttt -167.0 82.31 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.204 -0.935 . . . . 1.0 111.018 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.998 HG22 ' HG2' ' A' ' 50' ' ' GLU . 29.5 m -172.03 -114.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.238 0.542 . . . . 1.0 111.095 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.998 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -115.04 -47.45 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.683 1.23 . . . . 1.0 109.586 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 1.042 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . 34.98 41.99 0.07 Allowed 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.413 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.626 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 64.9 p -85.51 -17.25 36.97 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.87 -1.144 . . . . 1.0 108.537 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.478 ' OE1' ' HB2' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -159.95 119.82 2.92 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 154.73 129.05 1.22 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.15 -1.58 . . . . 1.0 109.15 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.863 HD21 ' CD1' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -81.3 131.12 35.27 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.652 -1.499 . . . . 1.0 109.334 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.833 HD12 ' HA ' ' A' ' 72' ' ' ALA . 1.3 mp -97.21 -25.75 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.492 -0.755 . . . . 1.0 112.217 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.923 HD13 HD12 ' A' ' 71' ' ' LEU . 6.1 tt -148.7 133.74 18.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.723 -1.86 . . . . 1.0 113.211 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.977 ' CH2' HG21 ' A' ' 151' ' ' VAL . 20.4 t-105 -145.73 117.59 8.2 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB2' ' HA ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -137.6 153.03 49.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.841 -1.162 . . . . 1.0 111.024 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 61' ' ' LYS . . . -158.37 -121.09 0.62 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.579 -1.809 . . . . 1.0 108.579 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.546 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER 172.33 -84.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.224 -1.162 . . . . 1.0 110.09 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.546 ' N ' ' HG3' ' A' ' 61' ' ' LYS . . . -61.31 132.0 47.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.81 -1.716 . . . . 1.0 108.81 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.5 ' O ' ' O ' ' A' ' 62' ' ' GLY . 18.6 mt 58.61 137.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.449 -1.03 . . . . 1.0 109.965 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 4.2 pt-20 -71.33 56.11 0.23 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.813 -1.179 . . . . 1.0 109.997 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 8.4 ptp180 167.98 45.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -92.52 -176.67 4.36 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-O 121.868 0.842 . . . . 1.0 112.441 -177.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.549 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 9.8 p-10 -87.59 141.7 28.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.777 -0.577 . . . . 1.0 111.548 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.794 ' CG ' HG22 ' A' ' 69' ' ' ILE . 6.6 t80 174.19 -100.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.561 -0.712 . . . . 1.0 111.029 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.794 HG22 ' CG ' ' A' ' 68' ' ' TYR . 1.8 tt -153.79 162.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.523 -1.361 . . . . 1.0 111.843 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.904 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -157.71 170.15 23.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 1.0 110.032 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.923 HD12 HD13 ' A' ' 57' ' ' LEU . 77.6 mt -145.17 125.79 14.17 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.833 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -152.71 172.36 16.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.94 -1.1 . . . . 1.0 111.325 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.042 HD13 ' HB1' ' A' ' 51' ' ' ALA . 5.5 mt -127.49 146.01 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 1.0 111.452 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.62 ' CG1' ' CG ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -141.46 122.69 13.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.306 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.1 m-20 73.76 -3.98 2.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.335 -0.853 . . . . 1.0 112.169 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.68 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 127.4 -0.65 6.97 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 118.866 -1.635 . . . . 1.0 111.045 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.723 ' C ' HG23 ' A' ' 73' ' ' ILE . 25.7 m-85 -133.93 134.13 42.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.93 -1.335 . . . . 1.0 110.545 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.79 HG23 HG13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -59.97 -167.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 1.0 109.946 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.947 ' HB2' HG22 ' A' ' 90' ' ' VAL . 1.3 pt20 -174.75 97.37 0.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.441 -0.787 . . . . 1.0 109.819 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.607 ' HE3' ' CD1' ' A' ' 91' ' ' LEU . 3.2 ttp -62.21 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.614 -0.834 . . . . 1.0 109.233 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.904 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 12.2 ttp -95.02 108.77 20.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.651 -0.656 . . . . 1.0 110.21 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.884 ' CE2' HG11 ' A' ' 89' ' ' VAL . 1.4 p90 -125.74 138.57 53.87 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.015 -1.474 . . . . 1.0 111.013 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 0.6 OUTLIER -136.6 94.93 3.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.75 -0.594 . . . . 1.0 110.444 -179.288 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -102.52 3.27 37.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.835 -0.541 . . . . 1.0 110.654 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -136.44 -43.03 0.1 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.302 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 167.72 -20.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.193 -1.181 . . . . 1.0 110.983 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 7.8 mttt -118.8 120.35 31.6 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.097 . . . . 1.0 110.081 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.602 ' HG3' ' CE1' ' A' ' 153' ' ' HIS . 52.6 Cg_endo -78.31 146.62 22.36 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.946 1.498 . . . . 1.0 110.151 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.884 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -112.97 121.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.323 -0.861 . . . . 1.0 108.729 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.947 HG22 ' HB2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -102.5 111.29 31.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.09 -1.444 . . . . 1.0 110.427 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.607 ' CD1' ' HE3' ' A' ' 80' ' ' MET . 11.7 mt -105.61 70.05 0.86 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.9 -1.519 . . . . 1.0 106.9 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.618 ' O ' HD13 ' A' ' 124' ' ' ILE . 20.0 mtp180 -60.5 148.97 35.89 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 122.121 0.963 . . . . 1.0 111.22 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.738 ' OG ' HG21 ' A' ' 118' ' ' VAL 0.253 48.2 t -67.57 150.67 48.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.824 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.588 ' N ' HD11 ' A' ' 124' ' ' ILE . 12.1 t -107.57 26.73 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.789 . . . . 1.0 109.023 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.975 ' HB ' HG11 ' A' ' 118' ' ' VAL . 2.1 t -139.88 153.3 69.6 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.663 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.9 Cg_endo -65.84 124.69 13.07 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.661 1.348 . . . . 1.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.994 ' CG1' HD11 ' A' ' 47' ' ' ILE . 3.3 tp -109.55 -8.42 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.805 . . . . 1.0 110.03 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 5.4 p-10 -93.77 56.89 2.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.758 . . . . 1.0 109.896 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 99' ' ' THR . 98.1 m -114.61 7.04 15.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.227 -0.921 . . . . 1.0 110.739 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.458 ' HA ' ' CA ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 60.54 10.94 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.331 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -104.47 163.11 12.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 1.0 109.742 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 15.6 m95 -78.08 91.87 4.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.003 -1.061 . . . . 1.0 110.864 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.552 HG21 HD12 ' A' ' 97' ' ' ILE . 22.9 m -86.63 167.5 14.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.76 -0.829 . . . . 1.0 108.76 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.523 ' N ' HG22 ' A' ' 103' ' ' THR . 23.1 t60 -123.98 132.45 53.71 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.208 -0.997 . . . . 1.0 109.782 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.488 HG22 HD11 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -126.78 142.94 41.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.318 -0.864 . . . . 1.0 108.979 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.724 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -148.34 179.65 7.62 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.018 -1.073 . . . . 1.0 109.309 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 108' ' ' TYR . . . -165.11 157.63 15.9 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.808 -1.182 . . . . 1.0 111.824 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 6.0 m-85 -136.21 104.39 5.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 1.0 109.299 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -103.02 134.75 45.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.911 -1.118 . . . . 1.0 109.945 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.527 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 3.0 t -130.56 84.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.161 -1.016 . . . . 1.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 32.4 mt-30 53.85 -2.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -179.37 -27.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.042 -1.661 . . . . 1.0 111.066 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.526 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -110.35 115.9 30.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 1.0 110.718 -178.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -103.54 149.89 17.46 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.72 ' CB ' HG22 ' A' ' 125' ' ' THR . 12.5 t -132.36 155.59 48.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.274 -1.133 . . . . 1.0 110.266 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 117' ' ' GLN . 1.6 tm? -123.65 144.89 49.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.802 -1.186 . . . . 1.0 108.679 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 1.033 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -121.04 81.35 1.76 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.411 -0.806 . . . . 1.0 112.3 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.975 HG11 ' HB ' ' A' ' 95' ' ' VAL . 91.4 t -70.29 80.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.772 -1.171 . . . . 1.0 107.933 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 67.12 59.77 6.61 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.072 -1.211 . . . . 1.0 110.072 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.456 ' H ' ' HG3' ' A' ' 117' ' ' GLN . 7.8 m120 36.68 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.898 . . . . 1.0 111.25 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -103.18 -161.4 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 1.0 109.919 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.577 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -39.82 99.38 0.2 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.555 -0.716 . . . . 1.0 109.375 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.1 Cg_endo -71.17 129.88 16.78 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.211 1.638 . . . . 1.0 110.892 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 93' ' ' SER . 3.0 mt -101.45 102.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.72 HG22 ' CB ' ' A' ' 115' ' ' SER . 30.2 p -114.06 173.42 6.45 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.261 1.029 . . . . 1.0 112.299 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.405 ' C ' ' OG ' ' A' ' 127' ' ' SER . . . -178.09 -171.35 41.37 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.532 -2.227 . . . . 1.0 107.532 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -159.5 171.01 20.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.597 -1.531 . . . . 1.0 110.892 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.564 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.6 OUTLIER -107.97 -177.89 0.52 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 1.0 110.193 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.8 Cg_endo -69.39 94.88 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 1.0 108.946 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.666 ' H ' HD12 ' A' ' 130' ' ' LEU . 3.4 mp -34.32 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.228 0.537 . . . . 1.0 111.098 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.03 -29.04 1.25 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.614 -1.394 . . . . 1.0 109.614 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.493 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -90.66 135.33 33.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -1.16 . . . . 1.0 110.333 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.435 ' C ' ' HG2' ' A' ' 134' ' ' GLN . 9.7 m -138.38 23.47 2.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 1.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.51 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -158.52 -49.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 1.0 110.398 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER 28.14 64.01 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.232 0.539 . . . . 1.0 111.523 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -52.55 96.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.122 -0.986 . . . . 1.0 110.199 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 68' ' ' TYR . 10.5 t -159.72 -172.88 3.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 1.0 109.759 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 91.59 -19.87 0.12 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 121.298 0.571 . . . . 1.0 110.544 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -47.99 -17.0 0.51 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 120.198 -1.001 . . . . 1.0 110.743 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -128.79 168.36 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.631 -1.511 . . . . 1.0 109.748 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 0.5 OUTLIER -154.88 145.96 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 1.0 110.861 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.633 ' CZ3' ' CG ' ' A' ' 26' ' ' GLU . 30.2 m95 -136.6 96.47 3.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.131 -1.803 . . . . 1.0 106.131 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.688 HD12 ' CB ' ' A' ' 57' ' ' LEU . 1.7 tp -112.34 130.05 56.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.97 1.47 . . . . 1.0 114.97 -175.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 106.99 10.05 28.88 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.701 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 124.93 -160.82 19.56 Favored Glycine 0 C--N 1.278 -2.648 0 N-CA-C 107.762 -2.135 . . . . 1.0 107.762 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.931 ' HB2' HD12 ' A' ' 149' ' ' LEU . 1.9 mmt -168.78 169.5 9.91 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.282 -1.367 . . . . 1.0 111.059 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.9 11.32 38.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -165.43 16.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.667 -0.646 . . . . 1.0 111.525 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.931 HD12 ' HB2' ' A' ' 146' ' ' MET . 9.2 mt -68.42 53.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.402 -1.436 . . . . 1.0 109.865 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 148' ' ' ARG . 10.5 p -55.19 -24.31 26.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.413 -1.699 . . . . 1.0 106.413 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.977 HG21 ' CH2' ' A' ' 58' ' ' TRP 0.311 12.7 p -48.21 -118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.051 -1.431 . . . . 1.0 111.86 178.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' A' ' 155' ' ' LEU . . . 79.81 -23.25 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.11 -0.993 . . . . 1.0 109.993 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.602 ' CE1' ' HG3' ' A' ' 88' ' ' PRO . 0.2 OUTLIER 75.68 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 1.0 111.163 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.577 ' CG ' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -150.04 74.92 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.823 -1.173 . . . . 1.0 111.137 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -142.47 178.41 1.51 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 120.696 -1.252 . . . . 1.0 110.029 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.62 ' CG ' ' CG1' ' A' ' 74' ' ' VAL . 52.6 Cg_endo -76.76 -164.2 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.707 1.372 . . . . 1.0 111.948 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 161' ' ' THR . 2.8 mttm -51.21 -10.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.609 -0.682 . . . . 1.0 112.131 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.609 ' HB3' ' CD1' ' A' ' 155' ' ' LEU . . . -32.75 -46.52 0.14 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.121 -0.987 . . . . 1.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.964 ' CD2' ' HB2' ' A' ' 152' ' ' ALA . 3.6 m-85 -83.97 -33.98 24.49 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.558 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -76.06 -1.7 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.977 -1.089 . . . . 1.0 108.813 178.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 161' ' ' THR . 2.6 m -140.74 83.24 1.88 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.547 -0.72 . . . . 1.0 109.29 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -43.54 165.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.154 -1.578 . . . . 1.0 109.154 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.802 ' CE1' ' HB2' ' A' ' 51' ' ' ALA . 32.6 t80 -70.63 142.67 51.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.286 . . . . 1.0 110.485 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.672 ' O ' HG21 ' A' ' 49' ' ' THR . 19.3 mt -119.79 79.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.761 ' HA2' HG21 ' A' ' 49' ' ' THR . . . -165.48 -163.19 18.33 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 1.8 m -114.41 146.92 40.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -1.183 . . . . 1.0 111.585 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.815 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -136.45 152.62 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.166 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.468 ' HG2' ' OD1' ' A' ' 169' ' ' ASP . 13.5 ttp180 -158.6 159.1 35.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 1.0 110.769 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.7 m-20 53.13 79.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 1.0 110.509 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.589 HG12 ' CB ' ' A' ' 45' ' ' LEU . 28.5 m -128.72 131.71 68.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.495 ' CG1' ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -150.88 149.24 14.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.03 -1.068 . . . . 1.0 110.899 -176.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.531 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 8.9 t -135.25 108.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 1.5 m-20 50.53 42.96 27.33 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.391 -1.443 . . . . 1.0 107.469 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.31 28.7 2.93 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.906 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 176' ' ' GLU . 4.7 mt-30 -100.98 -178.13 3.66 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.102 -0.999 . . . . 1.0 109.217 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 4.5 mm-40 69.62 -98.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.634 -0.666 . . . . 1.0 110.44 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER 69.27 -88.02 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.256 -0.903 . . . . 1.0 111.05 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 9.3 m80 -97.44 103.17 15.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.739 -1.225 . . . . 1.0 111.097 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.5 OUTLIER -67.4 -53.56 28.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 22.1 t -51.47 -23.05 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.699 . . . . 1.0 110.381 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 35.5 mt-10 -71.69 -58.43 3.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 1.0 110.01 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.575 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 12.3 t0 -87.49 -14.63 39.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 1.0 109.619 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -69.65 -34.16 73.62 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.254 -0.904 . . . . 1.0 108.873 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.655 ' HA ' HD11 ' A' ' 189' ' ' ILE . 11.3 mt -48.68 -24.23 1.3 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 1.0 108.975 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 1.2 t-20 -57.22 -20.11 25.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.101 0.953 . . . . 1.0 109.009 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.512 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 1.8 t30 -89.61 151.95 46.5 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.512 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 37.5 Cg_endo -61.82 -149.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.3 1.158 . . . . 1.0 109.309 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.504 ' C ' ' O ' ' A' ' 187' ' ' PRO . 20.5 m -33.06 136.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.355 -0.84 . . . . 1.0 111.197 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 184' ' ' LEU . 13.4 mt -127.78 153.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.505 -0.747 . . . . 1.0 109.795 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 17' ' ' ILE . 23.1 mt -131.2 155.27 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 1.0 110.648 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 18' ' ' ALA . 1.9 m-70 -92.29 -87.96 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.818 . . . . 1.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 191' ' ' HIS . 5.3 t -178.31 167.54 1.9 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.373 -0.931 . . . . 1.0 111.498 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 74.5 m -128.24 163.78 23.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.583 -0.698 . . . . 1.0 109.545 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -131.53 111.02 11.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 1.0 110.215 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.763 0 C-N-CA 118.904 -1.118 . . . . 1.0 110.497 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.584 -1.406 . . . . 1.0 109.584 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 p -128.1 48.08 2.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 1.0 110.059 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.29 41.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.372 -0.83 . . . . 1.0 110.319 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -117.58 -162.9 0.9 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 1.0 110.205 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 5' ' ' VAL . 27.9 m -53.11 119.56 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.24 -0.913 . . . . 1.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.415 ' HA ' HD13 ' A' ' 6' ' ' ILE . 23.0 mm -79.56 148.92 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.83 . . . . 1.0 110.39 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.439 ' O ' HG13 ' A' ' 7' ' ' ILE . 1.2 pp -119.72 120.47 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 1.0 110.06 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -121.4 115.62 23.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.104 -0.997 . . . . 1.0 110.098 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HG2' ' N ' ' A' ' 10' ' ' ALA . 22.3 ttpt -64.73 166.54 8.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.394 -0.816 . . . . 1.0 110.403 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' A' ' 9' ' ' LYS . . . -82.64 147.57 28.47 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.219 -0.926 . . . . 1.0 109.894 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.58 66.43 6.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.45 -0.781 . . . . 1.0 110.519 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.57 130.42 9.74 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -158.63 21.79 0.22 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.189 -1.183 . . . . 1.0 110.483 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.52 49.99 1.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.93 . . . . 1.0 110.133 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.1 pt-20 -72.4 70.62 0.88 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.267 -0.896 . . . . 1.0 110.785 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -112.3 119.41 38.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.533 -1.354 . . . . 1.0 109.79 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.628 ' CG1' HD12 ' A' ' 179' ' ' LEU . 10.1 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.533 -1.267 . . . . 1.0 110.421 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -91.15 115.59 28.14 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.731 -0.606 . . . . 1.0 110.532 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.783 ' CZ ' HD13 ' A' ' 167' ' ' ILE . 5.0 m-30 -74.52 167.6 21.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 1.0 109.114 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 23' ' ' THR . 1.4 p-10 -117.57 -10.13 10.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.057 -1.027 . . . . 1.0 110.18 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.497 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 105.45 -9.28 45.07 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' CD ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -147.04 21.16 1.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.167 -1.196 . . . . 1.0 110.055 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m -115.62 102.81 10.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.0 109.867 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.632 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -67.12 117.46 9.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 1.0 111.015 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.614 ' HE1' HG21 ' A' ' 17' ' ' ILE . 3.4 mmm -106.8 98.56 8.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.689 -1.257 . . . . 1.0 108.27 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' OE1' ' CZ3' ' A' ' 142' ' ' TRP . 4.6 pt-20 -107.84 152.3 24.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.311 -0.868 . . . . 1.0 110.261 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.562 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 3.3 m-85 -130.48 124.66 32.49 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.243 -0.983 . . . . 1.0 110.001 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.441 ' CD2' ' HB2' ' A' ' 140' ' ' ALA . 0.0 OUTLIER -97.55 89.64 4.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.567 -0.708 . . . . 1.0 110.287 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -88.67 151.72 22.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 1.0 109.781 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.32 108.4 19.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.172 -0.955 . . . . 1.0 110.666 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.787 HG11 ' OE1' ' A' ' 175' ' ' GLN . 19.1 m -135.3 169.35 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 1.0 110.003 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.24 126.06 18.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 1.0 110.314 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 103.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 1.0 110.002 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -58.57 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 1.0 110.489 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 36' ' ' LYS . 3.7 mt-10 -147.67 119.73 8.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.004 . . . . 1.0 110.789 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER 69.68 145.03 0.05 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.314 -0.867 . . . . 1.0 111.177 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.5 ' CB ' ' OD1' ' A' ' 136' ' ' ASP . . . -88.92 -37.58 15.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.764 . . . . 1.0 108.97 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.047 HD13 ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -106.94 155.42 19.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 1.0 110.091 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 1.013 ' N ' HD22 ' A' ' 38' ' ' LEU . 31.8 tt0 160.71 -75.63 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.949 0.88 . . . . 1.0 109.18 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.74 ' OG ' HG13 ' A' ' 110' ' ' VAL . 5.7 m -157.03 119.15 3.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.19 0.519 . . . . 1.0 110.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -103.67 163.3 12.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 1.0 110.439 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.556 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 59.1 m-70 -139.07 132.84 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 1.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.074 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 93.5 m-85 -135.24 115.44 13.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.57 -0.706 . . . . 1.0 109.625 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.825 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.1 mp0 -123.72 144.19 49.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.823 -1.173 . . . . 1.0 109.756 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.871 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -178.38 159.39 1.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.393 -0.923 . . . . 1.0 110.882 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 103' ' ' THR . 1.0 OUTLIER -123.49 154.38 39.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.156 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 166' ' ' CYS . 1.9 pt -148.14 156.01 9.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 117.907 -1.517 . . . . 1.0 112.045 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.615 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -105.94 86.45 2.38 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 176.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.566 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -75.27 153.36 38.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.125 -1.03 . . . . 1.0 112.841 -175.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 3.2 mm-40 -143.48 1.97 1.23 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.434 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.39 128.78 24.18 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.047 -1.033 . . . . 1.0 110.285 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.547 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 58.3 p -62.88 -15.4 54.72 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.379 -0.826 . . . . 1.0 110.844 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HG2' ' N ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -129.82 135.65 48.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.846 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 159.33 137.14 2.17 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -90.84 126.24 35.97 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.051 -1.264 . . . . 1.0 108.797 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.913 HG22 HD21 ' A' ' 143' ' ' LEU . 0.5 OUTLIER -91.25 -34.32 6.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.067 0.766 . . . . 1.0 113.067 -176.298 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 71' ' ' LEU . 3.1 tt -142.76 151.91 41.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.018 -1.676 . . . . 1.0 113.338 -175.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.686 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 9.6 t-105 -162.88 107.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -114.35 137.27 52.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.661 -1.274 . . . . 1.0 111.023 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.89 -179.64 16.2 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.37 -1.892 . . . . 1.0 108.37 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 13.6 tttp -118.54 54.08 0.96 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.885 -1.362 . . . . 1.0 110.299 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.47 -142.99 16.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mp 48.23 -152.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -1.102 . . . . 1.0 110.321 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 43.1 mt-10 -139.68 13.21 2.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 1.0 110.345 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER 171.0 64.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 1.0 108.949 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.57 140.17 49.0 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.182 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -56.49 164.89 1.25 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.634 -0.666 . . . . 1.0 110.796 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.635 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 1.1 t80 169.62 -118.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.829 -0.544 . . . . 1.0 109.798 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.946 HD11 ' CD2' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -130.06 172.88 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.734 -1.229 . . . . 1.0 111.001 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.801 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -174.95 174.67 2.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.692 -0.63 . . . . 1.0 109.636 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 57' ' ' LEU . 70.8 mt -152.43 117.59 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.92 -1.113 . . . . 1.0 109.146 -178.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -132.79 171.07 14.37 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 1.0 112.011 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.112 ' CG1' HG13 ' A' ' 78' ' ' VAL . 30.7 mt -121.86 139.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.476 -0.765 . . . . 1.0 111.559 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.922 HG11 ' NH2' ' A' ' 92' ' ' ARG . 11.7 p -141.43 144.66 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.675 -0.64 . . . . 1.0 110.112 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.779 ' OD1' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER 52.94 27.07 5.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.142 -0.974 . . . . 1.0 110.614 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.744 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 80.42 14.32 80.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 7.5 m-85 -126.64 148.52 49.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 1.0 110.071 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.112 HG13 ' CG1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.15 168.05 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.06 -1.025 . . . . 1.0 109.757 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 22.9 pt20 -160.17 123.23 3.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.098 -1.001 . . . . 1.0 110.944 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.802 ' HA ' HD23 ' A' ' 71' ' ' LEU . 5.4 tmm? -86.83 113.61 22.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.38 -0.825 . . . . 1.0 109.119 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.801 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 2.2 ptt? -100.94 141.12 34.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 1.0 110.765 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.946 ' CD2' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -120.19 105.43 10.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 1.0 110.583 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 6.4 t0 -120.86 40.38 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 1.0 109.901 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.812 HD23 ' HD1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -39.17 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.569 -0.707 . . . . 1.0 112.132 -178.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -142.8 -50.34 0.04 OUTLIER Glycine 0 N--CA 1.494 2.527 0 C-N-CA 118.862 -1.637 . . . . 1.0 110.83 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.46 ' H ' ' HD3' ' A' ' 87' ' ' LYS . 1.1 m -173.7 22.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -1.2 . . . . 1.0 110.717 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.574 ' CB ' ' HB3' ' A' ' 128' ' ' SER . 0.0 OUTLIER -129.99 80.91 70.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 1.0 109.292 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 42.5 Cg_endo -68.92 89.66 0.44 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.025 1.54 . . . . 1.0 111.192 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -75.18 155.23 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -127.99 119.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.321 -1.487 . . . . 1.0 110.801 178.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.822 HD21 ' C ' ' A' ' 114' ' ' GLY . 10.6 mp -112.73 69.25 0.69 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.922 ' NH2' HG11 ' A' ' 74' ' ' VAL . 4.6 mtt180 -56.78 178.01 0.07 Allowed 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.668 -1.213 . . . . 1.0 109.822 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.758 ' OG ' HG21 ' A' ' 118' ' ' VAL . 3.0 t -95.68 169.57 9.93 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.693 -0.629 . . . . 1.0 110.16 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 1.011 ' CG2' ' HB3' ' A' ' 122' ' ' ALA . 14.0 t -121.22 16.46 11.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 1.0 109.062 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.951 HG22 ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.84 160.56 60.32 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.661 -0.649 . . . . 1.0 109.331 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.951 ' HD2' HG22 ' A' ' 95' ' ' VAL . 44.3 Cg_endo -70.06 138.48 36.95 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.859 1.452 . . . . 1.0 110.358 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 76' ' ' GLY . 2.7 tp -121.53 -30.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.096 -1.002 . . . . 1.0 110.706 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.607 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 2.3 p-10 -73.7 57.45 0.58 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 1.0 109.544 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.724 ' O ' HG22 ' A' ' 99' ' ' THR . 16.8 m -114.12 19.77 16.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.563 -0.711 . . . . 1.0 110.282 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 46.7 22.28 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 1.0 110.921 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.32 144.94 43.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.056 -1.028 . . . . 1.0 110.1 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 7.5 m95 -59.46 95.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 1.0 109.881 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' SER . 26.5 m -94.09 164.7 12.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.156 -0.965 . . . . 1.0 109.485 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 40.6 t-80 -116.34 147.64 41.39 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.258 -0.901 . . . . 1.0 108.614 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.516 HD11 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -134.97 152.74 33.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.126 -0.984 . . . . 1.0 109.365 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.995 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -138.57 146.23 41.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.8 -1.188 . . . . 1.0 110.329 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 1.074 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -143.93 92.35 2.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 1.0 110.675 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.598 ' CZ ' ' OG ' ' A' ' 115' ' ' SER . 47.9 p90 -112.18 107.53 16.45 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.056 -1.058 . . . . 1.0 109.014 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.606 ' HD3' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -109.67 130.66 55.49 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.969 -178.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.74 HG13 ' OG ' ' A' ' 40' ' ' SER . 4.2 t -104.5 102.15 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.415 -0.803 . . . . 1.0 109.506 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.56 ' HA ' ' NH2' ' A' ' 109' ' ' ARG . 10.0 pt20 38.65 100.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.581 0.705 . . . . 1.0 112.469 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.56 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 1.1 ptt85 70.18 -50.0 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 1.0 111.644 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.56 ' N ' ' HG2' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -81.49 112.09 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.785 -1.197 . . . . 1.0 110.019 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.822 ' C ' HD21 ' A' ' 91' ' ' LEU . . . -103.39 159.65 16.9 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.144 -1.027 . . . . 1.0 111.732 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 125' ' ' THR . 1.0 OUTLIER -137.35 151.93 49.14 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.835 -0.803 . . . . 1.0 109.656 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -138.33 153.6 48.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.083 -1.011 . . . . 1.0 109.406 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 1.115 ' N ' HD13 ' A' ' 116' ' ' LEU . 1.1 mt-30 -158.28 111.32 2.38 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.768 -1.173 . . . . 1.0 111.644 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.828 HG11 ' CG1' ' A' ' 95' ' ' VAL . 90.7 t -71.29 97.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 64.54 43.12 97.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 1.0 109.509 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.9 OUTLIER 61.84 36.53 15.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -1.136 . . . . 1.0 110.713 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -96.29 -162.93 1.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.123 -0.985 . . . . 1.0 110.791 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 1.011 ' HB3' ' CG2' ' A' ' 94' ' ' THR . . . -43.2 118.17 2.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 1.0 109.246 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 47.7 Cg_endo -73.27 115.22 4.26 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.068 1.562 . . . . 1.0 112.436 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.703 HG21 ' O ' ' A' ' 92' ' ' ARG . 4.1 mp -91.23 102.08 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.619 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.9 p -116.96 179.93 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.502 1.144 . . . . 1.0 112.874 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 113' ' ' GLU . . . 169.42 -173.2 43.74 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 106.667 -2.573 . . . . 1.0 106.667 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -160.46 162.03 33.04 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.471 -1.605 . . . . 1.0 110.686 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.574 ' HB3' ' CB ' ' A' ' 87' ' ' LYS . 19.8 m -111.21 161.31 25.69 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.148 -0.97 . . . . 1.0 110.222 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.547 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.7 Cg_endo -68.16 78.32 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.972 1.511 . . . . 1.0 108.811 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.547 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.4 mt -12.99 131.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.596 0.712 . . . . 1.0 112.815 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 132' ' ' ALA . . . 161.85 99.62 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.756 ' O ' HG22 ' A' ' 133' ' ' THR . . . 173.68 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.459 -1.024 . . . . 1.0 109.716 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 132' ' ' ALA . 5.7 t 42.69 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.465 0.65 . . . . 1.0 110.779 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 133' ' ' THR . 0.5 OUTLIER 40.0 26.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 1.0 110.704 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.662 HD12 ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -89.87 36.62 0.86 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.118 -0.989 . . . . 1.0 109.5 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.5 ' OD1' ' CB ' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -51.37 171.03 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.053 -1.029 . . . . 1.0 109.076 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.0 t -113.16 133.41 55.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.037 -1.039 . . . . 1.0 109.748 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.739 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 28.9 p-10 -84.67 30.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 1.0 110.32 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 31' ' ' VAL . . . 44.84 24.1 0.68 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.739 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -116.75 151.67 35.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.146 . . . . 1.0 109.839 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.876 ' CD1' HD21 ' A' ' 57' ' ' LEU . 11.9 tp -154.22 150.05 27.65 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.482 -0.887 . . . . 1.0 110.639 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.624 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 8.0 m95 -126.48 118.19 24.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.074 -1.454 . . . . 1.0 107.074 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.913 HD21 HG22 ' A' ' 56' ' ' ILE . 1.1 tt -125.59 120.01 29.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 117.812 -1.555 . . . . 1.0 112.651 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 124.76 8.21 5.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 136.66 -134.34 7.06 Favored Glycine 0 C--N 1.291 -1.923 0 C-N-CA 119.007 -1.568 . . . . 1.0 109.848 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' MET . . . . . 1.055 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -170.74 158.94 6.27 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.424 -0.911 . . . . 1.0 111.712 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -92.23 -14.88 28.29 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -143.5 51.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.055 HD13 ' HB2' ' A' ' 146' ' ' MET . 10.0 tp -65.5 49.3 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.878 0.696 . . . . 1.0 112.878 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 148' ' ' ARG . 20.5 p -73.83 -19.67 60.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 105.167 -2.16 . . . . 1.0 105.167 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.749 ' CG1' HD12 ' A' ' 149' ' ' LEU 0.267 3.9 p -61.55 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.588 -1.187 . . . . 1.0 109.909 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.765 ' HB1' ' CD2' ' A' ' 159' ' ' TYR . . . 53.77 20.15 2.16 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.408 -1.432 . . . . 1.0 110.195 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.585 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 48.1 m80 32.98 -85.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.83 -0.544 . . . . 1.0 112.323 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ALA . 2.9 ptpp? -134.67 -29.83 1.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 1.0 113.082 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.996 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -60.34 138.44 91.99 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.684 -1.26 . . . . 1.0 109.078 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.594 ' N ' HD12 ' A' ' 155' ' ' LEU . 56.4 Cg_endo -81.54 -92.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.902 1.475 . . . . 1.0 114.642 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.612 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -55.03 -47.56 74.6 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.045 1.869 . . . . 1.0 116.045 -174.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.996 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -41.57 -44.19 2.94 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 120.731 1.605 . . . . 1.0 108.987 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.791 ' CE2' HD23 ' A' ' 155' ' ' LEU . 30.6 m-85 -84.39 -25.67 28.92 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.632 -1.227 . . . . 1.0 108.572 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.612 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -78.19 -3.28 41.85 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.336 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -135.02 82.81 1.98 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.19 166.46 0.01 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CD2' HD11 ' A' ' 167' ' ' ILE . 12.9 t80 -65.79 143.56 57.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.394 . . . . 1.0 112.046 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 164' ' ' ILE . 4.6 mt -122.02 85.14 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.648 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.33 -156.41 11.75 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.565 ' HB2' ' HB2' ' A' ' 48' ' ' LYS . 1.7 m -127.73 142.34 51.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.529 -0.983 . . . . 1.0 110.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.783 HD13 ' CZ ' ' A' ' 19' ' ' PHE . 3.3 mt -126.78 147.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.755 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.637 ' O ' HG13 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -160.28 170.79 20.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 1.0 110.231 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.3 m-20 41.71 67.83 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 1.0 109.852 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.871 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.1 m -124.38 126.47 72.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 O-C-N 121.063 -1.023 . . . . 1.0 109.895 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 175' ' ' GLN . 0.3 OUTLIER -134.67 151.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.889 -1.125 . . . . 1.0 111.666 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 2.4 p -134.32 108.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.568 ' O ' ' HD3' ' A' ' 174' ' ' ARG . 68.6 m-20 59.98 67.92 0.82 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.492 -1.67 . . . . 1.0 106.492 -176.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 35.34 28.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.473 -0.785 . . . . 1.0 111.633 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.787 ' OE1' HG11 ' A' ' 31' ' ' VAL . 32.2 mt-30 -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.294 -0.879 . . . . 1.0 109.644 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' CD2' ' A' ' 178' ' ' HIS . 18.3 tt0 -78.1 107.76 10.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 1.0 110.619 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.644 ' HB2' HG23 ' A' ' 170' ' ' VAL . 15.3 mt -90.0 85.24 6.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 1.0 110.53 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.577 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 1.8 m170 -56.96 114.42 2.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 1.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.975 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 3.6 mm? -59.3 -38.28 79.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.355 -0.841 . . . . 1.0 111.767 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 56.1 t -85.21 -39.62 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.196 0.813 . . . . 1.0 113.196 -177.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 14.2 mt-10 -57.78 -49.51 76.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.463 -1.398 . . . . 1.0 110.913 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.562 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 31.9 m-20 -87.54 -19.01 28.49 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.461 -0.774 . . . . 1.0 110.928 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.975 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -60.57 -34.95 74.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.52 -1.272 . . . . 1.0 108.452 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.2 mt -50.83 -22.76 2.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.715 -0.615 . . . . 1.0 109.805 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -51.2 -22.47 2.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.172 -0.955 . . . . 1.0 108.894 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.517 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 5.1 t30 -99.52 156.13 35.74 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 39.0 Cg_endo -65.17 -56.49 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.238 1.125 . . . . 1.0 110.948 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.473 ' O ' HG13 ' A' ' 189' ' ' ILE . 5.8 t -103.11 146.49 28.3 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.594 -0.691 . . . . 1.0 110.375 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 188' ' ' THR . 2.9 mp -139.99 124.29 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 1.0 110.349 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.536 ' O ' HG23 ' A' ' 17' ' ' ILE . 20.8 mt -109.56 159.36 17.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 1.0 109.559 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -101.61 -81.68 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.832 -1.168 . . . . 1.0 111.075 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -169.66 158.51 7.67 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.052 -1.03 . . . . 1.0 110.098 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.8 m -127.09 156.04 42.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 1.0 110.431 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -168.15 98.07 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.275 -0.891 . . . . 1.0 110.052 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.59 0 C-N-CA 118.701 -1.199 . . . . 1.0 110.537 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.306 -1.518 . . . . 1.0 109.306 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER -55.06 -165.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -1.174 . . . . 1.0 110.162 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 4' ' ' LYS . 2.9 tt0 -162.78 -63.12 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 1.0 110.311 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 3' ' ' GLU . 7.0 tttt 66.75 139.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 1.0 110.241 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 5' ' ' VAL . 35.2 m -89.05 141.14 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 1.0 110.15 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -139.17 92.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.922 . . . . 1.0 110.35 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 7' ' ' ILE . 1.7 mp -51.18 91.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 1.0 110.2 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 6' ' ' ILE . 13.1 tt0 -49.92 130.31 21.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.887 . . . . 1.0 110.173 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -112.02 144.02 42.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 1.0 110.11 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.5 132.5 52.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 1.0 110.291 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.28 47.61 1.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.735 . . . . 1.0 110.378 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.08 100.41 0.9 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.894 -1.282 . . . . 1.0 109.894 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -114.96 -30.88 6.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -1.145 . . . . 1.0 109.67 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -140.0 60.34 1.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.403 -0.81 . . . . 1.0 109.614 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.595 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.0 pt-20 -60.3 71.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.574 -0.704 . . . . 1.0 110.661 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -81.21 158.85 24.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.22 -1.55 . . . . 1.0 110.481 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.82 HG21 ' CE ' ' A' ' 25' ' ' MET . 12.3 mm -119.78 116.45 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 1.0 110.224 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 191' ' ' HIS . . . -81.12 122.73 27.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.418 -0.801 . . . . 1.0 110.537 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.74 ' CE1' HD12 ' A' ' 167' ' ' ILE . 3.0 m-85 -86.15 166.97 15.34 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.598 -0.89 . . . . 1.0 108.598 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 1.0 ' HA ' HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -127.37 3.07 6.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.84 -1.162 . . . . 1.0 111.083 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 99.88 -18.87 55.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.326 -1.51 . . . . 1.0 109.326 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 14.3 ttt180 -118.79 22.39 12.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.293 -1.122 . . . . 1.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 172.96 12.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 1.0 110.873 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.656 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -166.04 87.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.82 ' CE ' HG21 ' A' ' 17' ' ' ILE . 26.8 mtt -90.34 101.39 14.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.658 -1.276 . . . . 1.0 110.517 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.622 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 8.8 pt-20 -83.08 110.57 18.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.243 -0.91 . . . . 1.0 108.657 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.606 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 47.8 m-85 -100.95 99.24 9.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.975 -1.078 . . . . 1.0 110.387 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.461 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -93.14 103.35 15.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 1.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -94.96 164.58 12.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 1.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.3 94.36 9.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.283 -0.885 . . . . 1.0 110.405 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG21 HE22 ' A' ' 175' ' ' GLN . 0.0 OUTLIER -137.75 165.91 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.317 -0.864 . . . . 1.0 109.779 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.01 135.98 46.93 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.37 -0.831 . . . . 1.0 110.192 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -46.44 104.66 0.05 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.321 -0.862 . . . . 1.0 109.751 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 35' ' ' GLU . 6.8 p -77.73 6.68 6.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.298 -0.876 . . . . 1.0 110.545 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 34' ' ' SER . 1.3 tp10 71.13 1.69 3.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 1.0 110.165 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 18.7 pttt -83.73 152.41 24.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.126 -0.984 . . . . 1.0 109.62 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 135' ' ' LEU . . . -146.59 -78.35 0.17 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.022 -1.049 . . . . 1.0 109.887 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.115 HD13 ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.5 144.76 43.99 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.384 -0.926 . . . . 1.0 109.406 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.68 ' N ' HD22 ' A' ' 38' ' ' LEU . 1.3 tt0 151.98 -90.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.935 -0.765 . . . . 1.0 108.935 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -169.92 157.91 6.96 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.154 -1.018 . . . . 1.0 112.302 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -130.12 139.22 50.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 1.0 109.886 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.517 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 24.7 m80 -110.45 125.71 53.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.319 -0.863 . . . . 1.0 109.95 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.717 ' CD2' HG22 ' A' ' 172' ' ' VAL . 26.9 m-85 -140.16 119.34 12.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.921 . . . . 1.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.747 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -127.48 151.54 48.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.749 -1.22 . . . . 1.0 110.817 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.977 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 178.86 150.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 1.0 110.991 179.251 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.5 m -114.06 150.25 34.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.722 HG12 HD11 ' A' ' 97' ' ' ILE . 1.4 pt -144.38 153.3 15.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 117.821 -1.552 . . . . 1.0 112.583 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.632 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.5 OUTLIER -109.82 83.07 1.69 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.43 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.693 HG22 ' CE1' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -73.65 148.06 43.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.266 1.031 . . . . 1.0 112.808 -175.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 5.3 mm-40 -124.62 -18.49 5.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.711 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.85 130.3 46.71 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.729 -0.607 . . . . 1.0 109.677 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.727 HG22 ' CA ' ' A' ' 76' ' ' GLY . 1.9 p -60.92 -8.08 2.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 1.0 111.073 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -130.66 134.19 46.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.71 -1.244 . . . . 1.0 110.673 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.86 135.8 1.89 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.203 -1.559 . . . . 1.0 109.203 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.208 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -92.99 127.33 38.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.632 -1.511 . . . . 1.0 109.291 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -96.67 -27.05 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.715 . . . . 1.0 112.408 -176.657 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.003 HD13 HD12 ' A' ' 71' ' ' LEU . 6.0 tt -144.28 146.18 32.46 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.246 -1.534 . . . . 1.0 112.58 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.871 ' CH2' HG21 ' A' ' 151' ' ' VAL . 5.4 t-105 -159.6 116.33 2.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.782 -0.574 . . . . 1.0 109.538 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.482 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 0.9 OUTLIER -116.47 120.47 38.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.085 -1.01 . . . . 1.0 110.316 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.09 164.47 27.34 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.603 ' HA ' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -119.07 -89.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -1.23 . . . . 1.0 110.899 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.38 145.01 17.64 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.828 -1.309 . . . . 1.0 109.828 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tp 48.22 -165.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -1.135 . . . . 1.0 110.277 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -109.69 27.36 9.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 1.0 109.933 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -169.25 58.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 1.0 109.842 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -148.83 93.46 2.12 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.252 -0.979 . . . . 1.0 110.457 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 66' ' ' SER . 1.6 t0 55.13 150.49 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.568 -0.707 . . . . 1.0 110.645 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 83' ' ' ASP . 2.4 p90 175.24 173.84 0.25 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 120.692 -1.255 . . . . 1.0 110.461 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.539 HG12 ' HB3' ' A' ' 82' ' ' TYR . 1.5 mt -132.32 167.47 26.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.151 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.805 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -171.02 178.12 3.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.216 -0.927 . . . . 1.0 110.874 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.003 HD12 HD13 ' A' ' 57' ' ' LEU . 83.2 mt -146.66 129.88 16.58 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.591 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -150.77 165.11 34.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.833 -1.167 . . . . 1.0 112.559 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 56' ' ' ILE . 5.9 mt -104.54 137.94 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.706 0.765 . . . . 1.0 110.654 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.847 HG11 ' OE1' ' A' ' 79' ' ' GLN . 2.3 p -139.87 118.63 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.738 -0.601 . . . . 1.0 110.097 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 2.2 m-20 67.26 3.65 3.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 1.0 111.235 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 113.97 4.17 22.78 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.343 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.511 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.7 m-85 -131.41 126.67 35.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.053 -1.263 . . . . 1.0 109.701 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.722 HG13 ' N ' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -59.43 -173.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.929 -1.107 . . . . 1.0 110.461 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.847 ' OE1' HG11 ' A' ' 74' ' ' VAL . 9.0 pt20 -176.33 101.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.019 0.914 . . . . 1.0 110.133 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.918 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -78.47 126.01 30.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.805 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 5.0 ptt? -122.8 146.48 47.5 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.106 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.939 ' CZ ' HG11 ' A' ' 89' ' ' VAL . 4.3 p90 -129.77 120.56 25.25 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.888 -1.525 . . . . 1.0 110.519 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.572 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . 12.7 t70 -94.05 47.4 1.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.313 0.578 . . . . 1.0 110.568 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.046 ' HB3' HD13 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -62.83 -10.8 14.46 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -144.44 41.55 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.959 -1.257 . . . . 1.0 109.959 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 77.49 -35.28 0.21 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.5 -1.0 . . . . 1.0 111.516 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -102.51 103.84 34.32 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.767 -1.208 . . . . 1.0 110.362 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.522 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 51.6 Cg_endo -74.46 116.78 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.191 1.627 . . . . 1.0 111.234 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.939 HG11 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -71.91 172.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 178.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 90' ' ' VAL . 1.2 t -144.27 107.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.635 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.721 ' N ' HD22 ' A' ' 91' ' ' LEU . 3.0 mm? -95.23 90.11 5.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.293 -1.743 . . . . 1.0 106.293 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.904 ' O ' HD13 ' A' ' 124' ' ' ILE . 30.7 mtp180 -73.22 154.09 40.38 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.988 -1.085 . . . . 1.0 110.271 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.3 t -68.62 143.6 54.77 Favored 'General case' 0 C--N 1.288 -2.075 0 O-C-N 120.986 -1.071 . . . . 1.0 109.925 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.848 ' HB ' HD12 ' A' ' 124' ' ' ILE . 4.7 t -94.25 21.09 7.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.756 -1.215 . . . . 1.0 110.035 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.964 HG21 HG11 ' A' ' 118' ' ' VAL . 19.6 t -135.16 149.08 69.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 1.0 109.956 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.586 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 40.6 Cg_endo -66.53 134.39 35.43 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.681 1.358 . . . . 1.0 110.123 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.915 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.8 tt -125.15 -26.36 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 1.0 110.627 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.436 ' O ' ' OD1' ' A' ' 98' ' ' ASN . 8.7 p30 -70.73 58.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.212 -0.93 . . . . 1.0 110.475 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.846 HG23 ' HB2' ' A' ' 101' ' ' HIS . 7.8 t -130.91 22.31 4.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.339 -0.851 . . . . 1.0 109.956 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 m120 56.84 24.79 9.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.107 -0.996 . . . . 1.0 110.733 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.846 ' HB2' HG23 ' A' ' 99' ' ' THR . 15.2 m80 -113.23 152.97 29.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.03 . . . . 1.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.632 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 15.6 m95 -74.54 97.21 3.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.095 -1.003 . . . . 1.0 109.93 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.564 HG21 HD12 ' A' ' 97' ' ' ILE . 24.7 m -93.1 141.41 28.44 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.203 -0.999 . . . . 1.0 108.713 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 119' ' ' GLY . 25.5 t60 -98.49 142.49 30.04 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.425 -0.91 . . . . 1.0 108.566 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.656 HG22 HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -140.78 156.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.964 -1.085 . . . . 1.0 110.218 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.707 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -149.21 128.62 13.0 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.426 -0.796 . . . . 1.0 110.016 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -115.25 102.57 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.208 -0.933 . . . . 1.0 110.979 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 108' ' ' TYR . 2.9 p90 -117.38 109.4 16.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 1.0 109.381 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.638 ' HG3' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -103.49 142.86 33.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.35 -0.844 . . . . 1.0 110.848 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 109' ' ' ARG . 1.5 t -127.91 122.46 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.466 -0.771 . . . . 1.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 113' ' ' GLU . 23.1 mt-30 37.83 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 1.0 111.037 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 127' ' ' SER . 11.4 mmt85 65.34 -56.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.356 -0.84 . . . . 1.0 111.738 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.594 ' N ' ' HB3' ' A' ' 127' ' ' SER . 0.0 OUTLIER -67.1 114.72 6.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.945 0.878 . . . . 1.0 111.794 -176.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -100.25 159.19 19.39 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.62 ' O ' ' CE ' ' A' ' 80' ' ' MET . 12.5 t -141.04 148.84 40.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.527 -0.984 . . . . 1.0 109.925 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.918 HD23 ' HG2' ' A' ' 80' ' ' MET . 1.0 OUTLIER -145.81 131.15 18.58 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.036 -1.04 . . . . 1.0 110.042 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.853 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -135.37 145.3 47.21 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.937 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.964 HG11 HG21 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -89.81 113.68 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 52.14 46.09 56.73 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER 65.43 43.44 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -1.085 . . . . 1.0 111.38 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.534 ' HB2' HG12 ' A' ' 118' ' ' VAL . 2.2 mt-10 -105.5 -162.14 0.85 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.251 -0.905 . . . . 1.0 110.643 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.782 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -49.92 115.87 5.68 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.237 -0.915 . . . . 1.0 109.558 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.545 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 46.2 Cg_endo -73.57 119.08 5.75 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.879 1.462 . . . . 1.0 111.672 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.904 HD13 ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -86.32 118.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.686 ' HA ' HD12 ' A' ' 91' ' ' LEU . 12.3 p -126.73 171.65 11.01 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.606 -1.237 . . . . 1.0 113.628 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.512 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 169.51 153.62 8.62 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.513 -2.635 . . . . 1.0 106.513 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.594 ' HB3' ' N ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -119.71 163.48 17.36 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.607 -1.525 . . . . 1.0 111.028 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -67.64 -176.85 0.28 Allowed Pre-proline 0 C--N 1.3 -1.579 0 C-N-CA 119.906 -0.717 . . . . 1.0 109.207 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 131' ' ' GLY . 48.1 Cg_endo -74.59 42.44 0.8 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.548 1.288 . . . . 1.0 110.24 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER 34.63 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.841 0.829 . . . . 1.0 109.991 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -131.9 106.75 0.68 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.958 -1.257 . . . . 1.0 109.958 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 133' ' ' THR . . . 178.17 -54.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.5 -1.0 . . . . 1.0 109.88 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 132' ' ' ALA . 7.4 t 39.73 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.462 -0.773 . . . . 1.0 111.027 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -161.58 111.97 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.056 -1.028 . . . . 1.0 110.714 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.046 HD13 ' HB3' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -166.73 135.32 2.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 1.0 109.369 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 135' ' ' LEU . 14.2 m-20 -140.47 179.58 6.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.331 -0.856 . . . . 1.0 109.415 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.8 t -115.41 132.62 56.56 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.052 -1.03 . . . . 1.0 109.883 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 1.057 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 7.9 p-10 -78.77 13.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 1.0 110.44 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.69 18.38 10.83 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.283 -1.927 . . . . 1.0 108.283 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 1.057 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -136.47 170.34 16.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.443 -1.034 . . . . 1.0 109.937 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.903 ' CD1' HD21 ' A' ' 57' ' ' LEU . 12.3 tp -160.83 155.51 23.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.284 -0.885 . . . . 1.0 110.702 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.649 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 9.9 m95 -131.32 136.76 48.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.662 HD12 ' CB ' ' A' ' 57' ' ' LEU . 5.1 tp -140.97 123.74 16.15 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.593 -1.643 . . . . 1.0 113.321 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.32 1.05 12.63 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 110.098 -1.201 . . . . 1.0 110.098 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 144.05 -129.02 3.48 Favored Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.902 -1.679 . . . . 1.0 108.902 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' MET . . . . . 1.097 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -171.2 126.63 0.67 Allowed 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.358 -0.937 . . . . 1.0 111.747 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -12.69 27.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 1.0 108.872 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.578 ' N ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -152.73 61.59 0.8 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.097 HD13 ' HB2' ' A' ' 146' ' ' MET . 10.0 tp -64.39 44.33 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.386 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 148' ' ' ARG . 83.7 p -55.0 -28.83 55.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.871 HG21 ' CH2' ' A' ' 58' ' ' TRP 0.29 6.2 p -62.76 -135.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 114.414 -1.267 . . . . 1.0 108.137 177.514 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.808 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 54.56 18.06 1.87 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.936 -1.102 . . . . 1.0 110.861 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -79.58 0.18 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.942 -1.099 . . . . 1.0 112.928 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.522 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -52.03 -14.04 0.37 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.0 112.234 -177.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.73 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.6 pp -99.61 168.75 9.06 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.842 -1.162 . . . . 1.0 110.337 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 43.6 Cg_endo -68.33 -176.73 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.55 1.29 . . . . 1.0 113.228 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -62.05 -13.95 31.29 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.977 -0.556 . . . . 1.0 112.27 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -41.13 -35.12 0.53 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 1.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 1.208 ' CE2' HD13 ' A' ' 55' ' ' LEU . 5.4 m-85 -83.94 -30.12 26.54 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.32 -0.952 . . . . 1.0 109.766 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -68.67 -8.9 46.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.796 -1.162 . . . . 1.0 108.895 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -128.8 86.43 2.44 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -39.63 164.31 0.01 OUTLIER Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.212 -1.155 . . . . 1.0 110.212 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.693 ' CE1' HG22 ' A' ' 49' ' ' THR . 35.9 t80 -79.14 144.03 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.027 -1.278 . . . . 1.0 111.396 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 1.0 HG23 ' HA ' ' A' ' 20' ' ' ASP . 2.9 mt -128.98 68.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.644 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -148.83 -162.62 10.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.913 -2.075 . . . . 1.0 107.913 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.504 ' C ' HG13 ' A' ' 167' ' ' ILE . 13.4 m -118.97 148.05 43.4 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.405 -1.644 . . . . 1.0 111.138 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.74 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -131.95 151.14 34.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.651 -0.656 . . . . 1.0 109.504 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.55 ' NH2' HD13 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -161.6 151.75 17.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 1.0 110.178 -178.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.538 ' N ' ' HD3' ' A' ' 168' ' ' ARG . 36.1 m-20 56.44 75.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.455 -0.778 . . . . 1.0 109.972 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.977 HG12 ' CB ' ' A' ' 45' ' ' LEU . 26.9 m -128.32 122.45 57.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.699 -0.801 . . . . 1.0 109.559 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.493 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -132.73 156.59 42.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.459 -0.896 . . . . 1.0 111.124 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.717 HG22 ' CD2' ' A' ' 43' ' ' PHE . 6.6 t -134.35 104.65 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.7 OUTLIER 50.31 40.66 23.05 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.455 -1.403 . . . . 1.0 107.477 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER 72.7 27.68 2.23 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.054 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 29.0 mt-30 -103.08 177.66 4.78 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.039 -1.038 . . . . 1.0 110.703 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 6.0 tt0 66.12 -105.36 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.826 -0.547 . . . . 1.0 110.923 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 67.01 -58.11 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.301 -0.874 . . . . 1.0 111.232 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.576 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.3 m-70 -80.34 73.73 7.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.763 -1.21 . . . . 1.0 110.135 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 3.6 mt -49.8 -58.85 4.55 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.152 0.977 . . . . 1.0 112.217 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.587 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 30.1 t -74.39 -19.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.576 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.5 mt-10 -67.55 -62.26 1.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.351 -1.468 . . . . 1.0 110.002 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -71.84 -19.61 61.95 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 1.0 109.2 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -68.44 -27.42 66.16 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.508 -0.877 . . . . 1.0 108.81 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 184' ' ' LEU . 10.5 mt -57.66 -16.46 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 1.0 109.178 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -57.97 -14.61 6.71 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.496 -0.752 . . . . 1.0 109.699 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.54 ' O ' HD11 ' A' ' 189' ' ' ILE . 13.0 t30 -127.42 148.88 68.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.52 -0.737 . . . . 1.0 109.1 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' HG13 ' A' ' 189' ' ' ILE . 46.9 Cg_endo -73.63 -44.81 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.701 1.369 . . . . 1.0 110.81 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.07 103.1 0.7 Allowed 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.637 0.732 . . . . 1.0 110.639 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.54 HD11 ' O ' ' A' ' 186' ' ' ASN . 6.5 mt -144.46 98.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 18' ' ' ALA . 33.9 mt -111.92 152.6 27.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 1.0 110.81 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 8.1 m-70 -95.84 -174.61 3.18 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.469 -0.769 . . . . 1.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.0 t -102.16 153.53 19.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 1.0 110.476 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.4 m -128.97 166.7 18.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.332 -0.855 . . . . 1.0 109.808 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -170.71 98.41 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.968 . . . . 1.0 110.482 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.297 -1.699 0 C-N-CA 118.82 -1.152 . . . . 1.0 110.464 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.9 92.01 2.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -1.133 . . . . 1.0 110.071 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -73.72 66.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 1.0 110.183 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -145.73 36.1 1.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 1.0 110.059 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 5' ' ' VAL . 12.0 p -129.08 112.05 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 1.0 110.332 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 6' ' ' ILE . 3.6 tt -135.44 137.57 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.85 . . . . 1.0 110.0 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 8' ' ' GLU . 5.4 tp -128.98 154.8 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -0.948 . . . . 1.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.434 ' N ' HG13 ' A' ' 7' ' ' ILE . 5.5 tt0 -92.96 121.29 34.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.917 . . . . 1.0 110.074 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.6 mmtm -49.57 97.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.841 . . . . 1.0 110.247 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.25 139.91 58.11 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.198 -0.939 . . . . 1.0 109.971 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.57 55.23 2.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.478 -0.764 . . . . 1.0 110.47 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.37 100.41 2.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.479 -1.448 . . . . 1.0 109.479 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -137.42 -77.96 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 1.0 110.315 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . 52.34 50.55 18.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 1.0 109.929 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.581 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.5 pt-20 -59.81 72.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.749 . . . . 1.0 110.858 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -68.35 158.22 33.98 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.136 -1.603 . . . . 1.0 109.487 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.012 HG21 ' CE ' ' A' ' 25' ' ' MET . 17.3 mm -136.92 108.96 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.027 -1.046 . . . . 1.0 110.579 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 190' ' ' LEU . . . -78.82 138.4 38.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.741 . . . . 1.0 110.234 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.781 ' CE1' HD12 ' A' ' 167' ' ' ILE . 3.7 m-85 -104.16 175.36 5.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 1.0 109.633 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 1.9 p30 -128.37 -14.43 4.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 1.0 111.084 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 115.51 -13.84 18.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.909 -1.677 . . . . 1.0 108.909 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.91 15.11 4.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.44 -1.035 . . . . 1.0 109.109 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 24' ' ' TYR . 3.1 m -75.63 174.65 9.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.596 -0.69 . . . . 1.0 110.185 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.548 ' OH ' ' N ' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -147.62 103.67 3.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.526 -0.734 . . . . 1.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . 1.012 ' CE ' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -99.35 101.53 12.85 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.774 -1.204 . . . . 1.0 109.186 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.513 ' HG2' ' CE3' ' A' ' 142' ' ' TRP . 14.9 mt-10 -95.88 136.72 35.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 1.0 109.485 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.599 ' CE2' ' HG3' ' A' ' 25' ' ' MET . 69.8 m-85 -131.29 99.05 4.72 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.216 -0.994 . . . . 1.0 110.475 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.45 118.69 37.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 1.0 110.215 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.464 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 12.1 t-20 -140.44 156.73 46.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 1.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.67 149.14 23.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.961 . . . . 1.0 110.142 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -110.95 -95.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 1.0 109.907 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -144.86 107.19 4.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.064 . . . . 1.0 110.553 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -65.9 89.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 1.0 110.083 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.16 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -0.832 . . . . 1.0 109.329 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -148.47 -36.14 0.19 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.533 -0.729 . . . . 1.0 109.965 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.589 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 18.8 mtmt 43.42 54.24 5.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 1.0 110.036 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . 175.43 134.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 1.0 109.986 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.558 ' O ' ' CG ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -138.51 53.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.015 -1.053 . . . . 1.0 110.048 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER 54.68 3.82 0.06 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 179.699 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -171.07 167.87 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.252 -1.53 . . . . 1.0 111.38 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -138.79 116.04 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.689 ' O ' HG23 ' A' ' 172' ' ' VAL . 0.3 OUTLIER -89.96 143.67 26.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.118 -0.989 . . . . 1.0 110.956 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.657 ' CE1' HG21 ' A' ' 172' ' ' VAL . 51.2 m-85 -138.17 106.85 5.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.637 -0.664 . . . . 1.0 110.074 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.57 ' C ' HD23 ' A' ' 45' ' ' LEU . 3.5 mt-10 -114.78 145.82 41.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.98 -1.075 . . . . 1.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.81 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -179.45 152.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.529 -0.868 . . . . 1.0 111.244 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 103' ' ' THR . 1.5 m -118.52 152.71 35.46 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.48 HD13 HD11 ' A' ' 105' ' ' ILE . 2.2 pt -148.34 157.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 117.897 -1.521 . . . . 1.0 112.152 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.616 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 2.5 tttt -113.15 84.3 1.98 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.58 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -67.31 147.25 53.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 1.0 111.193 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.753 ' HB2' HG22 ' A' ' 164' ' ' ILE . 2.3 mm-40 -129.34 6.79 5.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.808 -0.757 . . . . 1.0 111.0 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.862 ' O ' HG23 ' A' ' 52' ' ' THR . . . -134.77 -85.97 0.4 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.91 -1.119 . . . . 1.0 110.624 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.001 HG22 ' CA ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER 155.98 -25.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.88 139.03 54.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.716 -0.615 . . . . 1.0 109.419 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 158.67 135.88 1.96 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.436 -1.364 . . . . 1.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.76 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -85.33 121.53 28.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 1.0 108.963 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.827 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -96.66 -29.25 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.782 -0.574 . . . . 1.0 112.482 -176.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.086 HD13 HD12 ' A' ' 71' ' ' LEU . 6.4 tt -147.73 152.9 38.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.39 -1.444 . . . . 1.0 113.145 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.958 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 4.2 t-105 -162.61 107.26 1.14 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.589 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.51 149.6 42.16 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.13 -0.981 . . . . 1.0 108.784 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 62' ' ' GLY . . . -138.01 39.05 1.64 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.313 -1.422 . . . . 1.0 110.846 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 60' ' ' GLY . 6.7 ttpp 44.38 24.7 0.1 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.907 -1.349 . . . . 1.0 110.293 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.491 ' N ' ' OD2' ' A' ' 138' ' ' ASP . . . 99.4 -139.03 14.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.256 -1.538 . . . . 1.0 109.256 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 57.14 -179.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -1.194 . . . . 1.0 110.67 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 12.0 pt-20 -133.95 35.8 3.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 1.0 110.573 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -179.89 32.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.147 -0.971 . . . . 1.0 109.625 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.43 152.36 30.17 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.401 -0.919 . . . . 1.0 111.492 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.559 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 70.9 m-20 -96.56 -80.71 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.402 -0.811 . . . . 1.0 109.364 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.591 ' CZ ' ' O ' ' A' ' 84' ' ' LEU . 10.1 m-85 60.17 -59.34 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.259 -0.9 . . . . 1.0 113.159 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' ASP . 5.5 mm -148.01 153.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.839 -1.788 . . . . 1.0 113.566 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.737 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -177.69 166.58 2.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.086 HD12 HD13 ' A' ' 57' ' ' LEU . 93.4 mt -150.72 99.83 2.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.445 -1.41 . . . . 1.0 109.945 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.581 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -114.06 175.09 5.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.306 -0.871 . . . . 1.0 111.837 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.949 HG12 HG13 ' A' ' 78' ' ' VAL . 20.4 mt -115.34 138.3 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.827 -0.546 . . . . 1.0 110.056 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.509 HG11 ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -141.23 125.3 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 110.516 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 5.9 m-20 62.77 33.98 14.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.335 -0.853 . . . . 1.0 111.739 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 1.001 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 81.43 8.08 87.52 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.741 -1.219 . . . . 1.0 110.41 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 74' ' ' VAL . 46.3 m-85 -129.36 165.89 20.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.272 . . . . 1.0 109.382 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.949 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -116.05 164.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 1.0 110.679 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.552 ' OE1' HG21 ' A' ' 90' ' ' VAL . 6.9 pt20 -149.66 133.3 16.77 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.565 -0.854 . . . . 1.0 111.432 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.971 ' CE ' HD12 ' A' ' 91' ' ' LEU . 6.7 tmm? -99.24 120.12 39.02 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.737 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 7.3 ptt? -120.24 143.54 48.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.87 -1.144 . . . . 1.0 111.569 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.887 ' CZ ' HG11 ' A' ' 89' ' ' VAL . 19.6 p90 -139.85 129.03 23.81 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.531 -1.268 . . . . 1.0 110.905 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 67' ' ' ASP . 66.7 t0 -120.45 60.82 0.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.232 1.015 . . . . 1.0 109.378 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.642 HD21 ' CD1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -38.35 -35.65 0.19 Allowed 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.705 -179.062 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.28 -54.77 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.527 -1.32 . . . . 1.0 110.887 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 3.4 t -163.28 -22.84 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.393 . . . . 1.0 112.269 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.522 ' HD2' ' HG3' ' A' ' 129' ' ' PRO . 4.7 mmtp -98.86 100.58 10.02 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.66 -1.275 . . . . 1.0 110.21 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 86' ' ' SER . 47.0 Cg_endo -72.5 141.96 35.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.926 1.487 . . . . 1.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.887 HG11 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.97 126.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.552 HG21 ' OE1' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -103.93 120.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 117.802 -1.559 . . . . 1.0 110.328 178.652 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.971 HD12 ' CE ' ' A' ' 80' ' ' MET . 33.3 mt -113.09 71.94 0.76 Allowed 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.687 ' O ' HG21 ' A' ' 124' ' ' ILE . 2.9 mtt180 -58.7 179.16 0.09 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.138 0.971 . . . . 1.0 110.822 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.558 ' HA ' HD13 ' A' ' 124' ' ' ILE . 1.6 t -105.82 155.77 18.98 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.721 -0.612 . . . . 1.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.804 ' HB ' HD11 ' A' ' 124' ' ' ILE . 15.2 t -111.19 26.87 10.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 1.0 109.912 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.802 ' CB ' HG11 ' A' ' 118' ' ' VAL . 8.3 t -133.77 147.38 64.11 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.445 -0.785 . . . . 1.0 109.62 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.7 Cg_endo -67.47 138.32 45.69 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.629 1.331 . . . . 1.0 110.554 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.79 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -126.91 -30.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 1.0 110.686 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.462 HD22 HG23 ' A' ' 52' ' ' THR . 31.2 p-10 -72.54 62.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 1.0 110.52 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 101' ' ' HIS . 15.2 t -124.86 13.18 8.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 1.0 109.868 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.474 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 2.2 m-80 62.95 10.6 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.239 -0.913 . . . . 1.0 111.236 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.47 ' H ' HG23 ' A' ' 99' ' ' THR . 2.6 m-70 -102.51 175.15 5.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.87 -1.143 . . . . 1.0 110.288 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.616 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 27.0 m95 -92.95 105.84 17.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.9 . . . . 1.0 110.074 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 104' ' ' HIS . 47.4 m -99.31 171.06 8.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.274 -0.891 . . . . 1.0 109.597 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.593 ' N ' HG22 ' A' ' 103' ' ' THR . 12.0 t-80 -125.02 130.18 51.81 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.085 -1.009 . . . . 1.0 108.423 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 47' ' ' ILE . 1.9 mt -123.46 159.6 27.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.128 -0.982 . . . . 1.0 110.123 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.882 ' O ' HD22 ' A' ' 116' ' ' LEU . 1.8 tppt? -149.84 147.99 28.63 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.184 -1.006 . . . . 1.0 110.039 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -151.52 108.3 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.604 -0.685 . . . . 1.0 109.954 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 20.0 p90 -120.88 105.39 10.65 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.05 -1.06 . . . . 1.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.622 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 3.8 ttp180 -72.17 123.84 23.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.575 -0.703 . . . . 1.0 110.006 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' GLN . 3.6 t -110.08 88.51 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.076 -1.015 . . . . 1.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 0.0 OUTLIER 35.4 103.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.144 0.497 . . . . 1.0 110.934 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.574 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 66.1 -53.71 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.286 -0.884 . . . . 1.0 110.235 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.591 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.6 tt0 -87.08 120.88 28.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.756 -1.215 . . . . 1.0 110.811 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.28 161.83 12.56 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.929 -1.129 . . . . 1.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 15.5 t -136.43 162.11 33.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.307 -1.114 . . . . 1.0 111.174 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.008 HD13 ' N ' ' A' ' 117' ' ' GLN . 1.4 tm? -147.4 139.15 24.11 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 1.008 ' N ' HD13 ' A' ' 116' ' ' LEU . 3.6 mt-30 -142.83 146.26 33.99 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.686 -1.205 . . . . 1.0 111.67 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.802 HG11 ' CB ' ' A' ' 95' ' ' VAL . 1.8 t -104.19 101.69 12.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.498 -1.667 . . . . 1.0 106.498 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 70.65 33.5 67.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.717 -1.753 . . . . 1.0 108.717 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.27 38.07 26.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.518 -0.99 . . . . 1.0 110.312 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -108.77 -156.97 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.66 -0.65 . . . . 1.0 110.826 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.91 99.66 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.709 -0.62 . . . . 1.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.59 ' HB3' ' CG ' ' A' ' 117' ' ' GLN . 48.5 Cg_endo -73.23 131.36 16.42 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 O-C-N 124.314 1.691 . . . . 1.0 112.009 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.804 HD11 ' HB ' ' A' ' 94' ' ' THR . 0.4 OUTLIER -97.19 101.96 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 176.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.43 HG22 ' CB ' ' A' ' 115' ' ' SER . 61.4 p -107.07 170.6 7.85 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.154 0.978 . . . . 1.0 112.023 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.66 157.6 18.89 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 107.644 -2.183 . . . . 1.0 107.644 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.591 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -133.63 162.66 31.32 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.866 -1.373 . . . . 1.0 110.275 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 5.0 p -90.08 172.18 7.46 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 1.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.522 ' HG3' ' HD2' ' A' ' 87' ' ' LYS . 51.6 Cg_endo -80.82 36.58 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.728 1.383 . . . . 1.0 109.133 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.422 HD12 ' NH1' ' A' ' 112' ' ' ARG . 1.5 mt 43.8 -162.91 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.5 -0.75 . . . . 1.0 110.307 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.02 -29.69 11.95 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.54 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.438 -1.036 . . . . 1.0 109.747 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -154.4 97.61 2.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 1.0 110.281 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 133' ' ' THR . 0.0 OUTLIER 43.76 -158.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 1.0 110.131 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.607 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -160.31 104.08 1.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 1.0 110.348 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -92.55 176.5 6.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 1.0 109.514 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 t -138.15 136.58 36.82 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.891 -1.131 . . . . 1.0 110.055 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.75 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 44.9 p-10 -89.06 22.78 2.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 1.0 109.457 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 52.52 18.15 5.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.943 -1.663 . . . . 1.0 108.943 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -109.63 150.18 28.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 1.0 109.273 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.925 HD11 ' CG ' ' A' ' 57' ' ' LEU . 7.4 tp -160.66 156.35 25.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 1.0 111.122 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.536 ' N ' ' HG ' ' A' ' 141' ' ' LEU . 76.5 m95 -131.7 105.43 7.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.919 -1.512 . . . . 1.0 106.919 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.838 HD13 HD12 ' A' ' 57' ' ' LEU . 3.6 tp -116.95 116.42 27.37 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.24 -1.384 . . . . 1.0 113.602 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 132.29 -1.04 4.86 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 119.668 -1.253 . . . . 1.0 110.638 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.536 ' O ' ' SD ' ' A' ' 146' ' ' MET . . . 154.37 -154.95 25.87 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 117.956 -2.069 . . . . 1.0 109.731 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.955 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -154.05 139.38 17.61 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.254 -0.978 . . . . 1.0 112.941 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.548 ' N ' ' OH ' ' A' ' 24' ' ' TYR . 40.9 tt0 -68.43 -50.91 49.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.582 0.706 . . . . 1.0 109.665 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -116.15 69.8 0.75 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.541 -1.281 . . . . 1.0 107.541 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.955 HD13 ' CB ' ' A' ' 146' ' ' MET . 0.1 OUTLIER -65.33 49.52 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.439 -0.788 . . . . 1.0 112.976 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 148' ' ' ARG . 88.0 p -83.34 -10.08 58.69 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.975 -1.861 . . . . 1.0 105.975 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.958 HG21 ' CZ3' ' A' ' 58' ' ' TRP . 4.9 p -79.86 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 115.227 -0.897 . . . . 1.0 110.336 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.797 ' HB1' ' O ' ' A' ' 155' ' ' LEU . . . 53.18 38.17 26.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.326 -1.484 . . . . 1.0 108.546 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.488 ' NE2' ' CG ' ' A' ' 67' ' ' ASP . 59.8 m170 3.92 -95.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.771 1.397 . . . . 1.0 114.771 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.463 ' CE ' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -98.31 26.59 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 1.0 112.739 -176.535 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 1.007 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -156.55 131.81 5.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 120.649 -1.282 . . . . 1.0 110.031 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.59 ' N ' HD12 ' A' ' 155' ' ' LEU . 55.1 Cg_endo -92.14 -66.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.793 1.418 . . . . 1.0 113.747 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.49 -56.9 15.43 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 114.403 1.26 . . . . 1.0 114.403 -176.062 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 1.007 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -41.38 -41.23 1.93 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.44 -1.413 . . . . 1.0 108.103 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.799 ' HD2' HD11 ' A' ' 149' ' ' LEU . 21.8 m-85 -83.27 -32.13 26.57 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.957 -1.097 . . . . 1.0 108.141 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.657 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -67.71 -10.51 53.15 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.107 -1.037 . . . . 1.0 109.079 178.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.499 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.4 m -129.56 99.33 5.13 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -49.76 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.655 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 19.3 t80 -79.76 148.19 31.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -1.175 . . . . 1.0 112.49 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.753 HG22 ' HB2' ' A' ' 50' ' ' GLU . 3.8 mt -124.94 82.32 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.655 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.48 -163.49 26.4 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.533 -1.827 . . . . 1.0 108.533 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 24.1 m -122.88 151.02 42.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.012 -1.287 . . . . 1.0 110.431 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -127.35 152.37 35.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.46 ' NH1' ' OD2' ' A' ' 169' ' ' ASP . 13.9 ttt-85 -159.09 148.37 18.64 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.049 -1.06 . . . . 1.0 110.721 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 93.6 m-20 52.5 84.52 0.05 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.877 -0.729 . . . . 1.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.81 HG12 ' CB ' ' A' ' 45' ' ' LEU . 20.7 m -127.78 131.2 70.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 C-N-CA 119.586 -0.845 . . . . 1.0 108.889 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.447 HG12 ' C ' ' A' ' 170' ' ' VAL . 0.0 OUTLIER -145.91 144.43 20.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 118.964 -1.094 . . . . 1.0 111.237 -177.092 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 175' ' ' GLN . 3.0 p -132.14 121.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 28.8 m-20 47.59 31.68 2.16 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.721 -1.237 . . . . 1.0 108.634 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 76.04 10.37 3.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.794 -0.566 . . . . 1.0 111.413 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.767 ' HB2' HG13 ' A' ' 172' ' ' VAL . 1.6 mp0 -91.84 -171.89 3.01 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.944 -1.098 . . . . 1.0 109.851 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.668 ' HG2' HG23 ' A' ' 170' ' ' VAL . 1.2 tt0 72.52 -107.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.614 -0.679 . . . . 1.0 110.084 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 67.18 -83.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.038 -1.039 . . . . 1.0 112.227 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.0 m-70 -60.75 84.75 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.947 -1.096 . . . . 1.0 111.079 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -55.74 -58.15 9.05 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.216 1.007 . . . . 1.0 111.354 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.969 ' O ' HD13 ' A' ' 184' ' ' LEU . 85.9 t -65.29 -23.56 33.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.898 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.2 mt-10 -63.6 -52.32 61.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.283 -1.511 . . . . 1.0 110.327 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.573 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 3.6 m-20 -94.98 -3.12 49.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.234 -0.916 . . . . 1.0 110.216 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -78.24 -28.91 47.92 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.263 -0.975 . . . . 1.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.969 HD13 ' O ' ' A' ' 180' ' ' VAL . 8.1 mp -59.27 -15.3 14.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 1.0 109.173 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 4.2 t-20 -51.23 -24.09 4.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.465 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 3.6 t30 -97.3 148.79 34.92 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.465 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 41.3 Cg_endo -67.48 -55.38 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.658 1.346 . . . . 1.0 111.588 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.437 ' C ' HG13 ' A' ' 189' ' ' ILE . 5.1 m -101.46 132.4 47.08 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.371 -0.831 . . . . 1.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.437 HG13 ' C ' ' A' ' 188' ' ' THR . 3.8 mt -130.46 111.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.73 . . . . 1.0 109.494 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.74 175.92 8.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.267 -0.896 . . . . 1.0 109.338 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.59 18.85 4.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.581 -1.247 . . . . 1.0 111.109 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.44 ' CA ' ' HB2' ' A' ' 18' ' ' ALA . 1.5 t 57.18 165.38 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.308 -0.87 . . . . 1.0 109.71 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 0.1 OUTLIER -134.04 146.34 50.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.063 -1.023 . . . . 1.0 110.455 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 176.55 40.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.327 -0.858 . . . . 1.0 110.659 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? . . . . . 0 C--N 1.291 -1.959 0 C-N-CA 118.427 -1.309 . . . . 1.0 110.647 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.595 -1.402 . . . . 1.0 109.595 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 m -102.93 -170.53 1.81 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -1.178 . . . . 1.0 110.41 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -130.38 8.62 5.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 1.0 109.857 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 124.5 27.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 1.0 109.922 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 t -105.2 114.88 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 1.0 110.122 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 6' ' ' ILE . 10.3 pt -121.21 83.87 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 1.0 110.554 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.75 133.6 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.003 -1.06 . . . . 1.0 110.295 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.93 91.16 3.51 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.249 -0.907 . . . . 1.0 110.073 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.84 96.9 4.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.082 -1.011 . . . . 1.0 110.543 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.62 121.61 45.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 1.0 109.928 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.91 -18.64 5.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 1.0 110.186 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' C ' ' OD1' ' A' ' 13' ' ' ASP . . . 68.79 -158.95 52.72 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.63 -1.388 . . . . 1.0 109.63 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' GLU . 1.5 m-20 -135.24 -101.36 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 1.0 110.128 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 41.99 24.42 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.008 -1.058 . . . . 1.0 111.029 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.0 tt0 -64.5 87.78 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.1 -1.0 . . . . 1.0 109.457 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.464 ' C ' HD13 ' A' ' 17' ' ' ILE . . . -116.49 138.26 51.52 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.471 -0.768 . . . . 1.0 111.356 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.638 HG13 HD23 ' A' ' 179' ' ' LEU . 0.8 OUTLIER -123.22 146.53 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.998 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -113.53 122.79 48.31 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.21 -0.931 . . . . 1.0 111.153 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.743 ' CE2' HD13 ' A' ' 167' ' ' ILE . 8.5 m-30 -87.88 148.03 24.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.457 -0.777 . . . . 1.0 109.3 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.475 ' OD1' ' HB ' ' A' ' 23' ' ' THR . 7.0 p-10 -103.4 2.47 33.92 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.181 -0.949 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.86 65.21 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.303 -1.519 . . . . 1.0 109.303 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.48 23.35 4.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -1.207 . . . . 1.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.475 ' HB ' ' OD1' ' A' ' 20' ' ' ASP . 5.2 t -109.55 163.26 13.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.898 . . . . 1.0 110.066 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.58 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 14.7 p90 -147.04 123.22 10.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 1.0 110.301 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.545 ' HE1' HG21 ' A' ' 17' ' ' ILE . 4.6 mtt -98.48 99.95 11.16 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.778 -1.201 . . . . 1.0 109.364 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 14.1 tt0 -88.87 98.51 11.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.509 -0.744 . . . . 1.0 109.989 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 13.1 m-30 -96.58 111.69 23.73 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.989 -1.07 . . . . 1.0 110.589 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -104.24 118.03 35.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.449 -0.782 . . . . 1.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 139' ' ' GLY . 9.4 m-20 -140.41 128.45 22.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 1.0 110.391 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.2 141.54 38.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 1.0 109.499 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 31' ' ' VAL . 8.7 p -166.32 133.82 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.094 . . . . 1.0 111.027 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -165.1 100.52 0.75 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 179.164 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 34' ' ' SER . 11.8 mtmm -91.43 77.59 5.77 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.402 -0.919 . . . . 1.0 109.525 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 35.4 m 57.03 94.25 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER 66.91 116.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.038 -0.726 . . . . 1.0 109.038 -178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 51.61 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.461 -0.774 . . . . 1.0 110.519 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 38' ' ' LEU . . . -131.53 44.63 2.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.273 -0.892 . . . . 1.0 109.248 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.546 ' H ' HD12 ' A' ' 38' ' ' LEU . 1.7 mp -51.97 -170.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.59 -0.693 . . . . 1.0 110.779 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -124.74 16.36 8.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.595 -0.691 . . . . 1.0 109.889 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.1 p -157.85 155.36 29.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 1.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 1.7 m-20 -131.66 160.15 36.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 1.0 110.486 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 20.8 m-70 -130.43 115.99 17.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 1.0 109.952 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.893 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 23.1 m-30 -119.5 114.81 22.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.179 -0.951 . . . . 1.0 109.816 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.856 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.4 mp0 -125.21 140.65 52.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 1.0 110.794 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.917 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.6 OUTLIER 179.84 159.26 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.098 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.507 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.64 161.19 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.507 ' CG2' ' C ' ' A' ' 46' ' ' SER . 7.4 pt -150.29 170.87 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 117.995 -1.482 . . . . 1.0 112.615 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 4.1 tttm -131.82 85.35 2.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.5 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -72.01 156.42 39.24 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.045 -1.034 . . . . 1.0 111.609 -177.521 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.1 mm-40 -136.9 -4.84 1.94 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.222 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.875 ' O ' HG23 ' A' ' 52' ' ' THR . . . -125.79 -82.54 0.63 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.144 -0.972 . . . . 1.0 110.429 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 158.57 -20.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.255 0.55 . . . . 1.0 109.641 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -130.2 146.46 51.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 1.0 110.353 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 149.2 135.11 2.45 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.047 HD13 ' CZ ' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -82.31 132.42 35.22 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.943 -1.327 . . . . 1.0 110.008 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.031 HD12 ' HA ' ' A' ' 72' ' ' ALA . 3.9 mp -97.84 -8.8 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 1.0 111.391 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.893 HD13 HD13 ' A' ' 71' ' ' LEU 0.292 6.5 tt -168.96 146.08 3.66 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 117.643 -1.623 . . . . 1.0 113.012 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 1.004 ' CE2' HG21 ' A' ' 151' ' ' VAL . 12.5 t-105 -150.89 118.2 6.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.661 . . . . 1.0 109.318 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.01 122.98 29.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.075 -1.016 . . . . 1.0 109.874 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.02 167.81 23.2 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.158 -1.577 . . . . 1.0 109.158 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -140.63 -23.15 0.8 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.285 . . . . 1.0 111.548 -179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . -134.07 132.68 6.5 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.531 -1.319 . . . . 1.0 110.563 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 62' ' ' GLY . 1.8 mt 46.9 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.974 . . . . 1.0 111.196 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -119.0 31.87 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 1.0 110.188 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -158.81 24.89 0.22 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.867 . . . . 1.0 108.923 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -116.65 -165.27 1.04 Allowed 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.828 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 1.3 t0 -43.94 135.72 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 1.0 109.985 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.63 ' CZ ' ' CB ' ' A' ' 83' ' ' ASP . 7.8 p90 -154.84 171.88 18.91 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.101 -1.0 . . . . 1.0 109.953 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.905 HD11 HD21 ' A' ' 135' ' ' LEU . 5.2 mt -146.14 119.27 2.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.646 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.943 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -140.95 -178.05 5.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.753 -1.217 . . . . 1.0 110.68 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.893 HD13 HD13 ' A' ' 57' ' ' LEU . 3.6 mp -149.24 116.06 5.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 1.031 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -129.19 178.87 6.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.173 -0.955 . . . . 1.0 111.842 -178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.992 ' CG1' HD11 ' A' ' 56' ' ' ILE . 4.0 mt -120.43 134.43 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.431 -0.793 . . . . 1.0 109.745 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.601 HG23 ' NE2' ' A' ' 79' ' ' GLN . 1.3 t -141.09 134.03 30.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.203 -0.935 . . . . 1.0 110.367 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 59.66 22.04 10.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.325 -0.859 . . . . 1.0 110.682 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.616 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 84.72 31.61 23.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -146.9 130.3 16.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -1.086 . . . . 1.0 110.079 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.631 ' CG2' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -78.16 -177.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.601 ' NE2' HG23 ' A' ' 74' ' ' VAL . 2.6 pt20 176.5 133.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.664 -1.273 . . . . 1.0 111.491 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.998 ' CE ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -91.14 109.43 20.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 1.0 109.219 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.943 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 8.3 ptt? -94.01 106.35 18.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.917 -1.114 . . . . 1.0 109.779 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.73 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -93.47 127.73 39.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.226 -0.921 . . . . 1.0 109.965 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.63 ' CB ' ' CZ ' ' A' ' 68' ' ' TYR . 5.7 t0 -131.88 43.2 3.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.054 -1.059 . . . . 1.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.867 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -64.37 -10.62 25.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.45 -0.9 . . . . 1.0 110.155 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -139.78 39.23 1.54 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.696 -1.24 . . . . 1.0 110.707 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.27 -8.22 1.37 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -1.201 . . . . 1.0 111.773 179.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 9.4 mmtt -109.12 102.96 50.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 120.783 -1.198 . . . . 1.0 109.76 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 82' ' ' TYR . 45.9 Cg_endo -73.63 105.4 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.219 1.641 . . . . 1.0 110.836 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.73 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -85.21 106.58 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.196 -0.94 . . . . 1.0 109.135 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 90' ' ' VAL . 7.9 p -86.38 81.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.138 -1.602 . . . . 1.0 111.269 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.998 HD12 ' CE ' ' A' ' 80' ' ' MET . 29.1 mt -71.97 70.12 0.75 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.76 ' CG ' HG22 ' A' ' 90' ' ' VAL . 11.5 mtp180 -64.35 171.53 3.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.547 -0.861 . . . . 1.0 110.347 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.2 t -96.96 152.19 18.96 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.788 -0.57 . . . . 1.0 109.761 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 94' ' ' THR . 2.3 t -102.25 26.85 7.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.924 -1.11 . . . . 1.0 109.407 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.562 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 9.0 t -128.31 147.69 64.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 1.0 109.177 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 43.3 Cg_endo -68.03 132.31 25.97 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.533 1.281 . . . . 1.0 110.228 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.631 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -110.94 -30.8 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.867 . . . . 1.0 110.701 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -69.09 61.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.032 -1.042 . . . . 1.0 109.415 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.602 ' O ' HG22 ' A' ' 99' ' ' THR . 19.0 m -122.43 10.34 9.82 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.498 -0.751 . . . . 1.0 109.999 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 99' ' ' THR . 7.0 m-80 55.25 15.64 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 1.0 110.515 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.03 172.68 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 1.0 109.435 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.572 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 45.3 m95 -94.7 118.12 31.21 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.075 -1.016 . . . . 1.0 111.004 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 46' ' ' SER . 54.3 m -116.5 152.36 34.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.487 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 65.0 t-80 -101.77 156.73 17.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.882 -1.136 . . . . 1.0 108.987 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.557 HG22 HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -145.84 154.65 13.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.132 -0.98 . . . . 1.0 109.614 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.755 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -148.21 147.62 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 1.0 109.905 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.893 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -139.72 99.19 3.64 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.651 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.637 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 52.6 p90 -110.0 106.83 16.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.958 -1.089 . . . . 1.0 109.136 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.559 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 4.5 tmm_? -94.11 144.7 25.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.543 -0.723 . . . . 1.0 111.28 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 15.4 t -128.56 116.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.8 mm-40 59.19 -89.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 1.0 109.954 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 127' ' ' SER . 2.6 ptt180 -128.08 -28.01 2.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.546 -0.721 . . . . 1.0 110.521 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.576 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 10.6 tt0 -82.47 114.9 21.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 1.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -102.17 156.76 18.54 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.637 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 40.6 t -129.81 151.16 50.69 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.481 -1.011 . . . . 1.0 109.896 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.755 HD22 ' O ' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -148.9 126.32 11.58 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.127 -0.983 . . . . 1.0 110.812 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.673 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -134.66 135.53 42.14 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.849 -1.157 . . . . 1.0 110.254 178.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 118' ' ' VAL . 1.2 t -81.67 101.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 71.29 40.81 60.38 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.011 -1.636 . . . . 1.0 109.011 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 36.0 m-80 61.64 27.68 17.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.467 -1.019 . . . . 1.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 2.4 mt-10 -93.0 -158.12 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.2 -0.937 . . . . 1.0 110.866 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 124' ' ' ILE . . . -41.15 109.92 0.68 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.443 -0.785 . . . . 1.0 109.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.557 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 44.5 Cg_endo -73.28 119.15 5.84 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.977 1.514 . . . . 1.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.726 HG21 ' O ' ' A' ' 92' ' ' ARG . 1.8 mp -95.19 100.07 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.704 -1.591 . . . . 1.0 106.704 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 115' ' ' SER . 12.3 p -109.03 148.99 29.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.177 0.989 . . . . 1.0 112.161 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.488 ' N ' ' CD2' ' A' ' 91' ' ' LEU . . . -152.2 161.31 29.33 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 106.786 -2.526 . . . . 1.0 106.786 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -135.52 159.01 42.94 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.68 -1.483 . . . . 1.0 111.029 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.59 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -94.61 -177.61 0.69 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.669 -0.645 . . . . 1.0 109.634 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 38.1 Cg_endo -64.14 102.25 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.376 -1.432 . . . . 1.0 108.376 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.486 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.3 pp -33.46 153.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.399 0.618 . . . . 1.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 132' ' ' ALA . . . 99.77 -64.92 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.311 -1.516 . . . . 1.0 109.311 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . 39.18 -145.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.477 -1.014 . . . . 1.0 109.842 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 132' ' ' ALA . 2.4 p -154.84 59.59 0.67 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.019 -1.051 . . . . 1.0 110.57 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 133' ' ' THR . 5.2 mt-30 56.94 153.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 1.0 110.078 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.905 HD21 HD11 ' A' ' 69' ' ' ILE . 13.6 tp -135.82 109.61 8.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.978 -1.076 . . . . 1.0 110.654 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.5 m-20 -106.92 158.75 16.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 1.0 109.557 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -113.65 153.28 29.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.075 -1.016 . . . . 1.0 110.281 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.721 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 28.0 p-10 -90.91 27.13 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.268 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 44.75 23.77 0.61 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.712 -1.755 . . . . 1.0 108.712 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.721 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -133.51 152.39 51.9 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.388 -1.066 . . . . 1.0 109.158 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.719 HD11 ' HG ' ' A' ' 57' ' ' LEU . 8.0 tp -158.61 161.36 37.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.105 -0.997 . . . . 1.0 110.703 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.744 ' CE3' ' HE3' ' A' ' 146' ' ' MET . 45.0 m95 -127.59 159.67 33.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.881 HD22 ' O ' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -153.91 118.84 5.02 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 116.873 -1.931 . . . . 1.0 113.801 -177.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.664 ' N ' HD13 ' A' ' 143' ' ' LEU . . . 111.26 5.66 26.37 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.497 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 134.27 -136.22 8.47 Favored Glycine 0 C--N 1.283 -2.366 0 C-N-CA 118.542 -1.789 . . . . 1.0 109.917 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.874 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -167.3 126.1 1.34 Allowed 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.892 -1.123 . . . . 1.0 112.037 -178.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.565 ' HB2' ' CG ' ' A' ' 24' ' ' TYR . 6.5 tp10 -58.74 -19.27 38.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.533 ' N ' ' HD3' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -146.03 69.69 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.468 -1.679 . . . . 1.0 106.468 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.922 HD11 ' CD2' ' A' ' 159' ' ' TYR . 3.5 tp -71.81 41.09 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.55 0.945 . . . . 1.0 113.55 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 p -76.79 -9.56 58.77 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.477 -1.675 . . . . 1.0 106.477 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' CE2' ' A' ' 58' ' ' TRP 0.269 8.2 p -72.66 -26.37 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.044 -0.98 . . . . 1.0 111.238 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.718 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . -40.23 -27.52 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.286 -0.884 . . . . 1.0 110.197 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 151' ' ' VAL . 28.7 m170 70.8 -92.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.324 0.583 . . . . 1.0 110.496 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -139.6 -4.11 1.45 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 111.217 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 155' ' ' LEU . 3.7 pp -47.16 170.01 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 1.0 108.608 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.679 ' O ' HD12 ' A' ' 155' ' ' LEU . 37.6 Cg_endo -61.12 178.4 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.331 1.174 . . . . 1.0 112.173 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -60.42 -6.7 1.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -0.865 . . . . 1.0 111.738 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -42.02 -38.98 1.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.91 -1.119 . . . . 1.0 108.934 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 1.047 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 3.8 m-85 -79.3 -34.0 42.79 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.323 -0.951 . . . . 1.0 109.113 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -65.64 -11.77 47.58 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.337 -0.945 . . . . 1.0 109.597 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -123.89 82.66 2.05 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.581 -0.699 . . . . 1.0 109.302 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 161' ' ' THR . . . -41.04 159.21 0.03 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.64 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 8.4 t80 -76.93 141.64 40.4 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.909 -1.348 . . . . 1.0 112.183 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 164' ' ' ILE . 6.0 mt -121.36 84.69 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.64 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.46 -154.38 9.45 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.427 -1.869 . . . . 1.0 108.427 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.49 ' C ' HG13 ' A' ' 167' ' ' ILE . 3.6 m -130.19 153.7 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.128 -1.219 . . . . 1.0 111.232 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.743 HD13 ' CE2' ' A' ' 19' ' ' PHE . 3.5 mt -134.76 153.19 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 3.6 ttt-85 -158.79 153.98 25.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.624 -1.298 . . . . 1.0 111.538 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 59.8 m-20 50.29 81.64 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.622 -0.674 . . . . 1.0 110.992 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.917 HG12 ' CB ' ' A' ' 45' ' ' LEU . 19.4 m -123.3 130.6 74.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.145 -1.022 . . . . 1.0 110.174 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.509 ' HB ' ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -138.51 144.36 30.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.246 -0.982 . . . . 1.0 110.948 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.557 HG13 ' HE1' ' A' ' 43' ' ' PHE . 70.1 t -127.89 91.22 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 12.3 m-20 57.96 50.87 9.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.574 -1.329 . . . . 1.0 107.855 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 37.6 mmm-85 61.56 34.74 17.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.708 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 3.1 mm100 -112.46 164.51 13.19 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.088 -1.007 . . . . 1.0 109.596 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.696 ' OE2' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER 71.5 -109.94 0.05 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.0 110.563 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 178' ' ' HIS . 0.2 OUTLIER 55.24 11.97 0.62 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 1.0 112.088 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.702 ' CE1' HD11 ' A' ' 177' ' ' LEU . 58.7 m-70 -144.45 75.5 1.46 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.996 -1.065 . . . . 1.0 108.776 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.696 HD12 ' OE2' ' A' ' 176' ' ' GLU 0.25 7.9 mp -54.64 -55.04 33.76 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.199 1.0 . . . . 1.0 111.17 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 4.9 t -63.2 -16.48 17.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.884 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.572 ' CG ' ' HB3' ' A' ' 178' ' ' HIS . 16.1 mt-10 -71.55 -51.54 22.96 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.882 -1.127 . . . . 1.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 82.1 m-20 -96.49 -14.96 21.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.559 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -65.78 -38.12 88.15 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.28 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.0 mt -45.6 -25.75 0.51 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 1.0 109.336 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -53.04 -23.14 6.89 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.155 0.979 . . . . 1.0 108.466 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.545 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 14.4 t30 -98.72 160.78 27.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.694 -1.224 . . . . 1.0 107.694 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 37.6 Cg_endo -62.94 -157.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.87 0.932 . . . . 1.0 111.119 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 187' ' ' PRO . 7.3 m -36.14 137.43 0.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 1.0 111.228 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.9 mm -86.5 156.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.502 -0.749 . . . . 1.0 109.985 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.6 mt -127.51 152.88 47.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 1.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -107.36 157.5 17.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.305 -0.872 . . . . 1.0 109.618 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.998 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 38.9 t -48.74 141.78 6.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.0 111.704 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.89 144.93 47.79 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 195' ' ' LYS . . . -130.07 103.51 6.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.956 -1.09 . . . . 1.0 111.019 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 194' ' ' ALA . 40.5 pttt . . . . . 0 C--N 1.297 -1.69 0 C-N-CA 118.987 -1.085 . . . . 1.0 110.604 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.594 -1.403 . . . . 1.0 109.594 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -68.88 -50.44 49.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -1.169 . . . . 1.0 110.082 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.46 173.17 4.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.828 . . . . 1.0 110.148 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -115.06 97.25 6.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 1.0 110.142 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 5' ' ' VAL . 7.6 p -133.43 133.56 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 1.0 110.034 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mt -117.93 112.1 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 1.0 110.338 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 7' ' ' ILE . 11.2 pt -100.15 81.91 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 1.0 109.897 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -132.07 123.94 28.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.913 . . . . 1.0 110.291 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -51.84 125.04 14.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.248 -0.908 . . . . 1.0 109.899 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.69 153.93 5.46 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.094 -1.004 . . . . 1.0 110.002 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.39 39.1 0.99 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.53 -0.731 . . . . 1.0 110.318 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.96 163.97 12.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.807 ' OD2' HG21 ' A' ' 180' ' ' VAL . 3.0 m-20 -158.66 -57.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -1.128 . . . . 1.0 110.044 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 41.89 48.03 3.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 1.0 109.942 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.49 ' OE1' ' NE2' ' A' ' 191' ' ' HIS . 0.7 OUTLIER -120.36 -164.81 1.12 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.886 0.851 . . . . 1.0 109.821 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -108.46 148.83 29.62 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.906 -0.496 . . . . 1.0 109.91 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 13.3 mm -121.56 131.69 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 1.0 109.251 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.49 ' HB2' ' CA ' ' A' ' 192' ' ' CYS . . . -96.18 130.1 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 1.0 110.998 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CZ ' ' SD ' ' A' ' 25' ' ' MET . 5.8 m-30 -94.89 174.71 6.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.389 -0.819 . . . . 1.0 109.473 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 10.0 p-10 -127.58 -6.82 5.73 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.235 -0.916 . . . . 1.0 110.546 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.47 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 98.38 -1.66 58.88 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 52.0 ttp85 -134.92 -5.71 2.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.947 -1.326 . . . . 1.0 110.947 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -87.42 140.27 29.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.774 -1.204 . . . . 1.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.423 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 3.0 p90 -112.26 95.21 5.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.298 -0.876 . . . . 1.0 110.188 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.56 ' SD ' ' CZ ' ' A' ' 19' ' ' PHE . 8.7 mtt -77.06 100.76 5.79 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.465 -0.894 . . . . 1.0 109.902 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 3.4 pm0 -107.29 121.91 45.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 1.0 110.606 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 25' ' ' MET . 17.4 m-85 -111.03 107.96 17.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.414 -0.804 . . . . 1.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.95 112.84 24.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 1.0 110.152 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.6 ' ND2' ' OE1' ' A' ' 175' ' ' GLN . 5.1 t30 -127.77 137.44 52.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 1.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.44 27.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 1.0 110.0 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.718 HG23 HG22 ' A' ' 32' ' ' THR . 34.1 m -122.72 -43.38 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.004 -1.06 . . . . 1.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.718 HG22 HG23 ' A' ' 31' ' ' VAL . 1.9 t -179.77 110.58 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.011 -1.056 . . . . 1.0 110.416 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 79.34 6.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 1.0 109.998 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -174.08 -67.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.365 -0.834 . . . . 1.0 110.014 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 36' ' ' LYS . 1.8 tt0 -67.7 62.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 1.0 109.425 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.666 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -39.23 118.84 0.84 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.751 . . . . 1.0 110.984 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 36' ' ' LYS . . . 67.15 152.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.4 -0.813 . . . . 1.0 110.873 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 38' ' ' LEU . 5.4 mp -119.26 138.92 52.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.381 -0.825 . . . . 1.0 109.818 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 38' ' ' LEU . 3.2 pt20 -41.57 -32.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 1.0 110.688 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.777 ' OG ' HG13 ' A' ' 110' ' ' VAL . 47.8 m -149.25 148.72 29.91 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.376 -0.828 . . . . 1.0 110.454 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.437 HD21 ' HZ ' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -112.02 147.18 36.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 1.0 110.158 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 30.7 m80 -123.01 123.36 40.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 1.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.731 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 26.5 m-85 -122.18 117.83 27.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 1.0 109.535 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.869 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.4 mt-10 -126.74 139.87 52.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 1.0 110.882 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.897 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.4 OUTLIER 179.1 164.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.489 -0.884 . . . . 1.0 111.003 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 103' ' ' THR . 50.0 m -124.7 149.71 46.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.352 -1.351 . . . . 1.0 107.352 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.621 HD13 HD11 ' A' ' 105' ' ' ILE . 3.7 pt -139.36 164.41 24.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.163 -1.415 . . . . 1.0 112.312 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.2 OUTLIER -116.45 86.9 2.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 177.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -72.31 155.67 39.92 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.977 -1.077 . . . . 1.0 111.063 -177.516 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.4 mm-40 -138.21 10.19 2.77 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.755 -0.778 . . . . 1.0 110.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 52' ' ' THR . . . -140.43 -85.51 0.21 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.117 -0.989 . . . . 1.0 110.61 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.64 -24.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 3.9 tt0 -125.03 138.19 54.21 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 156.73 138.81 2.6 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.042 -1.623 . . . . 1.0 109.042 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.244 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -88.72 128.32 35.61 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.83 -1.394 . . . . 1.0 109.602 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.796 HG22 HD21 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -90.83 -35.93 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.788 -0.57 . . . . 1.0 112.508 -176.143 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.084 HD13 HD12 ' A' ' 71' ' ' LEU . 2.3 tt -149.05 146.02 27.55 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.859 -1.151 . . . . 1.0 111.981 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.949 ' N ' HD23 ' A' ' 57' ' ' LEU . 3.5 t-105 -149.09 111.76 4.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.583 -1.266 . . . . 1.0 107.583 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.578 ' OG ' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -118.79 161.4 20.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.873 -1.142 . . . . 1.0 111.394 -178.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.5 127.04 1.29 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.504 -1.838 . . . . 1.0 108.504 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -76.59 11.7 1.55 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.054 -1.262 . . . . 1.0 110.829 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.54 51.8 53.51 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.101 -1.2 . . . . 1.0 110.101 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 66' ' ' SER . 0.7 OUTLIER -59.55 -165.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.202 -1.176 . . . . 1.0 109.589 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -108.02 -14.82 14.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.061 -1.024 . . . . 1.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.546 ' CZ ' ' HB2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -168.27 27.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.413 -0.804 . . . . 1.0 109.456 179.431 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -103.31 -177.91 3.51 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.627 -0.829 . . . . 1.0 110.196 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.644 ' CB ' ' O ' ' A' ' 83' ' ' ASP . 9.3 m-20 -103.89 -122.42 0.2 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.06 -1.025 . . . . 1.0 110.901 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.611 ' CG ' ' C ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER 179.12 -162.66 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.197 -1.564 . . . . 1.0 111.983 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.989 HD12 ' N ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -148.26 146.0 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.425 -178.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.113 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -146.63 -175.11 4.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 1.0 110.39 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.084 HD12 HD13 ' A' ' 57' ' ' LEU . 66.3 mt -149.56 126.2 11.0 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.009 -1.108 . . . . 1.0 108.009 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -145.22 173.33 12.04 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.824 -1.172 . . . . 1.0 111.964 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.67 HG12 HG13 ' A' ' 78' ' ' VAL . 16.9 mt -117.56 141.81 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.593 0.711 . . . . 1.0 111.086 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -139.28 130.17 33.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.743 -0.598 . . . . 1.0 110.164 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 1.2 m-20 58.36 21.31 8.19 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.224 -0.922 . . . . 1.0 111.602 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.823 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 92.39 20.05 36.47 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.628 -1.272 . . . . 1.0 110.252 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 76' ' ' GLY . 16.9 m-85 -138.19 144.29 40.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -1.126 . . . . 1.0 109.411 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.755 HG22 HD13 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -79.59 -167.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 1.0 109.103 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER 175.75 102.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 1.0 110.534 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.946 ' CE ' HD12 ' A' ' 91' ' ' LEU . 2.3 ttm -61.68 93.08 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.914 -0.714 . . . . 1.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 1.113 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 11.3 tmm? -89.94 111.29 22.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.804 -0.56 . . . . 1.0 110.005 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.871 ' CE2' HG11 ' A' ' 89' ' ' VAL . 2.8 p90 -143.1 141.29 31.2 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.346 -1.341 . . . . 1.0 110.986 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.644 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 0.6 OUTLIER -138.52 71.44 1.39 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.668 -0.645 . . . . 1.0 110.132 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.824 HD13 ' CD2' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -67.89 -7.37 27.67 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 120.069 -0.652 . . . . 1.0 110.006 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.62 -57.57 0.37 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.01 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -1.113 . . . . 1.0 110.55 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -110.37 124.48 33.17 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.95 . . . . 1.0 109.739 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.53 ' CA ' ' HB3' ' A' ' 83' ' ' ASP . 48.6 Cg_endo -73.7 139.12 27.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.784 1.413 . . . . 1.0 110.371 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.871 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.52 121.06 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 90' ' ' VAL . 7.2 p -99.06 81.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 118.346 -1.341 . . . . 1.0 111.09 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.946 HD12 ' CE ' ' A' ' 80' ' ' MET . 8.5 mt -76.63 71.33 3.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.622 -1.251 . . . . 1.0 107.622 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.641 ' O ' HG21 ' A' ' 124' ' ' ILE . 38.6 mtp180 -59.1 179.04 0.1 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.192 0.996 . . . . 1.0 111.347 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.864 ' HA ' HD13 ' A' ' 124' ' ' ILE . 3.1 t -114.84 149.1 37.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.45 -0.795 . . . . 1.0 109.904 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.756 ' O ' HG22 ' A' ' 94' ' ' THR . 54.5 m -106.85 34.37 3.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 1.0 109.423 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 1.014 HG11 HG21 ' A' ' 118' ' ' VAL . 0.8 OUTLIER -128.43 151.87 77.31 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.559 -0.713 . . . . 1.0 109.955 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 95' ' ' VAL . 43.5 Cg_endo -69.53 121.41 8.15 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.399 1.21 . . . . 1.0 109.892 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -109.58 -27.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 1.0 110.683 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 6.3 p-10 -82.06 61.11 5.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 1.0 109.847 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.708 ' O ' HG22 ' A' ' 99' ' ' THR . 27.0 m -123.1 14.86 9.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.823 . . . . 1.0 110.195 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.496 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER 53.54 18.05 1.32 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.937 -1.102 . . . . 1.0 110.108 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 5.5 m80 -116.14 144.59 43.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 1.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.56 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 21.1 m95 -59.44 109.52 0.91 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.437 -0.789 . . . . 1.0 111.138 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 104' ' ' HIS . 2.7 m -98.03 170.52 8.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.597 ' HB3' ' CA ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER -123.08 138.64 54.62 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.042 -1.037 . . . . 1.0 108.244 178.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.621 HD11 HD13 ' A' ' 47' ' ' ILE . 1.2 mt -134.91 149.16 29.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.103 -0.998 . . . . 1.0 109.608 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -148.34 130.19 15.2 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 1.0 109.709 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.731 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -122.46 109.39 14.31 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.263 -0.975 . . . . 1.0 111.295 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.662 ' CE2' ' CB ' ' A' ' 115' ' ' SER . 3.8 p90 -116.48 110.27 18.38 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.236 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.563 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 3.6 ttp180 -125.1 133.92 52.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.381 0.61 . . . . 1.0 110.44 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.777 HG13 ' OG ' ' A' ' 40' ' ' SER . 3.1 t -97.38 89.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 1.0 109.7 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 0.3 OUTLIER 21.24 48.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 4.3 tmm_? 167.96 -55.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.221 -0.924 . . . . 1.0 109.857 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -111.46 120.06 40.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 1.0 109.785 -179.725 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.06 162.57 15.29 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.946 -1.121 . . . . 1.0 111.618 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.662 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 13.5 t -141.61 155.6 45.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.737 -0.861 . . . . 1.0 109.829 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 117' ' ' GLN . 0.3 OUTLIER -149.65 125.98 10.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 120.956 -1.09 . . . . 1.0 110.908 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.745 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -135.1 134.99 40.85 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 1.014 HG21 HG11 ' A' ' 95' ' ' VAL . 9.9 p -76.2 102.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.597 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . 68.96 30.83 72.21 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 108.819 -1.712 . . . . 1.0 108.819 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 1.0 OUTLIER 72.93 29.99 1.75 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 1.0 110.688 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -97.3 -153.57 0.42 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 110.491 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 124' ' ' ILE . . . -36.81 101.92 0.23 Allowed Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.407 -0.808 . . . . 1.0 110.3 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.57 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 44.9 Cg_endo -71.02 116.65 4.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.57 . . . . 1.0 111.794 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.864 HD13 ' HA ' ' A' ' 93' ' ' SER . 1.2 mp -94.67 99.46 9.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 37.2 p -99.95 174.14 6.33 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.342 1.068 . . . . 1.0 112.39 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.12 154.1 10.15 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.486 -2.246 . . . . 1.0 107.486 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -137.14 167.18 22.04 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.26 -1.141 . . . . 1.0 109.927 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.0 174.75 5.68 Favored Pre-proline 0 C--N 1.3 -1.557 0 C-N-CA 119.089 -1.044 . . . . 1.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 130' ' ' LEU . 49.1 Cg_endo -78.71 43.68 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.735 1.387 . . . . 1.0 109.435 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.2 OUTLIER 42.47 105.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.724 0.773 . . . . 1.0 111.478 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.81 87.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.972 -1.251 . . . . 1.0 109.972 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.716 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -170.95 174.78 4.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -1.101 . . . . 1.0 109.788 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.8 t -179.22 156.98 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 1.0 110.427 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 135' ' ' LEU . 2.2 tt0 69.97 -60.44 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 1.0 111.131 179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.824 ' CD2' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -1.18 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.797 0.808 . . . . 1.0 112.064 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.573 ' C ' HG23 ' A' ' 137' ' ' THR . 37.5 m-20 -116.66 149.01 40.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.11 . . . . 1.0 110.038 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.573 HG23 ' C ' ' A' ' 136' ' ' ASP . 33.3 p -154.15 105.91 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 1.0 110.115 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.6 OUTLIER 167.11 -43.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.69 0.757 . . . . 1.0 109.206 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.4 -24.85 7.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.783 -1.327 . . . . 1.0 109.783 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -163.97 135.03 4.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.995 -1.297 . . . . 1.0 110.598 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 57' ' ' LEU . 6.2 tp -135.8 142.72 44.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 1.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 26' ' ' GLU . 44.2 m95 -117.73 148.09 42.35 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.796 HD21 HG22 ' A' ' 56' ' ' ILE . 1.6 tt -148.59 119.55 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 117.644 -1.623 . . . . 1.0 112.995 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.59 9.3 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.77 -1.332 . . . . 1.0 109.77 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 129.94 -148.52 18.5 Favored Glycine 0 C--N 1.287 -2.158 0 N-CA-C 108.024 -2.031 . . . . 1.0 108.024 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.964 ' CB ' HD13 ' A' ' 149' ' ' LEU 0.266 5.6 mmt -152.53 128.78 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.655 -0.818 . . . . 1.0 110.95 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 146' ' ' MET . 5.3 tm-20 -43.53 -50.23 7.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.023 -1.048 . . . . 1.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.723 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -127.88 79.24 1.88 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 123.022 1.392 . . . . 1.0 107.73 177.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.965 HD12 ' CG1' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -62.1 42.79 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.177 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 148' ' ' ARG . 92.9 p -50.81 -32.75 21.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 177.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.965 ' CG1' HD12 ' A' ' 149' ' ' LEU 0.313 7.1 p -65.9 -141.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 113.542 -1.663 . . . . 1.0 106.557 176.022 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.829 ' HB1' ' CB ' ' A' ' 159' ' ' TYR 0.278 . . 50.63 14.21 0.16 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.597 -1.314 . . . . 1.0 111.508 177.324 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.79 -45.23 6.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.688 -1.257 . . . . 1.0 111.402 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.491 ' NZ ' ' OD2' ' A' ' 83' ' ' ASP . 2.6 pttt -61.13 -6.69 2.13 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.279 -0.888 . . . . 1.0 111.15 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 1.063 HD11 ' CD1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -121.96 -174.82 0.32 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.904 -1.123 . . . . 1.0 110.781 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.591 ' N ' ' HG ' ' A' ' 155' ' ' LEU . 44.1 Cg_endo -70.19 174.98 9.09 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.626 1.329 . . . . 1.0 112.536 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.9 -11.43 1.45 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.682 -0.636 . . . . 1.0 111.948 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -37.29 -41.03 0.38 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.194 -0.941 . . . . 1.0 109.961 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 1.244 ' CE2' HD13 ' A' ' 55' ' ' LEU . 4.0 m-85 -83.0 -32.97 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.093 -1.043 . . . . 1.0 109.522 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -60.53 -15.47 27.69 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.88 -1.128 . . . . 1.0 108.227 178.652 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -115.9 83.5 1.95 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.03 163.94 0.01 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.808 -1.317 . . . . 1.0 109.808 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.586 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 20.0 t80 -77.01 142.32 39.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.763 -1.434 . . . . 1.0 111.647 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 164' ' ' ILE . 3.6 mt -123.93 87.15 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.586 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.25 -153.19 9.07 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 108.184 -1.966 . . . . 1.0 108.184 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 9.6 m -135.73 155.14 50.86 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.893 -1.123 . . . . 1.0 110.758 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.6 mt -133.68 153.34 36.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 121.385 -0.822 . . . . 1.0 109.412 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.415 ' HD3' ' O ' ' A' ' 15' ' ' GLU . 11.2 ttp85 -159.09 158.55 33.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.932 -1.105 . . . . 1.0 110.857 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 22.6 m-20 48.92 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.303 -0.873 . . . . 1.0 110.043 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.897 HG12 ' CB ' ' A' ' 45' ' ' LEU . 18.5 m -126.77 131.71 70.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 C-N-CA 119.179 -1.008 . . . . 1.0 110.004 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.92 149.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.579 -0.849 . . . . 1.0 110.511 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 54.4 t -131.46 94.19 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 1.3 m-20 71.44 38.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 74.51 18.1 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.248 0.547 . . . . 1.0 110.127 -179.342 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.6 ' OE1' ' ND2' ' A' ' 29' ' ' ASN . 7.0 mm-40 -89.09 111.02 21.67 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.344 -0.847 . . . . 1.0 109.732 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.44 106.4 6.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.887 -1.133 . . . . 1.0 109.274 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -89.32 86.96 6.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 1.0 111.077 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.583 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 80.2 m-70 -53.37 104.47 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.174 0.988 . . . . 1.0 109.39 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -46.84 -61.94 1.63 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.166 0.984 . . . . 1.0 109.777 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.807 HG21 ' OD2' ' A' ' 13' ' ' ASP . 36.2 t -54.04 -21.86 6.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.41 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 13.4 mt-10 -64.95 -53.06 52.32 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.265 -1.374 . . . . 1.0 109.914 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.9 OUTLIER -105.59 -22.48 12.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.009 -1.057 . . . . 1.0 109.731 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -59.39 -35.8 74.61 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.785 -1.197 . . . . 1.0 108.153 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.752 HD21 HG13 ' A' ' 180' ' ' VAL . 1.3 mm? -50.25 -20.73 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.718 . . . . 1.0 109.748 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 15.3 t-20 -52.22 -22.53 4.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 1.0 108.956 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.461 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 8.4 t30 -86.18 149.05 49.02 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 45.2 Cg_endo -72.35 -47.54 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.742 1.391 . . . . 1.0 110.599 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.91 118.99 37.6 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.746 -0.596 . . . . 1.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.571 HD12 HD22 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -117.9 128.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.308 -0.87 . . . . 1.0 109.515 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 19.9 mt -103.23 171.97 7.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.861 . . . . 1.0 110.088 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.599 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -121.72 1.78 10.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.056 -1.027 . . . . 1.0 110.911 -179.499 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.49 ' CA ' ' HB2' ' A' ' 18' ' ' ALA . 6.3 t 66.44 154.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 1.0 110.623 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.25 157.37 26.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 1.0 110.04 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -139.94 105.13 5.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.972 . . . . 1.0 110.581 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.7 0 C-N-CA 119.012 -1.075 . . . . 1.0 110.557 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 27.3 t 56.38 -83.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -1.103 . . . . 1.0 110.178 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.5 OUTLIER -44.73 144.32 1.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 1.0 110.132 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.11 159.14 1.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 1.0 109.84 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 m -109.44 149.7 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 1.0 110.122 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 6' ' ' ILE . 27.6 pt -80.33 144.98 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.086 -1.009 . . . . 1.0 110.228 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 7' ' ' ILE . 7.4 tt -122.51 103.3 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 1.0 110.18 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.48 120.18 35.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 1.0 110.07 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -74.04 156.55 37.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 1.0 110.182 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 12' ' ' GLY . . . -87.03 112.95 22.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.252 -0.905 . . . . 1.0 110.401 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.6 76.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.164 -0.96 . . . . 1.0 110.154 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 10' ' ' ALA . . . 153.99 158.28 8.55 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.514 -1.434 . . . . 1.0 109.514 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.742 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 7.9 t0 -166.15 -38.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.192 -1.181 . . . . 1.0 110.458 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . 71.32 88.97 0.1 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.247 -0.908 . . . . 1.0 110.156 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -112.57 -165.2 0.97 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.343 -0.848 . . . . 1.0 108.893 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.09 131.79 35.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.304 -0.873 . . . . 1.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.514 HG21 ' CE ' ' A' ' 25' ' ' MET . 26.4 mm -127.07 117.95 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 1.0 109.437 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.37 139.94 31.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 1.0 111.318 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.889 ' CD2' HG21 ' A' ' 23' ' ' THR . 8.3 m-85 -108.09 159.92 16.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' C ' HG12 ' A' ' 164' ' ' ILE . 4.1 p-10 -115.8 -3.31 12.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.952 -1.092 . . . . 1.0 110.779 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.478 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 109.49 -18.29 30.15 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 30.39 7.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.585 -0.95 . . . . 1.0 109.182 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.889 HG21 ' CD2' ' A' ' 19' ' ' PHE . 1.9 m -69.87 172.69 7.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 1.0 110.894 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.585 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 10.8 t80 -167.72 74.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.597 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 3.8 mmt -86.95 99.43 11.86 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.845 -1.142 . . . . 1.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.77 136.4 34.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 1.0 108.63 179.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 96.0 m-85 -130.92 104.5 7.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.017 -1.052 . . . . 1.0 110.903 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.536 ' HE2' ' HZ2' ' A' ' 142' ' ' TRP . 22.7 m-70 -108.13 120.21 41.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 1.0 109.576 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -155.31 170.69 21.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 1.0 110.524 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.15 153.88 17.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.412 -0.805 . . . . 1.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.8 p -162.48 26.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 1.0 110.735 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 35' ' ' GLU . 15.3 t -163.12 155.41 18.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 1.0 110.161 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 34' ' ' SER . 3.4 tttt -104.57 78.72 1.48 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 1.0 110.233 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER 73.9 -48.49 0.67 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -0.775 . . . . 1.0 110.624 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.426 ' O ' ' OG1' ' A' ' 32' ' ' THR . 5.8 tt0 -66.1 158.22 29.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 1.0 110.123 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -153.31 -168.38 2.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -0.873 . . . . 1.0 110.086 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 36' ' ' LYS . . . 65.77 98.18 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 1.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 38' ' ' LEU . 3.5 mm? -94.38 177.38 5.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 1.0 109.941 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -93.6 -26.36 17.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 1.0 109.986 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.7 p -163.6 133.55 4.23 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.704 -0.622 . . . . 1.0 110.342 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.6 HD21 ' HZ ' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -100.93 152.39 20.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 1.0 109.943 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.552 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 11.5 m80 -123.88 138.16 54.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -0.951 . . . . 1.0 110.03 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 1.016 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 21.2 m-85 -134.73 128.03 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 1.0 110.204 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.793 ' C ' HD23 ' A' ' 45' ' ' LEU . 8.2 mt-10 -133.8 148.9 51.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 1.0 110.114 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.994 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.8 OUTLIER 179.26 151.55 0.35 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.395 -0.922 . . . . 1.0 111.158 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.504 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.09 154.11 35.16 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 97' ' ' ILE . 5.5 pt -150.81 173.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 C-N-CA 117.96 -1.496 . . . . 1.0 112.312 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.652 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -127.33 82.92 2.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 178.284 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -66.86 161.21 24.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.119 -0.988 . . . . 1.0 111.256 -177.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.622 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 8.0 mm-40 -140.81 7.96 2.1 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.531 -0.867 . . . . 1.0 110.939 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 52' ' ' THR . . . -137.04 -86.66 0.31 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.142 -1.023 . . . . 1.0 111.063 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.93 -24.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.302 -0.999 . . . . 1.0 108.302 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -125.01 132.43 53.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.67 -0.644 . . . . 1.0 109.831 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 162.98 137.81 2.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.266 -1.534 . . . . 1.0 109.266 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.755 ' CD2' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -86.07 130.09 34.64 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.903 -1.351 . . . . 1.0 108.305 179.151 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.122 HD11 HG13 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -98.31 -26.27 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.553 -0.717 . . . . 1.0 112.178 -176.713 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.061 HD13 HD12 ' A' ' 71' ' ' LEU 0.264 7.9 tt -156.88 155.41 31.4 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 117.736 -1.586 . . . . 1.0 113.09 -175.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.811 ' N ' HD23 ' A' ' 57' ' ' LEU . 2.7 t-105 -156.23 114.35 3.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.683 ' OG ' HD21 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -133.89 179.92 5.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.89 -1.132 . . . . 1.0 111.063 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 61' ' ' LYS . . . 175.2 -131.55 1.97 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.301 -1.519 . . . . 1.0 109.301 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.1 OUTLIER 170.64 93.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.256 . . . . 1.0 110.073 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.32 -88.39 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tp -119.94 -173.06 2.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 1.0 110.718 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -93.23 44.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 1.0 110.051 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -177.54 35.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 1.0 109.371 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -128.09 140.05 52.17 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 119.739 -0.785 . . . . 1.0 110.718 -178.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.78 ' CG ' HD11 ' A' ' 135' ' ' LEU . 11.3 t0 55.39 130.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.613 -0.68 . . . . 1.0 111.01 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.578 ' CG ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 m-30 -105.32 77.93 1.34 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.608 -1.307 . . . . 1.0 112.211 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.442 HG12 ' CG ' ' A' ' 67' ' ' ASP . 21.0 mm -98.34 77.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.0 109.24 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.845 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -120.88 179.29 4.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 1.0 111.192 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.061 HD12 HD13 ' A' ' 57' ' ' LEU . 81.8 mt -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.252 -0.905 . . . . 1.0 108.723 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -112.18 178.39 4.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.079 . . . . 1.0 111.671 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.671 HG12 HG13 ' A' ' 78' ' ' VAL . 60.1 mt -129.6 139.58 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.456 -0.778 . . . . 1.0 110.971 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.613 HG13 ' NH1' ' A' ' 92' ' ' ARG . 1.9 p -140.41 139.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.759 -0.588 . . . . 1.0 109.945 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.515 ' OD2' HG22 ' A' ' 74' ' ' VAL . 69.3 m-20 59.13 20.49 8.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 1.0 110.944 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.828 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 88.14 16.54 59.11 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.845 -1.302 . . . . 1.0 109.845 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.421 ' C ' HG23 ' A' ' 73' ' ' ILE . 52.5 m-85 -133.97 135.76 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 1.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.122 HG13 HD11 ' A' ' 56' ' ' ILE . 1.6 t -76.24 177.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 1.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -163.46 127.66 2.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.2 -0.937 . . . . 1.0 110.891 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.803 ' HB2' HD23 ' A' ' 116' ' ' LEU . 8.4 tmm? -82.39 94.52 7.41 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.443 0.64 . . . . 1.0 110.606 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.845 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -73.81 120.56 19.57 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 178.089 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.667 ' CE1' HD22 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -143.35 91.73 2.3 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.426 -1.71 . . . . 1.0 111.691 -178.25 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.674 ' C ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.57 152.07 29.31 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.769 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.28 -35.56 1.34 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -103.41 -33.12 4.31 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.666 -1.773 . . . . 1.0 108.666 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 162.02 -12.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.445 -1.032 . . . . 1.0 111.523 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' C ' ' HB2' ' A' ' 83' ' ' ASP . 3.7 mttt -102.64 96.16 7.16 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.751 -1.218 . . . . 1.0 110.043 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HA ' ' CB ' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -70.42 123.99 10.39 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.065 1.561 . . . . 1.0 110.464 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -88.89 119.73 36.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 1.0 109.06 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 90' ' ' VAL . 8.7 p -99.29 81.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.667 -1.271 . . . . 1.0 110.529 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.649 HD12 ' CE ' ' A' ' 80' ' ' MET . 10.4 mt -78.15 82.08 4.49 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.613 ' NH1' HG13 ' A' ' 74' ' ' VAL . 1.2 mtt180 -57.9 176.58 0.15 Allowed 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 118.599 -1.24 . . . . 1.0 109.725 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.595 ' HA ' ' CD1' ' A' ' 124' ' ' ILE . 1.8 t -95.26 159.03 15.2 Favored 'General case' 0 C--N 1.286 -2.164 0 O-C-N 121.691 -0.63 . . . . 1.0 110.341 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 8.57 40.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 1.0 109.834 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.893 ' CG2' HG21 ' A' ' 118' ' ' VAL . 21.8 t -130.15 146.78 62.96 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 1.0 109.316 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.538 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.2 Cg_endo -69.76 153.04 69.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.588 1.31 . . . . 1.0 111.101 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -133.14 -27.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.862 . . . . 1.0 111.032 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.608 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 3.4 p-10 -72.16 65.0 0.57 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.994 -1.066 . . . . 1.0 111.061 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 101' ' ' HIS . 14.7 t -135.82 18.3 3.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 1.0 109.522 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.0 m120 57.31 23.64 9.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.82 . . . . 1.0 111.189 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.73 ' HB2' HG23 ' A' ' 99' ' ' THR . 2.8 m80 -112.0 147.71 35.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 1.0 110.007 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.652 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 23.4 m95 -68.21 104.7 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 1.0 110.057 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 104' ' ' HIS . 2.4 m -98.73 172.41 7.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 1.0 109.003 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.609 ' CD2' ' HA2' ' A' ' 119' ' ' GLY . 1.7 t60 -124.62 139.66 53.66 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.477 HD11 HD13 ' A' ' 47' ' ' ILE . 1.2 mt -129.28 157.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 119.193 -1.003 . . . . 1.0 109.19 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.842 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -146.46 156.5 43.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.105 -0.997 . . . . 1.0 109.539 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -158.22 119.46 3.49 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.526 -0.87 . . . . 1.0 110.516 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 2.3 p90 -129.27 107.3 9.43 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.203 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.605 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.4 OUTLIER -83.71 139.97 32.42 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.987 -0.685 . . . . 1.0 109.839 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.3 t -132.59 88.98 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 1.0 110.041 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 38.8 mt-30 44.58 102.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 1.0 111.121 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 5.3 ttt180 64.24 -52.34 0.27 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 1.0 111.423 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.65 ' CB ' ' OG ' ' A' ' 127' ' ' SER . 4.3 pt-20 -82.09 117.97 22.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.596 -1.315 . . . . 1.0 111.386 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.98 152.56 17.11 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.164 -1.174 . . . . 1.0 110.164 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.603 ' OG ' ' CZ ' ' A' ' 108' ' ' TYR . 32.8 t -133.84 161.88 33.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.13 -1.218 . . . . 1.0 111.538 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.051 HD13 ' N ' ' A' ' 117' ' ' GLN 0.252 1.7 tm? -144.24 155.42 43.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 1.051 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -163.02 123.13 2.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.334 -1.346 . . . . 1.0 112.742 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.893 HG21 ' CG2' ' A' ' 95' ' ' VAL . 3.0 m -71.4 106.53 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.639 -1.615 . . . . 1.0 106.639 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.609 ' HA2' ' CD2' ' A' ' 104' ' ' HIS . . . 75.54 -73.75 1.59 Allowed Glycine 0 C--N 1.287 -2.184 0 N-CA-C 108.817 -1.713 . . . . 1.0 108.817 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 3.5 t-20 178.22 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.404 -1.056 . . . . 1.0 109.602 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -96.99 -158.74 0.69 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.584 -0.698 . . . . 1.0 111.064 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -40.2 103.61 0.3 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 1.0 109.653 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 42.2 Cg_endo -71.33 126.45 12.29 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.02 1.537 . . . . 1.0 111.012 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.595 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 1.7 mp -82.46 99.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.824 -1.172 . . . . 1.0 107.901 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 16.4 p -98.18 177.08 5.51 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.057 -1.027 . . . . 1.0 110.838 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 113' ' ' GLU . . . -179.75 -161.86 27.75 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 107.122 -2.391 . . . . 1.0 107.122 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.65 ' OG ' ' CB ' ' A' ' 113' ' ' GLU . 3.5 m -174.71 154.01 1.89 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.099 -1.236 . . . . 1.0 110.721 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.576 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -80.32 -176.87 0.81 Allowed Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 36.0 Cg_endo -63.23 -60.02 0.19 Allowed 'Trans proline' 0 C--N 1.301 -1.96 0 N-CA-C 108.086 -1.544 . . . . 1.0 108.086 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 129' ' ' PRO . 3.4 pp 152.56 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.631 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.479 ' N ' HD12 ' A' ' 130' ' ' LEU . . . 77.45 -73.16 2.07 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 84' ' ' LEU . . . -64.43 75.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 1.0 110.199 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 131' ' ' GLY . 7.0 m -86.97 -23.82 24.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 1.0 110.133 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -100.43 121.49 41.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 1.0 110.124 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.78 HD11 ' CG ' ' A' ' 67' ' ' ASP . 3.1 tm? -155.81 106.68 2.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 1.0 109.808 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 11.0 m-20 -67.63 136.73 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 1.0 110.429 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -157.4 106.21 2.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 1.0 110.255 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 137' ' ' THR . 2.6 p30 161.28 -32.53 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.589 -0.695 . . . . 1.0 109.785 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -53.22 -21.38 11.62 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -143.64 164.89 29.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.346 . . . . 1.0 110.637 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 142' ' ' TRP . 9.1 tp -160.13 142.49 13.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 1.0 110.754 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 25.5 m95 -132.23 147.27 52.4 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.172 -1.418 . . . . 1.0 107.172 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.94 HD23 HD12 ' A' ' 57' ' ' LEU . 1.4 tm? -153.1 117.72 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.705 -1.598 . . . . 1.0 113.305 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.622 ' N ' HD13 ' A' ' 143' ' ' LEU . . . 119.38 5.12 11.59 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.323 -1.111 . . . . 1.0 110.323 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 139.89 -133.31 5.98 Favored Glycine 0 C--N 1.289 -2.075 0 C-N-CA 118.624 -1.751 . . . . 1.0 109.668 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.64 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -168.99 142.18 2.81 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.515 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.545 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 4.6 tm-20 -71.72 -26.98 62.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.51 -1.293 . . . . 1.0 107.51 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.501 ' CG ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.82 80.36 1.69 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.845 HD23 ' O ' ' A' ' 159' ' ' TYR . 0.3 OUTLIER -69.83 36.44 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.406 -0.809 . . . . 1.0 113.178 -176.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -71.27 -11.13 60.75 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.669 HG21 ' CZ2' ' A' ' 58' ' ' TRP 0.26 10.5 p -79.74 -9.64 12.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.212 -0.903 . . . . 1.0 110.676 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 153' ' ' HIS . . . -70.11 51.99 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 1.0 109.867 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.665 ' CD2' ' N ' ' A' ' 153' ' ' HIS . 1.8 p80 4.26 -86.29 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.688 ' HG3' ' O ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -160.77 100.2 1.27 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 123.299 1.523 . . . . 1.0 109.19 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.783 HD21 ' HD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -154.0 175.54 2.99 Favored Pre-proline 0 C--N 1.283 -2.314 0 O-C-N 120.843 -1.16 . . . . 1.0 109.756 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.732 ' O ' HD22 ' A' ' 155' ' ' LEU . 37.0 Cg_endo -61.29 -178.14 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 122.851 0.921 . . . . 1.0 111.572 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -55.61 -11.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.383 -0.823 . . . . 1.0 112.064 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.699 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -36.23 -43.77 0.37 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.915 . . . . 1.0 109.859 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.845 ' O ' HD23 ' A' ' 149' ' ' LEU . 8.9 m-85 -86.4 -27.7 24.03 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 1.0 109.384 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -75.8 -3.49 35.28 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.657 -1.217 . . . . 1.0 108.243 177.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 161' ' ' THR . 1.8 m -135.35 91.53 2.74 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.26 170.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 1.0 110.069 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.657 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 13.3 t80 -74.18 147.15 42.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.146 -1.208 . . . . 1.0 112.295 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.772 HG22 ' O ' ' A' ' 164' ' ' ILE . 3.6 mt -124.28 87.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.657 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.64 -153.9 9.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.147 -1.581 . . . . 1.0 109.147 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 48' ' ' LYS . 39.4 m -130.5 146.29 52.01 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.387 -1.066 . . . . 1.0 110.457 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.854 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -129.62 150.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.348 -0.845 . . . . 1.0 110.655 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 170' ' ' VAL . 9.4 ttt180 -159.49 168.47 26.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.012 -1.055 . . . . 1.0 110.452 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 14.2 m-20 44.63 58.87 3.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.895 . . . . 1.0 110.38 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.994 HG12 ' CB ' ' A' ' 45' ' ' LEU . 24.2 m -114.19 121.73 66.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.66 -0.816 . . . . 1.0 109.677 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.52 HG13 ' C ' ' A' ' 170' ' ' VAL . 1.0 OUTLIER -134.49 155.74 39.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.352 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.887 HG22 ' CD1' ' A' ' 43' ' ' PHE . 3.2 t -134.72 106.48 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 53.8 m-20 49.91 36.57 11.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.334 -1.479 . . . . 1.0 107.302 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 76.33 22.33 1.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.841 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 176' ' ' GLU . 21.6 mt-30 -99.34 -171.94 2.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.941 -1.1 . . . . 1.0 110.408 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.616 ' HG2' HG23 ' A' ' 170' ' ' VAL . 10.5 tt0 72.49 -102.77 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.675 -0.641 . . . . 1.0 110.801 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.1 mt 68.6 -92.98 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.43 -0.794 . . . . 1.0 112.479 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 88.3 m-70 -89.51 103.86 16.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.667 -1.271 . . . . 1.0 112.486 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.1 OUTLIER -68.67 -48.71 63.26 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 177.482 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.449 ' O ' HD12 ' A' ' 184' ' ' LEU . 10.3 t -47.5 -26.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 1.0 110.004 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 0.6 OUTLIER -72.11 -60.64 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 1.0 110.898 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.581 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -92.93 -15.81 25.88 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.007 -1.058 . . . . 1.0 110.397 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -71.69 -34.92 70.05 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 184' ' ' LEU . 12.7 mt -51.06 -21.15 1.7 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.533 -0.729 . . . . 1.0 109.207 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -42.71 -27.8 0.2 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.006 0.907 . . . . 1.0 108.701 179.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 187' ' ' PRO . 2.4 t30 -131.2 146.32 61.57 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.541 ' O ' HG22 ' A' ' 188' ' ' THR . 42.7 Cg_endo -68.06 -157.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.765 1.402 . . . . 1.0 110.853 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 187' ' ' PRO . 0.4 OUTLIER 63.54 9.98 4.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 1.0 110.514 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 189' ' ' ILE . 30.7 mm -68.53 94.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 1.0 109.951 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.98 164.14 12.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 1.0 110.597 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.15 154.25 22.0 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.214 -0.929 . . . . 1.0 110.092 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 6.5 t -80.19 140.91 36.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.965 . . . . 1.0 110.563 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 58.7 m -102.29 160.5 14.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.343 -0.848 . . . . 1.0 110.298 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 179.62 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 1.0 110.361 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 118.714 -1.195 . . . . 1.0 110.519 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.7 p -137.66 -67.84 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -1.121 . . . . 1.0 110.194 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.83 179.19 7.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 1.0 110.268 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -105.41 -160.4 0.75 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 1.0 109.934 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 5' ' ' VAL . 8.4 p -61.89 116.42 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 1.0 109.607 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.605 ' O ' HG23 ' A' ' 6' ' ' ILE . 1.7 tp -141.47 104.62 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 1.0 110.466 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 7' ' ' ILE . 4.5 mp -114.08 156.05 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 1.0 109.614 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.469 ' OE2' HD11 ' A' ' 6' ' ' ILE . 25.5 mm-40 -134.73 110.72 9.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 1.0 110.857 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 16.4 ptpt -125.44 137.67 53.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.044 -1.035 . . . . 1.0 109.603 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.7 127.28 50.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 1.0 110.274 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.46 48.22 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 1.0 110.119 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASP . . . 137.64 -112.69 0.93 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.756 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 2.0 t70 75.21 -6.3 1.99 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.49 -1.006 . . . . 1.0 110.849 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 13' ' ' ASP . . . 164.54 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 1.0 109.657 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.529 ' O ' ' CD ' ' A' ' 168' ' ' ARG . 0.4 OUTLIER -133.11 -166.33 1.75 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.141 -0.975 . . . . 1.0 109.967 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -138.44 168.3 20.05 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.741 -0.599 . . . . 1.0 109.839 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 191' ' ' HIS . 13.3 mm -134.11 109.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 1.0 110.137 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.787 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -73.25 129.83 38.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.539 -0.726 . . . . 1.0 109.934 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.586 ' CZ ' HD13 ' A' ' 167' ' ' ILE . 3.0 m-30 -95.68 133.49 39.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.404 -0.81 . . . . 1.0 109.326 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 -1.09 54.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 1.0 110.673 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.08 -7.39 62.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -122.02 7.13 9.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.206 -1.173 . . . . 1.0 109.904 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.575 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 8.9 t -81.63 164.45 21.84 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.995 0.902 . . . . 1.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' A' ' 23' ' ' THR . 6.0 m-30 -142.8 94.18 2.61 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.803 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 19' ' ' PHE . 2.4 mmt -94.21 101.63 13.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.841 -1.162 . . . . 1.0 109.795 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -117.65 120.54 38.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 1.0 110.361 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 27' ' ' TYR . 2.9 m-85 -115.03 110.89 20.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.836 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -101.57 85.18 2.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.08 -1.013 . . . . 1.0 110.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -112.8 163.17 14.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 1.0 109.982 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.27 94.5 4.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 1.0 110.24 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 32' ' ' THR . 17.3 m -45.41 -41.78 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.902 . . . . 1.0 110.335 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.509 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -178.4 107.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.28 -0.887 . . . . 1.0 110.004 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.76 86.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 1.0 110.394 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.75 -77.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 1.0 110.123 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -125.63 -41.95 1.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 1.0 110.231 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER 47.08 43.55 14.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 1.0 110.63 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.802 ' HB1' ' OE1' ' A' ' 134' ' ' GLN . . . -141.91 87.6 2.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.471 -0.768 . . . . 1.0 109.592 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 39' ' ' GLN . 2.8 mp -100.67 54.48 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 1.0 111.07 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 38' ' ' LEU . 7.0 tt0 64.12 -58.03 0.22 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.656 0.741 . . . . 1.0 111.33 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -127.89 163.75 23.76 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.369 -0.832 . . . . 1.0 110.982 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -108.97 155.67 20.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.45 -0.781 . . . . 1.0 109.748 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.533 ' O ' HG23 ' A' ' 172' ' ' VAL . 14.8 m-70 -123.48 133.39 54.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.071 . . . . 1.0 110.486 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.814 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 28.9 m-85 -136.76 117.09 13.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 1.0 109.926 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.715 ' C ' HD23 ' A' ' 45' ' ' LEU . 9.6 mt-10 -125.62 145.59 50.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.901 -1.124 . . . . 1.0 110.443 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.749 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 179.79 154.2 0.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.718 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.497 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -118.65 152.7 35.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.977 HD13 HD11 ' A' ' 105' ' ' ILE . 4.0 pt -148.67 160.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 117.81 -1.556 . . . . 1.0 112.697 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.644 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -114.63 83.79 1.95 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.332 -1.729 . . . . 1.0 106.332 177.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.495 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -66.97 150.87 48.64 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.042 0.925 . . . . 1.0 112.594 -176.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.853 ' HB2' HG22 ' A' ' 164' ' ' ILE . 4.5 mm-40 -140.85 2.99 1.81 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.863 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.25 125.64 12.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 1.0 110.12 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.452 ' HB ' ' N ' ' A' ' 76' ' ' GLY . 74.1 p -57.07 -14.95 4.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.473 -0.767 . . . . 1.0 111.408 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.615 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -128.76 132.01 47.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.936 -1.103 . . . . 1.0 111.452 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 166.66 136.28 2.0 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.397 -1.382 . . . . 1.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.732 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -89.64 118.86 29.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -1.213 . . . . 1.0 108.326 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.812 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -92.86 -31.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.756 -176.325 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.085 HD13 HD12 ' A' ' 71' ' ' LEU . 4.9 tt -147.3 151.47 36.66 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.664 -1.272 . . . . 1.0 112.605 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 1.154 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 0.6 OUTLIER -161.24 124.28 3.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.686 178.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.73 ' HB3' HD11 ' A' ' 69' ' ' ILE . 1.0 OUTLIER -121.89 156.57 33.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.951 -1.093 . . . . 1.0 109.719 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.1 133.45 3.2 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.148 -1.581 . . . . 1.0 109.148 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.547 ' CB ' ' HB3' ' A' ' 138' ' ' ASP . 18.2 tttt -85.02 40.19 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -1.218 . . . . 1.0 110.446 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 61.14 131.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.23 -1.148 . . . . 1.0 110.23 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 66' ' ' SER . 1.1 mt 176.25 174.87 0.32 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -1.071 . . . . 1.0 109.963 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.62 11.11 32.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 1.0 110.538 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 ptt-85 179.33 59.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.044 . . . . 1.0 109.71 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -140.79 152.43 45.2 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.55 -0.86 . . . . 1.0 110.514 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 2.9 m-20 -113.89 -48.97 2.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.008 . . . . 1.0 110.382 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.741 ' CE2' HD11 ' A' ' 135' ' ' LEU . 0.3 OUTLIER 79.37 -89.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 1.0 110.53 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -159.19 176.82 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.315 -1.491 . . . . 1.0 111.315 -179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.03 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -172.37 174.36 3.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.723 -0.611 . . . . 1.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.085 HD12 HD13 ' A' ' 57' ' ' LEU . 78.4 mt -146.16 95.57 2.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 1.0 109.139 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.586 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -115.53 177.13 4.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.505 -0.747 . . . . 1.0 112.112 -178.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 2.5 mt -117.81 138.2 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.767 -0.583 . . . . 1.0 110.025 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -142.39 133.25 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.42 -0.8 . . . . 1.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 3.3 m-20 61.62 23.86 14.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.068 -1.02 . . . . 1.0 111.432 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 84.39 18.66 61.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.974 -1.25 . . . . 1.0 109.974 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.29 150.27 45.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -1.091 . . . . 1.0 108.901 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.812 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -91.45 -176.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.734 -1.228 . . . . 1.0 109.878 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.738 ' HB2' HG22 ' A' ' 90' ' ' VAL . 3.4 pt20 -174.11 136.37 0.5 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.357 -0.839 . . . . 1.0 110.836 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.756 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -93.07 132.58 37.06 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.824 -0.75 . . . . 1.0 110.227 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . 1.03 ' HE3' ' CB ' ' A' ' 70' ' ' ALA . 3.6 ttm -107.74 137.64 45.39 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.637 -0.664 . . . . 1.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.594 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -134.71 102.03 5.14 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.127 -0.983 . . . . 1.0 109.758 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' TYR . 2.1 m-20 -110.79 34.35 4.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.652 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.804 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.4 OUTLIER -34.03 -29.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.731 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -118.4 -41.31 0.63 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.756 -1.337 . . . . 1.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 168.7 -28.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 1.0 109.743 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.497 ' HG3' ' CG ' ' A' ' 129' ' ' PRO . 12.4 mmmt -89.58 117.93 68.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.493 -0.754 . . . . 1.0 109.772 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 51.1 Cg_endo -78.06 130.38 10.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.922 1.485 . . . . 1.0 111.927 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -109.27 126.63 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 178.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -109.04 123.27 64.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.447 -1.408 . . . . 1.0 111.865 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.6 HD23 ' CE ' ' A' ' 80' ' ' MET . 0.3 OUTLIER -111.99 74.69 0.88 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.176 -1.416 . . . . 1.0 107.176 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.557 ' O ' HG21 ' A' ' 124' ' ' ILE . 0.8 OUTLIER -57.9 178.65 0.08 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.311 -0.956 . . . . 1.0 110.492 -178.165 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.488 ' OG ' HG21 ' A' ' 118' ' ' VAL 0.251 2.4 t -108.23 151.19 26.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.549 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.47 ' CG2' HD11 ' A' ' 124' ' ' ILE . 0.7 OUTLIER -103.63 26.18 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 1.0 109.73 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.554 HG12 ' HD2' ' A' ' 96' ' ' PRO . 2.4 t -128.57 146.98 62.2 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.508 -0.745 . . . . 1.0 109.146 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.554 ' HD2' HG12 ' A' ' 95' ' ' VAL . 40.8 Cg_endo -65.64 124.52 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.538 1.283 . . . . 1.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 98' ' ' ASN . 6.6 tp -109.95 -39.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 1.0 110.655 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.499 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 6.3 p-10 -67.56 63.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 1.0 110.635 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.685 HG23 ' CG ' ' A' ' 101' ' ' HIS . 15.0 t -124.09 11.19 8.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -0.999 . . . . 1.0 110.345 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 57.45 33.08 22.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.948 -1.095 . . . . 1.0 110.447 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.685 ' CG ' HG23 ' A' ' 99' ' ' THR . 5.7 m-70 -121.65 179.36 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 1.0 109.8 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.644 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 17.0 m95 -98.18 100.96 12.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.029 -1.044 . . . . 1.0 110.175 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 104' ' ' HIS . 9.7 m -96.43 170.7 9.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.362 -0.836 . . . . 1.0 109.429 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.564 ' N ' HG22 ' A' ' 103' ' ' THR . 6.9 t60 -122.15 120.83 35.37 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.682 -1.229 . . . . 1.0 107.682 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.977 HD11 HD13 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -107.92 146.65 13.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 120.937 -1.102 . . . . 1.0 109.456 -178.598 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.658 ' O ' HD22 ' A' ' 116' ' ' LEU . 6.9 tptm -142.38 142.09 32.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.318 -0.953 . . . . 1.0 109.527 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -137.03 110.09 7.73 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.613 ' O ' ' CD1' ' A' ' 108' ' ' TYR . 4.5 p90 -111.14 110.36 20.85 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.567 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -99.62 141.05 32.93 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.031 -0.668 . . . . 1.0 111.194 -178.036 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 5.9 t -127.55 97.61 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.628 -0.67 . . . . 1.0 109.199 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.453 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 2.0 mt-30 58.26 -134.54 1.04 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 1.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -70.81 -11.41 60.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.984 -1.072 . . . . 1.0 110.863 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.586 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -104.4 123.24 47.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 1.0 110.505 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.526 ' CA ' ' HG2' ' A' ' 109' ' ' ARG . . . -114.41 163.66 12.15 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.296 -0.954 . . . . 1.0 110.961 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.573 ' O ' ' CE ' ' A' ' 80' ' ' MET . 47.5 t -147.64 162.89 38.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.522 -0.987 . . . . 1.0 110.722 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.949 HD13 ' N ' ' A' ' 117' ' ' GLN 0.254 1.0 OUTLIER -139.5 157.08 46.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.177 -0.952 . . . . 1.0 108.892 -178.816 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.949 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.39 113.92 4.02 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.684 -1.26 . . . . 1.0 111.97 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 16.8 t -70.22 100.35 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.86 37.08 92.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 117' ' ' GLN . 0.3 OUTLIER 61.38 38.58 16.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -1.146 . . . . 1.0 110.704 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 9.6 mt-10 -108.47 -161.18 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.325 -0.859 . . . . 1.0 110.944 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -39.22 98.32 0.16 Allowed Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 45.8 Cg_endo -77.43 142.96 21.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 124.068 1.562 . . . . 1.0 112.394 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.557 HG21 ' O ' ' A' ' 92' ' ' ARG . 1.1 mp -106.05 110.43 31.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.877 -1.527 . . . . 1.0 106.877 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.561 ' C ' HD11 ' A' ' 91' ' ' LEU . 7.2 p -105.81 177.52 4.83 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.375 1.083 . . . . 1.0 112.146 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.597 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 170.78 160.98 20.62 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.834 -2.507 . . . . 1.0 106.834 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -139.28 168.52 19.63 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.735 -1.45 . . . . 1.0 110.892 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.2 p -87.2 -179.73 1.47 Allowed Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.515 -0.874 . . . . 1.0 110.037 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.497 ' CG ' ' HG3' ' A' ' 87' ' ' LYS . 46.2 Cg_endo -77.49 48.25 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.837 1.441 . . . . 1.0 109.675 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.9 OUTLIER 46.46 -176.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.614 -0.679 . . . . 1.0 110.5 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.689 ' O ' ' HB2' ' A' ' 132' ' ' ALA . . . 79.05 88.63 0.46 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.804 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . 170.02 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -1.132 . . . . 1.0 110.166 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 59.11 90.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 1.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.802 ' OE1' ' HB1' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 44.94 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 1.0 110.309 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.741 HD11 ' CE2' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -175.72 97.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 1.0 110.309 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 3.1 m-20 -52.17 -179.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 1.0 109.213 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 137' ' ' THR . 8.1 t -129.1 121.06 27.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.085 -1.01 . . . . 1.0 109.695 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.901 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 4.4 p-10 -60.93 -3.56 0.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 1.0 111.05 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 65.9 9.12 45.19 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.841 -1.704 . . . . 1.0 108.841 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.901 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -102.31 132.2 48.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -1.127 . . . . 1.0 108.394 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.989 ' CD1' HD21 ' A' ' 57' ' ' LEU . 9.5 tp -141.14 148.79 40.6 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.764 -1.174 . . . . 1.0 111.651 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 24.2 m95 -130.88 119.46 22.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 1.0 HD13 HD12 ' A' ' 57' ' ' LEU . 8.3 tp -125.13 118.83 26.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.934 -1.506 . . . . 1.0 113.539 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.81 8.8 7.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 119.99 -1.1 . . . . 1.0 110.672 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.582 ' O ' ' HE3' ' A' ' 146' ' ' MET . . . 148.33 -148.44 19.92 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.373 -1.87 . . . . 1.0 109.08 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.714 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -152.82 148.06 26.76 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.37 -0.932 . . . . 1.0 112.881 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.42 ' C ' ' HG2' ' A' ' 148' ' ' ARG . 12.1 tt0 -93.9 19.92 8.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.42 ' HG2' ' C ' ' A' ' 147' ' ' GLU . 2.0 ptm180 173.16 68.65 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.555 -1.646 . . . . 1.0 106.555 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.791 HD11 ' CD2' ' A' ' 159' ' ' TYR . 1.4 tp -73.46 36.03 0.08 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 1.0 112.706 -177.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.1 p -71.69 -13.67 61.8 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.795 -1.928 . . . . 1.0 105.795 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 1.154 HG21 ' CZ3' ' A' ' 58' ' ' TRP 0.257 7.1 p -76.28 -110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 114.889 -1.051 . . . . 1.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.693 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . 50.0 39.1 18.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.308 -1.495 . . . . 1.0 108.946 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.917 ' CE1' HD23 ' A' ' 155' ' ' LEU . 1.5 p80 13.39 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.786 0.661 . . . . 1.0 112.786 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 5.74 2.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.032 -1.042 . . . . 1.0 111.821 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.917 HD23 ' CE1' ' A' ' 153' ' ' HIS . 2.7 pp -60.63 178.81 0.24 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.197 -0.939 . . . . 1.0 110.979 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 46.4 Cg_endo -83.01 -159.49 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.461 1.243 . . . . 1.0 112.681 -178.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.0 OUTLIER -51.01 -13.08 0.13 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 113.042 0.756 . . . . 1.0 113.042 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.601 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . -37.69 -45.64 0.81 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.013 -1.055 . . . . 1.0 109.707 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.86 ' CE1' HD21 ' A' ' 155' ' ' LEU . 4.3 m-85 -84.57 -28.98 26.23 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.204 -0.935 . . . . 1.0 109.111 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.541 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -70.38 -8.53 51.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.246 -1.382 . . . . 1.0 108.402 178.261 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 161' ' ' THR . 1.3 m -128.47 98.47 5.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -50.1 -178.19 0.02 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.609 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 71.0 t80 -83.01 144.72 29.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.909 -1.347 . . . . 1.0 112.262 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.853 HG22 ' HB2' ' A' ' 50' ' ' GLU . 1.6 mt -127.57 88.67 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.609 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.94 -157.39 13.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.743 -1.743 . . . . 1.0 108.743 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 1.7 m -128.59 145.45 51.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.128 -1.219 . . . . 1.0 109.802 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.586 HD13 ' CZ ' ' A' ' 19' ' ' PHE . 3.4 mt -130.28 147.4 33.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.437 -0.789 . . . . 1.0 110.423 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -159.48 156.12 27.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 1.0 110.351 -179.249 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 17.8 m-20 51.38 81.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 1.0 110.411 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.749 HG12 ' HB2' ' A' ' 45' ' ' LEU 0.251 25.7 m -122.43 130.62 74.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.017 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.44 HG22 ' C ' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -145.04 141.4 22.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.102 -1.039 . . . . 1.0 111.649 -176.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 42' ' ' HIS . 1.3 p -127.0 119.34 52.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 1.5 m-20 62.14 30.53 17.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.23 32.09 2.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.756 -0.59 . . . . 1.0 110.451 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 71.9 mm-40 -104.73 120.13 40.63 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.354 -0.841 . . . . 1.0 110.064 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -78.55 110.97 14.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 1.0 109.556 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 179' ' ' LEU . 83.8 mt -78.81 96.21 5.57 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 1.0 111.31 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.586 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 46.8 m-70 -39.21 98.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.045 0.926 . . . . 1.0 110.247 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.777 ' O ' ' HB3' ' A' ' 183' ' ' ALA . 8.9 mt -49.09 -59.57 3.53 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.924 0.869 . . . . 1.0 112.963 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.781 ' HA ' HD23 ' A' ' 184' ' ' LEU . 86.7 t -75.52 -28.52 19.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 113.541 0.941 . . . . 1.0 113.541 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.586 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -58.64 -50.51 73.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 112.284 -178.365 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.3 OUTLIER -108.19 -28.51 9.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.946 -1.096 . . . . 1.0 111.535 -178.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 179' ' ' LEU . . . -63.05 -25.08 68.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.853 -1.539 . . . . 1.0 108.601 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.804 HD13 HG13 ' A' ' 189' ' ' ILE . 1.4 mm? -70.43 -2.19 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 1.0 110.303 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 11.3 t-20 -55.65 -29.62 59.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 1.0 109.469 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.48 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 2.7 t-20 -88.09 151.32 49.07 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.866 ' O ' HG22 ' A' ' 188' ' ' THR . 38.3 Cg_endo -64.77 149.47 89.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.45 1.237 . . . . 1.0 109.684 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 187' ' ' PRO . 5.2 t 49.34 148.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 122.272 1.034 . . . . 1.0 112.116 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.804 HG13 HD13 ' A' ' 184' ' ' LEU . 33.6 mm -144.71 113.06 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 1.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.25 176.48 6.3 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.053 -1.03 . . . . 1.0 109.349 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -115.96 -60.99 1.8 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.7 -1.2 . . . . 1.0 111.264 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.787 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.9 OUTLIER 178.25 162.4 0.65 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.422 -0.799 . . . . 1.0 110.195 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.713 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 1.4 m -131.0 148.37 52.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.146 -0.971 . . . . 1.0 109.886 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 167.17 41.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.18 -0.95 . . . . 1.0 110.395 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.291 -1.978 0 C-N-CA 118.701 -1.199 . . . . 1.0 110.528 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -117.57 89.04 3.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -1.133 . . . . 1.0 110.349 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 4' ' ' LYS . 2.2 tt0 -91.75 -67.14 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 1.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 3' ' ' GLU . 19.6 mtpp 48.87 -178.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.846 . . . . 1.0 110.372 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 5' ' ' VAL . 17.0 t -83.5 102.04 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 1.0 110.321 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 tt -97.86 142.93 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 1.0 110.057 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 pt -94.53 146.88 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.923 . . . . 1.0 110.406 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -109.96 108.84 19.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.22 -0.925 . . . . 1.0 110.274 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -49.72 133.0 21.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.875 . . . . 1.0 110.363 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.37 117.34 34.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 1.0 110.222 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.72 78.55 0.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 1.0 110.584 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.12 131.61 10.64 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -132.15 -62.15 0.85 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.261 . . . . 1.0 110.839 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 13' ' ' ASP . . . 177.77 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.948 -1.095 . . . . 1.0 110.817 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.646 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 3.3 pt-20 -35.35 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.196 0.998 . . . . 1.0 110.157 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -84.02 137.15 33.75 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 120.333 -1.479 . . . . 1.0 111.231 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.617 HG21 ' HE1' ' A' ' 25' ' ' MET . 12.2 mm -117.43 131.25 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.184 -0.948 . . . . 1.0 109.273 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.57 ' HB2' ' SG ' ' A' ' 192' ' ' CYS . . . -90.09 131.85 35.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.46 -0.775 . . . . 1.0 110.792 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.962 ' CE1' HD12 ' A' ' 167' ' ' ILE . 62.3 m-85 -101.51 177.02 5.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.712 -1.243 . . . . 1.0 109.29 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' C ' HG13 ' A' ' 164' ' ' ILE . 11.1 p-10 -141.92 -11.6 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.678 -1.264 . . . . 1.0 112.842 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 162' ' ' GLY . . . 111.64 -11.69 27.84 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.95 -1.595 . . . . 1.0 109.144 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 22' ' ' ARG . 3.6 ttp-105 -135.15 10.8 3.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -1.165 . . . . 1.0 111.504 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -112.81 121.17 43.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 1.0 110.627 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 1.9 p90 -104.02 122.25 44.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 1.0 110.256 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.617 ' HE1' HG21 ' A' ' 17' ' ' ILE . 3.2 mtp -119.45 98.41 6.12 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.937 -1.105 . . . . 1.0 108.307 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.6 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 0.8 OUTLIER -103.08 145.12 30.38 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.707 -0.797 . . . . 1.0 110.027 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.65 ' HA ' ' CB ' ' A' ' 182' ' ' ASP . 4.6 m-85 -126.1 116.52 21.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.011 -1.076 . . . . 1.0 110.477 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 139' ' ' GLY . 19.8 t60 -96.99 99.98 11.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.735 . . . . 1.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.6 131.32 34.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 1.0 110.03 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.16 95.37 8.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 1.0 110.194 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.77 -29.66 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 1.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 35' ' ' GLU . 1.8 t -178.36 177.44 0.96 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.093 -1.005 . . . . 1.0 110.719 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 34' ' ' SER . 3.5 pttp -63.77 94.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.428 -0.795 . . . . 1.0 110.818 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER 37.35 56.29 1.37 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.706 -0.622 . . . . 1.0 110.965 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' O ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -145.38 84.88 1.7 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.937 . . . . 1.0 110.107 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -122.28 132.01 54.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 1.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . 178.67 111.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 1.0 110.692 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.544 HD21 ' OD2' ' A' ' 138' ' ' ASP . 0.4 OUTLIER -137.42 -164.83 1.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 1.0 109.954 179.619 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -139.89 -15.41 1.02 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.123 -0.985 . . . . 1.0 111.475 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.521 ' OG ' ' NE2' ' A' ' 42' ' ' HIS . 1.2 p -126.82 104.87 8.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.247 -0.908 . . . . 1.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 109' ' ' ARG . 19.5 p-10 -85.65 142.75 28.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.529 -0.732 . . . . 1.0 110.222 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.673 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 49.7 m-70 -131.15 111.59 12.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 9.2 m-85 -116.81 115.55 25.77 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.525 -0.734 . . . . 1.0 110.902 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.833 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -124.97 144.42 50.38 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.037 -1.039 . . . . 1.0 109.174 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.013 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.4 OUTLIER -179.56 159.18 0.87 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.154 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 103' ' ' THR . 74.8 m -128.75 145.72 51.1 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.063 HG23 HD11 ' A' ' 105' ' ' ILE . 1.4 pt -124.72 -170.46 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 118.449 -1.3 . . . . 1.0 111.532 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.615 ' HD2' ' CD2' ' A' ' 102' ' ' TRP . 0.4 OUTLIER -148.11 146.13 28.67 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.343 -1.355 . . . . 1.0 107.343 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 46.1 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.042 -1.063 . . . . 1.0 110.014 -178.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.101 ' HG3' HD13 ' A' ' 73' ' ' ILE . 8.3 tt0 -176.95 -22.75 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.376 -0.827 . . . . 1.0 110.55 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 50' ' ' GLU . . . 78.64 -3.62 2.23 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.931 -0.481 . . . . 1.0 110.088 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.767 HG23 ' C ' ' A' ' 51' ' ' ALA . 1.7 p 78.82 -19.97 0.41 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.312 0.577 . . . . 1.0 111.387 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.734 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.3 OUTLIER -143.91 124.26 13.86 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.324 -0.86 . . . . 1.0 109.881 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.618 ' O ' HD12 ' A' ' 73' ' ' ILE . . . 164.86 139.92 2.75 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.043 HD22 HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -89.45 145.62 25.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.754 -1.439 . . . . 1.0 109.365 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.734 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -116.3 -4.61 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -174.727 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.995 HD13 HD12 ' A' ' 71' ' ' LEU . 2.8 tt -168.56 152.12 5.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 119.206 -2.184 . . . . 1.0 113.105 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.58 ' CD1' ' SD ' ' A' ' 146' ' ' MET . 1.5 t-105 -164.64 113.72 1.12 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.8 -0.562 . . . . 1.0 110.157 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 p -120.99 141.69 50.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.934 -1.104 . . . . 1.0 109.647 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 61' ' ' LYS . . . -99.12 -81.61 1.61 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.715 ' HE3' ' HB3' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 73.8 91.15 0.09 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.444 -1.033 . . . . 1.0 110.711 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.92 -103.8 0.46 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.414 ' H ' ' HB3' ' A' ' 66' ' ' SER . 0.2 OUTLIER -117.04 -175.33 2.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.214 -1.168 . . . . 1.0 109.842 179.338 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -87.78 23.71 1.93 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.949 . . . . 1.0 110.073 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.612 ' CG ' ' O ' ' A' ' 65' ' ' ARG 0.253 0.0 OUTLIER -159.13 24.26 0.2 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 123.002 1.382 . . . . 1.0 107.699 -179.269 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -87.92 -158.44 0.46 Allowed 'General case' 0 C--N 1.284 -2.254 0 O-C-N 120.829 -1.17 . . . . 1.0 111.948 -177.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.548 ' CB ' ' HA ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -47.26 155.61 0.3 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.879 -0.513 . . . . 1.0 112.009 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.739 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -124.03 102.5 7.78 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.874 -1.13 . . . . 1.0 110.242 178.184 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.74 ' C ' HD12 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -108.66 111.05 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 178.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.897 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -138.44 -173.92 3.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 1.0 111.185 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 57' ' ' LEU . 82.5 mt -153.31 110.83 3.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.666 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -126.95 176.19 7.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.75 -1.219 . . . . 1.0 111.321 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.101 HD13 ' HG3' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -124.46 140.22 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -0.834 . . . . 1.0 111.621 -178.135 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.792 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.4 p -142.58 132.85 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.82 -0.55 . . . . 1.0 110.324 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.792 ' CG ' HG22 ' A' ' 74' ' ' VAL . 2.9 m-20 66.45 27.02 9.95 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.949 -1.094 . . . . 1.0 110.826 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 81.41 -5.36 68.49 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -109.18 149.47 29.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.305 -1.114 . . . . 1.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.734 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -98.22 -169.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 1.0 109.647 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.513 ' HB2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER 178.12 126.47 0.05 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.101 -1.0 . . . . 1.0 111.31 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.982 ' HE3' HD12 ' A' ' 91' ' ' LEU . 22.8 ttp -91.54 125.7 36.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 1.0 109.59 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.897 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 4.0 ptt? -112.56 128.87 56.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.947 -1.095 . . . . 1.0 110.491 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.616 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -118.58 121.21 39.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 1.0 110.211 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.739 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.2 t70 -126.99 46.54 2.49 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.607 0.718 . . . . 1.0 109.965 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.709 ' CB ' HD13 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -70.34 53.8 0.14 Allowed 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.005 179.631 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' C ' ' OG ' ' A' ' 86' ' ' SER . . . 161.77 -66.4 0.25 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.417 ' OG ' ' C ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -169.03 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.001 -1.294 . . . . 1.0 111.53 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -99.48 112.65 63.87 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.809 -1.182 . . . . 1.0 111.222 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -76.11 114.98 4.02 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.939 1.494 . . . . 1.0 109.708 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.632 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -93.1 105.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.248 -0.907 . . . . 1.0 110.458 -179.229 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -90.26 120.79 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 119.972 -1.705 . . . . 1.0 110.445 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.982 HD12 ' HE3' ' A' ' 80' ' ' MET . 33.6 mt -113.35 76.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.506 ' O ' HG21 ' A' ' 124' ' ' ILE . 21.6 mtp180 -57.87 179.15 0.07 Allowed 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.213 -0.995 . . . . 1.0 110.651 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.692 ' OG ' HG11 ' A' ' 118' ' ' VAL . 1.4 t -104.77 167.02 9.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.005 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.27 17.42 15.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.332 -0.855 . . . . 1.0 109.771 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.756 HG13 ' HD2' ' A' ' 96' ' ' PRO . 68.0 t -135.45 150.46 72.41 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.534 -0.729 . . . . 1.0 110.171 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.756 ' HD2' HG13 ' A' ' 95' ' ' VAL . 42.8 Cg_endo -68.85 139.08 42.51 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.796 1.419 . . . . 1.0 110.39 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.93 HG23 ' OE1' ' A' ' 50' ' ' GLU . 2.7 tt -129.17 -27.21 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 1.0 111.034 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.607 ' CB ' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p30 -80.93 44.6 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.125 -0.984 . . . . 1.0 110.288 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.723 ' O ' HG22 ' A' ' 99' ' ' THR . 94.3 m -117.64 24.67 10.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 1.0 110.359 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 99' ' ' THR . 62.1 t30 59.77 41.16 18.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 1.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -130.02 137.69 50.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.832 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CD2' ' HD2' ' A' ' 48' ' ' LYS . 3.9 m95 -61.93 91.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 1.0 110.315 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.61 HG22 ' N ' ' A' ' 104' ' ' HIS . 54.5 m -80.56 172.5 13.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.061 -1.024 . . . . 1.0 108.927 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.61 ' N ' HG22 ' A' ' 103' ' ' THR . 0.9 OUTLIER -129.99 106.59 8.75 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.111 -0.993 . . . . 1.0 108.672 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.063 HD11 HG23 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -97.64 136.57 28.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 O-C-N 121.094 -1.004 . . . . 1.0 109.2 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.805 ' O ' HD22 ' A' ' 116' ' ' LEU . 1.3 tppt? -137.22 155.87 48.99 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.98 -1.088 . . . . 1.0 110.169 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -153.59 123.24 6.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.096 -1.002 . . . . 1.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.624 ' O ' ' CD1' ' A' ' 108' ' ' TYR . 41.6 p90 -126.24 112.16 15.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.538 ' NH1' ' N ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -120.53 154.8 34.83 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.369 -0.832 . . . . 1.0 110.432 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 112' ' ' ARG . 2.4 t -128.65 95.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 1.0 110.721 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 22.8 mt-30 34.71 24.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 0.2 OUTLIER 173.2 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.486 -1.384 . . . . 1.0 110.437 179.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -97.72 117.91 33.07 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.566 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.84 157.36 16.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.819 ' OG ' HG22 ' A' ' 125' ' ' THR . 38.7 t -135.69 157.59 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.452 -1.028 . . . . 1.0 109.949 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.068 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.3 tm? -137.19 153.1 50.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 1.068 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -158.59 128.12 5.72 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.538 -1.265 . . . . 1.0 111.617 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.692 HG11 ' OG ' ' A' ' 93' ' ' SER . 20.4 m -92.05 100.2 10.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 68.62 42.49 80.28 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.366 -1.093 . . . . 1.0 110.366 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 10.6 m-80 58.06 31.69 21.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.244 -1.151 . . . . 1.0 111.073 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 122' ' ' ALA . 1.3 tt0 -100.09 167.01 10.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 1.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.598 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -19.73 102.96 0.06 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 CA-C-O 120.989 0.423 . . . . 1.0 110.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 40.0 Cg_endo -69.24 131.38 21.85 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.258 1.662 . . . . 1.0 112.478 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.652 ' H ' HD12 ' A' ' 124' ' ' ILE . 4.5 mp -92.42 104.89 16.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 105.84 -1.911 . . . . 1.0 105.84 177.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.819 HG22 ' OG ' ' A' ' 115' ' ' SER . 32.7 p -118.55 160.98 20.8 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.902 -1.119 . . . . 1.0 112.401 -176.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.63 173.16 38.84 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 107.108 -2.397 . . . . 1.0 107.108 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -154.7 160.62 41.49 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.645 -1.503 . . . . 1.0 110.396 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.45 ' O ' ' CG ' ' A' ' 112' ' ' ARG . 50.1 m -105.71 160.86 24.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 118.955 -1.098 . . . . 1.0 109.248 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 130' ' ' LEU . 38.1 Cg_endo -64.51 -21.34 66.05 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 N-CA-C 108.196 -1.501 . . . . 1.0 108.196 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.564 ' CB ' ' O ' ' A' ' 129' ' ' PRO . 1.0 OUTLIER 155.92 -161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.36 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 148.09 -44.77 0.76 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -155.66 114.24 3.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -1.124 . . . . 1.0 110.381 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -63.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 1.0 110.222 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -100.55 76.76 1.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.0 110.508 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.709 HD13 ' CB ' ' A' ' 84' ' ' LEU . 1.1 tp -71.46 112.28 7.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.862 . . . . 1.0 109.789 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 5.3 m-20 -79.22 127.13 31.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.895 . . . . 1.0 109.937 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -148.94 105.66 3.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 1.0 110.12 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.544 ' OD2' HD21 ' A' ' 38' ' ' LEU . 0.6 OUTLIER 163.3 -38.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.65 0.738 . . . . 1.0 109.07 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.566 ' N ' ' HD3' ' A' ' 61' ' ' LYS . . . -44.57 -32.88 3.03 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.175 -1.17 . . . . 1.0 110.175 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.715 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . . . -161.02 153.33 20.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.769 -1.43 . . . . 1.0 109.897 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.922 HD11 HD21 ' A' ' 57' ' ' LEU . 30.0 tp -155.73 152.8 28.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 110.519 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.753 ' CD2' ' HE1' ' A' ' 146' ' ' MET . 31.4 m95 -118.31 161.87 19.22 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.881 ' CD2' HD12 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -152.83 111.29 3.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.2 -1.8 . . . . 1.0 113.42 -177.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.555 ' O ' ' CA ' ' A' ' 162' ' ' GLY . . . 125.96 -11.18 7.38 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.553 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 158.2 -140.43 6.98 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 119.005 -1.569 . . . . 1.0 109.707 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.753 ' HE1' ' CD2' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -168.11 152.35 6.24 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.183 -1.007 . . . . 1.0 111.098 -179.362 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -96.58 -8.96 30.47 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.877 0.846 . . . . 1.0 109.513 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -141.64 53.03 1.51 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.043 HD21 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.82 57.17 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 1.0 111.854 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 148' ' ' ARG . 29.6 p -59.49 -22.53 61.72 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.79 -1.93 . . . . 1.0 105.79 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.811 HG13 ' N ' ' A' ' 152' ' ' ALA 0.289 9.8 p -76.92 -130.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.49 -1.232 . . . . 1.0 108.831 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.811 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 55.86 50.72 13.47 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.804 -1.185 . . . . 1.0 108.578 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -52.58 -111.81 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.293 1.961 . . . . 1.0 116.293 -175.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 18.25 0.24 Allowed 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 113.944 1.09 . . . . 1.0 113.944 -175.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 1.102 HD22 ' CD2' ' A' ' 159' ' ' TYR . 5.1 tt -95.71 141.08 22.68 Favored Pre-proline 0 C--N 1.288 -2.089 0 O-C-N 120.858 -1.152 . . . . 1.0 110.499 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.895 ' O ' HD23 ' A' ' 155' ' ' LEU . 37.6 Cg_endo -62.05 -149.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.045 1.55 . . . . 1.0 111.327 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.1 OUTLIER -60.41 -10.42 4.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.837 -1.165 . . . . 1.0 112.869 -177.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 1.098 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -41.71 -35.35 0.76 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.814 -1.179 . . . . 1.0 109.428 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 1.102 ' CD2' HD22 ' A' ' 155' ' ' LEU . 32.4 m-85 -86.79 -31.99 20.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.744 -1.223 . . . . 1.0 108.928 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.531 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -72.68 -5.88 40.62 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.436 -1.305 . . . . 1.0 108.0 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.705 HG22 ' CD1' ' A' ' 164' ' ' ILE . 33.4 m -122.23 90.26 3.27 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 163' ' ' PHE . . . -57.06 106.87 0.8 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.057 -1.068 . . . . 1.0 110.562 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.929 ' HD1' HD11 ' A' ' 73' ' ' ILE . 89.5 t80 12.95 137.8 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 115.761 1.763 . . . . 1.0 115.761 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.705 ' CD1' HG22 ' A' ' 161' ' ' THR . 2.2 mt -131.08 86.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.084 -0.962 . . . . 1.0 108.827 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 48' ' ' LYS . . . -171.18 -161.17 21.38 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 107.2 -2.36 . . . . 1.0 107.2 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.3 m -129.27 142.57 50.8 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.87 -1.371 . . . . 1.0 110.023 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.962 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -128.24 157.89 40.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.402 -1.436 . . . . 1.0 112.285 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.576 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -165.36 168.31 16.92 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.061 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.4 m-20 43.78 72.89 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.214 -0.929 . . . . 1.0 110.658 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 1.013 HG12 ' CB ' ' A' ' 45' ' ' LEU . 26.8 m -127.67 123.25 60.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.89 -1.124 . . . . 1.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.521 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -136.0 152.17 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.53 -177.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -133.8 103.35 5.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.7 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 6.7 m-20 57.55 35.46 25.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.975 -1.121 . . . . 1.0 107.975 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 75.0 6.34 4.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.828 -0.545 . . . . 1.0 111.088 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.847 ' HB2' HG23 ' A' ' 172' ' ' VAL . 77.8 mm-40 -91.18 176.39 6.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.143 -0.973 . . . . 1.0 110.105 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.563 ' CB ' ' O ' ' A' ' 175' ' ' GLN . 30.0 tt0 83.68 -109.66 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 175' ' ' GLN . 0.4 OUTLIER 29.97 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.304 -0.873 . . . . 1.0 112.499 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 181' ' ' GLU . 9.5 m-70 -160.89 44.5 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.994 -1.066 . . . . 1.0 110.597 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.985 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 0.0 OUTLIER -52.17 -27.89 16.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 9.2 t -71.3 -35.23 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.12 0.486 . . . . 1.0 111.198 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 51.0 mt-10 -62.16 -56.07 22.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.049 -1.032 . . . . 1.0 109.54 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.65 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -81.89 -19.7 40.36 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.086 179.008 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 1.023 ' HB1' HD11 ' A' ' 189' ' ' ILE . . . -48.14 -41.76 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.818 -1.153 . . . . 1.0 107.94 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ALA . 3.4 mt -41.78 -26.3 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.369 0.604 . . . . 1.0 109.598 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 6.3 t-20 -62.8 -11.61 19.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.353 -0.842 . . . . 1.0 109.808 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.478 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 2.8 t-20 -123.85 154.21 67.35 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.539 -0.725 . . . . 1.0 109.182 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.478 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 37.3 Cg_endo -61.27 -162.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.671 1.353 . . . . 1.0 111.215 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 187' ' ' PRO . 4.8 m -40.74 134.56 1.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.21 -0.931 . . . . 1.0 111.263 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 1.023 HD11 ' HB1' ' A' ' 183' ' ' ALA . 3.1 mt -102.91 144.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.443 -0.785 . . . . 1.0 109.452 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.37 153.41 19.35 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.098 -1.001 . . . . 1.0 109.889 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.606 ' ND1' HD13 ' A' ' 17' ' ' ILE . 1.6 m-70 -112.68 152.25 29.23 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.289 -0.882 . . . . 1.0 109.618 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -105.77 119.98 40.53 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.424 -0.91 . . . . 1.0 109.974 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 193' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 20.5 m -121.73 165.36 15.92 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.984 -1.073 . . . . 1.0 110.909 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 173.15 91.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.477 -0.764 . . . . 1.0 110.048 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.297 -1.694 0 C-N-CA 118.743 -1.183 . . . . 1.0 110.47 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -162.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.363 -1.081 . . . . 1.0 110.36 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.94 85.73 3.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 110.396 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -148.19 140.16 24.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.13 -0.982 . . . . 1.0 110.136 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 5' ' ' VAL . 23.1 m -108.24 94.9 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 1.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 pt -70.59 143.94 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 1.0 110.334 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.757 HG23 ' O ' ' A' ' 7' ' ' ILE . 18.3 tt -125.62 87.93 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 1.0 110.201 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -43.63 130.15 5.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 1.0 110.184 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -126.34 152.96 45.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -0.979 . . . . 1.0 110.061 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.22 143.26 48.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.895 . . . . 1.0 110.362 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.98 81.71 7.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 1.0 110.146 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.81 115.87 1.85 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.533 -1.427 . . . . 1.0 109.533 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -137.89 70.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.152 -1.205 . . . . 1.0 110.268 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.12 72.53 1.41 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 1.0 109.964 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' CG ' ' O ' ' A' ' 15' ' ' GLU . 4.9 pt-20 -130.58 109.95 11.05 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.245 -0.909 . . . . 1.0 110.154 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -117.22 151.28 37.23 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.063 -1.023 . . . . 1.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 7.0 mm -119.52 133.27 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.037 . . . . 1.0 110.328 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -91.49 124.15 35.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.651 . . . . 1.0 110.431 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.751 ' CD2' HG21 ' A' ' 23' ' ' THR . 4.0 m-30 -91.1 132.69 35.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.0 109.209 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 2.3 p30 -97.74 2.16 49.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 1.0 110.545 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 103.51 -22.8 34.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.506 -1.838 . . . . 1.0 108.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.449 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 5.3 ttt-85 -107.25 -8.1 16.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.634 -0.921 . . . . 1.0 109.672 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.751 HG21 ' CD2' ' A' ' 19' ' ' PHE . 14.9 t -48.08 174.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 1.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.64 ' CE1' ' HB2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER 179.86 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 1.0 109.104 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 142' ' ' TRP . 25.0 mtt -96.26 101.33 12.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.943 -1.098 . . . . 1.0 111.007 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.64 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 18.7 tt0 -93.39 121.97 35.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.347 -0.846 . . . . 1.0 109.481 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CE2' ' CB ' ' A' ' 182' ' ' ASP . 6.2 m-85 -113.62 105.63 13.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.184 -0.947 . . . . 1.0 109.993 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.16 86.63 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 1.0 110.449 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -121.88 176.82 5.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.227 -0.92 . . . . 1.0 110.132 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.02 99.94 12.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.196 -0.94 . . . . 1.0 110.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 32' ' ' THR . 76.9 t -60.03 168.99 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.235 -0.915 . . . . 1.0 109.977 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.54 ' N ' HG12 ' A' ' 31' ' ' VAL . 6.0 p -126.94 -178.36 4.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.056 -1.028 . . . . 1.0 110.369 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -51.76 91.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 1.0 110.566 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' THR . 4.5 t -123.47 -19.22 5.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 1.0 110.311 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 1.5 mt-10 -177.25 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 1.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 23.5 ttpt 55.57 97.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.08 -1.013 . . . . 1.0 109.877 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 36' ' ' LYS . . . 43.28 70.59 0.29 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.253 -0.904 . . . . 1.0 109.311 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.789 ' H ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.38 -172.95 1.01 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.376 -0.827 . . . . 1.0 111.664 -178.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -119.25 9.26 11.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.517 -0.74 . . . . 1.0 109.345 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -161.61 131.26 4.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 5.0 m-80 -98.64 163.05 12.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.966 -1.084 . . . . 1.0 110.472 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -134.99 137.48 43.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 1.0 110.112 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.801 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 91.0 m-85 -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 1.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.81 ' C ' HD23 ' A' ' 45' ' ' LEU . 3.0 mt-10 -126.75 145.24 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.981 -1.074 . . . . 1.0 109.867 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.005 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.5 OUTLIER 179.08 156.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.401 -0.92 . . . . 1.0 111.412 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 103' ' ' THR . 4.8 m -122.13 154.99 36.66 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.612 -1.255 . . . . 1.0 107.612 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.571 HD13 HD11 ' A' ' 105' ' ' ILE . 3.3 pt -148.82 163.46 4.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 117.829 -1.548 . . . . 1.0 112.652 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.636 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.8 OUTLIER -114.3 83.31 1.86 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 177.241 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.569 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -70.67 150.7 45.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.084 -1.01 . . . . 1.0 112.434 -176.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.651 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 6.7 mm-40 -135.68 -3.12 2.35 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.35 0.595 . . . . 1.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.51 125.96 11.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.257 -0.902 . . . . 1.0 109.84 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.797 ' O ' HG22 ' A' ' 73' ' ' ILE . 47.5 p -55.51 -15.02 2.35 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.553 -0.717 . . . . 1.0 111.327 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -123.4 133.63 54.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.902 -1.124 . . . . 1.0 111.655 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 157.9 134.74 1.78 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.159 -1.177 . . . . 1.0 110.159 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.74 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -83.08 143.35 30.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.769 -1.43 . . . . 1.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.781 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -111.81 -47.03 5.94 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 C-N-CA 119.741 -0.784 . . . . 1.0 111.762 -177.19 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.98 HD13 HD12 ' A' ' 71' ' ' LEU . 5.7 tt -134.58 145.14 48.4 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.278 -1.514 . . . . 1.0 113.031 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.681 ' CH2' HG21 ' A' ' 151' ' ' VAL . 2.3 t-105 -149.68 117.12 6.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.804 . . . . 1.0 109.041 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -127.22 -176.08 3.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 1.0 110.694 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 61' ' ' LYS . . . 125.05 10.44 4.71 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER 78.33 -37.18 0.21 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.497 -1.002 . . . . 1.0 110.817 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.718 ' C ' HD22 ' A' ' 63' ' ' LEU . . . 118.51 85.91 1.05 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.718 HD22 ' C ' ' A' ' 62' ' ' GLY . 3.4 mm? -114.51 156.56 24.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -1.164 . . . . 1.0 109.72 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' C ' ' HG2' ' A' ' 65' ' ' ARG . 7.5 mm-40 -62.48 -30.7 71.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 1.0 110.339 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HG2' ' C ' ' A' ' 64' ' ' GLU . 2.1 ptm180 178.13 43.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.678 0.752 . . . . 1.0 109.187 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -110.63 -167.72 1.22 Allowed 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.725 -0.79 . . . . 1.0 110.628 -178.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 5.5 p-10 -40.31 133.21 1.87 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 1.0 110.829 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.671 ' CD1' ' CZ3' ' A' ' 58' ' ' TRP . 2.5 p90 -171.14 159.15 5.81 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.242 -0.911 . . . . 1.0 109.572 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.704 HD12 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -147.56 136.16 15.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 121.68 -0.637 . . . . 1.0 110.059 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.034 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -132.87 -174.33 3.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 1.0 110.455 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.98 HD12 HD13 ' A' ' 57' ' ' LEU . 66.0 mt -149.0 101.14 3.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.849 . . . . 1.0 108.722 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.785 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . . . -119.38 174.41 6.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.957 -1.089 . . . . 1.0 112.211 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 52' ' ' THR . 56.3 mt -113.86 131.17 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.668 -0.645 . . . . 1.0 110.597 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.568 HG22 ' OD2' ' A' ' 75' ' ' ASP . 2.5 p -139.96 131.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.415 -0.803 . . . . 1.0 110.077 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.568 ' OD2' HG22 ' A' ' 74' ' ' VAL . 28.0 m-20 61.24 10.12 2.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 1.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.658 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 95.19 9.36 58.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 78' ' ' VAL . 61.5 m-85 -133.32 108.46 8.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -1.095 . . . . 1.0 110.048 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.781 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -48.6 -175.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.77 0.795 . . . . 1.0 111.412 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.675 ' HB2' HG22 ' A' ' 90' ' ' VAL . 2.7 pt20 -172.9 124.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.672 0.749 . . . . 1.0 110.893 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.983 ' CE ' HD12 ' A' ' 91' ' ' LEU . 2.2 ttm -85.03 110.54 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.791 -0.568 . . . . 1.0 110.481 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . 1.034 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 37.1 mtm -89.45 116.71 27.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.906 -1.121 . . . . 1.0 109.885 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.704 ' CZ ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -111.92 116.38 30.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.693 -1.255 . . . . 1.0 109.163 178.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -124.98 48.09 2.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 1.0 110.469 -179.156 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -65.06 61.66 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.975 -0.69 . . . . 1.0 110.138 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 132.4 33.09 0.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.956 -1.258 . . . . 1.0 109.956 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.01 9.69 5.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.237 -1.155 . . . . 1.0 110.107 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -108.0 89.32 5.4 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 1.0 109.333 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.533 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -72.11 140.81 35.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.157 1.609 . . . . 1.0 111.599 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.625 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -137.12 119.14 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -97.46 114.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.354 -1.466 . . . . 1.0 111.403 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.983 HD12 ' CE ' ' A' ' 80' ' ' MET . 38.3 mt -104.38 71.97 1.03 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.137 -1.431 . . . . 1.0 107.137 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 51.1 mtp180 -57.33 178.58 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.052 0.93 . . . . 1.0 111.046 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.758 ' OG ' HG21 ' A' ' 118' ' ' VAL . 3.3 t -108.35 155.21 20.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.175 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.626 ' OG1' HD11 ' A' ' 124' ' ' ILE . 1.4 p -112.11 26.38 10.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 1.0 109.673 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.752 ' CG1' HG11 ' A' ' 118' ' ' VAL . 8.0 t -129.07 146.62 61.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.519 -0.738 . . . . 1.0 109.454 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.575 ' HD2' HG13 ' A' ' 95' ' ' VAL . 43.6 Cg_endo -67.85 116.17 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.754 1.397 . . . . 1.0 109.767 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.8 tp -106.78 -33.36 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.14 -0.975 . . . . 1.0 111.055 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -71.64 61.22 0.36 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 1.0 110.738 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -127.21 14.28 7.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 1.0 110.167 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.481 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 1.9 m120 58.63 40.88 23.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.995 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.554 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 1.1 m-70 -132.11 159.14 39.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 1.0 110.172 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.636 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 22.2 m95 -78.87 101.37 7.65 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.292 -0.963 . . . . 1.0 109.729 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.588 HG22 ' N ' ' A' ' 104' ' ' HIS . 5.9 m -101.93 171.66 7.39 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.441 -0.904 . . . . 1.0 109.009 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.588 ' N ' HG22 ' A' ' 103' ' ' THR . 8.4 t60 -119.97 143.9 47.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.07 -1.019 . . . . 1.0 108.791 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.571 HD11 HD13 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -133.67 159.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.22 -0.925 . . . . 1.0 109.172 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.808 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -152.45 148.47 27.47 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.659 -1.217 . . . . 1.0 110.307 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.801 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -144.23 102.21 3.82 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.526 -0.733 . . . . 1.0 110.374 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.579 ' CD2' ' O ' ' A' ' 108' ' ' TYR . 37.1 p90 -117.07 105.48 12.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 108.689 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.668 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -91.44 150.87 21.05 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.655 -0.818 . . . . 1.0 111.225 -178.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.7 t -136.93 96.51 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.679 -0.638 . . . . 1.0 110.799 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.582 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 61.0 mt-30 43.74 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.662 -0.649 . . . . 1.0 111.779 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER 54.2 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.616 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.8 tm-20 -95.97 109.75 22.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.108 -1.62 . . . . 1.0 109.919 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -99.05 161.43 20.07 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.067 -1.063 . . . . 1.0 110.892 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 125' ' ' THR . 33.7 t -132.7 156.67 46.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -1.17 . . . . 1.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.068 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.1 tm? -140.09 151.51 45.41 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 1.068 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.52 144.59 25.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.888 -1.133 . . . . 1.0 111.514 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.758 HG21 ' OG ' ' A' ' 93' ' ' SER . 41.1 t -102.86 98.92 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 177.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.21 39.52 82.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.715 -1.354 . . . . 1.0 109.715 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 119' ' ' GLY . 21.8 t-20 57.36 32.13 21.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -1.104 . . . . 1.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 5.3 mt-10 -114.8 -158.11 0.66 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.569 -0.707 . . . . 1.0 110.593 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -30.43 93.77 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.936 -0.477 . . . . 1.0 110.576 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.9 Cg_endo -77.12 142.65 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.039 1.547 . . . . 1.0 112.012 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 124' ' ' ILE . 3.3 mp -108.53 100.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.613 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.9 p -108.19 166.96 10.35 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.192 0.996 . . . . 1.0 111.962 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.7 167.76 38.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.222 -2.351 . . . . 1.0 107.222 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -136.88 170.0 16.82 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.555 -1.556 . . . . 1.0 110.929 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 31.7 p -96.92 163.57 19.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.921 -1.112 . . . . 1.0 110.431 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 130' ' ' LEU . 45.6 Cg_endo -71.65 55.62 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.954 1.502 . . . . 1.0 108.735 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.492 ' O ' ' HD2' ' A' ' 87' ' ' LYS . 4.7 mp 41.05 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.637 -0.665 . . . . 1.0 110.056 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.29 10.57 47.87 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.523 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -133.58 145.54 50.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.113 -1.228 . . . . 1.0 109.867 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 133' ' ' THR . 34.5 m -137.52 13.94 2.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.089 -1.007 . . . . 1.0 110.676 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' THR . 1.7 mt-30 179.94 160.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 1.0 110.54 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.745 HD13 ' HB3' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -166.08 61.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.485 -0.759 . . . . 1.0 109.893 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 4.2 m-20 -77.4 122.19 24.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.056 . . . . 1.0 109.439 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.77 164.23 18.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.08 . . . . 1.0 110.877 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.819 ' OD2' ' HB2' ' A' ' 140' ' ' ALA . 20.4 p-10 -89.82 29.35 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 1.0 110.204 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 52.29 18.09 4.64 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 1.0 109.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.819 ' HB2' ' OD2' ' A' ' 138' ' ' ASP . . . -64.34 158.76 22.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -1.21 . . . . 1.0 109.072 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.745 HD12 ' N ' ' A' ' 142' ' ' TRP . 6.8 tp -158.47 144.06 16.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.446 -1.302 . . . . 1.0 112.481 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.745 ' N ' HD12 ' A' ' 141' ' ' LEU . 19.2 m95 -131.88 97.27 4.13 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.952 HD12 HD12 ' A' ' 57' ' ' LEU . 2.8 tt -112.82 119.73 39.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.627 -1.295 . . . . 1.0 113.544 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 128.67 3.74 5.45 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.517 ' O ' ' SD ' ' A' ' 146' ' ' MET . . . 145.91 -147.72 18.93 Favored Glycine 0 C--N 1.283 -2.378 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' MET . . . . . 0.732 ' CB ' HD22 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -151.64 113.13 4.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.082 -1.047 . . . . 1.0 111.772 -178.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.64 -24.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.997 0.903 . . . . 1.0 109.025 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.555 ' HD2' ' N ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -145.68 83.47 1.65 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 178.316 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.732 HD22 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -71.58 22.84 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.275 -0.891 . . . . 1.0 112.757 -176.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.3 p -61.67 -19.68 62.6 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.768 HG13 ' N ' ' A' ' 152' ' ' ALA 0.288 10.5 p -71.51 -123.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.67 -1.15 . . . . 1.0 110.301 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.768 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 72.1 -71.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.702 -1.249 . . . . 1.0 108.796 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.559 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 52.94 155.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.919 1.342 . . . . 1.0 112.545 178.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER 44.16 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.006 1.484 . . . . 1.0 115.006 178.11 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 1.087 HD13 ' O ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -135.86 154.0 77.52 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.057 -1.652 . . . . 1.0 111.054 -179.387 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.654 ' N ' HD22 ' A' ' 155' ' ' LEU . 41.0 Cg_endo -65.62 -161.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.594 1.529 . . . . 1.0 113.629 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.0 OUTLIER -55.93 -8.88 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.561 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.988 ' HB3' HD21 ' A' ' 155' ' ' LEU . . . -39.85 -38.35 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.915 -1.116 . . . . 1.0 109.44 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.785 ' CZ ' ' HB2' ' A' ' 72' ' ' ALA . 10.2 m-85 -85.85 -31.6 22.16 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.855 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -65.04 -11.04 34.82 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.952 -1.499 . . . . 1.0 108.243 177.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -122.27 98.94 6.16 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -49.82 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.63 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 32.8 t80 -88.79 145.5 25.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.119 -1.224 . . . . 1.0 111.575 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 164' ' ' ILE . 2.5 mt -123.42 85.39 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.139 -1.43 . . . . 1.0 107.139 177.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.63 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.67 -156.13 11.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.316 -1.914 . . . . 1.0 108.316 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.0 m -133.41 154.06 51.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.112 -1.228 . . . . 1.0 110.311 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.9 mt -134.76 144.96 33.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.774 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.519 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 26.9 ttt180 -150.72 164.6 35.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.892 -1.13 . . . . 1.0 110.659 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.6 m-20 43.57 74.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.202 -0.936 . . . . 1.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 1.005 HG12 ' CB ' ' A' ' 45' ' ' LEU . 22.7 m -126.74 124.17 64.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 119.311 -0.955 . . . . 1.0 109.891 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.527 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -131.95 158.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.929 -1.108 . . . . 1.0 111.331 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 76.5 t -134.15 114.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 63.3 m-20 50.01 36.58 12.14 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.878 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.7 OUTLIER 67.61 34.25 4.64 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.377 0.608 . . . . 1.0 110.411 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 19.2 mm100 -114.45 -176.53 2.92 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 121.323 -0.861 . . . . 1.0 110.616 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 0.3 OUTLIER 67.91 -98.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 1.0 110.66 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 12.1 mt 60.37 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.894 -1.128 . . . . 1.0 111.477 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.536 ' HB3' ' HG3' ' A' ' 181' ' ' GLU . 2.6 m-70 -70.09 79.74 0.5 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.716 -1.24 . . . . 1.0 110.546 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.627 HD11 HG22 ' A' ' 170' ' ' VAL 0.263 0.5 OUTLIER -52.7 -61.23 2.42 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.201 1.001 . . . . 1.0 110.752 178.931 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.882 ' HA ' HD23 ' A' ' 184' ' ' LEU . 12.9 t -52.91 -18.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.632 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 178' ' ' HIS . 0.7 OUTLIER -73.63 -56.51 4.91 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.732 -1.187 . . . . 1.0 109.901 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.612 ' CB ' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -95.81 -18.38 20.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.099 -1.0 . . . . 1.0 109.8 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -73.74 -29.92 62.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.144 -0.972 . . . . 1.0 108.703 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.882 HD23 ' HA ' ' A' ' 180' ' ' VAL . 1.5 mm? -65.06 -8.8 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.424 -0.798 . . . . 1.0 109.987 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 184' ' ' LEU . 8.5 t-20 -43.85 -26.43 0.26 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.391 -0.818 . . . . 1.0 109.095 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 189' ' ' ILE . 2.2 t-20 -113.9 148.89 40.89 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 47.8 Cg_endo -76.97 -34.74 2.11 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.824 1.434 . . . . 1.0 110.68 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 4.51 0.42 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.697 -0.683 . . . . 1.0 112.76 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 186' ' ' ASN . 23.4 mm -61.95 117.35 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.323 -1.485 . . . . 1.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -120.59 159.64 24.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 110.829 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 18.9 m-70 -93.54 151.55 19.62 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.344 -0.847 . . . . 1.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' CYS . . . . . 0.741 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 9.2 t -52.65 139.79 25.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 1.0 111.913 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.67 145.88 48.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.479 -0.763 . . . . 1.0 109.763 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.37 96.99 1.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 1.0 110.566 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 118.952 -1.099 . . . . 1.0 110.466 179.086 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.571 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 3.6 pt-20 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.243 0.544 . . . . 1.0 110.531 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -95.35 136.95 35.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.662 -1.274 . . . . 1.0 110.766 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 190' ' ' LEU . 8.9 mm -127.43 118.16 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.278 -0.888 . . . . 1.0 109.702 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -80.76 142.46 33.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 1.0 111.216 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.718 ' CE1' HD12 ' A' ' 167' ' ' ILE . 9.1 m-85 -106.6 172.07 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 1.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.491 ' C ' HG12 ' A' ' 164' ' ' ILE . 3.8 p30 -127.32 -3.62 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 1.0 110.637 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.482 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 110.17 -9.8 31.34 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.85 -1.7 . . . . 1.0 108.85 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -127.72 -24.95 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -1.186 . . . . 1.0 110.773 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 133.76 37.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 1.0 110.369 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.618 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -128.17 114.55 17.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 1.0 110.365 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.527 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 6.0 mmt -83.23 99.07 9.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.85 -1.156 . . . . 1.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HG3' ' CH2' ' A' ' 142' ' ' TRP . 46.8 tt0 -87.77 87.98 7.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 1.0 109.456 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 182' ' ' ASP . 8.0 m-30 -92.18 97.03 10.65 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 1.0 110.236 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.15 104.39 16.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 1.0 110.007 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 138' ' ' ASP . 1.4 t-20 -147.36 162.97 37.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 1.0 110.338 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.69 50.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 1.0 110.376 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.472 ' H ' HG22 ' A' ' 31' ' ' VAL . 4.6 m . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.271 -0.893 . . . . 1.0 110.907 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.403 ' NE2' ' HB2' ' A' ' 40' ' ' SER . 2.5 tm0? . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.667 0.746 . . . . 1.0 109.809 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.455 ' OG ' HG13 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -160.72 146.22 14.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.732 -0.605 . . . . 1.0 109.467 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.609 ' N ' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -133.23 155.28 49.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.049 -1.032 . . . . 1.0 111.597 -178.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 8.8 m-70 -114.67 143.97 44.18 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 58.4 m-85 -129.02 121.76 28.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.097 -1.002 . . . . 1.0 110.644 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.746 ' C ' HD23 ' A' ' 45' ' ' LEU . 2.8 mt-10 -127.92 147.24 50.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.014 -1.054 . . . . 1.0 109.928 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.001 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.3 pt? 179.89 150.22 0.36 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.759 . . . . 1.0 110.548 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.479 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 1.9 m -120.17 154.07 35.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.479 ' CG2' ' C ' ' A' ' 46' ' ' SER . 1.5 pt -147.49 155.09 10.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.824 -1.55 . . . . 1.0 112.86 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -112.61 82.68 1.69 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 176.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.644 HG21 HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -70.19 163.63 25.98 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.867 -1.146 . . . . 1.0 111.289 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 0.8 OUTLIER -145.39 29.84 1.14 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.299 -0.96 . . . . 1.0 110.845 -178.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.984 ' O ' HG23 ' A' ' 52' ' ' THR . . . -162.24 -96.68 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.943 -1.103 . . . . 1.0 110.324 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.984 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 176.07 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.431 0.634 . . . . 1.0 109.824 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.519 ' HG3' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -119.23 138.77 52.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.43 -0.794 . . . . 1.0 110.61 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.81 135.77 1.89 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.255 -1.938 . . . . 1.0 108.255 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.937 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -84.87 131.68 34.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.743 -1.445 . . . . 1.0 109.552 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.977 HD12 ' HA ' ' A' ' 72' ' ' ALA . 4.6 mp -95.75 -40.28 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 1.0 112.714 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.984 HD13 HD12 ' A' ' 71' ' ' LEU . 7.1 tt -141.13 148.36 39.95 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.254 -1.529 . . . . 1.0 113.652 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.824 ' N ' HD23 ' A' ' 57' ' ' LEU . 7.3 t-105 -152.02 129.06 11.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.73 163.28 32.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.654 -1.279 . . . . 1.0 110.307 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 110.119 -1.192 . . . . 1.0 110.119 179.834 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.683 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 8.5 m-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 109' ' ' ARG . 19.0 mt -112.54 130.76 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.54 -1.35 . . . . 1.0 109.916 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.735 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -153.74 174.57 14.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 1.0 110.717 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.984 HD12 HD13 ' A' ' 57' ' ' LEU . 79.0 mt -146.22 110.4 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.977 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -129.98 164.38 24.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 1.0 112.466 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.942 ' CG1' HD11 ' A' ' 56' ' ' ILE . 9.3 mt -102.59 136.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.639 -0.663 . . . . 1.0 110.678 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 75' ' ' ASP . 4.0 p -140.63 131.44 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.157 -0.965 . . . . 1.0 110.806 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.567 ' CG ' HG22 ' A' ' 74' ' ' VAL . 7.4 m-20 63.8 8.79 4.0 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.352 -0.842 . . . . 1.0 111.032 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 104.56 13.73 25.4 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 35.8 m-85 -135.53 152.73 51.6 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.29 -1.124 . . . . 1.0 109.976 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.773 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.44 166.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 1.0 109.46 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 8.5 pt20 -164.12 126.39 2.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.094 -1.003 . . . . 1.0 110.936 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.813 ' CE ' HD12 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -86.53 103.24 14.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.735 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -104.78 119.39 38.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -0.751 . . . . 1.0 110.433 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.714 ' CE2' HG11 ' A' ' 89' ' ' VAL . 3.7 p90 -141.24 143.65 34.26 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.008 -1.477 . . . . 1.0 111.455 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 16.9 t0 -136.27 108.51 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.698 0.761 . . . . 1.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -110.39 30.4 6.81 Favored 'General case' 0 C--N 1.287 -2.122 0 O-C-N 121.723 -0.61 . . . . 1.0 109.852 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 86' ' ' SER . . . -164.21 -50.86 0.02 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 1.4 t 178.18 -18.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -1.11 . . . . 1.0 111.471 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 17.5 mmtt -119.51 117.86 32.63 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.724 -1.235 . . . . 1.0 110.662 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.07 143.92 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.877 1.462 . . . . 1.0 109.236 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.77 104.47 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 1.0 109.075 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 90' ' ' VAL . 8.7 p -91.1 82.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.483 -1.385 . . . . 1.0 111.261 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.813 HD12 ' CE ' ' A' ' 80' ' ' MET . 5.6 mt -75.02 74.51 2.21 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.572 ' O ' HG21 ' A' ' 124' ' ' ILE . 14.3 mtp180 -59.16 178.88 0.11 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.929 0.871 . . . . 1.0 111.213 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 118' ' ' VAL . 2.0 t -109.97 143.12 40.38 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 94' ' ' THR . 24.4 m -99.82 31.16 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.124 -0.985 . . . . 1.0 109.93 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.936 HG11 HG11 ' A' ' 118' ' ' VAL . 3.0 t -136.27 145.89 53.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 1.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.484 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.1 Cg_endo -65.2 134.48 39.44 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.612 1.322 . . . . 1.0 110.751 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 76' ' ' GLY . 2.6 tp -117.6 -24.5 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 1.0 110.581 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 8.4 p-10 -76.37 55.95 1.03 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.889 . . . . 1.0 109.177 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.618 HG22 ' O ' ' A' ' 99' ' ' THR . 24.2 m -110.89 14.62 22.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.485 -0.76 . . . . 1.0 110.588 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.67 18.76 0.77 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.08 -1.013 . . . . 1.0 110.624 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -117.32 162.95 17.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.129 -0.982 . . . . 1.0 110.378 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.677 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 16.5 m95 -76.74 101.64 5.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.149 -0.969 . . . . 1.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 104' ' ' HIS . 49.4 m -94.99 165.33 12.49 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.576 -0.85 . . . . 1.0 109.498 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.49 ' N ' HG22 ' A' ' 103' ' ' THR . 1.0 OUTLIER -118.06 136.82 53.32 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -135.31 155.83 37.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.052 -1.03 . . . . 1.0 108.953 -178.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.811 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -152.53 174.5 13.84 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.12 -1.432 . . . . 1.0 110.498 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.672 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -161.23 123.97 3.15 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.328 -0.949 . . . . 1.0 111.214 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 24.6 m-85 -105.24 106.68 17.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.8 ' CZ ' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -105.98 117.7 34.7 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.319 -0.952 . . . . 1.0 111.67 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.917 HG12 ' OE1' ' A' ' 111' ' ' GLN . 1.8 t -118.6 134.52 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.917 ' OE1' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER 29.74 -90.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.675 -0.641 . . . . 1.0 112.047 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -115.14 -14.78 11.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 1.0 112.138 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.7 tt0 -98.97 118.38 35.61 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.83 -1.169 . . . . 1.0 110.914 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.01 171.53 18.99 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.32 -0.943 . . . . 1.0 111.034 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.576 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -147.45 160.89 42.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.586 -0.95 . . . . 1.0 110.206 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.933 HD13 ' N ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -148.87 141.99 24.94 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.268 -0.895 . . . . 1.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.933 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -143.78 130.51 20.27 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.076 -1.05 . . . . 1.0 111.233 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.936 HG11 HG11 ' A' ' 95' ' ' VAL . 2.2 t -89.65 97.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.627 -1.62 . . . . 1.0 106.627 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 71.48 40.51 59.69 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.94 31.99 17.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.059 . . . . 1.0 110.497 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.541 ' N ' ' HG2' ' A' ' 117' ' ' GLN . 2.9 mt-10 -105.08 -158.18 0.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 1.0 110.619 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.34 99.9 0.19 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.664 -0.648 . . . . 1.0 110.013 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.639 ' C ' HD12 ' A' ' 124' ' ' ILE . 48.5 Cg_endo -75.73 135.47 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.154 1.607 . . . . 1.0 111.363 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.639 HD12 ' C ' ' A' ' 123' ' ' PRO . 1.5 mp -103.49 119.52 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.697 ' HA ' HD13 ' A' ' 91' ' ' LEU . 28.5 p -118.35 172.21 7.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.822 -1.174 . . . . 1.0 112.658 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -179.68 153.98 12.99 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.694 -2.163 . . . . 1.0 107.694 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -138.26 161.93 35.62 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.006 -1.291 . . . . 1.0 110.986 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 130' ' ' LEU . 3.2 m -89.94 163.58 31.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.764 . . . . 1.0 109.684 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -68.83 62.36 1.28 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.006 1.53 . . . . 1.0 109.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.2 pp 16.55 50.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.376 0.608 . . . . 1.0 112.366 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -99.95 2.66 56.9 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.668 -1.373 . . . . 1.0 109.668 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 84' ' ' LEU . . . -161.85 84.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -1.109 . . . . 1.0 109.651 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 133' ' ' THR . 91.2 m -87.92 11.5 15.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 1.0 110.624 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.431 ' HG3' ' C ' ' A' ' 133' ' ' THR . 86.3 mt-30 -144.23 92.08 2.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 1.0 110.632 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.475 HD22 HH21 ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.71 160.21 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 1.0 109.598 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -130.65 111.53 12.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.928 -1.107 . . . . 1.0 110.774 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 t -136.18 149.25 48.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -0.885 . . . . 1.0 109.847 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.713 ' OD1' ' HB2' ' A' ' 140' ' ' ALA . 5.5 p-10 -87.68 29.17 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 1.0 110.671 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 58.69 13.61 18.62 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.713 ' HB2' ' OD1' ' A' ' 138' ' ' ASP . . . -57.77 170.22 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 1.0 108.516 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -160.88 145.94 14.2 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.276 -1.37 . . . . 1.0 112.026 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.577 ' CH2' ' HG3' ' A' ' 26' ' ' GLU . 49.6 m95 -135.08 119.13 17.5 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.268 -1.752 . . . . 1.0 106.268 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.613 HD21 HG22 ' A' ' 56' ' ' ILE . 1.7 tt -130.93 123.46 28.94 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.334 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.87 2.17 10.42 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.454 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 141.58 -139.28 9.3 Favored Glycine 0 C--N 1.293 -1.828 0 C-N-CA 118.991 -1.576 . . . . 1.0 109.726 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.904 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -170.74 130.86 0.84 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.948 -1.101 . . . . 1.0 112.178 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -64.99 -42.65 94.34 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -113.14 67.95 0.67 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.975 -1.491 . . . . 1.0 106.975 177.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.904 HD13 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -66.32 37.78 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.194 -0.941 . . . . 1.0 113.403 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 148' ' ' ARG . 53.4 p -83.8 3.39 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 175.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.812 HG21 ' CZ2' ' A' ' 58' ' ' TRP . 14.9 p -86.59 -23.87 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.308 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 153' ' ' HIS . . . -41.82 -26.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 1.0 109.508 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.56 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER 83.38 -85.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.965 -0.459 . . . . 1.0 111.245 179.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -143.91 -7.17 0.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 1.0 111.776 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.746 HD22 ' CE1' ' A' ' 159' ' ' TYR . 4.2 pp -53.65 167.07 0.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.108 -0.995 . . . . 1.0 110.377 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.702 ' O ' HD12 ' A' ' 155' ' ' LEU . 42.7 Cg_endo -68.96 -165.67 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.734 1.386 . . . . 1.0 112.278 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 1.5 mttp -56.25 -9.97 0.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.189 -0.944 . . . . 1.0 112.171 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.519 ' HA ' ' HG3' ' A' ' 53' ' ' GLN . . . -38.2 -44.36 0.85 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 1.0 109.784 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.937 ' CE2' HD13 ' A' ' 55' ' ' LEU . 6.0 m-85 -87.87 -27.07 22.44 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.989 -1.084 . . . . 1.0 108.748 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.567 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -73.17 -6.59 46.78 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.435 -1.306 . . . . 1.0 107.981 177.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 161' ' ' THR . 4.4 m -122.2 83.91 2.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.67 171.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 167' ' ' ILE . 6.2 t80 -89.55 144.23 26.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -1.218 . . . . 1.0 111.391 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.567 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 5.9 mt -123.2 91.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.636 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -169.63 -154.07 8.97 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.48 -1.848 . . . . 1.0 108.48 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.562 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 2.9 m -124.09 144.56 49.8 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.204 -1.174 . . . . 1.0 110.516 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.718 HD12 ' CE1' ' A' ' 19' ' ' PHE 0.251 3.4 mt -134.1 145.59 32.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.534 -0.729 . . . . 1.0 109.425 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 6.5 ttp180 -162.0 157.25 23.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.69 -1.256 . . . . 1.0 111.023 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 4.2 m-20 57.37 63.49 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 1.001 HG12 ' CB ' ' A' ' 45' ' ' LEU . 27.1 m -119.58 117.82 55.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.937 0.875 . . . . 1.0 109.653 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 175' ' ' GLN . 0.5 OUTLIER -135.6 155.9 37.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.09 -1.044 . . . . 1.0 110.915 -178.072 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 3.6 p -134.74 112.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 94.6 m-20 59.04 37.49 24.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.24 32.59 14.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.764 -0.585 . . . . 1.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.603 ' O ' HG23 ' A' ' 171' ' ' ILE . 19.4 mm100 -118.45 176.16 5.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.186 -0.946 . . . . 1.0 110.44 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.606 ' O ' HD23 ' A' ' 177' ' ' LEU . 59.5 mm-40 65.18 -121.35 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 1.0 110.756 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.606 HD23 ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 57.62 7.31 0.52 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.866 . . . . 1.0 112.205 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.581 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 15.3 m-70 -110.14 56.53 0.62 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.545 -1.347 . . . . 1.0 108.538 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.72 ' O ' ' HB2' ' A' ' 183' ' ' ALA 0.261 12.3 mt -28.24 -61.45 0.11 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.966 0.889 . . . . 1.0 112.839 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.726 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.2 t -77.29 -20.28 14.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 113.367 0.877 . . . . 1.0 113.367 -176.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.581 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.1 mm-40 -63.46 -48.6 77.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.228 -1.545 . . . . 1.0 110.803 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.43 -12.12 20.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.155 -0.966 . . . . 1.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -70.09 -33.71 72.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.018 -1.052 . . . . 1.0 108.738 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.726 HD13 ' O ' ' A' ' 180' ' ' VAL . 1.2 mp -48.63 -23.66 1.09 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.795 . . . . 1.0 109.075 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -59.43 -16.52 24.02 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.875 0.845 . . . . 1.0 109.02 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.534 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 20.1 t30 -89.1 172.31 7.63 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 44.8 Cg_endo -87.73 -48.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.187 1.098 . . . . 1.0 111.357 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -118.31 145.87 44.76 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.427 -0.796 . . . . 1.0 111.115 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.34 130.29 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 1.0 110.208 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 17' ' ' ILE . 4.4 mt -115.62 169.13 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -110.6 -82.23 0.58 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.094 -1.004 . . . . 1.0 111.23 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--N 1.295 -1.762 0 O-C-N 121.033 -1.042 . . . . 1.0 111.044 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.591 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.4 pt-20 . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 121.409 0.623 . . . . 1.0 110.948 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.589 ' O ' ' CD2' ' A' ' 191' ' ' HIS . . . -85.17 140.98 30.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.402 -1.436 . . . . 1.0 109.302 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.868 HG21 ' CE ' ' A' ' 25' ' ' MET . 21.9 mm -111.52 122.71 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.694 -1.203 . . . . 1.0 110.788 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.32 122.05 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.369 -0.832 . . . . 1.0 110.093 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.812 ' CE1' HD12 ' A' ' 167' ' ' ILE . 4.6 m-85 -94.27 140.23 30.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 1.0 110.023 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -107.95 -7.66 16.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 1.0 110.214 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' GLY . . . 114.64 -11.83 21.06 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -124.06 -1.74 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.861 -1.376 . . . . 1.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.27 110.03 22.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.985 -1.072 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 5.4 p90 -100.17 156.09 17.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.177 -0.952 . . . . 1.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.868 ' CE ' HG21 ' A' ' 17' ' ' ILE . 3.4 mmt -122.16 100.32 6.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.154 -1.018 . . . . 1.0 110.341 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.618 ' HB3' ' CZ3' ' A' ' 142' ' ' TRP . 1.3 pp20? -78.36 106.08 10.04 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.618 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 44.2 m-85 -101.11 98.51 8.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.912 -1.118 . . . . 1.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -93.03 102.15 14.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 1.0 109.692 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -121.61 138.64 54.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 1.0 110.184 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -86.11 95.56 9.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 1.0 109.842 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.604 HG11 ' CB ' ' A' ' 138' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 1.0 110.534 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.802 0.334 . . . . 1.0 110.311 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -143.0 178.42 7.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.149 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.407 ' N ' ' OG ' ' A' ' 40' ' ' SER . 30.2 m120 -119.69 156.05 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 1.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 7.7 m80 -119.24 117.34 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 1.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.759 ' HD1' HG22 ' A' ' 172' ' ' VAL . 21.2 m-85 -112.28 120.25 41.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.694 . . . . 1.0 110.234 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.742 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -130.19 139.98 50.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.858 -1.151 . . . . 1.0 111.322 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.945 ' HB2' HG12 ' A' ' 170' ' ' VAL . 1.2 pt? -176.59 150.76 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 1.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -120.34 146.47 46.11 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.95 HG23 ' CD1' ' A' ' 105' ' ' ILE . 0.9 OUTLIER -127.69 -170.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.126 -1.43 . . . . 1.0 111.261 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.658 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.7 OUTLIER -153.16 136.77 15.99 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.014 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.622 HG23 ' HA ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER 52.68 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.51 -1.369 . . . . 1.0 109.238 -177.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.795 ' CG ' HD13 ' A' ' 73' ' ' ILE . 15.1 tt0 -173.87 22.63 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.305 -1.497 . . . . 1.0 110.283 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.703 ' HB2' ' CG2' ' A' ' 164' ' ' ILE . . . 45.93 -114.68 0.49 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.681 -1.208 . . . . 1.0 109.201 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.583 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 18.3 p -155.17 -40.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.002 -1.061 . . . . 1.0 109.583 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.66 131.33 53.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.415 -0.803 . . . . 1.0 109.647 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 168.07 138.3 2.43 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.439 -1.362 . . . . 1.0 109.885 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.947 HD22 HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -88.97 124.41 34.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.971 -1.311 . . . . 1.0 109.005 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.692 HD11 HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.3 -27.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.423 0.897 . . . . 1.0 113.423 -176.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.031 HD12 HD13 ' A' ' 143' ' ' LEU . 1.7 tt -143.32 151.69 40.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 119.85 -1.781 . . . . 1.0 113.089 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 58' ' ' TRP . 5.3 t-105 -160.22 106.93 1.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.403 0.621 . . . . 1.0 109.604 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.535 ' HG ' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -121.43 155.61 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 1.0 109.08 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.649 ' HA2' ' CG ' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.333 0 C-N-CA 118.725 -1.702 . . . . 1.0 111.749 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.681 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 110.776 -0.083 . . . . 1.0 110.776 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.547 ' HA ' ' CB ' ' A' ' 82' ' ' TYR . 8.9 pt -158.46 153.43 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.42 -0.8 . . . . 1.0 111.171 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.729 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -166.14 174.55 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.494 -0.754 . . . . 1.0 109.079 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.958 HD12 HD13 ' A' ' 57' ' ' LEU . 95.9 mt -150.91 134.28 16.22 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.925 -1.109 . . . . 1.0 108.165 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -146.87 179.55 7.51 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.032 -1.042 . . . . 1.0 112.652 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.795 HD13 ' CG ' ' A' ' 50' ' ' GLU . 2.5 mt -133.27 139.37 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.717 -0.614 . . . . 1.0 111.623 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.696 HG22 ' OE1' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -140.42 131.54 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.274 -0.891 . . . . 1.0 109.224 178.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 1.5 m-20 69.29 9.73 7.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.138 -0.976 . . . . 1.0 111.036 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 96.75 16.38 36.57 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.098 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.594 ' O ' HG23 ' A' ' 73' ' ' ILE . 90.6 m-85 -130.05 159.65 36.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -1.097 . . . . 1.0 109.32 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.692 HG12 HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -102.57 164.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.185 -0.947 . . . . 1.0 111.824 -178.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.837 ' HB2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -160.52 130.88 5.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.383 0.611 . . . . 1.0 110.413 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.806 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -92.69 115.95 28.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.049 . . . . 1.0 109.571 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.729 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.61 122.05 43.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.284 -0.885 . . . . 1.0 109.805 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.681 ' HB2' ' O ' ' A' ' 68' ' ' TYR . 15.9 p90 -140.73 144.98 35.85 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.561 -1.256 . . . . 1.0 111.351 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 86' ' ' SER . 0.1 OUTLIER -141.19 108.3 5.47 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.35 1.072 . . . . 1.0 109.652 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.564 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -104.54 34.49 3.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.436 -0.802 . . . . 1.0 109.897 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -168.34 -41.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.6 OUTLIER 165.63 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.291 -1.123 . . . . 1.0 111.146 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HD3' ' HG3' ' A' ' 129' ' ' PRO . 13.1 mtpt -121.18 116.98 30.83 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.831 -1.168 . . . . 1.0 110.572 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.516 ' N ' ' HB2' ' A' ' 83' ' ' ASP . 45.3 Cg_endo -75.62 160.63 37.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.928 1.488 . . . . 1.0 110.676 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.786 HG13 HD21 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -133.05 107.01 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 108.749 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.837 HG22 ' HB2' ' A' ' 79' ' ' GLN . 1.8 p -95.89 123.94 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.455 -1.403 . . . . 1.0 111.242 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.794 HD12 ' HE3' ' A' ' 80' ' ' MET . 0.7 OUTLIER -113.58 84.58 2.04 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.666 ' O ' HG21 ' A' ' 124' ' ' ILE . 30.9 mtp180 -59.65 178.01 0.18 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.239 -0.984 . . . . 1.0 111.266 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.727 ' OG ' HG21 ' A' ' 118' ' ' VAL . 2.9 t -101.78 159.03 15.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.512 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.18 24.61 12.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 1.0 109.522 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 96' ' ' PRO . 1.3 t -147.22 154.67 46.25 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 1.0 109.429 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 95' ' ' VAL . 38.3 Cg_endo -64.25 134.5 42.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.77 1.405 . . . . 1.0 109.715 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -114.15 -31.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 1.0 111.048 -178.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.483 ' CA ' ' HB3' ' A' ' 50' ' ' GLU . 12.6 p30 -82.16 47.88 1.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.968 -1.082 . . . . 1.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 99' ' ' THR . 2.0 m -87.59 6.55 33.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 110.906 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.622 ' HA ' HG23 ' A' ' 49' ' ' THR . 0.6 OUTLIER 66.7 7.43 5.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 111.538 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 4.2 m80 -112.53 173.63 6.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.896 -1.128 . . . . 1.0 110.366 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.658 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 2.6 m95 -75.98 88.37 2.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 1.0 109.967 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 104' ' ' HIS . 7.7 m -79.75 172.25 14.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.047 -1.033 . . . . 1.0 109.579 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.597 ' N ' HG22 ' A' ' 103' ' ' THR . 0.7 OUTLIER -123.19 119.84 31.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.95 ' CD1' HG23 ' A' ' 47' ' ' ILE . 1.6 mp -118.28 142.71 31.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.768 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 mttp -153.7 178.99 9.26 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.305 -1.358 . . . . 1.0 109.391 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -164.9 158.37 17.14 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.625 -1.23 . . . . 1.0 111.629 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.36 103.93 5.44 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -91.24 117.88 30.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 1.0 109.785 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 111' ' ' GLN . 20.6 t -114.88 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.078 -1.014 . . . . 1.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.504 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 9.9 tt0 60.1 -92.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 1.0 110.236 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.582 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -111.4 -21.23 11.92 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 1.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.582 ' N ' ' HG2' ' A' ' 112' ' ' ARG . 6.2 tt0 -92.22 108.27 19.83 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.966 0.889 . . . . 1.0 111.11 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -94.75 165.7 25.92 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 120.34 -0.933 . . . . 1.0 110.854 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.66 ' CB ' HG22 ' A' ' 125' ' ' THR . 16.2 t -146.48 156.88 43.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.259 -1.142 . . . . 1.0 110.73 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.072 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.7 tm? -123.1 146.9 47.32 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.095 -1.003 . . . . 1.0 108.859 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 1.072 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -126.52 92.97 3.67 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.347 -0.845 . . . . 1.0 111.844 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 116' ' ' LEU . 52.9 t -86.78 85.43 2.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.33 53.72 16.35 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.488 ' OD1' ' OE1' ' A' ' 117' ' ' GLN . 1.7 m-20 44.68 21.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.157 -1.202 . . . . 1.0 111.178 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -91.49 -176.37 4.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 1.0 109.813 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -41.12 100.46 0.22 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 1.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.464 ' N ' ' O ' ' A' ' 121' ' ' GLU . 41.1 Cg_endo -67.91 134.8 33.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.228 1.646 . . . . 1.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.747 HG22 ' HB3' ' A' ' 91' ' ' LEU . 1.5 mp -97.95 115.18 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.66 HG22 ' CB ' ' A' ' 115' ' ' SER . 12.2 p -120.25 174.48 6.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.072 -1.017 . . . . 1.0 112.181 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 114' ' ' GLY . . . -178.72 163.36 31.11 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.253 -2.339 . . . . 1.0 107.253 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.577 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -140.82 169.84 16.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.581 -1.54 . . . . 1.0 111.153 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.68 166.65 12.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.243 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.549 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.4 Cg_endo -66.94 89.92 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.779 1.41 . . . . 1.0 108.51 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -14.5 131.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.214 0.53 . . . . 1.0 112.111 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 130.43 55.92 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.564 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . -103.84 -122.31 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -1.125 . . . . 1.0 109.926 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.658 ' O ' HG23 ' A' ' 133' ' ' THR . 13.1 t -167.79 59.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.71 -1.244 . . . . 1.0 110.279 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 135' ' ' LEU . 11.3 mm-40 54.96 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.562 HD23 HG23 ' A' ' 133' ' ' THR . 0.2 OUTLIER 66.46 97.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 1.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.3 m-20 -69.28 178.96 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 1.0 109.723 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -153.08 105.77 2.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 1.0 109.805 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.604 ' CB ' HG11 ' A' ' 31' ' ' VAL . 1.9 p30 164.04 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.646 -0.659 . . . . 1.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -38.54 -44.31 1.73 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -164.87 162.75 21.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 1.0 110.257 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.533 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 14.7 tp -145.41 146.03 31.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 1.0 109.976 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.656 ' CG ' ' HE1' ' A' ' 146' ' ' MET . 37.1 m95 -135.81 131.36 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 1.031 HD13 HD12 ' A' ' 57' ' ' LEU . 5.4 tp -133.21 122.22 23.65 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.177 -1.409 . . . . 1.0 112.698 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 119.51 16.27 5.16 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.862 -1.295 . . . . 1.0 109.862 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 130.05 -137.54 9.6 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 119.099 -1.524 . . . . 1.0 109.919 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.791 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -168.05 134.38 2.01 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.846 -0.741 . . . . 1.0 110.388 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -47.45 -20.58 0.24 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.448 -0.782 . . . . 1.0 110.856 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -157.51 85.94 0.93 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.947 HD21 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -78.8 38.17 0.32 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.555 -1.341 . . . . 1.0 112.772 -177.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 151' ' ' VAL . 1.9 p -54.26 -26.37 28.59 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 104.55 -2.389 . . . . 1.0 104.55 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.833 HG13 ' N ' ' A' ' 152' ' ' ALA 0.282 7.7 p -59.28 -132.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.297 -1.32 . . . . 1.0 108.807 177.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.833 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 65.21 -67.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.136 -0.978 . . . . 1.0 109.544 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 151' ' ' VAL . 18.9 m170 38.16 -74.84 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.427 1.269 . . . . 1.0 114.427 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -52.6 -3.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.576 1.324 . . . . 1.0 114.576 -176.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.928 HD11 ' CD1' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -146.51 175.54 2.67 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 119.79 -1.819 . . . . 1.0 111.833 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 50.3 Cg_endo -77.51 -161.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.868 1.712 . . . . 1.0 113.809 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.635 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.1 OUTLIER -43.77 -20.7 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.365 -0.834 . . . . 1.0 113.071 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.542 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -36.77 -43.33 0.42 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.093 -1.004 . . . . 1.0 109.357 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.928 ' CD1' HD11 ' A' ' 155' ' ' LEU . 5.5 m-85 -89.27 -27.52 20.51 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.124 -0.985 . . . . 1.0 109.543 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -72.26 -7.87 51.76 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.225 -1.39 . . . . 1.0 107.407 177.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.537 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -130.84 98.51 4.64 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 21' ' ' GLY . . . -49.81 -175.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.618 ' CD2' HD11 ' A' ' 167' ' ' ILE . 44.6 t80 -67.58 152.77 45.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -1.135 . . . . 1.0 112.056 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 164' ' ' ILE . 1.3 mp -131.57 80.38 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.846 0.831 . . . . 1.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.57 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.67 -161.23 20.92 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 106.778 -2.529 . . . . 1.0 106.778 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.4 m -125.19 143.81 50.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.84 -1.388 . . . . 1.0 109.597 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.812 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.3 mt -124.0 156.77 31.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.749 -1.219 . . . . 1.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.591 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -167.47 152.56 7.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.883 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.538 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 17.4 m-20 56.11 64.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.115 -0.991 . . . . 1.0 110.426 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.945 HG12 ' HB2' ' A' ' 45' ' ' LEU . 24.3 m -116.64 133.1 64.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.566 ' HA ' ' HG3' ' A' ' 176' ' ' GLU . 1.0 OUTLIER -148.64 155.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.425 -1.31 . . . . 1.0 110.969 -176.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.759 HG22 ' HD1' ' A' ' 43' ' ' PHE . 13.4 t -132.82 91.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 8.0 m-20 57.05 46.26 19.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.862 -1.149 . . . . 1.0 108.023 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 72.26 31.79 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.257 0.551 . . . . 1.0 110.375 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.557 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . 34.2 mt-30 -108.42 176.06 5.25 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.3 -0.875 . . . . 1.0 110.076 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 177' ' ' LEU . 6.9 pt-20 44.09 -114.66 0.38 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.365 -0.209 . . . . 1.0 110.912 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 179' ' ' LEU . 8.6 tp 78.77 -59.24 0.41 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.35 -0.844 . . . . 1.0 110.375 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 4.8 m-70 -68.98 70.63 0.21 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.085 . . . . 1.0 109.288 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.866 HD11 HG22 ' A' ' 170' ' ' VAL 0.255 3.7 mp -44.1 -61.53 1.44 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.689 0.756 . . . . 1.0 112.087 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.565 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 94.5 t -68.29 -9.7 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.233 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 11.0 mt-10 -74.61 -62.09 1.65 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.699 -1.251 . . . . 1.0 110.012 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.618 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 8.2 m-20 -83.03 -12.62 57.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.99 . . . . 1.0 109.183 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -72.74 -31.31 64.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 1.0 109.038 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER -59.94 -14.14 14.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 1.0 109.188 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -46.27 -25.79 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.311 -0.868 . . . . 1.0 109.462 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.563 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 1.5 t-20 -93.26 175.12 3.32 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 43.7 Cg_endo -84.44 -90.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 122.889 0.942 . . . . 1.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 188' ' ' THR . 2.8 t -66.78 144.49 56.28 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.334 -0.854 . . . . 1.0 110.727 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.747 ' C ' HD13 ' A' ' 190' ' ' LEU . 3.2 mt -126.89 117.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 1.0 109.689 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.922 ' H ' HD22 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -94.39 136.06 35.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 1.0 109.055 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 16' ' ' ALA . 9.7 m80 -114.72 149.16 37.26 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.089 -1.007 . . . . 1.0 110.126 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 166' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 1.0 110.051 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.551 ' HG2' ' CD1' ' A' ' 179' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 121.756 0.788 . . . . 1.0 109.507 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -113.13 153.94 27.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 1.0 111.085 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.608 HG13 HD22 ' A' ' 179' ' ' LEU . 0.8 OUTLIER -114.84 144.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 177.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -104.2 136.07 44.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.756 -1.215 . . . . 1.0 111.443 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.841 ' CE1' HD12 ' A' ' 167' ' ' ILE . 6.6 m-85 -100.72 148.16 25.21 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -113.88 1.18 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 1.0 111.102 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 108.11 -18.13 34.03 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.396 -1.882 . . . . 1.0 108.396 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 42.02 3.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.932 . . . . 1.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -112.89 127.16 56.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.0 110.943 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CG ' ' HG3' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -118.76 87.56 2.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.323 -0.86 . . . . 1.0 109.684 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.458 ' SD ' ' CE1' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -76.0 100.7 4.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.15 -0.969 . . . . 1.0 110.475 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 6.2 tt0 -79.43 90.32 5.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 4.2 m-30 -95.24 111.8 23.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.487 -0.885 . . . . 1.0 111.319 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -133.44 153.7 51.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 1.0 109.71 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.49 167.44 27.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.001 -1.062 . . . . 1.0 110.398 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.28 97.16 9.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 1.0 110.443 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.6 t . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 1.0 110.034 179.817 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.706 ' NE2' HG13 ' A' ' 110' ' ' VAL . 3.0 tm0? . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.641 0.734 . . . . 1.0 110.101 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.575 -0.703 . . . . 1.0 110.187 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 109' ' ' ARG . 52.6 p-10 -108.52 149.41 28.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.175 -0.953 . . . . 1.0 110.666 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -123.41 125.65 45.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 1.0 109.42 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 m-85 -133.21 131.6 40.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.129 -0.982 . . . . 1.0 111.05 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.751 ' C ' HD23 ' A' ' 45' ' ' LEU . 6.7 mt-10 -137.9 140.61 40.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 1.0 110.404 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.816 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 179.92 154.28 0.54 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.289 -0.882 . . . . 1.0 110.798 179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.502 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -117.49 155.7 29.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.84 HD13 HD11 ' A' ' 105' ' ' ILE . 6.5 pt -149.16 176.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 1.0 112.802 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.604 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -130.92 83.22 2.1 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.509 ' OG1' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -67.04 152.14 46.34 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.127 0.965 . . . . 1.0 112.603 -176.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.928 ' HB2' HG22 ' A' ' 164' ' ' ILE . 11.0 mm-40 -141.92 1.03 1.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.396 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.24 124.86 11.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.973 -1.08 . . . . 1.0 110.187 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.879 HG22 ' HA2' ' A' ' 76' ' ' GLY . 17.8 p -59.96 -10.9 4.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.798 . . . . 1.0 110.796 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -128.35 130.11 47.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.063 . . . . 1.0 111.211 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 160.03 137.63 2.27 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.022 HD21 HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -90.44 127.75 36.31 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.549 -1.559 . . . . 1.0 108.884 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.728 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.07 -40.04 12.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.449 -0.782 . . . . 1.0 112.2 -176.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 141' ' ' LEU . 5.7 tt -142.79 139.11 30.86 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.092 -1.63 . . . . 1.0 113.693 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.73 ' N ' HD23 ' A' ' 57' ' ' LEU . 1.1 t-105 -145.32 106.35 4.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.281 -0.887 . . . . 1.0 108.661 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.578 ' CB ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -121.65 -166.58 1.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.782 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.08 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.793 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.447 ' CE1' ' OD1' ' A' ' 83' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 122.051 0.929 . . . . 1.0 111.236 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.562 ' CD1' ' HB3' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -146.39 155.63 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.597 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.984 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -149.1 -175.79 5.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.946 -1.096 . . . . 1.0 111.033 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.994 HD12 HD13 ' A' ' 57' ' ' LEU . 61.1 mt -151.31 116.54 5.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -136.38 171.47 14.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.749 -1.219 . . . . 1.0 111.764 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.593 HG13 HD11 ' A' ' 56' ' ' ILE . 45.7 mt -114.87 130.53 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.528 -0.732 . . . . 1.0 110.586 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -140.48 143.7 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 1.0 110.131 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.497 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 50.7 m-20 60.25 13.52 3.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 1.0 111.695 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.879 ' HA2' HG22 ' A' ' 52' ' ' THR . . . 93.09 10.04 60.11 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.587 -1.292 . . . . 1.0 109.997 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.28 141.7 48.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -1.141 . . . . 1.0 109.551 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.728 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -77.14 178.62 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.859 -1.151 . . . . 1.0 108.655 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.923 ' CD ' HG22 ' A' ' 90' ' ' VAL . 1.4 pp0? -173.98 125.67 0.36 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.61 -1.307 . . . . 1.0 111.694 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.641 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.8 ttm -69.41 129.04 38.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.984 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 13.2 tmm? -132.11 109.12 9.75 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.419 -0.801 . . . . 1.0 110.466 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.765 ' CE2' HG11 ' A' ' 89' ' ' VAL . 11.5 p90 -133.95 133.1 40.98 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.914 -1.514 . . . . 1.0 112.107 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -118.47 88.14 2.86 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.567 0.699 . . . . 1.0 109.728 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.674 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -73.14 -76.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.441 -0.787 . . . . 1.0 109.111 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -71.08 -42.56 58.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.004 -2.039 . . . . 1.0 108.004 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.606 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 1.3 t 160.79 147.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.606 ' CB ' ' O ' ' A' ' 86' ' ' SER . 0.2 OUTLIER 83.92 93.76 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.58 ' HB2' ' HG2' ' A' ' 81' ' ' MET . 41.4 Cg_endo -67.53 146.44 74.05 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.492 1.785 . . . . 1.0 111.763 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.69 117.44 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -99.47 98.14 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.96 -1.088 . . . . 1.0 110.573 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.623 HD12 ' HB3' ' A' ' 80' ' ' MET . 6.0 mt -93.94 75.45 4.17 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.696 ' O ' HG21 ' A' ' 124' ' ' ILE . 6.4 mtt180 -56.77 174.95 0.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.397 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 1.065 ' OG ' HG21 ' A' ' 118' ' ' VAL . 14.5 t -92.9 160.45 14.9 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.335 0.588 . . . . 1.0 110.564 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.694 HG21 ' HB3' ' A' ' 122' ' ' ALA . 14.9 t -102.64 8.04 39.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 1.0 109.642 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.751 HG13 ' HD2' ' A' ' 96' ' ' PRO . 51.2 t -129.87 150.9 77.19 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.751 ' HD2' HG13 ' A' ' 95' ' ' VAL . 45.3 Cg_endo -69.59 135.58 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.482 1.254 . . . . 1.0 110.2 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.613 HG21 HG22 ' A' ' 78' ' ' VAL . 1.1 tp -115.77 -31.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 1.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.45 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 17.2 p-10 -69.57 60.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.034 . . . . 1.0 109.909 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 99' ' ' THR . 18.0 m -124.06 16.63 9.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.46 -0.775 . . . . 1.0 110.392 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.487 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 48.0 t-20 50.65 39.13 20.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -129.69 135.74 48.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 1.0 110.111 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.604 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 44.9 m95 -57.29 110.29 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -0.97 . . . . 1.0 110.291 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 104' ' ' HIS . 35.9 m -110.62 171.94 7.16 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.59 ' N ' HG22 ' A' ' 103' ' ' THR . 31.8 t60 -117.39 129.64 55.98 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.987 -1.071 . . . . 1.0 108.412 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.84 HD11 HD13 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -122.01 147.89 25.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.318 -0.864 . . . . 1.0 108.823 -179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.819 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.0 OUTLIER -152.5 173.16 15.49 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.404 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -165.37 116.9 1.12 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.69 -1.256 . . . . 1.0 111.323 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 25.9 p90 -119.41 109.82 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.548 ' HG2' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -106.55 164.4 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 1.0 111.309 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.706 HG13 ' NE2' ' A' ' 39' ' ' GLN . 12.8 t -145.15 113.96 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 19.8 mt-30 58.46 -129.95 1.33 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.246 -0.909 . . . . 1.0 110.462 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -85.19 -1.22 56.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.96 -1.088 . . . . 1.0 110.22 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 7.6 tt0 -107.26 120.77 43.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.436 -0.79 . . . . 1.0 110.226 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -119.66 157.43 15.51 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 119.971 -1.109 . . . . 1.0 111.465 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 1.058 ' OG ' HG22 ' A' ' 125' ' ' THR . 2.8 t -133.26 150.93 51.91 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.192 -1.181 . . . . 1.0 110.836 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.125 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.3 tm? -113.83 154.11 28.01 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.123 -0.986 . . . . 1.0 109.434 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 1.125 ' N ' HD13 ' A' ' 116' ' ' LEU 0.26 0.1 OUTLIER -130.03 87.21 2.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.543 -0.723 . . . . 1.0 112.725 -178.495 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 1.065 HG21 ' OG ' ' A' ' 93' ' ' SER . 24.6 t -80.56 82.71 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.729 -1.212 . . . . 1.0 107.729 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 66.52 60.87 5.81 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 120' ' ' ASN . 12.8 p30 38.8 25.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.569 -0.96 . . . . 1.0 111.694 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 121' ' ' GLU . 1.3 pm0 -86.01 -174.77 5.26 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.355 -0.84 . . . . 1.0 109.236 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.694 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -46.62 104.66 0.42 Allowed Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.336 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.422 ' N ' ' O ' ' A' ' 121' ' ' GLU . 40.5 Cg_endo -65.13 130.24 25.12 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.971 1.511 . . . . 1.0 110.559 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.696 HG21 ' O ' ' A' ' 92' ' ' ARG . 3.8 mp -91.03 109.32 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.557 -0.857 . . . . 1.0 108.984 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 1.058 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.8 p -107.52 169.35 8.63 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.246 1.022 . . . . 1.0 111.291 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.444 ' N ' ' CD2' ' A' ' 91' ' ' LEU . . . 169.33 161.25 19.33 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 106.723 -2.551 . . . . 1.0 106.723 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 112' ' ' ARG . 0.7 OUTLIER -133.18 168.99 17.53 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.65 -1.5 . . . . 1.0 110.379 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -113.3 177.45 1.18 Allowed Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.742 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.2 Cg_endo -66.77 91.84 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.944 1.497 . . . . 1.0 108.851 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 131' ' ' GLY . 1.1 pp -47.64 -178.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.511 -0.743 . . . . 1.0 110.531 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.517 ' N ' HD12 ' A' ' 130' ' ' LEU . . . 161.08 -56.18 0.31 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.034 -1.626 . . . . 1.0 109.034 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -107.99 102.91 12.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 1.0 109.663 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 t -86.1 37.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 1.0 110.413 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -136.87 63.79 1.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 1.0 109.929 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -98.24 131.08 44.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 1.0 110.412 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.634 ' N ' HD13 ' A' ' 135' ' ' LEU . 1.0 OUTLIER -124.42 175.4 7.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 1.0 110.127 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 140.7 44.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 1.0 110.21 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.683 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 24.0 p-10 -88.53 35.66 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 1.0 110.519 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 42.63 25.44 0.31 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.683 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -116.35 166.5 11.99 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.075 -1.25 . . . . 1.0 109.301 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 1.001 HD11 HD21 ' A' ' 57' ' ' LEU . 10.6 tp -160.63 152.79 20.26 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.972 -1.091 . . . . 1.0 111.409 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.649 ' HB3' ' HE3' ' A' ' 146' ' ' MET . 25.2 m95 -133.96 126.05 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.621 -1.622 . . . . 1.0 106.621 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -143.05 135.81 27.74 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 117.899 -1.52 . . . . 1.0 113.725 -176.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 104.38 24.99 7.21 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.212 -1.955 . . . . 1.0 108.212 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.714 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 109.48 -153.35 16.93 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 106.663 -2.575 . . . . 1.0 106.663 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.936 ' HB2' HD12 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -170.75 174.0 5.1 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.159 -1.416 . . . . 1.0 111.958 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.56 ' HG3' ' CG ' ' A' ' 24' ' ' TYR . 37.6 mt-10 -96.05 -9.1 31.73 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -152.48 27.0 0.58 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.535 -0.728 . . . . 1.0 110.596 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.022 HD13 HD21 ' A' ' 55' ' ' LEU . 3.2 mt -70.54 61.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.597 -1.241 . . . . 1.0 109.293 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 148' ' ' ARG . 2.3 p -79.0 65.98 4.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.309 -2.108 . . . . 1.0 105.309 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.781 HG13 ' H ' ' A' ' 152' ' ' ALA . 1.2 p -149.58 -77.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.13 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.909 ' HB2' ' CB ' ' A' ' 159' ' ' TYR . . . 45.54 30.95 0.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.046 -1.033 . . . . 1.0 108.962 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 155' ' ' LEU . 1.0 OUTLIER 34.34 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.249 0.547 . . . . 1.0 110.781 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -148.51 10.75 0.86 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 1.0 111.198 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.3 OUTLIER -76.42 179.33 1.55 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 1.0 110.727 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 155' ' ' LEU . 48.2 Cg_endo -73.13 -161.39 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.301 1.685 . . . . 1.0 112.974 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -51.44 -9.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.654 -0.653 . . . . 1.0 112.417 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.951 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -34.75 -42.96 0.16 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.035 -1.041 . . . . 1.0 110.028 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.909 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . 6.6 m-85 -82.56 -33.39 28.11 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.317 -1.353 . . . . 1.0 109.916 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.6 OUTLIER -67.09 -11.51 57.36 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.876 -1.13 . . . . 1.0 108.406 178.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 161' ' ' THR . 1.8 m -129.27 96.48 4.32 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -48.29 178.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.696 ' CD2' HD11 ' A' ' 167' ' ' ILE . 23.0 t80 -68.64 145.24 54.08 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.342 . . . . 1.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.928 HG22 ' HB2' ' A' ' 50' ' ' GLU . 2.6 mt -123.1 86.43 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.31 -1.367 . . . . 1.0 107.31 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.621 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.97 -157.5 14.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 80.0 m -130.72 143.82 51.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -1.125 . . . . 1.0 109.748 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.841 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.2 mt -128.82 157.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.299 -0.876 . . . . 1.0 110.644 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 2.8 ttt85 -164.24 144.71 8.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.202 -0.937 . . . . 1.0 109.894 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 68.8 m-20 58.44 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.479 -0.763 . . . . 1.0 110.066 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.816 HG12 ' HB2' ' A' ' 45' ' ' LEU 0.251 26.8 m -132.92 135.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 119.989 -0.685 . . . . 1.0 109.257 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.515 HG22 ' N ' ' A' ' 175' ' ' GLN . 0.1 OUTLIER -141.63 152.18 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.741 -1.184 . . . . 1.0 111.679 -177.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.496 HG22 ' HD1' ' A' ' 43' ' ' PHE . 92.0 t -134.11 113.8 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.9 OUTLIER 56.49 38.01 29.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 1.0 108.104 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 73.28 30.06 1.6 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.276 0.56 . . . . 1.0 110.835 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.515 ' N ' HG22 ' A' ' 171' ' ' ILE . 4.1 mm-40 -98.01 110.91 23.4 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.249 -0.907 . . . . 1.0 109.967 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.7 102.17 10.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 1.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.587 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 4.1 mm? -86.26 92.76 8.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.817 -1.177 . . . . 1.0 110.987 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 0.4 OUTLIER -40.64 113.37 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.045 0.926 . . . . 1.0 110.166 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.813 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 10.9 mt -40.49 -56.53 2.03 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.847 0.832 . . . . 1.0 112.655 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 51.3 t -84.82 -22.25 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 2.3 mt-10 -62.07 -55.99 23.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.137 -1.602 . . . . 1.0 110.315 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.612 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -84.63 -19.47 32.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.356 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.813 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -64.28 -36.7 84.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.926 -1.109 . . . . 1.0 109.629 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 5.2 mt -50.05 -21.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.177 -0.952 . . . . 1.0 109.345 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 2.7 t-20 -54.99 -20.77 9.91 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.882 0.849 . . . . 1.0 108.876 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.476 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 4.3 t30 -95.83 152.36 39.0 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 40.6 Cg_endo -66.3 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.371 1.195 . . . . 1.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.716 ' O ' HD13 ' A' ' 189' ' ' ILE . 12.4 m -68.74 135.97 52.1 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.234 -0.916 . . . . 1.0 110.452 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 188' ' ' THR . 25.3 mm -122.92 127.46 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 1.0 109.805 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.462 ' O ' HG23 ' A' ' 17' ' ' ILE . 7.7 mt -121.34 173.18 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 1.0 110.394 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 2.5 m-70 -107.54 -84.3 0.53 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.144 -0.973 . . . . 1.0 111.185 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.293 -1.854 0 O-C-N 121.157 -0.964 . . . . 1.0 110.671 179.861 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.546 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.1 tt0 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.48 0.657 . . . . 1.0 109.685 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -95.62 155.16 16.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.347 -0.941 . . . . 1.0 110.289 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.906 HG21 ' HE1' ' A' ' 25' ' ' MET . 13.4 mm -135.66 122.82 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 1.0 110.576 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.25 132.49 34.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.875 . . . . 1.0 109.896 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.9 ' CE1' HD12 ' A' ' 167' ' ' ILE . 9.6 m-85 -102.47 172.67 6.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.216 . . . . 1.0 110.25 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.512 ' O ' HG12 ' A' ' 164' ' ' ILE . 0.5 OUTLIER -134.38 1.9 3.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 1.0 110.802 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.18 -26.22 25.03 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 8.1 ttt180 -104.45 10.8 35.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.912 -1.346 . . . . 1.0 109.364 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.691 HG21 ' HD2' ' A' ' 19' ' ' PHE . 6.3 t -55.22 175.53 0.07 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.676 0.75 . . . . 1.0 110.741 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.633 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -171.57 73.42 0.05 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.906 ' HE1' HG21 ' A' ' 17' ' ' ILE . 2.3 mmt -85.79 99.72 11.55 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.861 -1.149 . . . . 1.0 109.539 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -91.39 134.81 34.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 182' ' ' ASP . 48.9 m-85 -121.25 149.03 43.48 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.982 -1.074 . . . . 1.0 110.72 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -149.8 97.93 2.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.811 . . . . 1.0 110.186 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -139.31 174.99 9.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 1.0 110.084 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.06 148.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 1.0 110.033 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 31' ' ' VAL . 7.4 p . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 1.0 110.323 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 111' ' ' GLN . 3.9 pt20 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.244 0.545 . . . . 1.0 110.074 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.44 122.53 13.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 1.0 110.209 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.564 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.3 OUTLIER -124.58 117.08 23.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.475 -0.766 . . . . 1.0 110.279 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.515 ' O ' HG23 ' A' ' 172' ' ' VAL . 0.6 OUTLIER -84.67 142.22 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 1.0 109.463 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CE1' HG21 ' A' ' 172' ' ' VAL . 41.8 m-85 -130.81 120.98 24.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.133 -0.98 . . . . 1.0 111.151 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.729 ' C ' HD23 ' A' ' 45' ' ' LEU . 39.7 mt-10 -128.6 142.8 50.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 1.0 110.521 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.932 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.1 pt? -179.69 149.72 0.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.38 -0.825 . . . . 1.0 110.397 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 167' ' ' ILE . 49.7 m -121.24 149.36 42.98 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.598 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.551 HD11 HG13 ' A' ' 97' ' ' ILE . 1.7 pt -126.49 179.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.379 -0.928 . . . . 1.0 109.168 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.632 ' O ' ' OG1' ' A' ' 49' ' ' THR . 5.9 tttt -167.74 82.6 0.2 Allowed 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.674 -1.21 . . . . 1.0 110.641 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 1.069 HG22 ' HG2' ' A' ' 50' ' ' GLU . 90.2 m -171.97 -108.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.81 -0.556 . . . . 1.0 111.313 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.069 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.5 OUTLIER -122.18 -46.09 2.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.594 1.188 . . . . 1.0 109.626 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.883 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . 39.44 22.75 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.841 -1.072 . . . . 1.0 111.656 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.611 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 60.4 p -70.79 -18.22 62.76 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.409 -1.432 . . . . 1.0 108.796 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -159.6 118.68 2.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.093 -0.643 . . . . 1.0 109.727 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 155.21 136.74 2.25 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.194 -1.479 . . . . 1.0 109.541 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.92 HD13 ' CZ ' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -85.61 128.17 34.69 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.628 -1.229 . . . . 1.0 109.246 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.87 HD11 ' CG1' ' A' ' 78' ' ' VAL . 1.0 OUTLIER -90.49 -34.09 6.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.502 -0.749 . . . . 1.0 111.602 -177.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.094 HD13 HD12 ' A' ' 71' ' ' LEU . 5.7 tt -146.18 143.4 29.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.536 -1.353 . . . . 1.0 113.079 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.997 ' CZ2' HG21 ' A' ' 151' ' ' VAL . 31.0 t-105 -152.09 105.69 3.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 p -110.29 123.17 49.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 1.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 138' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.586 ' CZ ' ' HB ' ' A' ' 137' ' ' THR . 1.8 t80 . . . . . 0 N--CA 1.511 2.577 0 N-CA-C 111.857 0.317 . . . . 1.0 111.857 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 70' ' ' ALA . 5.6 mt -151.13 171.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.648 -1.282 . . . . 1.0 112.838 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.56 ' N ' ' CG2' ' A' ' 69' ' ' ILE . . . -177.18 167.12 2.4 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.094 HD12 HD13 ' A' ' 57' ' ' LEU . 90.4 mt -145.95 103.37 3.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.721 -1.237 . . . . 1.0 108.439 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -123.46 167.76 13.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 1.0 112.058 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.977 HG12 HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.5 132.53 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.739 0.78 . . . . 1.0 111.131 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.87 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.0 p -141.17 140.65 31.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.6 -0.687 . . . . 1.0 110.968 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.87 ' CG ' HG22 ' A' ' 74' ' ' VAL . 5.7 m-20 67.96 22.49 8.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.481 -0.762 . . . . 1.0 111.47 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.845 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 86.84 4.74 82.06 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.06 -1.543 . . . . 1.0 109.76 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 75' ' ' ASP . 87.2 m-85 -130.94 150.24 52.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.95 -1.324 . . . . 1.0 110.569 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.977 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.01 177.6 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.148 -0.97 . . . . 1.0 110.535 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 7.8 pt20 -167.49 123.81 1.12 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.254 -0.904 . . . . 1.0 110.89 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.87 ' HE1' HD23 ' A' ' 91' ' ' LEU . 6.0 tmm? -83.69 115.95 22.42 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 10.1 ptt? -119.79 149.15 42.51 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.905 -1.122 . . . . 1.0 111.143 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.777 ' CE2' HG11 ' A' ' 89' ' ' VAL . 24.7 p90 -158.03 132.81 8.45 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.194 -1.002 . . . . 1.0 110.951 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.667 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -121.02 75.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 1.0 110.329 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.676 HD12 ' CB ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -79.11 -5.86 55.11 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.68 -0.637 . . . . 1.0 110.379 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -121.5 -65.83 0.24 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.057 -1.217 . . . . 1.0 110.057 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.33 -33.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.053 -1.263 . . . . 1.0 111.243 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HD3' ' HD3' ' A' ' 129' ' ' PRO . 9.0 ptmt -124.58 138.06 30.48 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.944 -1.097 . . . . 1.0 110.959 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.536 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 49.8 Cg_endo -76.23 121.82 6.31 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 124.15 1.605 . . . . 1.0 111.414 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.777 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -77.4 168.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 178.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 90' ' ' VAL . 10.6 p -147.69 85.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.751 -1.218 . . . . 1.0 111.667 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.87 HD23 ' HE1' ' A' ' 80' ' ' MET . 0.7 OUTLIER -77.34 75.31 3.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.881 -1.137 . . . . 1.0 108.398 178.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 90' ' ' VAL . 34.8 mtp180 -58.47 178.82 0.09 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.955 0.884 . . . . 1.0 110.837 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.612 ' OG ' HG21 ' A' ' 118' ' ' VAL . 11.5 t -109.64 149.31 29.89 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.916 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.75 29.91 6.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -0.999 . . . . 1.0 109.908 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.726 HG13 ' HD2' ' A' ' 96' ' ' PRO . 74.2 t -133.74 150.27 74.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.514 -0.741 . . . . 1.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.726 ' HD2' HG13 ' A' ' 95' ' ' VAL . 42.1 Cg_endo -66.93 120.35 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.569 1.299 . . . . 1.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.845 HG22 ' O ' ' A' ' 76' ' ' GLY . 4.1 tp -104.89 -11.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 1.0 110.344 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.602 ' HB3' HG22 ' A' ' 52' ' ' THR . 8.5 p-10 -87.96 55.69 3.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 1.0 109.679 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 99' ' ' THR . 68.8 m -112.38 8.29 19.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.311 -0.868 . . . . 1.0 110.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.559 ' HA ' ' N ' ' A' ' 49' ' ' THR . 79.2 m-20 54.62 16.86 1.48 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 1.0 110.436 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -113.41 150.13 33.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.881 . . . . 1.0 109.984 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.62 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 4.3 m95 -60.75 89.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.013 -1.054 . . . . 1.0 110.687 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.676 HG21 HD12 ' A' ' 97' ' ' ILE . 23.3 m -87.56 150.57 23.62 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 119' ' ' GLY . 78.8 t60 -108.71 135.34 50.1 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.989 -1.085 . . . . 1.0 108.73 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 105' ' ' ILE . 0.5 OUTLIER -132.51 156.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.174 -0.954 . . . . 1.0 109.457 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.922 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -152.23 167.41 28.68 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.731 -1.188 . . . . 1.0 110.125 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -152.16 109.7 3.61 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.255 -0.978 . . . . 1.0 111.251 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 18.4 m-30 -83.58 102.28 12.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 1.0 108.802 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -92.99 127.37 38.48 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.96 -1.087 . . . . 1.0 109.728 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 111' ' ' GLN . 3.3 t -132.62 157.57 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 1.0 110.269 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -40.14 111.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.0 110.497 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.626 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 51.98 65.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 1.0 110.377 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.626 ' CB ' ' O ' ' A' ' 112' ' ' ARG . 2.2 tt0 156.85 113.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.632 0.73 . . . . 1.0 109.986 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 82' ' ' TYR . . . -120.86 166.15 13.96 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.199 -1.0 . . . . 1.0 110.618 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.607 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -144.51 166.7 24.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.491 -1.006 . . . . 1.0 110.315 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 117' ' ' GLN 0.252 1.1 tm? -145.47 151.92 38.96 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.151 -0.968 . . . . 1.0 109.312 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.992 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -153.89 107.95 3.02 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.813 -1.155 . . . . 1.0 111.788 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.612 HG21 ' OG ' ' A' ' 93' ' ' SER . 2.0 t -72.41 104.92 2.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.73 35.58 91.17 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.207 . . . . 1.0 110.084 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER 60.95 39.47 16.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.093 -1.239 . . . . 1.0 110.97 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -102.4 -167.84 1.45 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.522 -0.736 . . . . 1.0 110.733 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.572 ' N ' ' HG2' ' A' ' 121' ' ' GLU . . . -35.0 112.23 0.44 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 1.0 109.579 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.533 ' HB3' ' OE1' ' A' ' 117' ' ' GLN . 45.8 Cg_endo -72.95 118.14 5.43 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.133 1.596 . . . . 1.0 112.834 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.733 HD12 ' H ' ' A' ' 124' ' ' ILE . 5.4 mp -85.8 110.85 20.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 106.313 -1.736 . . . . 1.0 106.313 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 30.9 p -119.65 174.38 6.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.507 1.146 . . . . 1.0 112.756 -176.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.584 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 169.69 169.47 32.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 106.622 -2.591 . . . . 1.0 106.622 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -146.53 163.95 34.12 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.511 -1.582 . . . . 1.0 111.11 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.429 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -83.98 173.54 7.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.663 -0.648 . . . . 1.0 110.494 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -69.7 57.55 1.46 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 1.0 110.113 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.2 pp 10.22 57.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -132.68 73.35 0.46 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.676 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -159.94 -71.41 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -1.136 . . . . 1.0 110.493 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.8 OUTLIER 62.85 129.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -0.99 . . . . 1.0 109.887 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.17 75.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 1.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 68' ' ' TYR . 1.3 tm? -88.86 108.42 19.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 1.0 109.719 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.408 ' N ' HD22 ' A' ' 135' ' ' LEU . 60.9 m-20 -67.74 148.79 50.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 1.0 110.724 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -138.4 141.45 39.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 1.0 109.787 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.674 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 40.4 p-10 -84.16 22.1 1.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.194 -0.941 . . . . 1.0 111.075 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 45.51 22.41 0.65 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.405 -1.478 . . . . 1.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.674 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -104.92 162.57 13.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.109 -1.23 . . . . 1.0 109.252 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.723 HD11 ' HG ' ' A' ' 57' ' ' LEU . 6.7 tp -159.53 144.78 15.63 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.99 -1.069 . . . . 1.0 110.821 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.671 ' HB3' ' HE3' ' A' ' 146' ' ' MET . 13.1 m95 -125.99 141.88 51.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.768 HD21 HG22 ' A' ' 56' ' ' ILE . 1.5 tt -148.0 128.47 14.02 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 116.908 -1.917 . . . . 1.0 113.375 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 23' ' ' THR . . . 113.54 -5.32 24.66 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 146.69 -140.87 9.0 Favored Glycine 0 C--N 1.289 -2.039 0 C-N-CA 118.945 -1.598 . . . . 1.0 109.755 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 1.003 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -171.43 141.18 1.5 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.091 -1.043 . . . . 1.0 111.939 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.01 -16.08 55.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.783 0.801 . . . . 1.0 109.079 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HD2' ' SD ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -137.0 45.84 2.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.497 -1.298 . . . . 1.0 107.497 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' A' ' 146' ' ' MET . 11.5 tp -65.32 56.83 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.753 0.787 . . . . 1.0 112.146 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 148' ' ' ARG . 56.9 p -84.88 1.7 45.9 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.509 -1.663 . . . . 1.0 106.509 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.997 HG21 ' CZ2' ' A' ' 58' ' ' TRP . 3.3 p -85.47 -104.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.614 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.886 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . 52.64 45.52 28.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.476 -1.39 . . . . 1.0 108.936 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.525 ' C ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -18.03 -77.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.536 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 9.5 ptmt -97.95 -43.65 7.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.985 . . . . 1.0 111.874 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 1.118 HD21 ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -81.07 113.41 40.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 O-C-N 121.324 -0.86 . . . . 1.0 110.231 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -88.39 -68.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.58 1.305 . . . . 1.0 111.594 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.61 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 1.8 tttm -54.86 -50.67 68.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 1.0 111.944 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.671 ' CB ' HD12 ' A' ' 155' ' ' LEU . . . -43.72 -42.76 5.59 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 1.118 ' CE1' HD21 ' A' ' 155' ' ' LEU . 3.2 m-85 -78.42 -32.2 48.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -68.93 -12.35 61.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.753 -0.779 . . . . 1.0 109.926 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -128.65 81.9 2.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -41.31 158.35 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' A' ' 167' ' ' ILE . 62.9 t80 -71.57 137.08 47.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.959 -1.318 . . . . 1.0 110.5 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.756 ' O ' HG21 ' A' ' 49' ' ' THR . 4.4 mt -118.72 75.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.733 ' HA2' HG21 ' A' ' 49' ' ' THR . . . -159.11 -160.21 10.23 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.515 ' N ' ' OG1' ' A' ' 49' ' ' THR . 20.0 m -118.61 147.48 43.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -1.175 . . . . 1.0 111.445 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.9 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -134.95 157.22 40.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.694 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.524 ' NH2' ' OD1' ' A' ' 169' ' ' ASP . 22.1 ttt-85 -165.52 157.85 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.818 -1.176 . . . . 1.0 111.262 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.551 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 20.0 m-20 51.25 78.61 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.9 . . . . 1.0 110.451 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.932 HG12 ' CB ' ' A' ' 45' ' ' LEU . 16.8 m -124.81 129.55 73.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.363 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.436 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -148.13 148.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.269 -0.972 . . . . 1.0 110.947 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.692 HG21 ' CE1' ' A' ' 43' ' ' PHE . 14.9 p -135.7 123.56 36.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 23.2 m-20 49.95 30.92 4.3 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.409 -1.432 . . . . 1.0 107.86 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 68.09 28.76 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.186 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.678 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.8 OUTLIER -109.66 -170.06 1.59 Allowed 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.262 -0.899 . . . . 1.0 109.34 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.593 ' HB3' ' O ' ' A' ' 175' ' ' GLN . 36.6 tp10 76.59 -106.22 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.601 -0.687 . . . . 1.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.927 ' O ' HD12 ' A' ' 179' ' ' LEU . 3.6 mp 63.37 -94.91 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.185 -0.947 . . . . 1.0 112.515 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 7.3 m-70 -56.64 90.02 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.937 -1.102 . . . . 1.0 111.438 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.927 HD12 ' O ' ' A' ' 177' ' ' LEU 0.272 3.5 mp -63.57 -58.78 5.87 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.214 1.006 . . . . 1.0 110.868 178.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 184' ' ' LEU . 2.1 t -61.44 -16.45 14.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.933 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 3.4 mt-10 -72.3 -45.27 60.76 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.386 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.616 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 1.6 m-20 -101.8 -15.52 16.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.257 -0.902 . . . . 1.0 109.277 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -78.2 -37.51 45.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.326 -0.859 . . . . 1.0 109.299 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 180' ' ' VAL . 11.4 mt -55.74 -16.29 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 1.0 109.877 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 184' ' ' LEU . 9.8 t-20 -42.98 -27.01 0.16 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.824 0.821 . . . . 1.0 109.271 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 184' ' ' LEU . 2.3 t30 -134.74 143.17 45.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 188' ' ' THR . 46.1 Cg_endo -71.0 -158.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.632 1.333 . . . . 1.0 110.98 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 188' ' ' THR . 0.4 OUTLIER 64.09 22.91 13.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.603 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 1.001 ' C ' HD13 ' A' ' 190' ' ' LEU . 0.9 OUTLIER -92.78 112.6 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.272 -0.893 . . . . 1.0 110.781 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 1.001 HD13 ' C ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -109.48 149.56 29.41 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.13 -0.981 . . . . 1.0 109.201 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.6 ' CE1' ' CD1' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -99.63 101.63 12.89 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.97 -1.081 . . . . 1.0 109.835 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' HIS . 9.0 t . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 1.0 110.476 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.457 0.646 . . . . 1.0 110.047 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' ' CG ' ' A' ' 191' ' ' HIS . . . -110.47 160.93 16.17 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.291 -0.88 . . . . 1.0 110.453 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.69 HG21 ' CE ' ' A' ' 25' ' ' MET . 6.4 mm -127.27 125.71 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 1.0 109.222 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -92.55 138.57 31.39 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.415 -0.803 . . . . 1.0 110.964 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.903 ' CE1' HD12 ' A' ' 167' ' ' ILE . 12.2 m-85 -101.27 169.05 9.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.568 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.82 -7.56 5.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.967 . . . . 1.0 110.634 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.35 37.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -129.24 -13.15 4.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.05 -1.265 . . . . 1.0 110.737 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.861 HG23 ' ND2' ' A' ' 186' ' ' ASN . 2.3 m -69.53 130.47 42.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.211 -0.931 . . . . 1.0 110.507 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -116.09 118.02 31.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.358 -0.838 . . . . 1.0 109.487 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.69 ' CE ' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -91.55 101.3 13.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.641 -1.287 . . . . 1.0 110.096 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.602 ' OE1' ' CZ2' ' A' ' 142' ' ' TRP . 5.4 tp10 -79.99 97.03 6.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.852 -0.795 . . . . 1.0 108.852 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 25' ' ' MET . 19.0 m-85 -95.37 97.57 9.93 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.103 -1.039 . . . . 1.0 111.362 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.82 123.72 41.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 1.0 108.849 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -133.3 157.33 45.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.852 -1.155 . . . . 1.0 111.225 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' VAL . . . -105.94 101.8 11.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.662 -0.649 . . . . 1.0 109.553 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.942 HG21 ' OD2' ' A' ' 138' ' ' ASP . 2.8 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 1.0 109.988 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 35.7 tt0 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.3 0.571 . . . . 1.0 110.658 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB2' HG22 ' A' ' 110' ' ' VAL . 1.2 p -167.29 155.13 9.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.049 -1.032 . . . . 1.0 110.635 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.595 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -128.17 148.68 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 1.0 110.077 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 13.8 m-70 -114.47 126.59 55.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 1.0 109.641 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.695 ' CZ ' HD11 ' A' ' 69' ' ' ILE . 73.9 m-85 -120.21 122.47 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -0.987 . . . . 1.0 111.137 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.766 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -128.3 134.96 49.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.032 . . . . 1.0 110.576 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.894 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.1 pt? -175.18 156.59 2.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.956 -1.09 . . . . 1.0 111.293 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.406 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -119.68 155.18 32.88 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.608 HG23 ' CD1' ' A' ' 105' ' ' ILE . 6.9 pt -146.35 169.6 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 118.665 -1.214 . . . . 1.0 112.286 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.626 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -129.01 92.57 3.42 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 178.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.932 ' CG2' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -73.21 157.6 36.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 1.0 112.286 -177.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.885 ' HB2' HG22 ' A' ' 164' ' ' ILE . 6.8 mm-40 -148.9 12.65 0.87 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.043 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -151.07 8.32 0.54 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.454 -1.404 . . . . 1.0 112.223 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.876 HG22 ' CA ' ' A' ' 76' ' ' GLY . 0.7 OUTLIER 50.98 11.03 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.969 -1.082 . . . . 1.0 111.823 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.8 tt0 -158.76 137.92 11.43 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.902 -1.124 . . . . 1.0 110.163 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 148.35 139.35 3.16 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.982 ' CD2' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -87.07 126.21 34.62 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.021 -1.282 . . . . 1.0 108.693 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.968 HD11 ' CG1' ' A' ' 73' ' ' ILE . 3.4 mp -92.49 -32.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 1.0 111.708 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.021 HD13 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -144.15 148.17 34.68 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.802 -1.186 . . . . 1.0 113.017 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.816 ' CZ2' HG21 ' A' ' 151' ' ' VAL . 21.3 t-105 -156.23 111.82 2.97 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.576 ' CB ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -114.77 128.5 56.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.829 -1.17 . . . . 1.0 111.511 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.446 0 N-CA-C 108.286 -1.926 . . . . 1.0 108.286 178.877 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.567 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 2.7 m-85 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.868 0.366 . . . . 1.0 110.603 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.695 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 2.5 tt -110.67 110.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.006 -1.059 . . . . 1.0 110.19 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.598 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -133.67 176.52 8.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.132 -0.98 . . . . 1.0 110.476 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.021 HD12 HD13 ' A' ' 57' ' ' LEU . 42.4 mt -147.88 113.09 5.54 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.966 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -131.8 164.25 26.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.95 -1.094 . . . . 1.0 111.855 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.968 ' CG1' HD11 ' A' ' 56' ' ' ILE . 7.0 mt -108.64 136.46 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.849 . . . . 1.0 110.669 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.74 HG22 ' CG ' ' A' ' 75' ' ' ASP . 4.2 p -141.67 120.6 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.81 . . . . 1.0 111.28 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.74 ' CG ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER 70.57 14.08 7.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 1.0 110.938 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.95 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 99.05 7.68 54.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.789 -1.324 . . . . 1.0 109.789 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.22 146.44 49.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -1.225 . . . . 1.0 109.385 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.821 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -93.38 162.58 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 1.0 109.589 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.522 ' CB ' ' HA ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -159.17 139.41 12.13 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.212 -0.93 . . . . 1.0 110.152 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.719 ' CB ' HD23 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -107.61 115.86 30.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.349 -0.941 . . . . 1.0 110.253 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.598 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 3.0 ptp -89.39 133.79 34.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.582 -1.323 . . . . 1.0 110.128 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.616 ' OH ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -126.92 128.93 47.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 1.0 110.688 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.567 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.5 t0 -146.53 66.21 1.18 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.287 1.041 . . . . 1.0 109.466 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.766 ' HB3' HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -66.87 -3.68 7.51 Favored 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.563 -0.71 . . . . 1.0 111.074 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -137.98 -55.43 0.05 OUTLIER Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.554 -1.308 . . . . 1.0 110.62 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.49 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -176.01 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.213 -1.169 . . . . 1.0 110.678 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 15.8 mmtp -98.48 110.87 58.44 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.009 -1.057 . . . . 1.0 109.795 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 82' ' ' TYR . 43.1 Cg_endo -71.93 159.9 49.13 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.86 1.453 . . . . 1.0 110.712 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.543 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -137.02 116.98 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 90' ' ' VAL . 1.8 p -95.99 112.44 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.404 -1.435 . . . . 1.0 110.974 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.738 ' C ' HG21 ' A' ' 124' ' ' ILE . 4.6 mt -105.69 71.56 0.92 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.536 ' O ' HG21 ' A' ' 124' ' ' ILE . 3.4 mtp180 -60.07 178.14 0.2 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.99 0.9 . . . . 1.0 110.909 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.524 ' OG ' HG21 ' A' ' 118' ' ' VAL . 7.9 t -100.11 161.35 13.66 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.648 -0.658 . . . . 1.0 110.656 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.581 HG23 ' CD1' ' A' ' 124' ' ' ILE . 0.8 OUTLIER -118.71 25.75 10.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 1.0 109.485 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.004 ' HB ' HG11 ' A' ' 118' ' ' VAL . 2.2 t -137.53 147.34 57.19 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.708 -0.62 . . . . 1.0 109.617 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.449 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.2 Cg_endo -65.91 137.12 47.77 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.806 1.424 . . . . 1.0 110.783 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.95 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -128.94 -22.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 1.0 111.197 -179.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.48 ' CB ' HG23 ' A' ' 52' ' ' THR . 6.7 p30 -74.2 54.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.982 . . . . 1.0 111.317 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.783 HG23 ' HB2' ' A' ' 101' ' ' HIS . 14.2 t -128.87 30.77 5.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.263 -0.898 . . . . 1.0 108.906 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.461 ' CG ' ' O ' ' A' ' 99' ' ' THR . 5.9 p-10 40.49 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.948 -0.47 . . . . 1.0 111.578 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.783 ' HB2' HG23 ' A' ' 99' ' ' THR . 0.3 OUTLIER -102.02 160.03 14.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.0 -1.062 . . . . 1.0 109.049 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.626 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 20.0 m95 -81.11 102.34 10.19 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.037 -1.039 . . . . 1.0 109.838 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 104' ' ' HIS . 18.2 m -93.8 173.79 7.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 1.0 109.246 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.611 ' N ' HG22 ' A' ' 103' ' ' THR . 3.2 t60 -121.81 125.57 46.8 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.316 -1.364 . . . . 1.0 107.316 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.608 ' CD1' HG23 ' A' ' 47' ' ' ILE . 1.5 mp -124.25 147.67 28.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.759 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -152.94 179.42 8.7 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.27 -1.372 . . . . 1.0 109.38 -178.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -164.4 145.98 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.834 -1.166 . . . . 1.0 111.811 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 4.7 m-85 -136.54 104.8 5.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.448 -0.782 . . . . 1.0 109.576 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.593 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -95.63 131.28 42.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.978 . . . . 1.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.551 ' N ' ' HD3' ' A' ' 109' ' ' ARG . 85.8 t -137.53 104.22 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.365 -0.835 . . . . 1.0 110.687 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.475 ' O ' ' CB ' ' A' ' 112' ' ' ARG . 16.4 mt-30 40.83 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.591 -0.693 . . . . 1.0 112.206 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.1 OUTLIER 71.59 -50.61 0.69 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 1.0 112.734 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 6.3 tt0 -85.04 122.03 28.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.691 -1.256 . . . . 1.0 111.511 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.35 166.7 12.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.546 ' O ' ' CE ' ' A' ' 80' ' ' MET . 42.1 t -145.0 151.83 39.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.288 -1.125 . . . . 1.0 111.075 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.078 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -111.77 147.25 36.07 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 1.078 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -127.45 91.65 3.35 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.778 -1.169 . . . . 1.0 112.591 -177.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 1.004 HG11 ' HB ' ' A' ' 95' ' ' VAL . 70.4 t -78.93 87.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.748 -1.204 . . . . 1.0 107.748 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 56.88 58.28 15.33 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.802 -1.19 . . . . 1.0 110.348 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' A' ' 117' ' ' GLN . 3.6 t-20 41.4 24.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.433 -1.039 . . . . 1.0 112.237 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 1.1 mt-10 -97.83 -166.7 1.41 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.748 -1.22 . . . . 1.0 109.304 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.7 96.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.87 0 C-N-CA 120.0 -0.68 . . . . 1.0 109.587 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.529 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.8 Cg_endo -74.93 130.43 13.34 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.091 1.574 . . . . 1.0 110.871 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.746 HG22 ' HB3' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -86.05 144.5 9.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 O-C-N 121.153 -0.967 . . . . 1.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.61 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 4.6 p -138.83 158.13 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.524 -1.36 . . . . 1.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.734 ' N ' HD21 ' A' ' 91' ' ' LEU . . . -166.21 165.47 38.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.209 -2.356 . . . . 1.0 107.209 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -152.91 151.2 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.594 -1.533 . . . . 1.0 111.79 -179.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.1 p -106.02 173.96 2.89 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.746 -0.596 . . . . 1.0 109.911 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 131' ' ' GLY . 45.2 Cg_endo -70.65 67.77 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.915 1.482 . . . . 1.0 110.18 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.0 OUTLIER -4.04 70.28 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 121.581 0.705 . . . . 1.0 112.798 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -84.68 -71.17 1.32 Allowed Glycine 0 C--N 1.288 -2.093 0 N-CA-C 109.196 -1.562 . . . . 1.0 109.196 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.765 ' HB3' HD12 ' A' ' 84' ' ' LEU . . . -67.7 86.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -1.186 . . . . 1.0 109.369 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.877 HG22 ' NE2' ' A' ' 134' ' ' GLN . 16.7 m -19.0 -69.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.036 0.446 . . . . 1.0 111.986 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.877 ' NE2' HG22 ' A' ' 133' ' ' THR . 0.0 OUTLIER -113.65 -45.87 3.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 1.0 110.023 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 84' ' ' LEU . 0.2 OUTLIER 62.2 113.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.899 . . . . 1.0 110.346 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.504 ' C ' ' CG2' ' A' ' 137' ' ' THR . 15.2 m-20 -73.19 138.97 45.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 1.0 109.534 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.673 ' CG2' HD13 ' A' ' 135' ' ' LEU . 7.2 p -153.53 105.0 2.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 1.0 109.792 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.942 ' OD2' HG21 ' A' ' 31' ' ' VAL . 7.9 p-10 170.61 -39.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -24.91 -43.91 0.01 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -146.99 173.81 12.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.903 -1.351 . . . . 1.0 110.445 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.635 ' CD1' HD21 ' A' ' 57' ' ' LEU . 10.3 tp -160.86 148.79 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.344 -0.848 . . . . 1.0 110.248 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.607 ' CG ' ' HE3' ' A' ' 146' ' ' MET . 20.7 m95 -133.23 143.49 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.303 -0.999 . . . . 1.0 108.303 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.991 HD13 HD12 ' A' ' 57' ' ' LEU . 6.6 tp -145.68 118.89 8.89 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.945 -1.502 . . . . 1.0 112.974 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 122.67 1.86 9.75 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.367 -1.093 . . . . 1.0 110.367 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.493 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 144.32 -135.24 6.09 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 118.936 -1.602 . . . . 1.0 109.727 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 1.065 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -170.79 176.48 4.17 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.816 -0.814 . . . . 1.0 111.714 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -96.37 -25.35 15.76 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.919 0.866 . . . . 1.0 108.918 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.562 ' O ' ' CG ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.91 74.59 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.822 -1.548 . . . . 1.0 106.822 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.065 HD13 ' HB2' ' A' ' 146' ' ' MET . 3.8 tp -71.39 24.69 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 113.926 1.084 . . . . 1.0 113.926 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.6 p -62.16 -21.01 64.72 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 104.68 -2.341 . . . . 1.0 104.68 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.861 HG12 ' HA ' ' A' ' 149' ' ' LEU 0.284 13.5 p -58.32 -118.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.348 -1.297 . . . . 1.0 110.154 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 151' ' ' VAL . . . 70.24 -71.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.809 -1.182 . . . . 1.0 109.927 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.629 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 18.3 m170 132.16 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.477 ' HD3' ' HB3' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -137.14 12.11 3.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.005 . . . . 1.0 109.706 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 1.084 ' CD2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -70.36 165.61 42.86 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.421 -0.799 . . . . 1.0 111.126 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.611 ' N ' HD22 ' A' ' 155' ' ' LEU . 40.9 Cg_endo -64.97 -168.68 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.967 1.509 . . . . 1.0 112.448 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.565 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 2.2 mttp -53.28 -10.77 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 1.084 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -38.25 -44.82 0.91 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.044 -1.035 . . . . 1.0 109.983 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.981 ' O ' HD23 ' A' ' 149' ' ' LEU . 15.4 m-85 -84.37 -28.45 26.99 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.945 -1.097 . . . . 1.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -71.64 -7.08 45.67 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.57 -1.252 . . . . 1.0 108.544 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 161' ' ' THR . 1.3 m -131.72 98.27 4.44 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -47.38 175.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.628 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 54.5 t80 -79.07 149.24 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -1.157 . . . . 1.0 112.061 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.885 HG22 ' HB2' ' A' ' 50' ' ' GLU . 1.1 mt -130.8 88.17 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.628 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.2 -153.69 9.48 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.061 -1.616 . . . . 1.0 109.061 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.523 ' C ' HG13 ' A' ' 167' ' ' ILE . 15.0 m -137.32 148.03 46.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.465 -1.021 . . . . 1.0 110.06 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.903 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -133.84 153.64 36.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.526 -0.734 . . . . 1.0 109.717 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.503 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 18.7 ttt180 -163.02 162.37 25.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.657 -1.277 . . . . 1.0 110.963 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER 48.71 78.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.394 -0.816 . . . . 1.0 110.464 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.894 HG12 ' CB ' ' A' ' 45' ' ' LEU . 16.2 m -121.77 135.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 119.362 -0.935 . . . . 1.0 108.937 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.474 HG12 ' C ' ' A' ' 170' ' ' VAL . 0.0 OUTLIER -146.22 148.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.319 -0.953 . . . . 1.0 111.176 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.625 HG13 ' CD1' ' A' ' 43' ' ' PHE . 1.7 t -130.32 102.43 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 10.9 m-20 51.96 42.55 30.35 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 1.0 108.143 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 75.51 26.38 1.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.254 0.549 . . . . 1.0 110.421 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.614 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . 63.9 mt-30 -102.15 -174.67 2.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.358 -0.838 . . . . 1.0 109.726 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 1.9 mm-40 62.64 -92.99 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.685 -0.634 . . . . 1.0 110.656 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER 65.88 -87.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 1.0 111.21 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 59.7 m-70 -74.72 102.39 4.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.998 -1.063 . . . . 1.0 111.509 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 183' ' ' ALA 0.253 0.4 OUTLIER -57.22 -58.4 8.38 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 122.419 1.104 . . . . 1.0 109.709 177.881 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.694 ' O ' HD22 ' A' ' 184' ' ' LEU . 95.0 t -50.54 -31.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.99 -1.005 . . . . 1.0 111.262 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 19.7 mt-10 -61.69 -53.81 51.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.121 -0.987 . . . . 1.0 109.929 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.588 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 2.7 t0 -89.79 -15.46 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 1.0 109.665 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 180' ' ' VAL . . . -72.82 -25.08 61.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.326 -0.859 . . . . 1.0 109.032 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.694 HD22 ' O ' ' A' ' 180' ' ' VAL . 0.1 OUTLIER -62.61 -15.49 51.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 1.0 109.438 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -24.15 63.93 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.938 0.875 . . . . 1.0 108.777 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.861 ' ND2' HG23 ' A' ' 23' ' ' THR . 3.6 t-20 -96.46 151.06 37.8 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.487 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 38.8 Cg_endo -64.87 143.61 80.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.538 1.283 . . . . 1.0 111.212 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.473 ' CG2' ' N ' ' A' ' 189' ' ' ILE . 0.8 OUTLIER 49.9 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.585 -0.697 . . . . 1.0 110.648 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.473 ' N ' ' CG2' ' A' ' 188' ' ' THR . 14.2 mm -141.03 121.99 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 1.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 mt -111.25 159.23 18.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.148 -0.97 . . . . 1.0 110.641 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -127.57 153.33 46.52 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 1.0 109.409 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 4.1 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.021 -1.05 . . . . 1.0 110.47 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.54 0.686 . . . . 1.0 110.367 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.51 134.21 34.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.157 -1.589 . . . . 1.0 110.925 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 190' ' ' LEU . 6.8 mm -125.94 142.14 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -0.975 . . . . 1.0 109.29 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -98.58 133.58 42.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.425 -0.797 . . . . 1.0 111.043 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.815 ' CE1' HD12 ' A' ' 167' ' ' ILE . 7.5 m-85 -95.84 175.74 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 1.0 109.192 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 45.6 p-10 -139.5 4.63 2.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.956 . . . . 1.0 110.655 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.483 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.74 -30.58 10.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.577 -1.809 . . . . 1.0 108.577 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 23' ' ' THR . 3.4 ttp-105 -100.92 -12.78 18.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.455 -1.027 . . . . 1.0 109.628 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.809 HG21 ' CD2' ' A' ' 19' ' ' PHE . 11.8 m -42.82 135.52 2.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 1.0 110.379 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.669 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -133.75 99.14 4.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 4.1 mtt -93.98 100.63 12.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.39 -1.444 . . . . 1.0 109.407 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.633 ' CG ' ' CZ3' ' A' ' 142' ' ' TRP . 2.7 tm-20 -103.72 101.8 11.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 1.0 110.325 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 182' ' ' ASP . 19.7 m-30 -108.81 116.41 31.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.258 -0.902 . . . . 1.0 109.346 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -115.67 122.39 45.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 1.0 110.59 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -156.35 163.4 39.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.0 110.242 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.27 167.28 19.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.543 HG11 ' NE2' ' A' ' 175' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.882 0 O-C-N 121.089 -1.007 . . . . 1.0 110.83 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.657 0.742 . . . . 1.0 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.6 p -118.38 149.9 40.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 23.8 m-80 -133.59 117.31 16.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.032 -1.043 . . . . 1.0 111.158 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 6.5 m-70 -94.87 108.74 20.77 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 8.4 m-85 -113.83 118.04 33.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 1.0 111.333 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.644 ' C ' HD23 ' A' ' 45' ' ' LEU . 2.1 mt-10 -127.99 150.62 49.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.183 -0.948 . . . . 1.0 110.577 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER 179.9 153.55 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.266 -0.896 . . . . 1.0 110.552 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 167' ' ' ILE . 0.7 OUTLIER -130.12 149.42 51.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 1.0 109.787 179.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.994 HD11 ' CG1' ' A' ' 97' ' ' ILE . 9.4 pt -131.22 177.28 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.186 -1.006 . . . . 1.0 110.067 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.641 ' O ' ' OG1' ' A' ' 49' ' ' THR . 12.4 tttt -167.0 82.31 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.204 -0.935 . . . . 1.0 111.018 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.998 HG22 ' HG2' ' A' ' 50' ' ' GLU . 29.5 m -172.03 -114.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.238 0.542 . . . . 1.0 111.095 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.998 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -115.04 -47.45 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.683 1.23 . . . . 1.0 109.586 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 1.042 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . 34.98 41.99 0.07 Allowed 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.413 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.626 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 64.9 p -85.51 -17.25 36.97 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.87 -1.144 . . . . 1.0 108.537 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.478 ' OE1' ' HB2' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -159.95 119.82 2.92 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 154.73 129.05 1.22 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.15 -1.58 . . . . 1.0 109.15 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.863 HD21 ' CD1' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -81.3 131.12 35.27 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.652 -1.499 . . . . 1.0 109.334 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.833 HD12 ' HA ' ' A' ' 72' ' ' ALA . 1.3 mp -97.21 -25.75 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.492 -0.755 . . . . 1.0 112.217 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.923 HD13 HD12 ' A' ' 71' ' ' LEU . 6.1 tt -148.7 133.74 18.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.723 -1.86 . . . . 1.0 113.211 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.977 ' CH2' HG21 ' A' ' 151' ' ' VAL . 20.4 t-105 -145.73 117.59 8.2 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB2' ' HA ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -137.6 153.03 49.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.841 -1.162 . . . . 1.0 111.024 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' C ' ' OG1' ' A' ' 137' ' ' THR . . . . . . . . 0 N--CA 1.494 2.514 0 N-CA-C 108.579 -1.809 . . . . 1.0 108.579 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.794 ' CG ' HG22 ' A' ' 69' ' ' ILE . 6.6 t80 . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 120.487 0.184 . . . . 1.0 111.029 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.794 HG22 ' CG ' ' A' ' 68' ' ' TYR . 1.8 tt -153.79 162.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.523 -1.361 . . . . 1.0 111.843 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.904 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -157.71 170.15 23.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 1.0 110.032 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.923 HD12 HD13 ' A' ' 57' ' ' LEU . 77.6 mt -145.17 125.79 14.17 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.833 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -152.71 172.36 16.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.94 -1.1 . . . . 1.0 111.325 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.042 HD13 ' HB1' ' A' ' 51' ' ' ALA . 5.5 mt -127.49 146.01 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 1.0 111.452 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.62 ' CG1' ' CG ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -141.46 122.69 13.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.306 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.1 m-20 73.76 -3.98 2.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.335 -0.853 . . . . 1.0 112.169 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.68 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 127.4 -0.65 6.97 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 118.866 -1.635 . . . . 1.0 111.045 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.723 ' C ' HG23 ' A' ' 73' ' ' ILE . 25.7 m-85 -133.93 134.13 42.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.93 -1.335 . . . . 1.0 110.545 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.79 HG23 HG13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -59.97 -167.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 1.0 109.946 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.947 ' HB2' HG22 ' A' ' 90' ' ' VAL . 1.3 pt20 -174.75 97.37 0.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.441 -0.787 . . . . 1.0 109.819 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.607 ' HE3' ' CD1' ' A' ' 91' ' ' LEU . 3.2 ttp -62.21 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.614 -0.834 . . . . 1.0 109.233 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.904 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 12.2 ttp -95.02 108.77 20.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.651 -0.656 . . . . 1.0 110.21 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.884 ' CE2' HG11 ' A' ' 89' ' ' VAL . 1.4 p90 -125.74 138.57 53.87 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.015 -1.474 . . . . 1.0 111.013 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.53 ' OD2' ' CD ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -136.6 94.93 3.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.75 -0.594 . . . . 1.0 110.444 -179.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.493 HD12 ' CB ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -102.52 3.27 37.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.835 -0.541 . . . . 1.0 110.654 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -136.44 -43.03 0.1 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.302 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 167.72 -20.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.193 -1.181 . . . . 1.0 110.983 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.491 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 7.8 mttt -118.8 120.35 31.6 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.097 . . . . 1.0 110.081 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.602 ' HG3' ' CE1' ' A' ' 153' ' ' HIS . 52.6 Cg_endo -78.31 146.62 22.36 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.946 1.498 . . . . 1.0 110.151 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.884 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -112.97 121.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.323 -0.861 . . . . 1.0 108.729 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.947 HG22 ' HB2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -102.5 111.29 31.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.09 -1.444 . . . . 1.0 110.427 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.607 ' CD1' ' HE3' ' A' ' 80' ' ' MET . 11.7 mt -105.61 70.05 0.86 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.9 -1.519 . . . . 1.0 106.9 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.618 ' O ' HD13 ' A' ' 124' ' ' ILE . 20.0 mtp180 -60.5 148.97 35.89 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 122.121 0.963 . . . . 1.0 111.22 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.738 ' OG ' HG21 ' A' ' 118' ' ' VAL 0.253 48.2 t -67.57 150.67 48.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.824 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.588 ' N ' HD11 ' A' ' 124' ' ' ILE . 12.1 t -107.57 26.73 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.789 . . . . 1.0 109.023 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.975 ' HB ' HG11 ' A' ' 118' ' ' VAL . 2.1 t -139.88 153.3 69.6 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.663 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.9 Cg_endo -65.84 124.69 13.07 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.661 1.348 . . . . 1.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.994 ' CG1' HD11 ' A' ' 47' ' ' ILE . 3.3 tp -109.55 -8.42 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.805 . . . . 1.0 110.03 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 5.4 p-10 -93.77 56.89 2.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.758 . . . . 1.0 109.896 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 99' ' ' THR . 98.1 m -114.61 7.04 15.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.227 -0.921 . . . . 1.0 110.739 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.458 ' HA ' ' CA ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 60.54 10.94 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.331 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -104.47 163.11 12.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 1.0 109.742 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 15.6 m95 -78.08 91.87 4.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.003 -1.061 . . . . 1.0 110.864 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.552 HG21 HD12 ' A' ' 97' ' ' ILE . 22.9 m -86.63 167.5 14.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.76 -0.829 . . . . 1.0 108.76 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.523 ' N ' HG22 ' A' ' 103' ' ' THR . 23.1 t60 -123.98 132.45 53.71 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.208 -0.997 . . . . 1.0 109.782 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.488 HG22 HD11 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -126.78 142.94 41.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.318 -0.864 . . . . 1.0 108.979 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.724 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -148.34 179.65 7.62 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.018 -1.073 . . . . 1.0 109.309 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 108' ' ' TYR . . . -165.11 157.63 15.9 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.808 -1.182 . . . . 1.0 111.824 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 6.0 m-85 -136.21 104.39 5.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 1.0 109.299 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -103.02 134.75 45.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.911 -1.118 . . . . 1.0 109.945 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.527 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 3.0 t -130.56 84.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.161 -1.016 . . . . 1.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 32.4 mt-30 53.85 -2.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -179.37 -27.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.042 -1.661 . . . . 1.0 111.066 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.526 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -110.35 115.9 30.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 1.0 110.718 -178.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -103.54 149.89 17.46 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.72 ' CB ' HG22 ' A' ' 125' ' ' THR . 12.5 t -132.36 155.59 48.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.274 -1.133 . . . . 1.0 110.266 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 117' ' ' GLN . 1.6 tm? -123.65 144.89 49.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.802 -1.186 . . . . 1.0 108.679 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 1.033 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -121.04 81.35 1.76 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.411 -0.806 . . . . 1.0 112.3 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.975 HG11 ' HB ' ' A' ' 95' ' ' VAL . 91.4 t -70.29 80.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.772 -1.171 . . . . 1.0 107.933 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 67.12 59.77 6.61 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.072 -1.211 . . . . 1.0 110.072 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.456 ' H ' ' HG3' ' A' ' 117' ' ' GLN . 7.8 m120 36.68 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.898 . . . . 1.0 111.25 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -103.18 -161.4 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 1.0 109.919 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.577 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -39.82 99.38 0.2 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.555 -0.716 . . . . 1.0 109.375 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.1 Cg_endo -71.17 129.88 16.78 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.211 1.638 . . . . 1.0 110.892 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 93' ' ' SER . 3.0 mt -101.45 102.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.72 HG22 ' CB ' ' A' ' 115' ' ' SER . 30.2 p -114.06 173.42 6.45 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.261 1.029 . . . . 1.0 112.299 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.405 ' C ' ' OG ' ' A' ' 127' ' ' SER . . . -178.09 -171.35 41.37 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.532 -2.227 . . . . 1.0 107.532 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -159.5 171.01 20.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.597 -1.531 . . . . 1.0 110.892 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.564 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.6 OUTLIER -107.97 -177.89 0.52 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 1.0 110.193 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.8 Cg_endo -69.39 94.88 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 1.0 108.946 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.666 HD12 ' H ' ' A' ' 130' ' ' LEU . 3.4 mp -34.32 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.228 0.537 . . . . 1.0 111.098 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.03 -29.04 1.25 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.614 -1.394 . . . . 1.0 109.614 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.493 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -90.66 135.33 33.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -1.16 . . . . 1.0 110.333 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.435 ' C ' ' HG2' ' A' ' 134' ' ' GLN . 9.7 m -138.38 23.47 2.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 1.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.51 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -158.52 -49.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 1.0 110.398 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER 28.14 64.01 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.232 0.539 . . . . 1.0 111.523 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -52.55 96.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.122 -0.986 . . . . 1.0 110.199 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 68' ' ' TYR . 10.5 t -159.72 -172.88 3.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 1.0 109.759 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 91.59 -19.87 0.12 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 121.298 0.571 . . . . 1.0 110.544 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -47.99 -17.0 0.51 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 120.198 -1.001 . . . . 1.0 110.743 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -128.79 168.36 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.631 -1.511 . . . . 1.0 109.748 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 0.5 OUTLIER -154.88 145.96 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 1.0 110.861 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.633 ' CZ3' ' CG ' ' A' ' 26' ' ' GLU . 30.2 m95 -136.6 96.47 3.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.131 -1.803 . . . . 1.0 106.131 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.688 HD12 ' CB ' ' A' ' 57' ' ' LEU . 1.7 tp -112.34 130.05 56.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.97 1.47 . . . . 1.0 114.97 -175.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 106.99 10.05 28.88 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.701 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 124.93 -160.82 19.56 Favored Glycine 0 C--N 1.278 -2.648 0 N-CA-C 107.762 -2.135 . . . . 1.0 107.762 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.931 ' HB2' HD12 ' A' ' 149' ' ' LEU . 1.9 mmt -168.78 169.5 9.91 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.282 -1.367 . . . . 1.0 111.059 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.9 11.32 38.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -165.43 16.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.667 -0.646 . . . . 1.0 111.525 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.931 HD12 ' HB2' ' A' ' 146' ' ' MET . 9.2 mt -68.42 53.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.402 -1.436 . . . . 1.0 109.865 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 148' ' ' ARG . 10.5 p -55.19 -24.31 26.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.413 -1.699 . . . . 1.0 106.413 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.977 HG21 ' CH2' ' A' ' 58' ' ' TRP 0.311 12.7 p -48.21 -118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.051 -1.431 . . . . 1.0 111.86 178.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' A' ' 155' ' ' LEU . . . 79.81 -23.25 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.11 -0.993 . . . . 1.0 109.993 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.602 ' CE1' ' HG3' ' A' ' 88' ' ' PRO . 0.2 OUTLIER 75.68 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 1.0 111.163 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.577 ' O ' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -150.04 74.92 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.823 -1.173 . . . . 1.0 111.137 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -142.47 178.41 1.51 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 120.696 -1.252 . . . . 1.0 110.029 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.62 ' CG ' ' CG1' ' A' ' 74' ' ' VAL . 52.6 Cg_endo -76.76 -164.2 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.707 1.372 . . . . 1.0 111.948 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 161' ' ' THR . 2.8 mttm -51.21 -10.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.609 -0.682 . . . . 1.0 112.131 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.609 ' HB3' ' CD1' ' A' ' 155' ' ' LEU . . . -32.75 -46.52 0.14 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.121 -0.987 . . . . 1.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.964 ' CD2' ' HB2' ' A' ' 152' ' ' ALA . 3.6 m-85 -83.97 -33.98 24.49 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.558 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -76.06 -1.7 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.977 -1.089 . . . . 1.0 108.813 178.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 161' ' ' THR . 2.6 m -140.74 83.24 1.88 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.547 -0.72 . . . . 1.0 109.29 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -43.54 165.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.154 -1.578 . . . . 1.0 109.154 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.802 ' CE1' ' HB2' ' A' ' 51' ' ' ALA . 32.6 t80 -70.63 142.67 51.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.286 . . . . 1.0 110.485 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.672 ' O ' HG21 ' A' ' 49' ' ' THR . 19.3 mt -119.79 79.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.761 ' HA2' HG21 ' A' ' 49' ' ' THR . . . -165.48 -163.19 18.33 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 1.8 m -114.41 146.92 40.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -1.183 . . . . 1.0 111.585 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.815 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -136.45 152.62 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.166 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.468 ' HG2' ' OD1' ' A' ' 169' ' ' ASP . 13.5 ttp180 -158.6 159.1 35.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 1.0 110.769 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.7 m-20 53.13 79.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 1.0 110.509 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.589 HG12 ' CB ' ' A' ' 45' ' ' LEU . 28.5 m -128.72 131.71 68.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.495 ' CG1' ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -150.88 149.24 14.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.03 -1.068 . . . . 1.0 110.899 -176.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.531 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 8.9 t -135.25 108.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 1.5 m-20 50.53 42.96 27.33 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.391 -1.443 . . . . 1.0 107.469 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.31 28.7 2.93 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.906 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 176' ' ' GLU . 22.3 mt-30 -100.98 -178.13 3.66 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.102 -0.999 . . . . 1.0 109.217 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 4.5 mm-40 69.62 -98.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.634 -0.666 . . . . 1.0 110.44 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER 69.27 -88.02 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.256 -0.903 . . . . 1.0 111.05 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 17.4 m-70 -97.44 103.17 15.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.739 -1.225 . . . . 1.0 111.097 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.5 OUTLIER -67.4 -53.56 28.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 22.1 t -51.47 -23.05 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.699 . . . . 1.0 110.381 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 35.5 mt-10 -71.69 -58.43 3.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 1.0 110.01 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.575 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 12.3 t0 -87.49 -14.63 39.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 1.0 109.619 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -69.65 -34.16 73.62 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.254 -0.904 . . . . 1.0 108.873 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.655 ' HA ' HD11 ' A' ' 189' ' ' ILE . 11.3 mt -48.68 -24.23 1.3 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 1.0 108.975 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 1.2 t-20 -57.22 -20.11 25.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.101 0.953 . . . . 1.0 109.009 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.512 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 1.8 t30 -89.61 151.95 46.5 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.512 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 37.5 Cg_endo -61.82 -149.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.3 1.158 . . . . 1.0 109.309 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.504 ' C ' ' O ' ' A' ' 187' ' ' PRO . 20.5 m -33.06 136.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.355 -0.84 . . . . 1.0 111.197 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 184' ' ' LEU . 13.4 mt -127.78 153.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.505 -0.747 . . . . 1.0 109.795 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 17' ' ' ILE . 23.1 mt -131.2 155.27 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 1.0 110.648 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 18' ' ' ALA . 1.9 m-70 -92.29 -87.96 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.818 . . . . 1.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 191' ' ' HIS . 5.3 t . . . . . 0 C--N 1.296 -1.759 0 C-N-CA 119.373 -0.931 . . . . 1.0 111.498 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.579 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 3.1 pt-20 . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 121.459 0.647 . . . . 1.0 110.785 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -112.3 119.41 38.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.533 -1.354 . . . . 1.0 109.79 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.628 ' CG1' HD12 ' A' ' 179' ' ' LEU . 10.1 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.533 -1.267 . . . . 1.0 110.421 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -91.15 115.59 28.14 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.731 -0.606 . . . . 1.0 110.532 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.783 ' CZ ' HD13 ' A' ' 167' ' ' ILE . 5.0 m-30 -74.52 167.6 21.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 1.0 109.114 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 23' ' ' THR . 1.4 p-10 -117.57 -10.13 10.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.057 -1.027 . . . . 1.0 110.18 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.497 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 105.45 -9.28 45.07 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.54 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -147.04 21.16 1.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.167 -1.196 . . . . 1.0 110.055 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m -115.62 102.81 10.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.0 109.867 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.632 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -67.12 117.46 9.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 1.0 111.015 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.614 ' HE1' HG21 ' A' ' 17' ' ' ILE . 3.4 mmm -106.8 98.56 8.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.689 -1.257 . . . . 1.0 108.27 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.606 ' OE1' ' CZ3' ' A' ' 142' ' ' TRP . 4.6 pt-20 -107.84 152.3 24.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.311 -0.868 . . . . 1.0 110.261 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.562 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 3.3 m-85 -130.48 124.66 32.49 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.243 -0.983 . . . . 1.0 110.001 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.618 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -97.55 89.64 4.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.567 -0.708 . . . . 1.0 110.287 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -88.67 151.72 22.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 1.0 109.781 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.32 108.4 19.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.172 -0.955 . . . . 1.0 110.666 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.945 HG11 ' NE2' ' A' ' 175' ' ' GLN . 19.1 m . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 1.0 110.003 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.517 ' HG2' ' N ' ' A' ' 40' ' ' SER . 31.8 tt0 . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.949 0.88 . . . . 1.0 109.18 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.74 ' OG ' HG13 ' A' ' 110' ' ' VAL . 5.7 m -157.03 119.15 3.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.19 0.519 . . . . 1.0 110.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -103.67 163.3 12.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 1.0 110.439 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.556 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 59.1 m-70 -139.07 132.84 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 1.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.074 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 93.5 m-85 -135.24 115.44 13.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.57 -0.706 . . . . 1.0 109.625 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.825 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.1 mp0 -123.72 144.19 49.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.823 -1.173 . . . . 1.0 109.756 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.871 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -178.38 159.39 1.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.393 -0.923 . . . . 1.0 110.882 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 103' ' ' THR . 1.0 OUTLIER -123.49 154.38 39.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 166' ' ' CYS . 1.9 pt -148.14 156.01 9.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 117.907 -1.517 . . . . 1.0 112.045 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.615 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -105.94 86.45 2.38 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 176.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.566 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -75.27 153.36 38.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.125 -1.03 . . . . 1.0 112.841 -175.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 3.2 mm-40 -143.48 1.97 1.23 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.434 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.39 128.78 24.18 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.047 -1.033 . . . . 1.0 110.285 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.547 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 58.3 p -62.88 -15.4 54.72 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.379 -0.826 . . . . 1.0 110.844 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HG2' ' N ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -129.82 135.65 48.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.846 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 159.33 137.14 2.17 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -90.84 126.24 35.97 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.051 -1.264 . . . . 1.0 108.797 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.913 HG22 HD21 ' A' ' 143' ' ' LEU . 0.5 OUTLIER -91.25 -34.32 6.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.067 0.766 . . . . 1.0 113.067 -176.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 71' ' ' LEU . 3.1 tt -142.76 151.91 41.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.018 -1.676 . . . . 1.0 113.338 -175.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.686 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 9.6 t-105 -162.88 107.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -114.35 137.27 52.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.661 -1.274 . . . . 1.0 111.023 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 108.37 -1.892 . . . . 1.0 108.37 179.307 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 84' ' ' LEU . 1.1 t80 . . . . . 0 N--CA 1.504 2.267 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.946 HD11 ' CD2' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -130.06 172.88 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.734 -1.229 . . . . 1.0 111.001 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.801 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -174.95 174.67 2.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.692 -0.63 . . . . 1.0 109.636 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 57' ' ' LEU . 70.8 mt -152.43 117.59 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.92 -1.113 . . . . 1.0 109.146 -178.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -132.79 171.07 14.37 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 1.0 112.011 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.112 ' CG1' HG13 ' A' ' 78' ' ' VAL . 30.7 mt -121.86 139.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.476 -0.765 . . . . 1.0 111.559 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.922 HG11 ' NH2' ' A' ' 92' ' ' ARG . 11.7 p -141.43 144.66 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.675 -0.64 . . . . 1.0 110.112 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.779 ' OD1' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER 52.94 27.07 5.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.142 -0.974 . . . . 1.0 110.614 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.744 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 80.42 14.32 80.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 7.5 m-85 -126.64 148.52 49.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 1.0 110.071 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.112 HG13 ' CG1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.15 168.05 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.06 -1.025 . . . . 1.0 109.757 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 22.9 pt20 -160.17 123.23 3.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.098 -1.001 . . . . 1.0 110.944 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.802 ' HA ' HD23 ' A' ' 71' ' ' LEU . 5.4 tmm? -86.83 113.61 22.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.38 -0.825 . . . . 1.0 109.119 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.801 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 2.2 ptt? -100.94 141.12 34.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 1.0 110.765 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.946 ' CD2' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -120.19 105.43 10.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 1.0 110.583 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 85' ' ' GLY . 6.4 t0 -120.86 40.38 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 1.0 109.901 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.812 HD23 ' HD1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -39.17 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.569 -0.707 . . . . 1.0 112.132 -178.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -142.8 -50.34 0.04 OUTLIER Glycine 0 N--CA 1.494 2.527 0 C-N-CA 118.862 -1.637 . . . . 1.0 110.83 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.46 ' H ' ' HD3' ' A' ' 87' ' ' LYS . 1.1 m -173.7 22.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -1.2 . . . . 1.0 110.717 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.574 ' CB ' ' HB3' ' A' ' 128' ' ' SER . 0.0 OUTLIER -129.99 80.91 70.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 1.0 109.292 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 42.5 Cg_endo -68.92 89.66 0.44 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.025 1.54 . . . . 1.0 111.192 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -75.18 155.23 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -127.99 119.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.321 -1.487 . . . . 1.0 110.801 178.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.822 HD21 ' C ' ' A' ' 114' ' ' GLY . 10.6 mp -112.73 69.25 0.69 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.922 ' NH2' HG11 ' A' ' 74' ' ' VAL . 4.6 mtt180 -56.78 178.01 0.07 Allowed 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.668 -1.213 . . . . 1.0 109.822 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.758 ' OG ' HG21 ' A' ' 118' ' ' VAL . 3.0 t -95.68 169.57 9.93 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.693 -0.629 . . . . 1.0 110.16 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 1.011 ' CG2' ' HB3' ' A' ' 122' ' ' ALA . 14.0 t -121.22 16.46 11.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 1.0 109.062 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.951 HG22 ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.84 160.56 60.32 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.661 -0.649 . . . . 1.0 109.331 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.951 ' HD2' HG22 ' A' ' 95' ' ' VAL . 44.3 Cg_endo -70.06 138.48 36.95 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.859 1.452 . . . . 1.0 110.358 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 76' ' ' GLY . 2.7 tp -121.53 -30.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.096 -1.002 . . . . 1.0 110.706 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 98' ' ' ASN . 11.2 p30 -73.7 57.45 0.58 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 1.0 109.544 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 99' ' ' THR . 16.8 m -114.12 19.77 16.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.563 -0.711 . . . . 1.0 110.282 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 46.7 22.28 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 1.0 110.921 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.32 144.94 43.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.056 -1.028 . . . . 1.0 110.1 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 7.5 m95 -59.46 95.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 1.0 109.881 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' SER . 26.5 m -94.09 164.7 12.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.156 -0.965 . . . . 1.0 109.485 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 40.6 t-80 -116.34 147.64 41.39 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.258 -0.901 . . . . 1.0 108.614 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.516 HD11 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -134.97 152.74 33.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.126 -0.984 . . . . 1.0 109.365 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.995 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -138.57 146.23 41.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.8 -1.188 . . . . 1.0 110.329 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 1.074 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -143.93 92.35 2.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 1.0 110.675 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.598 ' CZ ' ' OG ' ' A' ' 115' ' ' SER . 47.9 p90 -112.18 107.53 16.45 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.056 -1.058 . . . . 1.0 109.014 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.606 ' HD3' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -109.67 130.66 55.49 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.969 -178.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.74 HG13 ' OG ' ' A' ' 40' ' ' SER . 4.2 t -104.5 102.15 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.415 -0.803 . . . . 1.0 109.506 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.56 ' HA ' ' NH2' ' A' ' 109' ' ' ARG . 10.0 pt20 38.65 100.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.581 0.705 . . . . 1.0 112.469 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.56 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 1.1 ptt85 70.18 -50.0 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 1.0 111.644 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.56 ' N ' ' HG2' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -81.49 112.09 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.785 -1.197 . . . . 1.0 110.019 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.822 ' C ' HD21 ' A' ' 91' ' ' LEU . . . -103.39 159.65 16.9 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.144 -1.027 . . . . 1.0 111.732 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 125' ' ' THR . 1.0 OUTLIER -137.35 151.93 49.14 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.835 -0.803 . . . . 1.0 109.656 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -138.33 153.6 48.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.083 -1.011 . . . . 1.0 109.406 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 1.115 ' N ' HD13 ' A' ' 116' ' ' LEU . 1.1 mt-30 -158.28 111.32 2.38 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.768 -1.173 . . . . 1.0 111.644 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.828 HG11 ' CG1' ' A' ' 95' ' ' VAL . 90.7 t -71.29 97.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 64.54 43.12 97.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 1.0 109.509 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.9 OUTLIER 61.84 36.53 15.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -1.136 . . . . 1.0 110.713 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -96.29 -162.93 1.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.123 -0.985 . . . . 1.0 110.791 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 1.011 ' HB3' ' CG2' ' A' ' 94' ' ' THR . . . -43.2 118.17 2.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 1.0 109.246 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 47.7 Cg_endo -73.27 115.22 4.26 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.068 1.562 . . . . 1.0 112.436 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.703 HG21 ' O ' ' A' ' 92' ' ' ARG . 4.1 mp -91.23 102.08 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.619 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.9 p -116.96 179.93 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.502 1.144 . . . . 1.0 112.874 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 113' ' ' GLU . . . 169.42 -173.2 43.74 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 106.667 -2.573 . . . . 1.0 106.667 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -160.46 162.03 33.04 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.471 -1.605 . . . . 1.0 110.686 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.574 ' HB3' ' CB ' ' A' ' 87' ' ' LYS . 19.8 m -111.21 161.31 25.69 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.148 -0.97 . . . . 1.0 110.222 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.547 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.7 Cg_endo -68.16 78.32 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.972 1.511 . . . . 1.0 108.811 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.547 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.4 mt -12.99 131.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.596 0.712 . . . . 1.0 112.815 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 132' ' ' ALA . . . 161.85 99.62 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.756 ' O ' HG22 ' A' ' 133' ' ' THR . . . 173.68 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.459 -1.024 . . . . 1.0 109.716 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 132' ' ' ALA . 5.7 t 42.69 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.465 0.65 . . . . 1.0 110.779 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 133' ' ' THR . 0.0 OUTLIER 40.0 26.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 1.0 110.704 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -89.87 36.62 0.86 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.118 -0.989 . . . . 1.0 109.5 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.7 OUTLIER -51.37 171.03 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.053 -1.029 . . . . 1.0 109.076 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.0 t -113.16 133.41 55.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.037 -1.039 . . . . 1.0 109.748 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.739 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 28.9 p-10 -84.67 30.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 1.0 110.32 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 31' ' ' VAL . . . 44.84 24.1 0.68 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.739 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -116.75 151.67 35.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.146 . . . . 1.0 109.839 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.876 ' CD1' HD21 ' A' ' 57' ' ' LEU . 11.9 tp -154.22 150.05 27.65 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.482 -0.887 . . . . 1.0 110.639 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.624 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 8.0 m95 -126.48 118.19 24.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.074 -1.454 . . . . 1.0 107.074 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.913 HD21 HG22 ' A' ' 56' ' ' ILE . 1.1 tt -125.59 120.01 29.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 117.812 -1.555 . . . . 1.0 112.651 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 124.76 8.21 5.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 136.66 -134.34 7.06 Favored Glycine 0 C--N 1.291 -1.923 0 C-N-CA 119.007 -1.568 . . . . 1.0 109.848 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 1.055 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -170.74 158.94 6.27 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.424 -0.911 . . . . 1.0 111.712 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -92.23 -14.88 28.29 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -143.5 51.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.055 HD13 ' HB2' ' A' ' 146' ' ' MET . 10.0 tp -65.5 49.3 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.878 0.696 . . . . 1.0 112.878 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 148' ' ' ARG . 20.5 p -73.83 -19.67 60.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 105.167 -2.16 . . . . 1.0 105.167 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.749 ' CG1' HD12 ' A' ' 149' ' ' LEU 0.267 3.9 p -61.55 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.588 -1.187 . . . . 1.0 109.909 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.765 ' HB1' ' CD2' ' A' ' 159' ' ' TYR . . . 53.77 20.15 2.16 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.408 -1.432 . . . . 1.0 110.195 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.585 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 48.1 m80 32.98 -85.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.83 -0.544 . . . . 1.0 112.323 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ALA . 2.9 ptpp? -134.67 -29.83 1.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 1.0 113.082 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.996 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -60.34 138.44 91.99 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.684 -1.26 . . . . 1.0 109.078 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.594 ' N ' HD12 ' A' ' 155' ' ' LEU . 56.4 Cg_endo -81.54 -92.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.902 1.475 . . . . 1.0 114.642 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.612 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -55.03 -47.56 74.6 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.045 1.869 . . . . 1.0 116.045 -174.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.996 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -41.57 -44.19 2.94 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 120.731 1.605 . . . . 1.0 108.987 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.791 ' CE2' HD23 ' A' ' 155' ' ' LEU . 30.6 m-85 -84.39 -25.67 28.92 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.632 -1.227 . . . . 1.0 108.572 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.612 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -78.19 -3.28 41.85 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.336 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -135.02 82.81 1.98 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.19 166.46 0.01 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CD2' HD11 ' A' ' 167' ' ' ILE . 12.9 t80 -65.79 143.56 57.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.394 . . . . 1.0 112.046 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 164' ' ' ILE . 4.6 mt -122.02 85.14 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.648 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.33 -156.41 11.75 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.565 ' HB2' ' HB2' ' A' ' 48' ' ' LYS . 1.7 m -127.73 142.34 51.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.529 -0.983 . . . . 1.0 110.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.783 HD13 ' CZ ' ' A' ' 19' ' ' PHE . 3.3 mt -126.78 147.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.755 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.637 ' O ' HG13 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -160.28 170.79 20.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 1.0 110.231 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.3 m-20 41.71 67.83 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 1.0 109.852 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.871 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.1 m -124.38 126.47 72.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 O-C-N 121.063 -1.023 . . . . 1.0 109.895 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 175' ' ' GLN . 0.3 OUTLIER -134.67 151.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.889 -1.125 . . . . 1.0 111.666 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 2.4 p -134.32 108.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.568 ' O ' ' HD3' ' A' ' 174' ' ' ARG . 68.6 m-20 59.98 67.92 0.82 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.492 -1.67 . . . . 1.0 106.492 -176.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 35.34 28.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.473 -0.785 . . . . 1.0 111.633 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.945 ' NE2' HG11 ' A' ' 31' ' ' VAL . 8.6 mt-30 -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.294 -0.879 . . . . 1.0 109.644 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' CD2' ' A' ' 178' ' ' HIS . 18.3 tt0 -78.1 107.76 10.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 1.0 110.619 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.644 ' HB2' HG23 ' A' ' 170' ' ' VAL . 15.3 mt -90.0 85.24 6.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 1.0 110.53 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.577 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 1.8 m170 -56.96 114.42 2.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 1.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.975 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 3.6 mm? -59.3 -38.28 79.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.355 -0.841 . . . . 1.0 111.767 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.448 HG22 ' HE1' ' A' ' 191' ' ' HIS . 56.1 t -85.21 -39.62 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.196 0.813 . . . . 1.0 113.196 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 14.2 mt-10 -57.78 -49.51 76.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.463 -1.398 . . . . 1.0 110.913 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.562 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 31.9 m-20 -87.54 -19.01 28.49 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.461 -0.774 . . . . 1.0 110.928 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.975 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -60.57 -34.95 74.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.52 -1.272 . . . . 1.0 108.452 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.2 mt -50.83 -22.76 2.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.715 -0.615 . . . . 1.0 109.805 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -51.2 -22.47 2.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.172 -0.955 . . . . 1.0 108.894 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.517 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 2.0 t-20 -99.52 156.13 35.74 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 39.0 Cg_endo -65.17 -56.49 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.238 1.125 . . . . 1.0 110.948 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.473 ' O ' HG13 ' A' ' 189' ' ' ILE . 5.8 t -103.11 146.49 28.3 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.594 -0.691 . . . . 1.0 110.375 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 188' ' ' THR . 2.9 mp -139.99 124.29 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 1.0 110.349 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.536 ' O ' HG23 ' A' ' 17' ' ' ILE . 20.8 mt -109.56 159.36 17.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 1.0 109.559 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -101.61 -81.68 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.832 -1.168 . . . . 1.0 111.075 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.29 -2.011 0 O-C-N 121.052 -1.03 . . . . 1.0 110.098 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.595 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 3.0 pt-20 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.514 0.674 . . . . 1.0 110.661 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -81.21 158.85 24.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.22 -1.55 . . . . 1.0 110.481 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.82 HG21 ' CE ' ' A' ' 25' ' ' MET . 12.3 mm -119.78 116.45 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 1.0 110.224 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 191' ' ' HIS . . . -81.12 122.73 27.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.418 -0.801 . . . . 1.0 110.537 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.74 ' CE1' HD12 ' A' ' 167' ' ' ILE . 3.0 m-85 -86.15 166.97 15.34 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.598 -0.89 . . . . 1.0 108.598 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 1.0 ' HA ' HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -127.37 3.07 6.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.84 -1.162 . . . . 1.0 111.083 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.484 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 99.88 -18.87 55.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.326 -1.51 . . . . 1.0 109.326 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 14.3 ttt180 -118.79 22.39 12.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.293 -1.122 . . . . 1.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 172.96 12.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 1.0 110.873 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.656 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -166.04 87.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.82 ' CE ' HG21 ' A' ' 17' ' ' ILE . 26.8 mtt -90.34 101.39 14.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.658 -1.276 . . . . 1.0 110.517 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.622 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 8.8 pt-20 -83.08 110.57 18.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.243 -0.91 . . . . 1.0 108.657 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.606 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 47.8 m-85 -100.95 99.24 9.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.975 -1.078 . . . . 1.0 110.387 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.461 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -93.14 103.35 15.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 1.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -94.96 164.58 12.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 1.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.3 94.36 9.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.283 -0.885 . . . . 1.0 110.405 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG21 HE22 ' A' ' 175' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.317 -0.864 . . . . 1.0 109.779 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.506 ' CG ' ' N ' ' A' ' 40' ' ' SER . 1.3 tt0 . . . . . 0 N--CA 1.502 2.139 0 N-CA-C 108.935 -0.765 . . . . 1.0 108.935 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -169.92 157.91 6.96 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.154 -1.018 . . . . 1.0 112.302 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -130.12 139.22 50.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 1.0 109.886 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.517 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 71.1 m-70 -110.45 125.71 53.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.319 -0.863 . . . . 1.0 109.95 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.717 ' CD2' HG22 ' A' ' 172' ' ' VAL . 26.9 m-85 -140.16 119.34 12.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.921 . . . . 1.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.747 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -127.48 151.54 48.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.749 -1.22 . . . . 1.0 110.817 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.977 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 178.86 150.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 1.0 110.991 179.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.5 m -114.06 150.25 34.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.722 HG12 HD11 ' A' ' 97' ' ' ILE . 1.4 pt -144.38 153.3 15.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 117.821 -1.552 . . . . 1.0 112.583 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.632 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.5 OUTLIER -109.82 83.07 1.69 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.693 HG22 ' CE1' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -73.65 148.06 43.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.266 1.031 . . . . 1.0 112.808 -175.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 5.3 mm-40 -124.62 -18.49 5.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.711 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.85 130.3 46.71 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.729 -0.607 . . . . 1.0 109.677 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.727 HG22 ' CA ' ' A' ' 76' ' ' GLY . 1.9 p -60.92 -8.08 2.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 1.0 111.073 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -130.66 134.19 46.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.71 -1.244 . . . . 1.0 110.673 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.86 135.8 1.89 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.203 -1.559 . . . . 1.0 109.203 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.208 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -92.99 127.33 38.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.632 -1.511 . . . . 1.0 109.291 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -96.67 -27.05 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.715 . . . . 1.0 112.408 -176.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.003 HD13 HD12 ' A' ' 71' ' ' LEU . 6.0 tt -144.28 146.18 32.46 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.246 -1.534 . . . . 1.0 112.58 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.871 ' CH2' HG21 ' A' ' 151' ' ' VAL . 5.4 t-105 -159.6 116.33 2.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.782 -0.574 . . . . 1.0 109.538 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -116.47 120.47 38.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.085 -1.01 . . . . 1.0 110.316 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.867 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 83' ' ' ASP . 2.4 p90 . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 122.052 0.93 . . . . 1.0 110.461 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.539 HG12 ' HB3' ' A' ' 82' ' ' TYR . 1.5 mt -132.32 167.47 26.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.151 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.805 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -171.02 178.12 3.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.216 -0.927 . . . . 1.0 110.874 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.003 HD12 HD13 ' A' ' 57' ' ' LEU . 83.2 mt -146.66 129.88 16.58 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.591 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -150.77 165.11 34.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.833 -1.167 . . . . 1.0 112.559 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 56' ' ' ILE . 5.9 mt -104.54 137.94 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.706 0.765 . . . . 1.0 110.654 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.847 HG11 ' OE1' ' A' ' 79' ' ' GLN . 2.3 p -139.87 118.63 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.738 -0.601 . . . . 1.0 110.097 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 2.2 m-20 67.26 3.65 3.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 1.0 111.235 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 113.97 4.17 22.78 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.343 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 31.7 m-85 -131.41 126.67 35.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.053 -1.263 . . . . 1.0 109.701 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.722 HG13 ' N ' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -59.43 -173.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.929 -1.107 . . . . 1.0 110.461 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.847 ' OE1' HG11 ' A' ' 74' ' ' VAL . 9.0 pt20 -176.33 101.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.019 0.914 . . . . 1.0 110.133 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.918 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -78.47 126.01 30.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.805 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 5.0 ptt? -122.8 146.48 47.5 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.106 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.939 ' CZ ' HG11 ' A' ' 89' ' ' VAL . 4.3 p90 -129.77 120.56 25.25 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.888 -1.525 . . . . 1.0 110.519 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.572 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . 12.7 t70 -94.05 47.4 1.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.313 0.578 . . . . 1.0 110.568 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.046 ' HB3' HD13 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -62.83 -10.8 14.46 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -144.44 41.55 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.959 -1.257 . . . . 1.0 109.959 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 77.49 -35.28 0.21 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.5 -1.0 . . . . 1.0 111.516 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -102.51 103.84 34.32 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.767 -1.208 . . . . 1.0 110.362 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.522 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 51.6 Cg_endo -74.46 116.78 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.191 1.627 . . . . 1.0 111.234 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.939 HG11 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -71.91 172.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 178.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.669 ' O ' HG12 ' A' ' 90' ' ' VAL . 1.2 t -144.27 107.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.635 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 91' ' ' LEU . 3.0 mm? -95.23 90.11 5.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.293 -1.743 . . . . 1.0 106.293 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.904 ' O ' HD13 ' A' ' 124' ' ' ILE . 30.7 mtp180 -73.22 154.09 40.38 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.988 -1.085 . . . . 1.0 110.271 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.3 t -68.62 143.6 54.77 Favored 'General case' 0 C--N 1.288 -2.075 0 O-C-N 120.986 -1.071 . . . . 1.0 109.925 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.848 ' HB ' HD12 ' A' ' 124' ' ' ILE . 4.7 t -94.25 21.09 7.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.756 -1.215 . . . . 1.0 110.035 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.964 HG21 HG11 ' A' ' 118' ' ' VAL . 19.6 t -135.16 149.08 69.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 1.0 109.956 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.586 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 40.6 Cg_endo -66.53 134.39 35.43 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.681 1.358 . . . . 1.0 110.123 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.915 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.8 tt -125.15 -26.36 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 1.0 110.627 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 98' ' ' ASN . 8.7 p30 -70.73 58.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.212 -0.93 . . . . 1.0 110.475 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.846 HG23 ' HB2' ' A' ' 101' ' ' HIS . 7.8 t -130.91 22.31 4.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.339 -0.851 . . . . 1.0 109.956 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 m120 56.84 24.79 9.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.107 -0.996 . . . . 1.0 110.733 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.846 ' HB2' HG23 ' A' ' 99' ' ' THR . 15.2 m80 -113.23 152.97 29.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.03 . . . . 1.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.632 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 15.6 m95 -74.54 97.21 3.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.095 -1.003 . . . . 1.0 109.93 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.564 HG21 HD12 ' A' ' 97' ' ' ILE . 24.7 m -93.1 141.41 28.44 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.203 -0.999 . . . . 1.0 108.713 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 119' ' ' GLY . 25.5 t60 -98.49 142.49 30.04 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.425 -0.91 . . . . 1.0 108.566 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.656 HG22 HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -140.78 156.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.964 -1.085 . . . . 1.0 110.218 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.707 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -149.21 128.62 13.0 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.426 -0.796 . . . . 1.0 110.016 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -115.25 102.57 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.208 -0.933 . . . . 1.0 110.979 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 108' ' ' TYR . 2.9 p90 -117.38 109.4 16.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 1.0 109.381 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.638 ' HG3' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -103.49 142.86 33.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.35 -0.844 . . . . 1.0 110.848 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 109' ' ' ARG . 1.5 t -127.91 122.46 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.466 -0.771 . . . . 1.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 113' ' ' GLU . 23.1 mt-30 37.83 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 1.0 111.037 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 127' ' ' SER . 11.4 mmt85 65.34 -56.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.356 -0.84 . . . . 1.0 111.738 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.594 ' N ' ' HB3' ' A' ' 127' ' ' SER . 0.0 OUTLIER -67.1 114.72 6.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.945 0.878 . . . . 1.0 111.794 -176.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -100.25 159.19 19.39 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.62 ' O ' ' CE ' ' A' ' 80' ' ' MET . 12.5 t -141.04 148.84 40.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.527 -0.984 . . . . 1.0 109.925 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.918 HD23 ' HG2' ' A' ' 80' ' ' MET . 1.0 OUTLIER -145.81 131.15 18.58 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.036 -1.04 . . . . 1.0 110.042 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.853 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -135.37 145.3 47.21 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.937 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.964 HG11 HG21 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -89.81 113.68 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 52.14 46.09 56.73 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER 65.43 43.44 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -1.085 . . . . 1.0 111.38 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.534 ' HB2' HG12 ' A' ' 118' ' ' VAL . 2.2 mt-10 -105.5 -162.14 0.85 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.251 -0.905 . . . . 1.0 110.643 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.782 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -49.92 115.87 5.68 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.237 -0.915 . . . . 1.0 109.558 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.545 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 46.2 Cg_endo -73.57 119.08 5.75 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.879 1.462 . . . . 1.0 111.672 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.904 HD13 ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -86.32 118.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.686 ' HA ' HD12 ' A' ' 91' ' ' LEU . 12.3 p -126.73 171.65 11.01 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.606 -1.237 . . . . 1.0 113.628 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.512 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 169.51 153.62 8.62 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.513 -2.635 . . . . 1.0 106.513 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.594 ' HB3' ' N ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -119.71 163.48 17.36 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.607 -1.525 . . . . 1.0 111.028 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -67.64 -176.85 0.28 Allowed Pre-proline 0 C--N 1.3 -1.579 0 C-N-CA 119.906 -0.717 . . . . 1.0 109.207 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 131' ' ' GLY . 48.1 Cg_endo -74.59 42.44 0.8 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.548 1.288 . . . . 1.0 110.24 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER 34.63 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.841 0.829 . . . . 1.0 109.991 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -131.9 106.75 0.68 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.958 -1.257 . . . . 1.0 109.958 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 133' ' ' THR . . . 178.17 -54.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.5 -1.0 . . . . 1.0 109.88 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 132' ' ' ALA . 7.4 t 39.73 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.462 -0.773 . . . . 1.0 111.027 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -161.58 111.97 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.056 -1.028 . . . . 1.0 110.714 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.046 HD13 ' HB3' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -166.73 135.32 2.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 1.0 109.369 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 135' ' ' LEU . 14.2 m-20 -140.47 179.58 6.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.331 -0.856 . . . . 1.0 109.415 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.8 t -115.41 132.62 56.56 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.052 -1.03 . . . . 1.0 109.883 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 1.057 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 7.9 p-10 -78.77 13.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 1.0 110.44 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.69 18.38 10.83 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.283 -1.927 . . . . 1.0 108.283 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 1.057 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -136.47 170.34 16.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.443 -1.034 . . . . 1.0 109.937 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.903 ' CD1' HD21 ' A' ' 57' ' ' LEU . 12.3 tp -160.83 155.51 23.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.284 -0.885 . . . . 1.0 110.702 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.649 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 9.9 m95 -131.32 136.76 48.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.662 HD12 ' CB ' ' A' ' 57' ' ' LEU . 5.1 tp -140.97 123.74 16.15 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.593 -1.643 . . . . 1.0 113.321 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.32 1.05 12.63 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 110.098 -1.201 . . . . 1.0 110.098 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 144.05 -129.02 3.48 Favored Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.902 -1.679 . . . . 1.0 108.902 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 1.097 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -171.2 126.63 0.67 Allowed 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.358 -0.937 . . . . 1.0 111.747 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -12.69 27.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 1.0 108.872 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.578 ' N ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -152.73 61.59 0.8 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.097 HD13 ' HB2' ' A' ' 146' ' ' MET . 10.0 tp -64.39 44.33 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.386 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 148' ' ' ARG . 83.7 p -55.0 -28.83 55.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.871 HG21 ' CH2' ' A' ' 58' ' ' TRP 0.29 6.2 p -62.76 -135.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 114.414 -1.267 . . . . 1.0 108.137 177.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.808 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 54.56 18.06 1.87 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.936 -1.102 . . . . 1.0 110.861 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -79.58 0.18 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.942 -1.099 . . . . 1.0 112.928 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.522 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -52.03 -14.04 0.37 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.0 112.234 -177.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.73 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.6 pp -99.61 168.75 9.06 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.842 -1.162 . . . . 1.0 110.337 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 43.6 Cg_endo -68.33 -176.73 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.55 1.29 . . . . 1.0 113.228 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -62.05 -13.95 31.29 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.977 -0.556 . . . . 1.0 112.27 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -41.13 -35.12 0.53 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 1.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 1.208 ' CE2' HD13 ' A' ' 55' ' ' LEU . 5.4 m-85 -83.94 -30.12 26.54 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.32 -0.952 . . . . 1.0 109.766 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -68.67 -8.9 46.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.796 -1.162 . . . . 1.0 108.895 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -128.8 86.43 2.44 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -39.63 164.31 0.01 OUTLIER Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.212 -1.155 . . . . 1.0 110.212 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.693 ' CE1' HG22 ' A' ' 49' ' ' THR . 35.9 t80 -79.14 144.03 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.027 -1.278 . . . . 1.0 111.396 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 1.0 HG23 ' HA ' ' A' ' 20' ' ' ASP . 2.9 mt -128.98 68.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.644 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -148.83 -162.62 10.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.913 -2.075 . . . . 1.0 107.913 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.504 ' C ' HG13 ' A' ' 167' ' ' ILE . 13.4 m -118.97 148.05 43.4 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.405 -1.644 . . . . 1.0 111.138 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.74 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -131.95 151.14 34.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.651 -0.656 . . . . 1.0 109.504 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.55 ' NH2' HD13 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -161.6 151.75 17.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 1.0 110.178 -178.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.538 ' N ' ' HD3' ' A' ' 168' ' ' ARG . 36.1 m-20 56.44 75.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.455 -0.778 . . . . 1.0 109.972 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.977 HG12 ' CB ' ' A' ' 45' ' ' LEU . 26.9 m -128.32 122.45 57.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.699 -0.801 . . . . 1.0 109.559 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.493 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -132.73 156.59 42.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.459 -0.896 . . . . 1.0 111.124 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.717 HG22 ' CD2' ' A' ' 43' ' ' PHE . 6.6 t -134.35 104.65 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.7 OUTLIER 50.31 40.66 23.05 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.455 -1.403 . . . . 1.0 107.477 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER 72.7 27.68 2.23 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.054 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 29.0 mt-30 -103.08 177.66 4.78 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.039 -1.038 . . . . 1.0 110.703 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 6.0 tt0 66.12 -105.36 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.826 -0.547 . . . . 1.0 110.923 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 67.01 -58.11 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.301 -0.874 . . . . 1.0 111.232 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.576 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.3 m-70 -80.34 73.73 7.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.763 -1.21 . . . . 1.0 110.135 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 3.6 mt -49.8 -58.85 4.55 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.152 0.977 . . . . 1.0 112.217 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.587 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 30.1 t -74.39 -19.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.576 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.5 mt-10 -67.55 -62.26 1.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.351 -1.468 . . . . 1.0 110.002 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -71.84 -19.61 61.95 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 1.0 109.2 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -68.44 -27.42 66.16 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.508 -0.877 . . . . 1.0 108.81 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 184' ' ' LEU . 10.5 mt -57.66 -16.46 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 1.0 109.178 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -57.97 -14.61 6.71 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.496 -0.752 . . . . 1.0 109.699 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.54 ' O ' HD11 ' A' ' 189' ' ' ILE . 13.0 t30 -127.42 148.88 68.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.52 -0.737 . . . . 1.0 109.1 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' HG13 ' A' ' 189' ' ' ILE . 46.9 Cg_endo -73.63 -44.81 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.701 1.369 . . . . 1.0 110.81 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.07 103.1 0.7 Allowed 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.637 0.732 . . . . 1.0 110.639 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.54 HD11 ' O ' ' A' ' 186' ' ' ASN . 6.5 mt -144.46 98.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 18' ' ' ALA . 33.9 mt -111.92 152.6 27.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 1.0 110.81 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 8.1 m-70 -95.84 -174.61 3.18 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.469 -0.769 . . . . 1.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 1.0 110.476 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.581 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.5 pt-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.297 0.57 . . . . 1.0 110.858 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -68.35 158.22 33.98 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.136 -1.603 . . . . 1.0 109.487 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.012 HG21 ' CE ' ' A' ' 25' ' ' MET . 17.3 mm -136.92 108.96 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.027 -1.046 . . . . 1.0 110.579 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 190' ' ' LEU . . . -78.82 138.4 38.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.741 . . . . 1.0 110.234 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.781 ' CE1' HD12 ' A' ' 167' ' ' ILE . 3.7 m-85 -104.16 175.36 5.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 1.0 109.633 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 1.9 p30 -128.37 -14.43 4.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 1.0 111.084 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 115.51 -13.84 18.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.909 -1.677 . . . . 1.0 108.909 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.91 15.11 4.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.44 -1.035 . . . . 1.0 109.109 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 24' ' ' TYR . 3.1 m -75.63 174.65 9.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.596 -0.69 . . . . 1.0 110.185 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.548 ' OH ' ' N ' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -147.62 103.67 3.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.526 -0.734 . . . . 1.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 1.012 ' CE ' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -99.35 101.53 12.85 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.774 -1.204 . . . . 1.0 109.186 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.513 ' HG2' ' CE3' ' A' ' 142' ' ' TRP . 14.9 mt-10 -95.88 136.72 35.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 1.0 109.485 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.599 ' CE2' ' HG3' ' A' ' 25' ' ' MET . 69.8 m-85 -131.29 99.05 4.72 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.216 -0.994 . . . . 1.0 110.475 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.45 118.69 37.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 1.0 110.215 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.464 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 12.1 t-20 -140.44 156.73 46.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 1.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.67 149.14 23.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.961 . . . . 1.0 110.142 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 1.0 109.907 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.499 2.025 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -171.07 167.87 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.252 -1.53 . . . . 1.0 111.38 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -138.79 116.04 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.689 ' O ' HG23 ' A' ' 172' ' ' VAL . 0.3 OUTLIER -89.96 143.67 26.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.118 -0.989 . . . . 1.0 110.956 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.657 ' CE1' HG21 ' A' ' 172' ' ' VAL . 51.2 m-85 -138.17 106.85 5.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.637 -0.664 . . . . 1.0 110.074 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.57 ' C ' HD23 ' A' ' 45' ' ' LEU . 3.5 mt-10 -114.78 145.82 41.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.98 -1.075 . . . . 1.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.81 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -179.45 152.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.529 -0.868 . . . . 1.0 111.244 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 103' ' ' THR . 1.5 m -118.52 152.71 35.46 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.48 HD13 HD11 ' A' ' 105' ' ' ILE . 2.2 pt -148.34 157.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 117.897 -1.521 . . . . 1.0 112.152 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.616 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 2.5 tttt -113.15 84.3 1.98 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.58 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -67.31 147.25 53.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 1.0 111.193 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.753 ' HB2' HG22 ' A' ' 164' ' ' ILE . 2.3 mm-40 -129.34 6.79 5.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.808 -0.757 . . . . 1.0 111.0 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.862 ' O ' HG23 ' A' ' 52' ' ' THR . . . -134.77 -85.97 0.4 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.91 -1.119 . . . . 1.0 110.624 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.001 HG22 ' CA ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER 155.98 -25.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.88 139.03 54.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.716 -0.615 . . . . 1.0 109.419 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 158.67 135.88 1.96 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.436 -1.364 . . . . 1.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.76 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -85.33 121.53 28.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 1.0 108.963 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.827 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -96.66 -29.25 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.782 -0.574 . . . . 1.0 112.482 -176.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.086 HD13 HD12 ' A' ' 71' ' ' LEU . 6.4 tt -147.73 152.9 38.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.39 -1.444 . . . . 1.0 113.145 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.958 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 4.2 t-105 -162.61 107.26 1.14 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.589 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.51 149.6 42.16 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.13 -0.981 . . . . 1.0 108.784 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.577 0 C-N-CA 119.313 -1.422 . . . . 1.0 110.846 -179.283 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.591 ' CZ ' ' O ' ' A' ' 84' ' ' LEU . 10.1 m-85 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 113.159 0.8 . . . . 1.0 113.159 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 68' ' ' TYR . 5.5 mm -148.01 153.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.839 -1.788 . . . . 1.0 113.566 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.737 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -177.69 166.58 2.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.086 HD12 HD13 ' A' ' 57' ' ' LEU . 93.4 mt -150.72 99.83 2.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.445 -1.41 . . . . 1.0 109.945 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.581 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -114.06 175.09 5.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.306 -0.871 . . . . 1.0 111.837 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.949 HG12 HG13 ' A' ' 78' ' ' VAL . 20.4 mt -115.34 138.3 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.827 -0.546 . . . . 1.0 110.056 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.509 HG11 ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -141.23 125.3 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 110.516 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 5.9 m-20 62.77 33.98 14.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.335 -0.853 . . . . 1.0 111.739 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 1.001 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 81.43 8.08 87.52 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.741 -1.219 . . . . 1.0 110.41 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 74' ' ' VAL . 46.3 m-85 -129.36 165.89 20.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.272 . . . . 1.0 109.382 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.949 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -116.05 164.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 1.0 110.679 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.552 ' OE1' HG21 ' A' ' 90' ' ' VAL . 6.9 pt20 -149.66 133.3 16.77 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.565 -0.854 . . . . 1.0 111.432 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.971 ' CE ' HD12 ' A' ' 91' ' ' LEU . 6.7 tmm? -99.24 120.12 39.02 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.737 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 7.3 ptt? -120.24 143.54 48.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.87 -1.144 . . . . 1.0 111.569 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.887 ' CZ ' HG11 ' A' ' 89' ' ' VAL . 19.6 p90 -139.85 129.03 23.81 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.531 -1.268 . . . . 1.0 110.905 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 86' ' ' SER . 66.7 t0 -120.45 60.82 0.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.232 1.015 . . . . 1.0 109.378 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.642 HD21 ' CD1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -38.35 -35.65 0.19 Allowed 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.705 -179.062 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.28 -54.77 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.527 -1.32 . . . . 1.0 110.887 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 3.4 t -163.28 -22.84 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.393 . . . . 1.0 112.269 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.522 ' HD2' ' HG3' ' A' ' 129' ' ' PRO . 4.7 mmtp -98.86 100.58 10.02 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.66 -1.275 . . . . 1.0 110.21 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 86' ' ' SER . 47.0 Cg_endo -72.5 141.96 35.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.926 1.487 . . . . 1.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.887 HG11 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.97 126.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.552 HG21 ' OE1' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -103.93 120.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 117.802 -1.559 . . . . 1.0 110.328 178.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.971 HD12 ' CE ' ' A' ' 80' ' ' MET . 33.3 mt -113.09 71.94 0.76 Allowed 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.687 ' O ' HG21 ' A' ' 124' ' ' ILE . 2.9 mtt180 -58.7 179.16 0.09 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.138 0.971 . . . . 1.0 110.822 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.558 ' HA ' HD13 ' A' ' 124' ' ' ILE . 1.6 t -105.82 155.77 18.98 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.721 -0.612 . . . . 1.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.804 ' HB ' HD11 ' A' ' 124' ' ' ILE . 15.2 t -111.19 26.87 10.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 1.0 109.912 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.802 ' CB ' HG11 ' A' ' 118' ' ' VAL . 8.3 t -133.77 147.38 64.11 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.445 -0.785 . . . . 1.0 109.62 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.7 Cg_endo -67.47 138.32 45.69 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.629 1.331 . . . . 1.0 110.554 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.79 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -126.91 -30.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 1.0 110.686 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.462 HD22 HG23 ' A' ' 52' ' ' THR . 31.2 p-10 -72.54 62.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 1.0 110.52 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 101' ' ' HIS . 15.2 t -124.86 13.18 8.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 1.0 109.868 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.474 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 0.7 OUTLIER 62.95 10.6 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.239 -0.913 . . . . 1.0 111.236 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.47 ' H ' HG23 ' A' ' 99' ' ' THR . 2.6 m-70 -102.51 175.15 5.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.87 -1.143 . . . . 1.0 110.288 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.616 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 27.0 m95 -92.95 105.84 17.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.9 . . . . 1.0 110.074 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 104' ' ' HIS . 47.4 m -99.31 171.06 8.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.274 -0.891 . . . . 1.0 109.597 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.593 ' N ' HG22 ' A' ' 103' ' ' THR . 12.0 t-80 -125.02 130.18 51.81 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.085 -1.009 . . . . 1.0 108.423 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 47' ' ' ILE . 1.9 mt -123.46 159.6 27.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.128 -0.982 . . . . 1.0 110.123 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.882 ' O ' HD22 ' A' ' 116' ' ' LEU . 1.8 tppt? -149.84 147.99 28.63 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.184 -1.006 . . . . 1.0 110.039 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -151.52 108.3 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.604 -0.685 . . . . 1.0 109.954 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 20.0 p90 -120.88 105.39 10.65 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.05 -1.06 . . . . 1.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.622 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 3.8 ttp180 -72.17 123.84 23.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.575 -0.703 . . . . 1.0 110.006 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' GLN . 3.6 t -110.08 88.51 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.076 -1.015 . . . . 1.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 0.0 OUTLIER 35.4 103.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.144 0.497 . . . . 1.0 110.934 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.574 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 66.1 -53.71 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.286 -0.884 . . . . 1.0 110.235 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.591 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.6 tt0 -87.08 120.88 28.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.756 -1.215 . . . . 1.0 110.811 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.28 161.83 12.56 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.929 -1.129 . . . . 1.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 15.5 t -136.43 162.11 33.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.307 -1.114 . . . . 1.0 111.174 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.008 HD13 ' N ' ' A' ' 117' ' ' GLN . 1.4 tm? -147.4 139.15 24.11 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 1.008 ' N ' HD13 ' A' ' 116' ' ' LEU . 3.6 mt-30 -142.83 146.26 33.99 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.686 -1.205 . . . . 1.0 111.67 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.802 HG11 ' CB ' ' A' ' 95' ' ' VAL . 1.8 t -104.19 101.69 12.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.498 -1.667 . . . . 1.0 106.498 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 70.65 33.5 67.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.717 -1.753 . . . . 1.0 108.717 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.27 38.07 26.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.518 -0.99 . . . . 1.0 110.312 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -108.77 -156.97 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.66 -0.65 . . . . 1.0 110.826 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.91 99.66 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.709 -0.62 . . . . 1.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.59 ' HB3' ' CG ' ' A' ' 117' ' ' GLN . 48.5 Cg_endo -73.23 131.36 16.42 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 O-C-N 124.314 1.691 . . . . 1.0 112.009 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.804 HD11 ' HB ' ' A' ' 94' ' ' THR . 0.4 OUTLIER -97.19 101.96 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 176.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.43 HG22 ' CB ' ' A' ' 115' ' ' SER . 61.4 p -107.07 170.6 7.85 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.154 0.978 . . . . 1.0 112.023 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.66 157.6 18.89 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 107.644 -2.183 . . . . 1.0 107.644 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.591 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -133.63 162.66 31.32 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.866 -1.373 . . . . 1.0 110.275 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 5.0 p -90.08 172.18 7.46 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 1.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.522 ' HG3' ' HD2' ' A' ' 87' ' ' LYS . 51.6 Cg_endo -80.82 36.58 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.728 1.383 . . . . 1.0 109.133 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.422 HD12 ' NH1' ' A' ' 112' ' ' ARG . 1.5 mt 43.8 -162.91 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.5 -0.75 . . . . 1.0 110.307 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.02 -29.69 11.95 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.54 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.438 -1.036 . . . . 1.0 109.747 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -154.4 97.61 2.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 1.0 110.281 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 133' ' ' THR . 1.3 tt0 43.76 -158.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 1.0 110.131 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.607 ' O ' HD23 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -160.31 104.08 1.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 1.0 110.348 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -92.55 176.5 6.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 1.0 109.514 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 t -138.15 136.58 36.82 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.891 -1.131 . . . . 1.0 110.055 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.75 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 44.9 p-10 -89.06 22.78 2.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 1.0 109.457 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 52.52 18.15 5.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.943 -1.663 . . . . 1.0 108.943 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -109.63 150.18 28.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 1.0 109.273 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.925 HD11 ' CG ' ' A' ' 57' ' ' LEU . 7.4 tp -160.66 156.35 25.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 1.0 111.122 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.536 ' N ' ' HG ' ' A' ' 141' ' ' LEU . 76.5 m95 -131.7 105.43 7.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.919 -1.512 . . . . 1.0 106.919 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.838 HD13 HD12 ' A' ' 57' ' ' LEU . 3.6 tp -116.95 116.42 27.37 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.24 -1.384 . . . . 1.0 113.602 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 132.29 -1.04 4.86 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 119.668 -1.253 . . . . 1.0 110.638 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.536 ' O ' ' SD ' ' A' ' 146' ' ' MET . . . 154.37 -154.95 25.87 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 117.956 -2.069 . . . . 1.0 109.731 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.955 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -154.05 139.38 17.61 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.254 -0.978 . . . . 1.0 112.941 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.548 ' N ' ' OH ' ' A' ' 24' ' ' TYR . 40.9 tt0 -68.43 -50.91 49.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.582 0.706 . . . . 1.0 109.665 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -116.15 69.8 0.75 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.541 -1.281 . . . . 1.0 107.541 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.955 HD13 ' CB ' ' A' ' 146' ' ' MET . 0.1 OUTLIER -65.33 49.52 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.439 -0.788 . . . . 1.0 112.976 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 148' ' ' ARG . 88.0 p -83.34 -10.08 58.69 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.975 -1.861 . . . . 1.0 105.975 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.958 HG21 ' CZ3' ' A' ' 58' ' ' TRP . 4.9 p -79.86 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 115.227 -0.897 . . . . 1.0 110.336 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.797 ' HB1' ' O ' ' A' ' 155' ' ' LEU . . . 53.18 38.17 26.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.326 -1.484 . . . . 1.0 108.546 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.477 ' C ' ' O ' ' A' ' 152' ' ' ALA . 59.8 m170 3.92 -95.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.771 1.397 . . . . 1.0 114.771 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.463 ' CE ' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -98.31 26.59 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 1.0 112.739 -176.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 1.007 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -156.55 131.81 5.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 120.649 -1.282 . . . . 1.0 110.031 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.59 ' N ' HD12 ' A' ' 155' ' ' LEU . 55.1 Cg_endo -92.14 -66.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.793 1.418 . . . . 1.0 113.747 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.49 -56.9 15.43 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 114.403 1.26 . . . . 1.0 114.403 -176.062 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 1.007 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -41.38 -41.23 1.93 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.44 -1.413 . . . . 1.0 108.103 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.799 ' HD2' HD11 ' A' ' 149' ' ' LEU . 21.8 m-85 -83.27 -32.13 26.57 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.957 -1.097 . . . . 1.0 108.141 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.657 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -67.71 -10.51 53.15 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.107 -1.037 . . . . 1.0 109.079 178.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.499 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.4 m -129.56 99.33 5.13 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -49.76 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.655 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 19.3 t80 -79.76 148.19 31.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -1.175 . . . . 1.0 112.49 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.753 HG22 ' HB2' ' A' ' 50' ' ' GLU . 3.8 mt -124.94 82.32 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.655 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.48 -163.49 26.4 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.533 -1.827 . . . . 1.0 108.533 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 24.1 m -122.88 151.02 42.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.012 -1.287 . . . . 1.0 110.431 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -127.35 152.37 35.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.46 ' NH1' ' OD2' ' A' ' 169' ' ' ASP . 13.9 ttt-85 -159.09 148.37 18.64 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.049 -1.06 . . . . 1.0 110.721 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 93.6 m-20 52.5 84.52 0.05 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.877 -0.729 . . . . 1.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.81 HG12 ' CB ' ' A' ' 45' ' ' LEU . 20.7 m -127.78 131.2 70.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 C-N-CA 119.586 -0.845 . . . . 1.0 108.889 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.447 HG12 ' C ' ' A' ' 170' ' ' VAL . 0.0 OUTLIER -145.91 144.43 20.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 118.964 -1.094 . . . . 1.0 111.237 -177.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 175' ' ' GLN . 3.0 p -132.14 121.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 28.8 m-20 47.59 31.68 2.16 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.721 -1.237 . . . . 1.0 108.634 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 76.04 10.37 3.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.794 -0.566 . . . . 1.0 111.413 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.767 ' HB2' HG13 ' A' ' 172' ' ' VAL . 1.6 mp0 -91.84 -171.89 3.01 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.944 -1.098 . . . . 1.0 109.851 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.668 ' HG2' HG23 ' A' ' 170' ' ' VAL . 1.2 tt0 72.52 -107.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.614 -0.679 . . . . 1.0 110.084 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 67.18 -83.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.038 -1.039 . . . . 1.0 112.227 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.0 m-70 -60.75 84.75 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.947 -1.096 . . . . 1.0 111.079 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -55.74 -58.15 9.05 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.216 1.007 . . . . 1.0 111.354 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.969 ' O ' HD13 ' A' ' 184' ' ' LEU . 85.9 t -65.29 -23.56 33.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.898 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.2 mt-10 -63.6 -52.32 61.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.283 -1.511 . . . . 1.0 110.327 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.573 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 3.6 m-20 -94.98 -3.12 49.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.234 -0.916 . . . . 1.0 110.216 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -78.24 -28.91 47.92 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.263 -0.975 . . . . 1.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.969 HD13 ' O ' ' A' ' 180' ' ' VAL . 8.1 mp -59.27 -15.3 14.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 1.0 109.173 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 4.2 t-20 -51.23 -24.09 4.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.465 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 3.6 t30 -97.3 148.79 34.92 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.465 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 41.3 Cg_endo -67.48 -55.38 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.658 1.346 . . . . 1.0 111.588 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.437 ' C ' HG13 ' A' ' 189' ' ' ILE . 5.1 m -101.46 132.4 47.08 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.371 -0.831 . . . . 1.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.437 HG13 ' C ' ' A' ' 188' ' ' THR . 3.8 mt -130.46 111.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.73 . . . . 1.0 109.494 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.74 175.92 8.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.267 -0.896 . . . . 1.0 109.338 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.59 18.85 4.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.581 -1.247 . . . . 1.0 111.109 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.44 ' CA ' ' HB2' ' A' ' 18' ' ' ALA . 1.5 t . . . . . 0 C--N 1.299 -1.609 0 O-C-N 121.308 -0.87 . . . . 1.0 109.71 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.0 tt0 . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.383 0.611 . . . . 1.0 109.457 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.464 ' C ' HD13 ' A' ' 17' ' ' ILE . . . -116.49 138.26 51.52 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.471 -0.768 . . . . 1.0 111.356 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.638 HG13 HD23 ' A' ' 179' ' ' LEU . 0.8 OUTLIER -123.22 146.53 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.998 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -113.53 122.79 48.31 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.21 -0.931 . . . . 1.0 111.153 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.743 ' CE2' HD13 ' A' ' 167' ' ' ILE . 8.5 m-30 -87.88 148.03 24.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.457 -0.777 . . . . 1.0 109.3 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.475 ' OD1' ' HB ' ' A' ' 23' ' ' THR . 7.0 p-10 -103.4 2.47 33.92 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.181 -0.949 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.86 65.21 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.303 -1.519 . . . . 1.0 109.303 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.48 23.35 4.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -1.207 . . . . 1.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.475 ' HB ' ' OD1' ' A' ' 20' ' ' ASP . 5.2 t -109.55 163.26 13.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.898 . . . . 1.0 110.066 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.58 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 14.7 p90 -147.04 123.22 10.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 1.0 110.301 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.545 ' HE1' HG21 ' A' ' 17' ' ' ILE . 4.6 mtt -98.48 99.95 11.16 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.778 -1.201 . . . . 1.0 109.364 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 14.1 tt0 -88.87 98.51 11.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.509 -0.744 . . . . 1.0 109.989 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 13.1 m-30 -96.58 111.69 23.73 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.989 -1.07 . . . . 1.0 110.589 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -104.24 118.03 35.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.449 -0.782 . . . . 1.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 139' ' ' GLY . 9.4 m-20 -140.41 128.45 22.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 1.0 110.391 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.2 141.54 38.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 1.0 109.499 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 31' ' ' VAL . 8.7 p . . . . . 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.094 . . . . 1.0 111.027 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.383 0.611 . . . . 1.0 109.889 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.1 p -157.85 155.36 29.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 1.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 1.7 m-20 -131.66 160.15 36.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 1.0 110.486 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 20.8 m-70 -130.43 115.99 17.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 1.0 109.952 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.893 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 23.1 m-30 -119.5 114.81 22.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.179 -0.951 . . . . 1.0 109.816 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.856 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.4 mp0 -125.21 140.65 52.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 1.0 110.794 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.917 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.6 OUTLIER 179.84 159.26 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.098 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.507 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.64 161.19 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.507 ' CG2' ' C ' ' A' ' 46' ' ' SER . 7.4 pt -150.29 170.87 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 117.995 -1.482 . . . . 1.0 112.615 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 4.1 tttm -131.82 85.35 2.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.5 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -72.01 156.42 39.24 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.045 -1.034 . . . . 1.0 111.609 -177.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.1 mm-40 -136.9 -4.84 1.94 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.222 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.875 ' O ' HG23 ' A' ' 52' ' ' THR . . . -125.79 -82.54 0.63 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.144 -0.972 . . . . 1.0 110.429 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 158.57 -20.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.255 0.55 . . . . 1.0 109.641 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -130.2 146.46 51.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 1.0 110.353 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 149.2 135.11 2.45 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.047 HD13 ' CZ ' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -82.31 132.42 35.22 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.943 -1.327 . . . . 1.0 110.008 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.031 HD12 ' HA ' ' A' ' 72' ' ' ALA . 3.9 mp -97.84 -8.8 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 1.0 111.391 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.893 HD13 HD13 ' A' ' 71' ' ' LEU 0.292 6.5 tt -168.96 146.08 3.66 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 117.643 -1.623 . . . . 1.0 113.012 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 1.004 ' CE2' HG21 ' A' ' 151' ' ' VAL . 12.5 t-105 -150.89 118.2 6.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.661 . . . . 1.0 109.318 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.01 122.98 29.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.075 -1.016 . . . . 1.0 109.874 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.158 -1.577 . . . . 1.0 109.158 -179.908 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.63 ' CZ ' ' CB ' ' A' ' 83' ' ' ASP . 7.8 p90 . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 122.024 0.916 . . . . 1.0 109.953 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.905 HD11 HD21 ' A' ' 135' ' ' LEU . 5.2 mt -146.14 119.27 2.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.646 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.943 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -140.95 -178.05 5.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.753 -1.217 . . . . 1.0 110.68 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.893 HD13 HD13 ' A' ' 57' ' ' LEU . 3.6 mp -149.24 116.06 5.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 1.031 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -129.19 178.87 6.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.173 -0.955 . . . . 1.0 111.842 -178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.992 ' CG1' HD11 ' A' ' 56' ' ' ILE . 4.0 mt -120.43 134.43 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.431 -0.793 . . . . 1.0 109.745 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.601 HG23 ' NE2' ' A' ' 79' ' ' GLN . 1.3 t -141.09 134.03 30.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.203 -0.935 . . . . 1.0 110.367 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 59.66 22.04 10.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.325 -0.859 . . . . 1.0 110.682 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.616 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 84.72 31.61 23.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -146.9 130.3 16.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -1.086 . . . . 1.0 110.079 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.631 ' CG2' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -78.16 -177.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.601 ' NE2' HG23 ' A' ' 74' ' ' VAL . 2.6 pt20 176.5 133.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.664 -1.273 . . . . 1.0 111.491 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.998 ' CE ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -91.14 109.43 20.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 1.0 109.219 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.943 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 8.3 ptt? -94.01 106.35 18.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.917 -1.114 . . . . 1.0 109.779 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.73 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -93.47 127.73 39.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.226 -0.921 . . . . 1.0 109.965 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.63 ' CB ' ' CZ ' ' A' ' 68' ' ' TYR . 5.7 t0 -131.88 43.2 3.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.054 -1.059 . . . . 1.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.867 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -64.37 -10.62 25.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.45 -0.9 . . . . 1.0 110.155 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -139.78 39.23 1.54 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.696 -1.24 . . . . 1.0 110.707 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.27 -8.22 1.37 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -1.201 . . . . 1.0 111.773 179.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 9.4 mmtt -109.12 102.96 50.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 120.783 -1.198 . . . . 1.0 109.76 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 82' ' ' TYR . 45.9 Cg_endo -73.63 105.4 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.219 1.641 . . . . 1.0 110.836 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.73 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -85.21 106.58 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.196 -0.94 . . . . 1.0 109.135 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 90' ' ' VAL . 7.9 p -86.38 81.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.138 -1.602 . . . . 1.0 111.269 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.998 HD12 ' CE ' ' A' ' 80' ' ' MET . 29.1 mt -71.97 70.12 0.75 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.76 ' CG ' HG22 ' A' ' 90' ' ' VAL . 11.5 mtp180 -64.35 171.53 3.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.547 -0.861 . . . . 1.0 110.347 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.2 t -96.96 152.19 18.96 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.788 -0.57 . . . . 1.0 109.761 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 94' ' ' THR . 2.3 t -102.25 26.85 7.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.924 -1.11 . . . . 1.0 109.407 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.562 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 9.0 t -128.31 147.69 64.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 1.0 109.177 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 43.3 Cg_endo -68.03 132.31 25.97 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.533 1.281 . . . . 1.0 110.228 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.631 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -110.94 -30.8 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.867 . . . . 1.0 110.701 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -69.09 61.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.032 -1.042 . . . . 1.0 109.415 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 99' ' ' THR . 19.0 m -122.43 10.34 9.82 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.498 -0.751 . . . . 1.0 109.999 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 99' ' ' THR . 6.8 m120 55.25 15.64 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 1.0 110.515 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.03 172.68 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 1.0 109.435 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.572 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 45.3 m95 -94.7 118.12 31.21 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.075 -1.016 . . . . 1.0 111.004 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 46' ' ' SER . 54.3 m -116.5 152.36 34.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.487 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 65.0 t-80 -101.77 156.73 17.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.882 -1.136 . . . . 1.0 108.987 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.557 HG22 HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -145.84 154.65 13.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.132 -0.98 . . . . 1.0 109.614 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.755 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -148.21 147.62 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 1.0 109.905 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.893 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -139.72 99.19 3.64 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.651 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.637 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 52.6 p90 -110.0 106.83 16.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.958 -1.089 . . . . 1.0 109.136 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.559 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 4.5 tmm_? -94.11 144.7 25.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.543 -0.723 . . . . 1.0 111.28 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 15.4 t -128.56 116.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.8 mm-40 59.19 -89.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 1.0 109.954 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 127' ' ' SER . 2.6 ptt180 -128.08 -28.01 2.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.546 -0.721 . . . . 1.0 110.521 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.576 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 10.6 tt0 -82.47 114.9 21.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 1.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -102.17 156.76 18.54 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.637 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 40.6 t -129.81 151.16 50.69 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.481 -1.011 . . . . 1.0 109.896 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.755 HD22 ' O ' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -148.9 126.32 11.58 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.127 -0.983 . . . . 1.0 110.812 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.673 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -134.66 135.53 42.14 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.849 -1.157 . . . . 1.0 110.254 178.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 118' ' ' VAL . 1.2 t -81.67 101.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 71.29 40.81 60.38 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.011 -1.636 . . . . 1.0 109.011 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 36.0 m-80 61.64 27.68 17.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.467 -1.019 . . . . 1.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 2.4 mt-10 -93.0 -158.12 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.2 -0.937 . . . . 1.0 110.866 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 124' ' ' ILE . . . -41.15 109.92 0.68 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.443 -0.785 . . . . 1.0 109.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.557 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 44.5 Cg_endo -73.28 119.15 5.84 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.977 1.514 . . . . 1.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.726 HG21 ' O ' ' A' ' 92' ' ' ARG . 1.8 mp -95.19 100.07 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.704 -1.591 . . . . 1.0 106.704 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 115' ' ' SER . 12.3 p -109.03 148.99 29.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.177 0.989 . . . . 1.0 112.161 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.488 ' N ' ' CD2' ' A' ' 91' ' ' LEU . . . -152.2 161.31 29.33 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 106.786 -2.526 . . . . 1.0 106.786 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -135.52 159.01 42.94 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.68 -1.483 . . . . 1.0 111.029 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.59 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -94.61 -177.61 0.69 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.669 -0.645 . . . . 1.0 109.634 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 38.1 Cg_endo -64.14 102.25 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.376 -1.432 . . . . 1.0 108.376 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.486 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.3 pp -33.46 153.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.399 0.618 . . . . 1.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 132' ' ' ALA . . . 99.77 -64.92 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.311 -1.516 . . . . 1.0 109.311 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . 39.18 -145.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.477 -1.014 . . . . 1.0 109.842 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 132' ' ' ALA . 2.4 p -154.84 59.59 0.67 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.019 -1.051 . . . . 1.0 110.57 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 133' ' ' THR . 5.2 mt-30 56.94 153.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 1.0 110.078 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.905 HD21 HD11 ' A' ' 69' ' ' ILE . 13.6 tp -135.82 109.61 8.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.978 -1.076 . . . . 1.0 110.654 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.5 m-20 -106.92 158.75 16.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 1.0 109.557 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -113.65 153.28 29.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.075 -1.016 . . . . 1.0 110.281 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.721 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 28.0 p-10 -90.91 27.13 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.268 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 44.75 23.77 0.61 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.712 -1.755 . . . . 1.0 108.712 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.721 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -133.51 152.39 51.9 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.388 -1.066 . . . . 1.0 109.158 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.719 HD11 ' HG ' ' A' ' 57' ' ' LEU . 8.0 tp -158.61 161.36 37.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.105 -0.997 . . . . 1.0 110.703 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.744 ' CE3' ' HE3' ' A' ' 146' ' ' MET . 45.0 m95 -127.59 159.67 33.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.881 HD22 ' O ' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -153.91 118.84 5.02 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 116.873 -1.931 . . . . 1.0 113.801 -177.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.664 ' N ' HD13 ' A' ' 143' ' ' LEU . . . 111.26 5.66 26.37 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.497 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 134.27 -136.22 8.47 Favored Glycine 0 C--N 1.283 -2.366 0 C-N-CA 118.542 -1.789 . . . . 1.0 109.917 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.874 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -167.3 126.1 1.34 Allowed 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.892 -1.123 . . . . 1.0 112.037 -178.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.565 ' HB2' ' CG ' ' A' ' 24' ' ' TYR . 6.5 tp10 -58.74 -19.27 38.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.533 ' N ' ' HD3' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -146.03 69.69 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.468 -1.679 . . . . 1.0 106.468 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.922 HD11 ' CD2' ' A' ' 159' ' ' TYR . 3.5 tp -71.81 41.09 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.55 0.945 . . . . 1.0 113.55 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 p -76.79 -9.56 58.77 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.477 -1.675 . . . . 1.0 106.477 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' CE2' ' A' ' 58' ' ' TRP 0.269 8.2 p -72.66 -26.37 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.044 -0.98 . . . . 1.0 111.238 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.718 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . -40.23 -27.52 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.286 -0.884 . . . . 1.0 110.197 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 151' ' ' VAL . 28.7 m170 70.8 -92.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.324 0.583 . . . . 1.0 110.496 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -139.6 -4.11 1.45 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 111.217 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.766 HD12 ' C ' ' A' ' 155' ' ' LEU . 3.7 pp -47.16 170.01 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 1.0 108.608 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.679 ' O ' HD12 ' A' ' 155' ' ' LEU . 37.6 Cg_endo -61.12 178.4 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.331 1.174 . . . . 1.0 112.173 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -60.42 -6.7 1.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -0.865 . . . . 1.0 111.738 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -42.02 -38.98 1.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.91 -1.119 . . . . 1.0 108.934 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 1.047 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 3.8 m-85 -79.3 -34.0 42.79 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.323 -0.951 . . . . 1.0 109.113 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -65.64 -11.77 47.58 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.337 -0.945 . . . . 1.0 109.597 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -123.89 82.66 2.05 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.581 -0.699 . . . . 1.0 109.302 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 161' ' ' THR . . . -41.04 159.21 0.03 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.64 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 8.4 t80 -76.93 141.64 40.4 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.909 -1.348 . . . . 1.0 112.183 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 164' ' ' ILE . 6.0 mt -121.36 84.69 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.64 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.46 -154.38 9.45 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.427 -1.869 . . . . 1.0 108.427 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.49 ' C ' HG13 ' A' ' 167' ' ' ILE . 3.6 m -130.19 153.7 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.128 -1.219 . . . . 1.0 111.232 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.743 HD13 ' CE2' ' A' ' 19' ' ' PHE . 3.5 mt -134.76 153.19 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 3.6 ttt-85 -158.79 153.98 25.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.624 -1.298 . . . . 1.0 111.538 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 59.8 m-20 50.29 81.64 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.622 -0.674 . . . . 1.0 110.992 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.917 HG12 ' CB ' ' A' ' 45' ' ' LEU . 19.4 m -123.3 130.6 74.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.145 -1.022 . . . . 1.0 110.174 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.509 ' HB ' ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -138.51 144.36 30.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.246 -0.982 . . . . 1.0 110.948 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.557 HG13 ' HE1' ' A' ' 43' ' ' PHE . 70.1 t -127.89 91.22 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 12.3 m-20 57.96 50.87 9.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.574 -1.329 . . . . 1.0 107.855 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 37.6 mmm-85 61.56 34.74 17.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.708 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 3.1 mm100 -112.46 164.51 13.19 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.088 -1.007 . . . . 1.0 109.596 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.696 ' OE2' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER 71.5 -109.94 0.05 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.0 110.563 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 178' ' ' HIS . 0.2 OUTLIER 55.24 11.97 0.62 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 1.0 112.088 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.702 ' CE1' HD11 ' A' ' 177' ' ' LEU . 58.7 m-70 -144.45 75.5 1.46 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.996 -1.065 . . . . 1.0 108.776 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.696 HD12 ' OE2' ' A' ' 176' ' ' GLU 0.25 7.9 mp -54.64 -55.04 33.76 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.199 1.0 . . . . 1.0 111.17 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 4.9 t -63.2 -16.48 17.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.884 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.572 ' CG ' ' HB3' ' A' ' 178' ' ' HIS . 16.1 mt-10 -71.55 -51.54 22.96 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.882 -1.127 . . . . 1.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 82.1 m-20 -96.49 -14.96 21.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.559 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -65.78 -38.12 88.15 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.28 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.0 mt -45.6 -25.75 0.51 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 1.0 109.336 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -53.04 -23.14 6.89 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.155 0.979 . . . . 1.0 108.466 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.545 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 1.7 t-20 -98.72 160.78 27.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.694 -1.224 . . . . 1.0 107.694 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 37.6 Cg_endo -62.94 -157.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.87 0.932 . . . . 1.0 111.119 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 187' ' ' PRO . 7.3 m -36.14 137.43 0.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 1.0 111.228 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.9 mm -86.5 156.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.502 -0.749 . . . . 1.0 109.985 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.6 mt -127.51 152.88 47.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 1.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -107.36 157.5 17.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.305 -0.872 . . . . 1.0 109.618 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.998 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 38.9 t . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.0 111.704 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.49 ' OE1' ' NE2' ' A' ' 191' ' ' HIS . 0.7 OUTLIER . . . . . 0 C--O 1.214 -0.767 0 CA-C-O 121.886 0.851 . . . . 1.0 109.821 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -108.46 148.83 29.62 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.906 -0.496 . . . . 1.0 109.91 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 13.3 mm -121.56 131.69 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 1.0 109.251 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.49 ' HB2' ' CA ' ' A' ' 192' ' ' CYS . . . -96.18 130.1 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 1.0 110.998 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CZ ' ' SD ' ' A' ' 25' ' ' MET . 5.8 m-30 -94.89 174.71 6.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.389 -0.819 . . . . 1.0 109.473 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 10.0 p-10 -127.58 -6.82 5.73 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.235 -0.916 . . . . 1.0 110.546 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.47 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 98.38 -1.66 58.88 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 52.0 ttp85 -134.92 -5.71 2.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.947 -1.326 . . . . 1.0 110.947 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -87.42 140.27 29.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.774 -1.204 . . . . 1.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.423 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 3.0 p90 -112.26 95.21 5.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.298 -0.876 . . . . 1.0 110.188 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.56 ' SD ' ' CZ ' ' A' ' 19' ' ' PHE . 8.7 mtt -77.06 100.76 5.79 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.465 -0.894 . . . . 1.0 109.902 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 3.4 pm0 -107.29 121.91 45.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 1.0 110.606 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 25' ' ' MET . 17.4 m-85 -111.03 107.96 17.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.414 -0.804 . . . . 1.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.95 112.84 24.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 1.0 110.152 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.479 ' OD1' ' OE1' ' A' ' 175' ' ' GLN . 1.7 t-20 -127.77 137.44 52.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 1.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.44 27.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 1.0 110.0 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.004 -1.06 . . . . 1.0 110.412 179.831 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.431 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 3.2 pt20 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.686 0.755 . . . . 1.0 110.688 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.777 ' OG ' HG13 ' A' ' 110' ' ' VAL . 47.8 m -149.25 148.72 29.91 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.376 -0.828 . . . . 1.0 110.454 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -112.02 147.18 36.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 1.0 110.158 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 30.7 m80 -123.01 123.36 40.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 1.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.731 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 26.5 m-85 -122.18 117.83 27.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 1.0 109.535 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.869 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.4 mt-10 -126.74 139.87 52.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 1.0 110.882 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.897 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.4 OUTLIER 179.1 164.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.489 -0.884 . . . . 1.0 111.003 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 103' ' ' THR . 50.0 m -124.7 149.71 46.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.352 -1.351 . . . . 1.0 107.352 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.621 HD13 HD11 ' A' ' 105' ' ' ILE . 3.7 pt -139.36 164.41 24.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.163 -1.415 . . . . 1.0 112.312 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.2 OUTLIER -116.45 86.9 2.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 177.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -72.31 155.67 39.92 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.977 -1.077 . . . . 1.0 111.063 -177.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.4 mm-40 -138.21 10.19 2.77 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.755 -0.778 . . . . 1.0 110.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 52' ' ' THR . . . -140.43 -85.51 0.21 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.117 -0.989 . . . . 1.0 110.61 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.64 -24.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.5 tt0 -125.03 138.19 54.21 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 156.73 138.81 2.6 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.042 -1.623 . . . . 1.0 109.042 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.244 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -88.72 128.32 35.61 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.83 -1.394 . . . . 1.0 109.602 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.796 HG22 HD21 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -90.83 -35.93 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.788 -0.57 . . . . 1.0 112.508 -176.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.084 HD13 HD12 ' A' ' 71' ' ' LEU . 2.3 tt -149.05 146.02 27.55 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.859 -1.151 . . . . 1.0 111.981 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.949 ' N ' HD23 ' A' ' 57' ' ' LEU . 3.5 t-105 -149.09 111.76 4.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.583 -1.266 . . . . 1.0 107.583 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.578 ' OG ' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -118.79 161.4 20.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.873 -1.142 . . . . 1.0 111.394 -178.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 108.504 -1.838 . . . . 1.0 108.504 179.597 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 122.159 0.98 . . . . 1.0 111.983 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.989 HD12 ' N ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -148.26 146.0 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.425 -178.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.113 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -146.63 -175.11 4.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 1.0 110.39 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.084 HD12 HD13 ' A' ' 57' ' ' LEU . 66.3 mt -149.56 126.2 11.0 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.009 -1.108 . . . . 1.0 108.009 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -145.22 173.33 12.04 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.824 -1.172 . . . . 1.0 111.964 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.67 HG12 HG13 ' A' ' 78' ' ' VAL . 16.9 mt -117.56 141.81 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.593 0.711 . . . . 1.0 111.086 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -139.28 130.17 33.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.743 -0.598 . . . . 1.0 110.164 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 1.2 m-20 58.36 21.31 8.19 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.224 -0.922 . . . . 1.0 111.602 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.823 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 92.39 20.05 36.47 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.628 -1.272 . . . . 1.0 110.252 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 76' ' ' GLY . 16.9 m-85 -138.19 144.29 40.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -1.126 . . . . 1.0 109.411 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.755 HG22 HD13 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -79.59 -167.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 1.0 109.103 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER 175.75 102.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 1.0 110.534 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.946 ' CE ' HD12 ' A' ' 91' ' ' LEU . 2.3 ttm -61.68 93.08 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.914 -0.714 . . . . 1.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 1.113 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 11.3 tmm? -89.94 111.29 22.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.804 -0.56 . . . . 1.0 110.005 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.871 ' CE2' HG11 ' A' ' 89' ' ' VAL . 2.8 p90 -143.1 141.29 31.2 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.346 -1.341 . . . . 1.0 110.986 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.53 ' HB3' ' CA ' ' A' ' 88' ' ' PRO . 0.6 OUTLIER -138.52 71.44 1.39 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.668 -0.645 . . . . 1.0 110.132 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.824 HD13 ' CD2' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -67.89 -7.37 27.67 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 120.069 -0.652 . . . . 1.0 110.006 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.62 -57.57 0.37 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.01 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -1.113 . . . . 1.0 110.55 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -110.37 124.48 33.17 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.95 . . . . 1.0 109.739 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.53 ' CA ' ' HB3' ' A' ' 83' ' ' ASP . 48.6 Cg_endo -73.7 139.12 27.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.784 1.413 . . . . 1.0 110.371 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.871 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.52 121.06 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 90' ' ' VAL . 7.2 p -99.06 81.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 118.346 -1.341 . . . . 1.0 111.09 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.946 HD12 ' CE ' ' A' ' 80' ' ' MET . 8.5 mt -76.63 71.33 3.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.622 -1.251 . . . . 1.0 107.622 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.641 ' O ' HG21 ' A' ' 124' ' ' ILE . 38.6 mtp180 -59.1 179.04 0.1 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.192 0.996 . . . . 1.0 111.347 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.864 ' HA ' HD13 ' A' ' 124' ' ' ILE . 3.1 t -114.84 149.1 37.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.45 -0.795 . . . . 1.0 109.904 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 94' ' ' THR . 54.5 m -106.85 34.37 3.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 1.0 109.423 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 1.014 HG11 HG21 ' A' ' 118' ' ' VAL . 0.8 OUTLIER -128.43 151.87 77.31 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.559 -0.713 . . . . 1.0 109.955 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 95' ' ' VAL . 43.5 Cg_endo -69.53 121.41 8.15 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.399 1.21 . . . . 1.0 109.892 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -109.58 -27.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 1.0 110.683 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 6.3 p-10 -82.06 61.11 5.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 1.0 109.847 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 99' ' ' THR . 27.0 m -123.1 14.86 9.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.823 . . . . 1.0 110.195 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.496 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 12.3 t-20 53.54 18.05 1.32 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.937 -1.102 . . . . 1.0 110.108 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 5.5 m80 -116.14 144.59 43.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 1.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.56 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 21.1 m95 -59.44 109.52 0.91 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.437 -0.789 . . . . 1.0 111.138 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 104' ' ' HIS . 2.7 m -98.03 170.52 8.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.597 ' HB3' ' CA ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER -123.08 138.64 54.62 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.042 -1.037 . . . . 1.0 108.244 178.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.621 HD11 HD13 ' A' ' 47' ' ' ILE . 1.2 mt -134.91 149.16 29.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.103 -0.998 . . . . 1.0 109.608 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -148.34 130.19 15.2 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 1.0 109.709 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.731 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -122.46 109.39 14.31 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.263 -0.975 . . . . 1.0 111.295 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.662 ' CE2' ' CB ' ' A' ' 115' ' ' SER . 3.8 p90 -116.48 110.27 18.38 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.236 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.563 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 3.6 ttp180 -125.1 133.92 52.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.381 0.61 . . . . 1.0 110.44 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.777 HG13 ' OG ' ' A' ' 40' ' ' SER . 3.1 t -97.38 89.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 1.0 109.7 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 0.3 OUTLIER 21.24 48.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 4.3 tmm_? 167.96 -55.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.221 -0.924 . . . . 1.0 109.857 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -111.46 120.06 40.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 1.0 109.785 -179.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.06 162.57 15.29 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.946 -1.121 . . . . 1.0 111.618 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.662 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 13.5 t -141.61 155.6 45.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.737 -0.861 . . . . 1.0 109.829 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 117' ' ' GLN . 0.3 OUTLIER -149.65 125.98 10.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 120.956 -1.09 . . . . 1.0 110.908 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.745 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -135.1 134.99 40.85 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 1.014 HG21 HG11 ' A' ' 95' ' ' VAL . 9.9 p -76.2 102.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.597 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . 68.96 30.83 72.21 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 108.819 -1.712 . . . . 1.0 108.819 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 1.0 OUTLIER 72.93 29.99 1.75 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 1.0 110.688 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -97.3 -153.57 0.42 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 110.491 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 124' ' ' ILE . . . -36.81 101.92 0.23 Allowed Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.407 -0.808 . . . . 1.0 110.3 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.57 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 44.9 Cg_endo -71.02 116.65 4.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.57 . . . . 1.0 111.794 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.864 HD13 ' HA ' ' A' ' 93' ' ' SER . 1.2 mp -94.67 99.46 9.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 37.2 p -99.95 174.14 6.33 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.342 1.068 . . . . 1.0 112.39 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.12 154.1 10.15 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.486 -2.246 . . . . 1.0 107.486 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -137.14 167.18 22.04 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.26 -1.141 . . . . 1.0 109.927 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.0 174.75 5.68 Favored Pre-proline 0 C--N 1.3 -1.557 0 C-N-CA 119.089 -1.044 . . . . 1.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 130' ' ' LEU . 49.1 Cg_endo -78.71 43.68 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.735 1.387 . . . . 1.0 109.435 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.2 OUTLIER 42.47 105.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.724 0.773 . . . . 1.0 111.478 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.81 87.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.972 -1.251 . . . . 1.0 109.972 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.716 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -170.95 174.78 4.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -1.101 . . . . 1.0 109.788 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.8 t -179.22 156.98 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 1.0 110.427 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER 69.97 -60.44 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 1.0 111.131 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.824 ' CD2' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -1.18 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.797 0.808 . . . . 1.0 112.064 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.573 ' C ' HG23 ' A' ' 137' ' ' THR . 37.5 m-20 -116.66 149.01 40.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.11 . . . . 1.0 110.038 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.573 HG23 ' C ' ' A' ' 136' ' ' ASP . 33.3 p -154.15 105.91 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 1.0 110.115 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.6 OUTLIER 167.11 -43.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.69 0.757 . . . . 1.0 109.206 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.4 -24.85 7.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.783 -1.327 . . . . 1.0 109.783 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -163.97 135.03 4.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.995 -1.297 . . . . 1.0 110.598 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 57' ' ' LEU . 6.2 tp -135.8 142.72 44.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 1.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 26' ' ' GLU . 44.2 m95 -117.73 148.09 42.35 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.796 HD21 HG22 ' A' ' 56' ' ' ILE . 1.6 tt -148.59 119.55 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 117.644 -1.623 . . . . 1.0 112.995 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.59 9.3 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.77 -1.332 . . . . 1.0 109.77 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 129.94 -148.52 18.5 Favored Glycine 0 C--N 1.287 -2.158 0 N-CA-C 108.024 -2.031 . . . . 1.0 108.024 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.964 ' CB ' HD13 ' A' ' 149' ' ' LEU 0.266 5.6 mmt -152.53 128.78 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.655 -0.818 . . . . 1.0 110.95 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 146' ' ' MET . 5.3 tm-20 -43.53 -50.23 7.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.023 -1.048 . . . . 1.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.723 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -127.88 79.24 1.88 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 123.022 1.392 . . . . 1.0 107.73 177.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.965 HD12 ' CG1' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -62.1 42.79 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.177 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 148' ' ' ARG . 92.9 p -50.81 -32.75 21.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 177.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.965 ' CG1' HD12 ' A' ' 149' ' ' LEU 0.313 7.1 p -65.9 -141.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 113.542 -1.663 . . . . 1.0 106.557 176.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.829 ' HB1' ' CB ' ' A' ' 159' ' ' TYR 0.278 . . 50.63 14.21 0.16 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.597 -1.314 . . . . 1.0 111.508 177.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.79 -45.23 6.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.688 -1.257 . . . . 1.0 111.402 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.491 ' NZ ' ' OD2' ' A' ' 83' ' ' ASP . 2.6 pttt -61.13 -6.69 2.13 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.279 -0.888 . . . . 1.0 111.15 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 1.063 HD11 ' CD1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -121.96 -174.82 0.32 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.904 -1.123 . . . . 1.0 110.781 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.591 ' N ' ' HG ' ' A' ' 155' ' ' LEU . 44.1 Cg_endo -70.19 174.98 9.09 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.626 1.329 . . . . 1.0 112.536 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.9 -11.43 1.45 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.682 -0.636 . . . . 1.0 111.948 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -37.29 -41.03 0.38 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.194 -0.941 . . . . 1.0 109.961 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 1.244 ' CE2' HD13 ' A' ' 55' ' ' LEU . 4.0 m-85 -83.0 -32.97 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.093 -1.043 . . . . 1.0 109.522 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -60.53 -15.47 27.69 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.88 -1.128 . . . . 1.0 108.227 178.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -115.9 83.5 1.95 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.03 163.94 0.01 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.808 -1.317 . . . . 1.0 109.808 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.586 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 20.0 t80 -77.01 142.32 39.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.763 -1.434 . . . . 1.0 111.647 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 164' ' ' ILE . 3.6 mt -123.93 87.15 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.586 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.25 -153.19 9.07 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 108.184 -1.966 . . . . 1.0 108.184 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 9.6 m -135.73 155.14 50.86 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.893 -1.123 . . . . 1.0 110.758 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.6 mt -133.68 153.34 36.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 121.385 -0.822 . . . . 1.0 109.412 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.415 ' HD3' ' O ' ' A' ' 15' ' ' GLU . 11.2 ttp85 -159.09 158.55 33.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.932 -1.105 . . . . 1.0 110.857 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 22.6 m-20 48.92 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.303 -0.873 . . . . 1.0 110.043 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.897 HG12 ' CB ' ' A' ' 45' ' ' LEU . 18.5 m -126.77 131.71 70.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 C-N-CA 119.179 -1.008 . . . . 1.0 110.004 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.92 149.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.579 -0.849 . . . . 1.0 110.511 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 54.4 t -131.46 94.19 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 1.3 m-20 71.44 38.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 74.51 18.1 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.248 0.547 . . . . 1.0 110.127 -179.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.479 ' OE1' ' OD1' ' A' ' 29' ' ' ASN . 7.0 mm-40 -89.09 111.02 21.67 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.344 -0.847 . . . . 1.0 109.732 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.44 106.4 6.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.887 -1.133 . . . . 1.0 109.274 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -89.32 86.96 6.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 1.0 111.077 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.583 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 80.2 m-70 -53.37 104.47 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.174 0.988 . . . . 1.0 109.39 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -46.84 -61.94 1.63 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.166 0.984 . . . . 1.0 109.777 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.752 HG13 HD21 ' A' ' 184' ' ' LEU . 36.2 t -54.04 -21.86 6.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.41 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 13.4 mt-10 -64.95 -53.06 52.32 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.265 -1.374 . . . . 1.0 109.914 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.9 OUTLIER -105.59 -22.48 12.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.009 -1.057 . . . . 1.0 109.731 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -59.39 -35.8 74.61 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.785 -1.197 . . . . 1.0 108.153 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.752 HD21 HG13 ' A' ' 180' ' ' VAL . 1.3 mm? -50.25 -20.73 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.718 . . . . 1.0 109.748 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.3 OUTLIER -52.22 -22.53 4.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 1.0 108.956 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.461 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 8.4 t30 -86.18 149.05 49.02 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 45.2 Cg_endo -72.35 -47.54 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.742 1.391 . . . . 1.0 110.599 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.91 118.99 37.6 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.746 -0.596 . . . . 1.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.571 HD12 HD22 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -117.9 128.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.308 -0.87 . . . . 1.0 109.515 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 19.9 mt -103.23 171.97 7.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.861 . . . . 1.0 110.088 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.599 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -121.72 1.78 10.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.056 -1.027 . . . . 1.0 110.911 -179.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.49 ' CA ' ' HB2' ' A' ' 18' ' ' ALA . 6.3 t . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 1.0 110.623 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 . . . . . 0 C--O 1.215 -0.741 0 N-CA-C 108.893 -0.78 . . . . 1.0 108.893 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.09 131.79 35.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.304 -0.873 . . . . 1.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.514 HG21 ' CE ' ' A' ' 25' ' ' MET . 26.4 mm -127.07 117.95 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 1.0 109.437 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.37 139.94 31.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 1.0 111.318 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.889 ' CD2' HG21 ' A' ' 23' ' ' THR . 8.3 m-85 -108.09 159.92 16.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' C ' HG12 ' A' ' 164' ' ' ILE . 4.1 p-10 -115.8 -3.31 12.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.952 -1.092 . . . . 1.0 110.779 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.478 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 109.49 -18.29 30.15 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 30.39 7.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.585 -0.95 . . . . 1.0 109.182 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.889 HG21 ' CD2' ' A' ' 19' ' ' PHE . 1.9 m -69.87 172.69 7.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 1.0 110.894 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.585 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 10.8 t80 -167.72 74.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.597 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 3.8 mmt -86.95 99.43 11.86 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.845 -1.142 . . . . 1.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.77 136.4 34.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 1.0 108.63 179.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 96.0 m-85 -130.92 104.5 7.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.017 -1.052 . . . . 1.0 110.903 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.536 ' HE2' ' HZ2' ' A' ' 142' ' ' TRP . 22.7 m-70 -108.13 120.21 41.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 1.0 109.576 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -155.31 170.69 21.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 1.0 110.524 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.15 153.88 17.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.412 -0.805 . . . . 1.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.8 p . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 1.0 110.735 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.885 0.85 . . . . 1.0 109.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.7 p -163.6 133.55 4.23 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.704 -0.622 . . . . 1.0 110.342 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.4 OUTLIER -100.93 152.39 20.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 1.0 109.943 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.552 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 11.5 m80 -123.88 138.16 54.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -0.951 . . . . 1.0 110.03 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 1.016 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 21.2 m-85 -134.73 128.03 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 1.0 110.204 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.793 ' C ' HD23 ' A' ' 45' ' ' LEU . 8.2 mt-10 -133.8 148.9 51.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 1.0 110.114 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.994 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.8 OUTLIER 179.26 151.55 0.35 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.395 -0.922 . . . . 1.0 111.158 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.504 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.09 154.11 35.16 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 97' ' ' ILE . 5.5 pt -150.81 173.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 C-N-CA 117.96 -1.496 . . . . 1.0 112.312 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.652 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -127.33 82.92 2.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 178.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -66.86 161.21 24.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.119 -0.988 . . . . 1.0 111.256 -177.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.622 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 8.0 mm-40 -140.81 7.96 2.1 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.531 -0.867 . . . . 1.0 110.939 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 52' ' ' THR . . . -137.04 -86.66 0.31 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.142 -1.023 . . . . 1.0 111.063 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.93 -24.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.302 -0.999 . . . . 1.0 108.302 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -125.01 132.43 53.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.67 -0.644 . . . . 1.0 109.831 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 162.98 137.81 2.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.266 -1.534 . . . . 1.0 109.266 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.755 ' CD2' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -86.07 130.09 34.64 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.903 -1.351 . . . . 1.0 108.305 179.151 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.122 HD11 HG13 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -98.31 -26.27 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.553 -0.717 . . . . 1.0 112.178 -176.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.061 HD13 HD12 ' A' ' 71' ' ' LEU 0.264 7.9 tt -156.88 155.41 31.4 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 117.736 -1.586 . . . . 1.0 113.09 -175.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.811 ' N ' HD23 ' A' ' 57' ' ' LEU . 2.7 t-105 -156.23 114.35 3.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.683 ' OG ' HD21 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -133.89 179.92 5.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.89 -1.132 . . . . 1.0 111.063 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.301 -1.519 . . . . 1.0 109.301 179.896 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.578 ' CG ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 m-30 . . . . . 0 N--CA 1.498 1.941 0 CA-C-O 121.066 0.46 . . . . 1.0 112.211 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 59' ' ' SER . 21.0 mm -98.34 77.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.0 109.24 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.845 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -120.88 179.29 4.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 1.0 111.192 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.061 HD12 HD13 ' A' ' 57' ' ' LEU . 81.8 mt -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.252 -0.905 . . . . 1.0 108.723 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -112.18 178.39 4.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.079 . . . . 1.0 111.671 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.671 HG12 HG13 ' A' ' 78' ' ' VAL . 60.1 mt -129.6 139.58 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.456 -0.778 . . . . 1.0 110.971 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.613 HG13 ' NH1' ' A' ' 92' ' ' ARG . 1.9 p -140.41 139.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.759 -0.588 . . . . 1.0 109.945 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.515 ' OD2' HG22 ' A' ' 74' ' ' VAL . 69.3 m-20 59.13 20.49 8.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 1.0 110.944 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.828 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 88.14 16.54 59.11 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.845 -1.302 . . . . 1.0 109.845 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.421 ' C ' HG23 ' A' ' 73' ' ' ILE . 52.5 m-85 -133.97 135.76 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 1.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.122 HG13 HD11 ' A' ' 56' ' ' ILE . 1.6 t -76.24 177.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 1.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -163.46 127.66 2.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.2 -0.937 . . . . 1.0 110.891 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.803 ' HB2' HD23 ' A' ' 116' ' ' LEU . 8.4 tmm? -82.39 94.52 7.41 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.443 0.64 . . . . 1.0 110.606 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.845 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -73.81 120.56 19.57 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 178.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.667 ' CE1' HD22 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -143.35 91.73 2.3 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.426 -1.71 . . . . 1.0 111.691 -178.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.674 ' C ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.57 152.07 29.31 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.769 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.28 -35.56 1.34 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -103.41 -33.12 4.31 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.666 -1.773 . . . . 1.0 108.666 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 162.02 -12.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.445 -1.032 . . . . 1.0 111.523 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.474 ' C ' ' HB2' ' A' ' 83' ' ' ASP . 3.7 mttt -102.64 96.16 7.16 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.751 -1.218 . . . . 1.0 110.043 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HA ' ' CB ' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -70.42 123.99 10.39 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.065 1.561 . . . . 1.0 110.464 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.54 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -88.89 119.73 36.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 1.0 109.06 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 90' ' ' VAL . 8.7 p -99.29 81.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.667 -1.271 . . . . 1.0 110.529 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.649 HD12 ' CE ' ' A' ' 80' ' ' MET . 10.4 mt -78.15 82.08 4.49 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.613 ' NH1' HG13 ' A' ' 74' ' ' VAL . 1.2 mtt180 -57.9 176.58 0.15 Allowed 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 118.599 -1.24 . . . . 1.0 109.725 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.595 ' HA ' ' CD1' ' A' ' 124' ' ' ILE . 1.8 t -95.26 159.03 15.2 Favored 'General case' 0 C--N 1.286 -2.164 0 O-C-N 121.691 -0.63 . . . . 1.0 110.341 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 8.57 40.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 1.0 109.834 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.893 ' CG2' HG21 ' A' ' 118' ' ' VAL . 21.8 t -130.15 146.78 62.96 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 1.0 109.316 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.538 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.2 Cg_endo -69.76 153.04 69.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.588 1.31 . . . . 1.0 111.101 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -133.14 -27.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.862 . . . . 1.0 111.032 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.486 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 9.1 p30 -72.16 65.0 0.57 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.994 -1.066 . . . . 1.0 111.061 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 101' ' ' HIS . 14.7 t -135.82 18.3 3.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 1.0 109.522 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 50' ' ' GLU . 1.0 OUTLIER 57.31 23.64 9.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.82 . . . . 1.0 111.189 179.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.73 ' HB2' HG23 ' A' ' 99' ' ' THR . 2.8 m80 -112.0 147.71 35.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 1.0 110.007 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.652 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 23.4 m95 -68.21 104.7 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 1.0 110.057 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 104' ' ' HIS . 2.4 m -98.73 172.41 7.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 1.0 109.003 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.609 ' CD2' ' HA2' ' A' ' 119' ' ' GLY . 1.7 t60 -124.62 139.66 53.66 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.477 HD11 HD13 ' A' ' 47' ' ' ILE . 1.2 mt -129.28 157.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 119.193 -1.003 . . . . 1.0 109.19 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.842 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -146.46 156.5 43.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.105 -0.997 . . . . 1.0 109.539 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -158.22 119.46 3.49 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.526 -0.87 . . . . 1.0 110.516 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 2.3 p90 -129.27 107.3 9.43 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.203 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.605 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.4 OUTLIER -83.71 139.97 32.42 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.987 -0.685 . . . . 1.0 109.839 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.3 t -132.59 88.98 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 1.0 110.041 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 38.8 mt-30 44.58 102.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 1.0 111.121 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 5.3 ttt180 64.24 -52.34 0.27 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 1.0 111.423 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.65 ' CB ' ' OG ' ' A' ' 127' ' ' SER . 4.3 pt-20 -82.09 117.97 22.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.596 -1.315 . . . . 1.0 111.386 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.98 152.56 17.11 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.164 -1.174 . . . . 1.0 110.164 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.603 ' OG ' ' CZ ' ' A' ' 108' ' ' TYR . 32.8 t -133.84 161.88 33.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.13 -1.218 . . . . 1.0 111.538 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.051 HD13 ' N ' ' A' ' 117' ' ' GLN 0.252 1.7 tm? -144.24 155.42 43.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 1.051 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -163.02 123.13 2.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.334 -1.346 . . . . 1.0 112.742 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.893 HG21 ' CG2' ' A' ' 95' ' ' VAL . 3.0 m -71.4 106.53 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.639 -1.615 . . . . 1.0 106.639 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.609 ' HA2' ' CD2' ' A' ' 104' ' ' HIS . . . 75.54 -73.75 1.59 Allowed Glycine 0 C--N 1.287 -2.184 0 N-CA-C 108.817 -1.713 . . . . 1.0 108.817 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 3.5 t-20 178.22 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.404 -1.056 . . . . 1.0 109.602 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -96.99 -158.74 0.69 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.584 -0.698 . . . . 1.0 111.064 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -40.2 103.61 0.3 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 1.0 109.653 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 42.2 Cg_endo -71.33 126.45 12.29 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.02 1.537 . . . . 1.0 111.012 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.595 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 1.7 mp -82.46 99.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.824 -1.172 . . . . 1.0 107.901 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 16.4 p -98.18 177.08 5.51 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.057 -1.027 . . . . 1.0 110.838 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 113' ' ' GLU . . . -179.75 -161.86 27.75 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 107.122 -2.391 . . . . 1.0 107.122 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.65 ' OG ' ' CB ' ' A' ' 113' ' ' GLU . 3.5 m -174.71 154.01 1.89 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.099 -1.236 . . . . 1.0 110.721 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.576 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -80.32 -176.87 0.81 Allowed Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 36.0 Cg_endo -63.23 -60.02 0.19 Allowed 'Trans proline' 0 C--N 1.301 -1.96 0 N-CA-C 108.086 -1.544 . . . . 1.0 108.086 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 129' ' ' PRO . 3.4 pp 152.56 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.631 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.479 ' N ' HD12 ' A' ' 130' ' ' LEU . . . 77.45 -73.16 2.07 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 84' ' ' LEU . . . -64.43 75.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 1.0 110.199 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 131' ' ' GLY . 7.0 m -86.97 -23.82 24.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 1.0 110.133 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -100.43 121.49 41.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 1.0 110.124 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 135' ' ' LEU . 3.1 tm? -155.81 106.68 2.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 1.0 109.808 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.63 136.73 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 1.0 110.429 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -157.4 106.21 2.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 1.0 110.255 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 137' ' ' THR . 2.6 p30 161.28 -32.53 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.589 -0.695 . . . . 1.0 109.785 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -53.22 -21.38 11.62 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -143.64 164.89 29.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.346 . . . . 1.0 110.637 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 142' ' ' TRP . 9.1 tp -160.13 142.49 13.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 1.0 110.754 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 25.5 m95 -132.23 147.27 52.4 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.172 -1.418 . . . . 1.0 107.172 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.94 HD23 HD12 ' A' ' 57' ' ' LEU . 1.4 tm? -153.1 117.72 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.705 -1.598 . . . . 1.0 113.305 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.622 ' N ' HD13 ' A' ' 143' ' ' LEU . . . 119.38 5.12 11.59 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.323 -1.111 . . . . 1.0 110.323 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 139.89 -133.31 5.98 Favored Glycine 0 C--N 1.289 -2.075 0 C-N-CA 118.624 -1.751 . . . . 1.0 109.668 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.64 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -168.99 142.18 2.81 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.515 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.545 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 4.6 tm-20 -71.72 -26.98 62.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.51 -1.293 . . . . 1.0 107.51 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.501 ' O ' ' CG ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.82 80.36 1.69 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.845 HD23 ' O ' ' A' ' 159' ' ' TYR . 0.3 OUTLIER -69.83 36.44 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.406 -0.809 . . . . 1.0 113.178 -176.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -71.27 -11.13 60.75 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.669 HG21 ' CZ2' ' A' ' 58' ' ' TRP 0.26 10.5 p -79.74 -9.64 12.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.212 -0.903 . . . . 1.0 110.676 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 153' ' ' HIS . . . -70.11 51.99 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 1.0 109.867 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.665 ' N ' ' CD2' ' A' ' 153' ' ' HIS . 1.8 p80 4.26 -86.29 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.688 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -160.77 100.2 1.27 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 123.299 1.523 . . . . 1.0 109.19 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.783 HD21 ' HD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -154.0 175.54 2.99 Favored Pre-proline 0 C--N 1.283 -2.314 0 O-C-N 120.843 -1.16 . . . . 1.0 109.756 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.732 ' O ' HD22 ' A' ' 155' ' ' LEU . 37.0 Cg_endo -61.29 -178.14 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 122.851 0.921 . . . . 1.0 111.572 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -55.61 -11.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.383 -0.823 . . . . 1.0 112.064 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.699 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -36.23 -43.77 0.37 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.915 . . . . 1.0 109.859 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.845 ' O ' HD23 ' A' ' 149' ' ' LEU . 8.9 m-85 -86.4 -27.7 24.03 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 1.0 109.384 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -75.8 -3.49 35.28 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.657 -1.217 . . . . 1.0 108.243 177.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 161' ' ' THR . 1.8 m -135.35 91.53 2.74 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.26 170.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 1.0 110.069 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.657 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 13.3 t80 -74.18 147.15 42.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.146 -1.208 . . . . 1.0 112.295 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.772 HG22 ' O ' ' A' ' 164' ' ' ILE . 3.6 mt -124.28 87.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.657 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.64 -153.9 9.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.147 -1.581 . . . . 1.0 109.147 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 48' ' ' LYS . 39.4 m -130.5 146.29 52.01 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.387 -1.066 . . . . 1.0 110.457 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.854 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -129.62 150.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.348 -0.845 . . . . 1.0 110.655 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 170' ' ' VAL . 9.4 ttt180 -159.49 168.47 26.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.012 -1.055 . . . . 1.0 110.452 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 14.2 m-20 44.63 58.87 3.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.895 . . . . 1.0 110.38 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.994 HG12 ' CB ' ' A' ' 45' ' ' LEU . 24.2 m -114.19 121.73 66.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.66 -0.816 . . . . 1.0 109.677 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.52 HG13 ' C ' ' A' ' 170' ' ' VAL . 1.0 OUTLIER -134.49 155.74 39.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.352 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.887 HG22 ' CD1' ' A' ' 43' ' ' PHE . 3.2 t -134.72 106.48 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 53.8 m-20 49.91 36.57 11.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.334 -1.479 . . . . 1.0 107.302 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 76.33 22.33 1.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.841 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 176' ' ' GLU . 21.6 mt-30 -99.34 -171.94 2.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.941 -1.1 . . . . 1.0 110.408 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.616 ' HG2' HG23 ' A' ' 170' ' ' VAL . 10.5 tt0 72.49 -102.77 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.675 -0.641 . . . . 1.0 110.801 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.1 mt 68.6 -92.98 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.43 -0.794 . . . . 1.0 112.479 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 88.3 m-70 -89.51 103.86 16.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.667 -1.271 . . . . 1.0 112.486 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.1 OUTLIER -68.67 -48.71 63.26 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 177.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.449 ' O ' HD12 ' A' ' 184' ' ' LEU . 10.3 t -47.5 -26.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 1.0 110.004 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 0.6 OUTLIER -72.11 -60.64 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 1.0 110.898 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.581 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -92.93 -15.81 25.88 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.007 -1.058 . . . . 1.0 110.397 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -71.69 -34.92 70.05 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 184' ' ' LEU . 12.7 mt -51.06 -21.15 1.7 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.533 -0.729 . . . . 1.0 109.207 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 16.9 t-20 -42.71 -27.8 0.2 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.006 0.907 . . . . 1.0 108.701 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 187' ' ' PRO . 2.4 t30 -131.2 146.32 61.57 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.541 ' O ' HG22 ' A' ' 188' ' ' THR . 42.7 Cg_endo -68.06 -157.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.765 1.402 . . . . 1.0 110.853 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 187' ' ' PRO . 0.4 OUTLIER 63.54 9.98 4.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 1.0 110.514 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 189' ' ' ILE . 30.7 mm -68.53 94.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 1.0 109.951 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.98 164.14 12.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 1.0 110.597 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.15 154.25 22.0 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.214 -0.929 . . . . 1.0 110.092 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.965 . . . . 1.0 110.563 -179.8 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.529 ' O ' ' CD ' ' A' ' 168' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.214 -0.792 0 CA-C-O 121.841 0.829 . . . . 1.0 109.967 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -138.44 168.3 20.05 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.741 -0.599 . . . . 1.0 109.839 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 191' ' ' HIS . 13.3 mm -134.11 109.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 1.0 110.137 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.787 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -73.25 129.83 38.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.539 -0.726 . . . . 1.0 109.934 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.586 ' CZ ' HD13 ' A' ' 167' ' ' ILE . 3.0 m-30 -95.68 133.49 39.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.404 -0.81 . . . . 1.0 109.326 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 -1.09 54.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 1.0 110.673 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.08 -7.39 62.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -122.02 7.13 9.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.206 -1.173 . . . . 1.0 109.904 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.575 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 8.9 t -81.63 164.45 21.84 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.995 0.902 . . . . 1.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' A' ' 23' ' ' THR . 6.0 m-30 -142.8 94.18 2.61 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.803 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 19' ' ' PHE . 2.4 mmt -94.21 101.63 13.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.841 -1.162 . . . . 1.0 109.795 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -117.65 120.54 38.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 1.0 110.361 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 27' ' ' TYR . 2.9 m-85 -115.03 110.89 20.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.836 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -101.57 85.18 2.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.08 -1.013 . . . . 1.0 110.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -112.8 163.17 14.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 1.0 109.982 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.27 94.5 4.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 1.0 110.24 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.902 . . . . 1.0 110.335 179.86 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.404 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 7.0 tt0 . . . . . 0 N--CA 1.495 1.805 0 CA-C-O 121.656 0.741 . . . . 1.0 111.33 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -127.89 163.75 23.76 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.369 -0.832 . . . . 1.0 110.982 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.97 155.67 20.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.45 -0.781 . . . . 1.0 109.748 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.533 ' O ' HG23 ' A' ' 172' ' ' VAL . 14.8 m-70 -123.48 133.39 54.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.071 . . . . 1.0 110.486 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.814 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 28.9 m-85 -136.76 117.09 13.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 1.0 109.926 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.715 ' C ' HD23 ' A' ' 45' ' ' LEU . 9.6 mt-10 -125.62 145.59 50.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.901 -1.124 . . . . 1.0 110.443 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.749 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 179.79 154.2 0.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.718 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.497 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -118.65 152.7 35.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.977 HD13 HD11 ' A' ' 105' ' ' ILE . 4.0 pt -148.67 160.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 117.81 -1.556 . . . . 1.0 112.697 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.644 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -114.63 83.79 1.95 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.332 -1.729 . . . . 1.0 106.332 177.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.495 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -66.97 150.87 48.64 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.042 0.925 . . . . 1.0 112.594 -176.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.853 ' HB2' HG22 ' A' ' 164' ' ' ILE . 4.5 mm-40 -140.85 2.99 1.81 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.863 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.25 125.64 12.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 1.0 110.12 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.452 ' HB ' ' N ' ' A' ' 76' ' ' GLY . 74.1 p -57.07 -14.95 4.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.473 -0.767 . . . . 1.0 111.408 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.615 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -128.76 132.01 47.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.936 -1.103 . . . . 1.0 111.452 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 166.66 136.28 2.0 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.397 -1.382 . . . . 1.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.732 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -89.64 118.86 29.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -1.213 . . . . 1.0 108.326 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.812 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -92.86 -31.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.756 -176.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.085 HD13 HD12 ' A' ' 71' ' ' LEU . 4.9 tt -147.3 151.47 36.66 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.664 -1.272 . . . . 1.0 112.605 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 1.154 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 0.6 OUTLIER -161.24 124.28 3.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.686 178.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.73 ' HB3' HD11 ' A' ' 69' ' ' ILE . 1.0 OUTLIER -121.89 156.57 33.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.951 -1.093 . . . . 1.0 109.719 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 109.148 -1.581 . . . . 1.0 109.148 179.706 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.741 ' CE2' HD11 ' A' ' 135' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 110.53 -0.174 . . . . 1.0 110.53 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -159.19 176.82 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.315 -1.491 . . . . 1.0 111.315 -179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.03 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -172.37 174.36 3.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.723 -0.611 . . . . 1.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.085 HD12 HD13 ' A' ' 57' ' ' LEU . 78.4 mt -146.16 95.57 2.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 1.0 109.139 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.586 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -115.53 177.13 4.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.505 -0.747 . . . . 1.0 112.112 -178.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 2.5 mt -117.81 138.2 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.767 -0.583 . . . . 1.0 110.025 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -142.39 133.25 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.42 -0.8 . . . . 1.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 3.3 m-20 61.62 23.86 14.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.068 -1.02 . . . . 1.0 111.432 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 84.39 18.66 61.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.974 -1.25 . . . . 1.0 109.974 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.29 150.27 45.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -1.091 . . . . 1.0 108.901 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.812 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -91.45 -176.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.734 -1.228 . . . . 1.0 109.878 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.796 ' NE2' HG21 ' A' ' 90' ' ' VAL . 1.5 pt20 -174.11 136.37 0.5 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.357 -0.839 . . . . 1.0 110.836 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.756 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -93.07 132.58 37.06 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.824 -0.75 . . . . 1.0 110.227 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 1.03 ' HE3' ' CB ' ' A' ' 70' ' ' ALA . 3.6 ttm -107.74 137.64 45.39 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.637 -0.664 . . . . 1.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.594 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -134.71 102.03 5.14 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.127 -0.983 . . . . 1.0 109.758 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 68' ' ' TYR . 2.1 m-20 -110.79 34.35 4.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.652 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.804 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.4 OUTLIER -34.03 -29.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.731 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -118.4 -41.31 0.63 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.756 -1.337 . . . . 1.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 168.7 -28.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 1.0 109.743 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.497 ' HG3' ' CG ' ' A' ' 129' ' ' PRO . 12.4 mmmt -89.58 117.93 68.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.493 -0.754 . . . . 1.0 109.772 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 51.1 Cg_endo -78.06 130.38 10.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.922 1.485 . . . . 1.0 111.927 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -109.27 126.63 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 178.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.796 HG21 ' NE2' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -109.04 123.27 64.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.447 -1.408 . . . . 1.0 111.865 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.6 HD23 ' CE ' ' A' ' 80' ' ' MET . 0.3 OUTLIER -111.99 74.69 0.88 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.176 -1.416 . . . . 1.0 107.176 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.557 ' O ' HG21 ' A' ' 124' ' ' ILE . 0.8 OUTLIER -57.9 178.65 0.08 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.311 -0.956 . . . . 1.0 110.492 -178.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.488 ' OG ' HG21 ' A' ' 118' ' ' VAL 0.251 2.4 t -108.23 151.19 26.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.549 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.47 ' CG2' HD11 ' A' ' 124' ' ' ILE . 0.7 OUTLIER -103.63 26.18 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 1.0 109.73 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.554 HG12 ' HD2' ' A' ' 96' ' ' PRO . 2.4 t -128.57 146.98 62.2 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.508 -0.745 . . . . 1.0 109.146 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.554 ' HD2' HG12 ' A' ' 95' ' ' VAL . 40.8 Cg_endo -65.64 124.52 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.538 1.283 . . . . 1.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 98' ' ' ASN . 6.6 tp -109.95 -39.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 1.0 110.655 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.499 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 6.3 p-10 -67.56 63.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 1.0 110.635 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.685 HG23 ' CG ' ' A' ' 101' ' ' HIS . 15.0 t -124.09 11.19 8.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -0.999 . . . . 1.0 110.345 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 57.45 33.08 22.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.948 -1.095 . . . . 1.0 110.447 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.685 ' CG ' HG23 ' A' ' 99' ' ' THR . 5.7 m-70 -121.65 179.36 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 1.0 109.8 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.644 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 17.0 m95 -98.18 100.96 12.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.029 -1.044 . . . . 1.0 110.175 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 104' ' ' HIS . 9.7 m -96.43 170.7 9.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.362 -0.836 . . . . 1.0 109.429 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.564 ' N ' HG22 ' A' ' 103' ' ' THR . 6.9 t60 -122.15 120.83 35.37 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.682 -1.229 . . . . 1.0 107.682 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.977 HD11 HD13 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -107.92 146.65 13.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 120.937 -1.102 . . . . 1.0 109.456 -178.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.658 ' O ' HD22 ' A' ' 116' ' ' LEU . 6.9 tptm -142.38 142.09 32.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.318 -0.953 . . . . 1.0 109.527 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -137.03 110.09 7.73 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.613 ' CD1' ' O ' ' A' ' 108' ' ' TYR . 4.5 p90 -111.14 110.36 20.85 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.567 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -99.62 141.05 32.93 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.031 -0.668 . . . . 1.0 111.194 -178.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 5.9 t -127.55 97.61 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.628 -0.67 . . . . 1.0 109.199 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.453 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 2.0 mt-30 58.26 -134.54 1.04 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 1.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -70.81 -11.41 60.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.984 -1.072 . . . . 1.0 110.863 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.586 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -104.4 123.24 47.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 1.0 110.505 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.526 ' CA ' ' HG2' ' A' ' 109' ' ' ARG . . . -114.41 163.66 12.15 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.296 -0.954 . . . . 1.0 110.961 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.573 ' O ' ' CE ' ' A' ' 80' ' ' MET . 47.5 t -147.64 162.89 38.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.522 -0.987 . . . . 1.0 110.722 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.949 HD13 ' N ' ' A' ' 117' ' ' GLN 0.254 1.0 OUTLIER -139.5 157.08 46.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.177 -0.952 . . . . 1.0 108.892 -178.816 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.949 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.39 113.92 4.02 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.684 -1.26 . . . . 1.0 111.97 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 16.8 t -70.22 100.35 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.86 37.08 92.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 117' ' ' GLN . 0.3 OUTLIER 61.38 38.58 16.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -1.146 . . . . 1.0 110.704 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 9.6 mt-10 -108.47 -161.18 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.325 -0.859 . . . . 1.0 110.944 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -39.22 98.32 0.16 Allowed Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 45.8 Cg_endo -77.43 142.96 21.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 124.068 1.562 . . . . 1.0 112.394 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.557 HG21 ' O ' ' A' ' 92' ' ' ARG . 1.1 mp -106.05 110.43 31.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.877 -1.527 . . . . 1.0 106.877 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.561 ' C ' HD11 ' A' ' 91' ' ' LEU . 7.2 p -105.81 177.52 4.83 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.375 1.083 . . . . 1.0 112.146 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.597 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 170.78 160.98 20.62 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.834 -2.507 . . . . 1.0 106.834 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -139.28 168.52 19.63 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.735 -1.45 . . . . 1.0 110.892 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.2 p -87.2 -179.73 1.47 Allowed Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.515 -0.874 . . . . 1.0 110.037 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.497 ' CG ' ' HG3' ' A' ' 87' ' ' LYS . 46.2 Cg_endo -77.49 48.25 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.837 1.441 . . . . 1.0 109.675 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.9 OUTLIER 46.46 -176.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.614 -0.679 . . . . 1.0 110.5 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.689 ' O ' ' HB2' ' A' ' 132' ' ' ALA . . . 79.05 88.63 0.46 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.804 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . 170.02 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -1.132 . . . . 1.0 110.166 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 59.11 90.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 1.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 135' ' ' LEU . 0.0 OUTLIER 44.94 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 1.0 110.309 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.741 HD11 ' CE2' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -175.72 97.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 1.0 110.309 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 3.1 m-20 -52.17 -179.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 1.0 109.213 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 137' ' ' THR . 8.1 t -129.1 121.06 27.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.085 -1.01 . . . . 1.0 109.695 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.901 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 4.4 p-10 -60.93 -3.56 0.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 1.0 111.05 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 65.9 9.12 45.19 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.841 -1.704 . . . . 1.0 108.841 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.901 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -102.31 132.2 48.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -1.127 . . . . 1.0 108.394 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.989 ' CD1' HD21 ' A' ' 57' ' ' LEU . 9.5 tp -141.14 148.79 40.6 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.764 -1.174 . . . . 1.0 111.651 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 24.2 m95 -130.88 119.46 22.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 1.0 HD13 HD12 ' A' ' 57' ' ' LEU . 8.3 tp -125.13 118.83 26.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.934 -1.506 . . . . 1.0 113.539 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.81 8.8 7.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 119.99 -1.1 . . . . 1.0 110.672 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.582 ' O ' ' HE3' ' A' ' 146' ' ' MET . . . 148.33 -148.44 19.92 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.373 -1.87 . . . . 1.0 109.08 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.714 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -152.82 148.06 26.76 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.37 -0.932 . . . . 1.0 112.881 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.42 ' C ' ' HG2' ' A' ' 148' ' ' ARG . 12.1 tt0 -93.9 19.92 8.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.42 ' HG2' ' C ' ' A' ' 147' ' ' GLU . 2.0 ptm180 173.16 68.65 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.555 -1.646 . . . . 1.0 106.555 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.791 HD11 ' CD2' ' A' ' 159' ' ' TYR . 1.4 tp -73.46 36.03 0.08 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 1.0 112.706 -177.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.1 p -71.69 -13.67 61.8 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.795 -1.928 . . . . 1.0 105.795 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 1.154 HG21 ' CZ3' ' A' ' 58' ' ' TRP 0.257 7.1 p -76.28 -110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 114.889 -1.051 . . . . 1.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.693 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . 50.0 39.1 18.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.308 -1.495 . . . . 1.0 108.946 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.917 ' CE1' HD23 ' A' ' 155' ' ' LEU . 1.5 p80 13.39 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.786 0.661 . . . . 1.0 112.786 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 5.74 2.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.032 -1.042 . . . . 1.0 111.821 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.917 HD23 ' CE1' ' A' ' 153' ' ' HIS . 2.7 pp -60.63 178.81 0.24 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.197 -0.939 . . . . 1.0 110.979 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 46.4 Cg_endo -83.01 -159.49 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.461 1.243 . . . . 1.0 112.681 -178.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.0 OUTLIER -51.01 -13.08 0.13 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 113.042 0.756 . . . . 1.0 113.042 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.601 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . -37.69 -45.64 0.81 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.013 -1.055 . . . . 1.0 109.707 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.86 ' CE1' HD21 ' A' ' 155' ' ' LEU . 4.3 m-85 -84.57 -28.98 26.23 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.204 -0.935 . . . . 1.0 109.111 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.541 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -70.38 -8.53 51.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.246 -1.382 . . . . 1.0 108.402 178.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 161' ' ' THR . 1.3 m -128.47 98.47 5.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -50.1 -178.19 0.02 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.609 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 71.0 t80 -83.01 144.72 29.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.909 -1.347 . . . . 1.0 112.262 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.853 HG22 ' HB2' ' A' ' 50' ' ' GLU . 1.6 mt -127.57 88.67 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.609 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.94 -157.39 13.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.743 -1.743 . . . . 1.0 108.743 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 1.7 m -128.59 145.45 51.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.128 -1.219 . . . . 1.0 109.802 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.586 HD13 ' CZ ' ' A' ' 19' ' ' PHE . 3.4 mt -130.28 147.4 33.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.437 -0.789 . . . . 1.0 110.423 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -159.48 156.12 27.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 1.0 110.351 -179.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 17.8 m-20 51.38 81.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 1.0 110.411 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.749 HG12 ' HB2' ' A' ' 45' ' ' LEU 0.251 25.7 m -122.43 130.62 74.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.017 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.44 HG22 ' C ' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -145.04 141.4 22.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.102 -1.039 . . . . 1.0 111.649 -176.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 42' ' ' HIS . 1.3 p -127.0 119.34 52.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 173' ' ' ASP . 1.5 m-20 62.14 30.53 17.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.23 32.09 2.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.756 -0.59 . . . . 1.0 110.451 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 71.9 mm-40 -104.73 120.13 40.63 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.354 -0.841 . . . . 1.0 110.064 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -78.55 110.97 14.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 1.0 109.556 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 179' ' ' LEU . 83.8 mt -78.81 96.21 5.57 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 1.0 111.31 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.586 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 46.8 m-70 -39.21 98.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.045 0.926 . . . . 1.0 110.247 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.777 ' O ' ' HB3' ' A' ' 183' ' ' ALA . 8.9 mt -49.09 -59.57 3.53 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.924 0.869 . . . . 1.0 112.963 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.781 ' HA ' HD23 ' A' ' 184' ' ' LEU . 86.7 t -75.52 -28.52 19.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 113.541 0.941 . . . . 1.0 113.541 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.586 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -58.64 -50.51 73.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 112.284 -178.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.3 OUTLIER -108.19 -28.51 9.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.946 -1.096 . . . . 1.0 111.535 -178.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 179' ' ' LEU . . . -63.05 -25.08 68.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.853 -1.539 . . . . 1.0 108.601 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.804 HD13 HG13 ' A' ' 189' ' ' ILE . 1.4 mm? -70.43 -2.19 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 1.0 110.303 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -55.65 -29.62 59.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 1.0 109.469 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.48 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 2.7 t-20 -88.09 151.32 49.07 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.866 ' O ' HG22 ' A' ' 188' ' ' THR . 38.3 Cg_endo -64.77 149.47 89.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.45 1.237 . . . . 1.0 109.684 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 187' ' ' PRO . 5.2 t 49.34 148.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 122.272 1.034 . . . . 1.0 112.116 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.804 HG13 HD13 ' A' ' 184' ' ' LEU . 33.6 mm -144.71 113.06 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 1.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.25 176.48 6.3 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.053 -1.03 . . . . 1.0 109.349 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -115.96 -60.99 1.8 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.7 -1.2 . . . . 1.0 111.264 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.787 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--N 1.29 -2.005 0 O-C-N 121.422 -0.799 . . . . 1.0 110.195 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.646 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 3.3 pt-20 . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 122.196 0.998 . . . . 1.0 110.157 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.02 137.15 33.75 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 120.333 -1.479 . . . . 1.0 111.231 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.617 HG21 ' HE1' ' A' ' 25' ' ' MET . 12.2 mm -117.43 131.25 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.184 -0.948 . . . . 1.0 109.273 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.57 ' HB2' ' SG ' ' A' ' 192' ' ' CYS . . . -90.09 131.85 35.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.46 -0.775 . . . . 1.0 110.792 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.962 ' CE1' HD12 ' A' ' 167' ' ' ILE . 62.3 m-85 -101.51 177.02 5.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.712 -1.243 . . . . 1.0 109.29 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.468 ' C ' HG13 ' A' ' 164' ' ' ILE . 11.1 p-10 -141.92 -11.6 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.678 -1.264 . . . . 1.0 112.842 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 162' ' ' GLY . . . 111.64 -11.69 27.84 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.95 -1.595 . . . . 1.0 109.144 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 3.6 ttp-105 -135.15 10.8 3.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -1.165 . . . . 1.0 111.504 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -112.81 121.17 43.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 1.0 110.627 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 1.9 p90 -104.02 122.25 44.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 1.0 110.256 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.617 ' HE1' HG21 ' A' ' 17' ' ' ILE . 3.2 mtp -119.45 98.41 6.12 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.937 -1.105 . . . . 1.0 108.307 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.6 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 0.8 OUTLIER -103.08 145.12 30.38 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.707 -0.797 . . . . 1.0 110.027 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.65 ' HA ' ' CB ' ' A' ' 182' ' ' ASP . 4.6 m-85 -126.1 116.52 21.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.011 -1.076 . . . . 1.0 110.477 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 139' ' ' GLY . 19.8 t60 -96.99 99.98 11.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.735 . . . . 1.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.6 131.32 34.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 1.0 110.03 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.16 95.37 8.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 1.0 110.194 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 1.0 110.406 -179.848 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 120.943 0.401 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.521 ' OG ' ' NE2' ' A' ' 42' ' ' HIS . 1.2 p -126.82 104.87 8.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.247 -0.908 . . . . 1.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 109' ' ' ARG . 19.5 p-10 -85.65 142.75 28.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.529 -0.732 . . . . 1.0 110.222 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.673 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 49.7 m-70 -131.15 111.59 12.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 9.2 m-85 -116.81 115.55 25.77 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.525 -0.734 . . . . 1.0 110.902 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.833 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -124.97 144.42 50.38 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.037 -1.039 . . . . 1.0 109.174 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.013 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.4 OUTLIER -179.56 159.18 0.87 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.154 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 103' ' ' THR . 74.8 m -128.75 145.72 51.1 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.063 HG23 HD11 ' A' ' 105' ' ' ILE . 1.4 pt -124.72 -170.46 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 118.449 -1.3 . . . . 1.0 111.532 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.615 ' HD2' ' CD2' ' A' ' 102' ' ' TRP . 0.4 OUTLIER -148.11 146.13 28.67 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.343 -1.355 . . . . 1.0 107.343 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 46.1 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.042 -1.063 . . . . 1.0 110.014 -178.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.101 ' HG3' HD13 ' A' ' 73' ' ' ILE . 8.3 tt0 -176.95 -22.75 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.376 -0.827 . . . . 1.0 110.55 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 50' ' ' GLU . . . 78.64 -3.62 2.23 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.931 -0.481 . . . . 1.0 110.088 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.767 HG23 ' C ' ' A' ' 51' ' ' ALA . 1.7 p 78.82 -19.97 0.41 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.312 0.577 . . . . 1.0 111.387 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.734 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.3 OUTLIER -143.91 124.26 13.86 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.324 -0.86 . . . . 1.0 109.881 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.618 ' O ' HD12 ' A' ' 73' ' ' ILE . . . 164.86 139.92 2.75 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.043 HD22 HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -89.45 145.62 25.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.754 -1.439 . . . . 1.0 109.365 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.734 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -116.3 -4.61 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -174.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.995 HD13 HD12 ' A' ' 71' ' ' LEU . 2.8 tt -168.56 152.12 5.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 119.206 -2.184 . . . . 1.0 113.105 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.58 ' CD1' ' SD ' ' A' ' 146' ' ' MET . 1.5 t-105 -164.64 113.72 1.12 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.8 -0.562 . . . . 1.0 110.157 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 p -120.99 141.69 50.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.934 -1.104 . . . . 1.0 109.647 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 -179.683 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.739 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.218 0 CA-C-O 121.304 0.573 . . . . 1.0 110.242 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.74 HD12 ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -108.66 111.05 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 178.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.897 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -138.44 -173.92 3.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 1.0 111.185 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 57' ' ' LEU . 82.5 mt -153.31 110.83 3.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.666 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -126.95 176.19 7.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.75 -1.219 . . . . 1.0 111.321 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.101 HD13 ' HG3' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -124.46 140.22 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -0.834 . . . . 1.0 111.621 -178.135 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.792 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.4 p -142.58 132.85 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.82 -0.55 . . . . 1.0 110.324 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.792 ' CG ' HG22 ' A' ' 74' ' ' VAL . 2.9 m-20 66.45 27.02 9.95 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.949 -1.094 . . . . 1.0 110.826 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 81.41 -5.36 68.49 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -109.18 149.47 29.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.305 -1.114 . . . . 1.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.734 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -98.22 -169.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 1.0 109.647 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.513 ' HB2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER 178.12 126.47 0.05 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.101 -1.0 . . . . 1.0 111.31 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.982 ' HE3' HD12 ' A' ' 91' ' ' LEU . 22.8 ttp -91.54 125.7 36.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 1.0 109.59 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.897 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 4.0 ptt? -112.56 128.87 56.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.947 -1.095 . . . . 1.0 110.491 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.616 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -118.58 121.21 39.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 1.0 110.211 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.739 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.2 t70 -126.99 46.54 2.49 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.607 0.718 . . . . 1.0 109.965 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.709 ' CB ' HD13 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -70.34 53.8 0.14 Allowed 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.005 179.631 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.417 ' C ' ' OG ' ' A' ' 86' ' ' SER . . . 161.77 -66.4 0.25 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.417 ' OG ' ' C ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -169.03 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.001 -1.294 . . . . 1.0 111.53 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -99.48 112.65 63.87 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.809 -1.182 . . . . 1.0 111.222 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -76.11 114.98 4.02 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.939 1.494 . . . . 1.0 109.708 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.632 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -93.1 105.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.248 -0.907 . . . . 1.0 110.458 -179.229 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -90.26 120.79 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 119.972 -1.705 . . . . 1.0 110.445 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.982 HD12 ' HE3' ' A' ' 80' ' ' MET . 33.6 mt -113.35 76.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.506 ' O ' HG21 ' A' ' 124' ' ' ILE . 21.6 mtp180 -57.87 179.15 0.07 Allowed 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.213 -0.995 . . . . 1.0 110.651 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.692 ' OG ' HG11 ' A' ' 118' ' ' VAL . 1.4 t -104.77 167.02 9.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.005 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.27 17.42 15.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.332 -0.855 . . . . 1.0 109.771 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.756 HG13 ' HD2' ' A' ' 96' ' ' PRO . 68.0 t -135.45 150.46 72.41 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.534 -0.729 . . . . 1.0 110.171 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.756 ' HD2' HG13 ' A' ' 95' ' ' VAL . 42.8 Cg_endo -68.85 139.08 42.51 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.796 1.419 . . . . 1.0 110.39 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.93 HG23 ' OE1' ' A' ' 50' ' ' GLU . 2.7 tt -129.17 -27.21 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 1.0 111.034 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.607 ' CB ' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p30 -80.93 44.6 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.125 -0.984 . . . . 1.0 110.288 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 99' ' ' THR . 94.3 m -117.64 24.67 10.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 1.0 110.359 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 99' ' ' THR . 62.1 t30 59.77 41.16 18.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 1.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -130.02 137.69 50.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.832 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CD2' ' HD2' ' A' ' 48' ' ' LYS . 3.9 m95 -61.93 91.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 1.0 110.315 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.61 HG22 ' N ' ' A' ' 104' ' ' HIS . 54.5 m -80.56 172.5 13.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.061 -1.024 . . . . 1.0 108.927 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.61 ' N ' HG22 ' A' ' 103' ' ' THR . 0.9 OUTLIER -129.99 106.59 8.75 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.111 -0.993 . . . . 1.0 108.672 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.063 HD11 HG23 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -97.64 136.57 28.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 O-C-N 121.094 -1.004 . . . . 1.0 109.2 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.805 ' O ' HD22 ' A' ' 116' ' ' LEU . 1.3 tppt? -137.22 155.87 48.99 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.98 -1.088 . . . . 1.0 110.169 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -153.59 123.24 6.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.096 -1.002 . . . . 1.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.624 ' CD1' ' O ' ' A' ' 108' ' ' TYR . 41.6 p90 -126.24 112.16 15.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.538 ' NH1' ' N ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -120.53 154.8 34.83 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.369 -0.832 . . . . 1.0 110.432 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 112' ' ' ARG . 2.4 t -128.65 95.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 1.0 110.721 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 22.8 mt-30 34.71 24.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 0.2 OUTLIER 173.2 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.486 -1.384 . . . . 1.0 110.437 179.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -97.72 117.91 33.07 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.566 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.84 157.36 16.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.819 ' OG ' HG22 ' A' ' 125' ' ' THR . 38.7 t -135.69 157.59 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.452 -1.028 . . . . 1.0 109.949 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.068 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.3 tm? -137.19 153.1 50.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 1.068 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -158.59 128.12 5.72 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.538 -1.265 . . . . 1.0 111.617 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.692 HG11 ' OG ' ' A' ' 93' ' ' SER . 20.4 m -92.05 100.2 10.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 68.62 42.49 80.28 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.366 -1.093 . . . . 1.0 110.366 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 10.6 m-80 58.06 31.69 21.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.244 -1.151 . . . . 1.0 111.073 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 122' ' ' ALA . 1.3 tt0 -100.09 167.01 10.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 1.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.598 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -19.73 102.96 0.06 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 CA-C-O 120.989 0.423 . . . . 1.0 110.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 40.0 Cg_endo -69.24 131.38 21.85 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.258 1.662 . . . . 1.0 112.478 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.652 HD12 ' H ' ' A' ' 124' ' ' ILE . 4.5 mp -92.42 104.89 16.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 105.84 -1.911 . . . . 1.0 105.84 177.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.819 HG22 ' OG ' ' A' ' 115' ' ' SER . 32.7 p -118.55 160.98 20.8 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.902 -1.119 . . . . 1.0 112.401 -176.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.63 173.16 38.84 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 107.108 -2.397 . . . . 1.0 107.108 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -154.7 160.62 41.49 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.645 -1.503 . . . . 1.0 110.396 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.45 ' O ' ' CG ' ' A' ' 112' ' ' ARG . 50.1 m -105.71 160.86 24.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 118.955 -1.098 . . . . 1.0 109.248 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 130' ' ' LEU . 38.1 Cg_endo -64.51 -21.34 66.05 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 N-CA-C 108.196 -1.501 . . . . 1.0 108.196 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.564 ' CB ' ' O ' ' A' ' 129' ' ' PRO . 1.0 OUTLIER 155.92 -161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.36 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 148.09 -44.77 0.76 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -155.66 114.24 3.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -1.124 . . . . 1.0 110.381 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -63.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 1.0 110.222 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -100.55 76.76 1.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.0 110.508 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.709 HD13 ' CB ' ' A' ' 84' ' ' LEU . 1.1 tp -71.46 112.28 7.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.862 . . . . 1.0 109.789 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.22 127.13 31.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.895 . . . . 1.0 109.937 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -148.94 105.66 3.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 1.0 110.12 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.6 OUTLIER 163.3 -38.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.65 0.738 . . . . 1.0 109.07 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.506 ' O ' ' ND1' ' A' ' 28' ' ' HIS . . . -44.57 -32.88 3.03 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.175 -1.17 . . . . 1.0 110.175 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . . . -161.02 153.33 20.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.769 -1.43 . . . . 1.0 109.897 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.922 HD11 HD21 ' A' ' 57' ' ' LEU . 30.0 tp -155.73 152.8 28.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 110.519 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.753 ' CD2' ' HE1' ' A' ' 146' ' ' MET . 31.4 m95 -118.31 161.87 19.22 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.881 ' CD2' HD12 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -152.83 111.29 3.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.2 -1.8 . . . . 1.0 113.42 -177.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.555 ' O ' ' CA ' ' A' ' 162' ' ' GLY . . . 125.96 -11.18 7.38 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.553 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 158.2 -140.43 6.98 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 119.005 -1.569 . . . . 1.0 109.707 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.753 ' HE1' ' CD2' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -168.11 152.35 6.24 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.183 -1.007 . . . . 1.0 111.098 -179.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -96.58 -8.96 30.47 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.877 0.846 . . . . 1.0 109.513 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -141.64 53.03 1.51 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.043 HD21 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.82 57.17 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 1.0 111.854 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 148' ' ' ARG . 29.6 p -59.49 -22.53 61.72 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.79 -1.93 . . . . 1.0 105.79 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.811 HG13 ' N ' ' A' ' 152' ' ' ALA 0.289 9.8 p -76.92 -130.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.49 -1.232 . . . . 1.0 108.831 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.811 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 55.86 50.72 13.47 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.804 -1.185 . . . . 1.0 108.578 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -52.58 -111.81 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.293 1.961 . . . . 1.0 116.293 -175.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 18.25 0.24 Allowed 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 113.944 1.09 . . . . 1.0 113.944 -175.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 1.102 HD22 ' CD2' ' A' ' 159' ' ' TYR . 5.1 tt -95.71 141.08 22.68 Favored Pre-proline 0 C--N 1.288 -2.089 0 O-C-N 120.858 -1.152 . . . . 1.0 110.499 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.895 ' O ' HD23 ' A' ' 155' ' ' LEU . 37.6 Cg_endo -62.05 -149.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.045 1.55 . . . . 1.0 111.327 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.1 OUTLIER -60.41 -10.42 4.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.837 -1.165 . . . . 1.0 112.869 -177.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 1.098 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -41.71 -35.35 0.76 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.814 -1.179 . . . . 1.0 109.428 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 1.102 ' CD2' HD22 ' A' ' 155' ' ' LEU . 32.4 m-85 -86.79 -31.99 20.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.744 -1.223 . . . . 1.0 108.928 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.531 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -72.68 -5.88 40.62 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.436 -1.305 . . . . 1.0 108.0 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.705 HG22 ' CD1' ' A' ' 164' ' ' ILE . 33.4 m -122.23 90.26 3.27 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 163' ' ' PHE . . . -57.06 106.87 0.8 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.057 -1.068 . . . . 1.0 110.562 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.929 ' HD1' HD11 ' A' ' 73' ' ' ILE . 89.5 t80 12.95 137.8 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 115.761 1.763 . . . . 1.0 115.761 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.705 ' CD1' HG22 ' A' ' 161' ' ' THR . 2.2 mt -131.08 86.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.084 -0.962 . . . . 1.0 108.827 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 48' ' ' LYS . . . -171.18 -161.17 21.38 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 107.2 -2.36 . . . . 1.0 107.2 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.3 m -129.27 142.57 50.8 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.87 -1.371 . . . . 1.0 110.023 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.962 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -128.24 157.89 40.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.402 -1.436 . . . . 1.0 112.285 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.576 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -165.36 168.31 16.92 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.061 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.4 m-20 43.78 72.89 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.214 -0.929 . . . . 1.0 110.658 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 1.013 HG12 ' CB ' ' A' ' 45' ' ' LEU . 26.8 m -127.67 123.25 60.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.89 -1.124 . . . . 1.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.521 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -136.0 152.17 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.53 -177.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -133.8 103.35 5.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 6.7 m-20 57.55 35.46 25.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.975 -1.121 . . . . 1.0 107.975 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 75.0 6.34 4.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.828 -0.545 . . . . 1.0 111.088 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.847 ' HB2' HG23 ' A' ' 172' ' ' VAL . 77.8 mm-40 -91.18 176.39 6.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.143 -0.973 . . . . 1.0 110.105 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.563 ' CB ' ' O ' ' A' ' 175' ' ' GLN . 30.0 tt0 83.68 -109.66 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 175' ' ' GLN . 0.4 OUTLIER 29.97 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.304 -0.873 . . . . 1.0 112.499 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 181' ' ' GLU . 2.3 m80 -160.89 44.5 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.994 -1.066 . . . . 1.0 110.597 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.985 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 0.0 OUTLIER -52.17 -27.89 16.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 9.2 t -71.3 -35.23 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.12 0.486 . . . . 1.0 111.198 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 51.0 mt-10 -62.16 -56.07 22.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.049 -1.032 . . . . 1.0 109.54 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.65 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -81.89 -19.7 40.36 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.086 179.008 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 1.023 ' HB1' HD11 ' A' ' 189' ' ' ILE . . . -48.14 -41.76 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.818 -1.153 . . . . 1.0 107.94 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ALA . 3.4 mt -41.78 -26.3 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.369 0.604 . . . . 1.0 109.598 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 6.3 t-20 -62.8 -11.61 19.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.353 -0.842 . . . . 1.0 109.808 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 187' ' ' PRO . 0.5 OUTLIER -123.85 154.21 67.35 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.539 -0.725 . . . . 1.0 109.182 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.518 ' O ' ' ND2' ' A' ' 186' ' ' ASN . 37.3 Cg_endo -61.27 -162.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.671 1.353 . . . . 1.0 111.215 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 187' ' ' PRO . 4.8 m -40.74 134.56 1.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.21 -0.931 . . . . 1.0 111.263 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 1.023 HD11 ' HB1' ' A' ' 183' ' ' ALA . 3.1 mt -102.91 144.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.443 -0.785 . . . . 1.0 109.452 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.37 153.41 19.35 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.098 -1.001 . . . . 1.0 109.889 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.606 ' ND1' HD13 ' A' ' 17' ' ' ILE . 1.6 m-70 -112.68 152.25 29.23 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.289 -0.882 . . . . 1.0 109.618 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.674 0 C-N-CA 119.424 -0.91 . . . . 1.0 109.974 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.9 pt-20 . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 121.937 0.875 . . . . 1.0 110.154 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -117.22 151.28 37.23 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.063 -1.023 . . . . 1.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 7.0 mm -119.52 133.27 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.037 . . . . 1.0 110.328 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -91.49 124.15 35.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.651 . . . . 1.0 110.431 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.751 ' CD2' HG21 ' A' ' 23' ' ' THR . 4.0 m-30 -91.1 132.69 35.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.0 109.209 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 2.3 p30 -97.74 2.16 49.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 1.0 110.545 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 103.51 -22.8 34.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.506 -1.838 . . . . 1.0 108.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.449 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 5.3 ttt-85 -107.25 -8.1 16.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.634 -0.921 . . . . 1.0 109.672 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.751 HG21 ' CD2' ' A' ' 19' ' ' PHE . 14.9 t -48.08 174.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 1.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.64 ' CE1' ' HB2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER 179.86 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 1.0 109.104 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 142' ' ' TRP . 25.0 mtt -96.26 101.33 12.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.943 -1.098 . . . . 1.0 111.007 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.64 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 18.7 tt0 -93.39 121.97 35.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.347 -0.846 . . . . 1.0 109.481 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CE2' ' CB ' ' A' ' 182' ' ' ASP . 6.2 m-85 -113.62 105.63 13.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.184 -0.947 . . . . 1.0 109.993 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.16 86.63 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 1.0 110.449 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -121.88 176.82 5.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.227 -0.92 . . . . 1.0 110.132 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.02 99.94 12.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.196 -0.94 . . . . 1.0 110.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 76.9 t . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.235 -0.915 . . . . 1.0 109.977 179.787 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.639 0.733 . . . . 1.0 109.345 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -161.61 131.26 4.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 5.0 m-80 -98.64 163.05 12.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.966 -1.084 . . . . 1.0 110.472 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -134.99 137.48 43.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 1.0 110.112 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.801 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 91.0 m-85 -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 1.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.81 ' C ' HD23 ' A' ' 45' ' ' LEU . 3.0 mt-10 -126.75 145.24 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.981 -1.074 . . . . 1.0 109.867 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.005 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.5 OUTLIER 179.08 156.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.401 -0.92 . . . . 1.0 111.412 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 103' ' ' THR . 4.8 m -122.13 154.99 36.66 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.612 -1.255 . . . . 1.0 107.612 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.571 HD13 HD11 ' A' ' 105' ' ' ILE . 3.3 pt -148.82 163.46 4.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 117.829 -1.548 . . . . 1.0 112.652 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.636 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.8 OUTLIER -114.3 83.31 1.86 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 177.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.569 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -70.67 150.7 45.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.084 -1.01 . . . . 1.0 112.434 -176.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.651 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 6.7 mm-40 -135.68 -3.12 2.35 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.35 0.595 . . . . 1.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.51 125.96 11.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.257 -0.902 . . . . 1.0 109.84 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.797 ' O ' HG22 ' A' ' 73' ' ' ILE . 47.5 p -55.51 -15.02 2.35 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.553 -0.717 . . . . 1.0 111.327 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -123.4 133.63 54.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.902 -1.124 . . . . 1.0 111.655 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 157.9 134.74 1.78 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.159 -1.177 . . . . 1.0 110.159 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.74 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -83.08 143.35 30.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.769 -1.43 . . . . 1.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.781 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -111.81 -47.03 5.94 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 C-N-CA 119.741 -0.784 . . . . 1.0 111.762 -177.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.98 HD13 HD12 ' A' ' 71' ' ' LEU . 5.7 tt -134.58 145.14 48.4 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.278 -1.514 . . . . 1.0 113.031 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.681 ' CH2' HG21 ' A' ' 151' ' ' VAL . 2.3 t-105 -149.68 117.12 6.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.804 . . . . 1.0 109.041 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -127.22 -176.08 3.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 1.0 110.694 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.732 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.671 ' CD1' ' CZ3' ' A' ' 58' ' ' TRP . 2.5 p90 . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 121.559 0.695 . . . . 1.0 109.572 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.704 HD12 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -147.56 136.16 15.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 121.68 -0.637 . . . . 1.0 110.059 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.034 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -132.87 -174.33 3.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 1.0 110.455 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.98 HD12 HD13 ' A' ' 57' ' ' LEU . 66.0 mt -149.0 101.14 3.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.849 . . . . 1.0 108.722 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.785 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . . . -119.38 174.41 6.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.957 -1.089 . . . . 1.0 112.211 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 52' ' ' THR . 56.3 mt -113.86 131.17 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.668 -0.645 . . . . 1.0 110.597 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.568 HG22 ' OD2' ' A' ' 75' ' ' ASP . 2.5 p -139.96 131.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.415 -0.803 . . . . 1.0 110.077 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.568 ' OD2' HG22 ' A' ' 74' ' ' VAL . 28.0 m-20 61.24 10.12 2.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 1.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.658 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 95.19 9.36 58.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 78' ' ' VAL . 61.5 m-85 -133.32 108.46 8.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -1.095 . . . . 1.0 110.048 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.781 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -48.6 -175.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.77 0.795 . . . . 1.0 111.412 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.675 ' HB2' HG22 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -172.9 124.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.672 0.749 . . . . 1.0 110.893 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.983 ' CE ' HD12 ' A' ' 91' ' ' LEU . 2.2 ttm -85.03 110.54 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.791 -0.568 . . . . 1.0 110.481 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 1.034 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 37.1 mtm -89.45 116.71 27.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.906 -1.121 . . . . 1.0 109.885 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.704 ' CZ ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -111.92 116.38 30.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.693 -1.255 . . . . 1.0 109.163 178.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -124.98 48.09 2.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 1.0 110.469 -179.156 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -65.06 61.66 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.975 -0.69 . . . . 1.0 110.138 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 132.4 33.09 0.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.956 -1.258 . . . . 1.0 109.956 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.01 9.69 5.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.237 -1.155 . . . . 1.0 110.107 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -108.0 89.32 5.4 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 1.0 109.333 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.533 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -72.11 140.81 35.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.157 1.609 . . . . 1.0 111.599 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.625 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -137.12 119.14 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -97.46 114.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.354 -1.466 . . . . 1.0 111.403 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.983 HD12 ' CE ' ' A' ' 80' ' ' MET . 38.3 mt -104.38 71.97 1.03 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.137 -1.431 . . . . 1.0 107.137 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 51.1 mtp180 -57.33 178.58 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.052 0.93 . . . . 1.0 111.046 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.758 ' OG ' HG21 ' A' ' 118' ' ' VAL . 3.3 t -108.35 155.21 20.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.175 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.626 ' OG1' HD11 ' A' ' 124' ' ' ILE . 1.4 p -112.11 26.38 10.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 1.0 109.673 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.752 ' CG1' HG11 ' A' ' 118' ' ' VAL . 8.0 t -129.07 146.62 61.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.519 -0.738 . . . . 1.0 109.454 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.575 ' HD2' HG13 ' A' ' 95' ' ' VAL . 43.6 Cg_endo -67.85 116.17 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.754 1.397 . . . . 1.0 109.767 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.8 tp -106.78 -33.36 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.14 -0.975 . . . . 1.0 111.055 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -71.64 61.22 0.36 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 1.0 110.738 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -127.21 14.28 7.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 1.0 110.167 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.481 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 1.9 m120 58.63 40.88 23.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.995 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . 0.554 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 1.1 m-70 -132.11 159.14 39.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 1.0 110.172 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.636 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 22.2 m95 -78.87 101.37 7.65 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.292 -0.963 . . . . 1.0 109.729 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.588 HG22 ' N ' ' A' ' 104' ' ' HIS . 5.9 m -101.93 171.66 7.39 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.441 -0.904 . . . . 1.0 109.009 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.588 ' N ' HG22 ' A' ' 103' ' ' THR . 8.4 t60 -119.97 143.9 47.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.07 -1.019 . . . . 1.0 108.791 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.571 HD11 HD13 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -133.67 159.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.22 -0.925 . . . . 1.0 109.172 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.808 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -152.45 148.47 27.47 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.659 -1.217 . . . . 1.0 110.307 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.801 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -144.23 102.21 3.82 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.526 -0.733 . . . . 1.0 110.374 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 108' ' ' TYR . 37.1 p90 -117.07 105.48 12.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 108.689 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.668 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -91.44 150.87 21.05 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.655 -0.818 . . . . 1.0 111.225 -178.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.7 t -136.93 96.51 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.679 -0.638 . . . . 1.0 110.799 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.582 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 17.4 mt-30 43.74 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.662 -0.649 . . . . 1.0 111.779 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER 54.2 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.616 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.8 tm-20 -95.97 109.75 22.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.108 -1.62 . . . . 1.0 109.919 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -99.05 161.43 20.07 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.067 -1.063 . . . . 1.0 110.892 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 125' ' ' THR . 33.7 t -132.7 156.67 46.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -1.17 . . . . 1.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.068 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.1 tm? -140.09 151.51 45.41 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 1.068 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.52 144.59 25.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.888 -1.133 . . . . 1.0 111.514 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.758 HG21 ' OG ' ' A' ' 93' ' ' SER . 41.1 t -102.86 98.92 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 177.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.21 39.52 82.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.715 -1.354 . . . . 1.0 109.715 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 119' ' ' GLY . 21.8 t-20 57.36 32.13 21.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -1.104 . . . . 1.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 5.3 mt-10 -114.8 -158.11 0.66 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.569 -0.707 . . . . 1.0 110.593 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -30.43 93.77 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.936 -0.477 . . . . 1.0 110.576 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.9 Cg_endo -77.12 142.65 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.039 1.547 . . . . 1.0 112.012 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.66 ' N ' HD12 ' A' ' 124' ' ' ILE . 3.3 mp -108.53 100.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.613 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.9 p -108.19 166.96 10.35 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.192 0.996 . . . . 1.0 111.962 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.7 167.76 38.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.222 -2.351 . . . . 1.0 107.222 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -136.88 170.0 16.82 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.555 -1.556 . . . . 1.0 110.929 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 31.7 p -96.92 163.57 19.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.921 -1.112 . . . . 1.0 110.431 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 130' ' ' LEU . 45.6 Cg_endo -71.65 55.62 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.954 1.502 . . . . 1.0 108.735 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.492 ' O ' ' HD2' ' A' ' 87' ' ' LYS . 4.7 mp 41.05 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.637 -0.665 . . . . 1.0 110.056 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.29 10.57 47.87 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.523 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -133.58 145.54 50.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.113 -1.228 . . . . 1.0 109.867 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 133' ' ' THR . 34.5 m -137.52 13.94 2.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.089 -1.007 . . . . 1.0 110.676 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' THR . 1.7 mt-30 179.94 160.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 1.0 110.54 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.745 HD13 ' HB3' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -166.08 61.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.485 -0.759 . . . . 1.0 109.893 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 4.2 m-20 -77.4 122.19 24.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.056 . . . . 1.0 109.439 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.77 164.23 18.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.08 . . . . 1.0 110.877 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.819 ' OD2' ' HB2' ' A' ' 140' ' ' ALA . 20.4 p-10 -89.82 29.35 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 1.0 110.204 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 52.29 18.09 4.64 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 1.0 109.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.819 ' HB2' ' OD2' ' A' ' 138' ' ' ASP . . . -64.34 158.76 22.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -1.21 . . . . 1.0 109.072 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.745 HD12 ' N ' ' A' ' 142' ' ' TRP . 6.8 tp -158.47 144.06 16.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.446 -1.302 . . . . 1.0 112.481 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.745 ' N ' HD12 ' A' ' 141' ' ' LEU . 19.2 m95 -131.88 97.27 4.13 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.952 HD12 HD12 ' A' ' 57' ' ' LEU . 2.8 tt -112.82 119.73 39.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.627 -1.295 . . . . 1.0 113.544 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 128.67 3.74 5.45 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.517 ' O ' ' SD ' ' A' ' 146' ' ' MET . . . 145.91 -147.72 18.93 Favored Glycine 0 C--N 1.283 -2.378 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . 0.732 ' CB ' HD22 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -151.64 113.13 4.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.082 -1.047 . . . . 1.0 111.772 -178.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.64 -24.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.997 0.903 . . . . 1.0 109.025 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.555 ' HD2' ' N ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -145.68 83.47 1.65 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 178.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.732 HD22 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -71.58 22.84 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.275 -0.891 . . . . 1.0 112.757 -176.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.3 p -61.67 -19.68 62.6 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.768 HG13 ' N ' ' A' ' 152' ' ' ALA 0.288 10.5 p -71.51 -123.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.67 -1.15 . . . . 1.0 110.301 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.768 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 72.1 -71.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.702 -1.249 . . . . 1.0 108.796 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.559 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 52.94 155.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.919 1.342 . . . . 1.0 112.545 178.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER 44.16 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.006 1.484 . . . . 1.0 115.006 178.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 1.087 ' O ' HD13 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -135.86 154.0 77.52 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.057 -1.652 . . . . 1.0 111.054 -179.387 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.654 ' N ' HD22 ' A' ' 155' ' ' LEU . 41.0 Cg_endo -65.62 -161.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.594 1.529 . . . . 1.0 113.629 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.0 OUTLIER -55.93 -8.88 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.988 ' HB3' HD21 ' A' ' 155' ' ' LEU . . . -39.85 -38.35 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.915 -1.116 . . . . 1.0 109.44 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.785 ' CZ ' ' HB2' ' A' ' 72' ' ' ALA . 10.2 m-85 -85.85 -31.6 22.16 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.855 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -65.04 -11.04 34.82 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.952 -1.499 . . . . 1.0 108.243 177.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -122.27 98.94 6.16 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -49.82 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.63 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 32.8 t80 -88.79 145.5 25.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.119 -1.224 . . . . 1.0 111.575 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 164' ' ' ILE . 2.5 mt -123.42 85.39 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.139 -1.43 . . . . 1.0 107.139 177.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.63 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.67 -156.13 11.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.316 -1.914 . . . . 1.0 108.316 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.0 m -133.41 154.06 51.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.112 -1.228 . . . . 1.0 110.311 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.9 mt -134.76 144.96 33.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.774 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.519 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 26.9 ttt180 -150.72 164.6 35.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.892 -1.13 . . . . 1.0 110.659 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.6 m-20 43.57 74.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.202 -0.936 . . . . 1.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 1.005 HG12 ' CB ' ' A' ' 45' ' ' LEU . 22.7 m -126.74 124.17 64.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 119.311 -0.955 . . . . 1.0 109.891 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.527 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -131.95 158.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.929 -1.108 . . . . 1.0 111.331 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 76.5 t -134.15 114.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 63.3 m-20 50.01 36.58 12.14 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.878 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.7 OUTLIER 67.61 34.25 4.64 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.377 0.608 . . . . 1.0 110.411 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 19.2 mm100 -114.45 -176.53 2.92 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 121.323 -0.861 . . . . 1.0 110.616 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 0.3 OUTLIER 67.91 -98.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 1.0 110.66 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 12.1 mt 60.37 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.894 -1.128 . . . . 1.0 111.477 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.536 ' HB3' ' HG3' ' A' ' 181' ' ' GLU . 2.6 m-70 -70.09 79.74 0.5 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.716 -1.24 . . . . 1.0 110.546 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.627 HD11 HG22 ' A' ' 170' ' ' VAL 0.263 0.5 OUTLIER -52.7 -61.23 2.42 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.201 1.001 . . . . 1.0 110.752 178.931 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.882 ' HA ' HD23 ' A' ' 184' ' ' LEU . 12.9 t -52.91 -18.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.632 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 178' ' ' HIS . 0.7 OUTLIER -73.63 -56.51 4.91 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.732 -1.187 . . . . 1.0 109.901 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.612 ' CB ' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -95.81 -18.38 20.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.099 -1.0 . . . . 1.0 109.8 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -73.74 -29.92 62.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.144 -0.972 . . . . 1.0 108.703 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.882 HD23 ' HA ' ' A' ' 180' ' ' VAL . 1.5 mm? -65.06 -8.8 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.424 -0.798 . . . . 1.0 109.987 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 184' ' ' LEU . 8.5 t-20 -43.85 -26.43 0.26 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.391 -0.818 . . . . 1.0 109.095 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 189' ' ' ILE . 2.2 t-20 -113.9 148.89 40.89 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 47.8 Cg_endo -76.97 -34.74 2.11 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.824 1.434 . . . . 1.0 110.68 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 4.51 0.42 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.697 -0.683 . . . . 1.0 112.76 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 186' ' ' ASN . 23.4 mm -61.95 117.35 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.323 -1.485 . . . . 1.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -120.59 159.64 24.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 110.829 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 18.9 m-70 -93.54 151.55 19.62 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.344 -0.847 . . . . 1.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' CYS . . . . . 0.741 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 9.2 t . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 1.0 111.913 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.501 -1.439 . . . . 1.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 t -125.97 127.9 46.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -1.132 . . . . 1.0 110.004 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -98.29 21.48 10.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 1.0 110.295 -179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 3' ' ' GLU . 1.1 mttt 66.91 -172.85 0.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 1.0 110.309 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.5 p -132.6 102.88 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 1.0 110.101 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -87.03 155.26 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.199 -0.938 . . . . 1.0 110.474 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.8 mt -125.92 82.72 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.186 -0.946 . . . . 1.0 110.17 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.77 87.74 2.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.082 -1.011 . . . . 1.0 110.229 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.48 109.58 10.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 1.0 110.403 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.62 86.84 2.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.055 -1.028 . . . . 1.0 109.842 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.09 26.32 2.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.88 . . . . 1.0 109.391 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.74 165.45 22.15 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -143.79 68.58 1.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -1.186 . . . . 1.0 110.382 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -128.54 63.38 1.45 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -0.944 . . . . 1.0 110.049 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.571 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 3.6 pt-20 -60.6 71.31 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.481 -0.762 . . . . 1.0 110.531 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -95.35 136.95 35.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.662 -1.274 . . . . 1.0 110.766 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 190' ' ' LEU . 8.9 mm -127.43 118.16 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.278 -0.888 . . . . 1.0 109.702 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.554 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -80.76 142.46 33.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 1.0 111.216 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.718 ' CE1' HD12 ' A' ' 167' ' ' ILE . 9.1 m-85 -106.6 172.07 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.586 -0.696 . . . . 1.0 109.358 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.491 ' C ' HG12 ' A' ' 164' ' ' ILE . 3.8 p30 -127.32 -3.62 6.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.979 . . . . 1.0 110.637 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.482 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 110.17 -9.8 31.34 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.85 -1.7 . . . . 1.0 108.85 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.9 ttp85 -127.72 -24.95 3.18 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -1.186 . . . . 1.0 110.773 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.92 133.76 37.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 1.0 110.369 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.618 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -128.17 114.55 17.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 1.0 110.365 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.527 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 6.0 mmt -83.23 99.07 9.73 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.85 -1.156 . . . . 1.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.577 ' HG3' ' CH2' ' A' ' 142' ' ' TRP . 46.8 tt0 -87.77 87.98 7.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 1.0 109.456 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 182' ' ' ASP . 8.0 m-30 -92.18 97.03 10.65 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.12 -0.987 . . . . 1.0 110.236 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.15 104.39 16.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.433 -0.792 . . . . 1.0 110.007 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 138' ' ' ASP . 1.4 t-20 -147.36 162.97 37.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.138 -0.976 . . . . 1.0 110.338 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.81 137.69 50.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 1.0 110.376 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 32' ' ' THR . 4.6 m -58.84 -47.93 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.271 -0.893 . . . . 1.0 110.907 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -163.21 110.54 1.2 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.936 -1.102 . . . . 1.0 110.463 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' O ' ' CB ' ' A' ' 34' ' ' SER . 47.2 mttp -62.91 97.3 0.1 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.273 -0.892 . . . . 1.0 110.004 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER 175.25 -51.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.153 -0.967 . . . . 1.0 110.765 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 28.9 mt-10 -101.7 -67.3 0.87 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.187 -0.945 . . . . 1.0 110.533 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.633 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 1.0 OUTLIER 63.01 77.23 0.34 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.315 -0.866 . . . . 1.0 110.01 -179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . 172.58 44.44 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.345 -0.847 . . . . 1.0 109.377 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.793 ' C ' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -47.75 173.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.775 0.798 . . . . 1.0 111.694 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.647 ' N ' HD22 ' A' ' 38' ' ' LEU . 2.5 tm0? -119.91 -20.61 7.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.433 -0.792 . . . . 1.0 109.809 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.455 ' OG ' HG13 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -160.72 146.22 14.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.732 -0.605 . . . . 1.0 109.467 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.609 ' N ' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -133.23 155.28 49.64 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.049 -1.032 . . . . 1.0 111.597 -178.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.534 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 8.8 m-70 -114.67 143.97 44.18 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.672 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 58.4 m-85 -129.02 121.76 28.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.097 -1.002 . . . . 1.0 110.644 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.746 ' C ' HD23 ' A' ' 45' ' ' LEU . 2.8 mt-10 -127.92 147.24 50.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.014 -1.054 . . . . 1.0 109.928 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.001 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.3 pt? 179.89 150.22 0.36 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.759 . . . . 1.0 110.548 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.479 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 1.9 m -120.17 154.07 35.33 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.983 -1.118 . . . . 1.0 107.983 178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.479 ' CG2' ' C ' ' A' ' 46' ' ' SER . 1.5 pt -147.49 155.09 10.82 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 C-N-CA 117.824 -1.55 . . . . 1.0 112.86 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.677 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -112.61 82.68 1.69 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 106.227 -1.768 . . . . 1.0 106.227 176.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.644 HG21 HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -70.19 163.63 25.98 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.867 -1.146 . . . . 1.0 111.289 -176.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.567 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 0.8 OUTLIER -145.39 29.84 1.14 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.299 -0.96 . . . . 1.0 110.845 -178.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.984 ' O ' HG23 ' A' ' 52' ' ' THR . . . -162.24 -96.68 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.965 0 C-N-CA 118.943 -1.103 . . . . 1.0 110.324 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.984 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 176.07 -35.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.431 0.634 . . . . 1.0 109.824 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.519 ' HG3' ' HA ' ' A' ' 158' ' ' ALA . 0.8 OUTLIER -119.23 138.77 52.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.43 -0.794 . . . . 1.0 110.61 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.81 135.77 1.89 Allowed Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.255 -1.938 . . . . 1.0 108.255 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.937 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -84.87 131.68 34.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.743 -1.445 . . . . 1.0 109.552 -179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.977 HD12 ' HA ' ' A' ' 72' ' ' ALA . 4.6 mp -95.75 -40.28 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.449 -0.782 . . . . 1.0 112.714 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.984 HD13 HD12 ' A' ' 71' ' ' LEU . 7.1 tt -141.13 148.36 39.95 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.254 -1.529 . . . . 1.0 113.652 -175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.824 ' N ' HD23 ' A' ' 57' ' ' LEU . 7.3 t-105 -152.02 129.06 11.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.721 -0.844 . . . . 1.0 108.721 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.73 163.28 32.58 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.654 -1.279 . . . . 1.0 110.307 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -178.37 -112.94 0.35 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.119 -1.192 . . . . 1.0 110.119 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 61.05 90.67 0.06 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.425 -1.044 . . . . 1.0 110.525 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.911 ' C ' HD13 ' A' ' 63' ' ' LEU . . . 168.25 -24.8 0.12 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.534 -1.426 . . . . 1.0 109.534 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.917 HD13 ' N ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -143.39 -168.11 2.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -1.144 . . . . 1.0 110.372 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.24 -2.69 10.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 1.0 110.122 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.513 ' HA ' ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -168.66 27.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 1.0 109.626 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.478 ' OG ' ' N ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -133.56 -174.02 3.39 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.662 -0.815 . . . . 1.0 111.147 -178.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.51 ' HB3' HD11 ' A' ' 63' ' ' LEU . 5.8 t0 33.53 89.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.089 0.471 . . . . 1.0 111.416 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.683 ' O ' ' HA ' ' A' ' 82' ' ' TYR . 8.5 m-30 -116.49 102.15 9.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.582 -0.699 . . . . 1.0 109.482 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.8 HD11 ' CZ ' ' A' ' 109' ' ' ARG . 19.0 mt -112.54 130.76 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 120.54 -1.35 . . . . 1.0 109.916 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.735 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -153.74 174.57 14.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.87 . . . . 1.0 110.717 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.984 HD12 HD13 ' A' ' 57' ' ' LEU . 79.0 mt -146.22 110.4 5.01 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 -178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.977 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -129.98 164.38 24.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.737 -1.227 . . . . 1.0 112.466 -178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.942 ' CG1' HD11 ' A' ' 56' ' ' ILE . 9.3 mt -102.59 136.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.639 -0.663 . . . . 1.0 110.678 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 75' ' ' ASP . 4.0 p -140.63 131.44 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.157 -0.965 . . . . 1.0 110.806 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.567 ' CG ' HG22 ' A' ' 74' ' ' VAL . 7.4 m-20 63.8 8.79 4.0 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.352 -0.842 . . . . 1.0 111.032 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 104.56 13.73 25.4 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 35.8 m-85 -135.53 152.73 51.6 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.29 -1.124 . . . . 1.0 109.976 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.773 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -92.44 166.86 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.197 -0.94 . . . . 1.0 109.46 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 8.5 pt20 -164.12 126.39 2.39 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.094 -1.003 . . . . 1.0 110.936 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.813 ' CE ' HD12 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -86.53 103.24 14.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.65 -0.87 . . . . 1.0 108.65 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.735 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -104.78 119.39 38.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -0.751 . . . . 1.0 110.433 -179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.714 ' CE2' HG11 ' A' ' 89' ' ' VAL . 3.7 p90 -141.24 143.65 34.26 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.008 -1.477 . . . . 1.0 111.455 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 16.9 t0 -136.27 108.51 7.28 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.698 0.761 . . . . 1.0 109.611 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -110.39 30.4 6.81 Favored 'General case' 0 C--N 1.287 -2.122 0 O-C-N 121.723 -0.61 . . . . 1.0 109.852 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 86' ' ' SER . . . -164.21 -50.86 0.02 OUTLIER Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.314 -1.514 . . . . 1.0 109.314 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 85' ' ' GLY . 1.4 t 178.18 -18.75 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.312 -1.11 . . . . 1.0 111.471 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 17.5 mmtt -119.51 117.86 32.63 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 120.724 -1.235 . . . . 1.0 110.662 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.07 143.92 33.15 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.877 1.462 . . . . 1.0 109.236 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.714 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.77 104.47 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 1.0 109.075 -179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.831 HG13 ' O ' ' A' ' 90' ' ' VAL . 8.7 p -91.1 82.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.483 -1.385 . . . . 1.0 111.261 -178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.813 HD12 ' CE ' ' A' ' 80' ' ' MET . 5.6 mt -75.02 74.51 2.21 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 177.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.572 ' O ' HG21 ' A' ' 124' ' ' ILE . 14.3 mtp180 -59.16 178.88 0.11 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.929 0.871 . . . . 1.0 111.213 -177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.59 ' OG ' HG21 ' A' ' 118' ' ' VAL . 2.0 t -109.97 143.12 40.38 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.881 -0.599 . . . . 1.0 110.193 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.49 HG22 ' O ' ' A' ' 94' ' ' THR . 24.4 m -99.82 31.16 3.35 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.124 -0.985 . . . . 1.0 109.93 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.936 HG11 HG11 ' A' ' 118' ' ' VAL . 3.0 t -136.27 145.89 53.86 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 1.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.484 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.1 Cg_endo -65.2 134.48 39.44 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.612 1.322 . . . . 1.0 110.751 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 76' ' ' GLY . 2.6 tp -117.6 -24.5 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 1.0 110.581 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.469 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 8.4 p-10 -76.37 55.95 1.03 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.277 -0.889 . . . . 1.0 109.177 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.618 HG22 ' O ' ' A' ' 99' ' ' THR . 24.2 m -110.89 14.62 22.08 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.485 -0.76 . . . . 1.0 110.588 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 51.67 18.76 0.77 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.08 -1.013 . . . . 1.0 110.624 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -117.32 162.95 17.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.129 -0.982 . . . . 1.0 110.378 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.677 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 16.5 m95 -76.74 101.64 5.9 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.149 -0.969 . . . . 1.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.49 HG22 ' N ' ' A' ' 104' ' ' HIS . 49.4 m -94.99 165.33 12.49 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.576 -0.85 . . . . 1.0 109.498 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.49 ' N ' HG22 ' A' ' 103' ' ' THR . 1.0 OUTLIER -118.06 136.82 53.32 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 105' ' ' ILE . 1.0 OUTLIER -135.31 155.83 37.92 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 O-C-N 121.052 -1.03 . . . . 1.0 108.953 -178.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.811 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -152.53 174.5 13.84 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.12 -1.432 . . . . 1.0 110.498 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.672 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -161.23 123.97 3.15 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.328 -0.949 . . . . 1.0 111.214 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 24.6 m-85 -105.24 106.68 17.29 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.8 ' CZ ' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -105.98 117.7 34.7 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.319 -0.952 . . . . 1.0 111.67 -178.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.917 HG12 ' OE1' ' A' ' 111' ' ' GLN . 1.8 t -118.6 134.52 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.75 -0.833 . . . . 1.0 108.75 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.917 ' OE1' HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER 29.74 -90.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.675 -0.641 . . . . 1.0 112.047 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.535 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -115.14 -14.78 11.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.993 -1.067 . . . . 1.0 112.138 -178.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.7 tt0 -98.97 118.38 35.61 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.83 -1.169 . . . . 1.0 110.914 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.01 171.53 18.99 Favored Glycine 0 N--CA 1.496 2.654 0 C-N-CA 120.32 -0.943 . . . . 1.0 111.034 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.576 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -147.45 160.89 42.07 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.586 -0.95 . . . . 1.0 110.206 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.933 HD13 ' N ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -148.87 141.99 24.94 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.268 -0.895 . . . . 1.0 109.238 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.933 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -143.78 130.51 20.27 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.076 -1.05 . . . . 1.0 111.233 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.936 HG11 HG11 ' A' ' 95' ' ' VAL . 2.2 t -89.65 97.75 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.627 -1.62 . . . . 1.0 106.627 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 71.48 40.51 59.69 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.351 -1.5 . . . . 1.0 109.351 -178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.94 31.99 17.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -1.059 . . . . 1.0 110.497 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.541 ' N ' ' HG2' ' A' ' 117' ' ' GLN . 2.9 mt-10 -105.08 -158.18 0.65 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 1.0 110.619 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.34 99.9 0.19 Allowed Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.664 -0.648 . . . . 1.0 110.013 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.639 ' C ' HD12 ' A' ' 124' ' ' ILE . 48.5 Cg_endo -75.73 135.47 17.81 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.154 1.607 . . . . 1.0 111.363 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.639 HD12 ' C ' ' A' ' 123' ' ' PRO . 1.5 mp -103.49 119.52 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.697 ' HA ' HD13 ' A' ' 91' ' ' LEU . 28.5 p -118.35 172.21 7.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.822 -1.174 . . . . 1.0 112.658 -176.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -179.68 153.98 12.99 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.694 -2.163 . . . . 1.0 107.694 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -138.26 161.93 35.62 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.006 -1.291 . . . . 1.0 110.986 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 130' ' ' LEU . 3.2 m -89.94 163.58 31.68 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.764 . . . . 1.0 109.684 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -68.83 62.36 1.28 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.006 1.53 . . . . 1.0 109.201 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.2 pp 16.55 50.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 121.376 0.608 . . . . 1.0 112.366 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -99.95 2.66 56.9 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.668 -1.373 . . . . 1.0 109.668 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 84' ' ' LEU . . . -161.85 84.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -1.109 . . . . 1.0 109.651 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 133' ' ' THR . 91.2 m -87.92 11.5 15.59 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 1.0 110.624 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.431 ' HG3' ' C ' ' A' ' 133' ' ' THR . 86.3 mt-30 -144.23 92.08 2.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.119 -0.988 . . . . 1.0 110.632 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.475 HD22 HH21 ' A' ' 109' ' ' ARG . 0.1 OUTLIER -100.71 160.21 14.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.944 . . . . 1.0 109.598 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.488 ' O ' ' HA3' ' A' ' 62' ' ' GLY . 29.1 m-20 -130.65 111.53 12.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.928 -1.107 . . . . 1.0 110.774 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 5.6 t -136.18 149.25 48.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.283 -0.885 . . . . 1.0 109.847 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.713 ' OD1' ' HB2' ' A' ' 140' ' ' ALA . 5.5 p-10 -87.68 29.17 0.92 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 1.0 110.671 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 58.69 13.61 18.62 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.713 ' HB2' ' OD1' ' A' ' 138' ' ' ASP . . . -57.77 170.22 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.08 -1.247 . . . . 1.0 108.516 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 27' ' ' TYR . 0.2 OUTLIER -160.88 145.94 14.2 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 118.276 -1.37 . . . . 1.0 112.026 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.577 ' CH2' ' HG3' ' A' ' 26' ' ' GLU . 49.6 m95 -135.08 119.13 17.5 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 106.268 -1.752 . . . . 1.0 106.268 176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.613 HD21 HG22 ' A' ' 56' ' ' ILE . 1.7 tt -130.93 123.46 28.94 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 117.677 -1.609 . . . . 1.0 113.334 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.87 2.17 10.42 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.454 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 141.58 -139.28 9.3 Favored Glycine 0 C--N 1.293 -1.828 0 C-N-CA 118.991 -1.576 . . . . 1.0 109.726 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.904 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -170.74 130.86 0.84 Allowed 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 118.948 -1.101 . . . . 1.0 112.178 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -64.99 -42.65 94.34 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.999 -1.111 . . . . 1.0 107.999 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -113.14 67.95 0.67 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 106.975 -1.491 . . . . 1.0 106.975 177.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.904 HD13 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -66.32 37.78 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.194 -0.941 . . . . 1.0 113.403 -176.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 148' ' ' ARG . 53.4 p -83.8 3.39 33.75 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.775 -1.565 . . . . 1.0 106.775 175.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.812 HG21 ' CZ2' ' A' ' 58' ' ' TRP . 14.9 p -86.59 -23.87 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.308 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.56 ' O ' ' CB ' ' A' ' 153' ' ' HIS . . . -41.82 -26.01 0.07 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.375 -0.828 . . . . 1.0 109.508 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.56 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER 83.38 -85.84 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.965 -0.459 . . . . 1.0 111.245 179.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -143.91 -7.17 0.74 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.631 -1.293 . . . . 1.0 111.776 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.746 HD22 ' CE1' ' A' ' 159' ' ' TYR . 4.2 pp -53.65 167.07 0.51 Allowed Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.108 -0.995 . . . . 1.0 110.377 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.702 ' O ' HD12 ' A' ' 155' ' ' LEU . 42.7 Cg_endo -68.96 -165.67 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.734 1.386 . . . . 1.0 112.278 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 1.5 mttp -56.25 -9.97 0.78 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.189 -0.944 . . . . 1.0 112.171 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.519 ' HA ' ' HG3' ' A' ' 53' ' ' GLN . . . -38.2 -44.36 0.85 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.209 -0.932 . . . . 1.0 109.784 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.937 ' CE2' HD13 ' A' ' 55' ' ' LEU . 6.0 m-85 -87.87 -27.07 22.44 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.989 -1.084 . . . . 1.0 108.748 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.567 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -73.17 -6.59 46.78 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.435 -1.306 . . . . 1.0 107.981 177.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 161' ' ' THR . 4.4 m -122.2 83.91 2.17 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.453 -0.943 . . . . 1.0 108.453 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.67 171.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.652 ' CE2' HD11 ' A' ' 167' ' ' ILE . 6.2 t80 -89.55 144.23 26.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.13 -1.218 . . . . 1.0 111.391 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.567 ' O ' ' CG ' ' A' ' 50' ' ' GLU . 5.9 mt -123.2 91.52 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 108.176 -1.046 . . . . 1.0 108.176 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.636 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -169.63 -154.07 8.97 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.48 -1.848 . . . . 1.0 108.48 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.562 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 2.9 m -124.09 144.56 49.8 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.204 -1.174 . . . . 1.0 110.516 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.718 HD12 ' CE1' ' A' ' 19' ' ' PHE 0.251 3.4 mt -134.1 145.59 32.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.534 -0.729 . . . . 1.0 109.425 -178.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 6.5 ttp180 -162.0 157.25 23.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.69 -1.256 . . . . 1.0 111.023 -178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 4.2 m-20 57.37 63.49 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.109 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 1.001 HG12 ' CB ' ' A' ' 45' ' ' LEU . 27.1 m -119.58 117.82 55.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.937 0.875 . . . . 1.0 109.653 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 175' ' ' GLN . 0.5 OUTLIER -135.6 155.9 37.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.09 -1.044 . . . . 1.0 110.915 -178.072 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 3.6 p -134.74 112.48 15.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 107.867 -1.16 . . . . 1.0 107.867 178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 94.6 m-20 59.04 37.49 24.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.24 32.59 14.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.764 -0.585 . . . . 1.0 110.609 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.603 ' O ' HG23 ' A' ' 171' ' ' ILE . 19.4 mm100 -118.45 176.16 5.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.186 -0.946 . . . . 1.0 110.44 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.606 ' O ' HD23 ' A' ' 177' ' ' LEU . 59.5 mm-40 65.18 -121.35 0.4 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.682 -0.636 . . . . 1.0 110.756 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.606 HD23 ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 57.62 7.31 0.52 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.315 -0.866 . . . . 1.0 112.205 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.581 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 15.3 m-70 -110.14 56.53 0.62 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.545 -1.347 . . . . 1.0 108.538 177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.72 ' O ' ' HB2' ' A' ' 183' ' ' ALA 0.261 12.3 mt -28.24 -61.45 0.11 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.966 0.889 . . . . 1.0 112.839 -179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.726 ' O ' HD13 ' A' ' 184' ' ' LEU . 2.2 t -77.29 -20.28 14.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 113.367 0.877 . . . . 1.0 113.367 -176.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.581 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.1 mm-40 -63.46 -48.6 77.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.228 -1.545 . . . . 1.0 110.803 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.43 -12.12 20.51 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.155 -0.966 . . . . 1.0 110.456 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -70.09 -33.71 72.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.018 -1.052 . . . . 1.0 108.738 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.726 HD13 ' O ' ' A' ' 180' ' ' VAL . 1.2 mp -48.63 -23.66 1.09 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.429 -0.795 . . . . 1.0 109.075 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -59.43 -16.52 24.02 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.875 0.845 . . . . 1.0 109.02 178.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.534 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 20.1 t30 -89.1 172.31 7.63 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 44.8 Cg_endo -87.73 -48.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 O-C-N 123.187 1.098 . . . . 1.0 111.357 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 95.3 m -118.31 145.87 44.76 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.427 -0.796 . . . . 1.0 111.115 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.34 130.29 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 1.0 110.208 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 17' ' ' ILE . 4.4 mt -115.62 169.13 9.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.0 110.826 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.554 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -110.6 -82.23 0.58 Allowed 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.094 -1.004 . . . . 1.0 111.23 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -177.28 178.93 1.03 Allowed 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.033 -1.042 . . . . 1.0 111.044 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.773 ' O ' ' HB3' ' A' ' 194' ' ' ALA . 0.0 OUTLIER -128.81 170.35 13.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.503 -0.748 . . . . 1.0 110.455 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 193' ' ' SER . . . 75.23 37.46 0.46 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.418 0.628 . . . . 1.0 110.087 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.047 0 C-N-CA 118.84 -1.144 . . . . 1.0 110.453 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.609 -1.396 . . . . 1.0 109.609 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 3' ' ' GLU . 22.9 t 50.79 79.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -1.189 . . . . 1.0 110.157 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' O ' ' O ' ' A' ' 4' ' ' LYS . 0.4 OUTLIER 58.75 47.88 12.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.343 -0.848 . . . . 1.0 110.508 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 3' ' ' GLU . 3.5 mmmm 55.33 108.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.296 -0.877 . . . . 1.0 110.63 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 5' ' ' VAL . 28.2 m -68.54 122.76 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.133 -0.98 . . . . 1.0 110.121 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 6' ' ' ILE . 2.6 pp -70.36 155.51 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 1.0 110.539 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.533 ' O ' HG22 ' A' ' 7' ' ' ILE . 5.6 mt -102.81 81.87 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 1.0 109.939 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.32 129.29 40.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.988 . . . . 1.0 110.389 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.84 101.4 3.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.321 -0.862 . . . . 1.0 110.352 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.97 118.41 19.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -0.883 . . . . 1.0 110.102 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.3 50.56 1.1 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 1.0 110.168 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -109.18 60.87 0.31 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.598 -1.401 . . . . 1.0 109.598 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' NH2' ' A' ' 168' ' ' ARG . 10.4 p-10 -116.0 8.04 14.49 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.739 -0.86 . . . . 1.0 109.961 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -118.36 59.07 0.81 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 1.0 109.805 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.591 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.4 pt-20 -66.31 70.54 0.07 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.267 -0.896 . . . . 1.0 110.948 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.589 ' O ' ' CD2' ' A' ' 191' ' ' HIS . . . -85.17 140.98 30.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.402 -1.436 . . . . 1.0 109.302 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.868 HG21 ' CE ' ' A' ' 25' ' ' MET . 21.9 mm -111.52 122.71 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.694 -1.203 . . . . 1.0 110.788 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.32 122.05 27.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.369 -0.832 . . . . 1.0 110.093 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.812 ' CE1' HD12 ' A' ' 167' ' ' ILE . 4.6 m-85 -94.27 140.23 30.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.087 -1.008 . . . . 1.0 110.023 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -107.95 -7.66 16.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.127 -0.983 . . . . 1.0 110.214 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.547 ' O ' ' N ' ' A' ' 162' ' ' GLY . . . 114.64 -11.83 21.06 Favored Glycine 0 N--CA 1.483 1.774 0 N-CA-C 109.208 -1.557 . . . . 1.0 109.208 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -124.06 -1.74 8.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.861 -1.376 . . . . 1.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.27 110.03 22.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.985 -1.072 . . . . 1.0 110.572 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 5.4 p90 -100.17 156.09 17.39 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.177 -0.952 . . . . 1.0 110.282 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.868 ' CE ' HG21 ' A' ' 17' ' ' ILE . 3.4 mmt -122.16 100.32 6.9 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.154 -1.018 . . . . 1.0 110.341 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.618 ' HB3' ' CZ3' ' A' ' 142' ' ' TRP . 1.3 pp20? -78.36 106.08 10.04 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.413 -0.958 . . . . 1.0 108.413 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.618 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 44.2 m-85 -101.11 98.51 8.93 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.912 -1.118 . . . . 1.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -93.03 102.15 14.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 1.0 109.692 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -121.61 138.64 54.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.116 -0.99 . . . . 1.0 110.184 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 31' ' ' VAL . . . -86.11 95.56 9.59 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 1.0 109.842 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.686 HG23 ' H ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -40.03 -79.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.5 -0.75 . . . . 1.0 110.534 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.686 ' H ' HG23 ' A' ' 31' ' ' VAL . 8.2 t -177.14 165.27 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.819 -1.175 . . . . 1.0 110.487 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 34' ' ' SER . 7.5 mmtm -73.56 96.57 2.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.328 -0.857 . . . . 1.0 110.078 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 9.9 t 174.97 -26.58 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.207 -0.933 . . . . 1.0 110.676 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 34' ' ' SER . 2.3 tt0 65.83 120.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.355 -0.841 . . . . 1.0 110.711 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 1.5 mtpt -119.5 145.73 46.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.888 . . . . 1.0 110.261 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . -179.16 49.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.253 -0.904 . . . . 1.0 110.219 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.55 ' N ' HD23 ' A' ' 38' ' ' LEU . 2.2 pt? -151.32 -165.08 2.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.264 -0.898 . . . . 1.0 110.271 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 38' ' ' LEU . 31.8 tt0 39.77 -113.75 0.16 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.47 -0.769 . . . . 1.0 110.311 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -143.0 178.42 7.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.93 -1.106 . . . . 1.0 111.149 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.407 ' N ' ' OG ' ' A' ' 40' ' ' SER . 30.2 m120 -119.69 156.05 31.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 1.0 109.85 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 7.7 m80 -119.24 117.34 28.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.144 -0.972 . . . . 1.0 110.297 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.759 ' HD1' HG22 ' A' ' 172' ' ' VAL . 21.2 m-85 -112.28 120.25 41.11 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.589 -0.694 . . . . 1.0 110.234 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.742 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.9 OUTLIER -130.19 139.98 50.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.858 -1.151 . . . . 1.0 111.322 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.945 ' HB2' HG12 ' A' ' 170' ' ' VAL . 1.2 pt? -176.59 150.76 0.88 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.332 -0.855 . . . . 1.0 110.518 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 m -120.34 146.47 46.11 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.95 HG23 ' CD1' ' A' ' 105' ' ' ILE . 0.9 OUTLIER -127.69 -170.82 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 C-N-CA 118.126 -1.43 . . . . 1.0 111.261 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.658 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.7 OUTLIER -153.16 136.77 15.99 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.065 -1.457 . . . . 1.0 107.065 179.014 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.622 HG23 ' HA ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER 52.68 162.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.773 0 O-C-N 120.51 -1.369 . . . . 1.0 109.238 -177.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.795 ' CG ' HD13 ' A' ' 73' ' ' ILE . 15.1 tt0 -173.87 22.63 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 O-C-N 120.305 -1.497 . . . . 1.0 110.283 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.703 ' HB2' ' CG2' ' A' ' 164' ' ' ILE . . . 45.93 -114.68 0.49 Allowed 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 118.681 -1.208 . . . . 1.0 109.201 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.583 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 18.3 p -155.17 -40.27 0.09 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.002 -1.061 . . . . 1.0 109.583 178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.66 131.33 53.76 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.415 -0.803 . . . . 1.0 109.647 179.746 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 168.07 138.3 2.43 Favored Glycine 0 N--CA 1.486 2.017 0 C-N-CA 119.439 -1.362 . . . . 1.0 109.885 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.947 HD22 HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -88.97 124.41 34.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.971 -1.311 . . . . 1.0 109.005 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.692 HD11 HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.3 -27.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 113.423 0.897 . . . . 1.0 113.423 -176.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.031 HD12 HD13 ' A' ' 143' ' ' LEU . 1.7 tt -143.32 151.69 40.77 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 119.85 -1.781 . . . . 1.0 113.089 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.458 ' CD1' ' O ' ' A' ' 58' ' ' TRP . 5.3 t-105 -160.22 106.93 1.57 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.403 0.621 . . . . 1.0 109.604 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.535 ' HG ' HD11 ' A' ' 69' ' ' ILE . 0.7 OUTLIER -121.43 155.61 34.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.196 -0.94 . . . . 1.0 109.08 179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.661 ' O ' ' HB3' ' A' ' 61' ' ' LYS . . . -148.59 -29.03 0.06 OUTLIER Glycine 0 N--CA 1.491 2.333 0 C-N-CA 118.725 -1.702 . . . . 1.0 111.749 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.661 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 73.2 -45.39 0.62 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 118.346 1.073 . . . . 1.0 110.615 -178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . -175.32 -136.11 2.23 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.646 HD22 HD21 ' A' ' 135' ' ' LEU . 1.5 mp 43.03 95.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.244 -1.15 . . . . 1.0 110.409 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.05 47.29 1.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 1.0 111.079 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.24 37.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.962 -1.086 . . . . 1.0 109.634 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.533 ' O ' ' CZ ' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -147.02 -179.14 6.6 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.141 -1.024 . . . . 1.0 110.675 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.628 ' O ' ' CD2' ' A' ' 68' ' ' TYR . 2.5 m-20 -108.78 -27.82 9.55 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.833 -1.167 . . . . 1.0 110.723 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.681 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 0.0 OUTLIER 53.35 -82.18 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.149 -0.969 . . . . 1.0 110.776 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.547 ' HA ' ' CB ' ' A' ' 82' ' ' TYR . 8.9 pt -158.46 153.43 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.42 -0.8 . . . . 1.0 111.171 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.729 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -166.14 174.55 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.494 -0.754 . . . . 1.0 109.079 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.958 HD12 HD13 ' A' ' 57' ' ' LEU . 95.9 mt -150.91 134.28 16.22 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 120.925 -1.109 . . . . 1.0 108.165 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -146.87 179.55 7.51 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.032 -1.042 . . . . 1.0 112.652 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.795 HD13 ' CG ' ' A' ' 50' ' ' GLU . 2.5 mt -133.27 139.37 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.717 -0.614 . . . . 1.0 111.623 -177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.696 HG22 ' OE1' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -140.42 131.54 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.274 -0.891 . . . . 1.0 109.224 178.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 1.5 m-20 69.29 9.73 7.46 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.138 -0.976 . . . . 1.0 111.036 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 52' ' ' THR . . . 96.75 16.38 36.57 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.098 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.594 ' O ' HG23 ' A' ' 73' ' ' ILE . 90.6 m-85 -130.05 159.65 36.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -1.097 . . . . 1.0 109.32 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.692 HG12 HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -102.57 164.3 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.185 -0.947 . . . . 1.0 111.824 -178.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.837 ' HB2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -160.52 130.88 5.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.383 0.611 . . . . 1.0 110.413 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.806 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -92.69 115.95 28.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.021 -1.049 . . . . 1.0 109.571 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.729 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -116.61 122.05 43.5 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.284 -0.885 . . . . 1.0 109.805 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.681 ' HB2' ' O ' ' A' ' 68' ' ' TYR . 15.9 p90 -140.73 144.98 35.85 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.561 -1.256 . . . . 1.0 111.351 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.566 ' CB ' ' HB2' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -141.19 108.3 5.47 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.35 1.072 . . . . 1.0 109.652 -179.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.564 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.2 OUTLIER -104.54 34.49 3.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.436 -0.802 . . . . 1.0 109.897 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -168.34 -41.15 0.03 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.542 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.6 OUTLIER 165.63 -17.24 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.291 -1.123 . . . . 1.0 111.146 179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.466 ' HD3' ' HG3' ' A' ' 129' ' ' PRO . 13.1 mtpt -121.18 116.98 30.83 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.831 -1.168 . . . . 1.0 110.572 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.516 ' N ' ' HB2' ' A' ' 83' ' ' ASP . 45.3 Cg_endo -75.62 160.63 37.93 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.928 1.488 . . . . 1.0 110.676 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.786 HG13 HD21 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -133.05 107.01 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.326 -0.859 . . . . 1.0 108.749 -179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.837 HG22 ' HB2' ' A' ' 79' ' ' GLN . 1.8 p -95.89 123.94 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.455 -1.403 . . . . 1.0 111.242 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.794 HD12 ' HE3' ' A' ' 80' ' ' MET . 0.7 OUTLIER -113.58 84.58 2.04 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 177.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.666 ' O ' HG21 ' A' ' 124' ' ' ILE . 30.9 mtp180 -59.65 178.01 0.18 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.239 -0.984 . . . . 1.0 111.266 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.727 ' OG ' HG21 ' A' ' 118' ' ' VAL . 2.9 t -101.78 159.03 15.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.512 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.18 24.61 12.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 1.0 109.522 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.607 HG13 ' HD2' ' A' ' 96' ' ' PRO . 1.3 t -147.22 154.67 46.25 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 1.0 109.429 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 95' ' ' VAL . 38.3 Cg_endo -64.25 134.5 42.52 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.77 1.405 . . . . 1.0 109.715 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 97' ' ' ILE . 0.1 OUTLIER -114.15 -31.66 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 1.0 111.048 -178.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.483 ' CA ' ' HB3' ' A' ' 50' ' ' GLU . 12.6 p30 -82.16 47.88 1.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.968 -1.082 . . . . 1.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 99' ' ' THR . 2.0 m -87.59 6.55 33.94 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 110.906 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.622 ' HA ' HG23 ' A' ' 49' ' ' THR . 0.6 OUTLIER 66.7 7.43 5.17 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.236 -0.915 . . . . 1.0 111.538 178.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 4.2 m80 -112.53 173.63 6.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.896 -1.128 . . . . 1.0 110.366 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.658 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 2.6 m95 -75.98 88.37 2.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.114 -0.991 . . . . 1.0 109.967 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.597 HG22 ' N ' ' A' ' 104' ' ' HIS . 7.7 m -79.75 172.25 14.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.047 -1.033 . . . . 1.0 109.579 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.597 ' N ' HG22 ' A' ' 103' ' ' THR . 0.7 OUTLIER -123.19 119.84 31.42 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.945 -1.132 . . . . 1.0 107.945 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.95 ' CD1' HG23 ' A' ' 47' ' ' ILE . 1.6 mp -118.28 142.71 31.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 N-CA-C 107.885 -1.154 . . . . 1.0 107.885 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.768 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 2.1 mttp -153.7 178.99 9.26 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.305 -1.358 . . . . 1.0 109.391 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.587 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -164.9 158.37 17.14 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.625 -1.23 . . . . 1.0 111.629 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -136.36 103.93 5.44 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -91.24 117.88 30.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.352 -0.843 . . . . 1.0 109.785 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 111' ' ' GLN . 20.6 t -114.88 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.078 -1.014 . . . . 1.0 110.077 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.504 ' O ' ' NH2' ' A' ' 109' ' ' ARG . 9.9 tt0 60.1 -92.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.254 -0.904 . . . . 1.0 110.236 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.582 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -111.4 -21.23 11.92 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.015 -1.053 . . . . 1.0 110.38 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.582 ' N ' ' HG2' ' A' ' 112' ' ' ARG . 6.2 tt0 -92.22 108.27 19.83 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.966 0.889 . . . . 1.0 111.11 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -94.75 165.7 25.92 Favored Glycine 0 N--CA 1.498 2.773 0 C-N-CA 120.34 -0.933 . . . . 1.0 110.854 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.66 ' CB ' HG22 ' A' ' 125' ' ' THR . 16.2 t -146.48 156.88 43.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.259 -1.142 . . . . 1.0 110.73 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.072 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.7 tm? -123.1 146.9 47.32 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.095 -1.003 . . . . 1.0 108.859 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 1.072 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -126.52 92.97 3.67 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.347 -0.845 . . . . 1.0 111.844 -178.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.742 HG23 HD12 ' A' ' 116' ' ' LEU . 52.9 t -86.78 85.43 2.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.33 53.72 16.35 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.725 -0.95 . . . . 1.0 110.725 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.488 ' OD1' ' OE1' ' A' ' 117' ' ' GLN . 1.7 m-20 44.68 21.25 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.157 -1.202 . . . . 1.0 111.178 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -91.49 -176.37 4.5 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.764 -1.21 . . . . 1.0 109.813 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -41.12 100.46 0.22 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.423 -0.798 . . . . 1.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.464 ' N ' ' O ' ' A' ' 121' ' ' GLU . 41.1 Cg_endo -67.91 134.8 33.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.228 1.646 . . . . 1.0 110.864 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.747 HG22 ' HB3' ' A' ' 91' ' ' LEU . 1.5 mp -97.95 115.18 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 1.0 108.654 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.66 HG22 ' CB ' ' A' ' 115' ' ' SER . 12.2 p -120.25 174.48 6.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.072 -1.017 . . . . 1.0 112.181 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 114' ' ' GLY . . . -178.72 163.36 31.11 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 107.253 -2.339 . . . . 1.0 107.253 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.577 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -140.82 169.84 16.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.581 -1.54 . . . . 1.0 111.153 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -100.68 166.65 12.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.243 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.549 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.4 Cg_endo -66.94 89.92 0.3 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.779 1.41 . . . . 1.0 108.51 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.549 ' C ' ' O ' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -14.5 131.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.214 0.53 . . . . 1.0 112.111 -178.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 130.43 55.92 0.1 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.813 -1.315 . . . . 1.0 109.813 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.564 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . -103.84 -122.31 0.2 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -1.125 . . . . 1.0 109.926 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.658 ' O ' HG23 ' A' ' 133' ' ' THR . 13.1 t -167.79 59.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.71 -1.244 . . . . 1.0 110.279 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.479 ' O ' ' CB ' ' A' ' 135' ' ' LEU . 11.3 mm-40 54.96 -87.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.341 -0.849 . . . . 1.0 110.121 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.646 HD21 HD22 ' A' ' 63' ' ' LEU . 0.2 OUTLIER 66.46 97.77 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 1.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 1.3 m-20 -69.28 178.96 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.909 . . . . 1.0 109.723 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.519 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -153.08 105.77 2.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.155 -0.966 . . . . 1.0 109.805 179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.604 ' CB ' HG11 ' A' ' 31' ' ' VAL . 1.9 p30 164.04 -29.75 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.646 -0.659 . . . . 1.0 109.691 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -38.54 -44.31 1.73 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.214 -1.154 . . . . 1.0 110.214 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -164.87 162.75 21.0 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.066 -1.255 . . . . 1.0 110.257 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.533 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 14.7 tp -145.41 146.03 31.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.384 -0.823 . . . . 1.0 109.976 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.656 ' CG ' ' HE1' ' A' ' 146' ' ' MET . 37.1 m95 -135.81 131.36 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.253 -1.017 . . . . 1.0 108.253 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 1.031 HD13 HD12 ' A' ' 57' ' ' LEU . 5.4 tp -133.21 122.22 23.65 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.177 -1.409 . . . . 1.0 112.698 -178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 119.51 16.27 5.16 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.862 -1.295 . . . . 1.0 109.862 177.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 130.05 -137.54 9.6 Favored Glycine 0 C--N 1.287 -2.182 0 C-N-CA 119.099 -1.524 . . . . 1.0 109.919 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.791 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -168.05 134.38 2.01 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.846 -0.741 . . . . 1.0 110.388 -179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -47.45 -20.58 0.24 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.448 -0.782 . . . . 1.0 110.856 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.595 ' O ' ' CG ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -157.51 85.94 0.93 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.515 -1.291 . . . . 1.0 107.515 178.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.947 HD21 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -78.8 38.17 0.32 Allowed 'General case' 0 C--N 1.29 -2.006 0 O-C-N 120.555 -1.341 . . . . 1.0 112.772 -177.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 151' ' ' VAL . 1.9 p -54.26 -26.37 28.59 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 104.55 -2.389 . . . . 1.0 104.55 174.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.833 HG13 ' N ' ' A' ' 152' ' ' ALA 0.282 7.7 p -59.28 -132.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.297 -1.32 . . . . 1.0 108.807 177.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.833 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 65.21 -67.62 0.12 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.136 -0.978 . . . . 1.0 109.544 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.545 ' N ' ' O ' ' A' ' 151' ' ' VAL . 18.9 m170 38.16 -74.84 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.427 1.269 . . . . 1.0 114.427 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -52.6 -3.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.576 1.324 . . . . 1.0 114.576 -176.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.928 HD11 ' CD1' ' A' ' 159' ' ' TYR . 0.9 OUTLIER -146.51 175.54 2.67 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 119.79 -1.819 . . . . 1.0 111.833 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 50.3 Cg_endo -77.51 -161.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.868 1.712 . . . . 1.0 113.809 -177.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.635 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.1 OUTLIER -43.77 -20.7 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.365 -0.834 . . . . 1.0 113.071 -178.414 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.542 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -36.77 -43.33 0.42 Allowed 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.093 -1.004 . . . . 1.0 109.357 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.928 ' CD1' HD11 ' A' ' 155' ' ' LEU . 5.5 m-85 -89.27 -27.52 20.51 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.124 -0.985 . . . . 1.0 109.543 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -72.26 -7.87 51.76 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 118.225 -1.39 . . . . 1.0 107.407 177.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.537 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.5 m -130.84 98.51 4.64 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 21' ' ' GLY . . . -49.81 -175.26 0.01 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.618 ' CD2' HD11 ' A' ' 167' ' ' ILE . 44.6 t80 -67.58 152.77 45.08 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.27 -1.135 . . . . 1.0 112.056 -179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 164' ' ' ILE . 1.3 mp -131.57 80.38 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 121.846 0.831 . . . . 1.0 109.899 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.57 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.67 -161.23 20.92 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 106.778 -2.529 . . . . 1.0 106.778 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.4 m -125.19 143.81 50.76 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.84 -1.388 . . . . 1.0 109.597 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.812 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.3 mt -124.0 156.77 31.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 120.749 -1.219 . . . . 1.0 111.689 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.591 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -167.47 152.56 7.13 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.23 -0.588 . . . . 1.0 109.883 -179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.538 ' N ' ' HG3' ' A' ' 168' ' ' ARG . 17.4 m-20 56.11 64.83 1.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.115 -0.991 . . . . 1.0 110.426 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.945 HG12 ' HB2' ' A' ' 45' ' ' LEU . 24.3 m -116.64 133.1 64.36 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.448 -0.945 . . . . 1.0 108.448 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.566 ' HA ' ' HG3' ' A' ' 176' ' ' GLU . 1.0 OUTLIER -148.64 155.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.425 -1.31 . . . . 1.0 110.969 -176.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.759 HG22 ' HD1' ' A' ' 43' ' ' PHE . 13.4 t -132.82 91.59 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.789 -0.819 . . . . 1.0 108.789 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 8.0 m-20 57.05 46.26 19.54 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.862 -1.149 . . . . 1.0 108.023 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.492 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 72.26 31.79 1.81 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.257 0.551 . . . . 1.0 110.375 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.557 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . 34.2 mt-30 -108.42 176.06 5.25 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.3 -0.875 . . . . 1.0 110.076 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.58 ' O ' ' CB ' ' A' ' 177' ' ' LEU . 6.9 pt-20 44.09 -114.66 0.38 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 122.365 -0.209 . . . . 1.0 110.912 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 179' ' ' LEU . 8.6 tp 78.77 -59.24 0.41 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.35 -0.844 . . . . 1.0 110.375 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 4.8 m-70 -68.98 70.63 0.21 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.963 -1.085 . . . . 1.0 109.288 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.866 HD11 HG22 ' A' ' 170' ' ' VAL 0.255 3.7 mp -44.1 -61.53 1.44 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.689 0.756 . . . . 1.0 112.087 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.565 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 94.5 t -68.29 -9.7 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-N 116.104 -0.498 . . . . 1.0 112.233 -176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 11.0 mt-10 -74.61 -62.09 1.65 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 120.699 -1.251 . . . . 1.0 110.012 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.618 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 8.2 m-20 -83.03 -12.62 57.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.99 . . . . 1.0 109.183 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -72.74 -31.31 64.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 1.0 109.038 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 0.2 OUTLIER -59.94 -14.14 14.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.294 -0.879 . . . . 1.0 109.188 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.515 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -46.27 -25.79 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.311 -0.868 . . . . 1.0 109.462 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.563 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 1.5 t-20 -93.26 175.12 3.32 Favored Pre-proline 0 C--N 1.3 -1.575 0 N-CA-C 108.1 -1.074 . . . . 1.0 108.1 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 43.7 Cg_endo -84.44 -90.73 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 122.889 0.942 . . . . 1.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 188' ' ' THR . 2.8 t -66.78 144.49 56.28 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.334 -0.854 . . . . 1.0 110.727 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.747 ' C ' HD13 ' A' ' 190' ' ' LEU . 3.2 mt -126.89 117.35 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.486 -0.759 . . . . 1.0 109.689 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.922 ' H ' HD22 ' A' ' 190' ' ' LEU . 0.0 OUTLIER -94.39 136.06 35.11 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.185 -0.947 . . . . 1.0 109.055 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 16' ' ' ALA . 9.7 m80 -114.72 149.16 37.26 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.089 -1.007 . . . . 1.0 110.126 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 166' ' ' CYS . 0.9 OUTLIER -70.68 -162.28 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 1.0 110.051 179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.76 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 0.0 OUTLIER -125.6 138.39 53.93 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.267 -0.896 . . . . 1.0 109.988 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 161.4 37.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.772 -0.58 . . . . 1.0 110.114 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.291 -1.954 0 C-N-CA 118.616 -1.234 . . . . 1.0 110.546 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.444 -1.463 . . . . 1.0 109.444 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 92.4 p 43.72 -92.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.287 -1.125 . . . . 1.0 110.307 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.0 OUTLIER -45.67 -50.09 13.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.125 -0.985 . . . . 1.0 110.052 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' O ' ' O ' ' A' ' 3' ' ' GLU . 4.1 ttmm 55.88 164.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -0.835 . . . . 1.0 110.146 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.81 156.2 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 1.0 110.362 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mt -120.94 115.19 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 1.0 110.368 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.568 HD13 ' N ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -67.44 148.92 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.775 . . . . 1.0 110.596 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -91.83 157.74 16.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.373 -0.829 . . . . 1.0 109.974 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.2 mtmt -124.72 138.16 54.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.186 -0.947 . . . . 1.0 110.416 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -104.38 87.68 2.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.279 -0.888 . . . . 1.0 109.486 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 13' ' ' ASP . . . -74.05 2.26 9.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.366 -0.834 . . . . 1.0 110.364 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.497 ' O ' ' CB ' ' A' ' 13' ' ' ASP . . . 58.91 -83.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.118 -1.593 . . . . 1.0 109.118 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . 0.4 OUTLIER 70.64 9.79 6.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -1.046 . . . . 1.0 110.632 179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 13' ' ' ASP . . . -176.56 37.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.221 -0.924 . . . . 1.0 110.421 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.551 ' HG2' ' CD1' ' A' ' 179' ' ' LEU . 0.5 OUTLIER -64.94 89.28 0.07 Allowed 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.294 -0.879 . . . . 1.0 109.507 179.654 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.577 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -113.13 153.94 27.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.164 -0.96 . . . . 1.0 111.085 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.608 HG13 HD22 ' A' ' 179' ' ' LEU . 0.8 OUTLIER -114.84 144.78 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 177.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -104.2 136.07 44.49 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.756 -1.215 . . . . 1.0 111.443 -178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.841 ' CE1' HD12 ' A' ' 167' ' ' ILE . 6.6 m-85 -100.72 148.16 25.21 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -113.88 1.18 14.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.982 -1.074 . . . . 1.0 111.102 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.475 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 108.11 -18.13 34.03 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.396 -1.882 . . . . 1.0 108.396 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.08 42.02 3.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.615 -0.932 . . . . 1.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.8 m -112.89 127.16 56.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.0 110.943 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.56 ' CG ' ' HG3' ' A' ' 147' ' ' GLU . 0.8 OUTLIER -118.76 87.56 2.76 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.323 -0.86 . . . . 1.0 109.684 179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.458 ' SD ' ' CE1' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -76.0 100.7 4.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.15 -0.969 . . . . 1.0 110.475 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 6.2 tt0 -79.43 90.32 5.04 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CD1' ' HB2' ' A' ' 182' ' ' ASP . 4.2 m-30 -95.24 111.8 23.6 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.487 -0.885 . . . . 1.0 111.319 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -133.44 153.7 51.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 1.0 109.71 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.49 167.44 27.16 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.001 -1.062 . . . . 1.0 110.398 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.28 97.16 9.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.276 -0.89 . . . . 1.0 110.443 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 32' ' ' THR . 16.6 t -73.12 -115.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -0.849 . . . . 1.0 110.034 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.429 ' N ' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -132.29 171.91 13.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.833 -1.167 . . . . 1.0 110.128 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' O ' ' CB ' ' A' ' 34' ' ' SER . 0.1 OUTLIER -116.1 78.67 1.21 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -0.966 . . . . 1.0 110.122 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 2.0 p 164.85 -71.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.474 -0.766 . . . . 1.0 109.927 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 83.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.89 . . . . 1.0 110.411 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 167.88 10.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.274 -0.891 . . . . 1.0 110.142 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.69 ' HB2' ' OD2' ' A' ' 136' ' ' ASP . . . 48.64 71.39 0.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 1.0 110.132 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.38 -166.9 0.37 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.29 -0.881 . . . . 1.0 110.138 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.706 ' NE2' HG13 ' A' ' 110' ' ' VAL . 3.0 tm0? -106.5 -14.45 15.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 1.0 110.101 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -150.23 154.6 38.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.575 -0.703 . . . . 1.0 110.187 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 109' ' ' ARG . 52.6 p-10 -108.52 149.41 28.87 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.175 -0.953 . . . . 1.0 110.666 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -123.41 125.65 45.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 1.0 109.42 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 39.2 m-85 -133.21 131.6 40.54 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.129 -0.982 . . . . 1.0 111.05 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.751 ' C ' HD23 ' A' ' 45' ' ' LEU . 6.7 mt-10 -137.9 140.61 40.45 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 1.0 110.404 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.816 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 179.92 154.28 0.54 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.289 -0.882 . . . . 1.0 110.798 179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.502 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -117.49 155.7 29.27 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.077 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.84 HD13 HD11 ' A' ' 105' ' ' ILE . 6.5 pt -149.16 176.58 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 117.792 -1.563 . . . . 1.0 112.802 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.604 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -130.92 83.22 2.1 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 178.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.509 ' OG1' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -67.04 152.14 46.34 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.127 0.965 . . . . 1.0 112.603 -176.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.928 ' HB2' HG22 ' A' ' 164' ' ' ILE . 11.0 mm-40 -141.92 1.03 1.44 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.396 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.24 124.86 11.08 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.973 -1.08 . . . . 1.0 110.187 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.879 HG22 ' HA2' ' A' ' 76' ' ' GLY . 17.8 p -59.96 -10.9 4.62 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.422 -0.798 . . . . 1.0 110.796 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.1 OUTLIER -128.35 130.11 47.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.063 . . . . 1.0 111.211 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 160.03 137.63 2.27 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.367 -1.493 . . . . 1.0 109.367 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.022 HD21 HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -90.44 127.75 36.31 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 120.549 -1.559 . . . . 1.0 108.884 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.728 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -91.07 -40.04 12.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.449 -0.782 . . . . 1.0 112.2 -176.181 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 141' ' ' LEU . 5.7 tt -142.79 139.11 30.86 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 120.092 -1.63 . . . . 1.0 113.693 -176.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.73 ' N ' HD23 ' A' ' 57' ' ' LEU . 1.1 t-105 -145.32 106.35 4.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.281 -0.887 . . . . 1.0 108.661 177.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.578 ' CB ' HD12 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -121.65 -166.58 1.4 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.385 -0.822 . . . . 1.0 109.782 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' LYS . . . 97.15 48.33 2.07 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.315 -1.514 . . . . 1.0 109.315 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 62' ' ' GLY . 0.2 OUTLIER 45.0 70.3 0.36 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.32 -1.106 . . . . 1.0 109.877 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 61' ' ' LYS . . . -41.38 132.34 3.54 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.805 -1.318 . . . . 1.0 109.805 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -149.2 -166.69 2.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -1.121 . . . . 1.0 110.13 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' H ' HD23 ' A' ' 63' ' ' LEU . 4.1 mt-10 -109.89 14.09 23.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.145 -0.972 . . . . 1.0 110.297 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 23.7 ptt-85 173.8 63.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.237 -0.914 . . . . 1.0 109.435 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.582 ' O ' ' CE2' ' A' ' 68' ' ' TYR . 0.1 OUTLIER -144.92 -177.31 5.46 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 119.337 -0.945 . . . . 1.0 110.807 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 84' ' ' LEU . 44.5 m-20 -94.58 162.29 13.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.431 -0.793 . . . . 1.0 109.768 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.582 ' CE2' ' O ' ' A' ' 66' ' ' SER . 0.3 OUTLIER 177.01 -167.0 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.467 -1.396 . . . . 1.0 111.236 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.562 ' CD1' ' HB3' ' A' ' 82' ' ' TYR . 0.1 OUTLIER -146.39 155.63 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 115.927 -0.579 . . . . 1.0 109.597 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.984 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -149.1 -175.79 5.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.946 -1.096 . . . . 1.0 111.033 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.994 HD12 HD13 ' A' ' 57' ' ' LEU . 61.1 mt -151.31 116.54 5.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -136.38 171.47 14.44 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.749 -1.219 . . . . 1.0 111.764 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.593 HG13 HD11 ' A' ' 56' ' ' ILE . 45.7 mt -114.87 130.53 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.528 -0.732 . . . . 1.0 110.586 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -140.48 143.7 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.56 -0.713 . . . . 1.0 110.131 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.497 ' OD2' ' NH1' ' A' ' 92' ' ' ARG . 50.7 m-20 60.25 13.52 3.99 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.427 -0.796 . . . . 1.0 111.695 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.879 ' HA2' HG22 ' A' ' 52' ' ' THR . . . 93.09 10.04 60.11 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.587 -1.292 . . . . 1.0 109.997 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -133.28 141.7 48.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.26 -1.141 . . . . 1.0 109.551 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.728 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.2 OUTLIER -77.14 178.62 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.859 -1.151 . . . . 1.0 108.655 179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.923 ' CD ' HG22 ' A' ' 90' ' ' VAL . 1.4 pp0? -173.98 125.67 0.36 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.61 -1.307 . . . . 1.0 111.694 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.641 ' HA ' HD23 ' A' ' 71' ' ' LEU . 2.8 ttm -69.41 129.04 38.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.984 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 13.2 tmm? -132.11 109.12 9.75 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.419 -0.801 . . . . 1.0 110.466 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.765 ' CE2' HG11 ' A' ' 89' ' ' VAL . 11.5 p90 -133.95 133.1 40.98 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 117.914 -1.514 . . . . 1.0 112.107 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -118.47 88.14 2.86 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.567 0.699 . . . . 1.0 109.728 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.674 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -73.14 -76.16 0.13 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.441 -0.787 . . . . 1.0 109.111 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -71.08 -42.56 58.6 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.004 -2.039 . . . . 1.0 108.004 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.606 ' O ' ' CB ' ' A' ' 87' ' ' LYS . 1.3 t 160.79 147.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.606 ' CB ' ' O ' ' A' ' 86' ' ' SER . 0.2 OUTLIER 83.92 93.76 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 -179.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.58 ' HB2' ' HG2' ' A' ' 81' ' ' MET . 41.4 Cg_endo -67.53 146.44 74.05 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 124.492 1.785 . . . . 1.0 111.763 -178.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.765 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.69 117.44 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -99.47 98.14 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.96 -1.088 . . . . 1.0 110.573 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.623 HD12 ' HB3' ' A' ' 80' ' ' MET . 6.0 mt -93.94 75.45 4.17 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.696 ' O ' HG21 ' A' ' 124' ' ' ILE . 6.4 mtt180 -56.77 174.95 0.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 119.28 -0.968 . . . . 1.0 110.397 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 1.065 ' OG ' HG21 ' A' ' 118' ' ' VAL . 14.5 t -92.9 160.45 14.9 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.335 0.588 . . . . 1.0 110.564 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.694 HG21 ' HB3' ' A' ' 122' ' ' ALA . 14.9 t -102.64 8.04 39.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 1.0 109.642 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.751 HG13 ' HD2' ' A' ' 96' ' ' PRO . 51.2 t -129.87 150.9 77.19 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.751 ' HD2' HG13 ' A' ' 95' ' ' VAL . 45.3 Cg_endo -69.59 135.58 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.482 1.254 . . . . 1.0 110.2 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.613 HG21 HG22 ' A' ' 78' ' ' VAL . 1.1 tp -115.77 -31.31 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.361 -0.837 . . . . 1.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.45 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 17.2 p-10 -69.57 60.29 0.14 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.045 -1.034 . . . . 1.0 109.909 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 99' ' ' THR . 18.0 m -124.06 16.63 9.24 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.46 -0.775 . . . . 1.0 110.392 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.487 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 48.0 t-20 50.65 39.13 20.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.948 -1.095 . . . . 1.0 110.37 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -129.69 135.74 48.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 1.0 110.111 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.604 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 44.9 m95 -57.29 110.29 0.82 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -0.97 . . . . 1.0 110.291 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 104' ' ' HIS . 35.9 m -110.62 171.94 7.16 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.919 -0.771 . . . . 1.0 108.919 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.59 ' N ' HG22 ' A' ' 103' ' ' THR . 31.8 t60 -117.39 129.64 55.98 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 120.987 -1.071 . . . . 1.0 108.412 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.84 HD11 HD13 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -122.01 147.89 25.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.318 -0.864 . . . . 1.0 108.823 -179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.819 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.0 OUTLIER -152.5 173.16 15.49 Favored 'General case' 0 C--N 1.293 -1.864 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.404 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -165.37 116.9 1.12 Allowed 'General case' 0 C--N 1.293 -1.859 0 O-C-N 120.69 -1.256 . . . . 1.0 111.323 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 41' ' ' ASN . 25.9 p90 -119.41 109.82 16.21 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.548 ' HG2' ' ND2' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -106.55 164.4 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 1.0 111.309 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.706 HG13 ' NE2' ' A' ' 39' ' ' GLN . 12.8 t -145.15 113.96 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 19.8 mt-30 58.46 -129.95 1.33 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.246 -0.909 . . . . 1.0 110.462 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -85.19 -1.22 56.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.96 -1.088 . . . . 1.0 110.22 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 7.6 tt0 -107.26 120.77 43.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.436 -0.79 . . . . 1.0 110.226 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -119.66 157.43 15.51 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 119.971 -1.109 . . . . 1.0 111.465 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 1.058 ' OG ' HG22 ' A' ' 125' ' ' THR . 2.8 t -133.26 150.93 51.91 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.192 -1.181 . . . . 1.0 110.836 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.125 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.3 tm? -113.83 154.11 28.01 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.123 -0.986 . . . . 1.0 109.434 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 1.125 ' N ' HD13 ' A' ' 116' ' ' LEU 0.26 0.1 OUTLIER -130.03 87.21 2.49 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.543 -0.723 . . . . 1.0 112.725 -178.495 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 1.065 HG21 ' OG ' ' A' ' 93' ' ' SER . 24.6 t -80.56 82.71 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.729 -1.212 . . . . 1.0 107.729 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 66.52 60.87 5.81 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 -179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 120' ' ' ASN . 12.8 p30 38.8 25.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.569 -0.96 . . . . 1.0 111.694 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 121' ' ' GLU . 1.3 pm0 -86.01 -174.77 5.26 Favored 'General case' 0 C--N 1.291 -1.947 0 O-C-N 121.355 -0.84 . . . . 1.0 109.236 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.694 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -46.62 104.66 0.42 Allowed Pre-proline 0 N--CA 1.488 1.428 0 C-N-CA 118.961 -1.096 . . . . 1.0 108.336 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.422 ' N ' ' O ' ' A' ' 121' ' ' GLU . 40.5 Cg_endo -65.13 130.24 25.12 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 123.971 1.511 . . . . 1.0 110.559 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.696 HG21 ' O ' ' A' ' 92' ' ' ARG . 3.8 mp -91.03 109.32 20.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.557 -0.857 . . . . 1.0 108.984 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 1.058 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.8 p -107.52 169.35 8.63 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.246 1.022 . . . . 1.0 111.291 -178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.444 ' N ' ' CD2' ' A' ' 91' ' ' LEU . . . 169.33 161.25 19.33 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 106.723 -2.551 . . . . 1.0 106.723 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 112' ' ' ARG . 0.7 OUTLIER -133.18 168.99 17.53 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.65 -1.5 . . . . 1.0 110.379 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -113.3 177.45 1.18 Allowed Pre-proline 0 N--CA 1.493 1.696 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.742 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.2 Cg_endo -66.77 91.84 0.3 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.944 1.497 . . . . 1.0 108.851 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 131' ' ' GLY . 1.1 pp -47.64 -178.28 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.511 -0.743 . . . . 1.0 110.531 -178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.517 ' N ' HD12 ' A' ' 130' ' ' LEU . . . 161.08 -56.18 0.31 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.034 -1.626 . . . . 1.0 109.034 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -107.99 102.91 12.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.431 -1.04 . . . . 1.0 109.663 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 10.4 t -86.1 37.92 0.74 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 1.0 110.413 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -136.87 63.79 1.56 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 1.0 109.929 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.634 HD13 ' N ' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -98.24 131.08 44.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 1.0 110.412 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.69 ' OD2' ' HB2' ' A' ' 37' ' ' ALA . 1.0 OUTLIER -124.42 175.4 7.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.317 -0.865 . . . . 1.0 110.127 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 70.9 p -135.61 140.7 44.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 1.0 110.21 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.683 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 24.0 p-10 -88.53 35.66 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 1.0 110.519 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 42.63 25.44 0.31 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.128 -1.589 . . . . 1.0 109.128 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.683 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -116.35 166.5 11.99 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.075 -1.25 . . . . 1.0 109.301 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 1.001 HD11 HD21 ' A' ' 57' ' ' LEU . 10.6 tp -160.63 152.79 20.26 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 118.972 -1.091 . . . . 1.0 111.409 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.649 ' HB3' ' HE3' ' A' ' 146' ' ' MET . 25.2 m95 -133.96 126.05 29.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.621 -1.622 . . . . 1.0 106.621 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -143.05 135.81 27.74 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 117.899 -1.52 . . . . 1.0 113.725 -176.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 104.38 24.99 7.21 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.212 -1.955 . . . . 1.0 108.212 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.714 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 109.48 -153.35 16.93 Favored Glycine 0 C--N 1.286 -2.238 0 N-CA-C 106.663 -2.575 . . . . 1.0 106.663 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.936 ' HB2' HD12 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -170.75 174.0 5.1 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.159 -1.416 . . . . 1.0 111.958 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.56 ' HG3' ' CG ' ' A' ' 24' ' ' TYR . 37.6 mt-10 -96.05 -9.1 31.73 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -152.48 27.0 0.58 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.535 -0.728 . . . . 1.0 110.596 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.022 HD13 HD21 ' A' ' 55' ' ' LEU . 3.2 mt -70.54 61.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 118.597 -1.241 . . . . 1.0 109.293 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 148' ' ' ARG . 2.3 p -79.0 65.98 4.32 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 105.309 -2.108 . . . . 1.0 105.309 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.781 HG13 ' H ' ' A' ' 152' ' ' ALA . 1.2 p -149.58 -77.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.13 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.909 ' HB2' ' CB ' ' A' ' 159' ' ' TYR . . . 45.54 30.95 0.83 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.046 -1.033 . . . . 1.0 108.962 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 155' ' ' LEU . 1.0 OUTLIER 34.34 -89.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.249 0.547 . . . . 1.0 110.781 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.549 ' N ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -148.51 10.75 0.86 Allowed 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.069 -1.019 . . . . 1.0 111.198 -179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.951 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.3 OUTLIER -76.42 179.33 1.55 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.057 -1.027 . . . . 1.0 110.727 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.552 ' HD2' ' CB ' ' A' ' 155' ' ' LEU . 48.2 Cg_endo -73.13 -161.39 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.301 1.685 . . . . 1.0 112.974 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -51.44 -9.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.654 -0.653 . . . . 1.0 112.417 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.951 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -34.75 -42.96 0.16 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.035 -1.041 . . . . 1.0 110.028 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.909 ' CB ' ' HB2' ' A' ' 152' ' ' ALA . 6.6 m-85 -82.56 -33.39 28.11 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.317 -1.353 . . . . 1.0 109.916 178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.6 OUTLIER -67.09 -11.51 57.36 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.876 -1.13 . . . . 1.0 108.406 178.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 161' ' ' THR . 1.8 m -129.27 96.48 4.32 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.739 -0.837 . . . . 1.0 108.739 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.495 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -48.29 178.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.696 ' CD2' HD11 ' A' ' 167' ' ' ILE . 23.0 t80 -68.64 145.24 54.08 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.919 -1.342 . . . . 1.0 110.81 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.928 HG22 ' HB2' ' A' ' 50' ' ' GLU . 2.6 mt -123.1 86.43 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 107.31 -1.367 . . . . 1.0 107.31 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.621 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.97 -157.5 14.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 109.261 -1.536 . . . . 1.0 109.261 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 80.0 m -130.72 143.82 51.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -1.125 . . . . 1.0 109.748 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.841 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.2 mt -128.82 157.53 41.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.299 -0.876 . . . . 1.0 110.644 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 169' ' ' ASP . 2.8 ttt85 -164.24 144.71 8.13 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.202 -0.937 . . . . 1.0 109.894 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.556 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 68.8 m-20 58.44 91.42 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.479 -0.763 . . . . 1.0 110.066 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.816 HG12 ' HB2' ' A' ' 45' ' ' LEU 0.251 26.8 m -132.92 135.3 57.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 C-N-CA 119.989 -0.685 . . . . 1.0 109.257 -179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.515 HG22 ' N ' ' A' ' 175' ' ' GLN . 0.1 OUTLIER -141.63 152.18 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.741 -1.184 . . . . 1.0 111.679 -177.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.496 HG22 ' HD1' ' A' ' 43' ' ' PHE . 92.0 t -134.11 113.8 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.9 OUTLIER 56.49 38.01 29.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.889 -1.132 . . . . 1.0 108.104 -178.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 73.28 30.06 1.6 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.276 0.56 . . . . 1.0 110.835 -179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.515 ' N ' HG22 ' A' ' 171' ' ' ILE . 4.1 mm-40 -98.01 110.91 23.4 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.249 -0.907 . . . . 1.0 109.967 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -81.7 102.17 10.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.054 -1.029 . . . . 1.0 109.875 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.587 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 4.1 mm? -86.26 92.76 8.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.817 -1.177 . . . . 1.0 110.987 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 0.4 OUTLIER -40.64 113.37 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.045 0.926 . . . . 1.0 110.166 179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.813 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 10.9 mt -40.49 -56.53 2.03 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.847 0.832 . . . . 1.0 112.655 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 51.3 t -84.82 -22.25 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.559 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 2.3 mt-10 -62.07 -55.99 23.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.137 -1.602 . . . . 1.0 110.315 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.612 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -84.63 -19.47 32.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 1.0 110.356 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.813 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -64.28 -36.7 84.96 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.926 -1.109 . . . . 1.0 109.629 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 180' ' ' VAL . 5.2 mt -50.05 -21.87 1.41 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.177 -0.952 . . . . 1.0 109.345 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 2.7 t-20 -54.99 -20.77 9.91 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.882 0.849 . . . . 1.0 108.876 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.476 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 4.3 t30 -95.83 152.36 39.0 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 108.555 -0.905 . . . . 1.0 108.555 178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 40.6 Cg_endo -66.3 -93.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.371 1.195 . . . . 1.0 110.236 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.716 ' O ' HD13 ' A' ' 189' ' ' ILE . 12.4 m -68.74 135.97 52.1 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.234 -0.916 . . . . 1.0 110.452 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 188' ' ' THR . 25.3 mm -122.92 127.46 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.436 -0.79 . . . . 1.0 109.805 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.462 ' O ' HG23 ' A' ' 17' ' ' ILE . 7.7 mt -121.34 173.18 7.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.251 -0.906 . . . . 1.0 110.394 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 2.5 m-70 -107.54 -84.3 0.53 Allowed 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.144 -0.973 . . . . 1.0 111.185 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.1 t -170.02 134.19 1.25 Allowed 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.157 -0.964 . . . . 1.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.752 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 1.4 m -112.29 144.75 41.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 1.0 110.276 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 160.08 40.94 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.65 -0.656 . . . . 1.0 109.745 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.86 0 C-N-CA 118.902 -1.119 . . . . 1.0 110.513 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m -106.68 -60.81 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -1.154 . . . . 1.0 110.205 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.0 -68.95 0.25 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.081 -1.012 . . . . 1.0 110.512 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -164.75 28.4 0.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.15 -0.969 . . . . 1.0 110.457 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.77 88.45 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.212 -0.93 . . . . 1.0 110.415 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.705 HD13 ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -124.39 82.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 1.0 109.682 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -115.03 92.49 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.221 -0.924 . . . . 1.0 110.057 -179.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -93.52 114.21 26.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.191 -0.943 . . . . 1.0 110.234 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 11.9 ptmt -127.37 147.02 50.27 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.381 -0.824 . . . . 1.0 109.766 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.02 164.27 12.1 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.332 -0.855 . . . . 1.0 110.383 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.88 -4.81 30.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.499 -0.75 . . . . 1.0 110.219 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.53 -174.37 15.2 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.215 -1.554 . . . . 1.0 109.215 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -121.02 63.56 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -1.205 . . . . 1.0 110.476 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -114.56 58.95 0.69 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.105 -0.997 . . . . 1.0 110.629 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.546 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 1.1 tt0 -55.94 90.58 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.237 -0.914 . . . . 1.0 109.685 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -95.62 155.16 16.86 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 119.347 -0.941 . . . . 1.0 110.289 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.906 HG21 ' HE1' ' A' ' 25' ' ' MET . 13.4 mm -135.66 122.82 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 1.0 110.576 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -89.25 132.49 34.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.299 -0.875 . . . . 1.0 109.896 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.9 ' CE1' HD12 ' A' ' 167' ' ' ILE . 9.6 m-85 -102.47 172.67 6.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.754 -1.216 . . . . 1.0 110.25 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.512 ' O ' HG12 ' A' ' 164' ' ' ILE . 0.5 OUTLIER -134.38 1.9 3.21 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 1.0 110.802 -179.492 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.18 -26.22 25.03 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.699 -1.36 . . . . 1.0 109.699 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 8.1 ttt180 -104.45 10.8 35.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.912 -1.346 . . . . 1.0 109.364 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.691 HG21 ' HD2' ' A' ' 19' ' ' PHE . 6.3 t -55.22 175.53 0.07 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.676 0.75 . . . . 1.0 110.741 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.633 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.2 OUTLIER -171.57 73.42 0.05 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.762 -0.829 . . . . 1.0 108.762 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.906 ' HE1' HG21 ' A' ' 17' ' ' ILE . 2.3 mmt -85.79 99.72 11.55 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 120.861 -1.149 . . . . 1.0 109.539 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -91.39 134.81 34.3 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.616 ' CD2' ' HB2' ' A' ' 182' ' ' ASP . 48.9 m-85 -121.25 149.03 43.48 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.982 -1.074 . . . . 1.0 110.72 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -149.8 97.93 2.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.403 -0.811 . . . . 1.0 110.186 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -139.31 174.99 9.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 1.0 110.084 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.06 148.64 22.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 1.0 110.033 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 31' ' ' VAL . 7.4 p -129.56 7.28 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.171 -0.956 . . . . 1.0 110.323 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.47 ' OG1' HG13 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -154.31 -178.29 7.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.16 -0.962 . . . . 1.0 110.168 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.93 87.51 7.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.236 -0.915 . . . . 1.0 110.419 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.57 18.79 6.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.245 -0.909 . . . . 1.0 110.472 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 32' ' ' THR . 2.6 mm-40 -143.72 -171.43 3.53 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.866 . . . . 1.0 109.811 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -179.35 109.9 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.081 -1.012 . . . . 1.0 110.162 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' C ' HD22 ' A' ' 38' ' ' LEU . . . -177.62 73.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 1.0 110.2 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.501 HD22 ' C ' ' A' ' 37' ' ' ALA . 4.1 mm? -104.44 168.43 9.1 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.347 -0.846 . . . . 1.0 110.155 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 111' ' ' GLN . 3.9 pt20 -114.42 4.16 15.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.244 -0.91 . . . . 1.0 110.074 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -142.44 122.53 13.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 1.0 110.209 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.564 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.3 OUTLIER -124.58 117.08 23.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.475 -0.766 . . . . 1.0 110.279 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.515 ' O ' HG23 ' A' ' 172' ' ' VAL . 0.6 OUTLIER -84.67 142.22 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 1.0 109.463 179.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.692 ' CE1' HG21 ' A' ' 172' ' ' VAL . 41.8 m-85 -130.81 120.98 24.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.133 -0.98 . . . . 1.0 111.151 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.729 ' C ' HD23 ' A' ' 45' ' ' LEU . 39.7 mt-10 -128.6 142.8 50.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 1.0 110.521 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.932 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.1 pt? -179.69 149.72 0.38 Allowed 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.38 -0.825 . . . . 1.0 110.397 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 167' ' ' ILE . 49.7 m -121.24 149.36 42.98 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.598 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.551 HD11 HG13 ' A' ' 97' ' ' ILE . 1.7 pt -126.49 179.95 3.07 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 C-N-CA 119.379 -0.928 . . . . 1.0 109.168 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.632 ' O ' ' OG1' ' A' ' 49' ' ' THR . 5.9 tttt -167.74 82.6 0.2 Allowed 'General case' 0 C--N 1.295 -1.773 0 C-N-CA 118.674 -1.21 . . . . 1.0 110.641 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 1.069 HG22 ' HG2' ' A' ' 50' ' ' GLU . 90.2 m -171.97 -108.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.81 -0.556 . . . . 1.0 111.313 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.069 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.5 OUTLIER -122.18 -46.09 2.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.594 1.188 . . . . 1.0 109.626 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.883 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . 39.44 22.75 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.841 -1.072 . . . . 1.0 111.656 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.611 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 60.4 p -70.79 -18.22 62.76 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.409 -1.432 . . . . 1.0 108.796 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -159.6 118.68 2.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.093 -0.643 . . . . 1.0 109.727 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 155.21 136.74 2.25 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.194 -1.479 . . . . 1.0 109.541 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.92 HD13 ' CZ ' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -85.61 128.17 34.69 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.628 -1.229 . . . . 1.0 109.246 179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.87 HD11 ' CG1' ' A' ' 78' ' ' VAL . 1.0 OUTLIER -90.49 -34.09 6.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 O-C-N 121.502 -0.749 . . . . 1.0 111.602 -177.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.094 HD13 HD12 ' A' ' 71' ' ' LEU . 5.7 tt -146.18 143.4 29.26 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.536 -1.353 . . . . 1.0 113.079 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.997 ' CZ2' HG21 ' A' ' 151' ' ' VAL . 31.0 t-105 -152.09 105.69 3.1 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.041 -0.726 . . . . 1.0 109.041 177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.1 p -110.29 123.17 49.31 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 1.0 110.152 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' O ' ' OD2' ' A' ' 138' ' ' ASP . . . -125.05 141.26 12.95 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.788 -1.325 . . . . 1.0 109.788 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 138' ' ' ASP . 0.8 OUTLIER -61.86 -43.25 99.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.321 -1.105 . . . . 1.0 110.487 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 149.63 -127.12 2.36 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.616 -1.394 . . . . 1.0 109.616 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.6 mt 47.71 -162.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.28 -1.129 . . . . 1.0 110.237 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.11 37.25 4.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 1.0 110.399 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 177.19 46.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.343 -0.848 . . . . 1.0 109.358 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.91 142.78 48.39 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.626 -0.829 . . . . 1.0 110.942 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.671 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 25.1 m-20 -98.53 -103.64 0.21 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.748 . . . . 1.0 110.035 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.671 ' CB ' ' O ' ' A' ' 67' ' ' ASP . 1.8 t80 102.6 -91.75 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 123.037 0.535 . . . . 1.0 111.857 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' A' ' 70' ' ' ALA . 5.6 mt -151.13 171.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.648 -1.282 . . . . 1.0 112.838 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.56 ' N ' ' CG2' ' A' ' 69' ' ' ILE . . . -177.18 167.12 2.4 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.094 HD12 HD13 ' A' ' 57' ' ' LEU . 90.4 mt -145.95 103.37 3.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.721 -1.237 . . . . 1.0 108.439 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -123.46 167.76 13.45 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 1.0 112.058 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.977 HG12 HG13 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -125.5 132.53 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 121.739 0.78 . . . . 1.0 111.131 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.87 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.0 p -141.17 140.65 31.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.6 -0.687 . . . . 1.0 110.968 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.87 ' CG ' HG22 ' A' ' 74' ' ' VAL . 5.7 m-20 67.96 22.49 8.56 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.481 -0.762 . . . . 1.0 111.47 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.845 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 86.84 4.74 82.06 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.06 -1.543 . . . . 1.0 109.76 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 75' ' ' ASP . 87.2 m-85 -130.94 150.24 52.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.95 -1.324 . . . . 1.0 110.569 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.977 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -97.01 177.6 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.148 -0.97 . . . . 1.0 110.535 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 7.8 pt20 -167.49 123.81 1.12 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.254 -0.904 . . . . 1.0 110.89 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.87 ' HE1' HD23 ' A' ' 91' ' ' LEU . 6.0 tmm? -83.69 115.95 22.42 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.101 -1.074 . . . . 1.0 108.101 178.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.548 ' HA ' ' O ' ' A' ' 89' ' ' VAL . 10.1 ptt? -119.79 149.15 42.51 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.905 -1.122 . . . . 1.0 111.143 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.777 ' CE2' HG11 ' A' ' 89' ' ' VAL . 24.7 p90 -158.03 132.81 8.45 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.194 -1.002 . . . . 1.0 110.951 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.667 ' OD1' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -121.02 75.28 1.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 1.0 110.329 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.676 HD12 ' CB ' ' A' ' 132' ' ' ALA . 0.5 OUTLIER -79.11 -5.86 55.11 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.68 -0.637 . . . . 1.0 110.379 179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -121.5 -65.83 0.24 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.057 -1.217 . . . . 1.0 110.057 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.33 -33.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.053 -1.263 . . . . 1.0 111.243 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' HD3' ' HD3' ' A' ' 129' ' ' PRO . 9.0 ptmt -124.58 138.06 30.48 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.944 -1.097 . . . . 1.0 110.959 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.536 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 49.8 Cg_endo -76.23 121.82 6.31 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 124.15 1.605 . . . . 1.0 111.414 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.777 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -77.4 168.83 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.239 -1.393 . . . . 1.0 107.239 178.14 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 90' ' ' VAL . 10.6 p -147.69 85.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.751 -1.218 . . . . 1.0 111.667 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.87 HD23 ' HE1' ' A' ' 80' ' ' MET . 0.7 OUTLIER -77.34 75.31 3.9 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.881 -1.137 . . . . 1.0 108.398 178.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.611 ' HG2' HG22 ' A' ' 90' ' ' VAL . 34.8 mtp180 -58.47 178.82 0.09 Allowed 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.955 0.884 . . . . 1.0 110.837 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.612 ' OG ' HG21 ' A' ' 118' ' ' VAL . 11.5 t -109.64 149.31 29.89 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.916 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.75 29.91 6.56 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.101 -0.999 . . . . 1.0 109.908 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.726 HG13 ' HD2' ' A' ' 96' ' ' PRO . 74.2 t -133.74 150.27 74.24 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.514 -0.741 . . . . 1.0 109.46 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.726 ' HD2' HG13 ' A' ' 95' ' ' VAL . 42.1 Cg_endo -66.93 120.35 7.44 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.569 1.299 . . . . 1.0 110.445 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.845 HG22 ' O ' ' A' ' 76' ' ' GLY . 4.1 tp -104.89 -11.35 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.457 -0.777 . . . . 1.0 110.344 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.602 ' HB3' HG22 ' A' ' 52' ' ' THR . 8.5 p-10 -87.96 55.69 3.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.309 -0.869 . . . . 1.0 109.679 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 99' ' ' THR . 68.8 m -112.38 8.29 19.48 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.311 -0.868 . . . . 1.0 110.828 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.559 ' HA ' ' N ' ' A' ' 49' ' ' THR . 79.2 m-20 54.62 16.86 1.48 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.933 -1.104 . . . . 1.0 110.436 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -113.41 150.13 33.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.291 -0.881 . . . . 1.0 109.984 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.62 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 4.3 m95 -60.75 89.73 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.013 -1.054 . . . . 1.0 110.687 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.676 HG21 HD12 ' A' ' 97' ' ' ILE . 23.3 m -87.56 150.57 23.62 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 119' ' ' GLY . 78.8 t60 -108.71 135.34 50.1 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 118.989 -1.085 . . . . 1.0 108.73 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 105' ' ' ILE . 0.5 OUTLIER -132.51 156.98 42.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 O-C-N 121.174 -0.954 . . . . 1.0 109.457 -178.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.922 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -152.23 167.41 28.68 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.731 -1.188 . . . . 1.0 110.125 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -152.16 109.7 3.61 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.255 -0.978 . . . . 1.0 111.251 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 18.4 m-30 -83.58 102.28 12.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.0 . . . . 1.0 108.802 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -92.99 127.37 38.48 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.96 -1.087 . . . . 1.0 109.728 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 111' ' ' GLN . 3.3 t -132.62 157.57 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 1.0 110.269 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 110' ' ' VAL . 0.6 OUTLIER -40.14 111.1 0.17 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.604 -0.685 . . . . 1.0 110.497 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.626 ' O ' ' CB ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 51.98 65.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.359 -0.838 . . . . 1.0 110.377 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.626 ' CB ' ' O ' ' A' ' 112' ' ' ARG . 2.2 tt0 156.85 113.65 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.632 0.73 . . . . 1.0 109.986 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.518 ' N ' ' OH ' ' A' ' 82' ' ' TYR . . . -120.86 166.15 13.96 Favored Glycine 0 N--CA 1.495 2.607 0 C-N-CA 120.199 -1.0 . . . . 1.0 110.618 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.607 ' O ' ' CE ' ' A' ' 80' ' ' MET . 1.2 t -144.51 166.7 24.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.491 -1.006 . . . . 1.0 110.315 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.992 HD13 ' N ' ' A' ' 117' ' ' GLN 0.252 1.1 tm? -145.47 151.92 38.96 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.151 -0.968 . . . . 1.0 109.312 -178.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.992 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.6 OUTLIER -153.89 107.95 3.02 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 118.813 -1.155 . . . . 1.0 111.788 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.612 HG21 ' OG ' ' A' ' 93' ' ' SER . 2.0 t -72.41 104.92 2.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.73 35.58 91.17 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.084 -1.207 . . . . 1.0 110.084 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER 60.95 39.47 16.58 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.093 -1.239 . . . . 1.0 110.97 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 122' ' ' ALA . 0.6 OUTLIER -102.4 -167.84 1.45 Allowed 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.522 -0.736 . . . . 1.0 110.733 -179.319 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.572 ' N ' ' HG2' ' A' ' 121' ' ' GLU . . . -35.0 112.23 0.44 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 121.498 -0.751 . . . . 1.0 109.579 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.533 ' HB3' ' OE1' ' A' ' 117' ' ' GLN . 45.8 Cg_endo -72.95 118.14 5.43 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.133 1.596 . . . . 1.0 112.834 -177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.733 HD12 ' H ' ' A' ' 124' ' ' ILE . 5.4 mp -85.8 110.85 20.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 106.313 -1.736 . . . . 1.0 106.313 176.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.502 ' C ' ' CD1' ' A' ' 91' ' ' LEU . 30.9 p -119.65 174.38 6.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.507 1.146 . . . . 1.0 112.756 -176.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.584 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 169.69 169.47 32.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 106.622 -2.591 . . . . 1.0 106.622 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -146.53 163.95 34.12 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.511 -1.582 . . . . 1.0 111.11 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.429 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -83.98 173.54 7.18 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.663 -0.648 . . . . 1.0 110.494 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.559 ' O ' ' N ' ' A' ' 131' ' ' GLY . 42.2 Cg_endo -69.7 57.55 1.46 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.973 1.512 . . . . 1.0 110.113 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.2 pp 10.22 57.18 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -132.68 73.35 0.46 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.623 -1.391 . . . . 1.0 109.623 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.676 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -159.94 -71.41 0.07 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -1.136 . . . . 1.0 110.493 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 132' ' ' ALA . 0.8 OUTLIER 62.85 129.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.115 -0.99 . . . . 1.0 109.887 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.17 75.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.351 -0.843 . . . . 1.0 110.62 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 68' ' ' TYR . 1.3 tm? -88.86 108.42 19.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -0.973 . . . . 1.0 109.719 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.408 ' N ' HD22 ' A' ' 135' ' ' LEU . 60.9 m-20 -67.74 148.79 50.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 1.0 110.724 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.586 ' HB ' ' CZ ' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -138.4 141.45 39.6 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.433 -0.792 . . . . 1.0 109.787 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.674 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 40.4 p-10 -84.16 22.1 1.27 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.194 -0.941 . . . . 1.0 111.075 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . 45.51 22.41 0.65 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.405 -1.478 . . . . 1.0 109.405 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.674 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -104.92 162.57 13.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.109 -1.23 . . . . 1.0 109.252 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.723 HD11 ' HG ' ' A' ' 57' ' ' LEU . 6.7 tp -159.53 144.78 15.63 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.99 -1.069 . . . . 1.0 110.821 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.671 ' HB3' ' HE3' ' A' ' 146' ' ' MET . 13.1 m95 -125.99 141.88 51.77 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.768 HD21 HG22 ' A' ' 56' ' ' ILE . 1.5 tt -148.0 128.47 14.02 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 116.908 -1.917 . . . . 1.0 113.375 -177.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 23' ' ' THR . . . 113.54 -5.32 24.66 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 109.739 -1.344 . . . . 1.0 109.739 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 146.69 -140.87 9.0 Favored Glycine 0 C--N 1.289 -2.039 0 C-N-CA 118.945 -1.598 . . . . 1.0 109.755 178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 1.003 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -171.43 141.18 1.5 Allowed 'General case' 0 C--N 1.291 -1.945 0 C-N-CA 119.091 -1.043 . . . . 1.0 111.939 -178.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.01 -16.08 55.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.783 0.801 . . . . 1.0 109.079 178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HD2' ' SD ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -137.0 45.84 2.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.497 -1.298 . . . . 1.0 107.497 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.003 HD13 ' HB2' ' A' ' 146' ' ' MET . 11.5 tp -65.32 56.83 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.753 0.787 . . . . 1.0 112.146 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 148' ' ' ARG . 56.9 p -84.88 1.7 45.9 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 106.509 -1.663 . . . . 1.0 106.509 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.997 HG21 ' CZ2' ' A' ' 58' ' ' TRP . 3.3 p -85.47 -104.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 115.362 -0.836 . . . . 1.0 110.614 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.886 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . 52.64 45.52 28.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.476 -1.39 . . . . 1.0 108.936 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.525 ' C ' ' O ' ' A' ' 152' ' ' ALA . 0.1 OUTLIER -18.03 -77.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 112.789 0.662 . . . . 1.0 112.789 -178.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.536 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 9.5 ptmt -97.95 -43.65 7.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.123 -0.985 . . . . 1.0 111.874 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 1.118 HD21 ' CE1' ' A' ' 159' ' ' TYR . 0.6 OUTLIER -81.07 113.41 40.69 Favored Pre-proline 0 C--N 1.292 -1.893 0 O-C-N 121.324 -0.86 . . . . 1.0 110.231 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -88.39 -68.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.58 1.305 . . . . 1.0 111.594 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.61 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 1.8 tttm -54.86 -50.67 68.12 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 1.0 111.944 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.671 ' CB ' HD12 ' A' ' 155' ' ' LEU . . . -43.72 -42.76 5.59 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 1.118 ' CE1' HD21 ' A' ' 155' ' ' LEU . 3.2 m-85 -78.42 -32.2 48.56 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -68.93 -12.35 61.54 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.753 -0.779 . . . . 1.0 109.926 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.791 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -128.65 81.9 2.05 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -41.31 158.35 0.04 OUTLIER Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.265 -1.534 . . . . 1.0 109.265 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.664 ' CD2' HD11 ' A' ' 167' ' ' ILE . 62.9 t80 -71.57 137.08 47.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.959 -1.318 . . . . 1.0 110.5 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.756 ' O ' HG21 ' A' ' 49' ' ' THR . 4.4 mt -118.72 75.08 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.403 -0.962 . . . . 1.0 108.403 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.733 ' HA2' HG21 ' A' ' 49' ' ' THR . . . -159.11 -160.21 10.23 Favored Glycine 0 N--CA 1.48 1.609 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -178.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.515 ' N ' ' OG1' ' A' ' 49' ' ' THR . 20.0 m -118.61 147.48 43.7 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.203 -1.175 . . . . 1.0 111.445 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.9 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -134.95 157.22 40.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 115.861 -0.608 . . . . 1.0 109.694 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.524 ' NH2' ' OD1' ' A' ' 169' ' ' ASP . 22.1 ttt-85 -165.52 157.85 15.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.818 -1.176 . . . . 1.0 111.262 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.551 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 20.0 m-20 51.25 78.61 0.11 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.9 . . . . 1.0 110.451 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.932 HG12 ' CB ' ' A' ' 45' ' ' LEU . 16.8 m -124.81 129.55 73.52 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.363 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.436 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -148.13 148.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 C-N-CA 119.269 -0.972 . . . . 1.0 110.947 -177.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.692 HG21 ' CE1' ' A' ' 43' ' ' PHE . 14.9 p -135.7 123.56 36.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.521 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 23.2 m-20 49.95 30.92 4.3 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.409 -1.432 . . . . 1.0 107.86 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 68.09 28.76 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.186 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.678 ' O ' HD12 ' A' ' 177' ' ' LEU . 0.8 OUTLIER -109.66 -170.06 1.59 Allowed 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.262 -0.899 . . . . 1.0 109.34 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.593 ' HB3' ' O ' ' A' ' 175' ' ' GLN . 36.6 tp10 76.59 -106.22 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.601 -0.687 . . . . 1.0 110.196 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.927 ' O ' HD12 ' A' ' 179' ' ' LEU . 3.6 mp 63.37 -94.91 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.185 -0.947 . . . . 1.0 112.515 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.564 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 7.3 m-70 -56.64 90.02 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.937 -1.102 . . . . 1.0 111.438 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.927 HD12 ' O ' ' A' ' 177' ' ' LEU 0.272 3.5 mp -63.57 -58.78 5.87 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-O 122.214 1.006 . . . . 1.0 110.868 178.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 184' ' ' LEU . 2.1 t -61.44 -16.45 14.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.933 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.564 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 3.4 mt-10 -72.3 -45.27 60.76 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.674 -1.21 . . . . 1.0 109.386 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.616 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 1.6 m-20 -101.8 -15.52 16.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.257 -0.902 . . . . 1.0 109.277 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -78.2 -37.51 45.38 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.326 -0.859 . . . . 1.0 109.299 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 180' ' ' VAL . 11.4 mt -55.74 -16.29 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -0.896 . . . . 1.0 109.877 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 184' ' ' LEU . 9.8 t-20 -42.98 -27.01 0.16 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.824 0.821 . . . . 1.0 109.271 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 184' ' ' LEU . 2.3 t30 -134.74 143.17 45.28 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 188' ' ' THR . 46.1 Cg_endo -71.0 -158.54 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.632 1.333 . . . . 1.0 110.98 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 188' ' ' THR . 0.4 OUTLIER 64.09 22.91 13.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.603 179.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 1.001 ' C ' HD13 ' A' ' 190' ' ' LEU . 0.9 OUTLIER -92.78 112.6 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.272 -0.893 . . . . 1.0 110.781 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 1.001 HD13 ' C ' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -109.48 149.56 29.41 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.13 -0.981 . . . . 1.0 109.201 179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.6 ' CE1' ' CD1' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -99.63 101.63 12.89 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.97 -1.081 . . . . 1.0 109.835 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' A' ' 191' ' ' HIS . 9.0 t -41.74 112.42 0.32 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 1.0 110.476 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 1.7 m -63.82 149.65 46.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.116 -0.99 . . . . 1.0 110.154 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.604 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 173.91 46.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 1.0 110.578 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.873 0 C-N-CA 118.433 -1.307 . . . . 1.0 110.55 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.455 -1.458 . . . . 1.0 109.455 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.9 p -128.14 99.7 5.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.266 -1.137 . . . . 1.0 110.259 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -44.9 135.52 5.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 1.0 110.148 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -139.21 126.62 21.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 1.0 110.076 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.9 t -105.17 140.82 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 1.0 110.315 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.565 HD12 ' N ' ' A' ' 6' ' ' ILE . 1.8 mp -70.13 143.05 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 1.0 109.973 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.7 mt -111.04 83.81 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.289 -0.882 . . . . 1.0 110.153 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.72 109.36 21.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 1.0 110.202 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 33.2 ttpt -66.19 129.1 38.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 1.0 110.359 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.84 126.43 37.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.344 -0.847 . . . . 1.0 110.257 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.21 69.1 1.52 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 1.0 110.486 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.1 111.47 3.4 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.23 -1.548 . . . . 1.0 109.23 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -138.01 68.38 1.4 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.208 -1.172 . . . . 1.0 110.515 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -103.12 17.36 24.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.22 -0.925 . . . . 1.0 110.284 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -46.08 90.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.815 . . . . 1.0 110.047 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -110.47 160.93 16.17 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.291 -0.88 . . . . 1.0 110.453 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.69 HG21 ' CE ' ' A' ' 25' ' ' MET . 6.4 mm -127.27 125.71 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 1.0 109.222 179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -92.55 138.57 31.39 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.415 -0.803 . . . . 1.0 110.964 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.903 ' CE1' HD12 ' A' ' 167' ' ' ILE . 12.2 m-85 -101.27 169.05 9.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 1.0 109.568 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.82 -7.56 5.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.152 -0.967 . . . . 1.0 110.634 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.04 -10.35 37.14 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 14.7 ttp180 -129.24 -13.15 4.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.05 -1.265 . . . . 1.0 110.737 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.861 HG23 ' ND2' ' A' ' 186' ' ' ASN . 2.3 m -69.53 130.47 42.53 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.211 -0.931 . . . . 1.0 110.507 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.6 ' CE2' ' HB2' ' A' ' 26' ' ' GLU . 0.4 OUTLIER -116.09 118.02 31.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.358 -0.838 . . . . 1.0 109.487 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.69 ' CE ' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -91.55 101.3 13.94 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 120.641 -1.287 . . . . 1.0 110.096 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.602 ' OE1' ' CZ2' ' A' ' 142' ' ' TRP . 5.4 tp10 -79.99 97.03 6.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.852 -0.795 . . . . 1.0 108.852 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 25' ' ' MET . 19.0 m-85 -95.37 97.57 9.93 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.103 -1.039 . . . . 1.0 111.362 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -97.82 123.72 41.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 1.0 108.849 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -133.3 157.33 45.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.852 -1.155 . . . . 1.0 111.225 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.436 ' O ' ' O ' ' A' ' 31' ' ' VAL . . . -105.94 101.8 11.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.662 -0.649 . . . . 1.0 109.553 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.942 HG21 ' OD2' ' A' ' 138' ' ' ASP . 2.8 t -62.12 -132.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.255 -0.903 . . . . 1.0 109.988 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.476 ' H ' HG12 ' A' ' 31' ' ' VAL . 9.2 t -124.87 158.65 32.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.756 -1.215 . . . . 1.0 110.836 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' O ' ' CB ' ' A' ' 34' ' ' SER . 1.3 pttp -96.52 82.39 3.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.817 . . . . 1.0 109.773 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER 170.93 -32.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 1.0 109.813 -179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.6 OUTLIER -94.64 13.27 24.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.505 -0.747 . . . . 1.0 109.908 179.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 4.9 pttt -41.63 140.97 0.85 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.442 -0.786 . . . . 1.0 110.133 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 36' ' ' LYS . . . 61.48 52.62 3.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 1.0 110.13 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.685 HD11 ' OD1' ' A' ' 41' ' ' ASN . 0.4 OUTLIER -61.85 162.5 8.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 110.163 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 35.7 tt0 -94.69 -3.79 48.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 1.0 110.658 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.499 ' O ' HD12 ' A' ' 38' ' ' LEU . 1.2 p -167.29 155.13 9.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.049 -1.032 . . . . 1.0 110.635 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.685 ' OD1' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -128.17 148.68 50.61 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.339 -0.851 . . . . 1.0 110.077 179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 13.8 m-70 -114.47 126.59 55.13 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.304 -0.872 . . . . 1.0 109.641 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.695 ' CZ ' HD11 ' A' ' 69' ' ' ILE . 73.9 m-85 -120.21 122.47 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.121 -0.987 . . . . 1.0 111.137 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.766 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.4 OUTLIER -128.3 134.96 49.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.048 -1.032 . . . . 1.0 110.576 -179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.894 ' CB ' HG12 ' A' ' 170' ' ' VAL . 1.1 pt? -175.18 156.59 2.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.956 -1.09 . . . . 1.0 111.293 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.406 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -119.68 155.18 32.88 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.608 HG23 ' CD1' ' A' ' 105' ' ' ILE . 6.9 pt -146.35 169.6 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 118.665 -1.214 . . . . 1.0 112.286 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.626 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -129.01 92.57 3.42 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 178.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.932 ' CG2' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -73.21 157.6 36.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 1.0 112.286 -177.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.885 ' HB2' HG22 ' A' ' 164' ' ' ILE . 6.8 mm-40 -148.9 12.65 0.87 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.897 -0.721 . . . . 1.0 111.043 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -151.07 8.32 0.54 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.454 -1.404 . . . . 1.0 112.223 -178.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.876 HG22 ' CA ' ' A' ' 76' ' ' GLY . 0.7 OUTLIER 50.98 11.03 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.969 -1.082 . . . . 1.0 111.823 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.8 tt0 -158.76 137.92 11.43 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.902 -1.124 . . . . 1.0 110.163 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 148.35 139.35 3.16 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.982 ' CD2' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -87.07 126.21 34.62 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.021 -1.282 . . . . 1.0 108.693 179.481 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.968 HD11 ' CG1' ' A' ' 73' ' ' ILE . 3.4 mp -92.49 -32.53 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 1.0 111.708 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.021 HD13 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -144.15 148.17 34.68 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.802 -1.186 . . . . 1.0 113.017 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.816 ' CZ2' HG21 ' A' ' 151' ' ' VAL . 21.3 t-105 -156.23 111.82 2.97 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.576 ' CB ' HG23 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -114.77 128.5 56.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.829 -1.17 . . . . 1.0 111.511 -178.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -122.97 98.7 0.62 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.286 -1.926 . . . . 1.0 108.286 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 61' ' ' LYS . 29.4 tptt -43.17 -57.3 3.01 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.325 -1.103 . . . . 1.0 111.788 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . -161.29 -92.16 0.09 OUTLIER Glycine 0 N--CA 1.493 2.436 0 C-N-CA 118.494 -1.812 . . . . 1.0 111.544 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 62' ' ' GLY . 0.8 OUTLIER -31.66 152.46 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.955 -0.732 . . . . 1.0 111.62 -178.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -81.67 43.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 1.0 110.227 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.51 31.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 1.0 109.404 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -131.37 171.05 13.82 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.325 -0.95 . . . . 1.0 111.648 -177.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.603 ' HA ' HD11 ' A' ' 135' ' ' LEU . 34.7 t0 31.01 78.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.13 0.49 . . . . 1.0 112.091 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.567 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 2.7 m-85 -92.47 77.55 5.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.188 -0.945 . . . . 1.0 110.603 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.695 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 2.5 tt -110.67 110.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.006 -1.059 . . . . 1.0 110.19 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.598 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -133.67 176.52 8.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.132 -0.98 . . . . 1.0 110.476 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.021 HD12 HD13 ' A' ' 57' ' ' LEU . 42.4 mt -147.88 113.09 5.54 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.966 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -131.8 164.25 26.43 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.95 -1.094 . . . . 1.0 111.855 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.968 ' CG1' HD11 ' A' ' 56' ' ' ILE . 7.0 mt -108.64 136.46 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -0.849 . . . . 1.0 110.669 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.74 HG22 ' CG ' ' A' ' 75' ' ' ASP . 4.2 p -141.67 120.6 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.405 -0.81 . . . . 1.0 111.28 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.74 ' CG ' HG22 ' A' ' 74' ' ' VAL . 0.9 OUTLIER 70.57 14.08 7.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.232 -0.917 . . . . 1.0 110.938 178.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.95 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 99.05 7.68 54.81 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.789 -1.324 . . . . 1.0 109.789 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.22 146.44 49.98 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -1.225 . . . . 1.0 109.385 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.821 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -93.38 162.58 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 1.0 109.589 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.522 ' CB ' ' HA ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -159.17 139.41 12.13 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.212 -0.93 . . . . 1.0 110.152 -179.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.719 ' CB ' HD23 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -107.61 115.86 30.92 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.349 -0.941 . . . . 1.0 110.253 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.598 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 3.0 ptp -89.39 133.79 34.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.582 -1.323 . . . . 1.0 110.128 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.616 ' OH ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -126.92 128.93 47.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 1.0 110.688 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.567 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.5 t0 -146.53 66.21 1.18 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.287 1.041 . . . . 1.0 109.466 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.766 ' HB3' HD12 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -66.87 -3.68 7.51 Favored 'General case' 0 C--N 1.289 -2.047 0 O-C-N 121.563 -0.71 . . . . 1.0 111.074 -179.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -137.98 -55.43 0.05 OUTLIER Glycine 0 N--CA 1.495 2.61 0 C-N-CA 119.554 -1.308 . . . . 1.0 110.62 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.49 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -176.01 -25.19 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.213 -1.169 . . . . 1.0 110.678 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 15.8 mmtp -98.48 110.87 58.44 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.009 -1.057 . . . . 1.0 109.795 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 82' ' ' TYR . 43.1 Cg_endo -71.93 159.9 49.13 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.86 1.453 . . . . 1.0 110.712 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.543 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -137.02 116.98 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 90' ' ' VAL . 1.8 p -95.99 112.44 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.404 -1.435 . . . . 1.0 110.974 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.738 ' C ' HG21 ' A' ' 124' ' ' ILE . 4.6 mt -105.69 71.56 0.92 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 106.744 -1.576 . . . . 1.0 106.744 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.536 ' O ' HG21 ' A' ' 124' ' ' ILE . 3.4 mtp180 -60.07 178.14 0.2 Allowed 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.99 0.9 . . . . 1.0 110.909 -177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.524 ' OG ' HG21 ' A' ' 118' ' ' VAL . 7.9 t -100.11 161.35 13.66 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.648 -0.658 . . . . 1.0 110.656 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.581 HG23 ' CD1' ' A' ' 124' ' ' ILE . 0.8 OUTLIER -118.71 25.75 10.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.362 -0.836 . . . . 1.0 109.485 179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.004 ' HB ' HG11 ' A' ' 118' ' ' VAL . 2.2 t -137.53 147.34 57.19 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.708 -0.62 . . . . 1.0 109.617 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.449 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.2 Cg_endo -65.91 137.12 47.77 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.806 1.424 . . . . 1.0 110.783 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.95 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -128.94 -22.34 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.38 -0.825 . . . . 1.0 111.197 -179.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.48 ' CB ' HG23 ' A' ' 52' ' ' THR . 6.7 p30 -74.2 54.09 0.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.13 -0.982 . . . . 1.0 111.317 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.783 HG23 ' HB2' ' A' ' 101' ' ' HIS . 14.2 t -128.87 30.77 5.03 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.263 -0.898 . . . . 1.0 108.906 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.461 ' CG ' ' O ' ' A' ' 99' ' ' THR . 5.9 p-10 40.49 24.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.948 -0.47 . . . . 1.0 111.578 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.783 ' HB2' HG23 ' A' ' 99' ' ' THR . 0.3 OUTLIER -102.02 160.03 14.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.0 -1.062 . . . . 1.0 109.049 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.626 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 20.0 m95 -81.11 102.34 10.19 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.037 -1.039 . . . . 1.0 109.838 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 104' ' ' HIS . 18.2 m -93.8 173.79 7.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 1.0 109.246 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.611 ' N ' HG22 ' A' ' 103' ' ' THR . 3.2 t60 -121.81 125.57 46.8 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.316 -1.364 . . . . 1.0 107.316 178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.608 ' CD1' HG23 ' A' ' 47' ' ' ILE . 1.5 mp -124.25 147.67 28.68 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.759 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -152.94 179.42 8.7 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.27 -1.372 . . . . 1.0 109.38 -178.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.652 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -164.4 145.98 8.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.834 -1.166 . . . . 1.0 111.811 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 4.7 m-85 -136.54 104.8 5.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.448 -0.782 . . . . 1.0 109.576 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.593 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.0 OUTLIER -95.63 131.28 42.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.136 -0.978 . . . . 1.0 109.013 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.551 ' N ' ' HD3' ' A' ' 109' ' ' ARG . 85.8 t -137.53 104.22 3.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.365 -0.835 . . . . 1.0 110.687 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.475 ' O ' ' CB ' ' A' ' 112' ' ' ARG . 16.4 mt-30 40.83 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.591 -0.693 . . . . 1.0 112.206 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.1 OUTLIER 71.59 -50.61 0.69 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 1.0 112.734 177.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 6.3 tt0 -85.04 122.03 28.68 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.691 -1.256 . . . . 1.0 111.511 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.593 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.35 166.7 12.17 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.546 ' O ' ' CE ' ' A' ' 80' ' ' MET . 42.1 t -145.0 151.83 39.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.288 -1.125 . . . . 1.0 111.075 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.078 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -111.77 147.25 36.07 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.715 -1.217 . . . . 1.0 107.715 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 1.078 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -127.45 91.65 3.35 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 118.778 -1.169 . . . . 1.0 112.591 -177.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 1.004 HG11 ' HB ' ' A' ' 95' ' ' VAL . 70.4 t -78.93 87.79 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.748 -1.204 . . . . 1.0 107.748 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 56.88 58.28 15.33 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.802 -1.19 . . . . 1.0 110.348 -178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' A' ' 117' ' ' GLN . 3.6 t-20 41.4 24.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.433 -1.039 . . . . 1.0 112.237 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 1.1 mt-10 -97.83 -166.7 1.41 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.748 -1.22 . . . . 1.0 109.304 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.479 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.7 96.85 0.12 Allowed Pre-proline 0 N--CA 1.496 1.87 0 C-N-CA 120.0 -0.68 . . . . 1.0 109.587 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.529 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.8 Cg_endo -74.93 130.43 13.34 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.091 1.574 . . . . 1.0 110.871 -178.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.746 HG22 ' HB3' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -86.05 144.5 9.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 O-C-N 121.153 -0.967 . . . . 1.0 108.624 179.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.61 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 4.6 p -138.83 158.13 44.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.524 -1.36 . . . . 1.0 111.768 -178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.734 ' N ' HD21 ' A' ' 91' ' ' LEU . . . -166.21 165.47 38.22 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.209 -2.356 . . . . 1.0 107.209 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -152.91 151.2 30.08 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.594 -1.533 . . . . 1.0 111.79 -179.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.1 p -106.02 173.96 2.89 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.746 -0.596 . . . . 1.0 109.911 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.578 ' O ' ' N ' ' A' ' 131' ' ' GLY . 45.2 Cg_endo -70.65 67.77 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.915 1.482 . . . . 1.0 110.18 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.751 ' O ' HD12 ' A' ' 130' ' ' LEU . 1.0 OUTLIER -4.04 70.28 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-O 121.581 0.705 . . . . 1.0 112.798 -179.601 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -84.68 -71.17 1.32 Allowed Glycine 0 C--N 1.288 -2.093 0 N-CA-C 109.196 -1.562 . . . . 1.0 109.196 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.765 ' HB3' HD12 ' A' ' 84' ' ' LEU . . . -67.7 86.98 0.22 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.183 -1.186 . . . . 1.0 109.369 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.877 HG22 ' NE2' ' A' ' 134' ' ' GLN . 16.7 m -19.0 -69.2 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 121.036 0.446 . . . . 1.0 111.986 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.877 ' NE2' HG22 ' A' ' 133' ' ' THR . 0.0 OUTLIER -113.65 -45.87 3.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.915 . . . . 1.0 110.023 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 84' ' ' LEU . 0.2 OUTLIER 62.2 113.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.261 -0.899 . . . . 1.0 110.346 179.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.504 ' C ' ' CG2' ' A' ' 137' ' ' THR . 15.2 m-20 -73.19 138.97 45.97 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 1.0 109.534 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.673 ' CG2' HD13 ' A' ' 135' ' ' LEU . 7.2 p -153.53 105.0 2.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.102 -0.999 . . . . 1.0 109.792 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.942 ' OD2' HG21 ' A' ' 31' ' ' VAL . 7.9 p-10 170.61 -39.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' A' ' 138' ' ' ASP . . . -24.91 -43.91 0.01 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 111.527 -0.629 . . . . 1.0 111.527 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -146.99 173.81 12.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.903 -1.351 . . . . 1.0 110.445 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.635 ' CD1' HD21 ' A' ' 57' ' ' LEU . 10.3 tp -160.86 148.79 15.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.344 -0.848 . . . . 1.0 110.248 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.607 ' CG ' ' HE3' ' A' ' 146' ' ' MET . 20.7 m95 -133.23 143.49 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.303 -0.999 . . . . 1.0 108.303 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.991 HD13 HD12 ' A' ' 57' ' ' LEU . 6.6 tp -145.68 118.89 8.89 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 117.945 -1.502 . . . . 1.0 112.974 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 122.67 1.86 9.75 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 110.367 -1.093 . . . . 1.0 110.367 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.493 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 144.32 -135.24 6.09 Favored Glycine 0 C--N 1.29 -2.017 0 C-N-CA 118.936 -1.602 . . . . 1.0 109.727 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 1.065 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -170.79 176.48 4.17 Favored 'General case' 0 C--N 1.293 -1.882 0 O-C-N 121.816 -0.814 . . . . 1.0 111.714 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -96.37 -25.35 15.76 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.919 0.866 . . . . 1.0 108.918 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.562 ' O ' ' CG ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.91 74.59 1.45 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.822 -1.548 . . . . 1.0 106.822 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.065 HD13 ' HB2' ' A' ' 146' ' ' MET . 3.8 tp -71.39 24.69 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 113.926 1.084 . . . . 1.0 113.926 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.6 p -62.16 -21.01 64.72 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 104.68 -2.341 . . . . 1.0 104.68 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.861 HG12 ' HA ' ' A' ' 149' ' ' LEU 0.284 13.5 p -58.32 -118.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.348 -1.297 . . . . 1.0 110.154 178.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 151' ' ' VAL . . . 70.24 -71.36 0.13 Allowed 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.809 -1.182 . . . . 1.0 109.927 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.629 ' CB ' ' O ' ' A' ' 152' ' ' ALA . 18.3 m170 132.16 -99.58 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.477 ' HD3' ' HB3' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -137.14 12.11 3.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.091 -1.005 . . . . 1.0 109.706 179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 1.084 ' CD2' ' HB3' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -70.36 165.61 42.86 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.421 -0.799 . . . . 1.0 111.126 -179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.611 ' N ' HD22 ' A' ' 155' ' ' LEU . 40.9 Cg_endo -64.97 -168.68 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.967 1.509 . . . . 1.0 112.448 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.565 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 2.2 mttp -53.28 -10.77 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 112.73 0.641 . . . . 1.0 112.73 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 1.084 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -38.25 -44.82 0.91 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.044 -1.035 . . . . 1.0 109.983 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.981 ' O ' HD23 ' A' ' 149' ' ' LEU . 15.4 m-85 -84.37 -28.45 26.99 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 120.945 -1.097 . . . . 1.0 109.297 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -71.64 -7.08 45.67 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.57 -1.252 . . . . 1.0 108.544 178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 161' ' ' THR . 1.3 m -131.72 98.27 4.44 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -47.38 175.66 0.01 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.628 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 54.5 t80 -79.07 149.24 32.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.233 -1.157 . . . . 1.0 112.061 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.885 HG22 ' HB2' ' A' ' 50' ' ' GLU . 1.1 mt -130.8 88.17 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.24 -1.763 . . . . 1.0 106.24 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.628 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.2 -153.69 9.48 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 109.061 -1.616 . . . . 1.0 109.061 -178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.523 ' C ' HG13 ' A' ' 167' ' ' ILE . 15.0 m -137.32 148.03 46.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.465 -1.021 . . . . 1.0 110.06 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.903 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -133.84 153.64 36.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 O-C-N 121.526 -0.734 . . . . 1.0 109.717 -178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.503 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 18.7 ttt180 -163.02 162.37 25.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.657 -1.277 . . . . 1.0 110.963 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 0.7 OUTLIER 48.71 78.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.394 -0.816 . . . . 1.0 110.464 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.894 HG12 ' CB ' ' A' ' 45' ' ' LEU . 16.2 m -121.77 135.26 62.46 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 C-N-CA 119.362 -0.935 . . . . 1.0 108.937 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.474 HG12 ' C ' ' A' ' 170' ' ' VAL . 0.0 OUTLIER -146.22 148.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.319 -0.953 . . . . 1.0 111.176 -176.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.625 HG13 ' CD1' ' A' ' 43' ' ' PHE . 1.7 t -130.32 102.43 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 10.9 m-20 51.96 42.55 30.35 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 1.0 108.143 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.53 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 75.51 26.38 1.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.254 0.549 . . . . 1.0 110.421 -179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.614 ' HB2' ' HB ' ' A' ' 172' ' ' VAL . 63.9 mt-30 -102.15 -174.67 2.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.358 -0.838 . . . . 1.0 109.726 179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 1.9 mm-40 62.64 -92.99 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.685 -0.634 . . . . 1.0 110.656 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER 65.88 -87.74 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.533 -0.729 . . . . 1.0 111.21 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 59.7 m-70 -74.72 102.39 4.62 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.998 -1.063 . . . . 1.0 111.509 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 183' ' ' ALA 0.253 0.4 OUTLIER -57.22 -58.4 8.38 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 122.419 1.104 . . . . 1.0 109.709 177.881 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.694 ' O ' HD22 ' A' ' 184' ' ' LEU . 95.0 t -50.54 -31.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.99 -1.005 . . . . 1.0 111.262 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 19.7 mt-10 -61.69 -53.81 51.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.121 -0.987 . . . . 1.0 109.929 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.588 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 2.7 t0 -89.79 -15.46 32.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 1.0 109.665 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.571 ' HB3' ' HA ' ' A' ' 180' ' ' VAL . . . -72.82 -25.08 61.01 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.326 -0.859 . . . . 1.0 109.032 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.694 HD22 ' O ' ' A' ' 180' ' ' VAL . 0.1 OUTLIER -62.61 -15.49 51.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 1.0 109.438 179.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -24.15 63.93 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.938 0.875 . . . . 1.0 108.777 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.861 ' ND2' HG23 ' A' ' 23' ' ' THR . 3.6 t-20 -96.46 151.06 37.8 Favored Pre-proline 0 C--N 1.297 -1.678 0 N-CA-C 108.803 -0.814 . . . . 1.0 108.803 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.487 ' O ' ' OD1' ' A' ' 186' ' ' ASN . 38.8 Cg_endo -64.87 143.61 80.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 O-C-N 123.538 1.283 . . . . 1.0 111.212 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.473 ' CG2' ' N ' ' A' ' 189' ' ' ILE . 0.8 OUTLIER 49.9 172.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.585 -0.697 . . . . 1.0 110.648 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.473 ' N ' ' CG2' ' A' ' 188' ' ' THR . 14.2 mm -141.03 121.99 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.422 -0.799 . . . . 1.0 109.4 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.6 mt -111.25 159.23 18.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.148 -0.97 . . . . 1.0 110.641 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -127.57 153.33 46.52 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 1.0 109.409 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 4.1 t -70.36 165.95 21.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.021 -1.05 . . . . 1.0 110.47 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.69 166.98 19.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.329 -0.857 . . . . 1.0 110.045 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -169.52 46.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 1.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.834 0 C-N-CA 118.717 -1.193 . . . . 1.0 110.406 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.7 OUTLIER 66.69 -161.6 0.24 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.184 -1.186 . . . . 1.0 109.999 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 2' ' ' SER . 3.0 mt-10 56.46 167.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.215 -0.928 . . . . 1.0 110.302 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tptp -173.28 88.42 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 1.0 109.897 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.673 ' O ' HG13 ' A' ' 5' ' ' VAL . 10.4 p -70.17 113.09 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 1.0 110.394 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.528 ' C ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -127.65 128.82 69.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 1.0 109.784 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.4 pt -91.19 146.57 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.111 -0.993 . . . . 1.0 110.37 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.53 138.33 36.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 1.0 110.038 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -127.77 90.52 3.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.339 -0.85 . . . . 1.0 110.364 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.96 132.33 55.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.491 -0.756 . . . . 1.0 109.652 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.47 60.22 6.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.174 -0.954 . . . . 1.0 110.384 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.43 108.17 2.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.629 -1.388 . . . . 1.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -164.49 46.03 0.1 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -1.234 . . . . 1.0 110.185 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 168' ' ' ARG . . . -122.93 53.77 1.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 1.0 110.408 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 2.4 pt-20 -77.85 79.96 4.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.845 . . . . 1.0 110.367 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.51 134.21 34.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.157 -1.589 . . . . 1.0 110.925 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 190' ' ' LEU . 6.8 mm -125.94 142.14 43.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -0.975 . . . . 1.0 109.29 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -98.58 133.58 42.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.425 -0.797 . . . . 1.0 111.043 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.815 ' CE1' HD12 ' A' ' 167' ' ' ILE . 7.5 m-85 -95.84 175.74 6.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.886 . . . . 1.0 109.192 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 45.6 p-10 -139.5 4.63 2.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.171 -0.956 . . . . 1.0 110.655 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.483 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 102.74 -30.58 10.12 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.577 -1.809 . . . . 1.0 108.577 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 23' ' ' THR . 3.4 ttp-105 -100.92 -12.78 18.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.455 -1.027 . . . . 1.0 109.628 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.809 HG21 ' CD2' ' A' ' 19' ' ' PHE . 11.8 m -42.82 135.52 2.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 1.0 110.379 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.669 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -133.75 99.14 4.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' A' ' 143' ' ' LEU . 4.1 mtt -93.98 100.63 12.74 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.39 -1.444 . . . . 1.0 109.407 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.633 ' CG ' ' CZ3' ' A' ' 142' ' ' TRP . 2.7 tm-20 -103.72 101.8 11.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.548 -0.72 . . . . 1.0 110.325 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 182' ' ' ASP . 19.7 m-30 -108.81 116.41 31.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.258 -0.902 . . . . 1.0 109.346 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -115.67 122.39 45.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 1.0 110.59 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -156.35 163.4 39.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.0 110.242 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.27 167.28 19.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 1.0 110.055 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.543 HG11 ' NE2' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -148.04 24.45 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.089 -1.007 . . . . 1.0 110.83 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.832 HG21 ' O ' ' A' ' 35' ' ' GLU . 5.8 t -178.53 -177.61 0.55 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.002 -1.061 . . . . 1.0 110.386 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' O ' ' C ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -83.43 94.42 7.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.218 -0.926 . . . . 1.0 110.557 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 33' ' ' LYS . 2.0 t 35.88 39.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.618 -0.676 . . . . 1.0 110.802 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.832 ' O ' HG21 ' A' ' 32' ' ' THR . 0.3 OUTLIER -154.77 74.9 0.95 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.215 -0.928 . . . . 1.0 110.336 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.601 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 1.9 mptp? -61.07 116.69 4.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 1.0 110.127 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . 175.33 117.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.383 -0.823 . . . . 1.0 109.715 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tp -127.5 -170.63 2.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.199 -0.938 . . . . 1.0 110.754 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.2 -34.64 0.64 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.657 0.742 . . . . 1.0 109.764 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.6 p -118.38 149.9 40.44 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.55 ' HB3' ' CE1' ' A' ' 43' ' ' PHE . 23.8 m-80 -133.59 117.31 16.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.032 -1.043 . . . . 1.0 111.158 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 6.5 m-70 -94.87 108.74 20.77 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.52 -0.919 . . . . 1.0 108.52 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 8.4 m-85 -113.83 118.04 33.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 1.0 111.333 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.644 ' C ' HD23 ' A' ' 45' ' ' LEU . 2.1 mt-10 -127.99 150.62 49.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.183 -0.948 . . . . 1.0 110.577 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.644 HD23 ' C ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER 179.9 153.55 0.5 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.266 -0.896 . . . . 1.0 110.552 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 167' ' ' ILE . 0.7 OUTLIER -130.12 149.42 51.84 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 1.0 109.787 179.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.994 HD11 ' CG1' ' A' ' 97' ' ' ILE . 9.4 pt -131.22 177.28 7.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 119.186 -1.006 . . . . 1.0 110.067 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.641 ' O ' ' OG1' ' A' ' 49' ' ' THR . 12.4 tttt -167.0 82.31 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.204 -0.935 . . . . 1.0 111.018 -178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.998 HG22 ' HG2' ' A' ' 50' ' ' GLU . 29.5 m -172.03 -114.0 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.238 0.542 . . . . 1.0 111.095 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.998 ' HG2' HG22 ' A' ' 49' ' ' THR . 0.9 OUTLIER -115.04 -47.45 2.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.683 1.23 . . . . 1.0 109.586 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 1.042 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . 34.98 41.99 0.07 Allowed 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.413 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.626 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 64.9 p -85.51 -17.25 36.97 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.87 -1.144 . . . . 1.0 108.537 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.478 ' OE1' ' HB2' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -159.95 119.82 2.92 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.063 -0.717 . . . . 1.0 109.063 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 154.73 129.05 1.22 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.15 -1.58 . . . . 1.0 109.15 -179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.863 HD21 ' CD1' ' A' ' 149' ' ' LEU . 0.1 OUTLIER -81.3 131.12 35.27 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.652 -1.499 . . . . 1.0 109.334 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.833 HD12 ' HA ' ' A' ' 72' ' ' ALA . 1.3 mp -97.21 -25.75 4.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.492 -0.755 . . . . 1.0 112.217 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.923 HD13 HD12 ' A' ' 71' ' ' LEU . 6.1 tt -148.7 133.74 18.19 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 119.723 -1.86 . . . . 1.0 113.211 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.977 ' CH2' HG21 ' A' ' 151' ' ' VAL . 20.4 t-105 -145.73 117.59 8.2 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.936 -0.764 . . . . 1.0 108.936 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB2' ' HA ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -137.6 153.03 49.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.841 -1.162 . . . . 1.0 111.024 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 61' ' ' LYS . . . -158.37 -121.09 0.62 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 108.579 -1.809 . . . . 1.0 108.579 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.546 ' HG3' ' N ' ' A' ' 62' ' ' GLY . 0.1 OUTLIER 172.33 -84.07 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.224 -1.162 . . . . 1.0 110.09 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.546 ' N ' ' HG3' ' A' ' 61' ' ' LYS . . . -61.31 132.0 47.92 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.81 -1.716 . . . . 1.0 108.81 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.5 ' O ' ' O ' ' A' ' 62' ' ' GLY . 18.6 mt 58.61 137.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.449 -1.03 . . . . 1.0 109.965 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 4.2 pt-20 -71.33 56.11 0.23 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.813 -1.179 . . . . 1.0 109.997 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.461 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 8.4 ptp180 167.98 45.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -92.52 -176.67 4.36 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-O 121.868 0.842 . . . . 1.0 112.441 -177.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.549 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 9.8 p-10 -87.59 141.7 28.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.777 -0.577 . . . . 1.0 111.548 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.794 ' CG ' HG22 ' A' ' 69' ' ' ILE . 6.6 t80 174.19 -100.32 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.561 -0.712 . . . . 1.0 111.029 178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.794 HG22 ' CG ' ' A' ' 68' ' ' TYR . 1.8 tt -153.79 162.51 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 O-C-N 120.523 -1.361 . . . . 1.0 111.843 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.904 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -157.71 170.15 23.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.535 -0.728 . . . . 1.0 110.032 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.923 HD12 HD13 ' A' ' 57' ' ' LEU . 77.6 mt -145.17 125.79 14.17 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 108.431 -0.952 . . . . 1.0 108.431 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.833 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -152.71 172.36 16.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.94 -1.1 . . . . 1.0 111.325 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.042 HD13 ' HB1' ' A' ' 51' ' ' ALA . 5.5 mt -127.49 146.01 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 1.0 111.452 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.62 ' CG1' ' CG ' ' A' ' 156' ' ' PRO . 0.1 OUTLIER -141.46 122.69 13.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.306 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 74' ' ' VAL . 3.1 m-20 73.76 -3.98 2.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.335 -0.853 . . . . 1.0 112.169 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.68 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 127.4 -0.65 6.97 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 118.866 -1.635 . . . . 1.0 111.045 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.723 ' C ' HG23 ' A' ' 73' ' ' ILE . 25.7 m-85 -133.93 134.13 42.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.93 -1.335 . . . . 1.0 110.545 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.79 HG23 HG13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -59.97 -167.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.153 -0.967 . . . . 1.0 109.946 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.947 ' HB2' HG22 ' A' ' 90' ' ' VAL . 1.3 pt20 -174.75 97.37 0.09 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.441 -0.787 . . . . 1.0 109.819 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.607 ' HE3' ' CD1' ' A' ' 91' ' ' LEU . 3.2 ttp -62.21 90.88 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.614 -0.834 . . . . 1.0 109.233 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.904 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 12.2 ttp -95.02 108.77 20.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.651 -0.656 . . . . 1.0 110.21 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.884 ' CE2' HG11 ' A' ' 89' ' ' VAL . 1.4 p90 -125.74 138.57 53.87 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 118.015 -1.474 . . . . 1.0 111.013 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.544 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 0.6 OUTLIER -136.6 94.93 3.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.75 -0.594 . . . . 1.0 110.444 -179.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -102.52 3.27 37.31 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.835 -0.541 . . . . 1.0 110.654 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -136.44 -43.03 0.1 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.302 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 167.72 -20.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.193 -1.181 . . . . 1.0 110.983 -179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.491 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 7.8 mttt -118.8 120.35 31.6 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.097 . . . . 1.0 110.081 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.602 ' HG3' ' CE1' ' A' ' 153' ' ' HIS . 52.6 Cg_endo -78.31 146.62 22.36 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.946 1.498 . . . . 1.0 110.151 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.884 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -112.97 121.89 66.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 121.323 -0.861 . . . . 1.0 108.729 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.947 HG22 ' HB2' ' A' ' 79' ' ' GLN . 0.5 OUTLIER -102.5 111.29 31.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.09 -1.444 . . . . 1.0 110.427 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.607 ' CD1' ' HE3' ' A' ' 80' ' ' MET . 11.7 mt -105.61 70.05 0.86 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 106.9 -1.519 . . . . 1.0 106.9 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.618 ' O ' HD13 ' A' ' 124' ' ' ILE . 20.0 mtp180 -60.5 148.97 35.89 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 122.121 0.963 . . . . 1.0 111.22 -177.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.738 ' OG ' HG21 ' A' ' 118' ' ' VAL 0.253 48.2 t -67.57 150.67 48.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.824 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.588 ' N ' HD11 ' A' ' 124' ' ' ILE . 12.1 t -107.57 26.73 9.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.437 -0.789 . . . . 1.0 109.023 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.975 ' HB ' HG11 ' A' ' 118' ' ' VAL . 2.1 t -139.88 153.3 69.6 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.663 ' HD2' HG13 ' A' ' 95' ' ' VAL . 40.9 Cg_endo -65.84 124.69 13.07 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.661 1.348 . . . . 1.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.994 ' CG1' HD11 ' A' ' 47' ' ' ILE . 3.3 tp -109.55 -8.42 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.413 -0.805 . . . . 1.0 110.03 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 5.4 p-10 -93.77 56.89 2.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.488 -0.758 . . . . 1.0 109.896 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 99' ' ' THR . 98.1 m -114.61 7.04 15.94 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.227 -0.921 . . . . 1.0 110.739 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.458 ' HA ' ' CA ' ' A' ' 49' ' ' THR . 0.9 OUTLIER 60.54 10.94 2.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.005 -1.059 . . . . 1.0 110.331 179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -104.47 163.11 12.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.193 -0.942 . . . . 1.0 109.742 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 15.6 m95 -78.08 91.87 4.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.003 -1.061 . . . . 1.0 110.864 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.552 HG21 HD12 ' A' ' 97' ' ' ILE . 22.9 m -86.63 167.5 14.48 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.76 -0.829 . . . . 1.0 108.76 178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.523 ' N ' HG22 ' A' ' 103' ' ' THR . 23.1 t60 -123.98 132.45 53.71 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.208 -0.997 . . . . 1.0 109.782 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.488 HG22 HD11 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -126.78 142.94 41.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 O-C-N 121.318 -0.864 . . . . 1.0 108.979 -179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.724 ' CB ' ' HB3' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -148.34 179.65 7.62 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 119.018 -1.073 . . . . 1.0 109.309 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.549 ' O ' ' CD1' ' A' ' 108' ' ' TYR . . . -165.11 157.63 15.9 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.808 -1.182 . . . . 1.0 111.824 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.549 ' CD1' ' O ' ' A' ' 107' ' ' ALA . 6.0 m-85 -136.21 104.39 5.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.555 -0.716 . . . . 1.0 109.299 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -103.02 134.75 45.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.911 -1.118 . . . . 1.0 109.945 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.527 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 3.0 t -130.56 84.53 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.161 -1.016 . . . . 1.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.523 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 32.4 mt-30 53.85 -2.22 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.482 1.29 . . . . 1.0 114.482 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 110' ' ' VAL . 0.0 OUTLIER -179.37 -27.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.042 -1.661 . . . . 1.0 111.066 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.526 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -110.35 115.9 30.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.966 -1.084 . . . . 1.0 110.718 -178.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -103.54 149.89 17.46 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.693 -0.963 . . . . 1.0 110.693 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.72 ' CB ' HG22 ' A' ' 125' ' ' THR . 12.5 t -132.36 155.59 48.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.274 -1.133 . . . . 1.0 110.266 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.033 HD13 ' N ' ' A' ' 117' ' ' GLN . 1.6 tm? -123.65 144.89 49.35 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.802 -1.186 . . . . 1.0 108.679 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 1.033 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -121.04 81.35 1.76 Allowed 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.411 -0.806 . . . . 1.0 112.3 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.975 HG11 ' HB ' ' A' ' 95' ' ' VAL . 91.4 t -70.29 80.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.772 -1.171 . . . . 1.0 107.933 177.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 121' ' ' GLU . . . 67.12 59.77 6.61 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.072 -1.211 . . . . 1.0 110.072 -179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.456 ' H ' ' HG3' ' A' ' 117' ' ' GLN . 7.8 m120 36.68 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.898 . . . . 1.0 111.25 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -103.18 -161.4 0.84 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.02 -1.05 . . . . 1.0 109.919 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.577 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -39.82 99.38 0.2 Allowed Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.555 -0.716 . . . . 1.0 109.375 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.487 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.1 Cg_endo -71.17 129.88 16.78 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.211 1.638 . . . . 1.0 110.892 -178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 93' ' ' SER . 3.0 mt -101.45 102.2 13.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.549 -0.908 . . . . 1.0 108.549 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.72 HG22 ' CB ' ' A' ' 115' ' ' SER . 30.2 p -114.06 173.42 6.45 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 122.261 1.029 . . . . 1.0 112.299 -177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.405 ' C ' ' OG ' ' A' ' 127' ' ' SER . . . -178.09 -171.35 41.37 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 107.532 -2.227 . . . . 1.0 107.532 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -159.5 171.01 20.47 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.597 -1.531 . . . . 1.0 110.892 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.564 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.6 OUTLIER -107.97 -177.89 0.52 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.359 -0.838 . . . . 1.0 110.193 -179.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.564 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 41.8 Cg_endo -69.39 94.88 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.851 1.448 . . . . 1.0 108.946 179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.666 HD12 ' H ' ' A' ' 130' ' ' LEU . 3.4 mp -34.32 152.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.228 0.537 . . . . 1.0 111.098 -178.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.03 -29.04 1.25 Allowed Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.614 -1.394 . . . . 1.0 109.614 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.493 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -90.66 135.33 33.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.228 -1.16 . . . . 1.0 110.333 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.435 ' C ' ' HG2' ' A' ' 134' ' ' GLN . 9.7 m -138.38 23.47 2.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 1.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.51 ' O ' ' HG ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -158.52 -49.24 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 1.0 110.398 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER 28.14 64.01 0.11 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.232 0.539 . . . . 1.0 111.523 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -52.55 96.74 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.122 -0.986 . . . . 1.0 110.199 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 68' ' ' TYR . 10.5 t -159.72 -172.88 3.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.372 -0.83 . . . . 1.0 109.759 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.578 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.0 OUTLIER 91.59 -19.87 0.12 Allowed 'General case' 0 N--CA 1.511 2.601 0 CA-C-O 121.298 0.571 . . . . 1.0 110.544 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -47.99 -17.0 0.51 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 120.198 -1.001 . . . . 1.0 110.743 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 138' ' ' ASP . . . -128.79 168.36 15.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.631 -1.511 . . . . 1.0 109.748 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 59' ' ' SER . 0.5 OUTLIER -154.88 145.96 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.033 -1.042 . . . . 1.0 110.861 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.633 ' CZ3' ' CG ' ' A' ' 26' ' ' GLU . 30.2 m95 -136.6 96.47 3.35 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.131 -1.803 . . . . 1.0 106.131 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.688 HD12 ' CB ' ' A' ' 57' ' ' LEU . 1.7 tp -112.34 130.05 56.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 114.97 1.47 . . . . 1.0 114.97 -175.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 106.99 10.05 28.88 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 176.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.701 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 124.93 -160.82 19.56 Favored Glycine 0 C--N 1.278 -2.648 0 N-CA-C 107.762 -2.135 . . . . 1.0 107.762 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.931 ' HB2' HD12 ' A' ' 149' ' ' LEU . 1.9 mmt -168.78 169.5 9.91 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 118.282 -1.367 . . . . 1.0 111.059 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.9 11.32 38.79 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.817 -0.808 . . . . 1.0 108.817 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -165.43 16.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.667 -0.646 . . . . 1.0 111.525 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.931 HD12 ' HB2' ' A' ' 146' ' ' MET . 9.2 mt -68.42 53.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.402 -1.436 . . . . 1.0 109.865 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 148' ' ' ARG . 10.5 p -55.19 -24.31 26.35 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 106.413 -1.699 . . . . 1.0 106.413 177.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.977 HG21 ' CH2' ' A' ' 58' ' ' TRP 0.311 12.7 p -48.21 -118.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 114.051 -1.431 . . . . 1.0 111.86 178.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' A' ' 155' ' ' LEU . . . 79.81 -23.25 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.11 -0.993 . . . . 1.0 109.993 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.602 ' CE1' ' HG3' ' A' ' 88' ' ' PRO . 0.2 OUTLIER 75.68 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.381 -0.824 . . . . 1.0 111.163 179.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.577 ' O ' ' CG ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -150.04 74.92 1.22 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.823 -1.173 . . . . 1.0 111.137 -179.166 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -142.47 178.41 1.51 Allowed Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 120.696 -1.252 . . . . 1.0 110.029 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.62 ' CG ' ' CG1' ' A' ' 74' ' ' VAL . 52.6 Cg_endo -76.76 -164.2 0.25 Allowed 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.707 1.372 . . . . 1.0 111.948 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.555 ' O ' ' N ' ' A' ' 161' ' ' THR . 2.8 mttm -51.21 -10.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.609 -0.682 . . . . 1.0 112.131 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.609 ' HB3' ' CD1' ' A' ' 155' ' ' LEU . . . -32.75 -46.52 0.14 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.121 -0.987 . . . . 1.0 109.848 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.964 ' CD2' ' HB2' ' A' ' 152' ' ' ALA . 3.6 m-85 -83.97 -33.98 24.49 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.558 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -76.06 -1.7 27.21 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.977 -1.089 . . . . 1.0 108.813 178.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 161' ' ' THR . 2.6 m -140.74 83.24 1.88 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.547 -0.72 . . . . 1.0 109.29 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -43.54 165.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.154 -1.578 . . . . 1.0 109.154 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.802 ' CE1' ' HB2' ' A' ' 51' ' ' ALA . 32.6 t80 -70.63 142.67 51.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.014 -1.286 . . . . 1.0 110.485 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.672 ' O ' HG21 ' A' ' 49' ' ' THR . 19.3 mt -119.79 79.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.761 ' HA2' HG21 ' A' ' 49' ' ' THR . . . -165.48 -163.19 18.33 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 1.8 m -114.41 146.92 40.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -1.183 . . . . 1.0 111.585 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.815 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -136.45 152.62 29.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.166 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.468 ' HG2' ' OD1' ' A' ' 169' ' ' ASP . 13.5 ttp180 -158.6 159.1 35.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -0.916 . . . . 1.0 110.769 -179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.7 m-20 53.13 79.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.455 -0.778 . . . . 1.0 110.509 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.589 HG12 ' CB ' ' A' ' 45' ' ' LEU . 28.5 m -128.72 131.71 68.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 108.39 -0.967 . . . . 1.0 108.39 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.495 ' CG1' ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -150.88 149.24 14.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.03 -1.068 . . . . 1.0 110.899 -176.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.531 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 8.9 t -135.25 108.67 9.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.19 -0.67 . . . . 1.0 109.19 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 1.5 m-20 50.53 42.96 27.33 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.391 -1.443 . . . . 1.0 107.469 -178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.31 28.7 2.93 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.906 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.544 ' O ' ' HB2' ' A' ' 176' ' ' GLU . 22.3 mt-30 -100.98 -178.13 3.66 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 121.102 -0.999 . . . . 1.0 109.217 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 175' ' ' GLN . 4.5 mm-40 69.62 -98.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.634 -0.666 . . . . 1.0 110.44 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.535 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER 69.27 -88.02 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.256 -0.903 . . . . 1.0 111.05 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 181' ' ' GLU . 17.4 m-70 -97.44 103.17 15.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.739 -1.225 . . . . 1.0 111.097 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.5 OUTLIER -67.4 -53.56 28.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.271 -0.893 . . . . 1.0 109.397 178.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 22.1 t -51.47 -23.05 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.582 -0.699 . . . . 1.0 110.381 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 178' ' ' HIS . 35.5 mt-10 -71.69 -58.43 3.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.174 -0.954 . . . . 1.0 110.01 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.575 ' HB3' ' CE1' ' A' ' 27' ' ' TYR . 12.3 t0 -87.49 -14.63 39.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.252 -0.905 . . . . 1.0 109.619 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -69.65 -34.16 73.62 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.254 -0.904 . . . . 1.0 108.873 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.655 ' HA ' HD11 ' A' ' 189' ' ' ILE . 11.3 mt -48.68 -24.23 1.3 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.407 -0.808 . . . . 1.0 108.975 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 1.2 t-20 -57.22 -20.11 25.28 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 122.101 0.953 . . . . 1.0 109.009 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.512 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 1.8 t30 -89.61 151.95 46.5 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.512 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 37.5 Cg_endo -61.82 -149.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.3 1.158 . . . . 1.0 109.309 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.504 ' C ' ' O ' ' A' ' 187' ' ' PRO . 20.5 m -33.06 136.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.355 -0.84 . . . . 1.0 111.197 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 184' ' ' LEU . 13.4 mt -127.78 153.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.505 -0.747 . . . . 1.0 109.795 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 17' ' ' ILE . 23.1 mt -131.2 155.27 47.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.951 . . . . 1.0 110.648 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 18' ' ' ALA . 1.9 m-70 -92.29 -87.96 0.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.392 -0.818 . . . . 1.0 110.291 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 191' ' ' HIS . 5.3 t -178.31 167.54 1.9 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.373 -0.931 . . . . 1.0 111.498 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 74.5 m -128.24 163.78 23.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.583 -0.698 . . . . 1.0 109.545 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -131.53 111.02 11.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.936 . . . . 1.0 110.215 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.763 0 C-N-CA 118.904 -1.118 . . . . 1.0 110.497 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.584 -1.406 . . . . 1.0 109.584 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.8 p -128.1 48.08 2.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -1.162 . . . . 1.0 110.059 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.29 41.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.372 -0.83 . . . . 1.0 110.319 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -117.58 -162.9 0.9 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 1.0 110.205 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 5' ' ' VAL . 27.9 m -53.11 119.56 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.24 -0.913 . . . . 1.0 110.308 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.415 ' HA ' HD13 ' A' ' 6' ' ' ILE . 23.0 mm -79.56 148.92 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.373 -0.83 . . . . 1.0 110.39 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 7' ' ' ILE . 1.2 pp -119.72 120.47 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 1.0 110.06 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -121.4 115.62 23.24 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.104 -0.997 . . . . 1.0 110.098 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' HG2' ' N ' ' A' ' 10' ' ' ALA . 22.3 ttpt -64.73 166.54 8.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.394 -0.816 . . . . 1.0 110.403 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' N ' ' HG2' ' A' ' 9' ' ' LYS . . . -82.64 147.57 28.47 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.219 -0.926 . . . . 1.0 109.894 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.58 66.43 6.24 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.45 -0.781 . . . . 1.0 110.519 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.57 130.42 9.74 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -158.63 21.79 0.22 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.189 -1.183 . . . . 1.0 110.483 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.52 49.99 1.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.93 . . . . 1.0 110.133 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 3.1 pt-20 -72.4 70.62 0.88 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.267 -0.896 . . . . 1.0 110.785 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.551 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -112.3 119.41 38.23 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.533 -1.354 . . . . 1.0 109.79 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.628 ' CG1' HD12 ' A' ' 179' ' ' LEU . 10.1 mm -112.14 131.42 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 118.533 -1.267 . . . . 1.0 110.421 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 191' ' ' HIS . . . -91.15 115.59 28.14 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.731 -0.606 . . . . 1.0 110.532 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.783 ' CZ ' HD13 ' A' ' 167' ' ' ILE . 5.0 m-30 -74.52 167.6 21.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.198 -0.939 . . . . 1.0 109.114 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.503 ' OD1' ' CB ' ' A' ' 23' ' ' THR . 1.4 p-10 -117.57 -10.13 10.67 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.057 -1.027 . . . . 1.0 110.18 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.497 ' HA2' ' C ' ' A' ' 162' ' ' GLY . . . 105.45 -9.28 45.07 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.639 -1.384 . . . . 1.0 109.639 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' O ' ' CD ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -147.04 21.16 1.24 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.167 -1.196 . . . . 1.0 110.055 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.503 ' CB ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m -115.62 102.81 10.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.03 -1.044 . . . . 1.0 109.867 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.632 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 4.5 p90 -67.12 117.46 9.18 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 1.0 111.015 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.614 ' HE1' HG21 ' A' ' 17' ' ' ILE . 3.4 mmm -106.8 98.56 8.21 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.689 -1.257 . . . . 1.0 108.27 178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.606 ' OE1' ' CZ3' ' A' ' 142' ' ' TRP . 4.6 pt-20 -107.84 152.3 24.59 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.311 -0.868 . . . . 1.0 110.261 -179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.562 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 3.3 m-85 -130.48 124.66 32.49 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.243 -0.983 . . . . 1.0 110.001 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.618 ' CE1' ' HB2' ' A' ' 140' ' ' ALA . 0.1 OUTLIER -97.55 89.64 4.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.567 -0.708 . . . . 1.0 110.287 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -88.67 151.72 22.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.238 -0.914 . . . . 1.0 109.781 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.32 108.4 19.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.172 -0.955 . . . . 1.0 110.666 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.945 HG11 ' NE2' ' A' ' 175' ' ' GLN . 19.1 m -135.3 169.35 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 1.0 110.003 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.24 126.06 18.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 1.0 110.314 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 103.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 1.0 110.002 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.18 -58.57 7.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 1.0 110.489 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.485 ' O ' ' CB ' ' A' ' 36' ' ' LYS . 3.7 mt-10 -147.67 119.73 8.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.093 -1.004 . . . . 1.0 110.789 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER 69.68 145.03 0.05 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.314 -0.867 . . . . 1.0 111.177 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.5 ' CB ' ' OD1' ' A' ' 136' ' ' ASP . . . -88.92 -37.58 15.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.477 -0.764 . . . . 1.0 108.97 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.047 HD13 ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -106.94 155.42 19.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.529 -0.732 . . . . 1.0 110.091 179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 1.013 ' N ' HD22 ' A' ' 38' ' ' LEU . 31.8 tt0 160.71 -75.63 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.949 0.88 . . . . 1.0 109.18 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.74 ' OG ' HG13 ' A' ' 110' ' ' VAL . 5.7 m -157.03 119.15 3.85 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.19 0.519 . . . . 1.0 110.032 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -103.67 163.3 12.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 1.0 110.439 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.556 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 59.1 m-70 -139.07 132.84 30.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 1.0 109.913 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.074 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 93.5 m-85 -135.24 115.44 13.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.57 -0.706 . . . . 1.0 109.625 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.825 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.1 mp0 -123.72 144.19 49.82 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.823 -1.173 . . . . 1.0 109.756 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.871 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.8 OUTLIER -178.38 159.39 1.2 Allowed 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.393 -0.923 . . . . 1.0 110.882 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 103' ' ' THR . 1.0 OUTLIER -123.49 154.38 39.23 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 178.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 166' ' ' CYS . 1.9 pt -148.14 156.01 9.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 117.907 -1.517 . . . . 1.0 112.045 -179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.615 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -105.94 86.45 2.38 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.333 -1.728 . . . . 1.0 106.333 176.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.566 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -75.27 153.36 38.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.125 -1.03 . . . . 1.0 112.841 -175.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.612 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 3.2 mm-40 -143.48 1.97 1.23 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.434 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.39 128.78 24.18 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.047 -1.033 . . . . 1.0 110.285 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.547 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 58.3 p -62.88 -15.4 54.72 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.379 -0.826 . . . . 1.0 110.844 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HG2' ' N ' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -129.82 135.65 48.66 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.188 -0.945 . . . . 1.0 110.846 -179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 159.33 137.14 2.17 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -90.84 126.24 35.97 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.051 -1.264 . . . . 1.0 108.797 179.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.913 HG22 HD21 ' A' ' 143' ' ' LEU . 0.5 OUTLIER -91.25 -34.32 6.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 113.067 0.766 . . . . 1.0 113.067 -176.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.092 HD13 HD12 ' A' ' 71' ' ' LEU . 3.1 tt -142.76 151.91 41.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.018 -1.676 . . . . 1.0 113.338 -175.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.686 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 9.6 t-105 -162.88 107.0 1.09 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -114.35 137.27 52.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.661 -1.274 . . . . 1.0 111.023 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.89 -179.64 16.2 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 108.37 -1.892 . . . . 1.0 108.37 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 61' ' ' LYS . 13.6 tttp -118.54 54.08 0.96 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.885 -1.362 . . . . 1.0 110.299 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.47 -142.99 16.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.776 -1.329 . . . . 1.0 109.776 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mp 48.23 -152.33 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -1.102 . . . . 1.0 110.321 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 43.1 mt-10 -139.68 13.21 2.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 1.0 110.345 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER 171.0 64.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 1.0 108.949 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.57 140.17 49.0 Favored 'General case' 0 C--N 1.286 -2.169 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.182 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -56.49 164.89 1.25 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.634 -0.666 . . . . 1.0 110.796 -179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.635 ' HB2' ' O ' ' A' ' 67' ' ' ASP . 1.1 t80 169.62 -118.27 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.829 -0.544 . . . . 1.0 109.798 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.946 HD11 ' CD2' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -130.06 172.88 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.734 -1.229 . . . . 1.0 111.001 -179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.801 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -174.95 174.67 2.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.692 -0.63 . . . . 1.0 109.636 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.092 HD12 HD13 ' A' ' 57' ' ' LEU . 70.8 mt -152.43 117.59 5.21 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.92 -1.113 . . . . 1.0 109.146 -178.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.697 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -132.79 171.07 14.37 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.956 -1.09 . . . . 1.0 112.011 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.112 ' CG1' HG13 ' A' ' 78' ' ' VAL . 30.7 mt -121.86 139.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.476 -0.765 . . . . 1.0 111.559 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.922 HG11 ' NH2' ' A' ' 92' ' ' ARG . 11.7 p -141.43 144.66 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.675 -0.64 . . . . 1.0 110.112 178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.779 ' OD1' HG22 ' A' ' 74' ' ' VAL . 0.4 OUTLIER 52.94 27.07 5.16 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.142 -0.974 . . . . 1.0 110.614 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.744 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 80.42 14.32 80.34 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 7.5 m-85 -126.64 148.52 49.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -1.119 . . . . 1.0 110.071 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.112 HG13 ' CG1' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -99.15 168.05 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.06 -1.025 . . . . 1.0 109.757 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 22.9 pt20 -160.17 123.23 3.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.098 -1.001 . . . . 1.0 110.944 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.802 ' HA ' HD23 ' A' ' 71' ' ' LEU . 5.4 tmm? -86.83 113.61 22.79 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.38 -0.825 . . . . 1.0 109.119 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.801 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 2.2 ptt? -100.94 141.12 34.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 1.0 110.765 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.946 ' CD2' HD11 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -120.19 105.43 10.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 1.0 110.583 -179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 67' ' ' ASP . 6.4 t0 -120.86 40.38 3.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 1.0 109.901 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.812 HD23 ' HD1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -39.17 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.569 -0.707 . . . . 1.0 112.132 -178.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -142.8 -50.34 0.04 OUTLIER Glycine 0 N--CA 1.494 2.527 0 C-N-CA 118.862 -1.637 . . . . 1.0 110.83 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.46 ' H ' ' HD3' ' A' ' 87' ' ' LYS . 1.1 m -173.7 22.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.159 -1.2 . . . . 1.0 110.717 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.574 ' CB ' ' HB3' ' A' ' 128' ' ' SER . 0.0 OUTLIER -129.99 80.91 70.2 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.157 -0.964 . . . . 1.0 109.292 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.404 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 42.5 Cg_endo -68.92 89.66 0.44 Allowed 'Trans proline' 0 C--N 1.3 -1.978 0 O-C-N 124.025 1.54 . . . . 1.0 111.192 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 81' ' ' MET . 0.3 OUTLIER -75.18 155.23 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 178.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 90' ' ' VAL . 0.3 OUTLIER -127.99 119.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.321 -1.487 . . . . 1.0 110.801 178.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.822 HD21 ' C ' ' A' ' 114' ' ' GLY . 10.6 mp -112.73 69.25 0.69 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.922 ' NH2' HG11 ' A' ' 74' ' ' VAL . 4.6 mtt180 -56.78 178.01 0.07 Allowed 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.668 -1.213 . . . . 1.0 109.822 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.758 ' OG ' HG21 ' A' ' 118' ' ' VAL . 3.0 t -95.68 169.57 9.93 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.693 -0.629 . . . . 1.0 110.16 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 1.011 ' CG2' ' HB3' ' A' ' 122' ' ' ALA . 14.0 t -121.22 16.46 11.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 1.0 109.062 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.951 HG22 ' HD2' ' A' ' 96' ' ' PRO . 0.4 OUTLIER -139.84 160.56 60.32 Favored Pre-proline 0 C--N 1.303 -1.436 0 O-C-N 121.661 -0.649 . . . . 1.0 109.331 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.951 ' HD2' HG22 ' A' ' 95' ' ' VAL . 44.3 Cg_endo -70.06 138.48 36.95 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.859 1.452 . . . . 1.0 110.358 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 76' ' ' GLY . 2.7 tp -121.53 -30.15 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.096 -1.002 . . . . 1.0 110.706 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 98' ' ' ASN . 11.2 p30 -73.7 57.45 0.58 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 1.0 109.544 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.724 HG22 ' O ' ' A' ' 99' ' ' THR . 16.8 m -114.12 19.77 16.16 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.563 -0.711 . . . . 1.0 110.282 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 46.7 22.28 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.302 -0.874 . . . . 1.0 110.921 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.32 144.94 43.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.056 -1.028 . . . . 1.0 110.1 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 7.5 m95 -59.46 95.26 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.086 -1.009 . . . . 1.0 109.881 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 46' ' ' SER . 26.5 m -94.09 164.7 12.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.156 -0.965 . . . . 1.0 109.485 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 40.6 t-80 -116.34 147.64 41.39 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.258 -0.901 . . . . 1.0 108.614 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.516 HD11 HD13 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -134.97 152.74 33.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.126 -0.984 . . . . 1.0 109.365 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.995 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -138.57 146.23 41.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.8 -1.188 . . . . 1.0 110.329 -179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 1.074 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -143.93 92.35 2.33 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 1.0 110.675 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.598 ' CZ ' ' OG ' ' A' ' 115' ' ' SER . 47.9 p90 -112.18 107.53 16.45 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.056 -1.058 . . . . 1.0 109.014 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.606 ' HD3' ' CZ ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -109.67 130.66 55.49 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.969 -178.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.74 HG13 ' OG ' ' A' ' 40' ' ' SER . 4.2 t -104.5 102.15 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.415 -0.803 . . . . 1.0 109.506 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.56 ' HA ' ' NH2' ' A' ' 109' ' ' ARG . 10.0 pt20 38.65 100.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.581 0.705 . . . . 1.0 112.469 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.56 ' HG2' ' N ' ' A' ' 113' ' ' GLU . 1.1 ptt85 70.18 -50.0 0.64 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 1.0 111.644 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.56 ' N ' ' HG2' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -81.49 112.09 18.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.785 -1.197 . . . . 1.0 110.019 -179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.822 ' C ' HD21 ' A' ' 91' ' ' LEU . . . -103.39 159.65 16.9 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 120.144 -1.027 . . . . 1.0 111.732 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.619 ' OG ' HG22 ' A' ' 125' ' ' THR . 1.0 OUTLIER -137.35 151.93 49.14 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.835 -0.803 . . . . 1.0 109.656 178.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 117' ' ' GLN . 3.2 tm? -138.33 153.6 48.99 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.083 -1.011 . . . . 1.0 109.406 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 1.115 ' N ' HD13 ' A' ' 116' ' ' LEU . 1.1 mt-30 -158.28 111.32 2.38 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 118.768 -1.173 . . . . 1.0 111.644 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.828 HG11 ' CG1' ' A' ' 95' ' ' VAL . 90.7 t -71.29 97.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 177.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 64.54 43.12 97.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.509 -1.436 . . . . 1.0 109.509 -178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.9 OUTLIER 61.84 36.53 15.99 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -1.136 . . . . 1.0 110.713 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -96.29 -162.93 1.0 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.123 -0.985 . . . . 1.0 110.791 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 1.011 ' HB3' ' CG2' ' A' ' 94' ' ' THR . . . -43.2 118.17 2.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.287 -0.883 . . . . 1.0 109.246 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 47.7 Cg_endo -73.27 115.22 4.26 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.068 1.562 . . . . 1.0 112.436 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.703 HG21 ' O ' ' A' ' 92' ' ' ARG . 4.1 mp -91.23 102.08 13.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.619 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.9 p -116.96 179.93 3.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.502 1.144 . . . . 1.0 112.874 -176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 113' ' ' GLU . . . 169.42 -173.2 43.74 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 106.667 -2.573 . . . . 1.0 106.667 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.546 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -160.46 162.03 33.04 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.471 -1.605 . . . . 1.0 110.686 179.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.574 ' HB3' ' CB ' ' A' ' 87' ' ' LYS . 19.8 m -111.21 161.31 25.69 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.148 -0.97 . . . . 1.0 110.222 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.547 ' O ' ' C ' ' A' ' 130' ' ' LEU . 40.7 Cg_endo -68.16 78.32 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.972 1.511 . . . . 1.0 108.811 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.547 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.4 mt -12.99 131.12 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.596 0.712 . . . . 1.0 112.815 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 132' ' ' ALA . . . 161.85 99.62 0.14 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.756 ' O ' HG22 ' A' ' 133' ' ' THR . . . 173.68 -48.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.459 -1.024 . . . . 1.0 109.716 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 132' ' ' ALA . 5.7 t 42.69 -173.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.465 0.65 . . . . 1.0 110.779 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 133' ' ' THR . 0.0 OUTLIER 40.0 26.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 1.0 110.704 -179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -89.87 36.62 0.86 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.118 -0.989 . . . . 1.0 109.5 179.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.5 ' OD1' ' CB ' ' A' ' 37' ' ' ALA . 0.7 OUTLIER -51.37 171.03 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.053 -1.029 . . . . 1.0 109.076 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.0 t -113.16 133.41 55.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.037 -1.039 . . . . 1.0 109.748 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.739 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 28.9 p-10 -84.67 30.21 0.57 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 1.0 110.32 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 31' ' ' VAL . . . 44.84 24.1 0.68 Allowed Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.963 -1.655 . . . . 1.0 108.963 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.739 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -116.75 151.67 35.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -1.146 . . . . 1.0 109.839 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.876 ' CD1' HD21 ' A' ' 57' ' ' LEU . 11.9 tp -154.22 150.05 27.65 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.482 -0.887 . . . . 1.0 110.639 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.624 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 8.0 m95 -126.48 118.19 24.42 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.074 -1.454 . . . . 1.0 107.074 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.913 HD21 HG22 ' A' ' 56' ' ' ILE . 1.1 tt -125.59 120.01 29.66 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 117.812 -1.555 . . . . 1.0 112.651 -177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 124.76 8.21 5.82 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 136.66 -134.34 7.06 Favored Glycine 0 C--N 1.291 -1.923 0 C-N-CA 119.007 -1.568 . . . . 1.0 109.848 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 1.055 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.6 OUTLIER -170.74 158.94 6.27 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 119.424 -0.911 . . . . 1.0 111.712 -178.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -92.23 -14.88 28.29 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -143.5 51.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 178.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.055 HD13 ' HB2' ' A' ' 146' ' ' MET . 10.0 tp -65.5 49.3 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 112.878 0.696 . . . . 1.0 112.878 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 148' ' ' ARG . 20.5 p -73.83 -19.67 60.67 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 105.167 -2.16 . . . . 1.0 105.167 175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.749 ' CG1' HD12 ' A' ' 149' ' ' LEU 0.267 3.9 p -61.55 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.588 -1.187 . . . . 1.0 109.909 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.765 ' HB1' ' CD2' ' A' ' 159' ' ' TYR . . . 53.77 20.15 2.16 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.408 -1.432 . . . . 1.0 110.195 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.585 ' CE1' ' SD ' ' A' ' 81' ' ' MET . 48.1 m80 32.98 -85.89 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.83 -0.544 . . . . 1.0 112.323 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' A' ' 152' ' ' ALA . 2.9 ptpp? -134.67 -29.83 1.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.847 -1.158 . . . . 1.0 113.082 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.996 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -60.34 138.44 91.99 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 120.684 -1.26 . . . . 1.0 109.078 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.594 ' N ' HD12 ' A' ' 155' ' ' LEU . 56.4 Cg_endo -81.54 -92.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.902 1.475 . . . . 1.0 114.642 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.612 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -55.03 -47.56 74.6 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 116.045 1.869 . . . . 1.0 116.045 -174.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.996 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -41.57 -44.19 2.94 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 120.731 1.605 . . . . 1.0 108.987 -178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.791 ' CE2' HD23 ' A' ' 155' ' ' LEU . 30.6 m-85 -84.39 -25.67 28.92 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 118.632 -1.227 . . . . 1.0 108.572 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.612 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -78.19 -3.28 41.85 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.336 179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -135.02 82.81 1.98 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.19 166.46 0.01 OUTLIER Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.651 ' CD2' HD11 ' A' ' 167' ' ' ILE . 12.9 t80 -65.79 143.56 57.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.83 -1.394 . . . . 1.0 112.046 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.765 HG22 ' O ' ' A' ' 164' ' ' ILE . 4.6 mt -122.02 85.14 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.33 -1.359 . . . . 1.0 107.33 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.648 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.33 -156.41 11.75 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.702 -1.359 . . . . 1.0 109.702 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.565 ' HB2' ' HB2' ' A' ' 48' ' ' LYS . 1.7 m -127.73 142.34 51.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.529 -0.983 . . . . 1.0 110.899 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.783 HD13 ' CZ ' ' A' ' 19' ' ' PHE . 3.3 mt -126.78 147.17 31.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.211 -0.931 . . . . 1.0 109.755 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.637 ' O ' HG13 ' A' ' 170' ' ' VAL . 0.2 OUTLIER -160.28 170.79 20.38 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 1.0 110.231 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.3 m-20 41.71 67.83 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.281 -0.887 . . . . 1.0 109.852 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.871 HG12 ' HB2' ' A' ' 45' ' ' LEU . 33.1 m -124.38 126.47 72.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 O-C-N 121.063 -1.023 . . . . 1.0 109.895 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.652 HG23 ' O ' ' A' ' 175' ' ' GLN . 0.3 OUTLIER -134.67 151.35 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.889 -1.125 . . . . 1.0 111.666 -178.196 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 2.4 p -134.32 108.61 11.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 106.833 -1.543 . . . . 1.0 106.833 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.568 ' O ' ' HD3' ' A' ' 174' ' ' ARG . 68.6 m-20 59.98 67.92 0.82 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.492 -1.67 . . . . 1.0 106.492 -176.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 35.34 28.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.473 -0.785 . . . . 1.0 111.633 -177.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.945 ' NE2' HG11 ' A' ' 31' ' ' VAL . 8.6 mt-30 -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.294 -0.879 . . . . 1.0 109.644 178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' CD2' ' A' ' 178' ' ' HIS . 18.3 tt0 -78.1 107.76 10.9 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.289 -0.882 . . . . 1.0 110.619 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.644 ' HB2' HG23 ' A' ' 170' ' ' VAL . 15.3 mt -90.0 85.24 6.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 1.0 110.53 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.577 ' CD2' ' OE2' ' A' ' 176' ' ' GLU . 1.8 m170 -56.96 114.42 2.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.164 -0.96 . . . . 1.0 110.066 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.975 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 3.6 mm? -59.3 -38.28 79.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.355 -0.841 . . . . 1.0 111.767 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.448 HG22 ' HE1' ' A' ' 191' ' ' HIS . 56.1 t -85.21 -39.62 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 113.196 0.813 . . . . 1.0 113.196 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 14.2 mt-10 -57.78 -49.51 76.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.463 -1.398 . . . . 1.0 110.913 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.562 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 31.9 m-20 -87.54 -19.01 28.49 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.461 -0.774 . . . . 1.0 110.928 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.975 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -60.57 -34.95 74.93 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.52 -1.272 . . . . 1.0 108.452 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 23.2 mt -50.83 -22.76 2.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.715 -0.615 . . . . 1.0 109.805 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -51.2 -22.47 2.66 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.172 -0.955 . . . . 1.0 108.894 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.517 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 2.0 t-20 -99.52 156.13 35.74 Favored Pre-proline 0 C--N 1.299 -1.592 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 39.0 Cg_endo -65.17 -56.49 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.238 1.125 . . . . 1.0 110.948 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.473 ' O ' HG13 ' A' ' 189' ' ' ILE . 5.8 t -103.11 146.49 28.3 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.594 -0.691 . . . . 1.0 110.375 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 188' ' ' THR . 2.9 mp -139.99 124.29 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.431 -0.793 . . . . 1.0 110.349 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.536 ' O ' HG23 ' A' ' 17' ' ' ILE . 20.8 mt -109.56 159.36 17.15 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 1.0 109.559 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.57 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -101.61 -81.68 0.48 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.832 -1.168 . . . . 1.0 111.075 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.6 OUTLIER -169.66 158.51 7.67 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.052 -1.03 . . . . 1.0 110.098 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 3.8 m -127.09 156.04 42.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.151 -0.968 . . . . 1.0 110.431 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -168.15 98.07 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.275 -0.891 . . . . 1.0 110.052 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.299 -1.59 0 C-N-CA 118.701 -1.199 . . . . 1.0 110.537 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.445 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.306 -1.518 . . . . 1.0 109.306 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER -55.06 -165.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -1.174 . . . . 1.0 110.162 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 4' ' ' LYS . 2.9 tt0 -162.78 -63.12 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.237 -0.914 . . . . 1.0 110.311 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' CB ' ' O ' ' A' ' 3' ' ' GLU . 7.0 tttt 66.75 139.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 1.0 110.241 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG22 ' H ' ' A' ' 5' ' ' VAL . 35.2 m -89.05 141.14 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 1.0 110.15 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 8' ' ' GLU . 0.9 OUTLIER -139.17 92.1 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.224 -0.922 . . . . 1.0 110.35 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.516 ' O ' HG22 ' A' ' 7' ' ' ILE . 1.7 mp -51.18 91.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.216 -0.928 . . . . 1.0 110.2 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 6' ' ' ILE . 13.1 tt0 -49.92 130.31 21.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.887 . . . . 1.0 110.173 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -112.02 144.02 42.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.897 . . . . 1.0 110.11 -179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -106.5 132.5 52.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 1.0 110.291 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.28 47.61 1.08 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.525 -0.735 . . . . 1.0 110.378 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.08 100.41 0.9 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.894 -1.282 . . . . 1.0 109.894 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -114.96 -30.88 6.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.254 -1.145 . . . . 1.0 109.67 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.52 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -140.0 60.34 1.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.403 -0.81 . . . . 1.0 109.614 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.595 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 3.0 pt-20 -60.3 71.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.574 -0.704 . . . . 1.0 110.661 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -81.21 158.85 24.73 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.22 -1.55 . . . . 1.0 110.481 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.82 HG21 ' CE ' ' A' ' 25' ' ' MET . 12.3 mm -119.78 116.45 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.092 -1.005 . . . . 1.0 110.224 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' A' ' 191' ' ' HIS . . . -81.12 122.73 27.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.418 -0.801 . . . . 1.0 110.537 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.74 ' CE1' HD12 ' A' ' 167' ' ' ILE . 3.0 m-85 -86.15 166.97 15.34 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.598 -0.89 . . . . 1.0 108.598 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 1.0 ' HA ' HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -127.37 3.07 6.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.84 -1.162 . . . . 1.0 111.083 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.484 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 99.88 -18.87 55.26 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.326 -1.51 . . . . 1.0 109.326 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 14.3 ttt180 -118.79 22.39 12.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.293 -1.122 . . . . 1.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.27 172.96 12.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 1.0 110.873 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.656 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -166.04 87.19 0.36 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.785 -1.191 . . . . 1.0 107.785 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.82 ' CE ' HG21 ' A' ' 17' ' ' ILE . 26.8 mtt -90.34 101.39 14.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.658 -1.276 . . . . 1.0 110.517 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.622 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 8.8 pt-20 -83.08 110.57 18.12 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.243 -0.91 . . . . 1.0 108.657 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.606 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 47.8 m-85 -100.95 99.24 9.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.975 -1.078 . . . . 1.0 110.387 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.461 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -93.14 103.35 15.64 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.278 -0.889 . . . . 1.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -94.96 164.58 12.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.087 -1.008 . . . . 1.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.3 94.36 9.72 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.283 -0.885 . . . . 1.0 110.405 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG21 HE22 ' A' ' 175' ' ' GLN . 0.0 OUTLIER -137.75 165.91 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.317 -0.864 . . . . 1.0 109.779 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.01 135.98 46.93 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.37 -0.831 . . . . 1.0 110.192 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -46.44 104.66 0.05 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.321 -0.862 . . . . 1.0 109.751 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 35' ' ' GLU . 6.8 p -77.73 6.68 6.95 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.298 -0.876 . . . . 1.0 110.545 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 34' ' ' SER . 1.3 tp10 71.13 1.69 3.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 1.0 110.165 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HB3' ' OG ' ' A' ' 34' ' ' SER . 18.7 pttt -83.73 152.41 24.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.126 -0.984 . . . . 1.0 109.62 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 135' ' ' LEU . . . -146.59 -78.35 0.17 Allowed 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.022 -1.049 . . . . 1.0 109.887 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.115 HD13 ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -74.5 144.76 43.99 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.384 -0.926 . . . . 1.0 109.406 179.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.68 ' N ' HD22 ' A' ' 38' ' ' LEU . 1.3 tt0 151.98 -90.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.935 -0.765 . . . . 1.0 108.935 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.567 ' OG ' HG13 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -169.92 157.91 6.96 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.154 -1.018 . . . . 1.0 112.302 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -130.12 139.22 50.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 1.0 109.886 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.517 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 71.1 m-70 -110.45 125.71 53.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.319 -0.863 . . . . 1.0 109.95 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.717 ' CD2' HG22 ' A' ' 172' ' ' VAL . 26.9 m-85 -140.16 119.34 12.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.921 . . . . 1.0 110.541 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.747 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -127.48 151.54 48.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.749 -1.22 . . . . 1.0 110.817 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.977 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 178.86 150.39 0.27 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.471 -0.768 . . . . 1.0 110.991 179.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 103' ' ' THR . 15.5 m -114.06 150.25 34.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.722 HG12 HD11 ' A' ' 97' ' ' ILE . 1.4 pt -144.38 153.3 15.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 C-N-CA 117.821 -1.552 . . . . 1.0 112.583 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.632 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.5 OUTLIER -109.82 83.07 1.69 Allowed 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.325 -2.102 . . . . 1.0 105.325 176.43 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.693 HG22 ' CE1' ' A' ' 163' ' ' PHE . 0.7 OUTLIER -73.65 148.06 43.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 122.266 1.031 . . . . 1.0 112.808 -175.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 164' ' ' ILE . 5.3 mm-40 -124.62 -18.49 5.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.711 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -128.85 130.3 46.71 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.729 -0.607 . . . . 1.0 109.677 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.727 HG22 ' CA ' ' A' ' 76' ' ' GLY . 1.9 p -60.92 -8.08 2.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.484 -0.76 . . . . 1.0 111.073 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -130.66 134.19 46.74 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.71 -1.244 . . . . 1.0 110.673 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 160.86 135.8 1.89 Allowed Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.203 -1.559 . . . . 1.0 109.203 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.208 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -92.99 127.33 38.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.632 -1.511 . . . . 1.0 109.291 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.746 HD11 HG13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -96.67 -27.05 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.555 -0.715 . . . . 1.0 112.408 -176.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.003 HD13 HD12 ' A' ' 71' ' ' LEU . 6.0 tt -144.28 146.18 32.46 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.246 -1.534 . . . . 1.0 112.58 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.871 ' CH2' HG21 ' A' ' 151' ' ' VAL . 5.4 t-105 -159.6 116.33 2.59 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.782 -0.574 . . . . 1.0 109.538 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.482 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 0.9 OUTLIER -116.47 120.47 38.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.085 -1.01 . . . . 1.0 110.316 -179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -93.09 164.47 27.34 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.603 ' HA ' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -119.07 -89.47 0.6 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -1.23 . . . . 1.0 110.899 -179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -96.38 145.01 17.64 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.828 -1.309 . . . . 1.0 109.828 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 tp 48.22 -165.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -1.135 . . . . 1.0 110.277 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -109.69 27.36 9.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.25 -0.906 . . . . 1.0 109.933 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -169.25 58.59 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 1.0 109.842 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.521 ' O ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -148.83 93.46 2.12 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.252 -0.979 . . . . 1.0 110.457 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.521 ' O ' ' O ' ' A' ' 66' ' ' SER . 1.6 t0 55.13 150.49 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.568 -0.707 . . . . 1.0 110.645 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 83' ' ' ASP . 2.4 p90 175.24 173.84 0.25 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 120.692 -1.255 . . . . 1.0 110.461 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.539 HG12 ' HB3' ' A' ' 82' ' ' TYR . 1.5 mt -132.32 167.47 26.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.151 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.805 ' HB3' ' HE2' ' A' ' 81' ' ' MET . . . -171.02 178.12 3.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.216 -0.927 . . . . 1.0 110.874 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.003 HD12 HD13 ' A' ' 57' ' ' LEU . 83.2 mt -146.66 129.88 16.58 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.181 -1.414 . . . . 1.0 107.181 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.591 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -150.77 165.11 34.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.833 -1.167 . . . . 1.0 112.559 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.746 HG13 HD11 ' A' ' 56' ' ' ILE . 5.9 mt -104.54 137.94 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.706 0.765 . . . . 1.0 110.654 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.847 HG11 ' OE1' ' A' ' 79' ' ' GLN . 2.3 p -139.87 118.63 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.738 -0.601 . . . . 1.0 110.097 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 2.2 m-20 67.26 3.65 3.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.309 -0.869 . . . . 1.0 111.235 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.915 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 113.97 4.17 22.78 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.641 -1.266 . . . . 1.0 110.343 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 31.7 m-85 -131.41 126.67 35.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.053 -1.263 . . . . 1.0 109.701 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.722 HG13 ' N ' ' A' ' 79' ' ' GLN . 0.4 OUTLIER -59.43 -173.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.929 -1.107 . . . . 1.0 110.461 -179.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.847 ' OE1' HG11 ' A' ' 74' ' ' VAL . 9.0 pt20 -176.33 101.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.019 0.914 . . . . 1.0 110.133 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.918 ' HG2' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -78.47 126.01 30.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.845 -0.798 . . . . 1.0 108.845 179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.805 ' HE2' ' HB3' ' A' ' 70' ' ' ALA . 5.0 ptt? -122.8 146.48 47.5 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.284 -0.966 . . . . 1.0 111.106 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.939 ' CZ ' HG11 ' A' ' 89' ' ' VAL . 4.3 p90 -129.77 120.56 25.25 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 117.888 -1.525 . . . . 1.0 110.519 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.572 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . 12.7 t70 -94.05 47.4 1.21 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.313 0.578 . . . . 1.0 110.568 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.046 ' HB3' HD13 ' A' ' 135' ' ' LEU . 0.5 OUTLIER -62.83 -10.8 14.46 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.32 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -144.44 41.55 1.09 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.959 -1.257 . . . . 1.0 109.959 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.562 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 77.49 -35.28 0.21 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.5 -1.0 . . . . 1.0 111.516 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -102.51 103.84 34.32 Favored Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 120.767 -1.208 . . . . 1.0 110.362 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.522 ' HG2' ' HD2' ' A' ' 154' ' ' LYS . 51.6 Cg_endo -74.46 116.78 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.191 1.627 . . . . 1.0 111.234 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.939 HG11 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -71.91 172.06 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 178.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.669 ' O ' HG12 ' A' ' 90' ' ' VAL . 1.2 t -144.27 107.09 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.635 177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.721 HD22 ' N ' ' A' ' 91' ' ' LEU . 3.0 mm? -95.23 90.11 5.74 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.293 -1.743 . . . . 1.0 106.293 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.904 ' O ' HD13 ' A' ' 124' ' ' ILE . 30.7 mtp180 -73.22 154.09 40.38 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.988 -1.085 . . . . 1.0 110.271 -178.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.3 t -68.62 143.6 54.77 Favored 'General case' 0 C--N 1.288 -2.075 0 O-C-N 120.986 -1.071 . . . . 1.0 109.925 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.848 ' HB ' HD12 ' A' ' 124' ' ' ILE . 4.7 t -94.25 21.09 7.32 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.756 -1.215 . . . . 1.0 110.035 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.964 HG21 HG11 ' A' ' 118' ' ' VAL . 19.6 t -135.16 149.08 69.07 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.222 -0.924 . . . . 1.0 109.956 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.586 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 40.6 Cg_endo -66.53 134.39 35.43 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.681 1.358 . . . . 1.0 110.123 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.915 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.8 tt -125.15 -26.36 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 1.0 110.627 -179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.436 ' OD1' ' O ' ' A' ' 98' ' ' ASN . 8.7 p30 -70.73 58.79 0.21 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.212 -0.93 . . . . 1.0 110.475 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.846 HG23 ' HB2' ' A' ' 101' ' ' HIS . 7.8 t -130.91 22.31 4.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.339 -0.851 . . . . 1.0 109.956 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.6 m120 56.84 24.79 9.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.107 -0.996 . . . . 1.0 110.733 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.846 ' HB2' HG23 ' A' ' 99' ' ' THR . 15.2 m80 -113.23 152.97 29.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.053 -1.03 . . . . 1.0 110.035 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.632 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 15.6 m95 -74.54 97.21 3.08 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.095 -1.003 . . . . 1.0 109.93 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.564 HG21 HD12 ' A' ' 97' ' ' ILE . 24.7 m -93.1 141.41 28.44 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.203 -0.999 . . . . 1.0 108.713 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.479 ' O ' ' N ' ' A' ' 119' ' ' GLY . 25.5 t60 -98.49 142.49 30.04 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 119.425 -0.91 . . . . 1.0 108.566 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.656 HG22 HD11 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -140.78 156.89 23.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.964 -1.085 . . . . 1.0 110.218 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.707 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -149.21 128.62 13.0 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.426 -0.796 . . . . 1.0 110.016 -179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -115.25 102.57 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.208 -0.933 . . . . 1.0 110.979 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 108' ' ' TYR . 2.9 p90 -117.38 109.4 16.75 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.075 -1.015 . . . . 1.0 109.381 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.638 ' HG3' ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -103.49 142.86 33.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.35 -0.844 . . . . 1.0 110.848 -178.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.591 ' N ' ' HD2' ' A' ' 109' ' ' ARG . 1.5 t -127.91 122.46 58.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.466 -0.771 . . . . 1.0 109.569 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 113' ' ' GLU . 23.1 mt-30 37.83 87.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 1.0 111.037 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 127' ' ' SER . 11.4 mmt85 65.34 -56.17 0.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.356 -0.84 . . . . 1.0 111.738 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.594 ' N ' ' HB3' ' A' ' 127' ' ' SER . 0.0 OUTLIER -67.1 114.72 6.09 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.945 0.878 . . . . 1.0 111.794 -176.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -100.25 159.19 19.39 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.575 -1.01 . . . . 1.0 110.575 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.62 ' O ' ' CE ' ' A' ' 80' ' ' MET . 12.5 t -141.04 148.84 40.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.527 -0.984 . . . . 1.0 109.925 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.918 HD23 ' HG2' ' A' ' 80' ' ' MET . 1.0 OUTLIER -145.81 131.15 18.58 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.036 -1.04 . . . . 1.0 110.042 -178.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.853 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -135.37 145.3 47.21 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.937 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.964 HG11 HG21 ' A' ' 95' ' ' VAL . 0.3 OUTLIER -89.81 113.68 26.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 52.14 46.09 56.73 Favored Glycine 0 C--N 1.284 -2.334 0 N-CA-C 109.327 -1.509 . . . . 1.0 109.327 -178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.6 OUTLIER 65.43 43.44 3.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.355 -1.085 . . . . 1.0 111.38 179.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.534 ' HB2' HG12 ' A' ' 118' ' ' VAL . 2.2 mt-10 -105.5 -162.14 0.85 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.251 -0.905 . . . . 1.0 110.643 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.782 ' HB3' HG21 ' A' ' 94' ' ' THR . . . -49.92 115.87 5.68 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.237 -0.915 . . . . 1.0 109.558 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.545 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 46.2 Cg_endo -73.57 119.08 5.75 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.879 1.462 . . . . 1.0 111.672 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.904 HD13 ' O ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -86.32 118.39 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 106.188 -1.782 . . . . 1.0 106.188 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.686 ' HA ' HD12 ' A' ' 91' ' ' LEU . 12.3 p -126.73 171.65 11.01 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.606 -1.237 . . . . 1.0 113.628 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.512 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 169.51 153.62 8.62 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 106.513 -2.635 . . . . 1.0 106.513 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.594 ' HB3' ' N ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -119.71 163.48 17.36 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.607 -1.525 . . . . 1.0 111.028 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.51 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.2 OUTLIER -67.64 -176.85 0.28 Allowed Pre-proline 0 C--N 1.3 -1.579 0 C-N-CA 119.906 -0.717 . . . . 1.0 109.207 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 131' ' ' GLY . 48.1 Cg_endo -74.59 42.44 0.8 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 O-C-N 123.548 1.288 . . . . 1.0 110.24 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER 34.63 32.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.841 0.829 . . . . 1.0 109.991 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 129' ' ' PRO . . . -131.9 106.75 0.68 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.958 -1.257 . . . . 1.0 109.958 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 133' ' ' THR . . . 178.17 -54.91 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.5 -1.0 . . . . 1.0 109.88 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 132' ' ' ALA . 7.4 t 39.73 29.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.462 -0.773 . . . . 1.0 111.027 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -161.58 111.97 1.65 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.056 -1.028 . . . . 1.0 110.714 179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.046 HD13 ' HB3' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -166.73 135.32 2.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.475 -0.766 . . . . 1.0 109.369 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 135' ' ' LEU . 14.2 m-20 -140.47 179.58 6.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.331 -0.856 . . . . 1.0 109.415 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 4.8 t -115.41 132.62 56.56 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.052 -1.03 . . . . 1.0 109.883 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 1.057 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 7.9 p-10 -78.77 13.33 1.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 1.0 110.44 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 54.69 18.38 10.83 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 108.283 -1.927 . . . . 1.0 108.283 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 1.057 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -136.47 170.34 16.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.443 -1.034 . . . . 1.0 109.937 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.903 ' CD1' HD21 ' A' ' 57' ' ' LEU . 12.3 tp -160.83 155.51 23.73 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.284 -0.885 . . . . 1.0 110.702 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.649 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 9.9 m95 -131.32 136.76 48.4 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.376 -1.342 . . . . 1.0 107.376 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.662 HD12 ' CB ' ' A' ' 57' ' ' LEU . 5.1 tp -140.97 123.74 16.15 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 117.593 -1.643 . . . . 1.0 113.321 -177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.32 1.05 12.63 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 110.098 -1.201 . . . . 1.0 110.098 177.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 144.05 -129.02 3.48 Favored Glycine 0 C--N 1.288 -2.127 0 N-CA-C 108.902 -1.679 . . . . 1.0 108.902 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 1.097 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -171.2 126.63 0.67 Allowed 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.358 -0.937 . . . . 1.0 111.747 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 -12.69 27.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.359 -0.838 . . . . 1.0 108.872 177.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.578 ' N ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -152.73 61.59 0.8 Allowed 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.723 -1.214 . . . . 1.0 107.723 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.097 HD13 ' HB2' ' A' ' 146' ' ' MET . 10.0 tp -64.39 44.33 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.386 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 148' ' ' ARG . 83.7 p -55.0 -28.83 55.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 105.468 -2.049 . . . . 1.0 105.468 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.871 HG21 ' CH2' ' A' ' 58' ' ' TRP 0.29 6.2 p -62.76 -135.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 114.414 -1.267 . . . . 1.0 108.137 177.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.808 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 54.56 18.06 1.87 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.936 -1.102 . . . . 1.0 110.861 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.67 -79.58 0.18 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.942 -1.099 . . . . 1.0 112.928 -177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.522 ' HD2' ' HG2' ' A' ' 88' ' ' PRO . 0.0 OUTLIER -52.03 -14.04 0.37 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.002 -1.061 . . . . 1.0 112.234 -177.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.73 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.6 pp -99.61 168.75 9.06 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.842 -1.162 . . . . 1.0 110.337 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 43.6 Cg_endo -68.33 -176.73 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.55 1.29 . . . . 1.0 113.228 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -62.05 -13.95 31.29 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.977 -0.556 . . . . 1.0 112.27 -178.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.473 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . -41.13 -35.12 0.53 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.96 -1.087 . . . . 1.0 109.579 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 1.208 ' CE2' HD13 ' A' ' 55' ' ' LEU . 5.4 m-85 -83.94 -30.12 26.54 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.32 -0.952 . . . . 1.0 109.766 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -68.67 -8.9 46.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.796 -1.162 . . . . 1.0 108.895 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -128.8 86.43 2.44 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.504 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -39.63 164.31 0.01 OUTLIER Glycine 0 N--CA 1.497 2.737 0 N-CA-C 110.212 -1.155 . . . . 1.0 110.212 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.693 ' CE1' HG22 ' A' ' 49' ' ' THR . 35.9 t80 -79.14 144.03 34.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.027 -1.278 . . . . 1.0 111.396 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 1.0 HG23 ' HA ' ' A' ' 20' ' ' ASP . 2.9 mt -128.98 68.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.597 -0.89 . . . . 1.0 108.597 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.644 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -148.83 -162.62 10.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 107.913 -2.075 . . . . 1.0 107.913 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.504 ' C ' HG13 ' A' ' 167' ' ' ILE . 13.4 m -118.97 148.05 43.4 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.405 -1.644 . . . . 1.0 111.138 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.74 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -131.95 151.14 34.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.651 -0.656 . . . . 1.0 109.504 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.55 ' NH2' HD13 ' A' ' 179' ' ' LEU . 0.0 OUTLIER -161.6 151.75 17.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 1.0 110.178 -178.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.538 ' N ' ' HD3' ' A' ' 168' ' ' ARG . 36.1 m-20 56.44 75.93 0.32 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.455 -0.778 . . . . 1.0 109.972 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.977 HG12 ' CB ' ' A' ' 45' ' ' LEU . 26.9 m -128.32 122.45 57.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 C-N-CA 119.699 -0.801 . . . . 1.0 109.559 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.493 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.6 OUTLIER -132.73 156.59 42.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.459 -0.896 . . . . 1.0 111.124 -178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.717 HG22 ' CD2' ' A' ' 43' ' ' PHE . 6.6 t -134.35 104.65 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.7 OUTLIER 50.31 40.66 23.05 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.455 -1.403 . . . . 1.0 107.477 -177.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.4 OUTLIER 72.7 27.68 2.23 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.054 -179.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.524 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 29.0 mt-30 -103.08 177.66 4.78 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.039 -1.038 . . . . 1.0 110.703 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 6.0 tt0 66.12 -105.36 0.1 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.826 -0.547 . . . . 1.0 110.923 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 67.01 -58.11 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.301 -0.874 . . . . 1.0 111.232 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.576 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.3 m-70 -80.34 73.73 7.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.763 -1.21 . . . . 1.0 110.135 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.667 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 3.6 mt -49.8 -58.85 4.55 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.152 0.977 . . . . 1.0 112.217 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.587 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 30.1 t -74.39 -19.45 17.04 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.576 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.5 mt-10 -67.55 -62.26 1.5 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.351 -1.468 . . . . 1.0 110.002 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -71.84 -19.61 61.95 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 1.0 109.2 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.667 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -68.44 -27.42 66.16 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.508 -0.877 . . . . 1.0 108.81 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.508 HD23 ' HA ' ' A' ' 184' ' ' LEU . 10.5 mt -57.66 -16.46 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.433 -0.792 . . . . 1.0 109.178 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -57.97 -14.61 6.71 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.496 -0.752 . . . . 1.0 109.699 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.54 ' O ' HD11 ' A' ' 189' ' ' ILE . 13.0 t30 -127.42 148.88 68.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.52 -0.737 . . . . 1.0 109.1 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.451 ' O ' HG13 ' A' ' 189' ' ' ILE . 46.9 Cg_endo -73.63 -44.81 0.46 Allowed 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.701 1.369 . . . . 1.0 110.81 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.07 103.1 0.7 Allowed 'General case' 0 C--N 1.29 -2.0 0 CA-C-O 121.637 0.732 . . . . 1.0 110.639 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.54 HD11 ' O ' ' A' ' 186' ' ' ASN . 6.5 mt -144.46 98.68 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.888 -0.782 . . . . 1.0 108.888 179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 18' ' ' ALA . 33.9 mt -111.92 152.6 27.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -0.889 . . . . 1.0 110.81 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.537 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 8.1 m-70 -95.84 -174.61 3.18 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.469 -0.769 . . . . 1.0 110.171 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 2.0 t -102.16 153.53 19.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 1.0 110.476 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 42.4 m -128.97 166.7 18.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.332 -0.855 . . . . 1.0 109.808 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -170.71 98.41 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.968 . . . . 1.0 110.482 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.297 -1.699 0 C-N-CA 118.82 -1.152 . . . . 1.0 110.464 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.9 92.01 2.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -1.133 . . . . 1.0 110.071 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -73.72 66.38 1.08 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 1.0 110.183 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -145.73 36.1 1.05 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 1.0 110.059 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.726 ' O ' HG13 ' A' ' 5' ' ' VAL . 12.0 p -129.08 112.05 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 1.0 110.332 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 6' ' ' ILE . 3.6 tt -135.44 137.57 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.85 . . . . 1.0 110.0 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.434 HG13 ' N ' ' A' ' 8' ' ' GLU . 5.4 tp -128.98 154.8 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.183 -0.948 . . . . 1.0 110.21 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.434 ' N ' HG13 ' A' ' 7' ' ' ILE . 5.5 tt0 -92.96 121.29 34.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.917 . . . . 1.0 110.074 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 9.6 mmtm -49.57 97.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.354 -0.841 . . . . 1.0 110.247 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.25 139.91 58.11 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.198 -0.939 . . . . 1.0 109.971 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.57 55.23 2.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.478 -0.764 . . . . 1.0 110.47 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.37 100.41 2.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.479 -1.448 . . . . 1.0 109.479 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -137.42 -77.96 0.39 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -1.146 . . . . 1.0 110.315 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . 52.34 50.55 18.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.145 -0.972 . . . . 1.0 109.929 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.581 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.5 pt-20 -59.81 72.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.749 . . . . 1.0 110.858 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -68.35 158.22 33.98 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 120.136 -1.603 . . . . 1.0 109.487 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.012 HG21 ' CE ' ' A' ' 25' ' ' MET . 17.3 mm -136.92 108.96 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.027 -1.046 . . . . 1.0 110.579 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 190' ' ' LEU . . . -78.82 138.4 38.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.514 -0.741 . . . . 1.0 110.234 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.781 ' CE1' HD12 ' A' ' 167' ' ' ILE . 3.7 m-85 -104.16 175.36 5.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.152 -0.967 . . . . 1.0 109.633 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD2' ' OG1' ' A' ' 23' ' ' THR . 1.9 p30 -128.37 -14.43 4.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 1.0 111.084 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 115.51 -13.84 18.11 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.909 -1.677 . . . . 1.0 108.909 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.91 15.11 4.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.44 -1.035 . . . . 1.0 109.109 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.478 HG22 ' H ' ' A' ' 24' ' ' TYR . 3.1 m -75.63 174.65 9.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.596 -0.69 . . . . 1.0 110.185 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.548 ' OH ' ' N ' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -147.62 103.67 3.55 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.526 -0.734 . . . . 1.0 110.366 -179.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 1.012 ' CE ' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -99.35 101.53 12.85 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.774 -1.204 . . . . 1.0 109.186 179.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.513 ' HG2' ' CE3' ' A' ' 142' ' ' TRP . 14.9 mt-10 -95.88 136.72 35.94 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.436 -0.79 . . . . 1.0 109.485 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.599 ' CE2' ' HG3' ' A' ' 25' ' ' MET . 69.8 m-85 -131.29 99.05 4.72 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.216 -0.994 . . . . 1.0 110.475 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -101.45 118.69 37.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.229 -0.92 . . . . 1.0 110.215 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.464 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 12.1 t-20 -140.44 156.73 46.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 1.0 110.226 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -98.67 149.14 23.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.961 . . . . 1.0 110.142 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -110.95 -95.85 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.247 -0.908 . . . . 1.0 109.907 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -144.86 107.19 4.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.997 -1.064 . . . . 1.0 110.553 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -65.9 89.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.209 -0.932 . . . . 1.0 110.083 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.16 -36.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -0.832 . . . . 1.0 109.329 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -148.47 -36.14 0.19 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.533 -0.729 . . . . 1.0 109.965 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.589 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 18.8 mtmt 43.42 54.24 5.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 1.0 110.036 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . 175.43 134.96 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.334 -0.854 . . . . 1.0 109.986 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.558 ' O ' ' CG ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -138.51 53.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.015 -1.053 . . . . 1.0 110.048 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.558 ' CG ' ' O ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER 54.68 3.82 0.06 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.818 0.673 . . . . 1.0 112.818 179.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -171.07 167.87 7.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.252 -1.53 . . . . 1.0 111.38 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.2 OUTLIER -138.79 116.04 11.1 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.689 ' O ' HG23 ' A' ' 172' ' ' VAL . 0.3 OUTLIER -89.96 143.67 26.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.118 -0.989 . . . . 1.0 110.956 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.657 ' CE1' HG21 ' A' ' 172' ' ' VAL . 51.2 m-85 -138.17 106.85 5.89 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.637 -0.664 . . . . 1.0 110.074 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.57 ' C ' HD23 ' A' ' 45' ' ' LEU . 3.5 mt-10 -114.78 145.82 41.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.98 -1.075 . . . . 1.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.81 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -179.45 152.61 0.53 Allowed 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.529 -0.868 . . . . 1.0 111.244 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 103' ' ' THR . 1.5 m -118.52 152.71 35.46 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.48 HD13 HD11 ' A' ' 105' ' ' ILE . 2.2 pt -148.34 157.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 117.897 -1.521 . . . . 1.0 112.152 -178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.616 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 2.5 tttt -113.15 84.3 1.98 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.58 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -67.31 147.25 53.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.045 -1.034 . . . . 1.0 111.193 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.753 ' HB2' HG22 ' A' ' 164' ' ' ILE . 2.3 mm-40 -129.34 6.79 5.33 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.808 -0.757 . . . . 1.0 111.0 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.862 ' O ' HG23 ' A' ' 52' ' ' THR . . . -134.77 -85.97 0.4 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.91 -1.119 . . . . 1.0 110.624 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.001 HG22 ' CA ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER 155.98 -25.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.457 -0.942 . . . . 1.0 108.457 -179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.4 OUTLIER -124.88 139.03 54.2 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.716 -0.615 . . . . 1.0 109.419 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 158.67 135.88 1.96 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.436 -1.364 . . . . 1.0 110.177 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.76 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -85.33 121.53 28.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -1.188 . . . . 1.0 108.963 179.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.827 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -96.66 -29.25 3.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.782 -0.574 . . . . 1.0 112.482 -176.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.086 HD13 HD12 ' A' ' 71' ' ' LEU . 6.4 tt -147.73 152.9 38.54 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.39 -1.444 . . . . 1.0 113.145 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.958 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 4.2 t-105 -162.61 107.26 1.14 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.647 -0.706 . . . . 1.0 110.589 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.51 149.6 42.16 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.13 -0.981 . . . . 1.0 108.784 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 62' ' ' GLY . . . -138.01 39.05 1.64 Allowed Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.313 -1.422 . . . . 1.0 110.846 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 60' ' ' GLY . 6.7 ttpp 44.38 24.7 0.1 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.907 -1.349 . . . . 1.0 110.293 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.491 ' N ' ' OD2' ' A' ' 138' ' ' ASP . . . 99.4 -139.03 14.21 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.256 -1.538 . . . . 1.0 109.256 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 57.14 -179.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.17 -1.194 . . . . 1.0 110.67 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 65' ' ' ARG . 12.0 pt-20 -133.95 35.8 3.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 1.0 110.573 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -179.89 32.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.147 -0.971 . . . . 1.0 109.625 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.43 152.36 30.17 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 119.401 -0.919 . . . . 1.0 111.492 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.559 ' HB2' ' HB3' ' A' ' 83' ' ' ASP . 70.9 m-20 -96.56 -80.71 0.43 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.402 -0.811 . . . . 1.0 109.364 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.591 ' CZ ' ' O ' ' A' ' 84' ' ' LEU . 10.1 m-85 60.17 -59.34 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.259 -0.9 . . . . 1.0 113.159 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' A' ' 67' ' ' ASP . 5.5 mm -148.01 153.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.839 -1.788 . . . . 1.0 113.566 -177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.737 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -177.69 166.58 2.15 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.153 -1.055 . . . . 1.0 108.153 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.086 HD12 HD13 ' A' ' 57' ' ' LEU . 93.4 mt -150.72 99.83 2.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.445 -1.41 . . . . 1.0 109.945 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.581 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -114.06 175.09 5.62 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.306 -0.871 . . . . 1.0 111.837 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.949 HG12 HG13 ' A' ' 78' ' ' VAL . 20.4 mt -115.34 138.3 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.827 -0.546 . . . . 1.0 110.056 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.509 HG11 ' NH2' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -141.23 125.3 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 1.0 110.516 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 5.9 m-20 62.77 33.98 14.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.335 -0.853 . . . . 1.0 111.739 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 1.001 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 81.43 8.08 87.52 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.741 -1.219 . . . . 1.0 110.41 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.431 ' O ' ' N ' ' A' ' 74' ' ' VAL . 46.3 m-85 -129.36 165.89 20.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.037 -1.272 . . . . 1.0 109.382 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.949 HG13 HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -116.05 164.06 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 1.0 110.679 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.552 ' OE1' HG21 ' A' ' 90' ' ' VAL . 6.9 pt20 -149.66 133.3 16.77 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.565 -0.854 . . . . 1.0 111.432 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.971 ' CE ' HD12 ' A' ' 91' ' ' LEU . 6.7 tmm? -99.24 120.12 39.02 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.737 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 7.3 ptt? -120.24 143.54 48.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.87 -1.144 . . . . 1.0 111.569 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.887 ' CZ ' HG11 ' A' ' 89' ' ' VAL . 19.6 p90 -139.85 129.03 23.81 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 118.531 -1.268 . . . . 1.0 110.905 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 67' ' ' ASP . 66.7 t0 -120.45 60.82 0.88 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.232 1.015 . . . . 1.0 109.378 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.642 HD21 ' CD1' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -38.35 -35.65 0.19 Allowed 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.405 -0.816 . . . . 1.0 110.705 -179.062 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.28 -54.77 0.1 Allowed Glycine 0 N--CA 1.494 2.535 0 C-N-CA 119.527 -1.32 . . . . 1.0 110.887 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.554 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 3.4 t -163.28 -22.84 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.832 -1.393 . . . . 1.0 112.269 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.522 ' HD2' ' HG3' ' A' ' 129' ' ' PRO . 4.7 mmtp -98.86 100.58 10.02 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.66 -1.275 . . . . 1.0 110.21 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 86' ' ' SER . 47.0 Cg_endo -72.5 141.96 35.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.926 1.487 . . . . 1.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.887 HG11 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -114.97 126.12 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.219 -1.03 . . . . 1.0 108.219 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.552 HG21 ' OE1' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -103.93 120.54 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 117.802 -1.559 . . . . 1.0 110.328 178.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.971 HD12 ' CE ' ' A' ' 80' ' ' MET . 33.3 mt -113.09 71.94 0.76 Allowed 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.883 -1.154 . . . . 1.0 107.883 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.687 ' O ' HG21 ' A' ' 124' ' ' ILE . 2.9 mtt180 -58.7 179.16 0.09 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 122.138 0.971 . . . . 1.0 110.822 -178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.558 ' HA ' HD13 ' A' ' 124' ' ' ILE . 1.6 t -105.82 155.77 18.98 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.721 -0.612 . . . . 1.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.804 ' HB ' HD11 ' A' ' 124' ' ' ILE . 15.2 t -111.19 26.87 10.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.102 -0.999 . . . . 1.0 109.912 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.802 ' CB ' HG11 ' A' ' 118' ' ' VAL . 8.3 t -133.77 147.38 64.11 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.445 -0.785 . . . . 1.0 109.62 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.547 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.7 Cg_endo -67.47 138.32 45.69 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.629 1.331 . . . . 1.0 110.554 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.79 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -126.91 -30.26 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 1.0 110.686 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.462 HD22 HG23 ' A' ' 52' ' ' THR . 31.2 p-10 -72.54 62.65 0.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.92 -1.113 . . . . 1.0 110.52 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 101' ' ' HIS . 15.2 t -124.86 13.18 8.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.348 -0.845 . . . . 1.0 109.868 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.474 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 0.7 OUTLIER 62.95 10.6 4.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.239 -0.913 . . . . 1.0 111.236 179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.47 ' H ' HG23 ' A' ' 99' ' ' THR . 2.6 m-70 -102.51 175.15 5.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.87 -1.143 . . . . 1.0 110.288 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.616 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 27.0 m95 -92.95 105.84 17.89 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.261 -0.9 . . . . 1.0 110.074 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.593 HG22 ' N ' ' A' ' 104' ' ' HIS . 47.4 m -99.31 171.06 8.22 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.274 -0.891 . . . . 1.0 109.597 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.593 ' N ' HG22 ' A' ' 103' ' ' THR . 12.0 t-80 -125.02 130.18 51.81 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.085 -1.009 . . . . 1.0 108.423 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 47' ' ' ILE . 1.9 mt -123.46 159.6 27.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.128 -0.982 . . . . 1.0 110.123 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.882 ' O ' HD22 ' A' ' 116' ' ' LEU . 1.8 tppt? -149.84 147.99 28.63 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.184 -1.006 . . . . 1.0 110.039 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -151.52 108.3 3.51 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.604 -0.685 . . . . 1.0 109.954 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.593 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 20.0 p90 -120.88 105.39 10.65 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.05 -1.06 . . . . 1.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.622 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 3.8 ttp180 -72.17 123.84 23.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.575 -0.703 . . . . 1.0 110.006 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 111' ' ' GLN . 3.6 t -110.08 88.51 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.076 -1.015 . . . . 1.0 109.692 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.574 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 0.0 OUTLIER 35.4 103.75 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 121.144 0.497 . . . . 1.0 110.934 -179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.574 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER 66.1 -53.71 0.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.286 -0.884 . . . . 1.0 110.235 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.591 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.6 tt0 -87.08 120.88 28.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.756 -1.215 . . . . 1.0 110.811 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.622 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -113.28 161.83 12.56 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.929 -1.129 . . . . 1.0 110.733 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.593 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 15.5 t -136.43 162.11 33.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.307 -1.114 . . . . 1.0 111.174 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.008 HD13 ' N ' ' A' ' 117' ' ' GLN . 1.4 tm? -147.4 139.15 24.11 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 1.008 ' N ' HD13 ' A' ' 116' ' ' LEU . 3.6 mt-30 -142.83 146.26 33.99 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 118.686 -1.205 . . . . 1.0 111.67 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.802 HG11 ' CB ' ' A' ' 95' ' ' VAL . 1.8 t -104.19 101.69 12.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.498 -1.667 . . . . 1.0 106.498 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 70.65 33.5 67.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.717 -1.753 . . . . 1.0 108.717 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.27 38.07 26.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.518 -0.99 . . . . 1.0 110.312 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -108.77 -156.97 0.6 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.66 -0.65 . . . . 1.0 110.826 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -37.91 99.66 0.19 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.709 -0.62 . . . . 1.0 109.8 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.59 ' HB3' ' CG ' ' A' ' 117' ' ' GLN . 48.5 Cg_endo -73.23 131.36 16.42 Favored 'Trans proline' 0 C--N 1.299 -2.055 0 O-C-N 124.314 1.691 . . . . 1.0 112.009 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.804 HD11 ' HB ' ' A' ' 94' ' ' THR . 0.4 OUTLIER -97.19 101.96 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 105.967 -1.864 . . . . 1.0 105.967 176.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.43 HG22 ' CB ' ' A' ' 115' ' ' SER . 61.4 p -107.07 170.6 7.85 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 122.154 0.978 . . . . 1.0 112.023 -176.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.66 157.6 18.89 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 107.644 -2.183 . . . . 1.0 107.644 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.591 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -133.63 162.66 31.32 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.866 -1.373 . . . . 1.0 110.275 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.505 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 5.0 p -90.08 172.18 7.46 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 1.0 109.452 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.522 ' HG3' ' HD2' ' A' ' 87' ' ' LYS . 51.6 Cg_endo -80.82 36.58 0.63 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.728 1.383 . . . . 1.0 109.133 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.422 HD12 ' NH1' ' A' ' 112' ' ' ARG . 1.5 mt 43.8 -162.91 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.27 0 O-C-N 121.5 -0.75 . . . . 1.0 110.307 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 103.02 -29.69 11.95 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.444 -1.462 . . . . 1.0 109.444 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.54 -142.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.438 -1.036 . . . . 1.0 109.747 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -154.4 97.61 2.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.005 . . . . 1.0 110.281 179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 133' ' ' THR . 1.3 tt0 43.76 -158.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.93 . . . . 1.0 110.131 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.607 ' O ' HD23 ' A' ' 135' ' ' LEU . 0.3 OUTLIER -160.31 104.08 1.45 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.325 -0.859 . . . . 1.0 110.348 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.8 OUTLIER -92.55 176.5 6.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.301 -0.874 . . . . 1.0 109.514 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 t -138.15 136.58 36.82 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.891 -1.131 . . . . 1.0 110.055 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.75 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 44.9 p-10 -89.06 22.78 2.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -0.836 . . . . 1.0 109.457 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 29' ' ' ASN . . . 52.52 18.15 5.02 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.943 -1.663 . . . . 1.0 108.943 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.75 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -109.63 150.18 28.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -1.188 . . . . 1.0 109.273 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.925 HD11 ' CG ' ' A' ' 57' ' ' LEU . 7.4 tp -160.66 156.35 25.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.851 -1.156 . . . . 1.0 111.122 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.536 ' N ' ' HG ' ' A' ' 141' ' ' LEU . 76.5 m95 -131.7 105.43 7.5 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.919 -1.512 . . . . 1.0 106.919 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.838 HD13 HD12 ' A' ' 57' ' ' LEU . 3.6 tp -116.95 116.42 27.37 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.24 -1.384 . . . . 1.0 113.602 -176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 132.29 -1.04 4.86 Favored Glycine 0 N--CA 1.48 1.633 0 C-N-CA 119.668 -1.253 . . . . 1.0 110.638 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.536 ' O ' ' SD ' ' A' ' 146' ' ' MET . . . 154.37 -154.95 25.87 Favored Glycine 0 C--N 1.289 -2.051 0 C-N-CA 117.956 -2.069 . . . . 1.0 109.731 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.955 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -154.05 139.38 17.61 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.254 -0.978 . . . . 1.0 112.941 -178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.548 ' N ' ' OH ' ' A' ' 24' ' ' TYR . 40.9 tt0 -68.43 -50.91 49.28 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.582 0.706 . . . . 1.0 109.665 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.498 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -116.15 69.8 0.75 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.541 -1.281 . . . . 1.0 107.541 178.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.955 HD13 ' CB ' ' A' ' 146' ' ' MET . 0.1 OUTLIER -65.33 49.52 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.439 -0.788 . . . . 1.0 112.976 -177.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 148' ' ' ARG . 88.0 p -83.34 -10.08 58.69 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.975 -1.861 . . . . 1.0 105.975 175.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.958 HG21 ' CZ3' ' A' ' 58' ' ' TRP . 4.9 p -79.86 -107.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 115.227 -0.897 . . . . 1.0 110.336 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.797 ' HB1' ' O ' ' A' ' 155' ' ' LEU . . . 53.18 38.17 26.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.326 -1.484 . . . . 1.0 108.546 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.488 ' NE2' ' CG ' ' A' ' 67' ' ' ASP . 59.8 m170 3.92 -95.07 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 114.771 1.397 . . . . 1.0 114.771 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.463 ' CE ' ' HB ' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -98.31 26.59 5.29 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.333 -0.854 . . . . 1.0 112.739 -176.535 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 1.007 HD11 ' HB3' ' A' ' 158' ' ' ALA . 0.1 OUTLIER -156.55 131.81 5.46 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 120.649 -1.282 . . . . 1.0 110.031 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.59 ' N ' HD12 ' A' ' 155' ' ' LEU . 55.1 Cg_endo -92.14 -66.38 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.793 1.418 . . . . 1.0 113.747 -178.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.657 ' HA ' ' CB ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.49 -56.9 15.43 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 114.403 1.26 . . . . 1.0 114.403 -176.062 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 1.007 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -41.38 -41.23 1.93 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.44 -1.413 . . . . 1.0 108.103 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.799 ' HD2' HD11 ' A' ' 149' ' ' LEU . 21.8 m-85 -83.27 -32.13 26.57 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 118.957 -1.097 . . . . 1.0 108.141 177.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.657 ' CB ' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -67.71 -10.51 53.15 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.107 -1.037 . . . . 1.0 109.079 178.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.499 ' O ' ' HA2' ' A' ' 54' ' ' GLY . 1.4 m -129.56 99.33 5.13 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.442 -0.947 . . . . 1.0 108.442 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 21' ' ' GLY . . . -49.76 -178.27 0.02 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.015 -1.234 . . . . 1.0 110.015 -178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.655 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 19.3 t80 -79.76 148.19 31.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.202 -1.175 . . . . 1.0 112.49 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.753 HG22 ' HB2' ' A' ' 50' ' ' GLU . 3.8 mt -124.94 82.32 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 107.917 -1.142 . . . . 1.0 107.917 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.655 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.48 -163.49 26.4 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.533 -1.827 . . . . 1.0 108.533 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 24.1 m -122.88 151.02 42.14 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.012 -1.287 . . . . 1.0 110.431 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.781 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -127.35 152.37 35.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 109.008 -0.738 . . . . 1.0 109.008 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.46 ' NH1' ' OD2' ' A' ' 169' ' ' ASP . 13.9 ttt-85 -159.09 148.37 18.64 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.049 -1.06 . . . . 1.0 110.721 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 93.6 m-20 52.5 84.52 0.05 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.877 -0.729 . . . . 1.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.81 HG12 ' CB ' ' A' ' 45' ' ' LEU . 20.7 m -127.78 131.2 70.05 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 C-N-CA 119.586 -0.845 . . . . 1.0 108.889 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.447 HG12 ' C ' ' A' ' 170' ' ' VAL . 0.0 OUTLIER -145.91 144.43 20.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 118.964 -1.094 . . . . 1.0 111.237 -177.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 175' ' ' GLN . 3.0 p -132.14 121.72 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 28.8 m-20 47.59 31.68 2.16 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.721 -1.237 . . . . 1.0 108.634 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.1 OUTLIER 76.04 10.37 3.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.794 -0.566 . . . . 1.0 111.413 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.767 ' HB2' HG13 ' A' ' 172' ' ' VAL . 1.6 mp0 -91.84 -171.89 3.01 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.944 -1.098 . . . . 1.0 109.851 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.668 ' HG2' HG23 ' A' ' 170' ' ' VAL . 1.2 tt0 72.52 -107.96 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.614 -0.679 . . . . 1.0 110.084 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 0.1 OUTLIER 67.18 -83.56 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.038 -1.039 . . . . 1.0 112.227 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.539 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 2.0 m-70 -60.75 84.75 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.947 -1.096 . . . . 1.0 111.079 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -55.74 -58.15 9.05 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.216 1.007 . . . . 1.0 111.354 179.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.969 ' O ' HD13 ' A' ' 184' ' ' LEU . 85.9 t -65.29 -23.56 33.29 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.33 -0.85 . . . . 1.0 111.898 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.539 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 6.2 mt-10 -63.6 -52.32 61.41 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.283 -1.511 . . . . 1.0 110.327 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.573 ' HB2' ' CD1' ' A' ' 27' ' ' TYR . 3.6 m-20 -94.98 -3.12 49.06 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.234 -0.916 . . . . 1.0 110.216 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -78.24 -28.91 47.92 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.263 -0.975 . . . . 1.0 108.786 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.969 HD13 ' O ' ' A' ' 180' ' ' VAL . 8.1 mp -59.27 -15.3 14.86 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -0.843 . . . . 1.0 109.173 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 26' ' ' GLU . 4.2 t-20 -51.23 -24.09 4.05 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.229 -1.026 . . . . 1.0 108.229 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.465 ' ND2' ' HD2' ' A' ' 187' ' ' PRO . 3.6 t30 -97.3 148.79 34.92 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 109.112 -0.699 . . . . 1.0 109.112 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.465 ' HD2' ' ND2' ' A' ' 186' ' ' ASN . 41.3 Cg_endo -67.48 -55.38 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.658 1.346 . . . . 1.0 111.588 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.437 ' C ' HG13 ' A' ' 189' ' ' ILE . 5.1 m -101.46 132.4 47.08 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.371 -0.831 . . . . 1.0 111.14 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.437 HG13 ' C ' ' A' ' 188' ' ' THR . 3.8 mt -130.46 111.0 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.532 -0.73 . . . . 1.0 109.494 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.62 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER -84.74 175.92 8.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.267 -0.896 . . . . 1.0 109.338 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.578 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -132.59 18.85 4.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 118.581 -1.247 . . . . 1.0 111.109 -179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.44 ' CA ' ' HB2' ' A' ' 18' ' ' ALA . 1.5 t 57.18 165.38 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.308 -0.87 . . . . 1.0 109.71 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 0.1 OUTLIER -134.04 146.34 50.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.063 -1.023 . . . . 1.0 110.455 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 176.55 40.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.327 -0.858 . . . . 1.0 110.659 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? . . . . . 0 C--N 1.291 -1.959 0 C-N-CA 118.427 -1.309 . . . . 1.0 110.647 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.595 -1.402 . . . . 1.0 109.595 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.9 m -102.93 -170.53 1.81 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.197 -1.178 . . . . 1.0 110.41 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -130.38 8.62 5.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 1.0 109.857 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 124.5 27.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 1.0 109.922 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 t -105.2 114.88 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 1.0 110.122 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 6' ' ' ILE . 10.3 pt -121.21 83.87 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.883 . . . . 1.0 110.554 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.75 133.6 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.003 -1.06 . . . . 1.0 110.295 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -115.93 91.16 3.51 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.249 -0.907 . . . . 1.0 110.073 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.84 96.9 4.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.082 -1.011 . . . . 1.0 110.543 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -112.62 121.61 45.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.307 -0.871 . . . . 1.0 109.928 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.91 -18.64 5.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.283 -0.886 . . . . 1.0 110.186 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' C ' ' OD1' ' A' ' 13' ' ' ASP . . . 68.79 -158.95 52.72 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.63 -1.388 . . . . 1.0 109.63 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 15' ' ' GLU . 1.5 m-20 -135.24 -101.36 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.146 . . . . 1.0 110.128 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 41.99 24.42 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.008 -1.058 . . . . 1.0 111.029 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.48 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.0 tt0 -64.5 87.78 0.05 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.1 -1.0 . . . . 1.0 109.457 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.464 ' C ' HD13 ' A' ' 17' ' ' ILE . . . -116.49 138.26 51.52 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.471 -0.768 . . . . 1.0 111.356 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.638 HG13 HD23 ' A' ' 179' ' ' LEU . 0.8 OUTLIER -123.22 146.53 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.47 -0.937 . . . . 1.0 108.47 178.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.998 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -113.53 122.79 48.31 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.21 -0.931 . . . . 1.0 111.153 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.743 ' CE2' HD13 ' A' ' 167' ' ' ILE . 8.5 m-30 -87.88 148.03 24.82 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.457 -0.777 . . . . 1.0 109.3 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.475 ' OD1' ' HB ' ' A' ' 23' ' ' THR . 7.0 p-10 -103.4 2.47 33.92 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.181 -0.949 . . . . 1.0 110.356 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.86 65.21 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.303 -1.519 . . . . 1.0 109.303 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -131.48 23.35 4.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.148 -1.207 . . . . 1.0 110.312 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.475 ' HB ' ' OD1' ' A' ' 20' ' ' ASP . 5.2 t -109.55 163.26 13.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.898 . . . . 1.0 110.066 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.58 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 14.7 p90 -147.04 123.22 10.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 1.0 110.301 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.545 ' HE1' HG21 ' A' ' 17' ' ' ILE . 4.6 mtt -98.48 99.95 11.16 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.778 -1.201 . . . . 1.0 109.364 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 142' ' ' TRP . 14.1 tt0 -88.87 98.51 11.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.509 -0.744 . . . . 1.0 109.989 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 182' ' ' ASP . 13.1 m-30 -96.58 111.69 23.73 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.989 -1.07 . . . . 1.0 110.589 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -104.24 118.03 35.64 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.449 -0.782 . . . . 1.0 110.153 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' O ' ' O ' ' A' ' 139' ' ' GLY . 9.4 m-20 -140.41 128.45 22.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 1.0 110.391 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.2 141.54 38.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.224 -0.922 . . . . 1.0 109.499 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 31' ' ' VAL . 8.7 p -166.32 133.82 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.95 -1.094 . . . . 1.0 111.027 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 32' ' ' THR . 0.8 OUTLIER -165.1 100.52 0.75 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.041 -1.096 . . . . 1.0 108.041 179.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 34' ' ' SER . 11.8 mtmm -91.43 77.59 5.77 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.402 -0.919 . . . . 1.0 109.525 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 35' ' ' GLU . 35.4 m 57.03 94.25 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.522 ' HB3' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER 66.91 116.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.038 -0.726 . . . . 1.0 109.038 -178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.77 51.61 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.461 -0.774 . . . . 1.0 110.519 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 38' ' ' LEU . . . -131.53 44.63 2.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.273 -0.892 . . . . 1.0 109.248 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.546 HD12 ' H ' ' A' ' 38' ' ' LEU . 1.7 mp -51.97 -170.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.59 -0.693 . . . . 1.0 110.779 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -124.74 16.36 8.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.595 -0.691 . . . . 1.0 109.889 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.1 p -157.85 155.36 29.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 1.0 110.115 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 1.7 m-20 -131.66 160.15 36.25 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.225 -0.922 . . . . 1.0 110.486 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 20.8 m-70 -130.43 115.99 17.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 1.0 109.952 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.893 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 23.1 m-30 -119.5 114.81 22.84 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.179 -0.951 . . . . 1.0 109.816 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.856 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.4 mp0 -125.21 140.65 52.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.936 -1.103 . . . . 1.0 110.794 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.917 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.6 OUTLIER 179.84 159.26 0.76 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.5 -0.88 . . . . 1.0 111.098 179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.507 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.64 161.19 21.79 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.507 ' CG2' ' C ' ' A' ' 46' ' ' SER . 7.4 pt -150.29 170.87 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 117.995 -1.482 . . . . 1.0 112.615 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 4.1 tttm -131.82 85.35 2.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.5 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -72.01 156.42 39.24 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.045 -1.034 . . . . 1.0 111.609 -177.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.1 mm-40 -136.9 -4.84 1.94 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.68 -0.808 . . . . 1.0 111.222 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.875 ' O ' HG23 ' A' ' 52' ' ' THR . . . -125.79 -82.54 0.63 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.144 -0.972 . . . . 1.0 110.429 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.875 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 158.57 -20.66 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.255 0.55 . . . . 1.0 109.641 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -130.2 146.46 51.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 1.0 110.353 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 149.2 135.11 2.45 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.818 -1.313 . . . . 1.0 109.818 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.047 HD13 ' CZ ' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -82.31 132.42 35.22 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.943 -1.327 . . . . 1.0 110.008 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.031 HD12 ' HA ' ' A' ' 72' ' ' ALA . 3.9 mp -97.84 -8.8 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.529 -0.732 . . . . 1.0 111.391 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.893 HD13 HD13 ' A' ' 71' ' ' LEU 0.292 6.5 tt -168.96 146.08 3.66 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 117.643 -1.623 . . . . 1.0 113.012 -176.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 1.004 ' CE2' HG21 ' A' ' 151' ' ' VAL . 12.5 t-105 -150.89 118.2 6.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.643 -0.661 . . . . 1.0 109.318 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.01 122.98 29.47 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.075 -1.016 . . . . 1.0 109.874 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.02 167.81 23.2 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.158 -1.577 . . . . 1.0 109.158 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -140.63 -23.15 0.8 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.285 . . . . 1.0 111.548 -179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 63' ' ' LEU . . . -134.07 132.68 6.5 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.531 -1.319 . . . . 1.0 110.563 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 62' ' ' GLY . 1.8 mt 46.9 -178.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.974 . . . . 1.0 111.196 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -119.0 31.87 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 1.0 110.188 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -158.81 24.89 0.22 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.312 -0.867 . . . . 1.0 108.923 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -116.65 -165.27 1.04 Allowed 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 119.799 -0.76 . . . . 1.0 110.828 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 1.3 t0 -43.94 135.72 4.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.381 -0.824 . . . . 1.0 109.985 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.63 ' CZ ' ' CB ' ' A' ' 83' ' ' ASP . 7.8 p90 -154.84 171.88 18.91 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.101 -1.0 . . . . 1.0 109.953 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.905 HD11 HD21 ' A' ' 135' ' ' LEU . 5.2 mt -146.14 119.27 2.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.646 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.943 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -140.95 -178.05 5.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.753 -1.217 . . . . 1.0 110.68 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.893 HD13 HD13 ' A' ' 57' ' ' LEU . 3.6 mp -149.24 116.06 5.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.516 -0.92 . . . . 1.0 108.516 -177.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 1.031 ' HA ' HD12 ' A' ' 56' ' ' ILE . . . -129.19 178.87 6.11 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.173 -0.955 . . . . 1.0 111.842 -178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.992 ' CG1' HD11 ' A' ' 56' ' ' ILE . 4.0 mt -120.43 134.43 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.431 -0.793 . . . . 1.0 109.745 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.601 HG23 ' NE2' ' A' ' 79' ' ' GLN . 1.3 t -141.09 134.03 30.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 121.203 -0.935 . . . . 1.0 110.367 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 59.66 22.04 10.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.325 -0.859 . . . . 1.0 110.682 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.616 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 84.72 31.61 23.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -146.9 130.3 16.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -1.086 . . . . 1.0 110.079 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.631 ' CG2' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -78.16 -177.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.248 -1.019 . . . . 1.0 108.248 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.601 ' NE2' HG23 ' A' ' 74' ' ' VAL . 2.6 pt20 176.5 133.79 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.664 -1.273 . . . . 1.0 111.491 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.998 ' CE ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -91.14 109.43 20.69 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 1.0 109.219 178.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.943 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 8.3 ptt? -94.01 106.35 18.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.917 -1.114 . . . . 1.0 109.779 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.73 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.3 OUTLIER -93.47 127.73 39.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.226 -0.921 . . . . 1.0 109.965 -179.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.63 ' CB ' ' CZ ' ' A' ' 68' ' ' TYR . 5.7 t0 -131.88 43.2 3.07 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.054 -1.059 . . . . 1.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.867 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.6 OUTLIER -64.37 -10.62 25.71 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.45 -0.9 . . . . 1.0 110.155 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -139.78 39.23 1.54 Allowed Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.696 -1.24 . . . . 1.0 110.707 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.27 -8.22 1.37 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -1.201 . . . . 1.0 111.773 179.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 9.4 mmtt -109.12 102.96 50.99 Favored Pre-proline 0 C--N 1.302 -1.462 0 O-C-N 120.783 -1.198 . . . . 1.0 109.76 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 82' ' ' TYR . 45.9 Cg_endo -73.63 105.4 1.99 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.219 1.641 . . . . 1.0 110.836 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.73 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -85.21 106.58 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.196 -0.94 . . . . 1.0 109.135 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 90' ' ' VAL . 7.9 p -86.38 81.85 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.138 -1.602 . . . . 1.0 111.269 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.998 HD12 ' CE ' ' A' ' 80' ' ' MET . 29.1 mt -71.97 70.12 0.75 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.856 -1.164 . . . . 1.0 107.856 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.76 ' CG ' HG22 ' A' ' 90' ' ' VAL . 11.5 mtp180 -64.35 171.53 3.07 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.547 -0.861 . . . . 1.0 110.347 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.2 t -96.96 152.19 18.96 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.788 -0.57 . . . . 1.0 109.761 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 94' ' ' THR . 2.3 t -102.25 26.85 7.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.924 -1.11 . . . . 1.0 109.407 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.562 ' CG1' ' HD2' ' A' ' 96' ' ' PRO . 9.0 t -128.31 147.69 64.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.526 -0.734 . . . . 1.0 109.177 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 43.3 Cg_endo -68.03 132.31 25.97 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.533 1.281 . . . . 1.0 110.228 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.631 HD13 ' CG2' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -110.94 -30.8 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.312 -0.867 . . . . 1.0 110.701 -179.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -69.09 61.65 0.12 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.032 -1.042 . . . . 1.0 109.415 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 99' ' ' THR . 19.0 m -122.43 10.34 9.82 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.498 -0.751 . . . . 1.0 109.999 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 99' ' ' THR . 6.8 m120 55.25 15.64 1.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 1.0 110.515 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.03 172.68 6.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.119 -0.988 . . . . 1.0 109.435 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.572 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 45.3 m95 -94.7 118.12 31.21 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.075 -1.016 . . . . 1.0 111.004 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 46' ' ' SER . 54.3 m -116.5 152.36 34.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.792 -0.818 . . . . 1.0 108.792 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.487 ' HB3' ' HA2' ' A' ' 119' ' ' GLY . 65.0 t-80 -101.77 156.73 17.33 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.882 -1.136 . . . . 1.0 108.987 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.557 HG22 HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -145.84 154.65 13.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 121.132 -0.98 . . . . 1.0 109.614 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.755 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -148.21 147.62 29.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.06 -1.025 . . . . 1.0 109.905 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.893 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -139.72 99.19 3.64 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.651 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.637 ' CZ ' ' CB ' ' A' ' 115' ' ' SER . 52.6 p90 -110.0 106.83 16.5 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.958 -1.089 . . . . 1.0 109.136 178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.559 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 4.5 tmm_? -94.11 144.7 25.26 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.543 -0.723 . . . . 1.0 111.28 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 15.4 t -128.56 116.74 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 9.8 mm-40 59.19 -89.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 1.0 109.954 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 127' ' ' SER . 2.6 ptt180 -128.08 -28.01 2.68 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.546 -0.721 . . . . 1.0 110.521 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.576 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 10.6 tt0 -82.47 114.9 21.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.089 -1.007 . . . . 1.0 110.582 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -102.17 156.76 18.54 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.446 -0.883 . . . . 1.0 111.063 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.637 ' CB ' ' CZ ' ' A' ' 108' ' ' TYR . 40.6 t -129.81 151.16 50.69 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.481 -1.011 . . . . 1.0 109.896 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.755 HD22 ' O ' ' A' ' 106' ' ' LYS . 0.2 OUTLIER -148.9 126.32 11.58 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.127 -0.983 . . . . 1.0 110.812 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.673 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -134.66 135.53 42.14 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.849 -1.157 . . . . 1.0 110.254 178.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.659 HG12 ' O ' ' A' ' 118' ' ' VAL . 1.2 t -81.67 101.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 107.443 -1.318 . . . . 1.0 107.443 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 71.29 40.81 60.38 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.011 -1.636 . . . . 1.0 109.011 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 36.0 m-80 61.64 27.68 17.05 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.467 -1.019 . . . . 1.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 2.4 mt-10 -93.0 -158.12 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.2 -0.937 . . . . 1.0 110.866 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.467 ' O ' ' CD1' ' A' ' 124' ' ' ILE . . . -41.15 109.92 0.68 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.443 -0.785 . . . . 1.0 109.864 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.557 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 44.5 Cg_endo -73.28 119.15 5.84 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.977 1.514 . . . . 1.0 111.039 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.726 HG21 ' O ' ' A' ' 92' ' ' ARG . 1.8 mp -95.19 100.07 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 106.704 -1.591 . . . . 1.0 106.704 177.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 115' ' ' SER . 12.3 p -109.03 148.99 29.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.177 0.989 . . . . 1.0 112.161 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.488 ' N ' ' CD2' ' A' ' 91' ' ' LEU . . . -152.2 161.31 29.33 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 106.786 -2.526 . . . . 1.0 106.786 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -135.52 159.01 42.94 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 120.68 -1.483 . . . . 1.0 111.029 -179.442 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.59 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -94.61 -177.61 0.69 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.669 -0.645 . . . . 1.0 109.634 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.59 ' HD2' ' CB ' ' A' ' 128' ' ' SER . 38.1 Cg_endo -64.14 102.25 0.37 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.376 -1.432 . . . . 1.0 108.376 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.486 ' C ' ' O ' ' A' ' 129' ' ' PRO . 1.3 pp -33.46 153.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.399 0.618 . . . . 1.0 110.865 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.445 ' O ' ' C ' ' A' ' 132' ' ' ALA . . . 99.77 -64.92 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.311 -1.516 . . . . 1.0 109.311 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.867 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . 39.18 -145.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.477 -1.014 . . . . 1.0 109.842 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 132' ' ' ALA . 2.4 p -154.84 59.59 0.67 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.019 -1.051 . . . . 1.0 110.57 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 133' ' ' THR . 5.2 mt-30 56.94 153.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.442 -0.786 . . . . 1.0 110.078 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.905 HD21 HD11 ' A' ' 69' ' ' ILE . 13.6 tp -135.82 109.61 8.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.978 -1.076 . . . . 1.0 110.654 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 37' ' ' ALA . 1.5 m-20 -106.92 158.75 16.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 1.0 109.557 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.1 t -113.65 153.28 29.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.075 -1.016 . . . . 1.0 110.281 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.721 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 28.0 p-10 -90.91 27.13 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 1.0 110.268 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' ASN . . . 44.75 23.77 0.61 Allowed Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.712 -1.755 . . . . 1.0 108.712 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.721 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -133.51 152.39 51.9 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.388 -1.066 . . . . 1.0 109.158 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.719 HD11 ' HG ' ' A' ' 57' ' ' LEU . 8.0 tp -158.61 161.36 37.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.105 -0.997 . . . . 1.0 110.703 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.744 ' CE3' ' HE3' ' A' ' 146' ' ' MET . 45.0 m95 -127.59 159.67 33.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.87 -1.53 . . . . 1.0 106.87 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.881 HD22 ' O ' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -153.91 118.84 5.02 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 116.873 -1.931 . . . . 1.0 113.801 -177.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.664 ' N ' HD13 ' A' ' 143' ' ' LEU . . . 111.26 5.66 26.37 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.295 -1.122 . . . . 1.0 110.295 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.497 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 134.27 -136.22 8.47 Favored Glycine 0 C--N 1.283 -2.366 0 C-N-CA 118.542 -1.789 . . . . 1.0 109.917 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.874 ' HB2' HD13 ' A' ' 149' ' ' LEU . 0.8 OUTLIER -167.3 126.1 1.34 Allowed 'General case' 0 C--N 1.286 -2.158 0 C-N-CA 118.892 -1.123 . . . . 1.0 112.037 -178.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.565 ' HB2' ' CG ' ' A' ' 24' ' ' TYR . 6.5 tp10 -58.74 -19.27 38.75 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 177.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.533 ' N ' ' HD3' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -146.03 69.69 1.22 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 106.468 -1.679 . . . . 1.0 106.468 178.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.922 HD11 ' CD2' ' A' ' 159' ' ' TYR . 3.5 tp -71.81 41.09 0.08 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 113.55 0.945 . . . . 1.0 113.55 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 p -76.79 -9.56 58.77 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.477 -1.675 . . . . 1.0 106.477 175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' CE2' ' A' ' 58' ' ' TRP 0.269 8.2 p -72.66 -26.37 23.77 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.044 -0.98 . . . . 1.0 111.238 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.718 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . -40.23 -27.52 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.286 -0.884 . . . . 1.0 110.197 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 151' ' ' VAL . 28.7 m170 70.8 -92.4 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.324 0.583 . . . . 1.0 110.496 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -139.6 -4.11 1.45 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.276 -0.89 . . . . 1.0 111.217 -179.438 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.766 HD12 ' C ' ' A' ' 155' ' ' LEU . 3.7 pp -47.16 170.01 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.085 -1.009 . . . . 1.0 108.608 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.679 ' O ' HD12 ' A' ' 155' ' ' LEU . 37.6 Cg_endo -61.12 178.4 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.331 1.174 . . . . 1.0 112.173 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.0 OUTLIER -60.42 -6.7 1.67 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.316 -0.865 . . . . 1.0 111.738 -178.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -42.02 -38.98 1.77 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.91 -1.119 . . . . 1.0 108.934 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 1.047 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 3.8 m-85 -79.3 -34.0 42.79 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.323 -0.951 . . . . 1.0 109.113 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -65.64 -11.77 47.58 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.337 -0.945 . . . . 1.0 109.597 -179.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -123.89 82.66 2.05 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.581 -0.699 . . . . 1.0 109.302 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 161' ' ' THR . . . -41.04 159.21 0.03 OUTLIER Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.64 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 8.4 t80 -76.93 141.64 40.4 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.909 -1.348 . . . . 1.0 112.183 -178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 164' ' ' ILE . 6.0 mt -121.36 84.69 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 107.666 -1.235 . . . . 1.0 107.666 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.64 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -170.46 -154.38 9.45 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.427 -1.869 . . . . 1.0 108.427 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.49 ' C ' HG13 ' A' ' 167' ' ' ILE . 3.6 m -130.19 153.7 48.29 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.128 -1.219 . . . . 1.0 111.232 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.743 HD13 ' CE2' ' A' ' 19' ' ' PHE . 3.5 mt -134.76 153.19 34.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 108.863 -0.792 . . . . 1.0 108.863 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 3.6 ttt-85 -158.79 153.98 25.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.624 -1.298 . . . . 1.0 111.538 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 59.8 m-20 50.29 81.64 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.622 -0.674 . . . . 1.0 110.992 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.917 HG12 ' CB ' ' A' ' 45' ' ' LEU . 19.4 m -123.3 130.6 74.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 C-N-CA 119.145 -1.022 . . . . 1.0 110.174 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.509 ' HB ' ' OE1' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -138.51 144.36 30.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.246 -0.982 . . . . 1.0 110.948 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.557 HG13 ' HE1' ' A' ' 43' ' ' PHE . 70.1 t -127.89 91.22 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 12.3 m-20 57.96 50.87 9.64 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.574 -1.329 . . . . 1.0 107.855 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 37.6 mmm-85 61.56 34.74 17.69 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.708 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 3.1 mm100 -112.46 164.51 13.19 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 121.088 -1.007 . . . . 1.0 109.596 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.696 ' OE2' HD12 ' A' ' 179' ' ' LEU . 0.0 OUTLIER 71.5 -109.94 0.05 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.0 110.563 178.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.702 HD11 ' CE1' ' A' ' 178' ' ' HIS . 0.2 OUTLIER 55.24 11.97 0.62 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.863 -1.148 . . . . 1.0 112.088 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.702 ' CE1' HD11 ' A' ' 177' ' ' LEU . 58.7 m-70 -144.45 75.5 1.46 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.996 -1.065 . . . . 1.0 108.776 177.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.696 HD12 ' OE2' ' A' ' 176' ' ' GLU 0.25 7.9 mp -54.64 -55.04 33.76 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.199 1.0 . . . . 1.0 111.17 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.475 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 4.9 t -63.2 -16.48 17.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.884 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.572 ' CG ' ' HB3' ' A' ' 178' ' ' HIS . 16.1 mt-10 -71.55 -51.54 22.96 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.882 -1.127 . . . . 1.0 110.023 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.508 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 82.1 m-20 -96.49 -14.96 21.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 1.0 109.559 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 179' ' ' LEU . . . -65.78 -38.12 88.15 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.137 -1.025 . . . . 1.0 108.28 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 12.0 mt -45.6 -25.75 0.51 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.536 -0.728 . . . . 1.0 109.336 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.1 OUTLIER -53.04 -23.14 6.89 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 122.155 0.979 . . . . 1.0 108.466 178.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.545 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 1.7 t-20 -98.72 160.78 27.05 Favored Pre-proline 0 C--N 1.3 -1.58 0 N-CA-C 107.694 -1.224 . . . . 1.0 107.694 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 37.6 Cg_endo -62.94 -157.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 122.87 0.932 . . . . 1.0 111.119 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 187' ' ' PRO . 7.3 m -36.14 137.43 0.25 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.517 -0.739 . . . . 1.0 111.228 -178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.9 mm -86.5 156.6 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.502 -0.749 . . . . 1.0 109.985 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 18.6 mt -127.51 152.88 47.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 1.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -107.36 157.5 17.91 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.305 -0.872 . . . . 1.0 109.618 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.998 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 38.9 t -48.74 141.78 6.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.894 . . . . 1.0 111.704 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.89 144.93 47.79 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 195' ' ' LYS . . . -130.07 103.51 6.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.956 -1.09 . . . . 1.0 111.019 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 194' ' ' ALA . 40.5 pttt . . . . . 0 C--N 1.297 -1.69 0 C-N-CA 118.987 -1.085 . . . . 1.0 110.604 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.594 -1.403 . . . . 1.0 109.594 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m -68.88 -50.44 49.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -1.169 . . . . 1.0 110.082 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -67.46 173.17 4.26 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.828 . . . . 1.0 110.148 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -115.06 97.25 6.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 1.0 110.142 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 5' ' ' VAL . 7.6 p -133.43 133.56 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 1.0 110.034 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mt -117.93 112.1 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 1.0 110.338 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 7' ' ' ILE . 11.2 pt -100.15 81.91 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 1.0 109.897 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -132.07 123.94 28.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.913 . . . . 1.0 110.291 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -51.84 125.04 14.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.248 -0.908 . . . . 1.0 109.899 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.69 153.93 5.46 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.094 -1.004 . . . . 1.0 110.002 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.39 39.1 0.99 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.53 -0.731 . . . . 1.0 110.318 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.96 163.97 12.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.807 ' OD2' HG21 ' A' ' 180' ' ' VAL . 3.0 m-20 -158.66 -57.98 0.07 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -1.128 . . . . 1.0 110.044 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 13' ' ' ASP . . . 41.89 48.03 3.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.857 . . . . 1.0 109.942 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.49 ' OE1' ' NE2' ' A' ' 191' ' ' HIS . 0.7 OUTLIER -120.36 -164.81 1.12 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.886 0.851 . . . . 1.0 109.821 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -108.46 148.83 29.62 Favored 'General case' 0 C--N 1.291 -1.977 0 O-C-N 121.906 -0.496 . . . . 1.0 109.91 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 13.3 mm -121.56 131.69 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 1.0 109.251 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.49 ' HB2' ' CA ' ' A' ' 192' ' ' CYS . . . -96.18 130.1 43.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.31 -0.869 . . . . 1.0 110.998 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.56 ' CZ ' ' SD ' ' A' ' 25' ' ' MET . 5.8 m-30 -94.89 174.71 6.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.389 -0.819 . . . . 1.0 109.473 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 10.0 p-10 -127.58 -6.82 5.73 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.235 -0.916 . . . . 1.0 110.546 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.47 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 98.38 -1.66 58.88 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 52.0 ttp85 -134.92 -5.71 2.42 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.947 -1.326 . . . . 1.0 110.947 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m -87.42 140.27 29.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.774 -1.204 . . . . 1.0 110.351 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.423 ' CD1' ' O ' ' A' ' 24' ' ' TYR . 3.0 p90 -112.26 95.21 5.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.298 -0.876 . . . . 1.0 110.188 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.56 ' SD ' ' CZ ' ' A' ' 19' ' ' PHE . 8.7 mtt -77.06 100.76 5.79 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.465 -0.894 . . . . 1.0 109.902 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 3.4 pm0 -107.29 121.91 45.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.277 -0.889 . . . . 1.0 110.606 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 25' ' ' MET . 17.4 m-85 -111.03 107.96 17.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.414 -0.804 . . . . 1.0 109.797 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.95 112.84 24.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.049 -1.032 . . . . 1.0 110.152 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.479 ' OD1' ' OE1' ' A' ' 175' ' ' GLN . 1.7 t-20 -127.77 137.44 52.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 1.0 110.477 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.86 142.44 27.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 1.0 110.0 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.718 HG23 HG22 ' A' ' 32' ' ' THR . 34.1 m -122.72 -43.38 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.004 -1.06 . . . . 1.0 110.412 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.718 HG22 HG23 ' A' ' 31' ' ' VAL . 1.9 t -179.77 110.58 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.011 -1.056 . . . . 1.0 110.416 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.19 79.34 6.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -0.937 . . . . 1.0 109.998 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -174.08 -67.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.365 -0.834 . . . . 1.0 110.014 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 36' ' ' LYS . 1.8 tt0 -67.7 62.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.256 -0.902 . . . . 1.0 109.425 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.666 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -39.23 118.84 0.84 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.751 . . . . 1.0 110.984 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.666 ' HB3' ' O ' ' A' ' 36' ' ' LYS . . . 67.15 152.8 0.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.4 -0.813 . . . . 1.0 110.873 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 38' ' ' LEU . 5.4 mp -119.26 138.92 52.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.381 -0.825 . . . . 1.0 109.818 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' A' ' 38' ' ' LEU . 3.2 pt20 -41.57 -32.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 1.0 110.688 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.777 ' OG ' HG13 ' A' ' 110' ' ' VAL . 47.8 m -149.25 148.72 29.91 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.376 -0.828 . . . . 1.0 110.454 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -112.02 147.18 36.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.389 -0.819 . . . . 1.0 110.158 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 30.7 m80 -123.01 123.36 40.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 1.0 109.949 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.731 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 26.5 m-85 -122.18 117.83 27.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 1.0 109.535 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.869 ' C ' HD23 ' A' ' 45' ' ' LEU . 1.4 mt-10 -126.74 139.87 52.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 1.0 110.882 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.897 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.4 OUTLIER 179.1 164.23 0.88 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.489 -0.884 . . . . 1.0 111.003 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 103' ' ' THR . 50.0 m -124.7 149.71 46.93 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.352 -1.351 . . . . 1.0 107.352 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.621 HD13 HD11 ' A' ' 105' ' ' ILE . 3.7 pt -139.36 164.41 24.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.163 -1.415 . . . . 1.0 112.312 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.56 ' HE2' ' CD1' ' A' ' 102' ' ' TRP . 0.2 OUTLIER -116.45 86.9 2.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.244 -1.391 . . . . 1.0 107.244 177.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -72.31 155.67 39.92 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.977 -1.077 . . . . 1.0 111.063 -177.516 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.621 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 4.4 mm-40 -138.21 10.19 2.77 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.755 -0.778 . . . . 1.0 110.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.843 ' O ' HG23 ' A' ' 52' ' ' THR . . . -140.43 -85.51 0.21 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.117 -0.989 . . . . 1.0 110.61 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.64 -24.34 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.44 -0.948 . . . . 1.0 108.44 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 1.5 tt0 -125.03 138.19 54.21 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 156.73 138.81 2.6 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.042 -1.623 . . . . 1.0 109.042 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.244 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -88.72 128.32 35.61 Favored 'General case' 0 N--CA 1.484 1.235 0 O-C-N 120.83 -1.394 . . . . 1.0 109.602 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.796 HG22 HD21 ' A' ' 143' ' ' LEU . 0.9 OUTLIER -90.83 -35.93 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.788 -0.57 . . . . 1.0 112.508 -176.143 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.084 HD13 HD12 ' A' ' 71' ' ' LEU . 2.3 tt -149.05 146.02 27.55 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.859 -1.151 . . . . 1.0 111.981 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.949 ' N ' HD23 ' A' ' 57' ' ' LEU . 3.5 t-105 -149.09 111.76 4.79 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.583 -1.266 . . . . 1.0 107.583 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.578 ' OG ' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -118.79 161.4 20.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.873 -1.142 . . . . 1.0 111.394 -178.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.5 127.04 1.29 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.504 -1.838 . . . . 1.0 108.504 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -76.59 11.7 1.55 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.054 -1.262 . . . . 1.0 110.829 -179.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.54 51.8 53.51 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.101 -1.2 . . . . 1.0 110.101 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 66' ' ' SER . 0.7 OUTLIER -59.55 -165.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.202 -1.176 . . . . 1.0 109.589 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -108.02 -14.82 14.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.061 -1.024 . . . . 1.0 110.326 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -168.27 27.09 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.413 -0.804 . . . . 1.0 109.456 179.431 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -103.31 -177.91 3.51 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 119.627 -0.829 . . . . 1.0 110.196 -179.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.644 ' CB ' ' O ' ' A' ' 83' ' ' ASP . 9.3 m-20 -103.89 -122.42 0.2 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.06 -1.025 . . . . 1.0 110.901 -179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.611 ' CG ' ' C ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER 179.12 -162.66 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.197 -1.564 . . . . 1.0 111.983 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.989 HD12 ' N ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -148.26 146.0 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.425 -178.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.113 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -146.63 -175.11 4.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.969 -1.082 . . . . 1.0 110.39 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.084 HD12 HD13 ' A' ' 57' ' ' LEU . 66.3 mt -149.56 126.2 11.0 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.009 -1.108 . . . . 1.0 108.009 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -145.22 173.33 12.04 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.824 -1.172 . . . . 1.0 111.964 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.67 HG12 HG13 ' A' ' 78' ' ' VAL . 16.9 mt -117.56 141.81 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 CA-C-O 121.593 0.711 . . . . 1.0 111.086 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.44 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 0.0 OUTLIER -139.28 130.17 33.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.743 -0.598 . . . . 1.0 110.164 -179.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' OD1' ' N ' ' A' ' 75' ' ' ASP . 1.2 m-20 58.36 21.31 8.19 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.224 -0.922 . . . . 1.0 111.602 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.823 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 92.39 20.05 36.47 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.628 -1.272 . . . . 1.0 110.252 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.557 ' CD1' ' O ' ' A' ' 76' ' ' GLY . 16.9 m-85 -138.19 144.29 40.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -1.126 . . . . 1.0 109.411 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.755 HG22 HD13 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -79.59 -167.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.758 -1.214 . . . . 1.0 109.103 179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER 175.75 102.62 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.314 -0.866 . . . . 1.0 110.534 -179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.946 ' CE ' HD12 ' A' ' 91' ' ' LEU . 2.3 ttm -61.68 93.08 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.914 -0.714 . . . . 1.0 109.227 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 1.113 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 11.3 tmm? -89.94 111.29 22.31 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.804 -0.56 . . . . 1.0 110.005 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.871 ' CE2' HG11 ' A' ' 89' ' ' VAL . 2.8 p90 -143.1 141.29 31.2 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.346 -1.341 . . . . 1.0 110.986 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.644 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 0.6 OUTLIER -138.52 71.44 1.39 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.668 -0.645 . . . . 1.0 110.132 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.824 HD13 ' CD2' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -67.89 -7.37 27.67 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 120.069 -0.652 . . . . 1.0 110.006 179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.62 -57.57 0.37 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.546 -1.422 . . . . 1.0 109.546 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -177.01 -29.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -1.113 . . . . 1.0 110.55 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -110.37 124.48 33.17 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.95 . . . . 1.0 109.739 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.53 ' CA ' ' HB3' ' A' ' 83' ' ' ASP . 48.6 Cg_endo -73.7 139.12 27.5 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.784 1.413 . . . . 1.0 110.371 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.871 HG11 ' CE2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -100.52 121.06 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 90' ' ' VAL . 7.2 p -99.06 81.97 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 118.346 -1.341 . . . . 1.0 111.09 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.946 HD12 ' CE ' ' A' ' 80' ' ' MET . 8.5 mt -76.63 71.33 3.22 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.622 -1.251 . . . . 1.0 107.622 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.641 ' O ' HG21 ' A' ' 124' ' ' ILE . 38.6 mtp180 -59.1 179.04 0.1 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.192 0.996 . . . . 1.0 111.347 -177.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.864 ' HA ' HD13 ' A' ' 124' ' ' ILE . 3.1 t -114.84 149.1 37.61 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.45 -0.795 . . . . 1.0 109.904 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.756 HG22 ' O ' ' A' ' 94' ' ' THR . 54.5 m -106.85 34.37 3.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.236 -0.915 . . . . 1.0 109.423 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 1.014 HG11 HG21 ' A' ' 118' ' ' VAL . 0.8 OUTLIER -128.43 151.87 77.31 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.559 -0.713 . . . . 1.0 109.955 -179.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 95' ' ' VAL . 43.5 Cg_endo -69.53 121.41 8.15 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.399 1.21 . . . . 1.0 109.892 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -109.58 -27.09 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 1.0 110.683 -179.196 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 98' ' ' ASN . 6.3 p-10 -82.06 61.11 5.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.193 -0.942 . . . . 1.0 109.847 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 99' ' ' THR . 27.0 m -123.1 14.86 9.85 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.823 . . . . 1.0 110.195 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.496 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 12.3 t-20 53.54 18.05 1.32 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.937 -1.102 . . . . 1.0 110.108 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 5.5 m80 -116.14 144.59 43.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.121 -0.987 . . . . 1.0 110.286 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.56 ' CD1' ' HE2' ' A' ' 48' ' ' LYS . 21.1 m95 -59.44 109.52 0.91 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.437 -0.789 . . . . 1.0 111.138 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.574 HG22 ' N ' ' A' ' 104' ' ' HIS . 2.7 m -98.03 170.52 8.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.597 ' HB3' ' CA ' ' A' ' 119' ' ' GLY . 0.8 OUTLIER -123.08 138.64 54.62 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.042 -1.037 . . . . 1.0 108.244 178.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.621 HD11 HD13 ' A' ' 47' ' ' ILE . 1.2 mt -134.91 149.16 29.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.103 -0.998 . . . . 1.0 109.608 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -148.34 130.19 15.2 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 1.0 109.709 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.731 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -122.46 109.39 14.31 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.263 -0.975 . . . . 1.0 111.295 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.662 ' CE2' ' CB ' ' A' ' 115' ' ' SER . 3.8 p90 -116.48 110.27 18.38 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.236 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.563 ' CB ' ' HA2' ' A' ' 114' ' ' GLY . 3.6 ttp180 -125.1 133.92 52.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.381 0.61 . . . . 1.0 110.44 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.777 HG13 ' OG ' ' A' ' 40' ' ' SER . 3.1 t -97.38 89.67 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.327 -0.858 . . . . 1.0 109.7 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 0.3 OUTLIER 21.24 48.76 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 112.822 0.675 . . . . 1.0 112.822 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 4.3 tmm_? 167.96 -55.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.221 -0.924 . . . . 1.0 109.857 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.3 OUTLIER -111.46 120.06 40.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 1.0 109.785 -179.725 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.06 162.57 15.29 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.946 -1.121 . . . . 1.0 111.618 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.662 ' CB ' ' CE2' ' A' ' 108' ' ' TYR . 13.5 t -141.61 155.6 45.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.737 -0.861 . . . . 1.0 109.829 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 117' ' ' GLN . 0.3 OUTLIER -149.65 125.98 10.81 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 120.956 -1.09 . . . . 1.0 110.908 -179.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.745 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -135.1 134.99 40.85 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.242 -0.911 . . . . 1.0 109.484 178.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 1.014 HG21 HG11 ' A' ' 95' ' ' VAL . 9.9 p -76.2 102.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 107.324 -1.362 . . . . 1.0 107.324 178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.597 ' CA ' ' HB3' ' A' ' 104' ' ' HIS . . . 68.96 30.83 72.21 Favored Glycine 0 C--N 1.286 -2.196 0 N-CA-C 108.819 -1.712 . . . . 1.0 108.819 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 1.0 OUTLIER 72.93 29.99 1.75 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.961 . . . . 1.0 110.688 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -97.3 -153.57 0.42 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.297 -0.877 . . . . 1.0 110.491 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.477 ' O ' HD12 ' A' ' 124' ' ' ILE . . . -36.81 101.92 0.23 Allowed Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.407 -0.808 . . . . 1.0 110.3 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.57 ' HB3' ' HG2' ' A' ' 117' ' ' GLN . 44.9 Cg_endo -71.02 116.65 4.78 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.57 . . . . 1.0 111.794 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.864 HD13 ' HA ' ' A' ' 93' ' ' SER . 1.2 mp -94.67 99.46 9.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 37.2 p -99.95 174.14 6.33 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.342 1.068 . . . . 1.0 112.39 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.12 154.1 10.15 Favored Glycine 0 N--CA 1.48 1.616 0 N-CA-C 107.486 -2.246 . . . . 1.0 107.486 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -137.14 167.18 22.04 Favored 'General case' 0 C--N 1.29 -2.003 0 O-C-N 121.26 -1.141 . . . . 1.0 109.927 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.0 174.75 5.68 Favored Pre-proline 0 C--N 1.3 -1.557 0 C-N-CA 119.089 -1.044 . . . . 1.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 130' ' ' LEU . 49.1 Cg_endo -78.71 43.68 1.5 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.735 1.387 . . . . 1.0 109.435 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.2 OUTLIER 42.47 105.39 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.724 0.773 . . . . 1.0 111.478 -179.698 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.81 87.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.972 -1.251 . . . . 1.0 109.972 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.716 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -170.95 174.78 4.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -1.101 . . . . 1.0 109.788 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 6.8 t -179.22 156.98 0.79 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.175 -0.953 . . . . 1.0 110.427 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.597 ' O ' ' C ' ' A' ' 135' ' ' LEU . 0.5 OUTLIER 69.97 -60.44 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 1.0 111.131 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.824 ' CD2' HD13 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -1.18 111.84 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.797 0.808 . . . . 1.0 112.064 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.573 ' C ' HG23 ' A' ' 137' ' ' THR . 37.5 m-20 -116.66 149.01 40.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.11 . . . . 1.0 110.038 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.573 HG23 ' C ' ' A' ' 136' ' ' ASP . 33.3 p -154.15 105.91 2.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 1.0 110.115 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 137' ' ' THR . 0.6 OUTLIER 167.11 -43.28 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.69 0.757 . . . . 1.0 109.206 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -50.4 -24.85 7.71 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.783 -1.327 . . . . 1.0 109.783 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -163.97 135.03 4.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.995 -1.297 . . . . 1.0 110.598 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.752 HD11 ' CG ' ' A' ' 57' ' ' LEU . 6.2 tp -135.8 142.72 44.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 1.0 110.055 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.569 ' CE3' ' HB3' ' A' ' 26' ' ' GLU . 44.2 m95 -117.73 148.09 42.35 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.184 -1.043 . . . . 1.0 108.184 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.796 HD21 HG22 ' A' ' 56' ' ' ILE . 1.6 tt -148.59 119.55 7.65 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 117.644 -1.623 . . . . 1.0 112.995 -178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 120.59 9.3 7.79 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.77 -1.332 . . . . 1.0 109.77 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.613 ' O ' ' HG2' ' A' ' 146' ' ' MET . . . 129.94 -148.52 18.5 Favored Glycine 0 C--N 1.287 -2.158 0 N-CA-C 108.024 -2.031 . . . . 1.0 108.024 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.964 ' CB ' HD13 ' A' ' 149' ' ' LEU 0.266 5.6 mmt -152.53 128.78 10.51 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 119.655 -0.818 . . . . 1.0 110.95 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 146' ' ' MET . 5.3 tm-20 -43.53 -50.23 7.22 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.023 -1.048 . . . . 1.0 109.435 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.723 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -127.88 79.24 1.88 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 123.022 1.392 . . . . 1.0 107.73 177.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.965 HD12 ' CG1' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -62.1 42.79 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.441 -0.8 . . . . 1.0 111.177 -179.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 148' ' ' ARG . 92.9 p -50.81 -32.75 21.01 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 104.812 -2.292 . . . . 1.0 104.812 177.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.965 ' CG1' HD12 ' A' ' 149' ' ' LEU 0.313 7.1 p -65.9 -141.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-N 113.542 -1.663 . . . . 1.0 106.557 176.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.829 ' HB1' ' CB ' ' A' ' 159' ' ' TYR 0.278 . . 50.63 14.21 0.16 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.597 -1.314 . . . . 1.0 111.508 177.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.79 -45.23 6.74 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.688 -1.257 . . . . 1.0 111.402 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.491 ' NZ ' ' OD2' ' A' ' 83' ' ' ASP . 2.6 pttt -61.13 -6.69 2.13 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.279 -0.888 . . . . 1.0 111.15 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 1.063 HD11 ' CD1' ' A' ' 159' ' ' TYR . 0.5 OUTLIER -121.96 -174.82 0.32 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 120.904 -1.123 . . . . 1.0 110.781 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.591 ' N ' ' HG ' ' A' ' 155' ' ' LEU . 44.1 Cg_endo -70.19 174.98 9.09 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 O-C-N 123.626 1.329 . . . . 1.0 112.536 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.1 OUTLIER -56.9 -11.43 1.45 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.682 -0.636 . . . . 1.0 111.948 -179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 157' ' ' LYS . . . -37.29 -41.03 0.38 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.194 -0.941 . . . . 1.0 109.961 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 1.244 ' CE2' HD13 ' A' ' 55' ' ' LEU . 4.0 m-85 -83.0 -32.97 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.093 -1.043 . . . . 1.0 109.522 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -60.53 -15.47 27.69 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.88 -1.128 . . . . 1.0 108.227 178.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -115.9 83.5 1.95 Allowed 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -41.03 163.94 0.01 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.808 -1.317 . . . . 1.0 109.808 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.586 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 20.0 t80 -77.01 142.32 39.96 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.763 -1.434 . . . . 1.0 111.647 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 164' ' ' ILE . 3.6 mt -123.93 87.15 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 107.08 -1.452 . . . . 1.0 107.08 177.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.586 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.25 -153.19 9.07 Favored Glycine 0 C--N 1.294 -1.789 0 N-CA-C 108.184 -1.966 . . . . 1.0 108.184 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 17' ' ' ILE . 9.6 m -135.73 155.14 50.86 Favored 'General case' 0 C--N 1.293 -1.869 0 C-N-CA 118.893 -1.123 . . . . 1.0 110.758 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.6 mt -133.68 153.34 36.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 121.385 -0.822 . . . . 1.0 109.412 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.415 ' HD3' ' O ' ' A' ' 15' ' ' GLU . 11.2 ttp85 -159.09 158.55 33.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.932 -1.105 . . . . 1.0 110.857 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 22.6 m-20 48.92 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.303 -0.873 . . . . 1.0 110.043 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.897 HG12 ' CB ' ' A' ' 45' ' ' LEU . 18.5 m -126.77 131.71 70.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 C-N-CA 119.179 -1.008 . . . . 1.0 110.004 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.92 149.55 26.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 C-N-CA 119.579 -0.849 . . . . 1.0 110.511 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 54.4 t -131.46 94.19 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 1.3 m-20 71.44 38.46 1.02 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.922 -1.14 . . . . 1.0 107.922 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 74.51 18.1 2.94 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.248 0.547 . . . . 1.0 110.127 -179.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.479 ' OE1' ' OD1' ' A' ' 29' ' ' ASN . 7.0 mm-40 -89.09 111.02 21.67 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.344 -0.847 . . . . 1.0 109.732 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.44 106.4 6.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.887 -1.133 . . . . 1.0 109.274 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 177' ' ' LEU . 0.1 OUTLIER -89.32 86.96 6.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.154 -0.966 . . . . 1.0 111.077 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.583 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 80.2 m-70 -53.37 104.47 0.1 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.174 0.988 . . . . 1.0 109.39 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.569 ' O ' ' CB ' ' A' ' 183' ' ' ALA . 1.0 OUTLIER -46.84 -61.94 1.63 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.166 0.984 . . . . 1.0 109.777 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.807 HG21 ' OD2' ' A' ' 13' ' ' ASP . 36.2 t -54.04 -21.86 6.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.41 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.583 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 13.4 mt-10 -64.95 -53.06 52.32 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 118.265 -1.374 . . . . 1.0 109.914 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.9 OUTLIER -105.59 -22.48 12.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.009 -1.057 . . . . 1.0 109.731 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -59.39 -35.8 74.61 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.785 -1.197 . . . . 1.0 108.153 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.752 HD21 HG13 ' A' ' 180' ' ' VAL . 1.3 mm? -50.25 -20.73 1.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.552 -0.718 . . . . 1.0 109.748 178.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.3 OUTLIER -52.22 -22.53 4.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.163 -0.961 . . . . 1.0 108.956 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.461 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 8.4 t30 -86.18 149.05 49.02 Favored Pre-proline 0 C--N 1.299 -1.589 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 45.2 Cg_endo -72.35 -47.54 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 123.742 1.391 . . . . 1.0 110.599 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.91 118.99 37.6 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.746 -0.596 . . . . 1.0 110.54 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.571 HD12 HD22 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -117.9 128.19 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.308 -0.87 . . . . 1.0 109.515 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 19.9 mt -103.23 171.97 7.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.861 . . . . 1.0 110.088 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.599 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 0.1 OUTLIER -121.72 1.78 10.01 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.056 -1.027 . . . . 1.0 110.911 -179.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.49 ' CA ' ' HB2' ' A' ' 18' ' ' ALA . 6.3 t 66.44 154.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.142 -0.974 . . . . 1.0 110.623 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.25 157.37 26.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 1.0 110.04 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -139.94 105.13 5.02 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.972 . . . . 1.0 110.581 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.7 0 C-N-CA 119.012 -1.075 . . . . 1.0 110.557 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.406 -1.478 . . . . 1.0 109.406 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 27.3 t 56.38 -83.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -1.103 . . . . 1.0 110.178 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.5 OUTLIER -44.73 144.32 1.17 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 1.0 110.132 179.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.11 159.14 1.6 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.841 . . . . 1.0 109.84 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 m -109.44 149.7 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 1.0 110.122 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 6' ' ' ILE . 27.6 pt -80.33 144.98 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.086 -1.009 . . . . 1.0 110.228 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.558 ' O ' HG23 ' A' ' 7' ' ' ILE . 7.4 tt -122.51 103.3 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 1.0 110.18 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.48 120.18 35.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.382 -0.824 . . . . 1.0 110.07 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -74.04 156.55 37.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 1.0 110.182 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.506 ' O ' ' N ' ' A' ' 12' ' ' GLY . . . -87.03 112.95 22.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.252 -0.905 . . . . 1.0 110.401 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.6 76.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.164 -0.96 . . . . 1.0 110.154 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 10' ' ' ALA . . . 153.99 158.28 8.55 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.514 -1.434 . . . . 1.0 109.514 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.742 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 7.9 t0 -166.15 -38.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.192 -1.181 . . . . 1.0 110.458 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 13' ' ' ASP . . . 71.32 88.97 0.1 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.247 -0.908 . . . . 1.0 110.156 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -112.57 -165.2 0.97 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.343 -0.848 . . . . 1.0 108.893 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -136.09 131.79 35.27 Favored 'General case' 0 C--N 1.292 -1.934 0 O-C-N 121.304 -0.873 . . . . 1.0 110.871 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.514 HG21 ' CE ' ' A' ' 25' ' ' MET . 26.4 mm -127.07 117.95 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.82 . . . . 1.0 109.437 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.37 139.94 31.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.395 -0.816 . . . . 1.0 111.318 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.889 ' CD2' HG21 ' A' ' 23' ' ' THR . 8.3 m-85 -108.09 159.92 16.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' C ' HG12 ' A' ' 164' ' ' ILE . 4.1 p-10 -115.8 -3.31 12.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.952 -1.092 . . . . 1.0 110.779 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.478 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 109.49 -18.29 30.15 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.121 -1.992 . . . . 1.0 108.121 -178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.04 30.39 7.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.585 -0.95 . . . . 1.0 109.182 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.889 HG21 ' CD2' ' A' ' 19' ' ' PHE . 1.9 m -69.87 172.69 7.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 1.0 110.894 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.585 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 10.8 t80 -167.72 74.65 0.13 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.118 -0.697 . . . . 1.0 109.118 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.597 ' HB3' ' CE2' ' A' ' 27' ' ' TYR . 3.8 mmt -86.95 99.43 11.86 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.845 -1.142 . . . . 1.0 109.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 0.2 OUTLIER -93.77 136.4 34.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 1.0 108.63 179.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 25' ' ' MET . 96.0 m-85 -130.92 104.5 7.17 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.017 -1.052 . . . . 1.0 110.903 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.536 ' HE2' ' HZ2' ' A' ' 142' ' ' TRP . 22.7 m-70 -108.13 120.21 41.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.362 -0.836 . . . . 1.0 109.576 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -155.31 170.69 21.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 1.0 110.524 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.15 153.88 17.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.412 -0.805 . . . . 1.0 110.343 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 31' ' ' VAL . 9.8 p -162.48 26.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 1.0 110.735 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 35' ' ' GLU . 15.3 t -163.12 155.41 18.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 1.0 110.161 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' O ' ' CB ' ' A' ' 34' ' ' SER . 3.4 tttt -104.57 78.72 1.48 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.091 -1.006 . . . . 1.0 110.233 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 33' ' ' LYS . 0.1 OUTLIER 73.9 -48.49 0.67 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.46 -0.775 . . . . 1.0 110.624 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.426 ' O ' ' OG1' ' A' ' 32' ' ' THR . 5.8 tt0 -66.1 158.22 29.12 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 1.0 110.123 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -153.31 -168.38 2.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -0.873 . . . . 1.0 110.086 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 36' ' ' LYS . . . 65.77 98.18 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 1.0 110.305 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 38' ' ' LEU . 3.5 mm? -94.38 177.38 5.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.386 -0.821 . . . . 1.0 109.941 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -93.6 -26.36 17.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 1.0 109.986 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 1.7 p -163.6 133.55 4.23 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.704 -0.622 . . . . 1.0 110.342 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 108' ' ' TYR . 0.4 OUTLIER -100.93 152.39 20.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 1.0 109.943 179.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.552 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 11.5 m80 -123.88 138.16 54.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.178 -0.951 . . . . 1.0 110.03 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 1.016 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 21.2 m-85 -134.73 128.03 32.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.393 -0.817 . . . . 1.0 110.204 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.793 ' C ' HD23 ' A' ' 45' ' ' LEU . 8.2 mt-10 -133.8 148.9 51.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.018 -1.051 . . . . 1.0 110.114 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.994 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.8 OUTLIER 179.26 151.55 0.35 Allowed 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.395 -0.922 . . . . 1.0 111.158 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.504 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -120.09 154.11 35.16 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 177.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 97' ' ' ILE . 5.5 pt -150.81 173.31 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 C-N-CA 117.96 -1.496 . . . . 1.0 112.312 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.652 ' HD2' ' CE2' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -127.33 82.92 2.12 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 178.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.55 ' HA ' ' CE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -66.86 161.21 24.42 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.119 -0.988 . . . . 1.0 111.256 -177.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.622 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 8.0 mm-40 -140.81 7.96 2.1 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.531 -0.867 . . . . 1.0 110.939 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.844 ' O ' HG23 ' A' ' 52' ' ' THR . . . -137.04 -86.66 0.31 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.142 -1.023 . . . . 1.0 111.063 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 51' ' ' ALA . 0.6 OUTLIER 155.93 -24.75 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.302 -0.999 . . . . 1.0 108.302 -179.223 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.3 OUTLIER -125.01 132.43 53.25 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.67 -0.644 . . . . 1.0 109.831 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 158' ' ' ALA . . . 162.98 137.81 2.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.266 -1.534 . . . . 1.0 109.266 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.755 ' CD2' HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -86.07 130.09 34.64 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.903 -1.351 . . . . 1.0 108.305 179.151 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.122 HD11 HG13 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -98.31 -26.27 3.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.553 -0.717 . . . . 1.0 112.178 -176.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.061 HD13 HD12 ' A' ' 71' ' ' LEU 0.264 7.9 tt -156.88 155.41 31.4 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 117.736 -1.586 . . . . 1.0 113.09 -175.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.811 ' N ' HD23 ' A' ' 57' ' ' LEU . 2.7 t-105 -156.23 114.35 3.33 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.683 ' OG ' HD21 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -133.89 179.92 5.94 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.89 -1.132 . . . . 1.0 111.063 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 61' ' ' LYS . . . 175.2 -131.55 1.97 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.301 -1.519 . . . . 1.0 109.301 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.1 OUTLIER 170.64 93.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.256 . . . . 1.0 110.073 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.32 -88.39 0.14 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tp -119.94 -173.06 2.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 1.0 110.718 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -93.23 44.71 1.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 1.0 110.051 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -177.54 35.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 1.0 109.371 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -128.09 140.05 52.17 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 119.739 -0.785 . . . . 1.0 110.718 -178.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.78 ' CG ' HD11 ' A' ' 135' ' ' LEU . 11.3 t0 55.39 130.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.613 -0.68 . . . . 1.0 111.01 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.578 ' CG ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 m-30 -105.32 77.93 1.34 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.608 -1.307 . . . . 1.0 112.211 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.442 HG12 ' CG ' ' A' ' 67' ' ' ASP . 21.0 mm -98.34 77.92 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.161 -0.962 . . . . 1.0 109.24 178.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.845 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -120.88 179.29 4.41 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 1.0 111.192 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.061 HD12 HD13 ' A' ' 57' ' ' LEU . 81.8 mt -149.17 94.79 2.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.252 -0.905 . . . . 1.0 108.723 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -112.18 178.39 4.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.973 -1.079 . . . . 1.0 111.671 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.671 HG12 HG13 ' A' ' 78' ' ' VAL . 60.1 mt -129.6 139.58 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.456 -0.778 . . . . 1.0 110.971 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.613 HG13 ' NH1' ' A' ' 92' ' ' ARG . 1.9 p -140.41 139.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.759 -0.588 . . . . 1.0 109.945 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.515 ' OD2' HG22 ' A' ' 74' ' ' VAL . 69.3 m-20 59.13 20.49 8.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 1.0 110.944 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.828 ' CA ' HG22 ' A' ' 52' ' ' THR . . . 88.14 16.54 59.11 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.845 -1.302 . . . . 1.0 109.845 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.421 ' C ' HG23 ' A' ' 73' ' ' ILE . 52.5 m-85 -133.97 135.76 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -1.135 . . . . 1.0 110.319 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.122 HG13 HD11 ' A' ' 56' ' ' ILE . 1.6 t -76.24 177.73 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 1.0 109.554 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.57 ' HB2' ' CG2' ' A' ' 90' ' ' VAL . 0.0 OUTLIER -163.46 127.66 2.86 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.2 -0.937 . . . . 1.0 110.891 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.803 ' HB2' HD23 ' A' ' 116' ' ' LEU . 8.4 tmm? -82.39 94.52 7.41 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.443 0.64 . . . . 1.0 110.606 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.845 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -73.81 120.56 19.57 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.667 -1.234 . . . . 1.0 107.667 178.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.667 ' CE1' HD22 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -143.35 91.73 2.3 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.426 -1.71 . . . . 1.0 111.691 -178.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.674 ' C ' HD23 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -112.57 152.07 29.31 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.475 -0.935 . . . . 1.0 108.475 178.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.769 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -131.28 -35.56 1.34 Allowed 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.569 ' O ' ' CB ' ' A' ' 86' ' ' SER . . . -103.41 -33.12 4.31 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.666 -1.773 . . . . 1.0 108.666 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 162.02 -12.43 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.445 -1.032 . . . . 1.0 111.523 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' C ' ' HB2' ' A' ' 83' ' ' ASP . 3.7 mttt -102.64 96.16 7.16 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.751 -1.218 . . . . 1.0 110.043 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.499 ' HA ' ' CB ' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -70.42 123.99 10.39 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.065 1.561 . . . . 1.0 110.464 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.54 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -88.89 119.73 36.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 121.506 -0.746 . . . . 1.0 109.06 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 90' ' ' VAL . 8.7 p -99.29 81.96 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.667 -1.271 . . . . 1.0 110.529 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.649 HD12 ' CE ' ' A' ' 80' ' ' MET . 10.4 mt -78.15 82.08 4.49 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.613 ' NH1' HG13 ' A' ' 74' ' ' VAL . 1.2 mtt180 -57.9 176.58 0.15 Allowed 'General case' 0 C--N 1.291 -1.942 0 C-N-CA 118.599 -1.24 . . . . 1.0 109.725 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.595 ' HA ' ' CD1' ' A' ' 124' ' ' ILE . 1.8 t -95.26 159.03 15.2 Favored 'General case' 0 C--N 1.286 -2.164 0 O-C-N 121.691 -0.63 . . . . 1.0 110.341 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.05 8.57 40.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -0.946 . . . . 1.0 109.834 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.893 ' CG2' HG21 ' A' ' 118' ' ' VAL . 21.8 t -130.15 146.78 62.96 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.447 -0.783 . . . . 1.0 109.316 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.538 ' HD2' ' CG1' ' A' ' 95' ' ' VAL . 44.2 Cg_endo -69.76 153.04 69.4 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.588 1.31 . . . . 1.0 111.101 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.577 HD11 HD11 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -133.14 -27.53 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.862 . . . . 1.0 111.032 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.486 ' HA ' ' HB ' ' A' ' 49' ' ' THR . 9.1 p30 -72.16 65.0 0.57 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.994 -1.066 . . . . 1.0 111.061 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.73 HG23 ' HB2' ' A' ' 101' ' ' HIS . 14.7 t -135.82 18.3 3.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 1.0 109.522 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.544 ' ND2' ' OE1' ' A' ' 50' ' ' GLU . 1.0 OUTLIER 57.31 23.64 9.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.82 . . . . 1.0 111.189 179.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.73 ' HB2' HG23 ' A' ' 99' ' ' THR . 2.8 m80 -112.0 147.71 35.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.078 -1.014 . . . . 1.0 110.007 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.652 ' CE2' ' HD2' ' A' ' 48' ' ' LYS . 23.4 m95 -68.21 104.7 1.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 1.0 110.057 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 104' ' ' HIS . 2.4 m -98.73 172.41 7.48 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.327 -0.858 . . . . 1.0 109.003 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.609 ' CD2' ' HA2' ' A' ' 119' ' ' GLY . 1.7 t60 -124.62 139.66 53.66 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.165 -1.05 . . . . 1.0 108.165 178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.477 HD11 HD13 ' A' ' 47' ' ' ILE . 1.2 mt -129.28 157.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 119.193 -1.003 . . . . 1.0 109.19 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.842 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -146.46 156.5 43.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.105 -0.997 . . . . 1.0 109.539 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -158.22 119.46 3.49 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.526 -0.87 . . . . 1.0 110.516 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 108' ' ' TYR . 2.3 p90 -129.27 107.3 9.43 Favored 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.203 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.605 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.4 OUTLIER -83.71 139.97 32.42 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.987 -0.685 . . . . 1.0 109.839 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.519 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.3 t -132.59 88.98 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 1.0 110.041 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.557 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 38.8 mt-30 44.58 102.82 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.413 -0.804 . . . . 1.0 111.121 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 5.3 ttt180 64.24 -52.34 0.27 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.172 -0.955 . . . . 1.0 111.423 178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.65 ' CB ' ' OG ' ' A' ' 127' ' ' SER . 4.3 pt-20 -82.09 117.97 22.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.596 -1.315 . . . . 1.0 111.386 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -105.98 152.56 17.11 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.164 -1.174 . . . . 1.0 110.164 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.603 ' OG ' ' CZ ' ' A' ' 108' ' ' TYR . 32.8 t -133.84 161.88 33.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.13 -1.218 . . . . 1.0 111.538 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.051 HD13 ' N ' ' A' ' 117' ' ' GLN 0.252 1.7 tm? -144.24 155.42 43.86 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 -179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 1.051 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -163.02 123.13 2.27 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.334 -1.346 . . . . 1.0 112.742 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.893 HG21 ' CG2' ' A' ' 95' ' ' VAL . 3.0 m -71.4 106.53 2.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 106.639 -1.615 . . . . 1.0 106.639 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.609 ' HA2' ' CD2' ' A' ' 104' ' ' HIS . . . 75.54 -73.75 1.59 Allowed Glycine 0 C--N 1.287 -2.184 0 N-CA-C 108.817 -1.713 . . . . 1.0 108.817 -177.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 3.5 t-20 178.22 33.29 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.404 -1.056 . . . . 1.0 109.602 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' O ' ' CG ' ' A' ' 117' ' ' GLN . 0.5 OUTLIER -96.99 -158.74 0.69 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.584 -0.698 . . . . 1.0 111.064 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -40.2 103.61 0.3 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 1.0 109.653 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 42.2 Cg_endo -71.33 126.45 12.29 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.02 1.537 . . . . 1.0 111.012 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.595 ' CD1' ' HA ' ' A' ' 93' ' ' SER . 1.7 mp -82.46 99.53 5.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 120.824 -1.172 . . . . 1.0 107.901 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 115' ' ' SER . 16.4 p -98.18 177.08 5.51 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.057 -1.027 . . . . 1.0 110.838 -178.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 113' ' ' GLU . . . -179.75 -161.86 27.75 Favored Glycine 0 N--CA 1.482 1.73 0 N-CA-C 107.122 -2.391 . . . . 1.0 107.122 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.65 ' OG ' ' CB ' ' A' ' 113' ' ' GLU . 3.5 m -174.71 154.01 1.89 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.099 -1.236 . . . . 1.0 110.721 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.576 ' CB ' ' HD2' ' A' ' 129' ' ' PRO . 0.0 OUTLIER -80.32 -176.87 0.81 Allowed Pre-proline 0 N--CA 1.487 1.406 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.58 ' O ' ' HB3' ' A' ' 130' ' ' LEU . 36.0 Cg_endo -63.23 -60.02 0.19 Allowed 'Trans proline' 0 C--N 1.301 -1.96 0 N-CA-C 108.086 -1.544 . . . . 1.0 108.086 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HB3' ' O ' ' A' ' 129' ' ' PRO . 3.4 pp 152.56 -164.04 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 115.97 -0.559 . . . . 1.0 109.631 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.479 ' N ' HD12 ' A' ' 130' ' ' LEU . . . 77.45 -73.16 2.07 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.863 -1.295 . . . . 1.0 109.863 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 84' ' ' LEU . . . -64.43 75.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.267 -1.137 . . . . 1.0 110.199 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 131' ' ' GLY . 7.0 m -86.97 -23.82 24.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 1.0 110.133 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 134' ' ' GLN . 0.8 OUTLIER -100.43 121.49 41.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 1.0 110.124 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.78 HD11 ' CG ' ' A' ' 67' ' ' ASP . 3.1 tm? -155.81 106.68 2.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 1.0 109.808 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.424 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 11.0 m-20 -67.63 136.73 54.87 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 1.0 110.429 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.0 OUTLIER -157.4 106.21 2.13 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 1.0 110.255 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.553 ' CB ' ' O ' ' A' ' 137' ' ' THR . 2.6 p30 161.28 -32.53 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.589 -0.695 . . . . 1.0 109.785 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 138' ' ' ASP . . . -53.22 -21.38 11.62 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -143.64 164.89 29.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.911 -1.346 . . . . 1.0 110.637 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.465 HD12 ' N ' ' A' ' 142' ' ' TRP . 9.1 tp -160.13 142.49 13.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 1.0 110.754 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 25.5 m95 -132.23 147.27 52.4 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.172 -1.418 . . . . 1.0 107.172 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.94 HD23 HD12 ' A' ' 57' ' ' LEU . 1.4 tm? -153.1 117.72 5.0 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 117.705 -1.598 . . . . 1.0 113.305 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.622 ' N ' HD13 ' A' ' 143' ' ' LEU . . . 119.38 5.12 11.59 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.323 -1.111 . . . . 1.0 110.323 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 139.89 -133.31 5.98 Favored Glycine 0 C--N 1.289 -2.075 0 C-N-CA 118.624 -1.751 . . . . 1.0 109.668 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.64 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.5 OUTLIER -168.99 142.18 2.81 Favored 'General case' 0 C--N 1.287 -2.127 0 C-N-CA 119.609 -0.836 . . . . 1.0 111.515 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.545 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 4.6 tm-20 -71.72 -26.98 62.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.51 -1.293 . . . . 1.0 107.51 177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.501 ' O ' ' CG ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -142.82 80.36 1.69 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.845 HD23 ' O ' ' A' ' 159' ' ' TYR . 0.3 OUTLIER -69.83 36.44 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.406 -0.809 . . . . 1.0 113.178 -176.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -71.27 -11.13 60.75 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.669 HG21 ' CZ2' ' A' ' 58' ' ' TRP 0.26 10.5 p -79.74 -9.64 12.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.212 -0.903 . . . . 1.0 110.676 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.533 ' O ' ' C ' ' A' ' 153' ' ' HIS . . . -70.11 51.99 0.12 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 1.0 109.867 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.665 ' N ' ' CD2' ' A' ' 153' ' ' HIS . 1.8 p80 4.26 -86.29 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.688 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -160.77 100.2 1.27 Allowed 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 123.299 1.523 . . . . 1.0 109.19 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.783 HD21 ' HD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -154.0 175.54 2.99 Favored Pre-proline 0 C--N 1.283 -2.314 0 O-C-N 120.843 -1.16 . . . . 1.0 109.756 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.732 ' O ' HD22 ' A' ' 155' ' ' LEU . 37.0 Cg_endo -61.29 -178.14 0.25 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 122.851 0.921 . . . . 1.0 111.572 -178.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -55.61 -11.51 0.93 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.383 -0.823 . . . . 1.0 112.064 -178.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.699 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -36.23 -43.77 0.37 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.235 -0.915 . . . . 1.0 109.859 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.845 ' O ' HD23 ' A' ' 149' ' ' LEU . 8.9 m-85 -86.4 -27.7 24.03 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.025 -1.047 . . . . 1.0 109.384 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -75.8 -3.49 35.28 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.657 -1.217 . . . . 1.0 108.243 177.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.582 HG22 ' O ' ' A' ' 161' ' ' THR . 1.8 m -135.35 91.53 2.74 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.819 -0.808 . . . . 1.0 108.819 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -44.26 170.73 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.069 -1.212 . . . . 1.0 110.069 -178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.657 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 13.3 t80 -74.18 147.15 42.82 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.146 -1.208 . . . . 1.0 112.295 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.772 HG22 ' O ' ' A' ' 164' ' ' ILE . 3.6 mt -124.28 87.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.657 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -172.64 -153.9 9.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.147 -1.581 . . . . 1.0 109.147 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 48' ' ' LYS . 39.4 m -130.5 146.29 52.01 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.387 -1.066 . . . . 1.0 110.457 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.854 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.5 mt -129.62 150.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.348 -0.845 . . . . 1.0 110.655 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.497 ' O ' HG13 ' A' ' 170' ' ' VAL . 9.4 ttt180 -159.49 168.47 26.12 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.012 -1.055 . . . . 1.0 110.452 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 14.2 m-20 44.63 58.87 3.64 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.267 -0.895 . . . . 1.0 110.38 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.994 HG12 ' CB ' ' A' ' 45' ' ' LEU . 24.2 m -114.19 121.73 66.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 C-N-CA 119.66 -0.816 . . . . 1.0 109.677 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.52 HG13 ' C ' ' A' ' 170' ' ' VAL . 1.0 OUTLIER -134.49 155.74 39.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.977 -1.089 . . . . 1.0 111.352 -178.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.887 HG22 ' CD1' ' A' ' 43' ' ' PHE . 3.2 t -134.72 106.48 7.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.595 -1.261 . . . . 1.0 107.595 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 53.8 m-20 49.91 36.57 11.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.334 -1.479 . . . . 1.0 107.302 -177.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 76.33 22.33 1.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.841 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 176' ' ' GLU . 21.6 mt-30 -99.34 -171.94 2.17 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 120.941 -1.1 . . . . 1.0 110.408 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.616 ' HG2' HG23 ' A' ' 170' ' ' VAL . 10.5 tt0 72.49 -102.77 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.675 -0.641 . . . . 1.0 110.801 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 1.1 mt 68.6 -92.98 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.43 -0.794 . . . . 1.0 112.479 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.495 ' O ' ' HB2' ' A' ' 181' ' ' GLU . 88.3 m-70 -89.51 103.86 16.46 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.667 -1.271 . . . . 1.0 112.486 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 179' ' ' LEU . 0.1 OUTLIER -68.67 -48.71 63.26 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.744 -1.206 . . . . 1.0 107.744 177.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.449 ' O ' HD12 ' A' ' 184' ' ' LEU . 10.3 t -47.5 -26.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 1.0 110.004 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 178' ' ' HIS . 0.6 OUTLIER -72.11 -60.64 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -0.926 . . . . 1.0 110.898 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.581 ' HB3' ' CD1' ' A' ' 27' ' ' TYR . 0.8 OUTLIER -92.93 -15.81 25.88 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.007 -1.058 . . . . 1.0 110.397 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -71.69 -34.92 70.05 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 184' ' ' LEU . 12.7 mt -51.06 -21.15 1.7 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.533 -0.729 . . . . 1.0 109.207 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 16.9 t-20 -42.71 -27.8 0.2 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.006 0.907 . . . . 1.0 108.701 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 187' ' ' PRO . 2.4 t30 -131.2 146.32 61.57 Favored Pre-proline 0 C--N 1.3 -1.569 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.541 ' O ' HG22 ' A' ' 188' ' ' THR . 42.7 Cg_endo -68.06 -157.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.866 0 O-C-N 123.765 1.402 . . . . 1.0 110.853 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 187' ' ' PRO . 0.4 OUTLIER 63.54 9.98 4.6 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 1.0 110.514 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 189' ' ' ILE . 30.7 mm -68.53 94.47 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 1.0 109.951 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.98 164.14 12.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.192 -0.942 . . . . 1.0 110.597 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -108.15 154.25 22.0 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.214 -0.929 . . . . 1.0 110.092 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . . . . . . . . . 6.5 t -80.19 140.91 36.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.157 -0.965 . . . . 1.0 110.563 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 58.7 m -102.29 160.5 14.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.343 -0.848 . . . . 1.0 110.298 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 179.62 49.79 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.215 -0.928 . . . . 1.0 110.361 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 118.714 -1.195 . . . . 1.0 110.519 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.524 -1.43 . . . . 1.0 109.524 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.7 p -137.66 -67.84 0.48 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -1.121 . . . . 1.0 110.194 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.83 179.19 7.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 1.0 110.268 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -105.41 -160.4 0.75 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.349 -0.844 . . . . 1.0 109.934 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.687 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.4 p -61.89 116.42 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -0.938 . . . . 1.0 109.607 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 6' ' ' ILE . 1.7 tp -141.47 104.62 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 1.0 110.466 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 7' ' ' ILE . 4.5 mp -114.08 156.05 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.266 -0.896 . . . . 1.0 109.614 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.469 ' OE2' HD11 ' A' ' 6' ' ' ILE . 25.5 mm-40 -134.73 110.72 9.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.114 -0.991 . . . . 1.0 110.857 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 16.4 ptpt -125.44 137.67 53.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.044 -1.035 . . . . 1.0 109.603 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -121.7 127.28 50.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 1.0 110.274 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.46 48.22 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 1.0 110.119 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.549 ' O ' ' CB ' ' A' ' 13' ' ' ASP . . . 137.64 -112.69 0.93 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.816 -1.313 . . . . 1.0 109.816 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.756 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 2.0 t70 75.21 -6.3 1.99 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.49 -1.006 . . . . 1.0 110.849 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.756 ' HB2' ' O ' ' A' ' 13' ' ' ASP . . . 164.54 77.22 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.212 -0.93 . . . . 1.0 109.657 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.529 ' O ' ' CD ' ' A' ' 168' ' ' ARG . 0.4 OUTLIER -133.11 -166.33 1.75 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.141 -0.975 . . . . 1.0 109.967 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -138.44 168.3 20.05 Favored 'General case' 0 C--N 1.291 -1.942 0 O-C-N 121.741 -0.599 . . . . 1.0 109.839 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 191' ' ' HIS . 13.3 mm -134.11 109.84 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 1.0 110.137 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.787 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -73.25 129.83 38.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.539 -0.726 . . . . 1.0 109.934 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.586 ' CZ ' HD13 ' A' ' 167' ' ' ILE . 3.0 m-30 -95.68 133.49 39.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.404 -0.81 . . . . 1.0 109.326 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.16 -1.09 54.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -0.948 . . . . 1.0 110.673 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.08 -7.39 62.44 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.288 -1.525 . . . . 1.0 109.288 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -122.02 7.13 9.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.206 -1.173 . . . . 1.0 109.904 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.575 ' O ' ' CD1' ' A' ' 24' ' ' TYR . 8.9 t -81.63 164.45 21.84 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.995 0.902 . . . . 1.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.575 ' CD1' ' O ' ' A' ' 23' ' ' THR . 6.0 m-30 -142.8 94.18 2.61 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.813 -0.631 . . . . 1.0 109.803 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.535 ' HG3' ' CZ ' ' A' ' 19' ' ' PHE . 2.4 mmt -94.21 101.63 13.62 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.841 -1.162 . . . . 1.0 109.795 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -117.65 120.54 38.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.368 -0.832 . . . . 1.0 110.361 -179.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 27' ' ' TYR . 2.9 m-85 -115.03 110.89 20.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 109.836 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -101.57 85.18 2.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.08 -1.013 . . . . 1.0 110.511 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -112.8 163.17 14.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 1.0 109.982 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.27 94.5 4.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.914 . . . . 1.0 110.24 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG23 ' N ' ' A' ' 32' ' ' THR . 17.3 m -45.41 -41.78 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.256 -0.902 . . . . 1.0 110.335 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.509 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -178.4 107.38 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.28 -0.887 . . . . 1.0 110.004 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.76 86.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 1.0 110.394 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.75 -77.63 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.353 -0.842 . . . . 1.0 110.123 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -125.63 -41.95 1.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -0.923 . . . . 1.0 110.231 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 136' ' ' ASP . 0.9 OUTLIER 47.08 43.55 14.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.245 -0.909 . . . . 1.0 110.63 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.802 ' HB1' ' OE1' ' A' ' 134' ' ' GLN . . . -141.91 87.6 2.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.471 -0.768 . . . . 1.0 109.592 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.516 ' O ' ' HB3' ' A' ' 39' ' ' GLN . 2.8 mp -100.67 54.48 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 1.0 111.07 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 38' ' ' LEU . 7.0 tt0 64.12 -58.03 0.22 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.656 0.741 . . . . 1.0 111.33 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.567 ' CB ' ' O ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -127.89 163.75 23.76 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.369 -0.832 . . . . 1.0 110.982 -179.38 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.97 155.67 20.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.45 -0.781 . . . . 1.0 109.748 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.533 ' O ' HG23 ' A' ' 172' ' ' VAL . 14.8 m-70 -123.48 133.39 54.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.987 -1.071 . . . . 1.0 110.486 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.814 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 28.9 m-85 -136.76 117.09 13.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.399 -0.813 . . . . 1.0 109.926 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.715 ' C ' HD23 ' A' ' 45' ' ' LEU . 9.6 mt-10 -125.62 145.59 50.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.901 -1.124 . . . . 1.0 110.443 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.749 ' HB2' HG12 ' A' ' 170' ' ' VAL . 0.9 OUTLIER 179.79 154.2 0.52 Allowed 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.822 -0.751 . . . . 1.0 110.718 179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.497 ' C ' ' CG2' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -118.65 152.7 35.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.977 HD13 HD11 ' A' ' 105' ' ' ILE . 4.0 pt -148.67 160.26 6.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 117.81 -1.556 . . . . 1.0 112.697 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.644 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.0 OUTLIER -114.63 83.79 1.95 Allowed 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.332 -1.729 . . . . 1.0 106.332 177.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.495 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -66.97 150.87 48.64 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.042 0.925 . . . . 1.0 112.594 -176.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.853 ' HB2' HG22 ' A' ' 164' ' ' ILE . 4.5 mm-40 -140.85 2.99 1.81 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.863 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -147.25 125.64 12.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 1.0 110.12 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.452 ' HB ' ' N ' ' A' ' 76' ' ' GLY . 74.1 p -57.07 -14.95 4.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.473 -0.767 . . . . 1.0 111.408 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.615 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -128.76 132.01 47.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.936 -1.103 . . . . 1.0 111.452 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 166.66 136.28 2.0 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.397 -1.382 . . . . 1.0 110.719 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.732 ' HB2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -89.64 118.86 29.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -1.213 . . . . 1.0 108.326 178.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.812 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -92.86 -31.14 4.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.756 -176.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.085 HD13 HD12 ' A' ' 71' ' ' LEU . 4.9 tt -147.3 151.47 36.66 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.664 -1.272 . . . . 1.0 112.605 -176.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 1.154 ' CZ3' HG21 ' A' ' 151' ' ' VAL . 0.6 OUTLIER -161.24 124.28 3.2 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.686 178.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.73 ' HB3' HD11 ' A' ' 69' ' ' ILE . 1.0 OUTLIER -121.89 156.57 33.03 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.951 -1.093 . . . . 1.0 109.719 178.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.1 133.45 3.2 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.148 -1.581 . . . . 1.0 109.148 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.547 ' CB ' ' HB3' ' A' ' 138' ' ' ASP . 18.2 tttt -85.02 40.19 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -1.218 . . . . 1.0 110.446 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . 61.14 131.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.23 -1.148 . . . . 1.0 110.23 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 66' ' ' SER . 1.1 mt 176.25 174.87 0.32 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -1.071 . . . . 1.0 109.963 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -105.62 11.11 32.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 1.0 110.538 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.6 ptt-85 179.33 59.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.03 -1.044 . . . . 1.0 109.71 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -140.79 152.43 45.2 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 119.55 -0.86 . . . . 1.0 110.514 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 2.9 m-20 -113.89 -48.97 2.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.088 -1.008 . . . . 1.0 110.382 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.741 ' CE2' HD11 ' A' ' 135' ' ' LEU . 0.3 OUTLIER 79.37 -89.24 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.619 -0.676 . . . . 1.0 110.53 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -159.19 176.82 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.315 -1.491 . . . . 1.0 111.315 -179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.03 ' CB ' ' HE3' ' A' ' 81' ' ' MET . . . -172.37 174.36 3.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.723 -0.611 . . . . 1.0 109.518 178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.085 HD12 HD13 ' A' ' 57' ' ' LEU . 78.4 mt -146.16 95.57 2.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.01 -1.056 . . . . 1.0 109.139 -178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.586 ' CB ' ' HA ' ' A' ' 55' ' ' LEU . . . -115.53 177.13 4.78 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.505 -0.747 . . . . 1.0 112.112 -178.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 53' ' ' GLN . 2.5 mt -117.81 138.2 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.767 -0.583 . . . . 1.0 110.025 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -142.39 133.25 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.42 -0.8 . . . . 1.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 3.3 m-20 61.62 23.86 14.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.068 -1.02 . . . . 1.0 111.432 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 84.39 18.66 61.89 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.974 -1.25 . . . . 1.0 109.974 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.29 150.27 45.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -1.091 . . . . 1.0 108.901 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.812 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -91.45 -176.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.734 -1.228 . . . . 1.0 109.878 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.796 ' NE2' HG21 ' A' ' 90' ' ' VAL . 1.5 pt20 -174.11 136.37 0.5 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.357 -0.839 . . . . 1.0 110.836 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.756 ' HA ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -93.07 132.58 37.06 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.824 -0.75 . . . . 1.0 110.227 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 1.03 ' HE3' ' CB ' ' A' ' 70' ' ' ALA . 3.6 ttm -107.74 137.64 45.39 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.637 -0.664 . . . . 1.0 109.659 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.594 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -134.71 102.03 5.14 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.127 -0.983 . . . . 1.0 109.758 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.554 ' CB ' ' HB2' ' A' ' 67' ' ' ASP . 2.1 m-20 -110.79 34.35 4.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 1.0 109.652 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.804 HD12 ' HB1' ' A' ' 132' ' ' ALA . 0.4 OUTLIER -34.03 -29.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.731 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . -118.4 -41.31 0.63 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.756 -1.337 . . . . 1.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.4 OUTLIER 168.7 -28.18 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 1.0 109.743 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.497 ' HG3' ' CG ' ' A' ' 129' ' ' PRO . 12.4 mmmt -89.58 117.93 68.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.493 -0.754 . . . . 1.0 109.772 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HB3' ' OD2' ' A' ' 83' ' ' ASP . 51.1 Cg_endo -78.06 130.38 10.28 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.922 1.485 . . . . 1.0 111.927 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -109.27 126.63 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.949 -1.13 . . . . 1.0 107.949 178.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.796 HG21 ' NE2' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -109.04 123.27 64.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 120.447 -1.408 . . . . 1.0 111.865 -178.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.6 HD23 ' CE ' ' A' ' 80' ' ' MET . 0.3 OUTLIER -111.99 74.69 0.88 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.176 -1.416 . . . . 1.0 107.176 177.276 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.557 ' O ' HG21 ' A' ' 124' ' ' ILE . 0.8 OUTLIER -57.9 178.65 0.08 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.311 -0.956 . . . . 1.0 110.492 -178.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.488 ' OG ' HG21 ' A' ' 118' ' ' VAL 0.251 2.4 t -108.23 151.19 26.27 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.549 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.47 ' CG2' HD11 ' A' ' 124' ' ' ILE . 0.7 OUTLIER -103.63 26.18 8.84 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.253 -0.904 . . . . 1.0 109.73 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.554 HG12 ' HD2' ' A' ' 96' ' ' PRO . 2.4 t -128.57 146.98 62.2 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.508 -0.745 . . . . 1.0 109.146 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.554 ' HD2' HG12 ' A' ' 95' ' ' VAL . 40.8 Cg_endo -65.64 124.52 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.538 1.283 . . . . 1.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 98' ' ' ASN . 6.6 tp -109.95 -39.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 1.0 110.655 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.499 ' N ' ' CG2' ' A' ' 97' ' ' ILE . 6.3 p-10 -67.56 63.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 1.0 110.635 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.685 HG23 ' CG ' ' A' ' 101' ' ' HIS . 15.0 t -124.09 11.19 8.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.102 -0.999 . . . . 1.0 110.345 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 0.2 OUTLIER 57.45 33.08 22.79 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.948 -1.095 . . . . 1.0 110.447 179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.685 ' CG ' HG23 ' A' ' 99' ' ' THR . 5.7 m-70 -121.65 179.36 4.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 1.0 109.8 179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.644 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 17.0 m95 -98.18 100.96 12.3 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.029 -1.044 . . . . 1.0 110.175 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.564 HG22 ' N ' ' A' ' 104' ' ' HIS . 9.7 m -96.43 170.7 9.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.362 -0.836 . . . . 1.0 109.429 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.564 ' N ' HG22 ' A' ' 103' ' ' THR . 6.9 t60 -122.15 120.83 35.37 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 107.682 -1.229 . . . . 1.0 107.682 179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.977 HD11 HD13 ' A' ' 47' ' ' ILE . 0.8 OUTLIER -107.92 146.65 13.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 O-C-N 120.937 -1.102 . . . . 1.0 109.456 -178.598 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.658 ' O ' HD22 ' A' ' 116' ' ' LEU . 6.9 tptm -142.38 142.09 32.38 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.318 -0.953 . . . . 1.0 109.527 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -137.03 110.09 7.73 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.966 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.613 ' CD1' ' O ' ' A' ' 108' ' ' TYR . 4.5 p90 -111.14 110.36 20.85 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.365 -0.976 . . . . 1.0 108.365 178.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.567 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -99.62 141.05 32.93 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 120.031 -0.668 . . . . 1.0 111.194 -178.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 5.9 t -127.55 97.61 4.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.628 -0.67 . . . . 1.0 109.199 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.453 ' O ' ' NH1' ' A' ' 109' ' ' ARG . 2.0 mt-30 58.26 -134.54 1.04 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.355 -0.841 . . . . 1.0 110.828 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.2 OUTLIER -70.81 -11.41 60.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.984 -1.072 . . . . 1.0 110.863 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.586 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -104.4 123.24 47.09 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.178 -0.951 . . . . 1.0 110.505 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.526 ' CA ' ' HG2' ' A' ' 109' ' ' ARG . . . -114.41 163.66 12.15 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.296 -0.954 . . . . 1.0 110.961 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.573 ' O ' ' CE ' ' A' ' 80' ' ' MET . 47.5 t -147.64 162.89 38.23 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.522 -0.987 . . . . 1.0 110.722 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.949 HD13 ' N ' ' A' ' 117' ' ' GLN 0.254 1.0 OUTLIER -139.5 157.08 46.44 Favored 'General case' 0 C--N 1.308 -1.218 0 O-C-N 121.177 -0.952 . . . . 1.0 108.892 -178.816 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.949 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -153.39 113.92 4.02 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.684 -1.26 . . . . 1.0 111.97 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 121' ' ' GLU . 16.8 t -70.22 100.35 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 106.534 -1.654 . . . . 1.0 106.534 176.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 65.86 37.08 92.98 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.513 -1.435 . . . . 1.0 109.513 -178.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.431 ' HA ' ' HB3' ' A' ' 117' ' ' GLN . 0.3 OUTLIER 61.38 38.58 16.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.252 -1.146 . . . . 1.0 110.704 179.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 9.6 mt-10 -108.47 -161.18 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.325 -0.859 . . . . 1.0 110.944 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -39.22 98.32 0.16 Allowed Pre-proline 0 N--CA 1.496 1.842 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 45.8 Cg_endo -77.43 142.96 21.47 Favored 'Trans proline' 0 C--N 1.3 -1.982 0 O-C-N 124.068 1.562 . . . . 1.0 112.394 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.557 HG21 ' O ' ' A' ' 92' ' ' ARG . 1.1 mp -106.05 110.43 31.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.877 -1.527 . . . . 1.0 106.877 177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.561 ' C ' HD11 ' A' ' 91' ' ' LEU . 7.2 p -105.81 177.52 4.83 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 122.375 1.083 . . . . 1.0 112.146 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.597 ' N ' HD11 ' A' ' 91' ' ' LEU . . . 170.78 160.98 20.62 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 106.834 -2.507 . . . . 1.0 106.834 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.586 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -139.28 168.52 19.63 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 120.735 -1.45 . . . . 1.0 110.892 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.2 p -87.2 -179.73 1.47 Allowed Pre-proline 0 N--CA 1.491 1.621 0 C-N-CA 119.515 -0.874 . . . . 1.0 110.037 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.497 ' CG ' ' HG3' ' A' ' 87' ' ' LYS . 46.2 Cg_endo -77.49 48.25 2.52 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.837 1.441 . . . . 1.0 109.675 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 129' ' ' PRO . 0.9 OUTLIER 46.46 -176.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.614 -0.679 . . . . 1.0 110.5 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.689 ' O ' ' HB2' ' A' ' 132' ' ' ALA . . . 79.05 88.63 0.46 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.832 -1.307 . . . . 1.0 109.832 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.804 ' HB1' HD12 ' A' ' 84' ' ' LEU . . . 170.02 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.275 -1.132 . . . . 1.0 110.166 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 59.11 90.16 0.05 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 1.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.802 ' OE1' ' HB1' ' A' ' 37' ' ' ALA . 0.0 OUTLIER 44.94 -160.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 1.0 110.309 179.593 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.741 HD11 ' CE2' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -175.72 97.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.377 -0.827 . . . . 1.0 110.309 179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 3.1 m-20 -52.17 -179.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.216 -0.928 . . . . 1.0 109.213 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 137' ' ' THR . 8.1 t -129.1 121.06 27.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.085 -1.01 . . . . 1.0 109.695 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.901 ' OD2' ' HB3' ' A' ' 140' ' ' ALA . 4.4 p-10 -60.93 -3.56 0.8 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 1.0 111.05 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 65.9 9.12 45.19 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 108.841 -1.704 . . . . 1.0 108.841 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.901 ' HB3' ' OD2' ' A' ' 138' ' ' ASP . . . -102.31 132.2 48.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -1.127 . . . . 1.0 108.394 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.989 ' CD1' HD21 ' A' ' 57' ' ' LEU . 9.5 tp -141.14 148.79 40.6 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.764 -1.174 . . . . 1.0 111.651 -178.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.548 ' CD1' ' N ' ' A' ' 142' ' ' TRP . 24.2 m95 -130.88 119.46 22.21 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.701 -1.592 . . . . 1.0 106.701 178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 1.0 HD13 HD12 ' A' ' 57' ' ' LEU . 8.3 tp -125.13 118.83 26.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 117.934 -1.506 . . . . 1.0 113.539 -177.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 121.81 8.8 7.25 Favored Glycine 0 N--CA 1.48 1.627 0 C-N-CA 119.99 -1.1 . . . . 1.0 110.672 176.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.582 ' O ' ' HE3' ' A' ' 146' ' ' MET . . . 148.33 -148.44 19.92 Favored Glycine 0 C--N 1.285 -2.264 0 C-N-CA 118.373 -1.87 . . . . 1.0 109.08 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.714 ' CB ' HD13 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -152.82 148.06 26.76 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.37 -0.932 . . . . 1.0 112.881 -178.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.42 ' C ' ' HG2' ' A' ' 148' ' ' ARG . 12.1 tt0 -93.9 19.92 8.37 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.42 ' HG2' ' C ' ' A' ' 147' ' ' GLU . 2.0 ptm180 173.16 68.65 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.555 -1.646 . . . . 1.0 106.555 -179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.791 HD11 ' CD2' ' A' ' 159' ' ' TYR . 1.4 tp -73.46 36.03 0.08 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.479 -0.763 . . . . 1.0 112.706 -177.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.1 p -71.69 -13.67 61.8 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 105.795 -1.928 . . . . 1.0 105.795 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 1.154 HG21 ' CZ3' ' A' ' 58' ' ' TRP 0.257 7.1 p -76.28 -110.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 114.889 -1.051 . . . . 1.0 109.875 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.693 ' HB2' ' CD2' ' A' ' 159' ' ' TYR . . . 50.0 39.1 18.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.308 -1.495 . . . . 1.0 108.946 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.917 ' CE1' HD23 ' A' ' 155' ' ' LEU . 1.5 p80 13.39 -98.41 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.786 0.661 . . . . 1.0 112.786 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 5.74 2.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.032 -1.042 . . . . 1.0 111.821 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.917 HD23 ' CE1' ' A' ' 153' ' ' HIS . 2.7 pp -60.63 178.81 0.24 Allowed Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.197 -0.939 . . . . 1.0 110.979 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 155' ' ' LEU . 46.4 Cg_endo -83.01 -159.49 0.11 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 O-C-N 123.461 1.243 . . . . 1.0 112.681 -178.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.0 OUTLIER -51.01 -13.08 0.13 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 113.042 0.756 . . . . 1.0 113.042 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.601 ' N ' ' HG2' ' A' ' 53' ' ' GLN . . . -37.69 -45.64 0.81 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.013 -1.055 . . . . 1.0 109.707 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.86 ' CE1' HD21 ' A' ' 155' ' ' LEU . 4.3 m-85 -84.57 -28.98 26.23 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.204 -0.935 . . . . 1.0 109.111 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.541 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -70.38 -8.53 51.41 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.246 -1.382 . . . . 1.0 108.402 178.261 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 161' ' ' THR . 1.3 m -128.47 98.47 5.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -50.1 -178.19 0.02 OUTLIER Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.761 -1.336 . . . . 1.0 109.761 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.609 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 71.0 t80 -83.01 144.72 29.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.909 -1.347 . . . . 1.0 112.262 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.853 HG22 ' HB2' ' A' ' 50' ' ' GLU . 1.6 mt -127.57 88.67 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.609 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.94 -157.39 13.71 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.743 -1.743 . . . . 1.0 108.743 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 48' ' ' LYS . 1.7 m -128.59 145.45 51.13 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.128 -1.219 . . . . 1.0 109.802 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.586 HD13 ' CZ ' ' A' ' 19' ' ' PHE . 3.4 mt -130.28 147.4 33.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 O-C-N 121.437 -0.789 . . . . 1.0 110.423 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.529 ' CD ' ' O ' ' A' ' 15' ' ' GLU . 0.3 OUTLIER -159.48 156.12 27.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.086 -1.009 . . . . 1.0 110.351 -179.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 17.8 m-20 51.38 81.01 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.321 -0.862 . . . . 1.0 110.411 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.749 HG12 ' HB2' ' A' ' 45' ' ' LEU 0.251 25.7 m -122.43 130.62 74.39 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.017 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.44 HG22 ' C ' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -145.04 141.4 22.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.102 -1.039 . . . . 1.0 111.649 -176.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 42' ' ' HIS . 1.3 p -127.0 119.34 52.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 173' ' ' ASP . 1.5 m-20 62.14 30.53 17.78 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.164 -1.05 . . . . 1.0 108.164 -177.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.481 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 71.23 32.09 2.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.756 -0.59 . . . . 1.0 110.451 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 71.9 mm-40 -104.73 120.13 40.63 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.354 -0.841 . . . . 1.0 110.064 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -78.55 110.97 14.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.374 -0.829 . . . . 1.0 109.556 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 179' ' ' LEU . 83.8 mt -78.81 96.21 5.57 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 1.0 111.31 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.586 ' CB ' ' HB2' ' A' ' 181' ' ' GLU . 46.8 m-70 -39.21 98.85 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.045 0.926 . . . . 1.0 110.247 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.777 ' O ' ' HB3' ' A' ' 183' ' ' ALA . 8.9 mt -49.09 -59.57 3.53 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.924 0.869 . . . . 1.0 112.963 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.781 ' HA ' HD23 ' A' ' 184' ' ' LEU . 86.7 t -75.52 -28.52 19.98 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 113.541 0.941 . . . . 1.0 113.541 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.586 ' HB2' ' CB ' ' A' ' 178' ' ' HIS . 1.0 OUTLIER -58.64 -50.51 73.58 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 112.284 -178.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 185' ' ' ASN . 0.3 OUTLIER -108.19 -28.51 9.43 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.946 -1.096 . . . . 1.0 111.535 -178.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 179' ' ' LEU . . . -63.05 -25.08 68.21 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 117.853 -1.539 . . . . 1.0 108.601 179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.804 HD13 HG13 ' A' ' 189' ' ' ILE . 1.4 mm? -70.43 -2.19 13.05 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.438 -0.789 . . . . 1.0 110.303 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 0.2 OUTLIER -55.65 -29.62 59.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 1.0 109.469 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.48 ' CG ' ' HD2' ' A' ' 187' ' ' PRO . 2.7 t-20 -88.09 151.32 49.07 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.866 ' O ' HG22 ' A' ' 188' ' ' THR . 38.3 Cg_endo -64.77 149.47 89.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.45 1.237 . . . . 1.0 109.684 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.866 HG22 ' O ' ' A' ' 187' ' ' PRO . 5.2 t 49.34 148.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 122.272 1.034 . . . . 1.0 112.116 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.804 HG13 HD13 ' A' ' 184' ' ' LEU . 33.6 mm -144.71 113.06 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.097 -1.002 . . . . 1.0 110.184 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.25 176.48 6.3 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.053 -1.03 . . . . 1.0 109.349 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.559 ' O ' ' N ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -115.96 -60.99 1.8 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.7 -1.2 . . . . 1.0 111.264 -179.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.787 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 0.9 OUTLIER 178.25 162.4 0.65 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.422 -0.799 . . . . 1.0 110.195 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.713 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 1.4 m -131.0 148.37 52.74 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.146 -0.971 . . . . 1.0 109.886 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 167.17 41.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.18 -0.95 . . . . 1.0 110.395 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.291 -1.978 0 C-N-CA 118.701 -1.199 . . . . 1.0 110.528 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.665 -1.374 . . . . 1.0 109.665 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -117.57 89.04 3.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.274 -1.133 . . . . 1.0 110.349 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.451 ' O ' ' O ' ' A' ' 4' ' ' LYS . 2.2 tt0 -91.75 -67.14 0.87 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.164 -0.96 . . . . 1.0 110.255 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.451 ' O ' ' O ' ' A' ' 3' ' ' GLU . 19.6 mtpp 48.87 -178.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.347 -0.846 . . . . 1.0 110.372 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' O ' HG12 ' A' ' 5' ' ' VAL . 17.0 t -83.5 102.04 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.28 -0.887 . . . . 1.0 110.321 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 tt -97.86 142.93 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 1.0 110.057 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 pt -94.53 146.88 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.224 -0.923 . . . . 1.0 110.406 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -109.96 108.84 19.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.22 -0.925 . . . . 1.0 110.274 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -49.72 133.0 21.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.875 . . . . 1.0 110.363 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -103.37 117.34 34.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.231 -0.918 . . . . 1.0 110.222 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.72 78.55 0.44 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 1.0 110.584 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.12 131.61 10.64 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.364 -1.494 . . . . 1.0 109.364 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -132.15 -62.15 0.85 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.057 -1.261 . . . . 1.0 110.839 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 13' ' ' ASP . . . 177.77 93.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.948 -1.095 . . . . 1.0 110.817 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.646 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 3.3 pt-20 -35.35 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.196 0.998 . . . . 1.0 110.157 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' N ' ' O ' ' A' ' 14' ' ' ALA . . . -84.02 137.15 33.75 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 120.333 -1.479 . . . . 1.0 111.231 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.617 HG21 ' HE1' ' A' ' 25' ' ' MET . 12.2 mm -117.43 131.25 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.184 -0.948 . . . . 1.0 109.273 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.57 ' HB2' ' SG ' ' A' ' 192' ' ' CYS . . . -90.09 131.85 35.73 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.46 -0.775 . . . . 1.0 110.792 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.962 ' CE1' HD12 ' A' ' 167' ' ' ILE . 62.3 m-85 -101.51 177.02 5.04 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.712 -1.243 . . . . 1.0 109.29 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.468 ' C ' HG13 ' A' ' 164' ' ' ILE . 11.1 p-10 -141.92 -11.6 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.678 -1.264 . . . . 1.0 112.842 -178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.655 ' HA2' ' O ' ' A' ' 162' ' ' GLY . . . 111.64 -11.69 27.84 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 118.95 -1.595 . . . . 1.0 109.144 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 22' ' ' ARG . 3.6 ttp-105 -135.15 10.8 3.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.22 -1.165 . . . . 1.0 111.504 -179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 53.1 m -112.81 121.17 43.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 1.0 110.627 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 24' ' ' TYR . 1.9 p90 -104.02 122.25 44.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 1.0 110.256 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.617 ' HE1' HG21 ' A' ' 17' ' ' ILE . 3.2 mtp -119.45 98.41 6.12 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.937 -1.105 . . . . 1.0 108.307 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.6 ' HB3' ' CE3' ' A' ' 142' ' ' TRP . 0.8 OUTLIER -103.08 145.12 30.38 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.707 -0.797 . . . . 1.0 110.027 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.65 ' HA ' ' CB ' ' A' ' 182' ' ' ASP . 4.6 m-85 -126.1 116.52 21.5 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.011 -1.076 . . . . 1.0 110.477 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' ND1' ' O ' ' A' ' 139' ' ' GLY . 19.8 t60 -96.99 99.98 11.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.735 . . . . 1.0 110.004 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -87.6 131.32 34.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 1.0 110.03 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.16 95.37 8.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 1.0 110.194 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t -66.77 -29.66 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.312 -0.868 . . . . 1.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 35' ' ' GLU . 1.8 t -178.36 177.44 0.96 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.093 -1.005 . . . . 1.0 110.719 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 34' ' ' SER . 3.5 pttp -63.77 94.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.428 -0.795 . . . . 1.0 110.818 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 33' ' ' LYS . 0.5 OUTLIER 37.35 56.29 1.37 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.706 -0.622 . . . . 1.0 110.965 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' O ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -145.38 84.88 1.7 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.2 -0.937 . . . . 1.0 110.107 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -122.28 132.01 54.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.311 -0.868 . . . . 1.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 36' ' ' LYS . . . 178.67 111.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.13 -0.981 . . . . 1.0 110.692 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.544 HD21 ' OD2' ' A' ' 138' ' ' ASP . 0.4 OUTLIER -137.42 -164.83 1.66 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 1.0 109.954 179.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -139.89 -15.41 1.02 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.123 -0.985 . . . . 1.0 111.475 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.521 ' OG ' ' NE2' ' A' ' 42' ' ' HIS . 1.2 p -126.82 104.87 8.28 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.247 -0.908 . . . . 1.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 109' ' ' ARG . 19.5 p-10 -85.65 142.75 28.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.529 -0.732 . . . . 1.0 110.222 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.673 ' O ' ' HA ' ' A' ' 172' ' ' VAL . 49.7 m-70 -131.15 111.59 12.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.258 -1.016 . . . . 1.0 108.258 179.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 9.2 m-85 -116.81 115.55 25.77 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.525 -0.734 . . . . 1.0 110.902 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.833 ' C ' HD23 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -124.97 144.42 50.38 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.037 -1.039 . . . . 1.0 109.174 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.013 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.4 OUTLIER -179.56 159.18 0.87 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.321 -0.952 . . . . 1.0 110.154 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 103' ' ' THR . 74.8 m -128.75 145.72 51.1 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.063 HG23 HD11 ' A' ' 105' ' ' ILE . 1.4 pt -124.72 -170.46 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 118.449 -1.3 . . . . 1.0 111.532 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.615 ' HD2' ' CD2' ' A' ' 102' ' ' TRP . 0.4 OUTLIER -148.11 146.13 28.67 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.343 -1.355 . . . . 1.0 107.343 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' ' O ' ' A' ' 48' ' ' LYS . 0.3 OUTLIER 46.1 -177.03 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.042 -1.063 . . . . 1.0 110.014 -178.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.101 ' HG3' HD13 ' A' ' 73' ' ' ILE . 8.3 tt0 -176.95 -22.75 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 O-C-N 121.376 -0.827 . . . . 1.0 110.55 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 50' ' ' GLU . . . 78.64 -3.62 2.23 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.931 -0.481 . . . . 1.0 110.088 -177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.767 HG23 ' C ' ' A' ' 51' ' ' ALA . 1.7 p 78.82 -19.97 0.41 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 121.312 0.577 . . . . 1.0 111.387 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.734 ' HG3' ' HB2' ' A' ' 158' ' ' ALA . 0.3 OUTLIER -143.91 124.26 13.86 Favored 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.324 -0.86 . . . . 1.0 109.881 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.618 ' O ' HD12 ' A' ' 73' ' ' ILE . . . 164.86 139.92 2.75 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.355 -1.498 . . . . 1.0 109.355 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.043 HD22 HD21 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -89.45 145.62 25.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.754 -1.439 . . . . 1.0 109.365 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.734 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -116.3 -4.61 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -174.727 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.995 HD13 HD12 ' A' ' 71' ' ' LEU . 2.8 tt -168.56 152.12 5.59 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 119.206 -2.184 . . . . 1.0 113.105 -177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.58 ' CD1' ' SD ' ' A' ' 146' ' ' MET . 1.5 t-105 -164.64 113.72 1.12 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.8 -0.562 . . . . 1.0 110.157 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 p -120.99 141.69 50.48 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.934 -1.104 . . . . 1.0 109.647 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.517 ' O ' ' CB ' ' A' ' 61' ' ' LYS . . . -99.12 -81.61 1.61 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.523 -1.431 . . . . 1.0 109.523 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.715 ' HE3' ' HB3' ' A' ' 140' ' ' ALA . 0.0 OUTLIER 73.8 91.15 0.09 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.444 -1.033 . . . . 1.0 110.711 -179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 135.92 -103.8 0.46 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.414 ' H ' ' HB3' ' A' ' 66' ' ' SER . 0.2 OUTLIER -117.04 -175.33 2.76 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.214 -1.168 . . . . 1.0 109.842 179.338 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -87.78 23.71 1.93 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.181 -0.949 . . . . 1.0 110.073 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.612 ' CG ' ' O ' ' A' ' 65' ' ' ARG 0.253 0.0 OUTLIER -159.13 24.26 0.2 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 123.002 1.382 . . . . 1.0 107.699 -179.269 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -87.92 -158.44 0.46 Allowed 'General case' 0 C--N 1.284 -2.254 0 O-C-N 120.829 -1.17 . . . . 1.0 111.948 -177.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.548 ' CB ' ' HA ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -47.26 155.61 0.3 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.879 -0.513 . . . . 1.0 112.009 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.739 ' CD2' ' HB3' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -124.03 102.5 7.78 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 118.874 -1.13 . . . . 1.0 110.242 178.184 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.74 HD12 ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -108.66 111.05 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 178.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.897 ' HB3' ' HE3' ' A' ' 81' ' ' MET . . . -138.44 -173.92 3.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 1.0 111.185 -178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.995 HD12 HD13 ' A' ' 57' ' ' LEU . 82.5 mt -153.31 110.83 3.52 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.666 ' HA ' ' HA ' ' A' ' 55' ' ' LEU . . . -126.95 176.19 7.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.75 -1.219 . . . . 1.0 111.321 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.101 HD13 ' HG3' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -124.46 140.22 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 O-C-N 121.365 -0.834 . . . . 1.0 111.621 -178.135 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.792 HG22 ' CG ' ' A' ' 75' ' ' ASP . 2.4 p -142.58 132.85 23.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.82 -0.55 . . . . 1.0 110.324 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.792 ' CG ' HG22 ' A' ' 74' ' ' VAL . 2.9 m-20 66.45 27.02 9.95 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.949 -1.094 . . . . 1.0 110.826 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 81.41 -5.36 68.49 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.182 -1.567 . . . . 1.0 109.182 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.0 m-30 -109.18 149.47 29.32 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.305 -1.114 . . . . 1.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.734 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -98.22 -169.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.739 -1.226 . . . . 1.0 109.647 179.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.513 ' HB2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER 178.12 126.47 0.05 Allowed 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.101 -1.0 . . . . 1.0 111.31 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.982 ' HE3' HD12 ' A' ' 91' ' ' LEU . 22.8 ttp -91.54 125.7 36.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 1.0 109.59 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.897 ' HE3' ' HB3' ' A' ' 70' ' ' ALA . 4.0 ptt? -112.56 128.87 56.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.947 -1.095 . . . . 1.0 110.491 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.616 ' HB2' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -118.58 121.21 39.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.373 -0.829 . . . . 1.0 110.211 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.739 ' HB3' ' CD2' ' A' ' 68' ' ' TYR . 4.2 t70 -126.99 46.54 2.49 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.607 0.718 . . . . 1.0 109.965 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.709 ' CB ' HD13 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -70.34 53.8 0.14 Allowed 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 119.995 -0.682 . . . . 1.0 110.005 179.631 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' C ' ' OG ' ' A' ' 86' ' ' SER . . . 161.77 -66.4 0.25 Allowed Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.961 -1.256 . . . . 1.0 109.961 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.417 ' OG ' ' C ' ' A' ' 85' ' ' GLY . 0.0 OUTLIER -169.03 -29.88 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.001 -1.294 . . . . 1.0 111.53 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -99.48 112.65 63.87 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.809 -1.182 . . . . 1.0 111.222 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -76.11 114.98 4.02 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.939 1.494 . . . . 1.0 109.708 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.632 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -93.1 105.17 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.248 -0.907 . . . . 1.0 110.458 -179.229 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -90.26 120.79 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 119.972 -1.705 . . . . 1.0 110.445 -179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.982 HD12 ' HE3' ' A' ' 80' ' ' MET . 33.6 mt -113.35 76.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.506 ' O ' HG21 ' A' ' 124' ' ' ILE . 21.6 mtp180 -57.87 179.15 0.07 Allowed 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 119.213 -0.995 . . . . 1.0 110.651 -178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.692 ' OG ' HG11 ' A' ' 118' ' ' VAL . 1.4 t -104.77 167.02 9.99 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.005 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.27 17.42 15.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.332 -0.855 . . . . 1.0 109.771 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.756 HG13 ' HD2' ' A' ' 96' ' ' PRO . 68.0 t -135.45 150.46 72.41 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.534 -0.729 . . . . 1.0 110.171 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.756 ' HD2' HG13 ' A' ' 95' ' ' VAL . 42.8 Cg_endo -68.85 139.08 42.51 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.796 1.419 . . . . 1.0 110.39 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.93 HG23 ' OE1' ' A' ' 50' ' ' GLU . 2.7 tt -129.17 -27.21 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 1.0 111.034 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.607 ' CB ' ' HB3' ' A' ' 50' ' ' GLU . 4.0 p30 -80.93 44.6 0.76 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.125 -0.984 . . . . 1.0 110.288 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 99' ' ' THR . 94.3 m -117.64 24.67 10.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.169 -0.957 . . . . 1.0 110.359 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 99' ' ' THR . 62.1 t30 59.77 41.16 18.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.217 -0.927 . . . . 1.0 110.388 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -130.02 137.69 50.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 1.0 109.832 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.615 ' CD2' ' HD2' ' A' ' 48' ' ' LYS . 3.9 m95 -61.93 91.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.002 -1.061 . . . . 1.0 110.315 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.61 HG22 ' N ' ' A' ' 104' ' ' HIS . 54.5 m -80.56 172.5 13.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.061 -1.024 . . . . 1.0 108.927 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.61 ' N ' HG22 ' A' ' 103' ' ' THR . 0.9 OUTLIER -129.99 106.59 8.75 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.111 -0.993 . . . . 1.0 108.672 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.063 HD11 HG23 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -97.64 136.57 28.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 O-C-N 121.094 -1.004 . . . . 1.0 109.2 -179.218 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.805 ' O ' HD22 ' A' ' 116' ' ' LEU . 1.3 tppt? -137.22 155.87 48.99 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 118.98 -1.088 . . . . 1.0 110.169 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -153.59 123.24 6.74 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.096 -1.002 . . . . 1.0 111.651 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.624 ' CD1' ' O ' ' A' ' 108' ' ' TYR . 41.6 p90 -126.24 112.16 15.42 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.114 -1.069 . . . . 1.0 108.114 177.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.538 ' NH1' ' N ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -120.53 154.8 34.83 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.369 -0.832 . . . . 1.0 110.432 -178.425 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 112' ' ' ARG . 2.4 t -128.65 95.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.166 -0.959 . . . . 1.0 110.721 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 112' ' ' ARG . 22.8 mt-30 34.71 24.58 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 178.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 111' ' ' GLN . 0.2 OUTLIER 173.2 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.486 -1.384 . . . . 1.0 110.437 179.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.558 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -97.72 117.91 33.07 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.566 -179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 109' ' ' ARG . . . -104.84 157.36 16.66 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.819 ' OG ' HG22 ' A' ' 125' ' ' THR . 38.7 t -135.69 157.59 46.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.452 -1.028 . . . . 1.0 109.949 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.068 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.3 tm? -137.19 153.1 50.5 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.848 -0.797 . . . . 1.0 108.848 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 1.068 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -158.59 128.12 5.72 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.538 -1.265 . . . . 1.0 111.617 179.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.692 HG11 ' OG ' ' A' ' 93' ' ' SER . 20.4 m -92.05 100.2 10.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 104' ' ' HIS . . . 68.62 42.49 80.28 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.366 -1.093 . . . . 1.0 110.366 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 10.6 m-80 58.06 31.69 21.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.244 -1.151 . . . . 1.0 111.073 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.598 ' O ' ' C ' ' A' ' 122' ' ' ALA . 1.3 tt0 -100.09 167.01 10.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.109 -0.994 . . . . 1.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.598 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -19.73 102.96 0.06 OUTLIER Pre-proline 0 N--CA 1.509 2.497 0 CA-C-O 120.989 0.423 . . . . 1.0 110.48 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 40.0 Cg_endo -69.24 131.38 21.85 Favored 'Trans proline' 0 C--N 1.302 -1.876 0 O-C-N 124.258 1.662 . . . . 1.0 112.478 -177.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.652 HD12 ' H ' ' A' ' 124' ' ' ILE . 4.5 mp -92.42 104.89 16.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 105.84 -1.911 . . . . 1.0 105.84 177.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.819 HG22 ' OG ' ' A' ' 115' ' ' SER . 32.7 p -118.55 160.98 20.8 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.902 -1.119 . . . . 1.0 112.401 -176.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.63 173.16 38.84 Favored Glycine 0 N--CA 1.481 1.689 0 N-CA-C 107.108 -2.397 . . . . 1.0 107.108 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.558 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -154.7 160.62 41.49 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.645 -1.503 . . . . 1.0 110.396 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.45 ' O ' ' CG ' ' A' ' 112' ' ' ARG . 50.1 m -105.71 160.86 24.62 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 118.955 -1.098 . . . . 1.0 109.248 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.564 ' O ' ' CB ' ' A' ' 130' ' ' LEU . 38.1 Cg_endo -64.51 -21.34 66.05 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 N-CA-C 108.196 -1.501 . . . . 1.0 108.196 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.564 ' CB ' ' O ' ' A' ' 129' ' ' PRO . 1.0 OUTLIER 155.92 -161.23 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.36 178.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 148.09 -44.77 0.76 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.404 -1.478 . . . . 1.0 109.404 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -155.66 114.24 3.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -1.124 . . . . 1.0 110.381 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.77 -63.24 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 1.0 110.222 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -100.55 76.76 1.86 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 1.0 110.508 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.709 HD13 ' CB ' ' A' ' 84' ' ' LEU . 1.1 tp -71.46 112.28 7.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.32 -0.862 . . . . 1.0 109.789 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 5.3 m-20 -79.22 127.13 31.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.895 . . . . 1.0 109.937 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 138' ' ' ASP . 0.7 OUTLIER -148.94 105.66 3.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 1.0 110.12 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.544 ' OD2' HD21 ' A' ' 38' ' ' LEU . 0.6 OUTLIER 163.3 -38.94 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.65 0.738 . . . . 1.0 109.07 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.566 ' N ' ' HD3' ' A' ' 61' ' ' LYS . . . -44.57 -32.88 3.03 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.175 -1.17 . . . . 1.0 110.175 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.715 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . . . -161.02 153.33 20.28 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.769 -1.43 . . . . 1.0 109.897 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.922 HD11 HD21 ' A' ' 57' ' ' LEU . 30.0 tp -155.73 152.8 28.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.337 -0.852 . . . . 1.0 110.519 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.753 ' CD2' ' HE1' ' A' ' 146' ' ' MET . 31.4 m95 -118.31 161.87 19.22 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.735 -1.209 . . . . 1.0 107.735 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.881 ' CD2' HD12 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -152.83 111.29 3.71 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.2 -1.8 . . . . 1.0 113.42 -177.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.555 ' O ' ' CA ' ' A' ' 162' ' ' GLY . . . 125.96 -11.18 7.38 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 110.127 -1.189 . . . . 1.0 110.127 177.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.553 ' HA2' ' CD2' ' A' ' 55' ' ' LEU . . . 158.2 -140.43 6.98 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 119.005 -1.569 . . . . 1.0 109.707 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.753 ' HE1' ' CD2' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -168.11 152.35 6.24 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.183 -1.007 . . . . 1.0 111.098 -179.362 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -96.58 -8.96 30.47 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.877 0.846 . . . . 1.0 109.513 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -141.64 53.03 1.51 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.315 -1.365 . . . . 1.0 107.315 178.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.043 HD21 HD22 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.82 57.17 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.267 0.556 . . . . 1.0 111.854 -178.115 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 148' ' ' ARG . 29.6 p -59.49 -22.53 61.72 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.79 -1.93 . . . . 1.0 105.79 176.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.811 HG13 ' N ' ' A' ' 152' ' ' ALA 0.289 9.8 p -76.92 -130.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-N 114.49 -1.232 . . . . 1.0 108.831 178.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.811 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 55.86 50.72 13.47 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 120.804 -1.185 . . . . 1.0 108.578 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.441 ' ND1' ' N ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER -52.58 -111.81 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 116.293 1.961 . . . . 1.0 116.293 -175.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 18.25 0.24 Allowed 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 113.944 1.09 . . . . 1.0 113.944 -175.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 1.102 HD22 ' CD2' ' A' ' 159' ' ' TYR . 5.1 tt -95.71 141.08 22.68 Favored Pre-proline 0 C--N 1.288 -2.089 0 O-C-N 120.858 -1.152 . . . . 1.0 110.499 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.895 ' O ' HD23 ' A' ' 155' ' ' LEU . 37.6 Cg_endo -62.05 -149.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.045 1.55 . . . . 1.0 111.327 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.1 OUTLIER -60.41 -10.42 4.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.837 -1.165 . . . . 1.0 112.869 -177.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 1.098 ' HB3' ' CD2' ' A' ' 155' ' ' LEU . . . -41.71 -35.35 0.76 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.814 -1.179 . . . . 1.0 109.428 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 1.102 ' CD2' HD22 ' A' ' 155' ' ' LEU . 32.4 m-85 -86.79 -31.99 20.59 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.744 -1.223 . . . . 1.0 108.928 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.531 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.3 OUTLIER -72.68 -5.88 40.62 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.436 -1.305 . . . . 1.0 108.0 177.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.705 HG22 ' CD1' ' A' ' 164' ' ' ILE . 33.4 m -122.23 90.26 3.27 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.666 ' O ' ' O ' ' A' ' 163' ' ' PHE . . . -57.06 106.87 0.8 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.057 -1.068 . . . . 1.0 110.562 -178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.929 ' HD1' HD11 ' A' ' 73' ' ' ILE . 89.5 t80 12.95 137.8 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.811 0 N-CA-C 115.761 1.763 . . . . 1.0 115.761 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.705 ' CD1' HG22 ' A' ' 161' ' ' THR . 2.2 mt -131.08 86.76 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 115.084 -0.962 . . . . 1.0 108.827 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 48' ' ' LYS . . . -171.18 -161.17 21.38 Favored Glycine 0 C--N 1.292 -1.883 0 N-CA-C 107.2 -2.36 . . . . 1.0 107.2 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.6 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.3 m -129.27 142.57 50.8 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.87 -1.371 . . . . 1.0 110.023 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.962 HD12 ' CE1' ' A' ' 19' ' ' PHE . 3.6 mt -128.24 157.89 40.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.402 -1.436 . . . . 1.0 112.285 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.576 ' HB3' ' CH2' ' A' ' 102' ' ' TRP . 0.3 OUTLIER -165.36 168.31 16.92 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.061 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.4 m-20 43.78 72.89 0.16 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.214 -0.929 . . . . 1.0 110.658 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 1.013 HG12 ' CB ' ' A' ' 45' ' ' LEU . 26.8 m -127.67 123.25 60.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 118.89 -1.124 . . . . 1.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.521 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -136.0 152.17 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.047 -1.061 . . . . 1.0 111.53 -177.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -133.8 103.35 5.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 174' ' ' ARG . 6.7 m-20 57.55 35.46 25.8 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.975 -1.121 . . . . 1.0 107.975 -177.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.52 ' CB ' ' O ' ' A' ' 173' ' ' ASP . 0.0 OUTLIER 75.0 6.34 4.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.828 -0.545 . . . . 1.0 111.088 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.847 ' HB2' HG23 ' A' ' 172' ' ' VAL . 77.8 mm-40 -91.18 176.39 6.6 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.143 -0.973 . . . . 1.0 110.105 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.563 ' CB ' ' O ' ' A' ' 175' ' ' GLN . 30.0 tt0 83.68 -109.66 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.471 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 175' ' ' GLN . 0.4 OUTLIER 29.97 40.96 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.304 -0.873 . . . . 1.0 112.499 -178.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 181' ' ' GLU . 2.3 m80 -160.89 44.5 0.18 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.994 -1.066 . . . . 1.0 110.597 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.985 ' O ' ' HB2' ' A' ' 183' ' ' ALA . 0.0 OUTLIER -52.17 -27.89 16.15 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.15 -1.056 . . . . 1.0 108.15 179.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 9.2 t -71.3 -35.23 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.12 0.486 . . . . 1.0 111.198 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 178' ' ' HIS . 51.0 mt-10 -62.16 -56.07 22.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.049 -1.032 . . . . 1.0 109.54 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.65 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -81.89 -19.7 40.36 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.086 179.008 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 1.023 ' HB1' HD11 ' A' ' 189' ' ' ILE . . . -48.14 -41.76 27.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.818 -1.153 . . . . 1.0 107.94 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 183' ' ' ALA . 3.4 mt -41.78 -26.3 0.08 Allowed 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.369 0.604 . . . . 1.0 109.598 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 182' ' ' ASP . 6.3 t-20 -62.8 -11.61 19.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.353 -0.842 . . . . 1.0 109.808 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 187' ' ' PRO . 0.5 OUTLIER -123.85 154.21 67.35 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.539 -0.725 . . . . 1.0 109.182 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.518 ' O ' ' ND2' ' A' ' 186' ' ' ASN . 37.3 Cg_endo -61.27 -162.49 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.671 1.353 . . . . 1.0 111.215 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 187' ' ' PRO . 4.8 m -40.74 134.56 1.83 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.21 -0.931 . . . . 1.0 111.263 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 1.023 HD11 ' HB1' ' A' ' 183' ' ' ALA . 3.1 mt -102.91 144.92 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.443 -0.785 . . . . 1.0 109.452 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.37 153.41 19.35 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.098 -1.001 . . . . 1.0 109.889 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.606 ' ND1' HD13 ' A' ' 17' ' ' ILE . 1.6 m-70 -112.68 152.25 29.23 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.289 -0.882 . . . . 1.0 109.618 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.57 ' SG ' ' HB2' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -105.77 119.98 40.53 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.424 -0.91 . . . . 1.0 109.974 179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 194' ' ' ALA . 20.5 m -121.73 165.36 15.92 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.984 -1.073 . . . . 1.0 110.909 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 193' ' ' SER . . . 173.15 91.26 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.477 -0.764 . . . . 1.0 110.048 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.297 -1.694 0 C-N-CA 118.743 -1.183 . . . . 1.0 110.47 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.549 -1.42 . . . . 1.0 109.549 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -162.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.363 -1.081 . . . . 1.0 110.36 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -99.94 85.73 3.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.899 . . . . 1.0 110.396 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -148.19 140.16 24.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.13 -0.982 . . . . 1.0 110.136 179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 5' ' ' VAL . 23.1 m -108.24 94.9 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 1.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 pt -70.59 143.94 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 1.0 110.334 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 7' ' ' ILE . 18.3 tt -125.62 87.93 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 1.0 110.201 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -43.63 130.15 5.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.115 -0.991 . . . . 1.0 110.184 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -126.34 152.96 45.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.134 -0.979 . . . . 1.0 110.061 179.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.22 143.26 48.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.267 -0.895 . . . . 1.0 110.362 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.98 81.71 7.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -0.902 . . . . 1.0 110.146 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.81 115.87 1.85 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.533 -1.427 . . . . 1.0 109.533 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -137.89 70.83 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.152 -1.205 . . . . 1.0 110.268 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.12 72.53 1.41 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 1.0 109.964 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' GLU . 4.9 pt-20 -130.58 109.95 11.05 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.245 -0.909 . . . . 1.0 110.154 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 191' ' ' HIS . . . -117.22 151.28 37.23 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.063 -1.023 . . . . 1.0 109.712 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 166' ' ' CYS . 7.0 mm -119.52 133.27 66.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.04 -1.037 . . . . 1.0 110.328 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HB2' ' HA ' ' A' ' 192' ' ' CYS . . . -91.49 124.15 35.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.658 -0.651 . . . . 1.0 110.431 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.751 ' CD2' HG21 ' A' ' 23' ' ' THR . 4.0 m-30 -91.1 132.69 35.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.178 -0.951 . . . . 1.0 109.209 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 22' ' ' ARG . 2.3 p30 -97.74 2.16 49.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.936 . . . . 1.0 110.545 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.411 ' O ' ' HA3' ' A' ' 162' ' ' GLY . . . 103.51 -22.8 34.84 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.506 -1.838 . . . . 1.0 108.506 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.449 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 5.3 ttt-85 -107.25 -8.1 16.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.634 -0.921 . . . . 1.0 109.672 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.751 HG21 ' CD2' ' A' ' 19' ' ' PHE . 14.9 t -48.08 174.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.43 -0.794 . . . . 1.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.64 ' CE1' ' HB2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER 179.86 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 1.0 109.104 -179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 142' ' ' TRP . 25.0 mtt -96.26 101.33 12.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.943 -1.098 . . . . 1.0 111.007 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.64 ' HB2' ' CE1' ' A' ' 24' ' ' TYR . 18.7 tt0 -93.39 121.97 35.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.347 -0.846 . . . . 1.0 109.481 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.612 ' CE2' ' CB ' ' A' ' 182' ' ' ASP . 6.2 m-85 -113.62 105.63 13.55 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.184 -0.947 . . . . 1.0 109.993 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.16 86.63 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 1.0 110.449 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -121.88 176.82 5.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.227 -0.92 . . . . 1.0 110.132 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -91.02 99.94 12.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.196 -0.94 . . . . 1.0 110.449 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 32' ' ' THR . 76.9 t -60.03 168.99 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.235 -0.915 . . . . 1.0 109.977 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.54 ' N ' HG12 ' A' ' 31' ' ' VAL . 6.0 p -126.94 -178.36 4.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.056 -1.028 . . . . 1.0 110.369 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -51.76 91.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.313 -0.867 . . . . 1.0 110.566 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' THR . 4.5 t -123.47 -19.22 5.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 1.0 110.311 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 36' ' ' LYS . 1.5 mt-10 -177.25 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 1.0 110.532 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 35' ' ' GLU . 23.5 ttpt 55.57 97.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.08 -1.013 . . . . 1.0 109.877 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 36' ' ' LYS . . . 43.28 70.59 0.29 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.253 -0.904 . . . . 1.0 109.311 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.789 ' H ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -72.38 -172.95 1.01 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.376 -0.827 . . . . 1.0 111.664 -178.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -119.25 9.26 11.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.517 -0.74 . . . . 1.0 109.345 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -161.61 131.26 4.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 5.0 m-80 -98.64 163.05 12.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.966 -1.084 . . . . 1.0 110.472 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -134.99 137.48 43.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 1.0 110.112 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.801 ' HB2' ' HB3' ' A' ' 107' ' ' ALA . 91.0 m-85 -143.13 119.61 11.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 1.0 110.387 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.81 ' C ' HD23 ' A' ' 45' ' ' LEU . 3.0 mt-10 -126.75 145.24 50.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.981 -1.074 . . . . 1.0 109.867 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.005 ' CB ' HG12 ' A' ' 170' ' ' VAL . 0.5 OUTLIER 179.08 156.4 0.5 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.401 -0.92 . . . . 1.0 111.412 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 103' ' ' THR . 4.8 m -122.13 154.99 36.66 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.612 -1.255 . . . . 1.0 107.612 177.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.571 HD13 HD11 ' A' ' 105' ' ' ILE . 3.3 pt -148.82 163.46 4.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 117.829 -1.548 . . . . 1.0 112.652 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.636 ' HE3' ' CD1' ' A' ' 102' ' ' TRP . 0.8 OUTLIER -114.3 83.31 1.86 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.503 -1.666 . . . . 1.0 106.503 177.241 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.569 HG22 ' HE1' ' A' ' 163' ' ' PHE . 0.0 OUTLIER -70.67 150.7 45.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.084 -1.01 . . . . 1.0 112.434 -176.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.651 ' CG ' ' O ' ' A' ' 164' ' ' ILE . 6.7 mm-40 -135.68 -3.12 2.35 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.35 0.595 . . . . 1.0 110.243 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -148.51 125.96 11.64 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.257 -0.902 . . . . 1.0 109.84 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.797 ' O ' HG22 ' A' ' 73' ' ' ILE . 47.5 p -55.51 -15.02 2.35 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.553 -0.717 . . . . 1.0 111.327 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -123.4 133.63 54.06 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.902 -1.124 . . . . 1.0 111.655 -178.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.546 ' HA2' ' O ' ' A' ' 161' ' ' THR . . . 157.9 134.74 1.78 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.159 -1.177 . . . . 1.0 110.159 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.74 HD13 ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -83.08 143.35 30.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.769 -1.43 . . . . 1.0 109.619 179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.781 HD11 ' CG1' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -111.81 -47.03 5.94 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.955 0 C-N-CA 119.741 -0.784 . . . . 1.0 111.762 -177.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.98 HD13 HD12 ' A' ' 71' ' ' LEU . 5.7 tt -134.58 145.14 48.4 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 120.278 -1.514 . . . . 1.0 113.031 -175.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.681 ' CH2' HG21 ' A' ' 151' ' ' VAL . 2.3 t-105 -149.68 117.12 6.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.414 -0.804 . . . . 1.0 109.041 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 p -127.22 -176.08 3.62 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.83 -1.169 . . . . 1.0 110.694 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 61' ' ' LYS . . . 125.05 10.44 4.71 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER 78.33 -37.18 0.21 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.497 -1.002 . . . . 1.0 110.817 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.718 ' C ' HD22 ' A' ' 63' ' ' LEU . . . 118.51 85.91 1.05 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.718 HD22 ' C ' ' A' ' 62' ' ' GLY . 3.4 mm? -114.51 156.56 24.37 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -1.164 . . . . 1.0 109.72 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' C ' ' HG2' ' A' ' 65' ' ' ARG . 7.5 mm-40 -62.48 -30.7 71.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 1.0 110.339 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HG2' ' C ' ' A' ' 64' ' ' GLU . 2.1 ptm180 178.13 43.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.678 0.752 . . . . 1.0 109.187 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -110.63 -167.72 1.22 Allowed 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.725 -0.79 . . . . 1.0 110.628 -178.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 83' ' ' ASP . 5.5 p-10 -40.31 133.21 1.87 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.388 -0.82 . . . . 1.0 110.829 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.671 ' CD1' ' CZ3' ' A' ' 58' ' ' TRP . 2.5 p90 -171.14 159.15 5.81 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.242 -0.911 . . . . 1.0 109.572 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.704 HD12 ' CZ ' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -147.56 136.16 15.42 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 121.68 -0.637 . . . . 1.0 110.059 179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.034 ' HB3' ' CE ' ' A' ' 81' ' ' MET . . . -132.87 -174.33 3.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.937 -1.102 . . . . 1.0 110.455 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.98 HD12 HD13 ' A' ' 57' ' ' LEU . 66.0 mt -149.0 101.14 3.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.341 -0.849 . . . . 1.0 108.722 -177.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.785 ' HB2' ' CZ ' ' A' ' 159' ' ' TYR . . . -119.38 174.41 6.38 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.957 -1.089 . . . . 1.0 112.211 -177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.797 HG22 ' O ' ' A' ' 52' ' ' THR . 56.3 mt -113.86 131.17 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.668 -0.645 . . . . 1.0 110.597 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.568 HG22 ' OD2' ' A' ' 75' ' ' ASP . 2.5 p -139.96 131.29 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.415 -0.803 . . . . 1.0 110.077 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.568 ' OD2' HG22 ' A' ' 74' ' ' VAL . 28.0 m-20 61.24 10.12 2.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.199 -0.938 . . . . 1.0 110.966 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.658 ' O ' HG22 ' A' ' 97' ' ' ILE . . . 95.19 9.36 58.16 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.959 -1.256 . . . . 1.0 109.959 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 78' ' ' VAL . 61.5 m-85 -133.32 108.46 8.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -1.095 . . . . 1.0 110.048 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.781 ' CG1' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -48.6 -175.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.77 0.795 . . . . 1.0 111.412 -178.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.675 ' HB2' HG22 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -172.9 124.28 0.44 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.672 0.749 . . . . 1.0 110.893 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.983 ' CE ' HD12 ' A' ' 91' ' ' LEU . 2.2 ttm -85.03 110.54 19.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.791 -0.568 . . . . 1.0 110.481 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 1.034 ' CE ' ' HB3' ' A' ' 70' ' ' ALA . 37.1 mtm -89.45 116.71 27.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.906 -1.121 . . . . 1.0 109.885 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.704 ' CZ ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -111.92 116.38 30.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.693 -1.255 . . . . 1.0 109.163 178.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 85' ' ' GLY . 0.3 OUTLIER -124.98 48.09 2.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 1.0 110.469 -179.156 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.745 ' HB3' HD13 ' A' ' 135' ' ' LEU . 0.4 OUTLIER -65.06 61.66 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.975 -0.69 . . . . 1.0 110.138 179.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . . . 132.4 33.09 0.41 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.956 -1.258 . . . . 1.0 109.956 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 85' ' ' GLY . 0.1 OUTLIER 73.01 9.69 5.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.237 -1.155 . . . . 1.0 110.107 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.492 ' HD2' ' O ' ' A' ' 130' ' ' LEU . 0.1 OUTLIER -108.0 89.32 5.4 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.334 -0.854 . . . . 1.0 109.333 179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.533 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 44.1 Cg_endo -72.11 140.81 35.03 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.157 1.609 . . . . 1.0 111.599 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.625 HG12 ' HB2' ' A' ' 82' ' ' TYR . 0.4 OUTLIER -137.12 119.14 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.135 -1.061 . . . . 1.0 108.135 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.675 HG22 ' HB2' ' A' ' 79' ' ' GLN . 1.0 OUTLIER -97.46 114.42 34.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 120.354 -1.466 . . . . 1.0 111.403 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.983 HD12 ' CE ' ' A' ' 80' ' ' MET . 38.3 mt -104.38 71.97 1.03 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.137 -1.431 . . . . 1.0 107.137 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' GLN . 51.1 mtp180 -57.33 178.58 0.07 Allowed 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.052 0.93 . . . . 1.0 111.046 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.758 ' OG ' HG21 ' A' ' 118' ' ' VAL . 3.3 t -108.35 155.21 20.8 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.175 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.626 ' OG1' HD11 ' A' ' 124' ' ' ILE . 1.4 p -112.11 26.38 10.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.143 -0.973 . . . . 1.0 109.673 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.752 ' CG1' HG11 ' A' ' 118' ' ' VAL . 8.0 t -129.07 146.62 61.49 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.519 -0.738 . . . . 1.0 109.454 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.575 ' HD2' HG13 ' A' ' 95' ' ' VAL . 43.6 Cg_endo -67.85 116.17 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.754 1.397 . . . . 1.0 109.767 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.8 tp -106.78 -33.36 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.14 -0.975 . . . . 1.0 111.055 -179.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -71.64 61.22 0.36 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.094 -1.004 . . . . 1.0 110.738 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.554 ' CG2' ' HB2' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -127.21 14.28 7.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 1.0 110.167 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.481 ' OD1' ' OE1' ' A' ' 50' ' ' GLU . 1.9 m120 58.63 40.88 23.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.995 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.554 ' HB2' ' CG2' ' A' ' 99' ' ' THR . 1.1 m-70 -132.11 159.14 39.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.933 -1.104 . . . . 1.0 110.172 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.636 ' CD1' ' HE3' ' A' ' 48' ' ' LYS . 22.2 m95 -78.87 101.37 7.65 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.292 -0.963 . . . . 1.0 109.729 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.588 HG22 ' N ' ' A' ' 104' ' ' HIS . 5.9 m -101.93 171.66 7.39 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.441 -0.904 . . . . 1.0 109.009 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.588 ' N ' HG22 ' A' ' 103' ' ' THR . 8.4 t60 -119.97 143.9 47.77 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.07 -1.019 . . . . 1.0 108.791 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.571 HD11 HD13 ' A' ' 47' ' ' ILE . 1.0 OUTLIER -133.67 159.17 42.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.22 -0.925 . . . . 1.0 109.172 -179.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.808 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -152.45 148.47 27.47 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.659 -1.217 . . . . 1.0 110.307 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.801 ' HB3' ' HB2' ' A' ' 43' ' ' PHE . . . -144.23 102.21 3.82 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.526 -0.733 . . . . 1.0 110.374 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.579 ' O ' ' CD2' ' A' ' 108' ' ' TYR . 37.1 p90 -117.07 105.48 12.33 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.261 -0.899 . . . . 1.0 108.689 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.668 ' HA ' ' HA2' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -91.44 150.87 21.05 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.655 -0.818 . . . . 1.0 111.225 -178.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 111' ' ' GLN . 75.7 t -136.93 96.51 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.679 -0.638 . . . . 1.0 110.799 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.582 ' O ' ' CD ' ' A' ' 112' ' ' ARG . 17.4 mt-30 43.74 107.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.662 -0.649 . . . . 1.0 111.779 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' A' ' 127' ' ' SER . 0.0 OUTLIER 54.2 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 113.636 0.976 . . . . 1.0 113.636 179.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.616 ' HA ' ' CB ' ' A' ' 127' ' ' SER . 1.8 tm-20 -95.97 109.75 22.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.108 -1.62 . . . . 1.0 109.919 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 109' ' ' ARG . . . -99.05 161.43 20.07 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 120.067 -1.063 . . . . 1.0 110.892 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 125' ' ' THR . 33.7 t -132.7 156.67 46.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.212 -1.17 . . . . 1.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.068 HD13 ' N ' ' A' ' 117' ' ' GLN . 2.1 tm? -140.09 151.51 45.41 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.242 -1.021 . . . . 1.0 108.242 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 1.068 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -150.52 144.59 25.44 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.888 -1.133 . . . . 1.0 111.514 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.758 HG21 ' OG ' ' A' ' 93' ' ' SER . 41.1 t -102.86 98.92 7.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 106.539 -1.652 . . . . 1.0 106.539 177.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 104' ' ' HIS . . . 69.21 39.52 82.65 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.715 -1.354 . . . . 1.0 109.715 -177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 119' ' ' GLY . 21.8 t-20 57.36 32.13 21.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -1.104 . . . . 1.0 110.52 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 118' ' ' VAL . 5.3 mt-10 -114.8 -158.11 0.66 Allowed 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.569 -0.707 . . . . 1.0 110.593 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.496 ' C ' ' O ' ' A' ' 121' ' ' GLU . . . -30.43 93.77 0.06 OUTLIER Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.936 -0.477 . . . . 1.0 110.576 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.515 ' N ' ' O ' ' A' ' 121' ' ' GLU . 44.9 Cg_endo -77.12 142.65 21.92 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.039 1.547 . . . . 1.0 112.012 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.66 ' N ' HD12 ' A' ' 124' ' ' ILE . 3.3 mp -108.53 100.69 11.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 107.684 -1.228 . . . . 1.0 107.684 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.613 HG22 ' OG ' ' A' ' 115' ' ' SER . 15.9 p -108.19 166.96 10.35 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.192 0.996 . . . . 1.0 111.962 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.7 167.76 38.88 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.222 -2.351 . . . . 1.0 107.222 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.616 ' CB ' ' HA ' ' A' ' 113' ' ' GLU . 0.7 OUTLIER -136.88 170.0 16.82 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.555 -1.556 . . . . 1.0 110.929 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 31.7 p -96.92 163.57 19.83 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.921 -1.112 . . . . 1.0 110.431 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.478 ' O ' ' O ' ' A' ' 130' ' ' LEU . 45.6 Cg_endo -71.65 55.62 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.954 1.502 . . . . 1.0 108.735 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.492 ' O ' ' HD2' ' A' ' 87' ' ' LYS . 4.7 mp 41.05 -164.5 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.637 -0.665 . . . . 1.0 110.056 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 99.29 10.57 47.87 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.005 -1.238 . . . . 1.0 110.005 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.523 ' CB ' HD12 ' A' ' 84' ' ' LEU . . . -133.58 145.54 50.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.113 -1.228 . . . . 1.0 109.867 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 133' ' ' THR . 34.5 m -137.52 13.94 2.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.089 -1.007 . . . . 1.0 110.676 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 133' ' ' THR . 1.7 mt-30 179.94 160.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 1.0 110.54 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.745 HD13 ' HB3' ' A' ' 84' ' ' LEU . 0.4 OUTLIER -166.08 61.1 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.485 -0.759 . . . . 1.0 109.893 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.436 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 4.2 m-20 -77.4 122.19 24.83 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.056 . . . . 1.0 109.439 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -122.77 164.23 18.73 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.971 -1.08 . . . . 1.0 110.877 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.819 ' OD2' ' HB2' ' A' ' 140' ' ' ALA . 20.4 p-10 -89.82 29.35 1.19 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -0.816 . . . . 1.0 110.204 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 52.29 18.09 4.64 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.11 -1.596 . . . . 1.0 109.11 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.819 ' HB2' ' OD2' ' A' ' 138' ' ' ASP . . . -64.34 158.76 22.67 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.143 -1.21 . . . . 1.0 109.072 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.745 HD12 ' N ' ' A' ' 142' ' ' TRP . 6.8 tp -158.47 144.06 16.68 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.446 -1.302 . . . . 1.0 112.481 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.745 ' N ' HD12 ' A' ' 141' ' ' LEU . 19.2 m95 -131.88 97.27 4.13 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 106.937 -1.505 . . . . 1.0 106.937 177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.952 HD12 HD12 ' A' ' 57' ' ' LEU . 2.8 tt -112.82 119.73 39.03 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.627 -1.295 . . . . 1.0 113.544 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 56' ' ' ILE . . . 128.67 3.74 5.45 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 176.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.517 ' O ' ' SD ' ' A' ' 146' ' ' MET . . . 145.91 -147.72 18.93 Favored Glycine 0 C--N 1.283 -2.378 0 N-CA-C 108.522 -1.831 . . . . 1.0 108.522 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . 0.732 ' CB ' HD22 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -151.64 113.13 4.37 Favored 'General case' 0 C--N 1.286 -2.181 0 C-N-CA 119.082 -1.047 . . . . 1.0 111.772 -178.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.64 -24.08 1.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.997 0.903 . . . . 1.0 109.025 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.555 ' HD2' ' N ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -145.68 83.47 1.65 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 178.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.732 HD22 ' CB ' ' A' ' 146' ' ' MET . 0.0 OUTLIER -71.58 22.84 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.275 -0.891 . . . . 1.0 112.757 -176.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.3 p -61.67 -19.68 62.6 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 106.266 -1.753 . . . . 1.0 106.266 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.768 HG13 ' N ' ' A' ' 152' ' ' ALA 0.288 10.5 p -71.51 -123.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.67 -1.15 . . . . 1.0 110.301 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.768 ' N ' HG13 ' A' ' 151' ' ' VAL . . . 72.1 -71.26 0.14 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.702 -1.249 . . . . 1.0 108.796 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.559 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER 52.94 155.26 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 122.919 1.342 . . . . 1.0 112.545 178.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.559 ' HG3' ' O ' ' A' ' 153' ' ' HIS . 0.0 OUTLIER 44.16 3.97 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 115.006 1.484 . . . . 1.0 115.006 178.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 1.087 ' O ' HD13 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -135.86 154.0 77.52 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.057 -1.652 . . . . 1.0 111.054 -179.387 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.654 ' N ' HD22 ' A' ' 155' ' ' LEU . 41.0 Cg_endo -65.62 -161.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.594 1.529 . . . . 1.0 113.629 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 0.0 OUTLIER -55.93 -8.88 0.49 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.988 ' HB3' HD21 ' A' ' 155' ' ' LEU . . . -39.85 -38.35 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.915 -1.116 . . . . 1.0 109.44 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.785 ' CZ ' ' HB2' ' A' ' 72' ' ' ALA . 10.2 m-85 -85.85 -31.6 22.16 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.855 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.534 ' HB2' ' HA ' ' A' ' 157' ' ' LYS . 0.5 OUTLIER -65.04 -11.04 34.82 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 117.952 -1.499 . . . . 1.0 108.243 177.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 161' ' ' THR . 1.2 m -122.27 98.94 6.16 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.487 -0.931 . . . . 1.0 108.487 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 161' ' ' THR . . . -49.82 -177.11 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.317 -1.113 . . . . 1.0 110.317 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.63 ' CZ ' ' HA3' ' A' ' 165' ' ' GLY . 32.8 t80 -88.79 145.5 25.57 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.119 -1.224 . . . . 1.0 111.575 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 164' ' ' ILE . 2.5 mt -123.42 85.39 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.139 -1.43 . . . . 1.0 107.139 177.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.63 ' HA3' ' CZ ' ' A' ' 163' ' ' PHE . . . -171.67 -156.13 11.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.316 -1.914 . . . . 1.0 108.316 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 47' ' ' ILE . 3.0 m -133.41 154.06 51.08 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.112 -1.228 . . . . 1.0 110.311 178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 19' ' ' PHE . 3.9 mt -134.76 144.96 33.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 120.074 -0.65 . . . . 1.0 109.774 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.519 ' HG2' ' N ' ' A' ' 169' ' ' ASP . 26.9 ttt180 -150.72 164.6 35.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.892 -1.13 . . . . 1.0 110.659 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 1.6 m-20 43.57 74.21 0.12 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.202 -0.936 . . . . 1.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 1.005 HG12 ' CB ' ' A' ' 45' ' ' LEU . 22.7 m -126.74 124.17 64.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 C-N-CA 119.311 -0.955 . . . . 1.0 109.891 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.527 HG13 ' C ' ' A' ' 170' ' ' VAL . 0.7 OUTLIER -131.95 158.25 43.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 118.929 -1.108 . . . . 1.0 111.331 -178.113 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 175' ' ' GLN . 76.5 t -134.15 114.11 18.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.703 -1.221 . . . . 1.0 107.703 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 63.3 m-20 50.01 36.58 12.14 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.878 -177.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 173' ' ' ASP . 0.7 OUTLIER 67.61 34.25 4.64 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.377 0.608 . . . . 1.0 110.411 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 172' ' ' VAL . 19.2 mm100 -114.45 -176.53 2.92 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 121.323 -0.861 . . . . 1.0 110.616 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 177' ' ' LEU . 0.3 OUTLIER 67.91 -98.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.451 -0.781 . . . . 1.0 110.66 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 176' ' ' GLU . 12.1 mt 60.37 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.894 -1.128 . . . . 1.0 111.477 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.536 ' HB3' ' HG3' ' A' ' 181' ' ' GLU . 2.6 m-70 -70.09 79.74 0.5 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.716 -1.24 . . . . 1.0 110.546 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.627 HD11 HG22 ' A' ' 170' ' ' VAL 0.263 0.5 OUTLIER -52.7 -61.23 2.42 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 122.201 1.001 . . . . 1.0 110.752 178.931 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.882 ' HA ' HD23 ' A' ' 184' ' ' LEU . 12.9 t -52.91 -18.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.632 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 178' ' ' HIS . 0.7 OUTLIER -73.63 -56.51 4.91 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.732 -1.187 . . . . 1.0 109.901 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.612 ' CB ' ' CE2' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -95.81 -18.38 20.43 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.099 -1.0 . . . . 1.0 109.8 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 179' ' ' LEU . . . -73.74 -29.92 62.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.144 -0.972 . . . . 1.0 108.703 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.882 HD23 ' HA ' ' A' ' 180' ' ' VAL . 1.5 mm? -65.06 -8.8 17.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.424 -0.798 . . . . 1.0 109.987 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 184' ' ' LEU . 8.5 t-20 -43.85 -26.43 0.26 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.391 -0.818 . . . . 1.0 109.095 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 189' ' ' ILE . 2.2 t-20 -113.9 148.89 40.89 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 186' ' ' ASN . 47.8 Cg_endo -76.97 -34.74 2.11 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 123.824 1.434 . . . . 1.0 110.68 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 4.51 0.42 Allowed 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.697 -0.683 . . . . 1.0 112.76 -178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 186' ' ' ASN . 23.4 mm -61.95 117.35 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.323 -1.485 . . . . 1.0 109.321 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 17' ' ' ILE . 12.3 mt -120.59 159.64 24.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 110.829 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 18.9 m-70 -93.54 151.55 19.62 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.344 -0.847 . . . . 1.0 110.552 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' CYS . . . . . 0.741 ' HA ' ' HB2' ' A' ' 18' ' ' ALA . 9.2 t -52.65 139.79 25.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.473 -0.767 . . . . 1.0 111.913 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.67 145.88 48.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.479 -0.763 . . . . 1.0 109.763 178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.37 96.99 1.09 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 1.0 110.566 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt . . . . . 0 C--N 1.295 -1.767 0 C-N-CA 118.952 -1.099 . . . . 1.0 110.466 179.086 . . . . . . . . 0 0 . 1 stop_ save_